PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Deevska, GM; Dotson, PP; Karakashian, AA; Isaac, G; Wrona, M; Kelly, SB; Merrill, AH; Nikolova-Karakashian, MN				Deevska, Gergana M.; Dotson, Patrick P., II; Karakashian, Alexander A.; Isaac, Giorgis; Wrona, Mark; Kelly, Samuel B.; Merrill, Alfred H., Jr.; Nikolova-Karakashian, Mariana N.			Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; RAT-LIVER MICROSOMES; DIACYLGLYCEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; DE-NOVO; QUANTITATIVE-ANALYSIS; MEMBRANE TOPOLOGY; GOLGI-APPARATUS; FATTY-ACIDS; CERAMIDE	This study investigates the consequences of elevating sphingomyelin synthase 1 (SMS1) activity, which generates the main mammalian sphingolipid, sphingomyelin. HepG2 cells stably transfected with SMS1 (HepG2-SMS1) exhibit elevated enzyme activity in vitro and increased sphingomyelin content ( mainly C22:0-and C24:0-sphingomyelin) but lower hexosylceramide (Hex-Cer) levels. HepG2-SMS1 cells have fewer triacylglycerols than controls but similar diacylglycerol acyltransferase activity, triacylglycerol secretion, and mitochondrial function. Treatment with 1mM palmitate increases de novo ceramide synthesis in both cell lines to a similar degree, causing accumulation of C16:0-ceramide (and some C18:0-,C20:0-, and C22: 0-ceramides) as well as C16: 0- and C18: 0- Hex-Cers. In these experiments, the palmitic acid is delivered as a complex with delipidated BSA(2:1,mol/mol) and does not induce significant lipotoxicity. Based on precursor labeling, the flux through SM synthase also increases, which is exacerbated in HepG2-SMS1 cells. In contrast, palmitate-induced lipid droplet formation is significantly reduced in HepG2-SMS1 cells. [C-14] Choline and [H-3] palmitate tracking shows that SMS1 overexpression apparently affects the partitioning of palmitate- enriched diacylglycerol between the phosphatidylcholine and triacylglycerol pathways, to the benefit of the former. Furthermore, triacylglycerols from HepG2-SMS1 cells are enriched in polyunsaturated fatty acids, which is indicative of active remodeling. Together, these results delineate novel metabolic interactions between glycerolipids and sphingolipids.	[Deevska, Gergana M.; Dotson, Patrick P., II; Karakashian, Alexander A.; Nikolova-Karakashian, Mariana N.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Isaac, Giorgis; Wrona, Mark] Waters Corp, Pharmaceut Discovery & Life Sci, Milford, MA 01757 USA; [Kelly, Samuel B.; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kelly, Samuel B.; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University of Kentucky; Waters Corporation; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Nikolova-Karakashian, MN (corresponding author), Chandler Med Ctr, MS513,800 Rose St, Lexington, KY 40536 USA.	mariana.karakashian@uky.edu	Wrona, Mark D/AAV-7476-2020	Wrona, Mark D/0000-0001-7172-1073	NCI [P30CA177558]; National Institutes of Health [P30CA177558]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019223] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. J. Holthuis (Utrecht University) for providing the SMS1 construct that was used as a reference and Dr. M. Mitov (University of Kentucky) for measuring the OCR in the Redox Metabolism Shared Resource Facility of the University of Kentucky Markey Cancer Center (supported by NCI, National Institutes of Health, Grant P30CA177558).	Abo-Hashema KAH, 1999, J BIOL CHEM, V274, P35577, DOI 10.1074/jbc.274.50.35577; Adada M, 2016, CHEM PHYS LIPIDS, V197, P45, DOI 10.1016/j.chemphyslip.2015.07.008; Bagnato C, 2003, J BIOL CHEM, V278, P52203, DOI 10.1074/jbc.M305760200; Bijl N, 2009, HEPATOLOGY, V50, P1431, DOI 10.1002/hep.23175; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; COLEMAN R, 1976, J BIOL CHEM, V251, P4537; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; De Clercq N., 2008, LIPID TECHNOL, V20, P232, DOI [10.1002/lite.200800060, DOI 10.1002/LITE.200800060]; DECLERCQ PE, 1984, J BIOL CHEM, V259, P9064; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Hanada K, 2010, P JPN ACAD B-PHYS, V86, P426, DOI 10.2183/pjab.86.426; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; KAHOVCOVA J, 1969, J CHROMATOGR, V40, P90, DOI 10.1016/S0021-9673(01)96622-1; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Leonardi R, 2009, J BIOL CHEM, V284, P27077, DOI 10.1074/jbc.M109.031336; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; LIPSKY NG, 1985, SCIENCE, V228, P745, DOI 10.1126/science.2581316; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Martinez L, 2015, ONCOTARGET, V6, P41479, DOI 10.18632/oncotarget.6286; Mehra VC, 2014, AM J PATHOL, V184, P1562, DOI 10.1016/j.ajpath.2014.01.009; MERRILL AH, 1995, J BIOL CHEM, V270, P13834, DOI 10.1074/jbc.270.23.13834; MERRILL AH, 1986, J BIOL CHEM, V261, P3764; Mora G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049269; Nikolova-Karakashian M, 2000, METHOD ENZYMOL, V311, P31; Osawa Y, 2011, FASEB J, V25, P1133, DOI 10.1096/fj.10-168351; Rojas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113929; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; Schmid PC, 1997, LIPIDS, V32, P1181, DOI 10.1007/s11745-997-0152-7; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; SPERRY WM, 1950, J BIOL CHEM, V187, P97; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; ULLMAN MD, 1974, J BIOL CHEM, V249, P1506; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; Waterman IJ, 2002, J LIPID RES, V43, P1555, DOI 10.1194/jlr.M200051-JLR200; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Wright MM, 2002, LIPIDS, V37, P663, DOI 10.1007/s11745-002-0947-6; Wurie HR, 2011, J BIOL CHEM, V286, P36238, DOI 10.1074/jbc.M111.251900; Yamaji T, 2015, TRAFFIC, V16, P101, DOI 10.1111/tra.12239; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200	49	12	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5110	5122		10.1074/jbc.M116.751602	http://dx.doi.org/10.1074/jbc.M116.751602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28087695	Green Published, hybrid			2022-12-28	WOS:000397590400030
J	Ano, Y; Dohata, A; Taniguchi, Y; Hoshi, A; Uchida, K; Takashima, A; Nakayama, H				Ano, Yasuhisa; Dohata, Atsushi; Taniguchi, Yoshimasa; Hoshi, Ayaka; Uchida, Kazuyuki; Takashima, Akihiko; Nakayama, Hiroyuki			Iso--acids, Bitter Components of Beer, Prevent Inflammation and Cognitive Decline Induced in a Mouse Model of Alzheimer's Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; inflammation; microglia; neuroinflammation; phagocytosis	PPAR-GAMMA AGONISTS; RECEPTOR-GAMMA; ALCOHOL-CONSUMPTION; THERAPEUTIC TARGET; MURINE MODEL; CD36; ISOHUMULONES; RESVERATROL; ALPHA; HOPS	Alongside the rapid growth in aging populations worldwide, prevention and therapy for age-related memory decline and dementia are in great demand to maintain a long, healthy life. Here we found that iso--acids, hop-derived bitter compounds in beer, enhance microglial phagocytosis and suppress inflammation via activation of the peroxisome proliferator-activated receptor . In normal mice, oral administration of iso--acids led to a significant increase both in CD11b and CD206 double-positive anti-inflammatory type microglia (p < 0.05) and in microglial phagocytosis in the brain. In Alzheimer's model 5xFAD mice, oral administration of iso--acids resulted in a 21% reduction in amyloid in the cerebral cortex as observed by immunohistochemical analysis, a significant reduction in inflammatory cytokines such as IL-1 and chemokines including macrophage inflammatory protein-1 in the cerebral cortex (p < 0.05) and a significant improvement in a novel object recognition test (p < 0.05), as compared with control-fed 5xFAD mice. The differences in iso--acid-fed mice were due to the induction of microglia to an anti-inflammatory phenotype. The present study is the first to report that amyloid deposition and inflammation are suppressed in a mouse model of Alzheimer's disease by a single component, iso--acids, via the regulation of microglial activation. The suppression of neuroinflammation and improvement in cognitive function suggests that iso--acids contained in beer may be useful for the prevention of dementia.	[Ano, Yasuhisa] Kirin Co Ltd, Res Labs Hlth Sci & Food Technol, Atsugi, Kanagawa 2360004, Japan; [Taniguchi, Yoshimasa; Hoshi, Ayaka] Kirin Co Ltd, Cent Labs Key Technol, Atsugi, Kanagawa 2360004, Japan; [Dohata, Atsushi; Uchida, Kazuyuki; Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Takashima, Akihiko] Natl Ctr Geriatr & Gerontol, Dept Neurobiol, Obu 4748511, Japan	University of Tokyo; National Center for Geriatrics & Gerontology	Ano, Y (corresponding author), Kirin Co Ltd, Res Labs Hlth Sci & Food Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	Yasuhisa_Ano@kirin.co.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Scientific Research on Innovation Area (Brain Protein Aging and Dementia control); Japan Agency for Medical Research and Development (AMED) DEMENTIA Research and Development Project [16dk0207026h0301]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Scientific Research on Innovation Area (Brain Protein Aging and Dementia control); Japan Agency for Medical Research and Development (AMED) DEMENTIA Research and Development Project(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-aid Project, Scientific Research on Innovation Area (Brain Protein Aging and Dementia control (to A. T.)) and by Japan Agency for Medical Research and Development (AMED) DEMENTIA Research and Development Project 16dk0207026h0301 (to A. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abumrad NA, 2005, J CLIN INVEST, V115, P2965, DOI 10.1172/JCI26955; Agarwal S., 2016, BIOCH BIOPH IN PRESS; Ano Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118512; Arntzen KA, 2010, ACTA NEUROL SCAND, V122, P23, DOI 10.1111/j.1600-0404.2010.01371.x; Ballesteros I, 2014, J LEUKOCYTE BIOL, V95, P587, DOI 10.1189/jlb.0613326; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cho YC, 2010, INT IMMUNOPHARMACOL, V10, P556, DOI 10.1016/j.intimp.2010.02.002; Horvat P, 2015, NEUROLOGY, V84, P287, DOI 10.1212/WNL.0000000000001164; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Li XW, 2015, AM J PATHOL, V185, P230, DOI 10.1016/j.ajpath.2014.09.016; Lynes MD, 2011, LIFE SCI, V88, P384, DOI 10.1016/j.lfs.2010.12.015; Matsui Toshifumi, 2011, Nihon Rinsho, V69 Suppl 10 Pt 2, P217; Modi KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130398; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; Namikoshi T, 2007, HYPERTENS RES, V30, P175, DOI 10.1291/hypres.30.175; Neafsey EJ, 2011, NEUROPSYCH DIS TREAT, V7, P465, DOI 10.2147/NDT.S23159; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Obara K, 2009, CLIN NUTR, V28, P278, DOI 10.1016/j.clnu.2009.03.012; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Panigrahy D, 2005, CANCER BIOL THER, V4, P687, DOI 10.4161/cbt.4.7.2014; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Porquet D, 2014, J ALZHEIMERS DIS, V42, P1209, DOI 10.3233/JAD-140444; Samovski D, 2015, DIABETES, V64, P353, DOI 10.2337/db14-0582; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Schmidt MV, 2010, THESCIENTIFICWORLDJO, V10, P2181, DOI 10.1100/tsw.2010.213; Sundaresan S, 2015, J NUTR, V145, P2195, DOI 10.3945/jn.115.215483; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Taniguchi Y, 2013, J AGR FOOD CHEM, V61, P3121, DOI 10.1021/jf3047187; Vidavalur Ramesh, 2006, Exp Clin Cardiol, V11, P217; Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014; Yajima H, 2005, INT J OBESITY, V29, P991, DOI 10.1038/sj.ijo.0802965; Yajima H, 2004, J BIOL CHEM, V279, P33456, DOI 10.1074/jbc.M403456200; Yu Y, 2015, CELL MOL NEUROBIOL, V35, P71, DOI 10.1007/s10571-014-0101-6	39	57	60	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3720	3728		10.1074/jbc.M116.763813	http://dx.doi.org/10.1074/jbc.M116.763813			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28087694	Green Published, hybrid			2022-12-28	WOS:000395542500015
J	Cheng, ZS; Landry, AP; Wang, YM; Ding, HE				Cheng, Zishuo; Landry, Aaron P.; Wang, Yiming; Ding, Huangen			Binding of Nitric Oxide in CDGSH-type [2Fe-2S] Clusters of the Human Mitochondrial Protein Miner2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						EPR; iron-sulfur protein; mitochondria; mitochondrial disease; mitochondrial metabolism; nitric oxide; Miner2; mitoNEET	DINITROSYL-IRON COMPLEXES; ZINC-FINGER PROTEIN; ESCHERICHIA-COLI; MEMBRANE PROTEIN; CRYSTAL-STRUCTURE; SULFUR CLUSTERS; HUMAN MITONEET; DIHYDROXYACID DEHYDRATASE; 4FE-4S CLUSTER; BREAST-CANCER	Iron-sulfur proteins are among the primary targets of nitric oxide in cells. Previous studies have shown that iron-sulfur clusters hosted by cysteine residues in proteins are readily disrupted by nitric oxide forming a protein-bound dinitrosyl iron complex, thiolate-bridged di-iron tetranitrosyl complex, or octanitrosyl cluster. Here we report that human mitochondrial protein Miner2 [2Fe-2S] clusters can bind nitric oxide without disruption of the clusters. Miner2 is a member of a new CDGSH iron-sulfur protein family that also includes two mitochondrial proteins: the type II diabetes-related mitoNEET and the Wolfram syndrome 2-linked Miner1. Miner2 contains two CDGSH motifs, and each CDGSH motif hosts a [2Fe-2S] cluster via three cysteine and one histidine residues. Binding of nitric oxide in the reduced Miner2 [2Fe-2S] clusters produces a major absorption peak at 422 nm without releasing iron or sulfide from the clusters. The EPR measurements and mass spectrometry analyses further reveal that nitric oxide binds to the reduced [2Fe-2S] clusters in Miner2, with each cluster binding one nitric oxide. Although the [2Fe-2S] cluster in purified human mitoNEET and Miner1 fails to bind nitric oxide, a single mutation of Asp-96 to Val in mitoNEET or Asp-123 to Val in Miner1 facilitates nitric oxide binding in the [2Fe-2S] cluster, indicating that a subtle change of protein structure may switch mitoNEET and Miner1 to bind nitric oxide. The results suggest that binding of nitric oxide in the CDGSH-type [2Fe-2S] clusters in mitochondrial protein Miner2 may represent a new nitric oxide signaling mode in cells.	[Cheng, Zishuo; Landry, Aaron P.; Wang, Yiming; Ding, Huangen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ding, HE (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	hding@lsu.edu	Ding, Huangen/AAJ-8550-2020; Cheng, Zishuo/U-6010-2017; Cheng, Zishuo/AAD-6861-2020	Ding, Huangen/0000-0002-4815-7336; 	National Institutes of Health [R15GM109399]; American Heart Association [13GRNT16890014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM109399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health Grant R15GM109399 and American Heart Association Grant 13GRNT16890014. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Bai F, 2015, P NATL ACAD SCI USA, V112, P3698, DOI 10.1073/pnas.1502960112; Bak DW, 2013, BIOCHEMISTRY-US, V52, P4687, DOI 10.1021/bi400540m; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Brown GC, 2007, FRONT BIOSCI-LANDMRK, V12, P1024, DOI 10.2741/2122; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; Crack JC, 2015, J BIOL CHEM, V290, P12689, DOI 10.1074/jbc.M115.643072; Crack JC, 2014, ACCOUNTS CHEM RES, V47, P3196, DOI 10.1021/ar5002507; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Dicus MM, 2010, J AM CHEM SOC, V132, P2037, DOI 10.1021/ja909359g; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Duan XW, 2009, BIOCHEM J, V417, P783, DOI 10.1042/BJ20081423; Fitzpatrick J, 2015, ACCOUNTS CHEM RES, V48, P2453, DOI 10.1021/acs.accounts.5b00246; Golinelli-Cohen MP, 2016, J BIOL CHEM, V291, P7583, DOI 10.1074/jbc.M115.711218; Grabarczyk DB, 2014, J AM CHEM SOC, V136, P11236, DOI 10.1021/ja505291j; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Huang LX, 1999, BIOCHEMISTRY-US, V38, P1912, DOI 10.1021/bi981954t; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Iwasaki T, 2009, J AM CHEM SOC, V131, P13659, DOI 10.1021/ja903228w; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Kusminski CM, 2016, DIABETES, V65, P1534, DOI 10.2337/db15-1323; Landry AP, 2017, FREE RADICAL BIO MED, V102, P240, DOI 10.1016/j.freeradbiomed.2016.12.001; Landry AP, 2015, FREE RADICAL BIO MED, V81, P119, DOI 10.1016/j.freeradbiomed.2015.01.017; Landry AP, 2014, J BIOL CHEM, V289, P4307, DOI 10.1074/jbc.M113.542050; Landry AP, 2011, FREE RADICAL BIO MED, V50, P1582, DOI 10.1016/j.freeradbiomed.2011.03.005; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Lin JZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024790; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Partridge JD, 2009, MOL MICROBIOL, V73, P680, DOI 10.1111/j.1365-2958.2009.06799.x; Ren BB, 2008, MOL MICROBIOL, V70, P953, DOI 10.1111/j.1365-2958.2008.06464.x; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shimberg GD, 2016, P NATL ACAD SCI USA, V113, P4700, DOI 10.1073/pnas.1517620113; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Tamir S, 2015, BBA-MOL CELL RES, V1853, P1294, DOI 10.1016/j.bbamcr.2014.10.014; Tinberg CE, 2010, J AM CHEM SOC, V132, P18168, DOI 10.1021/ja106290p; Tonzetich ZJ, 2009, J AM CHEM SOC, V131, P7964, DOI 10.1021/ja9030159; Tsai ML, 2015, ACCOUNTS CHEM RES, V48, P1184, DOI 10.1021/ar500459j; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wu G, 2015, BIOCHEMISTRY-US, V54, P7098, DOI 10.1021/acs.biochem.5b00994; Yang JJ, 2010, FREE RADICAL BIO MED, V49, P268, DOI 10.1016/j.freeradbiomed.2010.04.012; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	48	17	17	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3146	3153		10.1074/jbc.M116.766774	http://dx.doi.org/10.1074/jbc.M116.766774			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082676	Green Published, hybrid			2022-12-28	WOS:000395538800008
J	Martin, M; Hua, LQ; Wang, BL; Wei, H; Prabhu, L; Hartley, AV; Jiang, GL; Liu, YL; Lu, T				Martin, Matthew; Hua, Laiqing; Wang, Benlian; Wei, Han; Prabhu, Lakshmi; Hartley, Antja-Voy; Jiang, Guanglong; Liu, Yunlong; Lu, Tao			Novel Serine 176 Phosphorylation of YBX1 Activates NF-B in Colon Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						colon cancer; NF-B; phosphorylation; posttranslational modification (PTM); serine; YBX1	BOX-BINDING PROTEIN-1; KAPPA-B; BREAST-CANCER; KINASE CK2; P65 SUBUNIT; YB-1; RECEPTOR; GROWTH; BINDING-PROTEIN-1; MARKER	Y box protein 1 (YBX1) is a well known oncoprotein that has tumor-promoting functions. YBX1 is widely considered to be an attractive therapeutic target in cancer. To develop novel therapeutics to target YBX1, it is of great importance to understand how YBX1 is finely regulated in cancer. Previously, we have shown that YBX1 could function as a tumor promoter through phosphorylation of its Ser-165 residue, leading to the activation of the NF-B signaling pathway (1). In this study, using mass spectrometry analysis, we discovered a distinct phosphorylation site, Ser-176, on YBX1. Overexpression of the YBX1-S176A (serine-to-alanine) mutant in either HEK293 cells or colon cancer HT29 cells showed dramatically reduced NF-B-activating ability compared with that of WT-YBX1, confirming that Ser-176 phosphorylation is critical for the activation of NF-B by YBX1. Importantly, the mutant of Ser-176 and the previously reported Ser-165 sites regulate distinct groups of NF-B target genes, suggesting the unique and irreplaceable function of each of these two phosphorylated serine residues. Our important findings could provide a novel cancer therapy strategy by blocking either Ser-176 or Ser-165 phosphorylation or both of YBX1 in colon cancer.	[Martin, Matthew; Hua, Laiqing; Wei, Han; Prabhu, Lakshmi; Hartley, Antja-Voy; Lu, Tao] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr, Indianapolis, IN 46202 USA; [Lu, Tao] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Jiang, Guanglong; Liu, Yunlong; Lu, Tao] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Case Western Reserve University	Lu, T (corresponding author), Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	lut@iupui.edu	Jiang, Guanglong/N-5980-2019; Prabhu, Lakshmi/AAK-8659-2020	Prabhu, Lakshmi/0000-0002-2093-1115	American Cancer Society [4186265]; V Foundation Kay Yow Cancer Fund [068058-00002B]; Showalter Trust Fund [4486233]; Biomedical Research Grant [2286229]	American Cancer Society(American Cancer Society); V Foundation Kay Yow Cancer Fund; Showalter Trust Fund; Biomedical Research Grant	This work was supported by Grants 4186265 (to T. L.) from the American Cancer Society, 068058-00002B (to T. L.) from the V Foundation Kay Yow Cancer Fund, and 4486233 (to T. L.) from the Showalter Trust Fund, as well as Biomedical Research Grant 2286229 (to T. L.). The authors declare that they have no conflicts of interest with the contents of this article.	BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Caffarel MM, 2014, J PATHOL, V232, P386, DOI 10.1002/path.4305; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Filhol O, 2015, CELL MOL LIFE SCI, V72, P3305, DOI 10.1007/s00018-015-1929-8; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Garaud S, 2015, IMMUNOL CELL BIOL, V93, P425, DOI 10.1038/icb.2015.39; Gopal SK, 2015, ONCOTARGET, V6, P13718, DOI 10.18632/oncotarget.3764; Hagan CR, 2013, NUCLEIC ACIDS RES, V41, P8926, DOI 10.1093/nar/gkt706; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hirner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029709; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kuwano M, 2004, MOL CANCER THER, V3, P1485; Lasham A, 2013, BIOCHEM J, V449, P11, DOI 10.1042/BJ20121323; Li XL, 2014, J BIOL CHEM, V289, P11927, DOI 10.1074/jbc.M113.539965; Lu T, 2004, CELL CYCLE, V3, P1114; Lu T, 2015, CANCER RES, V75, P3692, DOI 10.1158/0008-5472.CAN-15-1022; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Lu T, 2009, P NATL ACAD SCI USA, V106, P16339, DOI 10.1073/pnas.0908560106; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Montenarh M, 2014, ADV CLIN EXP MED, V23, P153, DOI 10.17219/acem/37040; Narayan S, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0311-2; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Prabhu L, 2015, GENES DIS, V2, P240, DOI 10.1016/j.gendis.2015.05.001; Prabhu L, 2015, ONCOTARGET, V6, P29396, DOI 10.18632/oncotarget.5120; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Ryan SL, 2012, ACTA NEUROPATHOL, V123, P501, DOI 10.1007/s00401-011-0923-y; Shibao K, 1999, INT J CANCER, V83, P732; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Wang BL, 2015, J BIOL CHEM, V290, P20336, DOI 10.1074/jbc.M115.639849; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Zheng Y, 2013, CLIN CANCER RES, V19, P6484, DOI 10.1158/1078-0432.CCR-13-0265	41	43	43	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3433	3444		10.1074/jbc.M116.740258	http://dx.doi.org/10.1074/jbc.M116.740258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28077578	hybrid, Green Published			2022-12-28	WOS:000395538800032
J	Zhong, XZ; Zou, YJ; Sun, X; Dong, GF; Cao, Q; Pandey, A; Rainey, JK; Zhu, XJ; Dong, XP				Zhong, Xi Zoe; Zou, Yuanjie; Sun, Xue; Dong, Gaofeng; Cao, Qi; Pandey, Aditya; Rainey, Jan K.; Zhu, Xiaojuan; Dong, Xian-Ping			Inhibition of Transient Receptor Potential Channel Mucolipin-1 (TRPML1) by Lysosomal Adenosine Involved in Severe Combined Immunodeficiency Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenosine; calcium; calcium channel; lysosome; trafficking; TRPML1; lysosomal Ca2+	EQUILIBRATIVE NUCLEOSIDE TRANSPORTER-3; HUMAN FIBROBLAST LYSOSOMES; PLASMA-MEMBRANE REPAIR; DEAMINASE DEFICIENCY; FUNCTIONAL-CHARACTERIZATION; STORAGE DISEASES; CATION CHANNELS; GENE-THERAPY; LUMINAL PH; CA2+	Impaired adenosine homeostasis has been associated with numerous human diseases. Lysosomes are referred to as the cellular recycling centers that generate adenosine by breaking down nucleic acids or ATP. Recent studies have suggested that lysosomal adenosine overload causes lysosome defects that phenocopy patients with mutations in transient receptor potential channel mucolipin-1 (TRPML1), a lysosomal Ca2+ channel, suggesting that lysosomal adenosine overload may impair TRPML1 and then lead to subsequent lysosomal dysfunction. In this study, we demonstrate that lysosomal adenosine is elevated by deleting adenosine deaminase (ADA), an enzyme responsible for adenosine degradation. We also show that lysosomal adenosine accumulation inhibits TRPML1, which is rescued by overexpressing ENT3, the adenosine transporter situated in the lysosome membrane. Moreover, ADA deficiency results in lysosome enlargement, alkalinization, and dysfunction. These are rescued by activating TRPML1. Importantly, ADA-deficient B-lymphocytes are more vulnerable to oxidative stress, and this was rescued by TRPML1 activation. Our data suggest that lysosomal adenosine accumulation impairs lysosome function by inhibiting TRPML1 and subsequently leads to cell death in B-lymphocytes. Activating TRPML1 could be a new therapeutic strategy for those diseases.	[Zhong, Xi Zoe; Zou, Yuanjie; Sun, Xue; Dong, Gaofeng; Cao, Qi; Dong, Xian-Ping] Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada; [Pandey, Aditya; Rainey, Jan K.] Dalhousie Univ, Dept Biochem & Mol Biol, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada; [Sun, Xue; Zhu, Xiaojuan] Northeast Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun 130024, Jilin, Peoples R China; [Rainey, Jan K.] Dalhousie Univ, Dept Chem, 6274 Coburg Rd, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Northeast Normal University - China; Dalhousie University	Dong, XP (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada.	xpdong@dal.ca	Rainey, Jan K/C-1927-2008	Rainey, Jan K/0000-0003-0793-5573; Pandey, Aditya/0000-0002-7549-985X; Dong, Xianping/0000-0002-4496-7104	Department of Physiology and Biophysics, Dalhousie University; Dalhousie Medical Research Foundation (DMRF); DMRF; Canadian Institutes of Health Research (CIHR) [MOP-119349]; CIHR [201109MSH-261462-208625, MSH-122807]; Nova Scotia Health Research Foundation [MED-PRO-2011-7485]; Canada Foundation for Innovation Leaders Opportunity Fund [29291]; Natural Sciences and Engineering Research Council of Canada	Department of Physiology and Biophysics, Dalhousie University; Dalhousie Medical Research Foundation (DMRF); DMRF; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by start-up funds (to X.-P. D.) from the Department of Physiology and Biophysics, Dalhousie University; a Dalhousie Medical Research Foundation (DMRF) equipment grant; a DMRF new investigator award; Canadian Institutes of Health Research (CIHR) Grant MOP-119349; CIHR New Investigator Awards 201109MSH-261462-208625 (to X.-P. D.) and MSH-122807 (to J. K. R.); Nova Scotia Health Research Foundation Establishment Grant MED-PRO-2011-7485; Canada Foundation for Innovation Leaders Opportunity Fund-Funding for Research Infrastructure Grant 29291; and a Natural Sciences and Engineering Research Council of Canada research tools and instruments grant (to J. K. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Apasov SG, 2001, J CLIN INVEST, V108, P131, DOI 10.1172/JCI10360; ARSENIS C, 1970, J BIOL CHEM, V245, P205; Bach G, 1999, CLIN CHIM ACTA, V280, P173, DOI 10.1016/S0009-8981(98)00183-1; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Cao Q, 2015, DEV CELL, V33, P427, DOI 10.1016/j.devcel.2015.04.010; Cao Q, 2014, J BIOL CHEM, V289, P23189, DOI 10.1074/jbc.M114.567107; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; COHEN A, 1978, P NATL ACAD SCI USA, V75, P472, DOI 10.1073/pnas.75.1.472; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Haggie PM, 2009, J BIOL CHEM, V284, P7681, DOI 10.1074/jbc.M809161200; HEYDRICK SJ, 1991, J BIOL CHEM, V266, P8790; HIRSCHHORN R, 1991, AM J HUM GENET, V49, P878; Hsu CL, 2012, SCIENCE, V335, P89, DOI 10.1126/science.1213682; Huang P, 2014, J BIOL CHEM, V289, P17658, DOI 10.1074/jbc.M114.552158; Huynh C, 2004, P NATL ACAD SCI USA, V101, P16795, DOI 10.1073/pnas.0405905101; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200; LINDLEY ER, 1993, BIOCHEM J, V290, P457, DOI 10.1042/bj2900457; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mohsenin A, 2006, CURR OPIN PULM MED, V12, P54, DOI 10.1097/01.mcp.0000199002.46038.cb; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Obata T, 2002, LIFE SCI, V71, P2083, DOI 10.1016/S0024-3205(02)01993-8; Parkinson K, 2014, NAT CELL BIOL, V16, P87, DOI 10.1038/ncb2887; PISONI RL, 1989, J BIOL CHEM, V264, P4850; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Puntambekar P, 2004, J NEUROSCI, V24, P3663, DOI 10.1523/JNEUROSCI.4773-03.2004; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Ribeiro JA, 2002, PROG NEUROBIOL, V68, P377, DOI 10.1016/S0301-0082(02)00155-7; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Sauer AV, 2009, CURR OPIN ALLERGY CL, V9, P496, DOI 10.1097/ACI.0b013e3283327da5; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Shin K, 2013, FEBS OPEN BIO, V3, P328, DOI 10.1016/j.fob.2013.08.001; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Sun T, 2011, AUTOPHAGY, V7, P1308, DOI 10.4161/auto.7.11.17759; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	59	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3445	3455		10.1074/jbc.M116.743963	http://dx.doi.org/10.1074/jbc.M116.743963			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28087698	hybrid, Green Published			2022-12-28	WOS:000395538800033
J	Bigarella, CL; Li, JF; Rimmele, P; Liang, R; Sobol, RW; Ghaffari, S				Bigarella, Carolina L.; Li, Jianfeng; Rimmele, Pauline; Liang, Raymond; Sobol, Robert W.; Ghaffari, Saghi			FOXO3 Transcription Factor Is Essential for Protecting Hematopoietic Stem and Progenitor Cells from Oxidative DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; INDUCED APOPTOSIS; STRESS; XRCC1; MAINTENANCE; PATHWAY; PHOSPHORYLATION; DIFFERENTIATION; HOMEOSTASIS; INHIBITION	Accumulation of damaged DNA in hematopoietic stem cells (HSC) is associated with chromosomal abnormalities, genomic instability, and HSC aging and might promote hematological malignancies with age. Despite this, the regulatory pathways implicated in the HSC DNA damage response have not been fully elucidated. One of the sources of DNA damage is reactive oxygen species (ROS) generated by both exogenous and endogenous insults. Balancing ROS levels in HSC requires FOXO3, which is an essential transcription factor for HSC maintenance implicated in HSC aging. Elevated ROS levels result in defective Foxo3(-/-) HSC cycling, among many other deficiencies. Here, we show that loss of FOXO3 leads to the accumulation of DNA damage in primitive hematopoietic stem and progenitor cells (HSPC), associated specifically with reduced expression of genes implicated in the repair of oxidative DNA damage. We provide further evidence that Foxo3(-/-) HSPC are defective in DNAdamage repair. Specifically, we show that the base excision repair pathway, the main pathway utilized for the repair of oxidative DNA damage, is compromised in Foxo3(-/-) primitive hematopoietic cells. Treating mice in vivo withN-acetylcysteine reduces ROS levels, rescues HSC cycling defects, and partially mitigates HSPC DNA damage. These results indicate that DNA damage accrued as a result of elevated ROS in Foxo3(-/-) mutant HSPC is at least partially reversible. Collectively, our findings suggest that FOXO3 serves as a protector of HSC genomic stability and health.	[Bigarella, Carolina L.; Rimmele, Pauline; Liang, Raymond; Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA; [Li, Jianfeng; Sobol, Robert W.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Liang, Raymond; Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Dev & Stem Cell Biol Multidisciplinary Training A, New York, NY 10029 USA; [Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Oncol, New York, NY 10029 USA; [Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Ghaffari, Saghi] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; University of South Alabama; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ghaffari, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA.	saghi.ghaffari@mssm.edu	Sobol, Robert W./E-4125-2013	Sobol, Robert W./0000-0001-7385-3563	National Institutes of Health [CA148629, ES025138, CA205975, HL116365, T32 GM08553-13]; Myeloproliferative Neoplasm Foundation; Tisch Cancer Institute; American Society of Hematology; Roche Translational and Clinical Research Center; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA148629, R01CA205975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R43ES025138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myeloproliferative Neoplasm Foundation; Tisch Cancer Institute; American Society of Hematology; Roche Translational and Clinical Research Center; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grants CA148629 and ES025138 (to R.W.S.) and CA205975 and HL116365, Myeloproliferative Neoplasm Foundation, Tisch Cancer Institute, and American Society of Hematology (to S.G.). R.W.S. is a scientific consultant for Trevigen, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a Roche Translational and Clinical Research Center-Young Investigator award.; Supported by National Institutes of Health Grant T32 GM08553-13 and an American Heart Association fellowship.	Ahn JS, 2016, ONCOGENE, V35, P2235, DOI 10.1038/onc.2015.285; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Bigarella C., 2013, BLOOD, V122, P4199; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Brenkman AB, 2010, FASEB J, V24, P4271, DOI 10.1096/fj.10-158717; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15; Chapuis N, 2010, BLOOD, V116, P4240, DOI 10.1182/blood-2009-12-260711; COMMONER B, 1954, NATURE, V174, P689, DOI 10.1038/174689a0; Eijkelenboom A, 2013, CELL REP, V5, P1664, DOI 10.1016/j.celrep.2013.11.031; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Ghosh S, 2015, NEUROBIOL AGING, V36, P2319, DOI 10.1016/j.neurobiolaging.2015.04.004; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Gu TL, 2004, BLOOD, V103, P4622, DOI 10.1182/blood-2003-03-0820; Hillion J, 1997, BLOOD, V90, P3714, DOI 10.1182/blood.V90.9.3714; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Janik J, 2011, MUTAT RES-FUND MOL M, V709-10, P21, DOI 10.1016/j.mrfmmm.2011.02.009; Kuo LJ, 2008, IN VIVO, V22, P305; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Li J, 2010, BLOOD, V115, P1545, DOI 10.1182/blood-2009-07-234385; Li XL, 2015, J BIOL CHEM, V290, P2715, DOI 10.1074/jbc.M114.619536; Liang R, 2016, CELL CYCLE, V15, P861, DOI 10.1080/15384101.2015.1123355; Liang R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005526; Liang R, 2014, ANTIOXID REDOX SIGN, V20, P1902, DOI 10.1089/ars.2013.5300; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Marty C, 2013, LEUKEMIA, V27, P2187, DOI 10.1038/leu.2013.102; Mehta A, 2015, IMMUNITY, V42, P1021, DOI 10.1016/j.immuni.2015.05.017; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Muslimovic A, 2008, NAT PROTOC, V3, P1187, DOI 10.1038/nprot.2008.93; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Pellicano F, 2014, STEM CELLS, V32, P2324, DOI 10.1002/stem.1748; Rimmele P, 2014, STEM CELL R IN PRESS, V3, P1, DOI DOI 10.1016/J.STEMCR.2014.04.015; Rimmele P, 2015, EMBO REP, V16, P1164, DOI 10.15252/embr.201439704; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Santamaria CM, 2009, LEUKEMIA RES, V33, P1706, DOI 10.1016/j.leukres.2009.04.024; Santo EE, 2016, CELL CYCLE, V15, P879, DOI 10.1080/15384101.2016.1151721; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Scheijen B, 2004, ONCOGENE, V23, P3338, DOI 10.1038/sj.onc.1207456; Svilar D, 2012, JOVE-J VIS EXP, DOI 10.3791/4168; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Vandenberg CJ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.396; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292; Zhang X, 2014, AM J HEMATOL, V89, P954, DOI 10.1002/ajh.23786; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhang X, 2011, CURR DRUG TARGETS, V12, P1267, DOI 10.2174/138945011796150325	55	36	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3005	3015		10.1074/jbc.M116.769455	http://dx.doi.org/10.1074/jbc.M116.769455			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	27994057	hybrid, Green Published			2022-12-28	WOS:000395535100039
J	Das, D; Faridounnia, M; Kovacic, L; Kaptein, R; Boelens, R; Folkers, GE				Das, Devashish; Faridounnia, Maryam; Kovacic, Lidija; Kaptein, Robert; Boelens, Rolf; Folkers, Gert E.			Single-stranded DNA Binding by the Helix-Hairpin-Helix Domain of XPF Protein Contributes to the Substrate Specificity of the ERCC1-XPF Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HOLLIDAY JUNCTION RESOLVASE; FACIO-SKELETAL SYNDROME; PIGMENTOSUM GROUP-F; XERODERMA-PIGMENTOSUM; XPF-ERCC1 COMPLEX; COCKAYNE-SYNDROME; NUCLEAR ABNORMALITIES; SEQUENCE CONTEXTS; DISTINCT ROLES	The nucleotide excision repair protein complex ERCC1-XPF is required for incision of DNA upstream of DNA damage. Functional studies have provided insights into the binding of ERCC1XPF to various DNA substrates. However, because no structure for the ERCC1-XPF-DNA complex has been determined, the mechanism of substrate recognition remains elusive. Here we biochemically characterize the substrate preferences of the helix-hairpin-helix ( HhH) domains of XPF and ERCC-XPF and show that the binding to single-stranded DNA(ssDNA)/ dsDNA junctions is dependent on joint binding to the DNA binding domain of ERCC1 and XPF. We reveal that the homodimeric XPF is able to bind various ssDNA sequences but with a clear preference for guanine-containing substrates. NMR titration experiments and in vitro DNA binding assays also show that, within the heterodimeric ERCC1-XPF complex, XPF specifically recognizes ssDNA. On the other hand, the HhH domain of ERCC1 preferentially binds dsDNA through the hairpin region. The two separate non-overlapping DNA binding domains in the ERCC1-XPF heterodimer jointly bind to an ssDNA/ dsDNA substrate and, thereby, at least partially dictate the incision position during damage removal. Based on structural models, NMR titrations, DNA-binding studies, site-directed mutagenesis, charge distribution, and sequence conservation, we propose that the HhH domain of ERCC1 binds to dsDNA upstream of the damage, and XPF binds to the non-damaged strand within a repair bubble.	[Das, Devashish; Faridounnia, Maryam; Kaptein, Robert; Boelens, Rolf; Folkers, Gert E.] Univ Utrecht, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Kovacic, Lidija] Jozef Stefan Inst, Dept Mol & Biomed Sci, Jamova Cesta 39, Ljubljana 1000, Slovenia	Utrecht University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Folkers, GE (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	g.e.folkers@uu.nl	Faridounnia, Maryam/X-7736-2018; Boelens, Rolf/B-4702-2009; Folkers, Gert E/C-2863-2009; Das, Devashish/A-4165-2013	Faridounnia, Maryam/0000-0002-6260-7639; Boelens, Rolf/0000-0002-6939-8913; Folkers, Gert E/0000-0003-1070-0505; Das, Devashish/0000-0001-8501-8696	Netherlands Foundation for Chemical Research; Center for Biomedical Genetics; European Commission [031220/Spine2-complexes, 261863/Bio-NMR]; Slovenian Infrastructural Center for Analysis of Molecular Interaction; Slovenian Research Agency [Z1-4071]; Utrecht University	Netherlands Foundation for Chemical Research; Center for Biomedical Genetics; European Commission(European CommissionEuropean Commission Joint Research Centre); Slovenian Infrastructural Center for Analysis of Molecular Interaction; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Utrecht University	This work was supported by The Netherlands Foundation for Chemical Research, the Center for Biomedical Genetics, European Commission Project 031220/Spine2-complexes and Project 261863/Bio-NMR, the Slovenian Infrastructural Center for Analysis of Molecular Interaction, and the Slovenian Research Agency (Z1-4071). Funding for the open access charge was provided by Utrecht University. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Minawi AZ, 2008, NUCLEIC ACIDS RES, V36, P1, DOI 10.1093/nar/gkm888; Araujo SJ, 1999, MUTAT RES-DNA REPAIR, V435, P23, DOI 10.1016/S0921-8777(99)00042-7; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bessho T, 1997, J BIOL CHEM, V272, P3833, DOI 10.1074/jbc.272.6.3833; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Bowles M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks284; Cai Y, 2007, J MOL BIOL, V374, P292, DOI 10.1016/j.jmb.2007.09.034; Cai YQ, 2009, J MOL BIOL, V385, P30, DOI 10.1016/j.jmb.2008.09.087; Choi YJ, 2005, J BIOL CHEM, V280, P28644, DOI 10.1074/jbc.M501083200; Cleaver JE, 2008, MECH AGEING DEV, V129, P492, DOI 10.1016/j.mad.2008.01.005; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cleaver JE, 1999, HUM MUTAT, V14, P9, DOI 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.3.CO;2-Y; Cleaver JE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1024, DOI 10.2741/cleaver; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Das D, 2008, PROTEINS, V70, P1551, DOI 10.1002/prot.21635; Das D, 2012, STRUCTURE, V20, P667, DOI 10.1016/j.str.2012.02.009; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; de Laat WL, 1998, NUCLEIC ACIDS RES, V26, P4146, DOI 10.1093/nar/26.18.4146; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; Faridounnia M, 2015, J BIOL CHEM, V290, P20541, DOI 10.1074/jbc.M114.635169; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fisher LA, 2008, J BIOL CHEM, V283, P1275, DOI 10.1074/jbc.M708072200; Fisher LA, 2011, J MOL BIOL, V413, P337, DOI 10.1016/j.jmb.2011.08.034; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gaillard PHL, 2001, NUCLEIC ACIDS RES, V29, P872, DOI 10.1093/nar/29.4.872; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hayashi T, 1998, MUTAT RES-DNA REPAIR, V407, P269, DOI 10.1016/S0921-8777(98)00013-5; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; MATSUNAGA T, 1995, J BIOL CHEM, V270, P20862, DOI 10.1074/jbc.270.35.20862; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; MU D, 1994, NUCLEIC ACIDS RES, V22, P4869, DOI 10.1093/nar/22.23.4869; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Newman M, 2005, EMBO J, V24, P895, DOI 10.1038/sj.emboj.7600581; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; NISHIGORI C, 1986, ARCH DERMATOL, V122, P510, DOI 10.1001/archderm.122.5.510; Nishino T, 2005, STRUCTURE, V13, P1183, DOI 10.1016/j.str.2005.04.024; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; PARK CH, 1995, J BIOL CHEM, V270, P22657, DOI 10.1074/jbc.270.39.22657; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Su Y, 2012, J BIOL CHEM, V287, P21846, DOI 10.1074/jbc.M111.337899; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tripsianes K, 2005, STRUCTURE, V13, P1849, DOI 10.1016/j.str.2005.08.014; Tripsianes K, 2007, NUCLEIC ACIDS RES, V35, P5789, DOI 10.1093/nar/gkm503; Tsodikov OV, 2007, EMBO J, V26, P4768, DOI 10.1038/sj.emboj.7601894; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wakasugi M, 1997, J BIOL CHEM, V272, P16030, DOI 10.1074/jbc.272.25.16030; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Yagi T, 1997, MUTAGENESIS, V12, P41, DOI 10.1093/mutage/12.1.41; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	67	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2842	2853		10.1074/jbc.M116.747857	http://dx.doi.org/10.1074/jbc.M116.747857			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28028171	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000395535100024
J	Li, YN; Schang, G; Boehm, U; Deng, CX; Graff, J; Bernard, DJ				Li, Yining; Schang, Gauthier; Boehm, Ulrich; Deng, Chu-Xia; Graff, Jonathan; Bernard, Daniel J.			SMAD3 Regulates Follicle-stimulating Hormone Synthesis by Pituitary Gonadotrope Cells in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT TRANSCRIPTION; AMINO-ACID-SEQUENCE; TARGETED DISRUPTION; LUTEINIZING-HORMONE; GENE-EXPRESSION; GNRH RECEPTOR; DNA-BINDING; ACTIVATOR PROTEIN-1; NORMAL PUBERTY; FSH SYNTHESIS	Pituitary follicle-stimulating hormone (FSH) is an essential regulator of fertility in females and of quantitatively normal spermatogenesis in males. Pituitary-derived activins are thought to act as major stimulators of FSH synthesis by gonadotrope cells. In vitro, activins signal via SMAD3, SMAD4, and forkhead box L2 (FOXL2) to regulate transcription of the FSH beta subunit gene (Fshb). Consistent with this model, gonadotrope-specific Smad4 or Foxl2 knock-out mice have greatly reduced FSH and are subfertile. The role of SMAD3 in vivo is unresolved; however, residual FSH production in Smad4 conditional knockout mice may derive from partial compensation by SMAD3 and its ability to bind DNA in the absence of SMAD4. To test this hypothesis and determine the role of SMAD3 in FSH biosynthesis, we generated mice lacking both the SMAD3 DNA binding domain and SMAD4 specifically in gonadotropes. Conditional knock-out females were hypogonadal, acyclic, and sterile and had thread-like uteri; their ovaries lacked antral follicles and corpora lutea. Knock-out males were fertile but had reduced testis weights and epididymal sperm counts. These phenotypes were consistent with those of Fshb knock-out mice. Indeed, pituitary Fshb mRNA levels were nearly undetectable in both male and female knock-outs. In contrast, gonadotropin-releasing hormone receptor mRNA levels were significantly elevated in knock-outs in both sexes. Interestingly, luteinizing hormone production was altered in a sex-specific fashion. Overall, our analyses demonstrate that SMAD3 is required for FSH synthesis in vivo.	[Li, Yining; Schang, Gauthier; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Ctr Res Reprod & Dev, Montreal, PQ H3G 1Y6, Canada; [Boehm, Ulrich] Univ Saarland, Dept Pharmacol & Toxicol, Sch Med, D-66421 Homburg, Germany; [Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Macau Sar 999078, Peoples R China; [Graff, Jonathan] Univ Texas Southwestern, Dept Dev Biol, Dallas, TX 75390 USA	McGill University; Saarland University; University of Macau; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bernard, DJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Promenade Sir William Osler,Rm 1315, Montreal, PQ H3G 1Y6, Canada.	daniel.bernard@mcgill.ca		Bernard, Daniel/0000-0001-5365-5586	Canadian Institutes of Health Research Operating Grant [MOP-133394]; Natural Sciences and Engineering Research Council of Canada Discovery Grant [2015-05178]; Samuel Solomon Fellowship in Endocrinology from McGill University; Eunice Kennedy Shriver NICHD/National Institutes of Health (National Centers for Translational Research in Reproduction and Infertility) [P50-HD28934]; Canadian Foundation for Innovation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Samuel Solomon Fellowship in Endocrinology from McGill University; Eunice Kennedy Shriver NICHD/National Institutes of Health (National Centers for Translational Research in Reproduction and Infertility); Canadian Foundation for Innovation(Canada Foundation for Innovation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-133394 (to D.J.B.), Natural Sciences and Engineering Research Council of Canada Discovery Grant 2015-05178 (to D.J.B.), and a Samuel Solomon Fellowship in Endocrinology from McGill University (to Y.L.). The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by Eunice Kennedy Shriver NICHD/National Institutes of Health (National Centers for Translational Research in Reproduction and Infertility) Grant P50-HD28934. The Cell Vision Core Facility for Flow Cytometry and Single Cell Analysis at the McGill Life Science Complex was supported by funding from the Canadian Foundation for Innovation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795; Bernard DJ, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-52; Bernard DJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107797; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; BIELINSKA M, 1994, MOL ENDOCRINOL, V8, P919, DOI 10.1210/me.8.7.919; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Bull P, 2000, MOL HUM REPROD, V6, P582, DOI 10.1093/molehr/6.7.582; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; CARROLL RS, 1989, MOL ENDOCRINOL, V3, P1969, DOI 10.1210/mend-3-12-1969; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Clark AD, 2003, FERTIL STERIL, V79, P379, DOI 10.1016/S0015-0282(02)04660-5; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; Coss D, 2005, MOL ENDOCRINOL, V19, P2610, DOI 10.1210/me.2005-0047; Dalkin AC, 2001, ENDOCRINOLOGY, V142, P139, DOI 10.1210/en.142.1.139; Dalkin AC, 1999, ENDOCRINOLOGY, V140, P903, DOI 10.1210/en.140.2.903; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; FIDDES J C, 1981, Journal of Molecular and Applied Genetics, V1, P3; Fortin J, 2014, FASEB J, V28, P3396, DOI 10.1096/fj.14-249532; Fortin J, 2014, FASEB J, V28, P1474, DOI 10.1096/fj.13-237818; Fortin J, 2010, CELL SIGNAL, V22, P936, DOI 10.1016/j.cellsig.2010.01.019; Ghochani Y, 2012, ENDOCRINOLOGY, V153, P2023, DOI 10.1210/en.2011-1763; GOYETTE MC, 1992, MOL CELL BIOL, V12, P1387, DOI 10.1128/MCB.12.3.1387; Han SO, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-66; Ho CC, 2011, MOL CELL ENDOCRINOL, V332, P242, DOI 10.1016/j.mce.2010.10.019; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2267, DOI 10.1210/en.142.6.2267; Huhtaniemi IT, 2005, ENDOCRINE, V26, P207, DOI 10.1385/ENDO:26:3:207; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lamba P, 2006, J MOL ENDOCRINOL, V36, P201, DOI 10.1677/jme.1.01961; Lamba P, 2010, ENDOCRINOLOGY, V151, P5456, DOI 10.1210/en.2010-0605; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Layman LC, 2002, J CLIN ENDOCR METAB, V87, P3702, DOI 10.1210/jc.87.8.3702; Li QL, 2008, MOL CELL BIOL, V28, P7001, DOI 10.1128/MCB.00732-08; Lindstedt G, 1998, CLIN CHEM LAB MED, V36, P663, DOI 10.1515/CCLM.1998.118; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; MATTHEWS CH, 1993, NAT GENET, V5, P83, DOI 10.1038/ng0993-83; McGillivray SM, 2007, ENDOCRINOLOGY, V148, P762, DOI 10.1210/en.2006-0952; Oakes CC, 2007, J PHARMACOL EXP THER, V322, P1171, DOI 10.1124/jpet.107.121699; Pangas SA, 2000, TRENDS ENDOCRIN MET, V11, P309, DOI 10.1016/S1043-2760(00)00294-0; RATHNAM P, 1975, J BIOL CHEM, V250, P6735; Rejon CA, 2013, CELL SIGNAL, V25, P1403, DOI 10.1016/j.cellsig.2013.03.002; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steyn FJ, 2013, ENDOCRINOLOGY, V154, P4939, DOI 10.1210/en.2013-1502; Suszko MI, 2005, MOL ENDOCRINOL, V19, P1849, DOI 10.1210/me.2004-0475; Themmen APN, 2005, REPRODUCTION, V130, P263, DOI 10.1530/rep.1.00663; Tomic D, 2004, MOL ENDOCRINOL, V18, P2224, DOI 10.1210/me.2003-0414; Tran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076642; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Tran S, 2011, MOL ENDOCRINOL, V25, P1170, DOI 10.1210/me.2010-0480; Trarbach EB, 2007, PITUITARY, V10, P381, DOI 10.1007/s11102-007-0061-7; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Wang Y, 2012, NANO, V7, DOI 10.1142/S1793292012500427; Wang Y, 2008, ENDOCRINOLOGY, V149, P5577, DOI 10.1210/en.2008-0220; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; West BE, 2004, ENDOCRINOLOGY, V145, P4866, DOI 10.1210/en.2004-0598; Wreford NG, 2001, ENDOCRINOLOGY, V142, P2916, DOI 10.1210/en.142.7.2916; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	68	37	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2301	2314		10.1074/jbc.M116.759167	http://dx.doi.org/10.1074/jbc.M116.759167			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27994055	Green Published, hybrid			2022-12-28	WOS:000395530300022
J	Marques, MD; Pinto, JR; Moraes, AH; Iqbal, A; de Magalha, MTQ; Monteiro, J; Pedrote, MM; Sorenson, MM; Silva, JL; de Oliveira, GAP				Marques, Mayra de A.; Pinto, Jose Renato; Moraes, Adolfo H.; Iqbal, Anwar; de Magalha, Mariana T. Q.; Monteiro, Jamila; Pedrote, Murilo M.; Sorenson, Martha M.; Silva, Jerson L.; de Oliveira, Guilherme A. P.			Allosteric Transmission along a Loosely Structured Backbone Allows a Cardiac Troponin C Mutant to Function with Only One Ca2+ Ion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISPERSION NMR-SPECTROSCOPY; MAGNESIUM BINDING-SITES; HYPERTROPHIC CARDIOMYOPATHY; CALCIUM-BINDING; DILATED CARDIOMYOPATHY; TRYPTOPHAN MUTANTS; HIGH-PRESSURE; DOMAIN; MUTATIONS; PROTEINS	Hypertrophic cardiomyopathy (HCM) is one of the most common cardiomyopathies and a major cause of sudden death in young athletes. The Ca2+ sensor of the sarcomere, cardiac troponin C (cTnC), plays an important role in regulating muscle contraction. Although several cardiomyopathy-causing mutations have been identified in cTnC, the limited information about their structural defects has been mapped to the HCM phenotype. Here, we used high-resolution electron-spray ionization mass spectrometry (ESI-MS), Carr-Purcell-MeiboomGill relaxation dispersion (CPMG-RD), and affinity measurements of cTnC for the thin filament in reconstituted papillary muscles to provide evidence of an allosteric mechanism in mutant cTnC that may play a role to the HCM phenotype. We showed that the D145E mutation leads to altered dynamics on a mu s-ms time scale and deactivates both of the divalent cation-binding sites of the cTnC C-domain. CPMG-RD captured a low populated protein-folding conformation triggered by the Glu-145 replacement of Asp. Paradoxically, although D145E C-domain was unable to bind Ca2+, these changes along its backbone allowed it to attach more firmly to thin filaments than the wildtype isoform, providing evidence for an allosteric response of the Ca2+-binding site II in the N-domain. Our findings explain how the effects of an HCM mutation in the C-domain reflect up into the N-domain to cause an increase of Ca2+ affinity in site II, thus opening up new insights into the HCM phenotype.	[Marques, Mayra de A.; Iqbal, Anwar; Monteiro, Jamila; Pedrote, Murilo M.; Sorenson, Martha M.; Silva, Jerson L.; de Oliveira, Guilherme A. P.] Univ Fed Rio de Janeiro, Programa Biol Estrut, Inst Bioquim Med, Inst Nacl Biol Estrutural & Bioimagem,Ctr Nacl Re, BR-21941902 Rio De Janeiro, Brazil; [Pinto, Jose Renato] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32304 USA; [Moraes, Adolfo H.] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Quim, Belo Horizonte, MG, Brazil; [de Magalha, Mariana T. Q.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal do Rio de Janeiro; State University System of Florida; Florida State University; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Silva, JL; de Oliveira, GAP (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrut, Inst Bioquim Med, Inst Nacl Biol Estrutural & Bioimagem,Ctr Nacl Re, BR-21941902 Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br; gaugusto@bioqmed.ufrj.br	de Oliveira, Guilherme A. P./O-1192-2013; Pinto, Jose Renato/H-2631-2017; Silva, Jerson/J-8984-2014; SILVA, JERSON Lima/GRF-1442-2022; Marques, Mayra/AAN-3130-2021; Moraes, Adolfo/G-3931-2018	de Oliveira, Guilherme A. P./0000-0002-0063-5888; Pinto, Jose Renato/0000-0001-9092-4976; Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441; Moraes, Adolfo/0000-0002-3344-4084; Pedrote, Murilo/0000-0001-6744-9572; Torquato Quezado de Magalhaes, Mariana/0000-0003-4912-0233; Marques, Mayra/0000-0002-4131-4634	Brazilian Synchrotron Light Laboratory [SAXS-14200]; Brazilian Biosciences National Laboratory [RMN-15571]; National Council of Technological and Scientific Development (CNPQ); Ministry of Health (MS/Decit); Carlos Chagas Filho Foundation; CNPQ; National Institutes of Health [HL128683]; Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128683] Funding Source: NIH RePORTER	Brazilian Synchrotron Light Laboratory; Brazilian Biosciences National Laboratory; National Council of Technological and Scientific Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health (MS/Decit); Carlos Chagas Filho Foundation; CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant SAXS-14200 from the Brazilian Synchrotron Light Laboratory and Grant RMN-15571 from the Brazilian Biosciences National Laboratory. This work was also supported by grants from the National Council of Technological and Scientific Development (CNPQ), the Ministry of Health (MS/Decit), and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (to J.L.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; 1 Recipient of a doctoral fellowship from CNPQ.; 2 Recipient of National Institutes of Health Grant HL128683.; 3 Recipient of a CNPQ research fellowship.; 4 Recipient of a CNPQ research fellowship. To whom correspondence may be addressed. E-mail address: jerson@bioqmed.ufrj.br.; 5 Supported by the Cancer Foundation and the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro. To whom correspondence may be addressed. E-mail address: gaugusto@bioqmed.ufrj.	Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Cordina NM, 2013, BIOCHEMISTRY-US, V52, P1950, DOI 10.1021/bi4000172; Cordina NM, 2012, PROTEIN SCI, V21, P1376, DOI 10.1002/pro.2124; de Oliveira GAP, 2013, BIOCHEMISTRY-US, V52, P28, DOI 10.1021/bi301139d; De Simone A, 2015, ELIFE, V4, DOI 10.7554/eLife.02777; Dokholyan NV, 2016, CHEM REV, V116, P6463, DOI 10.1021/acs.chemrev.5b00544; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; FROMHERZ S, 1995, P NATL ACAD SCI USA, V92, P7652, DOI 10.1073/pnas.92.17.7652; GRABAREK Z, 1995, BIOCHEMISTRY-US, V34, P11872, DOI 10.1021/bi00037a027; GRABAREK Z, 1986, J BIOL CHEM, V261, P608; HANNON JD, 1992, CIRC RES, V71, P984, DOI 10.1161/01.RES.71.4.984; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Korzhnev DM, 2004, J AM CHEM SOC, V126, P7320, DOI 10.1021/ja049968b; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Marques MD, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00429; Moncrieffe MC, 1999, BIOCHEMISTRY-US, V38, P11973, DOI 10.1021/bi982048j; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Pan BS, 1996, J BIOL CHEM, V271, P817, DOI 10.1074/jbc.271.2.817; Parvatiyar MS, 2012, J BIOL CHEM, V287, P31845, DOI 10.1074/jbc.M112.377713; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Robertson IM, 2015, J MOL CELL CARDIOL, V87, P257, DOI 10.1016/j.yjmcc.2015.08.017; She MD, 1998, EUR J BIOCHEM, V252, P600, DOI 10.1046/j.1432-1327.1998.2520600.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Suarez MC, 2003, BIOCHEMISTRY-US, V42, P5522, DOI 10.1021/bi027102h; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swindle N, 2010, BIOCHEMISTRY-US, V49, P4813, DOI 10.1021/bi100400h; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Tugarinov V, 2015, ANGEW CHEM INT EDIT, V54, P11157, DOI 10.1002/anie.201505416; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang X, 2001, J BIOL CHEM, V276, P25456, DOI 10.1074/jbc.M102418200; Williams MR, 2016, P NATL ACAD SCI USA, V113, P3257, DOI 10.1073/pnas.1519541113; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031	45	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2379	2394		10.1074/jbc.M116.765362	http://dx.doi.org/10.1074/jbc.M116.765362			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28049727	Green Published, hybrid			2022-12-28	WOS:000395530300028
J	Jacobsen, FW; Stevenson, R; Li, C; Salimi-Moosavi, H; Liu, L; Wen, J; Luo, QZ; Daris, K; Buck, L; Miller, S; Ho, SY; Wang, W; Chen, Q; Walker, K; Wypych, J; Narhi, L; Gunasekaran, K				Jacobsen, Frederick W.; Stevenson, Riki; Li, Cynthia; Salimi-Moosavi, Hossein; Liu, Ling; Wen, Jie; Luo, Quanzhou; Daris, Kristine; Buck, Lynette; Miller, Sterling; Ho, Shu-Yin; Wang, Wei; Chen, Qing; Walker, Kenneth; Wypych, Jette; Narhi, Linda; Gunasekaran, Kannan			Engineering an IgG Scaffold Lacking Effector Function with Optimized Developability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; drug development; Fc receptor; immunoglobulin G (IgG); protein stability; aglycosylated IgG; antibody developability; antibody-dependent cellular cytotoxicity; complement-dependent cytotoxicity; disulfide engineering	FC-GAMMA-RIII; ANTIBODY THERAPEUTICS; BINDING-SITE; IN-VIVO; STABILITY; GLYCOSYLATION; ISOFORMS; SUBCLASS	IgG isotypes can differentially bind to Fc receptors and complement, making the selection of which isotype to pursue for development of a particular therapeutic antibody important in determining the safety and efficacy of the drug. IgG2 and IgG4 isotypes have significantly lower binding affinity to Fc receptors. Recent evidence suggests that the IgG2 isotype is not completely devoid of effector function, whereas the IgG4 isotype can undergo in vivo Fab arm exchange leading to bispecific antibody and off-target effects. Here an attempt was made to engineer an IgG1-based scaffold lacking effector function but with stability equivalent to that of the parent IgG1. Care was taken to ensure that both stability and lack of effector function was achieved with a minimum number of mutations. Among the Asn(297) mutants that result in lack of glycosylation and thus loss of effector function, we demonstrate that the N297G variant has better stability and developability compared with the N297Q or N297A variants. To further improve the stability of N297G, we introduced a novel engineered disulfide bond at a solvent inaccessible location in the CH2 domain. The resulting scaffold has stability greater than or equivalent to that of the parental IgG1 scaffold. Extensive biophysical analyses and pharmacokinetic (PK) studies in mouse, rat, and monkey further confirmed the developability of this unique scaffold, and suggest that it could be used for all Fc containing therapeutics (e.g. antibodies, bispecific antibodies, and Fc fusions) requiring lack of effector function or elimination of binding to Fc gamma receptors.	[Jacobsen, Frederick W.; Stevenson, Riki; Li, Cynthia; Salimi-Moosavi, Hossein; Liu, Ling; Wen, Jie; Luo, Quanzhou; Daris, Kristine; Buck, Lynette; Miller, Sterling; Ho, Shu-Yin; Wang, Wei; Chen, Qing; Walker, Kenneth; Wypych, Jette; Narhi, Linda; Gunasekaran, Kannan] Amgen Inc, Clin Immunol & Proc Dev, Biol Optimizat Therapeut Discovery, Thousand Oaks, CA 91320 USA	Amgen	Jacobsen, FW (corresponding author), One Amgen Ctr Dr,MS 29-2-A, Thousand Oaks, CA 91320 USA.; Gunasekaran, K (corresponding author), Affinita Biotech, 329 Oyster Point Blvd,3rd Floor, San Francisco, CA 94080 USA.	rjacobse@amgen.com; guna.kannan@yahoo.com			Amgen	Amgen(Amgen)	This work was supported by Amgen. All authors work or have worked at Amgen	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Aronson R, 2014, DIABETES CARE, V37, P2746, DOI 10.2337/dc13-0327; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Clarke SJ, 2009, J CLIN ONCOL, V27; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Everds NE, 2013, TOXICOL PATHOL, V41, P280, DOI 10.1177/0192623312467400; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Gunasekaran K, 1996, J MOL BIOL, V264, P191, DOI 10.1006/jmbi.1996.0633; Hari SB, 2010, BIOCHEMISTRY-US, V49, P9328, DOI 10.1021/bi100841u; Hristodorov D, 2013, MOL BIOTECHNOL, V54, P1056, DOI 10.1007/s12033-012-9612-x; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Ishihara T, 2010, J CHROMATOGR B, V878, P2141, DOI 10.1016/j.jchromb.2010.06.003; Ito T, 2013, PROTEIN SCI, V22, P1542, DOI 10.1002/pro.2340; Jacobsen FW, 2011, J IMMUNOL, V186, P341, DOI 10.4049/jimmunol.1001685; Jefferis R, 2009, TRENDS PHARMACOL SCI, V30, P356, DOI 10.1016/j.tips.2009.04.007; Jung ST, 2011, CURR OPIN BIOTECH, V22, P858, DOI 10.1016/j.copbio.2011.03.002; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Leabman MK, 2013, MABS-AUSTIN, V5, P896, DOI 10.4161/mabs.26436; Liu HF, 2010, MABS-AUSTIN, V2, P480, DOI 10.4161/mabs.2.5.12645; Liu L, 2017, J BIOL CHEM, V292, P1876, DOI 10.1074/jbc.M116.748707; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; Naso MF, 2010, MABS-AUSTIN, V2, P519, DOI 10.4161/mabs.2.5.13078; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Reusch D, 2015, GLYCOBIOLOGY, V25, P1325, DOI 10.1093/glycob/cwv065; Schneider-Merck T, 2010, J IMMUNOL, V184, P512, DOI 10.4049/jimmunol.0900847; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; TAO MH, 1989, J IMMUNOL, V143, P2595; Warncke M, 2012, J IMMUNOL, V188, P4405, DOI 10.4049/jimmunol.1200090; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; Zhang QC, 2013, J BIOL CHEM, V288, P16371, DOI 10.1074/jbc.M113.468397	39	46	56	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1865	1875		10.1074/jbc.M116.748525	http://dx.doi.org/10.1074/jbc.M116.748525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994062	Green Published, hybrid			2022-12-28	WOS:000395515600026
J	Wang, L; Xu, XH; Cao, YQ; Li, ZW; Cheng, H; Zhu, GY; Duan, FY; Na, J; Han, JDJ; Chen, YG				Wang, Lu; Xu, Xuanhao; Cao, Yaqiang; Li, Zhongwei; Cheng, Hao; Zhu, Gaoyang; Duan, Fuyu; Na, Jie; Han, Jing-Dong J.; Chen, Ye-Guang			Activin/Smad2-induced Histone H3 Lys-27 Trimethylation (H3K27me3) Reduction Is Crucial to Initiate Mesendoderm Differentiation of Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; ENDODERM DIFFERENTIATION; DEMETHYLASE JMJD3; MOUSE DEVELOPMENT; DNA METHYLATION; SELF-RENEWAL; TARGET GENES; IN-VITRO; HUMAN ES; TRANSCRIPTION	Differentiation of human embryonic stem cells into mesendoderm (ME) is directed by extrinsic signals and intrinsic epigenetic modifications. However, the dynamics of these epigenetic modifications and the mechanisms by which extrinsic signals regulate the epigenetic modifications during the initiation of ME differentiation remain elusive. In this study, we report that levels of histone H3 Lys-27 trimethylation (H3K27me3) decrease during ME initiation, which is essential for subsequent differentiation induced by the combined effects of activin and Wnt signaling. Furthermore, we demonstrate that activin mediates the H3K27me3 decrease via the Smad2-mediated reduction of EZH2 protein level. Our results suggest a two-step process of ME initiation: first, epigenetic priming via removal of H3K27me3 marks and, second, transcription activation. Our findings demonstrate a critical role of H3K27me3 priming and a direct interaction between extrinsic signals and epigenetic modifications during ME initiation.	[Wang, Lu; Xu, Xuanhao; Li, Zhongwei; Zhu, Gaoyang; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Cao, Yaqiang; Cheng, Hao; Han, Jing-Dong J.] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci Max Planck Partner Inst Computat, Key Lab Computat Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Duan, Fuyu; Na, Jie] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Li, Zhongwei] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Tsinghua University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Tsinghua University; Salk Institute	Chen, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Na, Jie/U-4518-2019; Chen, Ye-Guang/L-6998-2019; Cao, Yaqiang/ABC-3753-2021; Na, Jie/N-3522-2018	Na, Jie/0000-0003-1820-0548; Cao, Yaqiang/0000-0002-4665-1517; Na, Jie/0000-0003-1820-0548; Duan, Fuyu/0000-0001-5628-5226	National Natural Science Foundation of China [91519310, 31330049]; 973 Program Grant [2013CB933700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program Grant(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 91519310 and 31330049 and 973 Program Grant 2013CB933700 (to Y. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Auerbach RK, 2013, BIOINFORMATICS, V29, P1922, DOI 10.1093/bioinformatics/btt316; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bertero A, 2015, GENE DEV, V29, P702, DOI 10.1101/gad.255984.114; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Estaras C, 2015, MOL CELL, V58, P780, DOI 10.1016/j.molcel.2015.04.001; FAUST C, 1995, DEVELOPMENT, V121, P273; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Howard TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026791; Hubner MR, 2010, COLD SH Q B, V75, P43, DOI 10.1101/sqb.2010.75.020; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Kartikasari AER, 2013, EMBO J, V32, P1393, DOI 10.1038/emboj.2013.78; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Li M, 2012, NAT REV MOL CELL BIO, V13, P524, DOI 10.1038/nrm3393; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pethe P, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-18; Seuntjens E, 2009, CYTOKINE GROWTH F R, V20, P449, DOI 10.1016/j.cytogfr.2009.10.005; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang L, 2016, J MOL BIOL, V428, P1409, DOI 10.1016/j.jmb.2015.06.013; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yoon SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7546; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	54	21	23	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1339	1350		10.1074/jbc.M116.766949	http://dx.doi.org/10.1074/jbc.M116.766949			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27965357	hybrid, Green Published			2022-12-28	WOS:000393339800016
J	Wasser, CR; Herz, J				Wasser, Catherine R.; Herz, Joachim			Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMYLOID PRECURSOR PROTEIN; METABOTROPIC GLUTAMATE-RECEPTOR; PHOSPHOTYROSINE-BINDING DOMAIN; DENSITY LIPOPROTEIN RECEPTOR; APOLIPOPROTEIN-E; SYNAPTIC PLASTICITY; TAU PATHOLOGY; F-SPONDIN; BETA; APOER2	Over half a century ago, D. S. Falconer first reported a mouse with a reeling gate. Four decades later, the Reln gene was isolated and identified as the cause of the reeler phenotype. Initial studies found that loss of Reelin, a large, secreted glycoprotein encoded by the Reln gene, results in abnormal neuronal layering throughout several regions of the brain. In the years since, the known functions of Reelin signaling in the brain have expanded to include multiple postdevelopmental neuromodulatory roles, revealing an ever increasing body of evidence to suggest that Reelin signaling is a critical player in the modulation of synaptic function. In writing this review, we intend to highlight the most fundamental aspects of Reelin signaling and integrate how these various neuromodulatory effects shape and protect synapses.	[Wasser, Catherine R.; Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Wasser, Catherine R.; Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.; Herz, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.; Herz, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA.; Herz, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.	Joachim.Herz@UTSouthwestern.edu			National Institutes of Health [HL063762, NS093382, AG053391]; Consortium for Frontotemporal Dementia Research Grant [A108400]; Brightfocus Foundation Grant [A2016396S]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG053391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research Grant; Brightfocus Foundation Grant(BrightFocus Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants HL063762, NS093382, and AG053391 (to J.H.), Consortium for Frontotemporal Dementia Research Grant A108400, and Brightfocus Foundation Grant A2016396S. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Bal M, 2013, NEURON, V80, P934, DOI 10.1016/j.neuron.2013.08.024; Balmaceda V, 2014, FASEB J, V28, P1543, DOI 10.1096/fj.13-239350; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Bock HH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00166; Boehm-Cagan A, 2016, J ALZHEIMERS DIS, V54, P1219, DOI 10.3233/JAD-160467; Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Brosda J, 2011, NEUROBIOL DIS, V44, P239, DOI 10.1016/j.nbd.2011.07.008; Campo CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005505; Carvajal A. E., 2016, BIOCHIM BIOPHYS ACTA, V1863, P462; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Chen X, 2013, NEUROSCIENCE, V253, P435, DOI 10.1016/j.neuroscience.2013.08.054; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Chin J, 2007, J NEUROSCI, V27, P2727, DOI 10.1523/JNEUROSCI.3758-06.2007; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Curran T, 1998, BRAIN RES REV, V26, P285, DOI 10.1016/S0165-0173(97)00035-0; D'Arcangelo G, 2014, ADV NEUROSCI, V2014, DOI [10.1155/2014/597395, DOI 10.1155/2014/597395]; DelRio JA, 1996, J NEUROSCI, V16, P6896; Ding YY, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad5578; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Dumanis SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017203; Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Folsom TD, 2013, NEUROPHARMACOLOGY, V68, P122, DOI 10.1016/j.neuropharm.2012.08.015; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007; Guntupalli S, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3204519; Haas CA, 2010, EXP BRAIN RES, V200, P141, DOI 10.1007/s00221-009-1948-5; Harward SC, 2016, NATURE, V538, P99, DOI 10.1038/nature19766; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hellwig S, 2011, J NEUROSCI, V31, P2352, DOI 10.1523/JNEUROSCI.3984-10.2011; Herring A, 2012, J ALZHEIMERS DIS, V30, P963, DOI 10.3233/JAD-2012-112069; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hinrich AJ, 2016, EMBO MOL MED, V8, P328, DOI 10.15252/emmm.201505846; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Iafrati J, 2014, MOL PSYCHIATR, V19, P417, DOI 10.1038/mp.2013.66; Ishii K, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00229; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Knuesel I, 2010, PROG NEUROBIOL, V91, P257, DOI 10.1016/j.pneurobio.2010.04.002; Knuesel I, 2009, NEUROBIOL AGING, V30, P697, DOI 10.1016/j.neurobiolaging.2007.08.011; Koch S, 2002, EMBO J, V21, P5996, DOI 10.1093/emboj/cdf599; Kocherhans S, 2010, J NEUROSCI, V30, P9228, DOI 10.1523/JNEUROSCI.0418-10.2010; Kounnas Maria Z, 2017, Alzheimers Dement (N Y), V3, P65, DOI 10.1016/j.trci.2016.09.003; Kuzniewska B, 2013, MOL CELL BIOL, V33, P2149, DOI 10.1128/MCB.00008-13; Lane-Donovan C, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa6674; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Larios JA, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-108; Lee GH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00122; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Leemhuis J, 2010, J NEUROSCI, V30, P14759, DOI 10.1523/JNEUROSCI.4036-10.2010; Lilja AM, 2011, J ALZHEIMERS DIS, V23, P335, DOI 10.3233/JAD-2010-101242; Lussier AL, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00075; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Matsuki T, 2008, J CELL SCI, V121, P1869, DOI 10.1242/jcs.027334; May P, 2003, J BIOL CHEM, V278, P37386, DOI 10.1074/jbc.M305858200; Minami SS, 2010, FASEB J, V24, P58, DOI 10.1096/fj.09-138123; Morimura T, 2009, BRAIN RES, V1304, P26, DOI 10.1016/j.brainres.2009.09.087; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Orcinha C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00183; Paula-Lima AC, 2013, J NEUROCHEM, V126, P191, DOI 10.1111/jnc.12304; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Pujadas L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4443; Qui SF, 2006, NEUROBIOL LEARN MEM, V85, P228, DOI 10.1016/j.nlm.2005.11.001; Sabbagh JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00003; Salomon-Zimri S, 2014, NEURODEGENER DIS, V13, P86, DOI 10.1159/000354777; Shukla V, 2012, ARCH MED RES, V43, P655, DOI 10.1016/j.arcmed.2012.10.015; Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005; Smalheiser NR, 2000, P NATL ACAD SCI USA, V97, P1281, DOI 10.1073/pnas.97.3.1281; Sotelo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093672; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Telese F, 2015, NEURON, V86, P696, DOI 10.1016/j.neuron.2015.03.033; Tinnes S, 2013, FASEB J, V27, P2542, DOI 10.1096/fj.12-224899; Tinnes S, 2011, FASEB J, V25, P1002, DOI 10.1096/fj.10-168294; Wasser CR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005438; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Zhang L, 2013, J NEUROSCI RES, V91, P1581, DOI 10.1002/jnr.23263; Zhu XN, 2016, J NEUROSCI, V36, P10151, DOI 10.1523/JNEUROSCI.0845-16.2016	100	58	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1330	1338		10.1074/jbc.R116.766782	http://dx.doi.org/10.1074/jbc.R116.766782			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27994051	Green Published, hybrid			2022-12-28	WOS:000393339800015
J	Gimenez-Mascarell, P; Oyenarte, I; Hardy, S; Breiderhoff, T; Stuiver, M; Kostantin, E; Diercks, T; Pey, AL; Ereno-Orbea, J; Martinez-Chantar, ML; Khalaf-Nazzal, R; Claverie-Martin, F; Muller, D; Tremblay, ML; Martinez-Cruz, LA				Gimenez-Mascarell, Paula; Oyenarte, Iker; Hardy, Serge; Breiderhoff, Tilman; Stuiver, Marchel; Kostantin, Elie; Diercks, Tammo; Pey, Angel L.; Ereno-Orbea, June; Luz Martinez-Chantar, Maria; Khalaf-Nazzal, Reham; Claverie-Martin, Felix; Mueller, Dominik; Tremblay, Michel L.; Alfonso Martinez-Cruz, Luis			Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CYSTATHIONINE-BETA-SYNTHASE; CONE-ROD DYSTROPHY; CELL-GROWTH; CBS DOMAINS; CANCER; EXPRESSION; MUTATIONS; INVASION; TARGET	Phosphatases of regenerating liver (PRLs), the most oncogenic of all protein-tyrosine phosphatases (PTPs), play a critical role in metastatic progression of cancers. Recent findings established a new paradigm by uncovering that their association with magnesium transporters of the cyclinM(CNNM) family causes a rise in intracellular magnesium levels that promote oncogenic transformation. Recently, however, essential roles for regulation of the circadian rhythm and reproduction of the CNNM family have been highlighted. Here, we describe the crystal structure of PRL-1 in complex with the Bateman module of CNNM2 (CNNM2BAT), which consists of two cystathionine beta-synthase (CBS) domains (IPR000664) and represents an intracellular regulatory module of the transporter. The structure reveals a heterotetrameric association, consisting of a disclike homodimer of CNNM2(BAT) bound to two independent PRL-1 molecules, each one located at opposite tips of the disc. The structure highlights the key role played by Asp-558 at the extended loop of the CBS2 motif of CNNM2 in maintaining the association between the two proteins and proves that the interaction between CNNM2 and PRL-1 occurs via the catalytic domain of the phosphatase. Our data shed new light on the structural basis underlying the interaction between PRL phosphatases and CNNM transporters and provides a hypothesis about the molecular mechanism by which PRL-1, upon binding to CNNM2, might increase the intracellular concentration of Mg2+ thereby contributing to tumor progression and metastasis. The availability of this structure sets the basis for the rational design of compounds modulating PRL-1 andCNNM2activities.	[Gimenez-Mascarell, Paula; Oyenarte, Iker; Diercks, Tammo; Ereno-Orbea, June; Alfonso Martinez-Cruz, Luis] Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Technol Pk Bizkaia, Derio 48160, Bizkaia, Spain; [Hardy, Serge; Kostantin, Elie; Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Kostantin, Elie; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Tremblay, Michel L.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada; [Breiderhoff, Tilman; Mueller, Dominik] Charite, Dept Pediat Nephrol, D-13353 Berlin, Germany; [Breiderhoff, Tilman] Berlin Inst Hlth, Berlin, Germany; [Stuiver, Marchel] Leibniz Inst Mol Pharmacol FMP Berlin, Dept NMR Supported Struct Biol, In Cell NMR Lab, Robert Rossle Str 10, D-13125 Berlin, Germany; [Pey, Angel L.] Univ Granada, Fac Sci, Dept Phys Chem, Av Fuentenueva S-N, E-18071 Granada, Spain; [Luz Martinez-Chantar, Maria] Ctr Cooperat Res Biosci CIC bioGUNE, Metabol Unit, Technol Pk Bizkaia, Derio 48160, Bizkaia, Spain; [Khalaf-Nazzal, Reham] An Najah Natl Univ, Dept Biomed Sci, POB 7, Nablus, Palestine; [Claverie-Martin, Felix] Nuestra Senora de Candelaria Univ Hosp, Res Unit, Santa Cruz De Tenerife 38010, Spain	CIC bioGUNE; McGill University; McGill University; McGill University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Granada; CIC bioGUNE; An Najah National University	Tremblay, ML (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.; Tremblay, ML (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.; Tremblay, ML (corresponding author), McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada.; Muller, D (corresponding author), Charite, Dept Pediat Nephrol, D-13353 Berlin, Germany.; Martinez-Cruz, LA (corresponding author), Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Bizkaia Sci & Technol Pk Bldg 800, Derio 48160, Bizkaia, Spain.	Dominik.Mueller@charite.de; Michel.tremblay@mcgill.ca; amartinez@cicbiogune.es	Breiderhoff, Tilman/X-9364-2019; Chantar, Maria Luz Martinez/F-5190-2011; Diercks, Tammo/G-1167-2011; Diercks, Tammo/AAT-3731-2021; Martinez-Cruz, Luis Alfonso/G-2285-2011	Breiderhoff, Tilman/0000-0002-1676-7498; Chantar, Maria Luz Martinez/0000-0002-6446-9911; Diercks, Tammo/0000-0002-5200-0905; Diercks, Tammo/0000-0002-5200-0905; Claverie-Martin, Felix/0000-0003-2468-3267; Stuiver, Marchel/0000-0003-3437-4468; ereno orbea, june/0000-0002-5076-2105; Martinez-Cruz, Luis Alfonso/0000-0002-5856-9377; Pey, Angel Luis/0000-0001-7706-3243; OYENARTE, IKER/0000-0002-2870-3344; Gimenez Mascarell, Paula/0000-0002-7775-9440	Departamento de Educacion, Universidades e Investigacion del Gobierno Vasco [PI2010-17]; Departamento de Industria, Innovacion, Comercio y Turismo del Gobierno Vasco [ETORTEK IE05-14, IE07-202]; Diputacion Foral de Bizkaia [7/13/08/2006/11, 7/13/08/2005/14]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2010-17857]; Spanish Ministry of Economy and Competitiveness [BFU2013-47531-R]; Ministerio de Ciencia e Innovacion CONSOLIDER-INGENIO [CSD2008-00005]	Departamento de Educacion, Universidades e Investigacion del Gobierno Vasco; Departamento de Industria, Innovacion, Comercio y Turismo del Gobierno Vasco; Diputacion Foral de Bizkaia; Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Ministerio de Ciencia e Innovacion CONSOLIDER-INGENIO	This work was supported in part by Departamento de Educacion, Universidades e Investigacion del Gobierno Vasco Grant PI2010-17, Departamento de Industria, Innovacion, Comercio y Turismo del Gobierno Vasco Grants ETORTEK IE05-14 and IE07-202], Diputacion Foral de Bizkaia Grants 7/13/08/2006/11 and 7/13/08/2005/14, Spanish Ministerio de Ciencia e Innovacion (MICINN) Grant BFU2010-17857, Spanish Ministry of Economy and Competitiveness Grant BFU2013-47531-R, and Ministerio de Ciencia e Innovacion CONSOLIDER-INGENIO 2010 Program Grant CSD2008-00005 (to L. A. M.-C.). The authors declare that they have no conflicts of interest with the contents of this article.	Achiwa H, 2007, CANCER RES, V67, P643, DOI 10.1158/0008-5472.CAN-06-2436; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Corral-Rodriguez MA, 2014, BIOCHEM J, V464, P23, DOI 10.1042/BJ20140409; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Bai YP, 2011, J BIOL CHEM, V286, P42316, DOI 10.1074/jbc.M111.286302; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; ERNST RR, 1966, REV SCI INSTRUM, V37, P93, DOI 10.1063/1.1719961; Feeney KA, 2016, NATURE, V532, P375, DOI 10.1038/nature17407; Gomez-Garcia I, 2012, ACTA CRYSTALLOGR F, V68, P1198, DOI 10.1107/S1744309112035348; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; Hardy S, 2015, ONCOGENE, V34, P986, DOI 10.1038/onc.2014.33; Hirata Y, 2014, J BIOL CHEM, V289, P14731, DOI 10.1074/jbc.M114.551176; Jeong DG, 2005, J MOL BIOL, V345, P401, DOI 10.1016/j.jmb.2004.10.061; Jiao Y, 2015, AM J PHYSIOL-GASTR L, V308, pG85, DOI 10.1152/ajpgi.00084.2014; Jin SW, 2014, ONCOTARGET, V5, P3685, DOI 10.18632/oncotarget.1986; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleywegt GJ, 2002, STRUCTURE, V10, P465, DOI 10.1016/S0969-2126(02)00743-8; Kostantin E, 2016, J BIOL CHEM, V291, P10716, DOI 10.1074/jbc.M115.705863; Kozlov G, 2004, J BIOL CHEM, V279, P11882, DOI 10.1074/jbc.M312905200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lotan A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00331; Lu JW, 2012, CLIN TRANSL ONCOL, V14, P287, DOI 10.1007/s12094-012-0797-z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKusick V.A., 1998, MENDELIAN INHERITANC; Min SH, 2009, ONCOGENE, V28, P545, DOI 10.1038/onc.2008.409; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Quamme G. A., 2010, AM J PHYSIOL-CELL PH, V298; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Shinmei S, 2014, UROL ONCOL-SEMIN ORI, V32, P769, DOI 10.1016/j.urolonc.2014.03.007; Sponder G, 2016, PFLUG ARCH EUR J PHY, V468, P1223, DOI 10.1007/s00424-016-1816-7; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Sun JP, 2007, J BIOL CHEM, V282, P29043, DOI 10.1074/jbc.M703537200; Sun JP, 2005, BIOCHEMISTRY-US, V44, P12009, DOI 10.1021/bi0509191; Wang CY, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-7; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Yamazaki D, 2016, J CELL SCI, V129, P1940, DOI 10.1242/jcs.182220; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983; Yu L, 2007, BBA-MOL CELL RES, V1773, P1473, DOI 10.1016/j.bbamcr.2007.06.005; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zeng Q, 2003, CANCER RES, V63, P2716; Zeng Q, 1998, BIOCHEM BIOPH RES CO, V244, P421, DOI 10.1006/bbrc.1998.8291	53	36	37	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					786	801		10.1074/jbc.M116.759944	http://dx.doi.org/10.1074/jbc.M116.759944			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27899452	Green Published, hybrid			2022-12-28	WOS:000392318700003
J	Esser, L; Zhou, F; Pluchino, KM; Shiloach, J; Ma, JC; Tang, W; Gutierrez, C; Zhang, A; Shukla, S; Madigan, JP; Zhou, TQ; Kwong, PD; Ambudkar, SV; Gottesman, MM; Xia, D				Esser, Lothar; Zhou, Fei; Pluchino, Kristen M.; Shiloach, Joseph; Ma, Jichun; Tang, Wai-kwan; Gutierrez, Camilo; Zhang, Alex; Shukla, Suneet; Madigan, James P.; Zhou, Tongqing; Kwong, Peter D.; Ambudkar, Suresh V.; Gottesman, Michael M.; Xia, Di			Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; DRUG-BINDING; CRYSTAL-STRUCTURE; CATALYTIC CYCLE; NUCLEOTIDE; RESISTANCE; SITES; FLEXIBILITY; HYDROLYSIS; STATE	P-glycoprotein (P-gp) is a polyspecific ATP-dependent transporter linked to multidrug resistance in cancer; it plays important roles in determining the pharmacokinetics of many drugs. Understanding the structural basis of P-gp, substrate polyspecificity has been hampered by its intrinsic flexibility, which is facilitated by a 75-residue linker that connects the two halves of P-gp. Here we constructed a mutant murine P-gp with a shortened linker to facilitate structural determination. Despite dramatic reduction in rhodamine 123 and calcein-AM transport, the linker-shortened mutant P-gp possesses basal ATPase activity and binds ATP only in its N-terminal nucleotide-binding domain. Nine independently determined structures of wild type, the linker mutant, and a methylated P-gp at up to 3.3 angstrom resolution display significant movements of individual transmembrane domain helices, which correlated with the opening and closing motion of the two halves of P-gp. The open-and-close motion alters the surface topology of P-gp within the drug-binding pocket, providing a mechanistic explanation for the polyspecificity of P-gp in substrate interactions.	[Esser, Lothar; Zhou, Fei; Pluchino, Kristen M.; Ma, Jichun; Tang, Wai-kwan; Gutierrez, Camilo; Zhang, Alex; Shukla, Suneet; Madigan, James P.; Ambudkar, Suresh V.; Gottesman, Michael M.; Xia, Di] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37,Rm 2122C,37 Convent Dr, Bethesda, MD 20892 USA; [Shiloach, Joseph] NIDDK, Biotechnol Unit, NIH, Bethesda, MD 20892 USA; [Zhou, Tongqing; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Xia, D (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37,Rm 2122C,37 Convent Dr, Bethesda, MD 20892 USA.	xiad@mail.nih.gov	Zhou, Tongqing/A-6880-2010; Ambudkar, Suresh V/L-1317-2016	Zhou, Tongqing/0000-0002-3935-4637; 	Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005598, ZIABC010319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK015500] Funding Source: NIH RePORTER	Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020; Chufan EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082463; CORNWELL MM, 1987, FASEB J, V1, P51, DOI 10.1096/fasebj.1.1.2886389; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Hrycyna CA, 1998, BIOCHEMISTRY-US, V37, P13660, DOI 10.1021/bi9808823; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kapoor K, 2013, J BIOL CHEM, V288, P32622, DOI 10.1074/jbc.M113.498980; Kim YC, 2008, NAT METHODS, V5, P853, DOI 10.1038/nmeth1008-853; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Loo TW, 2014, J BIOL CHEM, V289, P8484, DOI 10.1074/jbc.M114.552075; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Ohnuma S, 2011, BIOCHEMISTRY-US, V50, P3724, DOI 10.1021/bi200073f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pluchino KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136396; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Shukla S, 2012, DRUG METAB DISPOS, V40, P304, DOI 10.1124/dmd.111.042721; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Sonveaux N, 1999, J BIOL CHEM, V274, P17649, DOI 10.1074/jbc.274.25.17649; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Wilkens Stephan, 2015, F1000Prime Rep, V7, P14, DOI 10.12703/P7-14; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	61	111	114	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					446	461		10.1074/jbc.M116.755884	http://dx.doi.org/10.1074/jbc.M116.755884			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27864369	Green Published, hybrid			2022-12-28	WOS:000392316100004
J	Kaur, A; Gautam, R; Srivastava, R; Chandel, A; Kumar, A; Karthikeyan, S; Bachhawat, AK				Kaur, Amandeep; Gautam, Ruchi; Srivastava, Ritika; Chandel, Avinash; Kumar, Akhilesh; Karthikeyan, Subramanian; Bachhawat, Anand Kumar			ChaC2, an Enzyme for Slow Turnover of Cytosolic Glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL CYCLOTRANSFERASES; CRYSTAL-STRUCTURE; PROTEIN; DEGRADATION; IDENTIFICATION; METABOLISM; PATHWAY; FAMILY	Glutathione degradation plays an important role in glutathione and redox homeostasis, and thus it is imperative to understand the enzymes and the mechanisms involved in glutathione degradation in detail. We describe here ChaC2, a member of the ChaC family of gamma-glutamylcyclotransferases, as an enzyme that degrades glutathione in the cytosol of mammalian cells. ChaC2 is distinct from the previously described ChaC1, to which ChaC2 shows similar to 50% sequence identity. Human and mouse ChaC2 proteins purified in vitro show 10 -20-fold lower catalytic efficiency than ChaC1, although they showed comparable K-m values (K-m of 3.7 +/- 0.4 mM and k(cat) of 15.9 +/- 1.0 min(-1) toward glutathione for human ChaC2; K-m of 2.2 +/- 0.4 mM and k(cat) of 225.2 +/- 15 min(-1) toward glutathione for human ChaC1). The ChaC1 and ChaC2 proteins also shared the same specificity for reduced glutathione, with no activity against either gamma-glutamyl amino acids or oxidized glutathione. The ChaC2 proteins were found to be expressed constitutively in cells, unlike the tightly regulated ChaC1. Moreover, lower eukaryotes have a single member of the ChaC family that appears to be orthologous to ChaC2. In addition, we determined the crystal structure of yeast ChaC2 homologue, GCG1, at 1.34 angstrom resolution, which represents the first structure of the ChaC family of proteins. The catalytic site is defined by a fortuitous benzoic acid molecule bound to the crystal structure. The mechanism for binding and catalytic activity of this new enzyme of glutathione degradation, which is involved in continuous but basal turnover of cytosolic glutathione, is proposed.	[Kaur, Amandeep; Chandel, Avinash; Kumar, Akhilesh; Bachhawat, Anand Kumar] Indian Inst Sci Educ & Res, Dept Biol Sci, Sas Nagar 140306, Punjab, India; [Gautam, Ruchi; Srivastava, Ritika; Karthikeyan, Subramanian] Council Sci & Ind Res CSIR, CSIR Inst Microbial Technol, Sect 39A, Chandigarh 160036, India; [Kumar, Akhilesh] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Miami	Bachhawat, AK (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Sas Nagar 140306, Punjab, India.; Karthikeyan, S (corresponding author), Council Sci & Ind Res CSIR, CSIR Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	skarthik@imtech.res.in; anand@iisermohali.ac.in		KAUR, AMANDEEP/0000-0002-2382-9327	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	We thank the EMBL staff Dr. Hassan Belrhali and Dr. Babu A. Manjasetty for providing support on the beamline and EMBL-DBT for providing access to the BM14 beamline at the ESRF. We also thank the Department of Biotechnology, Government of India for providing financial assistance to R. G. for collecting data at BM14.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Baudouin-Cornu P, 2012, J BIOL CHEM, V287, P4552, DOI 10.1074/jbc.M111.315705; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chi ZK, 2014, CELL REP, V7, P681, DOI 10.1016/j.celrep.2014.03.048; Crawford RR, 2015, J BIOL CHEM, V290, P15878, DOI 10.1074/jbc.M114.635144; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DeLano WL., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Fujiwara S, 2016, J BIOL CHEM, V291, P6813, DOI 10.1074/jbc.M115.678953; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hwang J, 2015, BIOCHEM BIOPH RES CO, V467, P218, DOI 10.1016/j.bbrc.2015.10.003; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kumar S, 2015, BIOCHEM J, V468, P73, DOI 10.1042/BJ20141154; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; Oakley AJ, 2010, J BIOL CHEM, V285, P9642, DOI 10.1074/jbc.M109.082099; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENNINCKX MJ, 1993, ADV MICROB PHYSIOL, V34, P239, DOI 10.1016/S0065-2911(08)60031-4; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Srikanth CV, 2005, CURR GENET, V47, P345, DOI 10.1007/s00294-005-0571-7; Steegborn C, 2001, STRUCTURE, V9, P1051, DOI 10.1016/S0969-2126(01)00665-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TATE SS, 1981, MOL CELL BIOCHEM, V39, P357, DOI 10.1007/BF00232585; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Winkler A, 2011, BIOCHEM BIOPH RES CO, V412, P121, DOI 10.1016/j.bbrc.2011.07.056; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	44	28	33	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					638	651		10.1074/jbc.M116.727479	http://dx.doi.org/10.1074/jbc.M116.727479			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27913623	Green Published, hybrid			2022-12-28	WOS:000392316100019
J	Zhang, YX; Li, Q; Youn, JY; Cai, H				Zhang, Yixuan; Li, Qiang; Youn, Ji Youn; Cai, Hua			Protein Phosphotyrosine Phosphatase 1B (PTP1B) in Calpain-dependent Feedback Regulation of Vascular Endothelial Growth Factor Receptor (VEGFR2) in Endothelial Cells IMPLICATIONS IN VEGF-DEPENDENT ANGIOGENESIS AND DIABETIC WOUND HEALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVATION; MICE; OVEREXPRESSION; EXPRESSION; PLATELETS; APOPTOSIS; INVASION; MODEL; NOTCH	The VEGF/VEGFR2/Akt/eNOS/NO pathway is essential to VEGF-induced angiogenesis. We have previously discovered a novel role of calpain in mediating VEGF-induced PI3K/AMPK/Akt/eNOS activation through Ezrin. Here, we sought to identify possible feedback regulation of VEGFR2 by calpain via its substrate protein phosphotyrosine phosphatase 1B (PTP1B), and the relevance of this pathway to VEGF-induced angiogenesis, especially in diabetic wound healing. Overexpression of PTP1B inhibited VEGF-induced VEGFR2 and Akt phosphorylation in bovine aortic endothelial cells, while PTP1B siRNA increased both, implicating negative regulation of VEGFR2 by PTP1B. Calpain inhibitor ALLN induced VEGFR2 activation, which can be completely blocked by PTP1B overexpression. Calpain activation induced by overexpression or Ca/A23187 resulted in PTP1B cleavage, which can be blocked by ALLN. Moreover, calpain activation inhibited VEGF-induced VEGFR2 phosphorylation, which can be restored by PTP1B siRNA. These data implicate calpain/PTP1B negative feedback regulation of VEGFR2, in addition to the primary signaling pathway of VEGF/VEGFR2/calpain/PI3K/AMPK/Akt/eNOS. Wenext examined a potential role of PTP1B in VEGF-induced angiogenesis. Endothelial cells transfected with PTP1B siRNA showed faster wound closure in response to VEGF. Aortic discs isolated from PTP1B siRNA-transfected mice also had augmented endothelial outgrowth. Importantly, PTP1B inhibition and/or calpain overexpression significantly accelerated wound healing in STZ-induced diabetic mice. In conclusion, our data for the first time demonstrate a calpain/PTP1B/VEGFR2 negative feedback loop in the regulation of VEGF-induced angiogenesis. Modulation of local PTP1B and/or calpain activities may prove beneficial in the treatment of impaired wound healing in diabetes.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA; [Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Cardiol,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Mol Med,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cai, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med & Cardiol, Dept Anesthesiol,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.; Cai, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med & Cardiol, Dept Med,Cardiovasc Res Labs, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.	hcai@mednet.ucla.edu		Zhang, Yixuan/0000-0001-7317-7235	National Heart, Lung and Blood Institute (NHLBI), National Institute of Health [HL077440, HL088975, HL108701, HL119968]; American Heart Association [12EIA8990025]; AHA Postdoctoral Fellowship Award [14POST20380995]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088975, R01HL077440, R01HL119968, R01HL108701] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI), National Institute of Health; American Heart Association(American Heart Association); AHA Postdoctoral Fellowship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute (NHLBI), National Institute of Health Grants HL077440 (to H. C.), HL088975 (to H. C.), HL108701 (to H. C., D. G. H.), HL119968 (to H. C.), an American Heart Association Established Investigator Award (EIA) 12EIA8990025 (to H. C.), and an AHA Postdoctoral Fellowship Award 14POST20380995 (to Y. X. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Besnier M, 2014, FASEB J, V28, P3351, DOI 10.1096/fj.13-245753; Blanes MG, 2007, J BIOL CHEM, V282, P10660, DOI 10.1074/jbc.M609048200; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Domingues I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025668; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Gao L, 2012, HYPERTENSION, V59, P158, DOI 10.1161/HYPERTENSIONAHA.111.181644; Gao L, 2009, J MOL CELL CARDIOL, V47, P752, DOI 10.1016/j.yjmcc.2009.07.025; Go Ronald S, 2003, Methods Mol Med, V85, P59; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Herre DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126866; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Lanahan AA, 2014, CIRCULATION, V130, P902, DOI 10.1161/CIRCULATIONAHA.114.009683; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Letavernier B, 2012, ARTERIOSCL THROM VAS, V32, P335, DOI 10.1161/ATVBAHA.111.240242; Liu C, 2014, HYPERTENSION, V63, P353, DOI 10.1161/HYPERTENSIONAHA.113.02361; Ma H, 2009, J OCUL PHARMACOL TH, V25, P409, DOI 10.1089/jop.2009.0030; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Oak JH, 2007, DIABETES, V56, P118, DOI 10.2337/db06-0288; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Suryawan A, 2003, AM J PHYSIOL-ENDOC M, V284, pE47, DOI 10.1152/ajpendo.00210.2002; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Tie L, 2009, AM J PHYSIOL-ENDOC M, V296, pE1423, DOI 10.1152/ajpendo.00150.2009; Wang H, 2008, DIABETES, V57, P540, DOI 10.2337/db07-0967; Wang Y, 2014, CELL REP, V6, P278, DOI 10.1016/j.celrep.2013.12.031; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.551; Youn JY, 2012, DIABETOLOGIA, V55, P2069, DOI 10.1007/s00125-012-2557-6; Youn JY, 2012, CLIN SCI, V123, P509, DOI 10.1042/CS20110407; Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467; Zheng Y, 2007, ARTERIOSCL THROM VAS, V27, P503, DOI 10.1161/01.ATV.0000256459.06671.3c	37	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					407	416		10.1074/jbc.M116.766832	http://dx.doi.org/10.1074/jbc.M116.766832			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27872190	Green Published, hybrid			2022-12-28	WOS:000392316100001
J	Kim, J; Park, C; Imlay, JA; Park, W				Kim, Jisun; Park, Chulwoo; Imlay, James A.; Park, Woojun			Lineage-specific SoxR-mediated Regulation of an Endoribonuclease Protects Non-enteric Bacteria from Redox-active Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACINETOBACTER-OLEIVORANS DR1; BURKHOLDERIA-XENOVORANS LB400; ESCHERICHIA-COLI; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; RNA-SEQ; STREPTOMYCES-COELICOLOR; PSEUDOMONAS-AERUGINOSA; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION	Bacteria use redox-sensitive transcription factors to coordinate responses to redox stress. The [2Fe-2S] cluster-containing transcription factor SoxR is particularly tuned to protect cells against redox-active compounds (RACs). In enteric bacteria, SoxR is paired with a second transcription factor, SoxS, that activates downstream effectors. However, SoxS is absent in nonenteric bacteria, raising questions as to how SoxR functions. Here, we first show that SoxR of Acinetobacter oleivorans displayed similar activation profiles in response to RACs as did its homolog from Escherichia coli but controlled a different set of target genes, including sinE, which encodes an endoribonuclease. Expression, gel mobility shift, and mutational analyses indicated that sinE is a direct target of SoxR. Redox potentials and permeability of RACs determined optimal sinE induction. Bioinformatics suggested that only a few gamma- and beta-proteobacteria might have SoxR-regulated sinE. Purified SinE, in the presence of Mg2+ ions, degrades rRNAs, thus inhibiting protein synthesis. Similarly, pretreatment of cells with RACs demonstrated a role for SinE in promoting persistence in the presence of antibiotics that inhibit protein synthesis. Our data improve our understanding of the physiology of soil microorganisms by suggesting that both non-enteric SoxR and its target SinE play protective roles in the presence of RACs and antibiotics.	[Kim, Jisun; Park, Chulwoo; Park, Woojun] Korea Univ, Dept Environm Sci & Ecol Engn, Lab Mol Environm Microbiol, Seoul 02841, South Korea; [Imlay, James A.] Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA	Korea University; University of Illinois System; University of Illinois Urbana-Champaign	Park, W (corresponding author), Korea Univ, Dept Environm Sci & Ecol Engn, Seoul 02841, South Korea.	wpark@korea.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2014R1A2A2A05007010]; Korea University Grant; National Institutes of Health [GM49640]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korea University Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Research Foundation of Korea (NRF) Grant NRF-2014R1A2A2A05007010 funded by the Korean government (MSIP) (to W. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a Korea University Grant.r Supported by National Institutes of Health Grant GM49640.	Carver T, 2010, BIOINFORMATICS, V26, P676, DOI 10.1093/bioinformatics/btq010; CHEN JJ, 1994, BIOCHIMIE, V76, P761, DOI 10.1016/0300-9084(94)90080-9; Dela Cruz R, 2010, J BACTERIOL, V192, P6428, DOI 10.1128/JB.00916-10; Denef VJ, 2006, APPL ENVIRON MICROB, V72, P585, DOI 10.1128/AEM.72.1.585-595.2006; Denef VJ, 2005, J BACTERIOL, V187, P7996, DOI 10.1128/JB.187.23.7996-8005.2005; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Dietrich LEP, 2011, MOL MICROBIOL, V79, P1119, DOI 10.1111/j.1365-2958.2011.07552.x; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Ding HG, 1996, J BIOL CHEM, V271, P33173, DOI 10.1074/jbc.271.52.33173; DRAPER WM, 1983, J AGR FOOD CHEM, V31, P734, DOI 10.1021/jf00118a014; Garg S, 2011, GEOCHIM COSMOCHIM AC, V75, P4310, DOI 10.1016/j.gca.2011.05.014; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; Heo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110215; HIDALGO E, 1994, EMBO J, V13, P138, DOI 10.1002/j.1460-2075.1994.tb06243.x; Hidalgo E, 1997, CELL, V88, P121, DOI 10.1016/S0092-8674(00)81864-4; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; Imlay JA, 2015, ANNU REV MICROBIOL, V69, P93, DOI 10.1146/annurev-micro-091014-104322; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jang IA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21121; Jung J, 2011, J MICROBIOL, V49, P208, DOI 10.1007/s12275-011-0395-8; Jung J, 2010, J BACTERIOL, V192, P4794, DOI 10.1128/JB.00722-10; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Kim J, 2015, APPL MICROBIOL BIOT, V99, P10611, DOI 10.1007/s00253-015-6914-5; Kim J, 2013, MICROBIOL-SGM, V159, P2616, DOI 10.1099/mic.0.070615-0; Kim J, 2013, J MICROBIOL BIOTECHN, V23, P1293, DOI 10.4014/jmb.1307.07059; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; Kwan BW, 2013, ANTIMICROB AGENTS CH, V57, P1468, DOI 10.1128/AAC.02135-12; Lee KL, 2015, MOL MICROBIOL, V97, P808, DOI 10.1111/mmi.13068; Leszczynska D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054737; Martin RG, 2003, METHOD ENZYMOL, V370, P278; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Miller JH., 1992, SHORT COURSE BACTERI, P72; Morishita R, 1999, J BIOL CHEM, V274, P20688, DOI 10.1074/jbc.274.29.20688; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naseer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106181; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; Okegbe C, 2012, ANTIOXID REDOX SIGN, V16, P658, DOI 10.1089/ars.2011.4249; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Pomposiello PJ, 2000, J BACTERIOL, V182, P23, DOI 10.1128/JB.182.1.23-29.2000; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Seo SW, 2015, CELL REP, V12, P1289, DOI 10.1016/j.celrep.2015.07.043; Sheplock R, 2013, MOL MICROBIOL, V87, P368, DOI 10.1111/mmi.12101; Shin JH, 2011, J BACTERIOL, V193, P75, DOI 10.1128/JB.00965-10; Singh AK, 2013, MOL MICROBIOL, V90, P983, DOI 10.1111/mmi.12410; Srinivasan VB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141314; Srinivasan VB, 2015, ANTIMICROB AGENTS CH, V59, P1236, DOI 10.1128/AAC.03626-14; Uppal S, 2008, FEMS MICROBIOL LETT, V279, P83, DOI 10.1111/j.1574-6968.2007.01009.x; Vercruysse M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004175; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617	54	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					121	133		10.1074/jbc.M116.757500	http://dx.doi.org/10.1074/jbc.M116.757500			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895125	Green Published, hybrid			2022-12-28	WOS:000391578000011
J	Alluri, H; Grimsley, M; Shaji, CA; Varghese, KP; Zhang, SYL; Peddaboina, C; Robinson, B; Beeram, MR; Huang, JH; Tharakan, B				Alluri, Himakarnika; Grimsley, Marcene; Shaji, Chinchusha Anasooya; Varghese, Kevin Paul; Zhang, Shenyuan L.; Peddaboina, Chander; Robinson, Bobby; Beeram, Madhava R.; Huang, Jason H.; Tharakan, Binu			Attenuation of Blood-Brain Barrier Breakdown and Hyperpermeability by Calpain Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; INJURY; PERMEABILITY; MATRIX-METALLOPROTEINASE-9; CLEAVAGE; EDEMA; DYSFUNCTION; MODULATION; INDUCTION	Blood-brain barrier (BBB) breakdown and the associated microvascular hyperpermeability followed by brain edema are hallmark features of several brain pathologies, including traumatic brain injuries (TBI). Recent studies indicate that pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) that is upregulated following traumatic injuries also promotes BBB dysfunction and hyperpermeability, but the underlying mechanisms are not clearly known. The objective of this study was to determine the role of calpains in mediating BBB dysfunction and hyperpermeability and to test the effect of calpain inhibition on theBBBfollowing traumatic insults to the brain. In these studies, rat brain microvascular endothelial cell monolayers exposed to calpain inhibitors (calpain inhibitor III and calpastatin) or transfected with calpain-1 siRNA demonstrated attenuation of IL-1 beta-induced monolayer hyperpermeability. Calpain inhibition led to protection against IL-1 beta-induced loss of zonula occludens-1 (ZO-1) at the tight junctions and alterations in F-actin cytoskeletal assembly. IL-1 beta treatment had no effect on ZO-1 gene (tjp1) or protein expression. Calpain inhibition via calpain inhibitor III and calpastatin decreased IL-1 beta-induced calpain activity significantly (p < 0.05). IL-1 beta had no detectable effect on intracellular calcium mobilization or endothelial cell viability. Furthermore, calpain inhibition preserved BBB integrity/permeability in a mouse controlled cortical impact model of TBI when studied using Evans blue assay and intravital microscopy. These studies demonstrate that calpain-1 acts as a mediator of IL-1 beta-induced loss of BBB integrity and permeability by altering tight junction integrity, promoting the displacement of ZO-1, and disorganization of cytoskeletal assembly. IL-1 beta-mediated alterations in permeability are neither due to the changes in ZO-1 expression nor cell viability. Calpain inhibition has beneficial effects against TBI-induced BBB hyperpermeability.	[Alluri, Himakarnika; Shaji, Chinchusha Anasooya; Peddaboina, Chander; Robinson, Bobby; Tharakan, Binu] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Surg,Coll Med, 702 SW HK Dodgen Loop, Temple, TX 76504 USA; [Huang, Jason H.] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Neurosurg,Coll Med, Temple, TX 76504 USA; [Beeram, Madhava R.] Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Pediat,Coll Med, Temple, TX 76504 USA; [Grimsley, Marcene] Texas Biosci Inst, Temple, TX 76502 USA; [Varghese, Kevin Paul] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Zhang, Shenyuan L.] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Physiol, Temple, TX 76504 USA	Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Tharakan, B (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Baylor Scott & White Hlth, Dept Surg,Coll Med, 702 SW HK Dodgen Loop, Temple, TX 76504 USA.	btharakan@medicine.tamhsc.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	Baylor Scott and White Health Academic Operations Research funds	Baylor Scott and White Health Academic Operations Research funds	This work was supported by Baylor Scott and White Health Academic Operations Research funds (to B. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Ali MAM, 2012, BIOCHEM BIOPH RES CO, V423, P1, DOI 10.1016/j.bbrc.2012.05.005; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alluri H, 2014, MICROCIRCULATION, V21, P187, DOI 10.1111/micc.12110; Anagli J, 2009, BIOCHEM BIOPH RES CO, V385, P94, DOI 10.1016/j.bbrc.2009.04.141; Blamire AM, 2000, J NEUROSCI, V20, P8153; Bralic M, 2012, COLLEGIUM ANTROPOL, V36, P1319; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; Chakraborti S, 2012, INDIAN J BIOCHEM BIO, V49, P316; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Elali A, 2011, STROKE, V42, P3238, DOI 10.1161/STROKEAHA.111.615559; Fei B, 2013, BBA-MOL CELL RES, V1833, P2153, DOI 10.1016/j.bbamcr.2013.05.010; Germano A, 2002, J NEUROTRAUM, V19, P887, DOI 10.1089/08977150260190474; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; Hu HX, 2009, MICROVASC RES, V78, P33, DOI 10.1016/j.mvr.2009.04.005; Jeong SY, 2013, P NATL ACAD SCI USA, V110, pE4007, DOI 10.1073/pnas.1316852110; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kotecki M, 2010, MICROVASC RES, V80, P339, DOI 10.1016/j.mvr.2010.07.012; Loot AE, 2013, J CARDIOVASC PHARM, V61, P528, DOI 10.1097/FJC.0b013e31828d0fa3; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Machida T, 2015, NEUROSCI LETT, V599, P109, DOI 10.1016/j.neulet.2015.05.028; Mayhan WG, 2001, MICROCIRCULATION, V8, P89, DOI 10.1038/sj.mn.7300154; Medeiros R, 2012, AM J PATHOL, V181, P616, DOI 10.1016/j.ajpath.2012.04.020; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Miyazaki T, 2011, CIRCULATION, V124, P2522, DOI 10.1161/CIRCULATIONAHA.111.021675; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; Pietsch M, 2010, CURR TOP MED CHEM, V10, P270, DOI 10.2174/156802610790725489; Prangsaengtong O, 2012, HUM CELL, V25, P36, DOI 10.1007/s13577-012-0042-7; Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Samantaray S, 2015, MOL NEUROBIOL, V52, P1054, DOI 10.1007/s12035-015-9255-6; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Toba S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01224; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Tsubokawa T, 2006, STROKE, V37, P1888, DOI 10.1161/01.STR.0000227259.15506.24; Wang T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-35; Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008; Yuan S. Y., 2010, C SERIES INTEGRATED, P39; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006; Zhao YZ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380469; Zhou MH, 2014, J BIOL CHEM, V289, P29446, DOI 10.1074/jbc.M114.578492	49	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					26958	26969		10.1074/jbc.M116.735365	http://dx.doi.org/10.1074/jbc.M116.735365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875293	hybrid, Green Published			2022-12-28	WOS:000391576300002
J	Davydova, N; Harris, NC; Roufail, S; Paquet-Fifield, S; Ishaq, M; Streltsov, VA; Williams, SP; Karnezis, T; Stacker, SA; Achen, MG				Davydova, Natalia; Harris, Nicole C.; Roufail, Sally; Paquet-Fifield, Sophie; Ishaq, Musarat; Streltsov, Victor A.; Williams, Steven P.; Karnezis, Tara; Stacker, Steven A.; Achen, Marc G.			Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VEGF-D PROMOTES; TUMOR LYMPHANGIOGENESIS; GENE-THERAPY; LYMPHATIC VESSELS; METASTASIS; SPECIFICITY; SPREAD; CANCER; LIGAND; ACTIVATION	VEGF-C and VEGF-D are secreted glycoproteins that induce angiogenesis and lymphangiogenesis in cancer, thereby promoting tumor growth and spread. They exhibit structural homology and activate VEGFR-2 and VEGFR-3, receptors on endothelial cells that signal for growth of blood vessels and lymphatics. VEGF-C and VEGF-D were thought to exhibit similar bioactivities, yet recent studies indicated distinct signaling mechanisms (e.g. tumor-derived VEGF-C promoted expression of the prostaglandin biosynthetic enzyme COX-2 in lymphatics, a response thought to facilitate metastasis via the lymphatic vasculature, whereas VEGF-D did not). Here we explore the basis of the distinct bioactivities of VEGF-D using a neutralizing antibody, peptide mapping, and mutagenesis to demonstrate that the N-terminal alpha-helix of mature VEGF-D (Phe(93)-Arg(108)) is critical for binding VEGFR-2 and VEGFR-3. Importantly, the N-terminal part of this alpha-helix, from Phe(93) to Thr(98), is required for binding VEGFR-3 but not VEGFR-2. Surprisingly, the corresponding part of the alpha-helix in mature VEGF-C did not influence binding to either VEGFR-2 or VEGFR-3, indicating distinct determinants of receptor binding by these growth factors. A variant of mature VEGF-D harboring a mutation in the N-terminal alpha-helix, D103A, exhibited enhanced potency for activating VEGFR-3, was able to promote increased COX-2 mRNA levels in lymphatic endothelial cells, and had enhanced capacity to induce lymphatic sprouting in vivo. This mutant may be useful for developing protein-based therapeutics to drive lymphangiogenesis in clinical settings, such as lymphedema. Our studies shed light on the VEGF-D structure/function relationship and provide a basis for understanding functional differences compared with VEGF-C.	[Davydova, Natalia; Harris, Nicole C.; Roufail, Sally; Paquet-Fifield, Sophie; Ishaq, Musarat; Williams, Steven P.; Karnezis, Tara; Stacker, Steven A.; Achen, Marc G.] Peter MacCallum Canc Ctr, Tumour Angiogenesis & Microenvironm Program, Melbourne, Vic 3000, Australia; [Streltsov, Victor A.] Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia; [Stacker, Steven A.; Achen, Marc G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia	Peter Maccallum Cancer Center; Florey Institute of Neuroscience & Mental Health; Peter Maccallum Cancer Center; University of Melbourne	Achen, MG (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic 3000, Australia.	marc.achen@petermac.org	Streltsov, Victor/M-9446-2019; Paquet-Fifield, Sophie/AAL-6410-2021	Streltsov, Victor/0000-0002-7846-4396; Stacker, Steven/0000-0003-4096-9273; Williams, Steven/0000-0002-9382-4337; Achen, Marc/0000-0002-3791-803X	National Health and Medical Research Council of Australia; Operational Infrastructure Support Program of the Victorian Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support Program of the Victorian Government	This work was supported by grants and fellowships from the National Health and Medical Research Council of Australia (to M. G. A. and S. A. S.) and the Operational Infrastructure Support Program of the Victorian Government. M. G. A. and S. A. S. are shareholders in Opthea Ltd. and are Inventors on patents assigned to Vegenics Pty. Ltd.	Achen MG, 2012, GROWTH FACTORS, V30, P283, DOI 10.3109/08977194.2012.704917; Achen MG, 2000, EUR J BIOCHEM, V267, P2505, DOI 10.1046/j.1432-1327.2000.01257.x; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Alitalo AK, 2013, CANCER RES, V73, P4212, DOI 10.1158/0008-5472.CAN-12-4539; Anisimov A, 2009, CIRC RES, V104, P1302, DOI 10.1161/CIRCRESAHA.109.197830; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; Baldwin ME, 2001, J BIOL CHEM, V276, P44307, DOI 10.1074/jbc.M106188200; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Chiu J, 2014, BIOCHEMISTRY-US, V53, P7, DOI 10.1021/bi401518b; Davydova N, 2012, PROTEIN EXPRES PURIF, V82, P232, DOI 10.1016/j.pep.2012.01.001; Davydova N, 2011, J MOL BIOL, V407, P581, DOI 10.1016/j.jmb.2011.02.009; Debinski W, 2001, MOL MED, V7, P598, DOI 10.1007/BF03401866; Duong T, 2014, BLOOD, V123, P1102, DOI 10.1182/blood-2013-04-495432; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; Harris NC, 2013, J BIOL CHEM, V288, P8176, DOI 10.1074/jbc.M112.439299; Harris NC, 2011, FASEB J, V25, P2615, DOI 10.1096/fj.10-179788; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Honkonen KM, 2013, ANN SURG, V257, P961, DOI 10.1097/SLA.0b013e31826ed043; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; Kajiya K, 2009, J INVEST DERMATOL, V129, P1292, DOI 10.1038/jid.2008.351; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Karpanen T, 2001, CANCER RES, V61, P1786; Le Guen L, 2014, DEVELOPMENT, V141, P1239, DOI 10.1242/dev.100495; Leppanen VM, 2013, P NATL ACAD SCI USA, V110, P12960, DOI 10.1073/pnas.1301415110; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005; Lyons TR, 2014, J CLIN INVEST, V124, P3901, DOI 10.1172/JCI73777; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; McColl BK, 2003, J EXP MED, V198, P863, DOI 10.1084/jem.20030361; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Norrmen C, 2011, CIRCULATION, V123, P1335, DOI 10.1161/CIRCULATIONAHA.107.704098; O-charoenrat P, 2001, CANCER-AM CANCER SOC, V92, P556, DOI 10.1002/1097-0142(20010801)92:3<556::AID-CNCR1355>3.0.CO;2-Q; Ober EA, 2004, EMBO REP, V5, P78, DOI 10.1038/sj.embor.7400047; Paquet-Fifield S, 2013, J INVEST DERMATOL, V133, P2074, DOI 10.1038/jid.2013.83; Saaristo A, 2002, J EXP MED, V196, P719, DOI 10.1084/jem.20020587; Sato T, 2016, J PATHOL, V239, P152, DOI 10.1002/path.4708; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2004, APMIS, V112, P539, DOI 10.1111/j.1600-0463.2004.apm11207-0812.x; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, FASEB J, V16, P922, DOI 10.1096/fj.01-0945rev; Stacker SA, 2016, JOVE-J VIS EXP, DOI 10.3791/53867; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Stacker SA, 2013, CHIN J CANCER, V32, P297, DOI 10.5732/cjc.012.10319; Swartz MA, 2014, CANCER IMMUNOL RES, V2, P701, DOI 10.1158/2326-6066.CIR-14-0115; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tervala TV, 2015, J SURG RES, V196, P200, DOI 10.1016/j.jss.2015.02.031; Toivanen PI, 2009, J BIOL CHEM, V284, P16037, DOI 10.1074/jbc.M109.001123; Visuri MT, 2015, ANGIOGENESIS, V18, P313, DOI 10.1007/s10456-015-9469-2; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Wise LM, 2003, J BIOL CHEM, V278, P38004, DOI 10.1074/jbc.M301194200; Yla-Herttuala S, 2013, GENE, V525, P217, DOI 10.1016/j.gene.2013.03.051; Yokoyama Y, 2003, BRIT J CANCER, V88, P237, DOI 10.1038/sj.bjc.6600701	67	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27265	27278		10.1074/jbc.M116.736801	http://dx.doi.org/10.1074/jbc.M116.736801			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27852824	Green Published, hybrid			2022-12-28	WOS:000391576300024
J	Bocedi, A; Fabrini, R; Lo Bello, M; Caccuri, AM; Federici, G; Mannervik, B; Cornish-Bowden, A; Ricci, G				Bocedi, Alessio; Fabrini, Raffaele; Lo Bello, Mario; Caccuri, Anna Maria; Federici, Giorgio; Mannervik, Bengt; Cornish-Bowden, Athel; Ricci, Giorgio			Evolution of Negative Cooperativity in Glutathione Transferase Enabled Preservation of Enzyme Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; DIGLUTATHIONYL-IRON COMPLEX; OF-THE-SITES; S-TRANSFERASE; ESCHERICHIA-COLI; NITRIC-OXIDE; DIMER INTERFACE; PHYSIOLOGICAL SIGNIFICANCE; POSITIVE COOPERATIVITY; PLASMODIUM-FALCIPARUM	Negative cooperativity in enzyme reactions, in which the first event makes subsequent events less favorable, is sometimes well understood at the molecular level, but its physiological role has often been obscure. Negative cooperativity occurs in human glutathione transferase (GST) GSTP1-1 when it binds and neutralizes a toxic nitric oxide adduct, the dinitrosyl-diglutathionyl iron complex (DNDGIC). However, the generality of this behavior across the divergent GST family and its evolutionary significance were unclear. To investigate, we studied 16 different GSTs, revealing that negative cooperativity is present only in more recently evolved GSTs, indicating evolutionary drift in this direction. In some variants, Hill coefficients were close to 0.5, the highest degree of negative cooperativity commonly observed (although smaller values of n(H) are theoretically possible). As DNDGIC is also a strong inhibitor of GSTs, we suggest negative cooperativity might have evolved to maintain a residual conjugating activity of GST against toxins even in the presence of high DNDGIC concentrations. Interestingly, two human isoenzymes that play a special protective role, safeguarding DNA from DNDGIC, display a classical half-of-the-sites interaction. Analysis of GST structures identified elements that could play a role in negative cooperativity in GSTs. Beside the well known lock-and-key and clasp motifs, other alternative structural interactions between subunits may be proposed for a few GSTs. Taken together, our findings suggest the evolution of self-preservation of enzyme function as a novel facility emerging from negative cooperativity.	[Bocedi, Alessio; Fabrini, Raffaele; Federici, Giorgio; Ricci, Giorgio] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Via Ric Sci 1, I-00133 Rome, Italy; [Lo Bello, Mario] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Caccuri, Anna Maria] Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00133 Rome, Italy; [Mannervik, Bengt] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden; [Cornish-Bowden, Athel] Aix Marseille Univ, CNRS, Bioenerget & Ingn Prot, Inst Microbiol Mediterranee, F-13009 Marseille, France	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; Stockholm University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ricci, G (corresponding author), Univ Roma Tor Vergata, Dept Chem Sci & Technol, Via Ric Sci 1, I-00133 Rome, Italy.	riccig@uniroma2.it	Cornish-Bowden, Athel/G-7362-2019; CACCURI, ANNA MARIA/AFU-2643-2022	Cornish-Bowden, Athel/0000-0001-6670-3006; 	grant "Consolidate the Foundations," University of Rome "Tor Vergata" [E82F16000810005]; Swedish Research Council	grant "Consolidate the Foundations," University of Rome "Tor Vergata"; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by the grant "Consolidate the Foundations," University of Rome "Tor Vergata" (E82F16000810005) and by a grant from the Swedish Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Abeliovich H, 2005, BIOPHYS J, V89, P76, DOI 10.1529/biophysj.105.060194; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Bocedi A, 2013, J BIOL CHEM, V288, P24936, DOI 10.1074/jbc.M113.476135; Boese M, 1997, J BIOL CHEM, V272, P21767, DOI 10.1074/jbc.272.35.21767; Caccuri AM, 1999, J BIOL CHEM, V274, P19276, DOI 10.1074/jbc.274.27.19276; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; CONWAY A, 1968, BIOCHEMISTRY-US, V7, P4011, DOI 10.1021/bi00851a031; Cornish-Bowden A, 2014, FEBS J, V281, P621, DOI 10.1111/febs.12469; Cornish-Bowden A, 2013, J THEOR BIOL, V319, P144, DOI 10.1016/j.jtbi.2012.12.010; CORNISHBOWDEN A, 1975, J THEOR BIOL, V51, P233, DOI 10.1016/0022-5193(75)90149-6; DANIELSON UH, 1985, BIOCHEM J, V231, P263, DOI 10.1042/bj2310263; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; EVANS CT, 1980, BIOCHEMISTRY-US, V19, P5809, DOI 10.1021/bi00566a023; Fabrini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014125; Gite SU, 1996, BIOCHEMISTRY-US, V35, P2658, DOI 10.1021/bi952640y; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayeshi R, 2007, FOOD CHEM TOXICOL, V45, P286, DOI 10.1016/j.fct.2006.07.027; Hegazy UM, 2004, J BIOL CHEM, V279, P9586, DOI 10.1074/jbc.M312320200; Hegazy UM, 2013, J MOL BIOL, V425, P1509, DOI 10.1016/j.jmb.2013.01.038; HERZFELD J, 1981, BIOCHEMISTRY-US, V20, P4936, DOI 10.1021/bi00520a020; Hornby JAT, 2002, BIOCHEMISTRY-US, V41, P14238, DOI 10.1021/bi020548d; JAKOBSON I, 1979, J BIOL CHEM, V254, P7085; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Labrou NE, 2000, EUR J BIOCHEM, V267, P6657, DOI 10.1046/j.1432-1327.2000.01761.x; Labrou NE, 2001, EUR J BIOCHEM, V268, P3950, DOI 10.1046/j.1432-1327.2001.02307.x; Laidler K. J., 1999, PHYS CHEM, P169; Larsson E, 2011, ANAL BIOCHEM, V412, P96, DOI 10.1016/j.ab.2011.01.024; Lee P, 1999, BIOCHEMISTRY-US, V38, P5754, DOI 10.1021/bi982779j; Liebau E, 2005, J BIOL CHEM, V280, P26121, DOI 10.1074/jbc.M503889200; Liebau E, 2009, J BIOL CHEM, V284, P22133, DOI 10.1074/jbc.M109.015198; Lien S, 2001, J BIOL CHEM, V276, P35599, DOI 10.1074/jbc.M103789200; Lo Bello M, 1998, J MOL BIOL, V284, P1717; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; LOBELLO M, 1995, J BIOL CHEM, V270, P1249; Lobysheva II, 1999, FEBS LETT, V454, P177, DOI 10.1016/S0014-5793(99)00777-2; Magnet S, 2001, BIOCHEMISTRY-US, V40, P3700, DOI 10.1021/bi002736e; MANNERVIK B, 1982, J BIOL CHEM, V257, P9909; MOCK WL, 1995, BIOORG MED CHEM LETT, V5, P627, DOI 10.1016/0960-894X(95)00085-8; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Paumi CM, 2004, BIOCHEMISTRY-US, V43, P2345, DOI 10.1021/bi035936+; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Protasevich II, 2004, BIOCHEMISTRY-US, V43, P13380, DOI 10.1021/bi0492509; REILLY RT, 1995, MOL PHARMACOL, V48, P72; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; RICCI G, 1995, J BIOL CHEM, V270, P1243, DOI 10.1074/jbc.270.3.1243; Ricci G, 2003, BIOCHEM J, V376, P71, DOI 10.1042/BJ20030860; RICCI G, 1989, J BIOL CHEM, V264, P5462; Rinaldi R, 2002, DRUG METAB DISPOS, V30, P1053, DOI 10.1124/dmd.30.10.1053; Rowe JD, 1997, BIOCHEM J, V325, P481, DOI 10.1042/bj3250481; Sayed Y, 2000, FEBS LETT, V465, P169, DOI 10.1016/S0014-5793(99)01747-0; Stella L, 2007, J BIOL CHEM, V282, P6372, DOI 10.1074/jbc.M609906200; Stenberg G, 2000, BIOCHEM BIOPH RES CO, V271, P59, DOI 10.1006/bbrc.2000.2579; TAHIR MK, 1986, J BIOL CHEM, V261, P1048; Taylor J.R., 1997, INTRO ERROR ANAL THE, V2nd ed., P45; TOMICH JM, 1981, BIOCHEMISTRY-US, V20, P6711, DOI 10.1021/bi00526a029; Vararattanavech A, 2003, PROTEIN PEPTIDE LETT, V10, P441, DOI 10.2174/0929866033478654; Vasilieva SV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P883, DOI 10.1023/B:BIRY.0000040220.13586.45; Wongsantichon J, 2006, BIOCHEM J, V394, P135, DOI 10.1042/BJ20050915; Xiao B, 1999, BIOCHEMISTRY-US, V38, P11887, DOI 10.1021/bi990468i	60	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26739	26749		10.1074/jbc.M116.749507	http://dx.doi.org/10.1074/jbc.M116.749507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27815499	hybrid, Green Published			2022-12-28	WOS:000391571400013
J	Pei, SS; Minhajuddin, M; D'Alessandro, A; Nemkov, T; Stevens, BM; Adane, B; Khan, N; Hagen, FK; Yadav, VK; De, S; Ashton, JM; Hansen, KC; Gutman, JA; Pollyea, DA; Crooks, PA; Smith, C; Jordan, CT				Pei, Shanshan; Minhajuddin, Mohammad; D'Alessandro, Angelo; Nemkov, Travis; Stevens, Brett M.; Adane, Biniam; Khan, Nabilah; Hagen, Fred K.; Yadav, Vinod K.; De, Subhajyoti; Ashton, John M.; Hansen, Kirk C.; Gutman, Jonathan A.; Pollyea, Daniel A.; Crooks, Peter A.; Smith, Clayton; Jordan, Craig T.			Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells (vol 291, pg 25280, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													D'Alessandro, Angelo/AAA-4695-2019; Minhajuddin, Mohammad/AAC-9227-2022; jordan, craig/D-7666-2014; Yadav, Vinod/J-9279-2014	D'Alessandro, Angelo/0000-0002-2258-6490; jordan, craig/0000-0003-0869-3465; Ashton, John/0000-0001-9875-5994; Yadav, Vinod/0000-0001-6450-7036				Pei SS, 2016, J BIOL CHEM, V291, P25280, DOI 10.1074/jbc.A116.750653	1	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25280	25280		10.1074/jbc.A116.750653	http://dx.doi.org/10.1074/jbc.A116.750653			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27888238	Green Published, hybrid			2022-12-28	WOS:000388880100043
J	Dhamija, S; Doerrie, A; Winzen, R; Dittrich-Breiholz, O; Taghipour, A; Kuehne, N; Kracht, M; Holtmann, H				Dhamija, Sonam; Doerrie, Anneke; Winzen, Reinhard; Dittrich-Breiholz, Oliver; Taghipour, Azadeh; Kuehne, Nancy; Kracht, Michael; Holtmann, Helmut			IL-1-induced post-transcriptional mechanisms target overlapping translational silencing and destabilizing elements in I kappa B zeta mRNA (vol 285, pg 29165, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Dhamija, Sonam/AAJ-2093-2020	Dhamija, Sonam/0000-0002-9569-2729; Kracht, Michael/0000-0002-8501-043X; Taghipour, Ali/0000-0001-7594-0097				Dhamija S, 2010, J BIOL CHEM, V285, P29165, DOI 10.1074/jbc.M110.146365	1	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24801	24801		10.1074/jbc.A110.146365	http://dx.doi.org/10.1074/jbc.A110.146365			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27864527	Green Published, hybrid			2022-12-28	WOS:000388875500038
J	Niewolik, D; Peter, I; Butscher, C; Schwarz, K				Niewolik, Doris; Peter, Ingrid; Butscher, Carmen; Schwarz, Klaus			Autoinhibition of the Nuclease ARTEMIS Is Mediated by a Physical Interaction between Its Catalytic and C-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; DNA-dependent serine; threonine protein kinase (DNA-PK); immunodeficiency; protein phosphorylation; protein-protein interaction; ARTEMIS; autoinhibition; NHEJ; V(D)J recombination	WISKOTT-ALDRICH-SYNDROME; DNA-LIGASE IV; B-CELL DIFFERENTIATION; STRAND BREAK REPAIR; V(D)J RECOMBINATION; DISEASE ALLELE; PROTEIN; PHOSPHORYLATION; MUTATIONS; COMPLEX	The nuclease ARTEMIS is essential for the development of B and T lymphocytes. It is required for opening DNA hairpins generated during antigen receptor gene assembly from variable (V), diversity (D), and joining (J) subgenic elements (V(D)J recombination). As a member of the non-homologous end-joining pathway, it is also involved in repairing a subset of pathological DNA double strand breaks. Loss of ARTEMIS function therefore results in radiosensitive severe combined immunodeficiency (RS-SCID). The hairpin opening activity is dependent on the DNA-dependent protein kinase catalytic subunit (DNA-PKcs), which can bind to and phosphorylate ARTEMIS. The ARTEMIS C terminus is dispensable for cellular V(D)J recombination and in vitro nuclease assays with C-terminally truncated ARTEMIS showing DNA-PKcs-independent hairpin opening activity. Therefore, it has been postulated that ARTEMIS is regulated via autoinhibition by its C terminus. To obtain evidence for the autoinhibition model, we performed co-immunoprecipitation experiments with combinations of ARTEMIS mutants. We show that an N-terminal fragment comprising the catalytic domain can interact both with itself and with a C-terminal fragment. Amino acid exchanges N456A+S457A+E458Q in the C terminus of full-length ARTEMIS resulted in unmasking of the N terminus and in increased ARTEMIS activity in cellular V(D)J recombination assays. Mutations in ARTEMIS-deficient patients impaired the interaction with the C terminus and also affected protein stability. The interaction between the N- and C-terminal domains was not DNA-PKcs-dependent, and phosphomimetic mutations in the C-terminal domain did not result in unmasking of the catalytic domain. Our experiments provide strong evidence that a physical interaction between the C-terminal and catalytic domains mediates ARTEMIS autoinhibition.	[Niewolik, Doris; Schwarz, Klaus] Univ Ulm, Inst Transfus Med, D-89081 Ulm, Germany; [Peter, Ingrid; Butscher, Carmen; Schwarz, Klaus] German Red Cross Blood Serv Baden Wuerttemberg He, Inst Clin Transfus Med & Immunogenet Ulm, D-89081 Ulm, Germany	Ulm University	Niewolik, D (corresponding author), Univ Ulm, Inst Transfus Med, D-89081 Ulm, Germany.	doris.niewolik@uni-ulm.de			Bundesministerium fuer Bildung und Forschung [01GM1517B]	Bundesministerium fuer Bildung und Forschung	Supported by Bundesministerium fuer Bildung und Forschung, Grant 01GM1517B.	Baretic D, 2014, CURR OPIN STRUC BIOL, V29, P134, DOI 10.1016/j.sbi.2014.11.003; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Chang HHY, 2016, NUCLEIC ACIDS RES, V44, P4991, DOI 10.1093/nar/gkw456; Chen L, 2005, CANCER SCI, V96, P134, DOI 10.1111/j.1349-7006.2005.00019.x; De Ioannes P, 2012, CELL REP, V2, P1505, DOI 10.1016/j.celrep.2012.11.004; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; de Miranda NFCC, 2011, ANN NY ACAD SCI, V1246, P50, DOI 10.1111/j.1749-6632.2011.06322.x; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Ege M, 2005, BLOOD, V105, P4179, DOI 10.1182/blood-2004-12-4861; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Huang Y, 2009, J EXP MED, V206, P893, DOI 10.1084/jem.20082396; Jacobs C, 2011, HUM MOL GENET, V20, P806, DOI 10.1093/hmg/ddq524; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lagresle-Peyrou C, 2008, MOL THER, V16, P396, DOI 10.1038/sj.mt.6300353; Li SC, 2014, J BIOL CHEM, V289, P7825, DOI 10.1074/jbc.M113.544874; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Malu S, 2012, J EXP MED, V209, P955, DOI 10.1084/jem.20111437; Massaad MJ, 2013, ANN NY ACAD SCI, V1285, P26, DOI 10.1111/nyas.12049; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Moshous D, 2003, J CLIN INVEST, V111, P381, DOI 10.1172/JCI200316774; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Noordzij JG, 2003, BLOOD, V101, P1446, DOI 10.1182/blood-2002-01-0187; Ochi T, 2014, DNA REPAIR, V17, P98, DOI 10.1016/j.dnarep.2014.02.010; Ochi T, 2013, STRUCTURE, V21, P672, DOI 10.1016/j.str.2013.02.014; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pannicke U, 2010, HUM MUTAT, V31, P197, DOI 10.1002/humu.21168; Perez-Becker Niehuis T, 2009, 26 ANN M ARB PAD IMM; Poinsignon C, 2004, EUR J IMMUNOL, V34, P3146, DOI 10.1002/eji.200425455; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rivera-Munoz P, 2016, GENE THER, V23, P176, DOI 10.1038/gt.2015.95; Soubeyrand S, 2006, J MOL BIOL, V358, P1200, DOI 10.1016/j.jmb.2006.02.061; SUWA A, 1994, P NATL ACAD SCI USA, V91, P6904, DOI 10.1073/pnas.91.15.6904; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; Wang JH, 2005, DNA REPAIR, V4, P556, DOI 10.1016/j.dnarep.2005.02.001; Wang JD, 2014, GENE DEV, V28, P2693, DOI 10.1101/gad.252478.114; Woodbine L, 2010, DNA REPAIR, V9, P1003, DOI 10.1016/j.dnarep.2010.07.001; Zhang XS, 2004, MOL CELL BIOL, V24, P9207, DOI 10.1128/MCB.24.20.9207-9220.2004	42	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3351	3365		10.1074/jbc.M116.770461	http://dx.doi.org/10.1074/jbc.M116.770461			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082683	Green Published, hybrid			2022-12-28	WOS:000395538800025
J	Yang, S; Qiang, L; Sample, A; Shah, P; He, YY				Yang, Seungwon; Qiang, Lei; Sample, Ashley; Shah, Palak; He, Yu-Ying			NF-B Signaling Activation Induced by Chloroquine Requires Autophagosome, p62 Protein, and c-Jun N-terminal Kinase (JNK) Signaling and Promotes Tumor Cell Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; melanoma; NF-B; p62 (sequestosome 1(SQSTM1)); tumor cell biology; chloroquine	KAPPA-B; CANCER; APOPTOSIS; SURVIVAL; TUMORIGENESIS; P62/SQSTM1; THERAPY; NRF2; ELIMINATION; INHIBITION	Macroautophagy (hereafter autophagy) is a catabolic cellular self-eating process by which unwanted organelles or proteins are delivered to lysosomes for degradation through autophagosomes. Although the role of autophagy in cancer has been shown to be context-dependent, the role of autophagy in tumor cell survival has attracted great interest in targeting autophagy for cancer therapy. One family of potential autophagy blockers is the quinoline-derived antimalarial family, including chloroquine (CQ). However, the molecular basis for tumor cell response to CQ remains poorly understood. We show here that in both squamous cell carcinoma cells and melanoma tumor cells, CQ induced NF-B activation and the expression of its target genes HIF-1, IL-8, BCL-2, and BCL-XL through the accumulation of autophagosomes, p62, and JNK signaling. The activation of NF-B further increased p62 gene expression. Either genetic knockdown of p62 or inhibition of NF-B sensitized tumor cells to CQ, resulting in increased apoptotic cell death following treatment. Our findings provide new molecular insights into the CQ response in tumor cells and CQ resistance in cancer therapy. These findings may facilitate development of improved therapeutic strategies by targeting the p62/NF-B pathway.	[Yang, Seungwon; Qiang, Lei; Sample, Ashley; Shah, Palak; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Sample, Ashley; He, Yu-Ying] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu	Qiang, Lei/B-2763-2012; Yang, Seungwon/AAM-7585-2021	Qiang, Lei/0000-0002-7164-3164; 	National Institutes of Health [ES024373]; NIEHS [ES016936]; American Cancer Society [RSG-13-078-01]; University of Chicago Cancer Research Center [P30 CA014599]; CTSA [UL1 TR000430]; University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024373, R01ES016936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Cancer Society(American Cancer Society); University of Chicago Cancer Research Center; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Chicago Friends of Dermatology Endowment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants ES024373 and ES016936 from NIEHS (to Y.-Y.H.), American Cancer Society Grant RSG-13-078-01 (to Y.-Y.H.), University of Chicago Cancer Research Center Grant P30 CA014599, CTSA Grant UL1 TR000430, and the University of Chicago Friends of Dermatology Endowment Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; CANN HM, 1961, PEDIATRICS, V27, P95; CANN HM, 1960, AM J DIS CHILD, V100, P797; Chang MA, 2014, PROSTATE, V74, P149, DOI 10.1002/pros.22737; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Encyclopaedia Britannica, 2009, LEAF NOS BAT; Eng CH, 2016, P NATL ACAD SCI USA, V113, P182, DOI 10.1073/pnas.1515617113; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; LaGory EL, 2016, NAT CELL BIOL, V18, P356, DOI 10.1038/ncb3330; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954; Maes H, 2014, CANCER CELL, V26, P190, DOI 10.1016/j.ccr.2014.06.025; Maes H, 2013, TRENDS MOL MED, V19, P428, DOI 10.1016/j.molmed.2013.04.005; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; OCHSENDORF FR, 1991, HAUTARZT, V42, P140; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Plowe CV, 2005, CURR TOP MICROBIOL, V295, P55; Qiang L, 2016, AUTOPHAGY, V12, P357, DOI 10.1080/15548627.2015.1110667; Qiang L, 2014, P NATL ACAD SCI USA, V111, P9241, DOI 10.1073/pnas.1322913111; Rebecca VW, 2016, ONCOGENE, V35, P1, DOI 10.1038/onc.2015.99; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rynes RI, 1997, BRIT J RHEUMATOL, V36, P799; Salas E, 2016, ONCOGENE, V35, P2913, DOI 10.1038/onc.2015.348; Selvaag E, 1997, J TOXICOL-CUTAN OCUL, V16, P5, DOI 10.3109/15569529709048883; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Son YO, 2014, J BIOL CHEM, V289, P28660, DOI 10.1074/jbc.M114.595496; Trocoli A, 2014, CELL DEATH DIFFER, V21, P1852, DOI 10.1038/cdd.2014.102; Uhlemann AC, 2005, CURR TOP MICROBIOL, V295, P39; Vadlamudi RK, 1998, FEBS LETT, V435, P138, DOI 10.1016/S0014-5793(98)01021-7; Vessoni AT, 2013, CELL DEATH DIFFER, V20, P1444, DOI 10.1038/cdd.2013.103; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088489; Yang S, 2012, BIOMATERIALS, V33, P2902, DOI 10.1016/j.biomaterials.2011.12.051; Yang S, 2011, BIOMATERIALS, V32, P2851, DOI 10.1016/j.biomaterials.2011.01.015; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Zhao BZ, 2014, J BIOL CHEM, V289, P35806, DOI 10.1074/jbc.M114.595397; Zhi Xiaoyong, 2015, F1000Prime Rep, V7, P18, DOI 10.12703/P7-18; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057	53	44	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3379	3388		10.1074/jbc.M116.756536	http://dx.doi.org/10.1074/jbc.M116.756536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082672	Green Published, hybrid			2022-12-28	WOS:000395538800027
J	Jusu, S; Presley, JF; Kremer, R				Jusu, Sylvester; Presley, John F.; Kremer, Richard			Phosphorylation of Human Retinoid X Receptor alpha at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1 alpha,25-Dihydroxyvitamin D-3-dependent DNA Binding in Ras-transformed Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; HUMAN HEPATOCELLULAR-CARCINOMA; CANCER CELL-LINES; ANALOG EB 1089; BREAST-CANCER; LIVING CELLS; RXR-ALPHA; HISTONE H1; MYELODYSPLASTIC SYNDROMES; HETERODIMER FORMATION	Human retinoid X receptor alpha (hRXR alpha) plays a critical role in DNA binding and transcriptional activity through heterodimeric association with several members of the nuclear receptor superfamily, including the human vitamin D receptor (hVDR). We previously showed that hRXR alpha phosphorylation at serine 260 through the Ras-Raf-MAPK ERK1/2 activation is responsible for resistance to the growth inhibitory effects of 1 alpha,25-dihy-droxyvitamin D-3 (1 alpha,25(OH)(2)D-3), the biologically active metabolite of vitamin D-3. To further investigate the mechanism of this resistance, we studied intranuclear dynamics of hVDR and hRXR alpha-tagged constructs in living cells together with endogenous and tagged protein in fixed cells. We find that hVDR-, hRXR alpha-, and hVDR-hRXR alpha complex accumulate in the nucleus in 1 alpha,25(OH)(2)D-3-treated HPK1A cells but to a lesser extent in HPK1A Ras-treated cells. Also, by using fluorescence resonance energy transfer (FRET), we demonstrate increased interaction of the hVDR-hRXR alpha complex in 1 alpha,25(OH)(2)D-3-treated HPK1A but not HPK1ARas cells. In HPK1ARas cells, 1 alpha,25(OH)(2)D-3-induced nuclear localization and interaction of hRXR alpha are restored when cells are treated with the MEK1/2 inhibitor UO126 or following transfection of the non-phosphorylatable hRXR alpha Ala-260 mutant. Finally, we demonstrate using fluorescence loss in photobleaching and quantitative co-localization with chromatin that RXR immobilization and co-localization with chromatin are significantly increased in 1 alpha,25(OH)(2)D(3)treated HPK1ARas cells transfected with the non-phosphory-latable hRXR alpha Ala-260 mutant. This suggests that hRXR alpha phosphorylation significantly disrupts its nuclear localization, interaction with VDR, intra-nuclear trafficking, and binding to chromatin of the hVDR-hRXR complex.	[Jusu, Sylvester; Kremer, Richard] McGill Univ, Royal Victoria Hosp, Calcium Res Lab, Dept Med, Montreal, PQ H4A 3J1, Canada; [Presley, John F.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Jusu, Sylvester; Kremer, Richard] McGill Univ, Ctr Hlth, Dept Med, Expt Therapeut & Metab Program, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada	McGill University; Royal Victoria Hospital; McGill University; McGill University	Kremer, R (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Expt Therapeut & Metab Program, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.	richard.kremer@mcgill.ca		Kremer, Richard/0000-0002-7053-2139	Canadian Institutes of Health Research [MOP10839]; Natural Sciences and Engineering Research Council of Canada [RGPIN 262040]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Grant MOP10839 from Canadian Institutes of Health Research (to R. K.) and Grant RGPIN 262040 from Natural Sciences and Engineering Research Council of Canada (to J. F. P.). The authors declare that they have no conflicts of interest with the contents of this article.	ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Aguirre RS, 2013, MOL PHARMACOL, V84, P218, DOI 10.1124/mol.113.085555; Akiyama N, 2010, LEUKEMIA RES, V34, P1151, DOI 10.1016/j.leukres.2010.04.006; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Avis I, 2005, CANCER RES, V65, P4181, DOI 10.1158/0008-5472.CAN-04-3441; BARSONY J, 1990, J CELL BIOL, V111, P2385, DOI 10.1083/jcb.111.6.2385; Barsony J, 1997, J BIOL CHEM, V272, P5774, DOI 10.1074/jbc.272.9.5774; Barsony J., 1997, MICROSC MICROANAL, P131; Bettoun DJ, 2003, MOL ENDOCRINOL, V17, P2320, DOI 10.1210/me.2003-0148; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; Bikle DD, 2012, CURR OSTEOPOROS REP, V10, P151, DOI 10.1007/s11914-012-0098-z; Bikle DD, 2012, REV ENDOCR METAB DIS, V13, P3, DOI 10.1007/s11154-011-9194-0; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub3; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Brosseau C, 2012, APOPTOSIS, V17, P164, DOI 10.1007/s10495-011-0670-5; Carlberg C, 2001, STEROIDS, V66, P213, DOI 10.1016/S0039-128X(00)00150-1; Chandler PD, 2014, CANCER EPIDEM BIOMAR, V23, P1944, DOI 10.1158/1055-9965.EPI-14-0522; Chen JX, 2016, J TISSUE ENG REGEN M, V10, P40, DOI 10.1002/term.1770; COLSTON K, 1981, ENDOCRINOLOGY, V108, P1083, DOI 10.1210/endo-108-3-1083; COLSTON KW, 1994, GUT, V35, P1219, DOI 10.1136/gut.35.9.1219; Colston KW, 2002, ENDOCR-RELAT CANCER, V9, P45, DOI 10.1677/erc.0.0090045; Crowe DL, 2004, BREAST CANCER RES, V6, pR546, DOI 10.1186/bcr913; Davis CD, 2008, AM J CLIN NUTR, V88, p565S, DOI 10.1093/ajcn/88.2.565S; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Dong D, 1998, BIOCHEMISTRY-US, V37, P10691, DOI 10.1021/bi980561r; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; El Abdaimi K, 2000, CANCER RES, V60, P4412; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Fujioka T, 1998, J UROLOGY, V160, P247, DOI 10.1016/S0022-5347(01)63098-2; Getzenberg RH, 1997, UROLOGY, V50, P999, DOI 10.1016/S0090-4295(97)00408-1; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Gulliford T, 1998, BRIT J CANCER, V78, P6, DOI 10.1038/bjc.1998.434; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; HELLSTROM E, 1990, EUR J HAEMATOL, V45, P255; Huang DC, 2002, MOL CANCER RES, V1, P56; Jain RK, 2011, INVEST NEW DRUG, V29, P1420, DOI 10.1007/s10637-010-9492-5; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Kane KF, 1996, CANCER RES, V56, P623; Kanemura N, 2008, LEUKEMIA RES, V32, P884, DOI 10.1016/j.leukres.2007.11.005; Konopleva M, 2004, MOL CANCER THER, V3, P1249; Kuusisto HV, 2012, FASEB J, V26, P1181, DOI 10.1096/fj.11-191585; Lee HY, 2000, J BIOL CHEM, V275, P32193, DOI 10.1074/jbc.M005490200; Li DS, 2002, MOL CELL BIOL, V22, P5782, DOI 10.1128/MCB.22.16.5782-5792.2002; Li J., 2016, IEEE T COMPUT, V1, P1, DOI DOI 10.1038/0NC.2016.90; Li M, 2001, DEVELOPMENT, V128, P675; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LU MJ, 1995, MOL BIOL CELL, V6, P1077, DOI 10.1091/mbc.6.8.1077; Lu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035722; Macoritto M, 2008, J BIOL CHEM, V283, P4943, DOI 10.1074/jbc.M707517200; Matsushima-Nishiwaki R, 2003, CARCINOGENESIS, V24, P1353, DOI 10.1093/carcin/bgg090; Matsushima-Nishiwaki R, 2001, CANCER RES, V61, P7675; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Moriwaki H, 2007, HEPATOL RES, V37, pS299, DOI 10.1111/j.1872-034X.2007.00201.x; Narayanan R, 2004, J BIOL CHEM, V279, P47298, DOI 10.1074/jbc.M404101200; Olmos-Ortiz A, 2015, NUTRIENTS, V7, P443, DOI 10.3390/nu7010443; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; Petrich A, 2008, LEUKEMIA LYMPHOMA, V49, P57, DOI 10.1080/10428190701713648; Pike JW, 2010, ENDOCRIN METAB CLIN, V39, P255, DOI 10.1016/j.ecl.2010.02.007; Polek TC, 2002, J ANDROL, V23, P9, DOI 10.1002/j.1939-4640.2002.tb02596.x; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Prufer K, 2000, J BIOL CHEM, V275, P41114, DOI 10.1074/jbc.M003791200; Quack M, 2000, MOL PHARMACOL, V57, P375; Racz A, 1999, J BIOL CHEM, V274, P19352, DOI 10.1074/jbc.274.27.19352; Rawson JB, 2012, NUTR CANCER, V64, P919, DOI 10.1080/01635581.2012.711418; Rossdeutscher L, 2015, CANCER PREV RES, V8, P120, DOI 10.1158/1940-6207.CAPR-14-0110; Schwartz GG, 2005, CLIN CANCER RES, V11, P8680, DOI 10.1158/1078-0432.CCR-05-1237; SEBAG M, 1992, J BIOL CHEM, V267, P12162; Shevde NK, 2002, P NATL ACAD SCI USA, V99, P13487, DOI 10.1073/pnas.202471299; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Solomon C, 1999, J CLIN INVEST, V103, P1729, DOI 10.1172/JCI6871; Solomon C, 2001, RADIAT RES, V155, P156, DOI 10.1667/0033-7587(2001)155[0156:VDRIRT]2.0.CO;2; Solomon C, 1998, J BIOL CHEM, V273, P17573, DOI 10.1074/jbc.273.28.17573; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Suda T., 1986, BONE MINERAL RES, V4, P1; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; van Leeuwen JPTM, 2001, CRIT REV EUKAR GENE, V11, P199; Yamazaki K, 2007, GUT, V56, P1557, DOI 10.1136/gut.2007.129858; Yasmin R, 2005, J BIOL CHEM, V280, P40152, DOI 10.1074/jbc.M507708200; YU JA, 1995, ANTI-CANCER DRUG, V6, P101, DOI 10.1097/00001813-199502000-00012; Zhang ZT, 2010, J CELL PHYSIOL, V224, P433, DOI 10.1002/jcp.22139	86	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1490	1509		10.1074/jbc.M116.758185	http://dx.doi.org/10.1074/jbc.M116.758185			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27852823	hybrid, Green Published			2022-12-28	WOS:000393339800029
J	Papadopoulos, T; Rhee, HJ; Subramanian, D; Paraskevopoulou, F; Mueller, R; Schultz, C; Brose, N; Rhee, JS; Betz, H				Papadopoulos, Theofilos; Rhee, Hong Jun; Subramanian, Devaraj; Paraskevopoulou, Foteini; Mueller, Rainer; Schultz, Carsten; Brose, Nils; Rhee, Jeong-Seop; Betz, Heinrich			Endosomal Phosphatidylinositol 3-Phosphate Promotes Gephyrin Clustering and GABAergic Neurotransmission at Inhibitory Postsynapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II PHOSPHOINOSITIDE 3-KINASE; RECEPTOR-ASSOCIATED PROTEIN; GLYCINE RECEPTOR; PLASMA-MEMBRANE; DEFICIENT MICE; ALPHA-ISOFORM; COLLYBISTIN; ACTIVATION; TRAFFICKING; SYNAPSES	The formation of neuronal synapses and the dynamic regulation of their efficacy depend on the proper assembly of the postsynaptic neurotransmitter receptor apparatus. Receptor recruitment to inhibitory GABAergic postsynapses requires the scaffold protein gephyrin and the guanine nucleotide exchange factor collybistin (Cb). In vitro, the pleckstrin homology domain of Cb binds phosphoinositides, specifically phosphatidylinositol 3-phosphate (PI3P). However, whether PI3P is required for inhibitory postsynapse formation is currently unknown. Here, we investigated the role of PI3P at developing GABAergic postsynapses by using a membrane-permeant PI3P derivative, time-lapse confocal imaging, electrophysiology, as well as knockdown and overexpression of PI3P-metabolizing enzymes. Our results provide the first in cellula evidence that PI3P located at early/sorting endosomes regulates the postsynaptic clustering of gephyrin and GABAA receptors and the strength of inhibitory, but not excitatory, postsynapses in cultured hippocampal neurons. In human embryonic kidney 293 cells, stimulation of gephyrin cluster formation by PI3P depends on Cb. We therefore conclude that the endosomal pool of PI3P, generated by the class III phosphatidylinositol 3-kinase, is important for the Cb-mediated recruitment of gephyrin and GABAA receptors to developing inhibitory postsynapses and thus the formation of postsynaptic membrane specializations.	[Papadopoulos, Theofilos; Paraskevopoulou, Foteini] Univ Med Gottingen, Dept Mol Biol, Ctr Biochem & Mol Cell Biol, Humboldtallee 23, D-37073 Gottingen, Germany; [Rhee, Hong Jun; Brose, Nils; Rhee, Jeong-Seop] Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany; [Subramanian, Devaraj; Mueller, Rainer; Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Schultz, Carsten] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA; [Betz, Heinrich] Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany; [Betz, Heinrich] Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany; [Paraskevopoulou, Foteini] Charite, NeuroCure Cluster Excellence, Charitepl 1, D-10117 Berlin, Germany	University of Gottingen; Max Planck Society; European Molecular Biology Laboratory (EMBL); Oregon Health & Science University; Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Papadopoulos, T (corresponding author), Univ Med Gottingen, Dept Mol Biol, Ctr Biochem & Mol Cell Biol, Humboldtallee 23, D-37073 Gottingen, Germany.	theofilos.papadopoulos@med.uni-goettingen.de		Papadopoulos, Theofilos/0000-0002-0684-2407; Mueller, Rainer/0000-0003-3464-494X	German Research Foundation [PA2087/1-3, SFB1190/P10, TRR83]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grants PA2087/1-3 (to T. P.), SFB1190/P10 (to N. B.), and TRR83 (to C. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Brown RA, 1999, J BIOL CHEM, V274, P14529, DOI 10.1074/jbc.274.21.14529; Brown RA, 2001, BIOCHEM SOC T, V29, P535, DOI 10.1042/BST0290535; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Burgalossi A, 2012, NAT PROTOC, V7, P1351, DOI 10.1038/nprot.2012.074; Chiou TT, 2011, J BIOL CHEM, V286, P22456, DOI 10.1074/jbc.M111.236190; El Sheikh Soha Salama, 2003, BMC Clin Pathol, V3, P4, DOI 10.1186/1472-6890-3-4; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Ketel K, 2016, NATURE, V529, P408, DOI 10.1038/nature16516; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Ktori C, 2003, BIOCHEM BIOPH RES CO, V306, P139, DOI 10.1016/S0006-291X(03)00933-1; Lionel AC, 2013, HUM MOL GENET, V22, P2055, DOI 10.1093/hmg/ddt056; Long P, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00083; Ludolphs M, 2016, J BIOL CHEM, V291, P244, DOI 10.1074/jbc.M115.673400; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Marat AL, 2016, EMBO J, V35, P561, DOI 10.15252/embj.201593564; Mayer S, 2013, P NATL ACAD SCI USA, V110, P20795, DOI 10.1073/pnas.1309078110; Mentel M, 2011, ANGEW CHEM INT EDIT, V50, P3811, DOI 10.1002/anie.201007796; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Nair R, 2013, J CELL BIOL, V200, P61, DOI 10.1083/jcb.201207113; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Papadopoulos T, 2015, J BIOL CHEM, V290, P8256, DOI 10.1074/jbc.M114.633024; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Raiborg C, 2013, FEBS J, V280, P2730, DOI 10.1111/febs.12116; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; SEITANIDOU T, 1992, J NEUROSCI, V12, P116; Soykan T, 2014, EMBO J, V33, P2113, DOI 10.15252/embj.201488143; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stopkova P, 2004, BIOL PSYCHIAT, V55, P981, DOI 10.1016/j.biopsych.2004.01.014; Subramanian D, 2010, NAT CHEM BIOL, V6, P324, DOI 10.1038/nchembio.348; Traer Colin J, 2006, Bull Cancer, V93, pE53; Tyagarajan SK, 2011, J CELL SCI, V124, P2786, DOI 10.1242/jcs.086199; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Wuchter J, 2012, J NEUROSCI, V32, P14821, DOI 10.1523/JNEUROSCI.1261-12.2012	59	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1160	1177		10.1074/jbc.M116.771592	http://dx.doi.org/10.1074/jbc.M116.771592			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27941024	Green Published, hybrid			2022-12-28	WOS:000393339800002
J	Diez, MDA; Miah, F; Stevenson, CEM; Lawson, DM; Iglesias, AA; Bornemann, S				Asencion Diez, Matias D.; Miah, Farzana; Stevenson, Clare E. M.; Lawson, David M.; Iglesias, Alberto A.; Bornemann, Stephen			The Production and Utilization of GDP-glucose in the Biosynthesis of Trehalose 6-Phosphate by Streptomyces venezuelae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ENZYMATIC-SYNTHESIS; COELICOLOR A3(2); ALPHA-GLUCAN; MACROMOLECULAR CRYSTALLOGRAPHY; MANNOSE PYROPHOSPHORYLASE; CARBOHYDRATE-METABOLISM; STRUCTURE VALIDATION; DIPHOSPHATE-GLUCOSE; MOLECULAR-GRAPHICS	Trehalose-6-phosphate synthase OtsA from streptomycetes is unusual in that it uses GDP-glucose as the donor substrate rather than the more commonly used UDP-glucose. We now confirm that OtsA from Streptomyces venezuelae has such a preference for GDP-glucose and can utilize ADP-glucose to some extent too. A crystal structure of the enzyme shows that it shares twin Rossmann-like domains with the UDP-glucose-specific OtsA from Escherichia coli. However, it is structurally more similar to Streptomyces hygroscopicus VldE, a GDP-valienol-dependent pseudoglycosyltransferase enzyme. Comparison of the donor binding sites reveals that the amino acids associated with the binding of diphosphoribose are almost all identical in these three enzymes. By contrast, the amino acids associated with binding guanine in VldE (Asn, Thr, and Val) are similar in S. venezuelae OtsA (Asp, Ser, and Phe, respectively) but not conserved in E. coli OtsA (His, Leu, and Asp, respectively), providing a rationale for the purine base specificity of S. venezuelae OtsA. To establish which donor is used in vivo, we generated an otsA null mutant in S. venezuelae. The mutant had a cell density-dependent growth phenotype and accumulated galactose 1-phosphate, glucose 1-phosphate, and GDP-glucose when grown on galactose. To determine how the GDP-glucose is generated, we characterized three candidate GDP-glucose pyrophosphorylases. SVEN_3027 is a UDP-glucose pyrophosphorylase, SVEN_ 3972 is an unusual ITP-mannose pyrophosphorylase, and SVEN_2781 is a pyrophosphorylase that is capable of generating GDP-glucose as well as GDP-mannose. We have therefore established how S. venezuelae can make and utilize GDP-glucose in the biosynthesis of trehalose 6-phosphate.	[Miah, Farzana; Stevenson, Clare E. M.; Lawson, David M.; Bornemann, Stephen] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Asencion Diez, Matias D.; Iglesias, Alberto A.] CCT Santa Fe, Lab Enzimol Mol, Inst Agrobiotecnol Litoral UNL CONICET, Fac Bioquim & Ciencias Biol, Colectora Ruta Nac 168 Km 0, RA-3000 Santa Fe, Argentina	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral	Bornemann, S (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stephen.bornemann@jic.ac.uk	Bornemann, Stephen/K-2938-2012	Bornemann, Stephen/0000-0001-5930-9473; Iglesias, Alberto/0000-0001-9729-7338; Asencion Diez, Matias Damian/0000-0001-6495-387X	United Kingdom Biotechnology and Biological Sciences Research Council [BB/F017294/1]; Institute Strategic Programme Grant [BB/J004561/1]; John Innes Foundation; European Molecular Biology Organization [ASTF537-2014]; CONICET; UNL; ANPCyT [PICT'15 1767]; BBSRC [BBS/E/J/000C0647] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0647] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Strategic Programme Grant; John Innes Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNL; ANPCyT(ANPCyT); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Doctoral Training Grant BB/F017294/1 and Institute Strategic Programme Grant BB/J004561/1, the John Innes Foundation, and the European Molecular Biology Organization (short term fellowship grant ASTF537-2014). The work in Argentina was supported by CONICET, UNL, and ANPCyT (PICT'15 1767). The authors declare that they have no conflicts of interest with the contents of this article.	Diez MDA, 2015, BBA-GEN SUBJECTS, V1850, P13, DOI 10.1016/j.bbagen.2014.09.023; Diez MDA, 2012, J BACTERIOL, V194, P1485, DOI 10.1128/JB.06377-11; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Barber G.A., 1966, METHOD ENZYMOL, V8, P266; BRUTON CJ, 1995, MOL MICROBIOL, V18, P89, DOI 10.1111/j.1365-2958.1995.mmi_18010089.x; Bush MJ, 2015, NAT REV MICROBIOL, V13, P749, DOI 10.1038/nrmicro3546; CARLSON DM, 1962, J BIOL CHEM, V237, P1260; Cavalier MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044934; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; ELBEIN AD, 1967, J BACTERIOL, V94, P1520, DOI 10.1128/JB.94.5.1520-1524.1967; ELBEIN AD, 1967, J BIOL CHEM, V242, P403; ELBEIN AD, 1968, J BACTERIOL, V96, P1623, DOI 10.1128/JB.96.5.1623-1631.1968; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Fusari C, 2006, ANAL BIOCHEM, V352, P145, DOI 10.1016/j.ab.2006.01.024; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hansen R. G., 1966, METHOD ENZYMOL, V8, P269; HEYFERGU.A, 1973, J BACTERIOL, V116, P1084, DOI 10.1128/JB.116.2.1084-1085.1973; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; KAWAGUCHI K, 1973, AGR BIOL CHEM TOKYO, V37, P75, DOI 10.1080/00021369.1973.10860641; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Koliwer-Brandl H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005768; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAPP D, 1971, J BIOL CHEM, V246, P4567; LAPP D, 1972, J BACTERIOL, V112, P327, DOI 10.1128/JB.112.1.327-336.1972; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; MARTIN MC, 1986, FEMS MICROBIOL LETT, V35, P49; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miah F, 2016, MICROBIOL-SGM, V162, P1208, DOI 10.1099/mic.0.000296; Miah F, 2013, CHEM BIOL, V20, P487, DOI 10.1016/j.chembiol.2013.02.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ning B, 1999, ARCH BIOCHEM BIOPHYS, V362, P339, DOI 10.1006/abbi.1998.1053; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1033.2000.01781.x; Nobre A, 2008, J BACTERIOL, V190, P7939, DOI 10.1128/JB.01055-08; Pan YT, 2002, EUR J BIOCHEM, V269, P6091, DOI 10.1046/j.1432-1033.2002.03327.x; PLASKITT KA, 1995, PHILOS T R SOC B, V347, P105, DOI 10.1098/rstb.1995.0016; Rashid AM, 2016, BIOCHEMISTRY-US, V55, P3270, DOI 10.1021/acs.biochem.6b00209; VERACHTERT H, 1964, BIOCHEM BIOPH RES CO, V15, P158, DOI 10.1016/0006-291X(64)90316-X; VERACHTERT H, 1966, J BIOL CHEM, V241, P2007; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yeo M, 2005, MICROBIOL-SGM, V151, P855, DOI 10.1099/mic.0.27428-0	58	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					945	954		10.1074/jbc.M116.758664	http://dx.doi.org/10.1074/jbc.M116.758664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27903647	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000392318700016
J	Rudolph, MJ; Vance, DJ; Cassidy, MS; Rong, YH; Mantis, NJ				Rudolph, Michael J.; Vance, David J.; Cassidy, Michael S.; Rong, Yinghui; Mantis, Nicholas J.			Structural Analysis of Single DomainAntibodies Bound to a Second Neutralizing Hot Spot on Ricin Toxin's Enzymatic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL EPITOPES; A-CHAIN; VACCINE; BINDING; MECHANISM; ANTIBODIES; GALACTOSE; SITE; STABILITY; LECTINS	Ricin toxin is a heterodimer consisting of RTA, a ribosomeinactivating protein, and RTB, a lectin that facilitates receptormediated uptake into mammalian cells. In previous studies, we demonstrated that toxin- neutralizing antibodies target four spatially distinct hot spots on RTA, which we refer to as epitope clusters I- IV. In this report, we identified and characterized three single domain camelid antibodies (VHH) against cluster II. One of these V(H)Hs, V5E1, ranks as one of the most potent ricinneutralizing antibodies described to date. We solved the X- ray crystal structures of each of the three V(H)Hs (E1, V1C7, and V5E1) in complex with RTA. V5E1 buries a total of 1,133 angstrom(2) of surface area on RTA and makes primary contacts with alpha-helixA (residues 18- 32), alpha-helix F (182- 194), as well as the F- G loop. V5E1, by virtue of complementarity determining region 3 (CDR3), may also engage with RTB and potentially interfere with the high affinity galactose- recognition element that plays a critical role in toxin attachment to cell surfaces and intracellular trafficking. The two other V(H)Hs, E1 and V1C7, bind epitopes adjacent to V5E1 but display only weak toxin neutralizing activity, thereby providing structural insights into specific residues within cluster II that may be critical contact points for toxin inactivation.	[Rudolph, Michael J.; Cassidy, Michael S.] New York Struct Biol Ctr, 89 Convent Ave, New York, NY 10027 USA; [Vance, David J.; Rong, Yinghui; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, 120 New Scotland Ave, Albany, NY 12208 USA; [Mantis, Nicholas J.] Univ Albany, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Rudolph, MJ (corresponding author), New York Struct Biol Ctr, 89 Convent Ave, New York, NY 10027 USA.; Mantis, NJ (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, 120 New Scotland Ave, Albany, NY 12208 USA.	mrudolph@nysbc.org; nicholas.mantis@health.ny.gov	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Mantis, Nicholas/0000-0002-5083-8640	NIAID from the National Institutes of Health [HHSN272201400021C]	NIAID from the National Institutes of Health	This work was supported by NIAID Contract No. HHSN272201400021C from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Carra JH, 2007, VACCINE, V25, P4149, DOI 10.1016/j.vaccine.2007.03.011; Castelletti D, 2004, CLIN EXP IMMUNOL, V136, P365, DOI 10.1111/j.1365-2249.2004.02442.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Herrera C, 2015, J BIOL CHEM, V290, P27880, DOI 10.1074/jbc.M115.658070; Herrera C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099788; Jandhyala DM, 2012, CURR TOP MICROBIOL, V357, P41, DOI 10.1007/82_2011_181; KATZIN BJ, 1991, PROTEINS, V10, P251, DOI 10.1002/prot.340100309; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li XP, 2013, J BIOL CHEM, V288, P30270, DOI 10.1074/jbc.M113.510966; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McHugh CA, 2004, PROTEIN SCI, V13, P2736, DOI 10.1110/ps.04897904; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; NEWTON DL, 1992, J BIOL CHEM, V267, P11917; O'Hara JM, 2014, IMMUNOL LETT, V158, P7, DOI 10.1016/j.imlet.2013.11.009; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Olson MA, 2004, PROTEIN ENG DES SEL, V17, P391, DOI 10.1093/protein/gzh043; Pincus SH, 2011, TOXINS, V3, P1163, DOI 10.3390/toxins3091163; READY MP, 1991, PROTEINS, V10, P270, DOI 10.1002/prot.340100311; Reisler Ronald B, 2012, Adv Prev Med, V2012, P149737, DOI 10.1155/2012/149737; Roy CJ, 2015, P NATL ACAD SCI USA, V112, P3782, DOI 10.1073/pnas.1502585112; Rudolph MJ, 2016, PROTEINS, V84, P1162, DOI 10.1002/prot.25062; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; Smallshaw JE, 2003, NAT BIOTECHNOL, V21, P387, DOI 10.1038/nbt800; Smallshaw JE, 2002, VACCINE, V20, P3422, DOI 10.1016/S0264-410X(02)00312-2; Spooner RA, 2015, TOXINS, V7, P49, DOI 10.3390/toxins7010049; Vance DJ, 2016, EXPERT REV VACCINES, V15, P1213, DOI 10.1586/14760584.2016.1168701; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Wahome P.G., 2013, CURR PROTOC TOXICOL, V23, DOI DOI 10.1002/0471140856.TX0223S55; WALES R, 1991, J BIOL CHEM, V266, P19172; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8; Zhu YW, 2013, J BIOL CHEM, V288, P25165, DOI 10.1074/jbc.M113.480830	42	17	17	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					872	883		10.1074/jbc.M116.758102	http://dx.doi.org/10.1074/jbc.M116.758102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27903650	hybrid, Green Published			2022-12-28	WOS:000392318700010
J	Li, JB; Wang, YF; Matye, DJ; Chavan, H; Krishnamurthy, P; Li, F; Li, TG				Li, Jibiao; Wang, Yifeng; Matye, David J.; Chavan, Hemantkumar; Krishnamurthy, Partha; Li, Feng; Li, Tiangang			Sortilin 1 Modulates Hepatic Cholesterol Lipotoxicity in Mice via Functional Interaction with Liver Carboxylesterase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTER HYDROLASE; NONALCOHOLIC STEATOHEPATITIS; REDUCES ATHEROSCLEROSIS; TRANSGENIC EXPRESSION; INSULIN-RESISTANCE; DIABETIC MICE; STEATOSIS; RECEPTOR; DISEASE; DIET	The liver plays a key role in cholesterol metabolism. Impaired hepatic cholesterol homeostasis causes intracellular free cholesterol accumulation and hepatocyte injury. Sortilin 1 (SORT1) is a lysosomal trafficking receptor that was identified by genome-wide association studies (GWAS) as a novel regulator of cholesterol metabolism in humans. Here we report that SORT1 deficiency protected against cholesterol accumulation-induced liver injury and inflammation in mice. Using an LC-MS/MS-based proteomics approach, we identified liver carboxylesterase 1 (CES1) as a novel SORT1-interacting protein. Mechanistic studies further showed that SORT1 may regulate CES1 lysosomal targeting and degradation and that SORT1 deficiency resulted in higher liver CES1 protein abundance. Previous studies have established an important role of hepatic CES1 in promoting intracellular cholesterol mobilization, cholesterol efflux, and bile acid synthesis. Consistently, high cholesterol atherogenic diet-challenged Sort1 knock-out mice showed less hepatic free cholesterol accumulation, increased bile acid synthesis, decreased biliary cholesterol secretion, and the absence of gallstone formation. SORT1 deficiency did not alter hepatic ceramide and fatty acid metabolism in high cholesterol atherogenic diet-fed mice. Finally, knockdown of liver CES1 in mice markedly increased the susceptibility to high cholesterol diet-induced liver injury and abolished the protective effect against cholesterol lipotoxicity in Sort1 knock-out mice. In summary, this study identified a novel SORT1-CES1 axis that regulates cholesterol-induced liver injury, which provides novel insights that improve our current understanding of the molecular links between SORT1 and cholesterol metabolism. This study further suggests that therapeutic inhibition of SORT1 may be beneficial in improving hepatic cholesterol homeostasis in metabolic and inflammatory liver diseases.	[Li, Jibiao; Wang, Yifeng; Matye, David J.; Chavan, Hemantkumar; Krishnamurthy, Partha; Li, Tiangang] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Li, Feng] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Kansas; University of Kansas Medical Center; Baylor College of Medicine	Li, TG (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	tli@kumc.edu	Li, Jibiao/A-5627-2017; Chavan, Hemant/ABA-4925-2021; Chavan, Hemantkumar/AAN-6756-2020; Li, Feng/M-5334-2016	Chavan, Hemantkumar/0000-0002-9963-6230; Li, Feng/0000-0002-9680-4614; Matye, David/0000-0001-6655-803X	American Diabetes Association Junior Faculty Award; National Institutes of Health [1R01DK102487-01]; National Center for Research Resources [5P20RR021940-07]; NIGMS from the National Institutes of Health [8 P20 GM103549-07, P30GM118247]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549, P30GM118247] Funding Source: NIH RePORTER	American Diabetes Association Junior Faculty Award(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an American Diabetes Association Junior Faculty Award (to T. L.), National Institutes of Health Grant 1R01DK102487-01 (to T. L.), National Center for Research Resources Grant 5P20RR021940-07, and NIGMS Grants 8 P20 GM103549-07 and P30GM118247 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baghdasaryan A, 2016, J HEPATOL, V64, P674, DOI 10.1016/j.jhep.2015.10.024; Bahitham W, 2016, BBA-MOL CELL BIOL L, V1861, P482, DOI 10.1016/j.bbalip.2016.03.009; Beltroy EP, 2005, HEPATOLOGY, V42, P886, DOI 10.1002/hep.20868; Bi LP, 2013, J LIPID RES, V54, P2754, DOI 10.1194/jlr.M039347; Bie JH, 2014, J LIPID RES, V55, P729, DOI 10.1194/jlr.M046524; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Canuel M, 2008, BIOCHEM BIOPH RES CO, V373, P292, DOI 10.1016/j.bbrc.2008.06.021; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Gan LT, 2014, J HEPATOL, V61, P1376, DOI 10.1016/j.jhep.2014.07.024; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hendrikx T, 2014, OBES REV, V15, P424, DOI 10.1111/obr.12159; Henkel AS, 2011, J LIPID RES, V52, P289, DOI 10.1194/jlr.M012781; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Ko KWS, 2009, BBA-MOL CELL BIOL L, V1791, P1133, DOI 10.1016/j.bbalip.2009.07.006; Li JB, 2014, J BIOL CHEM, V289, P22437, DOI 10.1074/jbc.M114.548933; Li J, 2015, BOUND VALUE PROBL, DOI 10.1186/s13661-014-0269-1; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Rabinowich L, 2015, J HEPATOL, V62, P175, DOI 10.1016/j.jhep.2014.08.030; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; van Rooyen DM, 2011, GASTROENTEROLOGY, V141, P1393, DOI 10.1053/j.gastro.2011.06.040; Wang S, 2015, P NATL ACAD SCI USA, V112, P3728, DOI 10.1073/pnas.1422455112; Wang YF, 2017, CELL MOL GASTROENTER, V3, P245, DOI 10.1016/j.jcmgh.2016.10.002; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xu JS, 2014, HEPATOLOGY, V59, P1761, DOI 10.1002/hep.26714; Yuan Q, 2013, J LIPID RES, V54, P3078, DOI 10.1194/jlr.M040998; Zhao B, 2005, PHYSIOL GENOMICS, V23, P304, DOI 10.1152/physiolgenomics.00187.2005; Zhao B, 2008, J LIPID RES, V49, P2212, DOI 10.1194/jlr.M800277-JLR200; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	43	30	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					146	160		10.1074/jbc.M116.762005	http://dx.doi.org/10.1074/jbc.M116.762005			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27881673	hybrid, Green Published			2022-12-28	WOS:000391578000013
J	Fu, PF; Ebenezer, DL; Berdyshev, EV; Bronova, IA; Shaaya, M; Harijith, A; Natarajan, V				Fu, Panfeng; Ebenezer, David L.; Berdyshev, Evgeny V.; Bronova, Irina A.; Shaaya, Mark; Harijith, Anantha; Natarajan, Viswanathan			Role of Sphingosine Kinase 1 and S1P Transporter Spns2 in HGF-mediated Lamellipodia Formation in Lung Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; BREAST-CANCER CELLS; FACTOR RECEPTOR; 1-PHOSPHATE; MIGRATION; MOTILITY; SPHINGOSINE-1-PHOSPHATE; POTENT; PROTRUSION; ACTIVATION	Hepatocyte growth factor (HGF) signaling via c-Met is known to promote endothelial cell motility and angiogenesis. We have previously reported that HGF stimulates lamellipodia formation and motility of human lung microvascular endothelial cells (HLMVECs) via PI3K/Akt signal transduction and reactive oxygen species generation. Here, we report a role for HGF-induced intracellular sphingosine-1-phosphate (S1P) generation catalyzed by sphingosine kinase 1 (SphK1), S1P transporter, spinster homolog 2 (Spns2), and S1P receptor, S1P(1), in lamellipodia formation and perhaps motility of HLMVECs. HGF stimulated SphK1 phosphorylation and enhanced intracellular S1P levels in HLMVECs, which was blocked by inhibition of SphK1. HGF enhanced co-localization of SphK1/p-SphK1 with actin/cortactin in lamellipodia and down-regulation or inhibition of SphK1 attenuated HGF-induced lamellipodia formation in HLMVECs. In addition, down-regulation of Spns2 also suppressed HGF-induced lamellipodia formation, suggesting a key role for inside-out S1P signaling. The HGF-mediated phosphorylation of SphK1 and its localization in lamellipodia was dependent on c-Met and ERK1/2 signaling, but not the PI3K/Akt pathway; however, blocking PI3K/Akt signaling attenuated HGF-mediated phosphorylation of Spns2. Down-regulation of S1P(1), but not S1P(2) or S1P(3), with specific siRNA attenuated HGF-induced lamellipodia formation. Further, HGF enhanced association of Spns2 with S1P(1) that was blocked by inhibiting SphK1 activity with PF-543. Moreover, HGF-induced migration of HLMVECs was attenuated by down-regulation of Spns2. Taken together, these results suggest that HGF/c-Met-mediated lamellipodia formation, and perhaps motility is dependent on intracellular generation of S1P via activation and localization of SphK1 to cell periphery and Spns2-mediated extracellular transportation of S1P and its inside-out signaling via S1P(1).	[Fu, Panfeng; Shaaya, Mark; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Ebenezer, David L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Harijith, Anantha] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; [Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Berdyshev, Evgeny V.; Bronova, Irina A.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Jewish Health	Natarajan, V (corresponding author), Univ Illinois, Dept Med & Pharmacol, COMRB, Rm 3137,909 South Wolcott Ave, Chicago, IL 60612 USA.	visnatar@uic.edu	Harijith, Anantha/AAA-5708-2021		National Institutes of Health [P01 HL060678, P01 HL098050]; College of Medicine, University of Illinois; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098050, T32HL007829, P01HL060678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Medicine, University of Illinois; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant P01 HL060678 Project 4 (to V.N.) and Grant P01 HL098050 (to V.N.) and by the College of Medicine, University of Illinois. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berdyshev E. V., 2011, ANAL BIOCHEM, V408, P12; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Bradley E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110119; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Cai WY, 2000, INVEST OPHTH VIS SCI, V41, P1885; Cerutis DR, 2004, J PERIODONTOL, V75, P297, DOI 10.1902/jop.2004.75.2.297; Duan HF, 2004, EXP CELL RES, V298, P593, DOI 10.1016/j.yexcr.2004.04.049; Endo A, 2002, J BIOL CHEM, V277, P23747, DOI 10.1074/jbc.M111794200; Ephstein Y, 2013, J BIOL CHEM, V288, P2191, DOI 10.1074/jbc.M112.404780; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fu PF, 2013, AM J RESP CELL MOL, V48, P477, DOI 10.1165/rcmb.2012-0242OC; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Gschwind A, 2002, CANCER RES, V62, P6329; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Liebmann C, 2000, CURR MED CHEM, V7, P911, DOI 10.2174/0929867003374589; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Mendoza MC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8859; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Nieuwenhuis B, 2009, J MOL MED, V87, P645, DOI 10.1007/s00109-009-0468-x; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Nishi T, 2014, BBA-MOL CELL BIOL L, V1841, P759, DOI 10.1016/j.bbalip.2013.07.012; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oh YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143695; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Purdie KJ, 2002, CARDIOVASC RES, V54, P659, DOI 10.1016/S0008-6363(02)00255-9; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Shida D, 2005, BIOCHEM BIOPH RES CO, V327, P907, DOI 10.1016/j.bbrc.2004.12.088; So J, 2005, GYNECOL ONCOL, V97, P870, DOI 10.1016/j.ygyno.2005.03.004; Sukocheva O, 2013, EXP CELL RES, V319, P455, DOI 10.1016/j.yexcr.2012.10.014; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556; Usatyuk PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063007; Waeber C, 2004, DRUG NEWS PERSPECT, V17, P365, DOI 10.1358/dnp.2004.17.6.829028; Wang XY, 2003, MOL CANCER THER, V2, P1085; Webb CP, 1998, ONCOGENE, V17, P2019, DOI 10.1038/sj.onc.1202135; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	43	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27187	27203		10.1074/jbc.M116.758946	http://dx.doi.org/10.1074/jbc.M116.758946			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864331	Green Published, hybrid			2022-12-28	WOS:000391576300018
J	Lok, HC; Sahni, S; Jansson, PJ; Kovacevic, Z; Hawkins, CL; Richardson, DR				Lok, Hiu Chuen; Sahni, Sumit; Jansson, Patric J.; Kovacevic, Zaklina; Hawkins, Clare L.; Richardson, Des R.			A Nitric Oxide Storage and Transport System That Protects Activated Macrophages from Endogenous Nitric Oxide Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; TRANSCRIPTION FACTOR NRF2; MULTIDRUG-RESISTANCE PROTEIN-1; DINITROSYL-IRON COMPLEXES; NITROGEN MONOXIDE NO; MOLECULAR-MECHANISMS; INTERFERON-GAMMA; CARCINOMA CELLS; MELANOMA-CELLS; TUMOR-CELLS	Nitric oxide (NO) is integral to macrophage cytotoxicity against tumors due to its ability to induce iron release from cancer cells. However, the mechanism for how activated macrophages protect themselves from endogenous NO remains unknown. We previously demonstrated by using tumor cells that glutathione S-transferase P1 (GSTP1) sequesters NO as dinitrosyl-dithiol iron complexes (DNICs) and inhibits NO-mediated iron release from cells via the transporter multidrug resistance protein 1 (MRP1/ABCC1). These prior studies also showed that MRP1 and GSTP1 protect tumor cells against NO cytotoxicity, which parallels their roles in defending cancer cells from cytotoxic drugs. Considering this, and because GSTP1 and MRP1 are up-regulated during macrophage activation, this investigation examined whether this NO storage/transport system protects macrophages against endogenous NO cytotoxicity in two well characterized macrophage cell types (J774 and RAW 264.7). MRP1 expression markedly increased upon macrophage activation, and the role ofMRP1in NO-induced Fe-59 release was demonstrated by Mrp1 siRNA and the MRP1 inhibitor, MK571, which inhibited NO-mediated iron efflux. Furthermore, Mrp1 silencing increased DNIC accumulation in macrophages, indicating a role for MRP1 in transporting DNICs out of cells. In addition, macrophage Fe-59 release was enhanced by silencing Gstp1, suggesting GSTP1 was responsible for DNIC binding/storage. Viability studies demonstrated that GSTP1 and MRP1 protect activated macrophages from NO cytotoxicity. This was confirmed by silencing nuclear factor-erythroid 2-related factor 2 (Nrf2), which decreased MRP1 and GSTP1 expression, concomitant with reduced Fe-59 release and macrophage survival. Together, these results demonstrate a mechanism by which macrophages protect themselves against NO cytotoxicity.	[Lok, Hiu Chuen; Sahni, Sumit; Jansson, Patric J.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; [Lok, Hiu Chuen; Sahni, Sumit; Jansson, Patric J.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Hawkins, Clare L.] Heart Res Inst, Sydney, NSW 2042, Australia	University of Sydney; University of Sydney; University of Sydney; Heart Research Institute	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia.; Richardson, DR (corresponding author), Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Hawkins, Clare/AAV-7424-2021; Hawkins, Clare L/F-6696-2014; Kovacevic, Zaklina/ABD-9581-2021; Jansson, Patric/AAC-4221-2022	Hawkins, Clare/0000-0003-2738-5089; Hawkins, Clare L/0000-0003-2738-5089; Kovacevic, Zaklina/0000-0002-4742-4690; Jansson, Patric/0000-0002-9322-653X; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274; Sahni, Sumit/0000-0002-2900-8845	National Health and Medical Research Council of Australia [1062026]; National Breast Cancer Foundation; Avner Pancreatic Cancer Foundation; National Health and Medical Research Peter Doherty Early Career Fellowship [1037323]; Cancer Institute New South Wales Early Career Fellowship [12-ECF2-17]; Australian Research Council [FT120100682]; National Health and Medical Research Council of Australia; National Breast Cancer Foundation [PS-16-030] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Avner Pancreatic Cancer Foundation; National Health and Medical Research Peter Doherty Early Career Fellowship; Cancer Institute New South Wales Early Career Fellowship; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This work was supported in part by National Health and Medical Research Council of Australia Project Grant 1062026 (to D. R. R. and C. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the National Breast Cancer Foundation and Avner Pancreatic Cancer Foundation.; Supported by National Health and Medical Research Peter Doherty Early Career Fellowship 1037323 and Cancer Institute New South Wales Early Career Fellowship 12-ECF2-17.; Supported by Australian Research Council Future Fellowship FT120100682.; Supported by the National Health and Medical Research Council of Australia Senior Principal Research Fellowship.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; ANDRADE SP, 1992, BRIT J PHARMACOL, V107, P1092, DOI 10.1111/j.1476-5381.1992.tb13412.x; BAKER E, 1985, AM J PHYSIOL, V248, pG93, DOI 10.1152/ajpgi.1985.248.1.G93; BAKER E, 1981, BRIT J HAEMATOL, V47, P493, DOI 10.1111/j.1365-2141.1981.tb02678.x; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; BASTIAN NR, 1994, J BIOL CHEM, V269, P5127; Buckley BJ, 2003, BIOCHEM BIOPH RES CO, V307, P973, DOI 10.1016/S0006-291X(03)01308-1; BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; COLE SPC, 1994, CANCER RES, V54, P5902; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; de Oliveira GA, 2017, ANTIOXID REDOX SIGN, V26, P1059, DOI 10.1089/ars.2016.6850; Depeille P, 2005, BRIT J CANCER, V93, P216, DOI 10.1038/sj.bjc.6602681; Depeille P, 2004, MOL PHARMACOL, V65, P897, DOI 10.1124/mol.65.4.897; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; DRAPIER JC, 1991, J BIOL CHEM, V266, P10162; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V208, P345, DOI 10.1006/bbrc.1995.1344; GomezFlores R, 1997, J IMMUNOL, V158, P3796; GRANT CE, 1994, CANCER RES, V54, P357; Hayashi A, 2003, BIOCHEM BIOPH RES CO, V310, P824, DOI 10.1016/j.bbrc.2003.09.086; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Held TK, 1999, INFECT IMMUN, V67, P206, DOI 10.1128/IAI.67.1.206-212.1999; HIBBS JB, 1984, BIOCHEM BIOPH RES CO, V123, P716, DOI 10.1016/0006-291X(84)90288-2; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Koley D, 2012, P NATL ACAD SCI USA, V109, P11522, DOI 10.1073/pnas.1201555109; LAMARRE J, 1993, J CLIN INVEST, V91, P1219, DOI 10.1172/JCI116283; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; Li CQ, 2009, P NATL ACAD SCI USA, V106, P14547, DOI 10.1073/pnas.0907539106; Li Q, 2014, J BIOL CHEM, V289, P19917, DOI 10.1074/jbc.M114.569764; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; Lok HC, 2014, FREE RADICAL BIO MED, V75, P14, DOI 10.1016/j.freeradbiomed.2014.07.002; Lok HC, 2012, J BIOL CHEM, V287, P607, DOI 10.1074/jbc.M111.310987; MacArthur PH, 2007, J CHROMATOGR B, V851, P93, DOI 10.1016/j.jchromb.2006.12.012; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; MCLEOD R, 1977, CELL IMMUNOL, V34, P156, DOI 10.1016/0008-8749(77)90238-6; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Morrow CS, 1998, CARCINOGENESIS, V19, P109, DOI 10.1093/carcin/19.1.109; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; Morrow CS, 1998, BIOCHEM PHARMACOL, V56, P1013, DOI 10.1016/S0006-2952(98)00240-8; MURRAY HW, 1981, J EXP MED, V153, P1302, DOI 10.1084/jem.153.5.1302; MURRAY HW, 1981, J EXP MED, V153, P1690, DOI 10.1084/jem.153.6.1690; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; NATHAN CF, 1981, J EXP MED, V153, P767, DOI 10.1084/jem.153.4.766; Paumi CM, 2001, J BIOL CHEM, V276, P7952, DOI 10.1074/jbc.M009400200; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; Peklak-Scott C, 2008, MOL CANCER THER, V7, P3247, DOI 10.1158/1535-7163.MCT-08-0250; Rahmanto YS, 2012, J BIOL CHEM, V287, P6960, DOI 10.1074/jbc.R111.329847; RICHARDSON D, 1992, J BIOL CHEM, V267, P13972; RICHARDSON DR, 1990, BIOCHIM BIOPHYS ACTA, V1053, P1, DOI 10.1016/0167-4889(90)90018-9; RICHARDSON DR, 1991, BIOCHIM BIOPHYS ACTA, V1091, P294, DOI 10.1016/0167-4889(91)90192-Z; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Ruetten H, 1996, BIOCHEM BIOPH RES CO, V225, P525, DOI 10.1006/bbrc.1996.1206; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sibhatu MB, 2008, CARCINOGENESIS, V29, P807, DOI 10.1093/carcin/bgn013; Silverstein PS, 2010, J NEUROIMMUNE PHARM, V5, P516, DOI 10.1007/s11481-009-9180-4; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tozer GM, 1997, CANCER RES, V57, P948; Vanin AF, 1998, NITRIC OXIDE-BIOL CH, V2, P224, DOI 10.1006/niox.1998.0180; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Wardrop SL, 2000, EUR J BIOCHEM, V267, P6586, DOI 10.1046/j.1432-1327.2000.01752.x; Wardrop SL, 2000, BIOCHEMISTRY-US, V39, P2748, DOI 10.1021/bi991099t; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Watts RN, 2001, J BIOL CHEM, V276, P4724, DOI 10.1074/jbc.M006318200; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Xu X, 2008, MOL PHARMACOL, V73, P833, DOI 10.1124/mol.107.041335; Yanatori I, 2016, J BIOL CHEM, V291, P17303, DOI 10.1074/jbc.M116.721936	85	29	31	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27042	27061		10.1074/jbc.M116.763714	http://dx.doi.org/10.1074/jbc.M116.763714			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27866158	hybrid, Green Published			2022-12-28	WOS:000391576300007
J	Bule, P; Alves, VD; Leitao, A; Ferreira, LMA; Bayer, EA; Smith, SP; Gilbert, HJ; Najmudin, S; Fontes, CMGA				Bule, Pedro; Alves, Victor D.; Leitao, Andre; Ferreira, Luis M. A.; Bayer, Edward A.; Smith, Steven P.; Gilbert, Harry J.; Najmudin, Shabir; Fontes, Carlos M. G. A.			Single Binding Mode Integration of Hemicellulose-degrading Enzymes via Adaptor Scaffoldins in Ruminococcus flavefaciens Cellulosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DOCKERIN; COHESIN; ATTACHMENT; COMPLEXES; REVEAL	The assembly of one of Nature's most elaborate multienzyme complexes, the cellulosome, results from the binding of enzyme-borne dockerins to reiterated cohesin domains located in a noncatalytic primary scaffoldin. Generally, dockerins present two similar cohesin-binding interfaces that support a dual binding mode. The dynamic integration of enzymes in cellulosomes, afforded by the dual binding mode, is believed to incorporate additional flexibility in highly populated multienzyme complexes. Ruminococcus flavefaciens, the primary degrader of plant structural carbohydrates in the rumen of mammals, uses a portfolio of more than 220 different dockerins to assemble the most intricate cellulosome known to date. A sequence-based analysis organized R. flavefaciens dockerins into six groups. Strikingly, a subset of R. flavefaciens cellulosomal enzymes, comprising dockerins of groups 3 and 6, were shown to be indirectly incorporated into primary scaffoldins via an adaptor scaffoldin termed ScaC. Here, we report the crystal structure of a group 3 R. flavefaciens dockerin, Doc3, in complex with ScaC cohesin. Doc3 is unusual as it presents a large cohesin-interacting surface that lacks the structural symmetry required to support a dual binding mode. In addition, dockerins of groups 3 and 6, which bind exclusively to ScaC cohesin, display a conserved mechanism of protein recognition that is similar to Doc3. Groups 3 and 6 dockerins are predominantly appended to hemicellulose-degrading enzymes. Thus, single binding mode dockerins interacting with adaptor scaffoldins exemplify an evolutionary pathway developed by R. flavefaciens to recruit hemicellulases to the sophisticated cellulosomes acting in the gastrointestinal tract of mammals.	[Bule, Pedro; Alves, Victor D.; Leitao, Andre; Ferreira, Luis M. A.; Najmudin, Shabir; Fontes, Carlos M. G. A.] Polo Univ Alto da Ajuda, ULisboa, Fac Med Vet, CIISA, Ave Univ Tecn, P-1300477 Lisbon, Portugal; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Universidade de Lisboa; Weizmann Institute of Science; Queens University - Canada; Newcastle University - UK	Fontes, CMGA (corresponding author), Polo Univ Alto da Ajuda, ULisboa, Fac Med Vet, CIISA, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.ulisboa.pt	Bule, Pedro/W-6838-2019	Bule, Pedro/0000-0003-2531-9926; Leitao, Andre/0000-0003-0500-3545; Alves, Victor Diogo/0000-0002-8430-4380; Fontes, Carlos/0000-0002-1219-9753; Smith, Steven/0000-0003-2710-4400	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) [PTDC/BIA-MIC/5947/2014];  [SFRH/BD/86821/2012]	Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal)(Portuguese Foundation for Science and Technology); 	This work was supported in part by Fundacao para a Ciencia e a Tecnologia (Lisbon, Portugal) Grant PTDC/BIA-MIC/5947/2014. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the individual fellowship SFRH/BD/86821/2012.	[Anonymous], [No title captured]; Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 2007, CURR OPIN BIOTECH, V18, P237, DOI 10.1016/j.copbio.2007.04.004; Bras JLA, 2012, J BIOL CHEM, V287, P44394, DOI 10.1074/jbc.M112.407700; Bule P, 2014, ACTA CRYSTALLOGR F, V70, P1065, DOI 10.1107/S2053230X14013181; Burton RA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00456; Cameron K, 2015, J BIOL CHEM, V290, P16215, DOI 10.1074/jbc.M115.653303; Cameron K, 2015, J BIOL CHEM, V290, P13578, DOI 10.1074/jbc.M114.633339; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Handelsman T, 2004, FEBS LETT, V572, P195, DOI 10.1016/j.febslet.2004.07.040; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Rincon MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012476; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Ruimy V., 2013, THESIS; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2011, METHODS, V55, P81, DOI 10.1016/j.ymeth.2011.06.010	33	9	9	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26658	26669		10.1074/jbc.M116.761643	http://dx.doi.org/10.1074/jbc.M116.761643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875311	hybrid, Green Published			2022-12-28	WOS:000391571400007
J	Calinescu, O; Linder, M; Wohlert, D; Yildiz, O; Kuhlbrandt, W; Fendler, K				Calinescu, Octavian; Linder, Mark; Woehlert, David; Yildiz, Oezkan; Kuehlbrandt, Werner; Fendler, Klaus			Electrogenic Cation Binding in the Electroneutral Na+/H+ Antiporter of Pyrococcus abyssi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROLES	Na+/H+ antiporters in the CPA1 branch of the cation proton antiporter family drive the electroneutral exchange of H+ against Na+ ions and ensure pH homeostasis in eukaryotic and prokaryotic organisms. Although their transport cycle is overall electroneutral, specific partial reactions are electrogenic. Here, we present an electrophysiological study of the PaNhaP Na+/H+ antiporter from Pyrococcus abyssi reconstituted into liposomes. Positive transient currents were recorded upon addition of Na+ to PaNhaP proteoliposomes, indicating a reaction where positive charge is rapidly displaced into the proteoliposomes with a rate constant of k > 200 s(-1). We attribute the recorded currents to an electrogenic reaction that includes Na+ binding and possibly occlusion. Subsequently, positive charge is transported out of the cell associated with H+ binding, so that the overall reaction is electroneutral. We show that the differences in pH profile and Na+ affinity of PaNhaP and the related MjNhaP1 from Methanocaldococcus jannaschii can be attributed to an additional negatively charged glutamate residue in PaNhaP. The results are discussed in the context of the physiological function of PaNhaP and other microbial Na+/H+ exchangers. We propose that both, electroneutral and electrogenic Na+/H+ antiporters, represent a carefully tuned self-regulatory system, which drives the cytoplasmic pH back to neutral after any deviation.	[Calinescu, Octavian; Linder, Mark; Fendler, Klaus] Max Planck Inst Biophys, Dept Biol Chem, D-60438 Frankfurt, Germany; [Linder, Mark; Woehlert, David; Yildiz, Oezkan; Kuehlbrandt, Werner] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany; [Calinescu, Octavian] Carol Davila Univ Med & Pharm, Dept Biophys, Bucharest 050474, Romania	Max Planck Society; Max Planck Society; Carol Davila University of Medicine & Pharmacy	Fendler, K (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	fendler@biophys.mpg.de	Calinescu, Octavian/P-4278-2014; Yildiz, Ozkan/P-9207-2016	Calinescu, Octavian/0000-0001-8003-0442; Kuhlbrandt, Werner/0000-0002-2013-4810; Yildiz, Ozkan/0000-0003-3659-2805; Wohlert, David/0000-0002-2030-3952; Fendler, Klaus/0000-0002-5699-7060	Israel Science Foundation [284/12]; Deutsche Forschungsgemeinschaft [SFB 807]; Romanian National Authority for Scientific Research and Innovation program CNCS-UEFISCDI project [PN-II-RU-TE-2014-4-0604]	Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Romanian National Authority for Scientific Research and Innovation program CNCS-UEFISCDI project	This work was supported in part by Israel Science Foundation Grant 284/12 (to K. F. and O. C.), Deutsche Forschungsgemeinschaft Grant SFB 807 (to K. F., W. K., and D. W.), and Romanian National Authority for Scientific Research and Innovation program CNCS-UEFISCDI project PN-II-RU-TE-2014-4-0604 (to O. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Bazzone A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156392; Bazzone A, 2013, JOVE-J VIS EXP, DOI 10.3791/50230; Braman J, 1996, Methods Mol Biol, V57, P31; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Calinescu O, 2015, BIOL CHEM, V396, P1091, DOI 10.1515/hsz-2014-0278; Calinescu O, 2014, FEBS LETT, V588, P3111, DOI 10.1016/j.febslet.2014.05.066; Calinescu O, 2014, J BIOL CHEM, V289, P13168, DOI 10.1074/jbc.M113.542993; Cohen GN, 2003, MOL MICROBIOL, V47, P1495, DOI 10.1046/j.1365-2958.2003.03381.x; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; ERAUSO G, 1993, ARCH MICROBIOL, V160, P338; Fuster DG, 2014, PFLUG ARCH EUR J PHY, V466, P61, DOI 10.1007/s00424-013-1408-8; Garcia-Celma JJ, 2010, BIOCHEMISTRY-US, V49, P6115, DOI 10.1021/bi100492p; Garcia-Celma JJ, 2009, P NATL ACAD SCI USA, V106, P7373, DOI 10.1073/pnas.0902471106; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Padan E, 2016, METAL IONS LIFE SCI, V16, P391, DOI 10.1007/978-3-319-21756-7_12; Paulino C, 2014, ELIFE, V3, DOI 10.7554/eLife.03583; Prokofeva MI, 2005, EXTREMOPHILES, V9, P437, DOI 10.1007/s00792-005-0461-4; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Teske A, 2009, EXTREMOPHILES, V13, P905, DOI 10.1007/s00792-009-0278-7; Wohlert D, 2014, ELIFE, V3, DOI 10.7554/eLife.03579	22	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26786	26793		10.1074/jbc.M116.761080	http://dx.doi.org/10.1074/jbc.M116.761080			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27821589	hybrid, Green Published			2022-12-28	WOS:000391571400017
J	Sato, S; Tomomori-Sato, C; Tsai, KL; Yu, XD; Sardiu, M; Saraf, A; Washburn, MP; Florens, L; Asturias, FJ; Conaway, RC; Conaway, JW				Sato, Shigeo; Tomomori-Sato, Chieri; Tsai, Kuang-Lei; Yu, Xiaodi; Sardiu, Mihaela; Saraf, Anita; Washburn, Michael P.; Florens, Laurence; Asturias, Francisco J.; Conaway, Ronald C.; Conaway, Joan W.			Role for the MED21-MED7 Hinge in Assembly of the Mediator-RNA Polymerase II Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; CARBOXY-TERMINAL DOMAIN; HEAD MODULE; TRANSCRIPTIONAL REGULATION; INITIATION COMPLEX; YEAST; ORGANIZATION; ARCHITECTURE; SUBUNIT; CONFORMATION	Mediator plays an integral role in activation of RNA polymerase II (Pol II) transcription. A key step in activation is binding of Mediator to Pol II to form the Mediator-Pol II holoenzyme. Here, we exploit a combination of biochemistry and macromolecular EM to investigate holoenzyme assembly. We identify a subset of human Mediator head module subunits that bind Pol II independent of other subunits and thus probably contribute to a major Pol II binding site. In addition, we show that binding of human Mediator to Pol II depends on the integrity of a conserved "hinge" in the middle module MED21-MED7 heterodimer. Point mutations in the hinge region leave core Mediator intact but lead to increased disorder of the middle module and markedly reduced affinity for Pol II. These findings highlight the importance of Mediator conformation for holoenzyme assembly.	[Sato, Shigeo; Tomomori-Sato, Chieri; Sardiu, Mihaela; Saraf, Anita; Washburn, Michael P.; Florens, Laurence; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA; [Tsai, Kuang-Lei; Asturias, Francisco J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Scripps Research Institute; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers.org		Florens, Laurence/0000-0002-9310-6650; Tomomori-Sato, Chieri/0000-0002-2543-293X	Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NIGMS, National Institutes of Health [GM41628, GM067167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628, R01GM067167] Funding Source: NIH RePORTER	Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation and by NIGMS, National Institutes of Health, Grants GM41628 (to R. C. C. and J. W. C.) and GM067167 (to F. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Cai G, 2012, STRUCTURE, V20, P899, DOI 10.1016/j.str.2012.02.023; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens Laurence, 2006, V328, P159; Gromoller A, 2000, FEBS LETT, V484, P48, DOI 10.1016/S0014-5793(00)02123-2; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; HENGARTNER CJ, 1995, GENE DEV, V9, P897, DOI 10.1101/gad.9.8.897; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kwon JY, 2001, FEBS LETT, V508, P305, DOI 10.1016/S0014-5793(01)03072-1; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lariviere L, 2013, NUCLEIC ACIDS RES, V41, P9266, DOI 10.1093/nar/gkt704; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Robinson PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08719; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tomomori-Sato Chieri, 2013, Methods Mol Biol, V977, P273, DOI 10.1007/978-1-62703-284-1_22; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Tudor M, 1999, GENE DEV, V13, P2365, DOI 10.1101/gad.13.18.2365; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang XJ, 2014, CELL RES, V24, P796, DOI 10.1038/cr.2014.64; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	50	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26886	26898		10.1074/jbc.M116.756098	http://dx.doi.org/10.1074/jbc.M116.756098			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27821593	Green Published, hybrid			2022-12-28	WOS:000391571400025
J	Sullivan, CS; Kumper, M; Temple, BS; Maness, PF				Sullivan, Chelsea S.; Kumper, Maike; Temple, Brenda S.; Maness, Patricia F.			The Neural Cell Adhesion Molecule (NCAM) Promotes Clustering and Activation of EphA3 Receptors in GABAergic Interneurons to Induce Ras Homolog Gene Family, Member A (RhoA)/Rho-associated protein kinase (ROCK)-mediated Growth Cone Collapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING DOMAIN; BIPOLAR DISORDER; PSA-NCAM; N-CAM; SYNAPTIC DEVELOPMENT; INHIBITORY SYNAPSES; POLYSIALIC ACID; CANDIDATE GENES; SCHIZOPHRENIA; ECTODOMAIN	Establishment of a proper balance of excitatory and inhibitory connectivity is achieved during development of cortical networks and adjusted through synaptic plasticity. The neural cell adhesion molecule (NCAM) and the receptor tyrosine kinase EphA3 regulate the perisomatic synapse density of inhibitory GABAergic interneurons in the mouse frontal cortex through ephrin-A5-induced growth cone collapse. In this study, it was demonstrated that binding of NCAM and EphA3 occurred between the NCAM Ig2 domain and EphA3 cysteine-rich domain (CRD). The binding interface was further refined through molecular modeling and mutagenesis and shown to be comprised of complementary charged residues in the NCAM Ig2 domain (Arg-156 and Lys-162) and the EphA3 CRD (Glu-248 and Glu-264). Ephrin-A5 induced co-clustering of surface-bound NCAM and EphA3 in GABAergic cortical interneurons in culture. Receptor clustering was impaired by a charge reversal mutation that disrupted NCAM/EphA3 association, emphasizing the importance of the NCAM/EphA3 binding interface for cluster formation. NCAM enhanced ephrin-A5-induced EphA3 autophosphorylation and activation of RhoA GTPase, indicating a role for NCAM in activating EphA3 signaling through clustering. NCAM-mediated clustering of EphA3 was essential for ephrin-A5-induced growth cone collapse in cortical GABAergic interneurons, and RhoA and a principal effector, Rho-associated protein kinase, mediated the collapse response. This study delineates a mechanism in which NCAM promotes ephrin-A5-dependent clustering of EphA3 through interaction of the NCAM Ig2 domain and the EphA3 CRD, stimulating EphA3 autophosphorylation and RhoA signaling necessary for growth cone repulsion in GABAergic interneurons in vitro, which may extend to remodeling of axonal terminals of interneurons in vivo.	[Sullivan, Chelsea S.; Kumper, Maike; Temple, Brenda S.; Maness, Patricia F.] Univ N Carolina, Sch Med, RL Juliano Struct Bioinformat Core, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Maness, PF (corresponding author), Univ North Carolina Chapel Hill, Sch Med, Dept Biochem & Biophys, 3020 Genet Med Res Bldg,Campus Box 7260, Chapel Hill, NC 27599 USA.	srclab@med.unc.edu	Ariel, Pablo/AGJ-4118-2022		National Institute of Health [R01 MH101605, F32 MH111189, P30 CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101605, R01MH113280, F32MH111189] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institute of Health Grants R01 MH101605, F32 MH111189, and P30 CA016086. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albrecht A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00043; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Gomez-Climent MA, 2011, CEREB CORTEX, V21, P1028, DOI 10.1093/cercor/bhq177; Arai M, 2004, BIOL PSYCHIAT, V55, P804, DOI 10.1016/j.biopsych.2004.01.009; Atz ME, 2007, PSYCHIAT GENET, V17, P55, DOI 10.1097/YPG.0b013e328012d850; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brennaman LH, 2014, J NEUROCHEM, V128, P267, DOI 10.1111/jnc.12468; Brennaman LH, 2013, CEREB CORTEX, V23, P162, DOI 10.1093/cercor/bhr392; Brennaman LH, 2008, MOL CELL NEUROSCI, V37, P781, DOI 10.1016/j.mcn.2008.01.006; Casey JP, 2012, HUM GENET, V131, P565, DOI 10.1007/s00439-011-1094-6; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Davis TL, 2008, STRUCTURE, V16, P873, DOI 10.1016/j.str.2008.03.008; Demyanenko GP, 2011, CEREB CORTEX, V21, P401, DOI 10.1093/cercor/bhq115; Dudanova I, 2010, CURR BIOL, V20, P2150, DOI 10.1016/j.cub.2010.11.021; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gray LJ, 2010, PSYCHIAT RES, V178, P374, DOI 10.1016/j.psychres.2008.07.012; Hata K, 2007, J NEUROSCI, V27, P14481, DOI 10.1523/JNEUROSCI.3847-07.2007; Himanen JP, 2012, SEMIN CELL DEV BIOL, V23, P35, DOI 10.1016/j.semcdb.2011.10.025; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Ikeda M, 2010, BIOL PSYCHIAT, V67, P263, DOI 10.1016/j.biopsych.2009.08.030; Inan M, 2013, NEUROBIOL DIS, V53, P36, DOI 10.1016/j.nbd.2012.11.013; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Janes PW, 2011, J CELL BIOL, V195, P1033, DOI 10.1083/jcb.201104037; Janes PW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000215; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; KALLAPUR SG, 1992, J NEUROSCI RES, V33, P538, DOI 10.1002/jnr.490330406; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Klein R, 2014, CURR OPIN NEUROBIOL, V27, P16, DOI 10.1016/j.conb.2014.02.006; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lewis DA, 2008, NEUROPSYCHOPHARMACOL, V33, P141, DOI 10.1038/sj.npp.1301563; Lisabeth EM, 2013, COLD SPRING HARB PER, V5, P1; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mann EO, 2009, J NEUROSCI, V29, P7513, DOI 10.1523/JNEUROSCI.6162-08.2009; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Meiri KF, 1998, J NEUROSCI, V18, P10429; Noren NK, 2009, BIOCHEM J, V422, P433, DOI 10.1042/BJ20090014; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; Puchkov D, 2011, CEREB CORTEX, V21, P2217, DOI 10.1093/cercor/bhq283; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Seiradake E., 2010, NAT STRUCT MOL BIOL; Seiradake E, 2013, NAT STRUCT MOL BIOL, V20, P958, DOI 10.1038/nsmb.2617; Seshadri S, 2013, NEUROBIOL DIS, V53, P26, DOI 10.1016/j.nbd.2013.01.009; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shi GF, 2010, CELL RES, V20, P1263, DOI 10.1038/cr.2010.115; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Soroka V, 2002, J BIOL CHEM, V277, P24676, DOI 10.1074/jbc.M109694200; Soroka V, 2010, ADV EXP MED BIOL, V663, P3, DOI 10.1007/978-1-4419-1170-4_1; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P902, DOI 10.1016/j.biopsych.2006.07.036; Tremblay R, 2016, NEURON, V91, P260, DOI 10.1016/j.neuron.2016.06.033; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Varea E, 2012, J PSYCHIATR RES, V46, P189, DOI 10.1016/j.jpsychires.2011.10.011; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weledji EP, 2014, ANN MED SURG, V3, P77, DOI 10.1016/j.amsu.2014.06.014; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Wu H, 2010, MOL CELL BIOL, V30, P5207, DOI 10.1128/MCB.00366-10; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110; Yue Xin, 2013, Methods Mol Biol, V1018, P221, DOI 10.1007/978-1-62703-444-9_21	77	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26262	26272		10.1074/jbc.M116.760017	http://dx.doi.org/10.1074/jbc.M116.760017			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27803162	Green Published, hybrid			2022-12-28	WOS:000391568200003
J	Imberdis, T; Heeres, JT; Yueh, H; Fang, C; Zhen, J; Rich, CB; Glicksman, M; Beeler, AB; Harris, DA				Imberdis, Thibaut; Heeres, James T.; Yueh, Han; Fang, Cheng; Zhen, Jessie; Rich, Celeste B.; Glicksman, Marcie; Beeler, Aaron B.; Harris, David A.			Identification of Anti-prion Compounds using a Novel Cellular Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CULTURED-CELLS; TRANSGENIC MICE; CONGO RED; PROTEIN; DISEASE; PRP; SCRAPIE; INHIBITION; RESISTANT	Prion diseases are devastating neurodegenerative disorders with no known cure. One strategy for developing therapies for these diseases is to identify compounds that block conversion of the cellular form of the prion protein (PrPC) into the infectious isoform (PrPSc). Most previous efforts to discover such molecules by high-throughput screening methods have utilized, as a read-out, a single kind of cellular assay system: neuroblastoma cells that are persistently infected with scrapie prions. Here, we describe the use of an alternative cellular assay based on suppressing the spontaneous cytotoxicity of a mutant form of PrP (Delta 105-125). Using this assay, we screened 75,000 compounds, and identified a group of phenethyl piperidines (exemplified by LD7), which reduces the accumulation of PrPSc in infected neuroblastoma cells by >90% at low micromolar doses, and inhibits PrPSc-induced synaptotoxicity in hippocampal neurons. By analyzing the structure-activity relationships of 35 chemical derivatives, we defined the pharmacophore of LD7, and identified a more potent derivative. Active compounds do not alter total or cell-surface levels of PrPC, and do not bind to recombinant PrP in surface plasmon resonance experiments, although at high concentrations they inhibit PrPSc-seeded conversion of recombinant PrP to a misfolded state in an in vitro reaction (RT-QuIC). This class of small molecules may provide valuable therapeutic leads, as well as chemical biological tools to identify cellular pathways underlying PrPSc metabolism and PrPC function.	[Imberdis, Thibaut; Heeres, James T.; Fang, Cheng; Rich, Celeste B.; Harris, David A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Yueh, Han; Zhen, Jessie; Beeler, Aaron B.] Boston Univ, Dept Chem, Boston, MA 02115 USA; [Glicksman, Marcie] Harvard Med Sch, Brigham & Womens Hosp, Lab Drug Discovery Neurodegenerat, Cambridge, MA 02139 USA; [Glicksman, Marcie] ORIG3N Inc, 27 Drydock Ave,6th Floor, Boston, MA 02210 USA	Boston University; Boston University; Harvard University; Brigham & Women's Hospital	Harris, DA (corresponding author), Boston Univ, Sch Med, 72 East Concord St, Boston, MA 02118 USA.	daharris@bu.edu		Harris, David/0000-0002-6985-5790; Imberdis, thibaut/0000-0002-0818-2617	National Institutes of Health [R01 NS065244, U24 NS049339]; Harvard NeuroDiscovery Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard NeuroDiscovery Center	This work was supported by National Institutes of Health Grants R01 NS065244 (to D. A. H.) and U24 NS049339 (to M. G.) and by the Harvard NeuroDiscovery Center (to M. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Belay ED, 2005, ANNU REV PUBL HEALTH, V26, P191, DOI 10.1146/annurev.publhealth.26.021304.144536; Biasini E, 2013, J NEUROSCI, V33, P2408, DOI 10.1523/JNEUROSCI.3406-12.2013; Biasini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033472; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Carr RAE, 2005, DRUG DISCOV TODAY, V10, P987, DOI 10.1016/S1359-6446(05)03511-7; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P6270, DOI 10.1128/JVI.67.10.6270-6272.1993; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Collinge J, 2009, LANCET NEUROL, V8, P334, DOI 10.1016/S1474-4422(09)70049-3; Fang C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005623; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Haik S, 2014, LANCET NEUROL, V13, P150, DOI 10.1016/S1474-4422(13)70307-7; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2009, PRION, V3, P195, DOI 10.4161/pri.3.4.9981; Massignan T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23180; Massignan T, 2011, METHODS, V53, P214, DOI 10.1016/j.ymeth.2010.11.005; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Miller MB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002128; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Poncet-Montange G, 2011, J BIOL CHEM, V286, P27718, DOI 10.1074/jbc.M111.234393; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Silber BM, 2014, BIOORGAN MED CHEM, V22, P1960, DOI 10.1016/j.bmc.2014.01.001; Sim Valerie L., 2012, Infectious Disorders - Drug Targets, V12, P144; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; WELLS GAH, 1995, BRAIN PATHOL, V5, P91, DOI 10.1111/j.1750-3639.1995.tb00580.x; Westergard L, 2011, J NEUROSCI, V31, P14005, DOI 10.1523/JNEUROSCI.1243-11.2011; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217	46	20	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26164	26176		10.1074/jbc.M116.745612	http://dx.doi.org/10.1074/jbc.M116.745612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803163	Green Published, hybrid			2022-12-28	WOS:000390345200033
J	Becker, CE; Creagh, EM; O'Neill, LAJ				Becker, Christine E.; Creagh, Emma M.; O'Neill, Luke A. J.			RAB39a binds caspase-1 and is required for caspase-1-dependent interleukin-1 beta secretion (vol 284, pg 34531, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Creagh, Emma/AAX-1064-2021	Creagh, Emma/0000-0001-7631-4370; O'Neill, Luke/0000-0002-4333-2748				Becker CE, 2009, J BIOL CHEM, V284, P34531, DOI 10.1074/jbc.M109.046102	1	2	2	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24800	24800		10.1074/jbc.A109.046102	http://dx.doi.org/10.1074/jbc.A109.046102			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27864526	Green Published, hybrid			2022-12-28	WOS:000388875500037
J	Medeiros, RCA; Girardi, KDD; Cardoso, FKL; Mietto, BD; Pinto, TGD; Gomez, LS; Rodrigues, LS; Gandini, M; Amaral, JJ; Antunes, SLG; Corte-Real, S; Rosa, PS; Pessolani, MCV; Nery, JAD; Sarno, EN; Batista-Silva, LR; Sola-Penna, M; de Oliveira, MF; Moraes, MO; Lara, FA				Medeiros, Rychelle Clayde Affonso; Girardi, Karina do Carmo de Vasconcelos; Cardoso, Fernanda Karlla Luz; Mietto, Bruno de Siqueira; Pinto, Thiago Gomes de Toledo; Gomez, Lilian Sales; Rodrigues, Luciana Silva; Gandini, Mariana; Amaral, Julio Jablonski; Antunes, Sergio Luiz Gomes; Corte-Real, Suzana; Rosa, Patricia Sammarco; Pessolani, Maria Cristina Vidal; Nery, Jose Augusto da Costa; Sarno, Euzenir Nunes; Batista-Silva, Leonardo Ribeiro; Sola-Penna, Mauro; de Oliveira, Marcus Fernandes; Moraes, Milton Ozorio; Lara, Flavio Alves			Subversion of Schwann cell glucose metabolism by Mycobacterium leprae (vol 291, pg 21375, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Gandini, Mariana/AAZ-6964-2021; Moraes, Milton Ozório/G-9753-2011; Sola-Penna, Mauro/E-8221-2011; Moraes, Milton/AFF-1842-2022	Moraes, Milton Ozório/0000-0003-2653-0037; Sola-Penna, Mauro/0000-0001-9796-6829; 				Medeiros RCA, 2016, J BIOL CHEM, V291, P21375, DOI 10.1074/jbc.M116.725283	1	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24803	24803		10.1074/jbc.A116.725283	http://dx.doi.org/10.1074/jbc.A116.725283			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27864529	hybrid, Green Published			2022-12-28	WOS:000388875500040
J	Solanas, G; Miravet, S; Casagolda, D; Castano, J; Raurell, I; Corrionero, A; de Herreros, AG; Dunach, M				Solanas, Guiomar; Miravet, Susana; Casagolda, David; Castano, Julio; Raurell, Imma; Corrionero, Ana; de Herreros, Antonio Garcia; Dunach, Mireia			beta-Catenin and plakoglobin N- and C-tails determine ligand specificity (vol 279, pg 49849, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Dunach, Mireia/E-3604-2015	Dunach, Mireia/0000-0001-9844-5603				Solanas G, 2004, J BIOL CHEM, V279, P49849, DOI 10.1074/jbc.M408685200	1	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23925	23927		10.1074/jbc.A116.408685	http://dx.doi.org/10.1074/jbc.A116.408685			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27837010	Green Published, hybrid			2022-12-28	WOS:000388498100008
J	Martinez-Rodriguez, L; Erdogan, O; Jimenez-Rodriguez, M; Gonzalez-Rivera, K; Williams, T; Li, L; Weinreb, V; Collier, M; Chandrasekaran, SN; Ambroggio, X; Kuhlman, B; Carter, CW				Martinez-Rodriguez, Luis; Erdogan, Ozguen; Jimenez-Rodriguez, Mariel; Gonzalez-Rivera, Katiria; Williams, Tishan; Li, Li; Weinreb, Violotta; Collier, Martha; Chandrasekaran, Srinivas Niranj; Ambroggio, Xavier; Kuhlman, Brian; Carter, Charles W., Jr.			Functional Class I and II amino acid-activating enzymes can be coded by opposite strands of the same gene (Vol 290, pg 19710, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Le Roux, Ozgun/0000-0002-9885-6872	NIGMS NIH HHS [R01 GM073960, R25 GM089569] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM089569, R01GM073960] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Martinez-Rodriguez L, 2015, J BIOL CHEM, V290, P19710, DOI 10.1074/jbc.M115.642876	1	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23830	23831		10.1074/jbc.A115.642876	http://dx.doi.org/10.1074/jbc.A115.642876			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27815453	Green Published, hybrid			2022-12-28	WOS:000387884400041
J	Zhao, JJ; Lin, JH; Yang, H; Kong, W; He, LL; Ma, X; Coppola, D; Cheng, JQ				Zhao, Jian-Jun; Lin, Jianhong; Yang, Hua; Kong, William; He, Lili; Ma, Xu; Coppola, Domenico; Cheng, Jin Q.			MicroRNA-221/222 negatively regulates estrogen receptor and is associated with tamoxifen resistance in breast cancer (vol 283, pg 31079, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	1	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22859	22859		10.1074/jbc.A116.806041	http://dx.doi.org/10.1074/jbc.A116.806041			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825097	Green Published, hybrid			2022-12-28	WOS:000386760600058
J	Gao, SB; Geng, CL; Song, TY; Lin, XR; Liu, JY; Cai, Z; Cang, Y				Gao, Shaobing; Geng, Chenlu; Song, Tianyu; Lin, Xuanru; Liu, Jiye; Cai, Zhen; Cang, Yong			Activation of c-Abl Kinase Potentiates the Anti-myeloma Drug Lenalidomide by Promoting DDA1 Protein Recruitment to the CRL4 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cancer therapy; molecular cell biology; ubiquitin ligase; ubiquitylation (ubiquitination); CRL4; DDA1; c-Abl; lenalidomide	TYROSINE KINASE; V-PROTEIN; DEGRADATION; BINDING; DESTRUCTION; CRL4(CDT2); COMPLEX; TARGETS; UBIQUITYLATION	Cullin-RING ligase 4 (CRL4), a complex of Cul4 and DDB1, regulates the cell cycle, DNA damage repair, and chromatin replication by targeting a variety of substrates for ubiquitination. CRL4 is also hijacked by viral proteins or thalidomide-derived compounds to degrade host restriction factors. Here we report that the c-Abl non-receptor kinase phosphorylates DDB1 at residue Tyr-316 to recruit a small regulatory protein, DDA1, leading to increased substrate ubiquitination. Pharmacological inhibition or genetic ablation of the Abl-DDB1-DDA1 axis decreases the ubiquitination of CRL4 substrates, including IKZF1 and IKZF3, in lenalidomide-treated multiple myeloma cells. Importantly, panobinostat, a recently approved anti-myeloma drug, and dexamethasone enhance lenalidomide-induced substrate degradation and cytotoxicity by activating c-Abl, therefore providing a mechanism underlying their combination with lenalidomide to treat multiple myeloma.	[Gao, Shaobing; Geng, Chenlu; Song, Tianyu; Liu, Jiye; Cang, Yong] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Gao, Shaobing; Geng, Chenlu; Song, Tianyu; Liu, Jiye; Cang, Yong] Zhejiang Univ, Innovat Ctr Cell Signaling Networks, Hangzhou 310058, Zhejiang, Peoples R China; [Lin, Xuanru; Cai, Zhen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Cang, Y (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Cang, Y (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Networks, Hangzhou 310058, Zhejiang, Peoples R China.	cangyong@zju.edu.cn	Song, Tianyu/AAN-3792-2020; Liu, Jiye/N-2843-2018; 高, 绍冰/GQA-8216-2022	Song, Tianyu/0000-0001-9834-6795; Liu, Jiye/0000-0001-7970-7508; 高, 绍冰/0000-0002-8307-9281; Cang, Yong/0000-0002-1148-7008	National 973 Plan for Basic Research [2015CB553803]; National Natural Science Foundation [91429302]; Fundamental Research Funds for the Central Universities; Key Construction Program of the National 985 Project	National 973 Plan for Basic Research; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Construction Program of the National 985 Project	This work was supported in part by National 973 Plan for Basic Research Grant 2015CB553803, National Natural Science Foundation Grant 91429302, and Fundamental Research Funds for the Central Universities and Key Construction Program of the National 985 Project. The authors declare that they have no conflicts of interest with the contents of this article.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Avigan D, 2014, NEW ENGL J MED, V371, P961, DOI 10.1056/NEJMe1407442; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Chen XA, 2006, MOL CELL, V22, P489, DOI 10.1016/j.molcel.2006.04.021; Cong F, 2002, J BIOL CHEM, V277, P34870, DOI 10.1074/jbc.M204416200; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Han JH, 2013, CELL, V155, P817, DOI 10.1016/j.cell.2013.10.014; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Laubach JP, 2015, CLIN CANCER RES, V21, P4767, DOI 10.1158/1078-0432.CCR-15-0530; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Liu JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4924; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Meijer E, 2009, NAT REV CLIN ONCOL, V6, P247, DOI 10.1038/nrclinonc.2009.50; Nakagawa T, 2015, MOL CELL, V57, P247, DOI 10.1016/j.molcel.2014.12.002; Olma MH, 2009, J CELL SCI, V122, P1035, DOI 10.1242/jcs.043539; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Van Nguyen T, 2016, MOL CELL, V61, P809, DOI 10.1016/j.molcel.2016.02.032; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433	40	6	6	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3683	3691		10.1074/jbc.M116.761551	http://dx.doi.org/10.1074/jbc.M116.761551			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28087699	Green Published, hybrid			2022-12-28	WOS:000395542500012
J	Lo, M; Kim, HS; Tong, RK; Bainbridge, TW; Vernes, JM; Zhang, Y; Lin, YL; Chung, S; Dennis, MS; Zuchero, YJY; Watts, RJ; Couch, JA; Meng, YG; Atwal, JK; Brezski, RJ; Spiess, C; Ernst, JA				Lo, Megan; Kim, Hok Seon; Tong, Raymond K.; Bainbridge, Travis W.; Vernes, Jean-Michel; Zhang, Yin; Lin, Yuwen Linda; Chung, Shan; Dennis, Mark S.; Zuchero, Y. Joy Yu; Watts, Ryan J.; Couch, Jessica A.; Meng, Y. Gloria; Atwal, Jasvinder K.; Brezski, Randall J.; Spiess, Christoph; Ernst, James A.			Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; complement; Fc receptor; Fc- receptor; protein stability; recombinant protein expression; aglycosylation; antibody-dependent; cell-mediated cytotoxicity (ADCC); bispecific antibody; complement-dependent cytotoxicity (CDC)	FC-GAMMA RECEPTORS; HUMAN IGG1; BINDING-SITE; MOUSE; COMPLEMENT; IMMUNOGLOBULIN; VARIANTS; OLIGOSACCHARIDE; IDENTIFICATION; AFFINITY	The antibody Fc region regulates antibody cytotoxic activities and serum half-life. In a therapeutic context, however, the cytotoxic effector function of an antibody is often not desirable and can create safety liabilities by activating native host immune defenses against cells expressing the receptor antigens. Several amino acid changes in the Fc region have been reported to silence or reduce the effector function of antibodies. These earlier studies focused primarily on the interaction of human antibodies with human Fc- receptors, and it remains largely unknown how such changes to Fc might translate to the context of a murine antibody. We demonstrate that the commonly used N297G (NG) and D265A, N297G (DANG) variants that are efficacious in attenuating effector function in primates retain potent complement activation capacity in mice, leading to safety liabilities in murine studies. In contrast, we found an L234A, L235A, P329G (LALA-PG) variant that eliminates complement binding and fixation as well as Fc--dependent, antibody-dependent, cell-mediated cytotoxity in both murine IgG2a and human IgG1. These LALA-PG substitutions allow a more accurate translation of results generated with an effectorless antibody between mice and primates. Further, we show that both human and murine antibodies containing the LALA-PG variant have typical pharmacokinetics in rodents and retain thermostability, enabling efficient knobs-into-holes bispecific antibody production and a robust path to generating highly effector-attenuated bispecific antibodies for preclinical studies.	[Lo, Megan; Tong, Raymond K.; Bainbridge, Travis W.; Ernst, James A.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Kim, Hok Seon; Zhang, Yin; Dennis, Mark S.; Brezski, Randall J.; Spiess, Christoph] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Vernes, Jean-Michel; Meng, Y. Gloria] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Lin, Yuwen Linda; Chung, Shan] Genentech Inc, Dept BioAnalyt Sci, San Francisco, CA 94080 USA; [Zuchero, Y. Joy Yu; Watts, Ryan J.; Couch, Jessica A.; Atwal, Jasvinder K.; Ernst, James A.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Couch, Jessica A.] Genentech Inc, Dept Safety Assessment, San Francisco, CA 94080 USA; [Lo, Megan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Lo, Megan] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Lo, Megan] Univ Calif San Francisco, Program Craniofacial Biol, San Francisco, CA 94143 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Spiess, C; Ernst, JA (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	spiess.christoph@gene.com; ernst.james@gene.com	Chung, Shan/AAK-5790-2021	Spiess, Christoph/0000-0002-0570-9700; Lo, Megan/0000-0002-6387-8182	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	This work was funded by Genentech, Inc. All authors are present or former paid employees of Genentech Inc.	Arduin E, 2015, MOL IMMUNOL, V63, P456, DOI 10.1016/j.molimm.2014.09.017; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Bakema JE, 2014, CURR TOP MICROBIOL, V382, P373, DOI 10.1007/978-3-319-07911-0_17; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; EPSTEIN SL, 1977, J IMMUNOL, V118, P935; Ernst LK, 2002, J MOL MED, V80, P248, DOI 10.1007/s00109-001-0294-2; Gelderman KA, 2004, TRENDS IMMUNOL, V25, P158, DOI 10.1016/j.it.2004.01.008; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Hristodorov D, 2013, MOL BIOTECHNOL, V54, P1056, DOI 10.1007/s12033-012-9612-x; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Lazar G. A., 2009, THERAPEUTIC MONOCLON, P350; Leabman MK, 2013, MABS-AUSTIN, V5, P896, DOI 10.4161/mabs.26436; Lu YM, 2011, J IMMUNOL METHODS, V365, P132, DOI 10.1016/j.jim.2010.12.014; Lund J, 1996, J IMMUNOL, V157, P4963; MCKAY EJ, 1981, IMMUNOL LETT, V3, P303, DOI 10.1016/0165-2478(81)90010-9; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; Nesspor TC, 2012, J MOL RECOGNIT, V25, P147, DOI 10.1002/jmr.2155; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Sazinsky SL, 2008, P NATL ACAD SCI USA, V105, P20167, DOI 10.1073/pnas.0809257105; Schlothauer T, 2016, PROTEIN ENG DES SEL, V29, P457, DOI 10.1093/protein/gzw040; Shatz W, 2013, MABS-AUSTIN, V5, P872, DOI 10.4161/mabs.26307; Sheridan C, 2015, NAT BIOTECHNOL, V33, P219, DOI 10.1038/nbt0315-219; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; TAO MH, 1989, J IMMUNOL, V143, P2595; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930; Welfle K, 1999, BBA-PROTEIN STRUCT M, V1431, P120, DOI 10.1016/S0167-4838(99)00046-1; Wong AW, 2010, BIOTECHNOL BIOENG, V106, P751, DOI 10.1002/bit.22749; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	44	115	133	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3900	3908		10.1074/jbc.M116.767749	http://dx.doi.org/10.1074/jbc.M116.767749			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28077575	Green Published, hybrid			2022-12-28	WOS:000395542500030
J	Bruender, NA; Bandarian, V				Bruender, Nathan A.; Bandarian, Vahe			The Creatininase Homolog MftE from Mycobacterium smegmatis Catalyzes a Peptide Cleavage Reaction in the Biosynthesis of a Novel Ribosomally Synthesized Post-translationally Modified Peptide (RiPP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOETHER BOND FORMATION; RADICAL SAM; PSEUDOMONAS-PUTIDA; CROSS-LINK; PYRROLOQUINOLINE QUINONE; NATURAL-PRODUCTS; PROTEIN; MATURATION; INTERMEDIATE; PURIFICATION	Most ribosomally synthesized and post-translationally modified peptide (RiPP) natural products are processed by tailoring enzymes to create complex natural products that are still recognizably peptide-based. However, some tailoring enzymes dismantle the peptide en route to synthesis of small molecules. A small molecule natural product of as yet unknown structure, mycofactocin, is thought to be synthesized in this way via the mft gene cluster found in many strains of mycobacteria. This cluster harbors at least six genes, which appear to be conserved across species. We have previously shown that one enzyme from this cluster, MftC, catalyzes the oxidative decarboxylation of the C-terminal Tyr of the substrate peptide MftA in a reaction that requires the MftB protein. Herein we show that mftE encodes a creatininase homolog that catalyzes cleavage of the oxidatively decarboxylated MftA peptide to liberate its final two residues, including the C-terminal decarboxylated Tyr (VY*). Unlike MftC, which requires MftB for function, MftE catalyzes the cleavage reaction in the absence of MftB. The identification of this novel metabolite, VY*, supports the notion that the mft cluster is involved in generating a small molecule from the MftA peptide. The ability to produce VY* from MftA by in vitro reconstitution of the activities of MftB, MftC, and MftE sets the stage for identification of the novel metabolite that results from the proteins encoded by the mft cluster.	[Bandarian, Vahe] Univ Utah, Dept Chem, 315 S 1400 E, Salt Lake City, UT 84112 USA; [Bruender, Nathan A.] St Cloud State Univ, Dept Chem & Biochem, St Cloud, MN 56301 USA	Utah System of Higher Education; University of Utah; Minnesota State Colleges & Universities; Saint Cloud State University	Bandarian, V (corresponding author), Univ Utah, Dept Chem, 315 S 1400 E, Salt Lake City, UT 84112 USA.	vahe@chem.utah.edu			NIGMS, National Institutes of Health [R01 GM120638, GM72623]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120638, R01GM072623] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants R01 GM120638 and GM72623 (to V.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADACHI H, 1989, J BIOCHEM-TOKYO, V105, P957, DOI 10.1093/oxfordjournals.jbchem.a122787; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Barr I, 2016, J BIOL CHEM, V291, P8877, DOI 10.1074/jbc.C115.699918; Beuth B, 2003, J MOL BIOL, V332, P287, DOI 10.1016/S0022-2836(03)00860-X; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P4131, DOI 10.1021/acs.biochem.6b00598; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2813, DOI 10.1021/acs.biochem.6b00355; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2122, DOI 10.1021/acs.biochem.6b00145; Cummings JA, 2010, BIOCHEMISTRY-US, V49, P611, DOI 10.1021/bi901935y; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fluhe L, 2013, J AM CHEM SOC, V135, P959, DOI 10.1021/ja310542g; Freeman MF, 2012, SCIENCE, V338, P387, DOI 10.1126/science.1226121; GOOSEN N, 1989, J BACTERIOL, V171, P447, DOI 10.1128/jb.171.1.447-455.1989; Haft DH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-21; Khaliullin B, 2016, FEBS LETT, V590, P2538, DOI 10.1002/1873-3468.12249; McCarty RM, 2013, BIOCHEMISTRY-US, V52, P188, DOI 10.1021/bi301156w; Morinaka BI, 2014, ANGEW CHEM INT EDIT, V53, P8503, DOI 10.1002/anie.201400478; Nakai T, 2015, J BIOL CHEM, V290, P11144, DOI 10.1074/jbc.M115.638320; Ono K, 2006, J BIOL CHEM, V281, P13672, DOI 10.1074/jbc.M600029200; Schramma KR, 2015, NAT CHEM, V7, P431, DOI [10.1038/NCHEM.2237, 10.1038/nchem.2237]; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Thoden JB, 2005, J BIOL CHEM, V280, P32784, DOI 10.1074/jbc.M505730200; Toyama H, 1997, MICROBIOL-SGM, V143, P595, DOI 10.1099/00221287-143-2-595; TSURU D, 1976, AGR BIOL CHEM TOKYO, V40, P1011, DOI 10.1080/00021369.1976.10862151; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Wieckowski BM, 2015, FEBS LETT, V589, P1802, DOI 10.1016/j.febslet.2015.05.032; Yoshimoto T, 2004, J MOL BIOL, V337, P399, DOI 10.1016/j.jmb.2004.01.022; YOSHIMOTO T, 1976, ARCH BIOCHEM BIOPHYS, V177, P508, DOI 10.1016/0003-9861(76)90462-8	31	9	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4371	4381		10.1074/jbc.M116.762062	http://dx.doi.org/10.1074/jbc.M116.762062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28077628	Green Published, hybrid			2022-12-28	WOS:000395837100036
J	Li, Y; Mayer, FP; Hasenhuetl, PS; Burtscher, V; Schicker, K; Sitte, HH; Freissmuth, M; Sandtner, W				Li, Yang; Mayer, Felix P.; Hasenhuetl, Peter S.; Burtscher, Verena; Schicker, Klaus; Sitte, Harald H.; Freissmuth, Michael; Sandtner, Walter			Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE; MANGANESE; PARKINSONISM; ZN2+; MONOTHERAPY; MUTATIONS; PROTEINS; SPECTRUM; CYCLE	The human dopamine transporter (DAT) has a tetrahedral Zn2+-binding site. Zn2+-binding sites are also recognized by other first-row transition metals. Excessive accumulation of manganese or of copper can lead to parkinsonism because of dopamine deficiency. Accordingly, we examined the effect of Mn2+, Co2+, Ni2+, and Cu2+ on transport-associated currents through DAT and DAT-H193K, a mutant with a disrupted Zn2+-binding site. All transition metals except Mn2+ modulated the transport cycle of wild-type DAT with affinities in the low micromolar range. In this concentration range, they were devoid of any action on DAT-H193K. The active transition metals reduced the affinity of DAT for dopamine. The affinity shift was most pronounced for Cu2+, followed by Ni2+ and Zn2+ (= Co2+). The extent of the affinity shift and the reciprocal effect of substrate on metal affinity accounted for the different modes of action: Ni2+ and Cu2+ uniformly stimulated and inhibited, respectively, the substrate-induced steady-state currents through DAT. In contrast, Zn2+ elicited biphasic effects on transport, i.e. stimulation at 1 mu M and inhibition at 10 mu M. A kinetic model that posited preferential binding of transition metal ions to the outward-facing apo state of DAT and a reciprocal interaction of dopamine and transition metals recapitulated all experimental findings. Allosteric activation of DAT via the Zn2+-binding site may be of interest to restore transport in loss-of-function mutants.	[Li, Yang; Mayer, Felix P.; Hasenhuetl, Peter S.; Burtscher, Verena; Schicker, Klaus; Sitte, Harald H.; Freissmuth, Michael; Sandtner, Walter] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstrasse 13a, A-1090 Vienna, Austria	Medical University of Vienna	Sandtner, W (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Waehringerstrasse 13a, A-1090 Vienna, Austria.	walter.sandtner@meduniwien.ac.at	Sitte, Harald/N-2681-2013; Hasenhuetl, Peter/AAG-6335-2019	Sitte, Harald/0000-0002-1339-7444; Hasenhuetl, Peter/0000-0002-3121-9502; Mayer, Felix/0000-0001-9837-8973; Burtscher, Verena/0000-0002-0464-0799; Schicker, Klaus/0000-0002-3068-7830; Freissmuth, Michael/0000-0001-9398-1765	Austrian Science Fund/FWF Project [P28090]; Project Program Grant [SFB35, F3506, F3510, W1232]; Chinese Scholarship Council Grant [201308310446]	Austrian Science Fund/FWF Project(Austrian Science Fund (FWF)); Project Program Grant; Chinese Scholarship Council Grant	This work was supported by the Austrian Science Fund/FWF Project P28090 (to W.S.), Project Program Grant SFB35 (Grants F3506 to H.H.S. and F3510 to M.F.), Project W1232 (to H.H.S.), and Chinese Scholarship Council Grant 201308310446 (to Y.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Auld DS, 2009, BIOMETALS, V22, P141, DOI 10.1007/s10534-008-9184-1; Bandmann O, 2015, LANCET NEUROL, V14, P103, DOI 10.1016/S1474-4422(14)70190-5; Bjorklund NL, 2007, EUR J PHARMACOL, V565, P17, DOI 10.1016/j.ejphar.2007.02.027; Couper J., 1837, BR ANN MED PHARM, V1, P41, DOI DOI 10.1002/JCP.22692; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Guilarte TR, 2008, J NEUROCHEM, V107, P1236, DOI 10.1111/j.1471-4159.2008.05695.x; Hamilton PJ, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0002-7; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; HECKMANN JM, 1994, J NEUROL NEUROSUR PS, V57, P1273, DOI 10.1136/jnnp.57.10.1273; Hermann W, 2002, J NEUROL, V249, P1082, DOI 10.1007/s00415-002-0795-0; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Ishida S, 2012, INTERNAL MED, V51, P1759, DOI 10.2169/internalmedicine.51.7341; Jeon B, 1998, J NEUROL NEUROSUR PS, V65, P60, DOI 10.1136/jnnp.65.1.60; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Laeuger P., 1991, ELECTROGENIC ION PUM; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li Y, 2015, J BIOL CHEM, V290, P31069, DOI 10.1074/jbc.M115.688275; Linn FHH, 2009, HEPATOLOGY, V50, P1442, DOI 10.1002/hep.23182; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Meinild AK, 2004, J BIOL CHEM, V279, P49671, DOI 10.1074/jbc.M407660200; MURPHY GF, 1961, SCIENCE, V133, P1706, DOI 10.1126/science.133.3465.1706-a; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Pifl C, 2009, NEUROPHARMACOLOGY, V56, P531, DOI 10.1016/j.neuropharm.2008.10.009; Rodier J, 1955, BRIT J IND MED, V12, P21; Sandtner W, 2014, BRIT J PHARMACOL, V171, P1007, DOI 10.1111/bph.12520; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Schilsky M, 2009, HEPATOLOGY, V50, P1341, DOI 10.1002/hep.23355; Schmid D, 2015, BRIT J PHARMACOL, V172, P4775, DOI 10.1111/bph.12766; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Srinivas K, 2008, J NEUROL SCI, V266, P104, DOI 10.1016/j.jns.2007.09.009; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wang P, 2007, CLIN NUCL MED, V32, P844, DOI 10.1097/RLU.0b013e318156baf8	40	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4235	4243		10.1074/jbc.M116.760140	http://dx.doi.org/10.1074/jbc.M116.760140			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28096460	hybrid, Green Published			2022-12-28	WOS:000395837100021
J	Bedard, M; Roy, V; Montagne, M; Lavigne, P				Bedard, Mikael; Roy, Vincent; Montagne, Martin; Lavigne, Pierre			Structural Insights into c-Myc-interacting Zinc Finger Protein-1 (Miz-1) Delineate Domains Required for DNA Scanning and Sequence-specific Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence anisotropy; nuclear magnetic resonance (NMR); protein dynamic; protein-DNA interaction; protein-protein interaction; structural biology; transcription factor; zinc finger	TRANSCRIPTION FACTOR IIIA; HUWE1 UBIQUITIN LIGASE; N-15 NMR RELAXATION; BACKBONE DYNAMICS; ROTATIONAL DIFFUSION; LINKER SEQUENCES; RECOGNITION; AFFINITY; MACROMOLECULES; SPECTROSCOPY	c-Myc-interacting zinc finger protein-1 (Miz-1) is a poly-Cys2His2 zinc finger (ZF) transcriptional regulator of many cell cycle genes. A Miz-1 DNA sequence consensus has recently been identified and has also unveiled Miz-1 functions in other cellular processes, underscoring its importance in the cell. Miz-1 contains 13 ZFs, but it is unknown why Miz-1 has so many ZFs and whether they recognize and bind DNA sequences in a typical fashion. Here, we used NMR to deduce the role of Miz-1 ZFs 1-4 in detecting the Miz-1 consensus sequence and preventing nonspecific DNA binding. In the construct containing the first 4 ZFs, we observed that ZFs 3 and 4 form an unusual compact and stable structure that restricts their motions. Disruption of this compact structure by an electrostatically mismatched A86K mutation profoundly affected the DNA binding properties of the WT construct. On the one hand, Miz1-4(WT) was found to bind the Miz-1 DNA consensus sequence weakly and through ZFs 1-3 only. On the other hand, the four ZFs in the structurally destabilized Miz1-4(A86K) mutant bound to the DNA consensus with a 30-fold increase in affinity (100 nm). The formation of such a thermodynamically stable but nonspecific complex is expected to slow down the rate of DNA scanning by Miz-1 during the search for its consensus sequence. Interestingly, we found that the motif stabilizing the compact structure between ZFs 3 and 4 is conserved and enriched in other long poly-ZF proteins. As discussed in detail, our findings support a general role of compact inter-ZF structures in minimizing the formation of off-target DNA complexes.	Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1H 5N4, Canada; McGill Univ, Grp Rech Axe Struct Prot GRASP, Montreal, PQ H3G 0B1, Canada	University of Sherbrooke; McGill University	Lavigne, P (corresponding author), Univ Laval, Regrp Strategique Fonct Struct & Ingn Prot PROTEO, Quebec City, PQ G1V 0A6, Canada.; Lavigne, P (corresponding author), Univ Sherbrooke, Inst Pharmacol Sherbrooke, 3001 12e Ave Nord,Campus Sante, Sherbrooke, PQ J1H 5N4, Canada.	pierre.lavigne@usherbrooke.ca			Natural Science and Engineering Research Council (NSERC) of Canada; Regroupement Strategique sur la Fonction, la Structure, et l'Ingenierie des Proteines (PROTEO); Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Regroupement Strategique sur la Fonction, la Structure, et l'Ingenierie des Proteines (PROTEO); Groupe de Recherche Axe sur la Structure des Proteines (GRASP)	This work was supported by the Natural Science and Engineering Research Council (NSERC) of Canada (grant to P. L. and studentships to M. B.) and by the Regroupement Strategique sur la Fonction, la Structure, et l'Ingenierie des Proteines (PROTEO). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a graduate studentship from the Groupe de Recherche Axe sur la Structure des Proteines (GRASP).	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Baber JL, 2001, J AM CHEM SOC, V123, P3953, DOI 10.1021/ja0041876; BabuRajendran N, 2010, NUCLEIC ACIDS RES, V38, P3477, DOI 10.1093/nar/gkq046; Barrilleaux BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101151; Bedard M, 2012, J BIOMOL NMR, V54, P317, DOI 10.1007/s10858-012-9670-1; Bernard D, 2013, J BIOMOL NMR, V57, P103, DOI 10.1007/s10858-013-9770-6; Bieri M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-421; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Breslin MB, 2002, NUCLEIC ACIDS RES, V30, P1038, DOI 10.1093/nar/30.4.1038; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Chen P, 2016, DIGEST DIS SCI, V61, P758, DOI 10.1007/s10620-015-3951-y; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; CLEMENS KR, 1994, J MOL BIOL, V244, P23, DOI 10.1006/jmbi.1994.1701; Do-Umehara HC, 2013, NAT IMMUNOL, V14, P461, DOI 10.1038/ni.2566; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Friedman JI, 2009, NUCLEIC ACIDS RES, V37, P3493, DOI 10.1093/nar/gkp161; Gagne SM, 1998, J MOL BIOL, V278, P667, DOI 10.1006/jmbi.1998.1723; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; Huang YS, 2015, BIOCHEM J, V466, P499, DOI 10.1042/BJ20141143; Kaplan T, 2005, PLOS COMPUT BIOL, V1, P5, DOI 10.1371/journal.pcbi.0010001; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; Lee BM, 2006, J MOL BIOL, V357, P275, DOI 10.1016/j.jmb.2005.12.010; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; OMICHINSKI JG, 1992, BIOCHEMISTRY-US, V31, P3907, DOI 10.1021/bi00131a004; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Persikov AV, 2014, NUCLEIC ACIDS RES, V42, P97, DOI 10.1093/nar/gkt890; Peter S, 2014, EMBO MOL MED, V6, P1525, DOI 10.15252/emmm.201403927; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Potter BM, 2005, J BIOL CHEM, V280, P28529, DOI 10.1074/jbc.M505217200; Rashkovan M, 2014, P NATL ACAD SCI USA, V111, pE5411, DOI 10.1073/pnas.1412107111; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Ryan RF, 1998, NUCLEIC ACIDS RES, V26, P703, DOI 10.1093/nar/26.3.703; Schaub FX, 2014, EMBO MOL MED, V6, P1509, DOI 10.15252/emmm.201404735; Schmidt D, 2004, MOL BIOL EVOL, V21, P2326, DOI 10.1093/molbev/msh246; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; THUKRAL SK, 1991, P NATL ACAD SCI USA, V88, P9188, DOI 10.1073/pnas.88.20.9188; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Tochio Naoya, 2015, Journal of Structural and Functional Genomics, V16, P55, DOI 10.1007/s10969-015-9196-3; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Wiese KE, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014290; Wolf E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3535; Wolfe SA, 1999, J MOL BIOL, V285, P1917, DOI 10.1006/jmbi.1998.2421; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Zandarashvili L, 2015, P NATL ACAD SCI USA, V112, pE5142, DOI 10.1073/pnas.1507726112; Zandarashvili L, 2012, P NATL ACAD SCI USA, V109, pE1724, DOI 10.1073/pnas.1121500109	63	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3323	3340		10.1074/jbc.M116.748699	http://dx.doi.org/10.1074/jbc.M116.748699			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28035002	hybrid, Green Published			2022-12-28	WOS:000395538800023
J	Afolayan, AJ; Alexander, M; Holme, RL; Michalkiewicz, T; Rana, U; Teng, RJ; Zemanovic, S; Sahoo, D; Pritchard, KA; Konduri, GG				Afolayan, Adeleye J.; Alexander, Maxwell; Holme, Rebecca L.; Michalkiewicz, Teresa; Rana, Ujala; Teng, Ru-Jeng; Zemanovic, Sara; Sahoo, Daisy; Pritchard, Kirkwood A., Jr.; Konduri, Girija G.			Domain Mapping of Heat Shock Protein 70 Reveals That Glutamic Acid 446 and Arginine 447 Are Critical for Regulating Superoxide Dismutase 2 Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OXIDATIVE STRESS; BINDING DOMAIN; PROTEIN; HYPERTENSION; EXPRESSION; ASSOCIATION; DEFICIENCY; INHIBITOR; RESIDUES; CROSS	Stress-inducible heat shock protein 70 (hsp70) interacts with superoxide dismutase 2 (SOD2) in the cytosol after synthesis to transfer the enzyme to the mitochondria for subsequent activation. However, the structural basis for this interaction remains to be defined. To map the SOD2-binding site in hsp70, mutants of hsp70 were made and tested for their ability to bind SOD2. These studies showed that SOD2 binds in the amino acid 393-537 region of the chaperone. To map the hsp70-binding site in SOD2, we used a series of pulldown assays and showed that hsp70 binds to the amino-terminal domain of SOD2. To better define the binding site, we used a series of decoy peptides derived from the primary amino acid sequence in the SOD2-binding site in hsp70. This study shows that SOD2 specifically binds to hsp70 at (445)GERAMT(450). Small peptides containing GERAMT inhibited the transfer of SOD2 to the mitochondria and decreased SOD2 activity in vitro and in vivo. To determine the amino acid residues in hsp70 that are critical for SOD2i nteractions, we substituted each amino acid residue for alanine or more conservative residues, glutamine or asparagine, in the GERAMT-binding site. Substitutions of E446A/Q and R447A/Q inhibited the ability of the GERAMT peptide to bind SOD2 and preserved SOD2 function more than other substitutions. Together, these findings indicate that the GERAMT sequence is critical for hsp70-mediated regulation of SOD2 and that Glu(446) and Arg(447) cooperate with other amino acid residues in the GERAMT-binding site for proper chaperone-dependent regulation of SOD2 antioxidant function.	[Afolayan, Adeleye J.; Alexander, Maxwell; Michalkiewicz, Teresa; Rana, Ujala; Teng, Ru-Jeng; Zemanovic, Sara; Konduri, Girija G.] Med Coll Wisconsin, Dept Pediat, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA; [Afolayan, Adeleye J.; Alexander, Maxwell; Holme, Rebecca L.; Michalkiewicz, Teresa; Rana, Ujala; Teng, Ru-Jeng; Zemanovic, Sara; Sahoo, Daisy; Pritchard, Kirkwood A., Jr.; Konduri, Girija G.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Holme, Rebecca L.; Sahoo, Daisy] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Afolayan, AJ (corresponding author), 999 N 92nd St,CCC Suite 410, Milwaukee, WI 53226 USA.	aafolaya@mcw.edu			Children's Hospital Research Institute [DOP 33017]; Department of Pediatrics of the Medical College of Wisconsin [CRI FP9523]; National Institutes of Health [KO8HL133379, RO1 HL057268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL133379, R01HL057268, R01HL128371, R01HL112270] Funding Source: NIH RePORTER	Children's Hospital Research Institute; Department of Pediatrics of the Medical College of Wisconsin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by The Children's Hospital Research Institute Grant DOP 33017 and Department of Pediatrics of the Medical College of Wisconsin Grant CRI FP9523 (to A. J.A. and G.G.K.), and National Institutes of Health Grants KO8HL133379 (to A.J.A.) and RO1 HL057268 (to G.G.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adesina SE, 2015, FREE RADICAL BIO MED, V87, P36, DOI 10.1016/j.freeradbiomed.2015.05.042; Afolayan AJ, 2014, AM J PHYSIOL-LUNG C, V306, pL351, DOI 10.1152/ajplung.00264.2013; Afolayan AJ, 2012, AM J PHYSIOL-LUNG C, V303, pL870, DOI 10.1152/ajplung.00098.2012; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Bag A, 2008, CANCER EPIDEM BIOMAR, V17, P3298, DOI 10.1158/1055-9965.EPI-08-0235; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bauer D, 2015, P NATL ACAD SCI USA, V112, P10389, DOI 10.1073/pnas.1504625112; Choi S, 2005, J BIOCHEM MOL BIOL, V38, P111; CRAIG EA, 1993, SCIENCE, V260, P1902, DOI 10.1126/science.8100364; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Duncan Emma J, 2015, Subcell Biochem, V78, P243, DOI 10.1007/978-3-319-11731-7_12; Farrow KN, 2010, RESP PHYSIOL NEUROBI, V174, P272, DOI 10.1016/j.resp.2010.08.018; Farrow KN, 2010, AM J PHYSIOL-LUNG C, V299, pL109, DOI 10.1152/ajplung.00309.2009; Farrow KN, 2008, AM J PHYSIOL-LUNG C, V295, pL979, DOI 10.1152/ajplung.90238.2008; Finka A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00029; Karnati S, 2013, HISTOCHEM CELL BIOL, V140, P105, DOI 10.1007/s00418-013-1099-4; Konduri GG, 2007, AM J PHYSIOL-HEART C, V292, pH1812, DOI 10.1152/ajpheart.00425.2006; Konzack A, 2014, BIOCHEM SOC T, V42, P1012, DOI 10.1042/BST20140076; Koyama H, 2013, MOLECULES, V18, P1383, DOI 10.3390/molecules18021383; Kudla J, 2016, PLANT CELL, V28, P1002, DOI 10.1105/tpc.16.00043; Kuo HT, 2015, AMINO ACIDS, V47, P885, DOI 10.1007/s00726-015-1916-2; Lepur A, 2016, J BIOMOL SCREEN, V21, P1100, DOI 10.1177/1087057116659438; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Leung HS, 2006, VASC PHARMACOL, V44, P299, DOI 10.1016/j.vph.2006.01.010; Lindahl PA, 2016, BIOCHEMISTRY-US, V55, P4140, DOI 10.1021/acs.biochem.6b00216; Mayer MP, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00058; Maynard SJ, 2014, J AM CHEM SOC, V136, P16683, DOI 10.1021/ja510265e; NEUPERT W, 1990, CELL, V63, P447, DOI 10.1016/0092-8674(90)90437-J; Rodriguez-Iturbe B, 2007, J APPL PHYSIOL, V102, P255, DOI 10.1152/japplphysiol.00513.2006; Sartoretto JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044627; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Sekhar A, 2016, P NATL ACAD SCI USA, V113, pE2794, DOI 10.1073/pnas.1601846113; Sekhar A, 2015, P NATL ACAD SCI USA, V112, P10395, DOI 10.1073/pnas.1508504112; Sharma H., 2016, RNA BIOL, V7, P1; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; Sun L, 2014, CELL PHYSIOL BIOCHEM, V34, P1614, DOI 10.1159/000366364; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Xu Y, 2015, ONCOGENE, V34, P4229, DOI 10.1038/onc.2014.355; Xu Y, 2008, MOL CANCER RES, V6, P1881, DOI 10.1158/1541-7786.MCR-08-0253; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhou RH, 2012, ARTERIOSCL THROM VAS, V32, P745, DOI 10.1161/ATVBAHA.111.243121	42	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2369	2378		10.1074/jbc.M116.756122	http://dx.doi.org/10.1074/jbc.M116.756122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028182	Green Published, hybrid			2022-12-28	WOS:000395530300027
J	Cheng, ZK; Zhu, Q; Dee, R; Opheim, Z; Mack, CP; Cyr, DM; Taylor, JM				Cheng, Zhaokang; Zhu, Qiang; Dee, Rachel; Opheim, Zachary; Mack, Christopher P.; Cyr, Douglas M.; Taylor, Joan M.			Focal Adhesion Kinase-mediated Phosphorylation of Beclin1 Protein Suppresses Cardiomyocyte Autophagy and Initiates Hypertrophic Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPRAVALVULAR AORTIC CONSTRICTION; CARDIAC-HYPERTROPHY; INHIBITS AUTOPHAGY; CELLULAR AUTOPHAGY; HEART; DELETION; DOMAIN; RATS; FAK	Autophagy is an evolutionarily conserved intracellular degradation/recycling system that is essential for cellular homeostasis but is dysregulated in a number of diseases, including myocardial hypertrophy. Although it is clear that limiting or accelerating autophagic flux can result in pathological cardiac remodeling, the physiological signaling pathways that fine-tune cardiac autophagy are poorly understood. Herein, we demonstrated that stimulation of cardiomyocytes with phenylephrine (PE), a well known hypertrophic agonist, suppresses autophagy and that activation of focal adhesion kinase (FAK) is necessary for PE-stimulated autophagy suppression and subsequent initiation of hypertrophic growth. Mechanistically, we showed that FAK phosphorylates Beclin1, a core autophagy protein, on Tyr233 and that this post-translational modification limits Beclin1 association with Atg14L and reduces Beclin1-dependent autophagosome formation. Remarkably, although ectopic expression of wild-type Beclin1 promoted cardiomyocyte atrophy, expression of a Y233E phosphomimetic variant of Beclin1 failed to affect cardiomyocyte size. Moreover, genetic depletion of Beclin1 attenuated PE-mediated/FAK-dependent initiation of myocyte hypertrophy in vivo. Collectively, these findings identify FAK as a novel negative regulator of Beclin1-mediated autophagy and indicate that this pathway can facilitate the promotion of compensatory hypertrophic growth. This novel mechanism to limit Beclin1 activity has important implications for treating a variety of pathologies associated with altered autophagic flux.	[Cheng, Zhaokang; Zhu, Qiang; Dee, Rachel; Opheim, Zachary; Mack, Christopher P.; Taylor, Joan M.] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [Mack, Christopher P.; Taylor, Joan M.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA; [Cyr, Douglas M.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Taylor, JM (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, 501 Brinkhous Bullitt Bldg,CB 7525, Chapel Hill, NC 27599 USA.	jmt3x@med.unc.edu		Cheng, Zhaokang/0000-0002-9646-4824; Taylor, Joan/0000-0002-8794-5167; Dee, Rachel/0000-0002-6982-8952; Cyr, Douglas/0000-0002-4928-3414	National Institutes of Health from NHLBI [HL-081844, HL-130367, K99/R00, K99HL119605]; American Heart Association [0355776U, 11POST7600008]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768, R01HL130367, R00HL119605, R01HL081844, R01HL109607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL-081844 and HL-130367 from NHLBI and American Heart Association Grant 0355776U (to J. M. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by American Heart Association Postdoctoral Fellowship 11POST7600008 and National Institutes of Health K99/R00 Pathway to Independence Award K99HL119605 from NHLBI.	Ceylan-Isik AF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0335-3; Cheng ZK, 2012, ARTERIOSCL THROM VAS, V32, P924, DOI 10.1161/ATVBAHA.112.245134; Cheng Z, 2014, J APPL MATH, DOI 10.1155/2014/369350; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; DAMMRICH J, 1983, VIRCHOWS ARCH B, V43, P265, DOI 10.1007/BF02932961; DAMMRICH J, 1983, VIRCHOWS ARCH B, V43, P287, DOI 10.1007/BF02932962; DiMichele LA, 2006, CIRC RES, V99, P636, DOI 10.1161/01.RES.0000240498.44752.d6; DiMichele LA, 2009, CIRC RES, V104, P1201, DOI 10.1161/CIRCRESAHA.109.195941; Farre JC, 2011, CELL, V144, P172, DOI 10.1016/j.cell.2011.01.005; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gabarra-Niecko V, 2002, BIOCHEM J, V365, P591, DOI 10.1042/BJ20020065; Gurkar AU, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3189; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hariharan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051632; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Hathaway CK, 2015, P NATL ACAD SCI USA, V112, P5141, DOI 10.1073/pnas.1504557112; Huang S, 2015, J CELL MOL MED, V19, P608, DOI 10.1111/jcmm.12445; Hurley JH, 2014, CELL, V157, P300, DOI 10.1016/j.cell.2014.01.070; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kanamori H, 2011, CARDIOVASC RES, V91, P330, DOI 10.1093/cvr/cvr073; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim Hye Joo, 2012, Evid Based Complement Alternat Med, V2012, P639469, DOI 10.1155/2012/639469; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Maejima Y, 2016, J MOL CELL CARDIOL, V95, P19, DOI 10.1016/j.yjmcc.2015.10.032; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nakaoka M, 2015, BIOCHEM BIOPH RES CO, V456, P250, DOI 10.1016/j.bbrc.2014.11.067; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Nishida K, 2016, J MOL CELL CARDIOL, V95, P11, DOI 10.1016/j.yjmcc.2015.12.003; Oyabu J, 2013, BIOCHEM BIOPH RES CO, V441, P787, DOI 10.1016/j.bbrc.2013.10.135; PFEIFER U, 1987, J MOL CELL CARDIOL, V19, P1179, DOI 10.1016/S0022-2828(87)80528-X; Pham CG, 2000, AM J PHYSIOL-HEART C, V279, pH2916, DOI 10.1152/ajpheart.2000.279.6.H2916; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Rothermel BA, 2008, CIRC RES, V103, P1363, DOI 10.1161/CIRCRESAHA.108.186551; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sandilands E, 2015, CELL SIGNAL, V27, P1816, DOI 10.1016/j.cellsig.2015.05.017; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Taylor JM, 2000, J BIOL CHEM, V275, P19250, DOI 10.1074/jbc.M909099199; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wauson EM, 2014, TRENDS ENDOCRIN MET, V25, P274, DOI 10.1016/j.tem.2014.03.006; Wei YJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05289; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Wesselborg S, 2015, CELL MOL LIFE SCI, V72, P4721, DOI 10.1007/s00018-015-2034-8; Xia PY, 2013, EMBO J, V32, P2685, DOI 10.1038/emboj.2013.189; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhang T, 2015, ELIFE, V4, DOI 10.7554/eLife.06734; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	55	30	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2065	2079		10.1074/jbc.M116.758268	http://dx.doi.org/10.1074/jbc.M116.758268			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27994061	Green Published, hybrid			2022-12-28	WOS:000395530300002
J	Moreau, C; Terrasse, R; Thielens, NM; Vernet, T; Gaboriaud, C; Di Guilmi, AM				Moreau, Christophe; Terrasse, Remi; Thielens, Nicole M.; Vernet, Thierry; Gaboriaud, Christine; Di Guilmi, Anne Marie			Deciphering Key Residues Involved in the Virulence-promoting Interactions between Streptococcus pneumoniae and Human Plasminogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; ALPHA-ENOLASE; REVEALS; ADHESIN	Bacterial pathogens recruit circulating proteins to their own surfaces, co-opting the host protein functions as a mechanism of virulence. Particular attention has focused on the binding of plasminogen (Plg) to bacterial surfaces, as it has been shown that this interaction contributes to bacterial adhesion to host cells, invasion of host tissues, and evasion of the immune system. Several bacterial proteins are known to serve as receptors for Plg including glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a cytoplasmic enzyme that appears on the cell surface in this moonlighting role. Although Plg typically binds to these receptors via several lysine-binding domains, the specific interactions that occur have not been documented in all cases. However, identification of the relevant residues could help define strategies for mitigating the virulence of important human pathogens, such as Streptococcus pneumoniae (Sp). To shed light on this question, we have described a combination of peptide-spot array screening, competition and SPR assays, high-resolution crystallography, and mutational analyses to characterize the interaction between SpGAPDH and Plg. We identified three SpGAPDH lysine residues that were instrumental in defining the kinetic and thermodynamic parameters of the interaction. Altogether, the integration of the data presented in this work allows us to propose a structural model for the molecular interaction of the SpGAPDH-Plg complex.	[Moreau, Christophe; Terrasse, Remi; Thielens, Nicole M.; Vernet, Thierry; Gaboriaud, Christine; Di Guilmi, Anne Marie] Univ Grenoble Alpes, IBS, CEA, CNRS, F-38044 Grenoble, France; [Moreau, Christophe] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Terrasse, Remi] Jacobs Univ Bremen, D-28759 Bremen, Germany	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Oxford; Jacobs University	Gaboriaud, C; Di Guilmi, AM (corresponding author), Univ Grenoble Alpes, IBS, CEA, CNRS, F-38044 Grenoble, France.	christine.gaboriaud@ibs.fr; anne-marie.di-guilmi@ibs.fr	Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302; Di Guilmi, Anne Marie/0000-0001-7335-3470; gaboriaud, christine/0000-0001-5308-0516	French Infrastructure for Integrated Structural Biology Initiative FRISBI [ANR-10-INSB-05-02]; Grenoble Alliance for Integrated Structural Cell Biology GRAL within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	French Infrastructure for Integrated Structural Biology Initiative FRISBI; Grenoble Alliance for Integrated Structural Cell Biology GRAL within the Grenoble Partnership for Structural Biology (PSB)	We thank Isabelle Bally and Jean-Baptiste Reiser for assistance and access to the SPR facility. We acknowledge the platforms of the Grenoble Instruct Centre (Integrated Structural Biology Grenoble (ISBG); UMS 3518 CNRS-CEA-UGA-EMBL) supported by the French Infrastructure for Integrated Structural Biology Initiative FRISBI (ANR-10-INSB-05-02) and by the Grenoble Alliance for Integrated Structural Cell Biology GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). Access to the European Synchrotron Radiation Facility beamline ID23-eh1 is acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; Ayres CA, 2014, ACTA CRYSTALLOGR F, V70, P1333, DOI 10.1107/S2053230X14019517; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frolet C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-190; Fulde M, 2014, THROMB HAEMOSTASIS, V111, P401, DOI 10.1160/TH13-05-0421; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Sanderson-Smith ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/272148; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Terrasse R, 2012, J BIOL CHEM, V287, P42620, DOI 10.1074/jbc.M112.423731; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200	32	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2217	2225		10.1074/jbc.M116.764209	http://dx.doi.org/10.1074/jbc.M116.764209			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011643	Green Published, hybrid			2022-12-28	WOS:000395530300015
J	Liu, L; Jacobsen, FW; Everds, N; Zhuang, Y; Yu, YB; Li, NY; Clark, D; Nguyen, MP; Fort, M; Narayanan, P; Kim, K; Stevenson, R; Narhi, L; Gunasekaran, K; Bussiere, JL				Liu, Ling; Jacobsen, Frederick W.; Everds, Nancy; Zhuang, Yao; Yu, Yan Bin; Li, Nianyu; Clark, Darcey; Mai Phuong Nguyen; Fort, Madeline; Narayanan, Padma; Kim, Kei; Stevenson, Riki; Narhi, Linda; Gunasekaran, Kannan; Bussiere, Jeanine L.			Biological Characterization of a Stable Effector Functionless (SEFL) Monoclonal Antibody Scaffold in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; Fc receptor; immunoglobulin G (IgG); phagocytosis; platelet; platelet depletion; antibody-dependent cellular cytotoxicity; complement-dependent cytotoxicity; cynomolgus macaque	DEPENDENT CELLULAR CYTOTOXICITY; LENGTH IGG ANTIBODIES; THERMAL-STABILITY; GLYCOSYLATION; EXPRESSION; FC; THERAPEUTICS; AGGREGATION; THERAPY	The stable effector functionLess (SEFL) antibody was designed as an IgG1 antibody with a constant region that lacks the ability to interact with Fc receptors. The engineering and stability and pharmacokinetic assessments of the SEFL scaffold is described in the accompanying article (Jacobsen, F. W., Stevenson, R., Li, C., Salimi-Moosavi, H., Liu, L., Wen, J., Luo, Q., Daris, K., Buck, L., Miller, S., Ho, S-Y., Wang, W., Chen, Q., Walker, K., Wypych, J., Narhi, L., and Gunasekaran, K. (2017) J. Biol. Chem. 292). The biological properties of these SEFL antibodies were assessed in a variety of human and cynomolgus monkey in vitro assays. Binding of parent molecules and their SEFL variants to human and cynomolgus monkey FcRs were evaluated using flow cytometry-based binding assays. The SEFL variants tested showed decreased binding affinity to human and cynomolgus FcRs compared with the wild-type IgG1 antibody. In addition, SEFL variants demonstrated no antibody-dependent cell-mediated cytotoxicity in vitro against Daudi cells with cynomolgus monkey peripheral blood mononuclear cells, and had minimal complement-dependent cytotoxicity activity similar to that of the negative control IgG2 in a CD20(+) human Raji lymphoma cell line. SEFL mutations eliminated off-target antibody-dependent monocyte phagocytosis of cynomolgus monkey platelets, and cynomolgus platelet activation in vitro. These experiments demonstrate that the SEFL modifications successfully eliminated Fc-associated effector binding and functions.	[Liu, Ling; Jacobsen, Frederick W.; Gunasekaran, Kannan] Amgen Inc, Dept Biol Optimizat, Thousand Oaks, CA 91320 USA; [Everds, Nancy; Li, Nianyu; Clark, Darcey; Mai Phuong Nguyen; Fort, Madeline; Narayanan, Padma; Kim, Kei; Bussiere, Jeanine L.] Amgen Inc, Dept Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA; [Zhuang, Yao; Yu, Yan Bin] Amgen Inc, Dept Clin Immunol, Thousand Oaks, CA 91320 USA; [Stevenson, Riki; Narhi, Linda] Amgen Inc, Dept Proc Dev, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen	Liu, L (corresponding author), One Amgen Ctr Dr,MS 14-2-A, Thousand Oaks, CA 91320 USA.	ling.liu@amgen.com	Ozkan, Hayri/T-6335-2017	Ozkan, Hayri/0000-0001-8443-8074	Amgen	Amgen(Amgen)	This work was supported by Amgen. All authors work or have worked at Amgen.	Fernandez LA, 2011, CURR OPIN BIOTECH, V22, P839, DOI 10.1016/j.copbio.2011.08.001; Awan FT, 2010, BLOOD, V115, P1204, DOI 10.1182/blood-2009-06-229039; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; Everds N, 2013, TOXICOL PATHOL, V41, P951, DOI 10.1177/0192623312474727; Everds NE, 2013, TOXICOL PATHOL, V41, P280, DOI 10.1177/0192623312467400; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Franey H, 2010, PROTEIN SCI, V19, P1601, DOI 10.1002/pro.434; Ha S, 2011, GLYCOBIOLOGY, V21, P1087, DOI 10.1093/glycob/cwr047; Ishiguro T, 2010, CANCER SCI, V101, P2227, DOI 10.1111/j.1349-7006.2010.01663.x; Ishihara T, 2010, J CHROMATOGR B, V878, P2141, DOI 10.1016/j.jchromb.2010.06.003; Jacobsen F., 2017, J BIOL CHEM, V292; Jacobsen FW, 2011, J IMMUNOL, V186, P341, DOI 10.4049/jimmunol.1001685; Jefferis R, 2009, TRENDS PHARMACOL SCI, V30, P356, DOI 10.1016/j.tips.2009.04.007; Ju MS, 2014, CURR OPIN BIOTECH, V30, P128, DOI 10.1016/j.copbio.2014.06.013; Jung ST, 2011, CURR OPIN BIOTECH, V22, P858, DOI 10.1016/j.copbio.2011.03.002; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Koren E., 2002, Current Pharmaceutical Biotechnology, V3, P349, DOI 10.2174/1389201023378175; Leabman MK, 2013, MABS-AUSTIN, V5, P896, DOI 10.4161/mabs.26436; Li CH, 2012, BIOCHEMISTRY-US, V51, P10056, DOI 10.1021/bi300702e; Liu HC, 2006, IMMUNOL LETT, V106, P144, DOI 10.1016/j.imlet.2006.05.011; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Natsume A, 2009, CANCER SCI, V100, P2411, DOI 10.1111/j.1349-7006.2009.01327.x; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Patel Dipa, 2010, Human Antibodies, V19, P89, DOI 10.3233/HAB-2010-0232; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Santostefano MJ, 2012, TOXICOL PATHOL, V40, P899, DOI 10.1177/0192623312444029; Schneider-Merck T, 2010, J IMMUNOL, V184, P512, DOI 10.4049/jimmunol.0900847; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; van Meerten T, 2006, CLIN CANCER RES, V12, P4027, DOI 10.1158/1078-0432.CCR-06-0066; Walsh G, 2003, NAT BIOTECHNOL, V21, P865, DOI 10.1038/nbt0803-865; Warncke M, 2012, J IMMUNOL, V188, P4405, DOI 10.4049/jimmunol.1200090	32	11	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1876	1883		10.1074/jbc.M116.748707	http://dx.doi.org/10.1074/jbc.M116.748707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994063	Green Published, hybrid			2022-12-28	WOS:000395515600027
J	Kemp, MG; Spandau, DF; Simman, R; Travers, JB				Kemp, Michael G.; Spandau, Dan F.; Simman, Richard; Travers, Jeffrey B.			Insulin-like Growth Factor 1 Receptor Signaling Is Required for Optimal ATR-CHK1 Kinase Signaling in Ultraviolet B (UVB)-irradiated Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; INDUCED DNA-DAMAGE; REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; FACTOR-I RECEPTOR; SKIN-CANCER; CHECKPOINT ACTIVATION; HUMAN-CELLS; ATR KINASE; S PHASE	UVB wavelengths of light induce the formation of photoproducts in DNA that are potentially mutagenic if not properly removed by the nucleotide excision repair machinery. As an additional mechanism to minimize the risk of mutagenesis, UVB-irradiated cells also activate a checkpoint signaling cascade mediated by the ATM and Rad3-related (ATR) and checkpoint kinase 1 (CHK1) kinases to transiently suppress DNA synthesis and cell cycle progression. Given that keratinocytes in geriatric skin display reduced activation of the insulin-like growth factor 1 receptor (IGF-1R) and alterations in DNA repair rate, apoptosis, and senescence following UVB exposure, here we used cultured human keratinocytes in vitro and skin explants ex vivo to examine how IGF-1R activation status affects ATR-CHK1 kinase signaling and the inhibition of DNA replication following UVB irradiation. We find that disruption of IGF-1R signaling with small-molecule inhibitors or IGF-1 withdrawal partially abrogates both the phosphorylation and activation of CHK1 by ATR and the accompanying inhibition of chromosomal DNA synthesis in UVB-irradiated keratinocytes. A critical protein factor that mediates both ATR-CHK1 signaling and nucleotide excision repair is replication protein A, and we find that its accumulation on UVB-damaged chromatin is partially attenuated in cells with an inactive IGF-1R. These results indicate that mutagenesis and skin carcinogenesis in IGF-1-deficient geriatric skin may be caused by defects in multiple cellular responses to UVB-induced DNA damage, including through a failure to properly suppress DNA synthesis on UVB-damaged DNA templates.	[Kemp, Michael G.; Simman, Richard; Travers, Jeffrey B.] Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA; [Spandau, Dan F.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Spandau, Dan F.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Travers, Jeffrey B.] Dayton Vet Affairs Med Ctr, Dayton, OH 45428 USA	University System of Ohio; Wright State University Dayton; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Kemp, MG (corresponding author), Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA.	mike.kemp@wright.edu	Kemp, Michael G./AAT-1545-2021	Kemp, Michael G./0000-0001-8203-0745; Travers, Jeffrey/0000-0001-7232-1039	NIEHS, National Institutes of Health [ES020866]; NIA, National Institutes of Health Grant [AG048946]; Veterans Administration Grant [1101CX000809]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048946] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000809] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIA, National Institutes of Health Grant; Veterans Administration Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIEHS, National Institutes of Health Grant ES020866 (to D. F. S. and J. B. T.), NIA, National Institutes of Health Grant AG048946 (to D. F. S. and J. B. T.), and by Veterans Administration Grant 1101CX000809 (to J. B. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acevedo J, 2016, J BIOL CHEM, V291, P13124, DOI 10.1074/jbc.M116.729194; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; BARRECA A, 1992, J CELL PHYSIOL, V151, P262, DOI 10.1002/jcp.1041510207; Belanger F, 2016, J BIOL CHEM, V291, P522, DOI 10.1074/jbc.M115.685883; Brown EJ, 2000, GENE DEV, V14, P397; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Fernandez TL, 2015, EXP DERMATOL, V24, P235, DOI 10.1111/exd.12637; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Guven M, 2015, J INVEST DERMATOL, V135, P2834, DOI 10.1038/jid.2015.255; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Jarrett SG, 2016, NUCLEIC ACIDS RES, V44, P10711, DOI 10.1093/nar/gkw871; Jarrett SG, 2014, MOL CELL, V54, P999, DOI 10.1016/j.molcel.2014.05.030; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kaufmann WK, 2010, CARCINOGENESIS, V31, P751, DOI 10.1093/carcin/bgp230; Kemp MG, 2016, J BIOL CHEM, V291, P9330, DOI 10.1074/jbc.M116.719740; Kemp MG, 2014, J BIOL CHEM, V289, P26574, DOI 10.1074/jbc.M114.597088; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Kohler C, 2016, CELL CYCLE, V15, P974, DOI 10.1080/15384101.2016.1152424; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuhn C, 1999, INT J CANCER, V80, P431, DOI 10.1002/(SICI)1097-0215(19990129)80:3<431::AID-IJC16>3.3.CO;2-X; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Lee TH, 2014, ONCOGENE, V33, P19, DOI 10.1038/onc.2012.539; Lewis DA, 2010, ONCOGENE, V29, P1475, DOI 10.1038/onc.2009.440; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Lewis DA, 2011, AGING-US, V3, P407, DOI 10.18632/aging.100318; Lewis DA, 2009, J INVEST DERMATOL, V129, P787, DOI 10.1038/jid.2008.293; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; Liu QH, 2000, GENE DEV, V14, P1448; Loesch MM, 2016, MOL ONCOL, V10, P1245, DOI 10.1016/j.molonc.2016.06.002; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Overmeer RM, 2011, J CELL BIOL, V192, P401, DOI 10.1083/jcb.201006011; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Smits VAJ, 2015, FEBS J, V282, P3681, DOI 10.1111/febs.13387; Spandau DF, 2012, J INVEST DERMATOL, V132, P1591, DOI 10.1038/jid.2012.29; TAVAKKOL A, 1992, J INVEST DERMATOL, V99, P343, DOI 10.1111/1523-1747.ep12616668; Tho LM, 2012, ONCOGENE, V31, P1366, DOI 10.1038/onc.2011.326; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Travers JB, 2013, DERMATOL SURG, V39, P967, DOI 10.1111/dsu.12138; Tsaalbi-Shtylik A, 2014, NUCLEIC ACIDS RES, V42, P4406, DOI 10.1093/nar/gkt1412; Wolf C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11752; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	62	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1231	1239		10.1074/jbc.M116.765883	http://dx.doi.org/10.1074/jbc.M116.765883			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27979966	hybrid, Green Published			2022-12-28	WOS:000393339800008
J	Nishi, A; Matamales, M; Musante, V; Valjent, E; Kuroiwa, M; Kitahara, Y; Rebholz, H; Greengard, P; Girault, JA; Nairn, AC				Nishi, Akinori; Matamales, Miriam; Musante, Veronica; Valjent, Emmanuel; Kuroiwa, Mahomi; Kitahara, Yosuke; Rebholz, Heike; Greengard, Paul; Girault, Jean-Antoine; Nairn, Angus C.			Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-II; CAMP-REGULATED PHOSPHOPROTEIN; DEPENDENT PROTEIN-KINASE; NEOSTRIATAL NEURONS; STRIATAL NEURONS; PHOSPHATASE CASCADE; IN-VITRO; PHOSPHORYLATION; RECEPTOR; ACTIVATION	The interaction of glutamate and dopamine in the striatum is heavily dependent on signaling pathways that converge on the regulatory protein DARPP-32. The efficacy of dopamine/D1 receptor/PKA signaling is regulated by DARPP-32 phosphorylated at Thr-34 (the PKA site), a process that inhibits protein phosphatase 1 (PP1) and potentiates PKA action. Activation of dopamine/D1receptor/PKA signaling also leads to dephosphorylation of DARPP-32 at Ser-97 (the CK2 site), leading to localization of phospho-Thr-34 DARPP-32 in the nucleus where it also inhibits PP1. In this study the role of glutamate in the regulation of DARPP-32 phosphorylation at four major sites was further investigated. Experiments using striatal slices revealed that glutamate decreased the phosphorylation states of DARPP-32 at Ser-97 as well as Thr-34, Thr-75, and Ser-130 by activating NMDA or AMPA receptors in both direct and indirect pathway striatal neurons. The effect of glutamate in decreasing Ser-97 phosphorylation was mediated by activation of PP2A. In vitro phosphatase assays indicated that the PP2A/PR72 heterotrimer complex was likely responsible for glutamate/Ca2+-regulated dephosphorylation of DARPP-32 at Ser-97. As a consequence of Ser-97 dephosphorylation, glutamate induced the nuclear localization in cultured striatal neurons of dephospho-Thr-34/dephospho-Ser-97 DARPP-32. It also reduced PKA-dependent DARPP-32 signaling in slices and in vivo. Taken together, the results suggest that by inducing dephosphorylation of DARPP-32 at Ser-97 and altering its cytonuclear distribution, glutamate may counteract dopamine/D1 receptor/PKA signaling at multiple cellular levels.	[Nishi, Akinori; Kuroiwa, Mahomi; Kitahara, Yosuke] Kurume Univ, Sch Med, Dept Pharmacol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan; [Matamales, Miriam; Girault, Jean-Antoine] UPMC UMR S839, INSERM, Inst Fer Moulin, F-75005 Paris, France; [Musante, Veronica; Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Valjent, Emmanuel] Univ Montpellier, UMR CNRS 5203, Inserm U1191, Inst Genom Fonct, F-34094 Montpellier, France; [Rebholz, Heike; Greengard, Paul] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10065 USA; [Matamales, Miriam] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld 4072, Australia; [Rebholz, Heike] CUNY City Coll, CUNY Sch Med, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA	Kurume University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Rockefeller University; University of Queensland; City University of New York (CUNY) System; City College of New York (CUNY)	Nishi, A (corresponding author), Kurume Univ, Sch Med, Dept Pharmacol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	nishia@med.kurume-u.ac.jp	Matamales, Miriam/J-5189-2014; Girault, Jean-Antoine/F-7518-2013	Matamales, Miriam/0000-0001-9978-0091; Girault, Jean-Antoine/0000-0002-7900-1705; Greengard, Paul/0000-0002-4437-0893; Rebholz, Heike/0000-0002-0400-7547; Valjent, Emmanuel/0000-0002-1034-606X; Nairn, Angus/0000-0002-7075-0195	National Institutes of Health [DA10044, MH090963]; Japan Society for the Promotion of Science [18300128, 16H05135, 26860951]; JPB Foundation; Leon Black Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG047270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16K10198] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JPB Foundation; Leon Black Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants DA10044 (NIDA) and MH090963 (NIMH) (both to P. G. and A. C. N.). This work was also supported by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (18300128 and 16H05135 (to A. N.) and 26860951 (to M. K.)) and by The JPB Foundation (to P. G.) and the Leon Black Family Foundation (to P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; DESDOUITS F, 1995, P NATL ACAD SCI USA, V92, P2682, DOI 10.1073/pnas.92.7.2682; Desdouits F, 1998, BIOCHEM J, V330, P211, DOI 10.1042/bj3300211; DESDOUITS F, 1995, J BIOL CHEM, V270, P8772, DOI 10.1074/jbc.270.15.8772; Engmann O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10099; Fino E, 2011, NEUROPHARMACOLOGY, V60, P780, DOI 10.1016/j.neuropharm.2011.01.023; GIRAULT JA, 1989, J BIOL CHEM, V264, P21748; GIRAULT JA, 1990, J NEUROCHEM, V55, P1772, DOI 10.1111/j.1471-4159.1990.tb04968.x; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; Hamada M, 2005, J PHARMACOL EXP THER, V315, P872, DOI 10.1124/jpet.105.090852; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; Kuroiwa M, 2008, J NEUROCHEM, V107, P1014, DOI 10.1111/j.1471-4159.2008.05702.x; Li L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7319; Liu F, 2001, P NATL ACAD SCI USA, V98, P11062, DOI 10.1073/pnas.191353898; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 2005, P NATL ACAD SCI USA, V102, P1199, DOI 10.1073/pnas.0409138102; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; Nishi A, 2003, P NATL ACAD SCI USA, V100, P1322, DOI 10.1073/pnas.0237126100; Nishi A, 1997, J NEUROSCI, V17, P8147; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; SOMMERCORN J, 1987, J BIOL CHEM, V262, P3839; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 2003, SCIENCE, V302, P1412, DOI 10.1126/science.1089681; Tanda K, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-19; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Valjent E, 2006, P NATL ACAD SCI USA, V103, P2932, DOI 10.1073/pnas.0511030103; Walaas SI, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00050; Yagishita S, 2014, SCIENCE, V345, P1616, DOI 10.1126/science.1255514; Yger M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00056	42	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1462	1476		10.1074/jbc.M116.752402	http://dx.doi.org/10.1074/jbc.M116.752402			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27998980	Green Published, hybrid			2022-12-28	WOS:000393339800027
J	Singh, AB; Liu, JW				Singh, Amar Bahadur; Liu, Jingwen			Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA SYNTHETASE; ENDOPLASMIC-RETICULUM STRESS; EXPRESSION IN-VIVO; LIVER X RECEPTOR; PPAR-DELTA; FATTY-ACIDS; DEPENDENT MECHANISM; INSULIN-RESISTANCE; METABOLISM; INFLAMMATION	Peroxisome proliferator- activated receptor delta (PPAR delta) regulates many genes involved in lipid metabolism. Hepatic lysophosphatidylcholine acyltransferase 3 ( LPCAT3) has critical functions in triglycerides transport and endoplasmic reticulum stress response due to its unique ability to catalyze the incorporation of polyunsaturated fatty acids into phospholipids. Previous studies identified liverXreceptor as the transcription factor controlling LPCAT3 expression in mouse liver tissue. Here we show that the hepatic LPCAT3 gene is transcriptionally regulated by PPAR delta. Adenovirus-mediated knockdown of PPAR delta in cultured hepatic cells and liver tissue reduced LPCAT3 mRNA levels, and exogenous overexpression of PPAR delta increased LPCAT3 mRNA expression. Activation of PPAR delta in HepG2, Huh7, and Hepa 1- 6 cells with its specific agonists increased LPCAT3 mRNA levels in all three hepatic cell lines. Through conducting sequence analysis, LPCAT3 promoter assays, and direct DNA binding assays, we have mapped the functional PPAR- responsive element to a proximal region from - 135 to - 123 of the LPCAT3 promoter that plays an essential role in mediating PPAR delta-induced transactivation of the LPCAT3 gene. Finally, we have provided in vivo evidence showing that activation of PPAR delta by agonist L165041 in mice increased hepatic LPCAT3 mRNA abundance and LPCAT enzymatic activity, which is associated with increased incorporations of arachidonate into liver phosphatidylcholine and phosphatidylethanolamine. Furthermore, transient liver- specific knockdown of LPCAT3 in mice affected PPAR delta-mediated activation of several hepatic genes involving in FA metabolism. Altogether, our new findings identify LPCAT3 as a direct PPAR delta target gene and suggest a novel function of PPAR delta in regulation of phospholipid metabolism through LPCAT3.	[Singh, Amar Bahadur; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Liu, JW (corresponding author), VA Palo Alto Hlth Care System, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	Jingwen.Liu@va.gov	Singh, Amar B/I-2253-2014	Singh, Amar B/0000-0002-7677-2424	Department of Veterans Affairs (Office of Research and Development, Medical Research Service); NCCIH, National Institutes of Health [1R01AT006336-01A1]; National Center for Complementary & Integrative Health [R01AT006336] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001419] Funding Source: NIH RePORTER	Department of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); NCCIH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs (Office of Research and Development, Medical Research Service) and by NCCIH, National Institutes of Health, Grant 1R01AT006336-01A1. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bojic LA, 2014, J LIPID RES, V55, P1254, DOI 10.1194/jlr.M046037; Cao AQ, 2010, J BIOL CHEM, V285, P16664, DOI 10.1074/jbc.M110.112805; Cash JG, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.12; Chehaibi K, 2015, BIOCHEM PHARMACOL, V94, P101, DOI 10.1016/j.bcp.2015.01.016; Coll Teresa, 2009, Curr Mol Pharmacol, V2, P46; Dong B, 2014, ATHEROSCLEROSIS, V235, P449, DOI 10.1016/j.atherosclerosis.2014.05.931; Dong B, 2013, J LIPID RES, V54, P1241, DOI 10.1194/jlr.M032599; Gao SY, 2012, HEPATOL RES, V42, P686, DOI 10.1111/j.1872-034X.2011.00961.x; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Ishibashi M, 2013, ARTERIOSCL THROM VAS, V33, P1171, DOI 10.1161/ATVBAHA.112.300812; Kan CFK, 2015, BBA-MOL CELL BIOL L, V1851, P577, DOI 10.1016/j.bbalip.2015.01.008; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; Kuch EM, 2014, BBA-MOL CELL BIOL L, V1841, P227, DOI 10.1016/j.bbalip.2013.10.018; Kuwata H, 2014, BBA-MOL CELL BIOL L, V1841, P44, DOI 10.1016/j.bbalip.2013.09.015; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Liu SH, 2011, J BIOL CHEM, V286, P1237, DOI 10.1074/jbc.M110.138115; Lopes-Marques M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-271; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Ramirez T, 2013, J GASTROEN HEPATOL, V28, P179, DOI 10.1111/j.1440-1746.2012.07256.x; Rong X, 2015, ELIFE, V4, DOI 10.7554/eLife.06557; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Salvado L, 2014, DIABETOLOGIA, V57, P2126, DOI 10.1007/s00125-014-3331-8; Salvado L, 2012, EXPERT OPIN THER TAR, V16, P209, DOI 10.1517/14728222.2012.658370; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Shende VR, 2015, BIOCHEM J, V472, P275, DOI 10.1042/BJ20150666; Singh AB, 2016, J BIOL CHEM, V291, P5373, DOI 10.1074/jbc.M115.696872; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Sun XW, 2016, J BIOL CHEM, V291, P1115, DOI 10.1074/jbc.M115.668269; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wierzbicki AS, 2009, CURR VASC PHARMACOL, V7, P277, DOI 10.2174/157016109788340703; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang J, 2013, J TOXICOL SCI, V38, P833; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	37	18	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					884	897		10.1074/jbc.M116.743575	http://dx.doi.org/10.1074/jbc.M116.743575			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27913621	hybrid, Green Published			2022-12-28	WOS:000392318700011
J	Chandrasekar, S; Sweredoski, MJ; Sohn, CH; Hess, S; Shan, SO				Chandrasekar, Sowmya; Sweredoski, Michael J.; Sohn, Chang Ho; Hess, Sonja; Shan, Shu-ou			Co-evolution of Two GTPases Enables Efficient Protein Targeting in an RNA-less Chloroplast Signal Recognition Particle Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRP RNA; TRANSLATING RIBOSOME; SUBUNIT; RECEPTOR; ACTIVATION; SEQUENCE; MECHANISM; COMPLEX; DOMAIN; REQUIREMENT	The signal recognition particle (SRP) is an essential ribonucleoprotein particle that mediates the co-translational targeting of newly synthesized proteins to cellular membranes. The SRP RNA is a universally conserved component of SRP that mediates key interactions between two GTPases in SRP and its receptor, thus enabling rapid delivery of cargo to the target membrane. Notably, this essential RNA is bypassed in the chloroplast (cp) SRP of green plants. Previously, we showed that the cpSRP and cpSRP receptor GTPases (cpSRP54 and cpFtsY, respectively) interact efficiently by themselves without the SRP RNA. Here, we explore the molecular mechanism by which this is accomplished. Fluorescence analyses showed that, in the absence of SRP RNA, the M-domain of cpSRP54 both accelerates and stabilizes complex assembly between cpSRP54 and cpFtsY. Crosslinking coupled with mass spectrometry and mutational analyses identified a new interaction between complementarily charged residues on the cpFtsY G-domain and the vicinity of the cpSRP54 M-domain. These residues are specifically conserved in plastids, and their evolution coincides with the loss of SRP RNA in green plants. These results provide an example of how proteins replace the functions of RNA during evolution.	[Chandrasekar, Sowmya; Sohn, Chang Ho; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Beckman Inst, Pasadena, CA 91125 USA; [Sweredoski, Michael J.; Hess, Sonja] CALTECH, Beckman Inst, Div Biol & Biol Engn, Proteome Explorat Lab, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Beckman Inst, Pasadena, CA 91125 USA.	sshan@caltech.edu	Sohn, Chang Ho/D-9492-2015		Beckman Institute; Gordon and Betty Moore Foundation [GBMF775]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114390] Funding Source: NIH RePORTER	Beckman Institute; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jesse Beauchamp for helpful discussions on the cross-linking and mass spectrometry experiments; members of the Proteome Exploration Laboratory for help with mass spectrometry experiments and analyses; the Guttman laboratory for help with phylogenic analysis, and members of the Shan laboratory for comments on the manuscript. The Proteome Exploration Laboratory was supported by the Beckman Institute and the Gordon and Betty Moore Foundation through Grant GBMF775.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Chandrasekar S, 2008, J MOL BIOL, V375, P425, DOI 10.1016/j.jmb.2007.09.061; Chu FX, 2004, P NATL ACAD SCI USA, V101, P16454, DOI 10.1073/pnas.0407456101; CLINE K, 1986, J BIOL CHEM, V261, P4804; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Dunschede B, 2015, J BIOL CHEM, V290, P13104, DOI 10.1074/jbc.M114.597922; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eichacker LA, 2001, BBA-MOL CELL RES, V1541, P120, DOI 10.1016/S0167-4889(01)00151-3; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Jaru-Ampornpan P, 2009, MOL BIOL CELL, V20, P3965, DOI 10.1091/mbc.E08-10-0989; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Koch HG, 2003, REV PHYSIOL BIOCH P, V146, P55, DOI 10.1007/s10254-002-0002-9; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; Nguyen TX, 2011, BIOCHEMISTRY-US, V50, P7208, DOI 10.1021/bi200742a; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Richter CV, 2008, FEBS LETT, V582, P3223, DOI 10.1016/j.febslet.2008.08.014; Rosenblad MA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26848; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shan SO, 2005, BIOCHEMISTRY-US, V44, P6214, DOI 10.1021/bi0500980; Shen K, 2013, J BIOL CHEM, V288, P36385, DOI 10.1074/jbc.M113.513614; Shen K, 2012, NATURE, V492, P271, DOI 10.1038/nature11726; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; Sohn CH, 2012, ANAL CHEM, V84, P2662, DOI 10.1021/ac202637n; Stengel KF, 2007, FEBS LETT, V581, P5671, DOI 10.1016/j.febslet.2007.11.024; Trager C, 2012, PLANT CELL, V24, P4819, DOI 10.1105/tpc.112.102996; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wild K, 2016, J MOL BIOL, V428, P2880, DOI 10.1016/j.jmb.2016.05.015; Zhang LX, 2002, FEBS LETT, V512, P13, DOI 10.1016/S0014-5793(02)02218-4; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; ZOPF D, 1993, J CELL BIOL, V120, P1113, DOI 10.1083/jcb.120.5.1113; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	47	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					386	396		10.1074/jbc.M116.752931	http://dx.doi.org/10.1074/jbc.M116.752931			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895118	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000391578000033
J	Crewe, C; Schafer, C; Lee, I; Kinter, M; Szweda, LI				Crewe, Clair; Schafer, Christopher; Lee, Irene; Kinter, Michael; Szweda, Luke I.			Regulation of Pyruvate Dehydrogenase Kinase 4 in the Heart through Degradation by the Lon Protease in Response to Mitochondrial Substrate Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE KIDNEY; COMPLEX; ACID; MECHANISMS; GLUCOSE; PURIFICATION; EXPRESSION; ISOENZYMES; COMPONENT; DISEASE	Cardiac metabolic inflexibility is driven by robust up-regulation of pyruvate dehydrogenase kinase 4 (PDK4) and phosphorylation-dependent inhibition of pyruvate dehydrogenase (PDH) within a single day of feeding mice a high fat diet. In the current study, we have discovered that PDK4 is a short lived protein (t(1/2) similar to 1 h) and is specifically degraded by the mitochondrial protease Lon. Lon does not rapidly degrade PDK1 and -2, indicating specificity toward the PDK isoform that is a potent modulator of metabolic flexibility. Moreover, PDK4 degradation appears regulated by dissociation from the PDH complex dependent on the respiratory state and energetic substrate availability of mouse heart mitochondria. Finally, we demonstrate that pharmacologic inhibition of PDK4 promotes PDK4 degradation in vitro and in vivo. These findings reveal a novel strategy to manipulate PDH activity by selectively targeting PDK4 content through dissociation and proteolysis.	[Crewe, Clair; Schafer, Christopher; Kinter, Michael; Szweda, Luke I.] Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Crewe, Clair; Szweda, Luke I.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Lee, Irene] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Case Western Reserve University	Szweda, LI (corresponding author), Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Luke-Szweda@omrf.org		Kinter, Michael/0000-0001-7409-8918	Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	This work was supported by the Oklahoma Medical Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; COOPER RH, 1974, BIOCHEM J, V143, P625, DOI 10.1042/bj1430625; Crewe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077280; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Kim TY, 2012, MOL CELL PROTEOMICS, V11, P1586, DOI 10.1074/mcp.M112.021162; LINN TC, 1972, ARCH BIOCHEM BIOPHYS, V148, P327, DOI 10.1016/0003-9861(72)90151-8; Liu ZM, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/959386; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; Mori J, 2013, AM J PHYSIOL-HEART C, V304, pH1103, DOI 10.1152/ajpheart.00636.2012; Ondrovicova G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; STEPP LR, 1983, J BIOL CHEM, V258, P9454; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sun Y, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-20; Tao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071997; Tso SC, 2006, J BIOL CHEM, V281, P27197, DOI 10.1074/jbc.M604339200; Tuganova A, 2002, BIOCHEM J, V366, P129, DOI 10.1042/BJ20020301; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200	30	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					305	312		10.1074/jbc.M116.754127	http://dx.doi.org/10.1074/jbc.M116.754127			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27856638	Green Published, hybrid			2022-12-28	WOS:000391578000026
J	Girard, BJ; Knutson, TP; Kuker, B; McDowell, L; Schwertfeger, KL; Ostrander, JH				Girard, Brian J.; Knutson, Todd P.; Kuker, Bethanie; McDowell, Laura; Schwertfeger, Kathryn L.; Ostrander, Julie H.			Cytoplasmic Localization of Proline, Glutamic Acid, Leucine-rich Protein 1 (PELP1) Induces Breast Epithelial Cell Migration through Up-regulation of Inhibitor of kappa B Kinase epsilon and Inflammatory Cross-talk with Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; MOUSE MODEL; CANCER; IKK; PROGRESSION; CYTOKINES; GROWTH; PHOSPHORYLATION; PROLIFERATION; COREGULATOR	Cytoplasmic localization of proline, glutamic acid, leucine-rich protein 1 (PELP1) is observed in similar to 40% of women with invasive breast cancer. In mouse models, PELP1 overexpression in the mammary gland leads to premalignant lesions and eventually mammary tumors. In preliminary clinical studies, cytoplasmic localization of PELP1 was seen in 36% of women at high risk of developing breast cancer. Here, we investigated whether cytoplasmic PELP1 signaling promotes breast cancer initiation in models of immortalized human mammary epithelial cells (HMECs). Global gene expression analysis was performed on HMEC lines expressing vector control, PELP1-wt, or mutant PELP1 in which the nuclear localization sequence was altered, resulting in cytoplasmic localization of PELP1 (PELP1-cyto). Global gene expression analysis identified that PELP1-cyto expression in HMECs induced NF-kappa B signaling pathways. Western blotting analysis of PELP1-cyto HMECs showed up-regulation of inhibitor of kappa B kinase epsilon (IKK epsilon) and increased phosphorylation of the NF-kappa B subunit RelB. To determine whether secreted factors produced by PELP1-cyto HMECs promote macrophage activation, THP-1 macrophages were treated with HMEC-conditioned medium (CM). PELP1-cyto CM induced changes in THP-1 gene expression as compared with control cell CM. Double conditioned medium (DCM) from the activated THP-1 cells was then applied to HMECs to determine whether paracrine signaling from PELP1-cyto-activated macrophages could in turn promote migration of HMECs. PELP1-cyto DCM induced robust HMEC migration, which was reduced in DCM from PELP1-cyto HMECs expressing IKK epsilon shRNA. Our findings suggest that cytoplasmic localization of PELP1 up-regulates pro-tumorigenic IKK epsilon and secreted inflammatory signals, which through paracrine macrophage activation regulates the migratory phenotype associated with breast cancer initiation.	[Girard, Brian J.; Knutson, Todd P.; Kuker, Bethanie; McDowell, Laura; Schwertfeger, Kathryn L.; Ostrander, Julie H.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Ostrander, Julie H.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ostrander, JH (corresponding author), Univ Minnesota, Canc Cardiol Res Bldg,MMC 2812A,2231 6th St SE, Minneapolis, MN 55455 USA.	hans1354@umn.edu	Knutson, Todd P/H-8304-2012		National Institutes of Health [K07CA131501]; Institutional Research Grant from the American Cancer Society [124166-IRG-58-001-52-IRG5]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114]; Masonic Cancer Center, University of Minnesota; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA132827, K07CA131501] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000113, UL1TR000114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Research Grant from the American Cancer Society; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Masonic Cancer Center, University of Minnesota(University of Minnesota System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by National Institutes of Health Grant K07CA131501, Institutional Research Grant 124166-IRG-58-001-52-IRG5 from the American Cancer Society, National Center for Advancing Translational Sciences of the National Institutes of Health Award UL1TR000114, and funds from the Masonic Cancer Center, University of Minnesota (to J. H. O.). J. H. O. received support from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Barbie TU, 2014, J CLIN INVEST, V124, P5411, DOI 10.1172/JCI75661; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bohrer LR, 2012, MOL CANCER RES, V10, P1294, DOI 10.1158/1541-7786.MCR-12-0275; Chakravarty D, 2011, CLIN CANCER RES, V17, P2250, DOI 10.1158/1078-0432.CCR-10-2718; Chakravarty D, 2010, CANCER RES, V70, P4092, DOI 10.1158/0008-5472.CAN-09-3834; Cortez V, 2014, CANCER RES, V74, P7395, DOI 10.1158/0008-5472.CAN-14-0993; Cortez V, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3229; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davidson NE, 2015, JAMA-J AM MED ASSOC, V313, P1109, DOI 10.1001/jama.2015.1945; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Degnim AC, 2007, J CLIN ONCOL, V25, P2671, DOI 10.1200/JCO.2006.09.0217; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girard BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121206; Girard BJ, 2014, MOL CELL ENDOCRINOL, V382, P642, DOI 10.1016/j.mce.2013.07.031; Goldberg JE, 2010, CURR DRUG TARGETS, V11, P1133; Hartman ZC, 2013, CANCER RES, V73, P3470, DOI 10.1158/0008-5472.CAN-12-4524-T; Hartmann LC, 2015, NEW ENGL J MED, V372, P1271, DOI 10.1056/NEJMc1501046; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hussein MR, 2006, J CLIN PATHOL, V59, P972, DOI 10.1136/jcp.2005.031252; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Jiang Zhe, 2014, Oncoscience, V1, P180; Kendellen MF, 2014, ONCOGENE, V33, P1297, DOI 10.1038/onc.2013.64; Kumar R, 2009, CLIN CANCER RES, V15, P4123, DOI 10.1158/1078-0432.CCR-08-2347; Leek RD, 1996, CANCER RES, V56, P4625; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Mann M, 2013, CARCINOGENESIS, V34, P1468, DOI 10.1093/carcin/bgt091; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Marsigliante S, 2016, MOL CARCINOGEN, V55, P1175, DOI 10.1002/mc.22360; Marsigliante S, 2013, J CELL PHYSIOL, V228, P1873, DOI 10.1002/jcp.24349; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Mohamed MM, 2014, INT J BIOCHEM CELL B, V46, P138, DOI 10.1016/j.biocel.2013.11.015; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nair SS, 2004, CANCER RES, V64, P6416, DOI 10.1158/0008-5472.CAN-04-1786; Ostrander JH, 2010, CANCER RES, V70, P4759, DOI 10.1158/0008-5472.CAN-09-2572; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Rajhans R, 2007, CANCER RES, V67, P5505, DOI 10.1158/0008-5472.CAN-06-3647; Rayala SK, 2006, MOL CANCER THER, V5, P230, DOI 10.1158/1535-7163.MCT-05-0276; Roy SS, 2014, ONCOGENE, V33, P3707, DOI 10.1038/onc.2013.332; Roy S, 2012, MOL CANCER RES, V10, P25, DOI 10.1158/1541-7786.MCR-11-0456; Sareddy GR, 2015, P NATL ACAD SCI USA, V112, pE6673, DOI 10.1073/pnas.1516729112; Schwertfeger KL, 2006, CANCER RES, V66, P5676, DOI 10.1158/0008-5472.CAN-05-3781; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Shen RR, 2012, MOL CELL BIOL, V32, P4756, DOI 10.1128/MCB.00468-12; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vadlamudi RK, 2005, CANCER RES, V65, P7724, DOI 10.1158/0008-5472.CAN-05-0614; Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449	58	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					339	350		10.1074/jbc.M116.739847	http://dx.doi.org/10.1074/jbc.M116.739847			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27881676	hybrid, Green Published			2022-12-28	WOS:000391578000029
J	El Hage, K; Pandyarajan, V; Phillips, NB; Smith, BJ; Menting, JG; Whittaker, J; Lawrence, MC; Meuwly, M; Weiss, MA				El Hage, Krystel; Pandyarajan, Vijay; Phillips, Nelson B.; Smith, Brian J.; Menting, John G.; Whittaker, Jonathan; Lawrence, Michael C.; Meuwly, Markus; Weiss, Michael A.			Extending Halogen-based Medicinal Chemistry to Proteins IODO-INSULIN AS A CASE STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNNATURAL AMINO-ACID; PARTICLE MESH EWALD; RECEPTOR-BINDING; LIGAND-BINDING; MOLECULAR-DYNAMICS; DIMERIC INSULIN; FORCE-FIELD; MODEL; SITE; MUTAGENESIS	Insulin, a protein critical for metabolic homeostasis, provides a classical model for protein design with application to human health. Recent efforts to improve its pharmaceutical formulation demonstrated that iodination of a conserved tyrosine (Tyr(B26)) enhances key properties of a rapid-acting clinical analog. Moreover, the broad utility of halogens in medicinal chemistry has motivated the use of hybrid quantum-and molecular-mechanical methods to study proteins. Here, we (i) undertook quantitative atomistic simulations of 3-[iodo-Tyr(B26)] insulin to predict its structural features, and (ii) tested these predictions by X-ray crystallography. Using an electrostatic model of the modified aromatic ring based on quantum chemistry, the calculations suggested that the analog, as a dimer and hexamer, exhibits subtle differences in aromatic-aromatic interactions at the dimer interface. Aromatic rings (Tyr(B16), Phe(B24), Phe(B25), 3-I-Tyr(B26), and their symmetry-related mates) at this interface adjust to enable packing of the hydrophobic iodine atoms within the core of each monomer. Strikingly, these features were observed in the crystal structure of a 3-[iodo-Tyr(B26)] insulin analog (determined as an R-6 zinc hexamer). Given that residues B24-B30 detach from the core on receptor binding, the environment of 3-I-Tyr(B26) in a receptor complex must differ from that in the free hormone. Based on the recent structure of a "micro-receptor" complex, we predict that 3-I-Tyr(B26) engages the receptor via directional halogen bonding and halogen-directed hydrogen bonding as follows: favorable electrostatic interactions exploiting, respectively, the halogen's electron-deficient sigma-hole and electronegative equatorial band. Inspired by quantum chemistry and molecular dynamics, such "halogen engineering" promises to extend principles of medicinal chemistry to proteins.	[El Hage, Krystel; Meuwly, Markus] Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland; [Pandyarajan, Vijay; Phillips, Nelson B.; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Menting, John G.; Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	University of Basel; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; La Trobe University; Walter & Eliza Hall Institute; University of Melbourne	Meuwly, M (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.; Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.; Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.; Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	m.meuwly@unibas.ch; michael.weiss@case.edu	Smith, Brian J/F-8282-2011; Lawrence, Michael C/A-5357-2009	Smith, Brian J/0000-0003-0498-1910; Menting, John/0000-0003-3638-3544; Lawrence, Michael/0000-0003-1999-0801; El Hage, Krystel/0000-0003-4837-3888; Pandyarajan, Vijay/0000-0002-8835-5601	National Institutes of Health from NIDDK [R01 DK04949 and DK079233]; Swiss National Science Foundation [200021-117810]; National Competence Center for Research Molecular and Ultrafast Science and Technology (CCR MUST); Australian National Health and Medical Research Council [1005896, 1058233]; Hazel and Pip Appel Fund; Sanofi (Germany); NCCR MUST through the Swiss National Science Foundation; Case Western Reserve University Medical Scientist Training Program by National Institutes of Heath Institutional Grant [T32 GM007250]; National Institutes of Health [F30 DK094685-04]; American Diabetes Association; National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme Grant [361646]; Victorian State Government Operational Infrastructure Support Grant; NCCR MUST; University of Basel; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094685, R01DK079233, R01DK040949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Competence Center for Research Molecular and Ultrafast Science and Technology (CCR MUST); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hazel and Pip Appel Fund; Sanofi (Germany)(Sanofi-Aventis); NCCR MUST through the Swiss National Science Foundation; Case Western Reserve University Medical Scientist Training Program by National Institutes of Heath Institutional Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme Grant; Victorian State Government Operational Infrastructure Support Grant; NCCR MUST; University of Basel; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 DK04949 and DK079233 from NIDDK (to M. A. W.), Swiss National Science Foundation Grant 200021-117810, National Competence Center for Research Molecular and Ultrafast Science and Technology (CCR MUST) (to M. M.), Australian National Health and Medical Research Council Project Grants 1005896 and 1058233, and the Hazel and Pip Appel Fund (to M. C. L.). M. A. W. has equity in Thermalin Diabetes, LLC (Cleveland, OH), where he serves as Chief Scientific Officer; he has also been a consultant to Merck Research Laboratories and DEKA Research and Development Corp. N. B. P. and J. W. are consultants to Thermalin Diabetes, LLC. Part of M. C. L.'s research is funded by Sanofi (Germany). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by the NCCR MUST through the Swiss National Science Foundation.r Supported by a predoctoral fellowship of the Case Western Reserve University Medical Scientist Training Program supported by National Institutes of Heath Institutional Grant T32 GM007250 and National Institutes of Health Fellowship F30 DK094685-04.r Supported in part by the American Diabetes Association.r Recipient of National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme Grant 361646 and Victorian State Government Operational Infrastructure Support Grant (to the Walter and Eliza Hall Institute).r Supported by the NCCR MUST and the University of Basel.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; BADER RFW, 1987, J AM CHEM SOC, V109, P7968, DOI 10.1021/ja00260a006; BADGER J, 1991, ACTA CRYSTALLOGR B, V47, P127, DOI 10.1107/S0108768190009570; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barany G., 1980, PEPTIDES, P273; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Bereau T, 2013, J CHEM THEORY COMPUT, V9, P5450, DOI 10.1021/ct400803f; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjorn LO, 2010, INTEGR COMP BIOL, V50, P138, DOI 10.1093/icb/icq017; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BURANT CF, 1988, BIOCHEM BIOPH RES CO, V152, P1353, DOI 10.1016/S0006-291X(88)80434-0; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; Chatterjee A, 2012, P NATL ACAD SCI USA, V109, P14841, DOI 10.1073/pnas.1212454109; Clark T, 2007, J MOL MODEL, V13, P291, DOI 10.1007/s00894-006-0130-2; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; Croll TI, 2016, STRUCTURE, V24, P469, DOI 10.1016/j.str.2015.12.014; Damm W, 1997, J COMPUT CHEM, V18, P1955, DOI 10.1002/(SICI)1096-987X(199712)18:16<1955::AID-JCC1>3.0.CO;2-L; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Dennington R., 2009, GAUSSVIEW VERSION 5; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DODSON GG, 1993, BIOCHEM SOC T, V21, P609, DOI 10.1042/bst0210609; El Hage K, 2016, J CHEM THEORY COMPUT, V12, P3008, DOI 10.1021/acs.jctc.6b00202; El Hage K, 2015, J COMPUT CHEM, V36, P210, DOI 10.1002/jcc.23786; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falconi M, 2001, J BIOMOL STRUCT DYN, V18, P761, DOI 10.1080/07391102.2001.10506705; Feller D, 1996, J COMPUT CHEM, V17, P1571, DOI 10.1002/(SICI)1096-987X(199610)17:13<1571::AID-JCC9>3.0.CO;2-P; FRANK BH, 1983, DIABETES, V32, P705, DOI 10.2337/diab.32.8.705; Frisch M. J., 2009, GAUSSIAN 09 REVISION; GURSKY O, 1992, BIOPHYS J, V63, P1210, DOI 10.1016/S0006-3495(92)81697-1; HAMLIN JL, 1974, J BIOL CHEM, V249, P21; Hedin F, 2016, J CHEM INF MODEL, V56, P1479, DOI 10.1021/acs.jcim.6b00280; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jorgensen WL, 2012, J CHEM THEORY COMPUT, V8, P3895, DOI 10.1021/ct300180w; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kolar M, 2014, PHYS CHEM CHEM PHYS, V16, P9987, DOI 10.1039/c3cp55188a; Kramer C, 2013, J CHEM INF MODEL, V53, P3410, DOI 10.1021/ci400548w; Kristensen C, 2002, J BIOL CHEM, V277, P18340, DOI 10.1074/jbc.M112249200; KRISTENSEN SM, 1991, J MOL BIOL, V218, P221, DOI 10.1016/0022-2836(91)90886-B; KUBIAK T, 1986, INT J PEPT PROT RES, V27, P514; Kupper FC, 2011, ANGEW CHEM INT EDIT, V50, P11598, DOI 10.1002/anie.201100028; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; LINDE S, 1981, H-S Z PHYSIOL CHEM, V362, P573, DOI 10.1515/bchm2.1981.362.1.573; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Lommerse JPM, 1996, J AM CHEM SOC, V118, P3108, DOI 10.1021/ja953281x; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARK AE, 1991, BIOCHEMISTRY-US, V30, P10866, DOI 10.1021/bi00109a009; Matter H, 2009, ANGEW CHEM INT EDIT, V48, P2911, DOI 10.1002/anie.200806219; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Metrangolo P, 2005, ACCOUNTS CHEM RES, V38, P386, DOI 10.1021/ar0400995; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; MIRMIRA RG, 1991, BIOCHEMISTRY-US, V30, P8222, DOI 10.1021/bi00247a019; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Pace CN, 2000, PROTEINS, P1; Pandyarajan V, 2012, CURR DIABETES REP, V12, P697, DOI 10.1007/s11892-012-0318-z; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P34709, DOI 10.1074/jbc.M114.608562; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; Papaioannou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144058; PEAVY DE, 1984, ENDOCRINOLOGY, V114, P1818, DOI 10.1210/endo-114-5-1818; Peterson KA, 2006, J PHYS CHEM A, V110, P13877, DOI 10.1021/jp065887l; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; Politzer P, 2013, PHYS CHEM CHEM PHYS, V15, P11178, DOI 10.1039/c3cp00054k; Politzer P, 2010, PHYS CHEM CHEM PHYS, V12, P7748, DOI 10.1039/c004189k; Poznanski J, 2016, ACTA BIOCHIM POL, V63, P203, DOI 10.18388/abp.2015_1106; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; Riley KE, 2013, ACCOUNTS CHEM RES, V46, P927, DOI 10.1021/ar300083h; Sandler B, 2004, J BIOL CHEM, V279, P55801, DOI 10.1074/jbc.M410124200; Scholfield MR, 2013, PROTEIN SCI, V22, P139, DOI 10.1002/pro.2201; Smith GD, 2000, ACTA CRYSTALLOGR D, V56, P1541, DOI 10.1107/S0907444900012749; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Swallow S., 2012, FLUORINE PHARM MED C, P34; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Wagner RL, 2001, MOL ENDOCRINOL, V15, P398, DOI 10.1210/me.15.3.398; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	112	22	22	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27023	27041		10.1074/jbc.M116.761015	http://dx.doi.org/10.1074/jbc.M116.761015			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875310	Green Published, hybrid			2022-12-28	WOS:000391576300006
J	Parag-Sharma, K; Leyme, A; DiGiacomo, V; Marivin, A; Broselid, S; Garcia-Marcos, M				Parag-Sharma, Kshitij; Leyme, Anthony; DiGiacomo, Vincent; Marivin, Arthur; Broselid, Stefan; Garcia-Marcos, Mikel			Membrane Recruitment of the Non-receptor Protein GIV/Girdin (G alpha-interacting, Vesicle-associated Protein/Girdin) Is Sufficient for Activating Heterotrimeric G Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; GROWTH-FACTOR RECEPTORS; CELL-MIGRATION; COUPLED RECEPTORS; TUMOR PROGRESSION; BREAST-CANCER; HUMAN-DISEASE; LIPID RAFTS; GIRDIN; GIV	GIV (aka Girdin) is a guanine nucleotide exchange factor that activates heterotrimeric G protein signaling downstream of RTKs and integrins, thereby serving as a platform for signaling cascade cross-talk. GIV is recruited to the cytoplasmic tail of receptors upon stimulation, but the mechanism of activation of its G protein regulatory function is not well understood. Here we used assays in humanized yeast models and G protein activity biosensors in mammalian cells to investigate the role of GIV subcellular compartmentalization in regulating its ability to promote G protein signaling. We found that in unstimulated cells GIV does not co-fractionate with its substrate G protein G alpha(i3) on cell membranes and that constitutive membrane anchoring of GIV in yeast cells or rapid membrane translocation in mammalian cells via chemically induced dimerization leads to robust G protein activation. We show that membrane recruitment of the GIV "G alpha binding and activating" motif alone is sufficient for G protein activation and that it does not require phosphomodification. Furthermore, we engineered a synthetic protein to show that recruitment of the GIV "G alpha binding and activating" motif to membranes via association with active RTKs, instead of via chemically induced dimerization, is also sufficient for G protein activation. These results reveal that recruitment of GIV to membranes in close proximity to its substrate G protein is a major mechanism responsible for the activation of its G protein regulatory function.	[Parag-Sharma, Kshitij; Leyme, Anthony; DiGiacomo, Vincent; Marivin, Arthur; Broselid, Stefan; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Rm K208, Boston, MA 02118 USA	Boston University	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K,Rm K208, Boston, MA 02118 USA.	mgm1@bu.edu		Parag-Sharma, Kshitij/0000-0003-3638-0941	National Institutes of Health [R01GM108733, R01GM112631]; American Cancer Society [RSG-13-362-01-TBE]; Karin Grunebaum Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108733, R01GM112631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Karin Grunebaum Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM108733 and R01GM112631, American Cancer Society Grant RSG-13-362-01-TBE, and funds from the Karin Grunebaum Research Foundation (to M. G.-M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Beas AO, 2012, MOL BIOL CELL, V23, P4623, DOI 10.1091/mbc.E12-02-0133; Bhandari D, 2015, P NATL ACAD SCI USA, V112, pE4874, DOI 10.1073/pnas.1514157112; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Coleman BD, 2016, MOL BIOL EVOL, V33, P820, DOI 10.1093/molbev/msv336; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Findlay GM, 2008, NAT STRUCT MOL BIOL, V15, P538, DOI 10.1038/nsmb0608-538; Garcia-Marcos M, 2006, BBA-BIOMEMBRANES, V1758, P796, DOI 10.1016/j.bbamem.2006.05.008; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2011, CELL ADHES MIGR, V5, P237, DOI 10.4161/cam.5.3.15909; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Gupta V, 2016, P NATL ACAD SCI USA, V113, pE5721, DOI 10.1073/pnas.1609502113; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hartung A, 2013, BBA-MOL CELL RES, V1833, P2803, DOI 10.1016/j.bbamcr.2013.07.012; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jun BY, 2013, DIS COLON RECTUM, V56, P51, DOI 10.1097/DCR.0b013e31826b9b7e; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Leyme A, 2016, J BIOL CHEM, V291, P8269, DOI 10.1074/jbc.M115.691550; Leyme A, 2015, J CELL BIOL, V210, P1165, DOI 10.1083/jcb.201506041; LIANG M, 1991, J BIOL CHEM, V266, P13342; Lin CS, 2014, MOL BIOL CELL, V25, P3654, DOI 10.1091/mbc.E14-05-0978; Lin CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002049; Ling Y, 2011, CANCER INVEST, V29, P405, DOI 10.3109/07357907.2011.568568; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu CG, 2012, MED ONCOL, V29, P1554, DOI 10.1007/s12032-011-0087-6; Liu C, 2012, MOL BIOL REP, V39, P8717, DOI 10.1007/s11033-012-1731-8; Lo IC, 2015, DEV CELL, V33, P189, DOI 10.1016/j.devcel.2015.02.009; Lopez-Sanchez I, 2015, MOL BIOL CELL, V26, P4313, DOI 10.1091/mbc.E15-07-0496; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Ma GS, 2015, MOL BIOL CELL, V26, P4209, DOI 10.1091/mbc.E15-08-0553; Ma GS, 2015, P NATL ACAD SCI USA, V112, pE2602, DOI 10.1073/pnas.1505543112; Mao JZ, 2012, CANCER SCI, V103, P1780, DOI 10.1111/j.1349-7006.2012.02378.x; Marivin A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad2429; Marty C, 2010, MOL PHARMACOL, V78, P12, DOI 10.1124/mol.110.063453; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; Muntean BS, 2016, J BIOL CHEM, V291, P7195, DOI 10.1074/jbc.M115.713446; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; QUILLIAM LA, 1994, P NATL ACAD SCI USA, V91, P8512, DOI 10.1073/pnas.91.18.8512; Sasaki K, 2015, J CELL SCI, V128, P2244, DOI 10.1242/jcs.160879; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Song XS, 2001, J BIOL CHEM, V276, P34651, DOI 10.1074/jbc.M105894200; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Wang HH, 2015, J AM SOC NEPHROL, V26, P314, DOI 10.1681/ASN.2013090985; Weng L, 2014, EMBO J, V33, P2098, DOI 10.15252/embj.201488289	70	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27098	27111		10.1074/jbc.M116.764431	http://dx.doi.org/10.1074/jbc.M116.764431			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864364	hybrid, Green Published			2022-12-28	WOS:000391576300011
J	Johnson, ZI; Shapiro, IM; Risbud, MV				Johnson, Zariel I.; Shapiro, Irving M.; Risbud, Makarand V.			RNA Sequencing Reveals a Role of TonEBP Transcription Factor in Regulation of Pro-inflammatory Genes in Response to Hyperosmolarity in Healthy Nucleus Pulposus Cells A HOMEOSTATIC RESPONSE?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERVERTEBRAL DISC; OSMOTIC-STRESS; DNA-BINDING; EXPRESSION; NFAT5; HYPERTONICITY; INDUCTION; CYTOKINE; SURVIVAL; LIPOPOLYSACCHARIDE	Transcription factor tonicity-responsive enhancer-binding protein (TonEBP/NFAT5) is critical for osmo-adaptation and extracellular matrix homeostasis of nucleus pulposus (NP) cells in their hypertonic tissue niche. Recent studies implicate TonEBP signaling in inflammatory disease and rheumatoid arthritis pathogenesis. However, broader functions of TonEBP in the disc remain unknown. RNA sequencing was performed on NP cells with TonEBP knockdown under hypertonic conditions. 1140 TonEBP-dependent genes were identified and categorized using Ingenuity Pathway Analysis. Bioinformatic analysis showed enrichment of matrix homeostasis and cytokine/chemokine signaling pathways. C-C motif chemokine ligand 2 (CCL2), interleukin 6 (IL6), tumor necrosis factor (TNF), and nitric oxide synthase 2 (NOS2) were studied further. Knockdown experiments showed that TonEBP was necessary to maintain expression levels of these genes. Gain-and loss-of-function experiments and site-directed mutagenesis demonstrated that TonEBP binding to a specific site in the CCL2 promoter is required for hypertonic inducibility. Despite inhibition by dominant-negative TonEBP, IL6 and NOS2 promoters were not hypertonicity-inducible. Whole-disc response to hypertonicity was studied in an ex vivo organ culture model, using wild-type and haploinsufficient TonEBP mice. Pro-inflammatory targets were induced by hypertonicity in discs from wild-type but not TonEBP-haploinsufficient mice. Mechanistically, NF-kappa B activity increased with hypertonicity and was necessary for hypertonic induction of target genes IL6, TNF, and NOS2 but not CCL2. Although TonEBP maintains transcription of genes traditionally considered pro-inflammatory, it is important to note that some of these genes also serve anabolic and pro-survival roles. Therefore, in NP cells, this phenomenon may reflect a physiological adaptation to diurnal osmotic loading of the intervertebral disc.	[Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511,Coll Bldg, Philadelphia, PA 19107 USA; [Johnson, Zariel I.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511,Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			National Institutes of Health [AR055655, AR064733, T32 AR052273]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR052273, R01AR064733, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants AR055655 and AR064733 (to M. V. R.) and by National Institutes of Health Grant T32 AR052273 (to I. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altun I, 2016, SPINE J, V16, P857, DOI 10.1016/j.spinee.2016.03.019; Borthakur A, 2011, SPINE, V36, P2190, DOI 10.1097/BRS.0b013e31820287bf; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Chen QC, 2015, MOL MED REP, V12, P219, DOI 10.3892/mmr.2015.3375; Chen SC, 2009, J CLIN INVEST, V119, P1647, DOI 10.1172/JCI35314; Cheng CC, 2009, J CELL PHYSIOL, V221, P668, DOI 10.1002/jcp.21904; Do Lee S, 2011, AM J PHYSIOL-RENAL, V300, pF707, DOI 10.1152/ajprenal.00227.2010; Dudek M, 2017, ANN RHEUM DIS, V76, P576, DOI 10.1136/annrheumdis-2016-209428; Esensten JH, 2005, NUCLEIC ACIDS RES, V33, P3845, DOI 10.1093/nar/gki701; EYRE DR, 1977, BIOCHIM BIOPHYS ACTA, V492, P29, DOI 10.1016/0005-2795(77)90211-2; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Gajghate S, 2009, J BONE MINER RES, V24, P992, DOI [10.1359/JBMR.090103, 10.1359/jbmr.090103]; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Hiyama A, 2009, J BIOL CHEM, V284, P9824, DOI 10.1074/jbc.M807081200; Hollborn M, 2015, MOL VIS, V21, P360; Huang WF, 2011, NUCLEIC ACIDS RES, V39, P475, DOI 10.1093/nar/gkq818; Inoue N, 2011, ORTHOP CLIN N AM, V42, P487, DOI 10.1016/j.ocl.2011.07.001; Ji WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088952; Johnson ZI, 2014, MATRIX BIOL, V40, P10, DOI 10.1016/j.matbio.2014.08.014; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; Kim NH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.61; Kojima R, 2010, J IMMUNOL, V184, P5253, DOI 10.4049/jimmunol.0901298; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Lee HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24921; Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053176; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Matsumura Y, 2009, J ORTHOP SCI, V14, P45, DOI 10.1007/s00776-008-1288-5; Phillips KLE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4408; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Roth I, 2010, MOL BIOL CELL, V21, P3459, DOI 10.1091/mbc.E10-02-0133; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; SATOMI K, 1992, SPINE, V17, P1329, DOI 10.1097/00007632-199211000-00012; Schleich C, 2015, J MAGN RESON IMAGING, V42, P1057, DOI 10.1002/jmri.24877; Suyama K, 2016, ONCOTARGET, V7, P23056, DOI 10.18632/oncotarget.8521; Tsai TT, 2007, J BONE MINER RES, V22, P965, DOI 10.1359/JBMR.070322; Tsai TT, 2006, J BIOL CHEM, V281, P25416, DOI 10.1074/jbc.M601969200; Ueno M, 2013, J LIPID RES, V54, P734, DOI 10.1194/jlr.M033365; van der Windt AE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3031; Watanabe Takuya, 2005, Kurume Medical Journal, V52, P39, DOI 10.2739/kurumemedj.52.39; Wright FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114129; Zenker S, 2014, J IMMUNOL, V192, P2830, DOI 10.4049/jimmunol.1300157	47	24	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26686	26697		10.1074/jbc.M116.757732	http://dx.doi.org/10.1074/jbc.M116.757732			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875309	Green Published, hybrid			2022-12-28	WOS:000391571400009
J	Kayode, O; Wang, RY; Pendlebury, DF; Cohen, I; Henin, RD; Hockla, A; Soares, AS; Papo, N; Caulfield, TR; Radisky, ES				Kayode, Olumide; Wang, Ruiying; Pendlebury, Devon F.; Cohen, Itay; Henin, Rachel D.; Hockla, Alexandra; Soares, Alexei S.; Papo, Niv; Caulfield, Thomas R.; Radisky, Evette S.			An Acrobatic Substrate Metamorphosis Reveals a Requirement for Substrate Conformational Dynamics in Trypsin Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED MOLECULAR-DYNAMICS; SERINE-PROTEASE MECHANISM; ENERGY LANDSCAPE; CATIONIC TRYPSIN; PEPTIDE-BOND; INHIBITOR; MESOTRYPSIN; SIMULATIONS; KUNITZ; DETERMINANTS	The molecular basis of enzyme catalytic power and specificity derives from dynamic interactions between enzyme and substrate during catalysis. Although considerable effort has been devoted to understanding how conformational dynamics within enzymes affect catalysis, the role of conformational dynamics within protein substrates has not been addressed. Here, we examine the importance of substrate dynamics in the cleavage of Kunitz-bovine pancreatic trypsin inhibitor protease inhibitors by mesotrypsin, finding that the varied conformational dynamics of structurally similar substrates can profoundly impact the rate of catalysis. A 1.4-angstrom crystal structure of a mesotrypsin-product complex formed with a rapidly cleaved substrate reveals a dramatic conformational change in the substrate upon proteolysis. By using long all-atom molecular dynamics simulations of acyl-enzyme intermediates with proteolysis rates spanning 3 orders of magnitude, we identify global and local dynamic features of substrates on the nanosecond-microsecond time scale that correlate with enzymatic rates and explain differential susceptibility to proteolysis. By integrating multiple enhanced sampling methods for molecular dynamics, we model a viable conformational pathway between substrate-like and product-like states, linking substrate dynamics on the nanosecond-microsecond time scale with large collective substrate motions on the much slower time scale of catalysis. Our findings implicate substrate flexibility as a critical determinant of catalysis.	[Kayode, Olumide; Wang, Ruiying; Pendlebury, Devon F.; Henin, Rachel D.; Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; [Caulfield, Thomas R.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Cohen, Itay; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Cohen, Itay; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Soares, Alexei S.] Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA; [Pendlebury, Devon F.] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA	Mayo Clinic; Mayo Clinic; Ben Gurion University; Ben Gurion University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Michigan System; University of Michigan	Caulfield, TR (corresponding author), Mayo Clin, Dept Neurosci, 310 Birdsall Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.; Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	caulfield.thomas@mayo.edu; radisky.evette@mayo.edu	Papo, Niv/R-3946-2017; Radisky, Evette S/C-8526-2012	Radisky, Evette S/0000-0003-3121-109X; Caulfield, Thomas/0000-0002-1055-3069	National Institutes of Health [R01CA154387]; European Research Council [33604]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01CA154387 (to E. S. R.), European Research Council "Ideas Program" ERC-2013-StG Grant 33604 (to N. P.), and a Prostate Cancer Foundation grant (to N. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alloy AP, 2015, J BIOL CHEM, V290, P21523, DOI 10.1074/jbc.M115.662429; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Caulfield T, 2012, PROTEINS, V80, P2489, DOI 10.1002/prot.24131; Caulfield T, 2011, J STRUCT BIOL, V176, P185, DOI 10.1016/j.jsb.2011.07.015; Caulfield Thomas R, 2011, J Biophys, V2011, P219515, DOI 10.1155/2011/219515; Caulfield TR, 2011, J MOL GRAPH MODEL, V29, P1006, DOI 10.1016/j.jmgm.2011.04.005; Cecchini M, 2004, J CHEM PHYS, V121, P10748, DOI 10.1063/1.1809588; Cheatham TE, 2001, BIOPOLYMERS, V56, P232; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELS M, 1992, PROTEIN ENG, V5, P669, DOI 10.1093/protein/5.7.669; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P131, DOI 10.1021/bi00542a020; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; HUBBARD SJ, 1994, PROTEIN SCI, V3, P757; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger Elmar, 2003, Methods Biochem Anal, V44, P509; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Kubitzki MB, 2007, BIOPHYS J, V92, P4262, DOI 10.1529/biophysj.106.103101; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LEESON DT, 1995, NAT STRUCT BIOL, V2, P848, DOI 10.1038/nsb1095-848; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Maximova T, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004619; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaneetham D, 2010, J BIOCHEM, V148, P467, DOI 10.1093/jb/mvq080; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ovchinnikov V, 2012, J PHYS CHEM B, V116, P8584, DOI 10.1021/jp212634z; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; Perakyla M, 2000, J AM CHEM SOC, V122, P3436, DOI 10.1021/ja991602p; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plattner N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8653; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Reblova K, 2007, BIOPHYS J, V93, P3932, DOI 10.1529/biophysj.107.110056; Reblova K, 2006, BIOPOLYMERS, V82, P504, DOI 10.1002/bip.20503; ROSENFIELD RE, 1978, ACTA CRYSTALLOGR A, V34, P828, DOI 10.1107/S0567739478001692; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2012, PROTEIN SCI, V21, P1103, DOI 10.1002/pro.2097; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Szabo A, 2014, J BIOL CHEM, V289, P4753, DOI 10.1074/jbc.M113.538884; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Torbeev VY, 2011, P NATL ACAD SCI USA, V108, P20982, DOI 10.1073/pnas.1111202108; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Winn M., 2001, CCP4 NEWSLETTER, V39; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Ye SJ, 2015, CHEM SCI, V6, P5246, DOI 10.1039/c4sc03227f; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106; Zhou YZ, 2016, J PHYS CHEM LETT, V7, P1138, DOI 10.1021/acs.jpclett.6b00373	79	17	18	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26304	26319		10.1074/jbc.M116.758417	http://dx.doi.org/10.1074/jbc.M116.758417			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27810896	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000391568200006
J	Xia, L; Wang, XR; Wang, XL; Liu, SH; Ding, XW; Chen, GQ; Lu, Y				Xia, Li; Wang, Xin-Ran; Wang, Xiao-Ling; Liu, Su-Hui; Ding, Xiao-Wei; Chen, Guo-Qiang; Lu, Ying			A Novel Role for Pyruvate Kinase M2 as a Corepressor for P53 during the DNA Damage Response in Human Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; GENE-TRANSCRIPTION; PKM2; CANCER; EXPRESSION; MDM2; TUMORIGENESIS; ACTIVATION; APOPTOSIS; PROMOTES	The pyruvate kinase (PK) is a rate-limiting glycolytic enzyme catalyzing the dephosphorylation of phosphoenolpyruvate to pyruvate, yielding one molecule of ATP. The M2 isoform of PK (PKM2) is predominantly expressed in normal proliferating cells and tumors, and both metabolic and non-metabolic activities for the enzyme in promoting tumor cell proliferation have been identified. However, the exact roles of PKM2 in tumor initiation, growth and maintenance are not yet fully understood. Using immunoprecipitation-coupled LC-MS/MS in MCF7 cells exposed to DNA-damaging agent, we report that the nuclear PKM2 interacts directly with P53 protein, a critical safeguard for genome stability. Specifically, PKM2 inhibits P53-dependent transactivation of the P21 gene by preventing P53 binding to the P21 promoter, leading to a nonstop G(1) phase. As a result, PKM2 expression provides a growth advantage for tumor cells in the presence of a DNA damage stimulus. In addition, PKM2 interferes with phosphorylation of P53 at serine 15, known to stimulate P53 activity by the ATM serine/threonine kinase. These findings reveal a new role for PKM2 in modulating the DNA damage response and illustrate a novel mechanism of PKM2 participating in tumorigenesis.	[Xia, Li; Wang, Xin-Ran; Wang, Xiao-Ling; Liu, Su-Hui; Ding, Xiao-Wei; Chen, Guo-Qiang; Lu, Ying] SJTU SM, Minist Educ, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol, Shanghai 200025, Peoples R China; [Chen, Guo-Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Chen, Guo-Qiang] SJTU SM, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Chen, GQ; Lu, Y (corresponding author), 280 Chong Qing South Rd, Shanghai 200025, Peoples R China.	chengq@shsmu.edu.cn; stove@shsmu.edu.cn		chen, guo qiang/0000-0003-4936-2363; Wang, Xinran/0000-0001-9505-9221	National Key Research Program of China [2015CB910403]; National Natural Science Foundation [81370652, 81230048, 81430061, 31570824]; Foundation for the author of National Excellent Doctoral Dissertation of China [201074]; Science and Technology Committee of Shanghai [13431900501]; Shanghai Human Resource and Social Security Bureau	National Key Research Program of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Foundation for the author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Science and Technology Committee of Shanghai(Shanghai Science & Technology Committee); Shanghai Human Resource and Social Security Bureau	This work was supported by National Key Research Program of China (NO2015CB910403), National Natural Science Foundation (81370652, 81230048, 81430061, 31570824), Foundation for the author of National Excellent Doctoral Dissertation of China (201074), Grants from Science and Technology Committee of Shanghai (13431900501) and Talent Development Project of Shanghai Human Resource and Social Security Bureau. The authors declare that they have no conflicts of interest with the contents of this article.	Akahira J, 2004, CLIN CANCER RES, V10, P2687, DOI 10.1158/1078-0432.CCR-03-0510; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Bluemlein K, 2011, ONCOTARGET, V2, P393; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; Cao LL, 2016, SCI CHINA LIFE SCI, V59, P257, DOI 10.1007/s11427-016-5011-z; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Cui D, 2014, ONCOGENE, V33, P2225, DOI 10.1038/onc.2013.170; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gao XL, 2013, J BIOL CHEM, V288, P15971, DOI 10.1074/jbc.M112.448753; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Hathurusinghe HR, 2007, ANN SURG ONCOL, V14, P2714, DOI 10.1245/s10434-007-9481-x; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052576; Ikeda Y, 1997, J BIOL CHEM, V272, P20495, DOI 10.1074/jbc.272.33.20495; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jenkins LMM, 2012, CARCINOGENESIS, V33, P1441, DOI 10.1093/carcin/bgs145; Jiang YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6566; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Keller KE, 2014, MOL CELL, V53, P700, DOI 10.1016/j.molcel.2014.02.015; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lu Y, 2006, LEUKEMIA, V20, P987, DOI 10.1038/sj.leu.2404218; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; NAGASAWA H, 1995, CANCER RES, V55, P1842; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Papadaki C, 2014, BRIT J CANCER, V111, P1757, DOI 10.1038/bjc.2014.492; Shandilya J, 2012, P NATL ACAD SCI USA, V109, P18797, DOI 10.1073/pnas.1207483109; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932	44	22	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26138	26150		10.1074/jbc.M116.737056	http://dx.doi.org/10.1074/jbc.M116.737056			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27810895	Green Published, hybrid			2022-12-28	WOS:000390345200031
J	Xu, CX; Xu, M; Tan, L; Yang, H; Permuth-Wey, J; Kruk, PA; Wenham, RM; Nicosia, SV; Lancaster, JM; Sellers, TA; Cheng, JQ				Xu, Cheng-Xiong; Xu, Meng; Tan, Lei; Yang, Hua; Permuth-Wey, Jennifer; Kruk, Patricia A.; Wenham, Robert M.; Nicosia, Santo V.; Lancaster, Johnathan M.; Sellers, Thomas A.; Cheng, Jin Q.			MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog (vol 287, pg 34970, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Xu CX, 2012, J BIOL CHEM, V287, P34970, DOI 10.1074/jbc.M112.374611	1	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22851	22851		10.1074/jbc.A112.374611	http://dx.doi.org/10.1074/jbc.A112.374611			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825089	hybrid, Green Published			2022-12-28	WOS:000386760600050
J	Lima, S; Milstien, S; Spiegel, S				Lima, Santiago; Milstien, Sheldon; Spiegel, Sarah			Sphingosine and Sphingosine Kinase 1 Involvement in Endocytic Membrane Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; endosome; sphingolipid; sphingosine kinase (SphK); sphingosine-1-phosphate (S1P); sphingosine	SPHINGOLIPID METABOLISM; PRESYNAPTIC TERMINALS; PLASMA-MEMBRANE; PROTEIN; INHIBITOR; BIF-1; CHOLESTEROL; RECRUITMENT; ENDOPHILIN; UVRAG	The balance between cholesterol and sphingolipids within the plasma membrane has long been implicated in endocytic membrane trafficking. However, in contrast to cholesterol functions, little is still known about the roles of sphingolipids and their metabolites. Perturbing the cholesterol/sphingomyelin balance was shown to induce narrow tubular plasma membrane invaginations enriched with sphingosine kinase 1 (SphK1), the enzyme that converts the bioactive sphingolipid metabolite sphingosine to sphingosine-1-phosphate, and suggested a role for sphingosine phosphorylation in endocytic membrane trafficking. Here we show that sphingosine and sphingosine-like SphK1 inhibitors induced rapid and massive formation of vesicles in diverse cell types that accumulated as dilated late endosomes. However, much smaller vesicles were formed in SphK1-deficient cells. Moreover, inhibition or deletion of SphK1 prolonged the lifetime of sphingosine-induced vesicles. Perturbing the plasma membrane cholesterol/sphingomyelin balance abrogated vesicle formation. This massive endosomal influx was accompanied by dramatic recruitment of the intracellular SphK1 and Bin/Amphiphysin/Rvs domain-containing proteins endophilin-A2 and endophilin-B1 to enlarged endosomes and formation of highly dynamic filamentous networks containing endophilin-B1 and SphK1. Together, our results highlight the importance of sphingosine and its conversion to sphingosine-1-phosphate by SphK1 in endocytic membrane trafficking.	[Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 1101 E Marshall St, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 1101 E Marshall St, Richmond, VA 23298 USA.; Lima, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 1101 E Marshall St, Richmond, VA 23892 USA.	santiago.lima@vcuhealth.org; sarah.spiegel@vcuhealth.org			National Institutes of Health [K22 CA187314, R01GM043880]; National Institutes of Health, NCI Cancer Center Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059, K22CA187314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants (K22 CA187314 (to S. L.) and R01GM043880 (to S. S.). The VCU Lipidomics and Microscopy Cores are supported in part by funding from the National Institutes of Health, NCI Cancer Center Support Grant P30 CA016059. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Boulakirba S, 2014, P NATL ACAD SCI USA, V111, P9473, DOI 10.1073/pnas.1401186111; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chan JP, 2012, J NEUROSCI, V32, P17909, DOI 10.1523/JNEUROSCI.2808-12.2012; Chan JP, 2012, GENE DEV, V26, P1070, DOI 10.1101/gad.188003.112; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Contreras FX, 2006, BIOPHYS J, V90, P4085, DOI 10.1529/biophysj.105.076471; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dutta Dipannita, 2012, Cell Logist, V2, P203; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; Georgieva R, 2010, J COLLOID INTERF SCI, V350, P502, DOI 10.1016/j.jcis.2010.07.022; Giraldo AMV, 2014, BIOCHEM SOC T, V42, P1460, DOI 10.1042/BST20140145; Goni FM, 2014, BIOCHEM SOC T, V42, P1401, DOI 10.1042/BST20140159; Hannich JT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004762; Hayashi S, 2002, J BIOL CHEM, V277, P33319, DOI 10.1074/jbc.M201442200; Hoglinger D, 2015, ELIFE, V4, DOI 10.7554/eLife.10616; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Kusner DJ, 2007, J BIOL CHEM, V282, P23147, DOI 10.1074/jbc.M700193200; Lee H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6514; Li L, 2015, CELL BIOL INT, V39, P531, DOI 10.1002/cbin.10424; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lima S, 2014, J LIPID RES, V55, P1525, DOI 10.1194/jlr.D048132; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Maceyka M, 2008, MOL CELL BIOL, V28, P5687, DOI 10.1128/MCB.00465-08; Maxfield FR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016931; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Meyer SGE, 2012, ARCH BIOCHEM BIOPHYS, V526, P60, DOI 10.1016/j.abb.2012.07.006; Michihara A, 2005, BIOL PHARM BULL, V28, P947, DOI 10.1248/bpb.28.947; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mora R, 2010, GLIA, V58, P1364, DOI 10.1002/glia.21013; Morgan J, 2009, EUKARYOT CELL, V8, P779, DOI 10.1128/EC.00037-09; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; Puchkov D, 2013, TRENDS CELL BIOL, V23, P493, DOI 10.1016/j.tcb.2013.05.002; Ramstedt B, 2006, BBA-BIOMEMBRANES, V1758, P1945, DOI 10.1016/j.bbamem.2006.05.020; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rosales KR, 2011, BIOCHEM J, V439, P299, DOI 10.1042/BJ20110853; Runkle KB, 2012, CANCER BIOL THER, V13, P956, DOI 10.4161/cbt.20951; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Shen HY, 2014, NAT CELL BIOL, V16, P652, DOI 10.1038/ncb2987; Shichiri M, 2012, J BIOL CHEM, V287, P2926, DOI 10.1074/jbc.M111.321281; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Takahashi Y, 2009, CELL DEATH DIFFER, V16, P947, DOI 10.1038/cdd.2009.19; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Thompson CR, 2005, J IMMUNOL, V174, P3551, DOI 10.4049/jimmunol.174.6.3551; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Tooze SA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018358; Torgersen ML, 2001, J CELL SCI, V114, P3737; Yonamine I, 2011, J CELL BIOL, V192, P557, DOI 10.1083/jcb.201004098; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Young MM, 2016, CELL REP, V17, P1532, DOI 10.1016/j.celrep.2016.10.019; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	76	42	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3074	3088		10.1074/jbc.M116.762377	http://dx.doi.org/10.1074/jbc.M116.762377			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28049734	Green Published, hybrid			2022-12-28	WOS:000395538800002
J	Shiba, E; Izawa, K; Kaitani, A; Isobe, M; Maehara, A; Uchida, K; Maeda, K; Nakano, N; Ogawa, H; Okumura, K; Kitamura, T; Shimizu, T; Kitaura, J				Shiba, Emiko; Izawa, Kumi; Kaitani, Ayako; Isobe, Masamichi; Maehara, Akie; Uchida, Koichiro; Maeda, Keiko; Nakano, Nobuhiro; Ogawa, Hideoki; Okumura, Ko; Kitamura, Toshio; Shimizu, Toshiaki; Kitaura, Jiro			Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; MAST-CELL ACTIVATION; FC-EPSILON-RI; NEUTROPHIL RECRUITMENT; MYD88; LMIR3; REGULATORS; LIGANDS; SYSTEM	LPS triggers inflammatory responses; however, the negative regulation of LPS responses in vivo remains poorly understood. CD300f is an inhibitory receptor among the CD300 family of paired activating and inhibitory receptors. We have previously identified ceramide as a ligand for CD300f and shown that the binding of ceramide to CD300f inhibits IgE-mediated mast cell activation and allergic responses in mouse models. Here we identify the critical role of CD300f in inhibiting LPS-induced skin inflammation. CD300f deficiency remarkably enhanced LPS-induced skin edema and neutrophil recruitment in mice. Higher levels of factors that increase vascular permeability and of factors that induce neutrophil recruitment were detected in LPS-injected skin pouch exudates of CD300f(-/-) mice as compared with wild-type mice. CD300f was highly expressed in mast cells and recruited neutrophils, but not in macrophages, among skin myeloid cells. CD300f deficiency failed to influence the intrinsic migratory ability of neutrophils. Ceramide-CD300f binding suppressed the release of chemical mediators from mast cells and from neutrophils in response to LPS. Adoptive transfer experiments indicated that mast cells mediated enhanced edema in LPS-stimulated skin of CD300f(-/-) mice, whereas mast cells together with recruited neutrophils mediated robust neutrophil accumulation. Importantly, administering a ceramide antibody or ceramide-containing vesicles enhanced or suppressed LPS-induced skin inflammation of wild-type mice, respectively. Thus, ceramide-CD300f binding inhibits LPS-induced skin inflammation, implicating CD300f as a negative regulator of Toll-like receptor 4 (TLR4) signaling in vivo.	[Shiba, Emiko; Izawa, Kumi; Kaitani, Ayako; Isobe, Masamichi; Maehara, Akie; Uchida, Koichiro; Maeda, Keiko; Nakano, Nobuhiro; Ogawa, Hideoki; Okumura, Ko; Shimizu, Toshiaki; Kitaura, Jiro] Juntendo Univ, Grad Sch Med, Atopy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Shiba, Emiko; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Izawa, Kumi; Kaitani, Ayako; Isobe, Masamichi; Maehara, Akie; Kitamura, Toshio; Kitaura, Jiro] Univ Tokyo, Div Cellular Therapy, Div Stem Cell Signaling, Inst Med Sci,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan	Juntendo University; Juntendo University; University of Tokyo	Kitaura, J (corresponding author), Juntendo Univ, Grad Sch Med, Atopy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.; Kitamura, T (corresponding author), Univ Tokyo, Div Cellular Therapy, Div Stem Cell Signaling, Inst Med Sci,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kitamura@ims.u-tokyo.ac.jp; j-kitaura@juntendo.ac.jp	Kitamura, Toshio/AAA-2071-2021	Nakano, Nobuhiro/0000-0002-5317-5950	Japan Society for the Promotion of Science (JSPS) KAKENHI [23390257, 26293231]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 23390257 and 26293231. The authors declare that they have no conflicts of interest with the contents of this article.	Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Fischer H, 2007, CELL MICROBIOL, V9, P1239, DOI 10.1111/j.1462-5822.2006.00867.x; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2014, J ALLERGY CLIN IMMUN, V133, P270, DOI 10.1016/j.jaci.2013.08.008; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; Jozefowski S, 2010, J IMMUNOL, V185, P6960, DOI 10.4049/jimmunol.0902926; Kim EJ, 2012, IMMUNOLOGY, V135, P226, DOI 10.1111/j.1365-2567.2011.03528.x; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Lee SM, 2012, CLIN EXP IMMUNOL, V167, P438, DOI 10.1111/j.1365-2249.2011.04528.x; Lee SM, 2011, J IMMUNOL, V186, P6296, DOI 10.4049/jimmunol.1002184; Malaviya R, 2000, J LEUKOCYTE BIOL, V67, P841, DOI 10.1002/jlb.67.6.841; Matsukawa T, 2016, GUT, V65, P777, DOI 10.1136/gutjnl-2014-308900; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Molteni M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6978936; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Schafer B, 2013, J ALLERGY CLIN IMMUN, V131, P541, DOI 10.1016/j.jaci.2012.05.009; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Tian LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4146; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825	31	22	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2924	2932		10.1074/jbc.M116.768366	http://dx.doi.org/10.1074/jbc.M116.768366			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28073916	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000395535100032
J	Schultz, V; Suflita, M; Liu, XY; Zhang, X; Yu, YL; Li, LY; Green, DE; Xu, YM; Zhang, FM; DeAngelis, PL; Liu, J; Linhardt, RJ				Schultz, Victor; Suflita, Mathew; Liu, Xinyue; Zhang, Xing; Yu, Yanlei; Li, Lingyun; Green, Dixy E.; Xu, Yongmei; Zhang, Fuming; DeAngelis, Paul L.; Liu, Jian; Linhardt, Robert J.			Heparan Sulfate Domains Required for Fibroblast Growth Factor 1 and 2 Signaling through Fibroblast Growth Factor Receptor 1c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HEPARINS; CHEMOENZYMATIC SYNTHESIS; HEPARIN/HEPARAN SULFATE; HEPAROSAN SYNTHASES; TERNARY COMPLEXES; CELL-ADHESION; FACTOR FAMILY; FGF; SPECIFICITY; EXPRESSION	A small library of well defined heparan sulfate (HS) polysaccharides was chemoenzymatically synthesized and used for a detailed structure-activity study of fibroblast growth factor (FGF) 1 and FGF2 signaling through FGF receptor (FGFR) 1c. The HS polysaccharide tested contained both undersulfated (NA) domains and highly sulfated (NS) domains as well as very well defined non-reducing termini. This study examines differences in the HS selectivity of the positive canyons of the FGF1(2)-FGFR1c(2) and FGF2(2)-FGFR1c(2) HS binding sites of the symmetric FGF(2)-FGFR(2)-HS2 signal transduction complex. The results suggest that FGF1(2)-FGFR1c(2) binding site prefers a longer NS domain at the non-reducing terminus than FGF2(2)-FGFR1c(2). In addition, FGF2(2)-FGFR1c(2) can tolerate an HS chain having an N-acetylglucosamine residue at its non-reducing end. These results clearly demonstrate the different specificity of FGF1(2)-FGFR1c(2) and FGF2(2)-FGFR1c(2) for well defined HS structures and suggest that it is now possible to chemoenzymatically synthesize precise HS polysaccharides that can selectively mediate growth factor signaling. These HS polysaccharides might be useful in both understanding and controlling the growth, proliferation, and differentiation of cells in stem cell therapies, wound healing, and the treatment of cancer.	[Schultz, Victor; Liu, Xinyue; Zhang, Xing; Yu, Yanlei; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Suflita, Mathew; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Li, Lingyun] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Green, Dixy E.; DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Xu, Yongmei; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; State University of New York (SUNY) System; Wadsworth Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of North Carolina; University of North Carolina Chapel Hill	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, 110 8th Ave, Troy, NY 12180 USA.	linhar@rpi.edu	Yu, Yanlei/AAQ-4432-2020; Liu, Xinyue/AAR-6887-2021; Yu, Yanlei/GNH-4836-2022	Liu, Xinyue/0000-0002-0934-4155; 	National Institutes of Health [HL094463, HL62244]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244, R01HL125371, R01HL094463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL094463 and HL62244. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baik JY, 2015, BIOTECHNOL J, V10, P1067, DOI 10.1002/biot.201400665; Brown A, 2013, BIOPHYS J, V104, P1720, DOI 10.1016/j.bpj.2013.02.051; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; DeAngelis Paul L, 2013, Methods Mol Biol, V1022, P215, DOI 10.1007/978-1-62703-465-4_17; DeAngelis PL, 2013, GLYCOBIOLOGY, V23, P764, DOI 10.1093/glycob/cwt016; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Faham S, 1998, CURR OPIN STRUC BIOL, V8, P578, DOI 10.1016/S0959-440X(98)80147-4; Gallagher JT, 1997, BIOCHEM SOC T, V25, P1206, DOI 10.1042/bst0251206; GALLAGHER JT, 1992, INT J BIOCHEM, V24, P553, DOI 10.1016/0020-711X(92)90326-V; GRIFFIN CC, 1995, CARBOHYD RES, V276, P183, DOI 10.1016/0008-6215(95)00166-Q; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; Hileman RE, 1997, GLYCOBIOLOGY, V7, P231; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kusche-Gullberg M, 2012, J BIOL CHEM, V287, P21950, DOI 10.1074/jbc.M112.350389; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Li GY, 2013, BIOPOLYMERS, V99, P675, DOI 10.1002/bip.22263; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; Li LY, 2012, ANAL CHEM, V84, P8822, DOI 10.1021/ac302232c; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Liu J, 2012, CURR OPIN STRUC BIOL, V22, P550, DOI 10.1016/j.sbi.2012.07.004; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X; Masuko S, 2012, J ORG CHEM, V77, P1449, DOI 10.1021/jo202322k; Melder RJ, 1996, NAT MED, V2, P992, DOI 10.1038/nm0996-992; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297; Mulloy B, 2001, CURR OPIN STRUC BIOL, V11, P623, DOI 10.1016/S0959-440X(00)00257-8; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; Otto NJ, 2012, J BIOL CHEM, V287, P7203, DOI 10.1074/jbc.M111.311704; PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Powell AK, 2002, J BIOL CHEM, V277, P28554, DOI 10.1074/jbc.M111754200; Puvirajesinghe TM, 2012, CHEM BIOL, V19, P553, DOI 10.1016/j.chembiol.2012.03.011; Ramani VC, 2013, FEBS J, V280, P2294, DOI 10.1111/febs.12168; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; ROSENBERG RD, 1978, P NATL ACAD SCI USA, V75, P3065, DOI 10.1073/pnas.75.7.3065; RUSNATI M, 1994, BIOCHEM BIOPH RES CO, V203, P450, DOI 10.1006/bbrc.1994.2203; Safaiyan F, 2000, BIOCHEMISTRY-US, V39, P10823, DOI 10.1021/bi000411s; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Smits NC, 2010, J BIOL CHEM, V285, P41143, DOI 10.1074/jbc.M110.153791; Staples GO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016689; Sterner E, 2014, J BIOL CHEM, V289, P9754, DOI 10.1074/jbc.M113.546937; Sterner E, 2013, BIOCHEMISTRY-US, V52, P9009, DOI 10.1021/bi401284r; Su HS, 1996, APPL ENVIRON MICROB, V62, P2723, DOI 10.1128/AEM.62.8.2723-2734.1996; Sun XJ, 2015, ANAL CHEM, V87, P6220, DOI 10.1021/acs.analchem.5b00913; Thao KNN, 2011, FEBS LETT, V585, P2698, DOI 10.1016/j.febslet.2011.07.024; Varki A, 2009, ESSENTIALS GLYCOBIOL, P1; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Yang B, 2012, J CHROMATOGR A, V1225, P91, DOI 10.1016/j.chroma.2011.12.063; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200; Zhou XX, 2011, GLYCOBIOLOGY, V21, P771, DOI 10.1093/glycob/cwr001	71	34	36	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2495	2509		10.1074/jbc.M116.761585	http://dx.doi.org/10.1074/jbc.M116.761585			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031461	hybrid, Green Published			2022-12-28	WOS:000395530300036
J	Pinar, A; Dowling, JK; Bitto, NJ; Robertson, AAB; Latz, E; Stewart, CR; Drummond, GR; Cooper, MA; McAuley, JL; Tate, MD; Mansell, A				Pinar, Anita; Dowling, Jennifer K.; Bitto, Natalie J.; Robertson, Avril A. B.; Latz, Eicke; Stewart, Cameron R.; Drummond, Grant R.; Cooper, Matthew A.; McAuley, Julie L.; Tate, Michelle D.; Mansell, Ashley			PB1-F2 Peptide Derived from Avian Influenza A Virus H7N9 Induces Inflammation via Activation of the NLRP3 Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; INFECTION; PATHOGENESIS; PROTEIN; MACROPHAGES; RESPONSES; HOST; MICE	The emergence of avian H7N9 influenza A virus in humans with associated high mortality has highlighted the threat of a potential pandemic. Fatal H7N9 infections are characterized by hyperinflammation and increased cellular infiltrates in the lung. Currently there are limited therapies to address the pathologies associated with H7N9 infection and the virulence factors that contribute to these pathologies. We have found that PB1-F2 derived from H7N9 activates the NLRP3 inflammasome and induces lung inflammation and cellular recruitment that is NLRP3-dependent. We have also shown that H7N9 and A/ Puerto Rico/ H1N1 (PR8) PB1-F2 peptide treatment induces significant mitochondrial reactive oxygen production, which contributes to NLRP3 activation. Importantly, treatment of cells or mice with the specific NLRP3 inhibitor MCC950 significantly reduces IL-1 beta maturation, lung cellular recruitment, and cytokine production. Together, these results suggest that PB1-F2 from H7N9 avian influenza A virus may be a major contributory factor to disease pathophysiology and excessive inflammation characteristic of clinical infections and that targeting the NLRP3 inflammasome may be an effective means to reduce the inflammatory burden associated with H7N9 infections.	[Pinar, Anita; Dowling, Jennifer K.; Bitto, Natalie J.; Tate, Michelle D.; Mansell, Ashley] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Pinar, Anita; Dowling, Jennifer K.; Bitto, Natalie J.; Tate, Michelle D.; Mansell, Ashley] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia; [Drummond, Grant R.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Robertson, Avril A. B.; Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4702, Australia; [Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, D-53127 Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA 01655 USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany; [Stewart, Cameron R.] CSIRO, Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [McAuley, Julie L.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Hudson Institute of Medical Research; Monash University; Monash University; University of Queensland; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Melbourne	Mansell, A (corresponding author), Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	ashley.mansell@hudson.org.au	Mansell, Ashley/B-9553-2008; Latz, Eicke/H-3951-2014; Stewart, Cameron R/E-6823-2011; Robertson, Avril/A-4043-2012; Cooper, Matthew A./C-7988-2009; Dowling, Jennifer/ABA-6670-2020; McAuley, Julie/W-1272-2019; McAuley, Julie/L-4454-2019	Mansell, Ashley/0000-0002-6540-1281; Latz, Eicke/0000-0003-1488-5666; Robertson, Avril/0000-0002-9652-8357; Cooper, Matthew A./0000-0003-3147-3460; McAuley, Julie/0000-0003-2493-3465; Stewart, Cameron/0000-0002-3395-7859; Tate, Michelle/0000-0002-0587-5514; Dowling, Jennifer/0000-0003-2842-1504; Bitto, Natalie/0000-0003-3533-9824; Pinar, Anita/0000-0001-7779-4986	Victorian State Government Operational Infrastructure Scheme; National Health and Medical Research Council of Australia [GNT1079924, GNT1062721, GNT1062977]; National Health and Medical Research Council Australia [511105]; National Health and Medical Research Council Early Career Fellowship [1035733]	Victorian State Government Operational Infrastructure Scheme; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Victorian State Government Operational Infrastructure Scheme and by National Health and Medical Research Council of Australia Project Grants GNT1079924, GNT1062721, and GNT1062977 (to A. M., J. L. M., and G. D., respectively). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by National Health and Medical Research Council Australia Fellowship 511105.r Supported by National Health and Medical Research Council Early Career Fellowship 1035733.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Coleman JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-9; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Kash JC, 2015, AM J PATHOL, V185, P1528, DOI 10.1016/j.ajpath.2014.08.030; Krumbholz A, 2011, MED MICROBIOL IMMUN, V200, P69, DOI 10.1007/s00430-010-0176-8; Lam TTY, 2015, NATURE, V522, P102, DOI 10.1038/nature14348; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; Normile D, 2015, SCIENCE, V347, P1188, DOI 10.1126/science.347.6227.1188; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tate MD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27912; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Yu L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/cid/cit541	30	58	59	5	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					826	836		10.1074/jbc.M116.756379	http://dx.doi.org/10.1074/jbc.M116.756379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27913620	Green Published, hybrid			2022-12-28	WOS:000392318700006
J	Benredjem, B; Girard, M; Rhainds, D; St-Onge, G; Heveker, N				Benredjem, Besma; Girard, Melanie; Rhainds, David; St-Onge, Genevieve; Heveker, Nikolaus			Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; EXTRACELLULAR LOOP; DEPENDENT ACTIVATION; SCAVENGING ACTIVITY; STRUCTURAL BASIS; SMALL-MOLECULE; INSECT CELLS; HUMAN CXCR4; BINDING	Atypical chemokine receptors do not mediate chemotaxis or G protein signaling, but they recruit arrestin. They also efficiently scavenge their chemokine ligands, thereby contributing to gradient maintenance and termination. ACKR3, also known as CXCR7, binds and degrades the constitutive chemokine CXCL12, which also binds the canonical receptor CXCR4, and CXCL11, which also binds CXCR3. Here we report comprehensive mutational analysis of the ACKR3 interaction with its chemokine ligands, using 30 substitution mutants. Readouts are radioligand binding competition, arrestin recruitment, and chemokine scavenging. Our results suggest different binding modes for both chemokines. CXCL11 depends on the ACKR3N terminus and some extracellular loop (ECL) positions for primary binding, ECL residues mediate secondary binding and arrestin recruitment potency. CXCL12 binding required key residues Asp-179(4.60) and Asp-275(6.58) (residue numbering follows the Ballesteros-Weinstein scheme), with no evident involvement of N-terminal residues, suggesting an uncommon mode of receptor engagement. Mutation of residues corresponding to CRS2 in CXCR4 (positions Ser-103(2.63) and Gln-301(7.39)) increased CXCL11 binding, but reduced CXCL12 affinity. Mutant Q301E(7.39) did not recruit arrestin. Mutant K118A(3.26) in ECL1 showed moderate baseline arrestin recruitment with ablation of ligand-induced responses. Substitutions that affected CXCL11 binding also diminished scavenging. However, detection of reduced CXCL12 scavenging by mutants with impaired CXCL12 affinity required drastically reduced receptor expression levels, suggesting that scavenging pathways can be saturated and that CXCL12 binding exceeds scavenging at higher receptor expression levels. Arrestin recruitment did not correlate with scavenging; although Q301E(7.39) degraded chemokines in the absence of arrestin, S103D(2.63) had reduced CXCL11 scavenging despite intact arrestin responses.	[Benredjem, Besma; Girard, Melanie; Rhainds, David; Heveker, Nikolaus] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3T 1J4, Canada; [Benredjem, Besma; Girard, Melanie; Rhainds, David; St-Onge, Genevieve; Heveker, Nikolaus] Univ Montreal, St Justine Hosp, Res Ctr, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Heveker, N (corresponding author), St Justine Hosp, Res Ctr, Dept Biochem & Mol Med, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nikolaus.heveker@recherche-ste-justine.qc.ca			Canadian Institutes of Health Research (CIHR) [MOP123421]; "Fondation Sainte Justine"; "Fonds de Recherche du Quebec Sante" (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); "Fondation Sainte Justine"; "Fonds de Recherche du Quebec Sante" (FRQS)	The work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP123421. The authors declare that they have no conflicts of interest with the contents of this article.r Both authors contributed to this work equally and held scholarships from the "Fondation Sainte Justine."r Recipient of scholarships from CIHR and "Fonds de Recherche du Quebec Sante" (FRQS).	Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baryshnikova OK, 2006, PROTEIN SCI, V15, P2568, DOI 10.1110/ps.062255806; Bonecchi R, 2008, BLOOD, V112, P493, DOI 10.1182/blood-2007-08-108316; Booth V, 2004, PROTEIN SCI, V13, P2022, DOI 10.1110/ps.04791404; Borroni EM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003627; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chabot DJ, 2000, J VIROL, V74, P4404, DOI 10.1128/JVI.74.9.4404-4413.2000; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Hanes MS, 2015, J BIOL CHEM, V290, P22385, DOI 10.1074/jbc.M115.675108; Hewit KD, 2014, J BIOL CHEM, V289, P12330, DOI 10.1074/jbc.M113.534545; Hoffmann F, 2012, J BIOL CHEM, V287, P28362, DOI 10.1074/jbc.M111.335679; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Katancik JA, 2000, CYTOKINE, V12, P1480, DOI 10.1006/cyto.2000.0742; Kleist AB, 2016, BIOCHEM PHARMACOL, V114, P53, DOI 10.1016/j.bcp.2016.04.007; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Mahabaleshwar H, 2012, DEVELOPMENT, V139, P2897, DOI 10.1242/dev.080408; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Montpas N, 2015, BIOCHEMISTRY-US, V54, P1505, DOI 10.1021/bi501526s; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Nedjai B, 2012, BRIT J PHARMACOL, V166, P912, DOI 10.1111/j.1476-5381.2011.01660.x; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Ott TR, 2004, J BIOL CHEM, V279, P42383, DOI 10.1074/jbc.M401097200; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rana S, 2010, J BIOL CHEM, V285, P31472, DOI 10.1074/jbc.M110.129213; Scholten DJ, 2014, MOL PHARMACOL, V85, P116, DOI 10.1124/mol.113.088633; Szpakowska M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005664; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhou HP, 1999, ARCH BIOCHEM BIOPHYS, V369, P267, DOI 10.1006/abbi.1999.1368; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555	45	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					31	42		10.1074/jbc.M116.762252	http://dx.doi.org/10.1074/jbc.M116.762252			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27875312	hybrid, Green Published			2022-12-28	WOS:000391578000003
J	Guilvout, I; Brier, S; Chami, M; Hourdel, V; Francetic, O; Pugsley, AP; Chamot-Rooke, J; Huysmans, GHM				Guilvout, Ingrid; Brier, Sebastien; Chami, Mohamed; Hourdel, Veronique; Francetic, Olivera; Pugsley, Anthony P.; Chamot-Rooke, Julia; Huysmans, Gerard H. M.			Prepore Stability Controls Productive Folding of the BAM-independent Multimeric Outer Membrane Secretin PulD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-EXCHANGE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; PROTEIN; CHAPERONE; INSERTION; ASSOCIATION; PULLULANASE; PROTEOLYSIS	Members of a group of multimeric secretion pores that assemble independently of any known membrane-embedded insertase in Gram-negative bacteria fold into a prepore before membrane-insertion occurs. The mechanisms and the energetics that drive the folding of these proteins are poorly understood. Here, equilibrium unfolding and hydrogen/deuterium exchange monitored by mass spectrometry indicated that a loss of 4-5 kJ/mol/protomer in the N-3 domain that is peripheral to the membrane-spanning C domain in the dodecameric secretin PulD, the founding member of this class, prevents pore formation by destabilizing the prepore into a poorly structured dodecamer as visualized by electron microscopy. Formation of native PulD-multimers by mixing protomers that differ in N-3 domain stability, suggested that the N-3 domain forms a thermodynamic seal onto the prepore. This highlights the role of modest free energy changes in the folding of preintegration forms of a hyperstable outer membrane complex and reveals a key driving force for assembly independently of the beta-barrel assembly machinery.	[Guilvout, Ingrid; Francetic, Olivera; Pugsley, Anthony P.; Huysmans, Gerard H. M.] Inst Pasteur, ERL 3526, CNRS, Mol Genet Unit, F-75724 Paris 15, France; [Guilvout, Ingrid; Francetic, Olivera] Inst Pasteur, Lab Macromol Syst & Signaling, F-75724 Paris 15, France; [Brier, Sebastien; Hourdel, Veronique; Chamot-Rooke, Julia] Inst Pasteur, CNRS, UMR 3528, Struct Mass Spectrometry & Prote Unit, F-75724 Paris 15, France; [Chami, Mohamed] Univ Basel, Biozentrum, BioEM Lab, CH-4058 Basel, Switzerland	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Basel	Chamot-Rooke, J (corresponding author), Inst Pasteur, CNRS, UMR 3528, Struct Mass Spectrometry & Prote Unit, F-75724 Paris 15, France.; Huysmans, GHM (corresponding author), Weill Cornell Med, Dept Phys & Biophys, New York, NY 10021 USA.	julia.chamot-rooke@pasteur.fr; ghh2001@med.cornell.edu	Francetic, Olivera/H-8915-2019; Huysmans, Gerard/AAJ-6285-2020; Brier, Sebastien/L-7787-2019; Brier, Sébastien/E-8558-2019; Chamot-Rooke, Julia/F-3644-2014	Francetic, Olivera/0000-0002-4145-5314; Brier, Sebastien/0000-0003-1758-8237; Chamot-Rooke, Julia/0000-0002-9427-543X	Swiss National Science Foundation (SystemsX.ch RTD CINA); CACSICE Equipex [ANR-11-EQPX-008]	Swiss National Science Foundation (SystemsX.ch RTD CINA)(Swiss National Science Foundation (SNSF)); CACSICE Equipex	We thank Prof. Henning Stahlberg (Biozentrum, University of Basel) for continued support. The EM work was supported in part by the Swiss National Science Foundation (SystemsX.ch RTD CINA). The MS work was supported by the CACSICE Equipex (ANR-11-EQPX-008).	Bai YW, 1995, METHOD ENZYMOL, V259, P344; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x; Collin S, 2013, RES MICROBIOL, V164, P390, DOI 10.1016/j.resmic.2013.03.023; Collin S, 2011, MOL MICROBIOL, V80, P655, DOI 10.1111/j.1365-2958.2011.07596.x; Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]; DENFERT C, 1989, J BIOL CHEM, V264, P17462; Dunstan RA, 2015, MOL MICROBIOL, V97, P616, DOI 10.1111/mmi.13055; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Fleming KG, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0026; Goyal P, 2014, NATURE, V516, P250, DOI 10.1038/nature13768; Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999; Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055; Guilvout I, 2014, STRUCTURE, V22, P582, DOI 10.1016/j.str.2014.02.009; Guilvout I, 2011, RES MICROBIOL, V162, P180, DOI 10.1016/j.resmic.2011.01.006; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Hoang HH, 2011, MBIO, V2, DOI 10.1128/mBio.00246-11; Hourdel V, 2016, BIOINFORMATICS, V32, P3413, DOI 10.1093/bioinformatics/btw420; Huyghues-Despointes BMP, 1999, BIOCHEMISTRY-US, V38, P16481, DOI 10.1021/bi9919450; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; Huysmans GHM, 2016, BIOCHEM SOC T, V44, P845, DOI 10.1042/BST20160003; Huysmans GHM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15068; Huysmans GHM, 2013, J BIOL CHEM, V288, P30700, DOI 10.1074/jbc.M113.489112; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; MICHAELIS S, 1985, J BACTERIOL, V164, P633, DOI 10.1128/JB.164.2.633-638.1985; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Nickerson NN, 2011, J BIOL CHEM, V286, P38833, DOI 10.1074/jbc.M111.279851; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Sathiyamoorthy K, 2011, BIOCHEMISTRY-US, V50, P5465, DOI 10.1021/bi101869h; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Singh J, 2014, J AM CHEM SOC, V136, P16704, DOI 10.1021/ja510964t; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tarry M, 2011, J MOL BIOL, V409, P642, DOI 10.1016/j.jmb.2011.04.034; Tosi T, 2014, STRUCTURE, V22, P1348, DOI 10.1016/j.str.2014.07.005; Wade KR, 2015, P NATL ACAD SCI USA, V112, P2204, DOI 10.1073/pnas.1423754112; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862	43	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					328	338		10.1074/jbc.M116.759498	http://dx.doi.org/10.1074/jbc.M116.759498			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27903652	Green Published, hybrid			2022-12-28	WOS:000391578000028
J	Kadyrova, LY; Dahal, BK; Kadyrov, FA				Kadyrova, Lyudmila Y.; Dahal, Basanta K.; Kadyrov, Farid A.			The Major Replicative Histone Chaperone CAF-1 Suppresses the Activity of the DNA Mismatch Repair System in the Cytotoxic Response to a DNA-methylating Agent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTL-ALPHA ENDONUCLEASE; ASSEMBLY FACTOR-I; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXTRACTS; TUMOR-CELLS; MUTATION AVOIDANCE; POLYMERASES DELTA; ALKYLATING-AGENTS; EXONUCLEASE-I; CHROMATIN	The DNA mismatch repair (MMR) system corrects DNA mismatches in the genome. It is also required for the cytotoxic response of O-6-methylguanine-DNA methyltransferase (MGMT)-deficient mammalian cells and yeast mgt1 Delta rad52 Delta cells to treatment with S(n)1-type methylating agents, which produce cytotoxic O-6-methylguanine (O-6-mG) DNA lesions. Specifically, an activity of the MMR system causes degradation of irreparable O-6-mG-T mispair-containing DNA, triggering cell death; this process forms the basis of treatments of MGMT-deficient cancers with S(n)1-type methylating drugs. Recent research supports the view that degradation of irreparable O-6-mG-T mispair-containing DNA by the MMR system and CAF-1-dependent packaging of the newly replicated DNA into nucleosomes are two concomitant processes that interact with each other. Here, we studied whether CAF-1 modulates the activity of the MMR system in the cytotoxic response to S(n)1-type methylating agents. We found that CAF-1 suppresses the activity of the MMR system in the cytotoxic response of yeast mgt1 Delta rad52 Delta cells to the prototypic S(n)1-type methylating agent N-methyl-N'-nitro-Nnitrosoguanidine. We also report evidence that in human MGMT-deficient cell-free extracts, CAF-1-dependent packaging of irreparable O-6-mG-T mispair-containing DNA into nucleosomes suppresses its degradation by the MMR system. Taken together, these findings suggest that CAF-1-dependent incorporation of irreparable O-6-mG-T mispair-containing DNA into nucleosomes suppresses its degradation by the MMR system, thereby defending the cell against killing by the S(n)1-type methylating agent.	[Kadyrova, Lyudmila Y.; Dahal, Basanta K.; Kadyrov, Farid A.] Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Kadyrov, FA (corresponding author), Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA.	fkadyrov@siumed.edu			NIGMS, National Institutes of Health [R01GM095758]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095758] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant R01GM095758. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ben-Shahar TR, 2009, MOL CELL BIOL, V29, P6353, DOI 10.1128/MCB.01051-09; Blanko ER, 2016, J BIOL CHEM, V291, P9203, DOI 10.1074/jbc.M115.713271; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Cejka P, 2005, CURR BIOL, V15, P1395, DOI 10.1016/j.cub.2005.07.032; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; CROSS SL, 1988, MOL CELL BIOL, V8, P945, DOI 10.1128/MCB.8.2.945; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Earley MC, 1998, P NATL ACAD SCI USA, V95, P15487, DOI 10.1073/pnas.95.26.15487; Erdeniz N, 2007, DNA REPAIR, V6, P1463, DOI 10.1016/j.dnarep.2007.04.013; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Glassner BJ, 1999, MUTAGENESIS, V14, P339, DOI 10.1093/mutage/14.3.339; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Greene CN, 2001, GENETICS, V159, P65; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; HSIANG YH, 1989, CANCER RES, V49, P5077; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kadyrova LY, 2016, DNA REPAIR, V38, P42, DOI 10.1016/j.dnarep.2015.11.023; Kadyrova LY, 2015, J BIOL CHEM, V290, P24051, DOI 10.1074/jbc.M115.660357; Kadyrova LY, 2013, CELL CYCLE, V12, P3286, DOI 10.4161/cc.26310; Kadyrova LY, 2011, P NATL ACAD SCI USA, V108, P2753, DOI 10.1073/pnas.1015914108; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kolodner RD, 2016, DNA REPAIR, V38, P3, DOI 10.1016/j.dnarep.2015.11.009; KRAKOFF IH, 1968, CANCER RES, V28, P1559; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kunkel TA, 2015, ANNU REV GENET, V49, P291, DOI 10.1146/annurev-genet-112414-054722; Li F, 2016, DNA REPAIR, V38, P68, DOI 10.1016/j.dnarep.2015.11.021; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Liang D, 2012, NUCLEIC ACIDS RES, V40, P9604, DOI 10.1093/nar/gks722; Longley MJ, 1997, J BIOL CHEM, V272, P10917; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Pena-Diaz J, 2012, TRENDS BIOCHEM SCI, V37, P206, DOI 10.1016/j.tibs.2012.03.001; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; RESNICK MA, 1976, MOL GEN GENET, V143, P119, DOI 10.1007/BF00266917; Russo MT, 2004, MOL CELL BIOL, V24, P465, DOI 10.1128/MCB.24.1.465-474.2004; Schopf B, 2012, P NATL ACAD SCI USA, V109, P1895, DOI 10.1073/pnas.1106696109; Shao HB, 2014, NUCLEIC ACIDS RES, V42, P7104, DOI 10.1093/nar/gku420; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Smith CE, 2015, J BIOL CHEM, V290, P21580, DOI 10.1074/jbc.M115.662189; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Stone JE, 2006, GENETICS, V173, P1223, DOI 10.1534/genetics.106.055616; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; Tsaryk R, 2006, CANCER LETT, V239, P305, DOI 10.1016/j.canlet.2005.08.036; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Umar A, 1997, CANCER RES, V57, P3949; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; XIAO W, 1991, EMBO J, V10, P2179, DOI 10.1002/j.1460-2075.1991.tb07753.x; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; ZHUKOVSKAYA N, 1994, CARCINOGENESIS, V15, P2189, DOI 10.1093/carcin/15.10.2189	86	6	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27298	27312		10.1074/jbc.M116.760561	http://dx.doi.org/10.1074/jbc.M116.760561			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27872185	Green Published, hybrid			2022-12-28	WOS:000391576300027
J	Khan, BR; Wherritt, DJ; Huhman, D; Sumner, LW; Chapman, KD; Blancaflor, EB				Khan, Bibi Rafeiza; Wherritt, Daniel J.; Huhman, David; Sumner, Lloyd W.; Chapman, Kent D.; Blancaflor, Elison B.			Malonylation of Glucosylated N-Lauroylethanolamine A NEW PATHWAY THAT DETERMINES N-ACYLETHANOLAMINE METABOLIC FATE IN PLANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID AMIDE HYDROLASE; ARABIDOPSIS-THALIANA SEEDLINGS; ENDOCANNABINOID SYSTEM; ROOT DEVELOPMENT; GLUTATHIONE; GROWTH; DETOXIFICATION; OVEREXPRESSION; IDENTIFICATION; BIOSYNTHESIS	N-Acylethanolamines (NAEs) are bioactive fatty acid derivatives present in trace amounts in many eukaryotes. Although NAEs have signaling and physiological roles in animals, little is known about their metabolic fate in plants. Our previous microarray analyses showed that inhibition of Arabidopsis thaliana seedling growth by exogenous N-lauroylethanolamine (NAE 12:0) was accompanied by the differential expression of multiple genes encoding small molecule-modifying enzymes. We focused on the gene At5g39050, which encodes a phenolic glucoside malonyltransferase 1 (PMAT1), to better understand the biological significance of NAE12:0-induced gene expression changes. PMAT1 expression was induced 3-5-fold by exogenous NAE 12:0. PMAT1 knockouts (pmat1) had reduced sensitivity to the growth-inhibitory effects of NAE 12:0 compared with wild type leading to the hypothesis that PMAT1 might be a previously uncharacterized regulator of NAE metabolism in plants. To test this hypothesis, metabolic profiling of wildtype and pmat1 seedlings treated with NAE 12:0 was conducted. Wild-type seedlings treated with NAE 12:0 accumulated glucosylated and malonylated forms of this NAE species, and structures were confirmed using nuclear magnetic resonance (NMR) spectroscopy. By contrast, only the peak corresponding to NAE 12:0-glucoside was detected in pmat1. Recombinant PMAT1 catalyzed the reaction converting NAE 12:0-glucoside to NAE 12:0-mono- or -dimalonylglucosides providing direct evidence that this enzyme is involved in NAE 12:0-glucose malonylation. Taken together, our results indicate that glucosylation of NAE 12:0 by a yet to be determined glucosyltransferase and its subsequent malonylation by PMAT1 could represent a mechanism for modulating the biological activities of NAEs in plants.	[Khan, Bibi Rafeiza; Huhman, David; Blancaflor, Elison B.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA; [Wherritt, Daniel J.] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Sumner, Lloyd W.] Univ Missouri, Dept Biochem, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Chapman, Kent D.] Univ North Texas, Dept Biol Sci, Div Biochem & Mol Biol, Denton, TX 76203 USA	Noble Research Institute; University of Texas System; University of Texas at San Antonio (UTSA); University of Missouri System; University of Missouri Columbia; University of North Texas System; University of North Texas Denton	Blancaflor, EB (corresponding author), 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	eblancaflor@noble.org	Sumner, Lloyd W/A-3270-2013; Wherritt, Daniel/AAY-6852-2020	Sumner, Lloyd W/0000-0002-4086-663X; Wherritt, Daniel/0000-0002-8616-9864; Huhman, David/0000-0002-3148-7400; Blancaflor, Elison/0000-0001-6115-9670; Khan, Bibi/0000-0002-7661-0142; Chapman, Kent/0000-0003-0489-3072	National Science Foundation under MRI [1126719]	National Science Foundation under MRI	Support for NMR instrumentation was provided by National Science Foundation under MRI Grant 1126719 (to L. W. S.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Blancaflor EB, 2014, PLANT J, V79, P568, DOI 10.1111/tpj.12427; Butler H, 2009, EUR J ENDOCRINOL, V161, P655, DOI 10.1530/EJE-09-0511; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; Cotter MQ, 2011, PLANT SIGNAL BEHAV, V6, P671, DOI 10.4161/psb.6.5.14704; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; De Petrocellis L, 2009, BEST PRACT RES CL EN, V23, P1, DOI 10.1016/j.beem.2008.10.013; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Gunning V, 2014, PLANT PHYSIOL, V165, P854, DOI 10.1104/pp.114.237180; Heiling S, 2010, PLANT CELL, V22, P273, DOI 10.1105/tpc.109.071449; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Keereetaweep J, 2015, PLANT J, V82, P315, DOI 10.1111/tpj.12821; Keereetaweep J, 2013, PLANT CELL, V25, P3824, DOI 10.1105/tpc.113.119024; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; Kim SC, 2010, PLANT SCI, V178, P411, DOI 10.1016/j.plantsci.2010.02.017; Klein M, 2000, PLANT J, V21, P289, DOI 10.1046/j.1365-313x.2000.00684.x; Kreuz K, 1996, PLANT PHYSIOL, V111, P349, DOI 10.1104/pp.111.2.349; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Luo J, 2007, PLANT J, V50, P678, DOI 10.1111/j.1365-313X.2007.03079.x; MATERN U, 1983, EUR J BIOCHEM, V133, P439, DOI 10.1111/j.1432-1033.1983.tb07483.x; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Motes CM, 2005, PROTOPLASMA, V226, P109, DOI 10.1007/s00709-005-0124-4; Neuefeind T, 1997, J MOL BIOL, V274, P446, DOI 10.1006/jmbi.1997.1402; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; SANDERMANN H, 1991, ARCH BIOCHEM BIOPHYS, V287, P341, DOI 10.1016/0003-9861(91)90488-5; Santino A, 2013, PLANT CELL REP, V32, P1085, DOI 10.1007/s00299-013-1441-2; Schmid HHO, 1996, CHEM PHYS LIPIDS, V80, P133, DOI 10.1016/0009-3084(96)02554-6; Shrestha R, 2003, J BIOL CHEM, V278, P34990, DOI 10.1074/jbc.M305613200; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Staswick P, 2009, PLANT SIGNAL BEHAV, V4, P757, DOI 10.1104/pp.109.138529; Suzuki H, 2002, PLANT PHYSIOL, V130, P2142, DOI 10.1104/pp.010447; Taguchi G, 2005, PLANT J, V42, P481, DOI 10.1111/j.1365-313X.2005.02387.x; Taguchi G, 2010, PLANT J, V63, P1031, DOI 10.1111/j.1365-313X.2010.04298.x; Teaster ND, 2007, PLANT CELL, V19, P2454, DOI 10.1105/tpc.106.048702; Teaster ND, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00032; Wang J, 2008, BBA-MOL CELL BIOL L, V1781, P710, DOI 10.1016/j.bbalip.2008.08.004; Wang YS, 2008, NEW PHYTOL, V177, P525, DOI 10.1111/j.1469-8137.2007.02261.x; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103	41	12	12	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27112	27121		10.1074/jbc.M116.751065	http://dx.doi.org/10.1074/jbc.M116.751065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27856641	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000391576300012
J	Kong, QR; Xie, BT; Zhang, H; Li, JY; Huang, TQ; Wei, RY; Liu, ZH				Kong, Qing-Ran; Xie, Bing-Teng; Zhang, Heng; Li, Jing-Yu; Huang, Tian-Qing; Wei, Ren-Yue; Liu, Zhong-Hua			RE1-silencing Transcription Factor (REST) Is Required for Nuclear Reprogramming by Inhibiting Transforming Growth Factor beta Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC-CELLS; TARGET; IDENTIFICATION; PLURIPOTENCY; HISTONE; DISEASE; MEMORY; NANOG	Differentiated cells can be reprogrammed by transcription factors, and these factors that are responsible for successful reprogramming need to be further identified. Here, we show that the neuronal repressor RE1-silencing transcription factor (REST) is rich in porcine oocytes and requires for nuclear transfer (NT)-mediated reprogramming through inhibiting TGF beta signaling pathway. REST was dramatically degraded after oocyte activation, but the residual REST was incorporated into the transferred donor nuclei during reprogramming in NT embryos. Inhibition of REST function in oocytes compromised the development of NT embryos but not that of IVF and PA embryos. Bioinformation analysis of putative targets of REST indicated that REST might function on reprogramming in NT embryos by inhibiting TGF beta pathway. Further results showed that the developmental failure of REST-inhibited NT embryos could be rescued by treatment of SB431542, an inhibitor of TGF beta pathway. Thus, REST is a newly discovered transcription factor that is required for NT-mediated nuclear reprogramming.	[Kong, Qing-Ran; Xie, Bing-Teng; Zhang, Heng; Li, Jing-Yu; Huang, Tian-Qing; Wei, Ren-Yue; Liu, Zhong-Hua] Northeast Agr Univ, Coll Life Sci, Key Lab Anim Cell & Genet Engn Heilongjiang Prov, Harbin 150030, Peoples R China	Northeast Agricultural University - China	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Key Lab Anim Cell & Genet Engn Heilongjiang Prov, Harbin 150030, Peoples R China.	liu086@126.com	Li, Jingyu/GSD-1924-2022		National Natural Science Foundation of China [31470079]; National Basic Research Program of China [2011CBA01006]; Fund for Fostering Talents in Basic Science of the National Natural Science Foundation of China [J1210069]; "Academic Backbone" Project of Northeast Agricultural University [15XG19]; Doctoral Research Foundation of Northeast Agricultural University [2009RC56, 2012RCB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fund for Fostering Talents in Basic Science of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Academic Backbone" Project of Northeast Agricultural University; Doctoral Research Foundation of Northeast Agricultural University	This work was support by National Natural Science Foundation of China Grant 31470079, National Basic Research Program of China Grant 2011CBA01006, the Fund for Fostering Talents in Basic Science of the National Natural Science Foundation of China Grant J1210069, "Academic Backbone" Project of Northeast Agricultural University Grant 15XG19, and Doctoral Research Foundation of Northeast Agricultural University Grants 2009RC56 and 2012RCB06. The authors declare that they have no conflicts of interest with the contents of this article.	Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Cao SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-4; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Gonda K, 2003, NAT CELL BIOL, V5, P205, DOI 10.1038/ncb939; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Jullien J, 2010, P NATL ACAD SCI USA, V107, P5483, DOI 10.1073/pnas.1000599107; Kagalwala MN, 2008, COLD SH Q B, V73, P227, DOI 10.1101/sqb.2008.73.042; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kong QR, 2014, J BIOL CHEM, V289, P6960, DOI 10.1074/jbc.M113.543793; Miyamoto K, 2011, P NATL ACAD SCI USA, V108, P7040, DOI 10.1073/pnas.1013634108; Negrini S, 2013, TRENDS CELL BIOL, V23, P289, DOI 10.1016/j.tcb.2013.01.006; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Papanayotou C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0539; Park Kyung-Soon, 2011, Int J Stem Cells, V4, P18; Perera A, 2015, CELL REP, V11, P283, DOI 10.1016/j.celrep.2015.03.020; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; Qureshi IA, 2010, ANN NY ACAD SCI, V1204, pE20, DOI 10.1111/j.1749-6632.2010.05718.x; Robertson EJ, 2014, SEMIN CELL DEV BIOL, V32, P73, DOI 10.1016/j.semcdb.2014.03.028; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tada M, 2003, DEV DYNAM, V227, P504, DOI 10.1002/dvdy.10337; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takaoka K, 2011, NAT CELL BIOL, V13, P743, DOI 10.1038/ncb2251; Tamada H, 2006, MOL CELL BIOL, V26, P1259, DOI 10.1128/MCB.26.4.1259-1271.2006; Tokoyoda K, 2012, CELL MOL LIFE SCI, V69, P1609, DOI 10.1007/s00018-012-0969-6; Wen DC, 2014, P NATL ACAD SCI USA, V111, P7325, DOI 10.1073/pnas.1406389111; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	36	5	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27334	27342		10.1074/jbc.M116.743849	http://dx.doi.org/10.1074/jbc.M116.743849			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27821591	Green Published, hybrid			2022-12-28	WOS:000391576300030
J	Venugopal, S; Martinez-Arguelles, DB; Chebbi, S; Hullin-Matsuda, F; Kobayashi, T; Papadopoulos, V				Venugopal, Sathvika; Martinez-Arguelles, Daniel Benjamin; Chebbi, Seimia; Hullin-Matsuda, Francoise; Kobayashi, Toshihide; Papadopoulos, Vassilios			Plasma Membrane Origin of the Steroidogenic Pool of Cholesterol Used in Hormone-induced Acute Steroid Formation in Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGOLYSIN-O; TUMOR-CELLS; ENDOSOMAL CHOLESTEROL; ENDOPLASMIC-RETICULUM; LIPID ORGANIZATION; ADRENAL-CORTEX; LIVING CELLS; TRANSPORT; TRAFFICKING; MITOCHONDRIA	Hormone-sensitive acute steroid biosynthesis requires trafficking of cholesterol from intracellular sources to the inner mitochondrial membrane. The precise location of the intracellular cholesterol and its transport mechanism are uncertain. Perfringolysin O, produced by Clostridium perfringens, binds cholesterol. Its fourth domain D4) retains cholesterol-binding properties but not cytotoxicity. We transfected steroidogenic MA-10 cells of mouse Leydig cell tumors with the mCherry-D4 plasmid. Tagged D4 with fluorescent proteins enabled us to track cholesterol. The staining was primarily localized to the inner leaflet of the plasma membrane and was partially released upon treatment with dibutyryl-cAMP Bt(2)cAMP), a cAMP analog. Inhibitors of cholesterol import into mitochondria blocked steroidogenesis and prevented release of D4 and presumably cholesterol) from the plasma membrane. We conclude that the bulk of the steroidogenic pool of cholesterol, mobilized by Bt(2)cAMP for acute steroidogenesis, originates from the plasma membrane. Treatment of the cells with steroid metabolites, 22R)-hydroxycholesterol and pregnenolone, also reduced D4 release from the plasma membrane, perhaps evidence for a feedback effect of elevated steroid formation on cholesterol release. Interestingly, D4 staining was localized to endosomes during Bt(2)cAMP stimulation suggesting that these organelles are on the route of cholesterol trafficking from the plasma membrane to mitochondria. Finally, D4 was expressed in primary rat Leydig cells with a lentivirus and was released from the plasma membrane following Bt(2)cAMP treatment. Weconclude that the plasma membrane is the source of cholesterol for steroidogenesis in these cells as well as in MA-10 cells.	[Venugopal, Sathvika; Martinez-Arguelles, Daniel Benjamin; Chebbi, Seimia; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H4A 3J1, Canada; [Venugopal, Sathvika; Martinez-Arguelles, Daniel Benjamin; Chebbi, Seimia; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [Hullin-Matsuda, Francoise; Kobayashi, Toshihide] RIKEN, Adv Sci Inst, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Hullin-Matsuda, Francoise; Kobayashi, Toshihide] Univ Lyon 1, INSA Lyon, INSERM, U1060, F-69621 Villeurbanne, France; [Kobayashi, Toshihide] Univ Strasbourg, CNRS, UMR 7213, F-67401 Illkirch Graffenstaden, France; [Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; McGill University; McGill University	Papadopoulos, V (corresponding author), Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave, Los Angeles, CA 90089 USA.	vpapadop@usc.edu	Papadopoulos, Vassilios/AAI-2613-2019; Hullin-Matsuda, Françoise/N-3880-2017; KOBAYASHI, TOSHIHIDE/S-8313-2019; Carmen, Team1/Y-7382-2019	Papadopoulos, Vassilios/0000-0002-1183-8568; Hullin-Matsuda, Françoise/0000-0002-6042-2841; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Carmen, Team1/0000-0003-4234-1746; Lab, Carmen/0000-0002-5935-3236	Le Fonds de la Recherche du Quebec-Sante	Le Fonds de la Recherche du Quebec-Sante	We thank Dr. Mario Ascoli (University of Iowa, Iowa City) for supplying the MA-10 cell line; Edward Daly and Pushwinder Kaur for their assistance with the mass spectrometry studies; and Rachel Chan and Esha Sanyal for their assistance in subcellular organelle isolations procedure. The Research Institute of McGill University Health Centre was supported by a Center Grant from Le Fonds de la Recherche du Quebec-Sante.	Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Akula N, 2012, BIOORG MED CHEM LETT, V22, P4139, DOI 10.1016/j.bmcl.2012.04.058; AOKI A, 1975, CELL TISSUE RES, V165, P49; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; BOYD GS, 1983, J STEROID BIOCHEM, V19, P1017, DOI 10.1016/0022-4731(83)90048-1; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Christian AE, 1997, J LIPID RES, V38, P2264; Cox BE, 2007, J LIPID RES, V48, P1012, DOI 10.1194/jlr.M600390-JLR200; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; de Araujo Mariana Eca Guimaraes, 2008, V424, P317, DOI 10.1007/978-1-60327-064-9_25; FREEMAN DA, 1987, J BIOL CHEM, V262, P13061; FREEMAN DA, 1989, ENDOCRINOLOGY, V124, P2527, DOI 10.1210/endo-124-5-2527; GOCZE PM, 1993, EXP CELL RES, V209, P21, DOI 10.1006/excr.1993.1279; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; HARMALA AS, 1994, BBA-LIPID LIPID MET, V1211, P317, DOI 10.1016/0005-2760(94)90156-2; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; Hughson FM, 2010, CURR OPIN CELL BIOL, V22, P454, DOI 10.1016/j.ceb.2010.03.011; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Ishitsuka R, 2011, J LIPID RES, V52, P2084, DOI 10.1194/jlr.D018184; Issop L, 2015, ENDOCRINOLOGY, V156, P334, DOI 10.1210/en.2014-1503; Issop L, 2013, MOL CELL ENDOCRINOL, V371, P34, DOI 10.1016/j.mce.2012.12.003; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Johnson BB, 2012, BIOCHEMISTRY-US, V51, P3373, DOI 10.1021/bi3003132; Kase ET, 2006, BBA-MOL CELL BIOL L, V1761, P1515, DOI 10.1016/j.bbalip.2006.09.010; Kennedy BE, 2012, J LIPID RES, V53, P2632, DOI 10.1194/jlr.M029942; KLINEFELTER GR, 1987, BIOL REPROD, V36, P769, DOI 10.1095/biolreprod36.3.769; Koziel K, 2009, INT J BIOCHEM CELL B, V41, P2440, DOI 10.1016/j.biocel.2009.07.003; Lebiedzinska M, 2009, ARCH BIOCHEM BIOPHYS, V486, P73, DOI 10.1016/j.abb.2009.03.007; Maekawa M, 2016, TOXINS, V8, DOI 10.3390/toxins8030067; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Midzak AS, 2015, PHARMACOL RES, V99, P393, DOI 10.1016/j.phrs.2015.03.023; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Nan XL, 2006, BIOPHYS J, V91, P728, DOI 10.1529/biophysj.105.074534; Ohno-Iwashita Y, 2004, ANAEROBE, V10, P125, DOI 10.1016/j.anaerobe.2003.09.003; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Porpaczy Z, 1997, EXP CELL RES, V234, P217, DOI 10.1006/excr.1997.3612; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rao RM, 2003, BIOL REPROD, V68, P114, DOI 10.1095/biolreprod.102.007518; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Shen WJ, 2012, ENDOCRINOLOGY, V153, P3249, DOI 10.1210/en.2012-1048; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; STEVENS VL, 1992, ENDOCRINOLOGY, V130, P1557, DOI 10.1210/en.130.3.1557; Suski JM, 2014, NAT PROTOC, V9, P312, DOI 10.1038/nprot.2014.016; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Wustner D, 2005, TRAFFIC, V6, P396, DOI 10.1111/j.1600-0854.2005.00285.x; Yan DG, 2008, INT REV CYTOL, V265, P253, DOI 10.1016/S0074-7696(07)65007-4; ZOLLER LC, 1975, ANAT REC, V182, P473, DOI 10.1002/ar.1091820406	66	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26109	26125		10.1074/jbc.M116.740928	http://dx.doi.org/10.1074/jbc.M116.740928			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27815506	Green Published, hybrid			2022-12-28	WOS:000390345200029
J	Kim, D; Sun, M; He, LL; Zhou, QH; Chen, J; Sun, XM; Bepler, G; Sebti, SM; Cheng, JQ				Kim, Donghwa; Sun, Mei; He, Lili; Zhou, Qing-Hua; Chen, Jun; Sun, Xia-Meng; Bepler, Gerold; Sebti, Said M.; Cheng, Jin Q.			A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation (vol 285, pg 8383, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Sun, Ellen/ABC-8094-2020	Sun, Ellen/0000-0001-7399-4075	NCI NIH HHS [P30 CA076292] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Kim D, 2010, J BIOL CHEM, V285, P8383, DOI 10.1074/jbc.M109.094060	1	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22856	22856		10.1074/jbc.A109.094060	http://dx.doi.org/10.1074/jbc.A109.094060			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825094	Green Published, hybrid			2022-12-28	WOS:000386760600055
J	Ho, O; Rogne, P; Edgren, T; Wolf-Watz, H; Login, FH; Wolf-Watz, M				Ho, Oanh; Rogne, Per; Edgren, Tomas; Wolf-Watz, Hans; Login, Frederic H.; Wolf-Watz, Magnus			Characterization of the Ruler Protein Interaction Interface on the Substrate Specificity Switch Protein in the Yersinia Type III Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gram-negative bacteria; nuclear magnetic resonance (NMR); protein conformation; secretion; type III secretion system (T3SS); YscI; YscP; YscU	NEEDLE LENGTH; BACTERIAL INJECTISOMES; SALMONELLA-TYPHIMURIUM; EXPORT APPARATUS; FLAGELLAR HOOK; YSCU; ENTEROCOLITICA; EXPRESSION; MECHANISM; COMPONENT	Many pathogenic Gram-negative bacteria use the type III secretion system (T3SS) to deliver effector proteins into eukaryotic host cells. In Yersinia, the switch to secretion of effector proteins is induced first after intimate contact between the bacterium and its eukaryotic target cell has been established, and the T3SS proteins YscP and YscU play a central role in this process. Here we identify the molecular details of the YscP binding site on YscU by means of nuclear magnetic resonance (NMR) spectroscopy. The binding interface is centered on the C-terminal domain of YscU. Disrupting the YscU-YscP interaction by introducing point mutations at the interaction interface significantly reduced the secretion of effector proteins and HeLa cell cytotoxicity. Interestingly, the binding of YscP to the slowly self-cleaving YscU variant P264A conferred significant protection against autoproteolysis. The YscP-mediated inhibition of YscU autoproteolysis suggests that the cleavage event may act as a timing switch in the regulation of early versus late T3SS substrates. We also show that YscU(C) binds to the inner rod protein YscI with a dissociation constant (K-d) of 3.8 m and with 1:1 stoichiometry. The significant similarity among different members of the YscU, YscP, and YscI families suggests that the protein-protein interactions discussed in this study are also relevant for other T3SS-containing Gram-negative bacteria.	[Ho, Oanh; Rogne, Per; Wolf-Watz, Magnus] Umea Univ, Chem Biol Ctr, Dept Chem, S-90187 Umea, Sweden; [Edgren, Tomas; Wolf-Watz, Hans; Login, Frederic H.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Edgren, Tomas; Wolf-Watz, Hans; Login, Frederic H.] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden	Umea University; Umea University; Umea University	Login, FH (corresponding author), Aarhus Univ, Dept Clin Med, Bartholins Alle 6,Bldg 1245, DK-8000 Aarhus C, Denmark.; Wolf-Watz, M (corresponding author), Umea Univ, Dept Chem, Bldg KBC,A3 Linnaeus Vag 10, S-90187 Umea, Sweden.	frederic.login@clin.au.dk; magnus.wolf-watz@umu.se		Rogne, Per/0000-0002-3687-9200	Swedish Research Council [2013-5954, 2015-02874]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council Grants 2013-5954 (to M. W.-W.) and 2015-02874 (to H. W.-W). The authors declare that they have no conflicts of interest with the contents of this article.	Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x; Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Bergeron JRC, 2016, J BIOL CHEM, V291, P1676, DOI 10.1074/jbc.M115.684423; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; Botteaux A, 2008, MOL MICROBIOL, V70, P1515, DOI 10.1111/j.1365-2958.2008.06499.x; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diepold A, 2012, MOL MICROBIOL, V85, P878, DOI 10.1111/j.1365-2958.2012.08146.x; Diepold A, 2011, MOL MICROBIOL, V82, P502, DOI 10.1111/j.1365-2958.2011.07830.x; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Feria JVM, 2015, MBIO, V6, DOI 10.1128/mBio.01459-15; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Frost S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049349; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Helgstrand M, 2000, J BIOMOL NMR, V18, P329, DOI 10.1023/A:1026729404698; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994; Lefebre MD, 2014, P NATL ACAD SCI USA, V111, P817, DOI 10.1073/pnas.1319698111; Login FH, 2015, J BIOL CHEM, V290, P26282, DOI 10.1074/jbc.M114.633677; Lountos GT, 2009, PROTEIN SCI, V18, P467, DOI 10.1002/pro.56; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Mizuno S, 2011, J MOL BIOL, V409, P558, DOI 10.1016/j.jmb.2011.04.008; Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679; PORTNOY DA, 1984, INFECT IMMUN, V43, P108, DOI 10.1128/IAI.43.1.108-114.1984; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Sal-Man N, 2012, BIOCHEM J, V442, P119, DOI 10.1042/BJ20111620; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x; Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Weise CF, 2014, BIOPHYS J, V107, P1950, DOI 10.1016/j.bpj.2014.09.005; Wiesand U, 2009, J MOL BIOL, V385, P854, DOI 10.1016/j.jmb.2008.10.034; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Yip CK, 2006, TRENDS BIOCHEM SCI, V31, P223, DOI 10.1016/j.tibs.2006.02.005; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; Zhong DL, 2012, J BIOL CHEM, V287, P25303, DOI 10.1074/jbc.M112.381574	48	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3299	3311		10.1074/jbc.M116.770255	http://dx.doi.org/10.1074/jbc.M116.770255			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28039361	Green Published, hybrid			2022-12-28	WOS:000395538800021
J	Merino, P; Diaz, A; Jeanneret, V; Wu, F; Torre, E; Cheng, LH; Yepes, M				Merino, Paola; Diaz, Ariel; Jeanneret, Valerie; Wu, Fang; Torre, Enrique; Cheng, Lihong; Yepes, Manuel			Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-2-MACROGLOBULIN RECEPTOR; GROWTH; PROTEIN; STROKE; INJURY; BRAIN; COMPLEXES; RECOVERY; SURVIVAL; MOTILITY	Axonal injury is a common cause of neurological dysfunction. Unfortunately, in contrast to axons from the peripheral nervous system, the limited capacity of regeneration of central nervous system (CNS) axons is a major obstacle for functional recovery in patients suffering neurological diseases that involve the subcortical white matter. Urokinase-type plasminogen activator (uPA) is a serine proteinase that upon binding to the urokinasetype plasminogen activator receptor (uPAR) catalyzes the conversion of plasminogen into plasmin on the cell surface. uPAR expression increases after an injury, and signaling through uPAR promotes tissue remodeling. However, it is yet unknown whether uPA binding to uPAR has an effect on axonal recovery in the CNS. Here, we used in vitro and in vivo models of CNS axonal injury to test the hypothesis that uPA binding to uPAR promotes axonal regeneration in the CNS. We found that newly formed growth cones from axons re-emerging from an axonal injury express uPAR and that binding of uPA to this uPAR promotes axonal recovery by a mechanism that does not require the generation of plasmin. Our data indicate that the binding of recombinant uPA or endogenous uPA to uPAR induces membrane recruitment and activation of beta 1 integrin via the low density lipoprotein receptor-related protein-1 ( LRP1), which leads to activation of the Rho family small GTPase Rac1 and Rac1induced axonal regeneration. Our results show that the uPA/ uPAR/LRP1 system is a potential target for the development of therapeutic strategies to promote axonal recovery following a CNS injury.	[Merino, Paola; Diaz, Ariel; Jeanneret, Valerie; Wu, Fang; Torre, Enrique; Cheng, Lihong; Yepes, Manuel] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Merino, Paola; Diaz, Ariel; Jeanneret, Valerie; Wu, Fang; Torre, Enrique; Cheng, Lihong; Yepes, Manuel] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Merino, Paola; Diaz, Ariel; Jeanneret, Valerie; Wu, Fang; Torre, Enrique; Cheng, Lihong; Yepes, Manuel] Yerkes Natl Primate Res Ctr, Div Neurosci, Atlanta, GA 30329 USA; [Yepes, Manuel] Vet Affairs Med Ctr, Dept Neurol, Atlanta, GA 30033 USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yepes, M (corresponding author), Emory Univ, Dept Neurol, Whitehead Biomed Res Bldg,615 Michael St,Ste 505J, Atlanta, GA 30322 USA.; Yepes, M (corresponding author), Emory Univ, Ctr Neurodegenerat Dis, Whitehead Biomed Res Bldg,615 Michael St,Ste 505J, Atlanta, GA 30322 USA.	myepes@emory.edu	Díaz, Ariel/ABF-7295-2020; Jeanneret, Valerie/AAY-6356-2020	Díaz, Ariel/0000-0001-5677-5751; Merino, Paola/0000-0002-5203-4507	National Institutes of Health Grants [NS-079331, NS-091201]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091201, R01NS079331] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003441] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants NS-079331 (to M. Y.) and NS-091201 (to M. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfano D, 2005, THROMB HAEMOSTASIS, V93, P205, DOI 10.1160/TH04-09-0592; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; FRIES W, 1993, BRAIN, V116, P369, DOI 10.1093/brain/116.2.369; Gaultier A, 2008, J CLIN INVEST, V118, P161, DOI 10.1172/JCI32371; GOLDBERG DJ, 1986, J CELL BIOL, V103, P1921, DOI 10.1083/jcb.103.5.1921; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hinman JD, 2014, CURR OPIN NEUROL, V27, P615, DOI 10.1097/WCO.0000000000000149; Hua ZL, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-015-0049-3; Hur EM, 2012, TRENDS NEUROSCI, V35, P164, DOI 10.1016/j.tins.2011.11.002; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Sturge J, 2003, J CELL BIOL, V162, P789, DOI 10.1083/jcb.200302124; Stys PK, 2011, TRENDS NEUROSCI, V34, P393, DOI 10.1016/j.tins.2011.06.004; Torre ER, 2010, MOL CELL NEUROSCI, V44, P135, DOI 10.1016/j.mcn.2010.03.003; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wu F, 2014, J NEUROSCI, V34, P14219, DOI 10.1523/JNEUROSCI.5309-13.2014; Wu F, 2012, J NEUROSCI, V32, P9848, DOI 10.1523/JNEUROSCI.1241-12.2012; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yoon C, 2013, J BIOL CHEM, V288, P26557, DOI 10.1074/jbc.M113.478552	41	45	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2741	2753		10.1074/jbc.M116.761650	http://dx.doi.org/10.1074/jbc.M116.761650			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	27986809	Green Published, hybrid			2022-12-28	WOS:000395535100016
J	Peck, BCE; Mah, AT; Pitman, WA; Ding, SL; Lund, PK; Sethupathy, P				Peck, Bailey C. E.; Mah, Amanda T.; Pitman, Wendy A.; Ding, Shengli; Lund, P. Kay; Sethupathy, Praveen			Functional Transcriptomics in Diverse Intestinal Epithelial Cell Types Reveals Robust MicroRNA Sensitivity in Intestinal Stem Cells to Microbial Status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUT MICROBIOTA; ENTEROENDOCRINE CELLS; EXPRESSION; MIR-375; MUCOSA; DIFFERENTIATION; PROLIFERATION; MICROFLORA; DIET; SOX9	Gut microbiota play an important role in regulating the development of the host immune system, metabolic rate, and at times, disease pathogenesis. The factors and mechanisms that mediate interactions between microbiota and the intestinal epithelium are not fully understood. We provide novel evidence that microbiota may control intestinal epithelial stem cell (IESC) proliferation in part through microRNAs (miRNAs). We demonstrate that miRNA profiles differ dramatically across functionally distinct cell types of the mouse jejunal intestinal epithelium and that miRNAs respond to microbiota in a highly cell type-specific manner. Importantly, we also show that miRNAs in IESCs are more prominently regulated by microbiota compared with miRNAs in any other intestinal epithelial cell subtype. We identify miR-375 as one miRNA that is significantly suppressed by the presence of microbiota in IESCs. Using a novel method to knockdown gene and miRNA expression ex vivo enteroids, we demonstrate that we can knock down gene expression in Lgr5(+) IESCs. Furthermore, when we knock down miR-375 in IESCs, we observe significantly increased proliferative capacity. Understanding the mechanisms by which microbiota regulate miRNA expression in IESCs and other intestinal epithelial cell subtypes will elucidate a critical molecular network that controls intestinal homeostasis and, given the heightened interest in miRNA-based therapies, may offer novel therapeutic strategies in the treatment of gastrointestinal diseases associated with altered IESC function.	[Peck, Bailey C. E.; Lund, P. Kay; Sethupathy, Praveen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Peck, Bailey C. E.; Pitman, Wendy A.; Sethupathy, Praveen] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Mah, Amanda T.; Lund, P. Kay] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Ding, Shengli; Lund, P. Kay] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Peck, BCE (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Sch Med, 5100H Genet Med Bldg CB 7264,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Sethupathy, P (corresponding author), Univ N Carolina, Dept Genet, Sch Med, 5091 Genet Med Bldg CB 7264,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	bpeck@email.unc.edu; Praveen_sethupathy@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Ariel, Pablo/AGJ-4118-2022	Peck, Bailey/0000-0002-4316-0966	National Institutes of Health [P39DK034987, P40OD010995.]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105965, F31DK105747, P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092, R25GM055336] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Eric Blue for help in developing the GF Sox9-EGFP resource, Elaine Glenny for critical assistance with the anaerobic chamber and the protocol for conventionalization, Dr. C. Lisa Kurtz, Dr. Emily Moorefield, Dr. Jeanette Baran-Gale, and Dr. Kasia Kedziora for technical assistance and training, Dr. John Rawls, Dr. Scott Magness, Dr. Susan Henning, Dr. Michael Shanahan, and Dr. Ajay Gulati for helpful discussions as well as Felicia Heyward and UNC Flow Cytometry Core Facility, the UNC Gnotobiotic Core Facility, Dr. Zhao Lai and the UTHSCSA Genome Sequencing Facility, and Dr. Bob Bagnell and the UNC Microscopy Services Laboratory for critical services. The UNC Gnotobiotic Core Facility is supported through National Institutes of Health Grants P39DK034987 and P40OD010995.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andres SF, 2013, J CELL SCI, V126, P5645, DOI 10.1242/jcs.132985; Archambaud C, 2013, MBIO, V4, DOI 10.1128/mBio.00707-13; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baran-Gale J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073240; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Camp JG, 2014, GENOME RES, V24, P1504, DOI 10.1101/gr.165845.113; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cobo ER, 2015, MUCOSAL IMMUNOL, V8, P1360, DOI 10.1038/mi.2015.27; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; El Aidy S, 2013, GUT, V62, P1306, DOI 10.1136/gutjnl-2011-301955; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; Everard A, 2014, REV ENDOCR METAB DIS, V15, P189, DOI 10.1007/s11154-014-9288-6; Fuller MK, 2012, J SURG RES, V178, P48, DOI 10.1016/j.jss.2012.03.037; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; GUENET JL, 1970, CR ACAD SCI D NAT, V270, P3087; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; ISHIKAWA K, 1986, ACTA ANAT, V127, P296; Jaladanki R. N., 2011, REGULATION GASTROINT; Knudsen LA, 2015, ENDOCRINOLOGY, V156, P3971, DOI 10.1210/en.2015-1088; Liu SR, 2016, CELL HOST MICROBE, V19, P32, DOI 10.1016/j.chom.2015.12.005; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mah AT, 2014, ENDOCRINOLOGY, V155, P3302, DOI 10.1210/en.2014-1112; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Mudge JM, 2015, MAMM GENOME, V26, P366, DOI 10.1007/s00335-015-9583-x; Nathan G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122108; Nezami BG, 2014, GASTROENTEROLOGY, V146, P473, DOI 10.1053/j.gastro.2013.10.053; Patro R., 2015, 021592 BIORXIV; Peck BCE, 2016, J BIOL CHEM, V291, P15975, DOI 10.1074/jbc.M116.733733; Pedron T, 2012, MBIO, V3, DOI 10.1128/mBio.00116-12; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Roche KC, 2015, GASTROENTEROLOGY, V149, P1553, DOI 10.1053/j.gastro.2015.07.004; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sasabe J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.125, 10.1038/nmicrobiol.2016.125]; Seiler KM, 2015, CELL TISSUE RES, V361, P427, DOI 10.1007/s00441-015-2111-1; Sharma R, 1996, EXPERIENTIA, V52, P664, DOI 10.1007/BF01925570; Siciliano V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3364; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; URIBE A, 1994, GASTROENTEROLOGY, V107, P1259, DOI 10.1016/0016-5085(94)90526-6; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Velasquez-Manoff M, 2015, NATURE, V518, pS3, DOI 10.1038/518S3a; Walker EM, 2014, DEV BIOL, V392, P283, DOI 10.1016/j.ydbio.2014.05.017; Wang DL, 2012, CIRC RES, V111, P967, DOI [10.1161/circresaha.112.266502, 10.1161/CIRCRESAHA.112.266502]; Wang Y, 2013, NUCLEIC ACIDS RES, V41, P3833, DOI 10.1093/nar/gks1460; Whissell G, 2014, NAT CELL BIOL, V16, P695, DOI 10.1038/ncb2992; Yan JW, 2014, INT J CANCER, V135, P1011, DOI 10.1002/ijc.28563; Zhang ZW, 2013, CELL PHYSIOL BIOCHEM, V32, P1808, DOI 10.1159/000356614	59	71	73	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2586	2600		10.1074/jbc.M116.770099	http://dx.doi.org/10.1074/jbc.M116.770099			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28053090	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000395535100003
J	Xiao, YT; Dai, Q; Hu, RQ; Pacheco, S; Yang, YB; Liang, GM; Soberon, M; Bravo, A; Liu, KY; Wu, KM				Xiao, Yutao; Dai, Qing; Hu, Ruqin; Pacheco, Sabino; Yang, Yongbo; Liang, Gemei; Soberon, Mario; Bravo, Alejandra; Liu, Kaiyu; Wu, Kongming			A Single Point Mutation Resulting in Cadherin Mislocalization Underpins Resistance against Bacillus thuringiensis Toxin in Cotton Bollworm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUROPEAN CORN-BORER; HELICOVERPA-ARMIGERA; BT TOXIN; INSECT RESISTANCE; ENDOPLASMIC-RETICULUM; HELIOTHIS-VIRESCENS; HUBNER LEPIDOPTERA; CRY1AC RESISTANCE; PINK-BOLLWORM; CROPS	Transgenic plants that produce Bacillus thuringiensis (Bt) crystalline (Cry) toxins are cultivated worldwide to control insect pests. Resistance to B. thuringiensis toxins threatens this technology, and although different resistance mechanisms have been identified, some have not been completely elucidated. To gain new insights into these mechanisms, we performed multiple back-crossing from a 3000-fold Cry1Ac-resistant BtR strain from cotton bollworm (Helicoverpa armigera), isolating a 516-fold Cry1Ac-resistant strain (96CAD). Cry1Ac resistance in 96CAD was tightly linked to a mutant cadherin allele (mHaCad) that contained 35 amino acid substitutions compared with HaCad from a susceptible strain (96S). We observed significantly reduced levels of the mHaCad protein on the surface of the midgut epithelium in 96CAD as compared with 96S. Expression of both cadherin alleles from 96CAD and 96S in insect cells and immunofluorescence localization in insect midgut tissue sections showed that the HaCAD protein from 96S localizes on the cell membrane, whereas the mutant 96CAD-mHaCad was retained in the endoplasmic reticulum (ER). Mapping of the mutations identified a D172G substitution mainly responsible for cadherin mislocalization. Our finding of a mutation affecting membrane receptor trafficking represents an unusual and previously unrecognized B. thuringiensis resistance mechanism.	[Xiao, Yutao; Hu, Ruqin; Liang, Gemei; Wu, Kongming] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, West Yuanmingyuan Rd, Beijing 100193, Peoples R China; [Xiao, Yutao] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen 518120, Peoples R China; [Dai, Qing; Hu, Ruqin; Yang, Yongbo; Liu, Kaiyu] Cent China Normal Univ, Coll Life Sci, 152 Luoyu Ave, Wuhan 430079, Peoples R China; [Pacheco, Sabino; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo Postal 510-3, Cuernavaca 62250, Morelos, Mexico	Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Central China Normal University; Universidad Nacional Autonoma de Mexico	Wu, KM (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, West Yuanmingyuan Rd, Beijing 100193, Peoples R China.; Liu, KY (corresponding author), Cent China Normal Univ, Coll Life Sci, 152 Luoyu Ave, Wuhan 430079, Peoples R China.	liukaiyu@mail.ccnu.edu.cn; wukongming@caas.cn	Pacheco, Sabino/AFJ-9017-2022; de la Parra, Maria Alejandra Bravo/R-6740-2017	Bravo, Alejandra/0000-0002-7573-7475; wu, kongming/0000-0003-2499-1032; Pacheco, Sabino/0000-0002-0208-0046	National Natural Science Foundation [31321004, 31601646]; Key Project for Breeding Genetic Modified Organisms Grant [2016ZX0812-004]; PAPIIT-UNAM [IA202616]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Project for Breeding Genetic Modified Organisms Grant; PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by National Natural Science Foundation Grants 31321004 and 31601646, Key Project for Breeding Genetic Modified Organisms Grant 2016ZX0812-004, and PAPIIT-UNAM Grant IA202616. M.S. and A.B. are coauthors of a patent on modified B. thuringiensis toxins, "Suppression of resistance in insects to Bacillus thuringiensis Cry toxins, using toxins that do not require the cadherin receptor" (patent numbers CA2690188A1, CN101730712A, EP2184293A2, EP2184293A4, EP2184293B1, WO2008150150A2, and WO2008150150A3).	Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Cao GC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05629; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Castagnola A, 2011, DIFFERENTIATION, V81, P192, DOI 10.1016/j.diff.2010.12.001; Chen WC, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/462929; CICCARELLI E, 1993, EUR J BIOCHEM, V213, P271, DOI 10.1111/j.1432-1033.1993.tb17759.x; Console L, 2015, BBA-MOL CELL RES, V1853, P1636, DOI 10.1016/j.bbamcr.2015.03.017; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Dalecky A, 2006, PLOS BIOL, V4, P1048, DOI 10.1371/journal.pbio.0040181; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; FIELD MC, 1994, J BIOL CHEM, V269, P10830; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Guo Z.-W., 2015, DATABASE, V2015, P1, DOI DOI 10.1371/J0URNAL.PGEN.1005124; Guo ZJ, 2015, INSECT BIOCHEM MOLEC, V59, P30, DOI 10.1016/j.ibmb.2015.01.009; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Kaniakova M, 2012, J NEUROCHEM, V123, P385, DOI 10.1111/jnc.12002; Khajuria C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-286; Kilisch M, 2015, PFLUG ARCH EUR J PHY, V467, P1105, DOI 10.1007/s00424-014-1672-2; LANKFORD SP, 1993, J BIOL CHEM, V268, P4814; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liang GeMei, 1999, Plant Protection, V25, P15; Liu CX, 2009, J INSECT PHYSIOL, V55, P686, DOI 10.1016/j.jinsphys.2009.05.001; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rabiau N, 2009, IN VIVO, V23, P203; Ray-Sinha A, 2009, MOL MEMBR BIOL, V26, P448, DOI 10.3109/09687680903333839; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Siqueira HAA, 2006, APPL ENVIRON MICROB, V72, P5318, DOI 10.1128/AEM.00219-06; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; Tay WT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005534; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Xu P, 2016, CYTOTECHNOLOGY, V68, P481, DOI 10.1007/s10616-014-9801-5; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhang HN, 2013, PESTIC BIOCHEM PHYS, V107, P148, DOI 10.1016/j.pestbp.2013.06.007; Zhang HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053418; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	50	30	36	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2933	2943		10.1074/jbc.M116.768671	http://dx.doi.org/10.1074/jbc.M116.768671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28082675	Green Published, hybrid			2022-12-28	WOS:000395535100033
J	Bischler, T; Hsieh, PK; Resch, M; Liu, QS; Tan, HS; Foley, PL; Hartleib, A; Sharma, CM; Belasco, JG				Bischler, Thorsten; Hsieh, Ping-kun; Resch, Marcus; Liu, Quansheng; Tan, Hock Siew; Foley, Patricia L.; Hartleib, Anika; Sharma, Cynthia M.; Belasco, Joel G.			Identification of the RNA Pyrophosphohydrolase RppH of Helicobacter pylori and Global Analysis of Its RNA Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; Helicobacter pylori; RNA degradation; RNA modification; RNA turnover; RNA-protein interaction; Nudix; deep sequencing	MESSENGER-RNA; ESCHERICHIA-COLI; NUDIX HYDROLASE; CHEMOTAXIS RECEPTOR; DEGRADATION; ENZYME; PROTEIN; SPECIFICITY; SEQUENCE; SEQ	RNA degradation is crucial for regulating gene expression in all organisms. Like the decapping of eukaryotic mRNAs, the conversion of the 5'-terminal triphosphate of bacterial transcripts to a monophosphate can trigger RNA decay by exposing the transcript to attack by 5'-monophosphate-dependent ribonucleases. In both biological realms, this deprotection step is catalyzed by members of the Nudix hydrolase family. The genome of the gastric pathogen Helicobacter pylori, a Gram-negative epsilonproteobacterium, encodes two proteins resembling Nudix enzymes. Here we present evidence that one of them, HP1228 (renamed HpRppH), is an RNA pyrophosphohydrolase that triggers RNA degradation in H. pylori, whereas the other, HP0507, lacks such activity. In vitro, HpRppH converts RNA 5'-triphosphates and diphosphates to monophosphates. It requires at least two unpaired nucleotides at the 5' end of its substrates and prefers three or more but has only modest sequence preferences. The influence of HpRppH on RNA degradation in vivo was examined by using RNA-seq to search the H. pylori transcriptome for RNAs whose 5'-phosphorylation state and cellular concentration are governed by this enzyme. Analysis of cDNA libraries specific for transcripts bearing a 5'-triphosphate and/or monophosphate revealed at least 63 potential HpRppH targets. These included mRNAs and sRNAs, several of which were validated individually by half-life measurements and quantification of their 5'-terminal phosphorylation state in wild-type and mutant cells. These findings demonstrate an important role for RppH in post-transcriptional gene regulation in pathogenic Epsilonproteobacteria and suggest a possible basis for the phenotypes of H. pylori mutants lacking this enzyme.	[Bischler, Thorsten; Resch, Marcus; Hartleib, Anika; Sharma, Cynthia M.] Univ Wurzburg, Res Ctr Infect Dis, Josef Schneider Str 2-D15, D-97080 Wurzburg, Germany; [Bischler, Thorsten; Resch, Marcus; Tan, Hock Siew; Hartleib, Anika; Sharma, Cynthia M.] Univ Wurzburg, Inst Mol Infect Biol, Josef Schneider Str 2-D15, D-97080 Wurzburg, Germany; [Hsieh, Ping-kun; Liu, Quansheng; Foley, Patricia L.; Belasco, Joel G.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Hsieh, Ping-kun; Liu, Quansheng; Foley, Patricia L.; Belasco, Joel G.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	University of Wurzburg; University of Wurzburg; New York University; New York University	Sharma, CM (corresponding author), Univ Wurzburg, Inst Mol Infect Biol, Josef Schneider Str 2-D15, D-97080 Wurzburg, Germany.; Belasco, JG (corresponding author), NYU, Sch Med, Skirball Inst, 540 First Ave, New York, NY 10016 USA.	cynthia.sharma@uni-wuerzburg.de; joel.belasco@med.nyu.edu	Sharma, Cynthia/D-2869-2013; Siew, Tan Hock/AAM-6779-2020	Siew, Tan Hock/0000-0003-0794-6782; Sharma, Cynthia Mira/0000-0002-2321-9705; Bischler, Thorsten/0000-0001-9288-9481	Young Investigator Program at the Research Center for Infectious Diseases in Wurzburg, Germany; Bavarian Research Network for Molecular Biosystems (BioSysNet); German Research Association (DFG) [Sh580/1-1]; National Institutes of Health [5R01GM035769, 5R01GM112940]; National Institutes of Health Fellowship [T32AI007180]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035769, R01GM112940] Funding Source: NIH RePORTER	Young Investigator Program at the Research Center for Infectious Diseases in Wurzburg, Germany; Bavarian Research Network for Molecular Biosystems (BioSysNet); German Research Association (DFG)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the Sharma laboratory was supported by the Young Investigator Program at the Research Center for Infectious Diseases in Wurzburg, Germany; the Bavarian Research Network for Molecular Biosystems (BioSysNet); and DFG project Sh580/1-1 of the German Research Association (DFG). Research in the Belasco laboratory was supported by National Institutes of Health Grants 5R01GM035769 and 5R01GM112940 (to J.G.B.) and National Institutes of Health Fellowship T32AI007180 (to P.L.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], PYMOL MOL GRAPH SYST; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bischler T, 2015, METHODS, V86, P89, DOI 10.1016/j.ymeth.2015.06.012; Boneca IG, 2003, NUCLEIC ACIDS RES, V31, P1704, DOI 10.1093/nar/gkg250; Boneca IG, 2008, APPL ENVIRON MICROB, V74, P2095, DOI 10.1128/AEM.01348-07; Bonnin RA, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/395753; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cartwright JL, 2000, J BIOL CHEM, V275, P32925, DOI 10.1074/jbc.M005015200; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Celesnik H, 2008, METHOD ENZYMOL, V447, P83, DOI 10.1016/S0076-6879(08)02205-2; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Croxen MA, 2006, J BACTERIOL, V188, P2656, DOI 10.1128/JB.188.7.2656-2665.2006; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Forstner KU, 2014, BIOINFORMATICS, V30, P3421, DOI 10.1093/bioinformatics/btu533; Foley PL, 2015, J BIOL CHEM, V290, P9478, DOI 10.1074/jbc.M114.634659; Fulton DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-270; Gabelli SB, 2007, STRUCTURE, V15, P1014, DOI 10.1016/j.str.2007.06.018; Gabelli SB, 2002, BIOCHEMISTRY-US, V41, P9279, DOI 10.1021/bi0259296; Goodwin A, 1998, MOL MICROBIOL, V28, P383, DOI 10.1046/j.1365-2958.1998.00806.x; Guo BP, 2002, P NATL ACAD SCI USA, V99, P8354, DOI 10.1073/pnas.122244899; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hsieh PK, 2013, P NATL ACAD SCI USA, V110, P8864, DOI 10.1073/pnas.1222670110; Hui MP, 2014, ANNU REV GENET, V48, P537, DOI 10.1146/annurev-genet-120213-092340; Kaberdin VR, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-23; Kang LW, 2003, STRUCTURE, V11, P1015, DOI 10.1016/S0969-2126(03)00154-0; Kim D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002867; Liechti G, 2012, J BACTERIOL, V194, P839, DOI 10.1128/JB.05757-11; Liu H, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00013; Luciano DJ, 2012, J BACTERIOL, V194, P6233, DOI 10.1128/JB.01223-12; Lundin A, 2003, J BIOL CHEM, V278, P12574, DOI 10.1074/jbc.M212542200; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Mathy N, 2010, MOL MICROBIOL, V75, P489, DOI 10.1111/j.1365-2958.2009.07004.x; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Pernitzsch SR, 2014, P NATL ACAD SCI USA, V111, pE501, DOI 10.1073/pnas.1315152111; Piton J, 2013, P NATL ACAD SCI USA, V110, P8858, DOI 10.1073/pnas.1221510110; Redko Y, 2016, RNA BIOL, V13, P243, DOI 10.1080/15476286.2015.1132141; Redko Y, 2013, NUCLEIC ACIDS RES, V41, P288, DOI 10.1093/nar/gks945; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Sharma CM, 2014, CURR OPIN MICROBIOL, V19, P97, DOI 10.1016/j.mib.2014.06.010; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; Spickler C, 2001, J BACTERIOL, V183, P1106, DOI 10.1128/JB.183.3.1106-1109.2001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; van Amsterdam K, 2006, FEMS MICROBIOL REV, V30, P131, DOI 10.1111/j.1574-6976.2005.00006.x; Vasilyev N, 2015, J BIOL CHEM, V290, P9487, DOI 10.1074/jbc.M114.634824; Yagi T, 2003, BIOCHEM J, V370, P409, DOI 10.1042/BJ20021140	58	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1934	1950		10.1074/jbc.M116.761171	http://dx.doi.org/10.1074/jbc.M116.761171			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27974459	hybrid, Green Published			2022-12-28	WOS:000395515600032
J	Goldberg, AA; Nkengfac, B; Sanchez, AMJ; Moroz, N; Qureshi, ST; Koromilas, AE; Wang, S; Burelle, Y; Hussain, SN; Kristof, AS				Goldberg, Alexander A.; Nkengfac, Bernard; Sanchez, Anthony M. J.; Moroz, Nikolay; Qureshi, Salman T.; Koromilas, Antonis E.; Wang, Shuo; Burelle, Yan; Hussain, Sabah N.; Kristof, Arnold S.			Regulation of ULK1 Expression and Autophagy by STAT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; autophagy; mammalian target of rapamycin (mTOR); proteolysis; signal transducers and activators of transcription 1 (STAT1)	TRANSCRIPTION FACTORS; DEACETYLASE ACTIVITY; SIGNAL-TRANSDUCTION; MAMMALIAN TARGET; GENE-EXPRESSION; INTERFERON; MTOR; PATHWAYS; GAMMA; ACETYLATION	Autophagy involves the lysosomal degradation of cytoplasmic contents for regeneration of anabolic substrates during nutritional or inflammatory stress. Its initiation occurs rapidly after inactivation of the protein kinase mammalian target of rapamycin (mTOR) (or mechanistic target of rapamycin), leading to dephosphorylation of Unc-51-like kinase 1 (ULK1) and autophagosome formation. Recent studies indicate that mTOR can, in parallel, regulate the activity of stress transcription factors, including signal transducer and activator of transcription-1 (STAT1). The current study addresses the role of STAT1 as a transcriptional suppressor of autophagy genes and autophagic activity. We show that STAT1-deficient human fibrosarcoma cells exhibited enhanced autophagic flux as well as its induction by pharmacological inhibition of mTOR. Consistent with enhanced autophagy initiation, ULK1 mRNA and protein levels were increased in STAT1-deficient cells. By chromatin immunoprecipitation, STAT1 bound a putative regulatory sequence in the ULK1 5-flanking region, the mutation of which increased ULK1 promoter activity, and rendered it unresponsive to mTOR inhibition. Consistent with an anti-apoptotic effect of autophagy, rapamycin-induced apoptosis and cytotoxicity were blocked in STAT1-deficient cells but restored in cells simultaneously exposed to the autophagy inhibitor ammonium chloride. In vivo, skeletal muscle ULK1 mRNA and protein levels as well as autophagic flux were significantly enhanced in STAT1-deficient mice. These results demonstrate a novel mechanism by which STAT1 negatively regulates ULK1 expression and autophagy.	[Goldberg, Alexander A.; Nkengfac, Bernard; Sanchez, Anthony M. J.; Moroz, Nikolay; Qureshi, Salman T.; Hussain, Sabah N.; Kristof, Arnold S.] McGill Univ, Ctr Hlth, Dept Crit Care, Montreal, PQ H4A 3J1, Canada; [Goldberg, Alexander A.; Nkengfac, Bernard; Sanchez, Anthony M. J.; Moroz, Nikolay; Qureshi, Salman T.; Hussain, Sabah N.; Kristof, Arnold S.] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H4A 3J1, Canada; [Goldberg, Alexander A.; Nkengfac, Bernard; Sanchez, Anthony M. J.; Moroz, Nikolay; Qureshi, Salman T.; Hussain, Sabah N.; Kristof, Arnold S.] McGill Univ, Meakins Christie Labs, Montreal, PQ H4A 3J1, Canada; [Koromilas, Antonis E.; Wang, Shuo] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Burelle, Yan] Univ Montreal, Fac Pharm, Montreal, PQ H3T 1J4, Canada	McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Universite de Montreal	Kristof, AS (corresponding author), McGill Univ, Ctr Hlth, Res Inst, 1001 Decarie Blvd,EM3-2219, Montreal, PQ H4A 3J1, Canada.	arnold.kristof@mcgill.ca	Burelle, Yan/AAF-8104-2021; Hussain, Sabah/ABC-5315-2021; Sanchez, Anthony MJ/N-8092-2019	Burelle, Yan/0000-0001-9379-146X; Sanchez, Anthony MJ/0000-0003-3054-6349; , Alexander/0000-0002-7471-8598	NCI; National Institutes of Health Grant [R01CA125436-01A1]; Canada Research Chairs [950-213853]; Fonds de Recherche du Quebec-Sante [31052]; Canadian Institutes of Health Research; Meakins Christie Post-doctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA125436] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chairs(Canada Research ChairsCGIAR); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Meakins Christie Post-doctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grant R01CA125436-01A1 (to A. S. K.). This work was also supported by Canada Research Chairs (950-213853; to A. S. K.), Fonds de Recherche du Quebec-Sante (31052; to A. S. K.), Canadian Institutes of Health Research (to S. N. H., S. T. Q., and Y. B.), and a Meakins Christie Post-doctoral Fellowship (to B. N. and A. M. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Bin L, 2008, TRENDS PHARMACOL SCI, V29, P505, DOI 10.1016/j.tips.2008.07.008; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Culig Zoran, 2013, Front Biosci (Schol Ed), V5, P277; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fielhaber J. A., 2010, AM J RESP CRIT CARE, V181, pA3542; Fielhaber JA, 2012, J BIOL CHEM, V287, P14325, DOI 10.1074/jbc.M111.246785; Fielhaber JA, 2009, J BIOL CHEM, V284, P24341, DOI 10.1074/jbc.M109.033530; Hoefer J, 2012, AM J PATHOL, V180, P2097, DOI 10.1016/j.ajpath.2012.01.026; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klampfer L, 2004, J BIOL CHEM, V279, P30358, DOI 10.1074/jbc.M401359200; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Kusama Y, 2009, APOPTOSIS, V14, P1165, DOI 10.1007/s10495-009-0390-2; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McCormick J, 2012, J CELL MOL MED, V16, P386, DOI 10.1111/j.1582-4934.2011.01323.x; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mofarrahi M, 2013, AUTOPHAGY, V9, P1604, DOI 10.4161/auto.25955; Mofarrahi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047265; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Pitroda SP, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-68; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Saleiro D, 2015, CELL REP, V11, P605, DOI 10.1016/j.celrep.2015.03.056; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Sibinga NES, 1999, J BIOL CHEM, V274, P12139, DOI 10.1074/jbc.274.17.12139; Srinivasan P, 2011, IMMUNOLOGY, V132, P209, DOI 10.1111/j.1365-2567.2010.03355.x; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhu S, 2013, AUTOPHAGY, V9, P317, DOI 10.4161/auto.22923; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	55	17	19	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1899	1909		10.1074/jbc.M116.771584	http://dx.doi.org/10.1074/jbc.M116.771584			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28011640	hybrid, Green Published			2022-12-28	WOS:000395515600029
J	Miller, WP; Ravi, S; Martin, TD; Kimball, SR; Dennis, MD				Miller, William P.; Ravi, Suhana; Martin, Tony D.; Kimball, Scot R.; Dennis, Michael D.			Activation of the Stress Response Kinase JNK (c-Jun N-terminal Kinase) Attenuates Insulin Action in Retina through a p70S6K1-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal kinase (JNK); insulin resistance; mammalian target of rapamycin (mTOR); retina; Type 2 diabetes; insulin action; retinopathy	HIGH-FAT-DIET; DIABETIC-RETINOPATHY; PROTEIN-KINASE; S6 KINASE; AUTOINHIBITORY DOMAIN; NH2-TERMINAL KINASE; MTOR COMPLEX; PHOSPHORYLATION; RESISTANCE; GROWTH	Despite recent advances in therapeutics, diabetic retinopathy remains a leading cause of vision impairment. Improvement in the treatment of diabetic retinopathy requires a better understanding of the molecular mechanisms that cause neurovascular complications, particularly in type 2 diabetes. Recent studies demonstrate that rodents fed a high fat diet exhibit retinal dysfunction concomitant with attenuated Akt phosphorylation. The purpose of the present study was to evaluate the impact of a high fat/high sucrose diet on retinal insulin signaling and evaluate the mechanism(s) responsible for the changes. Mice fed a high fat/sucrose diet exhibited attenuated Akt phosphorylation in the retina as compared with mice fed normal chow. Retinas of mice fed a high fat/sucrose diet also exhibited elevated levels of activated JNK as well as enhanced p70S6K1 autoinhibitory domain phosphorylation. In cells, JNK activation enhanced p70S6K1 phosphorylation and mTORC1-dependent activation of the kinase, as evidenced by enhanced phosphorylation of key substrates. Rictor phosphorylation by p70S6K1 was specifically enhanced by the addition of phosphomimetic mutations in the autoinhibitory domain and was more sensitive to inhibition of the kinase as compared with rpS6. Notably, rictor and IRS-1 phosphorylation by p70S6K1 attenuate insulin action through a negative feedback pathway. Indeed, p70S6K1 inhibition prevented the repressive effect of JNK activation on insulin action in retinas. Overall, the results identify the JNK/S6K1 axis as a key molecular mechanism whereby a high fat/sucrose diet impairs insulin action in retina.	[Miller, William P.; Ravi, Suhana; Martin, Tony D.; Kimball, Scot R.; Dennis, Michael D.] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, H166,500 Univ Dr, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Dennis, MD (corresponding author), Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, H166,500 Univ Dr, Hershey, PA 17033 USA.	mdennis@psu.edu		Dennis, Michael/0000-0002-0645-6864; MILLER, WILLIAM PHILLIP/0000-0003-0157-6389	National Institutes of Health [EY023612, DK13499]; American Diabetes Association Pathway to Stop Diabetes [1-14-INI-04]; NATIONAL EYE INSTITUTE [K99EY023612, R00EY023612, R01EY029702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Pathway to Stop Diabetes; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY023612 (to M. D. D.) and DK13499 (to S. R. K.). This work was also supported by The American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-04. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Chang RCA, 2015, INVEST OPHTH VIS SCI, V56, P2367, DOI 10.1167/iovs.14-16143; Dennis MD, 2015, J BIOL CHEM, V290, P3865, DOI 10.1074/jbc.M114.623058; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; Hannan KM, 2003, BIOCHEM J, V370, P469, DOI 10.1042/BJ20021709; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hiratani K, 2005, BIOCHEM BIOPH RES CO, V335, P836, DOI 10.1016/j.bbrc.2005.07.152; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hong Z, 2016, MOL CELL BIOCHEM, V419, P1, DOI 10.1007/s11010-016-2722-1; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kwak D, 2012, J BIOL CHEM, V287, P18398, DOI 10.1074/jbc.M111.326538; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Liu XB, 2008, DIABETES, V57, P1651, DOI 10.2337/db07-1761; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mancini JE, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-14; Marcal AC, 2013, CELL BIOCHEM FUNCT, V31, P65, DOI 10.1002/cbf.2861; Martin TD, 2014, AM J PHYSIOL-ENDOC M, V306, pE1397, DOI 10.1152/ajpendo.00064.2014; Miller WP, 2016, INVEST OPHTH VIS SCI, V57, P1327, DOI 10.1167/iovs.15-18719; Parillo M, 2004, BRIT J NUTR, V92, P7, DOI 10.1079/BJN20041117; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Poulaki V, 2004, AM J PATHOL, V165, P457, DOI 10.1016/S0002-9440(10)63311-1; PRICE DJ, 1991, J BIOL CHEM, V266, P16281; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rajagopal R, 2016, DIABETES, V65, P1072, DOI 10.2337/db15-1255; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; Reiter CEN, 2003, PROG RETIN EYE RES, V22, P545, DOI 10.1016/S1350-9462(03)00035-1; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Su KH, 2016, NAT CELL BIOL, V18, P527, DOI 10.1038/ncb3335; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; U.S. Department of Health and Human Service, 2014, NAT DIAB STAT REP, P9; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; Zhang J, 2013, BBA-MOL BASIS DIS, V1832, P1980, DOI 10.1016/j.bbadis.2013.06.013; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	48	17	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1591	1602		10.1074/jbc.M116.760868	http://dx.doi.org/10.1074/jbc.M116.760868			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27965359	hybrid, Green Published			2022-12-28	WOS:000395515600005
J	Ishii, T; Ueyama, T; Shigyo, M; Kohta, M; Kondoh, T; Kuboyama, T; Uebi, T; Hamada, T; Gutmann, DH; Aiba, A; Kohmura, E; Tohda, C; Saito, N				Ishii, Taiji; Ueyama, Takehiko; Shigyo, Michiko; Kohta, Masaaki; Kondoh, Takeshi; Kuboyama, Tomoharu; Uebi, Tatsuya; Hamada, Takeshi; Gutmann, David H.; Aiba, Atsu; Kohmura, Eiji; Tohda, Chihiro; Saito, Naoaki			A Novel Rac1-GSPT1 Signaling Pathway Controls Astrogliosis Following Central Nervous System Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; CELL-CYCLE ARREST; NADPH OXIDASE; RAC1 ACTIVITY; CANCER-CELLS; BRAIN-INJURY; IN-VIVO; REACTIVE ASTROGLIOSIS; ISCHEMIA-REPERFUSION; COMPLEX-FORMATION	Astrogliosis (i.e. glial scar), which is comprised primarily of proliferated astrocytes at the lesion site and migrated astrocytes from neighboring regions, is one of the key reactions in determining outcomes after CNS injury. In an effort to identify potential molecules/pathways that regulate astrogliosis, we sought to determine whether Rac/Rac-mediated signaling in astrocytes represents a novel candidate for therapeutic intervention following CNS injury. For these studies, we generated mice with Rac1 deletion under the control of the GFAP (glial fibrillary acidic protein) promoter (GFAP-Cre; Rac1(flox/flox)). GFAP-Cre; Rac1(flox/flox) (Rac1-KO) mice exhibited better recovery after spinal cord injury and exhibited reduced astrogliosis at the lesion site relative to control. Reduced astrogliosis was also observed in Rac1-KO mice following microbeam irradiation-induced injury. Moreover, knockdown (KD) or KO of Rac1 in astrocytes (LN229 cells, primary astrocytes, or primary astrocytes from Rac1-KO mice) led to delayed cell cycle progression and reduced cell migration. Rac1-KD or Rac1-KO astrocytes additionally had decreased levels of GSPT1 (G1 to S phase transition 1) expression and reduced responses of IL-1 beta and GSPT1 to LPS treatment, indicating that IL-1 beta and GSPT1 are downstream molecules of Rac1 associated with inflammatory condition. Furthermore, GSPT1-KD astrocytes had cell cycle delay, with no effect on cell migration. The cell cycle delay induced by Rac1-KD was rescued by overexpression of GSPT1. Based on these results, we propose that Rac1-GSPT1 represents a novel signaling axis in astrocytes that accelerates proliferation in response to inflammation, which is one important factor in the development of astrogliosis/glial scar following CNS injury.	[Ishii, Taiji; Ueyama, Takehiko; Uebi, Tatsuya; Hamada, Takeshi; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan; [Shigyo, Michiko; Kuboyama, Tomoharu; Tohda, Chihiro] Toyama Univ, Inst Nat Med, Dept Biosci, Div Neuromed Sci, Toyama 9300194, Japan; [Kohta, Masaaki; Kondoh, Takeshi; Kohmura, Eiji] Kobe Univ, Grad Sch Med, Dept Neurosurg, Kobe, Hyogo 6500017, Japan; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Aiba, Atsu] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Anim Resources, Tokyo 1130033, Japan	Kobe University; University of Toyama; Kobe University; Washington University (WUSTL); University of Tokyo	Ueyama, T; Saito, N (corresponding author), 1-1 Rokkodai Cho,Nada Ku, Kobe, Hyogo 6578501, Japan.	tueyama@kobe-u.ac.jp; naosaito@kobe-u.ac.jp	SHIGYO, MICHIKO/W-8435-2019; Kuboyama, Tomoharu/S-2639-2016	SHIGYO, MICHIKO/0000-0002-8523-9867; Kuboyama, Tomoharu/0000-0003-3037-9974; Aiba, Atsu/0000-0002-8192-0778; Kohta, Masaaki/0000-0001-5936-7163; Gutmann, David/0000-0002-3127-5045	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [26460340, 25861276, 26670044, 25293060]; Suzuken Memorial Foundation [09-048]; Institute of Natural Medicine, University of Toyama	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation; Institute of Natural Medicine, University of Toyama	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 26460340 (to T. Ueyama), 25861276 (to M. K.), 26670044 (to C. T.), and 25293060 (to N. S.), by the Suzuken Memorial Foundation (Grant 09-048 to T. Ueyama), and by a Grant-in Aid for the Cooperative Research Project from Institute of Natural Medicine, University of Toyama in 2015 and 2016 (to T. Ueyama). The authors declare that they have no conflicts of interest with the contents of this article.	Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015; Carrizzo A, 2014, CURR DRUG TARGETS, V15, P1231, DOI 10.2174/1389450115666141027110156; Chauvin C, 2005, MOL CELL BIOL, V25, P5801, DOI 10.1128/MCB.25.14.5801-5811.2005; Chauvin C, 2007, MOL CELL BIOL, V27, P5619, DOI 10.1128/MCB.00035-07; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Cooney SJ, 2014, FREE RADICAL RES, V48, P929, DOI 10.3109/10715762.2014.927578; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Davies T, 2012, J CELL BIOL, V198, P769, DOI 10.1083/jcb.201207197; Denes A, 2013, DIS MODEL MECH, V6, P1043, DOI 10.1242/dmm.011601; Fujita Y, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00338; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kassai H, 2008, EUR J NEUROSCI, V28, P257, DOI 10.1111/j.1460-9568.2008.06343.x; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; KIKUCHI Y, 1988, EMBO J, V7, P1175, DOI 10.1002/j.1460-2075.1988.tb02928.x; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Litchfield K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9690; Liu LN, 2014, ONCOL REP, V32, P1395, DOI 10.3892/or.2014.3388; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Nair S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-173; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nariyama N, 2009, APPL RADIAT ISOTOPES, V67, P155, DOI 10.1016/j.apradiso.2008.08.002; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ovcharenko D, 2005, RNA, V11, P985, DOI 10.1261/rna.7288405; Ozaki M, 2000, FASEB J, V14, P418, DOI 10.1096/fasebj.14.2.418; Pedersen E, 2012, J CELL SCI, V125, P5379, DOI 10.1242/jcs.107011; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shirafuji T, 2014, J NEUROSCI, V34, P9268, DOI 10.1523/JNEUROSCI.4278-13.2014; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Talukder MAH, 2013, AM J PHYSIOL-HEART C, V304, pH294, DOI 10.1152/ajpheart.00367.2012; Teshigawara K, 2013, BRIT J PHARMACOL, V168, P903, DOI 10.1111/j.1476-5381.2012.02211.x; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Ueyama T, 2001, J NEUROCHEM, V79, P903, DOI 10.1046/j.1471-4159.2001.00624.x; Ueyama T, 2016, EMBO MOL MED, V8, P1310, DOI 10.15252/emmm.201606609; Uyama A, 2011, J SYNCHROTRON RADIAT, V18, P671, DOI 10.1107/S090904951101185X; Wang SJ, 2012, J CELL BIOL, V199, P331, DOI 10.1083/jcb.201202041; Xiao RL, 2015, BIOMED PHARMACOTHER, V74, P138, DOI 10.1016/j.biopha.2015.08.006; Yoshida T, 2010, MOL CANCER THER, V9, P1657, DOI 10.1158/1535-7163.MCT-09-0906; Yukinaga H, 2014, J CELL SCI, V127, P1805, DOI 10.1242/jcs.139733; Zhang L, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/5026984	58	20	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1240	1250		10.1074/jbc.M116.748871	http://dx.doi.org/10.1074/jbc.M116.748871			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27941025	hybrid, Green Published			2022-12-28	WOS:000393339800009
J	Siddiqui, S; Schwarz, F; Springer, S; Khedri, Z; Yu, H; Deng, LQ; Verhagen, A; Naito-Matsui, Y; Jiang, WP; Kim, D; Zhou, J; Ding, BB; Chen, X; Varki, N; Varki, A				Siddiqui, Shoib; Schwarz, Flavio; Springer, Stevan; Khedri, Zahra; Yu, Hai; Deng, Lingquan; Verhagen, Andrea; Naito-Matsui, Yuko; Jiang, Weiping; Kim, Daniel; Zhou, Jie; Ding, Beibei; Chen, Xi; Varki, Nissi; Varki, Ajit			Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MSIGLEC-E; PROTEIN; CELLS; NEUTROPHIL; ROLES; CD22; RECOGNITION; ENGAGEMENT; RECEPTOR; LECTIN	CD33-related Siglecs are a family of proteins widely expressed on innate immune cells. Binding of sialylated glycans or other ligands triggers signals that inhibit or activate inflammation. Immunomodulation by Siglecs has been extensively studied, but relationships between structure and functions are poorly explored. Here we present new data relating to the structure and function of Siglec-E, the major CD33-related Siglec expressed on mouse neutrophils, monocytes, macrophages, and dendritic cells. Wegenerated nine new rat monoclonal antibodies specific to mouse Siglec-E, with no cross-reactivity to Siglec-F. Although all antibodies detected Siglec-E on transfected human HEK293T cells, only two reacted with mouse bone marrow neutrophils by flow cytometry and on spleen sections by immunohistochemistry. Moreover, whereas all antibodies recognized Siglec-E-Fc on immunoblots, binding was dependent on intact disulfide bonds and N-glycans, and only two antibodies recognized native Siglec-E within spleen lysates. Thus, we further investigated the impact of Siglec-E homodimerization. Homology-based structural modeling predicted a cysteine residue (Cys-298) in position to form a disulfide bridge between two Siglec-E polypeptides. Mutagenesis of Cys-298 confirmed its role in dimerization. In keeping with the high level of 9-O-acetylation found in mice, sialoglycan array studies indicate that this modification has complex effects on recognition by Siglec-E, in relationship to the underlying structures. However, we found no differences in phosphorylation or SHP-1 recruitment between dimeric and monomeric Siglec-E expressed on HEK293A cells. Phylogenomic analyses predicted that only some human and mouse Siglecs form disulfide-linked dimers. Notably, Siglec-9,	[Siddiqui, Shoib; Schwarz, Flavio; Springer, Stevan; Khedri, Zahra; Deng, Lingquan; Verhagen, Andrea; Naito-Matsui, Yuko; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Med, GRTC, La Jolla, CA 92093 USA; [Siddiqui, Shoib; Schwarz, Flavio; Springer, Stevan; Khedri, Zahra; Deng, Lingquan; Verhagen, Andrea; Naito-Matsui, Yuko; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, GRTC, La Jolla, CA 92093 USA; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Jiang, Weiping; Kim, Daniel; Zhou, Jie; Ding, Beibei] BioLegend Inc, San Diego, CA 92121 USA; [Schwarz, Flavio] DE Res & Technol Ctr, 200 Gbc Dr, Newark, DE 19702 USA; [Deng, Lingquan] GlycoMimetics Inc, 9708 Med Ctr Dr, Rockville, MD 20850 USA; [Naito-Matsui, Yuko] Kobe Pharmaceut Univ, Higashinada Ku, 4-19-1 Motoyamakita, Kobe, Hyogo 6588558, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; Kobe Pharmaceutical University	Varki, A (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	chen, xi/GXH-3653-2022; Chen, Xi/H-1811-2018; Siddiqui, Shoib/M-7713-2017	Chen, Xi/0000-0002-3160-614X; Siddiqui, Shoib/0000-0002-7028-290X	National Institutes of Health [P01HL107150, R01GM32373]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL107150 and R01GM32373 (to A. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali SR, 2014, J EXP MED, V211, P1231, DOI 10.1084/jem.20131853; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; Boyd CR, 2009, J IMMUNOL, V183, P7703, DOI 10.4049/jimmunol.0902780; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Chang YC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003846; Chen G., 2014, APPL INFORM, V1, P1, DOI DOI 10.7554/ELIFE.04066; Chen LY, 2003, HUM MOL GENET, V12, P2547, DOI 10.1093/hmg/ddg263; Claude J, 2013, J NEUROSCI, V33, P18270, DOI 10.1523/JNEUROSCI.2211-13.2013; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Deng LQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004540; DULAC C, 1992, NEURON, V8, P323, DOI 10.1016/0896-6273(92)90298-R; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Floyd H, 2000, J BIOL CHEM, V275, P861, DOI 10.1074/jbc.275.2.861; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KOJIMA N, 1994, J BIOL CHEM, V269, P30451; Laubli H, 2014, P NATL ACAD SCI USA, V111, P14211, DOI 10.1073/pnas.1409580111; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; McMillan SJ, 2013, BLOOD, V121, P2084, DOI 10.1182/blood-2012-08-449983; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; POWELL LD, 1995, J BIOL CHEM, V270, P7523, DOI 10.1074/jbc.270.13.7523; POWELL LD, 1995, J BIOL CHEM, V270, P14243, DOI 10.1074/jbc.270.24.14243; Razi N, 1999, GLYCOBIOLOGY, V9, P1225, DOI 10.1093/glycob/9.11.1225; Schnaar RL, 2016, J LEUKOCYTE BIOL, V99, P825, DOI 10.1189/jlb.3RI0116-021R; Schwarz F, 2015, ELIFE, V4, DOI 10.7554/eLife.06184; Schwarz F, 2015, ADV EXP MED BIOL, V842, P1, DOI 10.1007/978-3-319-11280-0_1; Spence S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3459; Varki A., 2009, ESSENTIALS GLYCOBIOL, P459; Yu ZB, 2001, BIOCHEM J, V353, P483, DOI 10.1042/0264-6021:3530483; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang M, 2004, GLYCOBIOLOGY, V14, P939, DOI 10.1093/glycob/cwh126; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009	35	17	18	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1029	1037		10.1074/jbc.M116.738351	http://dx.doi.org/10.1074/jbc.M116.738351			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27920204	Green Published, hybrid			2022-12-28	WOS:000392318700022
J	Corbisier, J; Huszagh, A; Gales, C; Parmentier, M; Springael, JY				Corbisier, Jenny; Huszagh, Alexandre; Gales, Celine; Parmentier, Marc; Springael, Jean-Yves			Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MU-OPIOID RECEPTOR; SMALL-MOLECULE; HEALTHY-VOLUNTEERS; POTENT INHIBITION; ANTAGONIST; ACTIVATION; MECHANISM; PHARMACOKINETICS; PHARMACODYNAMICS; INTERNALIZATION	Biased agonism at G protein-coupled receptors constitutes a promising area of research for the identification of new therapeutic molecules. In this study we identified two novel biased ligands for the chemokine receptors CCR2 and CCR5 and characterized their functional properties. We showed that J113863 and its enantiomer UCB35625, initially identified as high affinity antagonists for CCR1 and CCR3, also bind with low affinity to the closely related receptors CCR2 and CCR5. Binding of J113863 and UCB35625 to CCR2 or CCR5 resulted in the full or partial activation of the three G(i) proteins and the two Go isoforms. Unlike chemokines, the compounds did not activate G12. Binding of J113863 to CCR2 or CCR5 also induced the recruitment of beta-arrestin 2, whereas UCB35625 did not. UCB35625 induced the chemotaxis of L1.2 cells expressing CCR2 or CCR5. In contrast, J113863 induced the migration of L1.2-CCR2 cells but antagonized the chemokine-induced migration of L1.2-CCR5 cells. We also showed that replacing the phenylalanine 3.33 in CCR5 TM3 by the corresponding histidine of CCR2 converts J113863 from an antagonist for cell migration and a partial agonist in other assays to a full agonist in all assays. Further analyses indicated that F3.33H substitution strongly increased the activation of G proteins and beta-arrestin 2 by J113863. These results highlight the biased nature of the J113863 and UCB35625 that act either as antagonist, partial agonist, or full agonist according to the receptor, the enantiomer, and the signaling pathway investigated.	[Corbisier, Jenny; Huszagh, Alexandre; Parmentier, Marc; Springael, Jean-Yves] ULB, IRIBHM, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium; [Gales, Celine] Univ Toulouse III Paul Sabatier, INSERM, Inst Malad Metab & Cardiovasc, F-31432 Toulouse, France; [Huszagh, Alexandre] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California Irvine	Springael, JY (corresponding author), ULB, IRIBHM, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	jyspring@ulb.ac.be		GALES, Celine/0000-0002-4938-1583				Ajram L, 2014, EUR J PHARMACOL, V729, P75, DOI 10.1016/j.ejphar.2014.02.007; Amat M, 2006, BRIT J PHARMACOL, V149, P666, DOI 10.1038/sj.bjp.0706912; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BARTSCH W, 1990, EUR J CLIN PHARMACOL, V38, pS104, DOI 10.1007/BF01409475; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Bonner K, 2013, J ALLERGY CLIN IMMUN, V132, P942, DOI 10.1016/j.jaci.2013.04.015; COOPER MJ, 1974, LIFE SCI, V15, P1665, DOI 10.1016/0024-3205(74)90333-6; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; de Mendonca FL, 2005, J BIOL CHEM, V280, P4808, DOI 10.1074/jbc.M412267200; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ferain T, 2011, J PHARMACOL EXP THER, V337, P655, DOI 10.1124/jpet.111.179622; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Mehvar R, 2001, J PHARM PHARM SCI, V4, P185; NICHOLS AJ, 1989, CHIRALITY, V1, P265, DOI 10.1002/chir.530010404; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Rentsch KM, 2002, J BIOCHEM BIOPH METH, V54, P1, DOI 10.1016/S0165-022X(02)00124-0; Sabroe I, 2000, J BIOL CHEM, V275, P25985, DOI 10.1074/jbc.M908864199; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Soergel DG, 2013, J CLIN PHARMACOL, V53, P892, DOI 10.1002/jcph.111; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Steen A, 2013, J BIOL CHEM, V288, P12511, DOI 10.1074/jbc.M112.449587; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Viney JM, 2014, J IMMUNOL, V192, P3419, DOI 10.4049/jimmunol.1300232; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wise EL, 2007, J BIOL CHEM, V282, P27935, DOI 10.1074/jbc.M703255200; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	37	13	13	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					575	584		10.1074/jbc.M116.757559	http://dx.doi.org/10.1074/jbc.M116.757559			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27895119	Green Published, hybrid			2022-12-28	WOS:000392316100014
J	Yagita, Y; Shinohara, K; Abe, Y; Nakagawa, K; Al-Owain, M; Alkuraya, FS; Fujiki, Y				Yagita, Yuichi; Shinohara, Kyoko; Abe, Yuichi; Nakagawa, Keiko; Al-Owain, Mohammed; Alkuraya, Fowzan S.; Fujiki, Yukio			Deficiency of a Retinal Dystrophy Protein, Acyl-CoA Binding Domain-containing 5 (ACBD5), Impairs Peroxisomal beta-Oxidation of Very-long-chain Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; OVARY CELL MUTANTS; DOCOSAHEXAENOIC ACID; ZELLWEGER-SYNDROME; LIGAND-BINDING; DIPOLYUNSATURATED PHOSPHATIDYLCHOLINES; COMPLEMENTATION GROUP; MACULAR DYSTROPHY; VERTEBRATE RETINA; ABC TRANSPORTERS	Acyl-CoA binding domain-containing 5 (ACBD5) is a peroxisomal protein that carries an acyl-CoA binding domain (ACBD) at its N-terminal region. The recent identification of a mutation in the ACBD5 gene in patients with a syndromic form of retinal dystrophy highlights the physiological importance of ACBD5 in humans. However, the underlying pathogenic mechanisms and the precise function of ACBD5 remain unclear. We herein report that ACBD5 is a peroxisomal tail-anchored membrane protein exposing its ACBD to the cytosol. Using patient-derived fibroblasts and ACBD5 knock-out HeLa cells generated via genome editing, we demonstrate that ACBD5 deficiency causes a moderate but significant defect in peroxisomal beta-oxidation of very-long-chain fatty acids (VLCFAs) and elevates the level of cellular phospholipids containing VLCFAs without affecting peroxisome biogenesis, including the import of membrane and matrix proteins. Both the N-terminal ACBD and peroxisomal localization of ACBD5 are prerequisite for efficient VLCFA beta-oxidation in peroxisomes. Furthermore, ACBD5 preferentially binds very-long-chain fatty acyl-CoAs (VLC-CoAs). Together, these results suggest a direct role of ACBD5 in peroxisomal VLCFA beta-oxidation. Based on our findings, we propose that ACBD5 captures VLC-CoAs on the cytosolic side of the peroxisomal membrane so that the transport of VLC-CoAs into peroxisomes and subsequent beta-oxidation thereof can proceed efficiently. Our study reclassifies ACBD5-related phenotype as a novel peroxisomal disorder.	[Yagita, Yuichi; Shinohara, Kyoko; Nakagawa, Keiko] Kyushu Univ, Dept Biol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan; [Yagita, Yuichi; Shinohara, Kyoko; Nakagawa, Keiko] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan; [Abe, Yuichi; Fujiki, Yukio] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Al-Owain, Mohammed; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, MBC 03 POB 3354, Riyadh 11211, Saudi Arabia	Kyushu University; Kyushu University; Kyushu University; King Faisal Specialist Hospital & Research Center	Fujiki, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yfujiki@kyudai.jp			Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; King Salman Center for Disability Research; Takeda Science Foundation; Naito Foundation; Japan Foundation for Applied Enzymology;  [24247038];  [25112518];  [25116717];  [26116007];  [15K14511];  [15K21743]; Grants-in-Aid for Scientific Research [15K14511] Funding Source: KAKEN	Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; King Salman Center for Disability Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Japan Foundation for Applied Enzymology; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 24247038, 25112518, 25116717, 26116007, 15K14511, and 15K21743 (to Y. F.); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (to Y. Y.); a grant from the King Salman Center for Disability Research grant (to F. S. A.); and grants from the Takeda Science Foundation, the Naito Foundation, and Japan Foundation for Applied Enzymology (to Y. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2014, BBA-MOL CELL BIOL L, V1841, P610, DOI 10.1016/j.bbalip.2014.01.001; Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Augoff K, 2010, ACTA BIOCHIM POL, V57, P533; AVELDANO MI, 1987, J BIOL CHEM, V262, P1180; AVELDANO MI, 1983, J LIPID RES, V24, P620; AVELDANO MI, 1987, J BIOL CHEM, V262, P1172; Bazan NG, 2007, INVEST OPHTH VIS SCI, V48, P4866, DOI 10.1167/iovs.07-0918; Berger J, 2016, BBA-MOL CELL RES, V1863, P934, DOI 10.1016/j.bbamcr.2015.12.005; Bernstein PS, 2001, INVEST OPHTH VIS SCI, V42, P3331; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Burton M, 2005, BIOCHEM J, V392, P299, DOI 10.1042/BJ20050664; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Faergeman NJ, 2007, MOL CELL BIOCHEM, V299, P55, DOI 10.1007/s11010-005-9040-3; Faergeman NJ, 1996, BIOCHEMISTRY-US, V35, P14118, DOI 10.1021/bi960545z; Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003; Ferdinandusse S, 2006, ANN NEUROL, V59, P92, DOI 10.1002/ana.20702; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Ferdinandusse S, 2007, HUM MUTAT, V28, P904, DOI 10.1002/humu.20535; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fujiki Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00307; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; Harkewicz R, 2012, J BIOL CHEM, V287, P11469, DOI 10.1074/jbc.M111.256073; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; Itoyama A, 2012, J CELL SCI, V125, P589, DOI 10.1242/jcs.087452; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kinoshita N, 1998, J BIOL CHEM, V273, P24122, DOI 10.1074/jbc.273.37.24122; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; MARTINEZ M, 1992, BRAIN RES, V583, P171, DOI 10.1016/S0006-8993(10)80021-6; MARTINEZ M, 1989, LIPIDS, V24, P261, DOI 10.1007/BF02535160; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Mukai S, 2002, J BIOL CHEM, V277, P9548, DOI 10.1074/jbc.M108635200; Mukai S, 2006, J BIOL CHEM, V281, P37311, DOI 10.1074/jbc.M607178200; Nazarko TY, 2014, AUTOPHAGY, V10, P1348, DOI 10.4161/auto.29073; Nazarko TY, 2014, J CELL BIOL, V204, P541, DOI 10.1083/jcb.201307050; Neess D, 2015, PROG LIPID RES, V59, P1, DOI 10.1016/j.plipres.2015.04.001; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Neuringer M, 2003, J PEDIATR-US, V143, pS87, DOI 10.1067/S0022-3476(03)00406-2; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; POLLTHE BT, 1988, AM J HUM GENET, V42, P422; RASMUSSEN JT, 1990, BIOCHEM J, V265, P849, DOI 10.1042/bj2650849; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; Shimozawa N, 2011, BRAIN DEV-JPN, V33, P770, DOI 10.1016/j.braindev.2011.03.004; Smith KD, 1999, NEUROCHEM RES, V24, P521, DOI 10.1023/A:1022535930009; Soupene E, 2015, J LIPID RES, V56, P1961, DOI 10.1194/jlr.M061937; Suzuki Y, 1997, AM J HUM GENET, V61, P1153, DOI 10.1086/301599; SUZUKI Y, 1991, BIOCHEM PHARMACOL, V41, P453, DOI 10.1016/0006-2952(91)90544-F; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; Wanders RJA, 2004, AM J MED GENET A, V126A, P355, DOI 10.1002/ajmg.a.20661; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P389, DOI 10.1007/BF02435984; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wanders RJA, 2014, BIOCHIMIE, V98, P36, DOI 10.1016/j.biochi.2013.08.022; Waterham HR, 2016, BBA-MOL CELL RES, V1863, P922, DOI 10.1016/j.bbamcr.2015.11.015; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445; Xiao S, 2011, PROG LIPID RES, V50, P141, DOI 10.1016/j.plipres.2010.11.002; Yagita Y, 2013, J CELL BIOL, V200, P651, DOI 10.1083/jcb.201211077; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	69	54	54	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					691	705		10.1074/jbc.M116.760090	http://dx.doi.org/10.1074/jbc.M116.760090			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27899449	Green Published, hybrid			2022-12-28	WOS:000392316100024
J	Terashima, M; Tange, S; Ishimura, A; Suzuki, T				Terashima, Minoru; Tange, Shoichiro; Ishimura, Akihiko; Suzuki, Takeshi			MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; TUMOR-SUPPRESSOR; GENE-EXPRESSION; MIR-200 FAMILY; X-CHROMOSOME; E-CADHERIN; TGF-BETA; HISTONE; JARID2; PRC2	Histone methylation is implicated in a number of biological and pathological processes, including cancer development. In this study, we investigated the molecular mechanism for the recruitment of Polycomb repressive complex-2 (PRC2) and its accessory component, JARID2, to chromatin, which regulates methylation of lysine 27 of histone H3 (H3K27), during epithelial-mesenchymal transition (EMT) of cancer cells. The expression of MEG3 long noncoding RNA (lncRNA), which could interact with JARID2, was clearly increased during transforming growth factor-beta (TGF-beta)-induced EMT of human lung cancer cell lines. Knockdown of MEG3 inhibited TGF-beta-mediated changes in cell morphology and cell motility characteristic of EMT and counteracted TGF-beta-dependent changes in the expression of EMT-related genes such as CDH1, ZEB family, and the microRNA-200 family. Overexpression of MEG3 influenced the expression of these genes and enhanced the effects of TGF-beta in their expressions. Chromatin immunoprecipitation (ChIP) revealed that MEG3 regulated the recruitment of JARID2 and EZH2 and histone H3 methylation on the regulatory regions of CDH1 and microRNA-200 family genes for transcriptional repression. RNA immunoprecipitation and chromatin isolation by RNA purification assays indicated that MEG3 could associate with JARID2 and the regulatory regions of target genes to recruit the complex. This study demonstrated a crucial role of MEG3 lncRNA in the epigenetic regulation of the EMT process in lung cancer cells.	[Terashima, Minoru; Tange, Shoichiro; Ishimura, Akihiko; Suzuki, Takeshi] Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Suzuki, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kanazawa, Ishikawa 9201192, Japan.	suzuki-t@staff.kanazawa-u.ac.jp	Terashima, Minoru/D-8462-2015	Suzuki, Takeshi/0000-0002-1737-0900	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590346, 15K08263]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research C 24590346 and 15K08263 (to T. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bartonicek N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0530-6; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chu Ci, 2012, J Vis Exp, DOI 10.3791/3912; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ghosal S, 2013, STEM CELLS DEV, V22, P2240, DOI 10.1089/scd.2013.0014; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Ke XS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-669; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Oktyabri D, 2016, BIOCHIMIE, V123, P20, DOI 10.1016/j.biochi.2016.01.005; Oktyabri D, 2014, BIOCHEM BIOPH RES CO, V453, P124, DOI 10.1016/j.bbrc.2014.09.082; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Puda A, 2012, AM J HEMATOL, V87, P245, DOI 10.1002/ajh.22257; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Suzuki T, 2013, CANCER SCI, V104, P795, DOI 10.1111/cas.12169; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tange S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115684; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Walters ZS, 2014, ONCOGENE, V33, P1148, DOI 10.1038/onc.2013.46; Wang Y, 2013, EXP CELL RES, V319, P160, DOI 10.1016/j.yexcr.2012.07.019; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yoshida M, 2011, BIOCHEM J, V437, P555, DOI 10.1042/BJ20110343; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	56	140	151	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					82	99		10.1074/jbc.M116.750950	http://dx.doi.org/10.1074/jbc.M116.750950			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27852821	Green Published, hybrid			2022-12-28	WOS:000391578000008
J	Kajitani, N; Miyano, K; Okada-Tsuchioka, M; Abe, H; Itagaki, K; Hisaoka-Nakashima, K; Morioka, N; Uezono, Y; Takebayashi, M				Kajitani, Naoto; Miyano, Kanako; Okada-Tsuchioka, Mami; Abe, Hiromi; Itagaki, Kei; Hisaoka-Nakashima, Kazue; Morioka, Norimitsu; Uezono, Yasuhito; Takebayashi, Minoru			Identification of Lysophosphatidic Acid Receptor 1 in Astroglial Cells as a Target for Glial Cell Line-derived Neurotrophic Factor Expression Induced by Antidepressants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; SIGNAL-REGULATED KINASE; PROTEIN ALPHA-SUBUNIT; PERTUSSIS-TOXIN; AMITRIPTYLINE; ASTROCYTES; GDNF; ACTIVATION; RELEASE; LPA(1)	Preclinical and clinical evidence suggests that glial cell line-derived neurotrophic factor (GDNF) is important in the therapeutic effect of antidepressants. A previous study demonstrated that the tricyclic antidepressant amitriptyline induces G alpha(i/o) activation, which leads to GDNF expression in astrocytes. However, the specific target expressed in astrocytes that mediates antidepressant-evoked G alpha(i/o) activation has yet to be identified. Thus, the current study explored the possibility that antidepressant-induced G alpha(i/o) activation depends on lysophosphatidic acid receptor 1 (LPAR1), a G alpha(i/o)-coupled receptor. GDNF mRNA expression was examined using real-time PCR and G alpha(i/o) activation was examined using the cell-based receptor assay system CellKey (TM) in rat C6 astroglial cells and rat primary cultured astrocytes. LPAR1 antagonists blocked GDNF mRNA expression and G alpha(i/o) activation evoked by various classes of antidepressants (amitriptyline, nortriptyline, mianserin, and fluoxetine). In addition, deletion of LPAR1 by RNAi suppressed amitriptyline-evoked GDNF mRNA expression. Treatment of astroglial cells with the endogenous LPAR agonist LPA increased GDNF mRNA expression through LPAR1, whereas treatment of primary cultured neurons with LPA failed to affect GDNF mRNA expression. Astrocytic GDNF expression evoked by either amitriptyline or LPA utilized, in part, transactivation of fibroblast growth factor receptor and a subsequent ERK cascade. The current results suggest that LPAR1 is a novel, specific target of antidepressants that leads to GDNF expression in astrocytes.	[Kajitani, Naoto; Okada-Tsuchioka, Mami; Abe, Hiromi; Itagaki, Kei; Takebayashi, Minoru] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Div Psychiat & Neurosci, 3-1 Aoyama, Kure 7370023, Japan; [Kajitani, Naoto; Okada-Tsuchioka, Mami; Abe, Hiromi; Itagaki, Kei; Takebayashi, Minoru] Chugoku Canc Ctr, 3-1 Aoyama, Kure 7370023, Japan; [Miyano, Kanako; Uezono, Yasuhito] Natl Canc Ctr, Div Canc Pathophysiol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan; [Itagaki, Kei; Takebayashi, Minoru] Natl Hosp Org, Dept Psychiat, Kure Med Ctr, 3-1 Aoyama, Kure 7370023, Japan; [Hisaoka-Nakashima, Kazue; Morioka, Norimitsu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Div Support Care Res, Exploratory Oncol Res & Clin Trial Ctr, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan	National Cancer Center - Japan; Hiroshima University; National Cancer Center - Japan	Takebayashi, M (corresponding author), Chugoku Canc Ctr, 3-1 Aoyama, Kure 7370023, Japan.; Takebayashi, M (corresponding author), Natl Hosp Org, Dept Psychiat, Kure Med Ctr, 3-1 Aoyama, Kure 7370023, Japan.	mtakebayashi@kure-nh.go.jp	Morioka, Norimitsu/J-3165-2019	Morioka, Norimitsu/0000-0001-9148-4167; Miyano, Kanako/0000-0003-1673-6074; Kajitani, Naoto/0000-0001-7245-9206	Japan Society for the Promotion of Science KAKENHI Grants [25860199, 15K09819, 15K08686, 16K08568, 16K19796, 16K18883]; SENSHIN Medical Research; Grants-in-Aid for Scientific Research [15K09819] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SENSHIN Medical Research(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 25860199, 15K09819, 15K08686, 16K08568, 16K19796, and 16K18883 and a grant from SENSHIN Medical Research. The authors declare that they have no conflicts of interest with the contents of this article.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Erb SJ, 2016, J BIOL CHEM, V291, P19725, DOI 10.1074/jbc.M116.727263; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; Galeotti N, 2002, NEUROPSYCHOPHARMACOL, V27, P554; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; Hisaoka K, 2001, J NEUROCHEM, V79, P25, DOI 10.1046/j.1471-4159.2001.00531.x; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Hisaoka-Nakashima K, 2015, J BIOL CHEM, V290, P13678, DOI 10.1074/jbc.M114.622415; Kajitani N, 2015, J NEUROCHEM, V135, P27, DOI 10.1111/jnc.13247; Kajitani N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051197; Kowal D, 2002, BIOCHEM BIOPH RES CO, V294, P655, DOI 10.1016/S0006-291X(02)00535-1; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Lin PY, 2015, J PSYCHIATR RES, V63, P20, DOI 10.1016/j.jpsychires.2015.02.004; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; McAlhany RE, 1999, ALCOHOL CLIN EXP RES, V23, P1691, DOI 10.1111/j.1530-0277.1999.tb04062.x; MIYAKE K, 1990, J PHARM SCI, V79, P288, DOI 10.1002/jps.2600790403; Miyano K, 2014, J PHARMACOL SCI, V126, P302, DOI 10.1254/jphs.14R13CP; Olianas MC, 2015, BIOCHEM PHARMACOL, V95, P311, DOI 10.1016/j.bcp.2015.04.002; Rancoule C, 2011, EXPERT OPIN INV DRUG, V20, P657, DOI 10.1517/13543784.2011.566864; Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032; Santin LJ, 2009, GENES BRAIN BEHAV, V8, P772, DOI 10.1111/j.1601-183X.2009.00524.x; Sato K, 2011, J NEUROCHEM, V117, P164, DOI 10.1111/j.1471-4159.2011.07188.x; Spohr TCDSE, 2008, J BIOL CHEM, V283, P7470, DOI 10.1074/jbc.M707758200; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Urs NM, 2005, J CELL SCI, V118, P5291, DOI 10.1242/jcs.02634; Yung YC, 2015, NEURON, V85, P669, DOI 10.1016/j.neuron.2015.01.009; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004; Zhao J, 2014, CELL SIGNAL, V26, P2406, DOI 10.1016/j.cellsig.2014.07.005	30	17	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27364	27370		10.1074/jbc.M116.753871	http://dx.doi.org/10.1074/jbc.M116.753871			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864362	Green Published, hybrid			2022-12-28	WOS:000391576300033
J	Lin, MT; Kuo, IH; Chang, CC; Chu, CY; Chen, HY; Lin, BR; Sureshbabu, M; Shih, HJ; Kuo, ML				Lin, Ming-Tsan; Kuo, I-Hsin; Chang, Cheng-Chi; Chu, Chia-Yu; Chen, Hsing-Yu; Lin, Been-Ren; Sureshbabu, Munisamy; Shih, Hou-Jung; Kuo, Min-Liang			RETRACTION: Involvement of hypoxia-inducing factor-1 alpha-dependent plasminogen activator inhibitor-1 up-regulation in Cyr61/CCN1-induced gastric cancer cell invasion (Retraction of Vol 283, Pg 15807, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction														LIN, MING-TSAN/0000-0001-7313-7057; CHU, CHIA-YU/0000-0002-9370-3279; LIN, BEEN-REN/0000-0001-8354-1758				LIN MT, 2008, THE JOURNAL OF BIOLO, V283, P15807, DOI DOI 10.1074/JBC.A116.708933	1	5	5	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27433	27433		10.1074/jbc.A116.708933	http://dx.doi.org/10.1074/jbc.A116.708933			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	28039333	hybrid, Green Published			2022-12-28	WOS:000391576300038
J	Karlshoj, S; Amarandi, RM; Larsen, O; Daugvilaite, V; Steen, A; Brvar, M; Pui, A; Frimurer, TM; Ulven, T; Rosenkilde, MM				Karlshoj, Stefanie; Amarandi, Roxana Maria; Larsen, Olav; Daugvilaite, Viktorija; Steen, Anne; Brvar, Matjaz; Pui, Aurel; Frimurer, Thomas Michael; Ulven, Trond; Rosenkilde, Mette Marie			Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION SITE; 7-TRANSMEMBRANE RECEPTOR; TRANSMEMBRANE HELIX; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HIV-1 INFECTION; BINDING-SITE; ACTIVATION; SWITCH; LIGAND	The small molecule metal ion chelators bipyridine and terpyridine complexed with Zn2+ (ZnBip and ZnTerp) act as CCR5 agonists and strong positive allosteric modulators of CCL3 binding to CCR5, weak modulators of CCL4 binding, and competitors for CCL5 binding. Here we describe their binding site using computational modeling, binding, and functional studies on WT and mutated CCR5. The metal ion Zn2+ is anchored to the chemokine receptor-conserved Glu-283(VII:06/7.39). Both chelators interact with aromatic residues in the transmembrane receptor domain. The additional pyridine ring of ZnTerp binds deeply in the major binding pocket and, in contrast to ZnBip, interacts directly with the Trp-248(VI:13/6.48) microswitch, contributing to its 8-fold higher potency. The impact of Trp-248 was further confirmed by ZnClTerp, a chloro-substituted version of ZnTerp that showed no inherent agonism but maintained positive allosteric modulation of CCL3 binding. Despite a similar overall binding mode of all three metal ion chelator complexes, the pyridine ring of ZnClTerp blocks the conformational switch of Trp-248 required for receptor activation, thereby explaining its lack of activity. Importantly, ZnClTerp becomes agonist to the same extent as ZnTerp upon Ala mutation of Ile-116(III:16/3.40), a residue that constrains the Trp-248 microswitch in its inactive conformation. Binding studies with I-125-CCL3 revealed an allosteric interface between the chemokine and the small molecule binding site, including residues Tyr-37(I:07/1.39), Trp-86(II:20/2.60), and Phe-109(III:09/3.33). The small molecules and CCL3 approach this interface from opposite directions, with some residues being mutually exploited. This study provides new insight into the molecular mechanism of CCR5 activation and paves the way for future allosteric drugs for chemokine receptors.	[Karlshoj, Stefanie; Amarandi, Roxana Maria; Larsen, Olav; Daugvilaite, Viktorija; Steen, Anne; Rosenkilde, Mette Marie] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3,Panum Bldg 18-5, DK-2200 Copenhagen, Denmark; [Amarandi, Roxana Maria; Pui, Aurel] Alexandru Ioan Cuza Univ, Fac Chem, Bd Carol 11, RO-700506 Iasi, Romania; [Frimurer, Thomas Michael] Univ Copenhagen, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Blegdamsvej 3, DK-2200 Copenhagen, Denmark; [Brvar, Matjaz; Ulven, Trond] Univ Southern Denmark, Dept Chem & Phys, Campusvej 55, DK-5230 Odense, Denmark	University of Copenhagen; Alexandru Ioan Cuza University; Novo Nordisk Foundation; University of Copenhagen; University of Southern Denmark	Rosenkilde, MM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3,Panum Bldg 18-5, DK-2200 Copenhagen, Denmark.	rosenkilde@sund.ku.dk	Ulven, Trond/H-5500-2015; Daugvilaite, Viktorija/AAI-1490-2019; Amarandi, Roxana-Maria/AAR-8564-2021; DAUGVILAITE, VIKTORIJA/E-2573-2017	Ulven, Trond/0000-0002-8135-1755; Daugvilaite, Viktorija/0000-0001-8786-348X; DAUGVILAITE, VIKTORIJA/0000-0001-8786-348X; Brvar, Matjaz/0000-0001-7995-7902; Rosenkilde, Mette Marie/0000-0001-9600-3254; Karlshoj, Stefanie/0000-0001-6505-0883; Amarandi, Roxana-Maria/0000-0002-9937-6539; Frimruer, Thomas/0000-0002-9682-8245; Pui, Aurel/0000-0002-0343-5718	AP Moller Maersk Foundation; Aase and Einar Danielsen Foundation; Horslev Foundation; Novo Nordisk Fonden [NNF12OC0001900] Funding Source: researchfish	AP Moller Maersk Foundation; Aase and Einar Danielsen Foundation; Horslev Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in whole or part by the AP Moller Maersk Foundation, the Aase and Einar Danielsen Foundation, and the Horslev Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Amarandi RM, 2016, METHOD ENZYMOL, V570, P155, DOI 10.1016/bs.mie.2015.09.001; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Brandish PE, 2003, ANAL BIOCHEM, V313, P311, DOI 10.1016/S0003-2697(02)00630-9; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Elling CE, 1999, P NATL ACAD SCI USA, V96, P12322, DOI 10.1073/pnas.96.22.12322; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Holst B, 2000, MOL PHARMACOL, V58, P263, DOI 10.1124/mol.58.2.263; Ioachim E, 2005, EUR J ORG CHEM, V2005, P3775, DOI 10.1002/ejoc.200500335; Jensen PC, 2008, J BIOL CHEM, V283, P23121, DOI 10.1074/jbc.M803458200; Kissow H, 2012, REGUL PEPTIDES, V179, P91, DOI 10.1016/j.regpep.2012.08.016; Klein A, 2014, J ORGANOMET CHEM, V774, P86, DOI 10.1016/j.jorganchem.2014.10.013; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Liu KM, 2015, CHEM COMMUN, V51, P1124, DOI 10.1039/c4cc08494b; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; Mirzadegan T, 2000, J BIOL CHEM, V275, P25562, DOI 10.1074/jbc.M000692200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Proudfoot AEI, 2010, EXPERT OPIN INV DRUG, V19, P345, DOI 10.1517/13543780903535867; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Rosenkilde MM, 2006, MOL PHARMACOL, V70, P1892, DOI 10.1124/mol.106.027425; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319, DOI 10.2174/15680266106061319; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Rosenkilde MM, 1998, FEBS LETT, V439, P35, DOI 10.1016/S0014-5793(98)01331-3; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Rosenkilde MM, 1999, J BIOL CHEM, V274, P956, DOI 10.1074/jbc.274.2.956; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Santos-Martins D, 2014, J CHEM INF MODEL, V54, P2371, DOI 10.1021/ci500209e; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Steen A, 2014, BRIT J PHARMACOL, V171, P1566, DOI 10.1111/bph.12553; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Steen A, 2013, J BIOL CHEM, V288, P12511, DOI 10.1074/jbc.M112.449587; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thiele S, 2014, BRIT J PHARMACOL, V171, P5313, DOI 10.1111/bph.12842; Thiele S, 2014, CURR MED CHEM, V21, P3594, DOI 10.2174/0929867321666140716093155; Thiele S, 2012, J MED CHEM, V55, P8164, DOI 10.1021/jm301121j; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Thirstrup K, 1996, J BIOL CHEM, V271, P7875, DOI 10.1074/jbc.271.14.7875; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhao LX, 2006, ARCH PHARM RES, V29, P1091, DOI 10.1007/BF02969297	60	9	9	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26860	26874		10.1074/jbc.M116.740183	http://dx.doi.org/10.1074/jbc.M116.740183			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27834679	hybrid, Green Published			2022-12-28	WOS:000391571400023
J	He, JM; Zhu, H; Zheng, GS; Liu, PP; Wang, J; Zhao, GP; Zhu, GQ; Jiang, WH; Lu, YH				He, Juan-Mei; Zhu, Hong; Zheng, Guo-Song; Liu, Pan-Pan; Wang, Jin; Zhao, Guo-Ping; Zhu, Guo-Qiang; Jiang, Wei-Hong; Lu, Yin-Hua			Direct Involvement of the Master Nitrogen Metabolism Regulator GlnR in Antibiotic Biosynthesis in Streptomyces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; SECONDARY METABOLISM; 2-COMPONENT SYSTEM; COELICOLOR; IDENTIFICATION; AVERMITILIS; PROMOTERS; REGULON; BINDING	GlnR, an OmpR-like orphan two-component system response regulator, is a master regulator of nitrogen metabolism in the genus Streptomyces. In this work, evidence that GlnR is also directly involved in the regulation of antibiotic biosynthesis is provided. In the model strain Streptomyces coelicolor M145, an in-frame deletion of glnR resulted in markedly increased actinorhodin (ACT) production but reduced undecylprodigiosin (RED) biosynthesis when exposed to R2YE culture medium. Transcriptional analysis coupled with DNA binding studies revealed that GlnR represses ACT but activates RED production directly via the pathway-specific activator genes actII-ORF4 and redZ, respectively. The precise GlnR-binding sites upstream of these two target genes were defined. In addition, the direct involvement of GlnR in antibiotic biosynthesis was further identified in Streptomyces avermitilis, which produces the important anthelmintic agent avermectin. We found that S. avermitilis GlnR (GlnRsav) could stimulate avermectin but repress oligomycin production directly through the respective pathway-specific activator genes, aveR and olmRI/RII. To the best of our knowledge, this report describes the first experimental evidence demonstrating that GlnR regulates antibiotic biosynthesis directly through pathway-specific regulators in Streptomyces. Our results suggest that GlnR-mediated regulation of antibiotic biosynthesis is likely to be universal in streptomycetes. These findings also indicate that GlnR is not only a master nitrogen regulator but also an important controller of secondary metabolism, which may help to balance nitrogen metabolism and antibiotic biosynthesis in streptomycetes.	[He, Juan-Mei; Zhu, Hong; Zheng, Guo-Song; Liu, Pan-Pan; Wang, Jin; Zhao, Guo-Ping; Jiang, Wei-Hong; Lu, Yin-Hua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [He, Juan-Mei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhu, Guo-Qiang] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; [Jiang, Wei-Hong] SICAM, Jiangsu Natl Synerget Innovat Ctr Adv Mat, Nanjing 210009, Jiangsu, Peoples R China; [Lu, Yin-Hua] Shanghai Collaborat Innovat Ctr Biomfg Technol, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yangzhou University	Jiang, WH; Lu, YH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.; Zhu, GQ (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China.; Jiang, WH (corresponding author), SICAM, Jiangsu Natl Synerget Innovat Ctr Adv Mat, Nanjing 210009, Jiangsu, Peoples R China.; Lu, YH (corresponding author), Shanghai Collaborat Innovat Ctr Biomfg Technol, Shanghai 200237, Peoples R China.	yzgqzhu@yzu.edu.cn; whjiang@sibs.ac.cn; yhlu@sibs.ac.cn	liu, pan/HIR-9103-2022; Wang, Jin/P-5458-2019	Wang, Jin/0000-0003-4008-9284; Zhao, Guo-Ping/0000-0002-7621-6620	National Natural Science Foundation of China [31630003, 31421061, 31370081, 31570072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31630003, 31421061, 31370081, and 31570072. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMIDIS T, 1990, J BACTERIOL, V172, P2962, DOI 10.1128/jb.172.6.2962-2969.1990; Cen XF, 2016, BIOCHEM BIOPH RES CO, V471, P510, DOI 10.1016/j.bbrc.2016.02.044; Chen YH, 2010, APPL MICROBIOL BIOT, V86, P19, DOI 10.1007/s00253-009-2428-3; Chen YL, 2013, MICROBIOL-SGM, V159, P2571, DOI 10.1099/mic.0.071449-0; Fedoryshyn M, 2008, APPL MICROBIOL BIOT, V78, P1065, DOI 10.1007/s00253-008-1382-9; Fink D, 2002, MOL MICROBIOL, V46, P331, DOI 10.1046/j.1365-2958.2002.03150.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hesketh A, 2009, MOL MICROBIOL, V74, P1427, DOI 10.1111/j.1365-2958.2009.06941.x; Huang H, 2015, ACTA BIOCH BIOPH SIN, V47, DOI 10.1093/abbs/gmv007; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Liao CH, 2015, P NATL ACAD SCI USA, V112, P15630, DOI 10.1073/pnas.1508465112; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Lu YH, 2011, J BACTERIOL, V193, P3020, DOI 10.1128/JB.00017-11; Martin Juan F, 2012, Subcell Biochem, V64, P115, DOI 10.1007/978-94-007-5055-5_6; Martin JF, 2010, CURR OPIN MICROBIOL, V13, P263, DOI 10.1016/j.mib.2010.02.008; McKenzie NL, 2007, J BACTERIOL, V189, P5284, DOI 10.1128/JB.00305-07; Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Pullan ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-175; Qiu JF, 2011, APPL MICROBIOL BIOT, V92, P337, DOI 10.1007/s00253-011-3439-4; Qu S, 2015, APPL MICROBIOL BIOT, V99, P4771, DOI 10.1007/s00253-015-6437-0; Reuther J, 2007, J MOL MICROB BIOTECH, V12, P139, DOI 10.1159/000096469; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Sambrook J., 2001, MOL CLONING LAB MANU; Tiffert Y, 2008, MOL MICROBIOL, V67, P861, DOI 10.1111/j.1365-2958.2007.06092.x; Tiffert Y, 2011, APPL MICROBIOL BIOT, V89, P1149, DOI 10.1007/s00253-011-3086-9; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; Wang R, 2013, MOL MICROBIOL, V87, P30, DOI 10.1111/mmi.12080; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Wilkinson CJ, 2002, J MOL MICROB BIOTECH, V4, P417; Yao LL, 2014, APPL MICROBIOL BIOT, V98, P7935, DOI 10.1007/s00253-014-5878-1; Yu H, 2007, ARCH MICROBIOL, V188, P89, DOI 10.1007/s00203-007-0228-7; Yu ZY, 2012, MOL MICROBIOL, V85, P535, DOI 10.1111/j.1365-2958.2012.08126.x	35	32	37	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26443	26454		10.1074/jbc.M116.762476	http://dx.doi.org/10.1074/jbc.M116.762476			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27875313	hybrid, Green Published			2022-12-28	WOS:000391568200018
J	Samyn, DR; Van der Veken, J; Van Zeebroeck, G; Persson, BL; Karlsson, BCG				Samyn, Dieter R.; Van der Veken, Jeroen; Van Zeebroeck, Griet; Persson, Bengt L.; Karlsson, Bjorn C. G.			Key Residues and Phosphate Release Routes in the Saccharomyces cerevisiae Pho84 Transceptor THE ROLE OF TYR179 IN FUNCTIONAL REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEERED MOLECULAR-DYNAMICS; MAJOR FACILITATOR SUPERFAMILY; FORCE-FIELD; MEAN FORCE; SIMULATIONS; TRANSPORTER; PARAMETERS; MEMBRANE; POTENTIALS; MECHANISM	Pho84, a major facilitator superfamily (MFS) protein, is the main high-affinity Pi transceptor in Saccharomyces cerevisiae. Although transport mechanisms have been suggested for other MFS members, the key residues and molecular events driving transport by Pi: H+ symporters are unclear. The current Pho84 transport model is based on the inward-facing occluded crystal structure of the Pho84 homologue PiPT in the fungus Piriformospora indica. However, this model is limited by the lack of experimental data on the regulatory residues for each stage of the transport cycle. In this study, an open, inward-facing conformation of Pho84 was used to study the release of Pi. A comparison of this conformation with the model for Pi release in PiPT revealed that Tyr(179) in Pho84 (Tyr150 in PiPT) is not part of the Pi binding site. This difference may be due to a lack of detailed information on the Pi release step in PiPT. Molecular dynamics simulations of Pho84 in which a residue adjacent to Tyr(179), Asp(178), is protonated revealed a conformational change in Pho84 from an open, inward-facing state to an occluded state. Tyr(179) then became part of the binding site as was observed in the PiPT crystal structure. The importance of Tyr(179) in regulating Pi release was supported by site-directed mutagenesis and transport assays. Using trehalase activity measurements, we demonstrated that the release of Pi is a critical step for transceptor signaling. Our results add to previous studies on PiPT, creating a more complete picture of the proton-coupled Pi transport cycle of a transceptor.	[Karlsson, Bjorn C. G.] Linnaeus Univ, Computat Chem & Biochem Grp, SE-39182 Kalmar, Sweden; [Samyn, Dieter R.; Van der Veken, Jeroen; Persson, Bengt L.; Karlsson, Bjorn C. G.] Linnaeus Univ, Ctr Biomat Chem, SE-39182 Kalmar, Sweden; [Van Zeebroeck, Griet] VIB, Dept Mol Microbiol, Kasteelpk Arenberg 31, BE-3001 Leuven Heverlee, Flanders, Belgium; [Van Zeebroeck, Griet] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Kasteelpk Arenberg 31, BE-3001 Leuven Heverlee, Flanders, Belgium; [Samyn, Dieter R.] Concordia Univ, Dept Biol, Loyola Campus,7141 Sherbrooke St W, Montreal, PQ H4B 1R6, Canada; [Van der Veken, Jeroen] Inst Agr & Fisheries Res ILVO, Appl Genet & Breeding, Plant Sci Unit, Caritasstr 39, BE-9090 Melle, Belgium	Linnaeus University; Linnaeus University; Flanders Institute for Biotechnology (VIB); KU Leuven; Concordia University - Canada; Institute For Agricultural & Fisheries Research	Karlsson, BCG (corresponding author), Linnaeus Univ, Ctr Biomat Chem, Computat Chem & Biochem Grp, SE-39182 Kalmar, Sweden.	bjorn.karlsson@lnu.se	Samyn, Dieter/ABG-2291-2021; Karlsson, Björn/AAS-8956-2021; Samyn, Dieter/K-6887-2017	Karlsson, Björn/0000-0002-7392-0591; Samyn, Dieter/0000-0002-0381-251X; Van der Veken, Jeroen/0000-0002-8615-6502	Linnaeus University; Crafoord Foundation	Linnaeus University; Crafoord Foundation	This work was supported by the Linnaeus University and the Crafoord Foundation. The authors declare that they have no conflicts of interest regarding the contents of this article.	Andersson M, 2012, STRUCTURE, V20, P1893, DOI 10.1016/j.str.2012.08.021; [Anonymous], 2008, AMBER 10; BORSTPAUWELS GWFH, 1993, BIOCHIM BIOPHYS ACTA, V1145, P15, DOI 10.1016/0005-2736(93)90376-B; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Frisch M.J., 2010, DJ FOX; Gullingsrud JR, 1999, J COMPUT PHYS, V151, P190, DOI 10.1006/jcph.1999.6218; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hummer G, 2010, P NATL ACAD SCI USA, V107, P21441, DOI 10.1073/pnas.1015661107; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kosztin D, 1999, BIOPHYS J, V76, P188, DOI 10.1016/S0006-3495(99)77188-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagerstedt JO, 2004, FEBS LETT, V578, P262, DOI 10.1016/j.febslet.2004.11.012; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Liu YF, 2015, BIOPHYS J, V109, P542, DOI 10.1016/j.bpj.2015.06.037; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Pernambuco MB, 1996, MICROBIOL-SGM, V142, P1775, DOI 10.1099/13500872-142-7-1775; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; Samyn DR, 2016, ADV EXP MED BIOL, V892, P253, DOI 10.1007/978-3-319-25304-6_10; Samyn DR, 2012, BIOCHEM J, V445, P413, DOI 10.1042/BJ20112086; Schothorst J, 2013, CURR GENET, V59, P197, DOI 10.1007/s00294-013-0413-y; Steinbrecher T, 2012, J CHEM THEORY COMPUT, V8, P4405, DOI 10.1021/ct300613v; Stroud RM, 2007, P NATL ACAD SCI USA, V104, P1445, DOI 10.1073/pnas.0610349104; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Wykoff DD, 2001, GENETICS, V159, P1491; Xu YC, 2003, J AM CHEM SOC, V125, P11340, DOI 10.1021/ja029775t; Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u	43	7	8	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26388	26398		10.1074/jbc.M116.738112	http://dx.doi.org/10.1074/jbc.M116.738112			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27875295	hybrid, Green Published			2022-12-28	WOS:000391568200013
J	Pan, XY; Zhao, W; Wang, CY; Lin, J; Zeng, XY; Ren, RX; Wang, K; Xun, TR; Shai, Y; Liu, SW				Pan, Xiao-Yan; Zhao, Wei; Wang, Chun-Yan; Lin, Jian; Zeng, Xiao-Yun; Ren, Ru-Xia; Wang, Keng; Xun, Tian-Rong; Shai, Yechiel; Liu, Shu-Wen			Heat Shock Protein 90 Facilitates Latent HIV Reactivation through Maintaining the Function of Positive Transcriptional Elongation Factor b (p-TEFb) under Proteasome Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; GENE-EXPRESSION; REPLICATION; INFECTION	The persistence of HIV in resting memory CD4(+) T cells at a latent state is considered as the major barrier on the path to achieve a cure for HIV. Proteasome inhibitors (PIs) were previously reported as latency reversing agents (LRAs) but the mechanism underlying this function is yet unclear. Here we demonstrate that PIs reactivate latent HIV ex vivo without global T cell activation, and may facilitate host innate immune responses. Mechanistically, latent HIV reactivation induced by PIs is mediated by heat shock factor 1 (HSF1) via the recruitment of the heat shock protein (HSP) 90-positive transcriptional elongation factor b (p-TEFb) complex. Specifically, HSP90 downstream HSF1 gives positive feedback to the reactivation process through binding to cyclin-dependent kinase 9 (CDK9) and preventing it from undergoing degradation by the proteasome. Overall, these findings suggest proteasome inhibitors as potential latency reversing agents. In addition, HSF1/HSP90 involved in HIV transcription elongation, may serve as therapeutic targets in HIV eradication.	[Pan, Xiao-Yan; Zhao, Wei; Lin, Jian; Zeng, Xiao-Yun; Ren, Ru-Xia; Wang, Keng; Xun, Tian-Rong; Liu, Shu-Wen] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab Drug Screening, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Chun-Yan] Southern Med Univ, Nanfang Hosp, Dept Clin Lab, Guangzhou 510515, Guangdong, Peoples R China; [Shai, Yechiel] Weizmann Inst Sci, Dept Biochem, IL-76100 Rehovot, Israel; [Liu, Shu-Wen] Southern Med Univ, Guangdong Prov Inst Nephrol, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Weizmann Institute of Science; Southern Medical University - China	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biochem, IL-76100 Rehovot, Israel.; Liu, SW (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	Yechiel.Shai@weizmann.ac.il; liusw@smu.edu.cn	Pan, Xiaoyan/AAN-1582-2020	Liu, Shuwen/0000-0001-6346-5006	Natural Science Foundation of China [31370781]; National SAMP;T Key Special Foundation [2014ZX09509001-004]; Natural Science Foundation of Guangdong Province [S2011020005207]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National SAMP;T Key Special Foundation; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by Natural Science Foundation of China Grant 31370781, National S&T Key Special Foundation Grant 2014ZX09509001-004, and Natural Science Foundation of Guangdong Province Grant S2011020005207 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Borsa M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0298-0; Bruner KM, 2015, TRENDS MICROBIOL, V23, P192, DOI 10.1016/j.tim.2015.01.013; Budhiraja S, 2013, FUTURE VIROL, V8, P649, DOI [10.2217/fvl.13.52, 10.2217/FVL.13.52]; Chan JKL, 2011, CURR OPIN HIV AIDS, V6, P12, DOI 10.1097/COH.0b013e32834124fd; Chen IY, 2015, TRENDS MICROBIOL, V23, P55, DOI 10.1016/j.tim.2014.09.007; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Egger L, 2007, CELL DEATH DIFFER, V14, P1172, DOI 10.1038/sj.cdd.4402125; Hsu HT, 2014, J IMMUNOL, V192, P4957, DOI 10.4049/jimmunol.1300631; Itzen F, 2014, NUCLEIC ACIDS RES, V42, P7577, DOI 10.1093/nar/gku449; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Joshi P, 2016, J BIOL CHEM, V291, P10332, DOI 10.1074/jbc.M116.717538; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Miller LK, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-120; Mitchell S, 2016, WIRES SYST BIOL MED, V8, P227, DOI 10.1002/wsbm.1331; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Olesen R, 2015, J VIROL, V89, P10176, DOI 10.1128/JVI.01484-15; Pan XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26294; Rawat P, 2011, NUCLEIC ACIDS RES, V39, P5879, DOI 10.1093/nar/gkr198; Roesch F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002792; Scherz-Shouval R, 2014, CELL, V158, P564, DOI 10.1016/j.cell.2014.05.045; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Sreedhar AS, 2004, BBA-PROTEINS PROTEOM, V1697, P233, DOI 10.1016/j.bbapap.2003.11.027; Wheeler DS, 2003, BIOCHEM BIOPH RES CO, V301, P54, DOI 10.1016/S0006-291X(02)02986-8; Yang HC, 2009, P NATL ACAD SCI USA, V106, P6321, DOI 10.1073/pnas.0809536106; Yoon YJ, 2011, J BIOL CHEM, V286, P1737, DOI 10.1074/jbc.M110.179440	35	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26177	26187		10.1074/jbc.M116.743906	http://dx.doi.org/10.1074/jbc.M116.743906			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27799305	hybrid, Green Published			2022-12-28	WOS:000390345200034
J	Yang, L; Sun, M; Sun, XM; Cheng, GZ; Nicosia, SV; Cheng, JQ				Yang, Lin; Sun, Mei; Sun, Xia-meng; Cheng, George Z.; Nicosia, Santo V.; Cheng, Jin Q.			Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212 (vol 282, pg 10981, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Sun, Ellen/ABC-8094-2020	Sun, Ellen/0000-0001-7399-4075				Yang L, 2007, J BIOL CHEM, V282, P10981, DOI 10.1074/jbc.M700445200	1	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22843	22843		10.1074/jbc.A116.700445	http://dx.doi.org/10.1074/jbc.A116.700445			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825081	Green Published, hybrid			2022-12-28	WOS:000386760600042
J	Zeng, ZP; Wang, K; Li, YY; Xia, N; Nie, SF; Lv, BJ; Zhang, M; Tu, X; Li, QQ; Tang, TT; Cheng, X				Zeng, Zhipeng; Wang, Ke; Li, Yuanyuan; Xia, Ni; Nie, Shaofang; Lv, Bingjie; Zhang, Min; Tu, Xin; Li, Qianqian; Tang, Tingting; Cheng, Xiang			Down-regulation of microRNA-451a facilitates the activation and proliferation of CD4(+) T cells by targeting Myc in patients with dilated cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular disease; inflammation; microRNA (miRNA); Myc (c-Myc); T helper cells	CARDIAC-HYPERTROPHY; TUMOR-SUPPRESSOR; HEART-FAILURE; C-MYC; EXPRESSION; RECEPTOR; AUTOANTIBODIES; CLASSIFICATION; INTERLEUKIN-2; CARDIOLOGY	CD4(+) T cells are abnormally activated in patients with dilated cardiomyopathy (DCM) and might be associated with the immunopathogenesis of the disease. However, the underlying mechanisms of CD4(+) T cell activation remain largely undefined. Our aim was to investigate whether the dysregulation of microRNAs (miRNAs) was associated with CD4(+) T cell activation in DCM. CD4(+) T cells from DCM patients showed increased expression levels of CD25 and CD69 and enhanced proliferation in response to anti-CD3/28, indicating an activated state. miRNA profiling analysis of magnetically sorted CD4(+) T cells revealed a distinct pattern of miRNA expression in CD4(+) T cells from DCM patients compared with controls. The level of miRNA-451a (miR-451a) was significantly decreased in the CD4(+) T cells of DCM patients compared with that of the controls. The transfection of T cells with an miR-451a mimic inhibited their activation and proliferation, whereas an miR-451a inhibitor produced the opposite effects. Myc was directly inhibited by miR-451a via interaction with its 3-UTR, thus identifying it as an miR-451a target in T cells. The knockdown of Myc suppressed the activation and proliferation of T cells, and the expression of Myc was significantly up-regulated at the mRNA level in CD4(+) T cells from patients with DCM. A strong inverse correlation was observed between the Myc mRNA expression and miR-451a transcription level. Our data suggest that the down-regulation of miR-451a contributes to the activation and proliferation of CD4(+) T cells by targeting the transcription factor Myc in DCM patients and may contribute to the immunopathogenesis of DCM.	[Zeng, Zhipeng; Wang, Ke; Li, Yuanyuan; Xia, Ni; Nie, Shaofang; Lv, Bingjie; Zhang, Min; Tang, Tingting; Cheng, Xiang] Huazhong Univ Sci & Technol, Lab Cardiovasc Immunol, Key Lab Biol Targeted Therapy,Minist Educ, Inst Cardiol,Union Hosp,Tongji Med Coll, Wuhan 430022, Peoples R China; [Tu, Xin; Li, Qianqian] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, CardioX Ctr, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China; [Tu, Xin; Li, Qianqian] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tang, TT; Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Lab Cardiovasc Immunol, Key Lab Biol Targeted Therapy,Minist Educ, Inst Cardiol,Union Hosp,Tongji Med Coll, Wuhan 430022, Peoples R China.	tangtingting@hust.edu.cn; nathancx@hust.edu.cn	li, yuanyuan/GZA-4435-2022; 饭, 蔡/AAI-5850-2020	Li, Qianqian/0000-0002-8974-9768	National Basic Research Program of China 973 Program [2013CB531103, 2012CB517805]; National Natural Science Foundation of China [91339118, 81561130161, 81525003, 81200177, 81670361, 81400364, 81500186, 81600187]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 973 Program Grants 2013CB531103 and 2012CB517805 (to X. C.) and National Natural Science Foundation of China Grants 91339118, 81561130161, and 81525003 (to X. C.), 81200177 and 81670361 (to T. T. T.), 81400364 (to N. X.), 81500186 (to S. F. N.), and 81600187 (to M. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Bocharov G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00264; Charlot-Rabiega P, 2011, J BIOL CHEM, V286, P27350, DOI 10.1074/jbc.M111.221010; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen DQ, 2014, EUR J CANCER, V50, P3050, DOI 10.1016/j.ejca.2014.09.008; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Fan Kuan-Lu, 2013, Indian Heart J, V65, P12, DOI 10.1016/j.ihj.2012.12.022; Gupta MK, 2013, J MOL CELL CARDIOL, V62, P131, DOI 10.1016/j.yjmcc.2013.05.011; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Iwata M, 2001, J AM COLL CARDIOL, V37, P418, DOI 10.1016/S0735-1097(00)01109-8; Jahns R, 2008, AUTOIMMUNITY, V41, P454, DOI 10.1080/08916930802031603; Kim IM, 2014, CIRC RES, V114, P833, DOI 10.1161/CIRCRESAHA.114.302766; Kroesen BJ, 2015, IMMUNOLOGY, V144, P1, DOI 10.1111/imm.12367; Kuwabara Y, 2015, CIRC RES, V116, P279, DOI 10.1161/CIRCRESAHA.116.304707; Lauer B, 2000, J AM COLL CARDIOL, V35, P11, DOI 10.1016/S0735-1097(99)00485-4; Li XY, 2011, J EXP MED, V208, P663, DOI 10.1084/jem.20102384; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Morandi F, 2013, INT IMMUNOL, V25, P279, DOI 10.1093/intimm/dxs108; Nevers T, 2015, CIRC-HEART FAIL, V8, P776, DOI 10.1161/CIRCHEARTFAILURE.115.002225; Noutsias M, 2011, EUR J HEART FAIL, V13, P611, DOI 10.1093/eurjhf/hfr014; Posternak V., 2016, F1000RESEARCH, V5, DOI [DOI 10.12688/F1000RESEARCH.7879.1, 10.12688/f1000research.7879.1]; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Satoh M, 2011, J CARD FAIL, V17, P923, DOI 10.1016/j.cardfail.2011.07.012; Sonkoly E, 2010, J ALLERGY CLIN IMMUN, V126, P581, DOI 10.1016/j.jaci.2010.05.045; Takahashi Y, 2010, CLIN SCI, V119, P395, DOI 10.1042/CS20100003; Teteloshvili Nato, 2015, Microrna, V4, P117; Ueno A, 2007, HEART VESSELS, V22, P316, DOI 10.1007/s00380-007-0977-x; Wang HM, 2015, J CANCER RES THER, V11, pC216, DOI 10.4103/0973-1482.168189; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Weber M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/532915; Yndestad A, 2003, CARDIOVASC RES, V60, P141, DOI 10.1016/S0008-6363(03)00362-6; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007; Zhao S, 2011, ARTHRITIS RHEUM-US, V63, P1376, DOI 10.1002/art.30196; Zhao YY, 2015, BBA-MOL BASIS DIS, V1852, P2024, DOI 10.1016/j.bbadis.2015.07.016; Zhu XM, 2013, J CELL MOL MED, V17, P1173, DOI 10.1111/jcmm.12096; Zhu ZF, 2015, J LEUKOCYTE BIOL, V97, P797, DOI 10.1189/jlb.5A1014-469RR	42	24	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 7	2017	292	14					6004	6013		10.1074/jbc.M116.765107	http://dx.doi.org/10.1074/jbc.M116.765107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER5AI	27974462	hybrid, Green Published			2022-12-28	WOS:000398813200033
J	Butler, CT; Reynolds, AL; Tosetto, M; Dillon, ET; Guiry, PJ; Cagney, G; O'Sullivan, J; Kennedy, BN				Butler, Clare T.; Reynolds, Alison L.; Tosetto, Miriam; Dillon, Eugene T.; Guiry, Patrick J.; Cagney, Gerard; O'Sullivan, Jacintha; Kennedy, Breandan N.			A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; calpain; cell migration; colorectal cancer; drug development; endothelial cell; G protein-coupled receptor (GPCR); leukotriene; pharmacology; vascular endothelial growth factor (VEGF)	NF-KAPPA-B; CELL LUNG-CANCER; EXPRESSION; VEGF; MECHANISMS; IDENTIFICATION; DISCOVERY; SURVIVAL; THERAPY; PATHWAY	Excess blood vessel growth contributes to the pathology of metastatic cancers and age-related retinopathies. Despite development of improved treatments, these conditions are associated with high economic costs and drug resistance. Bevacizumab (Avastin (R)), a monoclonal antibody against vascular endothelial growth factor (VEGF), is used clinically to treat certain types of metastatic cancers. Unfortunately, many patients do not respond or inevitably become resistant to bevacizumab, highlighting the need for more effective antiangiogenic drugs with novel mechanisms of action. Previous studies discovered quininib, an antiangiogenic small molecule antagonist of cysteinyl leukotriene receptors 1 and 2 (CysLT(1) and CysLT(2)). Here, we screened a series of quininib analogues and identified a more potent antiangiogenic novel chemical entity (IUPAC name (E)-2-(2-quinolin-2-yl-vinyl)-benzene-1,4-diol HCl) hereafter designated Q8. Q8 inhibits developmental angiogenesis in Tg(fli1:EGFP) zebrafish and inhibits human microvascular endothelial cell (HMEC-1) proliferation, tubule formation, and migration. Q8 elicits antiangiogenic effects in a VEGF-independent in vitro model of angiogenesis and exerts an additive antiangiogenic response with the anti-VEGF biologic bevacizumab. Cell-based receptor binding assays confirm that Q8 is a CysLT(1) antagonist and is sufficient to reduce cellular levels of NF-B and calpain-2 and secreted levels of the proangiogenic proteins intercellular adhesion molecule-1, vascular cell adhesion protein-1, and VEGF. Distinct reductions of VEGF by bevacizumab explain the additive antiangiogenic effects observed in combination with Q8. In summary, Q8 is a more effective antiangiogenic drug compared with quininib. The VEGF-independent activity coupled with the additive antiangiogenic response observed in combination with bevacizumab demonstrates that Q8 offers an alternative therapeutic strategy to combat resistance associated with conventional anti-VEGF therapies.	[Butler, Clare T.; Reynolds, Alison L.; Dillon, Eugene T.; Cagney, Gerard; Kennedy, Breandan N.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Guiry, Patrick J.] Univ Coll Dublin, UCD Sch Chem, UCD Ctr Synth & Chem Biol, Dublin 4, Ireland; [Tosetto, Miriam] St Vincents Univ Hosp, Ctr Colorectal Dis, Dublin 4, Ireland; [O'Sullivan, Jacintha] Trinity Coll Dublin, St Jamess Hosp, Dept Surg, Trinity Translat Med Inst, Dublin 8, Ireland	University College Dublin; University College Dublin; University College Dublin; Saint Vincent's University Hospital; Trinity College Dublin	Kennedy, BN (corresponding author), Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, UCD Conway Inst F062, Dublin D04 V1W8, Ireland.	brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019	kennedy, Breandan/0000-0001-7991-4689; O'Sullivan, Jacintha/0000-0001-8622-9858; Cagney, Gerard/0000-0001-7189-9496; Reynolds, Alison/0000-0002-3147-0094	Irish Cancer Society Scholarship Grant [CRS13BUT]; Enterprise Ireland Grant [CF/20111319]	Irish Cancer Society Scholarship Grant; Enterprise Ireland Grant	This work was supported by Irish Cancer Society Scholarship Grant CRS13BUT and Enterprise Ireland Grant CF/20111319. J. O. and B. N. K. are inventors on United States Patent 8916586 B2, and A. L. R., J. O., and B. N. K. are inventors on United States Patent 9388138 B2.	Adair TH., 2010, C SERIES INTEGRATED, V2, P1, DOI DOI 10.4199/C00017ED1V01Y201009ISP010; Alswied A, 2015, J BIOL CHEM, V290, P29555, DOI 10.1074/jbc.M115.678292; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Behl T, 2016, PROSTAG OTH LIPID M, V122, P1, DOI 10.1016/j.prostaglandins.2015.12.001; Burke L, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00103; Calzado MA, 2007, CURR MED CHEM, V14, P367, DOI 10.2174/092986707779941113; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Duah E, 2013, SCI REP-UK, V3, DOI 10.1038/srep03274; Edelman MJ, 2013, TRANSL LUNG CANCER R, V2, P304, DOI 10.3978/j.issn.2218-6751.2013.01.02; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; FOLKMAN J, 1980, T OPHTHAL SOC UK, V100, P346; Galvin O, 2016, J CONTROL RELEASE, V233, P198, DOI 10.1016/j.jconrel.2016.04.004; Gunther JB, 2009, SURV OPHTHALMOL, V54, P372, DOI 10.1016/j.survophthal.2009.02.004; Han YS, 2009, GRAEF ARCH CLIN EXP, V247, P541, DOI 10.1007/s00417-008-0976-3; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Jung CH, 2012, INFLAMMATION, V35, P1041, DOI 10.1007/s10753-011-9409-2; Kanaoka Y, 2013, J BIOL CHEM, V288, P10967, DOI 10.1074/jbc.C113.453704; Kennedy B. N., 2014, Patent No. [WO 2014012889 A1, 2014012889]; Kotz J, 2012, SCIBX, V5, P1, DOI DOI 10.1038/SCIBX.2012.380; Kumler I, 2014, CANCER TREAT REV, V40, P960, DOI 10.1016/j.ctrv.2014.05.006; Lieu C, 2011, CLIN CANCER RES, V17, P6130, DOI 10.1158/1078-0432.CCR-11-0659; Lieu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077117; Lin T. J., 2011, U.S. Patent, Patent No. [20110117106 A1, 20110117106]; Loges Sonja, 2010, Genes Cancer, V1, P12, DOI 10.1177/1947601909356574; Lynch TJ, 2014, J THORAC ONCOL, V9, P1332, DOI 10.1097/JTO.0000000000000257; Magnusson C, 2010, EUR J CANCER, V46, P826, DOI 10.1016/j.ejca.2009.12.022; Metheny-Barlow LJ, 2003, CELL RES, V13, P309, DOI 10.1038/sj.cr.7290176; Montero AJ, 2012, CURR ONCOL REP, V14, P1, DOI 10.1007/s11912-011-0202-z; Murphy AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep34523; MURPHY CS, 1991, MOL PHARMACOL, V39, P421; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Park MH, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020015; Reynolds AL, 2016, J BIOL CHEM, V291, P7242, DOI 10.1074/jbc.M115.710665; Riaz MK, 2016, J SURG ONCOL, V114, P323, DOI 10.1002/jso.24333; Salajegheh A., 2016, ANGIOGENESIS HLTH DI, P375; Savari S, 2014, WORLD J GASTROENTERO, V20, P968, DOI 10.3748/wjg.v20.i4.968; Schaecher K, 2004, NEUROCHEM RES, V29, P1443, DOI 10.1023/B:NERE.0000026410.56000.dd; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Smith TJ, 2011, NEW ENGL J MED, V364, P2060, DOI 10.1056/NEJMsb1013826; Spirina LV, 2013, J CANCER RES CLIN, V139, P625, DOI 10.1007/s00432-012-1366-0; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Tsai MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23979; Turtay MG, 2010, CLIN INVEST MED, V33, pE413; van Wetering S, 2003, AM J PHYSIOL-CELL PH, V285, pC343, DOI 10.1152/ajpcell.00048.2003; Wang ZW, 2015, SEMIN CANCER BIOL, V35, pS224, DOI 10.1016/j.semcancer.2015.01.001; World Health Organization, 2012, GLOBOCAN 2012 EST CA; Wu YJ, 2006, CIRC RES, V99, P315, DOI 10.1161/01.RES.0000235986.35957.a3; Xie TX, 2010, ONCOL REP, V23, P725, DOI 10.3892/or_00000690; Xu L, 2010, PHARMAZIE, V65, P750, DOI 10.1691/ph.2010.9810; ZAMBONI R, 1992, J MED CHEM, V35, P3832, DOI 10.1021/jm00099a011	62	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3552	3567		10.1074/jbc.M116.747766	http://dx.doi.org/10.1074/jbc.M116.747766			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28035003	Green Published, hybrid			2022-12-28	WOS:000395542500002
J	Young, BM; Nguyen, E; Chedrawe, MAJ; Rainey, JK; Dupre, DJ				Young, Brent M.; Nguyen, Elaine; Chedrawe, Matthew A. J.; Rainey, Jan K.; Dupre, Denis J.			Differential Contribution of Transmembrane Domains IV, V, VI, and VII to Human Angiotensin II Type 1 Receptor Homomer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiotensin II; bioluminescence resonance energy transfer (BRET); dimerization; G protein-coupled receptor (GPCR); oligomerization; protein structure; transmembrane domain; angiotensin II type 1 receptor (AT1R)	PROTEIN-COUPLED RECEPTORS; FUNCTIONAL SELECTIVITY; ADRENERGIC-RECEPTORS; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; IN-VIVO; ANTAGONIST; ACTIVATION; INHIBITION; TARGETS	G protein-coupled receptors (GPCRs) play an important role in drug therapy and represent one of the largest families of drug targets. The angiotensin II type 1 receptor (AT1R) is notable as it has a central role in the treatment of cardiovascular disease. Blockade of AT1R signaling has been shown to alleviate hypertension and improve outcomes in patients with heart failure. Despite this, it has become apparent that our initial understanding of AT1R signaling is oversimplified. There is considerable evidence to suggest that AT1R signaling is highly modified in the presence of receptor-receptor interactions, but there is very little structural data available to explain this phenomenon even with the recent elucidation of the AT1R crystal structure. The current study investigates the involvement of transmembrane domains in AT1R homomer assembly with the goal of identifying hydrophobic interfaces that contribute to receptor-receptor affinity. A recently published crystal structure of the AT1R was used to guide site-directed mutagenesis of outward-facing hydrophobic residues within the transmembrane region of the AT1R. Bioluminescence resonance energy transfer was employed to analyze how receptor mutation affects the assembly of AT1R homomers with a specific focus on hydrophobic residues. Mutations within transmembrane domains IV, V, VI, and VII had no effect on angiotensin-mediated -arrestin1 recruitment; however, they exhibited differential effects on the assembly of AT1R into oligomeric complexes. Our results demonstrate the importance of hydrophobic amino acids at the AT1R transmembrane interface and provide the first glimpse of the requirements for AT1R complex assembly.	[Young, Brent M.; Nguyen, Elaine; Chedrawe, Matthew A. J.; Dupre, Denis J.] Dalhousie Univ, Fac Med, Dept Pharmacol, Sir Charles Tupper Med Bldg,Rm 6C,5850 Coll St, Halifax, NS B3H 4R2, Canada; [Rainey, Jan K.] Dalhousie Univ, Fac Med, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Rainey, Jan K.] Dalhousie Univ, Fac Med, Dept Chem, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Dupre, DJ (corresponding author), Dalhousie Univ, Fac Med, Dept Pharmacol, Sir Charles Tupper Med Bldg,Rm 6C,5850 Coll St, Halifax, NS B3H 4R2, Canada.	denis.dupre@dal.ca	Rainey, Jan K/C-1927-2008; Dupre, Denis J/AAI-2631-2021	Rainey, Jan K/0000-0003-0793-5573; Dupre, Denis J/0000-0001-6401-6157	NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS, National Institutes of Health Grant P41-GM103311).	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Balakumar P, 2014, J MOL ENDOCRINOL, V53, pR71, DOI 10.1530/JME-14-0125; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; BARNES PJ, 1995, AM J RESP CRIT CARE, V152, P838, DOI 10.1164/ajrccm.152.3.7663795; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Cvijic Mary Ellen, 2015, Drug Discov Today Technol, V18, P30, DOI 10.1016/j.ddtec.2015.10.005; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hansen JL, 2004, J BIOL CHEM, V279, P24108, DOI 10.1074/jbc.M400092200; Harikumar KG, 2016, J BIOL CHEM, V291, P17332, DOI 10.1074/jbc.M116.730754; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; KOUTALOS Y, 1986, PHOTOCHEM PHOTOBIOL, V44, P809; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Liu Y, 2016, CANCER LETT, V376, P226, DOI 10.1016/j.canlet.2016.03.031; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodrigues-Ferreira S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00024; Unal H, 2013, J BIOL CHEM, V288, P540, DOI 10.1074/jbc.M112.392514; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zhang HT, 2015, J BIOL CHEM, V290, P29127, DOI 10.1074/jbc.M115.689000; Zhang HT, 2015, CELL, V161, P833, DOI 10.1016/j.cell.2015.04.011	29	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3341	3350		10.1074/jbc.M116.750380	http://dx.doi.org/10.1074/jbc.M116.750380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28096461	hybrid, Green Published			2022-12-28	WOS:000395538800024
J	Jonak, CR; Lainez, NM; Roybal, LL; Williamson, AD; Coss, D				Jonak, Carrie R.; Lainez, Nancy M.; Roybal, Lacey L.; Williamson, Alexa D.; Coss, Djurdjica			c-JUN Dimerization Protein 2 (JDP2) Is a Transcriptional Repressor of Follicle-stimulating Hormone beta(FSH beta) and Is Required for Preventing Premature Reproductive Senescence in Female Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GONADOTROPIN-RELEASING-HORMONE; ANTI-MULLERIAN HORMONE; POLYCYSTIC-OVARY-SYNDROME; MESSENGER RIBONUCLEIC-ACIDS; RAT ESTROUS-CYCLE; N-TERMINAL KINASE; LUTEINIZING-HORMONE; BETA-GENE; FSH-BETA; HISTONE ACETYLATION	Follicle-stimulating hormone (FSH) regulates follicular growth and stimulates estrogen synthesis in the ovaries. FSH is a heterodimer consisting of an alpha subunit, also present in luteinizing hormone, and a unique beta subunit, which is transcriptionally regulated by gonadotropin-releasing hormone 1 (GNRH). Because most FSH is constitutively secreted, tight transcriptional regulation is critical for maintaining FSH levels within a narrow physiological range. Previously, we reported that GNRH induces FSH beta (Fshb) transcription via induction of the AP-1 transcription factor, a heterodimer of c-FOS and c-JUN. Herein, we identify c-JUN-dimerization protein 2 (JDP2) as a novel repressor of GNRH-mediated Fshb induction. JDP2 exhibited high basal expression and bound the Fshb promoter at an AP-1-binding site in a complex with c-JUN. GNRH treatment induced c-FOS to replace JDP2 as a c-JUN binding partner, forming transcriptionally active AP-1. Subsequently, rapid c-FOS degradation enabled reformation of the JDP2 complex. In vivo studies revealed that JDP2 null male mice have normal reproductive function, as expected from a negative regulator of the FSH hormone. Female JDP2 null mice, however, exhibited early puberty, observed as early vaginal opening, larger litters, and early reproductive senescence. JDP2 null females had increased levels of circulating FSH and higher expression of the Fshb subunit in the pituitary, resulting in elevated serum estrogen and higher numbers of large ovarian follicles. Disruption of JDP2 function therefore appears to cause early cessation of reproductive function, a condition that has been associated with elevated FSH in women.	[Jonak, Carrie R.; Lainez, Nancy M.; Roybal, Lacey L.; Williamson, Alexa D.; Coss, Djurdjica] Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Coss, D (corresponding author), Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA.	djurdjica.coss@ucr.edu		Coss, Djurdjica/0000-0003-0692-1612	Eunice Kennedy Shriver NICHD/National Institutes of Health (SCCPIR) Grant [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934, R01HD057549] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/National Institutes of Health (SCCPIR) Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Dr. Aronheim for the JDP2 expression vector. We are especially grateful to Drs. Akira for JDP2 null mice and Mellon for L beta T2 cells. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is a fee-for-service core facility and is supported in part by Eunice Kennedy Shriver NICHD/National Institutes of Health (SCCPIR) Grant U54-HD28934.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; BAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951, DOI 10.1210/en.136.11.4951; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Broekmans FJ, 2008, TRENDS ENDOCRIN MET, V19, P340, DOI 10.1016/j.tem.2008.08.002; BURRIN JM, 1989, MOL ENDOCRINOL, V3, P1643, DOI 10.1210/mend-3-10-1643; CESNJAJ M, 1994, ENDOCRINOLOGY, V135, P692, DOI 10.1210/en.135.2.692; Chand AL, 2010, HUM REPROD UPDATE, V16, P39, DOI 10.1093/humupd/dmp031; Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; Coss D, 2007, MOL ENDOCRINOL, V21, P3071, DOI 10.1210/me.2007-0247; Darlyuk-Saadon I, 2012, BBA-GENE REGUL MECH, V1819, P1142, DOI 10.1016/j.bbagrm.2012.09.005; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Ely HA, 2011, MOL ENDOCRINOL, V25, P669, DOI 10.1210/me.2010-0437; GAY V L, 1970, Federation Proceedings, V29, P1880; Goswami D, 2007, HORM RES, V68, P196, DOI 10.1159/000102537; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Haisenleder DJ, 2011, ENDOCRINOLOGY, V152, P4443, DOI 10.1210/en.2011-1501; Hall JE, 1998, J ENDOCRINOL INVEST, V21, P602, DOI 10.1007/BF03350785; He CY, 2010, HUM GENET, V128, P515, DOI 10.1007/s00439-010-0878-4; Howles CM, 2000, MOL CELL ENDOCRINOL, V161, P25, DOI 10.1016/S0303-7207(99)00219-1; Huhtaniemi I, 2006, MOL CELL ENDOCRINOL, V254, P84, DOI 10.1016/j.mce.2006.04.015; Huhtaniemi I, 2006, MOL CELL ENDOCRINOL, V252, P126, DOI 10.1016/j.mce.2006.03.026; Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Katz S, 2001, FEBS LETT, V506, P196, DOI 10.1016/S0014-5793(01)02907-6; Kissell KA, 2014, HUM REPROD, V29, P1764, DOI 10.1093/humrep/deu142; Lamminen T, 2005, MOL HUM REPROD, V11, P601, DOI 10.1093/molehr/gah198; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Layman LC, 2000, SEMIN REPROD MED, V18, P5, DOI 10.1055/s-2000-13470; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Lindaman LL, 2013, MOL CELL ENDOCRINOL, V365, P316, DOI 10.1016/j.mce.2012.11.012; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Mbarek H, 2016, AM J HUM GENET, V98, P898, DOI 10.1016/j.ajhg.2016.03.008; McArdle CA, 1996, J BIOL CHEM, V271, P23711, DOI 10.1074/jbc.271.39.23711; McArdle CA, 2002, J ENDOCRINOL, V173, P1, DOI 10.1677/joe.0.1730001; McArdle CA, 1999, MOL CELL ENDOCRINOL, V151, P129, DOI 10.1016/S0303-7207(99)00024-6; Meduri G, 2007, HUM REPROD, V22, P117, DOI 10.1093/humrep/del346; Mistry DS, 2011, MOL ENDOCRINOL, V25, P1387, DOI 10.1210/me.2011-0032; Morales AJ, 1996, J CLIN ENDOCR METAB, V81, P2854, DOI 10.1210/jc.81.8.2854; Nakade K, 2007, CELL DEATH DIFFER, V14, P1398, DOI 10.1038/sj.cdd.4402129; Nicol L, 2004, J MOL ENDOCRINOL, V32, P467, DOI 10.1677/jme.0.0320467; ORTOLANO GA, 1988, ENDOCRINOLOGY, V123, P2946, DOI 10.1210/endo-123-6-2946; PADMANABHAN V, 1995, BIOL REPROD, V53, P263, DOI 10.1095/biolreprod53.2.263; Pan J., 2004, NUCL ACIDS S SER OXF, DOI [10.1093/nass/48.1.189, DOI 10.1093/NASS/48.1.189]; Park M, 2014, FERTIL STERIL, V102, P847, DOI 10.1016/j.fertnstert.2014.05.031; Reddy GR, 2013, MOL ENDOCRINOL, V27, P253, DOI 10.1210/me.2012-1168; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; STOJILKOVIC SS, 1994, ENDOCR REV, V15, P462, DOI 10.1210/er.15.4.462; Taieb J, 2011, MOL ENDOCRINOL, V25, P645, DOI 10.1210/me.2010-0297; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang HZ, 2014, P NATL ACAD SCI USA, V111, P5735, DOI 10.1073/pnas.1321404111; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Weidenfeld-Baranboim K, 2011, BIOCHEM J, V436, P661, DOI 10.1042/BJ20101031; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; Xie CC, 2015, MOL CELL ENDOCRINOL, V411, P223, DOI 10.1016/j.mce.2015.04.033; Xie JJ, 2005, MOL ENDOCRINOL, V19, P2624, DOI 10.1210/me.2005-0056; ZMEILI SM, 1986, ENDOCRINOLOGY, V119, P1867, DOI 10.1210/endo-119-4-1867	63	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2646	2659		10.1074/jbc.M116.771808	http://dx.doi.org/10.1074/jbc.M116.771808			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28007961	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000395535100008
J	Saleem, S; Biswas, SC				Saleem, Suraiya; Biswas, Subhas Chandra			Tribbles Pseudokinase 3 Induces Both Apoptosis and Autophagy in Amyloid-beta-induced Neuronal Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; ANTI-TUMORAL ACTION; ALZHEIMERS-DISEASE; CELL-DEATH; ER STRESS; TRANSCRIPTION FACTOR; SYMPATHETIC NEURONS; SIGNALING PATHWAY; MEDIATES DEATH; TRB3 LINKS	Amyloid-beta(A beta)-induced neuron death is considered central to the pathogenesis of Alzheimer's disease (AD). Among several death modalities, autophagy and apoptosis play important roles in A beta-induced neuron death suggesting that there may be regulatory mechanisms that initiate both cell death pathways. However, molecules that govern both pathways have not been identified. Here, we report that, upon A beta treatment, tribbles pseudokinase 3 (Trib3, an ortholog of Drosophila Tribbles) is up-regulated in neurons both in vivo and in vitro. Increased Trib3 levels inhibited the activity of the kinase Akt by interacting with it. As a result, forkhead box O1 (FoxO1), a transcription factor that is negatively regulated by Akt, was activated, translocated to the nucleus, and induced the pro-apoptotic gene BCL2-like 11 (Bim). Conversely, FoxO1 responded to A beta insult by binding to the Trib3 gene promoter, enhancing its expression. Our investigations further revealed that Trib3 also induces autophagy. Wefound that Trib3 indirectly activates unc-51-like autophagy-activating kinase1 (Ulk1) by impeding phosphorylation of, and thus inactivating, a negative regulator of Ulk1, mechanistic target of rapamycin. Ulk1 activation augmented autophagosome formation and reduced autophagy flux. Thus, Trib3 was required for formation of autophagosomes, which accumulated in neurons as autophagic flux was thwarted. Most importantly, silencing endogenous Trib3 strongly protected neurons from A beta insult. Our results suggest that a self-amplifying feed-forward loop among Trib3, Akt, and FoxO1 in A beta-treated neurons induces both apoptosis and autophagy, culminating in neuron death. Thus, Trib3 may serve as a potential therapeutic target for AD.	[Saleem, Suraiya; Biswas, Subhas Chandra] Indian Inst Chem Biol, Council Sci & Ind Res, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Biswas, SC (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	biswassc@gmail.com			Council of Scientific and Industrial Research, Government of India [miND BSC0115]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by one of the 12th Five Year Plan Projects, miND BSC0115, from the Council of Scientific and Industrial Research, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Aime P, 2015, J NEUROSCI, V35, P10731, DOI 10.1523/JNEUROSCI.0614-15.2015; Akhter R, 2014, J BIOL CHEM, V289, P10812, DOI 10.1074/jbc.M113.519355; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Cardinale A, 2012, J BIOL CHEM, V287, P2618, DOI 10.1074/jbc.M111.276550; Chen TJ, 2009, J NEUROSCI RES, V87, P2297, DOI 10.1002/jnr.22057; Corcoran CA, 2005, CANCER BIOL THER, V4, P1063, DOI 10.4161/cbt.4.10.2205; Cravero JD, 2009, ARTHRITIS RHEUM-US, V60, P492, DOI 10.1002/art.24225; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Francois A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0139-x; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gilbert BJ, 2013, J CLIN PATHOL, V66, P362, DOI 10.1136/jclinpath-2013-201515; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Hegde ML, 2004, J MOL NEUROSCI, V22, P19, DOI 10.1385/JMN:22:1-2:19; Hegedus Z, 2006, CELL MOL LIFE SCI, V63, P1632, DOI 10.1007/s00018-006-6007-9; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Huang SB, 2013, J BIOL CHEM, V288, P33654, DOI 10.1074/jbc.M113.518134; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Liang JH, 2014, NEUROSCI BULL, V30, P308, DOI 10.1007/s12264-013-1418-8; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Moreira PI, 2010, EXPERT REV NEUROTHER, V10, P1209, DOI [10.1586/ern.10.84, 10.1586/ERN.10.84]; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Nixon RA, 2001, J ALZHEIMERS DIS, V3, P97, DOI 10.3233/JAD-2001-3114; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Onoue S, 2002, PEPTIDES, V23, P1471, DOI 10.1016/S0196-9781(02)00085-2; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Pajak B, 2009, FOLIA NEUROPATHOL, V47, P252; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Sakai S, 2010, BIOL PHARM BULL, V33, P1112, DOI 10.1248/bpb.33.1112; Salazar M, 2009, AUTOPHAGY, V5, P1048, DOI 10.4161/auto.5.7.9508; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sanphui P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.148; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Song MS, 2011, NEUROSCIENCE, V178, P181, DOI 10.1016/j.neuroscience.2010.12.055; Takahashi Y, 2008, J LIPID RES, V49, P880, DOI 10.1194/jlr.M700545-JLR200; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Troy CM, 2000, J NEUROSCI, V20, P1386; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Wu M, 2003, J BIOL CHEM, V278, P27072, DOI 10.1074/jbc.M209814200; Xuan ZY, 2005, MECH AGEING DEV, V126, P209, DOI 10.1016/j.mad.2004.09.021; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Zareen N, 2013, CELL DEATH DIFFER, V20, P1719, DOI 10.1038/cdd.2013.128; Zhang J, 2011, ORAL ONCOL, V47, P934, DOI 10.1016/j.oraloncology.2011.06.512; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zheng L, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-19; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	84	45	47	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2571	2585		10.1074/jbc.M116.744730	http://dx.doi.org/10.1074/jbc.M116.744730			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28011637	hybrid, Green Published			2022-12-28	WOS:000395535100002
J	Feng, TC; Tammineni, P; Agrawal, C; Jeong, YY; Cai, Q				Feng, Tuancheng; Tammineni, Prasad; Agrawal, Chanchal; Jeong, Yu Young; Cai, Qian			Autophagy-mediated Regulation of BACE1 Protein Trafficking and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid precursor protein (APP); autophagy; beta-secretase 1 (BACE1); protein degradation; trafficking; transport; APP processing; autophagic stress; axonal transport; lysosomal degradation	AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; PRIMARY NEURONS; RETROGRADE TRANSPORT; HIPPOCAMPAL-NEURONS; HUNTINGTON-DISEASE; MAMMALIAN TARGET; AXONAL-TRANSPORT; CORTICAL-NEURONS	beta-Site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) is the major neuronal -secretase for amyloid- generation and is degraded in lysosomes. The autophagy-lysosomal system plays a key role in the maintenance of cellular homeostasis in neurons. Recent studies established that nascent autophagosomes in distal axons move predominantly in the retrograde direction toward the soma, where mature lysosomes are mainly located. However, it remains unknown whether autophagy plays a critical role in regulation of BACE1 trafficking and degradation. Here, we report that induction of neuronal autophagy enhances BACE1 turnover, which is suppressed by lysosomal inhibition. A significant portion of BACE1 is recruited to the autophagy pathway and co-migrates robustly with autophagic vacuoles along axons. Moreover, we reveal that autophagic vacuole-associated BACE1 is accumulated in the distal axon of Alzheimer's disease-related mutant human APP transgenic neurons and mouse brains. Inducing autophagy in mutant human APP neurons augments autophagic retention of BACE1 in distal axons, leading to enhanced beta-cleavage of APP. This phenotype can be reversed by Snapin-enhanced retrograde transport, which facilitates BACE1 trafficking to lysosomes for degradation. Therefore, our study provides new insights into autophagy-mediated regulation of BACE1 turnover and APP processing, thus building a foundation for future development of potential Alzheimer's disease therapeutic strategies.	[Feng, Tuancheng; Tammineni, Prasad; Agrawal, Chanchal; Jeong, Yu Young; Cai, Qian] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Cai, Q (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Nelson Labs, 604 Allison Rd, Piscataway, NJ 08854 USA.	cai@biology.rutgers.edu		Tammineni, Prasad/0000-0002-5030-7786	National Institutes of Health [R00AG033658, R01NS089737]; Alzheimer's Association [NIRG-14-321833]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG033658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health Grants R00AG033658 and R01NS089737 (to Q.C.) and Alzheimer's Association Grant NIRG-14-321833 (to Q.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Cai QA, 2010, NEURON, V68, P73, DOI 10.1016/j.neuron.2010.09.022; Cheng XT, 2015, AUTOPHAGY, V11, P1434, DOI 10.1080/15548627.2015.1062203; Cheng XT, 2015, J CELL BIOL, V209, P377, DOI 10.1083/jcb.201412046; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Evin G, 2010, INT J BIOCHEM CELL B, V42, P1923, DOI 10.1016/j.biocel.2010.08.017; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Funderburk SF, 2010, MT SINAI J MED, V77, P59, DOI 10.1002/msj.20161; Funmilayo E, 2016, J BIOL CHEM, V291, P15753, DOI 10.1074/jbc.M116.718023; Goslin K., 1998, CULTURING NERVE CELL, P339; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Kang EL, 2012, J BIOL CHEM, V287, P42867, DOI 10.1074/jbc.M112.407072; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Lafay-Chebassier C, 2006, J NEUROSCI RES, V84, P1323, DOI 10.1002/jnr.21039; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Lefort R, 2012, J NEUROSCI, V32, P10674, DOI 10.1523/JNEUROSCI.6473-11.2012; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Maday S, 2014, DEV CELL, V30, P71, DOI 10.1016/j.devcel.2014.06.001; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nagahara AH, 2013, J NEUROSCI, V33, P15596, DOI 10.1523/JNEUROSCI.5195-12.2013; Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Overly CC, 1996, J NEUROSCI, V16, P6056; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; SUZUKI K, 1967, ACTA NEUROPATHOL, V8, P276, DOI 10.1007/BF00688828; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Willem M, 2009, SEMIN CELL DEV BIOL, V20, P175, DOI 10.1016/j.semcdb.2009.01.003; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Xie YX, 2015, NEURON, V87, P355, DOI 10.1016/j.neuron.2015.06.026; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Ye X, 2014, CELL REP, V6, P24, DOI 10.1016/j.celrep.2013.12.008; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Yue ZY, 2009, BBA-MOL CELL RES, V1793, P1496, DOI 10.1016/j.bbamcr.2009.01.016; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	69	43	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1679	1690		10.1074/jbc.M116.766584	http://dx.doi.org/10.1074/jbc.M116.766584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28028177	Green Published, hybrid			2022-12-28	WOS:000395515600012
J	Ding, YH; Gong, Z; Dong, X; Liu, K; Liu, Z; Liu, C; He, SM; Dong, MQ; Tang, C				Ding, Yue-He; Gong, Zhou; Dong, Xu; Liu, Kan; Liu, Zhu; Liu, Chao; He, Si-Min; Dong, Meng-Qiu; Tang, Chun			Modeling Protein Excited-state Structures from "Over-length" Chemical Cross-links	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-BINDING-PROTEIN; SUGAR PHOSPHOTRANSFERASE SYSTEM; MASS-SPECTROMETRY; ENZYME-I; CONFORMATIONAL ENSEMBLES; MOLECULAR ARCHITECTURE; DISTANCE RESTRAINTS; ANGSTROM RESOLUTION; DYNAMIC EQUILIBRIUM; INITIATION COMPLEX	Chemical cross-linking coupled with mass spectroscopy (CXMS) provides proximity information for the cross-linked residues and is used increasingly for modeling protein structures. However, experimentally identified cross-links are sometimes incompatible with the known structure of a protein, as the distance calculated between the cross-linked residues far exceeds the maximum length of the cross-linker. The discrepancies may persist even after eliminating potentially false cross-links and excluding intermolecular ones. Thus the "overlength" cross-links may arise from alternative excited-state conformation of the protein. Here we present a method and associated software DynaXL for visualizing the ensemble structures of multidomain proteins based on intramolecular cross-links identified by mass spectrometry with high confidence. Representing the cross-linkers and cross-linking reactions explicitly, we show that the protein excited-state structure can be modeled with as few as two over-length cross-links. We demonstrate the generality of our method with three systems: calmodulin, enzyme I, and glutamine-binding protein, and we show that these proteins alternate between different conformations for interacting with other proteins and ligands. Taken together, the over-length chemical cross-links contain valuable information about protein dynamics, and our findings here illustrate the relationship between dynamic domain movement and protein function.	[Gong, Zhou; Dong, Xu; Liu, Kan; Tang, Chun] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom Mol Phys, Natl Ctr Magnet Resonance Wuhan, Wuhan Inst Phys & Math,CAS Key Lab Magnet Resonan, Wuhan 430071, Hubei Province, Peoples R China; [Ding, Yue-He; Dong, Meng-Qiu] Natl Inst Biol Sci, 7 Sci Pk Rd,ZGC Life Sci Pk, Beijing 102206, Peoples R China; [Liu, Zhu; Tang, Chun] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Chao; He, Si-Min] Chinese Acad Sci, Inst Comp Technol, Key Lab Intelligent Informat Proc, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; National Institute of Biological Sciences, Beijing; Zhejiang University; Chinese Academy of Sciences; Institute of Computing Technology, CAS	Dong, MQ (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,ZGC Life Sci Pk, Beijing 102206, Peoples R China.; Tang, C (corresponding author), Chinese Acad Sci, Wuhan Inst Phys & Math, 30 W Xiao Hong Shan, Wuhan 43001, Peoples R China.	dongmengqiu@nibs.ac.cn; tanglab@wipm.ac.cn	Tang, Chun/P-4060-2019; ding, yuehe/AAZ-6994-2021; liu, chao/GQZ-6687-2022	liu, zhu/0000-0003-4073-7237; Dong, Meng-Qiu/0000-0002-6094-1182; Liu, Kan/0000-0002-5484-5039; Tang, Chun/0000-0001-6477-6500	Chinese Ministry of Science and Technology [2013CB910200, 2016YFA0501200, 2014CB849800, 2012CB910602]; National Natural Science Foundation of China [31225007, 21375010, 31400735, 31400644]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Ministry of Science and Technology (2013CB910200, 2016YFA0501200 (to C. T.), 2014CB849800 (to M.-Q. D.), and 2012CB910602 (to C. L.)) and the National Natural Science Foundation of China (31225007 to (to C. T.), 21375010 (to M.-Q. D.), 31400735 (to Z. G.), and 31400644 (to X. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Anthis NJ, 2011, J AM CHEM SOC, V133, P18966, DOI 10.1021/ja2082813; Belsom A, 2016, MOL CELL PROTEOMICS, V15, P1105, DOI 10.1074/mcp.M115.048504; Bermejo GA, 2012, PROTEIN SCI, V21, P1824, DOI 10.1002/pro.2163; Bertini I, 2004, P NATL ACAD SCI USA, V101, P6841, DOI 10.1073/pnas.0308641101; Bertini I, 2009, J AM CHEM SOC, V131, P5134, DOI 10.1021/ja8080764; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Case DA, 2014, AMBER 14; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferber M, 2016, NAT METHODS, V13, P515, DOI [10.1038/NMETH.3838, 10.1038/nmeth.3838]; Fernandez-Leiro R, 2016, NATURE, V537, P339, DOI 10.1038/nature19948; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Gong Zhou, 2015, Biophys Rep, V1, P127, DOI 10.1007/s41048-015-0015-y; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Jenner M, 2011, ANGEW CHEM INT EDIT, V50, P8291, DOI 10.1002/anie.201101077; Kahraman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073411; Kahraman A, 2011, BIOINFORMATICS, V27, P2163, DOI 10.1093/bioinformatics/btr348; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee YJ, 2009, J AM SOC MASS SPECTR, V20, P1896, DOI 10.1016/j.jasms.2009.06.020; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; Liu C, 2014, ANAL CHEM, V86, P5286, DOI 10.1021/ac404246w; Liu Z, 2014, BIOCHEMISTRY-US, V53, P1403, DOI 10.1021/bi4015715; Lossl P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112886; Lopez A, 2016, J MASS SPECTROM, V51, P504, DOI 10.1002/jms.3777; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Petrotchenko EV, 2014, J PROTEOMICS, V109, P104, DOI 10.1016/j.jprot.2014.06.014; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Politis A, 2014, NAT METHODS, V11, P403, DOI [10.1038/NMETH.2841, 10.1038/nmeth.2841]; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Taverner T, 2002, J BIOL CHEM, V277, P46487, DOI 10.1074/jbc.M207370200; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Venditti V, 2015, P NATL ACAD SCI USA, V112, P11565, DOI 10.1073/pnas.1515366112; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Xue ZD, 2013, BIOINFORMATICS, V29, P247, DOI 10.1093/bioinformatics/btt209; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200	54	28	29	4	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1187	1196		10.1074/jbc.M116.761841	http://dx.doi.org/10.1074/jbc.M116.761841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27994050	Green Published, hybrid			2022-12-28	WOS:000393339800004
J	Thweatt, JL; Ferlez, BH; Golbeck, JH; Bryant, DA				Thweatt, Jennifer L.; Ferlez, Bryan H.; Golbeck, John H.; Bryant, Donald A.			BciD Is a Radical S-Adenosyl-L-methionine (SAM) Enzyme That Completes Bacteriochlorophyllide e Biosynthesis by Oxidizing a Methyl Group into a Formyl Group at C-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN SULFUR BACTERIA; CHLOROBIUM-TEPIDUM CHLOROSOMES; C-20 METHYLTRANSFERASE; C BIOSYNTHESIS; PHOTOSYSTEM-I; CHLOROPHYLL-A; LIGHT; GENE; MUTANT; BCHU	Green bacteria are chlorophotorophs that synthesize bacteriochlorophyll (BChl) c, d, or e, which assemble into supramolecular, nanotubular structures in large light-harvesting structures called chlorosomes. The biosynthetic pathways of these chlorophylls are known except for one reaction. Null mutants of bciD, which encodes a putative radical S-adenosyl-L-methionine (SAM) protein, are unable to synthesize BChl e but accumulate BChl c; however, it is unknown whether BciD is sufficient to convert BChl c (or its precursor, bacteriochlorophyllide (BChlide) c) into BChl e (or BChlide e). To determine the function of BciD, we expressed the bciD gene of Chlorobaculum limnaeum strain DSMZ 1677(T) in Escherichia coli and purified the enzyme under anoxic conditions. Electron paramagnetic resonance spectroscopy of BciD indicated that it contains a single [4Fe-4S] cluster. In assays containing SAM, BChlide c or d, and sodium dithionite, BciD catalyzed the conversion of SAM into 5'-deoxyadenosine and BChlide c or d into BChlide e or f, respectively. Our analyses also identified intermediates that are proposed to be 7(1)-OH-BChlide c and d. Thus, BciD is a radical SAM enzyme that converts the methyl group of BChlide c or d into the formyl group of BChlide e or f. This probably occurs by a mechanism involving consecutive hydroxylation reactions of the C-7 methyl group to form a geminal diol intermediate, which spontaneously dehydrates to produce the final products, BChlide e or BChlide f. The demonstration that BciD is sufficient to catalyze the conversion of BChlide c into BChlide e completes the biosynthetic pathways for all "Chlorobium chlorophylls."	[Thweatt, Jennifer L.; Ferlez, Bryan H.; Golbeck, John H.; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Golbeck, John H.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Dept Biochem & Mol Biol, Althouse Lab 403C, University Pk, PA 16802 USA.	dab14@psu.edu		Ferlez, Bryan/0000-0003-0505-2099	Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences (CSGB), Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-94ER20137, DE-FG02-98ER20314]	Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences (CSGB), Office of Basic Energy Sciences of the United States Department of Energy	This work was supported by Grants DE-FG02-94ER20137 (to D. A. B.) and DE-FG02-98ER20314 (to J. H. G) from the Photosynthetic Systems Program, Division of Chemical Sciences, Geosciences, and Biosciences (CSGB), Office of Basic Energy Sciences of the United States Department of Energy. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PG, 2013, BBA-BIOENERGETICS, V1827, P1235, DOI 10.1016/j.bbabio.2013.07.004; Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; BOBE FW, 1990, BIOCHEMISTRY-US, V29, P4340, DOI 10.1021/bi00470a012; Borrego CM, 1999, PHOTOSYNTH RES, V59, P159, DOI 10.1023/A:1006161302838; BORREGO CM, 1994, PHOTOSYNTH RES, V41, P157, DOI 10.1007/BF02184156; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCHDUE M, 1978, FEMS MICROBIOL LETT, V3, P305, DOI 10.1111/j.1574-6968.1978.tb01953.x; Bryant DA, 2002, BIOCHEMISTRY-US, V41, P14403, DOI 10.1021/bi026599s; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Bryant DA, 2013, ADV BOT RES, V66, P99, DOI 10.1016/B978-0-12-397923-0.00004-7; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Chen GE, 2016, J BACTERIOL, V198, P2056, DOI 10.1128/JB.00121-16; Chew A. Gomez Maqueo, 2005, PHOTOSYNTHESIS FUNDA, P875; Chew AGM, 2007, J BACTERIOL, V189, P6176, DOI 10.1128/JB.00519-07; Delli-Bovi TA, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-73; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Frigaard N-U., 2006, COMPLEX INTRACELLULA, V2, P79, DOI [10.1007/7171_021, DOI 10.1007/7171_021]; Frigaard NU, 1997, ARCH MICROBIOL, V167, P343, DOI 10.1007/s002030050453; Frigaard NU, 2002, J BACTERIOL, V184, P3368, DOI 10.1128/JB.184.12.3368-3376.2002; Frigaard NU, 2001, APPL ENVIRON MICROB, V67, P2538, DOI 10.1128/AEM.67.6.2538-2544.2001; Harada J, 2005, FEBS LETT, V579, P1983, DOI 10.1016/j.febslet.2005.01.087; Harada J., 2005, PHOTOSYNTHESIS FUNDA, P119; Harada J, 2015, MOL MICROBIOL, V98, P1184, DOI 10.1111/mmi.13208; Harada J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060026; Harada J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00671; Ho Ming-Yang, 2017, Photosynth Res, V131, P187, DOI 10.1007/s11120-016-0303-5; Imhoff JF, 2003, INT J SYST EVOL MICR, V53, P941, DOI 10.1099/ijs.0.02403-0; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Liu ZF, 2012, ISME J, V6, P1869, DOI 10.1038/ismej.2012.24; Liu ZF, 2011, J BIOL CHEM, V286, P22393, DOI 10.1074/jbc.M111.249433; Llorens-Mares T, 2017, ISME J, V11, P201, DOI 10.1038/ismej.2016.93; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Mallorqui N, 2005, J PALEOLIMNOL, V34, P271, DOI 10.1007/s10933-005-3731-3; Manske AK, 2005, APPL ENVIRON MICROB, V71, P8049, DOI 10.1128/AEM.71.12.8049-8060.2005; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Maresca J. A., 2007, THESIS; Maresca JA, 2004, J BACTERIOL, V186, P2558, DOI 10.1128/JB.186.9.2558-2566.2004; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; Marschall E, 2010, ENVIRON MICROBIOL, V12, P1348, DOI 10.1111/j.1462-2920.2010.02178.x; Montano GA, 2003, BIOPHYS J, V85, P2560, DOI 10.1016/S0006-3495(03)74678-5; MONTESINOS E, 1983, APPL ENVIRON MICROB, V46, P1007, DOI 10.1128/AEM.46.5.1007-1016.1983; Niedzwiedzki DM, 2014, J PHYS CHEM B, V118, P2295, DOI 10.1021/jp409495m; Oostergetel GT, 2010, PHOTOSYNTH RES, V104, P245, DOI 10.1007/s11120-010-9533-0; Orf GS, 2013, PHOTOSYNTH RES, V116, P315, DOI 10.1007/s11120-013-9869-3; Orf GS, 2013, BBA-BIOENERGETICS, V1827, P493, DOI 10.1016/j.bbabio.2013.01.006; Oster U, 1997, J BIOL CHEM, V272, P9671; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Saga Y, 2004, J PHOTOCH PHOTOBIO B, V75, P89, DOI 10.1016/j.jphotobiol.2004.05.012; Saga Y, 2015, BIOCHEMISTRY-US, V54, P4998, DOI 10.1021/acs.biochem.5b00311; Scheer Hugo, 2006, V25, P1; Seo D, 2001, BBA-BIOENERGETICS, V1503, P377, DOI 10.1016/S0005-2728(00)00245-0; SHEN GZ, 1995, PHOTOSYNTH RES, V44, P41, DOI 10.1007/BF00018295; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tank M., 2016, MODERN TOPICS PHOTOT; Teramura M, 2016, PHOTOSYNTH RES, V130, P33, DOI 10.1007/s11120-016-0220-7; Teramura M, 2016, PLANT CELL PHYSIOL, V57, P1048, DOI 10.1093/pcp/pcw045; Tomitani A, 1999, NATURE, V400, P159, DOI 10.1038/22101; Tsukatani Y, 2013, PHOTOCH PHOTOBIO SCI, V12, P2195, DOI 10.1039/c3pp50253h; Van Gemerden H, 1995, ANOXYGENIC PHOTOSYNT, P49; Vila X, 2001, HYDROBIOLOGIA, V452, P15, DOI 10.1023/A:1011909330390; Vogl K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00298; Wada K, 2006, J MOL BIOL, V360, P839, DOI 10.1016/j.jmb.2006.05.057; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Yang J, 2011, MOL CELL, V44, P997, DOI 10.1016/j.molcel.2011.10.020; Yoon KS, 2001, J BIOL CHEM, V276, P44027, DOI 10.1074/jbc.M107852200; ZHAO JD, 1990, FEBS LETT, V276, P175, DOI 10.1016/0014-5793(90)80536-R; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	72	19	21	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1361	1373		10.1074/jbc.M116.767665	http://dx.doi.org/10.1074/jbc.M116.767665			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27994052	Green Published, hybrid			2022-12-28	WOS:000393339800018
J	Zhang, BY; Wang, G; Xu, XW; Yang, SS; Zhuang, TH; Wang, GP; Ren, H; Cheng, SY; Jiang, Q; Zhang, CM				Zhang, Boyan; Wang, Gang; Xu, Xiaowei; Yang, Sisi; Zhuang, Tenghan; Wang, Guopeng; Ren, He; Cheng, Steven Y.; Jiang, Qing; Zhang, Chuanmao			DAZ-interacting Protein 1 (Dzip1) Phosphorylation by Polo-like Kinase 1 (Plk1) Regulates the Centriolar Satellite Localization of the BBSome Protein during the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; ZINC-FINGER PROTEIN; MITOTIC ENTRY; PRIMARY CILIA; GLI TURNOVER; ZEBRAFISH; ENCODES; COMPLEX; CILIOGENESIS; IGUANA/DZIP1	The function of the primary cilia, which is assembled in most vertebrate cells, is achieved by transport in and out of kinds of signaling receptors. The BBSome protein complex could recognize and target membrane proteins to the cilia, but how the BBSome itself is transported into the cilia is poorly understood. Here we demonstrate that the centrosome protein Dzip1 mediates the assembly of the BBSome-Dzip1-PCM1 complex in the centriolar satellites (CS) at the G(0) phase for ciliary translocation of the BBSome. Phosphorylation of Dzip1 at Ser-210 by Plk1 (polo-like kinase 1) during the G(2) phase promotes disassembly of this complex, resulting in removal of Dzip1 and the BBSome from the CS. Inhibiting the kinase activity of Plk1 maintains the CS localization of the BBSome and Dzip1 at the G(2) phase. Collectively, our findings reveal the cell cycle-dependent regulation of BBSome transport to the CS and highlight a potential mechanism that the BBSome-mediated signaling pathways are accordingly regulated during the cell cycle.	[Zhang, Boyan; Wang, Gang; Xu, Xiaowei; Yang, Sisi; Zhuang, Tenghan; Wang, Guopeng; Ren, He; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Zhang, Boyan; Wang, Gang; Xu, Xiaowei; Yang, Sisi; Zhuang, Tenghan; Wang, Guopeng; Ren, He; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China; [Cheng, Steven Y.] Nanjing Med Univ, Sch Basic Med Sci, Dept Dev Genet, Nanjing 210029, Jiangsu, Peoples R China	Peking University; Peking University; Nanjing Medical University	Zhang, CM (corresponding author), Peking Univ, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China.; Zhang, CM (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China.	zhangcm@pku.edu.cn	Wang, Gang/Q-7267-2019	Xu, Xiaowei/0000-0001-6050-9536; Ren, He/0000-0003-0660-3657; Zhang, Boyan/0000-0001-7112-9870; Wang, Gang/0000-0002-0297-6467	National Natural Science Foundation of China (NSFC) [31520103906, 31571386, 31371365, 31430051]; Ministry of Science and Technology of China [2016YFA0100501, 2016YFA0500201]; Postdoctoral Fellowship of the Peking-Tsinghua Center for Life Sciences at Peking University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Postdoctoral Fellowship of the Peking-Tsinghua Center for Life Sciences at Peking University	This work was supported by the National Natural Science Foundation of China (NSFC) (31520103906, 31571386, 31371365, and 31430051) and the Ministry of Science and Technology of China (2016YFA0100501 and 2016YFA0500201). The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by a Postdoctoral Fellowship of the Peking-Tsinghua Center for Life Sciences at Peking University.	Barbelanne M, 2015, HUM MOL GENET, V24, P2185, DOI 10.1093/hmg/ddu738; Brand M, 1996, DEVELOPMENT, V123, P129; Chamling X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004083; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Jin ZG, 2011, J BIOL CHEM, V286, P36171, DOI 10.1074/jbc.M111.274761; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kim HR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-65; Lee K, 2011, J CELL BIOL, V195, P1093, DOI 10.1083/jcb.201106093; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Moore FL, 2004, GENOMICS, V83, P834, DOI 10.1016/j.ygeno.2003.11.005; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Schwend T, 2013, J BIOL CHEM, V288, P32809, DOI 10.1074/jbc.M113.512962; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Tay SY, 2010, DEV DYNAM, V239, P527, DOI 10.1002/dvdy.22199; Wang CB, 2013, J BIOL CHEM, V288, P29518, DOI 10.1074/jbc.M113.492066; Wang G, 2013, J CELL SCI, V126, P1355, DOI 10.1242/jcs.114918; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Zhang BY, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002129; Zhang QH, 2013, J CELL SCI, V126, P2372, DOI 10.1242/jcs.111740; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004	30	20	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1351	1360		10.1074/jbc.M116.765438	http://dx.doi.org/10.1074/jbc.M116.765438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27979967	hybrid, Green Published			2022-12-28	WOS:000393339800017
J	Alcaino, C; Musgaard, M; Minguez, T; Mazzaferro, S; Faundez, M; Iturriaga-Vasquez, P; Biggin, PC; Bermudez, I				Alcaino, Constanza; Musgaard, Maria; Minguez, Teresa; Mazzaferro, Simone; Faundez, Manuel; Iturriaga-Vasquez, Patricio; Biggin, Philip C.; Bermudez, Isabel			Role of the Cys Loop and Transmembrane Domain in the Allosteric Modulation of alpha 4 beta 2 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; X-RAY-STRUCTURE; BINDING-SITES; AGONIST-BINDING; SUBUNIT; POTENTIATION; SENSITIVITY; IDENTIFICATION; INTERFACE; DESFORMYLFLUSTRABROMINE	Allosteric modulators of pentameric ligand-gated ion channels are thought to act on elements of the pathways that couple agonist binding to channel gating. Using alpha 4 beta 2 nicotinic acetylcholine receptors and the alpha 4 beta 2-selective positive modulators 17 beta-estradiol (beta EST) and desformylflustrabromine (dFBr), we have identified pathways that link the binding sites for these modulators to the Cys loop, a region that is critical for channel gating in all pentameric ligand-gated ion channels. Previous studies have shown that the binding site for potentiating beta EST is in the C-terminal (post-M4) region of the alpha 4 subunit. Here, using homology modeling in combination with mutagenesis and electrophysiology, we identified the binding site for potentiating dFBr on the top half of a cavity between the third (M3) and fourth transmembrane (M4) alpha-helices of the alpha 4 subunit. We found that the binding sites for beta EST and dFBr communicate with the Cys loop, through interactions between the last residue of post-M4 and Phe(170) of the conserved FPF sequence of the Cys loop, and that these interactions affect potentiating efficacy. In addition, interactions between a residue in M3 (Tyr(309)) and Phe(167), a residue adjacent to the Cys loop FPF motif, also affect dFBr potentiating efficacy. Thus, the Cys loop acts as a key control element in the allosteric transduction pathway for potentiating beta EST and dFBr. Overall, we propose that positive allosteric modulators that bind the M3-M4 cavity or post-M4 region increase the efficacy of channel gating through interactions with the Cys loop.	[Alcaino, Constanza; Minguez, Teresa; Mazzaferro, Simone; Bermudez, Isabel] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Musgaard, Maria; Biggin, Philip C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Faundez, Manuel] Univ Chile, Fac Sci, Santiago 7800003, Chile; [Iturriaga-Vasquez, Patricio] Univ La Frontera, Fac Ingn & Ciencias, Dept Ciencias Quim & Recursos Nat, Temuco 4811230, Chile	Oxford Brookes University; University of Oxford; Universidad de Chile; Universidad de La Frontera	Bermudez, I (corresponding author), Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England.	ibermudez@brookes.ac.uk	Viñas, Teresa Minguez/ABI-7354-2020; Alcaino, Constanza/AAD-9788-2020	Viñas, Teresa Minguez/0000-0001-8049-3869; Alcaino, Constanza/0000-0001-9595-4330; Mazzaferro, Simone/0000-0003-4402-5325; Faundez Parraguez, Manuel/0000-0002-1621-5327; Bermudez, Isabel/0000-0001-7692-1509; Musgaard, Maria/0000-0001-6096-9014; Biggin, Philip/0000-0001-5100-8836	Oxford Brookes University; Leverhulme Trust [RPG-059]; Alfred Benzon Foundation; CONYCIT [1150615]	Oxford Brookes University; Leverhulme Trust(Leverhulme Trust); Alfred Benzon Foundation; CONYCIT	The work was supported by Oxford Brookes University funding (to C. A. and S. M.), Leverhulme Trust Grant RPG-059 (to M. M.), Alfred Benzon Foundation funding (to M. M.), and CONYCIT Grant 1150615 (to P. I.-V. and M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bondarenko V, 2013, BBA-BIOMEMBRANES, V1828, P398, DOI 10.1016/j.bbamem.2012.09.014; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Broad LM, 2006, J PHARMACOL EXP THER, V318, P1108, DOI 10.1124/jpet.106.104505; Cadugan DJ, 2007, BIOPHYS J, V93, P859, DOI 10.1529/biophysj.107.105171; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Carswell CL, 2015, STRUCTURE, V23, P1655, DOI 10.1016/j.str.2015.06.020; Cecchini M, 2015, NEUROPHARMACOLOGY, V96, P137, DOI 10.1016/j.neuropharm.2014.12.006; Changeux JP, 2013, NAT REV MOL CELL BIO, V14, P819, DOI 10.1038/nrm3695; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; De Rosa MJ, 2002, MOL PHARMACOL, V62, P406, DOI 10.1124/mol.62.2.406; Hamouda AK, 2016, MOL PHARMACOL, V89, P575, DOI 10.1124/mol.116.103341; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Hsiao B, 2001, J NEUROSCI, V21, P1848, DOI 10.1523/JNEUROSCI.21-06-01848.2001; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Jin XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144631; Jin XC, 2011, J NEUROSCI, V31, P5045, DOI 10.1523/JNEUROSCI.4802-10.2011; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Pandya A, 2011, J MOL NEUROSCI, V45, P42, DOI 10.1007/s12031-011-9509-3; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; Sala F, 2005, NEUROSCI LETT, V373, P144, DOI 10.1016/j.neulet.2004.10.002; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Weltzin MM, 2015, J PHARMACOL EXP THER, V354, P184, DOI 10.1124/jpet.115.223933; Weltzin MM, 2014, EUR J PHARMACOL, V732, P159, DOI 10.1016/j.ejphar.2012.06.001; Weltzin MM, 2010, J PHARMACOL EXP THER, V334, P917, DOI 10.1124/jpet.110.167684; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u	45	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					551	562		10.1074/jbc.M116.751206	http://dx.doi.org/10.1074/jbc.M116.751206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27864368	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000392316100012
J	Harshbarger, W; Gondi, S; Ficarro, SB; Hunter, J; Udayakumar, D; Gurbani, D; Singer, WD; Liu, Y; Li, LB; Marto, JA; Westover, KD				Harshbarger, Wayne; Gondi, Sudershan; Ficarro, Scott B.; Hunter, John; Udayakumar, Durga; Gurbani, Deepak; Singer, William D.; Liu, Yan; Li, Lianbo; Marto, Jarrod A.; Westover, Kenneth D.			Structural and Biochemical Analyses Reveal the Mechanism of Glutathione S-Transferase Pi 1 Inhibition by the Anti-cancer Compound Piperlongumine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; TUMOR-CELLS; EXPRESSION; POTENT; GST; JNK; CONJUGATE; APOPTOSIS; AUTOPHAGY; BINDING	Glutathione S-transferase pi 1 (GSTP1) is frequently overexpressed in cancerous tumors and is a putative target of the plant compound piperlongumine (PL), which contains two reactive olefins and inhibits proliferation in cancer cells but not normal cells. PL exposure of cancer cells results in increased reactive oxygen species and decreased GSH. These data in tandem with other information led to the conclusion that PL inhibits GSTP1, which forms covalent bonds between GSH and various electrophilic compounds, through covalent adduct formation at the C7-C8 olefin of PL, whereas the C2-C3 olefin of PL was postulated to react with GSH. However, direct evidence for this mechanism has been lacking. To investigate, we solved the X-ray crystal structure of GSTP1 bound to PL and GSH at 1.1 angstrom resolution to rationalize previously reported structure activity relationship studies. Surprisingly, the structure showed that a hydrolysis product of PL (hPL) was conjugated to glutathione at the C7-C8 olefin, and this complex was bound to the active site of GSTP1; no covalent bond formation between hPL and GSTP1 was observed. Mass spectrometry (MS) analysis of the reactions between PL and GSTP1 confirmed that PL does not label GSTP1. Moreover, MS data also indicated that nucleophilic attack on PL at the C2-C3 olefin led to PL hydrolysis. Although hPL inhibits GSTP1 enzymatic activity in vitro, treatment of cells susceptible to PL with hPL did not have significant antiproliferative effects, suggesting that hPL is not membrane-permeable. Altogether, our data suggest a model wherein PL is a prodrug whose intracellular hydrolysis initiates the formation of the hPL-GSH conjugate, which blocks the active site of and inhibits GSTP1 and thereby cancer cell proliferation.	[Harshbarger, Wayne; Gondi, Sudershan; Hunter, John; Udayakumar, Durga; Gurbani, Deepak; Singer, William D.; Liu, Yan; Li, Lianbo; Westover, Kenneth D.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Harshbarger, Wayne; Gondi, Sudershan; Hunter, John; Udayakumar, Durga; Gurbani, Deepak; Singer, William D.; Liu, Yan; Li, Lianbo; Westover, Kenneth D.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Westover, KD (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Westover, KD (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	kenneth.westover@utsouthwestern.edu	Westover, Ken/AAZ-1795-2020; Li, Lianbo/H-1152-2011	Westover, Ken/0000-0003-3653-5923; Li, Lianbo/0000-0003-0107-7125; GURBANI, DEEPAK/0000-0002-0982-7173	U.S. Department of Energy, Office of Biological and Environmental Research [DEAC02-06CH11357]	U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	Results shown in this report are derived from work performed at the Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under Contract DEAC02-06CH11357.	Adams DJ, 2012, P NATL ACAD SCI USA, V109, P15115, DOI 10.1073/pnas.1212802109; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Asakura T, 2007, APOPTOSIS, V12, P1269, DOI 10.1007/s10495-007-0053-0; Bharadwaj U, 2015, ONCOGENE, V34, P1341, DOI 10.1038/onc.2014.72; Boskovic ZV, 2013, TETRAHEDRON, V69, P7559, DOI 10.1016/j.tet.2013.05.080; Chen JL, 2014, BIOCHEM BIOPH RES CO, V447, P77, DOI 10.1016/j.bbrc.2014.03.100; CIACCIO PJ, 1990, CANCER COMMUN, V2, P279, DOI 10.3727/095535490820874263; Elsby R, 2003, J BIOL CHEM, V278, P22243, DOI 10.1074/jbc.M301211200; Federici L, 2009, CANCER RES, V69, P8025, DOI 10.1158/0008-5472.CAN-09-1314; Ficarro SB, 2009, ANAL CHEM, V81, P4566, DOI 10.1021/ac9004452; Ficarro SB, 2009, ANAL CHEM, V81, P3440, DOI 10.1021/ac802720e; Ginzburg S, 2014, PROSTATE, V74, P177, DOI 10.1002/pros.22739; Han JG, 2014, MOL CANCER THER, V13, P2422, DOI 10.1158/1535-7163.MCT-14-0171; Han SS, 2013, LEUKEMIA RES, V37, P146, DOI 10.1016/j.leukres.2012.11.009; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Jarvius M, 2013, BIOCHEM BIOPH RES CO, V431, P117, DOI 10.1016/j.bbrc.2013.01.017; Jin HO, 2014, J CANCER RES CLIN, V140, P2039, DOI 10.1007/s00432-014-1777-1; Kim TH, 2014, NEURO-ONCOLOGY, V16, P1354, DOI 10.1093/neuonc/nou088; KODERA Y, 1994, CANCER CHEMOTH PHARM, V34, P203; Lee H.H., 2015, EVID-BASED COMPL ALT, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0134486; Lim SM, 2014, ANGEW CHEM INT EDIT, V53, P199, DOI 10.1002/anie.201307387; Liu JM, 2013, BIOCHEM BIOPH RES CO, V437, P87, DOI 10.1016/j.bbrc.2013.06.042; Liu YY, 2014, NANOSCALE, V6, P4325, DOI 10.1039/c3nr06599e; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; MANNERVIK B, 1987, CARCINOGENESIS, V8, P1929, DOI 10.1093/carcin/8.12.1929; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morgan AS, 1996, CANCER CHEMOTH PHARM, V37, P363, DOI 10.1007/s002800050398; Niu MS, 2015, CHEM-BIOL INTERACT, V237, P66, DOI 10.1016/j.cbi.2015.05.016; Niu MS, 2015, BIOCHEM BIOPH RES CO, V462, P326, DOI 10.1016/j.bbrc.2015.04.136; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; OBrien ML, 1996, EUR J CANCER, V32A, P967, DOI 10.1016/0959-8049(96)00051-2; Parikh JR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-364; Patel K, 2015, J PHARM SCI-US, V104, P4417, DOI 10.1002/jps.24637; Pei SS, 2013, J BIOL CHEM, V288, P33542, DOI 10.1074/jbc.M113.511170; PLOEMEN JHTM, 1993, XENOBIOTICA, V23, P913, DOI 10.3109/00498259309059418; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Randhawa H, 2013, TOXICOL IN VITRO, V27, P1626, DOI 10.1016/j.tiv.2013.04.006; SINGER WD, 1992, BIOCHEM PHARMACOL, V43, P545, DOI 10.1016/0006-2952(92)90577-6; Tsuboi K, 2011, J AM CHEM SOC, V133, P16605, DOI 10.1021/ja2066972; Wang F, 2015, INT J IMMUNOPATH PH, V28, P362, DOI 10.1177/0394632015598849; Wang W, 2007, EUR J PHARMACOL, V568, P61, DOI 10.1016/j.ejphar.2007.04.021; Wang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.358; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zou P, 2015, ONCOTARGET, V6, P36505, DOI 10.18632/oncotarget.5364	46	51	52	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					112	120		10.1074/jbc.M116.750299	http://dx.doi.org/10.1074/jbc.M116.750299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27872191	Green Published, hybrid			2022-12-28	WOS:000391578000010
J	Kesavardhana, S; Das, R; Citron, M; Datta, R; Ecto, L; Srilatha, NS; DiStefano, D; Swoyer, R; Joyce, JG; Dutta, S; LaBranche, CC; Montefiori, DC; Flynn, JA; Varadarajan, R				Kesavardhana, Sannula; Das, Raksha; Citron, Michael; Datta, Rohini; Ecto, Linda; Srilatha, Nonavinakere Seetharam; DiStefano, Daniel; Swoyer, Ryan; Joyce, Joseph G.; Dutta, Somnath; LaBranche, Celia C.; Montefiori, David C.; Flynn, Jessica A.; Varadarajan, Raghavan			Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMOLECULAR DISULFIDE BOND; TYPE-1 ENVELOPE GLYCOPROTEIN; STANDARDIZED ASSESSMENTS; VACCINE; POTENT; BROAD; ENV; IMMUNOGEN; EFFICACY; RESPONSES	A major goal for HIV-1 vaccine development is an ability to elicit strong and durable broadly neutralizing antibody (bNAb) responses. The trimeric envelope glycoprotein (Env) spikes on HIV-1 are known to contain multiple epitopes that are susceptible to bNAbs isolated from infected individuals. Nonetheless, all trimeric and monomeric Env immunogens designed to date have failed to elicit such antibodies. We report the structure-guided design of HIV-1 cyclically permuted gp120 that forms homogeneous, stable trimers, and displays enhanced binding to multiple bNAbs, including VRC01, VRC03, VRCPG04, PGT128, and the quaternary epitope-specific bNAbs PGT145 and PGDM1400. Constructs that were cyclically permuted in the V1 loop region and contained an N-terminal trimerization domain to stabilize V1V2-mediated quaternary interactions, showed the highest homogeneity and the best antigenic characteristics. In guinea pigs, a DNA prime-protein boost regimen with these new gp120 trimer immunogens elicited potent neutralizing antibody responses against highly sensitive Tier 1A isolates and weaker neutralizing antibody responses with an average titer of about 115 against a panel of heterologous Tier 2 isolates. A modest fraction of the Tier 2 virus neutralizing activity appeared to target the CD4 binding site on gp120. These results suggest that cyclically permuted HIV-1 gp120 trimers represent a viable platform in which further modifications may be made to eventually achieve protective bNAb responses.	[Kesavardhana, Sannula; Das, Raksha; Datta, Rohini; Srilatha, Nonavinakere Seetharam; Dutta, Somnath; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Citron, Michael; Ecto, Linda; DiStefano, Daniel; Swoyer, Ryan; Joyce, Joseph G.; Flynn, Jessica A.] Merck & Co Inc, West Point, PA 19486 USA; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Dept Surg, Durham, NC 27705 USA	Indian Institute of Science (IISC) - Bangalore; Merck & Company; Duke University	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.; Flynn, JA (corresponding author), Merck & Co Inc, West Point, PA 19486 USA.	jessica_flynn@merck.com; varadar@mbu.iisc.ernet.in	Datta, Rohini/ABB-7867-2020; Dutta, Somnath/AAI-2977-2020	Dutta, Somnath/0000-0002-3181-0108; Datta, Rohini/0000-0003-2693-1922	Department of Biotechnology Government of India; Department of Science and Technology Government of India; International AIDS Vaccine Initiative; National Institutes of Health NIAID [R01AI118366, HHSN27201100016C]; Council of Scientific and Industrial Research, Government of India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118366] Funding Source: NIH RePORTER	Department of Biotechnology Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology Government of India(Department of Science & Technology (India)); International AIDS Vaccine Initiative; National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Departments of Biotechnology and Science and Technology Government of India, the International AIDS Vaccine Initiative, and National Institutes of Health NIAID Grant R01AI118366 (to R. V.), and National Institutes of Health NIAID Contract HHSN27201100016C (to D. C. M.) for the neutralizing antibody assays. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of a fellowship from the Council of Scientific and Industrial Research, Government of India.	Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Dames SA, 1998, NAT STRUCT BIOL, V5, P687, DOI 10.1038/1382; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kesavardhana S, 2014, J VIROL, V88, P9590, DOI 10.1128/JVI.00494-14; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lewis GK, 2014, P NATL ACAD SCI USA, V111, P15614, DOI 10.1073/pnas.1413550111; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2007, CHANNELS, V1; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liu J., 2008, EURASIP J ADV SIG PR, V2008, P1, DOI DOI 10.1074/JBC.M802695200; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; Nicely NI, 2015, EBIOMEDICINE, V2, P713, DOI 10.1016/j.ebiom.2015.06.016; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Prajapati RS, 2007, BIOCHEMISTRY-US, V46, P10339, DOI 10.1021/bi700577m; Priya RS, 2015, J BIOL CHEM, V290, P9195, DOI 10.1074/jbc.M114.621185; Rathore U, 2014, BBA-PROTEINS PROTEOM, V1844, P1891, DOI 10.1016/j.bbapap.2014.05.010; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roederer M, 2014, NATURE, V505, P502, DOI 10.1038/nature12893; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Saha P, 2012, BIOCHEMISTRY-US, V51, P1836, DOI 10.1021/bi300003v; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2000, J VIROL, V74, P5091, DOI 10.1128/JVI.74.11.5091-5100.2000; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trama AM, 2014, CELL HOST MICROBE, V16, P215, DOI 10.1016/j.chom.2014.07.003; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2016, J VIROL, V90, P636, DOI 10.1128/JVI.01645-15	71	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					278	291		10.1074/jbc.M116.725614	http://dx.doi.org/10.1074/jbc.M116.725614			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27879316	Green Published, hybrid			2022-12-28	WOS:000391578000024
J	Coope, A; Milanski, M; Arruda, AP; Ignacio-Souza, LM; Saad, MJ; Anhe, GF; Velloso, LA				Coope, Andressa; Milanski, Marciane; Arruda, Ana P.; Ignacio-Souza, Leticia M.; Saad, Mario J.; Anhe, Gabriel F.; Velloso, Licio A.			RETRACTION: Chaperone insufficiency links TLR4 signaling to endoplasmic reticulum stress (Retraction of Vol 287, Pg 15580, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Saad, Mario/ABD-8262-2020					Coope A, 2012, J BIOL CHEM, V287, P15580, DOI 10.1074/jbc.M111.315218	1	0	0	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26936	26936		10.1074/jbc.A111.315218	http://dx.doi.org/10.1074/jbc.A111.315218			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	28011878	Green Published, hybrid			2022-12-28	WOS:000391571400031
J	Gierisch, ME; Pfistner, F; Lopez-Garcia, LA; Harder, L; Schafer, BW; Niggli, FK				Gierisch, Maria E.; Pfistner, Franziska; Lopez-Garcia, Laura A.; Harder, Lena; Schafer, Beat W.; Niggli, Felix K.			Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETS TRANSCRIPTION FACTORS; EWINGS-SARCOMA; DNA-BINDING; PROSTATE-CANCER; ONCOGENIC PHENOTYPE; GENE FUSIONS; TUMOR-CELLS; TARGET GENE; FAMILY; DOMAIN	E-26 transformation-specific (ETS) proteins are transcription factors directing gene expression through their conserved DNA binding domain. They are implicated as truncated forms or interchromosomal rearrangements in a variety of tumors including Ewing sarcoma, a pediatric tumor of the bone. Tumor cells express the chimeric oncoprotein EWS-FLI1 from a specific t(22;11)(q24;12) translocation. EWS-FLI1 harbors a strong transactivation domain from EWSR1 and the DNA-binding ETS domain of FLI1 in the C-terminal part of the protein. Although Ewing cells are crucially dependent on continuous expression of EWS-FLI1, its regulation of turnover has not been characterized in detail. Here, we identify the EWS-FLI1 protein as a substrate of the ubiquitin-proteasome system with a characteristic polyubiquitination pattern. Using a global protein stability approach, we determined the half-life of EWS-FLI1 to lie between 2 and 4 h, whereas full-length EWSR1 and FLI1 were more stable. By mass spectrometry, we identified two ubiquitin acceptor lysine residues of which only mutation of Lys-380 in the ETS domain of the FLI1 part abolished EWS-FLI1 ubiquitination and stabilized the protein posttranslationally. Expression of this highly stable mutant protein in Ewing cells while simultaneously depleting the endogenous wild type protein differentially modulates two subgroups of target genes to be either EWS-FLI1 protein-dependent or turnover-dependent. The majority of target genes are in an unaltered state and cannot be further activated. Our study provides novel insights into EWS-FLI1 turnover, a critical pathway in Ewing sarcoma pathogenesis, and lays new ground to develop novel therapeutic strategies in Ewing sarcoma.	[Schafer, Beat W.] Univ Childrens Hosp, Dept Oncol, Steinwiesstr 32, CH-8032 Zurich, Switzerland; [Schafer, Beat W.] Univ Childrens Hosp, Childrens Res Ctr, Steinwiesstr 32, CH-8032 Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich	Schafer, BW (corresponding author), Univ Childrens Hosp, Dept Oncol, Steinwiesstr 32, CH-8032 Zurich, Switzerland.; Schafer, BW (corresponding author), Univ Childrens Hosp, Childrens Res Ctr, Steinwiesstr 32, CH-8032 Zurich, Switzerland.	beat.schaefer@kispi.uzh.ch	Niggli, Felix/L-6547-2017	Niggli, Felix/0000-0002-7553-3712; Schafer, Beat/0000-0001-5988-2915; Gierisch, Maria/0000-0002-8053-4402	Swiss National Science Foundation [31003A-144177]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 31003A-144177. The authors declare that they have no conflicts of interest with the contents of this article.	An J, 2015, MOL CELL, V59, P904, DOI 10.1016/j.molcel.2015.07.025; Bachmaier R, 2009, ONCOGENE, V28, P1280, DOI 10.1038/onc.2008.484; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Bolstad B, 2005, BIOINFORMATICS COMPU; Boro A, 2012, INT J CANCER, V131, P2153, DOI 10.1002/ijc.27472; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; Davidson B, 2001, CLIN CANCER RES, V7, P551; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Elzi DJ, 2014, J PROTEOME RES, V13, P3783, DOI 10.1021/pr500387m; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Gan WJ, 2015, MOL CELL, V59, P917, DOI 10.1016/j.molcel.2015.07.026; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Grunewald TGP, 2012, MOL CANCER RES, V10, P52, DOI 10.1158/1541-7786.MCR-11-0524; Hagenbuchner J., 2016, BIOCHEM PHARMACOL, V107, P1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Howarth MM, 2014, J CLIN INVEST, V124, P5275, DOI 10.1172/JCI72124; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaenicke LA, 2016, MOL CELL, V61, P54, DOI 10.1016/j.molcel.2015.11.007; Ji Z, 2007, ONCOGENE, V26, P395, DOI 10.1038/sj.onc.1209789; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540; Klevernic IV, 2009, BIOCHEM J, V418, P625, DOI 10.1042/BJ20082097; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Kovar H, 1996, CELL GROWTH DIFFER, V7, P429; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Laudet V, 1999, ONCOGENE, V18, P1351, DOI 10.1038/sj.onc.1202444; Lelievre E, 2001, INT J BIOCHEM CELL B, V33, P391, DOI 10.1016/S1357-2725(01)00025-5; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; Matsunobu T, 2006, CANCER RES, V66, P803, DOI 10.1158/0008-5472.CAN-05-1972; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Petermann R, 1998, ONCOGENE, V17, P603, DOI 10.1038/sj.onc.1201964; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Schlottmann S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00107; Selvanathan SP, 2015, P NATL ACAD SCI USA, V112, pE1307, DOI 10.1073/pnas.1500536112; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Toretsky JA, 1997, J NEURO-ONCOL, V31, P9, DOI 10.1023/A:1005716926800; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Welford SM, 2001, J BIOL CHEM, V276, P41977, DOI 10.1074/jbc.M106757200; Williamson A, 2013, MOL CELL, V49, P591, DOI 10.1016/j.molcel.2013.01.028; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	62	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26922	26933		10.1074/jbc.M116.752063	http://dx.doi.org/10.1074/jbc.M116.752063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875302	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000391571400028
J	Schiemer, J; Bohm, A; Lin, L; Merrill-Skoloff, G; Flaumenhaft, R; Huang, JS; Le Breton, GC; Chishti, AH				Schiemer, James; Bohm, Andrew; Lin, Li; Merrill-Skoloff, Glenn; Flaumenhaft, Robert; Huang, Jin-Sheng; Le Breton, Guy C.; Chishti, Athar H.			G alpha(13) Switch Region 2 Relieves Talin Autoinhibition to Activate alpha IIb beta 3 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CELL-ADHESION; G-PROTEIN; INSIDE-OUT; CONFORMATIONAL ACTIVATION; THROMBUS FORMATION; STRUCTURAL BASIS; HEAD DOMAIN; OUTSIDE-IN; PLATELETS; RETRACTION	Integrins function as bi-directional signaling transducers that regulate cell-cell and cell-matrix signals across the membrane. A key modulator of integrin activation is talin, a large cytoskeletal protein that exists in an autoinhibited state in quiescent cells. Talin is a large 235-kDa protein composed of an N-terminal 45-kDa FERM (4.1, ezrin-, radixin-, and moesin-related protein) domain, also known as the talin head domain, and a series of helical bundles known as the rod domain. The talin head domain consists of four distinct lobes designated as F0-F3. Integrin binding and activation are mediated through the F3 region, a critically regulated domain in talin. Regulation of the F3 lobe is accomplished through autoinhibition via anti-parallel dimerization. In the anti-parallel dimerization model, the rod domain region of one talin molecule binds to the F3 lobe on an adjacent talin molecule, thus achieving the state of autoinhibition. Platelet functionality requires integrin activation for adherence and thrombus formation, and thus regulation of talin presents a critical node where pharmacological intervention is possible. A major mechanism of integrin activation in platelets is through heterotrimeric G protein signaling regulating hemostasis and thrombosis. Here, we provide evidence that switch region 2 (SR2) of the ubiquitously expressed G protein (G alpha 13) directly interacts with talin, relieves its state of autoinhibition, and triggers integrin activation. Biochemical analysis of G alpha 13 shows SR2 binds directly to the F3 lobe of talin's head domain and competes with the rod domain for binding. Intramolecular FRET analysis shows G alpha 13 can relieve autoinhibition in a cellular milieu. Finally, a myristoylated SR2 peptide shows demonstrable decrease in thrombosis in vivo. Altogether, we present a mechanistic basis for the regulation of talin through G alpha 13.	[Schiemer, James; Bohm, Andrew; Lin, Li; Chishti, Athar H.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Schiemer, James; Chishti, Athar H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA; [Lin, Li; Chishti, Athar H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Pharmacol & Expt Therapeut & Mol Microbio, Boston, MA 02111 USA; [Merrill-Skoloff, Glenn; Flaumenhaft, Robert] Harvard Med Sch, Div Hemostasis & Thrombosis, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Huang, Jin-Sheng] Univ Illinois, Prot Res Lab, Res Resources Ctr, Chicago, IL 60612 USA; [Le Breton, Guy C.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	Tufts University; Tufts University; Tufts University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chishti, AH (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	athar.chishti@tufts.edu		Merrill-Skoloff, Glenn/0000-0003-2337-5107	National Institutes of Health [HL089517, HL060961, HL24530-29]; American Society of Hematology Bridge Grant Award; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112809, R01HL089517, R01HL024530, R01HL060961, R01HL125275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Bridge Grant Award; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL089517 (to A. H. C.), HL060961 (to A. H. C.), and HL24530-29 (to G. C. L.), American Society of Hematology Bridge Grant Award (to A. S. H.), and a grant-in-aid from the American Heart Association. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; CHEN YP, 1994, J BIOL CHEM, V269, P18307; COLLIER NC, 1982, J BIOL CHEM, V257, P6937; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Gautam N, 2003, STRUCTURE, V11, P359, DOI 10.1016/S0969-2126(03)00054-6; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; GOLDMANN WH, 1994, J STRUCT BIOL, V112, P3, DOI 10.1006/jsbi.1994.1002; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Goult BT, 2013, J STRUCT BIOL, V184, P21, DOI 10.1016/j.jsb.2013.05.014; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Gros E., 1967, METHOD ENZYMOL, V11, P238; Haling JR, 2011, BLOOD, V117, P1719, DOI 10.1182/blood-2010-09-305433; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; He LS, 2003, CYTOM PART A, V55A, P71, DOI 10.1002/cyto.a.10073; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Lagarrigue F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9492; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332; Leisner TM, 2011, BLOOD, V117, P1442, DOI 10.1182/blood-2010-11-317230; Liu Yang, 2012, World J Exp Med, V2, P30, DOI 10.5493/wjem.v2.i2.30; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Manganello JM, 2003, J BIOL CHEM, V278, P124, DOI 10.1074/jbc.M209219200; Moore DT, 2012, P NATL ACAD SCI USA, V109, P793, DOI 10.1073/pnas.1117220108; Nagy P., 2001, CURR PROTOC CYTOM; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Plow EF, 2015, BLOOD, V125, P207, DOI 10.1182/blood-2014-11-608992; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Song XQ, 2012, CELL RES, V22, P1533, DOI 10.1038/cr.2012.97; Spagnuolo CC, 2006, J AM CHEM SOC, V128, P12040, DOI 10.1021/ja063212q; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; Srinivasan S, 2015, J BIOL CHEM, V290, P25129, DOI 10.1074/jbc.M115.650978; Stefanini L, 2014, BLOOD, V123, P2722, DOI 10.1182/blood-2013-12-543363; Stritt S, 2015, BLOOD, V125, P219, DOI 10.1182/blood-2014-08-597542; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Vaiskunaite R, 2000, J BIOL CHEM, V275, P26206, DOI 10.1074/jbc.M001863200; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wang JH, 2012, CELL RES, V22, P1512, DOI 10.1038/cr.2012.103; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6880; Ye X, 2016, BBA-BIOMEMBRANES, V1858, P1833, DOI 10.1016/j.bbamem.2016.05.005; Zg H., 2016, STRUCTURE, V24, P721	53	9	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26598	26612		10.1074/jbc.M116.747279	http://dx.doi.org/10.1074/jbc.M116.747279			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27803165	Green Published, hybrid			2022-12-28	WOS:000391571400002
J	Brady, G; Boggan, L; Bowie, A; O'Neill, LAJ				Brady, Gareth; Boggan, Louise; Bowie, Andrew; O'Neill, Luke A. J.			Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1 (vol 280, pg 30723, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														O'Neill, Luke/0000-0002-4333-2748; Bowie, Andrew/0000-0001-5316-4373				Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25278	25278		10.1074/jbc.A116.500435	http://dx.doi.org/10.1074/jbc.A116.500435			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27888236	Green Published, hybrid			2022-12-28	WOS:000388880100041
J	Matthews, S; Belcher, JD; Tee, KL; Girvan, HM; McLean, KJ; Rigby, SEJ; Levy, CW; Leys, D; Parker, DA; Blankley, RT; Munro, AW				Matthews, Sarah; Belcher, James D.; Tee, Kang Lan; Girvan, Hazel M.; McLean, Kirsty J.; Rigby, Stephen E. J.; Levy, Colin W.; Leys, David; Parker, David A.; Blankley, Richard T.; Munro, Andrew W.			Catalytic Determinants of Alkene Production by the Cytochrome P450 Peroxygenase OleT(JE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID ALPHA-HYDROXYLASE; SPHINGOMONAS-PAUCIMOBILIS; FLAVOCYTOCHROME P450BM3; FATTY-ACIDS; MYCOBACTERIUM-TUBERCULOSIS; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; COMPOUND I; HEME IRON; DECARBOXYLATION	The Jeotgalicoccus sp. peroxygenase cytochrome P450 OleT(JE) (CYP152L1) is a hydrogen peroxide-driven oxidase that catalyzes oxidative decarboxylation of fatty acids, producing terminal alkenes with applications as fine chemicals and biofuels. Understanding mechanisms that favor decarboxylation over fatty acid hydroxylation in OleT(JE) could enable protein engineering to improve catalysis or to introduce decarboxylation activity into P450s with different substrate preferences. In this manuscript, we have focused on OleT(JE) active site residues Phe(79), His(85), and Arg(245) to interrogate their roles in substrate binding and catalytic activity. His85 is a potential proton donor to reactive iron-oxo species during substrate decarboxylation. The H85Q mutant substitutes a glutamine found in several peroxygenases that favor fatty acid hydroxylation. H85Q OleT(JE) still favors alkene production, suggesting alternative protonation mechanisms. However, the mutant undergoes only minor substrate binding-induced heme iron spin state shift toward high spin by comparison with WT OleT(JE), indicating the key role of His85 in this process. Phe79 interacts with His85, and Phe79 mutants showed diminished affinity for shorter chain (C10-C16) fatty acids and weak substrate-induced high spin conversion. F79A OleT(JE) is least affected in substrate oxidation, whereas the F79W/Y mutants exhibit lower stability and cysteine thiolate protonation on reduction. Finally, Arg245 is crucial for binding the substrate carboxylate, and R245E/L mutations severely compromise activity and heme content, although alkene products are formed from some substrates, including stearic acid (C18:0). The results identify crucial roles for the active site amino acid trio in determining OleTJE catalytic efficiency in alkene production and in regulating protein stability, heme iron coordination, and spin state.	[Matthews, Sarah; Belcher, James D.; Tee, Kang Lan; Girvan, Hazel M.; McLean, Kirsty J.; Rigby, Stephen E. J.; Levy, Colin W.; Leys, David; Munro, Andrew W.] Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Manchester M1 7DN, Lancs, England; [Parker, David A.] Westhollow Technol Ctr, Houston, TX 77028 USA; [Blankley, Richard T.] Agilent Technol UK Ltd, Chester SK8 3GR, Cheshire, England	University of Manchester; Agilent Technologies	Munro, AW (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Sch Chem, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044; Girvan, Hazel/0000-0003-2299-8644; Tee, Kang Lan/0000-0001-9458-733X	UK Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC/Shell UK Ltd. [BB/N006275/1, BB/K017802/1]; BBSRC and Agilent Technologies UK Ltd. for BBSRC Industrial CASE Ph. D. Studentship [BB/J012645/1]; Biotechnology and Biological Sciences Research Council [1225743, BB/N006275/1, BB/K017802/1, BB/E013007/1] Funding Source: researchfish; BBSRC [BB/N006275/1, BB/K017802/1, BB/E013007/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC/Shell UK Ltd.; BBSRC and Agilent Technologies UK Ltd. for BBSRC Industrial CASE Ph. D. Studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) and by BBSRC/Shell UK Ltd. for Research Grants BB/N006275/1 (to A.W.M. and D.L., supporting K.J.M. and H.M.G.) and BB/K017802/1 (to A.W.M. and D.L., supporting K.L.T.). This work was also supported by BBSRC and Agilent Technologies UK Ltd. for BBSRC Industrial CASE Ph. D. Studentship BB/J012645/1 (to A.W.M. and R.T.B., supporting S.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Amaya JA, 2016, J INORG BIOCHEM, V158, P11, DOI 10.1016/j.jinorgbio.2016.02.031; Belcher J, 2014, J BIOL CHEM, V289, P6535, DOI 10.1074/jbc.M113.527325; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Dennig A, 2015, ANGEW CHEM INT EDIT, V54, P8819, DOI 10.1002/anie.201502925; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Fujishiro T, 2011, J BIOL CHEM, V286, P29941, DOI 10.1074/jbc.M111.245225; Girhard M, 2007, BIOCHEM BIOPH RES CO, V362, P114, DOI 10.1016/j.bbrc.2007.07.155; Girvan HM, 2004, J BIOL CHEM, V279, P23274, DOI 10.1074/jbc.M401716200; Grant JL, 2016, P NATL ACAD SCI USA, V113, P10049, DOI 10.1073/pnas.1606294113; Grant JL, 2015, J AM CHEM SOC, V137, P4940, DOI 10.1021/jacs.5b01965; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; Herman NA, 2016, CURR OPIN CHEM BIOL, V35, P22, DOI 10.1016/j.cbpa.2016.08.009; Hrycay EG, 2012, ARCH BIOCHEM BIOPHYS, V522, P71, DOI 10.1016/j.abb.2012.01.003; Imai Y, 2000, J BIOCHEM-TOKYO, V128, P189, DOI 10.1093/oxfordjournals.jbchem.a022740; Joo H, 1999, NATURE, V399, P670, DOI 10.1038/21395; Joyce MG, 2004, J BIOL CHEM, V279, P23287, DOI 10.1074/jbc.M401717200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Lee DJ, 2003, P AMER CONTR CONF, P278; Li QS, 2001, BIOCHEM BIOPH RES CO, V280, P1258, DOI 10.1006/bbrc.2001.4261; Liu Y, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-28; Matsunaga I, 1999, LIPIDS, V34, P841, DOI 10.1007/s11745-999-0431-3; Matsunaga I, 1997, J BIOL CHEM, V272, P23592, DOI 10.1074/jbc.272.38.23592; Matsunaga I, 1998, J BIOCHEM-TOKYO, V124, P105, DOI 10.1093/oxfordjournals.jbchem.a022068; Matsunaga I, 2002, BIOCHEMISTRY-US, V41, P1886, DOI 10.1021/bi011883p; Matsunaga I, 2001, ARCH BIOCHEM BIOPHYS, V394, P45, DOI 10.1006/abbi.2001.2512; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Yan JY, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0219-x; Zachos L, 2015, CHEM COMMUN, V51, P1918, DOI 10.1039/c4cc07276f; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024	39	55	58	2	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 24	2017	292	12					5128	5143		10.1074/jbc.M116.762336	http://dx.doi.org/10.1074/jbc.M116.762336			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7XL	28053093	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000397590400034
J	Meng, X; Wang, YT; Wang, XM; Wrennall, JA; Rimington, TL; Li, HY; Cai, ZW; Ford, RC; Sheppard, DN				Meng, Xin; Wang, Yiting; Wang, Xiaomeng; Wrennall, Joe A.; Rimington, Tracy L.; Li, Hongyu; Cai, Zhiwei; Ford, Robert C.; Sheppard, David N.			Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; chloride channel; cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); protein purification; protein stability; ivacaftor; lumacaftor	NUCLEOTIDE-BINDING DOMAIN; CFTR POTENTIATOR; THERMODYNAMIC STABILITY; ENDOPLASMIC-RETICULUM; DELTA-F508 MUTATION; CHANNEL FUNCTION; PLASMA-MEMBRANE; IN-VITRO; F508DEL-CFTR; MECHANISM	Cystic fibrosis (CF) is caused by mutations that disrupt the plasma membrane expression, stability, and function of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel. Two small molecules, the CFTR corrector lumacaftor and the potentiator ivacaftor, are now used clinically to treat CF, although some studies suggest that they have counteracting effects on CFTR stability. Here, we investigated the impact of these compounds on the instability of F508del-CFTR, the most common CF mutation. To study individual CFTR Cl- channels, we performed single-channel recording, whereas to assess entire CFTR populations, we used purified CFTR proteins and macroscopic CFTR Cl- currents. At 37 degrees C, low temperature-rescued F508del-CFTR more rapidly lost function in cell-free membrane patches and showed altered channel gating and current flow through open channels. Compared with purified wild-type CFTR, the full-length F508del-CFTR was about 10 degrees C less thermostable. Lumacaftor partially stabilized purified full-length F508del-CFTR and slightly delayed deactivation of individual F508del-CFTR Cl- channels. By contrast, ivacaftor further destabilized full-length F508del-CFTR and accelerated channel deactivation. Chronic (prolonged) co-incubation of F508del-CFTR-expressing cells with lumacaftor and ivacaftor deactivated macroscopic F508del-CFTR Cl- currents. However, at the single-channel level, chronic co-incubation greatly increased F508del-CFTR channel activity and temporal stability in most, but not all, cell-free membrane patches. We conclude that chronic lumacaftor and ivacaftor co-treatment restores stability in a small subpopulation of F508del-CFTR Cl- channels but that the majority remain destabilized. A fuller understanding of these effects and the characterization of the small F508del-CFTR subpopulation might be crucial for CF therapy development.	[Meng, Xin; Wang, Xiaomeng; Rimington, Tracy L.; Ford, Robert C.] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Michael Smith Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England; [Wang, Yiting; Wrennall, Joe A.; Li, Hongyu; Cai, Zhiwei; Sheppard, David N.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England	University of Manchester; University of Bristol	Ford, RC (corresponding author), Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Michael Smith Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.; Sheppard, DN (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England.	robert.ford@manchester.ac.uk; D.N.Sheppard@bristol.ac.uk	wang, yiting/GYU-5306-2022; Sheppard, David N/AAV-4187-2021	Sheppard, David N/0000-0001-5533-9130; Rimington, Tracy/0000-0002-0059-123X	Cystic Fibrosis Foundation Therapeutics [FORD13XX0]; Cystic Fibrosis Trust; Beijing Sun-Hope Intellectual Property Ltd.; Medical Research Council (DTG) [MR/K501359/1]; China Scholarship Council; University of Manchester; Engineering and Physical Sciences Research Council [EP/J00961X/1]; Cystic Fibrosis Foundation Therapeutics Grant [SHEPPA14XX0]; EPSRC [EP/J00961X/1] Funding Source: UKRI; Medical Research Council [1373338] Funding Source: researchfish; Cystic Fibrosis Trust [SRC005] Funding Source: researchfish	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Trust; Beijing Sun-Hope Intellectual Property Ltd.; Medical Research Council (DTG)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); China Scholarship Council(China Scholarship Council); University of Manchester; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cystic Fibrosis Foundation Therapeutics Grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Cystic Fibrosis Trust	This work was supported by Cystic Fibrosis Foundation Therapeutics Grant FORD13XX0 and the Cystic Fibrosis Trust. This work was also supported by scholarships from Beijing Sun-Hope Intellectual Property Ltd. (to Y. W.), the Medical Research Council (DTG Grant MR/K501359/1) (to J. A. W.), and the Cystic Fibrosis Trust (to T. L. R.). R. C. F. consulted for Vertex Pharmaceuticals in 2015 and 2016.; Supported by the China Scholarship Council and the University of Manchester (President's Award).; Supported by Engineering and Physical Sciences Research Council Grant EP/J00961X/1.; Supported in part by Cystic Fibrosis Foundation Therapeutics Grant SHEPPA14XX0.	Abu-Arish A, 2015, BIOPHYS J, V109, P85, DOI 10.1016/j.bpj.2015.04.042; Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Baroni D, 2014, EUR BIOPHYS J BIOPHY, V43, P341, DOI 10.1007/s00249-014-0956-y; Birket SE, 2016, AM J PHYSIOL-LUNG C, V310, pL928, DOI 10.1152/ajplung.00395.2015; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; BROUILLETTE CG, 1982, J BIOL CHEM, V257, P12; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cui GY, 2013, J BIOL CHEM, V288, P20758, DOI 10.1074/jbc.M113.476226; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Farinha CM, 2013, CHEM BIOL, V20, P943, DOI 10.1016/j.chembiol.2013.06.004; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Flume PA, 2012, CHEST, V142, P718, DOI 10.1378/chest.11-2672; Frizzell R. A., 2012, PERSPECT MED, V2; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gao XL, 2015, P NATL ACAD SCI USA, V112, P2461, DOI 10.1073/pnas.1420676112; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; Hong H, 2014, ARCH BIOCHEM BIOPHYS, V564, P297, DOI 10.1016/j.abb.2014.07.031; Hughes LK, 2008, MOL MEMBR BIOL, V25, P528, DOI 10.1080/09687680802487967; Hunt J. F., 2013, PERSPECT MED, V3; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; Kopeikin Z, 2014, J CYST FIBROS, V13, P508, DOI 10.1016/j.jcf.2014.04.003; Lansdell KA, 2000, J PHYSIOL-LONDON, V524, P317, DOI 10.1111/j.1469-7793.2000.t01-1-00317.x; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Li HY, 2012, AM J PHYSIOL-RENAL, V303, pF1176, DOI 10.1152/ajprenal.00130.2012; Li HY, 2004, KIDNEY INT, V66, P1926, DOI 10.1111/j.1523-1755.2004.00967.x; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Loo TW, 2013, BIOCHEM PHARMACOL, V86, P612, DOI 10.1016/j.bcp.2013.06.028; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Matthes E, 2016, BRIT J PHARMACOL, V173, P459, DOI 10.1111/bph.13365; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Meng X., 2016, THESIS; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Moran O, 2005, CELL MOL LIFE SCI, V62, P446, DOI 10.1007/s00018-004-4422-3; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; O'Ryan L, 2012, JOVE-J VIS EXP, DOI 10.3791/3860; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pollock N, 2014, JOVE-J VIS EXP, DOI 10.3791/51447; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schmidt A, 2008, BRIT J PHARMACOL, V153, P1311, DOI 10.1038/sj.bjp.0707663; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Sheppard DN, 1997, J PHYSIOL-LONDON, V503, P333, DOI 10.1111/j.1469-7793.1997.333bh.x; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; Wang Y. C., 2016, THESIS; Wang YT, 2014, BRIT J PHARMACOL, V171, P4490, DOI 10.1111/bph.12791; Xu Z, 2014, J PHYSIOL-LONDON, V592, P1931, DOI 10.1113/jphysiol.2014.271817; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882	77	32	34	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3706	3719		10.1074/jbc.M116.751537	http://dx.doi.org/10.1074/jbc.M116.751537			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28087700	Green Published, hybrid			2022-12-28	WOS:000395542500014
J	Jia, L; Yan, F; Cao, WF; Chen, ZM; Zheng, H; Li, HX; Pan, Y; Narula, N; Ren, XB; Li, H; Zhou, PB				Jia, Lei; Yan, Fan; Cao, Wenfeng; Chen, Zhengming; Zheng, Hong; Li, Haixin; Pan, Yi; Narula, Navneet; Ren, Xiubao; Li, Hui; Zhou, Pengbo			Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE MICROARRAY; P53 EXPRESSION; PROGRESSION; MUTATIONS; CARCINOMA; ENCODES; SUBUNIT; SMOKING	The Cullin-RING ubiquitin ligase 4 (CRL4) is implicated in controlling cell cycle, DNA damage repair, and checkpoint response based on studies employing cell lines and mouse models. CRL4 proteins, including CUL4A and CUL4B, are often highly accumulated in human malignancies. Elevated CRL4 attenuatesDNAdamage repair and increases genome instability that is believed to facilitate tumorigenesis. However, this has yet to be evaluated in human patients with cancer. In our study, 352 lung cancer and 62 normal lung specimens of Asian origin were constructed into tissue microarrays of four distinct lung cancer subtypes. Expression of CUL4A, CUL4B, and their substrates was detected by immunohistochemistry and analyzed statistically for their prognostic value and association with DNA damage response and genomic instability. Our results show that both CUL4A and CUL4B are overexpressed in the majority of lung carcinomas (P-CUL4A < 0.001 and P-CUL4B < 0.001) and significantly associated with tumor size (P-CUL4A < 0.001 and P-CUL4B = 0.002), lymphatic invasion (P-CUL4A = 0.004 and P-CUL4B < 0.001), metastasis (P-CUL4A = 0.019 and P-CUL4B = 0.006), and advanced TNM stage (P-CUL4A < 0.001 and P-CUL4B < 0.001), which parallels gene amplification and abnormal activation of the canonical WNT signaling. Moreover, overexpression of CUL4A, but not CUL4B, is significantly associated with tobacco smoking (p = 0.01) and is inversely correlated withXPC and P21, both of which are substrates ofCUL4A(P-CUL4A = 0.019 and P-CUL4B = 0.006). Higher levels of CUL4A or CUL4B are significantly associated with the overall survival of patients(P-CUL4A <0.001 and P-CUL4B <0.001) and progression-free survival (P-CUL4A <0.001 and P-CUL4B = 0.001). Our findings revealed that CUL4A and CUL4B are differentially associated with etiologic factors for pulmonary malignancies and are independent prognostic markers for the survival of distinct lung cancer subtypes.	[Jia, Lei; Yan, Fan; Ren, Xiubao; Li, Hui; Zhou, Pengbo] Tianjin Med Univ, Canc Inst & Hosp, Dept Immunol, Key Lab Canc Immunol & Biotherapy, Tianjin 300060, Peoples R China; [Cao, Wenfeng; Pan, Yi] Tianjin Med Univ, Canc Inst & Hosp, Dept Pathol, Key Lab Tianjin Canc Prevent & Treatment, Tianjin 300060, Peoples R China; [Zheng, Hong; Li, Haixin] Tianjin Med Univ, Canc Inst & Hosp,Natl Clin Res Ctr Canc, Dept Epidemiol & Biostat,Tianjin Key Lab Canc Pre, Key Lab Breast Canc Prevent & Therapy,Minist Educ, Tianjin 300060, Peoples R China; [Li, Hui] Tianjin Med Univ, Canc Inst & Hosp, Dept Gastrointestinal Canc Biol, Tianjin 300060, Peoples R China; [Yan, Fan; Narula, Navneet; Zhou, Pengbo] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Chen, Zhengming] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10065 USA	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Cornell University; Cornell University	Ren, XB; Li, H; Zhou, PB (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Immunol, Key Lab Canc Immunol & Biotherapy, Tianjin 300060, Peoples R China.; Li, H (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Gastrointestinal Canc Biol, Tianjin 300060, Peoples R China.; Zhou, PB (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA.	rwziyi@yahoo.com; lihui@tjmuch.com; pez2001@med.cornell.edu			National Key Technology R&D Program of China [2015BAI12B12]; National Sciences Foundation of China [81272221, 81472471]; Tianjin Medical University Cancer Institute and Hospital Research [B1309]; National Institutes of Health [R01 CA159925, CA098210]; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R56CA098210, R01CA098210, R01CA159925] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Medical University Cancer Institute and Hospital Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Key Technology R&D Program of China Grant 2015BAI12B12, National Sciences Foundation of China Grants 81272221 and 81472471 (to X.R.), Tianjin Medical University Cancer Institute and Hospital Research Grant B1309 (to F.Y.), National Institutes of Health Grants R01 CA159925 and CA098210, and translational grant from the V Foundation for Cancer Research (to P.Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Camerini A, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-38; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen LC, 1998, CANCER RES, V58, P3677; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; Dai W, 2016, ONCOTARGETS THER, V9, P2297, DOI 10.2147/OTT.S98875; Dohna M, 2000, GENE CHROMOSOME CANC, V28, P145, DOI 10.1002/(SICI)1098-2264(200006)28:2<145::AID-GCC3>3.0.CO;2-7; Fujikawa H, 2012, J GASTROENTEROL, V47, P775, DOI 10.1007/s00535-012-0532-0; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Hotakainen K, 2003, INT J CANCER, V104, P631, DOI 10.1002/ijc.11000; Hung MS, 2011, J CELL MOL MED, V15, P350, DOI 10.1111/j.1582-4934.2009.00971.x; Idikio HA, 2011, INT J CLIN EXP PATHO, V4, P505; Ishida M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103993; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jiang T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0534-7; Kerzendorfer C, 2011, MECH AGEING DEV, V132, P366, DOI 10.1016/j.mad.2011.02.003; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; Lee J, 2013, BLOOD, V121, P4082, DOI 10.1182/blood-2012-09-455204; Lee J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00021; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Marin I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-267; Meyers DG, 2008, AM J CARDIOL, V102, P1421, DOI 10.1016/j.amjcard.2008.06.065; Michiels EMC, 2002, J PEDIAT HEMATOL ONC, V24, P205, DOI 10.1097/00043426-200203000-00009; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; MORABIA A, 1991, CANCER, V68, P2074, DOI 10.1002/1097-0142(19911101)68:9<2074::AID-CNCR2820680939>3.0.CO;2-X; Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838; Pan WW, 2013, J BIOL CHEM, V288, P29680, DOI 10.1074/jbc.M113.495069; Ren SC, 2012, J MOL MED, V90, P1121, DOI 10.1007/s00109-012-0885-0; Sakoda LC, 2012, INT J MOL EPIDEMIOL, V3, P1; Salvi S, 2016, ONCOTARGET, V7, P37839, DOI 10.18632/oncotarget.9341; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Selamat SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021443; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; van Cruijsen H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-180; Wang YS, 2014, CANCER RES, V74, P520, DOI 10.1158/0008-5472.CAN-13-2182; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Yin Y, 2016, J BIOL CHEM, V291, P6923, DOI 10.1074/jbc.M115.699660; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	46	31	35	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2966	2978		10.1074/jbc.M116.765230	http://dx.doi.org/10.1074/jbc.M116.765230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	27974468	hybrid, Green Published			2022-12-28	WOS:000395535100036
J	Witek, MA; Kuiper, EG; Minten, E; Crispell, EK; Conn, GL				Witek, Marta A.; Kuiper, Emily G.; Minten, Elizabeth; Crispell, Emily K.; Conn, Graeme L.			A Novel Motif for S-Adenosyl-L-methionine Binding by the Ribosomal RNA Methyltransferase TlyA from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; isothermal titration calorimetry (ITC); Mycobacterium tuberculosis; protein motif; proteolysis; RNA methylation; RNA methyltransferase; S-adenosylmethionine (SAM); site-directed mutagenesis; X-ray crystallography	CATALYTIC-ACTIVITY; RESISTANCE; CAPREOMYCIN; 16S; PURIFICATION; EXPRESSION; HEMOLYSIN; HOMOLOGY; VIOMYCIN; FAMILY	Capreomycin is a potent ribosome-targeting antibiotic that is an essential component of current antituberculosis treatments, particularly in the case of multidrug-resistant Mycobacterium tuberculosis (Mtb). Optimal capreomycin binding and Mtb ribosome inhibition requires ribosomal RNA methylation in both ribosome subunits by TlyA (Rv1694), an enzyme with dual 2'-O-methytransferase and putative hemolytic activities. Despite the important role of TlyA in capreomycin sensitivity and identification of inactivating mutations in the corresponding Mtb gene tlyA, which cause resistance to capreomycin, our current structural and mechanistic understanding of TlyA action remains limited. Here, we present structural and functional analyses of Mtb TlyA interaction with its obligatory co-substrate for methyltransferase activity, S-adenosyl-l-methionine (SAM). Despite adopting a complete class I methyltransferase fold containing conserved SAM-binding and catalytic motifs, the isolated TlyA carboxyl-terminal domain exhibits no detectable affinity for SAM. Further analyses identify a tetrapeptide motif (RXWV) in the TlyA interdomain linker as indispensable for co-substrate binding. Our results also suggest that structural plasticity of the RXWV motif could contribute to TlyA domain interactions, as well as specific recognition of its two structurally distinct ribosomal RNA targets. Our findings thus reveal a novel motif requirement for SAM binding by TlyA and set the stage for future mechanistic studies of TlyA substrate recognition and modification that underpin Mtb sensitivity to capreomycin.	[Witek, Marta A.; Kuiper, Emily G.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Kuiper, Emily G.; Minten, Elizabeth] Emory Univ, Sch Med, Biochem Cell & Dev Biol Program, Atlanta, GA 30322 USA; [Crispell, Emily K.] Emory Univ, Sch Med, Microbiol & Mol Genet Program, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Conn, GL (corresponding author), Dept Biochem, 4135 O Wayne Rollins Res Ctr,1510 Clifton Rd. NE, Atlanta, GA 30322 USA.	gconn@emory.edu		Conn, Graeme/0000-0002-2419-380X	National Science Foundation Major Research Instrumentation Program [104177]; Winship Cancer Institute's shared resource program; Biochemistry Department of Emory University; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088025] Funding Source: NIH RePORTER	National Science Foundation Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Winship Cancer Institute's shared resource program; Biochemistry Department of Emory University; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Auto-iTC<INF>200</INF> instrument was purchased with support from the National Science Foundation Major Research Instrumentation Program Grant 104177, the Winship Cancer Institute's shared resource program, and the Biochemistry Department of Emory University. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Argonne National Laboratory, was supported by the U.S. Department of Energy under Contract DE-AC02-06CH11357. We are grateful to Dr. Christine M. Dunham and her group, as well as other members of the Conn lab for useful discussions during this work and the preparation of the manuscript. We also thank Drs. Haian Fu, Eric A. Ortlund, Daniel Reines, and Keith D. Wilkinson for comments on the final manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arenas NE, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-16; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avent ML, 2011, INTERN MED J, V41, P441, DOI 10.1111/j.1445-5994.2011.02452.x; Bugl H, 2000, MOL CELL, V6, P349, DOI 10.1016/S1097-2765(00)00035-6; Conn G. L., 2009, DNA RNA MODIFICATION, P524; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295; DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720; Dunkle JA, 2014, P NATL ACAD SCI USA, V111, P6275, DOI 10.1073/pnas.1402789111; Feder M, 2003, GENE, V302, P129, DOI 10.1016/S0378-1119(02)01097-1; Ito T, 2015, P NATL ACAD SCI USA, V112, pE4197, DOI 10.1073/pnas.1422981112; Johansen SK, 2006, MOL CELL, V23, P173, DOI 10.1016/j.molcel.2006.05.044; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Long K. S., 2009, DNA RNA MODIFICATION, P537; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P3192, DOI 10.1128/AAC.49.8.3192-3197.2005; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P571, DOI 10.1128/AAC.49.2.571-577.2005; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; Monshupanee T, 2012, MOL MICROBIOL, V85, P1194, DOI 10.1111/j.1365-2958.2012.08168.x; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Noeske J, 2015, NAT STRUCT MOL BIOL, V22, P336, DOI 10.1038/nsmb.2994; O'Gara M, 1999, J MOL BIOL, V287, P201, DOI 10.1006/jmbi.1999.2608; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Punekar AS, 2012, NUCLEIC ACIDS RES, V40, P10507, DOI 10.1093/nar/gks727; Rahman A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-35; Savic M, 2008, J BACTERIOL, V190, P5855, DOI 10.1128/JB.00076-08; Stanley RE, 2010, NAT STRUCT MOL BIOL, V17, P289, DOI 10.1038/nsmb.1755; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Witek MA, 2016, NUCLEIC ACIDS RES, V44, P342, DOI 10.1093/nar/gkv1306; Witek MA, 2014, BBA-PROTEINS PROTEOM, V1844, P1648, DOI 10.1016/j.bbapap.2014.06.012; World Health Organization, 2015, GLOB TUB REP 2015; Wren BW, 1998, MICROBIOL-SGM, V144, P1205, DOI 10.1099/00221287-144-5-1205; Zelinskaya N, 2011, PROTEIN EXPRES PURIF, V75, P89, DOI 10.1016/j.pep.2010.07.005	37	13	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1977	1987		10.1074/jbc.M116.752659	http://dx.doi.org/10.1074/jbc.M116.752659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28031456	Green Published, hybrid			2022-12-28	WOS:000395515600035
J	Hayashi, Y; Nemoto-Sasaki, Y; Matsumoto, N; Tanikawa, T; Oka, S; Tanaka, Y; Arai, S; Wada, I; Sugiura, T; Yamashita, A				Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Matsumoto, Naoki; Tanikawa, Takashi; Oka, Saori; Tanaka, Yusuke; Arai, Seisuke; Wada, Ikuo; Sugiura, Takayuki; Yamashita, Atsushi			Carboxyl-terminal Tail-mediated Homodimerizations of Sphingomyelin Synthases Are Responsible for Efficient Export from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; MEMBRANE-PROTEIN; MAMMALIAN-CELLS; LIVING CELLS; RECEPTOR; OLIGOMERIZATION; LOCALIZATION; TOPOLOGY; ER; PHOSPHATIDYLCHOLINE	Sphingomyelin synthase (SMS) is the key enzyme for crosstalk between bioactive sphingolipids and glycerolipids. In mammals, SMS consists of two isoforms: SMS1 is localized in the Golgi apparatus, whereas SMS2 is localized in both the Golgi and plasma membranes. SMS2 seems to exert cellular functions through protein-protein interactions; however, the existence and functions of quaternary structures of SMS1 and SMS2 remain unclear. Here we demonstrate that both SMS1 and SMS2 form homodimers. The SMSs have six membrane-spanning domains, and theNandCtermini of both proteins face the cytosolic side of the Golgi apparatus. Chemical cross-linking and bimolecular fluorescence complementation revealed that the N-and/or C-terminal tails of the SMSs were in close proximity to those of the other SMS in the homodimer. Homodimer formation was significantly decreased by C-terminal truncations, SMS1-Delta C22 and SMS2-C30, indicating that the C-terminal tails of the SMSs are primarily responsible for homodimer formation. Moreover, immunoprecipitation using deletion mutants revealed that the C-terminal tail of SMS2 mainly interacted with the C-terminal tail of its homodimer partner, whereas the C-terminal tail of SMS1 mainly interacted with a site other than the C-terminal tail of its homodimer partner. Interestingly, homodimer formation occurred in the endoplasmic reticulum ( ER) membrane before trafficking to the Golgi apparatus. Reduced homodimerization caused by C-terminal truncations of SMSs significantly reduced ER-to-Golgi transport. Our findings suggest that the C-terminal tails of SMSs are involved in homodimer formation, which is required for efficient transport from the ER.	[Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Matsumoto, Naoki; Tanikawa, Takashi; Oka, Saori; Tanaka, Yusuke; Sugiura, Takayuki; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan; [Arai, Seisuke; Wada, Ikuo] Fukushima Med Univ, Sch Med, Dept Cell Sci, Inst Biomed Sci, Hikarigaoka 1, Fukushima, Fukushima 9601295, Japan	Teikyo University; Fukushima Medical University	Yamashita, A (corresponding author), Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan.	ayamashi@pharm.teikyo-u.ac.jp		Wada, Ikuo/0000-0001-5668-6994; Yamashita, Atsushi/0000-0002-2544-2134	Japan Society for the Promotion of Science [15K18868, 15K07946]; Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, and Technology; Grants-in-Aid for Scientific Research [15K14462] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Young Scientists (B) 15K18868 (to Y. H.) and for Scientific Research (C) 15K07946 (to A. Y.) from the Japan Society for the Promotion of Science. This work was also supported in part by the Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; BOROCHOV H, 1977, BIOCHIM BIOPHYS ACTA, V470, P382, DOI 10.1016/0005-2736(77)90129-8; Boulaflous A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-144; Cranfill PJ, 2016, NAT METHODS, V13, P557, DOI [10.1038/NMETH.3891, 10.1038/nmeth.3891]; Crichton PG, 2013, J BIOL CHEM, V288, P22163, DOI 10.1074/jbc.M113.484329; Fasana E, 2010, FASEB J, V24, P1419, DOI 10.1096/fj.09-147850; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Gao XD, 2000, J BIOL CHEM, V275, P17718, DOI 10.1074/jbc.M909946199; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hayashi Y, 2014, J BIOL CHEM, V289, P30842, DOI 10.1074/jbc.M114.574285; Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Korkhov VM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-59; Lenormand C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060813; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Liu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.266pe23; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Lord C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013367; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MARGGRAF WD, 1984, BIOCHIM BIOPHYS ACTA, V793, P346, DOI 10.1016/0005-2760(84)90248-0; Martzoukou O, 2015, J MOL BIOL, V427, P2679, DOI 10.1016/j.jmb.2015.05.021; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nazari M, 2012, BIOPHYS J, V102, P498, DOI 10.1016/j.bpj.2011.12.029; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Separovic D, 2007, BIOCHEM BIOPH RES CO, V358, P196, DOI 10.1016/j.bbrc.2007.04.095; Skube SB, 2010, CYTOSKELETON, V67, P1, DOI 10.1002/cm.20409; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Springer S, 2014, TRAFFIC, V15, P531, DOI 10.1111/tra.12157; Subathra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023644; Tani M, 2009, BIOCHEM BIOPH RES CO, V381, P328, DOI 10.1016/j.bbrc.2009.02.063; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Volkova EG, 2012, BIOL OPEN, V1, P802, DOI 10.1242/bio.20121537; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Yeang C, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-89; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004	50	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1122	1141		10.1074/jbc.M116.746602	http://dx.doi.org/10.1074/jbc.M116.746602			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27927984	hybrid, Green Published			2022-12-28	WOS:000392318700031
J	Antoniades, I; Stylianou, P; Christodoulou, N; Skourides, PA				Antoniades, Ioanna; Stylianou, Panayiota; Christodoulou, Neophytos; Skourides, Paris A.			Addressing the Functional Determinants of FAK during Ciliogenesis in Multiciliated Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CILIATED EPITHELIAL-CELLS; PROTEIN-TYROSINE KINASES; AMINO-TERMINAL DOMAIN; GROWTH-FACTOR; BASAL BODIES; FERM DOMAIN; CONFORMATIONAL-CHANGES; SIGNAL-TRANSDUCTION; DEPENDENT FUNCTIONS	We previously identified focal adhesion kinase (FAK) as an important regulator of ciliogenesis in multiciliated cells. FAK and other focal adhesion (FA) proteins associate with the basal bodies and their striated rootlets and form complexes named ciliary adhesions (CAs). CAs display similarities with FAs but are established in an integrin independent fashion and are responsible for anchoring basal bodies to the actin cytoskeleton during ciliogenesis as well as in mature multiciliated cells. FAK down-regulation leads to aberrant ciliogenesis due to impaired association between the basal bodies and the actin cytoskeleton, suggesting that FAK is an important regulator of the CA complex. However, the mechanism through which FAK functions in the complex is not clear, and in this study we examined the role of this protein in both ciliogenesis and ciliary function. Weshow that localization of FAK at CAs depends on interactions taking place at the amino-terminal (FERM) and carboxyl-terminal (FAT) domains and that both domains are required for proper ciliogenesis and ciliary function. Furthermore, we show that an interaction with another CA protein, paxillin, is essential for correct localization of FAK in multiciliated cells. This interaction is indispensable for both ciliogenesis and ciliary function. Finally, we provide evidence that despite the fact that FAK is in the active, open conformation at CAs, its kinase activity is dispensable for ciliogenesis and ciliary function revealing that FAK plays a scaffolding role in multiciliated cells. Overall these data show that the role of FAK at CAs displays similarities but also important differences compared with its role at FAs.	[Antoniades, Ioanna; Stylianou, Panayiota; Christodoulou, Neophytos; Skourides, Paris A.] Univ Cyprus, Dept Biol Sci, Lab Cell Biol & Mol Embryol, 1 Univ Ave, CY-2109 Nicosia, Cyprus	University of Cyprus	Skourides, PA (corresponding author), Univ Cyprus, Dept Biol Sci, Lab Cell Biol & Mol Embryol, 1 Univ Ave, CY-2109 Nicosia, Cyprus.	skourip@ucy.ac.cy	Christodoulou, Neophytos/AAB-7645-2019	Christodoulou, Neophytos/0000-0003-4338-5847				ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Antoniades I, 2014, DEV CELL, V28, P70, DOI 10.1016/j.devcel.2013.12.003; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; Brami-Cherrier K, 2014, EMBO J, V33, P356, DOI 10.1002/embj.201386399; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Burke MC, 2014, J CELL BIOL, V207, P123, DOI 10.1083/jcb.201406140; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chen TH, 2011, ONCOGENE, V30, P153, DOI 10.1038/onc.2010.398; Cibois M., 2014, INDUCTION DIFFERENTI, P112; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Deramaudt TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092059; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fonar Y, 2011, MOL BIOL CELL, V22, P2409, DOI 10.1091/mbc.E10-12-0932; Fujita H, 1998, J BIOL CHEM, V273, P26516, DOI 10.1074/jbc.273.41.26516; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637, DOI 10.1091/mbc.6.6.637; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ioannou A, 2013, DEV BIOL, V380, P243, DOI 10.1016/j.ydbio.2013.05.004; Jacamo RO, 2005, BIOCHEM BIOPH RES CO, V334, P1299, DOI 10.1016/j.bbrc.2005.07.034; Kardash E, 2011, NAT PROTOC, V6, P1835, DOI 10.1038/nprot.2011.395; KLOTZ C, 1986, J CELL BIOL, V103, P613, DOI 10.1083/jcb.103.2.613; Lawson C, 2012, CELL ADHES MIGR, V6, P302, DOI 10.4161/cam.20488; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P21526, DOI 10.1074/jbc.M110.129999; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Otey CA, 1996, INT REV CYTOL, V167, P161, DOI 10.1016/S0074-7696(08)61347-9; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Papusheva E, 2009, J CELL SCI, V122, P656, DOI 10.1242/jcs.028738; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Petridou NI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6240; Petridou NI, 2013, DEVELOPMENT, V140, P4266, DOI 10.1242/dev.096073; Petridou NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042577; Poullet P, 2001, J BIOL CHEM, V276, P37686, DOI 10.1074/jbc.M106175200; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schmidt KN, 2012, J CELL BIOL, V199, P1083, DOI 10.1083/jcb.201202126; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Serrels B, 2012, J CELL BIOL, V196, P185, DOI 10.1083/jcb.201112128; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; SOROKIN SP, 1968, J CELL SCI, V3, P207; Stewart A, 2002, BIOCHEM BIOPH RES CO, V299, P62, DOI 10.1016/S0006-291X(02)02547-0; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Thomas SM, 1999, J CELL SCI, V112, P181; Thordarson P, 2003, ORG BIOMOL CHEM, V1, P1216, DOI 10.1039/b211015f; TURNER CE, 1994, J CELL SCI, V107, P1583; Walentek P, 2016, ELIFE, V5, DOI 10.7554/eLife.17557; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128; Werner ME, 2011, J CELL BIOL, V195, P19, DOI 10.1083/jcb.201106110; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Zachary I, 1997, INT J BIOCHEM CELL B, V29, P929, DOI 10.1016/S1357-2725(97)00008-3; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; Zhang J, 2000, MOL CARCINOGEN, V27, P177, DOI 10.1002/(SICI)1098-2744(200003)27:3<177::AID-MC4>3.3.CO;2-J; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhao XF, 2010, J CELL BIOL, V189, P955, DOI 10.1083/jcb.200912094	83	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					488	504		10.1074/jbc.M116.767111	http://dx.doi.org/10.1074/jbc.M116.767111			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27895123	Green Published, hybrid			2022-12-28	WOS:000392316100007
J	Ting, YH; Lu, TJ; Johnson, AW; Shie, JT; Chen, BR; Suresh, SS; Lo, KY				Ting, Ya-Han; Lu, Ting-Jun; Johnson, Arlen W.; Shie, Jing-Ting; Chen, Bo-Ru; Kumar, Suresh S.; Lo, Kai-Yin			Bcp1 Is the Nuclear Chaperone of Rpl23 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							60S RIBOSOMAL-SUBUNIT; EXPORT RECEPTOR; CRYSTAL-STRUCTURE; PROTEIN COMPLEXES; INITIATION-FACTOR; DIAMOND-SYNDROME; PLASMA-MEMBRANE; CELL-GROWTH; YEAST; BIOGENESIS	Eukaryotic ribosomes are composed of rRNAs and ribosomal proteins. Ribosomal proteins are translated in the cytoplasm and imported into the nucleus for assembly with the rRNAs. It has been shown that chaperones or karyopherins responsible for import can maintain the stability of ribosomal proteins by neutralizing unfavorable positive charges and thus facilitate their transports. Among 79 ribosomal proteins in yeast, only a few are identified with specific chaperones. Besides the classic role in maintaining protein stability, chaperones have additional roles in transport, chaperoning the assembly site, and dissociation of ribosomal proteins from karyopherins. Bcp1 has been shown to be necessary for the export of Mss4, a phosphatidylinositol 4-phosphate 5-kinase, and required for ribosome biogenesis. However, its specific function in ribosome biogenesis has not been described. Here, we show that Bcp1 dissociates Rpl23 from the karyopherins and associates with Rpl23 afterward. Loss of Bcp1 causes instability of Rpl23 and deficiency of 60S subunits. In summary, Bcp1 is a novel 60S biogenesis factor via chaperoning Rpl23 in the nucleus.	[Ting, Ya-Han; Lu, Ting-Jun; Shie, Jing-Ting; Chen, Bo-Ru; Kumar, Suresh S.; Lo, Kai-Yin] Natl Taiwan Univ, Dept Agr Chem, 1 Sec 4,Roosevelt Rd, Taipei 10617, Taiwan; [Johnson, Arlen W.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Kumar, Suresh S.] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Serdang 43400, Malaysia	National Taiwan University; University of Texas System; University of Texas Austin; Universiti Putra Malaysia	Lo, KY (corresponding author), Natl Taiwan Univ, Dept Agr Chem, 1 Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	kaiyin@ntu.edu.tw		Johnson, Arlen/0000-0002-4742-085X; LO, KAI-YIN/0000-0003-0440-6836	National Science Council of Taiwan [NSC 99-2313-B-002-048-MY2]; National Taiwan University [101R7818]; National Institutes of Health [GM53655]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053655] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Council of Taiwan under Contract NSC 99-2313-B-002-048-MY2, National Taiwan University Career Development Project Grant 101R7818, and National Institutes of Health Grant GM53655(to A. W. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Audhya A, 2003, EMBO J, V22, P4223, DOI 10.1093/emboj/cdg397; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Calvino FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7510; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Defoiche J, 2009, CLIN CHEM, V55, P1824, DOI 10.1373/clinchem.2008.119446; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Eisinger DP, 1997, MOL CELL BIOL, V17, P5146, DOI 10.1128/MCB.17.9.5146; Fan JJ, 2009, CELL CYCLE, V8, P3019; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Holzer S, 2013, J MOL BIOL, V425, P4154, DOI 10.1016/j.jmb.2013.08.022; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Horigome C, 2009, BIOSCI BIOTECH BIOCH, V73, P443, DOI 10.1271/bbb.80599; Hung NJ, 2008, MOL BIOL CELL, V19, P735, DOI 10.1091/mbc.E07-09-0968; Iouk TL, 2001, MOL CELL BIOL, V21, P1260, DOI 10.1128/MCB.21.4.1260-1271.2001; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Koch B, 2012, J BIOL CHEM, V287, P21806, DOI 10.1074/jbc.M112.365791; Kressler D, 2012, SCIENCE, V338, P666, DOI 10.1126/science.1226960; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Liu JM, 2001, ONCOGENE, V20, P336, DOI 10.1038/sj.onc.1204098; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Maurer P, 2001, MOL BIOL CELL, V12, P539, DOI 10.1091/mbc.12.3.539; Meng XB, 2003, GENE, V302, P139, DOI 10.1016/S0378-1119(02)01098-3; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pausch P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8494; Pillet B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005565; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Schutz S, 2014, ELIFE, V3, DOI 10.7554/eLife.03473; Si K, 1999, MOL CELL BIOL, V19, P1416; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Tsuno A, 2000, MOL CELL BIOL, V20, P2066, DOI 10.1128/MCB.20.6.2066-2074.2000; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wyler E, 2014, FEBS LETT, V588, P3685, DOI 10.1016/j.febslet.2014.08.013; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Yao YH, 2010, RNA, V16, P1007, DOI 10.1261/rna.2012310; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	58	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					585	596		10.1074/jbc.M116.747634	http://dx.doi.org/10.1074/jbc.M116.747634			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27913624	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000392316100015
J	Nouri, K; Fansa, EK; Amin, E; Dvorsky, R; Gremer, L; Willbold, D; Schmitt, L; Timson, DJ; Ahmadian, MR				Nouri, Kazem; Fansa, Eyad K.; Amin, Ehsan; Dvorsky, Radovan; Gremer, Lothar; Willbold, Dieter; Schmitt, Lutz; Timson, David J.; Ahmadian, Mohammad R.			IQGAP1 Interaction with RHO Family Proteins Revisited KINETIC AND EQUILIBRIUM EVIDENCE FOR MULTIPLE DISTINCT BINDING SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; CELL-CELL ADHESION; CRYSTAL-STRUCTURE; ACTIN-FILAMENTS; SECONDARY STRUCTURE; SYSTEMATIC-APPROACH; NEURITE OUTGROWTH; FUNCTIONAL BASIS; STRUCTURAL BASIS; CDC42	IQ motif-containing GTPase activating protein 1 (IQGAP1) plays a central role in the physical assembly of relevant signaling networks that are responsible for various cellular processes, including cell adhesion, polarity, and transmigration. The RHO family proteins CDC42 and RAC1 have been shown to mainly interact with the GAP-related domain (GRD) of IQGAP1. However, the role of its RASGAPC-terminal (RGCT) and C-terminal domains in the interactions with RHO proteins has remained obscure. Here, we demonstrate that IQGAP1 interactions with RHO proteins underlie a multiple-step binding mechanism: (i) a high affinity, GTP-dependent binding of RGCT to the switch regions of CDC42 or RAC1 and (ii) a very low affinity binding of GRD and a C terminus adjacent to the switch regions. These data were confirmed by phosphomimetic mutation of serine 1443 to glutamate within RGCT, which led to a significant reduction of IQGAP1 affinity for CDC42 and RAC1, clearly disclosing the critical role of RGCT for these interactions. Unlike CDC42, an extremely low affinity was determined for the RAC1-GRD interaction, suggesting that the molecular nature of IQGAP1 interaction with CDC42 partially differs from that of RAC1. Our study provides new insights into the interaction characteristics of IQGAP1 with RHO family proteins and highlights the complementary importance of kinetic and equilibrium analyses. We propose that the ability of IQGAP1 to interact with RHO proteins is based on a multiple-step binding process, which is a prerequisite for the dynamic functions of IQGAP1 as a scaffolding protein and a critical mechanism in temporal regulation and integration of IQGAP1-mediated cellular responses.	[Nouri, Kazem; Fansa, Eyad K.; Amin, Ehsan; Dvorsky, Radovan; Ahmadian, Mohammad R.] Heinrich Heine Univ, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany; [Gremer, Lothar; Willbold, Dieter] Heinrich Heine Univ, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Gremer, Lothar; Willbold, Dieter] Forschungszentrum Julich, ICS 6, D-52428 Julich, Germany; [Schmitt, Lutz] Heinrich Heine Univ, Inst Biochem, D-40225 Dusseldorf, Germany; [Timson, David J.] Univ Brighton, Sch Pharm & Biomol Sci, Huxley Bldg,Lewes Rd, Brighton BN2 4GJ, E Sussex, England; [Fansa, Eyad K.] Max Planck Inst Mol Physiol, Struct Biol Grp, D-44227 Dortmund, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; University of Brighton; Max Planck Society	Ahmadian, MR (corresponding author), Heinrich Heine Univ, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1,Gebaude 22-03, D-40225 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Amin, Ehsan/GPC-5382-2022; Dvorsky, Radovan/ABE-3042-2020; Willbold, Dieter/A-6280-2013; Gremer, Lothar/H-9128-2013	Willbold, Dieter/0000-0002-0065-7366; Gremer, Lothar/0000-0001-7065-5027; Nouri, Kazem/0000-0001-7787-1304; Timson, David/0000-0002-0985-8818; Amin, Ehsan/0000-0003-2995-8864	German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB 974, IRTG 1902]; International Graduate School of Protein Science and Technology (iGRASP); Research Committee of the Medical Faculty of the Heinrich-Heine University Dusseldorf [9772617]; Biotechnology and Biological Sciences Research Council (BBSRC, UK) "Biochemical analysis of human IQGAP proteins" [BB/D000394/1]; Action Cancer Grant [PG2 2005]; BBSRC [BB/D000394/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D000394/1] Funding Source: researchfish	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); International Graduate School of Protein Science and Technology (iGRASP); Research Committee of the Medical Faculty of the Heinrich-Heine University Dusseldorf; Biotechnology and Biological Sciences Research Council (BBSRC, UK) "Biochemical analysis of human IQGAP proteins"(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Action Cancer Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft) through both the Collaborative Research Center 974 (SFB 974) "Communication and Systems Relevance during Liver Injury and Regeneration" and the International Research Training Group 1902 (IRTG 1902) "Intra- and interorgan communication of the cardiovascular system," and by the International Graduate School of Protein Science and Technology (iGRASP), the Research Committee of the Medical Faculty of the Heinrich-Heine University Dusseldorf (Grant 9772617), Biotechnology and Biological Sciences Research Council (BBSRC, UK) "Biochemical analysis of human IQGAP proteins" Grant BB/D000394/1, and Action Cancer Grant PG2 2005. The authors declare that they have no conflicts of interest with the contents of this article.	Abel AM, 2015, MOL IMMUNOL, V65, P336, DOI 10.1016/j.molimm.2015.02.012; Amin E, 2016, J BIOL CHEM, V291, P20353, DOI 10.1074/jbc.M116.736967; Amin E, 2013, BIOL CHEM, V394, P1399, DOI 10.1515/hsz-2013-0181; Bhattacharya M, 2014, J CLIN INVEST, V124, P4895, DOI 10.1172/JCI76658; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Carlier MF, 2015, CELL MOL LIFE SCI, V72, P3051, DOI 10.1007/s00018-015-1914-2; Casteel DE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377499; Choi Suyong, 2015, Advances in Biological Regulation, V60, P29, DOI 10.1016/j.jbior.2015.10.004; Dolnik O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004463; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Elliott Sarah F, 2012, World J Biol Chem, V3, P53, DOI 10.4331/wjbc.v3.i3.53; Fansa EK, 2013, BIOCHEM BIOPH RES CO, V434, P785, DOI 10.1016/j.bbrc.2013.04.012; Fiegen D, 2002, FEBS LETT, V525, P100, DOI 10.1016/S0014-5793(02)03094-6; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gotthardt K, 2007, BIOL CHEM, V388, P67, DOI 10.1515/BC.2007.008; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hota PK, 2012, CELL MOL LIFE SCI, V69, P3765, DOI 10.1007/s00018-012-1019-0; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jaiswal M, 2013, BIOL CHEM, V394, P89, DOI 10.1515/hsz-2012-0207; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Jausoro I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056574; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kimura T, 2013, MOL CELL BIOL, V33, P4834, DOI 10.1128/MCB.00895-13; Kurella VB, 2009, J BIOL CHEM, V284, P14857, DOI 10.1074/jbc.M808974200; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V262, P1, DOI 10.1006/bbrc.1999.1122; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lam B Daniel, 2013, Small GTPases, V4, P78, DOI 10.4161/sgtp.23310; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; LeCour L, 2016, STRUCTURE, V24, P1499, DOI 10.1016/j.str.2016.06.016; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li R, 1999, J BIOL CHEM, V274, P29648, DOI 10.1074/jbc.274.42.29648; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Liu J, 2014, J PROTEOME RES, V13, P1156, DOI 10.1021/pr400787p; Malarkannan S, 2012, J IMMUNOL, V188, P2057, DOI 10.4049/jimmunol.1102439; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Nomanbhoy T, 1999, BIOCHEMISTRY-US, V38, P15878, DOI 10.1021/bi9916832; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Nouri K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143634; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Pathmanathan S, 2011, BIOCHEM SOC T, V39, P694, DOI 10.1042/BST0390694; Raines RT, 2015, METHODS MOL BIOL, V1278, P323, DOI 10.1007/978-1-4939-2425-7_19; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Ruiz-Velasco R, 2002, J BIOL CHEM, V277, P33081, DOI 10.1074/jbc.M202664200; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Suyama M, 1999, NUCLEIC ACIDS RES, V27, P338, DOI 10.1093/nar/27.1.338; Takeda S, 2011, BIOCHEM BIOPH RES CO, V410, P29, DOI 10.1016/j.bbrc.2011.05.099; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Vidal-Quadras M, 2011, TRAFFIC, V12, P1879, DOI 10.1111/j.1600-0854.2011.01274.x; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042975; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776; Zhang S, 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1155/2014/302702	76	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26364	26376		10.1074/jbc.M116.752121	http://dx.doi.org/10.1074/jbc.M116.752121			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27815503	Green Published, hybrid			2022-12-28	WOS:000391568200011
J	Nadeau, SA; An, W; Mohapatra, BC; Mushtaq, I; Bielecki, TA; Luan, HT; Zutshi, N; Ahmad, G; Storck, MD; Sanada, M; Ogawa, S; Band, V; Band, H				Nadeau, Scott A.; An, Wei; Mohapatra, Bhopal C.; Mushtaq, Insha; Bielecki, Timothy A.; Luan, Haitao; Zutshi, Neha; Ahmad, Gulzar; Storck, Matthew D.; Sanada, Masashi; Ogawa, Seishi; Band, Vimla; Band, Hamid			Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; leukemia; mutagenesis; oncogene; receptor tyrosine kinase; CBL; proline-Rich region; tyrosine kinase binding domain	PHOSPHOTYROSINE-BINDING DOMAIN; ACQUIRED UNIPARENTAL DISOMY; PROTEIN-TYROSINE KINASE; RING FINGER MUTATIONS; HOMOLOGY 3 DOMAIN; LIGASE C-CBL; NEGATIVE REGULATION; DOWN-REGULATION; PHOSPHATIDYLINOSITOL 3-KINASE; PROTOONCOGENE PRODUCT	Mutations of the tyrosine kinase-directed ubiquitin ligase CBL cause myeloid leukemias, but the molecular determinants of the dominant leukemogenic activity of mutant CBL oncogenes are unclear. Here, we first define a gain-of-function attribute of the most common leukemia-associated CBL mutant, Y371H, by demonstrating its ability to increase proliferation of hematopoietic stem/progenitor cells (HSPCs) derived from CBL-null and CBL/CBL-B-null mice. Next, we express second-site point/deletion mutants of CBL-Y371H in CBL/CBL-B-null HSPCs or the cytokine-dependent human leukemic cell line TF-1 to show that individual or combined Tyr Phe mutations of established phosphotyrosine residues (Tyr-700, Tyr-731, and Tyr-774) had little impact on the activity of the CBL-Y371H mutant in HSPCs, and the triple Tyr Phe mutant was only modestly impaired in TF-1 cells. In contrast, intact tyrosine kinase-binding (TKB) domain and proline-rich region (PRR) were critical in both cell models. PRR deletion reduced the stem cell factor (SCF)-induced hyper-phosphorylation of the CBL-Y371H mutant and the c-KIT receptor and eliminated the sustained p-ERK1/2 and p-AKT induction by SCF. GST fusion protein pulldowns followed by phospho-specific antibody array analysis identified distinct CBL TKB domains or PRR-binding proteins that are phosphorylated in CBL-Y371H-expressing TF-1 cells. Our results support a model of mutant CBL gain-of-function in which mutant CBL proteins effectively compete with the remaining wild type CBL-B and juxtapose TKB domain-associated PTKs with PRR-associated signaling proteins to hyper-activate signaling downstream of hematopoietic growth factor receptors. Elucidation of mutant CBL domains required for leukemogenesis should facilitate targeted therapy approaches for patients with mutant CBL-driven leukemias.	[Nadeau, Scott A.; An, Wei; Mohapatra, Bhopal C.; Mushtaq, Insha; Bielecki, Timothy A.; Luan, Haitao; Zutshi, Neha; Ahmad, Gulzar; Storck, Matthew D.; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Nadeau, Scott A.; An, Wei; Luan, Haitao; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Mohapatra, Bhopal C.; Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Mushtaq, Insha; Zutshi, Neha; Band, Hamid] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE 68198 USA; [Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Fred & Pamela Buffet Canc Ctr, Omaha, NE 68198 USA; [Sanada, Masashi; Ogawa, Seishi] Kyoto Univ, Dept Pathol & Tumor Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Kyoto University	Band, H (corresponding author), Univ Nebraska Med Ctr, Eppley Inst, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	hband@unmc.edu	Band, Hamid/AAF-4701-2020; Ogawa, Seishi/AAE-7088-2019	Mohapatra, Bhopal/0000-0003-3434-4306; Bielecki, Timothy/0000-0003-4561-0892; Storck, Matthew/0000-0002-4029-8943	National Institutes of Health NCI Cancer Center [P30CA036727]; NATIONAL CANCER INSTITUTE [R01CA096844, P30CA036727, R01CA144027, T32CA009476, R01CA099163, R01CA116552, R01CA105489, R01CA087986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26221308, 15H05909] Funding Source: KAKEN	National Institutes of Health NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. Inder Verma (Salk Institute) for the gift of pCL-Eco plasmid and Dr. David Root (Broad Institute) for plK plasmid. We thank the Band laboratory members for discussion and the staff of the University of Nebraska Medical Center Flow Cytometry Research Facility and the Center for Comparative Medicine for assistance. The University of Nebraska Medical Center Confocal, Flow Cytometry, and other Core facilities were supported by National Institutes of Health NCI Cancer Center Support Grant P30CA036727 (to the Fred and Pamela Buffett Cancer Center and the Nebraska Research Initiative).	Adapala NS, 2010, J BIOL CHEM, V285, P36745, DOI 10.1074/jbc.M110.124628; An W, 2015, ONCOTARGET, V6, P10498, DOI 10.18632/oncotarget.3403; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; Aranaz P, 2012, HAEMATOL-HEMATOL J, V97, P1234, DOI 10.3324/haematol.2011.052605; Bacher U, 2010, ANN HEMATOL, V89, P643, DOI 10.1007/s00277-010-0920-6; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Bard F, 2002, EUR J CELL BIOL, V81, P26, DOI 10.1078/0171-9335-00217; Bartkiewicz M, 1999, J BIOL CHEM, V274, P30887, DOI 10.1074/jbc.274.43.30887; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Bunda S, 2015, ONCOGENE, V34, P789, DOI 10.1038/onc.2013.596; Bunda S, 2013, CANCER RES, V73, P2540, DOI 10.1158/0008-5472.CAN-12-3425; Caligiuri MA, 2007, BLOOD, V110, P1022, DOI 10.1182/blood-2006-12-061176; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Duan L, 2011, J BIOL CHEM, V286, P620, DOI 10.1074/jbc.M110.188086; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Duyvestyn JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094717; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fernandes MS, 2010, J BIOL CHEM, V285, P32596, DOI 10.1074/jbc.M110.106161; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; Ghosh AK, 2004, J BIOL CHEM, V279, P36132, DOI 10.1074/jbc.M404189200; Graham LJ, 1998, BIOCHEM BIOPH RES CO, V249, P537, DOI 10.1006/bbrc.1998.9177; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Javadi M, 2013, J BIOL CHEM, V288, P19459, DOI 10.1074/jbc.M113.475087; Kales SC, 2012, NAT STRUCT MOL BIOL, V19, P131, DOI 10.1038/nsmb.2241; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lill NL, 2000, J BIOL CHEM, V275, P367, DOI 10.1074/jbc.275.1.367; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Makishima H, 2012, LEUKEMIA, V26, P1547, DOI 10.1038/leu.2012.7; Marengere LEM, 1997, J IMMUNOL, V159, P70; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; MEISNER H, 1995, MOL CELL BIOL, V15, P3571; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Muramatsu H, 2010, BLOOD, V115, P1969, DOI 10.1182/blood-2009-06-226340; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nadeau S, 2012, BIOCH ANAL BIOCH, P7921, DOI DOI 10.4172/2161-1009.S6-001; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Naramura M, 2010, P NATL ACAD SCI USA, V107, P16274, DOI 10.1073/pnas.1007575107; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; Rao N, 2000, J IMMUNOL, V164, P4616, DOI 10.4049/jimmunol.164.9.4616; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Rathinam C, 2008, GENE DEV, V22, P992, DOI 10.1101/gad.1651408; Rathinam C, 2010, CANCER CELL, V18, P341, DOI 10.1016/j.ccr.2010.09.008; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; REEDQUIST KA, 1994, P NATL ACAD SCI USA, V91, P4135, DOI 10.1073/pnas.91.10.4135; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; RIVEROLEZCANO OM, 1994, J BIOL CHEM, V269, P17363; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sanjay A, 2006, FEBS J, V273, P5442, DOI 10.1111/j.1742-4658.2006.05535.x; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; SAWASDIKOSOL S, 1995, J BIOL CHEM, V270, P2893, DOI 10.1074/jbc.270.7.2893; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Wang L, 2002, ONCOGENE, V21, P5346, DOI 10.1038/sj.onc.1205670; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; YEE NS, 1994, J BIOL CHEM, V269, P31991; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768	77	8	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3666	3682		10.1074/jbc.M116.772723	http://dx.doi.org/10.1074/jbc.M116.772723			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28082680	Green Published, hybrid			2022-12-28	WOS:000395542500011
J	Waz, S; Nakamura, T; Hirata, K; Koga-Ogawa, Y; Chirifu, M; Arimori, T; Tamada, T; Ikemizu, S; Nakabeppu, Y; Yamagata, Y				Waz, Shaimaa; Nakamura, Teruya; Hirata, Keisuke; Koga-Ogawa, Yukari; Chirifu, Mami; Arimori, Takao; Tamada, Taro; Ikemizu, Shinji; Nakabeppu, Yusaku; Yamagata, Yuriko			Structural and Kinetic Studies of the Human Nudix Hydrolase MTH1 Reveal the Mechanism for Its Broad Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DNA-DAMAGE; HUMAN MUTT HOMOLOG; X-RAY ANALYSIS; CRYSTAL-STRUCTURE; PROTEIN; CANCER; EXPRESSION; CRYSTALLIZATION; NUCLEOTIDES; RECOGNITION	The human MutT homolog 1 (hMTH1, human NUDT1) hydrolyzes oxidatively damaged nucleoside triphosphates and is the main enzyme responsible for nucleotide sanitization. hMTH1 recently has received attention as an anticancer target because hMTH1 blockade leads to accumulation of oxidized nucleotides in the cell, resulting in mutations and death of cancer cells. Unlike Escherichia coli MutT, which shows high substrate specificity for 8-oxoguanine nucleotides, hMTH1 has broad substrate specificity for oxidized nucleotides, including 8-oxo-dGTP and 2-oxo-dATP. However, the reason for this broad substrate specificity remains unclear. Here, we determined crystal structures of hMTH1 in complex with 8-oxodGTP or 2-oxo-dATP at neutral pH. These structures based on high quality data showed that the base moieties of two substrates are located on the similar but not the same position in the substrate binding pocket and adopt a different hydrogen-bonding pattern, and both triphosphate moieties bind to the hMTH1 Nudix motif (i.e. the hydrolase motif) similarly and align for the hydrolysis reaction. We also performed kinetic assays on the substrate-binding Asp-120 mutants (D120N and D120A), and determined their crystal structures in complex with the substrates. Analyses of bond lengths with high-resolution X-ray data and the relationship between the structure and enzymatic nucleotides via an exchange of the protonation state at two neighboring aspartate residues (Asp-119 and Asp-120) in its substrate binding pocket. To our knowledge, this mechanism of broad substrate recognition by enzymes has not been reported previously and may have relevance for anticancer drug development strategies targeting hMTH1.	[Waz, Shaimaa; Nakamura, Teruya; Hirata, Keisuke; Koga-Ogawa, Yukari; Chirifu, Mami; Ikemizu, Shinji; Yamagata, Yuriko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan; [Nakamura, Teruya] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8620973, Japan; [Arimori, Takao; Tamada, Taro] Natl Inst Quantum & Radiol Sci & Technol, Quantum Beam Sci Res Directorate, Tokai, Ibaraki 3191106, Japan; [Nakabeppu, Yusaku] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Koga-Ogawa, Yukari] Nihon Inst Med Sci, Iruma, Saitama 3500435, Japan; [Arimori, Takao] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Kumamoto University; Kumamoto University; National Institutes for Quantum Science & Technology; Kyushu University; Osaka University	Yamagata, Y (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	yamagata@gpo.kumamoto-u.ac.jp	Nakabeppu, Yusaku/A-8902-2011	Nakabeppu, Yusaku/0000-0002-6739-242X; Arimori, Takao/0000-0002-6063-5572; Tamada, Taro/0000-0003-1419-8022; Nakamura, Teruya/0000-0003-2013-3057; Waz, Shaimaa/0000-0002-1665-4864	Ministry of Education Culture, Sports, Sciences and Technology of Japan; Egyptian Ministry of Higher Education	Ministry of Education Culture, Sports, Sciences and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF))	This work was supported in part by Grants-in-aid for Scientific Research and the Photon and Quantum Basic Research Coordinated Development Program from the Ministry of Education, Culture, Sports, Sciences and Technology of Japan and the Egyptian Ministry of Higher Education (to S. W.). The authors declare that they have no conflicts of interest with the contents of this article	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed HU, 2007, ACTA CRYSTALLOGR D, V63, P906, DOI 10.1107/S0907444907029976; [Anonymous], PYMOL MOL GRAPHICS S; Arimori T, 2011, NUCLEIC ACIDS RES, V39, P8972, DOI 10.1093/nar/gkr575; Blakeley MP, 2008, CURR OPIN STRUC BIOL, V18, P593, DOI 10.1016/j.sbi.2008.06.009; Bridge G, 2014, CANCERS, V6, P1597, DOI 10.3390/cancers6031597; Cai JP, 1997, NUCLEIC ACIDS RES, V25, P1170, DOI 10.1093/nar/25.6.1170; Carter M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8871; Chatake T, 2003, PROTEINS, V50, P516, DOI 10.1002/prot.10303; Coskun E, 2015, DNA REPAIR, V33, P101, DOI 10.1016/j.dnarep.2015.05.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher SJ, 2012, ACTA CRYSTALLOGR D, V68, P800, DOI 10.1107/S0907444912012589; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; Fujii Y, 1999, J BIOL CHEM, V274, P38251, DOI 10.1074/jbc.274.53.38251; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Hori M, 2010, FREE RADICAL BIO MED, V48, P1197, DOI 10.1016/j.freeradbiomed.2010.02.002; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; Inoue M, 1998, J BIOL CHEM, V273, P11069, DOI 10.1074/jbc.273.18.11069; Ishibashi T, 2005, NUCLEIC ACIDS RES, V33, P3779, DOI 10.1093/nar/gki682; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Kettle JG, 2016, J MED CHEM, V59, P2346, DOI 10.1021/acs.jmedchem.5b01760; Koga Y, 2013, ACTA CRYSTALLOGR F, V69, P45, DOI 10.1107/S1744309112048002; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Mishima M, 2004, J BIOL CHEM, V279, P33806, DOI 10.1074/jbc.M402393200; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; Nakabeppu Y, 2014, INT J MOL SCI, V15, P12543, DOI 10.3390/ijms150712543; Nakamura T, 2006, ACTA CRYSTALLOGR F, V62, P1283, DOI 10.1107/S1744309106049529; Nakamura T, 2010, J BIOL CHEM, V285, P444, DOI 10.1074/jbc.M109.066373; Nissink JWM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151154; Okamoto K, 1996, INT J CANCER, V65, P437, DOI 10.1002/(SICI)1097-0215(19960208)65:4<437::AID-IJC7>3.0.CO;2-Y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel A, 2015, ONCOGENE, V34, P2586, DOI 10.1038/onc.2014.195; Rai P, 2010, MUTAT RES-GEN TOX EN, V703, P71, DOI 10.1016/j.mrgentox.2010.07.010; Sakai Y, 2002, J BIOL CHEM, V277, P8579, DOI 10.1074/jbc.M110566200; SEPIOL J, 1976, Z NATURFORSCH C, V31, P361; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Streib M, 2014, ANGEW CHEM INT EDIT, V53, P305, DOI 10.1002/anie.201307849; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; TOPAL MD, 1982, P NATL ACAD SCI-BIOL, V79, P2211, DOI 10.1073/pnas.79.7.2211; Tsuzuki T, 2001, MUTAT RES-FUND MOL M, V477, P71, DOI 10.1016/S0027-5107(01)00108-7; Tsuzuki T, 2007, CANCER SCI, V98, P465, DOI 10.1111/j.1349-7006.2007.00409.x; Ventura I, 2013, NEUROBIOL DIS, V49, P148, DOI 10.1016/j.nbd.2012.09.002; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200	47	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2785	2794		10.1074/jbc.M116.749713	http://dx.doi.org/10.1074/jbc.M116.749713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28035004	Green Published, hybrid			2022-12-28	WOS:000395535100019
J	Kafkova, L; Debler, EW; Fisk, JC; Jain, K; Clarke, SG; Read, LK				Kafkova, Lucie; Debler, Erik W.; Fisk, John C.; Jain, Kanishk; Clarke, Steven G.; Read, Laurie K.			The Major Protein Arginine Methyltransferase in Trypanosoma brucei Functions as an Enzyme-Prozyme Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; REGULATORY SUBUNIT PROZYME; SUBSTRATE-SPECIFICITY; IN-VIVO; ALLOSTERIC ACTIVATION; N-METHYLTRANSFERASE; PROTEOMIC ANALYSIS; HUMAN INTERACTOME; METHYLATION; RNA	Prozymes are catalytically inactive enzyme paralogs that dramatically stimulate the function of weakly active enzymes through complex formation. The two prozymes described to date reside in the polyamine biosynthesis pathway of the human parasite Trypanosoma brucei, an early branching eukaryote that lacks transcriptional regulation and regulates its proteome through posttranscriptional and posttranslational means. Arginine methylation is a common posttranslational modification in eukaryotes catalyzed by protein arginine methyltransferases (PRMTs) that are typically thought to function as homodimers. Wedemonstrate that a major T. brucei PRMT, TbPRMT1, functions as a heterotetrameric enzyme-prozyme pair. The inactive PRMT paralog, TbPRMT1(PRO), is essential for catalytic activity of the TbPRMT1(ENZ) subunit. Mutational analysis definitively demonstrates that TbPRMT1(ENZ) is the cofactor-binding subunit and carries all catalytic activity of the complex. Our results are the first demonstration of an obligate heteromeric PRMT, and they suggest that enzyme-prozyme organization is expanded in trypanosomes as a posttranslational means of enzyme regulation.	[Kafkova, Lucie; Fisk, John C.; Read, Laurie K.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; [Kafkova, Lucie; Fisk, John C.; Read, Laurie K.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Debler, Erik W.] Rockefeller Univ, Cell Biol Lab, New York, NY 10065 USA; [Jain, Kanishk; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Jain, Kanishk; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rockefeller University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Read, LK (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14214 USA.	lread@buffalo.edu		Jain, Kanishk/0000-0001-8039-0464; Debler, Erik/0000-0002-2587-2150; Kafkova, Lucie/0000-0001-9072-8019	National Institutes of Health [R01 AI060260, R01 GM026020]; National Institutes of Health Ruth L. Kirschstein National Service [GM007185]; American Heart Association [15PRE24480155]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060260, R01AI061580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 AI060260 (to L. K. R.) and R01 GM026020 (to S. G. C.), National Institutes of Health Ruth L. Kirschstein National Service Award GM007185 to (K. J.), and American Heart Association Predoctoral Fellowship 15PRE24480155 (to L. K.). The authors declare that they havenoconflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bilbe G, 2015, SCIENCE, V348, P974, DOI 10.1126/science.aaa3683; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Daniels JP, 2010, MICROBIOL MOL BIOL R, V74, P552, DOI 10.1128/MMBR.00024-10; Debler EW, 2016, P NATL ACAD SCI USA, V113, P2068, DOI 10.1073/pnas.1525783113; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Fisk JC, 2011, EUKARYOT CELL, V10, P1013, DOI 10.1128/EC.05103-11; Fisk JC, 2010, EUKARYOT CELL, V9, P866, DOI 10.1128/EC.00018-10; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Fritz M, 2015, NUCLEIC ACIDS RES, V43, P8013, DOI 10.1093/nar/gkv731; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Hadjikyriacou A, 2015, J BIOL CHEM, V290, P16723, DOI 10.1074/jbc.M115.659433; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Hayman ML, 2001, NUCLEIC ACIDS RES, V29, P5216, DOI 10.1093/nar/29.24.5216; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Hung CJ, 2007, J BIOCHEM MOL BIOL, V40, P617; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Ivanov IP, 2010, J MOL EVOL, V70, P289, DOI 10.1007/s00239-010-9331-5; Iyer LM, 2016, BIOESSAYS, V38, P27, DOI 10.1002/bies.201500104; Keating J, 2015, ACTA TROP, V150, P4, DOI 10.1016/j.actatropica.2015.06.003; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee WC, 2015, BIOCHEMISTRY-US, V54, P7514, DOI 10.1021/acs.biochem.5b00995; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Lott K, 2015, NUCLEIC ACIDS RES, V43, P5501, DOI 10.1093/nar/gkv428; Lott K, 2014, MICROBIOLOGYOPEN, V3, P595, DOI 10.1002/mbo3.191; Lott K, 2013, J PROTEOMICS, V91, P210, DOI 10.1016/j.jprot.2013.07.010; Lueong S, 2016, MOL MICROBIOL, V100, P457, DOI 10.1111/mmi.13328; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Morriswood B, 2013, EUKARYOT CELL, V12, P356, DOI 10.1128/EC.00326-12; Neault M, 2012, NUCLEIC ACIDS RES, V40, P9513, DOI 10.1093/nar/gks764; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Niu LF, 2008, PLANT PHYSIOL, V148, P490, DOI 10.1104/pp.108.124727; Pak ML, 2011, BIOCHEMISTRY-US, V50, P8226, DOI 10.1021/bi200644c; Pasternack DA, 2007, EUKARYOT CELL, V6, P1665, DOI 10.1128/EC.00133-07; Pelletier M, 2005, MOL BIOCHEM PARASIT, V144, P206, DOI 10.1016/j.molbiopara.2005.08.015; Pelletier M, 2001, MOL BIOCHEM PARASIT, V118, P49, DOI 10.1016/S0166-6851(01)00367-X; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Read LK, 2016, WIRES RNA, V7, P33, DOI 10.1002/wrna.1313; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Nguyen S, 2015, J BIOL CHEM, V290, P19987, DOI 10.1074/jbc.M115.656785; Nguyen S, 2013, J BIOL CHEM, V288, P15256, DOI 10.1074/jbc.M113.461137; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Toma-Fukai S, 2016, J MOL BIOL, V428, P1197, DOI 10.1016/j.jmb.2016.02.007; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Velez N, 2013, J BIOL CHEM, V288, P5232, DOI 10.1074/jbc.M112.442475; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087267; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang YC, 2015, MOL PHYLOGENET EVOL, V84, P101, DOI 10.1016/j.ympev.2014.12.002; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2009, MOL BIOCHEM PARASIT, V168, P1, DOI 10.1016/j.molbiopara.2009.05.009; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Xiao YJ, 2013, MOL MICROBIOL, V88, P846, DOI 10.1111/mmi.12226; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, J HYDRAULIC ENG, V3, P3, DOI DOI 10.3321/J.ISSN:1000-0534.2000.03.003.(IN	70	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2089	2100		10.1074/jbc.M116.757112	http://dx.doi.org/10.1074/jbc.M116.757112			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27998975	hybrid, Green Published			2022-12-28	WOS:000395530300004
J	Noguchi, K; Hongama, K; Hariki, S; Nonomiya, Y; Katayama, K; Sugimoto, Y				Noguchi, Kohji; Hongama, Keita; Hariki, Shiori; Nonomiya, Yuma; Katayama, Kazuhiro; Sugimoto, Yoshikazu			Functional Effects of AKT3 on Aurora Kinase Inhibitor-induced Aneuploidy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AKT PKB; cancer; cancer biology; cell division; drug resistance; mitosis	CANCER RESISTANCE PROTEIN; CELL-CYCLE ARREST; B KINASE; PLK1 PHOSPHORYLATION; CENTRAL SPINDLE; GROWTH; ACTIVATION; MUTATION; REVEALS; MK-2206	The suppression of mitotic Aurora kinases (AURKs) by AURK inhibitors frequently causes cytokinetic failure, leading to polyploidy or aneuploidy, indicating the critical role of AURK-mediated phosphorylation during cytokinesis. We demonstrate the deregulated expression of AKT3 in Aurora kinase inhibitor (AURKi)-resistant cells, which we established from human colorectal cancer HCT 116 cells. The AKT family, which includes AKT1, -2, and -3, plays multiple roles in antiapoptotic functions and drug resistance and is involved in cell growth and survival pathways. We found that an AKT inhibitor, AZD5363, showed synergistic effect with an AURKi, VX-680, on two AKT3-expressing AURKi-resistant cell lines, and AKT3 knockdown sensitized cells to VX-680. Consistent with these activities, AKT3 expression suppressed AURKi-induced apoptosis and conferred resistance to AURKi. Thus, AKT3 expression affects cell sensitivity to AURKi. Moreover, we found that AKT3 expression suppressed AURKi-induced aneuploidy, and inversely AKT3 knockdown enhanced it. In addition, partial co-localization of AKT3 with AURKB was observed during anaphase. Overall, this study suggests that AKT3 could repress the antiproliferative effects of AURKi, with a novel activity particularly suppressing the aneuploidy induction.	[Noguchi, Kohji; Hongama, Keita; Hariki, Shiori; Nonomiya, Yuma; Katayama, Kazuhiro; Sugimoto, Yoshikazu] Keio Univ, Fac Pharm, Div Chemotherapy, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan	Keio University	Noguchi, K (corresponding author), Keio Univ, Fac Pharm, Div Chemotherapy, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	noguchi-kj@pha.keio.ac.jp	Katayama, Kazuhiro/AAH-2914-2019	Katayama, Kazuhiro/0000-0003-4232-7661	Japan Society for the Promotion of Science KAKENHI [S1411004, 15K14409, 26460076]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants-in-Aid S1411004, 15K14409, and 26460076. The authors declare that they have no conflicts of interest with the contents of this article	Bastos RN, 2013, J CELL BIOL, V202, P605, DOI 10.1083/jcb.201301094; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Chen L, 2015, BIOCHEMISTRY-US, V54, P2473, DOI 10.1021/acs.biochem.5b00016; Choi BH, 2014, J BIOL CHEM, V289, P14066, DOI 10.1074/jbc.M114.558155; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Dominguez-Brauer C, 2015, MOL CELL, V60, P524, DOI 10.1016/j.molcel.2015.11.006; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Goldenson B, 2015, ONCOGENE, V34, P537, DOI 10.1038/onc.2014.14; Grundy M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-254; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hilton JF, 2014, J CLIN ONCOL, V32, P57, DOI 10.1200/JCO.2013.50.7988; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Kasahara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2879; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Katayama K, 2009, ANTICANCER RES, V29, P1059; Kawahara H, 2010, CANCER SCI, V101, P1493, DOI 10.1111/j.1349-7006.2010.01539.x; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kumari G, 2014, J BIOL CHEM, V289, P16072, DOI 10.1074/jbc.M114.555060; Li ZG, 2014, MOL CELL BIOL, V34, P3642, DOI 10.1128/MCB.00814-14; Lin J, 2013, CLIN CANCER RES, V19, P1760, DOI 10.1158/1078-0432.CCR-12-3072; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mende I, 2001, ONCOGENE, V20, P4419, DOI 10.1038/sj.onc.1204486; Mitsuhashi J, 2007, HUM GENE THER, V18, P895, DOI 10.1089/hum.2007.075; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Noguchi K, 1996, ONCOGENE, V13, P39; Noguchi K, 2004, J BIOL CHEM, V279, P32716, DOI 10.1074/jbc.M404104200; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; Onishi K, 2007, GENES CELLS, V12, P535, DOI 10.1111/j.1365-2443.2007.01071.x; Rines DR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r44; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; SATO W, 1995, CANCER CHEMOTH PHARM, V35, P271, DOI 10.1007/BF00689444; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Toi M, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.08.1646; Uehara R, 2013, J CELL BIOL, V202, P623, DOI 10.1083/jcb.201302123; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	55	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1910	1924		10.1074/jbc.M116.747048	http://dx.doi.org/10.1074/jbc.M116.747048			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28028179	Green Published, hybrid			2022-12-28	WOS:000395515600030
J	Luhtala, N; Aslanian, A; Yates, JR; Hunter, T				Luhtala, Natalie; Aslanian, Aaron; Yates, John R., III; Hunter, Tony			Secreted Glioblastoma Nanovesicles Contain Intracellular Signaling Proteins and Active Ras Incorporated in a Farnesylation-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOSOMAL PROTEINS; GROWTH-FACTOR; CANCER EXOSOMES; MESSENGER-RNAS; LEUKEMIA-CELLS; ACTIVATION; MEDIATE; IDENTIFICATION; MICROVESICLES; EXPRESSION	Glioblastomas (GBMs) are malignant brain tumors with a median survival of less than 18 months. Redundancy of signaling pathways represented within GBMs contributes to their therapeutic resistance. Exosomes are extracellular nanovesicles released from cells and present in human biofluids that represent a possible biomarker of tumor signaling state that could aid in personalized treatment. Herein, we demonstrate that mouse GBM cell-derived extracellular nanovesicles resembling exosomes from an H-RasV12 myr-Akt mouse model for GBM are enriched for intracellular signaling cascade proteins (GO: 0007242) and Ras protein signal transduction (GO: 0007265), and contain active Ras. Active Ras isolated from human and mouse GBM extracellular nanovesicles lysates using the Ras-binding domain of Raf also coprecipitates with ESCRT (endosomal sorting complex required for transport)-associated exosome proteins Vps4a and Alix. Although we initially hypothesized a role for active Ras protein signaling in exosome biogenesis, we found that GTP binding of K-Ras was dispensable for its packaging within extracellular nanovesicles and for the release of Alix. By contrast, farnesylation of K-Ras was required for its packaging within extracellular nanovesicles, yet expressing a K-Ras farnesylation mutant did not decrease the number of nanovesicles or the amount of Alix protein released per cell. Overall, these results emphasize the primary importance of membrane association in packaging of extracellular nanovesicle factors and indicate that screening nanovesicles within human fluids could provide insight into tissue origin and the wiring of signaling proteins at membranes to predict onset and behavior of cancer and other diseases linked to deregulated membrane signaling states.	[Luhtala, Natalie; Aslanian, Aaron; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, Canc Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Aslanian, Aaron; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Hunter, T (corresponding author), 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu			National Institutes of Health NCI [CA194584, CA80100, CA82683]; Cancer Center Support Grant [CA14195]; National Center for Research Resources [5P41RR011823-17]; National Institutes of Health NIGMS [8P41GM103533-17]; George E. Hewitt Foundation for Medical Research Fellowship; American Cancer Society [127795-PF-15-030-01-CSM]; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [R01CA082683, R01CA194584, P30CA014195, R01CA080100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); George E. Hewitt Foundation for Medical Research Fellowship; American Cancer Society(American Cancer Society); Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health NCI Grants CA194584, CA80100, and CA82683 (to T. H.), Cancer Center Support Grant CA14195 (Waitt Advanced Biophotonics Core), and National Center for Research Resources Grant 5P41RR011823-17 and National Institutes of Health NIGMS Grant 8P41GM103533-17 (to J. R. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by the George E. Hewitt Foundation for Medical Research Fellowship and American Cancer Society Fellowship 127795-PF-15-030-01-CSM.r Supported by the Leona M. and Harry B. Helmsley Charitable Trust.	Adjei AA, 2001, CLIN CANCER RES, V7, P1438; Amos S, 2006, CELL DEATH DIFFER, V13, P642, DOI 10.1038/sj.cdd.4401783; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Bleck M, 2014, P NATL ACAD SCI USA, V111, P12211, DOI 10.1073/pnas.1321655111; Blum R, 2005, CANCER RES, V65, P999; Bouterfa HL, 2000, ANTICANCER RES, V20, P2761; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; Butch ER, 1996, J BIOL CHEM, V271, P4230; Cai ZJ, 2012, J IMMUNOL, V188, P5954, DOI 10.4049/jimmunol.1103466; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fiordalis JJ, 2002, J BIOL CHEM, V277, P10813, DOI 10.1074/jbc.M107684200; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gelabert-Baldrich M, 2014, FASEB J, V28, P3023, DOI 10.1096/fj.13-241158; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Gui YX, 2015, ONCOTARGET, V6, P37043, DOI 10.18632/oncotarget.6158; Holmen SL, 2005, CANCER RES, V65, P8250, DOI 10.1158/0008-5472.CAN-05-1173; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hood JL, 2009, LAB INVEST, V89, P1317, DOI 10.1038/labinvest.2009.94; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hurh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070486; Jeuken J, 2007, ACTA NEUROPATHOL, V114, P121, DOI 10.1007/s00401-007-0239-0; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kiel C, 2009, J BIOL CHEM, V284, P31893, DOI 10.1074/jbc.M109.031153; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Li YC, 2014, CELL REP, V9, P1946, DOI 10.1016/j.celrep.2014.10.058; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Luga V, 2013, CANCER RES, V73, P6843, DOI 10.1158/0008-5472.CAN-13-1791; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lugli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139233; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Nassar N, 2010, BIOCHEMISTRY-US, V49, P1970, DOI 10.1021/bi9020742; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Prigent SA, 1996, J BIOL CHEM, V271, P25639, DOI 10.1074/jbc.271.41.25639; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Robert Mc, 2008, Biomed Imaging Interv J, V4, pe3, DOI 10.2349/biij.4.1.e3; Rodriguez M, 2015, ONCOTARGET, V6, P40575, DOI 10.18632/oncotarget.5818; Russell JS, 1999, CANCER RES, V59, P5239; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Schiebe M, 2000, J NEURO-ONCOL, V49, P197, DOI 10.1023/A:1006410702284; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Sharghi-Namini S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04031; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Simpson RJ, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18374; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Suetsugu A, 2013, ADV DRUG DELIVER REV, V65, P383, DOI 10.1016/j.addr.2012.08.007; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P2148, DOI 10.1074/mcp.M112.027086; Taverna S, 2012, INT J CANCER, V130, P2033, DOI 10.1002/ijc.26217; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tomlinson PR, 2015, ANN CLIN TRANSL NEUR, V2, P353, DOI 10.1002/acn3.175; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WESTERMARK B, 1995, GLIA, V15, P257, DOI 10.1002/glia.440150307; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhang L, 2013, MOL MED REP, V8, P272, DOI 10.3892/mmr.2013.1458; Zheng ZY, 2012, ONCOGENE, V31, P4630, DOI 10.1038/onc.2011.607; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	92	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					611	628		10.1074/jbc.M116.747618	http://dx.doi.org/10.1074/jbc.M116.747618			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909058	hybrid, Green Published			2022-12-28	WOS:000392316100017
J	Roy, S; Lu, K; Nayak, MK; Bhuniya, A; Ghosh, T; Kundu, S; Ghosh, S; Baral, R; Dasgupta, PS; Basu, S				Roy, Soumyabrata; Lu, Kai; Nayak, Mukti Kant; Bhuniya, Avishek; Ghosh, Tithi; Kundu, Suman; Ghosh, Sarbari; Baral, Rathindranath; Dasgupta, Partha Sarathi; Basu, Sujit			Activation of D-2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE DEHYDROGENASE 1A1; TUMOR-INITIATING CELLS; ENDOTHELIAL GROWTH-FACTOR; SELF-RENEWAL; PROGNOSTIC VALUE; DOWN-REGULATION; GASTRIC-CANCER; EXPRESSION; IDENTIFICATION; MARKER	Lung carcinoma is the leading cause of cancer-related death worldwide, and among this cancer, non-small cell lung carcinoma (NSCLC) comprises the majority of cases. Furthermore, recurrence and metastasis of NSCLC correlate well with CD133+ve tumor cells, a small population of tumor cells that have been designated as cancer stem cells (CSC). We have demonstrated for the first time high expression of D-2 dopamine (DA) receptors in CD133+ve adenocarcinoma NSCLC cells. Also, activation of D-2 DA receptors in these cells significantly inhibited their proliferation, clonogenic ability, and invasiveness by suppressing extracellular signal-regulated kinases 1/2 (ERK1/2) and AKT, as well as down-regulation of octamer-binding transcription factor 4 (Oct-4) expression and matrix metalloproteinase-9 (MMP-9) secretion by these cells. These results are of significance as D-2 DA agonists that are already in clinical use for treatment of other diseases may be useful in combination with conventional chemotherapy and radiotherapy for better management of NSCLC patients by targeting both tumor cells and stem cell compartments in the tumor mass.	[Roy, Soumyabrata; Bhuniya, Avishek; Ghosh, Tithi; Ghosh, Sarbari; Baral, Rathindranath; Dasgupta, Partha Sarathi] Chittaranjan Natl Canc Inst, Dept Immunoregulat & Immunodiagnost, Kolkata 700026, W Bengal, India; [Lu, Kai; Basu, Sujit] Ohio State Univ, Dept Pathol, 166 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA; [Nayak, Mukti Kant] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata 700010, India; [Kundu, Suman] Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata 700032, India; [Basu, Sujit] Ohio State Univ, Dept Internal Med, Div Med Oncol, 166 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University System of Ohio; Ohio State University	Basu, S (corresponding author), Ohio State Univ, Dept Pathol, 166 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.; Dasgupta, PS (corresponding author), Chittaranjan Natl Canc Inst, Kolkata 700026, W Bengal, India.; Basu, S (corresponding author), Ohio State Univ, Dept Med Oncol, 166 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	partha42002@yahoo.com; sujit.basu@osumc.edu	Kundu, Suman/AAL-6066-2021	Kundu, Suman/0000-0002-8591-1166; GHOSH HALDER, TITHI/0000-0002-4292-1153; Bhuniya, Avishek/0000-0001-6253-0400	Council of Scientific and Industrial Research [21(0895)/12/EMR-II]; National Institutes of Health [R01DK098045, R01CA169158, R01HL131405]; NATIONAL CANCER INSTITUTE [R01CA169158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098045] Funding Source: NIH RePORTER	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Council of Scientific and Industrial Research Grant 21(0895)/12/EMR-II (to P. S. D.) and National Institutes of Health Grants R01DK098045, R01CA169158, and R01HL131405 (to S. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Lamki RS, 2016, ONCOTARGET, V7, P24111, DOI 10.18632/oncotarget.8125; Alamgeer M, 2013, THORAX, V68, P1095, DOI 10.1136/thoraxjnl-2012-203021; Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; Barr MP, 2016, J THORAC ONCOL, V11, pS87, DOI 10.1016/S1556-0864(16)30188-5; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Bozzi Y, 2006, TRENDS NEUROSCI, V29, P167, DOI 10.1016/j.tins.2006.01.002; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Cao L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-71; Chakroborty D, 2004, CLIN CANCER RES, V10, P4349, DOI 10.1158/1078-0432.CCR-04-0059; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Chakroborty D, 2011, P NATL ACAD SCI USA, V108, P20730, DOI 10.1073/pnas.1108696108; Chang HW, 2014, J MOL ENDOCRINOL, V52, P87, DOI 10.1530/JME-13-0044; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chavali PL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.449; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Danesi R, 2009, ADV DRUG DELIVER REV, V61, P408, DOI 10.1016/j.addr.2009.03.001; Dawood S, 2014, ONCOLOGY-NY, V28, P1101; Denton MD, 1996, KIDNEY INT, V50, P4, DOI 10.1038/ki.1996.280; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Ganguly S, 2010, AM J PATHOL, V177, P2701, DOI 10.2353/ajpath.2010.100617; GOLDBERG LI, 1989, J CARDIOVASC PHARM, V14, pS19, DOI 10.1097/00005344-198906145-00005; Gomez-Casal R, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-94; Han J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-173; Hoeppner LH, 2015, MOL ONCOL, V9, P270, DOI 10.1016/j.molonc.2014.08.008; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P2970, DOI 10.1002/cncr.25869; Huang C, 2007, CANCER GENET CYTOGEN, V175, P19, DOI 10.1016/j.cancergencyto.2007.01.003; ISHIBASHI M, 1994, CANCER RES, V54, P3442; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Le HB, 2013, MOL MED REP, V8, P1511, DOI 10.3892/mmr.2013.1667; Li HW, 2011, J SURG ONCOL, V103, P558, DOI 10.1002/jso.21806; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Li X, 2012, J THORAC ONCOL, V7, P1235, DOI 10.1097/JTO.0b013e318257cc6d; Li Z, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-17; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu F, 2014, ACTA BIOCH BIOPH SIN, V46, P15, DOI 10.1093/abbs/gmt123; Liu H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.340; Liu JC, 2002, J BIOL CHEM, V277, P35819, DOI 10.1074/jbc.M202920200; Liu SP, 2013, GASTROENTEROLOGY, V144, P1031, DOI 10.1053/j.gastro.2013.01.046; Lu K., 2012, COMP MATH MATH PHYS, V2012, P7; Lu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09642; Mak AB, 2011, J BIOL CHEM, V286, P41046, DOI 10.1074/jbc.M111.261545; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Nassar D, 2016, ANNU REV PATHOL-MECH, V11, P47, DOI 10.1146/annurev-pathol-012615-044438; Qu HY, 2013, INT J CLIN EXP PATHO, V6, P2644; Rappa F, 2013, BIOCHIMIE, V95, P782, DOI 10.1016/j.biochi.2012.11.007; Roudi R, 2015, CANCER INVEST, V33, P294, DOI 10.3109/07357907.2015.1034869; Sarkar C, 2008, CLIN CANCER RES, V14, P2502, DOI 10.1158/1078-0432.CCR-07-1778; Schiffer D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/725921; Senogles SE, 2007, ANTI-CANCER DRUG, V18, P801, DOI 10.1097/CAD.0b013e3280b10d36; Sheikhpour M, 2013, INT J IMMUNOPATH PH, V26, P393, DOI 10.1177/039463201302600212; Shome S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031682; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SOKOLOFF P, 1989, BIOCHEM BIOPH RES CO, V162, P575, DOI 10.1016/0006-291X(89)92349-8; Steinmetz Nicole F, 2011, Cancers (Basel), V3, P2870, DOI 10.3390/cancers3032870; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wang WM, 2014, TUMOR BIOL, V35, P9769, DOI 10.1007/s13277-014-2270-9; Wang YK, 2010, CARCINOGENESIS, V31, P1376, DOI 10.1093/carcin/bgq120; Wu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100168; Xu DM, 2010, CANCER RES, V70, P6988, DOI 10.1158/0008-5472.CAN-10-0242; Yang L, 2014, MODERN PATHOL, V27, P775, DOI 10.1038/modpathol.2013.189; Zhang LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09447; Zhu YF, 2014, EXP CELL RES, V324, P146, DOI 10.1016/j.yexcr.2014.03.020	74	32	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					435	445		10.1074/jbc.M116.748970	http://dx.doi.org/10.1074/jbc.M116.748970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27920206	Green Published, hybrid			2022-12-28	WOS:000392316100003
J	Agamasu, C; Ghanam, RH; Xu, F; Sun, Y; Chen, YB; Saad, JS				Agamasu, Constance; Ghanam, Ruba H.; Xu, Fei; Sun, Yong; Chen, Yabing; Saad, Jamil S.			The Interplay between Calmodulin and Membrane Interactions with the Pleckstrin Homology Domain of Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; PROTEIN-KINASE-B; PHOSPHOLIPID-BILAYER NANODISCS; HIGH-RESOLUTION STRUCTURE; HIV-1 MATRIX PROTEIN; TARGET RECOGNITION; PHOSPHATIDYLINOSITOL 3-KINASE; BIOPHYSICAL CHARACTERIZATION; INOSITOL PHOSPHATES; NMR-SPECTROSCOPY	The Akt protein, a serine/threonine kinase, plays important roles in cell survival, apoptosis, and oncogenes. Akt is translocated to the plasma membrane for activation. Akt-membrane binding is mediated by direct interactions between its pleckstrin homology domain (PHD) and phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3). It has been shown that Akt activation in breast cancer cells is modulated by calmodulin (CaM). However, the molecular mechanism of the interplay between CaM and membrane binding is not established. Here, we employed nuclear magnetic resonance (NMR) and biochemical and biophysical techniques to characterize how PI(3,4,5)P-3, CaM, and membrane mimetics (nanodisc) bind to Akt(PHD). We show that PI(3,4,5)P-3 binding to Akt(PHD) displaces the C-terminal lobe of CaM but not the weakly binding N-terminal lobe. However, binding of a PI(3,4,5)P-3-embedded membrane nanodisc to Akt(PHD) with a 10(3)-fold tighter affinity than PI(3,4,5)P-3 is able to completely displace CaM. We also show that Akt(PHD) binds to both layers of the nanodisc, indicating proper incorporation of PI(3,4,5)P-3 on the nanodisc surface. No detectable binding has been observed between Akt(PHD) and PI(3,4,5)P-3-free nanodiscs, demonstrating that PI(3,4,5)P-3 is required for membrane binding, CaM displacement, and Akt activation. Using pancreatic cancer cells, we demonstrate that inhibition of Akt-CaM binding attenuated Akt activation. Our findings support a model by which CaM binds to Akt to facilitate its translocation to the membrane. Elucidation of the molecular details of the interplay between membrane and CaM binding to Akt may help in the development of potential targets to control the pathophysiological processes of cell survival.	[Agamasu, Constance; Ghanam, Ruba H.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Xu, Fei; Sun, Yong; Chen, Yabing] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sun, Yong; Chen, Yabing] Birmingham Vet Affairs Med Ctr, Res Dept, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Saad, JS (corresponding author), 845 19th St South, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484	National Institutes of Health [1S10RR026478]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002296, IK6BX003617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Veterans Affairs(US Department of Veterans Affairs)	We thank the Comprehensive Cancer Center, University of Alabama at Birmingham, for supporting the High-Field NMR facility and the X-ray core facility that houses the Auto-ITC200 (acquired through National Institutes of Health Grant 1S10RR026478).	Agamasu C, 2015, J BIOL CHEM, V290, P27403, DOI 10.1074/jbc.M115.673939; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Borch J, 2009, BIOL CHEM, V390, P805, DOI 10.1515/BC.2009.091; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Fernandez TF, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.471821; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; Gorbatyuk VY, 2006, MOL CELL, V24, P511, DOI 10.1016/j.molcel.2006.10.007; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kobashigawa Y, 2011, ANAL BIOCHEM, V410, P77, DOI 10.1016/j.ab.2010.11.021; KRISHNARAJU K, 1991, BRIT J CANCER, V63, P346, DOI 10.1038/bjc.1991.82; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Liao Y, 2010, AM J TRANSL RES, V2, P19; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao X, 2012, ARTERIOSCL THROM VAS, V32, P2171, DOI 10.1161/ATVBAHA.112.253872; Meuillet EJ, 2011, CURR MED CHEM, V18, P2727; Miao BC, 2011, AUTOPHAGY, V7, P650, DOI 10.4161/auto.7.6.15248; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Parikh C, 2012, P NATL ACAD SCI USA, V109, P19368, DOI 10.1073/pnas.1204384109; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Sauer K, 2013, BLOOD, V121, P286, DOI 10.1182/blood-2012-05-429241; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XX, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005147; Wu WT, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5730; Xu Q, 2010, J MOL BIOL, V396, P31, DOI 10.1016/j.jmb.2009.11.006; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yokogawa M, 2012, J BIOL CHEM, V287, P34936, DOI 10.1074/jbc.M112.398255; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yuan KY, 2013, CLIN CANCER RES, V19, P4750, DOI 10.1158/1078-0432.CCR-13-0516; Yun SJ, 2009, FEBS LETT, V583, P685, DOI 10.1016/j.febslet.2009.01.005	67	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					251	263		10.1074/jbc.M116.752816	http://dx.doi.org/10.1074/jbc.M116.752816			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27872186	Green Published, hybrid			2022-12-28	WOS:000391578000022
J	Dai, QG; Xie, FR; Han, YJ; Ma, XH; Zhou, SR; Jiang, LY; Zou, WG; Wang, J				Dai, Qinggang; Xie, Furong; Han, Yujiao; Ma, Xuhui; Zhou, Siru; Jiang, Lingyong; Zou, Weiguo; Wang, Jun			Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; EVEROLIMUS; MARKER; GROWTH; ROLES; PROLIFERATION; ACTIVATION; PROMOTES; SURVIVAL; CANCER	Mammalian target of rapamycin complex 1 (mTORC1) is involved in anabolic metabolism in both osteoblasts and chondrocytes, but the role of mTORC1 in osteoclast biology in vivo remains to be elucidated. In this study, we showed that deletion of regulatory-associated protein of mTOR (Raptor) in osteoclasts led to an increase in bone mass with decreased bone resorption. Raptor-deficient bone marrow-derived macrophages exhibited lower mTORC1-S6K1 signaling and retarded osteoclast differentiation, as determined by the number of osteoclasts, tartrate-resistant acid phosphatase activity, and expression of osteoclast-specific genes. Enforced expression of constitutively active S6K1 rescued the impaired osteoclast differentiation in Raptor-deficient bone marrow-derived macrophages. Furthermore, pharmacological inhibition of mTORC1 signaling by rapamycin could also inhibit osteoclast differentiation and osteoclast-specific gene expression. Taken together, our findings demonstrate that mTORC1 plays a key role in the network of catabolic bone resorption in osteoclasts and may serve as a potential pharmacological target for the regulation of osteoclast activity in bone metabolic disorders.	[Dai, Qinggang; Xie, Furong; Wang, Jun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Pediat Dent,Shanghai Key Lab Stomatol, Shanghai 200011, Peoples R China; [Ma, Xuhui] Shanghai Jiao Tong Univ, Sch Med, Dept Oral & Maxillofacial Head & Neck Oncol, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200011, Peoples R China; [Zhou, Siru; Jiang, Lingyong] Shanghai Jiao Tong Univ, Dept Oral & Craniomaxillofacial Sci, Ctr Craniofacial Orthodont, Shanghai Key Lab Stomatol,Sch Med,Peoples Hosp 9, Shanghai 200011, Peoples R China; [Dai, Qinggang; Han, Yujiao; Zou, Weiguo] Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, LY (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral & Craniomaxillofacial Sci, Ctr Craniofacial Orthodont,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Wang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Pediat Dent, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.	jly117@sina.com; zouwg94@sibcb.ac.cn; wangjun202@126.com		Dai, Qinggang/0000-0002-8177-2496	973 Program from the Chinese Ministry of Science and Technology [2014CB964704, 2015CB964503]; Science and Technology Commission of Shanghai [124119b0101]; National Natural Science Foundation of China [31371463, 81371121, 81570950]; Shanghai Summit and Plateau Disciplines; "Chen Xing" project from Shanghai Jiaotong University; National Science Fund for Excellent Young Scholars [81322027]	973 Program from the Chinese Ministry of Science and Technology; Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Summit and Plateau Disciplines; "Chen Xing" project from Shanghai Jiaotong University; National Science Fund for Excellent Young Scholars	This work was supported in part by grants from the 973 Program from the Chinese Ministry of Science and Technology (2014CB964704 and 2015CB964503), the Science and Technology Commission of Shanghai (124119b0101), the National Natural Science Foundation of China (31371463, 81371121, and 81570950), Shanghai Summit and Plateau Disciplines, and the "Chen Xing" project from Shanghai Jiaotong University. The authors declare that they have no conflicts of interest with the contents of this article.r A scholar of the National 1000 Young Talents Program of China. Supported by the National Science Fund for Excellent Young Scholars (81322027). To whom correspondence may be addressed: Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Rd., SIBCB Bldg., Rm. 1401, Shanghai 200031, China. Tel.: 86-21-54921320; Fax: 86-21-54921320; E-mail: zouwg94@sibcb.ac.cn.	ANDERSSON GN, 1989, J HISTOCHEM CYTOCHEM, V37, P115, DOI 10.1177/37.1.2461980; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Boyce BF, 2013, J BONE MINER RES, V28, P711, DOI 10.1002/jbmr.1885; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen C, 2015, J EXP MED, V212, P73, DOI 10.1084/jem.20140643; Chen J.-H., 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1037/COU0000095; Chen JQ, 2014, DEVELOPMENT, V141, P2848, DOI 10.1242/dev.108811; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Gnant M, 2013, JNCI-J NATL CANCER I, V105, P654, DOI 10.1093/jnci/djt026; Greenblatt MB, 2015, J EXP MED, V212, P1283, DOI 10.1084/jem.20150407; Hadji P, 2013, CRIT REV ONCOL HEMAT, V87, P101, DOI 10.1016/j.critrevonc.2013.05.015; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Hu YW, 2016, J CELL BIOCHEM, V117, P413, DOI 10.1002/jcb.25287; Huang B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005426; Indo Y, 2013, J BONE MINER RES, V28, P2392, DOI 10.1002/jbmr.1976; Kneissel M, 2004, BONE, V35, P1144, DOI 10.1016/j.bone.2004.07.013; Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Liu XQ, 2014, BIOMATERIALS, V35, P5721, DOI 10.1016/j.biomaterials.2014.04.006; Martin SK, 2015, STEM CELLS, V33, P1359, DOI 10.1002/stem.1931; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Simone V, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1717-8; Singha UK, 2008, J CELL BIOCHEM, V103, P434, DOI 10.1002/jcb.21411; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Wang SY, 2011, BIOMATERIALS, V32, P4546, DOI 10.1016/j.biomaterials.2011.03.014; Xia TT, 2012, DIABETES, V61, P2461, DOI 10.2337/db11-1278; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Xu S, 2016, J BONE MINER RES, V31, P1320, DOI 10.1002/jbmr.2800; Yan B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11151; Yeh LCC, 2013, J CELL BIOCHEM, V114, P1760, DOI 10.1002/jcb.24519; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zou DH, 2011, BIOMATERIALS, V32, P9707, DOI 10.1016/j.biomaterials.2011.09.005; Zou WG, 2013, J EXP MED, V210, P1793, DOI 10.1084/jem.20111790	36	55	63	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					196	204		10.1074/jbc.M116.764761	http://dx.doi.org/10.1074/jbc.M116.764761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27879318	Green Published, hybrid			2022-12-28	WOS:000391578000017
J	Poms, M; Ansorge, P; Martinez-Gil, L; Jurt, S; Gottstein, D; Fracchiolla, KE; Cohen, LS; Guntert, P; Mingarro, I; Naider, F; Zerbe, O				Poms, Martin; Ansorge, Philipp; Martinez-Gil, Luis; Jurt, Simon; Gottstein, Daniel; Fracchiolla, Katrina E.; Cohen, Leah S.; Guentert, Peter; Mingarro, Ismael; Naider, Fred; Zerbe, Oliver			NMR Investigation of Structures of G-protein Coupled Receptor Folding Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE HELICES; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; BIOPHYSICAL ANALYSIS; MOVEMENT PROTEIN; NASCENT CHAINS	Folding of G-protein coupled receptors (GPCRs) according to the two-stage model (Popot, J. L., and Engelman, D. M. (1990) Biochemistry 29, 4031-4037) is postulated to proceed in 2 steps: partitioning of the polypeptide into the membrane followed by diffusion until native contacts are formed. Herein we investigate conformational preferences of fragments of the yeast Ste2p receptor using NMR. Constructs comprising the first, the first two, and the first three transmembrane (TM) segments, as well as a construct comprising TM1-TM2 covalently linked to TM7 were examined. We observed that the isolated TM1 does not form a stable helix nor does it integrate well into the micelle. TM1 is significantly stabilized upon interaction with TM2, forming a helical hairpin reported previously (Neumoin, A., Cohen, L. S., Arshava, B., Tantry, S., Becker, J. M., Zerbe, O., and Naider, F. (2009) Biophys. J. 96, 3187-3196), and in this case the protein integrates into the hydrophobic interior of the micelle. TM123 displays a strong tendency to oligomerize, but hydrogen exchange data reveal that the center of TM3 is solvent exposed. In all GPCRs so-far structurally characterized TM7 forms many contacts with TM1 and TM2. In our study TM127 integrates well into the hydrophobic environment, but TM7 does not stably pack against the remaining helices. Topology mapping in microsomal membranes also indicates that TM1 does not integrate in a membrane-spanning fashion, but that TM12, TM123, and TM127 adopt predominantly native-like topologies. The data from our study would be consistent with the retention of individual helices of incompletely synthesized GPCRs in the vicinity of the translocon until the complete receptor is released into the membrane interior.	[Poms, Martin; Ansorge, Philipp; Jurt, Simon; Zerbe, Oliver] Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Martinez-Gil, Luis; Mingarro, Ismael] Univ Valencia, Dept Biochem & Mol Biol, ERI BioTecMed, E-46100 Burjassot, Spain; [Gottstein, Daniel; Guentert, Peter] Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Gottstein, Daniel; Guentert, Peter] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Fracchiolla, Katrina E.; Cohen, Leah S.; Naider, Fred] CUNY Coll Staten Isl, Dept Chem, Staten Isl, NY 10314 USA; [Fracchiolla, Katrina E.; Cohen, Leah S.; Naider, Fred] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA; [Fracchiolla, Katrina E.; Cohen, Leah S.; Naider, Fred] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10016 USA; [Guentert, Peter] ETH, Phys Chem Lab, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland	University of Zurich; University of Valencia; Goethe University Frankfurt; Goethe University Frankfurt; City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zerbe, O (corresponding author), Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	oliver.zerbe@chem.uzh.ch	Mingarro, Ismael/B-4745-2014	Mingarro, Ismael/0000-0002-1910-1229; Poms, Martin/0000-0002-4426-314X	Swiss National Science Foundation [31003A_124469]; Spanish Ministry of Economy and Competitiveness [BFU2016-79487]; Generalitat Valenciana [PROMETEOII/2014/061]; National Institutes of Health NIGMS [22087]; Leonard and Esther Kurtz Term Professorship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Leonard and Esther Kurtz Term Professorship	This work was supported in part by Swiss National Science Foundation Grant 31003A_124469, Spanish Ministry of Economy and Competitiveness Grant BFU2016-79487, and Generalitat Valenciana Grant PROMETEOII/2014/061. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health NIGMS Grant 22087, the Leonard and Esther Kurtz Term Professorship, and during the writing of this paper was a Erna and Jakob Michael Visiting Professor at the Weizmann Institute of Science.	Albert AD, 2000, METHOD ENZYMOL, V315, P107; Baeza-Delgado C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23397; Bano-Polo M, 2013, J MOL BIOL, V425, P830, DOI 10.1016/j.jmb.2012.12.001; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Bowie JU, 2013, SCIENCE, V339, P398, DOI 10.1126/science.1228655; Buchner L, 2015, J BIOMOL NMR, V62, P81, DOI 10.1007/s10858-015-9921-z; Caroccia KE, 2011, BIOPOLYMERS, V96, P757, DOI 10.1002/bip.21614; Chamberlain AK, 2003, ADV PROTEIN CHEM, V63, P19; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Cohen LS, 2008, BIOPOLYMERS, V90, P117, DOI 10.1002/bip.20950; Cohen LS, 2010, J PEPT SCI, V16, P213, DOI 10.1002/psc.1222; Donate-Macian P, 2015, BIOCHEM BIOPH RES CO, V462, P221, DOI 10.1016/j.bbrc.2015.04.120; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Eilers M, 2005, BIOCHEMISTRY-US, V44, P8959, DOI 10.1021/bi047316u; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; FESIK SW, 1988, BIOCHEMISTRY-US, V27, P8297, DOI 10.1021/bi00422a001; Finger C, 2006, J MOL BIOL, V358, P1221, DOI 10.1016/j.jmb.2006.02.065; Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hagn F, 2013, J AM CHEM SOC, V135, P1919, DOI 10.1021/ja310901f; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Ismail N, 2008, BIOCHEM J, V411, P495, DOI 10.1042/BJ20071597; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P6144, DOI 10.1021/bi00141a027; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Katragadda M, 2001, J PEPT RES, V58, P79, DOI 10.1034/j.1399-3011.2001.00904.x; KILLIAN JA, 1994, FEBS LETT, V348, P161, DOI 10.1016/0014-5793(94)00594-X; Kobilka B, 2013, ANGEW CHEM INT EDIT, V52, P6380, DOI 10.1002/anie.201302116; Krishnamani V, 2012, BIOCHEMISTRY-US, V51, P1061, DOI 10.1021/bi201770y; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; LIAO MJ, 1983, J BIOL CHEM, V258, P9949; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583; Marino J, 2012, BBA-BIOMEMBRANES, V1818, P3055, DOI 10.1016/j.bbamem.2012.07.023; Martin NP, 1999, BIOCHEMISTRY-US, V38, P682, DOI 10.1021/bi982062w; Martin NP, 2002, J MOL BIOL, V317, P765, DOI 10.1006/jmbi.2002.5444; Martinez-Gil L, 2008, BIOPHYS J, V95, pL36, DOI 10.1529/biophysj.108.138602; Martinez-Gil L, 2007, VIROLOGY, V367, P348, DOI 10.1016/j.virol.2007.06.006; Martinez-Gil L, 2011, FEBS J, V278, P3846, DOI 10.1111/j.1742-4658.2011.08185.x; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; MIOZZARI GF, 1978, J BACTERIOL, V133, P1457, DOI 10.1128/JB.133.3.1457-1466.1978; MUTO Y, 1993, J BIOMOL NMR, V3, P165; Neumoin A, 2009, BIOPHYS J, V96, P3187, DOI 10.1016/j.bpj.2009.01.012; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; NILSSON I, 1993, J BIOL CHEM, V268, P5798; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PERVUSHIN K V, 1991, Journal of Biomolecular NMR, V1, P313, DOI 10.1007/BF02192857; PERVUSHIN KV, 1994, EUR J BIOCHEM, V219, P571, DOI 10.1111/j.1432-1033.1994.tb19973.x; PERVUSHIN KV, 1992, FEBS LETT, V308, P190, DOI 10.1016/0014-5793(92)81272-N; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Popot JL, 2016, BIOCHEMISTRY-US, V55, P5, DOI 10.1021/acs.biochem.5b01134; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rasmussen S. G., 2007, NATURE; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; ROSS A, 1993, J BIOMOL NMR, V3, P215; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Sauri A, 2005, J BIOL CHEM, V280, P25907, DOI 10.1074/jbc.M412476200; Sauri A, 2007, J MOL BIOL, V366, P366, DOI 10.1016/j.jmb.2006.11.052; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shao X, 2012, BIOPHYS J, V103, P817, DOI 10.1016/j.bpj.2012.07.012; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shenkarev ZO, 2013, BBA-BIOMEMBRANES, V1828, P776, DOI 10.1016/j.bbamem.2012.11.005; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; STALEY JP, 1994, PROTEIN SCI, V3, P1822, DOI 10.1002/pro.5560031021; Tamborero S, 2011, J MOL BIOL, V406, P571, DOI 10.1016/j.jmb.2011.01.009; Tastan O, 2014, BBA-BIOENERGETICS, V1837, P656, DOI 10.1016/j.bbabio.2013.11.021; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Virkki MT, 2014, PROTEIN SCI, V23, P981, DOI 10.1002/pro.2483; White SH, 2003, FEBS LETT, V555, P116, DOI 10.1016/S0014-5793(03)01153-0; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Whitley P, 2014, BIOL CHEM, V395, P1417, DOI 10.1515/hsz-2014-0205; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Xie HB, 2000, BIOCHEMISTRY-US, V39, P15462, DOI 10.1021/bi001432p; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zou C, 2008, CHEMBIOCHEM, V9, P2276, DOI 10.1002/cbic.200800221	91	6	6	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27170	27186		10.1074/jbc.M116.740985	http://dx.doi.org/10.1074/jbc.M116.740985			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864365	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000391576300017
J	Huang, HC; Lee, CP; Liu, HK; Chang, MF; Lai, YH; Lee, YC; Huang, C				Huang, Hsiu-Chen; Lee, Chung-Pei; Liu, Hui-Kang; Chang, Ming-Fu; Lai, Yu-Heng; Lee, Yu-Ching; Huang, Cheng			Cellular Nuclear Export Factors TAP and Aly Are Required for HDAg-L-mediated Assembly of Hepatitis Delta Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; FRAGMENT-LENGTH-POLYMORPHISM; SIGNAL-INTERACTING PROTEIN; B SURFACE-ANTIGEN; LARGE FORM; REPLICATION; DOMAIN; IDENTIFICATION; TRANSPORT; RECEPTOR	Hepatitis delta virus (HDV) is a satellite virus of hepatitis B virus (HBV). HDV genome encodes two forms of hepatitis delta antigen (HDAg), small HDAg (HDAg-S), which is required for viral replication, and large HDAg (HDAg-L), which is essential for viral assembly. HDAg-L is identical to HDAg-S except that it bears a 19-amino acid extension at the C terminus. Both HDAgs contain a nuclear localization signal (NLS), but only HDAg-L contains a CRM1-independent nuclear export signal at its C terminus. The nuclear export activity of HDAg-L is important for HDV particle formation. However, the mechanisms of HDAg-L-mediated nuclear export of HDV ribonucleoprotein are not clear. In this study, the host cellular RNA export complex TAP-Aly was found to form a complex with HDAg-L, but not with an export-defective HDAg-Lmutant, in which Pro(205) was replaced by Ala. HDAg-L was found to colocalize with TAP and Aly in the nucleus. The C-terminal domain of HDAg-L was shown to directly interact with the N terminus of TAP, whereas an HDAg-L mutant lacking the NLS failed to interact with full-length TAP. In addition, small hairpin RNA-mediated down-regulation of TAP or Aly reduced nuclear export of HDAg-L and assembly of HDV virions. Furthermore, a peptide, TAT-HDAg-L(198-210), containing the 10-amino acid TAT peptide and HDAg-L(198-210), inhibited the interaction between HDAg-L and TAP and blocked HDV virion assembly and secretion. These data demonstrate that formation and release of HDV particles are mediated by TAP and Aly.	[Huang, Hsiu-Chen] Natl Hsinchu Univ Educ, Dept Appl Sci, Hsinchu 30014, Taiwan; [Lee, Chung-Pei] Natl Taipei Univ Nursing & Hlth Sci, Sch Nursing, Taipei 11219, Taiwan; [Liu, Hui-Kang; Huang, Cheng] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei 11221, Taiwan; [Liu, Hui-Kang] Taipei Med Univ, PhD Program Clin Drug Discovery Bot Herbs, Taipei 11031, Taiwan; [Chang, Ming-Fu] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10051, Taiwan; [Lai, Yu-Heng] Chinese Culture Univ, Dept Chem, Taipei 11114, Taiwan; [Lee, Yu-Ching] Taipei Med Univ, Ctr Translat Med, Taipei 11031, Taiwan; [Lee, Yu-Ching] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Med Biotechnol, Taipei 11031, Taiwan; [Huang, Cheng] Univ Taipei, Dept Earth & Life Sci, Taipei 10048, Taiwan	National Tsing Hua University; National Taipei University of Nursing & Health Science (NTUNHS); National Research Institute of Chinese Medicine; Taipei Medical University; National Taiwan University; Chinese Culture University; Taipei Medical University; Taipei Medical University; University of Taipei	Huang, C (corresponding author), Natl Res Inst Chinese Med, 155-1,Sec 2,Linong St, Taipei 11221, Taiwan.	chengh@nricm.edu.tw		CHANG, MING-FU/0000-0001-7062-3578	Ministry of Science and Technology, Taiwan [MOST104-2320-B-077-003-MY3, MOST103-2313-B-134-001-MY3]; National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taiwan [MOHW105-NRICM-M-315-000106, MM10501-0274]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taiwan	This work was supported by Grants MOST104-2320-B-077-003-MY3 and MOST103-2313-B-134-001-MY3 from the Ministry of Science and Technology, Taiwan and Grants MOHW105-NRICM-M-315-000106 and MM10501-0274 from the National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Alves C, 2008, VIROLOGY, V370, P12, DOI 10.1016/j.virol.2007.07.034; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; BONINO F, 1986, J VIROL, V58, P945, DOI 10.1128/JVI.58.3.945-950.1986; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; CHANG MF, 1988, J VIROL, V62, P2403, DOI 10.1128/JVI.62.7.2403-2410.1988; CHANG MF, 1994, J VIROL, V68, P646, DOI 10.1128/JVI.68.2.646-653.1994; CHANG MF, 1995, J VIROL, V69, P2508, DOI 10.1128/JVI.69.4.2508-2514.1995; CHANG MF, 1992, J VIROL, V66, P6019, DOI 10.1128/JVI.66.10.6019-6027.1992; Chou HC, 1998, J VIROL, V72, P3684, DOI 10.1128/JVI.72.5.3684-3690.1998; Chou YC, 2005, J VIROL, V79, P1813, DOI 10.1128/JVI.79.3.1813-1823.2005; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136/gut.46.3.420; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; GLENN JS, 1992, SCIENCE, V256, P1331, DOI 10.1126/science.1598578; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; Hsu SC, 2002, HEPATOLOGY, V35, P665, DOI 10.1053/jhep.2002.31777; Huang C, 2007, J VIROL, V81, P5985, DOI 10.1128/JVI.02809-06; Huang C, 2013, J VIROL, V87, P1596, DOI 10.1128/JVI.02357-12; Huang C, 2009, J VIROL, V83, P12314, DOI 10.1128/JVI.01044-09; Huang HC, 2012, J VIROL, V86, P9443, DOI 10.1128/JVI.00873-12; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; HWANG SB, 1993, J VIROL, V67, P7659, DOI 10.1128/JVI.67.12.7659-7662.1993; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; Johnson LA, 2009, J VIROL, V83, P1184, DOI 10.1128/JVI.02010-08; Juillard F, 2009, J VIROL, V83, P12759, DOI 10.1128/JVI.01276-09; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Komla-Soukha I, 2006, J VIROL, V80, P4648, DOI 10.1128/JVI.80.10.4648-4655.2006; KUO MYP, 1989, J VIROL, V63, P1945, DOI 10.1128/JVI.63.5.1945-1950.1989; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; LAI MMC, 1995, ANNU REV BIOCHEM, V64, P259, DOI 10.1146/annurev.bi.64.070195.001355; Lee CH, 2001, J BIOL CHEM, V276, P8142, DOI 10.1074/jbc.M004477200; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Lischka P, 2001, EMBO J, V20, P7271, DOI 10.1093/emboj/20.24.7271; LUO GX, 1990, J VIROL, V64, P1021, DOI 10.1128/JVI.64.3.1021-1027.1990; MACNAUGHTON TB, 1993, J VIROL, V67, P2228, DOI 10.1128/JVI.67.4.2228-2234.1993; Macnaughton TB, 2002, J VIROL, V76, P3928, DOI 10.1128/JVI.76.8.3928-3935.2002; O'Malley B, 2005, J VIROL, V79, P1142, DOI 10.1128/JVI.79.2.1142-1153.2005; Polson AG, 1998, MOL CELL BIOL, V18, P1919, DOI 10.1128/MCB.18.4.1919; Polson AG, 1996, NATURE, V380, P454; RIZZETTO M, 1983, HEPATOLOGY, V3, P729; RIZZETTO M, 1983, ANN INTERN MED, V98, P437, DOI 10.7326/0003-4819-98-4-437; Rizzuti M, 2015, DRUG DISCOV TODAY, V20, P76, DOI 10.1016/j.drudis.2014.09.017; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; SARACCO G, 1988, ANN INTERN MED, V108, P380, DOI 10.7326/0003-4819-108-3-380; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022671; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang D, 2001, J VIROL, V75, P3600, DOI 10.1128/JVI.75.8.3600-3604.2001; Wang YH, 2005, J VIROL, V79, P8113, DOI 10.1128/JVI.79.13.8113-8120.2005; WEINER AJ, 1988, J VIROL, V62, P594, DOI 10.1128/JVI.62.2.594-599.1988; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374; Wu JC, 1998, J GEN VIROL, V79, P1105, DOI 10.1099/0022-1317-79-5-1105; WU JC, 1995, LANCET, V346, P939, DOI 10.1016/S0140-6736(95)91558-3; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	58	8	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26226	26238		10.1074/jbc.M116.754853	http://dx.doi.org/10.1074/jbc.M116.754853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27807029	hybrid, Green Published			2022-12-28	WOS:000390345200038
J	Luo, RB; Chen, PW; Wagenbach, M; Jian, XY; Jenkins, L; Wordeman, L; Randazzo, PA				Luo, Ruibai; Chen, Pei-Wen; Wagenbach, Michael; Jian, Xiaoying; Jenkins, Lisa; Wordeman, Linda; Randazzo, Paul A.			Direct functional interaction of the kinesin-13 family member kinesin-like protein 2A (Kif2A) and Arf GAP with GTP-binding protein-like, ankyrin repeats and PH domains 1 (AGAP1) (vol 291, pg 21350, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Jenkins, Lisa/AAI-2490-2021	Wordeman, Linda/0000-0002-9444-0650	NATIONAL CANCER INSTITUTE [ZICBC011430] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069429] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Luo RB, 2016, J BIOL CHEM, V291, P21350, DOI 10.1074/jbc.M116.732479	1	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25761	25761		10.1074/jbc.A116.732479	http://dx.doi.org/10.1074/jbc.A116.732479			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27913662	hybrid, Green Published			2022-12-28	WOS:000390095300040
J	Bauer, B; Wotapek, T; Zoller, T; Rutkowski, E; Steinle, A				Bauer, Bjoern; Wotapek, Tanja; Zoeller, Tobias; Rutkowski, Emilia; Steinle, Alexander			The Activating C-type Lectin-like Receptor NKp65 Signals through a Hemi-immunoreceptor Tyrosine-based Activation Motif (hemITAM) and Spleen Tyrosine Kinase (Syk)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface receptor; innate immunity; lectin; natural killer cells (NK cells); signal transduction; spleen tyrosine kinase (Syk); NKp65; hemITAM	KILLER GENE-COMPLEX; CUTTING EDGE; NK CELLS; DISTINCT PATHWAYS; NKP80 DEFINES; SH2 DOMAINS; CLEC-2; LIGAND; PLATELETS; GLYCOSYLATION	NKp65 is an activating human C-type lectin-like receptor (CTLR) triggering cellular cytotoxicity and cytokine secretion upon high-affinity interaction with the cognate CTLR keratinocyte-associated C-type lectin (KACL) selectively expressed by human keratinocytes. Previously, we demonstrated that NKp65-mediated cellular cytotoxicity depends on tyrosine 7, located in a cytoplasmic sequence motif of NKp65 resembling a hemi-immunoreceptor tyrosine-based activation motif (hemITAM). HemITAMs have been reported for a few activating myeloid-specific CTLRs, including Dectin-1 and CLEC-2, and consist of a single tyrosine signaling unit preceded by a triacidic motif. Upon receptor engagement, the hemITAM undergoes phosphotyrosinylation and specifically recruits spleen tyrosine kinase (Syk), initiating cellular activation. In this study, we addressed the functionality of the putative hemITAM of NKp65. We show that NKp65 forms homodimers and is phosphorylated at the hemITAM-embedded tyrosine 7 upon engagement by antibodies or KACL homodimers. HemITAM phosphotyrosinylation initiates a signaling pathway involving and depending on Syk, leading to cellular activation and natural killer (NK) cell degranulation. However, although NKp65 utilizes Syk for NK cell activation, a physical association of Syk with the NKp65 hemITAM could not be detected, unlike shown previously for the hemITAM of myeloid CTLR. Failure of NKp65 to recruit Syk is not due to an alteration of the triacidic motif, which rather affects the efficiency of hemITAM phosphotyrosinylation. In summary, NKp65 utilizes a hemITAM-like motif for cellular activation that requires Syk, although Syk appears not to be recruited to NKp65.	[Bauer, Bjoern; Wotapek, Tanja; Zoeller, Tobias; Rutkowski, Emilia; Steinle, Alexander] Goethe Univ, Inst Mol Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Steinle, A (corresponding author), Goethe Univ, Inst Mol Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	alexander.steinle@kgu.de		Steinle, Alexander/0000-0001-5081-8503	Deutsche Forschungsgemeinschaft (DFG) [STE 828/6-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG; STE 828/6-2) (to A. S.). A. S. holds a patent on NKp65.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; AOKI Y, 1995, J BIOL CHEM, V270, P15658, DOI 10.1074/jbc.270.26.15658; Bartel Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00362; Bauer B, 2015, IMMUNOLOGY, V145, P114, DOI 10.1111/imm.12432; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Dennehy KM, 2011, J IMMUNOL, V186, P657, DOI 10.4049/jimmunol.0904117; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Freud AG, 2016, CELL REP, V16, P379, DOI 10.1016/j.celrep.2016.05.095; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; GONG JH, 1994, LEUKEMIA, V8, P652; Hao L, 2006, P NATL ACAD SCI USA, V103, P3192, DOI 10.1073/pnas.0511280103; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Hughes CE, 2013, J BIOL CHEM, V288, P5127, DOI 10.1074/jbc.M112.411462; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Klimosch SN, 2013, BLOOD, V122, P2380, DOI 10.1182/blood-2013-01-479790; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YL, 2013, P NATL ACAD SCI USA, V110, P11505, DOI 10.1073/pnas.1303300110; MALEK SN, 1993, J BIOL CHEM, V268, P22557; Manne BK, 2015, J BIOL CHEM, V290, P11557, DOI 10.1074/jbc.M114.629527; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Rajasekaran K, 2013, NAT IMMUNOL, V14, P1127, DOI 10.1038/ni.2708; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Ruckrich T, 2013, J BIOL CHEM, V288, P17725, DOI 10.1074/jbc.M113.453548; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Spalton JC, 2009, J THROMB HAEMOST, V7, P1192, DOI 10.1111/j.1538-7836.2009.03451.x; Spreu J, 2007, IMMUNOGENETICS, V59, P903, DOI 10.1007/s00251-007-0263-1; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.3.CO;2-W; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471	44	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3213	3223		10.1074/jbc.M116.759977	http://dx.doi.org/10.1074/jbc.M116.759977			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082678	Green Published, hybrid			2022-12-28	WOS:000395538800014
J	Neal, S; Mak, R; Bennett, EJ; Hampton, R				Neal, Sonya; Mak, Raymond; Bennett, Eric J.; Hampton, Randolph			A Cdc48 "Retrochaperone" Function Is Required for the Solubility of Retrotranslocated, Integral Membrane Endoplasmic Reticulum-associated Degradation (ERAD-M) Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; endoplasmic reticulum (ER); endoplasmic-reticulum-associated protein degradation (ERAD); ubiquitin; ubiquitin ligase; Cdc48; Hmg2; Npl4; Retrotranslocation; Ufd1	CYTOSOLIC QUALITY-CONTROL; COENZYME-A REDUCTASE; HMG-COA REDUCTASE; UBIQUITIN-LIGASE; AAA-ATPASE; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; REGULATED DEGRADATION; PROTEIN DISLOCATION; MISFOLDED PROTEINS; YEAST	A surprising feature of endoplasmic reticulum (ER)-associated degradation (ERAD) is the movement, or retrotranslocation, of ubiquitinated substrates from the ER lumen or membrane to the cytosol where they are degraded by the 26S proteasome. Multispanning ER membrane proteins, called ERAD-M substrates, are retrotranslocated to the cytosol as full-length intermediates during ERAD, and we have investigated how they maintain substrate solubility. Using an in vivo assay, we show that retrotranslocated ERAD-M substrates are moved to the cytoplasm as part of the normal ERAD pathway, where they are part of a solely proteinaceous complex. Using proteomics and direct biochemical confirmation, we found that Cdc48 serves as a critical retrochaperone for these ERAD-M substrates. Cdc48 binding to retrotranslocated, ubiquitinated ERAD-M substrates is required for their solubility; removal of the polyubiquitin chains or competition for binding by addition of free polyubiquitin liberated Cdc48 from retrotranslocated proteins and rendered them insoluble. All components of the canonical Cdc48 complex Cdc48-Npl4-Ufd1 were present in solubilized ERAD-M substrates. This function of the complex was observed for both HRD and DOA pathway substrates. Thus, in addition to the long known ATP-dependent extraction of ERAD substrates during retrotranslocation, the Cdc48 complex is generally and critically needed for the solubility of retrotranslocated ERAD-M intermediates.	[Neal, Sonya; Mak, Raymond; Bennett, Eric J.; Hampton, Randolph] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, R (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu		Mak, Raymond/0000-0002-7081-8671	National Institutes of Health [5R37DK051996-18]; National Institutes of Health Postdoctoral Fellowship [1F32GM111024-01]; Burroughs Wellcome Fund [1013987, DP2GM119132]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM119132, F32GM111024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 5R37DK051996-18 (to R. H.), National Institutes of Health Postdoctoral Fellowship 1F32GM111024-01 (to S. N.), and Burroughs Wellcome Fund 1013987 (to S. N.) and DP2GM119132 (to E. J. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baldridge RD, 2016, CELL, V166, P394, DOI 10.1016/j.cell.2016.05.048; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Casson J, 2016, BIOCHEM SOC T, V44, P796, DOI 10.1042/BST20160045; CATT K, 1967, SCIENCE, V158, P1570, DOI 10.1126/science.158.3808.1570; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gallagher PS, 2014, J CELL SCI, V127, P1980, DOI 10.1242/jcs.141838; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Mateja A, 2015, SCIENCE, V347, P1152, DOI 10.1126/science.1261671; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nakatsukasa K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148327; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodrigo-Brenni MC, 2014, MOL CELL, V55, P227, DOI 10.1016/j.molcel.2014.05.025; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Song C, 2007, BIOCHEMISTRY-US, V46, P14889, DOI 10.1021/bi700499j; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Vangala JR, 2016, CURR BIOL, V26, pR834, DOI 10.1016/j.cub.2016.08.008; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vashistha N, 2016, P NATL ACAD SCI USA, V113, P5934, DOI 10.1073/pnas.1603079113; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wu X, 2016, J CELL BIOL, V213, P49, DOI 10.1083/jcb.201510098; Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042; Xu Y, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.40; Ye Y., 2003, J CELL BIOL, P21; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	59	25	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3112	3128		10.1074/jbc.M116.770610	http://dx.doi.org/10.1074/jbc.M116.770610			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28077573	hybrid, Green Published			2022-12-28	WOS:000395538800005
J	Yuan, WJ; Guo, SG; Gao, JQ; Zhong, MM; Yan, GH; Wu, WM; Chao, YP; Jiang, Y				Yuan, Wenjie; Guo, Shuguang; Gao, Jiaoqi; Zhong, Mingming; Yan, Gonghong; Wu, Wangmeng; Chao, Yapeng; Jiang, Yu			General Control Nonderepressible 2 (GCN2) Kinase Inhibits Target of Rapamycin Complex 1 in Response to Amino Acid Starvation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; TRANSLATIONAL CONTROL; CONTROLS TORC1; CELL-GROWTH; PROTEIN; BINDING; PHOSPHORYLATION; ASSOCIATION; ACTIVATION; AUTOPHAGY	In eukaryotic cells, two conserved protein kinases, Gcn2 and TOR complex 1 (TORC1), couple amino acid conditions to protein translation. Gcn2 functions as an amino acid sensor and is activated by uncharged tRNAs that accumulate when intracellular amino acids are limited. Activated Gcn2 phosphorylates and inhibits eukaryotic initiation factor-2 alpha (eIF2 alpha), resulting in repression of general protein synthesis. Like Gcn2, TORC1 is also involved in sensing amino acid conditions. However, the underlying mechanism remains unclear. In the present study, we show that TORC1 is a direct target of Gcn2 kinase in the yeast Saccharomyces cerevisiae. In response to amino acid starvation, Gcn2 binds to TORC1 and phosphorylates Kog1, the unique regulatory subunit of TORC1, resulting in down-regulation of TORC1 kinase activity. In the absence of Gcn2, TORC1 signaling activity increases and becomes unresponsive to amino acid starvation. Our findings demonstrate that TORC1 is an effector of Gcn2 in amino acid signaling, hence defining a novel mechanism by which TORC1 senses amino acid starvation.	[Yuan, Wenjie; Gao, Jiaoqi] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Peoples R China; [Yuan, Wenjie; Guo, Shuguang; Gao, Jiaoqi; Zhong, Mingming; Yan, Gonghong; Wu, Wangmeng; Jiang, Yu] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Chao, Yapeng] Chinese Acad Sci, Inst Microbiol, State Key Labs Transducer Technol, Beijing 100101, Peoples R China	Dalian University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Sciences; Institute of Microbiology, CAS	Jiang, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	yuj5@pitt.edu			National Institutes of Health [CA169186]; National Natural Science Foundation of China [81272269]; NATIONAL CANCER INSTITUTE [R21CA169186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA169186 (to Y.J.) and National Natural Science Foundation of China Grant 81272269 (to Y.J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Cully M, 2009, BIOCHEM SOC T, V37, P284, DOI 10.1042/BST0370284; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Duran RV, 2012, CELL RES, V22, P1207, DOI 10.1038/cr.2012.68; Duvel K, 2003, CURR TOP MICROBIOL, V279, P19; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Garcia-Barrio M, 2002, J BIOL CHEM, V277, P30675, DOI 10.1074/jbc.M203187200; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; Kubota H, 2001, J BIOL CHEM, V276, P17591, DOI 10.1074/jbc.M011793200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; PAIN VM, 1994, BIOCHIMIE, V76, P718, DOI 10.1016/0300-9084(94)90076-0; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Powers T, 2007, CELL METAB, V6, P1, DOI 10.1016/j.cmet.2007.06.009; Proud CG, 2014, AM J CLIN NUTR, V99, p231S, DOI 10.3945/ajcn.113.066753; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Shaw RJ, 2008, TRENDS BIOCHEM SCI, V33, P565, DOI 10.1016/j.tibs.2008.09.005; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wei YH, 2011, METHODS MOL BIOL, V759, P307, DOI 10.1007/978-1-61779-173-4_18; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Yan GH, 2012, MOL CELL, V45, P743, DOI 10.1016/j.molcel.2012.01.028; Zhu SH, 1996, J BIOL CHEM, V271, P24989, DOI 10.1074/jbc.271.40.24989	48	34	36	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2660	2669		10.1074/jbc.M116.772194	http://dx.doi.org/10.1074/jbc.M116.772194			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28057755	hybrid, Green Published			2022-12-28	WOS:000395535100009
J	Erikson, JM; Valente, AJ; Mummidi, S; Kandikattu, HK; DeMarco, VG; Bender, SB; Fay, WP; Siebenlist, U; Chandrasekar, B				Erikson, John M.; Valente, Anthony J.; Mummidi, Srinivas; Kandikattu, Hemanth Kumar; DeMarco, Vincent G.; Bender, Shawn B.; Fay, William P.; Siebenlist, Ulrich; Chandrasekar, Bysani			Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion- induced Myocardial Injury and Adverse Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ISCHEMIA-REPERFUSION INJURY; IMPROVES CARDIAC-FUNCTION; MICROBUBBLE DESTRUCTION; NITRIC-OXIDE; CARDIOMYOCYTE APOPTOSIS; UP-REGULATION; CIKS ACT1; IN-VITRO; ULTRASOUND	Re-establishing blood supply is the primary goal for reducing myocardial injury in subjects with ischemic heart disease. Paradoxically, reperfusion results in nitroxidative stress and a marked inflammatory response in the heart. TRAF3IP2 (TRAF3 Interacting Protein 2; previously known as CIKS or Act1) is an oxidative stress-responsive cytoplasmic adapter molecule that is an upstream regulator of both I kappa B kinase (IKK) and c-Jun N-terminal kinase (JNK), and an important mediator of autoimmune and inflammatory responses. Here we investigated the role of TRAF3IP2 in ischemia/reperfusion (I/R)-induced nitroxidative stress, inflammation, myocardial dysfunction, injury, and adverse remodeling. Our data show that I/R up-regulates TRAF3IP2 expression in the heart, and its gene deletion, in a conditional cardiomyocyte-specific manner, significantly attenuates I/R-induced nitroxidative stress, IKK/NF-kappa B and JNK/AP-1 activation, inflammatory cytokine, chemokine, and adhesion molecule expression, immune cell infiltration, myocardial injury, and contractile dysfunction. Furthermore, Traf3ip2 gene deletion blunts adverse remodeling 12 weeks post-I/R, as evidenced by reduced hypertrophy, fibrosis, and contractile dysfunction. Supporting the genetic approach, an interventional approach using ultrasound-targeted microbubble destruction-mediated delivery of phosphorothioated TRAF3IP2 antisense oligonucleotides into the LV in a clinically relevant time frame significantly inhibits TRAF3IP2 expression and myocardial injury in wild type mice post-I/R. Furthermore, ameliorating myocardial damage by targeting TRAF3IP2 appears to be more effective to inhibiting its downstream signaling intermediates NF-kappa B and JNK. Therefore, TRAF3IP2 could be a potential therapeutic target in ischemic heart disease.	[Erikson, John M.; Valente, Anthony J.; Mummidi, Srinivas] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Kandikattu, Hemanth Kumar; DeMarco, Vincent G.; Fay, William P.; Chandrasekar, Bysani] Univ Missouri, Dept Med, Sch Med, Columbia, MO 65211 USA; [Kandikattu, Hemanth Kumar; DeMarco, Vincent G.; Fay, William P.; Chandrasekar, Bysani] Harry S Truman Mem Vet Hosp, Res Serv, Columbia, MO 65201 USA; [DeMarco, Vincent G.; Bender, Shawn B.; Fay, William P.; Chandrasekar, Bysani] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Bender, Shawn B.; Siebenlist, Ulrich] Univ Missouri, Sch Med, Dept Biomed Sci, Columbia, MO 65211 USA; [Bender, Shawn B.; Chandrasekar, Bysani] Dalton Cardiovasc Res Ctr, Columbia, MO 65201 USA; [Siebenlist, Ulrich] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Health San Antonio; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chandrasekar, B (corresponding author), Univ Missouri, Sch Med, Med Cardiol, 1 Hosp Dr, Columbia, MO 65212 USA.	chandrasekarb@health.missouri.edu	Mummidi, Srinivas/H-3335-2017; Kandikattu, Hemanth Kumar/AAW-7746-2020	Mummidi, Srinivas/0000-0002-4068-6380; Kandikattu, Hemanth Kumar/0000-0001-5114-3341	United States Department of Veterans Affairs, Office of Research and Development-Biomedical Laboratory Research and Development [I01-BX002255]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000722, ZIAAI001095] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002255, IK2BX002030] Funding Source: NIH RePORTER	United States Department of Veterans Affairs, Office of Research and Development-Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported in part by United States Department of Veterans Affairs, Office of Research and Development-Biomedical Laboratory Research and Development (ORD-BLRD) Service Award I01-BX002255. The authors declare that they have no conflicts of interest with the contents of this article. The contents of this report do not represent the views of the Department of Veterans Affairs or the United States government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Chandrasekar B, 2000, FREE RADICAL BIO MED, V28, P1579, DOI 10.1016/S0891-5849(00)00273-2; Chandrasekar B, 1997, FEBS LETT, V401, P30, DOI 10.1016/S0014-5793(96)01426-3; Chandrasekar B, 2001, CIRCULATION, V103, P2296; Chen SY, 2017, METHODS MOL BIOL, V1521, P205, DOI 10.1007/978-1-4939-6588-5_14; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Dawn B, 2001, J MOL CELL CARDIOL, V33, P161, DOI 10.1006/jmcc.2000.1291; Eklund EA, 1996, J IMMUNOL, V157, P2418; Entman ML, 2000, Z KARDIOL, V89, P82; Erikson JM, 2003, J MOL CELL CARDIOL, V35, P119, DOI 10.1016/S0022-2828(02)00289-4; Ferdinandy P, 2003, BRIT J PHARMACOL, V138, P532, DOI 10.1038/sj.bjp.0705080; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Frantz S, 2007, AM J PATHOL, V171, P507, DOI 10.2353/ajpath.2007.061042; Frazziano G, 2014, AM J PHYSIOL-HEART C, V306, pH197, DOI 10.1152/ajpheart.00977.2012; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Ha HL, 2014, P NATL ACAD SCI USA, V111, pE3422, DOI 10.1073/pnas.1400513111; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; He HP, 1999, CELL DEATH DIFFER, V6, P987, DOI 10.1038/sj.cdd.4400572; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jones WK, 2005, CARDIOVASC TOXICOL, V5, P183, DOI 10.1385/CT:5:2:183; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kim YS, 2010, INT HEART J, V51, P348, DOI 10.1536/ihj.51.348; Kurian GA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1656450; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Levrand S, 2006, FREE RADICAL BIO MED, V41, P886, DOI 10.1016/j.freeradbiomed.2006.04.034; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Ma XL, 2001, J PHARMACOL EXP THER, V298, P879; Ma XL, 1999, CIRCULATION, V99, P1685, DOI 10.1161/01.CIR.99.13.1685; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Misra A, 2003, CIRCULATION, V108, P3075, DOI 10.1161/01.CIR.0000108929.93074.0B; Moss NC, 2007, AM J PHYSIOL-HEART C, V293, pH2248, DOI 10.1152/ajpheart.00776.2007; Mukherjee D, 2000, J AM COLL CARDIOL, V35, P1678, DOI 10.1016/S0735-1097(00)00575-1; Onai Y, 2004, CARDIOVASC RES, V63, P51, DOI 10.1016/j.cardiores.2004.03.002; Pall ML, 2013, INT J MOL SCI, V14, P22274, DOI 10.3390/ijms141122274; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; Porter TR, 1996, J ULTRAS MED, V15, P577; Qian Yi, 2007, Frontiers of Environmental Science and Engineering in China, V1, P1, DOI 10.1007/s11783-007-0001-9; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Schlaak JF, 2001, SCAND J IMMUNOL, V54, P396, DOI 10.1046/j.1365-3083.2001.00986.x; Schlegel P, 2016, HUM GENE THER METHOD, V27, P71, DOI 10.1089/hgtb.2015.120; Shohet RV, 2000, CIRCULATION, V101, P2554, DOI 10.1161/01.CIR.101.22.2554; Siddesha JM, 2013, J MOL CELL CARDIOL, V65, P9, DOI 10.1016/j.yjmcc.2013.09.015; Squadrito F, 2003, LAB INVEST, V83, P1097, DOI 10.1097/01.LAB.0000082060.39079.A6; SRINIVASAN SK, 1995, ANTISENSE RES DEV, V5, P131, DOI 10.1089/ard.1995.5.131; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Valente AJ, 2013, FREE RADICAL BIO MED, V60, P125, DOI 10.1016/j.freeradbiomed.2013.02.012; Valente AJ, 2012, J MOL CELL CARDIOL, V53, P113, DOI 10.1016/j.yjmcc.2012.04.009; Venkatachalam K, 2009, J BIOL CHEM, V284, P7853, DOI 10.1074/jbc.M808824200; Venkatesan B, 2013, CELL SIGNAL, V25, P359, DOI 10.1016/j.cellsig.2012.10.009; Wang JF, 2015, INT J CANCER, V137, P2478, DOI 10.1002/ijc.29597; Wei JQ, 2011, J BIOL CHEM, V286, P13995, DOI 10.1074/jbc.M110.211334; Wei K, 1997, J AM COLL CARDIOL, V29, P1081, DOI 10.1016/S0735-1097(97)00029-6; Williams CR, 2012, AM J PHYSIOL-CELL PH, V303, pC213, DOI 10.1152/ajpcell.00227.2011; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yariswamy M, 2016, J BIOL CHEM, V291, P19425, DOI 10.1074/jbc.M116.724138; Yin TG, 1997, J BIOL CHEM, V272, P19943, DOI 10.1074/jbc.272.32.19943; Zen K, 2006, J MOL CELL CARDIOL, V40, P799, DOI 10.1016/j.yjmcc.2006.03.012; Zhao ZD, 2003, J IMMUNOL, V170, P5674, DOI 10.4049/jimmunol.170.11.5674	61	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2345	2358		10.1074/jbc.M116.764522	http://dx.doi.org/10.1074/jbc.M116.764522			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28053087	Green Published, hybrid			2022-12-28	WOS:000395530300025
J	Bode, DC; Baker, MD; Viles, JH				Bode, David C.; Baker, Mark D.; Viles, John H.			Ion Channel Formation by Amyloid-beta(42) Oligomers but Not Amyloid-beta(40) in Cellular Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; ZN2+-SENSITIVE CHANNEL; CALCIUM-CHANNELS; SINGLE-MOLECULE; LIPID-BILAYERS; PEPTIDE; PORE	A central hallmark of Alzheimer's disease is the presence of extracellular amyloid plaques chiefly consisting of amyloid-beta (A beta) peptides in the brain interstitium. A beta largely exists in two isoforms, 40 and 42 amino acids long, but a large body of evidence points toA beta (1-42) rather than A beta (1-40) as the cytotoxic form. One proposed mechanism by which A beta exerts toxicity is the formation of ion channel pores that disrupt intracellular Ca2+ homeostasis. However, previous studies using membrane mimetics have not identified any notable difference in the channel forming properties between A beta (1-40) and A beta (1-42). Here, we tested whether a more physiological environment, membranes excised from HEK293 cells of neuronal origin, would reveal differences in the relative channel forming ability of monomeric, oligomeric, and fibrillar forms of both A beta (1-40) and A beta (1-42). A beta preparations were characterized with transmission electron microscopy and thioflavin T fluorescence. A beta was then exposed to the extracellular face of excised membranes, and transmembrane currents were monitored using patch clamp. Our data indicated that A beta (1-42) assemblies in oligomeric preparations form voltage-independent, non-selective ion channels. In contrast, A beta (1-40) oligomers, fibers, and monomers did not form channels. Ion channel conductance results suggested that A beta (1-42) oligomers, but not monomers and fibers, formed three distinct pore structures with 1.7-, 2.1-, and 2.4-nm pore diameters. Our findings demonstrate that only A beta (1-42) contains unique structural features that facilitate membrane insertion and channel formation, now aligning ion channel formation with the differential neurotoxic effect of A beta (1-40) and A beta (1-42) in Alzheimer's disease.	[Bode, David C.; Viles, John H.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England; [Baker, Mark D.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Neurosci & Trauma, Blizard Inst, 4 Newark St, London E1 2AT, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Viles, JH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.; Baker, MD (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Neurosci & Trauma, Blizard Inst, 4 Newark St, London E1 2AT, England.	m.d.baker@qmul.ac.uk; j.viles@qmul.ac.uk			Life Science initiative, Queen Mary, University of London; Biotechnology and Biological Sciences Research Council [BB/M023877/1]; BBSRC [BB/M023877/1] Funding Source: UKRI	Life Science initiative, Queen Mary, University of London; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Life Science initiative, Queen Mary, University of London and Biotechnology and Biological Sciences Research Council Grant BB/M023877/1. The authors declare that they have no conflicts of interest with the contents of this article.	Arispe N, 2004, J MEMBRANE BIOL, V197, P33, DOI 10.1007/s00232-003-0638-7; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Ashley RH, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-21; Bahadi R, 2003, AM J PHYSIOL-CELL PH, V285, pC873, DOI 10.1152/ajpcell.00147.2003; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; Capone R, 2012, BIOCHEMISTRY-US, V51, P776, DOI 10.1021/bi2017427; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Ding H, 2012, BIOPHYS J, V103, P1500, DOI 10.1016/j.bpj.2012.08.051; DURELL SR, 1994, BIOPHYS J, V67, P2137, DOI 10.1016/S0006-3495(94)80717-9; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; HILLE B, 1978, BIOPHYS J, V22, P283, DOI 10.1016/S0006-3495(78)85489-7; Hirakura Y, 1999, J NEUROSCI RES, V57, P458, DOI 10.1002/(SICI)1097-4547(19990815)57:4<458::AID-JNR5>3.0.CO;2-4; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; Jang H, 2009, BIOPHYS J, V97, P3029, DOI 10.1016/j.bpj.2009.09.014; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Kawahara M, 1997, BIOPHYS J, V73, P67, DOI 10.1016/S0006-3495(97)78048-2; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Klein AM, 1999, ANN NY ACAD SCI, V893, P314, DOI 10.1111/j.1749-6632.1999.tb07845.x; Kourie JI, 2002, CELL BIOCHEM BIOPHYS, V36, P191, DOI 10.1385/CBB:36:2-3:191; Kourie JI, 2001, CELL MOL NEUROBIOL, V21, P255, DOI 10.1023/A:1010995121153; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lin H, 1999, BIOCHEMISTRY-US, V38, P11189, DOI 10.1021/bi982997c; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A; Meleleo D, 2013, J BIOENERG BIOMEMBR, V45, P369, DOI 10.1007/s10863-013-9513-0; Mobley DL, 2004, BIOPHYS J, V86, P3585, DOI 10.1529/biophysj.103.032342; Narayan P, 2013, J AM CHEM SOC, V135, P1491, DOI 10.1021/ja3103567; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Peters C, 2016, J ALZHEIMERS DIS, V53, P197, DOI 10.3233/JAD-160170; Peters C, 2016, J ALZHEIMERS DIS, V51, P689, DOI 10.3233/JAD-150896; Prangkio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047261; Prince M, 2015, WORLD ALZHEIMERS REP; Qiu LM, 2011, J PHYS CHEM B, V115, P9795, DOI 10.1021/jp2012842; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rhee SK, 1998, J BIOL CHEM, V273, P13379, DOI 10.1074/jbc.273.22.13379; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Schlumberger Limited, 2009, LOG INT CHARTS; Serra-Batiste M, 2016, P NATL ACAD SCI USA, V113, P10866, DOI 10.1073/pnas.1605104113; Spangler S G, 1972, Ala J Med Sci, V9, P218; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tosatto L, 2012, BBA-BIOMEMBRANES, V1818, P2876, DOI 10.1016/j.bbamem.2012.07.007; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309	60	112	115	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1404	1413		10.1074/jbc.M116.762526	http://dx.doi.org/10.1074/jbc.M116.762526			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27927987	hybrid, Green Published			2022-12-28	WOS:000393339800022
J	Raghawan, AK; Sripada, A; Gopinath, G; Pushpanjali, P; Kumar, Y; Radha, V; Swarup, G				Raghawan, Akhouri Kishore; Sripada, Anand; Gopinath, Gayathri; Pushpanjali, Pendyala; Kumar, Yatender; Radha, Vegesna; Swarup, Ghanshyam			A Disease-associated Mutant of NLRC4 Shows Enhanced Interaction with SUG1 Leading to Constitutive FADD-dependent Caspase-8 Activation and Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMASOME ACTIVATION; CAUSES AUTOINFLAMMATION; IL-1-BETA PRODUCTION; BACTERIAL LIGANDS; APOPTOSIS; IPAF; UBIQUITINATION; MUTATION; PHOSPHORYLATION; RECOGNITION	Nod-like receptor family card containing 4 (NLRC4)/Ipaf is involved in recognition of pathogen-associated molecular patterns leading to caspase-1 activation and cytokine release, which mediate protective innate immune response. Point mutations in NLRC4 cause autoinflammatory syndromes. Although all the mutations result in constitutive caspase-1 activation, their phenotypic presentations are different, implying that these mutations cause different alterations in properties of NLRC4. NLRC4 interacts with SUG1 and induces caspase-8-mediated cell death. Here, we show that one of the autoinflammatory syndrome-causing mutants of NLRC4, H443P, but not T337A and V341A, constitutively activates caspase-8 and induces apoptotic cell death in human lung epithelial cells. Compared with wild type NLRC4, the H443P mutant shows stronger interaction with SUG1 and with ubiquitinated cellular proteins. Phosphorylation of NLRC4 at Ser(533) plays a crucial role in caspase-8 activation and cell death. However, H443P mutant does not require Ser533 phosphorylation for caspase-8 activation and cell death. Caspase-8 activation by NLRC4 and its H443P mutant are dependent on the adaptor protein FADD. A phosphomimicking mutant of NLRC4, S533D does not require SUG1 activity for inducing cell death. Ubiquitin-tagged NLRC4 could induce cell death and activate caspase-8 independent of Ser533 phosphorylation. Our work suggests that SUG1-mediated signaling results in enhanced ubiquitination and regulates FADD-dependent caspase-8 activation by NLRC4. We show that the autoinflammation-associated H443P mutant is altered in interaction with SUG1 and ubiquitinated proteins, triggering constitutive caspase-8-mediated cell death dependent on FADD but independent of Ser533 phosphorylation.	[Raghawan, Akhouri Kishore; Sripada, Anand; Gopinath, Gayathri; Pushpanjali, Pendyala; Kumar, Yatender; Radha, Vegesna; Swarup, Ghanshyam] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India; [Kumar, Yatender] Netaji Subhas Inst Technol, Dwarka Sect 3, New Delhi 110078, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Netaji Subhas University of Technology	Radha, V; Swarup, G (corresponding author), Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India.	vradha@ccmb.res.in; gshyam@ccmb.res.in	Kishore Raghawan, Akhouri/AFJ-4326-2022; Kumar, Yatender/AAG-1920-2020	Kishore Raghawan, Akhouri/0000-0002-1628-5974; Swarup, Ghanshyam/0000-0002-8098-0509	Department of Biotechnology, Government of India [BT/PR14917/BRB/10/888/2010]; J. C. Bose National fellowship; Council for Scientific and Industrial Research of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); J. C. Bose National fellowship; Council for Scientific and Industrial Research of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Biotechnology, Government of India Grant BT/PR14917/BRB/10/888/2010 (to G. S. and V. R.), a J. C. Bose National fellowship (to G. S.), and a fellowship from the Council for Scientific and Industrial Research of India (to A. K. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Bekes M, 2009, CELL, V137, P604, DOI 10.1016/j.cell.2009.04.052; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Chi W, 2014, P NATL ACAD SCI USA, V111, P11181, DOI 10.1073/pnas.1402819111; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Diebolder CA, 2015, STRUCTURE, V23, P2349, DOI 10.1016/j.str.2015.10.001; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Durairaj G, 2014, BIOMOLECULES, V4, P827, DOI 10.3390/biom4030827; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kong H, 2015, TUMOR BIOL, V36, P7501, DOI 10.1007/s13277-015-3473-4; Kumar Y, 2010, BIOCHEM J, V427, P91, DOI 10.1042/BJ20091349; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Makino Y, 1997, J BIOL CHEM, V272, P23201, DOI 10.1074/jbc.272.37.23201; Man SM, 2013, J IMMUNOL, V191, P5239, DOI 10.4049/jimmunol.1301581; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Matusiak M, 2015, P NATL ACAD SCI USA, V112, P1541, DOI 10.1073/pnas.1417945112; Nordlander S, 2014, MUCOSAL IMMUNOL, V7, P775, DOI 10.1038/mi.2013.95; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Radha V, 2002, APOPTOSIS, V7, P195, DOI 10.1023/A:1015370512425; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Sadasivam S, 2005, ONCOGENE, V24, P627, DOI 10.1038/sj.onc.1208201; Sellin ME, 2014, CELL HOST MICROBE, V16, P237, DOI 10.1016/j.chom.2014.07.001; Shivakrupa R, 2003, J BIOL CHEM, V278, P52188, DOI 10.1074/jbc.M310656200; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Thalappilly S, 2006, FEBS J, V273, P2766, DOI 10.1111/j.1742-4658.2006.05293.x; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	38	31	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1218	1230		10.1074/jbc.M116.763979	http://dx.doi.org/10.1074/jbc.M116.763979			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27974463	Green Published, hybrid			2022-12-28	WOS:000393339800007
J	Sondergaard, MT; Liu, YJ; Larsen, KT; Nani, A; Tian, XX; Holt, C; Wang, RW; Wimmer, R; Van Petegem, F; Fill, M; Chen, SRW; Overgaard, MT				Sondergaard, Mads Toft; Liu, Yingjie; Larsen, Kamilla Taunsig; Nani, Alma; Tian, Xixi; Holt, Christian; Wang, Ruiwu; Wimmer, Reinhard; Van Petegem, Filip; Fill, Michael; Chen, S. R. Wayne; Overgaard, Michael Toft			The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; VENTRICULAR-TACHYCARDIA; CALCIUM-BINDING; RELEASE; ACTIVATION; THRESHOLD; DISSOCIATION; HYPERTROPHY; TERMINATION; MUTANTS	A number of point mutations in the intracellular Ca2+ -sensing protein calmodulin (CaM) are arrhythmogenic, yet their underlying mechanisms are not clear. These mutations generally decrease Ca2+ binding to CaM and impair inhibition of CaM-regulated Ca2+ channels like the cardiac Ca2+ release channel (ryanodine receptor, RyR2), and it appears that attenuated CaM Ca2+ binding correlates with impaired CaM-dependent RyR2 inhibition. Here, we investigated the RyR2 inhibitory action of the CaM p.Phe142Leu mutation (F142L; numbered including the start-Met), which markedly reduces CaM Ca2+ binding. Surprisingly, CaM-F142L had little to no aberrant effect on RyR2-mediated store overload-induced Ca2+ release in HEK293 cells compared with CaM-WT. Furthermore, CaM-F142L enhanced CaM-dependent RyR2 inhibition at the single channel level compared with CaM-WT. This is in stark contrast to the actions of arrhythmogenic CaM mutations N54I, D96V, N98S, and D130G, which all diminish CaM-dependent RyR2 inhibition. Thermodynamic analysis showed that apoCaM-F142L converts an endothermal interaction between CaM and the CaM-binding domain (CaMBD) of RyR2 into an exothermal one. Moreover, NMR spectra revealed that the CaM-F142L-CaMBD interaction is structurally different from that of CaM-WT at low Ca2+. These data indicate a distinct interaction between CaM-F142L and the RyR2 CaMBD, which may explain the stronger CaM-dependent RyR2 inhibition by CaM-F142L, despite its reduced Ca2+ binding. Collectively, these results add to our understanding of CaM-dependent regulation of RyR2 as well as the mechanistic effects of arrhythmogenic CaM mutations. The unique properties of the CaM-F142L mutation may provide novel clues on how to suppress excessive RyR2 Ca2+ release by manipulating the CaM-RyR2 interaction.	[Sondergaard, Mads Toft; Larsen, Kamilla Taunsig; Holt, Christian; Wimmer, Reinhard; Overgaard, Michael Toft] Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark; [Sondergaard, Mads Toft; Liu, Yingjie; Tian, Xixi; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 1N4, Canada; [Sondergaard, Mads Toft; Liu, Yingjie; Tian, Xixi; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Nani, Alma; Fill, Michael; Chen, S. R. Wayne] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	Aalborg University; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; University of British Columbia; Rush University	Overgaard, MT (corresponding author), Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark.	mto@bio.aau.dk	Wimmer, Reinhard/M-2346-2019; Overgaard, Michael Toft/E-1354-2011; Wimmer, Reinhard/A-7901-2012; Van petegem, Filip/M-6061-2016	Overgaard, Michael Toft/0000-0002-1423-2481; Wimmer, Reinhard/0000-0001-6942-5056; Sondergaard, Mads Toft/0000-0001-6779-5109; Van petegem, Filip/0000-0003-2728-8537	Danish Council for Independent Research [DFF-4181-00447, DFF-4093-00242]; Obelske Family Foundation; Novo Nordic Foundation [NNF15OC001776299]; Lundbeck Foundation [2013-14432]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; National Institutes of Health [AR054098, HL057832]; Lundbeck Foundation [R151-2013-14432] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0017762, NNF16OC0023344] Funding Source: researchfish; Alberta Innovates [201400104] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111397] Funding Source: NIH RePORTER	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Obelske Family Foundation; Novo Nordic Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); Alberta Innovates; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from the Danish Council for Independent Research (DFF-4181-00447), the Obelske Family Foundation, the Novo Nordic Foundation (NNF15OC001776299), and the Lundbeck Foundation (2013-14432) (to M. T. O.) and by a postdoctoral fellowship from the Danish Council for Independent Research (DFF-4093-00242 to M. T. S.). This work was also supported by research grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada, the Canada Foundation for Innovation, and the Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research (to S. R. W. C.). Support for this research was also provided by National Institutes of Health Grants AR054098 and HL057832 (to M. F.) and HL057832 (to S. R. W. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adair GS, 1925, J BIOL CHEM, V63, P529; Arnaiz-Cot JJ, 2013, J PHYSIOL-LONDON, V591, P4287, DOI 10.1113/jphysiol.2013.256123; Berridge M. J., 2014, BIOCHEM J, DOI [10.1042/csb0001007, DOI 10.1042/CSB0001007]; Boczek NJ, 2016, CIRC-CARDIOVASC GENE, V9, P136, DOI 10.1161/CIRCGENETICS.115.001323; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; CHAMBERLAIN BK, 1984, J BIOL CHEM, V259, P7540; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; Driessen HE, 2014, NETH HEART J, V22, P198, DOI 10.1007/s12471-014-0549-5; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Fearnley CJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004242; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; Holdgate GA, 2001, BIOTECHNIQUES, V31, P164; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jiang J, 2010, BIOCHEM J, V432, P89, DOI 10.1042/BJ20100505; Jimenez-Jaimez J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153851; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Lau K, 2014, BIOCHEMISTRY-US, V53, P932, DOI 10.1021/bi401502x; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; LINSE S, 1991, J BIOL CHEM, V266, P8050; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Marsman RF, 2014, J AM COLL CARDIOL, V63, P259, DOI 10.1016/j.jacc.2013.07.091; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Mizusawa Y, 2014, CIRC J, V78, P2827, DOI 10.1253/circj.CJ-14-0905; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; Ono M, 2010, CARDIOVASC RES, V87, P609, DOI 10.1093/cvr/cvq108; Oo YW, 2015, MOL PHARMACOL, V88, P57, DOI 10.1124/mol.115.097691; PEDIGO S, 1995, BIOCHEMISTRY-US, V34, P10676, DOI 10.1021/bi00033a044; Qin J, 2009, BIOPHYS J, V97, P1961, DOI 10.1016/j.bpj.2009.07.030; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shea MA, 1996, BIOCHEMISTRY-US, V35, P2943, DOI 10.1021/bi951934g; Sondergaard MT, 2015, J BIOL CHEM, V290, P26151, DOI 10.1074/jbc.M115.676627; Sondergaard MT, 2015, FEBS J, V282, P803, DOI 10.1111/febs.13184; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Tan Z, 2016, BIOCHEM J, V473, P4159, DOI 10.1042/BCJ20160620; Tian XX, 2013, BIOCHEM J, V455, P367, DOI 10.1042/BJ20130805; Uchinoumi H, 2016, BIOPHYS J, V110, p599A, DOI 10.1016/j.bpj.2015.11.3198; Van Petegem F, 2015, J MOL BIOL, V427, P31, DOI 10.1016/j.jmb.2014.08.004; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Vassilakopoulou V, 2015, BBA-GEN SUBJECTS, V1850, P2168, DOI 10.1016/j.bbagen.2015.07.001; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Walweel K, 2017, CLIN EXP PHARMACOL P, V44, P135, DOI 10.1111/1440-1681.12669; Xu L, 2004, BIOPHYS J, V86, P797, DOI 10.1016/S0006-3495(04)74155-7; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yamaguchi N, 2007, J CLIN INVEST, V117, P1344, DOI 10.1172/JCI29515; Yamaguchi N, 2013, AM J PHYSIOL-HEART C, V305, pH86, DOI 10.1152/ajpheart.00144.2013; Yang Y, 2014, CIRC RES, V114, P295, DOI 10.1161/CIRCRESAHA.114.302857; Yin G, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000996; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	54	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1385	1395		10.1074/jbc.M116.766253	http://dx.doi.org/10.1074/jbc.M116.766253			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27927985	Green Published, hybrid			2022-12-28	WOS:000393339800020
J	Goldberg, AB; Cho, E; Miller, CJ; Lou, HJ; Turk, BE				Goldberg, Allison B.; Cho, Eunice; Miller, Chad J.; Lou, Hua Jane; Turk, Benjamin E.			Identification of a Substrate-selective Exosite within the Metalloproteinase Anthrax Lethal Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BACILLUS-ANTHRACIS; CRYSTAL-STRUCTURE; MELANOMA-CELLS; MAPK; INHIBITORS; DOMAIN; SITE; PHOSPHORYLATION; INACTIVATION	The metalloproteinase anthrax lethal factor (LF) is secreted by Bacillus anthracis to promote disease virulence through disruption of host signaling pathways. LF is a highly specific protease, exclusively cleaving mitogen-activated protein kinase kinases (MKKs) and rodent NLRP1B (NACHT leucine-rich repeat and pyrin domain-containing protein 1B). How LF achieves such restricted substrate specificity is not understood. Previous studies have suggested the existence of an exosite interaction between LF and MKKs that promotes cleavage efficiency and specificity. Through a combination of in silico prediction and site-directed mutagenesis, we have mapped an exosite to a non-catalytic region of LF. Mutations within this site selectively impair proteolysis of full-length MKKs yet have no impact on cleavage of short peptide substrates. Although this region appears important for cleaving all LF protein substrates, we found that mutation of specific residues within the exosite differentially affects MKK and NLRP1B cleavage in vitro and in cultured cells. Oneresidue in particular, Trp-271, is essential for cleavage of MKK3, MKK4, and MKK6 but dispensable for targeting of MEK1, MEK2, and NLRP1B. Analysis of chimeric substrates suggests that this residue interacts with the MKK catalytic domain. Wefound that LF-W271A blocked ERK phosphorylation and growth in a melanoma cell line, suggesting that it may provide a highly selective inhibitor of MEK1/2 for use as a cancer therapeutic. These findings provide insight into how a bacterial toxin functions to specifically impair host signaling pathways and suggest a general strategy for mapping protease exosite interactions.	[Goldberg, Allison B.; Cho, Eunice; Miller, Chad J.; Lou, Hua Jane; Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA	Yale University	Turk, BE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	ben.turk@yale.edu		Miller, Chad/0000-0002-2087-6566	National Institutes of Health [R01 GM105947, R01 GM104047, T32 GM007324]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105947, R01GM104047, T32GM007324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM105947, R01 GM104047, and T32 GM007324. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Alouf JE, 2000, METH MOL B, V145, P1; ARORA N, 1993, J BIOL CHEM, V268, P3334; ARORA N, 1992, J BIOL CHEM, V267, P15542; Bannwarth L, 2012, CHEM BIOL, V19, P875, DOI 10.1016/j.chembiol.2012.05.013; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Brossier F, 2004, INFECT IMMUN, V72, P6313, DOI 10.1128/IAI.72.11.6313-6317.2004; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; Chavarria-Smith J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003452; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; Forino M, 2005, P NATL ACAD SCI USA, V102, P9499, DOI 10.1073/pnas.0502733102; Golden HB, 2013, INT J CARDIOL, V168, P3884, DOI 10.1016/j.ijcard.2013.06.050; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001375; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hellmich KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049741; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Jabaiah AM, 2012, BIOL CHEM, V393, P933, DOI 10.1515/hsz-2012-0162; Kandadi MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013335; Khashan R, 2012, PROTEINS, V80, P2207, DOI 10.1002/prot.24110; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; Lee CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017165; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Liang XD, 2004, J BIOL CHEM, V279, P52473, DOI 10.1074/jbc.M409105200; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Maize KM, 2014, ACTA CRYSTALLOGR D, V70, P2813, DOI 10.1107/S1399004714018161; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; Ngai S, 2010, FEBS J, V277, P119, DOI 10.1111/j.1742-4658.2009.07458.x; Panchal RG, 2004, NAT STRUCT MOL BIOL, V11, P67, DOI 10.1038/nsmb711; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Rabideau AE, 2016, ACS CHEM BIOL, V11, P1490, DOI 10.1021/acschembio.6b00169; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schnell S, 1997, J THEOR BIOL, V187, P207, DOI 10.1006/jtbi.1997.0425; Shoop WL, 2005, P NATL ACAD SCI USA, V102, P7958, DOI 10.1073/pnas.0502159102; Tiedje C, 2014, J INTERF CYTOK RES, V34, P220, DOI 10.1089/jir.2013.0146; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Turk BE, 2004, NAT STRUCT MOL BIOL, V11, P60, DOI 10.1038/nsmb708; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Vin H, 2013, ELIFE, V2, DOI 10.7554/eLife.00969; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Xu QP, 2012, J BACTERIOL, V194, P2987, DOI 10.1128/JB.00038-12	53	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					814	825		10.1074/jbc.M116.761734	http://dx.doi.org/10.1074/jbc.M116.761734			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27909054	hybrid, Green Published			2022-12-28	WOS:000392318700005
J	Tsutsui, H; Yamanishi, Y; Ohtsuka, H; Sato, S; Yoshikawa, S; Karasuyama, H				Tsutsui, Hidemitsu; Yamanishi, Yoshinori; Ohtsuka, Hiromi; Sato, Shingo; Yoshikawa, Soichiro; Karasuyama, Hajime			The Basophil-specific Protease mMCP-8 Provokes an Inflammatory Response in the Skin with Microvascular Hyperpermeability and Leukocyte Infiltration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; CHRONIC ALLERGIC INFLAMMATION; SERINE PROTEASES; TRICHINELLA-SPIRALIS; MAMMALIAN EVOLUTION; IMMUNE-RESPONSES; CHYMASE LOCUS; HOST-DEFENSE; EXPRESSION; BIOLOGY	Basophils have often been erroneously considered to be minor relatives or blood-circulating precursors of tissue-resident mast cells because of some phenotypic similarity between them, including basophilic secretory granules in the cytoplasm. However, recent studies revealed that the repertoire of serine proteases stored in secretory granules is distinct in them. Particularly, mouse mast cell protease 8 (mMCP-8) is specifically expressed by basophils but not mast cells despite its name. Therefore, mMCP-8 is commonly used as a basophil-specific marker, but its functional property remains uncertain. Here we prepared recombinant mMCP-8 and examined its activity in vitro and in vivo. Purified recombinant mMCP-8 showed heatsensitive proteolytic activity when beta-tubulin was used as a substrate. One intradermal shot of mMCP-8, not heat-inactivated, induced cutaneous swelling with increased microvascular permeability in a cyclooxygenase-dependent manner. Moreover, repeated intradermal injection of mMCP-8 promoted skin infiltration of leukocytes, predominantly neutrophils and, to a lesser extent, monocytes and eosinophils, in conjunction with up-regulation of chemokine expression in the skin lesion. These results suggest that mMCP-8 is an important effector molecule in basophil- elicited inflammation, providing novel insights into how basophils exert a crucial and non-redundant role, distinct from that played by mast cells, in immune responses.	[Tsutsui, Hidemitsu; Yamanishi, Yoshinori; Ohtsuka, Hiromi; Sato, Shingo; Yoshikawa, Soichiro; Karasuyama, Hajime] Tokyo Med & Dent Univ, Dept Immune Regulat, Grad Sch Med & Dent Sci, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Yamanishi, Y (corresponding author), Tokyo Med & Dent Univ, Dept Immune Regulat, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	yamanishi.mbch@tmd.ac.jp	Karasuyama, Hajime/A-7966-2011	Karasuyama, Hajime/0000-0003-0689-0836	Japan Science and Technology Agency [1A145]; Japan Society for the Promotion of Science [15H05786, 15K20969]; Grants-in-Aid for Scientific Research [15H05786] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Research Grant 1A145 from the Japan Science and Technology Agency (to H. K.) and Japan Society for the Promotion of Science Grants 15H05786 (to H. K.) and 15K20969 (to Y. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Falcone FH, 2000, BLOOD, V96, P4028; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Gallwitz M, 2007, IMMUNOGENETICS, V59, P391, DOI 10.1007/s00251-007-0202-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Goping IS, 2006, J CELL SCI, V119, P858, DOI 10.1242/jcs.02791; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Huang CF, 1998, J IMMUNOL, V160, P1910; Hunt JE, 1997, J BIOL CHEM, V272, P29158, DOI 10.1074/jbc.272.46.29158; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; Lutzelschwab C, 1998, EUR J IMMUNOL, V28, P1022, DOI 10.1002/(SICI)1521-4141(199803)28:03<1022::AID-IMMU1022>3.0.CO;2-1; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Miller HRP, 2002, IMMUNOLOGY, V105, P375, DOI 10.1046/j.1365-2567.2002.01375.x; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Siracusa MC, 2011, ANN NY ACAD SCI, V1217, P166, DOI 10.1111/j.1749-6632.2010.05918.x; Sokol CL, 2010, MUCOSAL IMMUNOL, V3, P129, DOI 10.1038/mi.2009.137; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Tani K, 2000, J LEUKOCYTE BIOL, V67, P585, DOI 10.1002/jlb.67.4.585; Terakawa M, 2005, BIOCHEM BIOPH RES CO, V332, P969, DOI 10.1016/j.bbrc.2005.04.172; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Ugajin T, 2009, J LEUKOCYTE BIOL, V86, P1417, DOI 10.1189/jlb.0609400; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Yamanishi Y, 2010, J EXP MED, V207, P1501, DOI 10.1084/jem.20090581	42	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1061	1067		10.1074/jbc.M116.754648	http://dx.doi.org/10.1074/jbc.M116.754648			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27932459	hybrid, Green Published			2022-12-28	WOS:000392318700025
J	Ulbricht, D; Oertwig, K; Arnsburg, K; Saalbach, A; Pippel, J; Strater, N; Heiker, JT				Ulbricht, David; Oertwig, Kathrin; Arnsburg, Kristin; Saalbach, Anja; Pippel, Jan; Straeter, Norbert; Heiker, John T.			Basic Residues of beta-Sheet A Contribute to Heparin Binding and Activation of Vaspin (Serpin A12)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISCERAL ADIPOSE-TISSUE; PROTEIN-C INHIBITOR; ENDOTHELIAL-CELLS; KALLIKREIN 7; COFACTOR-II; ANTITHROMBIN; SITE; IDENTIFICATION; SPECIFICITY; OBESITY	Many members of the serine protease inhibitor (serpin) family are activated by glycosaminoglycans (GAGs). Visceral adipose tissue-derived serpin (vaspin), serpin A12 of the serpin family, and its target protease kallikrein 7 (KLK7) are heparinbinding proteins, and inhibition of KLK7 by vaspin is accelerated by heparin. However, the nature of GAG binding to vaspin is not known. Here, we measured vaspin binding of various glycosaminoglycans and low molecular weight heparins by microscale thermophoresis and analyzed acceleration of protease inhibition by these molecules. In addition, basic residues contributing to heparin binding and heparin activation were identified by a selective labeling approach. Together, these data show that vaspin binds heparin with high affinity (KD = 21 +/- 2 nM) and that binding takes place at a basic patch on top of beta-sheet A and is different from other heparin-binding serpins. Mutation of basic residues decreased heparin binding and activation of vaspin. Similarly, reactive center loop insertion into sheet A decreased heparin binding because it disturbs the basic cluster. Finally, using vaspin-overexpressing keratinocyte cells, we show that a significant part of secreted vaspin is bound in the extracellular matrix on the cell surface. Together, basic residues of central beta-sheet A contribute to heparin binding and activation of vaspin. Thus, binding toGAGsin the extracellular matrix can direct and regulate vaspin interaction with target proteases or other proteins and may play an important role in the various beneficial functions of vaspin in different tissues. Many members of the serine protease inhibitor (serpin) family are activated by glycosaminoglycans (GAGs). Visceral adipose tissue-derived serpin (vaspin), serpin A12 of the serpin family, and its target protease kallikrein 7 (KLK7) are heparinbinding proteins, and inhibition of KLK7 by vaspin is accelerated by heparin. However, the nature of GAG binding to vaspin is not known. Here, we measured vaspin binding of various glycosaminoglycans and low molecular weight heparins by microscale thermophoresis and analyzed acceleration of protease inhibition by these molecules. In addition, basic residues contributing to heparin binding and heparin activation were identified by a selective labeling approach. Together, these data show that vaspin binds heparin with high affinity (K-D = 21 +/- 2 nM) and that binding takes place at a basic patch on top of beta-sheet A and is different from other heparin-binding serpins. Mutation of basic residues decreased heparin binding and activation of vaspin. Similarly, reactive center loop insertion into sheet A decreased heparin binding because it disturbs the basic cluster. Finally, using vaspin-overexpressing keratinocyte cells, we show that a significant part of secreted vaspin is bound in the extracellular matrix on the cell surface. Together, basic residues of central beta-sheet A contribute to heparin binding and activation of vaspin. Thus, binding toGAGsin the extracellular matrix can direct and regulate vaspin interaction with target proteases or other proteins and may play an important role in the various beneficial functions of vaspin in different tissues.	[Ulbricht, David; Oertwig, Kathrin; Arnsburg, Kristin; Heiker, John T.] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [Saalbach, Anja] Univ Leipzig, Dept Dermatol Venerol & Allergol, D-04103 Leipzig, Germany; [Pippel, Jan; Straeter, Norbert] Univ Leipzig, Ctr Biotechnol & Biomed, Inst Bioanalyt Chem, D-04103 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Heiker, JT (corresponding author), Univ Leipzig, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.	jheiker@uni-leipzig.de	Saalbach, Anja/ABD-4003-2021; Heiker, John/O-9728-2019; Strater, Norbert/P-4856-2018	Saalbach, Anja/0000-0002-1084-3875; Heiker, John/0000-0003-2822-3006; Pippel, Jan/0000-0003-3829-3809; Strater, Norbert/0000-0002-2001-0500	European Union; Free State of Saxony; Deutsche Forschungsgemeinschaft [SFB1052]	European Union(European Commission); Free State of Saxony; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the European Union and the Free State of Saxony (to J. T. H.) and by Deutsche Forschungsgemeinschaft SFB1052 "Obesity Mechanisms" Grants C4 (to N. S.), C7 (to J. T. H.), and B5 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BRAY B, 1989, BIOCHEM J, V262, P225, DOI 10.1042/bj2620225; Chen VC, 2001, J BIOL CHEM, V276, P1276, DOI 10.1074/jbc.M005791200; Chen VC, 2000, J BIOL CHEM, V275, P40371, DOI 10.1074/jbc.M005691200; Cosmi B, 1997, CIRCULATION, V95, P118, DOI 10.1161/01.CIR.95.1.118; Debela M, 2008, BIOL CHEM, V389, P623, DOI 10.1515/BC.2008.075; EHRLICH HJ, 1992, J BIOL CHEM, V267, P11606; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Heiker JT, 2014, J PEPT SCI, V20, P299, DOI 10.1002/psc.2621; Heiker JT, 2013, CELL MOL LIFE SCI, V70, P2569, DOI 10.1007/s00018-013-1258-8; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Hida K, 2000, J LIPID RES, V41, P1615; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Jung CH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-41; Kim M.-S., 2011, Patent, Patent No. [WO2011138977 A1, 2011138977]; Kloting N, 2011, DIABETOLOGIA, V54, P1819, DOI 10.1007/s00125-011-2137-1; Luo X, 2016, INT J OBESITY, V40, P947, DOI 10.1038/ijo.2016.24; Nakatsuka A, 2013, CIRC RES, V112, P771, DOI 10.1161/CIRCRESAHA.111.300049; Nakatsuka A, 2012, DIABETES, V61, P2823, DOI 10.2337/db12-0232; Neese LL, 1998, ARCH BIOCHEM BIOPHYS, V355, P101, DOI 10.1006/abbi.1998.0716; Oliveira JR, 2015, BBA-PROTEINS PROTEOM, V1854, P73, DOI 10.1016/j.bbapap.2014.10.018; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Ori A, 2009, MOL CELL PROTEOMICS, V8, P2256, DOI 10.1074/mcp.M900031-MCP200; Phalitakul S, 2012, BIOCHEM BIOPH RES CO, V423, P844, DOI 10.1016/j.bbrc.2012.06.052; Pippel J, 2016, BIOL CHEM, V397, P111, DOI 10.1515/hsz-2015-0229; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; Saalbach A, 2016, AM J PATHOL, V186, P639, DOI 10.1016/j.ajpath.2015.10.030; Schultz S, 2013, BIOCHEM J, V452, P271, DOI 10.1042/BJ20121880; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; STONE SR, 1994, BIOCHEMISTRY-US, V33, P7731, DOI 10.1021/bi00190a028; Ulbricht D, 2015, BIOCHEM J, V470, P357, DOI 10.1042/BJ20150643; WHINNA HC, 1991, J BIOL CHEM, V266, P8129; Yang LK, 2012, BIOCHEMISTRY-US, V51, P4078, DOI 10.1021/bi300353c	37	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					994	1004		10.1074/jbc.M116.748020	http://dx.doi.org/10.1074/jbc.M116.748020			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27941022	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000392318700020
J	Bowen, A; Wear, MP; Cordero, RJB; Oscarson, S; Casadevall, A				Bowen, Anthony; Wear, Maggie P.; Cordero, Radames J. B.; Oscarson, Stefan; Casadevall, Arturo			A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN; CAPSULAR GLUCURONOXYLOMANNAN; CATALYTIC ANTIBODIES; CRYSTAL-STRUCTURE; FINE SPECIFICITY; SITE; IDENTIFICATION; ISOTYPE; DNA; AUTOANTIBODIES	Studies in the 1980s first showed that some natural antibodies were "catalytic" and able to hydrolyze peptide or phosphodiester bonds in antigens. Many naturally occurring catalytic antibodies have since been isolated from human sera and associated with positive and negative outcomes in autoimmune disease and infection. The function and prevalence of these antibodies, however, remain unclear. A previous study suggested that the 18B7 monoclonal antibody against glucuronoxylomannan (GXM), the major component of the Cryptococcus neoformans polysaccharide capsule, hydrolyzed a peptide antigen mimetic. Using mass spectrometry and Forster resonance energy transfer techniques, we confirm and characterize the hydrolytic activity of 18B7 against peptide mimetics and show that 18B7 is able to hydrolyze an oligosaccharide substrate, providing the first example of a naturally occurring catalytic antibody for polysaccharides. Additionally, we show that the catalytic 18B7 antibody increases release of capsular polysaccharide from fungal cells. A serine protease inhibitor blocked peptide and oligosaccharide hydrolysis by 18B7, and a putative serine protease-like active site was identified in the light chain variable region of the antibody. An algorithm was developed to detect similar sites present in unique antibody structures in the Protein Data Bank. The putative site was found in 14 of 63 (22.2%) catalytic antibody structures and 119 of 1602 (7.4%) antibodies with no annotation of catalytic activity. The ability of many antibodies to cleave antigen, albeit slowly, supports the notion that this activity is an important immunoglobulin function in host defense. The discovery of GXM hydrolytic activity suggests new therapeutic possibilities for polysaccharide-binding antibodies.	[Bowen, Anthony] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Wear, Maggie P.; Cordero, Radames J. B.; Casadevall, Arturo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Rm E5132,615 N Wolfe St, Baltimore, MD 21205 USA; [Oscarson, Stefan] Univ Coll Dublin, UCD Sch Chem & Chem Biol, Ctr Synth & Chem Biol, Dublin 4, Ireland	Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University College Dublin	Casadevall, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Rm E5132,615 N Wolfe St, Baltimore, MD 21205 USA.	acasade1@jhu.edu	Bowen, Anthony/O-4982-2015; Cordero, Radamés JB/F-6912-2011	Bowen, Anthony/0000-0003-1064-8372; Cordero, Radamés JB/0000-0002-3026-7094; Oscarson, Stefan/0000-0002-8273-4918; Wear, Maggie/0000-0002-8581-7831	National Institutes of Health Medical Scientist Training Program Training Grant [T32-GM007288]; National Institutes of Health [R37-AI033142]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033142, T32AI007417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health Medical Scientist Training Program Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Medical Scientist Training Program Training Grant T32-GM007288 and National Institutes of Health Award R37-AI033142. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baranova SV, 2010, INT IMMUNOL, V22, P671, DOI 10.1093/intimm/dxq051; Barker JA, 2003, BIOINFORMATICS, V19, P1644, DOI 10.1093/bioinformatics/btg226; Barrera GJ, 2009, IMMUNOL LETT, V123, P52, DOI 10.1016/j.imlet.2009.02.001; Bowen A, 2016, TRENDS IMMUNOL, V2016; Bryan RA, 2013, FUTURE MICROBIOL, V8, P1081, DOI 10.2217/fmb.13.79; Buneva VN, 1998, APPL BIOCHEM BIOTECH, V75, P63, DOI 10.1007/BF02787709; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; CASADEVALL A, 1992, J IMMUNOL METHODS, V154, P27, DOI 10.1016/0022-1759(92)90209-C; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dong ZM, 1996, J CLIN INVEST, V97, P689, DOI 10.1172/JCI118466; Dong ZM, 1997, INFECT IMMUN, V65, P557, DOI 10.1128/IAI.65.2.557-563.1997; Eryilmaz E, 2013, MOL IMMUNOL, V56, P588, DOI 10.1016/j.molimm.2013.06.006; Frases S, 2009, P NATL ACAD SCI USA, V106, P1228, DOI 10.1073/pnas.0808995106; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Ivan G, 2009, BIOCHEM BIOPH RES CO, V383, P417, DOI 10.1016/j.bbrc.2009.04.022; JACKSON DY, 1991, P NATL ACAD SCI USA, V88, P58, DOI 10.1073/pnas.88.1.58; Janda A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00022; Janda A, 2015, J BIOL CHEM, V290, P12090, DOI 10.1074/jbc.M114.618975; Janda A, 2012, J BIOL CHEM, V287, P35409, DOI 10.1074/jbc.M112.404483; Jencks W, 1969, CATALYSIS CHEM ENZYM, P288; Kim HK, 2005, ACTA CRYSTALLOGR D, V61, P920, DOI 10.1107/S0907444905009042; Kim KK, 1997, STRUCTURE, V5, P1571, DOI 10.1016/S0969-2126(97)00306-7; Kirshner DA, 2013, NUCLEIC ACIDS RES, V41, pW256, DOI 10.1093/nar/gkt403; KOZEL TR, 1977, INFECT IMMUN, V18, P701, DOI 10.1128/IAI.18.3.701-707.1977; KOZEL TR, 1976, INFECT IMMUN, V14, P62, DOI 10.1128/IAI.14.1.62-67.1976; Lang YZ, 2014, MAR DRUGS, V12, P4005, DOI 10.3390/md12074005; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; LI L, 1995, J IMMUNOL, V154, P3328; Martinez LR, 2004, INFECT IMMUN, V72, P3674, DOI 10.1128/IAI.72.6.3674-3679.2004; MATSUURA K, 1994, BIOCHEM BIOPH RES CO, V204, P57, DOI 10.1006/bbrc.1994.2425; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; MUKHERJEE J, 1995, J EXP MED, V181, P405, DOI 10.1084/jem.181.1.405; MUKHERJEE J, 1992, INFECT IMMUN, V60, P4534, DOI 10.1128/IAI.60.11.4534-4541.1992; MUKHERJEE J, 1993, J EXP MED, V177, P1105, DOI 10.1084/jem.177.4.1105; MUKHERJEE J, 1994, CAN J MICROBIOL, V40, P888, DOI 10.1139/m94-141; Nakouzi A, 2009, VACCINE, V27, P3513, DOI 10.1016/j.vaccine.2009.03.089; Nam KH, 2009, BIOCHEM BIOPH RES CO, V389, P247, DOI 10.1016/j.bbrc.2009.08.123; Nevinsky GA, 2003, J CELL MOL MED, V7, P265, DOI 10.1111/j.1582-4934.2003.tb00227.x; Nilmeier JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062535; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Nishiyama Y, 2007, MOL IMMUNOL, V44, P2707, DOI 10.1016/j.molimm.2006.12.005; Odintsova ES, 2006, BIOCHEMISTRY-MOSCOW+, V71, P251, DOI 10.1134/S0006297906030047; Okochi N, 2007, APPL MICROBIOL BIOT, V77, P597, DOI 10.1007/s00253-007-1197-0; Oscarson S, 2005, VACCINE, V23, P3961, DOI 10.1016/j.vaccine.2005.02.029; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2012, ADV EXP MED BIOL, V750, P56, DOI 10.1007/978-1-4614-3461-0_5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2007, AIDS RES HUM RETROV, V23, P1541, DOI 10.1089/aid.2007.0081; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; RASO V, 1975, BIOCHEMISTRY-US, V14, P591, DOI 10.1021/bi00674a020; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Sapparapu G, 2012, J BIOL CHEM, V287, P36096, DOI 10.1074/jbc.M112.401075; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SUN M, 1994, J BIOL CHEM, V269, P734; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Thiagarajan P, 2000, BIOCHEMISTRY-US, V39, P6459, DOI 10.1021/bi992588w; Valadon P, 1996, J MOL BIOL, V261, P11, DOI 10.1006/jmbi.1996.0438; Wootla B, 2008, J IMMUNOL, V180, P7714, DOI 10.4049/jimmunol.180.11.7714; Wootla B, 2011, BLOOD, V117, P2257, DOI 10.1182/blood-2010-07-296103; Xia YM, 2016, MOL IMMUNOL, V69, P33, DOI 10.1016/j.molimm.2015.11.001; Yang YH, 2010, RHEUMATOLOGY, V49, P34, DOI 10.1093/rheumatology/kep328; Young ACM, 1997, J MOL BIOL, V274, P622, DOI 10.1006/jmbi.1997.1407; Yu J, 1998, P NATL ACAD SCI USA, V95, P2880, DOI 10.1073/pnas.95.6.2880; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68; ZHOU GW, 1994, SCIENCE, V265, P1059, DOI 10.1126/science.8066444	77	25	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					417	434		10.1074/jbc.M116.767582	http://dx.doi.org/10.1074/jbc.M116.767582			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27872188	Green Published, hybrid			2022-12-28	WOS:000392316100002
J	Oza, J; Ganguly, B; Kulkarni, A; Ginjala, V; Yao, M; Ganesan, S				Oza, Jay; Ganguly, Bratati; Kulkarni, Atul; Ginjala, Vasudeva; Yao, Ming; Ganesan, Shridar			A novel role of chromodomain protein CBX8 in DNA damage response (vol 291, pg 22881, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Oza, Jay/ABG-8272-2021					Oza J, 2016, J BIOL CHEM, V291, P22881, DOI 10.1074/jbc.M116.725879	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					761	761		10.1074/jbc.A116.725879	http://dx.doi.org/10.1074/jbc.A116.725879			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	28087730	hybrid, Green Published			2022-12-28	WOS:000392316100030
J	Bagenholm, V; Reddy, SK; Bouraoui, H; Morrill, J; Kulcinskaja, E; Bahr, CM; Aurelius, O; Rogers, T; Xiao, Y; Logan, DT; Martens, EC; Koropatkin, NM; Stalbrand, H				Bagenholm, Viktoria; Reddy, Sumitha K.; Bouraoui, Hanene; Morrill, Johan; Kulcinskaja, Evelina; Bahr, Constance M.; Aurelius, Oskar; Rogers, Theresa; Xiao, Yao; Logan, Derek T.; Martens, Eric C.; Koropatkin, Nicole M.; Stalbrand, Henrik			Galactomannan Catabolism Conferred by a Polysaccharide Utilization Locus of Bacteroides ovatus ENZYME SYNERGY AND CRYSTAL STRUCTURE OF A beta-MANNANASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; HUMAN GUT MICROBIOTA; SUBSTRATE-SPECIFICITY; BIOCHEMICAL ANALYSES; SYMBIOTIC PROTIST; SIGNAL PEPTIDES; GUAR GUM; PURIFICATION; HYDROLASE; THETAIOTAOMICRON	A recently identified polysaccharide utilization locus (PUL) from Bacteroides ovatus ATCC 8483 is transcriptionally up-regulated during growth on galacto-and glucomannans. It encodes two glycoside hydrolase family 26 (GH26) beta-mannanases, BoMan26A and BoMan26B, and a GH36 alpha-galactosidase, BoGal36A. The PUL also includes two glycan-binding proteins, confirmed by beta-mannan affinity electrophoresis. When this PUL was deleted, B. ovatus was no longer able to grow on locust bean galactomannan. BoMan26A primarily formed mannobiose from mannan polysaccharides. BoMan26B had higher activity on galactomannan with a high degree of galactosyl substitution and was shown to be endo-acting generating a more diverse mixture of oligosaccharides, including mannobiose. Of the two beta-mannanases, only BoMan26B hydrolyzed galactoglucomannan. A crystal structure of BoMan26A revealed a similar structure to the exo-mannobiohydrolase CjMan26C from Cellvibrio japonicus, with a conserved glycone region (-1 and -2 subsites), including a conserved loop closing the active site beyond subsite -2. Analysis of cellular location by immunolabeling and fluorescence microscopy suggests that BoMan26B is surface-exposed and associated with the outer membrane, although BoMan26A and BoGal36A are likely periplasmic. In light of the cellular location and the biochemical properties of the two characterized beta-mannanases, we propose a scheme of sequential action by the glycoside hydrolases encoded by the beta-mannan PUL and involved in the beta-mannan utilization pathway in B. ovatus. The outer membrane-associated BoMan26B initially acts on the polysaccharide galactomannan, producing comparably large oligosaccharide fragments. Galactomanno-oligosaccharides are further processed in the periplasm, degalactosylated by BoGal36A, and subsequently hydrolyzed into mainly mannobiose by the beta-mannanase BoMan26A.	[Aurelius, Oskar; Logan, Derek T.; Stalbrand, Henrik] Lund Univ, Dept Biochem & Struct Biol, POB 124, S-22100 Lund, Sweden; [Bahr, Constance M.; Rogers, Theresa; Xiao, Yao; Martens, Eric C.; Koropatkin, Nicole M.] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA; [Kulcinskaja, Evelina] Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England; [Aurelius, Oskar] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England	Lund University; University of Michigan System; University of Michigan; University of Nottingham; Diamond Light Source	Stalbrand, H (corresponding author), Lund Univ, Dept Biochem & Struct Biol, POB 124, S-22100 Lund, Sweden.	henrik.stalbrand@biochemistry.lu.se	Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019	Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; Kulcinskaja, Evelina/0000-0002-0557-7672; Rogers, Theresa/0000-0002-9741-5768	Swedish Foundation for Strategic Research Grant [RBP 14-0046]; Swedish Innovation Agency [2013-03024]; Swedish Research Agency FORMAS Grant [213-2014-1254]	Swedish Foundation for Strategic Research Grant; Swedish Innovation Agency; Swedish Research Agency FORMAS Grant	This work was supported by The Swedish Foundation for Strategic Research Grant RBP 14-0046 (to H. S.), Swedish Innovation Agency Grant 2013-03024 (to H. S.), and Swedish Research Agency FORMAS Grant 213-2014-1254 (to H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht S, 2011, J AGR FOOD CHEM, V59, P12658, DOI 10.1021/jf203091h; Barak S, 2014, INT J BIOL MACROMOL, V66, P74, DOI 10.1016/j.ijbiomac.2014.02.017; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Bolam DN, 1996, BIOCHEMISTRY-US, V35, P16195, DOI 10.1021/bi961866d; Cameron E. A., 2014, MBIO, V5, DOI DOI 10.1128/MBI0.01441-14; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GHERARDINI F, 1985, J BACTERIOL, V161, P500, DOI 10.1128/JB.161.2.500-506.1985; GHERARDINI FC, 1987, J BACTERIOL, V169, P2038, DOI 10.1128/jb.169.5.2038-2043.1987; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hekmat O, 2010, BIOCHEMISTRY-US, V49, P4884, DOI 10.1021/bi100097f; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Hong PY, 2014, APPL ENVIRON MICROB, V80, P2084, DOI 10.1128/AEM.03176-13; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawaguchi K, 2014, ARCH MICROBIOL, V196, P17, DOI 10.1007/s00203-013-0938-y; Koropatkin N, 2009, BIOCHEMISTRY-US, V48, P1532, DOI 10.1021/bi801942a; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kulcinskaja E, 2013, APPL ENVIRON MICROB, V79, P133, DOI 10.1128/AEM.02118-12; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lundqvist J, 2002, CARBOHYD POLYM, V48, P29, DOI 10.1016/S0144-8617(01)00210-7; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNulty NP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001637; Morrill J, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0055-4; Mudgil D, 2014, J FOOD SCI TECH MYS, V51, P409, DOI 10.1007/s13197-011-0522-x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reddy SK, 2016, FEBS LETT, V590, P2106, DOI 10.1002/1873-3468.12250; Reddy SK, 2013, FEBS LETT, V587, P3444, DOI 10.1016/j.febslet.2013.08.029; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; Rosengren A, 2012, BIOCATAL BIOTRANSFOR, V30, P338, DOI 10.3109/10242422.2012.674726; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schorsch C, 1997, CARBOHYD POLYM, V34, P165, DOI 10.1016/S0144-8617(97)00095-7; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Shipman JA, 1999, J BACTERIOL, V181, P7206, DOI 10.1128/JB.181.23.7206-7211.1999; STALBRAND H, 1993, J BIOTECHNOL, V29, P229, DOI 10.1016/0168-1656(93)90055-R; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tsukagoshi H, 2014, BIOCHEM BIOPH RES CO, V452, P520, DOI 10.1016/j.bbrc.2014.08.103; Tsukagoshi H, 2014, J BIOL CHEM, V289, P10843, DOI 10.1074/jbc.M114.555383; VALENTINE PJ, 1992, APPL ENVIRON MICROB, V58, P1534, DOI 10.1128/AEM.58.5.1534-1540.1992; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu BZ, 2002, J BIOTECHNOL, V92, P267, DOI 10.1016/S0168-1656(01)00367-4; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yan XX, 2008, J MOL BIOL, V379, P535, DOI 10.1016/j.jmb.2008.03.068; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345; Zhang ML, 2014, P NATL ACAD SCI USA, V111, pE3708, DOI 10.1073/pnas.1406156111	63	65	66	6	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					229	243		10.1074/jbc.M116.746438	http://dx.doi.org/10.1074/jbc.M116.746438			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27872187	Green Published, hybrid			2022-12-28	WOS:000391578000020
J	Upton, HE; Chan, H; Feigon, J; Collins, K				Upton, Heather E.; Chan, Henry; Feigon, Juli; Collins, Kathleen			Shared Subunits of Tetrahymena Telomerase Holoenzyme and Replication Protein A Have Different Functions in Different Cellular Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; CRYPTOSPORIDIUM-PARVUM; LENGTH REGULATION; GENE-EXPRESSION; CST COMPLEX; RPA; BINDING; RNA; MAINTENANCE; SEQUENCE	In most eukaryotes, telomere maintenance relies on telomeric repeat synthesis by a reverse transcriptase named telomerase. To synthesize telomeric repeats, the catalytic subunit telomerase reverse transcriptase (TERT) uses the RNA subunit (TER) as a template. In the ciliate Tetrahymena thermophila, the telomerase holoenzyme consists of TER, TERT, and eight additional proteins, including the telomeric repeat single-stranded DNA-binding protein Teb1 and its heterotrimer partners Teb2 and Teb3. Teb1 is paralogous to the large subunit of the general single-stranded DNA binding heterotrimer replication protein A (RPA). Little is known about the function of Teb2 and Teb3, which are structurally homologous to the RPA middle and small subunits, respectively. Here, epitope-tagging Teb2 and Teb3 expressed at their endogenous gene loci enabled affinity purifications that revealed that, unlike other Tetrahymena telomerase holoenzyme subunits, Teb2 and Teb3 are not telomerase-specific. Teb2 and Teb3 assembled into other heterotrimer complexes, which when recombinantly expressed had the general single-stranded DNA binding activity of RPA complexes, unlike the telomere-specific DNA binding of Teb1 or the TEB heterotrimer of Teb1, Teb2, and Teb3. TEB had no more DNA binding affinity than Teb1 alone. In contrast, heterotrimers reconstituted with Teb2 and Teb3 and two other Tetrahymena RPA large subunit paralogs had higher DNA binding affinity than their large subunit alone. Teb1 and TEB, but not RPA, increased telomerase processivity. We conclude that in the telomerase holoenzyme, instead of binding DNA, Teb2 and Teb3 are Teb1 assembly factors. These findings demonstrate that Tetrahymena telomerase holoenzyme and RPA complexes share subunits and that RPA subunits have distinct functions in different heterotrimer assemblies.	[Upton, Heather E.; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Chan, Henry; Feigon, Juli] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu			National Institutes of Health [S10RR025622]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048123, R01GM054198, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work used the Vincent J. Coates Proteomics/Mass Spectrometry Laboratory at UC Berkeley, supported in part by National Institutes of Health Grant S10RR025622.	Arnoult N, 2015, NAT STRUCT MOL BIOL, V22, P859, DOI 10.1038/nsmb.3092; Baumann P, 2010, FEBS LETT, V584, P3779, DOI 10.1016/j.febslet.2010.05.024; Bhattacharjee A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006342; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Chen R, 2014, BIOESSAYS, V36, P1156, DOI 10.1002/bies.201400107; Couvillion MT, 2012, METHOD CELL BIOL, V109, P347, DOI 10.1016/B978-0-12-385967-9.00012-8; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Doksani Y, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016576; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Hockemeyer D, 2015, NAT STRUCT MOL BIOL, V22, P848, DOI 10.1038/nsmb.3083; Hong K, 2013, MOL CELL BIOL, V33, P3962, DOI 10.1128/MCB.00792-13; Jacob NK, 2001, EMBO J, V20, P4299, DOI 10.1093/emboj/20.15.4299; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Linger BR, 2011, MOL BIOL CELL, V22, P4161, DOI 10.1091/mbc.E11-06-0551; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lloyd NR, 2016, BIOCHEMISTRY-US, V55, P5326, DOI 10.1021/acs.biochem.6b00496; Londono-Vallejo JA, 2012, TRENDS BIOCHEM SCI, V37, P391, DOI 10.1016/j.tibs.2012.05.004; MacNeil DE, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090064; Martinez P, 2015, TRENDS BIOCHEM SCI, V40, P504, DOI 10.1016/j.tibs.2015.06.003; Mason AC, 2010, BIOCHEMISTRY-US, V49, P5919, DOI 10.1021/bi100380n; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Min BS, 2010, J BIOL CHEM, V285, P16434, DOI 10.1074/jbc.M110.119172; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; O'Connor CM, 2006, MOL CELL BIOL, V26, P2029, DOI 10.1128/MCB.26.6.2029-2036.2006; Podlevsky JD, 2016, RNA BIOL, V13, P720, DOI 10.1080/15476286.2016.1205768; Rice C, 2016, COMPUT STRUCT BIOTEC, V14, P161, DOI 10.1016/j.csbj.2016.04.002; Rider SD, 2005, J BIOL CHEM, V280, P31460, DOI 10.1074/jbc.M504466200; Rider SD, 2008, J CELL BIOCHEM, V104, P2207, DOI 10.1002/jcb.21784; Rubtsova MP, 2009, BIOCHEMISTRY-MOSCOW+, V74, P92, DOI 10.1134/S0006297909010143; Ruehle MD, 2016, GENETICS, V203, P649, DOI 10.1534/genetics.114.169748; Sakaguchi K, 2009, FEBS J, V276, P943, DOI 10.1111/j.1742-4658.2008.06841.x; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Sugitani N, 2015, PROG BIOPHYS MOL BIO, V117, P206, DOI 10.1016/j.pbiomolbio.2014.12.001; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Upton HE, 2014, MOL CELL BIOL, V34, P4200, DOI 10.1128/MCB.01030-14; Wan BB, 2015, NAT STRUCT MOL BIOL, V22, P1023, DOI 10.1038/nsmb.3126; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Xiong J, 2011, SCI CHINA LIFE SCI, V54, P65, DOI 10.1007/s11427-010-4114-1; Zeng ZX, 2011, P NATL ACAD SCI USA, V108, P20357, DOI 10.1073/pnas.1113624108; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063	53	16	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					217	228		10.1074/jbc.M116.763664	http://dx.doi.org/10.1074/jbc.M116.763664			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895115	Green Published, hybrid			2022-12-28	WOS:000391578000019
J	Cividini, F; Scott, BT; Dai, AZ; Han, WL; Suarez, J; Diaz-Juarez, J; Diemer, T; Casteel, DE; Dillmann, WH				Cividini, Federico; Scott, Brian T.; Dai, Anzhi; Han, Wenlong; Suarez, Jorge; Diaz-Juarez, Julieta; Diemer, Tanja; Casteel, Darren E.; Dillmann, Wolfgang H.			O-GlcNAcylation of 8-Oxoguanine DNA Glycosylase (Ogg1) Impairs Oxidative Mitochondrial DNA Lesion Repair in Diabetic Hearts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; GLCNAC TRANSFERASE; TETRATRICOPEPTIDE REPEATS; CYTOSOLIC PROTEINS; CARDIAC MYOCYTES; LINKED GLCNAC; HIGH-GLUCOSE; DAMAGE; NUCLEAR; REPLICATION	mtDNA damage in cardiac myocytes resulting from increased oxidative stress is emerging as an important factor in the pathogenesis of diabetic cardiomyopathy. A prevalent lesion that occurs in mtDNA damage is the formation of 8-hydroxy-2'-deoxyguanosine (8-OHdG), which can cause mutations when not repaired properly by 8-oxoguanine DNA glycosylase (Ogg1). Although the mtDNA repair machinery has been described in cardiac myocytes, the regulation of this repair has been incompletely investigated. Here we report that the hearts of type 1 diabetic mice, despite having increased Ogg1 protein levels, had significantly lower Ogg1 activity than the hearts of control, non-type 1 diabetic mice. In diabetic hearts, we further observed increased levels of 8-OHdG and an increased amount of mtDNA damage. Interestingly, Ogg1 was found to be highly O-GlcNAcylated in diabetic mice compared with controls. In vitro experiments demonstrated that O-GlcNAcylation inhibits Ogg1 activity, which could explain the mtDNA lesion accumulation observed in vivo. Reducing Ogg1 O-GlcNAcylation in vivo by introducing a dominant negative O-GlcNAc transferase mutant (F460A) restored Ogg1 enzymatic activity and, consequently, reduced 8-OHdG and mtDNA damage despite the adverse hyperglycemic milieu. Taken together, our results implicate hyperglycemia-induced O-GlcNAcylation of Ogg1 in increased mtDNA damage and, therefore, provide a new plausible biochemical mechanism for diabetic cardiomyopathy.	[Cividini, Federico; Scott, Brian T.; Dai, Anzhi; Han, Wenlong; Suarez, Jorge; Diemer, Tanja; Casteel, Darren E.; Dillmann, Wolfgang H.] Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Diaz-Juarez, Julieta] Inst Nacl Cardiol, Dept Pharmacol, Juan Badiano 41, Tlalpan 14080, DF, Mexico	University of California System; University of California San Diego	Cividini, F; Dillmann, WH (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	fcividini@ucsd.edu; wdillmann@ucsd.edu		Scott, Brian/0000-0002-1321-7204; Cividini, Federico/0000-0001-6312-6514	National Institutes of Health [HL066941, NS047101]; P. Robert Majumder Charitable Foundation; University of California Institute for Mexico; United States (UC MEXUS); Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) [CN 15-1489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P. Robert Majumder Charitable Foundation; University of California Institute for Mexico; United States (UC MEXUS); Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants HL066941 (to W. H. D., PI project 3) and NS047101, and a grant from the P. Robert Majumder Charitable Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by the University of California Institute for Mexico and the United States (UC MEXUS) and the Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) (CN 15-1489).	Aguilar H, 2014, AM J PHYSIOL-CELL PH, V306, pC794, DOI 10.1152/ajpcell.00251.2013; ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348; Anson RM, 2000, FASEB J, V14, P355, DOI 10.1096/fasebj.14.2.355; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213; Bennett CE, 2013, LIFE SCI, V92, P657, DOI 10.1016/j.lfs.2012.09.007; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Costa RAP, 2011, J BIOENERG BIOMEMBR, V43, P25, DOI 10.1007/s10863-011-9329-8; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122; Gredilla R, 2010, EXP GERONTOL, V45, P478, DOI 10.1016/j.exger.2010.01.017; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; Hu JP, 2005, NUCLEIC ACIDS RES, V33, P3271, DOI 10.1093/nar/gki636; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Kovalenko Olga A, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1901s62; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus BD, 2005, J BIOL CHEM, V280, P35537, DOI 10.1074/jbc.M504948200; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2012, J BIOL CHEM, V287, P28882, DOI 10.1074/jbc.M112.363721; Marsh SA, 2014, J BIOL CHEM, V289, P34449, DOI 10.1074/jbc.R114.585984; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; Mirbahai L, 2010, DNA REPAIR, V9, P144, DOI 10.1016/j.dnarep.2009.11.009; Nakabeppu Y, 2004, ANN NY ACAD SCI, V1011, P101, DOI 10.1196/annals.1293.011; Ngoh GA, 2010, CIRC RES, V107, P171, DOI 10.1161/CIRCRESAHA.110.224675; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sikorsky JA, 2007, BIOCHEM BIOPH RES CO, V355, P431, DOI 10.1016/j.bbrc.2007.01.169; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Tyrberg Bjorn, 2002, BMC Endocr Disord, V2, P2, DOI 10.1186/1472-6823-2-2; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200	48	30	31	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26515	26528		10.1074/jbc.M116.754481	http://dx.doi.org/10.1074/jbc.M116.754481			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27816939	Green Published, hybrid			2022-12-28	WOS:000391568200024
J	Park, T; Koptyra, M; Curran, T				Park, Taeju; Koptyra, Mateusz; Curran, Tom			Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN CRK; EPITHELIAL OVARIAN CARCINOMAS; KEY SIGNALING INTEGRATORS; CELL-PROLIFERATION; JNK ACTIVATION; MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; MALIGNANT FEATURE; GASTRIC-CANCER; MESSENGER-RNA	CT10 regulator of kinase (Crk) and Crk-like (CrkL) are the cellular counterparts of the viral oncogene v-Crk. Elevated levels of Crk and CrkL have been observed in many human cancers; inhibition of Crk and CrkL expression reduced the tumor-forming potential of cancer cell lines. Despite a close relationship between the Crk family proteins and tumorigenesis, how Crk and CrkL contribute to cell growth is unclear. We ablated endogenous Crk and CrkL from cultured fibroblasts carrying floxed alleles of Crk and CrkL by transfection with synthetic Cre mRNA (synCre). Loss of Crk and CrkL induced by synCre transfection blocked cell proliferation and caused shrinkage of the cytoplasm and the nucleus, formation of adherens junctions, and reduced cell motility. Ablation of Crk or CrkL alone conferred a much more modest reduction in cell proliferation. Reintroduction of CrkI, CrkII, or CrkL individually rescued cell proliferation in the absence of the endogenous Crk and CrkL, suggesting that Crk and CrkL play overlapping functions in regulating fibroblast growth. Serum and basic FGF induced phosphorylation of Akt, MAP kinases, and S6 kinase and Fos expression in the absence of Crk and CrkL, suggesting that cells lacking Crk and CrkL are capable of initiating major signal transduction pathways in response to extracellular stimuli. Furthermore, cell cycle and cell death analyses demonstrated that fibroblasts lacking Crk and CrkL become arrested at the G1-S transition and undergo a modest apoptosis. Taken together, our results suggest that Crk and CrkL play essential overlapping roles in fibroblast growth.	[Park, Taeju; Koptyra, Mateusz; Curran, Tom] Childrens Mercy Kansas City, Childrens Res Inst, Kansas City, MO 64108 USA	Children's Mercy Hospital	Park, T (corresponding author), Childrens Mercy Kansas City, Childrens Res Inst, Kansas City, MO 64108 USA.	tjpark@cmh.edu	Curran, Tom/F-5234-2018; Curran, Thomas/AAE-7631-2019	Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Koptyra, Mateusz/0000-0002-3857-6633; Park, Taeju/0000-0003-3897-3994				Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; Batt DB, 1998, J BIOL CHEM, V273, P3408, DOI 10.1074/jbc.273.6.3408; Bell Emily S, 2012, Genes Cancer, V3, P341, DOI 10.1177/1947601912459951; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Cheng SM, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0494-1; Cheng SM, 2015, TUMOR BIOL, V36, P915, DOI 10.1007/s13277-014-2724-0; Deng YP, 2008, J CELL BIOCHEM, V105, P1172, DOI 10.1002/jcb.21829; Elmansuri AZ, 2016, ONCOTARGET, V7, P27094, DOI 10.18632/oncotarget.8314; Fathers KE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3183; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Han G, 2015, CYTOKINE, V76, P163, DOI 10.1016/j.cyto.2015.05.009; Huang S, 2002, EXP CELL RES, V275, P255, DOI 10.1006/excr.2002.5504; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Huang YP, 2015, J CLIN INVEST, V125, P1019, DOI 10.1172/JCI77278; Isakov N, 2008, TRENDS IMMUNOL, V29, P388, DOI 10.1016/j.it.2008.04.006; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Kodama H, 2003, HYPERTENSION, V41, P1372, DOI 10.1161/01.HYP.0000069698.11814.F4; Koptyra M, 2016, MOL CARCINOGEN, V55, P97, DOI 10.1002/mc.22262; Kuhn AN, 2012, CURR GENE THER, V12, P347; Kumar S, 2014, J CELL BIOCHEM, V115, P819, DOI 10.1002/jcb.24749; Lamorte L, 2000, ONCOGENE, V19, P5973, DOI 10.1038/sj.onc.1203977; Lamorte L, 2002, MOL BIOL CELL, V13, P1449, DOI 10.1091/mbc.01-10-0477; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li FF, 2012, EUR J PHARMACOL, V678, P1, DOI 10.1016/j.ejphar.2011.12.018; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Lohez OD, 2003, J CELL BIOL, V161, P67, DOI 10.1083/jcb.200208140; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; Matsumoto R, 2015, CANCER SCI, V106, P709, DOI 10.1111/cas.12662; MAYER BJ, 1988, COLD SPRING HARB SYM, V53, P907, DOI 10.1101/SQB.1988.053.01.104; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mochizuki N, 2000, J BIOL CHEM, V275, P12667, DOI 10.1074/jbc.275.17.12667; Mortazavi F, 2011, CLIN EXP METASTAS, V28, P391, DOI 10.1007/s10585-011-9378-8; Nishihara H, 2002, CANCER LETT, V180, P55, DOI 10.1016/S0304-3835(01)00763-7; Park TJ, 2014, ONCOGENE, V33, P5121, DOI 10.1038/onc.2013.453; Park TJ, 2006, MOL CELL BIOL, V26, P6272, DOI 10.1128/MCB.00472-06; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Paski SC, 2002, CAN J PHYSIOL PHARM, V80, P790, DOI 10.1139/Y02-101; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Rodrigues GA, 1997, EMBO J, V16, P2634, DOI 10.1093/emboj/16.10.2634; Rodrigues SP, 2005, MOL CANCER RES, V3, P183; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Senechal K, 1996, J BIOL CHEM, V271, P23255, DOI 10.1074/jbc.271.38.23255; Sriram Ganapathy, 2010, Genes Cancer, V1, P1132, DOI 10.1177/1947601910397188; Takino T, 2003, CANCER RES, V63, P2335; Tanaka S, 1997, P NATL ACAD SCI USA, V94, P2356, DOI 10.1073/pnas.94.6.2356; Tsuda Masumi, 2012, Genes Cancer, V3, P334, DOI 10.1177/1947601912458687; Wang J, 2011, MOL CARCINOGEN, V50, P506, DOI 10.1002/mc.20745; Wang JQ, 2013, CHEM-BIOL INTERACT, V206, P230, DOI 10.1016/j.cbi.2013.09.003; Wang L, 2007, BIOCHEM BIOPH RES CO, V362, P976, DOI 10.1016/j.bbrc.2007.08.106; Wang Y, 2013, MOL CARCINOGEN, V52, P890, DOI 10.1002/mc.21935; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe T, 2006, MOL CANCER RES, V4, P499, DOI 10.1158/1541-7786.MCR-05-0141; Yamada S, 2011, CANCER LETT, V303, P84, DOI 10.1016/j.canlet.2011.01.004; Yanagi H, 2012, BIOCHEM BIOPH RES CO, V418, P104, DOI 10.1016/j.bbrc.2011.12.142; Yeung CL, 2013, ONCOGENE, V32, P5429, DOI 10.1038/onc.2012.590	59	12	12	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26273	26290		10.1074/jbc.M116.764613	http://dx.doi.org/10.1074/jbc.M116.764613			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27807028	Green Published, hybrid			2022-12-28	WOS:000391568200004
J	Gasper, R; Schwach, J; Hartmann, J; Holtkamp, A; Wiethaus, J; Riedel, N; Hofmann, E; Frankenberg-Dinkel, N				Gasper, Raphael; Schwach, Julia; Hartmann, Jana; Holtkamp, Andrea; Wiethaus, Jessica; Riedel, Natascha; Hofmann, Eckhard; Frankenberg-Dinkel, Nicole			Distinct Features of Cyanophage-encoded T-type Phycobiliprotein Lyase Phi CpeT THE ROLE OF AUXILIARY METABOLIC GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteriophage; microbiology; photosynthetic pigment; protein crystallization; viral protein	BILE-PIGMENTS; PHYCOERYTHRIN; PROCHLOROCOCCUS; BIOSYNTHESIS; PHYCOCYANOBILIN; IDENTIFICATION; REDUCTION; PROTEINS; INSIGHT; VIRUSES	Auxiliary metabolic genes (AMG) are commonly found in the genomes of phages that infect cyanobacteria and increase the fitness of the cyanophage. AMGs are often homologs of host genes, and also typically related to photosynthesis. For example, the phi cpeT gene in the cyanophage P-HM1 encodes a putative phycobiliprotein lyase related to cyanobacterial T-type lyases, which facilitate attachment of linear tetrapyrrole chromophores to Cys-155 of phycobiliprotein -subunits, suggesting that phi CpeT may also help assemble light-harvesting phycobiliproteins during infection. To investigate this possibility, we structurally and biochemically characterized recombinant phi CpeT. The solved crystal structure of phi CpeT at 1.8- resolution revealed that the protein adopts a similar fold as the cyanobacterial T-type lyase CpcT from Nostoc sp. PCC7120 but overall is more compact and smaller. phi CpeT specifically binds phycoerythrobilin (PEB) in vitro leading to a tight complex that can also be formed in Escherichia coli when it is co-expressed with genes encoding PEB biosynthesis (i.e. ho1 and pebS). The formed phi CpeT<bold>PEB complex was very stable as the chromophore was not lost during chromatography and displayed a strong red fluorescence with a fluorescence quantum yield of </bold>phi(F) = 0.3. This complex was not directly able to transfer PEB to the host phycobiliprotein -subunit. However, it could assist the host lyase CpeS in its function by providing a pool of readily available PEB, a feature that might be important for fast phycobiliprotein assembly during phage infection.	[Gasper, Raphael; Hofmann, Eckhard] Ruhr Univ Bochum, Prot Crystallog Grp, D-44780 Bochum, Germany; [Schwach, Julia; Holtkamp, Andrea; Wiethaus, Jessica; Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, Fac Biol & Biotechnol, Physiol Microorganisms Grp, D-44780 Bochum, Germany; [Hartmann, Jana; Riedel, Natascha; Frankenberg-Dinkel, Nicole] Tech Univ Kaiserslautern, Div Microbiol, Dept Biol, D-67663 Kaiserslautern, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Kaiserslautern	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, Physiol Microorganisms Grp, D-44780 Bochum, Germany.	nfranken@bio.uni-kl.de	Frankenberg-Dinkel, Nicole/C-1058-2011; Hofmann, Eckhard/GPF-5024-2022	Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Hofmann, Eckhard/0000-0003-4874-372X	Deutsche Forschungsgemeinschaft; European Union [Ziel2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the European Union within the Ziel2.NRW Science-to-Business program (to N. F. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Busch AWU, 2011, BIOCHEM J, V439, P257, DOI 10.1042/BJ20110814; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Doron S, 2016, ISME J, V10, P1437, DOI 10.1038/ismej.2015.210; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; GOSSAUER A, 1979, CHEM BER-RECL, V112, P2243, DOI 10.1002/cber.19791120631; Hess WR, 1996, P NATL ACAD SCI USA, V93, P11126, DOI 10.1073/pnas.93.20.11126; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KROIS D, 1993, J CHEM SOC PERK T 2, P1351, DOI 10.1039/p29930001351; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Overkamp KE, 2014, J BIOL CHEM, V289, P26691, DOI 10.1074/jbc.M114.591131; Overkamp KE, 2014, HANDB PORPHYR SCI, V28, P187; Puxty RJ, 2015, PHOTOSYNTH RES, V126, P71, DOI 10.1007/s11120-014-0057-x; Rodriguez EA, 2016, NAT METHODS, V13, P763, DOI [10.1038/NMETH.3935, 10.1038/nmeth.3935]; Shan J, 2008, FEMS MICROBIOL LETT, V283, P154, DOI 10.1111/j.1574-6968.2008.01148.x; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Steglich C, 2005, ENVIRON MICROBIOL, V7, P1611, DOI 10.1111/j.1462-2920.2005.00855.x; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Terry M., 2002, HEME CHLOROPHYLL BIL, P273; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; Weigele PR, 2007, ENVIRON MICROBIOL, V9, P1675, DOI 10.1111/j.1462-2920.2007.01285.x; WELLER JP, 1980, CHEM BER-RECL, V113, P1603, DOI 10.1002/cber.19801130439; Wiethaus J, 2010, J BIOL CHEM, V285, P37561, DOI 10.1074/jbc.M110.172619; Zhang J, 2012, GENE, V511, P88, DOI 10.1016/j.gene.2012.09.004; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhou W, 2014, J BIOL CHEM, V289, P26677, DOI 10.1074/jbc.M114.586743	35	16	17	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3089	3098		10.1074/jbc.M116.769703	http://dx.doi.org/10.1074/jbc.M116.769703			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28073912	Green Published, hybrid			2022-12-28	WOS:000395538800003
J	Xiao, XW; Chen, CD; Guo, P; Zhang, T; Fischbach, S; Fusco, J; Shiota, C; Prasadan, K; Dong, H; Gittes, GK				Xiao, Xiangwei; Chen, Congde; Guo, Ping; Zhang, Ting; Fischbach, Shane; Fusco, Joseph; Shiota, Chiyo; Prasadan, Krishna; Dong, Henry; Gittes, George K.			Forkhead Box Protein 1 (FoxO1) Inhibits Accelerated Cell Aging in Pancreas-specific SMAD7 Mutant Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; cell; cell proliferation; diabetes; type 2 diabetes; TGF; FoxO1; SMAD7	BETA-CELL; ISLET TRANSPLANTATION; TRANSCRIPTION FACTORS; DIABETES-MELLITUS; PRIMARY MECHANISM; ADULT PANCREAS; PROLIFERATION; MASS; DEDIFFERENTIATION; REPLICATION	The mechanisms underlying the effects of exocrine dysfunction on the development of diabetes remain largely unknown. Here we show that pancreatic depletion of SMAD7 resulted in age-dependent increases in cell dysfunction with accelerated glucose intolerance, followed by overt diabetes. The accelerated cell dysfunction and loss of proliferation capacity, two features of cell aging, appeared to be non-cell-autonomous, secondary to the adjacent exocrine failure as a bystander effect. Increased Forkhead box protein 1 (FoxO1) acetylation and nuclear retention was followed by progressive FoxO1 loss in cells that marked the onset of diabetes. Moreover, forced FoxO1 expression in cells prevented cell dysfunction and loss in this model. Thus, we present a model of accelerated cell aging that may be useful for studying the mechanisms underlying cell failure in diabetes. Moreover, we provide evidence highlighting a critical role of FoxO1 in maintaining cell identity in the context of SMAD7 failure.	[Xiao, Xiangwei; Chen, Congde; Guo, Ping; Fischbach, Shane; Fusco, Joseph; Shiota, Chiyo; Prasadan, Krishna; Gittes, George K.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat,Div Pediat Surg, Pittsburgh, PA 15224 USA; [Zhang, Ting; Dong, Henry] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat,Div Immunogenet, Pittsburgh, PA 15224 USA; [Chen, Congde] Wenzhou Med Univ, Affiliated Hosp 2, Dept Pediat Surg, Wenzhou 325000, Peoples R China; [Chen, Congde] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Peoples R China; [Guo, Ping] Univ Texas Hlth Sci Ctr Houston, Dept Orthoped Surg, Houston, TX 77054 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wenzhou Medical University; Wenzhou Medical University; University of Texas System; University of Texas Health Science Center Houston	Xiao, XW; Gittes, GK (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Surg,Div Pediat Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	xiangwei.xiao@chp.edu; gittesgk@upmc.edu		Dong, H. Henry/0000-0003-0279-5241; Xiao, Xiangwei/0000-0003-0890-9203	Cochrane-Weber Endowed Fund in Diabetes Research [NO19831]; National Institutes of Health [R01 DK098196]; Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098196, R01DK098437] Funding Source: NIH RePORTER	Cochrane-Weber Endowed Fund in Diabetes Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Cochrane-Weber Endowed Fund in Diabetes Research Grant NO19831 (to X. X.), National Institutes of Health Grant R01 DK098196 (to G. K. G.), and the Children's Hospital of Pittsburgh. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; DiMagno MJ, 2012, CURR OPIN GASTROEN, V28, P523, DOI 10.1097/MOG.0b013e3283567dea; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Gohary Y, 2014, DIABETES, V63, P224, DOI 10.2337/db13-0432; El-Gohary Y, 2013, DEV BIOL, V378, P83, DOI 10.1016/j.ydbio.2013.04.003; Furuta H, 1998, DIABETES, V47, P1356, DOI 10.2337/diabetes.47.8.1356; Gaglia JL, 2005, ARCH MED RES, V36, P273, DOI 10.1016/j.arcmed.2005.03.014; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gunasekaran U, 2011, AGING-US, V3, P565, DOI 10.18632/aging.100350; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Maeda H, 2011, PANCREATOLOGY, V11, P268, DOI 10.1159/000328785; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Pipeleers D, 2008, DIABETES OBES METAB, V10, P54, DOI 10.1111/j.1463-1326.2008.00941.x; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Salpeter SJ, 2013, DIABETES, V62, P2843, DOI 10.2337/db13-0160; Sander M, 2000, DEVELOPMENT, V127, P5533; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Stolovich-Rain M, 2012, J BIOL CHEM, V287, P27407, DOI 10.1074/jbc.M112.350736; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654; Xiao XW, 2016, ENDOCRINOLOGY, V157, P1348, DOI 10.1210/en.2015-1986; Xiao XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21127; Xiao XW, 2015, STEM CELL TRANSL MED, V4, P655, DOI 10.5966/sctm.2014-0248; Xiao XW, 2014, NAT PROTOC, V9, P2719, DOI 10.1038/nprot.2014.183; Xiao XW, 2014, DIABETOLOGIA, V57, P991, DOI 10.1007/s00125-014-3179-y; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Xiao XW, 2013, J BIOL CHEM, V288, P25297, DOI 10.1074/jbc.M113.484022; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xiao XW, 2013, J BIOL CHEM, V288, P8636, DOI 10.1074/jbc.M112.422949; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428	44	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3456	3465		10.1074/jbc.M116.770032	http://dx.doi.org/10.1074/jbc.M116.770032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28057752	Green Published, hybrid			2022-12-28	WOS:000395538800034
J	Bernard, K; Logsdon, NJ; Miguel, V; Benavides, GA; Zhang, JH; Carter, AB; Darley-Usmar, VM; Thannickal, VJ				Bernard, Karen; Logsdon, Naomi J.; Miguel, Veronica; Benavides, Gloria A.; Zhang, Jianhua; Carter, A. Brent; Darley-Usmar, Victor M.; Thannickal, Victor J.			NADPH Oxidase 4 (Nox4) Suppresses Mitochondrial Biogenesis and Bioenergetics in Lung Fibroblasts via a Nuclear Factor Erythroid-derived 2-like 2 (Nrf2)-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-FACTOR-A; ANTIOXIDANT RESPONSE; CONTRACTILE ACTIVITY; SKELETAL-MUSCLE; THYROID-HORMONE; SMOOTH-MUSCLE; COMPLEX I; NRF2; EXPRESSION; ACTIVATION	Mitochondrial bioenergetics are critical for cellular homeostasis and stress responses. The reactive oxygen species-generating enzyme, NADPH oxidase 4 (Nox4), regulates a number of physiological and pathological processes, including cellular differentiation, host defense, and tissue fibrosis. In this study we explored the role of constitutive Nox4 activity in regulating mitochondrial function. An increase in mitochondrial oxygen consumption and reserve capacity was observed in murine and human lung fibroblasts with genetic deficiency (or silencing) of Nox4. Inhibition of Nox4 expression/activity by genetic or pharmacological approaches resulted in stimulation of mitochondrial biogenesis, as evidenced by elevated mitochondrial-to-nuclear DNA ratio and increased expression of the mitochondrial markers transcription factor A (TFAM), citrate synthase, voltage-dependent anion channel (VDAC), and cytochrome c oxidase subunit 4 (COX IV). Induction of mitochondrial biogenesis was dependent on TFAM up-regulation but was independent of the activation of the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha). The enhancement of mitochondrial bioenergetics as well as the increase in mitochondrial proteins in Nox4-deficient lung fibroblasts is inhibited by silencing of nuclear factor erythroid-derived 2-like 2 (Nrf2), supporting a key role for Nrf2 in control of mitochondrial biogenesis. Together, these results indicate a critical role for both Nox4 and Nrf2 in counter-regulation of mitochondrial biogenesis and metabolism.	[Bernard, Karen; Logsdon, Naomi J.; Carter, A. Brent; Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA; [Benavides, Gloria A.; Zhang, Jianhua; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Benavides, Gloria A.; Zhang, Jianhua; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Ctr Free Rad Biol & Med, Birmingham, AL USA; [Carter, A. Brent] Birmingham Vet Adm Med Ctr, Birmingham, AL 35294 USA; [Miguel, Veronica] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Bernard, K (corresponding author), Div Pulm Allergy & Crit Care Med, 901 19th St South,BMRII 464, Birmingham, AL 35294 USA.	kbernard@uab.edu	Miguel, Veronica/AAA-3645-2021	Darley-Usmar, Victor/0000-0001-8921-7086; Miguel, Veronica/0000-0001-9863-0710	National Institutes of Health [P30AG050886]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG050886, R01AG046210] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We are grateful to UAB Nathan Shock Center (funded by National Institutes of Health Grant P30AG050886) for technical support.	Barbour Jayne Alexandra, 2014, Int J Cell Biol, V2014, P156020, DOI 10.1155/2014/156020; Bartz RR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00291; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Collu-Marchese M, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150073; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; DAVIES KJA, 1981, ARCH BIOCHEM BIOPHYS, V209, P539, DOI 10.1016/0003-9861(81)90312-X; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Dong XC, 2002, J BIOL CHEM, V277, P43309, DOI 10.1074/jbc.M206958200; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; FITTS RH, 1975, AM J PHYSIOL, V228, P1029, DOI 10.1152/ajplegacy.1975.228.4.1029; Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Gregg JL, 2014, CANCER RES, V74, P3501, DOI 10.1158/0008-5472.CAN-13-2979; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hirschhauser C, 2015, ANTIOXID REDOX SIGN, V23, P1106, DOI 10.1089/ars.2014.6238; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koziel R, 2013, BIOCHEM J, V452, P231, DOI 10.1042/BJ20121778; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Merry TL, 2016, J PHYSIOL-LONDON, V594, P5195, DOI 10.1113/JP271957; Mistry RK, 2016, J BIOL CHEM, V291, P1774, DOI 10.1074/jbc.M115.685578; Morrish F, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014225; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Pendyala S, 2011, FREE RADICAL BIO MED, V50, P1749, DOI 10.1016/j.freeradbiomed.2011.03.022; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Tornatore TF, 2011, AM J PHYSIOL-HEART C, V300, pH902, DOI 10.1152/ajpheart.00319.2010; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Wu KLH, 2016, FREE RADICAL BIO MED, V97, P58, DOI 10.1016/j.freeradbiomed.2016.05.012; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; You YH, 2016, J AM SOC NEPHROL, V27, P466, DOI 10.1681/ASN.2015030302; Zambrano A, 2014, J CELL BIOL, V204, P129, DOI 10.1083/jcb.201305084	61	68	69	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3029	3038		10.1074/jbc.M116.752261	http://dx.doi.org/10.1074/jbc.M116.752261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049732	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000395535100041
J	Mazzaferro, S; Bermudez, I; Sine, SM				Mazzaferro, Simone; Bermudez, Isabel; Sine, Steven M.			alpha 4 beta 2 Nicotinic Acetylcholine Receptors RELATIONSHIPS BETWEEN SUBUNIT STOICHIOMETRY AND FUNCTION AT THE SINGLE CHANNEL LEVEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP RECEPTORS; ACH BINDING-SITE; ALTERNATE STOICHIOMETRIES; SELECTIVE AGONIST; INTERFACE; SENSITIVITY; RESOLUTION; KINETICS; MICE; (ALPHA-4)(2)(BETA-2)(3)	Acetylcholine receptors comprising alpha 4 and beta 2 subunits are the most abundant class of nicotinic acetylcholine receptor in the brain. They contribute to cognition, reward, mood, and nociception and are implicated in a range of neurological disorders. Previous measurements of whole-cell macroscopic currents showed that alpha 4 and beta 2 subunits assemble in two predominant pentameric stoichiometries, which differ in their sensitivity to agonists, antagonists, and allosteric modulators. Here we compare agonist-elicited single channel currents from receptors assembled with an excess of either the alpha 4 or beta 2 subunit, forming receptor populations biased toward one or the other stoichiometry, with currents from receptors composed of five concatemeric subunits in which the subunit stoichiometry is predetermined. Our results associate each subunit stoichiometry with a unique single channel conductance, mean open channel lifetime, and sensitivity to the allosteric potentiator 3-[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl] benzonitrile (NS-9283). Receptors with the composition (alpha 4 beta 2)(2)alpha 4 exhibit high single channel conductance, brief mean open lifetime, and strong potentiation by NS-9283, whereas receptors with the composition (alpha 4 beta 2)(2)beta 2 exhibit low single channel conductance and long mean open lifetime and are not potentiated by NS-9283. Thus single channel current measurements reveal bases for the distinct functional and pharmacological properties endowed by different stoichiometries of alpha 4 and beta 2 subunits and establish pentameric concatemers as a means to delineate interactions between subunits that confer these properties.	[Mazzaferro, Simone; Sine, Steven M.] Mayo Clin, Coll Med, Receptor Biol Lab, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Bermudez, Isabel] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 OBP, England	Mayo Clinic; Mayo Clinic; Mayo Clinic; Oxford Brookes University	Sine, SM (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	sine@mayo.edu		Mazzaferro, Simone/0000-0003-4402-5325	National Institutes of Health [NS031744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031744, R01NS031744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant NS031744 (to S.M.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Benallegue N, 2013, BRIT J PHARMACOL, V170, P304, DOI 10.1111/bph.12268; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Carignano C, 2016, BBA-BIOMEMBRANES, V1858, P1964, DOI 10.1016/j.bbamem.2016.05.019; Chen Y, 2003, NEUROPHARMACOLOGY, V45, P334, DOI 10.1016/S0028-3908(03)00189-8; Colquhoun D., 1983, SINGLE CHANNEL RECOR, P483, DOI 10.1007/978-1-4615-7858-1_11; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Marubio LM, 1999, NATURE, V398, P805, DOI 10.1038/19756; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mukhtasimova N, 2016, J GEN PHYSIOL, V148, P43, DOI 10.1085/jgp.201611584; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Ragozzino D, 1997, EUR J NEUROSCI, V9, P480, DOI 10.1111/j.1460-9568.1997.tb01625.x; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SINE SM, 1994, J BIOL CHEM, V269, P8808; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zoli M, 1998, J NEUROSCI, V18, P4461; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	43	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2729	2740		10.1074/jbc.M116.764183	http://dx.doi.org/10.1074/jbc.M116.764183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28031459	Green Published, hybrid			2022-12-28	WOS:000395535100015
J	Torri, A; Carpi, D; Bulgheroni, E; Crosti, MC; Moro, M; Gruarin, P; Rossi, RL; Rossetti, G; Di Vizio, D; Hoxha, M; Bollati, V; Gagliani, C; Tacchetti, C; Paroni, M; Geginat, J; Corti, L; Venegoni, L; Berti, E; Pagani, M; Matarese, G; Abrignani, S; de Candia, P				Torri, Anna; Carpi, Donatella; Bulgheroni, Elisabetta; Crosti, Maria-Cristina; Moro, Monica; Gruarin, Paola; Rossi, Riccardo L.; Rossetti, Grazisa; Di Vizio, Dolores; Hoxha, Mirjam; Bollati, Valentina; Gagliani, Cristina; Tacchetti, Carlo; Paroni, Moira; Geginat, Jens; Corti, Laura; Venegoni, Luigia; Berti, Emilio; Pagani, Massimiliano; Matarese, Giuseppe; Abrignani, Sergio; de Candia, Paola			Extracellular MicroRNA Signature of Human Helper T Cell Subsets in Health and Autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULATING MICRORNAS; GENE-FUNCTION; EXOSOMES; BIOMARKERS; MICROVESICLES; ACTIVATION; SECRETION; MECHANISM; PATHOGENESIS; MODULATION	Upon T cell receptor stimulation, CD4 (+) T helper ( Th) lymphocytes release extracellular vesicles ( EVs) containing microRNAs. However, no data are available on whether human CD4 (+) T cell subsets release EVs containing different pattern of microRNAs. The present work aimed at filling this gap by assessing the microRNA content in EVs released upon in vitro T cell receptor stimulation of Th1, Th17, and T regulatory ( Treg) cells. Our results indicate that EVs released by Treg cells are significantly different compared with those released by the other subsets. In particular, miR-146a-5p, miR-150-5p, and miR-21-5p are enriched, whereas miR-106a-5p, miR-155-5p, and miR-19a-3p are depleted in Treg-derived EVs. The in vitro identified EV-associated microRNA signature was increased in serum of autoimmune patients with psoriasis and returned to healthy levels upon effective treatment with etanercept, a biological drug targeting the TNF pathway and suppressing inflammation. Moreover, Gene Set Enrichment Analysis showed an over-representation of genes relevant for T cell activation, such as CD40L, IRAK1, IRAK2, STAT1, and c-Myb in the list of validated targets of Treg-derived EV miRNAs. At functional level, Treg-derived ( but not Th1/ Th17-derived) EVs inhibited CD4 (+) T cell proliferation and suppressed two relevant targets of miR-146a-5p: STAT1 and IRAK2. In conclusion, our work identified the miRNAs specifically released by different human CD4 (+) T cell subsets and started to unveil the potential use of their quantity in human serum to mark the pathologicaleli citation of these cells in vivo and their biological effect in cell to cell communication during the adaptive immune response.	[Torri, Anna; Carpi, Donatella; Bulgheroni, Elisabetta; Crosti, Maria-Cristina; Moro, Monica; Gruarin, Paola; Rossi, Riccardo L.; Rossetti, Grazisa; Paroni, Moira; Geginat, Jens; Pagani, Massimiliano; Abrignani, Sergio] INGM Ist Nazl Genet Mol Romeo Enrica Invernizzi, I-20122 Milan, Italy; [Di Vizio, Dolores] Cedars Sinai Med Ctr, Div Canc Biol & Therapeut, Dept Surg, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Di Vizio, Dolores] Cedars Sinai Med Ctr, Div Canc Biol & Therapeut, Dept Biomed Sci, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Di Vizio, Dolores] Cedars Sinai Med Ctr, Div Canc Biol & Therapeut, Dept Pathol & Lab Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Hoxha, Mirjam; Bollati, Valentina] Univ Milan, Lab Epidemiol Mol & Epigenet Ambientale, Dipartimento Sci Clin & Comunita, I-20122 Milan, Italy; [Venegoni, Luigia] Univ Milan, Dipartimento Fisiopatol Med Chirurg & Trapianti, I-20122 Milan, Italy; [Pagani, Massimiliano] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, I-20122 Milan, Italy; [Abrignani, Sergio] Univ Milan, DISCCO Dipartimento Sci Clin & Comunita, I-20122 Milan, Italy; [Gagliani, Cristina; Tacchetti, Carlo] Univ Genoa, Dipartimento Med Sperimentale, I-16132 Genoa, Italy; [Corti, Laura; Berti, Emilio] Osped Maggiore Policlin, Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, Dipartimento Dermatol, I-20122 Milan, Italy; [Berti, Emilio] Univ Milano Bicocca, Dipartimento Med, I-20126 Milan, Italy; [Matarese, Giuseppe] Univ Napoli Federico II, Ist Endocrinol & Oncol Sperimentale, Consiglio Nazl Ric, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [de Candia, Paola] IRCCS Ist Ricovero & Cura Carattere Sci Mu, MultiMed, I-20138 Milan, Italy	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Milan; University of Milan; University of Milan; University of Milan; University of Genoa; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Matarese, G (corresponding author), Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy.; Abrignani, S (corresponding author), Via F Sforza 28, I-20122 Milan, Italy.; de Candia, P (corresponding author), Via Fantoli 16-15, I-20138 Milan, Italy.	giuseppe.matarese@unina.it; abrignani@ingm.org; paola.decandia@multimedica.it	de Candia, Paola/Z-1498-2019; de Candia, Paola/HGC-8826-2022; Matarese, Giuseppe/AAO-4077-2021; Geginat, Jens/AAA-5818-2019; rossetti, grazisa/C-3722-2015; Venegoni, Luigia/K-6085-2018; Rossi, Riccardo/M-8999-2019; Paroni, Moira/K-6470-2016	de Candia, Paola/0000-0003-4767-446X; de Candia, Paola/0000-0003-4767-446X; Matarese, Giuseppe/0000-0001-9429-0616; Geginat, Jens/0000-0003-4813-0384; rossetti, grazisa/0000-0001-6361-311X; Venegoni, Luigia/0000-0002-1846-1206; Rossi, Riccardo/0000-0002-4964-3264; Berti, Emilio/0000-0001-6753-4910; Pagani, Massimiliano/0000-0002-7017-9304; TACCHETTI, CARLO/0000-0003-4602-000X; Bollati, Valentina/0000-0002-0370-9598; Paroni, Moira/0000-0001-8199-3128; Abrignani, Sergio/0000-0002-0794-3285	European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Lilly program; Institute Merieux [2009-3603]; European Research Council Advanced Grant [269022]; Fondazione Invernizzi; European Foundation for the Study of Diabetes [JDRF Lilly 2015_4] Funding Source: researchfish	European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Lilly program; Institute Merieux; European Research Council Advanced Grant(European Research Council (ERC)); Fondazione Invernizzi; European Foundation for the Study of Diabetes	This work was supported by funds from the European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Lilly program 2015 (to G.M. and P.d.C.); by Institute Merieux Grant 2009-3603 and European Research Council Advanced Grant 269022 (to S.A.); and by Fondazione Invernizzi. The authors declare that they have no conflicts of interest with the contents of this article.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Bhairavabhotla R, 2016, HUM IMMUNOL, V77, P201, DOI 10.1016/j.humimm.2015.12.004; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; Cordiali-Fei P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/236060; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; de Candia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075348; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ghoreschi K, 2007, CLIN DERMATOL, V25, P574, DOI 10.1016/j.clindermatol.2007.08.012; Goretti E, 2013, INT J CARDIOL, V168, P4548, DOI 10.1016/j.ijcard.2013.06.092; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Gulinelli S, 2012, EUR J IMMUNOL, V42, P3334, DOI 10.1002/eji.201142268; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830, DOI 10.4049/jimmunol.171.9.4830; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Keijsers RRMC, 2015, EXP DERMATOL, V24, P65, DOI 10.1111/exd.12575; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marabita F, 2016, BRIEF BIOINFORM, V17, P204, DOI 10.1093/bib/bbv056; Mashima R, 2015, IMMUNOLOGY, V145, P323, DOI 10.1111/imm.12468; Mattozzi C, 2013, DERMATOLOGY, V227, P134, DOI 10.1159/000353398; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Moussay E, 2011, P NATL ACAD SCI USA, V108, P6573, DOI 10.1073/pnas.1019557108; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Peche H, 2006, AM J TRANSPLANT, V6, P1541, DOI 10.1111/j.1600-6143.2006.01344.x; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Quaglino P, 2011, DERMATOLOGY, V223, P57, DOI 10.1159/000330330; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roderburg C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054612; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wahlgren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049723; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang HG, 2006, J IMMUNOL, V176, P7385, DOI 10.4049/jimmunol.176.12.7385	63	49	49	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2903	2915		10.1074/jbc.M116.769893	http://dx.doi.org/10.1074/jbc.M116.769893			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28077577	Green Published, hybrid			2022-12-28	WOS:000395535100030
J	Espejo, AB; Gao, GZ; Black, K; Gayatri, S; Veland, N; Kim, J; Chen, TP; Sudol, M; Walker, C; Bedford, MT				Espejo, Alexsandra B.; Gao, Guozhen; Black, Karynne; Gayatri, Sitaram; Veland, Nicolas; Kim, Jeesun; Chen, Taiping; Sudol, Marius; Walker, Cheryl; Bedford, Mark T.			PRMT5 C-terminal Phosphorylation Modulates a 14-3-3/PDZ Interaction Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS E6; ARGININE METHYLTRANSFERASE PRMT5; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE; PDZ DOMAINS; MESSENGER-RNA; BINDING; METHYLATION; RECOGNITION; ONCOPROTEINS	PRMT5 is the primary enzyme responsible for the deposition of the symmetric dimethylarginine in mammalian cells. In an effort to understand how PRMT5 is regulated, we identified a threonine phosphorylation site within a C-terminal tail motif, which is targeted by the Akt/serum-and glucocorticoid-inducible kinases. While investigating the function of this post-translational modification, we serendipitously discovered that its free C-terminal tail binds PDZ domains (when unphosphorylated) and 14-3-3 proteins (when phosphorylated). In essence, a phosphorylation event within the last few residues of the C-terminal tail generates a posttranslational modification-dependent PDZ/14-3-3 interaction "switch." The C-terminal motif of PRMT5 is required for plasma membrane association, and loss of this switching capacity is not compatible with life. This signaling phenomenon was recently reported for theHPVE6 oncoprotein but has not yet been observed for mammalian proteins. To investigate the prevalence of PDZ/14-3-3 switching in signal transduction, we built a protein domain microarray that harbors PDZ domains and 14-3-3 proteins. We have used this microarray to interrogate the C-terminal tails of a small group of candidate proteins and identified ERBB4, PGHS2, and IRK1 (as well as E6 and PRMT5) as conforming to this signaling mode, suggesting that PDZ/14-3-3 switching may be a broad biological paradigm.	[Espejo, Alexsandra B.; Gao, Guozhen; Black, Karynne; Gayatri, Sitaram; Veland, Nicolas; Kim, Jeesun; Chen, Taiping; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Espejo, Alexsandra B.; Gayatri, Sitaram; Veland, Nicolas] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Sudol, Marius] Natl Univ Singapore, Dept Physiol, Mechanobiol Inst, Singapore 117597, Singapore; [Sudol, Marius] ASTAR, IMCB, Singapore 117597, Singapore; [Walker, Cheryl] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bedford, MT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA.	mtbedford@mdanderson.org	Gayatri, Sitaram/GLT-7340-2022; Gao, Guozhen/U-1554-2019	Gao, Guozhen/0000-0002-9510-1474; Espejo, Alexsandra/0000-0002-8841-7219; Walker, Cheryl/0000-0003-4854-9695; Sudol, Marius/0000-0003-3051-6406; bedford, mark/0000-0002-8899-1050; Veland, Nicolas/0000-0002-3096-7867	National Institutes of Health MPI Grant [ES023206]; CPRIT Grant [RP130432]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health MPI Grant; CPRIT Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Institutes of Health MPI Grant ES023206.; Supported by CPRIT Grant RP130432 for the protein array analysis.	Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Beltran-Alvarez P, 2013, FEBS LETT, V587, P3159, DOI 10.1016/j.febslet.2013.07.043; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Boon SS, 2013, J VIROL, V87, P1586, DOI 10.1128/JVI.02074-12; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler JS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202416; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cheng DH, 2012, METHOD ENZYMOL, V512, P71, DOI 10.1016/B978-0-12-391940-3.00004-4; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Czechanski A, 2014, NAT PROTOC, V9, P559, DOI 10.1038/nprot.2014.030; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Fern RJ, 1995, AM J PHYSIOL-RENAL, V269, pF751, DOI 10.1152/ajprenal.1995.269.6.F751; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Ganguly N, 2009, J BIOSCIENCES, V34, P113, DOI 10.1007/s12038-009-0013-7; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; Hadjikyriacou A, 2015, J BIOL CHEM, V290, P16723, DOI 10.1074/jbc.M115.659433; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Kuhne C, 2000, ONCOGENE, V19, P5884, DOI 10.1038/sj.onc.1203988; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Li ZW, 2015, EMBO J, V34, P748, DOI 10.15252/embj.201489319; Likhite N, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad0872; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Smith AJ, 2011, PHYSIOLOGY, V26, P181, DOI 10.1152/physiol.00042.2010; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Tanaka H, 2009, MOL CANCER RES, V7, P557, DOI 10.1158/1541-7786.MCR-08-0197; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Tommasino M, 2014, SEMIN CANCER BIOL, V26, P13, DOI 10.1016/j.semcancer.2013.11.002; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783; Yoo BK, 2012, AM J PHYSIOL-GASTR L, V303, pG180, DOI 10.1152/ajpgi.00069.2012; ZHANG HY, 1993, P NATL ACAD SCI USA, V90, P3880, DOI 10.1073/pnas.90.9.3880; Zhang T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8140	51	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2255	2265		10.1074/jbc.M116.760330	http://dx.doi.org/10.1074/jbc.M116.760330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031468	Green Published, hybrid			2022-12-28	WOS:000395530300018
J	Patra, AP; Sharma, S; Ainavarapu, RK				Patra, Aditya Prasad; Sharma, Shobhona; Ainavarapu, Rama Koti			Force Spectroscopy of the Plasmodium falciparum Vaccine Candidate Circumsporozoite Protein Suggests a Mechanically Pliable Repeat Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDING PATHWAYS; BINDING-PROTEIN; MALARIA; GENE; SPOROZOITES; MOLECULE; EXPRESSION; ANTIGEN; CLONING; TRAP	The most effective vaccine candidate of malaria is based on the Plasmodium falciparum circumsporozoite protein (CSP), a major surface protein implicated in the structural strength, motility, and immune evasion properties of the infective sporozoites. It is suspected that reversible conformational changes of CSP are required for infection of the mammalian host, but the detailed structure and dynamic properties of CSP remain incompletely understood, limiting our understanding of its function in the infection. Here, we report the structural and mechanical properties of the CSP studied using singlemolecule force spectroscopy on several constructs, one including the central region of CSP, which is rich in NANP amino acid repeats (CSPrep), and a second consisting of a near full length sequence without the signal and anchor hydrophobic domains (CSP Delta HP). Our results show that the CSPrep is heterogeneous, with 40% of molecules requiring virtually no mechanical force to unfold (< 10 piconewtons (pN)), suggesting that these molecules are mechanically compliant and perhaps act as entropic springs, whereas the remaining 60% are partially structured with low mechanical resistance (similar to 70 pN). CSP Delta HP having multiple force peaks suggests specifically folded domains, with two major populations possibly indicating the open and collapsed forms. Our findings suggest that the overall low mechanical resistance of the repeat region, exposed on the outer surface of the sporozoites, combined with the flexible full length conformations of CSP, may provide the sporozoites not only with immune evasion properties, but also with lubricating capacity required during its navigation through the mosquito and vertebrate host tissues. We anticipate that these findings would further assist in the design and development of future malarial vaccines.	[Patra, Aditya Prasad; Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Dr Homi Bhabha Rd, Bombay 400005, Maharashtra, India; [Ainavarapu, Rama Koti] Tata Inst Fundamental Res, Dept Chem Sci, Dr Homi Bhabha Rd, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR)	Sharma, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Dr Homi Bhabha Rd, Bombay 400005, Maharashtra, India.; Ainavarapu, RK (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Dr Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	sharma@tifr.res.in; koti@tifr.res.in	Ainavarapu, Sri Rama Koti/D-1231-2011	Ainavarapu, Sri Rama Koti/0000-0002-1646-2731	Department of Atomic Energy (DAE); Tata Institute of Fundamental Research (TIFR)	Department of Atomic Energy (DAE)(Department of Atomic Energy (DAE)); Tata Institute of Fundamental Research (TIFR)(Tata Institute of Fundamental Research (TIFR))	This work was supported by the Department of Atomic Energy (DAE) and Tata Institute of Fundamental Research (TIFR). The authors declare that they have no conflicts of interest with the contents of this article.	Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018; Aggarwal V, 2011, J BIOL CHEM, V286, P28056, DOI 10.1074/jbc.M111.249045; Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; ARNOT DE, 1985, SCIENCE, V230, P815, DOI 10.1126/science.2414847; BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6; BISANG C, 1995, J AM CHEM SOC, V117, P7904, DOI 10.1021/ja00135a008; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; Das S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002858; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; ELLIS J, 1983, NATURE, V302, P536, DOI 10.1038/302536a0; ENEA V, 1984, P NATL ACAD SCI-BIOL, V81, P7520, DOI 10.1073/pnas.81.23.7520; Ferguson DJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113923; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; GALINSKI MR, 1987, CELL, V48, P311, DOI 10.1016/0092-8674(87)90434-X; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Herrera R, 2015, INFECT IMMUN, V83, P3771, DOI 10.1128/IAI.02676-14; Kaslow DC, 2015, VACCINE, V33, P7425, DOI 10.1016/j.vaccine.2015.09.061; Kotamarthi HC, 2014, J PHYS CHEM B, V118, P11449, DOI 10.1021/jp507463q; Kotamarthi HC, 2013, J AM CHEM SOC, V135, P14768, DOI 10.1021/ja406238q; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; LOCKYER MJ, 1987, MOL BIOCHEM PARASIT, V22, P101, DOI 10.1016/0166-6851(87)90073-9; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mishra S, 2012, J IMMUNOL METHODS, V377, P47, DOI 10.1016/j.jim.2012.01.009; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; MULLER HM, 1993, EMBO J, V12, P2881, DOI 10.1002/j.1460-2075.1993.tb05950.x; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; NARDIN EH, 1993, ANNU REV IMMUNOL, V11, P687, DOI 10.1146/annurev.iy.11.040193.003351; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Rathore D, 2000, P NATL ACAD SCI USA, V97, P8530, DOI 10.1073/pnas.140224597; ROBSON KJH, 1995, EMBO J, V14, P3883, DOI 10.1002/j.1460-2075.1995.tb00060.x; Sarkar A, 2005, J BIOL CHEM, V280, P6261, DOI 10.1074/jbc.C400573200; SCHOFIELD L, 1990, J IMMUNOL, V144, P2781; SHARMA S, 1986, J IMMUNOL, V137, P357; SHARMA S, 1985, SCIENCE, V229, P779, DOI 10.1126/science.4023712; Sinnis P, 2007, PARASITOL INT, V56, P171, DOI 10.1016/j.parint.2007.04.002; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Tossavainen H, 2006, PROTEIN SCI, V15, P1760, DOI 10.1110/ps.052068506; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; WHO, 2015, WORLD MAL REP 2015; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249	48	9	9	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2110	2119		10.1074/jbc.M116.754796	http://dx.doi.org/10.1074/jbc.M116.754796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031457	hybrid, Green Published			2022-12-28	WOS:000395530300006
J	Morii, M; Kubota, S; Honda, T; Yuki, R; Morinaga, T; Kuga, T; Tomonaga, T; Yamaguchi, N; Yamaguchi, N				Morii, Mariko; Kubota, Sho; Honda, Takuya; Yuki, Ryuzaburo; Morinaga, Takao; Kuga, Takahisa; Tomonaga, Takeshi; Yamaguchi, Noritaka; Yamaguchi, Naoto			Src Acts as an Effector for Ku70-dependent Suppression of Apoptosis through Phosphorylation of Ku70 at Tyr-530	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; apoptosis; phosphotyrosine signaling; Src; tyrosine-protein kinase (tyrosine kinase); Ku70	MEDIATED TYROSINE PHOSPHORYLATION; C-SRC; CELL-DEATH; SIGNALING PATHWAY; FAMILY KINASES; CANCER-CELLS; NUCLEAR-LOCALIZATION; LYSINE ACETYLATION; PLASMA-MEMBRANE; BREAK REPAIR	Src-family tyrosine kinases are widely expressed in many cell types and participate in a variety of signal transduction pathways. Despite the significance of Src in suppression of apoptosis, its mechanism remains poorly understood. Here we show that Src acts as an effector for Ku70-dependent suppression of apoptosis. Inhibition of endogenous Src activity promotes UV-induced apoptosis, which is impaired by Ku70 knockdown. Src phosphorylates Ku70 at Tyr-530, being close to the possible acetylation sites involved in promotion of apoptosis. Src-mediated phosphorylation of Ku70 at Tyr-530 decreases acetylation of Ku70, whereas Src inhibition augments acetylation of Ku70. Importantly, knockdown-rescue experiments with stable Ku70 knockdown cells show that the nonphosphorylatable Y530F mutant of Ku70 reduces the ability of Ku70 to suppress apoptosis accompanied by augmentation of Ku70 acetylation. Our results reveal that Src plays a protective role against hyperactive apoptotic cell death by reducing apoptotic susceptibility through phosphorylation of Ku70 at Tyr-530.	[Morii, Mariko; Kubota, Sho; Honda, Takuya; Yuki, Ryuzaburo; Morinaga, Takao; Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Mol Cell Biol Lab, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Tomonaga, Takeshi; Yamaguchi, Noritaka] Natl Inst Biomed Innovat Hlth & Nutr, Lab Proteome Res, Ibaraki, Osaka 5670085, Japan	Chiba University	Yamaguchi, N (corresponding author), Chiba Univ, Mol Cell Biol Lab, Grad Sch Pharmaceut Sci, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp	Kuga, Takahisa/AAX-9334-2020	Honda, Takuya/0000-0002-7141-0088; Kubota, Sho/0000-0001-6119-1259	Japanese Ministry of Education, Culture, Sports, Science, and Technology; LGS Program for Leading Graduate Schools (Chiba University Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics); Chiba Foundation for Health Promotion and Disease Prevention; Japan Foundation for Applied Enzymology;  [15K07922];  [16K08227];  [16J04363];  [16J04141]; Grants-in-Aid for Scientific Research [16J04363, 15K19545, 26460081, 16J04141] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); LGS Program for Leading Graduate Schools (Chiba University Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics); Chiba Foundation for Health Promotion and Disease Prevention; Japan Foundation for Applied Enzymology; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 15K07922 (to Na. Y.) and 16K08227 (to No. Y.) and the LGS Program for Leading Graduate Schools (Chiba University Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics), the Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, the Chiba Foundation for Health Promotion and Disease Prevention (to No. Y.), and the Japan Foundation for Applied Enzymology (to Na. Y.). The authors declare that they have no conflicts of interest with the contents of this article.; LGS research assistants supported by Grants-in-aid for the Japan Society for the Promotion of Science (JSPS) Research Fellow 16J04363 (to M.M.) and 16J04141 (to T.H.).	Aoyama K, 2015, CELL BIOL INT, V39, P446, DOI 10.1002/cbin.10413; Aoyama K, 2013, EXP CELL RES, V319, P3251, DOI 10.1016/j.yexcr.2013.09.003; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Bijlmakers MJJE, 1997, J CELL BIOL, V137, P1029, DOI 10.1083/jcb.137.5.1029; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Cans C, 2000, BIOCHEM PHARMACOL, V60, P1203, DOI 10.1016/S0006-2952(00)00434-2; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chen CS, 2007, CANCER RES, V67, P5318, DOI 10.1158/0008-5472.CAN-06-3996; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Com E, 2007, MOL CELL PROTEOMICS, V6, P1842, DOI 10.1074/mcp.M700119-MCP200; Corcoran A, 2013, FEBS J, V280, P1944, DOI 10.1111/febs.12224; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Fattah FJ, 2008, P NATL ACAD SCI USA, V105, P8703, DOI 10.1073/pnas.0712060105; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; GILLET G, 1995, EMBO J, V14, P1372, DOI 10.1002/j.1460-2075.1995.tb07123.x; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Hasegawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116048; Honda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38751; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Iwama A, 1996, EMBO J, V15, P5866, DOI 10.1002/j.1460-2075.1996.tb00973.x; Johnson D, 2000, CELL DEATH DIFFER, V7, P685, DOI 10.1038/sj.cdd.4400700; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kubota S, 2015, J BIOL CHEM, V290, P10891, DOI 10.1074/jbc.M115.643882; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lopez J, 2012, CELL DEATH DIFFER, V19, P1459, DOI 10.1038/cdd.2012.21; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Mazumder S, 2007, MOL CELL BIOL, V27, P3511, DOI 10.1128/MCB.01448-06; Mera A, 1999, J BIOL CHEM, V274, P15766, DOI 10.1074/jbc.274.22.15766; MOHN H, 1995, BIOCHEM J, V309, P657; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Morii M, 2015, CELL BIOL INT, V39, P923, DOI 10.1002/cbin.10460; Morinaga T, 2014, J BIOL CHEM, V289, P26327, DOI 10.1074/jbc.M114.580001; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sasaki H, 2014, ARCH BIOCHEM BIOPHYS, V550, P12, DOI 10.1016/j.abb.2014.03.012; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Subramanian C, 2007, NEOPLASIA, V9, P495, DOI 10.1593/neo.07262; Subramanian C, 2011, NEOPLASIA, V13, P726, DOI 10.1593/neo.11558; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tamura T, 2000, INT IMMUNOL, V12, P1205, DOI 10.1093/intimm/12.8.1205; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Yamaguchi N, 2001, J CELL SCI, V114, P1631; Yamaguchi N, 2017, J CELL BIOCHEM, V118, P1453, DOI 10.1002/jcb.25804; Yamaguchi N, 2015, BIOCHEM J, V471, P67, DOI 10.1042/BJ20150372; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yuki R, 2015, J CELL BIOCHEM, V116, P954, DOI 10.1002/jcb.25046; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	87	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1648	1665		10.1074/jbc.M116.753202	http://dx.doi.org/10.1074/jbc.M116.753202			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27998981	Green Published, hybrid			2022-12-28	WOS:000395515600010
J	Gulia, R; Sharma, R; Bhattacharyya, S				Gulia, Ravinder; Sharma, Rohan; Bhattacharyya, Samarjit			Critical Role for Ubiquitination in the Endocytosis of Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; PROTEIN-COUPLED RECEPTOR; FRAGILE-X-SYNDROME; PROTEASOME SYSTEM; AMPA RECEPTORS; SYNAPTIC PLASTICITY; CANCER THERAPEUTICS; MEMBRANE-PROTEIN; MECHANISMS; PHOSPHORYLATION	Group I metabotropic glutamate receptors (mGluRs) play important roles in various neuronal processes and elicit changes in synaptic efficacy through AMPA receptor (AMPAR) endocytosis. Trafficking of mGluRs plays an important role in controlling the precise localization of these receptors at specific region of the cell; it also regulates the activity of these receptors. Despite this obvious significance, we know very little about the cellular mechanisms that control the trafficking of group I mGluRs. We show here that ligand-mediated internalization of group I mGluRs is ubiquitination-dependent. A lysine residue (Lys(1112)) at the C-terminal tail of mGluR1 (a member of the group I mGluR family) plays crucial role in this process. Our data suggest that Lys(63)-linked polyubiquitination is involved in the ligand-mediated endocytosis of mGluR1. Wealso show here that the mGluR1 internalization is dependent on a specific E3 ubiquitin ligase, Siah-1A. Furthermore, acute knockdown of Siah-1A enhances the mGluR-mediated AMPAR endocytosis. These studies reveal a novel function of ubiquitination in the regulation of group I mGluRs, as well as its role in mGluR-dependent AMPAR endocytosis.	[Gulia, Ravinder; Sharma, Rohan; Bhattacharyya, Samarjit] Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sect 81, Sas Nagar 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Bhattacharyya, S (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sect 81, Sas Nagar 140306, Punjab, India.	samarjit@iisermohali.ac.in	Gulia, Ravinder/AAD-3983-2021	Bhattacharyya, Samarjit/0000-0002-7055-7555	Indian Institute of Science Education and Research Mohali; University Grants Commission, India	Indian Institute of Science Education and Research Mohali; University Grants Commission, India(University Grants Commission, India)	This work was supported by Indian Institute of Science Education and Research Mohali and University Grants Commission, India fellowships (to R. G. and R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alonso V, 2013, MOL ENDOCRINOL, V27, P558, DOI 10.1210/me.2012-1404; Anwyl R, 2006, PROG NEUROBIOL, V78, P17, DOI 10.1016/j.pneurobio.2005.12.001; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bhattacharyya S, 2016, INT J BIOCHEM CELL B, V77, P205, DOI 10.1016/j.biocel.2016.03.003; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Citri A, 2009, EUR J NEUROSCI, V30, P1443, DOI 10.1111/j.1460-9568.2009.06950.x; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Dey A, 2008, NAT REV DRUG DISCOV, V7, P1031, DOI 10.1038/nrd2759; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Francesconi A, 2000, P NATL ACAD SCI USA, V97, P6185, DOI 10.1073/pnas.97.11.6185; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hislop JN, 2011, TRAFFIC, V12, P137, DOI 10.1111/j.1600-0854.2010.01121.x; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Ishikawa K, 1999, GENES CELLS, V4, P381, DOI 10.1046/j.1365-2443.1999.00269.x; Kammermeier PJ, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-15; Kim CH, 2008, J NEUROSCI RES, V86, P1, DOI 10.1002/jnr.21437; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Mahato PK, 2015, NEUROSCIENCE, V306, P138, DOI 10.1016/j.neuroscience.2015.08.031; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pandey S, 2014, J NEUROCHEM, V131, P602, DOI 10.1111/jnc.12930; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Regalado MP, 2006, J NEUROSCI, V26, P2343, DOI 10.1523/JNEUROSCI.5247-05.2006; Satheshkumar PS, 2009, J VIROL, V83, P2469, DOI 10.1128/JVI.01986-08; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Widagdo J, 2015, CELL REP; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200	48	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1426	1437		10.1074/jbc.M116.752105	http://dx.doi.org/10.1074/jbc.M116.752105			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	28011638	hybrid, Green Published			2022-12-28	WOS:000393339800024
J	Riess, M; Fuchs, NV; Idica, A; Hamdorf, M; Flory, E; Pedersen, IM; Konig, R				Riess, Maximilian; Fuchs, Nina V.; Idica, Adam; Hamdorf, Matthias; Flory, Egbert; Pedersen, Irene Munk; Koenig, Renate			Interferons Induce Expression of SAMHD1 in Monocytes through Down-regulation of miR-181a and miR-30a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTS HIV-1 INFECTION; COMMUNITY-DRIVEN RESOURCE; ADAPTIVE IMMUNE-RESPONSES; GAMMA-INDUCED PROTEIN; STERILE ALPHA MOTIF; BINDING-SITES; UP-REGULATION; GENE; IDENTIFICATION	SAMHD1 is a phosphohydrolase maintaining cellular dNTP homeostasis but also acts as a critical regulator in innate immune responses due to its antiviral activity and association with autoimmune disease, leading to aberrant activation of interferon. SAMHD1 expression is differentially regulated by interferon in certain primary cells, but the underlying mechanism is not understood. Here, we report a detailed characterization of the promotor region, the 5' - and 3'-untranslated region (UTR) of SAMHD1, and the mechanism responsible for the cell type-dependent up-regulation of SAMHD1 protein by interferon. We demonstrate that induction of SAMHD1 by type I and II interferons depends on 3'-UTR post-transcriptional regulation, whereas the promoter drives basal expression levels. We reveal novel functional target sites for the microRNAs miR-181a, miR30a, and miR-155 in the SAMHD1 3'-UTR. Furthermore, we demonstrate that down-regulation of endogenous miR-181a and miR-30a levels inversely correlates with SAMHD1 protein up-regulation upon type I and II interferon stimulation in primary human monocytes. These miRNAs are not modulated by interferon in macrophages or dendritic cells, and consequently protein levels of SAMHD1 remain unchanged. These results suggest that SAMHD1 is a non-classical interferon-stimulated gene regulated through cell type-dependent down-regulation of miR-181a and miR-30a in innate sentinel cells.	[Riess, Maximilian; Fuchs, Nina V.; Koenig, Renate] Paul Ehrlich Inst, Host Pathogen Interact Grp, D-63225 Langen, Germany; [Flory, Egbert] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Idica, Adam; Hamdorf, Matthias; Pedersen, Irene Munk] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Koenig, Renate] Sanford Burnham Prebys Med Discovery Inst, Immun & Pathogenesis Program, La Jolla, CA 92037 USA; [Koenig, Renate] German Ctr Infect Res DZIF, D-63225 Langen, Germany	Paul Ehrlich Institute; Paul Ehrlich Institute; University of California System; University of California Irvine; Sanford Burnham Prebys Medical Discovery Institute; German Center for Infection Research	Konig, R (corresponding author), Paul Ehrlich Inst, Host Pathogen Interact, D-63225 Langen, Germany.	renate.koenig@pei.de	Riess, Maximilian/AAI-9050-2020; König, Renate/AAB-8918-2019	Riess, Maximilian/0000-0001-5545-4825; König, Renate/0000-0003-4882-9179; Fuchs, Nina/0000-0003-4175-0740	DZIF [TTU 01.802, TTU 04.802]	DZIF	This work was supported by DZIF TTU 01.802 and TTU 04.802 (to R. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Mohsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109220; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Ballana E, 2015, TRENDS MICROBIOL, V23, P680, DOI 10.1016/j.tim.2015.08.002; Barriocanal M, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00655; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Buchanan EL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22629; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Danino YM, 2015, BBA-GENE REGUL MECH, V1849, P1116, DOI 10.1016/j.bbagrm.2015.04.003; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Enright AJ, 2004, GENOME BIOL, V5; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Goujon C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-23; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Guo ZW, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav102; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Jin CZ, 2016, AIDS, V30, P2053, DOI 10.1097/QAD.0000000000001166; Jin CZ, 2014, BIOCHEM BIOPH RES CO, V452, P760, DOI 10.1016/j.bbrc.2014.08.151; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kambara H, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00676; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee TY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S3; Lesurf R, 2016, NUCLEIC ACIDS RES, V44, pD126, DOI 10.1093/nar/gkv1203; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; [李帅 Li Shuai], 2011, [水文, Hydrology], V31, P35; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liao WP, 2008, PROTEOMICS, V8, P2640, DOI 10.1002/pmic.200700954; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Martin-Gayo E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004930; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Ohler U, 2000, Pac Symp Biocomput, P380; Pauls E, 2013, J IMMUNOL, V190, P4736, DOI 10.4049/jimmunol.1203226; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pilakka-Kanthikeel S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0285-9; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Reese M.G., 1995, 7 INT GEN SEQ AN C H; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmidt S, 2015, J LEUKOCYTE BIOL, V98, P5, DOI 10.1189/jlb.4HI0714-338RR; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; Sommer AFR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26616; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Yang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29665; Zhao DC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-114	74	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					264	277		10.1074/jbc.M116.752584	http://dx.doi.org/10.1074/jbc.M116.752584			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27909056	hybrid, Green Published			2022-12-28	WOS:000391578000023
J	Merriman, C; Huang, Q; Rutter, GA; Fu, D				Merriman, Chengfeng; Huang, Qiong; Rutter, Guy A.; Fu, Dax			Lipid-tuned Zinc Transport Activity of Human ZnT8 Protein Correlates with Risk for Type-2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN SECRETORY GRANULES; PANCREATIC BETA-CELLS; GLUCOSE-HOMEOSTASIS; YIIP; MUTATIONS; MICE	Zinc is a critical element for insulin storage in the secretory granules of pancreatic beta cells. The islet-specific zinc transporter ZnT8 mediates granular sequestration of zinc ions. A genetic variant of human ZnT8 arising from a single nonsynonymous nucleotide change contributes to increased susceptibility to type-2 diabetes (T2D), but it remains unclear how the high risk variant (Arg-325), which is also a higher frequency (>50%) allele, is correlated with zinc transport activity. Here, we compared the activity of Arg-325 with that of a low risk ZnT8 variant (Trp-325). The Arg-325 variant was found to be more active than the Trp-325 form following induced expression in HEK293 cells. We further examined the functional consequences of changing lipid conditions to mimic the impact of lipid remodeling on ZnT8 activity during insulin granule biogenesis. Purified ZnT8 variants in proteoliposomes exhibited more than 4-fold functional tunability by the anionic phospholipids, lysophosphatidylcholine and cholesterol. Over a broad range of permissive lipid compositions, the Arg-325 variant consistently exhibited accelerated zinc transport kinetics versus the Trp-form. In agreement with the human genetic finding that rare loss-of-function mutations in ZnT8 are associated with reduced T2D risk, our results suggested that the common high risk Arg-325 variant is hyperactive, and thus may be targeted for inhibition to reduce T2D risk in the general populations.	[Merriman, Chengfeng; Huang, Qiong; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, 725 North Wolfe St, Baltimore, MD 21205 USA; [Rutter, Guy A.] Imperial Coll London, Dept Med, Sect Cell Biol & Funct Genom, London W12 ONN, England	Johns Hopkins University; Johns Hopkins Medicine; Imperial College London	Fu, D (corresponding author), Johns Hopkins Sch Med, Dept Physiol, 725 North Wolfe St, Baltimore, MD 21205 USA.	dfu3@jhmi.edu	Huang, Qiong/HGC-7895-2022	Huang, Qiong/0000-0002-0570-5961; Rutter, Guy/0000-0001-6360-0343; Fu, Dax/0000-0002-2663-1316	National Institutes of Health [R01 GM065137]; National Nature Science Foundation of China [GP 81673492]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM065137. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported in part by National Nature Science Foundation of China Grant GP 81673492.	Bonnefond A, 2015, CELL METAB, V21, P357, DOI 10.1016/j.cmet.2014.12.020; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Chabosseau P, 2016, ARCH BIOCHEM BIOPHYS, V611, P79, DOI 10.1016/j.abb.2016.05.022; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; CULLIS PR, 1986, CHEM PHYS LIPIDS, V40, P127, DOI 10.1016/0009-3084(86)90067-8; Davidson HW, 2014, TRENDS ENDOCRIN MET, V25, P415, DOI 10.1016/j.tem.2014.03.008; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kim I, 2011, PHARMACOGENOMICS J, V11, P191, DOI 10.1038/tpj.2010.22; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; MacDonald MJ, 2015, J BIOL CHEM, V290, P11075, DOI 10.1074/jbc.M114.628420; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Rutter GA, 2015, DIABETOLOGIA, V58, P31, DOI 10.1007/s00125-014-3405-7; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tsuchiya M, 2010, ENDOCRINOLOGY, V151, P4705, DOI 10.1210/en.2010-0623; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200	22	54	55	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					26950	26957		10.1074/jbc.M116.764605	http://dx.doi.org/10.1074/jbc.M116.764605			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875315	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000391576300001
J	Rivera-Colon, Y; Maguire, A; Liszczak, GP; Olia, AS; Marmorstein, R				Rivera-Colon, Yadilette; Maguire, Andrew; Liszczak, Glen P.; Olia, Adam S.; Marmorstein, Ronen			Molecular Basis for Cohesin Acetylation by Establishment of Sister Chromatid Cohesion N-Acetyltransferase ESCO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; STRUCTURE VALIDATION; CATALYTIC MECHANISM; KINETIC MECHANISM; ROBERTS-SYNDROME; DNA-BINDING; PROTEIN; ALPHA-TAT1; SWITCH; ECO1	Protein acetylation is a prevalent posttranslational modification that is regulated by diverse acetyltransferase enzymes. Although histone acetyltransferases (HATs) have been well characterized both structurally and mechanistically, far less is known about non-histone acetyltransferase enzymes. The human ESCO1 and ESCO2 paralogs acetylate the cohesin complex subunit SMC3 to regulate the separation of sister chromatids during mitosis and meiosis. Missense mutations within the acetyltransferase domain of these proteins correlate with diseases, including endometrial cancers and Roberts syndrome. Despite their biological importance, the mechanisms underlying acetylation by the ESCO proteins are not understood. Here, we report the X-ray crystal structure of the highly conserved zinc finger-acetyltransferase moiety of ESCO1 with accompanying structure-based mutagenesis and biochemical characterization. We find that the ESCO1 acetyltransferase core is structurally homologous to the Gcn5 HAT, but contains unique additional features including a zinc finger and an similar to 40-residue loop region that appear to play roles in protein stability and SMC3 substrate binding. We identify key residues that play roles in substrate binding and catalysis, and rationalize the functional consequences of disease-associated mutations. Together, these studies reveal the molecular basis for SMC3 acetylation by ESCO1 and have broader implications for understanding the structure/function of non-histone acetyltransferases.	[Rivera-Colon, Yadilette; Maguire, Andrew; Liszczak, Glen P.; Olia, Adam S.; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Maguire, Andrew; Liszczak, Glen P.; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Perelman Sch Med, 421 Curie Blvd,Biomed Res Bldg 2-3,Rm 454, Philadelphia, PA 19104 USA.	marmor@mail.med.upenn.edu			National Institutes of Health [R01 GM060293, R35 GM118090, P01 AG031862, T32 GM098910, K12 GM081259]; NATIONAL CANCER INSTITUTE [P30CA016520, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098910, R35GM118090, K12GM081259, R01GM060293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 GM060293, R35 GM118090, and P01 AG031862 (to R. M.), T32 GM098910 (to G. P. L.), and K12 GM081259 (to Y. R-C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DELATORRE JG, 1992, ANAL ULTRACENTRIFUGA, P333; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedmann DR, 2013, FEBS J, V280, P5570, DOI 10.1111/febs.12373; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Gordillo M., 2006, ROBERTS SYNDROME GEN; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kouznetsova E, 2016, STRUCTURE, V24, P789, DOI 10.1016/j.str.2016.03.021; Lau OD, 2000, J BIOL CHEM, V275, P21953, DOI 10.1074/jbc.M003219200; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marmorstein R, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018762; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pramanik KC, 2014, MOL CANCER THER, V13, P687, DOI 10.1158/1535-7163.MCT-13-0863; Price JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063313; Rahman S, 2015, P NATL ACAD SCI USA, V112, P11270, DOI 10.1073/pnas.1505323112; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sutton A, 2003, J BIOL CHEM, V278, P16887, DOI 10.1074/jbc.M210709200; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 2000, BIOCHEMISTRY-US, V39, P11961, DOI 10.1021/bi001272h; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zhang SY, 2016, TUMOR BIOL, V37, P5165, DOI 10.1007/s13277-015-4375-1	47	11	13	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26468	26477		10.1074/jbc.M116.752220	http://dx.doi.org/10.1074/jbc.M116.752220			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27803161	Green Published, hybrid			2022-12-28	WOS:000391568200020
J	He, LL; Yang, H; Ma, YH; Pledger, WJ; Cress, WD; Cheng, JQ				He, Lili; Yang, Hua; Ma, Yihong; Pledger, W. Jack; Cress, W. Douglas; Cheng, Jin Q.			Identification of Aurora-A as a direct target of E2F3 during G(2)/M cell cycle progression (vol 283, pg 31012, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		He LL, 2008, J BIOL CHEM, V283, P31012, DOI 10.1074/jbc.M803547200	1	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22842	22842		10.1074/jbc.A116.803547	http://dx.doi.org/10.1074/jbc.A116.803547			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825080	hybrid, Green Published			2022-12-28	WOS:000386760600041
J	Sun, M; Yang, L; Feldman, RI; Sun, XM; Bhalla, KN; Jove, R; Nicosia, SV; Cheng, JQ				Sun, Mei; Yang, Lin; Feldman, Richard I.; Sun, Xia-meng; Bhalla, Kapil N.; Jove, Richard; Nicosia, Santo V.; Cheng, Jin Q.			Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85, androgen receptor, and Src (vol 278, pg 42992, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Sun, Ellen/ABC-8094-2020	Sun, Ellen/0000-0001-7399-4075; Bhalla, Kapil/0000-0001-5209-5126				Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200	1	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22841	22841		10.1074/jbc.A116.306295	http://dx.doi.org/10.1074/jbc.A116.306295			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825079	Green Published, hybrid			2022-12-28	WOS:000386760600040
J	Yuan, ZQ; Feldman, RI; Sussman, GE; Coppola, D; Nicosia, SV; Cheng, JQ				Yuan, Zeng-qiang; Feldman, Richard I.; Sussman, Gene E.; Coppola, Domenico; Nicosia, Santo V.; Cheng, Jin Q.			AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1. IMPLICATION OF AKT2 IN CHEMORESISTANCE (vol 278, pg 23432, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200	1	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22847	22847		10.1074/jbc.A116.302674	http://dx.doi.org/10.1074/jbc.A116.302674			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825085	hybrid, Green Published			2022-12-28	WOS:000386760600046
J	Marshall, SA; Fisher, K; Cheallaigh, AN; White, MD; Payne, KAP; Parker, DA; Rigby, SEJ; Leys, D				Marshall, Stephen A.; Fisher, Karl; Cheallaigh, Aisling N. I.; White, Mark D.; Payne, Karl A. P.; Parker, D. A.; Rigby, Stephen E. J.; Leys, David			Oxidative Maturation and Structural Characterization of Prenylated FMN Binding by UbiD, a Decarboxylase Involved in Bacterial Ubiquinone Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; VANILLIC ACID; COENZYME-Q; CHORISMATE; COFACTOR; 4-HYDROXYBENZOATE; ACCUMULATION; DERIVATIVES; MECHANISM; MEMBRANE	The activity of the reversible decarboxylase enzyme Fdc1 is dependent on prenylated FMN (prFMN), a recently discovered cofactor. The oxidized prFMN supports a 1,3-dipolar cycloaddition mechanism that underpins reversible decarboxylation. Fdc1 is a distinct member of the UbiD family of enzymes, with the canonical UbiD catalyzing the (de) carboxylation of para-hydroxybenzoic acid-type substrates. Here we show that the Escherichia coli UbiD enzyme, which is implicated in ubiquinone biosynthesis, cannot be isolated in an active holoenzyme form despite the fact active holoFdc1 is readily obtained. Formation of holoUbiD requires reconstitution in vitro of the apoUbiD with reduced prFMN. Furthermore, although the Fdc1 apoenzyme can be readily reconstituted and activated, in vitro oxidation to the mature prFMN cofactor stalls at formation of a radical prFMN species in holoUbiD. Further oxidative maturation in vitro occurs only at alkaline pH, suggesting a proton-coupled electron transfer precedes formation of the fully oxidized prFMN. Crystal structures of holoUbiD reveal a relatively open active site potentially occluded from solvent through domain motion. The presence of a prFMN sulfite-adduct in one of the UbiD crystal structures confirms oxidative maturation does occur at ambient pH on a slow time scale. Activity could not be detected for a range of putative para-hydroxybenzoic acid substrates tested. However, the lack of an obvious hydrophobic binding pocket for the octaprenyl tail of the proposed ubiquinone precursor substrate does suggest UbiD might act on a non-prenylated precursor. Our data reveals an unexpected variation occurs in domain mobility, prFMN binding, and maturation by the UbiD enzyme family.	[Marshall, Stephen A.; Fisher, Karl; Cheallaigh, Aisling N. I.; White, Mark D.; Payne, Karl A. P.; Rigby, Stephen E. J.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England; [Parker, D. A.] Westhollow Technol Ctr, Innovat Biodomain Shell Int Explorat & Prod, Houston, TX 77082 USA; [Cheallaigh, Aisling N. I.] AstraZeneca, Silk Rd, Macclesfield SK10 2NA, Cheshire, England; [White, Mark D.] Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England	University of Manchester; AstraZeneca; University of Oxford	Leys, D (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Fisher, Karl/A-5956-2013	Fisher, Karl/0000-0003-3539-8939; White, Mark/0000-0002-1431-0339; payne, karl/0000-0002-6331-6374	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K017802/1]; BBSRC iCASE studentship; BBSRC [BB/K017802/1, BB/E013007/1, BB/P000622/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013007/1, 1352655, BB/P000622/1, BB/K017802/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC iCASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/ K017802/ 1 and a BBSRC iCASE studentship to S. A. M. The authors declare that they have no conflict of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez-Rodriguez ML, 2003, FEMS MICROBIOL LETT, V220, P49, DOI 10.1016/S0378-1097(03)00053-3; Aussel L, 2014, BBA-BIOENERGETICS, V1837, P1004, DOI 10.1016/j.bbabio.2014.01.015; Baunach M, 2015, ANGEW CHEM INT EDIT, V54, P12550, DOI 10.1002/anie.201507120; Belcher J, 2014, J BIOL CHEM, V289, P6535, DOI 10.1074/jbc.M113.527325; Chow KT, 1999, MICROBIOL-SGM, V145, P2393, DOI 10.1099/00221287-145-9-2393; Cornforth R. H., 1969, METHODS ENZYMOL, V15, P359; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Dutton P L, 1978, Methods Enzymol, V54, P411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KL, 2016, BIOCHEMISTRY-US, V55, P2857, DOI 10.1021/acs.biochem.6b00170; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; HAMILTON JA, 1971, BIOCHEM J, V123, P435, DOI 10.1042/bj1230435; Hasson MS, 1998, BIOCHEMISTRY-US, V37, P9918, DOI 10.1021/bi973047e; HELLER C, 1960, J CHEM PHYS, V32, P1535, DOI 10.1063/1.1730955; HOFFMAN BM, 1984, J MAGN RESON, V59, P110, DOI 10.1016/0022-2364(84)90287-7; Jacewicz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063161; Jordan F, 2013, ACS CATAL, V3, P1601, DOI 10.1021/cs400272x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE J, 1974, J BACTERIOL, V118, P41, DOI 10.1128/JB.118.1.41-45.1974; LEPPIK RA, 1976, BIOCHIM BIOPHYS ACTA, V436, P800, DOI 10.1016/0005-2736(76)90407-7; Li TF, 2012, BIOORG CHEM, V43, P2, DOI 10.1016/j.bioorg.2012.03.001; MAGER HIX, 1990, PHOTOCHEM PHOTOBIOL, V51, P223, DOI 10.1111/j.1751-1097.1990.tb01707.x; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; METZLER DE, 1954, J AM CHEM SOC, V76, P648, DOI 10.1021/ja01632a004; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NICHOLS BP, 1992, J BACTERIOL, V174, P5309, DOI 10.1128/JB.174.16.5309-5316.1992; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Payne KAP, 2015, NATURE, V522, P497, DOI 10.1038/nature14560; Pellissier H, 2007, TETRAHEDRON, V63, P3235, DOI 10.1016/j.tet.2007.01.009; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Schleicher E, 2010, APPL MAGN RESON, V37, P339, DOI 10.1007/s00723-009-0101-8; Shepherd SA, 2015, CHEM SCI, V6, P3454, DOI 10.1039/c5sc00913h; SIEBERT M, 1994, MICROBIOL-SGM, V140, P897, DOI 10.1099/00221287-140-4-897; Thulasiram HV, 2006, J ORG CHEM, V71, P1739, DOI 10.1021/jo052384n; UCHIDA K, 1991, AGR BIOL CHEM TOKYO, V55, P2299, DOI 10.1080/00021369.1991.10870950; Wessjohann L, 1996, ANGEW CHEM INT EDIT, V35, P1697, DOI 10.1002/anie.199616971; White MD, 2015, NATURE, V522, P502, DOI 10.1038/nature14559; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; YOUNG IG, 1972, J BACTERIOL, V110, P18, DOI 10.1128/JB.110.1.18-25.1972	43	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4623	4637		10.1074/jbc.M116.762732	http://dx.doi.org/10.1074/jbc.M116.762732			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28057757	Green Published, hybrid			2022-12-28	WOS:000397585100020
J	Lynagh, T; Komnatnyy, VV; Pless, SA				Lynagh, Timothy; Komnatnyy, Vitaly V.; Pless, Stephan A.			Unique Contributions of an Arginine Side Chain to Ligand Recognition in a Glutamate-gated Chloride Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; glutamate; ion channel; membrane protein; neurotransmitter; Unnatural amino acids; arginine; ligand recognition; channel activation	UNNATURAL AMINO-ACIDS; SITE-DIRECTED MUTAGENESIS; TRANSFER-RNA-SYNTHETASE; IN-VIVO INCORPORATION; CYS-LOOP RECEPTOR; MOLECULAR DETERMINANTS; GLYCINE RECEPTORS; ION CHANNELS; BINDING-SITE; AGONIST	Glutamate recognition by neurotransmitter receptors often relies on Arg residues in the binding site, leading to the assumption that charge-charge interactions underlie ligand recognition. However, assessing the precise chemical contribution of Arg side chains to protein function and pharmacology has proven to be exceedingly difficult in such large and complex proteins. Using the in vivo nonsense suppression approach, we report the first successful incorporation of the isosteric, titratable Arg analog, canavanine, into a neurotransmitter receptor in a living cell, utilizing a glutamate-gated chloride channel from the nematode Haemonchus contortus. Our data unveil a surprisingly small contribution of charge at a conserved arginine side chain previously suggested to form a salt bridge with the ligand, glutamate. Instead, our data show that Arg contributes crucially to ligand sensitivity via a hydrogen bond network, where Arg interacts both with agonist and with a conserved Thr side chain within the receptor. Together, the data provide a new explanation for the reliance of neurotransmitter receptors on Arg side chains and highlight the exceptional capacity of unnatural amino acid incorporation for increasing our understanding of ligand recognition.	[Lynagh, Timothy; Komnatnyy, Vitaly V.; Pless, Stephan A.] Univ Copenhagen, Dept Drug Design & Pharmacol, Ctr Biopharmaceut, DK-2100 Copenhagen H, Denmark	University of Copenhagen	Pless, SA (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Ctr Biopharmaceut, DK-2100 Copenhagen H, Denmark.	stephan.pless@sund.ku.dk		Pless, Stephan/0000-0001-6654-114X; Lynagh, Timothy/0000-0003-4888-4098	Center for Biopharmaceuticals (University of Copenhagen); Carlsberg Foundation; Lundbeck Foundation; Danish Council for Independent Research (Det Frie Forskningsrad); Lundbeck Foundation [R139-2012-12390, R171-2014-558] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011767] Funding Source: researchfish	Center for Biopharmaceuticals (University of Copenhagen); Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research (Det Frie Forskningsrad); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Center for Biopharmaceuticals (University of Copenhagen), the Carlsberg Foundation, the Lundbeck Foundation, and the Danish Council for Independent Research (Det Frie Forskningsrad). The authors declare that they have no conflicts of interest with the contents of this article.	Akahoshi A, 2011, BIOCHEM BIOPH RES CO, V414, P625, DOI 10.1016/j.bbrc.2011.09.137; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BORDERS CL, 1994, PROTEIN SCI, V3, P541; BOYAR A, 1982, J AM CHEM SOC, V104, P1995, DOI 10.1021/ja00371a033; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; Chen ZL, 2004, J BIOL CHEM, V279, P876, DOI 10.1074/jbc.M307684200; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Daeffler KNM, 2014, ACS CHEM BIOL, V9, P2283, DOI 10.1021/cb500323d; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Dougherty DA, 2014, CHEMBIOCHEM, V15, P1710, DOI 10.1002/cbic.201402080; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Hampson DR, 1999, J BIOL CHEM, V274, P33488, DOI 10.1074/jbc.274.47.33488; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Huang RQ, 1999, J NEUROPHYSIOL, V82, P1233, DOI 10.1152/jn.1999.82.3.1233; JUDICE JK, 1993, SCIENCE, V261, P1578, DOI 10.1126/science.8103944; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kawamoto S, 1997, MOL BRAIN RES, V47, P339; Krishnakumar R, 2014, FEBS LETT, V588, P383, DOI 10.1016/j.febslet.2013.11.039; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Le DD, 2013, J AM CHEM SOC, V135, P2879, DOI 10.1021/ja3108214; Lynagh T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08558; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Pajpanova T, 1997, AMINO ACIDS, V12, P191, DOI 10.1007/BF01386482; Pless SA, 2013, ANNU REV PHARMACOL, V53, P211, DOI 10.1146/annurev-pharmtox-011112-140343; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Smart TG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009662; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Wolstenholme AJ, 2012, J BIOL CHEM, V287, P40232, DOI 10.1074/jbc.R112.406280; Yu RL, 2014, BIOCHEMISTRY-US, V53, P6041, DOI 10.1021/bi500815f	36	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3940	3946		10.1074/jbc.M116.772939	http://dx.doi.org/10.1074/jbc.M116.772939			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096462	Green Published, hybrid			2022-12-28	WOS:000395542500034
J	Carrer, A; Parris, JLD; Trefely, S; Henry, RA; Montgomery, DC; Torres, A; Viola, JM; Kuo, YM; Blair, IA; Meier, JL; Andrews, AJ; Snyder, NW; Wellen, KE				Carrer, Alessandro; Parris, Joshua L. D.; Trefely, Sophie; Henry, Ryan A.; Montgomery, David C.; Torres, AnnMarie; Viola, John M.; Kuo, Yin-Ming; Blair, Ian A.; Meier, Jordan L.; Andrews, Andrew J.; Snyder, Nathaniel W.; Wellen, Kathryn E.			Impact of a High-fat Diet on Tissue Acyl-CoA and Histone Acetylation Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl-CoA; adipose tissue; diet; histone acetylation; liver	ATP-CITRATE-LYASE; ONE-CARBON METABOLISM; CELLULAR-METABOLISM; DNA METHYLATION; DYNAMICS; TRANSCRIPTION; EPIGENETICS; MECHANISMS; COENZYME; CANCER	Cellular metabolism dynamically regulates the epigenome via availability of the metabolite substrates of chromatin-modifying enzymes. The impact of diet on the metabolism-epigenome axis is poorly understood but could alter gene expression and influence metabolic health. ATP citrate-lyase produces acetyl-CoA in the nucleus and cytosol and regulates histone acetylation levels in many cell types. Consumption of a high-fat diet (HFD) results in suppression of ATP citrate-lyase levels in tissues such as adipose and liver, but the impact of diet on acetyl-CoA and histone acetylation in these tissues remains unknown. Here we examined the effects of HFD on levels of acyl-CoAs and histone acetylation in mouse white adipose tissue (WAT), liver, and pancreas. We report that mice consuming a HFD have reduced levels of acetyl-CoA and/or acetyl-CoA:CoA ratio in these tissues. In WAT and the pancreas, HFD also impacted the levels of histone acetylation; in particular, histone H3 lysine 23 acetylation was lower in HFD-fed mice. Genetic deletion of Acly in cultured adipocytes also suppressed acetyl-CoA and histone acetylation levels. In the liver, no significant effects on histone acetylation were observed with a HFD despite lower acetyl-CoA levels. Intriguingly, acetylation of several histone lysines correlated with the acetyl-CoA: (iso)butyryl-CoA ratio in liver. Butyryl-CoA and isobutyryl-CoA interacted with the acetyltransferase P300/CBP-associated factor (PCAF) in liver lysates and inhibited its activity in vitro. This study thus provides evidence that diet can impact tissue acyl-CoA and histone acetylation levels and that acetyl-CoA abundance correlates with acetylation of specific histone lysines in WAT but not in the liver.	[Carrer, Alessandro; Parris, Joshua L. D.; Trefely, Sophie; Torres, AnnMarie; Viola, John M.; Wellen, Kathryn E.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Blair, Ian A.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Trefely, Sophie; Snyder, Nathaniel W.] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA; [Henry, Ryan A.; Kuo, Yin-Ming; Andrews, Andrew J.] Fox Chase Canc Ctr, Dept Canc Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Montgomery, David C.; Meier, Jordan L.] NCI, Biol Chem Lab, Ctr Canc Res, NIH, Ft Detrick, MD 21702 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Drexel University; Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wellen, KE (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, 421 Curie Blvd,BRB 2-2 Rm 653, Philadelphia, PA 19104 USA.	wellenk@exchange.upenn.edu	Trefely, Sophie/AAL-9434-2020; Carrer, Alessandro/AAE-8813-2020; Meier, Jordan/N-2608-2014	Carrer, Alessandro/0000-0002-9300-6879; Snyder, Nathaniel/0000-0001-5643-8747; Meier, Jordan/0000-0002-0537-7101; Trefely, Sophie/0000-0003-3816-6869	American Diabetes Association [7-12-JF-59]; Pancreatic Cancer Action Network-American Association; Abramson Cancer Center Basic Science Center; NCI, National Institutes of Health [R01CA174761, ZIABC011488]; National Institutes of Health [R21HD087866, K22ES26235]; Penn-PREP post-baccalaureate program; Penn-PORT IRACDA postdoctoral fellowship [K12 GM081259]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD087866] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016520, ZIABC011488, R01CA174761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES026235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102503, K12GM081259] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Pancreatic Cancer Action Network-American Association; Abramson Cancer Center Basic Science Center; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn-PREP post-baccalaureate program; Penn-PORT IRACDA postdoctoral fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Diabetes Association Grant 7-12-JF-59, NCI, National Institutes of Health Grant R01CA174761, by a Pancreatic Cancer Action Network-American Association for Cancer Research career development award (to K. E. W.), by the Abramson Cancer Center Basic Science Center for Excellence in Cancer Metabolism (to K. E. W. and I. A. B.), by National Institutes of Health Grants R21HD087866 and K22ES26235 (to N. W. S.), and by NCI, National Institutes of Health Grant ZIABC011488-04 (to J. L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Penn-PREP post-baccalaureate program.; Supported by Penn-PORT IRACDA postdoctoral fellowship K12 GM081259.	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carrer A, 2015, CURR OPIN BIOTECH, V34, P23, DOI 10.1016/j.copbio.2014.11.012; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Cluntun AA, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0135-3; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Etchegaray JP, 2016, MOL CELL, V62, P695, DOI 10.1016/j.molcel.2016.05.029; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Frey AJ, 2016, ANAL BIOANAL CHEM, V408, P3651, DOI 10.1007/s00216-016-9448-5; FUKUDA H, 1992, EUR J BIOCHEM, V209, P217, DOI 10.1111/j.1432-1033.1992.tb17279.x; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Henry RA, 2013, BIOCHEMISTRY-US, V52, P5746, DOI 10.1021/bi400684q; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Jiang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006884; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Kuo YM, 2014, METHODS, V70, P127, DOI 10.1016/j.ymeth.2014.08.003; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Liu XJ, 2015, MOL CELL PROTEOMICS, V14, P1489, DOI 10.1074/mcp.M114.044859; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Meier JL, 2013, ACS CHEM BIOL, V8, P2607, DOI 10.1021/cb400689r; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Montgomery DC, 2016, J AM CHEM SOC, V138, P6388, DOI 10.1021/jacs.6b03036; Montgomery DC, 2015, CHEM BIOL, V22, P1030, DOI 10.1016/j.chembiol.2015.06.015; Palladino AA, 2012, MOL GENET METAB, V107, P679, DOI 10.1016/j.ymgme.2012.10.007; Peleg S, 2016, EMBO REP, V17, P455, DOI 10.15252/embr.201541132; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Snyder NW, 2015, ANAL BIOCHEM, V474, P59, DOI 10.1016/j.ab.2014.12.014; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Su XY, 2016, CURR OPIN CHEM BIOL, V30, P52, DOI 10.1016/j.cbpa.2015.10.030; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Waterborg JH, 1998, J BIOL CHEM, V273, P27602, DOI 10.1074/jbc.273.42.27602; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069	43	89	90	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3312	3322		10.1074/jbc.M116.750620	http://dx.doi.org/10.1074/jbc.M116.750620			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28077572	Green Published, hybrid			2022-12-28	WOS:000395538800022
J	Nguyen, TT; Savory, JGA; Brooke-Bisschop, T; Ringuette, R; Foley, T; Hess, BL; Mulatz, KJ; Trinkle-Mulcahy, L; Lohnes, D				Nguyen, Thinh T.; Savory, Joanne G. A.; Brooke-Bisschop, Travis; Ringuette, Randy; Foley, Tanya; Hess, Bradley L.; Mulatz, Kirk J.; Trinkle-Mulcahy, Laura; Lohnes, David			Cdx2 Regulates Gene Expression through Recruitment of Brg1-associated Switch-Sucrose Non-fermentable (SWI-SNF) Chromatin Remodeling Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ChiP; chromatin remodeling; intestine; MS; transcription; Brg1; SWI-SNF; Cdx; gene expression	QUANTITATIVE MASS-SPECTROMETRY; TRANSCRIPTION FACTOR CDX2; INTESTINAL STEM-CELLS; TUMOR-SUPPRESSOR; HOMEOBOX GENE; SWI/SNF COMPLEX; PRACTICAL GUIDE; HUMAN CANCER; HOX GENES; IN-VIVO	The packaging of genomic DNA into nucleosomes creates a barrier to transcription that can be relieved through ATP-dependent chromatin remodeling via complexes such as the switch-sucrose non-fermentable (SWI-SNF) chromatin remodeling complex. The SWI-SNF complex remodels chromatin via conformational or positional changes of nucleosomes, thereby altering the access of transcriptional machinery to target genes. The SWI-SNF complex has limited ability to bind to sequence-specific elements, and, therefore, its recruitment to target loci is believed to require interaction with DNA-associated transcription factors. The Cdx family of homeodomain transcript ion factors (Cdx1, Cdx2, and Cdx4) are essential for a number of developmental programs in the mouse. Cdx1 and Cdx2 also regulate intestinal homeostasis throughout life. Although a number of Cdx target genes have been identified, the basis by which Cdx members impact their transcription is poorly understood. We have found that Cdx members interact with the SWI-SNF complex and make direct contact with Brg1, a catalytic member of SWI-SNF. Both Cdx2 and Brg1 co-occupy a number of Cdx target genes, and both factors are necessary for transcriptional regulation of such targets. Finally, Cdx2 and Brg1 occupancy occurs coincident with chromatin remodeling at some of these loci. Taken together, our findings suggest that Cdx transcription factors regulate target gene expression, in part, through recruitment of Brg1-associated SWI-SNF chromatin remodeling activity.	[Nguyen, Thinh T.; Savory, Joanne G. A.; Brooke-Bisschop, Travis; Ringuette, Randy; Foley, Tanya; Hess, Bradley L.; Mulatz, Kirk J.; Trinkle-Mulcahy, Laura; Lohnes, David] Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Lohnes, D (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dlohnes@uottawa.ca		Ringuette, Randy/0000-0002-7158-2904				Alexander JM, 2015, DEVELOPMENT, V142, P1418, DOI 10.1242/dev.109496; Aoyagi S, 2005, VITAM HORM, V70, P281, DOI 10.1016/S0083-6729(05)70009-1; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Beck F, 2010, BIOCHEM SOC T, V38, P353, DOI 10.1042/BST0380353; Beland M, 2004, MOL CELL BIOL, V24, P5028, DOI 10.1128/MCB.24.11.5028-5038.2004; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Ferrier DEK, 2001, EVOL DEV, V3, P263, DOI 10.1046/j.1525-142x.2001.003004263.x; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Grainger S, 2012, DEV BIOL, V361, P1, DOI 10.1016/j.ydbio.2011.09.034; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Holik AZ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004453; Holik AZ, 2013, STEM CELLS, V31, P2457, DOI 10.1002/stem.1498; Houle M., 2003, CDX HOMEODOMAIN PROT, P69; Hryniuk A, 2014, J BIOL CHEM, V289, P33343, DOI 10.1074/jbc.M114.583823; Hryniuk A, 2012, DEV BIOL, V363, P426, DOI 10.1016/j.ydbio.2012.01.010; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lariviere N, 2014, J PROTEOME RES, V13, P3432, DOI 10.1021/pr500392m; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Meier K, 2014, EPIGENETICS-US, V9, P1485, DOI 10.4161/15592294.2014.971580; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Mudhasani R, 2005, MOL IMMUNOL, V42, P673, DOI 10.1016/j.molimm.2004.09.021; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Ohkawa Y, 2012, METHODS MOL BIOL, V798, P531, DOI 10.1007/978-1-61779-343-1_32; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Pilon N, 2006, DEV BIOL, V289, P55, DOI 10.1016/j.ydbio.2005.10.005; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; San Roman AK, 2015, STEM CELL REP, V5, P673, DOI 10.1016/j.stemcr.2015.09.006; Savory JGA, 2011, DEVELOPMENT, V138, P1361, DOI 10.1242/dev.056622; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Schenborn E T, 2000, Methods Mol Biol, V130, P135; Sif S, 2004, J CELL BIOCHEM, V91, P1087, DOI 10.1002/jcb.20005; Simmini S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6728; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Subtil C, 2007, CANCER LETT, V247, P197, DOI 10.1016/j.canlet.2006.04.004; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Trinkle-Mulcahy L, 2012, PROTEOMICS, V12, P1623, DOI 10.1002/pmic.201100438; Trotter K., 2008, NUCL RECEPT SIGNAL, V6, P1, DOI DOI 10.1621/NRS.06004; Trotter KW, 2008, MOL CELL BIOL, V28, P1413, DOI 10.1128/MCB.01301-07; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Verzi MP, 2011, MOL CELL BIOL, V31, P2026, DOI 10.1128/MCB.01250-10; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010622; Wu S, 2014, CELL CYCLE, V13, P2869, DOI 10.4161/15384101.2014.946834; Yamamoto H, 2003, BIOCHEM BIOPH RES CO, V300, P813, DOI 10.1016/S0006-291X(02)02935-2; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010	64	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3389	3399		10.1074/jbc.M116.752774	http://dx.doi.org/10.1074/jbc.M116.752774			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082674	hybrid, Green Published			2022-12-28	WOS:000395538800028
J	Yadav, H; Devalaraja, S; Chung, ST; Rane, SG				Yadav, Hariom; Devalaraja, Samir; Chung, Stephanie T.; Rane, Sushil G.			TGF-1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); diabetes; FOXO; gluconeogenesis; liver; obesity; phosphoprotein phosphatase; SMAD transcription factor; transforming growth factor (TGF-)	ACTIVATED PROTEIN-KINASE; TGF-BETA; GENE-EXPRESSION; C-ELEGANS; PHOSPHOENOLPYRUVATE CARBOXYKINASE; INSULIN SENSITIVITY; DIETARY RESTRICTION; TRANSGENIC MICE; DB/DB MICE; GROWTH	Maintenance of glucose homeostasis is essential for normal physiology. Deviation from normal glucose levels, in either direction, increases susceptibility to serious medical complications such as hypoglycemia and diabetes. Maintenance of glucose homeostasis is achieved via functional interactions among various organs: liver, skeletal muscle, adipose tissue, brain, and the endocrine pancreas. The liver is the primary site of endogenous glucose production, especially during states of prolonged fasting. However, enhanced gluconeogenesis is also a signature feature of type 2 diabetes (T2D). Thus, elucidating the signaling pathways that regulate hepatic gluconeogenesis would allow better insight into the process of normal endogenous glucose production as well as how this process is impaired in T2D. Here we demonstrate that the TGF-1/Smad3 signaling pathway promotes hepatic gluconeogenesis, both upon prolonged fasting and during T2D. In contrast, genetic and pharmacological inhibition of TGF-1/Smad3 signals suppressed endogenous glucose production. TGF-1 and Smad3 signals achieved this effect via the targeting of key regulators of hepatic gluconeogenesis, protein phosphatase 2A (PP2A), AMP-activated protein kinase (AMPK), and FoxO1 proteins. Specifically, TGF-1 signaling suppressed the LKB1-AMPK axis, thereby facilitating the nuclear translocation of FoxO1 and activation of key gluconeogenic genes, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase. These findings underscore an important role of TGF-1/Smad3 signaling in hepatic gluconeogenesis, both in normal physiology and in the pathophysiology of metabolic diseases such as diabetes, and are thus of significant medical relevance.	[Yadav, Hariom; Devalaraja, Samir; Chung, Stephanie T.; Rane, Sushil G.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20854 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rane, SG (corresponding author), NIDDK, Clin Res Ctr, Diabet Endocrinol & Obes Branch, NIH, Bldg 10,9000 Rockville Pike, Bethesda, MD 20814 USA.	ranes@mail.nih.gov	Yadav, Hariom/I-2455-2018	Yadav, Hariom/0000-0003-4504-1597	National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055106, ZIADK055107] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Aoyama H, 2006, INT J MOL MED, V18, P433; Awad H, 2014, PEDIATR PULM, V49, P885, DOI 10.1002/ppul.22919; Baur JA, 2014, CELL METAB, V20, P197, DOI 10.1016/j.cmet.2014.07.013; Chung ST, 2013, DIABETES, V62, pA56; Datto MB, 1999, MOL CELL BIOL, V19, P2495; della Vecchia NF, 2014, BIOMACROMOLECULES, V15, P3811, DOI 10.1021/bm501139h; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hou XG, 2010, BIOCHEM BIOPH RES CO, V396, P199, DOI 10.1016/j.bbrc.2010.04.017; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Osorio Joana, 2012, Nat Rev Endocrinol, V8, P257, DOI 10.1038/nrendo.2012.34; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; PILKIS SJ, 1988, ANNU REV BIOCHEM, V57, P755, DOI 10.1146/annurev.bi.57.070188.003543; Ramakrishnan SK, 2016, CELL METAB, V23, P505, DOI 10.1016/j.cmet.2016.01.004; Rosmond R, 2003, HORM RES, V59, P191, DOI 10.1159/000069323; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Schon Hans-Theo, 2014, Hepatobiliary Surg Nutr, V3, P386, DOI 10.3978/j.issn.2304-3881.2014.11.06; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Stopa M, 2000, J BIOL CHEM, V275, P29308, DOI 10.1074/jbc.M003282200; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; Tiano JP, 2015, J BIOL CHEM, V290, P11431, DOI 10.1074/jbc.A114.617399; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; VENEZIALE CM, 1983, J BIOL CHEM, V258, P4257; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	43	56	66	5	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3420	3432		10.1074/jbc.M116.764910	http://dx.doi.org/10.1074/jbc.M116.764910			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28069811	hybrid, Green Published			2022-12-28	WOS:000395538800031
J	Andrich, K; Hegenbart, U; Kimmich, C; Kedia, N; Bergen, HR; Schonland, S; Wanker, E; Bieschke, J				Andrich, Kathrin; Hegenbart, Ute; Kimmich, Christoph; Kedia, Niraja; Bergen, H. Robert, III; Schoenland, Stefan; Wanker, Erich; Bieschke, Jan			Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEROZOITE SURFACE PROTEIN-2; BENCE-JONES PROTEINS; FIBRIL FORMATION; 3-DIMENSIONAL STRUCTURE; VARIABLE DOMAINS; GREEN TEA; IN-VITRO; MOLECULAR-INTERACTIONS; THERMODYNAMIC ANALYSIS; THERMAL-STABILITY	Intervention into amyloid deposition with anti-amyloid agents like the polyphenol epigallocatechin-3-gallate (EGCG) is emerging as an experimental secondary treatment strategy in systemic light chain amyloidosis (AL). In both AL and multiple myeloma (MM), soluble immunoglobulin light chains (LC) are produced by clonal plasma cells, but only in AL do they form amyloid deposits in vivo. Weinvestigated the amyloid formation of patient-derived LC and their susceptibility to EGCG in vitro to probe commonalities and systematic differences in their assembly mechanisms. Weisolated nine LC from the urine of AL and MM patients. We quantified their thermodynamic stabilities and monitored their aggregation under physiological conditions by thioflavin T fluorescence, light scattering, SDS stability, and atomic force microscopy. LC from all patients formed amyloid-like aggregates, albeit with individually different kinetics. LC existed as dimers, similar to 50% of which were linked by disulfide bridges. Our results suggest that cleavage into LC monomers is required for efficient amyloid formation. The kinetics of AL LC displayed a transition point in concentration dependence, which MM LC lacked. The lack of concentration dependence of MM LC aggregation kinetics suggests that conformational change of the light chain is rate-limiting for these proteins. Aggregation kinetics displayed two distinct phases, which corresponded to the formation of oligomers and amyloid fibrils, respectively. EGCG specifically inhibited the second aggregation phase and induced the formation of SDS-stable, non-amyloid LC aggregates. Our data suggest that EGCG intervention does not depend on the individual LC sequence and is similar to the mechanism observed for amyloid-beta and alpha-synuclein.	[Andrich, Kathrin; Kedia, Niraja; Bieschke, Jan] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Andrich, Kathrin; Wanker, Erich] Max Delbruck Ctr Mol Med Helmholtz Assoc, D-13125 Berlin, Germany; [Hegenbart, Ute; Kimmich, Christoph; Schoenland, Stefan] Univ Heidelberg Hosp, Dept Internal Med 5, Hematol Amyloidosis Ctr, D-69120 Heidelberg, Germany; [Bergen, H. Robert, III] Mayo Clin, Translat PKD Ctr, Rochester, MN 55905 USA	Washington University (WUSTL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruprecht Karls University Heidelberg; Mayo Clinic	Bieschke, J (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	bieschke@wustl.edu	Schönland, Stefan/AAV-5607-2020; Bieschke, Jan/AAG-2705-2019	Schönland, Stefan/0000-0002-4853-5579; Bieschke, Jan/0000-0002-3485-9767; Wanker, Erich/0000-0001-8072-1630	German Ministry for Science and Education (BMBF GERAMY) [01GM1107C, 01GM1107A]; Diabetes Research Center at Washington University (National Institutes of Health) [P30 DK020579]; German Science Foundation (DFG) [BI 1409/1-1]; MRC [MC_UU_00024/6] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA015083, P50CA186781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	German Ministry for Science and Education (BMBF GERAMY)(Federal Ministry of Education & Research (BMBF)); Diabetes Research Center at Washington University (National Institutes of Health); German Science Foundation (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by German Ministry for Science and Education (BMBF GERAMY) Grants 01GM1107C and 01GM1107A, by the Diabetes Research Center at Washington University (National Institutes of Health Grant No. 5, P30 DK020579), and by German Science Foundation (DFG) Grant BI 1409/1-1. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe M, 2013, PROTEIN SCI, V22, P467, DOI 10.1002/pro.2228; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; Andrich K, 2015, ADV EXP MED BIOL, V863, P139, DOI 10.1007/978-3-319-18365-7_7; Arosio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033372; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BAUMSTARK JS, 1983, PREP BIOCHEM, V13, P315, DOI 10.1080/00327488308068176; Bergen HR, 2016, CLIN CHEM, V62, P243, DOI 10.1373/clinchem.2015.242651; Bergen HR, 2004, BIOMED CHROMATOGR, V18, P191, DOI 10.1002/bmc.323; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Blancas-Mejia LM, 2016, BIOCHEMISTRY-US, V55, P2967, DOI 10.1021/acs.biochem.6b00090; Blancas-Mejia LM, 2015, BIOPHYS CHEM, V207, P13, DOI 10.1016/j.bpc.2015.07.005; Blancas-Mejia LM, 2014, J MOL BIOL, V426, P347, DOI 10.1016/j.jmb.2013.10.016; Blancas-Mejia LM, 2009, J MOL BIOL, V386, P1153, DOI 10.1016/j.jmb.2008.12.069; Brumshtein B, 2015, ELIFE, V4, DOI 10.7554/eLife.10935; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Chandrashekaran IR, 2011, ARCH BIOCHEM BIOPHYS, V513, P153, DOI 10.1016/j.abb.2011.07.008; Chandrashekaran IR, 2010, BIOCHEMISTRY-US, V49, P5899, DOI 10.1021/bi902197x; Chung CM, 2005, BIOPHYS J, V88, P4232, DOI 10.1529/biophysj.105.061317; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; COHN JR, 1978, ANN CLIN LAB SCI, V8, P270; Davern S, 2011, BBA-MOL BASIS DIS, V1812, P32, DOI 10.1016/j.bbadis.2010.07.022; DAVIES DR, 1975, ANNU REV BIOCHEM, V44, P639, DOI 10.1146/annurev.bi.44.070175.003231; Desport E, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-54; DiCostanzo AC, 2012, J BIOL CHEM, V287, P27997, DOI 10.1074/jbc.M112.362921; Ehrenmann F, 2010, NUCLEIC ACIDS RES, V38, pD301, DOI 10.1093/nar/gkp946; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Feige MJ, 2007, J MOL BIOL, V365, P1232, DOI 10.1016/j.jmb.2006.10.049; Garai K, 2013, P NATL ACAD SCI USA, V110, P3321, DOI 10.1073/pnas.1222478110; Gauci AJ, 2011, J ALZHEIMERS DIS, V27, P767, DOI 10.3233/JAD-2011-111061; GLENNER GG, 1971, SCIENCE, V174, P712, DOI 10.1126/science.174.4010.712; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433, DOI 10.1093/oxfordjournals.jbchem.a132661; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Grelle G, 2011, BIOCHEMISTRY-US, V50, P10624, DOI 10.1021/bi2012383; Gupta P, 2015, RSC ADV, V5, P95717, DOI 10.1039/c5ra17794d; HOPKINS TR, 1967, BIOCHEM BIOPH RES CO, V28, P480, DOI 10.1016/0006-291X(67)90337-3; Hunstein W, 2007, BLOOD, V110, P2216, DOI 10.1182/blood-2007-05-089243; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Kaas Quentin, 2007, Briefings in Functional Genomics & Proteomics, V6, P253, DOI 10.1093/bfgp/elm032; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; KLATSKIN G, 1969, AM J PATHOL, V56, P1; KLAUSNER RD, 1983, BIOCHEM J, V212, P801, DOI 10.1042/bj2120801; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; KRATZIN HD, 1989, BIOL CHEM H-S, V370, P263, DOI 10.1515/bchm3.1989.370.1.263; KYLE RA, 1992, BLOOD, V79, P1817; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Lee YK, 2009, BRAIN RES, V1250, P164, DOI 10.1016/j.brainres.2008.10.012; Lefranc M.-P., 2001, IMMUNOGLOBULIN FACTS, P17; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006; Lefranc MP, 2003, LEUKEMIA, V17, P260, DOI 10.1038/sj.leu.2402637; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Li CX, 2013, ADV MATER, V25, P3694, DOI 10.1002/adma.201300904; Li CX, 2013, NANOSCALE, V5, P6207, DOI 10.1039/c3nr01644g; Liao RL, 2001, CIRCULATION, V104, P1594, DOI 10.1161/circ.104.14.1594; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; MANTULIN WW, 1980, J BIOL CHEM, V255, P8185; Marin-Argany M, 2015, PROTEIN SCI, V24, P1829, DOI 10.1002/pro.2790; Martin DJ, 2011, BIOPHYS CHEM, V158, P81, DOI 10.1016/j.bpc.2011.05.011; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Mereles D, 2008, CLIN RES CARDIOL, V97, P341, DOI 10.1007/s00392-008-0649-6; Mereles D, 2010, CLIN RES CARDIOL, V99, P483, DOI 10.1007/s00392-010-0142-x; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Pelaez-Aguilar AE, 2015, BIOCHEMISTRY-US, V54, P4978, DOI 10.1021/acs.biochem.5b00288; POLJAK RJ, 1975, NATURE, V256, P373, DOI 10.1038/256373a0; Poshusta TL, 2013, INT J MOL SCI, V14, P22604, DOI 10.3390/ijms141122604; ROBINSON EL, 1982, CLIN CHEM, V28, P2254; Ruiz M, 2002, IMMUNOGENETICS, V53, P857, DOI 10.1007/s00251-001-0408-6; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; SCHIFFER M, 1985, J MOL BIOL, V186, P475, DOI 10.1016/0022-2836(85)90120-2; Sengupta S, 2001, J BIOL CHEM, V276, P30111, DOI 10.1074/jbc.M104324200; Shinagawa A, 2001, INT J HEMATOL, V73, P526, DOI 10.1007/BF02994017; Sikkink LA, 2008, AMYLOID, V15, P29, DOI 10.1080/13506120701815324; SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P451, DOI 10.1021/cn200133x; SOLLING K, 1976, SCAND J CLIN LAB INV, V36, P447, DOI 10.3109/00365517609054462; SOLOMON A, 1969, J BIOL CHEM, V244, P3393; STEVENS PW, 1995, PROTEIN SCI, V4, P421; SUN T, 1979, AM J CLIN PATHOL, V72, P5; TEPPO AM, 1985, DIABETES, V34, P589, DOI 10.2337/diabetes.34.6.589; TSUNENAGA M, 1987, BIOCHEMISTRY-US, V26, P6044, DOI 10.1021/bi00393a015; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wang SH, 2012, J PHYS CHEM B, V116, P5803, DOI 10.1021/jp209406t; Wang SH, 2010, J PHYS CHEM B, V114, P11576, DOI 10.1021/jp1001435; Wobst HJ, 2015, FEBS LETT, V589, P77, DOI 10.1016/j.febslet.2014.11.026	91	27	27	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2328	2344		10.1074/jbc.M116.750323	http://dx.doi.org/10.1074/jbc.M116.750323			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031465	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000395530300024
J	Verhelst, J; Van Hoecke, L; Spitaels, J; De Vlieger, D; Kolpe, A; Saelens, X				Verhelst, Judith; Van Hoecke, Lien; Spitaels, Jan; De Vlieger, Dorien; Kolpe, Annasaheb; Saelens, Xavier			Chemical-controlled Activation of Antiviral Myxovirus Resistance Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS; MX-PROTEINS; OLIGOMERIZATION; OVEREXPRESSION; REQUIREMENTS; SENSITIVITY; POLYMERASE; RAPAMYCIN; REVEALS; TARGET	The antiviral myxovirus resistance protein 1 (MX1) is an interferon-induced GTPase that plays an important role in the defense of mammalian cells against influenza A viruses. Mouse MX1 interacts with the influenza ribonucleoprotein complexes (vRNPs) and can prevent the interaction between polymerase basic 2 (PB2) and the nucleoprotein (NP) of influenza A viruses. However, it is unclear whether mouse MX1 disrupts the PB2-NP interaction in the context of pre-existing vRNPs or prevents the assembly of new vRNP components. Here, we describe a conditionally active mouse MX1 variant that only exerts antiviral activity in the presence of a small molecule drug. Once activated, this MX1 construct phenocopies the antiviral and NP binding activity of wild type MX1. The interaction between PB2 and NP is disrupted within minutes after the addition of the small molecule activator. These findings support a model in which mouse MX1 interacts with the incoming influenza A vRNPs and inhibits their activity by disrupting the PB2-NP interaction.	[Verhelst, Judith; Van Hoecke, Lien; Spitaels, Jan; De Vlieger, Dorien; Kolpe, Annasaheb; Saelens, Xavier] VIB, Ctr Med Biotechnol, Technol Pk 927, B-9052 Ghent, Belgium; [Verhelst, Judith; Van Hoecke, Lien; Spitaels, Jan; De Vlieger, Dorien; Kolpe, Annasaheb; Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Saelens, X (corresponding author), VIB, Ctr Med Biotechnol, Technol Pk 927, B-9052 Ghent, Belgium.	xavier.saelens@vib-ugent.be	Saelens, Xavier/N-5728-2015	Kolpe, Annasaheb/0000-0002-1255-1593; Van Hoecke, Lien/0000-0001-8602-4211; , Xavier/0000-0002-3861-6965	Ghent University Special Research Fund [BOF12/GOA/014]; IWT-Vlaanderen; FP7 ITN UniVacFlu	Ghent University Special Research Fund(Ghent University); IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FP7 ITN UniVacFlu	This work was supported by Ghent University Special Research Fund (Project BOF12/GOA/014) (to X.S. and J.V.) This work was also supported by grants from IWT-Vlaanderen (to J.S. and D.D.V.) and FP7 ITN UniVacFlu (to A.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Edwards SR, 2007, J BIOL CHEM, V282, P13395, DOI 10.1074/jbc.M700498200; Engelhardt OG, 2006, REV MED VIROL, V16, P329, DOI 10.1002/rmv.512; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; HUANG T, 1992, J VIROL, V66, P4154, DOI 10.1128/JVI.66.7.4154-4160.1992; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; Nigg PE, 2015, J BIOL CHEM, V290, P29893, DOI 10.1074/jbc.M115.681494; Patzina C, 2014, J BIOL CHEM, V289, P6020, DOI 10.1074/jbc.M113.543892; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Stankunas K, 2007, CHEMBIOCHEM, V8, P1162, DOI 10.1002/cbic.200700087; STRANDEN AM, 1993, VIROLOGY, V197, P642, DOI 10.1006/viro.1993.1639; Verhelst J, 2015, JOVE-J VIS EXP, DOI 10.3791/52871; Verhelst J, 2015, J VIROL, V89, P10879, DOI 10.1128/JVI.01744-15; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	23	4	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2226	2236		10.1074/jbc.M116.748806	http://dx.doi.org/10.1074/jbc.M116.748806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011636	hybrid, Green Published			2022-12-28	WOS:000395530300016
J	Chin, S; Yang, DH; Miles, AJ; Eckford, PDW; Molinski, S; Wallace, BA; Bear, CE				Chin, Stephanie; Yang, Donghe; Miles, Andrew J.; Eckford, Paul D. W.; Molinski, Steven; Wallace, B. A.; Bear, Christine E.			Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine-mediated cross-linking; cystic fibrosis transmembrane conductance regulator (CFTR); ion channel; phosphorylation; spectroscopy; synchrotron radiation circular dichroism	NUCLEOTIDE-BINDING DOMAIN; I-TASSER SERVER; CIRCULAR-DICHROISM; PROTEIN-STRUCTURE; R-DOMAIN; CHANNEL; DELTA-F508; STABILITY; MODEL; SITES	Cystic fibrosis transmembrane conductance regulator (CFTR) is a multidomain membrane protein that functions as a phosphorylation-regulated anion channel. The interface between its two cytosolic nucleotide binding domains and coupling helices conferred by intracellular loops extending from the channel pore domains has been referred to as a transmission interface and is thought to be critical for the regulated channel activity of CFTR. Phosphorylation of the regulatory domain of CFTR by protein kinase A (PKA) is required for its channel activity. However, it was unclear if phosphorylation modifies the transmission interface. Here, we studied purified full-length CFTR protein using spectroscopic techniques to determine the consequences of PKA-mediated phosphorylation. Synchrotron radiation circular dichroism spectroscopy confirmed that purified full-length wild-type CFTR is folded and structurally responsive to phosphorylation. Intrinsic tryptophan fluorescence studies of CFTR showed that phosphorylation reduced iodide-mediated quenching, consistent with an effect of phosphorylation in burying tryptophans at the transmission interface. Importantly, the rate of phosphorylation-dependent channel activation was compromised by the introduction of disease-causing mutations in either of the two coupling helices predicted to interact with nucleotide binding domain 1 at the interface. Together, these results suggest that phosphorylation modifies the interface between the catalytic and pore domains of CFTR and that this modification facilitates CFTR channel activation.	[Chin, Stephanie; Yang, Donghe; Eckford, Paul D. W.; Molinski, Steven; Bear, Christine E.] Hosp Sick Children, Programme Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Chin, Stephanie; Molinski, Steven; Bear, Christine E.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Miles, Andrew J.; Wallace, B. A.] Univ London, Inst Struct & Mol Biol, Birkbeck Coll, London WC1E 7HX, England; [Bear, Christine E.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of London; Birkbeck University London; University of Toronto	Bear, CE (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Programme Mol Struct & Funct, 686 Bay St,Rm 209420 U West, Toronto, ON M5G 0A4, Canada.	bear@sickkids.ca	Molinski, Steven V/J-9509-2015; Eckford, Paul/ABE-9189-2021; Wallace, B A/C-3753-2008	Wallace, B A/0000-0001-9649-5092; Molinski, Steven/0000-0001-9215-8232	NSERC (Natural Science and Engineering Research Council); CIHR (Canadian Institutes of Health Research); UK Biotechnology and Biological Sciences Research Council; ISA synchrotron; BBSRC [BB/J019135/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/02959, BB/J019135/1] Funding Source: researchfish	NSERC (Natural Science and Engineering Research Council)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ISA synchrotron; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from NSERC (Natural Science and Engineering Research Council; to S.C.) and CIHR (Canadian Institutes of Health Research). This work was also supported by a grant from the UK Biotechnology and Biological Sciences Research Council (to B.A.W.) and by beamtime grants from the ISA synchrotron (to B.A.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Charalambous K, 2009, BBA-BIOMEMBRANES, V1788, P1279, DOI 10.1016/j.bbamem.2009.02.005; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Dawson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074347; DeLano W. L, 2016, PYMOL MOL GRAPHICS S; Di Bartolo ND, 2011, J BIOL CHEM, V286, P18807, DOI 10.1074/jbc.M110.176891; DiBartolo N, 2011, BIOCHEM SOC T, V39, P751, DOI 10.1042/BST0390751; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2015, JOVE-J VIS EXP, DOI 10.3791/52427; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Eggensperger S, 2014, J BIOL CHEM, V289, P33098, DOI 10.1074/jbc.M114.592832; Ehrhardt A, 2016, J BIOL CHEM, V291, P1854, DOI 10.1074/jbc.M115.704809; Gao XL, 2015, P NATL ACAD SCI USA, V112, P2461, DOI 10.1073/pnas.1420676112; Golin J, 2015, BIOCHEM J, V467, P353, DOI 10.1042/BJ20150042; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Hudson RP, 2012, J BIOL CHEM, V287, P28480, DOI 10.1074/jbc.M112.371138; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Liang XB, 2012, MOL BIOL CELL, V23, P996, DOI 10.1091/mbc.E11-08-0662; Linsdell Paul, 2017, Adv Exp Med Biol, V925, P13, DOI 10.1007/5584_2016_33; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2015, J BIOL CHEM, V290, P16954, DOI 10.1074/jbc.M115.652602; Loo TW, 2011, METHODS MOL BIOL, V741, P23, DOI 10.1007/978-1-61779-117-8_3; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mihalyi C, 2016, ELIFE, V5, DOI 10.7554/eLife.18164; Miles AJ, 2005, PROTEIN SCI, V14, P368, DOI 10.1110/ps.041019905; Miles AJ, 2003, SPECTROSC-INT J, V17, P653, DOI 10.1155/2003/379137; Molinski SV, 2015, J BIOMOL SCREEN, V20, P1204, DOI 10.1177/1087057115605834; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Ostedgaard LS, 2001, J BIOL CHEM, V276, P7689, DOI 10.1074/jbc.R100001200; Pasyk S, 2015, PROTEOMICS, V15, P447, DOI 10.1002/pmic.201400218; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schlamadinger DE, 2011, JOVE-J VIS EXP, DOI 10.3791/2669; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sorum B, 2015, CELL, V163, P724, DOI 10.1016/j.cell.2015.09.052; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Yang JY, 2016, J MOL BIOL, V428, P693, DOI 10.1016/j.jmb.2015.09.024; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014	53	6	6	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1988	1999		10.1074/jbc.M116.762633	http://dx.doi.org/10.1074/jbc.M116.762633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28003367	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000395515600036
J	Jorgensen, S; Have, CT; Underwood, CR; Johansen, LD; Wellendorph, P; Gjesing, AP; Jorgensen, CV; Quan, S; Rui, G; Inoue, A; Linneberg, A; Grarup, N; Jun, W; Pedersen, O; Hansen, T; Brauner-Osborne, H				Jorgensen, Stine; Have, Christian Theil; Underwood, Christina Rye; Johansen, Lars Dan; Wellendorph, Petrine; Gjesing, Anette Prior; Jorgensen, Christinna V.; Quan, Shi; Rui, Gao; Inoue, Asuka; Linneberg, Allan; Grarup, Niels; Jun, Wang; Pedersen, Oluf; Hansen, Torben; Brauner-Osborne, Hans			Genetic Variations in the Human G Protein-coupled Receptor Class C, Group 6, Member A (GPRC6A) Control Cell Surface Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID RECEPTOR; L-ARGININE; CLONING; OSTEOCALCIN; GPCR; MICE; DIET	GPRC6A is a G protein-coupled receptor activated by Lamino acids, which, based on analyses of knock-out mice, has been suggested to have physiological functions in metabolism and testicular function. The human ortholog is, however, mostly retained intracellularly in contrast to the cell surface-expressed murine and goldfish orthologs. The latter orthologs are G(q)-coupled and lead to intracellular accumulation of inositol phosphates and calcium release. In the present study we cloned the bonobo chimpanzee GPRC6A receptor, which is 99% identical to the human receptor, and show that it is cell surface-expressed and functional. By analyses of chimeric human/mouse and human/bonobo receptors, bonobo receptor mutants, and the single nucleotide polymorphism database at NCBI, we identify an insertion/deletion variation in the third intracellular loop responsible for the intracellular retention and lack of function of the human ortholog. Genetic analyses of the 1000 genome database and the Inter99 cohort of 6,000 Danes establish the distribution of genotypes among ethnic groups, showing that the cell surface-expressed and functional variant is much more prevalent in the African population than in European and Asian populations and that this variant is partly linked with a stop codon early in the receptor sequence (rs6907580, amino acid position 57). In conclusion, our data solve a more than decade-old question of why the cloned human GPRC6A receptor is not cell surface-expressed and functional and provide a genetic framework to study human phenotypic traits in large genome sequencing projects linked with physiological measurement and biomarkers.	[Jorgensen, Stine; Underwood, Christina Rye; Johansen, Lars Dan; Wellendorph, Petrine; Jorgensen, Christinna V.; Brauner-Osborne, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Have, Christian Theil; Gjesing, Anette Prior; Grarup, Niels; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn,Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Quan, Shi; Rui, Gao; Jun, Wang] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Biochem, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Linneberg, Allan] Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, DK-2100 Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Beijing Genomics Institute (BGI); Tohoku University; Japan Science & Technology Agency (JST); Rigshospitalet; University of Copenhagen; University of Copenhagen	Brauner-Osborne, H (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark.	hbo@sund.ku.dk	Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020; Gjesing, Anette/ACC-7521-2022; Brauner-Osborne, Hans/D-7260-2011; Wellendorph, Petrine/H-8328-2015	Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Gjesing, Anette/0000-0003-4580-1576; Hansen, Torben/0000-0001-8748-3831; Brauner-Osborne, Hans/0000-0001-9495-7388; Have, Christian Theil/0000-0002-8634-4781; Jorgensen, Christinna Vangsgaard/0000-0001-6089-899X; Wellendorph, Petrine/0000-0002-5455-8013; Linneberg, Allan/0000-0002-0994-0184	Danish Council for Independent Research, Medical Sciences; Novo Nordisk Foundation; Lundbeck Foundation; Japan Science and Technology Agency; Precursory Research for Embryonic Science and Technology; AstraZeneca; Lundbeck Foundation [R171-2014-505] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0010365] Funding Source: researchfish	Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Precursory Research for Embryonic Science and Technology; AstraZeneca(AstraZeneca); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by funds from the Danish Council for Independent Research, Medical Sciences (to H.B.-O.), the Novo Nordisk Foundation (to H.B.-O.), the Lundbeck Foundation (to C.R.U.), the Japan Science and Technology Agency, Precursory Research for Embryonic Science and Technology (to A.I.), and AstraZeneca (to H.B.-O.). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen and is partially funded by an unrestricted donation from the Novo Nordisk Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alamshah A, 2016, DIABETES OBES METAB, V18, P508, DOI 10.1111/dom.12644; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Clemmensen C, 2014, BRIT J PHARMACOL, V171, P1129, DOI 10.1111/bph.12365; Clemmensen C., 2016, DIABETES OB IN PRESS; Clemmensen C, 2013, PHYSIOL BEHAV, V118, P144, DOI 10.1016/j.physbeh.2013.05.015; Clemmensen C, 2013, J ENDOCRINOL, V217, P151, DOI 10.1530/JOE-12-0550; Exome Variant Server, NHLBI GO EX SEQ PROJ; Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004; Gao R, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-13; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276; Jong YJI, 2014, MOL PHARMACOL, V86, P774, DOI 10.1124/mol.114.094763; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kinsey-Jones JS, 2015, OBESITY, V23, P1194, DOI 10.1002/oby.21083; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Norskov-Lauritsen L, 2015, FEBS LETT, V589, P588, DOI 10.1016/j.febslet.2015.01.019; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Pagano A, 2001, J NEUROSCI, V21, P1189; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Pi M, 2012, ENDOCRINOLOGY, V153, P2062, DOI 10.1210/en.2011-2117; Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2010, J BONE MINER RES, V25, P1092, DOI 10.1359/jbmr.091037; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Rueda P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146846; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Smajilovic S, 2013, AMINO ACIDS, V44, P383, DOI 10.1007/s00726-012-1341-8; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Wellendorph P, 2007, GENE, V396, P257, DOI 10.1016/j.gene.2007.03.008; Wellendorph P, 2009, J MOL ENDOCRINOL, V42, P215, DOI 10.1677/JME-08-0149	41	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1524	1534		10.1074/jbc.M116.756577	http://dx.doi.org/10.1074/jbc.M116.756577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27986810	Green Published, hybrid			2022-12-28	WOS:000393339800031
J	Chen, XJ; Li, WN; Riley, AM; Soliman, M; Chakraborty, S; Stamatkin, CW; Obukhov, AG				Chen, Xingjuan; Li, Wennan; Riley, Ashley M.; Soliman, Mario; Chakraborty, Saikat; Stamatkin, Christopher W.; Obukhov, Alexander G.			Molecular Determinants of the Sensitivity to G(q/11)-Phospholipase C-dependent Gating, Gd3(+) Potentiation, and Ca2(+) Permeability in the Transient Receptor Potential Canonical Type 5 (TRPC5) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION CHANNELS; MOUSE-BRAIN; IDENTIFICATION; MECHANISMS; INJECTION; PROTEINS; RESIDUE; CLONING	Transient receptor potential canonical type 5 (TRPC5) is a Ca2+ -permeable cation channel that is highly expressed in the brain and is implicated in motor coordination, innate fear behavior, and seizure genesis. The channel is activated by a signal downstream of the G-protein-coupled receptor (GPCR)-G(q/ 11) -phospholipase C (PLC) pathway. In this study we aimed to identify the molecular mechanisms involved in regulating TRPC5 activity. Wereport that Arg-593, a residue located in the E4 loop near the TRPC5 extracellular Gd3+ binding site, is critical for conferring the sensitivity to GPCR-G(q/11)-PLC-dependent gating on TRPC5. Indeed, guanosine 5' -O-(thiotriphosphate) and GPCR agonists only weakly activate the TRPC5(R593A) mutant, whereas the addition of Gd3+ rescues the mutant's sensitivity to GPCR-G(q/ 11)-PLC-dependent gating. Computer modeling suggests that Arg-593 may cross-bridge the E3 and E4 loops, forming the " molecular fulcrum." While validating the model using site-directed mutagenesis, we found that the Tyr542 residue is critical for establishing a functional Gd3+ binding site, the Tyr-541 residue participates in fine-tuning Gd3+ -sensitivity, and that the Asn-584 residue determines Ca2+ permeability of the TRPC5 channel. This is the first report providing molecular insights into the molecular mechanisms regulating the sensitivity to GPCR-G(q/ 11)-PLC-dependent gating of a receptor- operated channel.	[Chen, Xingjuan; Li, Wennan; Riley, Ashley M.; Soliman, Mario; Chakraborty, Saikat; Stamatkin, Christopher W.; Obukhov, Alexander G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr,MS360A, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Obukhov, AG (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr,MS360A, Indianapolis, IN 46202 USA.	aobukhov@iu.edu	chen, xingjuan/V-4064-2019; Obukhov, Alexander G./C-7246-2008	chen, xingjuan/0000-0002-7380-8399; Obukhov, Alexander G./0000-0002-3862-6004	National Institutes of Health [R01HL083381, R01HL115140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083381, R01HL115140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL083381 and R01HL115140 (NHLBI; to A. G. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beck A, 2013, J BIOL CHEM, V288, P19471, DOI 10.1074/jbc.M113.478305; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; BLANK JL, 1991, J BIOL CHEM, V266, P18206; Blondeau P, 2007, CHEM SOC REV, V36, P198, DOI 10.1039/b603089k; BORDERS CL, 1994, PROTEIN SCI, V3, P541; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen XJ, 2014, CELLS-BASEL, V3, P247, DOI 10.3390/cells3020247; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kapoor R, 2010, PAIN PHYSICIAN, V13, pE321; Kumar S, 2012, J CELL PHYSIOL, V227, P1408, DOI 10.1002/jcp.22855; Obukhov AG, 2005, J NEUROSCI, V25, P1234, DOI 10.1523/JNEUROSCI.4451-04.2005; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Obukhov AG, 2008, J CELL PHYSIOL, V216, P162, DOI 10.1002/jcp.21388; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Park KW, 2010, J KOREAN MED SCI, V25, P505, DOI 10.3346/jkms.2010.25.3.505; Phelan KD, 2014, P NATL ACAD SCI USA, V111, P11533, DOI 10.1073/pnas.1411442111; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Puram SV, 2011, GENE DEV, V25, P2659, DOI 10.1101/gad.174060.111; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Semtner M, 2007, J BIOL CHEM, V282, P33868, DOI 10.1074/jbc.M702577200; Sossey-Alaoui K, 1999, GENOMICS, V60, P330, DOI 10.1006/geno.1999.5924; Sukumar P, 2010, BIOCHEM BIOPH RES CO, V393, P50, DOI 10.1016/j.bbrc.2010.01.074; Tai C, 2011, HIPPOCAMPUS, V21, P958, DOI 10.1002/hipo.20807; Thakur DP, 2016, P NATL ACAD SCI USA, V113, P1092, DOI 10.1073/pnas.1522294113; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Zheng F, 2014, CELLS-BASEL, V3, P288, DOI 10.3390/cells3020288	33	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					898	911		10.1074/jbc.M116.755470	http://dx.doi.org/10.1074/jbc.M116.755470			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27920205	Green Published, hybrid			2022-12-28	WOS:000392318700012
J	Enyindah-Asonye, G; Li, Y; Xin, W; Singer, NG; Gupta, N; Fung, J; Lin, F				Enyindah-Asonye, Gospel; Li, Yan; Xin, Wei; Singer, Nora G.; Gupta, Neetu; Fung, John; Lin, Feng			CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; CHRONIC PLAQUE PSORIASIS; B-1 CELLS; B-CELLS; ANTIBODY REPERTOIRE; DOUBLE-BLIND; T-CELLS; LYMPHOCYTES; MICE; COMPLEMENT	Intestinal ischemia/reperfusion (I/R) injury is a relatively common pathological condition that can lead to multi-organ failure and mortality. Regulatory mechanism for this disease is poorly understood, although it is established that circulating pathogenic natural IgM, which is primarily produced by B1a cells outside of the peritoneal cavity, are integrally involved. CD6 was originally identified as a marker for T cells and was later found to be present on some subsets of B cells in humans; however, whether CD6 plays any role in intestinal I/R-induced injury and, if so, the underlying mechanisms, remain unknown. Here we report that CD6(-/-) mice were significantly protected from intestinal inflammation and mucosal damage compared with WT mice in a model of intestinal I/R-induced injury. Mechanistically, we found that CD6 was selectively expressed on B1 cells outside of the bone marrow and peritoneal cavity and that pathogenic natural IgM titers were reduced in the CD6(-/-) mice in association with significantly decreased B1a cell population. Our results reveal an unexpected role of CD6 in the pathogenesis of intestinal IR-induced injury by regulating the self-renewal of B1a cells.	[Enyindah-Asonye, Gospel; Li, Yan; Gupta, Neetu; Lin, Feng] Cleveland Clin, Dept Immunol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Xin, Wei] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Singer, Nora G.] Metrohlth Med Ctr, Div Rheumatol, Cleveland, OH 44106 USA; [Singer, Nora G.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Fung, John] Cleveland Clin, Inst Digest Dis, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; MetroHealth System; Case Western Reserve University; Cleveland Clinic Foundation	Lin, F (corresponding author), Cleveland Clin, Dept Immunol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	linf2@ccf.org	FUNG, John Julian/A-2679-2012	FUNG, John Julian/0000-0002-3038-0441; Enyindah-Asonye, Gospel/0000-0002-4575-9622	National Institutes of Health [NS081443, AR061564]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS081443 and AR061564 (to F. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso R, 2010, J AUTOIMMUN, V35, P336, DOI 10.1016/j.jaut.2010.07.005; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Austen WG, 2003, INT J IMMUNOPATH PH, V16, P1; Ban KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041584; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Berland R, 2003, P NATL ACAD SCI USA, V100, P13459, DOI 10.1073/pnas.2233620100; Braun F, 2004, TRANSPL P, V36, P267, DOI 10.1016/j.transproceed.2004.01.082; Choi YS, 2012, EUR J IMMUNOL, V42, P120, DOI 10.1002/eji.201141890; Chopra A, 2016, CLIN RHEUMATOL, V35, P1059, DOI 10.1007/s10067-015-2988-9; Chumley MJ, 2002, J IMMUNOL, V169, P1735, DOI 10.4049/jimmunol.169.4.1735; Cuzzocrea S, 1999, J LEUKOCYTE BIOL, V66, P471, DOI 10.1002/jlb.66.3.471; Dal Porto JM, 2004, IMMUNITY, V21, P443, DOI 10.1016/j.immuni.2004.07.018; Dogra S, 2015, J AM ACAD DERMATOL, V73, P331, DOI 10.1016/j.jaad.2015.03.040; DUNN R, 1979, J MOL BIOL, V128, P277, DOI 10.1016/0022-2836(79)90088-3; Edgerton C, 2009, CLIN IMMUNOL, V130, P313, DOI 10.1016/j.clim.2008.09.019; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Fleming SD, 2002, J IMMUNOL, V169, P2126, DOI 10.4049/jimmunol.169.4.2126; Gimferrer I, 2004, J IMMUNOL, V173, P2262, DOI 10.4049/jimmunol.173.4.2262; Gimferrer I, 2003, J BIOL CHEM, V278, P8564, DOI 10.1074/jbc.M209591200; Grootjans J, 2010, AM J PATHOL, V176, P2283, DOI 10.2353/ajpath.2010.091069; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Holodick NE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00129; Holodick NE, 2010, EUR J IMMUNOL, V40, P3007, DOI 10.1002/eji.201040545; Jordo ED, 2011, MOL IMMUNOL, V48, P1307, DOI 10.1016/j.molimm.2011.01.010; Kretschmer K, 2003, J IMMUNOL, V171, P1192, DOI 10.4049/jimmunol.171.3.1192; Krop I, 1996, EUR J IMMUNOL, V26, P238, DOI 10.1002/eji.1830260137; Krupashankar DS, 2014, J AM ACAD DERMATOL, V71, P484, DOI 10.1016/j.jaad.2014.01.897; Kulik L, 2009, J IMMUNOL, V182, P5363, DOI 10.4049/jimmunol.0803980; Kyaw T, 2011, CIRC RES, V109, P830, DOI 10.1161/CIRCRESAHA.111.248542; Lenaerts K, 2013, CURR OPIN ORGAN TRAN, V18, P298, DOI 10.1097/MOT.0b013e32835ef1eb; Merino MC, 2006, MEDICINA-BUENOS AIRE, V66, P165; Nair P, 2010, CLIN EXP IMMUNOL, V162, P116, DOI 10.1111/j.1365-2249.2010.04235.x; Nguyen TTT, 2015, J IMMUNOL, V194, P1489, DOI 10.4049/jimmunol.1401880; Oliveira MI, 2012, EUR J IMMUNOL, V42, P195, DOI 10.1002/eji.201040528; Orta-Mascaro M, 2016, J EXP MED, V213, P1387, DOI 10.1084/jem.20151785; Osorio LM, 1997, BLOOD, V89, P2833, DOI 10.1182/blood.V89.8.2833; Padilla ND, 2007, SURGERY, V142, P722, DOI 10.1016/j.surg.2007.05.015; Pierro Agostino, 2004, Semin Pediatr Surg, V13, P11, DOI 10.1053/j.sempedsurg.2003.09.003; Pinto M, 2013, BIODRUGS, V27, P191, DOI 10.1007/s40259-013-0027-4; Reid RR, 2002, J IMMUNOL, V169, P5433, DOI 10.4049/jimmunol.169.10.5433; Rodriguez Pedro C, 2012, Results Immunol, V2, P204, DOI 10.1016/j.rinim.2012.11.001; Roncagalli R, 2014, NAT IMMUNOL, V15, P384, DOI 10.1038/ni.2843; Shigematsu T, 2002, MICROCIRCULATION, V9, P99, DOI 10.1038/sj.mn.7800126; STALL AM, 1992, ANN NY ACAD SCI, V651, P33; Stoermann B, 2007, EUR J IMMUNOL, V37, P1613, DOI 10.1002/eji.200636640; Tuboly E, 2016, MICROBIOL IMMUNOL, V60, P35, DOI 10.1111/1348-0421.12338; Vollmar B, 2011, LANGENBECK ARCH SURG, V396, P13, DOI 10.1007/s00423-010-0727-x; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Watson MJ, 2012, SURGERY, V152, P843, DOI 10.1016/j.surg.2012.03.001; Williams JP, 1999, J APPL PHYSIOL, V86, P938, DOI 10.1152/jappl.1999.86.3.938; Wong SC, 2002, J BIOL CHEM, V277, P30707, DOI 10.1074/jbc.M202460200; WORTIS HH, 1995, P NATL ACAD SCI USA, V92, P3348, DOI 10.1073/pnas.92.8.3348; Xu DZ, 2009, SHOCK, V31, P493, DOI 10.1097/SHK.0b013e318188b3cc; Yang Y, 2007, P NATL ACAD SCI USA, V104, P4542, DOI 10.1073/pnas.0700001104; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2008, MOL IMMUNOL, V45, P4036, DOI 10.1016/j.molimm.2008.06.013; Zimmerman AW, 2006, BLOOD, V107, P3212, DOI 10.1182/blood-2005-09-3881	59	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					661	671		10.1074/jbc.M116.749804	http://dx.doi.org/10.1074/jbc.M116.749804			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909060	Green Published, hybrid			2022-12-28	WOS:000392316100021
J	Ghalali, A; Ye, ZW; Hogberg, J; Stenius, U				Ghalali, Aram; Ye, Zhi-wei; Hogberg, Johan; Stenius, Ulla			RETRACTION: Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor beta-activated stem cells (Retraction of Vol 289, Pg 11601, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Ghalali A, 2014, J BIOL CHEM, V289, P11601, DOI 10.1074/jbc.M113.537241	1	0	0	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					760	760		10.1074/jbc.A113.537241	http://dx.doi.org/10.1074/jbc.A113.537241			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	28087729	hybrid, Green Published			2022-12-28	WOS:000392316100029
J	Snyder, AJ; Danthi, P				Snyder, Anthony J.; Danthi, Pranav			Lipids Cooperate with the Reovirus Membrane Penetration Peptide to Facilitate Particle Uncoating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE SUBVIRAL PARTICLES; REVERSE GENETICS SYSTEM; CAPSID PROTEIN MU-1; MAMMALIAN REOVIRUSES; L-CELLS; PERSISTENT INFECTIONS; IMAGE-RECONSTRUCTION; IN-VITRO; ELECTRON CRYOMICROSCOPY; PUTATIVE AUTOCLEAVAGE	Virus-host interactions play a role in many stages of the viral lifecycle, including entry. Reovirus, a model system for studying the entry mechanisms of nonenveloped viruses, undergoes a series of regulated structural transitions that culminate in delivery of the viral genetic material. Lipids can trigger one of these conformational changes, infectious subviral particle (ISVP)-to-ISVP* conversion. ISVP* formation releases two virally encoded peptides, myristoylated mu 1N (myr-mu 1N) and Phi. Among these, myr-mu 1N is sufficient to form pores within membranes. Released myr-mu 1N can also promote ISVP* formation in trans. Using thermal inactivation as a readout for ISVP-to-ISVP* conversion, we demonstrate that lipids render ISVPs less thermostable in a virus concentration-dependent manner. Under conditions in which neither lipids alone nor myr-mu 1N alone promotes ISVP-to-ISVP* conversion, myr-mu 1N induces particle uncoating when lipids are present. These data suggest that the pore-forming activity and the ISVP*-promoting activity of myr-mu 1N are linked. Lipid-associated myr-mu 1N interacts with ISVPs and triggers efficient ISVP* formation. The cooperativity between a reovirus component and lipids reveals a distinct virus-host interaction in which membranes can facilitate nonenveloped virus entry.	[Snyder, Anthony J.; Danthi, Pranav] Indiana Univ, Dept Biol, Simon Hall MSB1,212 South Hawthorne Dr, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Danthi, P (corresponding author), Indiana Univ, Dept Biol, Simon Hall MSB1,212 South Hawthorne Dr, Bloomington, IN 47405 USA.	pdanthi@indiana.edu	Danthi, Pranav/H-6330-2019	Danthi, Pranav/0000-0001-6199-6022	NIAID, National Institutes of Health [1R01AI110637]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110637] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant 1R01AI110637 (to P. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agosto MA, 2008, P NATL ACAD SCI USA, V105, P10571, DOI 10.1073/pnas.0802039105; Agosto MA, 2007, J VIROL, V81, P7400, DOI 10.1128/JVI.02720-06; Agosto MA, 2006, P NATL ACAD SCI USA, V103, P16496, DOI 10.1073/pnas.0605835103; AMERONGEN HM, 1994, J VIROL, V68, P8428, DOI 10.1128/JVI.68.12.8428-8432.1994; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Baer GS, 1997, J VIROL, V71, P4921, DOI 10.1128/JVI.71.7.4921-4928.1997; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; BASS DM, 1990, J VIROL, V64, P1830, DOI 10.1128/JVI.64.4.1830-1833.1990; BODKIN DK, 1989, J VIROL, V63, P4676, DOI 10.1128/JVI.63.11.4676-4681.1989; BORSA J, 1973, J VIROL, V11, P207, DOI 10.1128/JVI.11.2.207-217.1973; BORSA J, 1974, INTERVIROLOGY, V4, P171; BORSA J, 1974, INTERVIROLOGY, V3, P15, DOI 10.1159/000149739; BORSA J, 1979, J GEN VIROL, V45, P161, DOI 10.1099/0022-1317-45-1-161; BORSA J, 1973, J VIROL, V11, P552, DOI 10.1128/JVI.11.4.552-564.1973; BORSA J, 1976, BIOCHIM BIOPHYS ACTA, V451, P619, DOI 10.1016/0304-4165(76)90157-4; BORSA J, 1981, VIROLOGY, V111, P191, DOI 10.1016/0042-6822(81)90664-4; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; CHANG CT, 1971, VIROLOGY, V46, P544, DOI 10.1016/0042-6822(71)90058-4; Chappell JD, 2000, J VIROL, V74, P8472, DOI 10.1128/JVI.74.18.8472-8479.2000; Dermody T.S., 2013, FIELDS VIROLOGY, P1304; DERMODY TS, 1993, J VIROL, V67, P2055, DOI 10.1128/JVI.67.4.2055-2063.1993; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; GENTSCH JR, 1987, VIROLOGY, V161, P245, DOI 10.1016/0042-6822(87)90192-9; GENTSCH JR, 1985, J VIROL, V56, P356, DOI 10.1128/JVI.56.2.356-364.1985; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; JOKLIK WK, 1972, VIROLOGY, V49, P700, DOI 10.1016/0042-6822(72)90527-2; Kielian M, 2014, ANNU REV VIROL, V1, P171, DOI 10.1146/annurev-virology-031413-085521; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; LI QH, 1994, J VIROL, V68, P3965, DOI 10.1128/JVI.68.6.3965-3970.1994; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Luisoni S, 2015, CELL HOST MICROBE, V18, P75, DOI 10.1016/j.chom.2015.06.006; Maginnis MS, 2008, J VIROL, V82, P3181, DOI 10.1128/JVI.01612-07; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Mendez II, 2000, J VIROL METHODS, V90, P59, DOI 10.1016/S0166-0934(00)00217-2; Middleton JK, 2002, J VIROL, V76, P1051, DOI 10.1128/JVI.76.3.1051-1061.2002; Nibert ML, 2005, J MOL BIOL, V345, P461, DOI 10.1016/j.jmb.2004.10.026; NIBERT ML, 1991, J VIROL, V65, P1960, DOI 10.1128/JVI.65.4.1960-1967.1991; Nygaard RM, 2012, J VIROL, V86, P1238, DOI 10.1128/JVI.06429-11; Odegard AL, 2004, J VIROL, V78, P8732, DOI 10.1128/JVI.78.16.8732-8745.2004; Patel A, 2016, J BIOL CHEM, V291, P12408, DOI 10.1074/jbc.M115.700856; PAUL RW, 1989, VIROLOGY, V172, P382, DOI 10.1016/0042-6822(89)90146-3; Pollard EC., 1953, PHYSICS VIRUSES, P103, DOI [10.5962/bhl.title.10187, DOI 10.5962/BHL.TITLE.10187]; Sarkar P, 2010, J VIROL, V84, P12723, DOI 10.1128/JVI.01385-10; SILVERSTEIN SC, 1972, VIROLOGY, V47, P797, DOI 10.1016/0042-6822(72)90571-5; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; Snyder AJ, 2016, J VIROL, V90, P2628, DOI 10.1128/JVI.02997-15; STURZENBECKER LJ, 1987, J VIROL, V61, P2351, DOI 10.1128/JVI.61.8.2351-2361.1987; Tsai B, 2007, ANNU REV CELL DEV BI, V23, P23, DOI 10.1146/annurev.cellbio.23.090506.123454; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Wetzel JD, 1997, J VIROL, V71, P299, DOI 10.1128/JVI.71.1.299-306.1997; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Zhang L, 2009, J VIROL, V83, P7004, DOI 10.1128/JVI.00377-09; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002; Zhang X, 2005, STRUCTURE, V13, P1545, DOI 10.1016/j.str.2005.07.012; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	63	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26773	26785		10.1074/jbc.M116.747477	http://dx.doi.org/10.1074/jbc.M116.747477			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875299	Green Published, hybrid			2022-12-28	WOS:000391571400016
J	Kienitz, MC; Vladimirova, D; Muller, C; Pott, L; Rinne, A				Kienitz, Marie-Cecile; Vladimirova, Dilyana; Mueller, Christian; Pott, Lutz; Rinne, Andreas			Receptor Species-dependent Desensitization Controls KCNQ1/KCNE1 K+ Channels as Downstream Effectors of G(q) Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; MEDIATED DESENSITIZATION; QUANTITATIVE PROPERTIES; PHOSPHOLIPASE-C; PHOSPHORYLATION; PKC; ACTIVATION; INTERNALIZATION; MODULATION; MECHANISMS	Activation of G(q) protein-coupled receptors (G(q)PCRs) might induce divergent cellular responses, related to receptor-specific activation of different branches of the G(q) signaling pathway. Receptor-specific desensitization provides a mechanism of effector modulation by restricting the spatiotemporal activation of signaling components downstream of G(q). We quantified signaling events downstream of G(q)PCR activation with FRET-based biosensors in CHO and HEK 293 cells. KCNQ1/KCNE1 channels (I-Ks) were measured as a functional readout of receptor-specific activation. Activation of muscarinic M-1 receptors (M-1-Rs) caused robust and reversible inhibition of I-Ks. In contrast, activation of alpha(1B)-adrenergic receptors (alpha(1B)-ARs) induced transient inhibition of I-Ks, which turned into delayed facilitation after agonist withdrawal. As a novel finding, we demonstrate that G(q)PCR-specific kinetics of I-Ks modulation are determined by receptor-specific desensitization, evident at the level of G alpha(q) activation, phosphatidylinositol 4,5-bisphosphate (PIP2) depletion, and diacylglycerol production. Sustained I-Ks inhibition during M-1-R stimulation is attributed to robust membrane PIP2 depletion, whereas the rapid desensitization of alpha(1B)-AR delimits PIP2 reduction and augments current activation by protein kinase C(PKC). Overexpression of Ca2+-independent PKC delta did not affect the time course of alpha(1B)-AR-induced diacylglycerol formation, excluding a contribution of PKC delta to alpha(1B)-AR desensitization. Pharmacological inhibition of Ca2+-dependent PKC isoforms abolished fast alpha(1B) receptor desensitization and augmented I-Ks reduction, but did not affect I-Ks facilitation. These data indicate a contribution of Ca2+-dependent PKCs to alpha(1B)-AR desensitization, whereas I-Ks facilitation is induced by Ca2+-independent PKC isoforms. In contrast, neither inhibition of Ca2+-dependent/Ca2+-independent isoforms nor overexpression of PKC delta induced M-1 receptor desensitization, excluding a contribution of PKC to M-1-R-induced I-Ks modulation.	[Kienitz, Marie-Cecile; Vladimirova, Dilyana; Mueller, Christian; Pott, Lutz; Rinne, Andreas] Ruhr Univ Bochum, Inst Physiol, Univ Str 150, D-44780 Bochum, Germany	Ruhr University Bochum	Kienitz, MC (corresponding author), Ruhr Univ Bochum, Inst Physiol, Univ Str 150, D-44780 Bochum, Germany.	cecile.kienitz@rub.de	Rinne, Andreas/AAO-1685-2020; Rinne, Andreas/G-7986-2017	Rinne, Andreas/0000-0003-3535-2498; Rinne, Andreas/0000-0003-3535-2498; Pott, Lutz/0000-0002-4000-4132				Garcia-Sainz JA, 2011, IUBMB LIFE, V63, P811, DOI 10.1002/iub.519; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Bodmann EL, 2015, EUR J CELL BIOL, V94, P415, DOI 10.1016/j.ejcb.2015.06.004; Castillo-Badillo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121165; Chen XJ, 2014, CELLS-BASEL, V3, P247, DOI 10.3390/cells3020247; Cho H, 2005, P NATL ACAD SCI USA, V102, P15241, DOI 10.1073/pnas.0408851102; Dickson EJ, 2013, J GEN PHYSIOL, V141, P521, DOI 10.1085/jgp.201210886; Diviani D, 1997, J BIOL CHEM, V272, P28712, DOI 10.1074/jbc.272.45.28712; Diviani D, 1996, J BIOL CHEM, V271, P5049; Falkenburger BH, 2013, J GEN PHYSIOL, V141, P537, DOI 10.1085/jgp.201210887; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Garcia-Sainz JA, 2000, EUR J PHARMACOL, V389, P1, DOI 10.1016/S0014-2999(99)00896-1; Hertel F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020855; Hogue M, 2014, CELL SIGNAL, V26, P1213, DOI 10.1016/j.cellsig.2014.02.012; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Hui X, 2014, MOL CELL BIOL, V34, P2370, DOI 10.1128/MCB.00040-14; Iacovelli L, 1999, MOL PHARMACOL, V56, P316, DOI 10.1124/mol.56.2.316; Kienitz MC, 2015, CELL SIGNAL, V27, P1457, DOI 10.1016/j.cellsig.2015.04.002; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; LATTION AL, 1994, J BIOL CHEM, V269, P22887; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Matavel A, 2010, CHANNELS, V4, P3, DOI 10.4161/chan.4.1.10227; Matavel A, 2009, J MOL CELL CARDIOL, V46, P704, DOI 10.1016/j.yjmcc.2009.02.006; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; O-Uchi J, 2015, BIOCHEM BIOPH RES CO, V465, P464, DOI 10.1016/j.bbrc.2015.08.040; O-Uchi J, 2015, J MOL CELL CARDIOL, V79, P203, DOI 10.1016/j.yjmcc.2014.11.020; Perez-Aso M, 2013, BBA-MOL CELL RES, V1833, P2322, DOI 10.1016/j.bbamcr.2013.06.013; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Toews M. L., 2003, REGULATION ALPHAIB A; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; van Koppen CJ, 2003, PHARMACOL THERAPEUT, V98, P197, DOI 10.1016/S0163-7258(03)00032-9; Vazquez-Prado J, 2000, J BIOL CHEM, V275, P6553, DOI 10.1074/jbc.275.9.6553; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Violin JD, 2006, J BIOL CHEM, V281, P36411, DOI 10.1074/jbc.M607956200; Willets JM, 2007, J NEUROCHEM, V103, P2268, DOI 10.1111/j.1471-4159.2007.04931.x; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672; Zhong HY, 1999, EUR J PHARMACOL, V375, P261, DOI 10.1016/S0014-2999(99)00222-8	45	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26410	26426		10.1074/jbc.M116.746974	http://dx.doi.org/10.1074/jbc.M116.746974			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27834678	Green Published, hybrid			2022-12-28	WOS:000391568200015
J	Park, S; Kim, D; Kaneko, S; Szewczyk, KM; Nicosia, SV; Yu, H; Jove, R; Cheng, JQ				Park, Sungman; Kim, Donghwa; Kaneko, Satoshi; Szewczyk, Kristen M.; Nicosia, Santo V.; Yu, Hua; Jove, Richard; Cheng, Jin Q.			Molecular cloning and characterization of the human AKT1 promoter uncovers its up-regulation by the Src/Stat3 pathway (vol 280, pg 38932, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Park S, 2005, J BIOL CHEM, V280, P38932, DOI 10.1074/jbc.M504011200	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22844	22844		10.1074/jbc.A116.504011	http://dx.doi.org/10.1074/jbc.A116.504011			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825082	Green Published, hybrid			2022-12-28	WOS:000386760600043
J	Kognole, AA; Payne, CM				Kognole, Abhishek A.; Payne, Christina M.			Inhibition of Mammalian Glycoprotein YKL-40 IDENTIFICATION OF THE PHYSIOLOGICAL LIGAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING FREE-ENERGY; CRYSTAL-STRUCTURE; ARTICULAR CHONDROCYTES; MOLECULAR-STRUCTURE; EPITHELIAL-CELLS; STRUCTURAL BASIS; SYNOVIAL-FLUID; SERUM YKL-40; FORCE-FIELD; I COLLAGEN	YKL-40 is a mammalian glycoprotein associated with progression, severity, and prognosis of chronic inflammatory diseases and a multitude of cancers. Despite this well documented association, identification of the lectin's physiological ligand and, accordingly, biological function has proven experimentally difficult. YKL-40 has been shown to bind chito-oligosaccharides; however, the production of chitin by the human body has not yet been documented. Possible alternative ligands include proteoglycans, polysaccharides, and fibers like collagen, all of which makeup the extracellular matrix. It is likely that YKL-40 is interacting with these alternative polysaccharides or proteins within the body, extending its function to cell biological roles such as mediating cellular receptors and cell adhesion and migration. Here, we consider the feasibility of polysaccharides, including cello-oligosaccharides, hyaluronan, heparan sulfate, heparin, and chondroitin sulfate, and collagen-like peptides as physiological ligands for YKL-40. We use molecular dynamics simulations to resolve the molecular level recognition mechanisms and calculate the free energy of binding the hypothesized ligands to YKL-40, addressing thermodynamic preference relative to chito-oligosaccharides. Our results suggest that chitohexaose and hyaluronan preferentially bind to YKL-40 over collagen, and hyaluronan is likely the preferred physiological ligand, because the negatively charged hyaluronan shows enhanced affinity for YKL-40 over neutral chitohexaose. Collagen binds in two locations at the YKL-40 surface, potentially related to a role in fibrillar formation. Finally, heparin non-specifically binds at the YKL-40 surface, as predicted from structural studies. Overall, YKL-40 likely binds many natural ligands in vivo, but its concurrence with physical maladies may be related to associated increases in hyaluronan.	[Kognole, Abhishek A.; Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, 177 F Paul Anderson Tower, Lexington, KY 40506 USA	University of Kentucky	Payne, CM (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, 177 F Paul Anderson Tower, Lexington, KY 40506 USA.	christy.payne@uky.edu	Payne, Christina/ABE-8330-2020; Kognole, Abhishek A./AAB-5491-2019	Payne, Christina/0000-0001-5264-0964; Kognole, Abhishek A./0000-0002-6033-2344	Kentucky Science and Engineering Foundation [KSEF-148-502-13-307]; National Science Foundation [ACI-1053575, MCB090159]	Kentucky Science and Engineering Foundation; National Science Foundation(National Science Foundation (NSF))	This work was supported by Kentucky Science and Engineering Foundation Grant KSEF-148-502-13-307). Computational time for this research was provided by the Extreme Science and Engineering Discovery Environment (83), which is supported by National Science Foundation Grant ACI-1053575 under Allocation MCB090159. The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANGYAL SJ, 1969, ANGEW CHEM INT EDIT, V8, P157, DOI 10.1002/anie.196901571; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bigg HF, 2006, J BIOL CHEM, V281, P21082, DOI 10.1074/jbc.M601153200; Bleau G, 1999, EXS, V87, P211; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Bronowska AK, 2011, THERMODYNAMICS - INTERACTION STUDIES - SOLIDS, LIQUIDS AND GASES, P1; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Connor JR, 2000, OSTEOARTHR CARTILAGE, V8, P87, DOI 10.1053/joca.1999.0276; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; De Ceuninck F, 1998, J CELL BIOCHEM, V69, P414, DOI 10.1002/(SICI)1097-4644(19980615)69:4<414::AID-JCB3>3.0.CO;2-Q; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; EMSLEY J, 1980, CHEM SOC REV, V9, P91, DOI 10.1039/cs9800900091; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hamre AG, 2015, BIOCHEMISTRY-US, V54, P7292, DOI 10.1021/acs.biochem.5b00830; Hamre AG, 2015, J PHYS CHEM B, V119, P9601, DOI 10.1021/acs.jpcb.5b03817; Harvey S, 1998, CLIN CHEM, V44, P509; Houston DR, 2003, J BIOL CHEM, V278, P30206, DOI 10.1074/jbc.M303371200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Iwata T, 2009, BIOCHEM BIOPH RES CO, V388, P511, DOI 10.1016/j.bbrc.2009.08.024; Jiang W, 2010, J CHEM THEORY COMPUT, V6, P2559, DOI 10.1021/ct1001768; Jiang W, 2009, J CHEM THEORY COMPUT, V5, P2583, DOI 10.1021/ct900223z; Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553; JOHANSEN JS, 1993, BRIT J RHEUMATOL, V32, P949; Johansen JS, 2006, DAN MED BULL, V53, P172; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Lal A, 1999, CANCER RES, V59, P5403; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Liu LK, 2014, ACTA CRYSTALLOGR F, V70, P1155, DOI 10.1107/S2053230X14015532; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Mayne CG, 2013, J COMPUT CHEM, V34, P2757, DOI 10.1002/jcc.23422; Meyer MF, 1996, P NATL ACAD SCI USA, V93, P4543, DOI 10.1073/pnas.93.10.4543; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Mohanty AK, 2003, J BIOL CHEM, V278, P14451, DOI 10.1074/jbc.M208967200; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; Okuyama K, 2012, BIOPOLYMERS, V97, P607, DOI 10.1002/bip.22048; Park JA, 2010, J BIOL CHEM, V285, P29817, DOI 10.1074/jbc.M110.103416; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Semino CE, 1996, P NATL ACAD SCI USA, V93, P4548, DOI 10.1073/pnas.93.10.4548; Sheinerman FB, 1998, J MOL BIOL, V278, P439, DOI 10.1006/jmbi.1998.1688; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Siaens R, 2004, J NUCL MED, V45, P1209; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; ul-Haq Z, 2007, BIOCHEM BIOPH RES CO, V359, P221, DOI 10.1016/j.bbrc.2007.05.074; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	81	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2624	2636		10.1074/jbc.M116.764985	http://dx.doi.org/10.1074/jbc.M116.764985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28053085	hybrid, Green Published			2022-12-28	WOS:000395535100006
J	Kuan, YC; Hashidume, T; Shibata, T; Uchida, K; Shimizu, M; Inoue, J; Sato, R				Kuan, Yen-Chou; Hashidume, Tsutomu; Shibata, Takahiro; Uchida, Koji; Shimizu, Makoto; Inoue, Jun; Sato, Ryuichiro			Heat Shock Protein 90 Modulates Lipid Homeostasis by Regulating the Stability and Function of Sterol Regulatory Element-binding Protein (SREBP) and SREBP Cleavage-activating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER; PPAR-GAMMA; HSP90; SCAP; INHIBITION; METABOLISM; COMPLEXES; REVEALS; DOMAINS; CELLS	Sterol regulatory element-binding proteins (SREBPs) are the key transcription factors that modulate lipid biosynthesis. SREBPs are synthesized as endoplasmic reticulum-bound precursors that require proteolytic activation in the Golgi apparatus. The stability and maturation of precursor SREBPs depend on their binding to SREBP cleavage-activating protein (SCAP), which escorts the SCAP-SREBP complex to the Golgi apparatus. In this study, we identified heat shock protein (HSP) 90 as a novel SREBP regulator that binds to and stabilizes SCAP-SREBP. In HepG2 cells, HSP90 inhibition led to proteasome-dependent degradation of SCAP-SREBP, which resulted in the down-regulation of SREBP target genes and the reduction in intracellular triglyceride and cholesterol levels. Wealso demonstrated in vivo that HSP90 inhibition decreased SCAP-SREBP protein, down-regulated SREBP target genes, and reduced lipids levels in mouse livers. We propose that HSP90 plays an indispensable role in SREBP regulation by stabilizing the SCAP-SREBP complex, facilitating the activation of SREBP to maintain lipids homeostasis.	[Kuan, Yen-Chou; Hashidume, Tsutomu; Shimizu, Makoto; Inoue, Jun; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Food Biochem Lab, Tokyo 1138657, Japan; [Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Nutri Life Sci Lab, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Sato, Ryuichiro] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo 1000004, Japan	University of Tokyo; University of Tokyo; Nagoya University	Sato, R (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp	; Shibata, Takahiro/I-6872-2014	Kuan, Yen-Chou/0000-0001-6870-0685; Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	JSPS KAKENHI [15H05781]; Cross-ministerial Strategic Innovation Promotion Program [14533567]; Japanese Agency for Medical Research and Development [16gm0910008h0001]; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research [17F17100] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cross-ministerial Strategic Innovation Promotion Program; Japanese Agency for Medical Research and Development; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (S) 15H05781, Cross-ministerial Strategic Innovation Promotion Program Grant 14533567, and Japanese Agency for Medical Research and Development Grant 16gm0910008h0001 (to R.S.), and a Research Grant from the Tojuro Iijima Foundation for Food Science and Technology (to Y.-C.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ambade A, 2014, J HEPATOL, V61, P903, DOI 10.1016/j.jhep.2014.05.024; Bhat R, 2014, J MED CHEM, V57, P8718, DOI 10.1021/jm500823a; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chehab M, 2015, ONCOTARGET, V6, P8454, DOI 10.18632/oncotarget.3502; Chen CY, 2006, MOL BIOL CELL, V17, P3494, DOI 10.1091/mbc.E05-12-1096; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Cheng CM, 2015, CANCER CELL, V28, P569, DOI 10.1016/j.ccell.2015.09.021; Donnelly BF, 2013, J BIOL CHEM, V288, P13124, DOI 10.1074/jbc.M113.455394; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gong X, 2016, CELL RES, V26, P1197, DOI 10.1038/cr.2016.123; Inoue Jun, 2013, Biomol Concepts, V4, P417, DOI 10.1515/bmc-2013-0009; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kim HR, 1999, IUBMB LIFE, V48, P429, DOI 10.1080/713803536; Li JJ, 2016, ONCOTARGET, V7, P52392, DOI 10.18632/oncotarget.10721; Miyata S, 2015, J BIOL CHEM, V290, P20565, DOI 10.1074/jbc.M115.656975; Nguyen MT, 2013, CELL DEATH DIFFER, V20, P1654, DOI 10.1038/cdd.2013.129; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Proia DA, 2015, CANCER IMMUNOL RES, V3, P583, DOI 10.1158/2326-6066.CIR-15-0057; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Ru P, 2016, CELL REP, V16, P1527, DOI 10.1016/j.celrep.2016.07.017; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Shao W, 2014, J BIOL CHEM, V289, P7547, DOI 10.1074/jbc.M113.545699; Stankiewicz Marta, 2012, Biomol Concepts, V3, P79, DOI 10.1515/bmc.2011.054; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wheeler MC, 2014, J LIPID RES, V55, P1702, DOI 10.1194/jlr.M048918; Ye J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004754; Zhang L, 2014, ONCOTARGET, V5, P1132, DOI 10.18632/oncotarget.1584; Zhang YX, 2016, J BIOL CHEM, V291, P12888, DOI 10.1074/jbc.M116.729798; Zhang YX, 2013, J BIOL CHEM, V288, P14059, DOI 10.1074/jbc.M113.469528	34	43	44	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3016	3028		10.1074/jbc.M116.767277	http://dx.doi.org/10.1074/jbc.M116.767277			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28003358	Green Published, hybrid			2022-12-28	WOS:000395535100040
J	Draheim, KM; Huet-Calderwood, C; Simon, B; Calderwood, DA				Draheim, Kyle M.; Huet-Calderwood, Clotilde; Simon, Bertrand; Calderwood, David A.			Nuclear Localization of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP1) Influences (SS)1 Integrin Activation and Recruits Krev/Interaction Trapped-1 (KRIT1) to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell compartmentalization; cerebral cavernous malformation; integrin; KRIT1 (Krev interaction trapped); protein targeting; ICAP1 (integrin cytoplasmic domain-associated protein)	CEREBRAL CAVERNOUS MALFORMATIONS; VASCULAR INTEGRITY; CCM PATHOGENESIS; RHO KINASE; CELL; COMPLEX; BINDING; RAP1; FIBRONECTIN; PROLIFERATION	Binding of ICAP1 (integrin cytoplasmic domain-associated protein-1) to the cytoplasmic tails of 1 integrins inhibits integrin activation. ICAP1 also binds to KRIT1 (Krev interaction trapped-1), a protein whose loss of function leads to cerebral cavernous malformation, a cerebrovascular dysplasia occurring in up to 0.5% of the population. We previously showed that KRIT1 functions as a switch for 1 integrin activation by antagonizing ICAP1-mediated inhibition of integrin activation. Here we use overexpression studies, mutagenesis, and flow cytometry to show that ICAP1 contains a functional nuclear localization signal and that nuclear localization impairs the ability of ICAP1 to suppress integrin activation. Moreover, we find that ICAP1 drives the nuclear localization of KRIT1 in a manner dependent upon a direct ICAP1/KRIT1 interaction. Thus, nuclear-cytoplasmic shuttling of ICAP1 influences both integrin activation and KRIT1 localization, presumably impacting nuclear functions of KRIT1.	[Draheim, Kyle M.; Huet-Calderwood, Clotilde; Simon, Bertrand; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University	Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol & Cell Biol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142; Simon, Bertrand/0000-0002-1825-053X	National Institutes of Health Grants [R01NS085078, F32HL127948]; American Cancer Society Grant [122171-PF-12-051-01-CSM]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL127948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085078] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Grant(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01NS085078 (to D. A. C.) and F32HL127948 ( to K. M. D.) and by American Cancer Society Grant 122171-PF-12-051-01-CSM (to K. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Baycin-Hizal D, 2012, J PROTEOME RES, V11, P5265, DOI 10.1021/pr300476w; Beraud-Dufour S, 2007, FEBS J, V274, P5518, DOI 10.1111/j.1742-4658.2007.06068.x; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Bouvard D, 2006, EUR J CELL BIOL, V85, P275, DOI 10.1016/j.ejcb.2005.10.005; Bouvard D, 2003, J BIOL CHEM, V278, P6567, DOI 10.1074/jbc.M211258200; Bouvard D, 2007, DEVELOPMENT, V134, P2615, DOI 10.1242/dev.000877; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cavalcanti DD, 2012, J NEUROSURG, V116, P122, DOI 10.3171/2011.8.JNS101241; Draheim KM, 2014, J CELL SCI, V127, P701, DOI 10.1242/jcs.138388; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Faurobert E, 2013, J CELL BIOL, V202, P545, DOI 10.1083/jcb.201303044; Fisher OS, 2014, CELL MOL LIFE SCI, V71, P1881, DOI 10.1007/s00018-013-1532-9; Fournier HN, 2005, MOL BIOL CELL, V16, P1859, DOI 10.1091/mbc.E04-08-0744; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Gingras AR, 2013, J BIOL CHEM, V288, P23639, DOI 10.1074/jbc.M113.462911; Gingras AR, 2012, J CELL BIOL, V199, P39, DOI 10.1083/jcb.201205109; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Liu WZ, 2013, ACTA CRYSTALLOGR F, V69, P494, DOI 10.1107/S1744309113010762; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Marzo S, 2014, EUR J HISTOCHEM, V58, P62, DOI 10.4081/ejh.2014.2358; McDonald DA, 2014, HUM MOL GENET, V23, P4357, DOI 10.1093/hmg/ddu153; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Millon-Fremillon A, 2013, J BIOL CHEM, V288, P20248, DOI 10.1074/jbc.M113.455956; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Pozzati E, 1996, NEUROSURGERY, V38, P662, DOI 10.1227/00006123-199604000-00006; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Riant F, 2013, NEUROGENETICS, V14, P133, DOI 10.1007/s10048-013-0362-0; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Shaiken TE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04923; Stahl S, 2008, HUM MUTAT, V29, P709, DOI 10.1002/humu.20712; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Tanriover G, 2013, CLIN NEUROL NEUROSUR, V115, P438, DOI 10.1016/j.clineuro.2012.06.023; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; Tu X, 2002, J BIOL CHEM, V277, P44357, DOI 10.1074/jbc.M208001200; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Ye F, 2014, FRONT MED-PRC, V8, P6, DOI 10.1007/s11684-014-0317-3; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2008, NEUROSURGERY, V63, P571, DOI 10.1227/01.NEU.0000325255.30268.B0; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	61	15	16	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1884	1898		10.1074/jbc.M116.762393	http://dx.doi.org/10.1074/jbc.M116.762393			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28003363	hybrid, Green Published			2022-12-28	WOS:000395515600028
J	Galon-Tilleman, H; Yang, H; Bednarek, MA; Spurlock, SM; Paavola, KJ; Ko, B; To, C; Luo, J; Tian, H; Jermutus, L; Grimsby, J; Rondinone, CM; Konkar, A; Kaplan, DD				Galon-Tilleman, Hadas; Yang, Hong; Bednarek, Maria A.; Spurlock, Sandra M.; Paavola, Kevin J.; Ko, Brian; To, Carmen; Luo, Jian; Tian, Hui; Jermutus, Lutz; Grimsby, Joseph; Rondinone, Cristina M.; Konkar, Anish; Kaplan, Daniel D.			Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular; diabetes; G protein-coupled receptor (GPCR); metabolic syndrome; obesity; signal transduction; apelin; APJ; ligand-receptor promiscuity; metabolic syndrome	HEART-FAILURE; CARDIOVASCULAR FUNCTION; ENDOGENOUS LIGAND; HETERODIMERIZATION; ANTAGONIZES; PEPTIDE; BINDING; ROLES	Apelin-36 was discovered as the endogenous ligand for the previously orphan receptor APJ. Apelin-36 has been linked to two major types of biological activities: cardiovascular (stimulation of cardiac contractility and suppression of blood pressure) and metabolic (improving glucose homeostasis and lowering body weight). It has been assumed that both of these activities are modulated through APJ. Here, we demonstrate that the metabolic activity of apelin-36 can be separated from canonical APJ activation. We developed a series of apelin-36 variants in which evolutionarily conserved residues were mutated, and evaluated their ability to modulate glucose homeostasis and body weight in chronic mouse models. We found that apelin-36(L28A) retains full metabolic activity, but is 100-fold impaired in its ability to activate APJ. In contrast to its full metabolic activity, apelin-36(L28A) lost the ability to suppress blood pressure in spontaneously hypertensive rats (SHR). We took advantage of these findings to develop a longer-acting variant of apelin-36 that could modulate glucose homeostasis without impacting blood pressure (or activating APJ). Apelin-36-[L28C(30kDa-PEG)] is 10,000-fold less potent than apelin-36 at activating the APJ receptor but retains its ability to significantly lower blood glucose and improve glucose tolerance in diet-induced obese mice. Apelin-36-[L28C(30kDa-PEG)] provides a starting point for the development of diabetes therapeutics that are devoid of the blood pressure effects associated with canonical APJ activation.	[Galon-Tilleman, Hadas; Yang, Hong; Spurlock, Sandra M.; Paavola, Kevin J.; Ko, Brian; To, Carmen; Luo, Jian; Tian, Hui; Kaplan, Daniel D.] NGM Biopharmaceut, 333 Oyster Point Blvd, South San Francisco, CA 94080 USA; [Bednarek, Maria A.; Jermutus, Lutz] MedImmune Ltd, Dept Antibody Discovery & Prot Engn, Cambridge CB21 6GH, England; [Grimsby, Joseph; Rondinone, Cristina M.; Konkar, Anish] MedImmune LLC, Dept Cardiovasc & Metab Dis Res, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Kaplan, DD (corresponding author), NGM Biopharmaceut, 333 Oyster Point Blvd, South San Francisco, CA 94080 USA.	dkaplan@ngmbio.com	Jermutus, Lutz/AAU-2047-2020	Kaplan, Daniel/0000-0001-8297-560X				Bai B, 2014, J CELL MOL MED, V18, P2071, DOI 10.1111/jcmm.12404; Bai B, 2014, CELL SIGNAL, V26, P1549, DOI 10.1016/j.cellsig.2014.03.022; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Ceraudo E, 2014, J BIOL CHEM, V289, P24599, DOI 10.1074/jbc.M113.541698; Chandrasekaran B, 2008, EUR J HEART FAIL, V10, P725, DOI 10.1016/j.ejheart.2008.06.002; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; Fan XJ, 2003, BIOCHEMISTRY-US, V42, P10163, DOI 10.1021/bi030049s; Fonseca VA, 2009, DIABETES CARE, V32, pS151, DOI 10.2337/dc09-S301; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; International Diabetes Federation, 2015, IDF DIABETES ATLAS, P50; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Jia ZQ, 2012, PEPTIDES, V38, P181, DOI 10.1016/j.peptides.2012.09.003; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; Murza A, 2012, CHEMMEDCHEM, V7, P318, DOI 10.1002/cmdc.201100492; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Yang PR, 2015, TRENDS PHARMACOL SCI, V36, P560, DOI 10.1016/j.tips.2015.06.002; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	33	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1925	1933		10.1074/jbc.M116.748103	http://dx.doi.org/10.1074/jbc.M116.748103			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994053	Green Published, hybrid			2022-12-28	WOS:000395515600031
J	Timm, KN; Hu, DE; Williams, M; Wright, AJ; Kettunen, MI; Kennedy, BWC; Larkin, TJ; Dzien, P; Marco-Rius, I; Bohndiek, SE; Brindle, KM				Timm, Kerstin N.; Hu, De-En; Williams, Michael; Wright, Alan J.; Kettunen, Mikko I.; Kennedy, Brett W. C.; Larkin, Timothy J.; Dzien, Piotr; Marco-Rius, Irene; Bohndiek, Sarah E.; Brindle, Kevin M.			Assessing Oxidative Stress in Tumors by Measuring the Rate of Hyperpolarized [1-C-13]Dehydroascorbic Acid Reduction Using C-13 Magnetic Resonance Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX STATUS; VITAMIN-C; IN-VIVO; GLUTATHIONE SYNTHESIS; DEHYDROASCORBIC ACID; BUTHIONINE SULFOXIMINE; TETRAZOLIUM SALT; CELL METABOLISM; CONTRAST AGENTS; CANCER	Rapid cancer cell proliferation promotes the production of reducing equivalents, which counteract the effects of relatively high levels of reactive oxygen species. Reactive oxygen species levels increase in response to chemotherapy and cell death, whereas an increase in antioxidant capacity can confer resistance to chemotherapy and is associated with an aggressive tumor phenotype. The pentose phosphate pathway is a major site of NADPH production in the cell, which is used to maintain the main intracellular antioxidant, glutathione, in its reduced state. Previous studies have shown that the rate of hyperpolarized [1-C-13]dehydroascorbic acid (DHA) reduction, which can be measured in vivo using non-invasive C-13 magnetic resonance spectroscopic imaging, is increased in tumors and that this is correlated with the levels of reduced glutathione. We show here that the rate of hyperpolarized [1-C-13]DHA reduction is increased in tumors that have been oxidatively prestressed by depleting the glutathione pool by buthionine sulfoximine treatment. This increase was associated with a corresponding increase in pentose phosphate pathway flux, assessed using C-13-labeled glucose, and an increase in glutaredoxin activity, which catalyzes the glutathione-dependent reduction of DHA. These results show that the rate of DHA reduction depends not only on the level of reduced glutathione, but also on the rate of NADPH production, contradicting the conclusions of some previous studies. Hyperpolarized [1-C-13]DHA can be used, therefore, to assess the capacity of tumor cells to resist oxidative stress in vivo. However, DHA administration resulted in transient respiratory arrest and cardiac depression, which may prevent translation to the clinic.	[Timm, Kerstin N.; Hu, De-En; Kettunen, Mikko I.; Kennedy, Brett W. C.; Larkin, Timothy J.; Dzien, Piotr; Marco-Rius, Irene; Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 0RE, England; [Timm, Kerstin N.; Hu, De-En; Williams, Michael; Wright, Alan J.; Kettunen, Mikko I.; Kennedy, Brett W. C.; Larkin, Timothy J.; Dzien, Piotr; Marco-Rius, Irene; Bohndiek, Sarah E.; Brindle, Kevin M.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Bohndiek, Sarah E.] Univ Cambridge, Dept Phys, Cambridge CB2 0RE, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Brindle, KM (corresponding author), Canc Res UK, Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	kmb1001@cam.ac.uk	Bohndiek, Sarah/S-9416-2019; Kettunen, Mikko I/K-2299-2012; Marco-Rius, Irene/ABB-5520-2020; Timm, Kerstin/AAW-7262-2020	Kettunen, Mikko I/0000-0002-2004-660X; Marco-Rius, Irene/0000-0001-5076-8526; Timm, Kerstin/0000-0001-9136-7518; Bohndiek, Sarah/0000-0003-0371-8635	Medical Research Council and Cancer Research UK; Cancer Research UK; European Union Seventh Framework Programme [FP7/2007-2013, 264780]; Cancer Research UK Programme [C14303/A17197]; CRUK-EPSRC Imaging Centre in Cambridge and Manchester [C197/A16465]; Cancer Research UK [16465, 17242] Funding Source: researchfish	Medical Research Council and Cancer Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Union Seventh Framework Programme(European Commission); Cancer Research UK Programme(Cancer Research UK); CRUK-EPSRC Imaging Centre in Cambridge and Manchester(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK)	Recipient of Medical Research Council and Cancer Research UK studentships.; Recipient of a Cancer Research UK studentship.; Supported by European Union Seventh Framework Programme Grant FP7/2007-2013 under the Marie Curie Initial Training Network METAFLUX (Project 264780).; Work in this author's laboratory is supported by Cancer Research UK Programme Grant C14303/A17197 and the CRUK-EPSRC Imaging Centre in Cambridge and Manchester (Grant C197/A16465).	Agus DB, 1999, CANCER RES, V59, P4555; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bobko AA, 2012, MAGN RESON MED, V67, P1827, DOI 10.1002/mrm.23196; Bohndiek SE, 2011, J AM CHEM SOC, V133, P11795, DOI 10.1021/ja2045925; Boren J, 2001, J BIOL CHEM, V276, P37747; BRITTEN RA, 1992, INT J RADIAT ONCOL, V22, P769, DOI 10.1016/0360-3016(92)90521-I; BURDON RH, 1993, FREE RADICAL RES COM, V18, P369, DOI 10.3109/10715769309147503; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cisternas P, 2014, J NEUROCHEM, V129, P663, DOI 10.1111/jnc.12663; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Couto N, 2016, FREE RADICAL BIO MED, V95, P27, DOI 10.1016/j.freeradbiomed.2016.02.028; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Do QN, 2014, CHEMMEDCHEM, V9, P1116, DOI 10.1002/cmdc.201402034; Fiorani M, 2013, J NUTR BIOCHEM, V24, P467, DOI 10.1016/j.jnutbio.2012.01.009; Fritz H, 2014, INTEGR CANCER THER, V13, P280, DOI 10.1177/1534735414534463; Galaris D, 1997, FREE RADICAL BIO MED, V22, P657, DOI 10.1016/S0891-5849(96)00382-6; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Halliwell B., 2007, FREE RADICAL BIO MED, P162; Harris T, 2013, NMR BIOMED, V26, P1831, DOI 10.1002/nbm.3024; Hyodo F, 2008, J PHARM PHARMACOL, V60, P1049, DOI 10.1211/jpp.60.8.0011; Ilangovan G, 2002, MOL CELL BIOCHEM, V234, P393, DOI 10.1023/A:1015967305659; Kaiser LG, 2010, J MAGN RESON, V202, P259, DOI 10.1016/j.jmr.2009.11.013; Keller MA, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.20145228; Keshari KR, 2015, DIABETES, V64, P344, DOI 10.2337/db13-1829; Keshari KR, 2013, J NUCL MED, V54, P922, DOI 10.2967/jnumed.112.115402; Keshari KR, 2011, P NATL ACAD SCI USA, V108, P18606, DOI 10.1073/pnas.1106920108; Kim JH, 2014, RADIAT ONCOL J, V32, P103, DOI 10.3857/roj.2014.32.3.103; Kuppusamy P, 2002, CANCER RES, V62, P307; Lau ATY, 2008, J CELL BIOCHEM, V104, P657, DOI 10.1002/jcb.21655; Li LZ, 2012, J BIOENERG BIOMEMBR, V44, P645, DOI 10.1007/s10863-012-9469-5; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Lumata L, 2011, PHYS MED BIOL, V56, pN85, DOI 10.1088/0031-9155/56/5/N01; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; May JM, 1996, FREE RADICAL BIO MED, V20, P543, DOI 10.1016/0891-5849(95)02130-2; Meier S, 2011, MOL BIOSYST, V7, P2834, DOI 10.1039/c1mb05202k; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Okazawa H, 2014, Q J NUCL MED MOL IM, V58, P387; PATTERSON JW, 1951, AM J PHYSIOL, V167, P119, DOI 10.1152/ajplegacy.1951.167.1.119; RAAP AK, 1983, HISTOCHEM J, V15, P977, DOI 10.1007/BF01002493; Raftos JE, 2010, J BIOL CHEM, V285, P23557, DOI 10.1074/jbc.M109.067017; Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; RUSSO A, 1986, CANCER RES, V46, P2845; Savini I, 2000, BIOCHEM J, V345, P665, DOI 10.1042/0264-6021:3450665; Song JH, 2001, BRAIN RES, V895, P66, DOI 10.1016/S0006-8993(01)02029-7; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Timm KN, 2015, MAGN RESON MED, V74, P1543, DOI 10.1002/mrm.25561; Witney TH, 2010, BRIT J CANCER, V103, P1400, DOI 10.1038/sj.bjc.6605945; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727; Witney TH, 2010, BIOCHEM SOC T, V38, P1220, DOI 10.1042/BST0381220; Zhu PJ, 2008, RAPID COMMUN MASS SP, V22, P432, DOI 10.1002/rcm.3380; Zitka O, 2012, ONCOL LETT, V4, P1247, DOI 10.3892/ol.2012.931	57	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1737	1748		10.1074/jbc.M116.761536	http://dx.doi.org/10.1074/jbc.M116.761536			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994059	hybrid, Green Published			2022-12-28	WOS:000395515600016
J	Zhao, X; Khurana, S; Charkraborty, S; Tian, YQ; Sedor, JR; Bruggman, LA; Kao, HY				Zhao, Xuan; Khurana, Simran; Charkraborty, Sharmistha; Tian, Yuqian; Sedor, John R.; Bruggman, Leslie A.; Kao, Hung-Ying			Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucocorticoid receptor; podocyte; transcription coactivator; transcription corepressor; translation control; actinin 4; podocyte; transactivation; transrepression	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; HEAT-SHOCK PROTEINS; GLOMERULAR-DISEASES; NEPHROTIC SYNDROME; ALPHA-ACTININ-4; GENES; ALPHA; TRANSCRIPTION; MECHANISMS; MUTATIONS	Glucocorticoids are a general class of steroids that possess renoprotective activity in glomeruli through their interaction with the glucocorticoid receptor. However, the mechanisms by which glucocorticoids ameliorate proteinuria and glomerular disease are not well understood. In this study, we demonstrated that actinin 4 (ACTN4), an actin-cross-linking protein known to coordinate cytoskeletal organization, interacts with the glucocorticoid receptor (GR) in the nucleus of human podocytes (HPCs), a key cell type in the glomerulus critical for kidney filtration function. The GR-ACTN4 complex enhances glucocorticoid response element (GRE)-driven reporter activity. Stable knockdown of ACTN4 by shRNA in HPCs significantly reduces dexamethasone-mediated induction of GR target genes and GRE-driven reporter activity without disrupting dexamethasone-induced nuclear translocation of GR. Synonymous mutations or protein expression losses in ACTN4 are associated with kidney diseases, including focal segmental glomerulosclerosis, characterized by proteinuria and podocyte injury. We found that focal segmental glomerulosclerosis-linked ACTN4 mutants lose their ability to bind liganded GR and support GRE-mediated transcriptional activity. Mechanistically, GR and ACTN4 interact in the nucleus of HPCs. Furthermore, disruption of the LXXLL nuclear receptor-interacting motif present in ACTN4 results in reduced GR interaction and dexamethasone-mediated transactivation of a GRE reporter while still maintaining its actin-binding activity. In contrast, an ACTN4 isoform, ACTN4 (Iso), that loses its actin-binding domain is still capable of potentiating a GRE reporter. Dexamethasone induces the recruitment of ACTN4 and GR to putative GREs in dexamethasone-transactivated promoters, SERPINE1, ANGPLT4, CCL20, and SAA1 as well as the NF-B (p65) binding sites on GR-transrepressed promoters such as IL-1, IL-6, and IL-8. Taken together, our data establish ACTN4 as a transcriptional co-regulator that modulates both dexamethasone-transactivated and -transrepressed genes in podocytes.	[Zhao, Xuan; Khurana, Simran; Charkraborty, Sharmistha; Tian, Yuqian; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Sedor, John R.; Bruggman, Leslie A.] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Educ & Res, Cleveland, OH 44106 USA; [Sedor, John R.; Bruggman, Leslie A.] Case Western Reserve Univ, Sch Med, Dept Med, MetroHlth Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System	Kao, HY (corresponding author), Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu			National Institutes of Health [R01 DK078965]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK078965. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An HT, 2014, J BIOL CHEM, V289, P4969, DOI 10.1074/jbc.M113.515395; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bose B, 2014, CLIN J AM SOC NEPHRO, V9, P626, DOI 10.2215/CJN.05810513; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Cheng XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060213; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Coppo R, 2013, CONTRIB NEPHROL, V181, P84, DOI 10.1159/000348637; Dai SC, 2010, NEPHROL DIAL TRANSPL, V25, P824, DOI 10.1093/ndt/gfp394; Dai SC, 2009, NEPHRON CLIN PRACT, V111, pC87, DOI 10.1159/000191198; De Bosscher K, 2000, J NEUROIMMUNOL, V109, P16, DOI 10.1016/S0165-5728(00)00297-6; Eichler TE, 2005, TOXICOL SCI, V84, P120, DOI 10.1093/toxsci/kfi048; Feng D, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0036-8; Gershoni-Baruch R, 2003, ARTHRITIS RHEUM, V48, P1149, DOI 10.1002/art.10944; Grgic I, 2014, KIDNEY INT, V86, P1116, DOI 10.1038/ki.2014.204; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Huang Y, 2008, J AM SOC NEPHROL, V19, P329, DOI 10.1681/ASN.2007040510; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Khurana S, 2012, J BIOL CHEM, V287, P35418, DOI 10.1074/jbc.M112.401364; Khurana S, 2012, J BIOL CHEM, V287, P12027, DOI 10.1074/jbc.M112.345421; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Korbet SM, 2012, J AM SOC NEPHROL, V23, P1769, DOI 10.1681/ASN.2012040389; Korbet SM, 2012, CLIN J AM SOC NEPHRO, V7, P1545, DOI 10.2215/CJN.08290812; Liu ZM, 2011, J BIOL CHEM, V286, P30795, DOI 10.1074/jbc.M111.255984; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Pani A, 2013, AUTOIMMUN REV, V12, P848, DOI 10.1016/j.autrev.2012.11.012; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Smith LJ, 1996, ARCH INTERN MED, V156, P2181, DOI 10.1001/archinte.156.19.2181; Thorn CF, 2003, EUR J IMMUNOL, V33, P2630, DOI 10.1002/eji.200323985; Villa L, 2013, J PATHOL, V229, P672, DOI 10.1002/path.4151; Wada T, 2005, J AM SOC NEPHROL, V16, P2615, DOI 10.1681/ASN.2005020142; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167; Zahran AM, 2014, RENAL FAILURE, V36, P1067, DOI 10.3109/0886022X.2014.917936; Zhao X, 2015, J BIOL CHEM, V290, P338, DOI 10.1074/jbc.M114.597260	39	23	25	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1637	1647		10.1074/jbc.M116.755546	http://dx.doi.org/10.1074/jbc.M116.755546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27998979	Green Published, hybrid			2022-12-28	WOS:000395515600009
J	Sweeney, CG; Tremblay, BP; Stockner, T; Sitte, HH; Melikian, HE				Sweeney, Carolyn G.; Tremblay, Bradford P.; Stockner, Thomas; Sitte, Harald H.; Melikian, Haley E.			Dopamine Transporter Amino and Carboxyl Termini Synergistically Contribute to Substrate and Inhibitor Affinities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SEROTONIN TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; PROTEIN-KINASE; C-TERMINUS; N-TERMINUS; SALT BRIDGE; RESIDUES; INTERNALIZATION; AMPHETAMINES	Extracellular dopamine and serotonin concentrations are determined by the presynaptic dopamine (DAT) and serotonin (SERT) transporters, respectively. Numerous studies have investigated the DAT and SERT structural elements contributing to inhibitor and substrate binding. To date, crystallographic studies have focused on conserved transmembrane domains, where multiple substrate binding and translocation features are conserved. However, it is unknown what, if any, role the highly divergent intracellular N and C termini contribute to these processes. Here, we used chimeric proteins to test whether DAT and SERT N and C termini contribute to transporter substrate and inhibitor affinities. Replacing the DATN terminus with that of SERT had no effect on DA transport V-max but significantly decreased DAT substrate affinities for DA and amphetamine. Similar losses in uptake inhibition were observed for small DAT inhibitors, whereas substituting the DAT C terminus with that of SERT affected neither substrate nor inhibitor affinities. In contrast, the N-terminal substitution was completely tolerated by the larger DAT inhibitors, which exhibited no loss in apparent affinity. Remarkably, all affinity losses were rescued in DAT chimeras encoding both SERT N and C termini. The sensitivity to amino-terminal substitution was specific for DAT, because replacing the SERT N and/or C termini affected neither substrate nor inhibitor affinities. Taken together, these findings provide compelling experimental evidence that DAT N and C termini synergistically contribute to substrate and inhibitor affinities.	[Sweeney, Carolyn G.; Tremblay, Bradford P.; Melikian, Haley E.] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, 303 Belmont St, Worcester, MA 01604 USA; [Stockner, Thomas; Sitte, Harald H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria	University of Massachusetts System; University of Massachusetts Worcester; Medical University of Vienna	Melikian, HE (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, 303 Belmont St, Worcester, MA 01604 USA.	haley.melikian@umassmed.edu	Sitte, Harald/N-2681-2013; Stockner, Thomas/A-9509-2014; Melikian, Haley/S-8301-2016	Sitte, Harald/0000-0002-1339-7444; Stockner, Thomas/0000-0002-7071-8283; Melikian, Haley/0000-0002-9694-5556	National Institutes of Health [DA15169, DA039592]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA039592, R01DA015169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes of Health Grants DA15169 (to H. E. M.) and DA039592 (C. G. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALI SA, 1995, BIOTECHNIQUES, V18, P746; Bermingham DP, 2016, PHARMACOL REV, V68, P888, DOI 10.1124/pr.115.012260; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Buchmayer F, 2013, P NATL ACAD SCI USA, V110, P11642, DOI 10.1073/pnas.1220552110; Cartier E, 2015, EBIOMEDICINE, V2, P135, DOI 10.1016/j.ebiom.2015.01.007; Chen NH, 2001, J NEUROCHEM, V77, P1116, DOI 10.1046/j.1471-4159.2001.00312.x; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fenollar-Ferrer C, 2014, BIOCHEMISTRY-US, V53, P5444, DOI 10.1021/bi500637f; Freyberg Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10652; Gaffaney JD, 2014, NEUROCHEM INT, V73, P16, DOI 10.1016/j.neuint.2013.11.003; German CL, 2015, PHARMACOL REV, V67, P1005, DOI 10.1124/pr.114.010397; Gu HH, 2001, MOL BIOL CELL, V12, P3797, DOI 10.1091/mbc.12.12.3797; Guptaroy B, 2011, MOL PHARMACOL, V79, P520, DOI 10.1124/mol.110.069039; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Khelashvili G, 2015, PROTEINS, V83, P952, DOI 10.1002/prot.24792; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Koban F, 2015, J BIOL CHEM, V290, P13263, DOI 10.1074/jbc.M115.641357; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Moritz AE, 2013, J BIOL CHEM, V288, P20, DOI 10.1074/jbc.M112.407874; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Prasad HC, 2009, PHILOS T R SOC B, V364, P163, DOI 10.1098/rstb.2008.0143; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Rickhag M, 2013, J BIOL CHEM, V288, P27534, DOI 10.1074/jbc.M112.441295; Rickhag M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2568; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; Seimandi M, 2013, J NEUROSCI, V33, P16189, DOI 10.1523/JNEUROSCI.0076-13.2013; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Vuorenpaa A, 2016, J BIOL CHEM, V291, P5634, DOI 10.1074/jbc.M115.702050; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Wu S, 2015, P NATL ACAD SCI USA, V112, P15480, DOI 10.1073/pnas.1512957112; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	48	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1302	1309		10.1074/jbc.M116.762872	http://dx.doi.org/10.1074/jbc.M116.762872			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27986813	hybrid, Green Published			2022-12-28	WOS:000393339800013
J	van Rosmalen, M; Janssen, BMG; Hendrikse, NM; van der Linden, AJ; Pieters, PA; Wanders, D; de Greef, TFA; Merkx, M				van Rosmalen, Martijn; Janssen, Brian M. G.; Hendrikse, Natalie M.; van der Linden, Ardjan J.; Pieters, Pascal A.; Wanders, Dave; de Greef, Tom F. A.; Merkx, Maarten			Affinity Maturation of a Cyclic Peptide Handle for Therapeutic Antibodies Using Deep Mutational Scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPUTATIONAL DESIGN; SURFACE DISPLAY; YEAST DISPLAY; PROTEIN; SITE; MUTAGENESIS; GENERATION; STABILITY; EVOLUTION; STRATEGY	Meditopes are cyclic peptides that bind in a specific pocket in the antigen-binding fragment of a therapeutic antibody such as cetuximab. Provided their moderate affinity can be enhanced, meditope peptides could be used as specific non-covalent and paratope-independent handles in targeted drug delivery, molecular imaging, and therapeutic drug monitoring. Here we show that the affinity of a recently reported meditope for cetuximab can be substantially enhanced using a combination of yeast display and deep mutational scanning. Deep sequencing was used to construct a fitness landscape of this protein-peptide interaction, and four mutations were identified that together improved the affinity for cetuximab 10-fold to 15 nM. Importantly, the increased affinity translated into enhanced cetuximab-mediated recruitment to EGF receptor-overexpressing cancer cells. Although in silico Rosetta simulations correctly identified positions that were tolerant to mutation, modeling did not accurately predict the affinity-enhancing mutations. The experimental approach reported here should be generally applicable and could be used to develop meditope peptides with low nano-molar affinity for other therapeutic antibodies.	[Merkx, Maarten] Eindhoven Univ Technol, Biol Chem Lab, POB 513 STO 3-22, NL-5600 MB Eindhoven, Netherlands; Eindhoven Univ Technol, Dept Biomed Engn, ICMS, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology	Merkx, M (corresponding author), Eindhoven Univ Technol, Biol Chem Lab, POB 513 STO 3-22, NL-5600 MB Eindhoven, Netherlands.	m.merkx@tue.nl	Merkx, Maarten/E-7009-2011	de Greef, Tom/0000-0002-9338-284X; Hendrikse, Natalie/0000-0001-8644-3408; Pieters, Pascal/0000-0003-2032-0100	European Research Council (ERC) [ERC-2011-StG 280255]; ERC Proof-of-Concept Grant [ERC-2013-PoC 632274]; NanoNext, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners	European Research Council (ERC)(European Research Council (ERC)); ERC Proof-of-Concept Grant; NanoNext, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners	This work was supported by European Research Council (ERC) Starting Grant ERC-2011-StG 280255, ERC Proof-of-Concept Grant ERC-2013-PoC 632274, and NanoNext, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal P, 2015, BIOCONJUGATE CHEM, V26, P176, DOI 10.1021/bc5004982; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Avery KN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07817; Beerli RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131177; BJORCK L, 1988, J IMMUNOL, V140, P1194; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chang HJ, 2014, STRUCTURE, V22, P9, DOI 10.1016/j.str.2013.10.005; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Donaldson JM, 2013, P NATL ACAD SCI USA, V110, P17456, DOI 10.1073/pnas.1307309110; Doolan KM, 2015, J MOL BIOL, V427, P328, DOI 10.1016/j.jmb.2014.10.024; Forsyth CM, 2013, MABS-AUSTIN, V5, P523, DOI 10.4161/mabs.24979; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Harris DT, 2016, J BIOL CHEM, V291, P24566, DOI 10.1074/jbc.M116.748681; Hui JZ, 2015, BIOCONJUGATE CHEM, V26, P1456, DOI 10.1021/acs.bioconjchem.5b00275; Janssen BMG, 2013, CHEM SCI, V4, P1442, DOI 10.1039/c3sc22033h; Kabat E. A., 1991, SEQUENCES PROTEINS I, P662; Kadonosono T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103397; Kim YS, 2006, PROTEINS, V62, P1026, DOI 10.1002/prot.20618; Kimura RH, 2009, PROTEINS, V77, P359, DOI 10.1002/prot.22441; Koenig P, 2015, J BIOL CHEM, V290, P21773, DOI 10.1074/jbc.M115.662783; Kornberger P, 2014, MABS-AUSTIN, V6, P354, DOI 10.4161/mabs.27444; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kowalsky CA, 2015, J BIOL CHEM, V290, P26457, DOI 10.1074/jbc.M115.676635; Lee Y, 2016, ANAL CHEM, V88, P9503, DOI 10.1021/acs.analchem.6b02071; Mazzucchelli S, 2010, ACS NANO, V4, P5693, DOI 10.1021/nn101307r; Mishra P, 2016, CELL REP, V15, P588, DOI 10.1016/j.celrep.2016.03.046; Muguruma K, 2016, BIOCONJUGATE CHEM, V27, P1606, DOI 10.1021/acs.bioconjchem.6b00149; Murelli RP, 2009, J AM CHEM SOC, V131, P17090, DOI 10.1021/ja906844e; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Pavoor TV, 2009, P NATL ACAD SCI USA, V106, P11895, DOI 10.1073/pnas.0902828106; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Reich L, 2015, J MOL BIOL, V427, P2135, DOI 10.1016/j.jmb.2014.09.025; Riemer AB, 2005, JNCI-J NATL CANCER I, V97, P1663, DOI 10.1093/jnci/dji373; Riemer AB, 2004, J IMMUNOL, V173, P394, DOI 10.4049/jimmunol.173.1.394; Rosenthal ME, 2012, MED HYPOTHESES, V79, P138, DOI 10.1016/j.mehy.2012.04.013; Shin H, 2015, INT J MOL SCI, V16, P23094, DOI 10.3390/ijms160923094; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Smith SN, 2015, METHODS MOL BIOL, V1319, P95, DOI 10.1007/978-1-4939-2748-7_6; Sochaj AM, 2015, BIOTECHNOL ADV, V33, P775, DOI 10.1016/j.biotechadv.2015.05.001; Starita Lea M, 2015, Cold Spring Harb Protoc, V2015, P711, DOI 10.1101/pdb.top077503; Strauch EM, 2014, P NATL ACAD SCI USA, V111, P675, DOI 10.1073/pnas.1313605111; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Van Blarcom T, 2015, J MOL BIOL, V427, P1513, DOI 10.1016/j.jmb.2014.09.020; van Geel R, 2015, BIOCONJUGATE CHEM, V26, P2233, DOI 10.1021/acs.bioconjchem.5b00224; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Williams J. C., 2014, U. S. Patent, Patent No. [US 8658774 B2, 8658774]; Xu ZH, 2012, J IMMUNOL, V189, P4470, DOI 10.4049/jimmunol.1201813; Yao HZ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020194; Zouali M, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00063; Zouali Moncef, 2007, Chem Immunol Allergy, V93, P92, DOI 10.1159/000100860	58	15	15	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1477	1489		10.1074/jbc.M116.764225	http://dx.doi.org/10.1074/jbc.M116.764225			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27974464	Green Published, hybrid			2022-12-28	WOS:000393339800028
J	McConnell, HL; Kersch, CN; Woltjer, RL; Neuwelt, EA				McConnell, Heather L.; Kersch, Cymon N.; Woltjer, Randall L.; Neuwelt, Edward A.			The Translational Significance of the Neurovascular Unit*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BLOOD-BRAIN-BARRIER; AMYLOID-BETA-PEPTIDE; STEM-CELLS; THERAPEUTIC TARGETS; IN-VITRO; ASTROCYTE; MICROGLIA; PERICYTES; CLEARANCE; SYSTEM	The mammalian brain is supplied with blood by specialized vasculature that is structurally and functionally distinct from that of the periphery. A defining feature of this vasculature is a physical blood-brain barrier ( BBB). The BBB separates blood components from the brain microenvironment, regulating the entry and exit of ions, nutrients, macromolecules, and energy metabolites. Over the last two decades, physiological studies of cerebral blood flow dynamics have demonstrated that substantial intercellular communication occurs between cells of the vasculature and the neurons and glia that abut the vasculature. These findings suggest that the BBB does not function independently, but as a module within the greater context of a multicellular neurovascular unit (NVU) that includes neurons, astrocytes, pericytes, and microglia as well as the blood vessels themselves. Here, we describe the roles of these NVU components as well as how they act in concert to modify cerebrovascular function and permeability in health and in select diseases.	[Neuwelt, Edward A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Neurosurg, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Vet Affairs, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Neuwelt, EA (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA.	neuwelte@ohsu.edu		McConnell, Heather/0000-0002-0505-6316	National Institutes of Health [CA199111, CA137488]; U. S. Department of Defense [W81XWH-14-1-0108]; Walter S. and Lucienne Driskill Foundation; U. S. Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA199111, R01CA137488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Defense(United States Department of Defense); Walter S. and Lucienne Driskill Foundation; U. S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA199111 and CA137488 (to E. A. N.), U. S. Department of Defense Grant W81XWH-14-1-0108, the Walter S. and Lucienne Driskill Foundation, and a Merit Review from the U. S. Department of Veterans Affairs. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ABOUNADER R, 1995, BRIT J PHARMACOL, V116, P2245, DOI 10.1111/j.1476-5381.1995.tb15060.x; Adkins CE, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00136; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Avila-Munoz E, 2014, AGEING RES REV, V18, P29, DOI 10.1016/j.arr.2014.07.004; Bayerl SH, 2016, GLIA, V64, P1210, DOI 10.1002/glia.22994; Becker CM, 2015, NEURO-ONCOLOGY, V17, P1210, DOI 10.1093/neuonc/nov081; BETZ AL, 1980, BRAIN RES, V192, P17, DOI 10.1016/0006-8993(80)91004-5; Burgett ME, 2016, ONCOTARGET, V7, P43852, DOI 10.18632/oncotarget.9700; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Caspani EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101402; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Charles N, 2010, CELL CYCLE, V9, P3012, DOI 10.4161/cc.9.15.12710; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; Chen WL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0487-0; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; De Bock M, 2014, BBA-MOL CELL RES, V1843, P2211, DOI 10.1016/j.bbamcr.2014.04.016; De Michele M, 2005, EXP BRAIN RES, V165, P375, DOI 10.1007/s00221-005-2303-0; Farnsworth RH, 2014, ONCOGENE, V33, P3496, DOI 10.1038/onc.2013.304; Filosa JA, 2016, NEUROSCIENCE, V323, P96, DOI 10.1016/j.neuroscience.2015.03.064; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gordon GRJ, 2011, EXP PHYSIOL, V96, P393, DOI 10.1113/expphysiol.2010.053132; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gotoh J, 2001, AM J PHYSIOL-HEART C, V280, pH821, DOI 10.1152/ajpheart.2001.280.2.H821; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hartmann DA, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.4.041402; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Iliff JJ, 2015, LANCET NEUROL, V14, P977, DOI 10.1016/S1474-4422(15)00221-5; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Infanger DW, 2013, CANCER RES, V73, P7079, DOI 10.1158/0008-5472.CAN-13-1355; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jolivel V, 2015, ACTA NEUROPATHOL, V129, P279, DOI 10.1007/s00401-014-1372-1; Joutel A, 2016, J CEREBR BLOOD F MET, V36, P143, DOI 10.1038/jcbfm.2015.62; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Kim JY, 2015, CNS NEUROSCI THER, V21, P309, DOI 10.1111/cns.12360; Kothur K, 2016, CYTOKINE, V77, P227, DOI 10.1016/j.cyto.2015.10.001; Krstic D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-151; Lacoste B, 2014, NEURON, V83, P1117, DOI 10.1016/j.neuron.2014.07.034; Lajoie JM, 2015, ANNU REV PHARMACOL, V55, P613, DOI 10.1146/annurev-pharmtox-010814-124852; Lockman PR, 2010, CLIN CANCER RES, V16, P5664, DOI 10.1158/1078-0432.CCR-10-1564; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Ma S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001469; Mao JM, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0034-3; Mignogna C, 2016, PATHOL RES PRACT, V212, P491, DOI 10.1016/j.prp.2016.02.020; Motegi H, 2014, NEUROPATHOLOGY, V34, P378, DOI 10.1111/neup.12117; Nagy JI, 2003, CELL COMMUN ADHES, V10, P401, DOI 10.1080/15419060390263191; Nakagomi T, 2015, STEM CELLS, V33, P1962, DOI 10.1002/stem.1977; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; Oberoi RK, 2016, NEURO-ONCOLOGY, V18, P27, DOI 10.1093/neuonc/nov164; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Pardridge WM, 2015, EXPERT OPIN THER TAR, V19, P1059, DOI 10.1517/14728222.2015.1042364; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Pishko GL, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/2045-8118-12-5; Rosenberg RN, 2016, JAMA NEUROL, V73, P867, DOI 10.1001/jamaneurol.2016.0301; Ruhrberg C, 2013, CELL MOL LIFE SCI, V70, P1675, DOI 10.1007/s00018-013-1277-5; Sakuma R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0523-9; Scremin O U, 1973, Stroke, V4, P233; Shaifer CA, 2010, INT J CANCER, V127, P2063, DOI 10.1002/ijc.25249; Shalaby T, 2015, INT J MOL SCI, V16, P29103, DOI 10.3390/ijms161226150; Sharma A, 2016, BIOCHEM BIOPH RES CO, V473, P688, DOI 10.1016/j.bbrc.2015.12.022; Simon MJ, 2016, BBA-MOL BASIS DIS, V1862, P442, DOI 10.1016/j.bbadis.2015.10.014; Sosunov AA, 2014, J NEUROSCI, V34, P2285, DOI 10.1523/JNEUROSCI.4037-13.2014; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Stankovic ND, 2016, ACTA NEUROPATHOL, V131, P347, DOI 10.1007/s00401-015-1524-y; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tanigami H, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/964652; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Torbett BE, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00070; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Watkins S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5196; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wilhelm I, 2014, MOL PHARMACEUT, V11, P1949, DOI 10.1021/mp500046f; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; YAKSH TL, 1987, J CEREBR BLOOD F MET, V7, P315, DOI 10.1038/jcbfm.1987.69; Yoon SS, 2012, BIOMOL THER, V20, P245, DOI 10.4062/biomolther.2012.20.3.245; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150; Zhou QH, 2011, DRUG METAB DISPOS, V39, P1149, DOI 10.1124/dmd.111.038349; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	100	151	156	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					762	770		10.1074/jbc.R116.760215	http://dx.doi.org/10.1074/jbc.R116.760215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27920202	hybrid, Green Published			2022-12-28	WOS:000392318700001
J	Chandrasekar, S; Shan, SO				Chandrasekar, Sowmya; Shan, Shu-ou			Anionic Phospholipids and the Albino3 Translocase Activate Signal Recognition Particle-Receptor Interaction during Light-harvesting Chlorophyll a/b-binding Protein Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST SRP PATHWAY; THYLAKOID MEMBRANES; TRANSLATING RIBOSOME; ESCHERICHIA-COLI; STRUCTURAL BASIS; GTPASE ACTIVITY; CPSRP43; FTSY; RNA; SUBSTRATE	The universally conserved signal recognition particle (SRP) co-translationally delivers newly synthesized membrane and secretory proteins to the target cellular membrane. The only exception is found in the chloroplast of green plants, where the chloroplast SRP (cpSRP) post-translationally targets light-harvesting chlorophyll a/b-binding proteins (LHCP) to the thylakoid membrane. The mechanism and regulation of this post-translational mode of targeting by cpSRP remain unclear. Using biochemical and biophysical methods, here we show that anionic phospholipids activate the cpSRP receptor cpFtsY to promote rapid and stable cpSRP54.cpFtsY complex assembly. Furthermore, the stromal domain of the Alb3 translocase binds with high affinity to and regulates GTP hydrolysis in the cpSRP54.cpFtsY complex, suggesting that cpFtsY is primarily responsible for initial recruitment of the targeting complex to Alb3. These results suggest a new model for the sequential recruitment, remodeling, and unloading of the targeting complex at membrane translocase sites in the post-translational cpSRP pathway.	[Chandrasekar, Sowmya; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu			National Institutes of Health [1R01GM114390]; Gordon and Betty Moore Foundation; American Federation for Aging Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); American Federation for Aging Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM114390 and fellowships from the Gordon and Betty Moore Foundation and American Federation for Aging Research (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Bahari L, 2007, J BIOL CHEM, V282, P32168, DOI 10.1074/jbc.M705429200; Bals T, 2010, FEBS LETT, V584, P4138, DOI 10.1016/j.febslet.2010.08.053; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Chandrasekar S, 2017, J BIOL CHEM, V292, P386, DOI 10.1074/jbc.M116.752931; CONNOLLY T, 1993, J CELL BIOL, V123, P799, DOI 10.1083/jcb.123.4.799; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eichacker LA, 2001, BBA-MOL CELL RES, V1541, P120, DOI 10.1016/S0167-4889(01)00151-3; Falk S, 2010, J BIOL CHEM, V285, pLE25, DOI 10.1074/jbc.L110.160093; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Horn A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9875; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Jaru-Ampornpan P, 2009, MOL BIOL CELL, V20, P3965, DOI 10.1091/mbc.E08-10-0989; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Koch HG, 2003, REV PHYSIOL BIOCH P, V146, P55, DOI 10.1007/s10254-002-0002-9; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; Liang FC, 2016, P NATL ACAD SCI USA, V113, pE1615, DOI 10.1073/pnas.1524777113; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; Mandon EC, 2009, CURR OPIN CELL BIOL, V21, P501, DOI 10.1016/j.ceb.2009.04.010; Marty NJ, 2009, J BIOL CHEM, V284, P14891, DOI 10.1074/jbc.M900775200; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Nguyen TX, 2011, BIOCHEMISTRY-US, V50, P7208, DOI 10.1021/bi200742a; Parlitz R, 2007, J BIOL CHEM, V282, P32176, DOI 10.1074/jbc.M705430200; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Richter CV, 2008, FEBS LETT, V582, P3223, DOI 10.1016/j.febslet.2008.08.014; Richter CV, 2010, EUR J CELL BIOL, V89, P965, DOI 10.1016/j.ejcb.2010.06.020; Saraogi I, 2014, J CELL BIOL, V205, P693, DOI 10.1083/jcb.201311028; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Sivaraja V, 2005, J BIOL CHEM, V280, P41465, DOI 10.1074/jbc.M507077200; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Trager C, 2012, PLANT CELL, V24, P4819, DOI 10.1105/tpc.112.102996; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Woolhead CA, 2001, J BIOL CHEM, V276, P40841, DOI 10.1074/jbc.M106523200; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; ZOPF D, 1993, J CELL BIOL, V120, P1113, DOI 10.1083/jcb.120.5.1113; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	58	9	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					397	406		10.1074/jbc.M116.752956	http://dx.doi.org/10.1074/jbc.M116.752956			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895124	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000391578000034
J	Hewett, SJ; Shi, JX; Gong, YF; Dhandapani, K; Pilbeam, C; Hewett, JA				Hewett, Sandra J.; Shi, Jingxue; Gong, Yifan; Dhandapani, Krishnan; Pilbeam, Carol; Hewett, James A.			Spontaneous Glutamatergic Synaptic Activity Regulates Constitutive COX-2 Expression in Neurons OPPOSING ROLES FOR THE TRANSCRIPTION FACTORS CREB (cAMP RESPONSE ELEMENT BINDING) PROTEIN AND Sp1 (STIMULATORY PROTEIN-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-D-ASPARTATE; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; CYCLOOXYGENASE-2 GENE-TRANSCRIPTION; DOMINANT-NEGATIVE INHIBITOR; CELL-SURFACE EXPRESSION; LONG-TERM POTENTIATION; NERVOUS-SYSTEM; UP-REGULATION; H SYNTHASE-1	Burgeoning evidence supports a role for cyclooxygenase metabolites in regulating membrane excitability in various forms of synaptic plasticity. Two cyclooxygenases, COX-1 and COX-2, catalyze the initial step in the metabolism of arachidonic acid to prostaglandins. COX-2 is generally considered inducible, but in glutamatergic neurons in some brain regions, including the cerebral cortex, it is constitutively expressed. However, the transcriptional mechanisms by which this occurs have not been elucidated. Here, we used quantitative PCR and also analyzed reporter gene expression in a mouse line carrying a construct consisting of a portion of the proximal promoter region of the mouse COX-2 gene upstream of luciferase cDNA to characterize COX-2 basal transcriptional regulation in cortical neurons. Extracts from the whole brain and from the cerebral cortex, hippocampus, and olfactory bulbs exhibited high luciferase activity. Moreover, constitutive COX-2 expression and luciferase activity were detected in cortical neurons, but not in cortical astrocytes, cultured from wild-type and transgenic mice, respectively. Constitutive COX-2 expression depended on spontaneous but not evoked excitatory synaptic activity and was shown to be N-methyl-D-aspartate receptor-dependent. Constitutive promoter activity was reduced in neurons transfected with a dominant-negative cAMP response element binding protein (CREB) and was eliminated by mutating the CRE-binding site on the COX-2 promoter. However, mutation of the stimulatory protein-1 (Sp1)-binding site resulted in an N-methyl-D-aspartate receptor-dependent enhancement of COX-2 promoter activity. Basal binding of the transcription factors CREB and Sp1 to the native neuronal COX-2 promoter was confirmed. In toto, our data suggest that spontaneous glutamatergic synaptic activity regulates constitutive neuronal COX-2 expression via Sp1 and CREB protein-dependent transcriptional mechanisms.	[Hewett, Sandra J.; Shi, Jingxue; Gong, Yifan; Hewett, James A.] Syracuse Univ, Dept Biol, Program Neurosci, Syracuse, NY 13210 USA; [Dhandapani, Krishnan] Augusta Univ, Med Coll Georgia, Dept Neurosurg, Augusta, GA 30912 USA; [Pilbeam, Carol] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA	Syracuse University; University System of Georgia; Augusta University; University of Connecticut	Hewett, SJ; Hewett, JA (corresponding author), Syracuse Univ, Dept Biol, Program Neurosci, Syracuse, NY 13210 USA.	shewett@syr.edu; jhewett@syr.edu		Dhandapani, Krishnan/0000-0001-7044-1117	National Institutes of Health [NS036812, NS082982, T32 DC005355]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS082982, R29NS036812, R01NS036812, R21NS056304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC005355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grants NS036812 (to S. J. H. and J. A. H.), NS082982 (to J. A. H.), and T32 DC005355 (to K. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams J, 1996, J NEUROCHEM, V66, P6; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; BHATTACHARYYA DK, 1995, ARCH BIOCHEM BIOPHYS, V317, P19, DOI 10.1006/abbi.1995.1130; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Chen C, 2005, J NEUROPHYSIOL, V93, P929, DOI 10.1152/jn.00696.2004; Choudhary S, 2004, BIOCHEM BIOPH RES CO, V322, P395, DOI 10.1016/j.bbrc.2004.07.129; Chu C, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-44; Cowley TR, 2008, EUR J NEUROSCI, V27, P2999, DOI 10.1111/j.1460-9568.2008.06251.x; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Fang QC, 2014, DIABETES, V63, P4165, DOI 10.2337/db14-0182; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; Fogal B, 2005, NEUROSCIENCE, V132, P929, DOI 10.1016/j.neuroscience.2005.01.036; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hamby ME, 2006, J NEUROSCI METH, V150, P128, DOI 10.1016/j.jneumeth.2005.06.016; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hewett SJ, 2006, PHARMACOL THERAPEUT, V112, P335, DOI 10.1016/j.pharmthera.2005.04.011; Hewett SJ, 2000, J PHARMACOL EXP THER, V293, P417; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jackman NA, 2010, GLIA, V58, P1806, DOI 10.1002/glia.21050; Jang JH, 2005, FREE RADICAL BIO MED, V38, P1604, DOI 10.1016/j.freeradbiomed.2005.02.023; Kaltschmidt B, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-16; Kang YJ, 2006, J IMMUNOL, V177, P8111, DOI 10.4049/jimmunol.177.11.8111; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; Kirkby NS, 2016, P NATL ACAD SCI USA, V113, P434, DOI 10.1073/pnas.1517642113; Koch H, 2010, J NEUROSCI, V30, P11678, DOI 10.1523/JNEUROSCI.4665-09.2010; KRAEMER SA, 1992, ARCH BIOCHEM BIOPHYS, V293, P391, DOI 10.1016/0003-9861(92)90411-O; Kuan CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147886; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Le TD, 2010, P NATL ACAD SCI USA, V107, P3198, DOI 10.1073/pnas.0915020107; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Lee KM, 2004, EUR J NEUROSCI, V19, P3375, DOI 10.1111/j.0953-816X.2004.03441.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lubelski D, 2012, BRAIN RES, V1429, P18, DOI 10.1016/j.brainres.2011.10.033; Lukiw WJ, 1998, J NEUROSCI RES, V53, P583, DOI 10.1002/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.3.CO;2-B; McIlhinney RAJ, 1996, NEUROSCIENCE, V70, P989, DOI 10.1016/0306-4522(95)00419-X; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Monti B, 2002, EUR J NEUROSCI, V16, P1490, DOI 10.1046/j.1460-9568.2002.02232.x; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Murray HJ, 2003, NEUROPHARMACOLOGY, V44, P374, DOI 10.1016/S0028-3908(02)00375-1; Rakhit S, 2005, MOL PHARMACOL, V67, P1158, DOI 10.1124/mol.104.005447; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Sang N, 2006, NEUROSCIENTIST, V12, P425, DOI 10.1177/1073858406290794; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1992, EMBO J, V11, P3577, DOI 10.1002/j.1460-2075.1992.tb05441.x; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; SONNENBERG JL, 1989, J NEUROSCI RES, V24, P72, DOI 10.1002/jnr.490240111; Straiker A, 2011, BRIT J PHARMACOL, V164, P1672, DOI 10.1111/j.1476-5381.2011.01486.x; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Taylor AL, 2002, J BIOL CHEM, V277, P43881, DOI 10.1074/jbc.M205872200; Teather LA, 2002, LEARN MEMORY, V9, P41, DOI 10.1101/lm.43602; Tegeder I, 2004, J NEUROSCI, V24, P1637, DOI 10.1523/JNEUROSCI.3118-03.2004; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Trackey JL, 2001, J NEUROCHEM, V79, P445, DOI 10.1046/j.1471-4159.2001.00584.x; Uliasz TF, 2012, METHODS MOL BIOL, V814, P61, DOI 10.1007/978-1-61779-452-0_5; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; WANG LH, 1993, BIOCHEM BIOPH RES CO, V190, P406, DOI 10.1006/bbrc.1993.1062; Wardlaw SA, 2002, MOL PHARMACOL, V62, P326, DOI 10.1124/mol.62.2.326; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xu Q, 2000, J BIOL CHEM, V275, P24583, DOI 10.1074/jbc.M003894200; Xu XM, 1997, J BIOL CHEM, V272, P6943, DOI 10.1074/jbc.272.11.6943; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yang HW, 2008, CURR PHARM DESIGN, V14, P1443, DOI 10.2174/138161208784480144; Yang HW, 2008, MOL CELL NEUROSCI, V37, P682, DOI 10.1016/j.mcn.2007.12.019; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	78	13	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27279	27288		10.1074/jbc.M116.737353	http://dx.doi.org/10.1074/jbc.M116.737353			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875294	Green Published, hybrid			2022-12-28	WOS:000391576300025
J	Kilpatrick, CL; Murakami, S; Feng, MY; Wu, X; Lal, R; Chen, G; Du, KY; Luscher, B				Kilpatrick, Casey L.; Murakami, Shoko; Feng, Mengyang; Wu, Xia; Lal, Rachnanjali; Chen, Gong; Du, Keyong; Luscher, Bernhard			Dissociation of Golgi-associated DHHC-type Zinc Finger Protein (GODZ)- and Sertoli Cell Gene with a Zinc Finger Domain-beta (SERZ-beta)-mediated Palmitoylation by Loss of Function Analyses in Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC GABA(A) RECEPTORS; CYSTEINE-RICH DOMAIN; GAMMA-2 SUBUNIT; S-PALMITOYLATION; TRAFFICKING; IDENTIFICATION; GAP-43; SYNAPSES; GEPHYRIN; REVEALS	The gamma 2 subunit of GABA type A receptors (GABA(A)Rs) is thought to be subject to palmitoylation by both Golgi-associated DHHC-type zinc finger protein (GODZ; also known as DHHC3) and its paralog Sertoli cell gene with a zinc finger domain-beta (SERZ-beta; DHHC7) based on overexpression of enzymes and substrates in heterologous cells. Here we have further investigated the substrate specificity of these enzymes by characterization of GODZ and SERZ-beta knock-out (KO) mice as well as double KO (DKO) neurons. Palmitoylation of gamma 2 and a second substrate, growth-associated protein of 43 kDa, that is independently implicated in trafficking of GABA(A)Rs was significantly reduced in brain of GODZ KO versus wild-type (WT) mice but unaltered in SERZ-beta KO mice. Accumulation of GABA(A)Rs at synapses, GABAergic innervation, and synaptic function were reduced in GODZ KO and DKO neurons to a similar extent, indicating that SERZ-beta does not contribute to palmitoylation or trafficking of GABA(A)Rs even in the absence of GODZ. Notably, these effects were seen only when mutant neurons were grown in competition with WT neurons, thereby mimicking conditions of shRNA-transfected neurons previously used to characterize GODZ. However, GABA-evoked whole-cell currents of DKO neurons and the GABA(A)R cell surface expression in DKO neurons and GODZ or SERZ-beta KO brain slices were unaltered, indicating that GODZ-mediated palmitoylation selectively controls the pool of receptors at synapses. The different substrate specificities of GODZ and SERZ-beta in vivo were correlated with their differential localization to cis-versus trans-Golgi compartment, a mechanism that was compromised by overexpression of GODZ.	[Kilpatrick, Casey L.; Luscher, Bernhard] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Murakami, Shoko; Feng, Mengyang; Wu, Xia; Lal, Rachnanjali; Chen, Gong; Luscher, Bernhard] Penn State Univ, Dept Biol, 209 Life Sci Bldg, University Pk, PA 16802 USA; [Chen, Gong; Luscher, Bernhard] Penn State Univ, CMIND, University Pk, PA 16802 USA; [Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Tufts Medical Center	Luscher, B (corresponding author), Penn State Univ, Dept Biol, 209 Life Sci Bldg, University Pk, PA 16802 USA.	BXL25@psu.edu	Luscher, Bernhard/C-3528-2009; Feng, Mengyang/AAQ-7181-2021	Luscher, Bernhard/0000-0003-1375-1906; Feng, Mengyang/0000-0003-3175-836X	National Institutes of Health [MH62391, MH062391, MH083911, DK084319, OD010625]; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084319, R01DK084319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083911, R56MH062391, R01MH062391, R01MH099851] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants MH62391 and MH062391 (to B. L.), MH083911 (to G. C.), DK084319 (to K. D.), and OD010625 (to Simon Watkins, Center for Biologic Imagining at the University of Pittsburgh, PA) and by a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; BANKER G, 1998, CULTURING NERVE CELL; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brigidi GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9200; Chaudhary J, 2002, ENDOCRINOLOGY, V143, P426, DOI 10.1210/en.143.2.426; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2013, J CELL BIOL, V202, P145, DOI 10.1083/jcb.201302071; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gottlieb CD, 2015, J BIOL CHEM, V290, P29259, DOI 10.1074/jbc.M115.691147; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; Jarvela T, 2012, J CELL SCI, V125, P973, DOI 10.1242/jcs.094441; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Linstedt AD, 1997, MOL BIOL CELL, V8, P1073, DOI 10.1091/mbc.8.6.1073; LIU YC, 1993, BIOCHEMISTRY-US, V32, P10714, DOI 10.1021/bi00091a023; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Oku S, 2013, J BIOL CHEM, V288, P19816, DOI 10.1074/jbc.M112.431676; Ren Z, 2016, BIOL PSYCHIAT, V80, P457, DOI 10.1016/j.biopsych.2016.02.009; Ren Z, 2015, NEUROPHARMACOLOGY, V88, P171, DOI 10.1016/j.neuropharm.2014.07.019; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; STROUS GJ, 1986, CRC CR REV BIOCH MOL, V21, P119, DOI 10.3109/10409238609113610; Trenchi A, 2009, BIOCHEM J, V421, P357, DOI 10.1042/BJ20090484; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang CY, 2015, MOL CELL BIOL, V35, P1712, DOI 10.1128/MCB.01332-14; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002	48	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27371	27386		10.1074/jbc.M116.732768	http://dx.doi.org/10.1074/jbc.M116.732768			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875292	Green Published, hybrid			2022-12-28	WOS:000391576300034
J	Suzuki, S; Ogawa, M; Ohta, S; Nunomura, S; Nanri, Y; Shiraishi, H; Mitamura, Y; Yoshihara, T; Lee, JJ; Izuhara, K				Suzuki, Shoichi; Ogawa, Masahiro; Ohta, Shoichiro; Nunomura, Satoshi; Nanri, Yasuhiro; Shiraishi, Hiroshi; Mitamura, Yasutaka; Yoshihara, Tomohito; Lee, James J.; Izuhara, Kenji			Induction of Airway Allergic Inflammation by Hypothiocyanite via Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOCHLOROUS ACID; BRONCHIAL-ASTHMA; INNATE IMMUNITY; HOST-DEFENSE; INTERLEUKIN-13; SMOKING; ACTIVATION; REACTIVITY; APOPTOSIS; PERIOSTIN	Hypothiocyanite (OSCN-) serves as a potent innate defense system against microbes in the lungs. OSCN- is generated by the catalysis of peroxidases using thiocyanate transported via several anion transporters, including pendrin/SLC26A4 and hydrogen peroxide (H2O2) generated by Duox1 and Duox2. We previously demonstrated that expression of pendrin, peroxidases, and Duox1/Duox2 is up-regulated in bronchial asthma patients and/or asthma model mice and that these molecules are important in accelerating airway inflammation. However, it remained unclear how activating these molecules would lead to airway inflammation. In this study, we examined whether OSCN- produced via the pendrin/peroxidase/Duox pathway causes inflammation via airway epithelial cells. In an in vitro OSCN- production system, OSCN-, but not H2O2, activated NF-kappa B, a transcription factor critical for inflammatory responses, in the airway epithelial cells. OSCN- was sensed by protein kinase A (PKA) followed by formation of the dimerization of PKA. The dimerized PKA, the active form, was critical in activating NF-kappa B. Detoxifying H2O2, mainly by catalase, enabled the dominant abilities of OSCN- to dimerize PKA and activate NF-kappa B, compared with untreated H2O2. Furthermore, OSCN- in high doses caused necrosis of the cells, inducing release of IL-33, a trigger to initiate type 2 inflammation. These results demonstrate that OSCN- in low doses activates NF-kappa B via PKA in airway epithelial cells, whereas OSCN- in high doses causes necrosis, suggesting an important role in airway allergic inflammation for the production of OSCN- via the pendrin/peroxidase/Duox pathway.	[Suzuki, Shoichi; Ogawa, Masahiro; Ohta, Shoichiro; Nunomura, Satoshi; Nanri, Yasuhiro; Shiraishi, Hiroshi; Mitamura, Yasutaka; Yoshihara, Tomohito; Izuhara, Kenji] Saga Med Sch, Dept Biomol Sci, Div Med Biochem, 5-1-1 Nabeshima, Saga 8498501, Japan; [Lee, James J.] Mayo Clin Arizona, Div Pulm Med, Scottsdale, AZ 85259 USA	Saga University; Mayo Clinic; Mayo Clinic Phoenix	Izuhara, K (corresponding author), Saga Med Sch, Dept Biomol Sci, Div Med Biochem, 5-1-1 Nabeshima, Saga 8498501, Japan.	kizuhara@cc.saga-u.ac.jp	Mitamura, Yasutaka/X-2529-2019; Nunomura, Satoshi/Q-4249-2017; Mitamura, Yasutaka/AAT-2110-2021	Nunomura, Satoshi/0000-0002-9315-4185; Mitamura, Yasutaka/0000-0001-6389-9285	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Barrett TJ, 2012, CHEM RES TOXICOL, V25, P263, DOI 10.1021/tx200219s; Bozonet SM, 2010, FREE RADICAL BIO MED, V49, P1054, DOI 10.1016/j.freeradbiomed.2010.06.028; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Chandler JD, 2013, J BIOL CHEM, V288, P18421, DOI 10.1074/jbc.M113.468090; Gras D, 2013, PHARMACOL THERAPEUT, V140, P290, DOI 10.1016/j.pharmthera.2013.07.008; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hawkins CL, 2009, FREE RADICAL RES, V43, P1147, DOI 10.3109/10715760903214462; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; HUSGAFVELPURSIAINEN K, 1987, INT ARCH OCC ENV HEA, V59, P337, DOI 10.1007/BF00405277; Izuhara K, 2003, CLIN CHEM LAB MED, V41, P860, DOI 10.1515/CCLM.2003.130; Izuhara K, 2015, ALLERGOL INT, V64, pS3, DOI 10.1016/j.alit.2015.04.012; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lambrecht BN, 2013, EUR J IMMUNOL, V43, P3125, DOI 10.1002/eji.201343730; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lefrancais E, 2012, EUR CYTOKINE NETW, V23, P120, DOI 10.1684/ecn.2012.0320; Liu ZG, 2004, IMMUNOL REV, V201, P57, DOI 10.1111/j.0105-2896.2004.00186.x; Lloyd MM, 2008, BIOCHEM J, V414, P271, DOI 10.1042/BJ20080468; Lloyd MM, 2013, FREE RADICAL BIO MED, V65, P1352, DOI 10.1016/j.freeradbiomed.2013.10.007; Lorentzen D, 2011, FREE RADICAL BIO MED, V50, P1144, DOI 10.1016/j.freeradbiomed.2011.02.013; Midwinter RG, 2006, BIOCHEM J, V396, P71, DOI 10.1042/BJ20052026; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nakagami Y, 2008, J IMMUNOL, V181, P2203, DOI 10.4049/jimmunol.181.3.2203; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Niikura Y, 2002, J BIOCHEM, V132, P53, DOI 10.1093/oxfordjournals.jbchem.a003198; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; Polosa R, 2013, EUR RESPIR J, V41, P716, DOI 10.1183/09031936.00073312; Ramalingam TR, 2005, CURR OPIN ALLERGY CL, V5, P392, DOI 10.1097/01.all.0000182542.30100.6f; Reber LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049512; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; SALOOJEE Y, 1982, THORAX, V37, P521, DOI 10.1136/thx.37.7.521; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schuliga M, 2015, BIOMOLECULES, V5, P1266, DOI 10.3390/biom5031266; Suzuki S, 2016, J ALLERGY CLIN IMMUN, V138, P1458, DOI 10.1016/j.jaci.2016.04.047; Tamimi A, 2012, RESP MED, V106, P319, DOI 10.1016/j.rmed.2011.11.003; Taniguchi K, 2014, J INVEST DERMATOL, V134, P1295, DOI 10.1038/jid.2013.500; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	43	17	20	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27219	27227		10.1074/jbc.M116.746909	http://dx.doi.org/10.1074/jbc.M116.746909			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864363	hybrid, Green Published			2022-12-28	WOS:000391576300020
J	Zhang, WP; Lu, L; Lai, QL; Zhu, BK; Li, ZR; Xu, Y; Shao, ZZ; Herrup, K; Moore, BS; Ross, AC; Qian, PY				Zhang, Weipeng; Lu, Liang; Lai, Qiliang; Zhu, Beika; Li, Zhongrui; Xu, Ying; Shao, Zongze; Herrup, Karl; Moore, Bradley S.; Ross, Avena C.; Qian, Pei-Yuan			Family-wide Structural Characterization and Genomic Comparisons Decode the Diversity-oriented Biosynthesis of Thalassospiramides by Marine Proteobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALPAIN; GENES	The thalassospiramide lipopeptides have great potential for therapeutic applications; however, their structural and functional diversity and biosynthesis are poorly understood. Here, by cultivating 130 Rhodospirillaceae strains sampled from oceans worldwide, we discovered 21 new thalassospiramide analogues and demonstrated their neuroprotective effects. To investigate the diversity of biosynthetic gene cluster (BGC) architectures, we sequenced the draft genomes of 28 Rhodospirillaceae strains. Our family-wide genomic analysis revealed three types of dysfunctional BGCs and four functional BGCs whose architectures correspond to four production patterns. This correlation allowed us to reassess the "diversity-oriented biosynthesis" proposed for the microbial production of thalassospiramides, which involves iteration of several key modules. Preliminary evolutionary investigation suggested that the functional BGCs could have arisen through module/domain loss, whereas the dysfunctional BGCs arose through horizontal gene transfer. Further comparative genomics indicated that thalassospiramide production is likely to be attendant on particular genes/pathways for amino acid metabolism, signaling transduction, and compound efflux. Our findings provide a systematic understanding of thalassospiramide production and new insights into the underlying mechanism.	[Zhang, Weipeng; Lu, Liang; Zhu, Beika; Li, Zhongrui; Herrup, Karl; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Lai, Qiliang; Shao, Zongze] State Ocean Adm, Inst Oceanog 3, Xiamen 361000, Peoples R China; [Xu, Ying] Shenzhen Univ, Sch Life Sci, Shenzhen 518060, Guangdong, Peoples R China; [Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92037 USA; [Ross, Avena C.] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada	Hong Kong University of Science & Technology; State Oceanic Administration; Shenzhen University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Queens University - Canada	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.; Ross, AC (corresponding author), Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada.	avena.ross@queensu.ca; boqianpy@ust.hk	Xu, Ying/E-2072-2018; Shao, Zongze/T-6682-2017; Zhu, Beika/AAT-5205-2020	Xu, Ying/0000-0003-4658-3283; Shao, Zongze/0000-0002-4784-090X; Moore, Bradley/0000-0002-4652-1253; Qian, Pei-Yuan/0000-0003-4074-9078	China Ocean Mineral Resources Research and Development Association [DY135]; Natural Sciences and Engineering Research Council of Canada (NSERC-DG); National Institutes of Health [GM97509]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097509] Funding Source: NIH RePORTER	China Ocean Mineral Resources Research and Development Association; Natural Sciences and Engineering Research Council of Canada (NSERC-DG)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the China Ocean Mineral Resources Research and Development Association (DY135 to P. Y. Q.), the Natural Sciences and Engineering Research Council of Canada (NSERC-DG to A. C. R.), and the National Institutes of Health (GM97509 to B. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bai YF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06640; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Janecek S., 2016, CELL MOL LIFE SCI, V6, P1; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Kudo F, 2014, NAT PROD REP, V31, P1056, DOI 10.1039/c4np00007b; Leloup L, 2011, EXPERT OPIN THER TAR, V15, P309, DOI 10.1517/14728222.2011.553611; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Lu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08783; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; Meiser P, 2008, CHEM BIOL, V15, P771, DOI 10.1016/j.chembiol.2008.06.005; Morton JD, 2013, INVEST OPHTH VIS SCI, V54, P389, DOI 10.1167/iovs.12-11088; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Niu GQ, 2013, CHEM BIOL, V20, P34, DOI 10.1016/j.chembiol.2012.10.017; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oh DC, 2007, ORG LETT, V9, P1525, DOI 10.1021/ol070294u; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Richter TKS, 2015, ENVIRON MICROBIOL, V17, P2158, DOI 10.1111/1462-2920.12669; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Ross AC, 2013, J AM CHEM SOC, V135, P1155, DOI 10.1021/ja3119674; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Schmerk CL, 2015, ENVIRON MICROBIOL, V17, P735, DOI 10.1111/1462-2920.12509; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Wu Q, 2000, NEUROBIOL AGING, V21, P797, DOI 10.1016/S0197-4580(00)00219-0; Zhang KC, 2010, P NATL ACAD SCI USA, V107, P6234, DOI 10.1073/pnas.0912903107; Zhang P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06647; Zhang WP, 2015, ENVIRON MICROBIOL, V17, P4089, DOI 10.1111/1462-2920.12978; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	37	6	7	1	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27228	27238		10.1074/jbc.M116.756858	http://dx.doi.org/10.1074/jbc.M116.756858			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875306	hybrid, Green Published			2022-12-28	WOS:000391576300021
J	Goblirsch, BR; Jensen, MR; Mohamed, FA; Wackett, LP; Wilmot, CM				Goblirsch, Brandon R.; Jensen, Matthew R.; Mohamed, Fatuma A.; Wackett, Lawrence P.; Wilmot, Carrie M.			Substrate Trapping in Crystals of the Thiolase OleA Identifies Three Channels That Enable Long Chain Olefin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-HEAD CONDENSATION; ACYL; INTERMEDIATE; KETOSYNTHASE; HYDROCARBON; FEATURES; COMPLEX	Phylogenetically diverse microbes that produce long chain, olefinic hydrocarbons have received much attention as possible sources of renewable energy biocatalysts. One enzyme that is critical for this process is OleA, a thiolase superfamily enzyme that condenses two fatty acyl-CoA substrates to produce a beta-ketoacid product and initiates the biosynthesis of long chain olefins in bacteria. Thiolases typically utilize a ping-pong mechanism centered on an active site cysteine residue. Reaction with the first substrate produces a covalent cysteine-thioester tethered acyl group that is transferred to the second substrate through formation of a carbon-carbon bond. Although the basics of thiolase chemistry are precedented, the mechanism by which OleA accommodates two substrates with extended carbon chains and a coenzyme moiety-unusual for a thiolase-are unknown. Gaining insights into this process could enable manipulation of the system for large scale olefin production with hydrocarbon chains lengths equivalent to those of fossil fuels. In this study, mutagenesis of the active site cysteine in Xanthomonas campestris OleA (Cys(143)) enabled trapping of two catalytically relevant species in crystals. In the resulting structures, long chain alkyl groups (C-12 and C14) and phospho-pantetheinate define three substrate channels in a T-shaped configuration, explaining how OleA coordinates its two substrates and product. The C143A OleA co-crystal structure possesses a single bound acyl-CoA representing the Michaelis complex with the first substrate, whereas the C143S co-crystal structure contains both acyl-CoA and fatty acid, defining how a second substrate binds to the acyl-enzyme intermediate. An active site glutamate (Glu beta(117)) is positioned to deprotonate bound acyl-CoA and initiate carbon-carbon bond formation.	[Wilmot, Carrie M.] Univ Minnesota, Dept Biochem, Mol Biol, St Paul, MN 55108 USA; Univ Minnesota, Biophys & Biotechnol Inst, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wilmot, CM (corresponding author), Univ Minnesota, Dept Biochem, Mol Biol, St Paul, MN 55108 USA.	wilmo004@umn.edu		Jensen, Matthew/0000-0001-5469-1239	National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008700] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Computer resources were provided by the Basic Sciences Computing Laboratory of the University of Minnesota Supercomputing Institute. X-ray data were collected at the Kahlert Structural Biology Laboratory at the University of Minnesota and National Institute of General Medical Sciences and National Cancer Institute Collaborative Access Team at the APS, Argonne National Laboratory (Argonne, IL). National Institute of General Medical Sciences and National Cancer Institute Collaborative Access Team at the APS has been funded in whole or in part with federal funds from the National Cancer Institute (Grant ACB-12002) and the National Institute of General Medical Sciences (Grant AGM-12006). This research used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. We thank Ed Hoeffner for Kahlert Structural Biology Laboratory support, and the staff at Sector 23, APS for support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Bonnett SA, 2011, BIOCHEMISTRY-US, V50, P9633, DOI 10.1021/bi201096w; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHESTER N, 1993, ANAL BIOCHEM, V209, P284, DOI 10.1006/abio.1993.1121; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erol O, 2010, CHEMBIOCHEM, V11, P1253, DOI 10.1002/cbic.201000085; Frias JA, 2011, J BIOL CHEM, V286, P10930, DOI 10.1074/jbc.M110.216127; Friedman L., 2008, U. S. Patent, Patent No. [WO2008147781A2, 2008147781, WO 2008/147781 A2]; Goblirsch BR, 2012, BIOCHEMISTRY-US, V51, P4138, DOI 10.1021/bi300386m; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Kancharla P, 2016, CHEMBIOCHEM, V17, P1426, DOI 10.1002/cbic.201600063; Kresovic D, 2015, BEILSTEIN J ORG CHEM, V11, P1412, DOI 10.3762/bjoc.11.152; MIZIORKO HM, 1976, BIOCHEM BIOPH RES CO, V69, P92, DOI 10.1016/S0006-291X(76)80277-X; Musayev F, 2005, J MOL BIOL, V346, P1313, DOI 10.1016/j.jmb.2004.12.044; Olsen JG, 2001, STRUCTURE, V9, P233, DOI 10.1016/S0969-2126(01)00583-4; Pan H, 2002, STRUCTURE, V10, P1559, DOI 10.1016/S0969-2126(02)00889-4; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Sachdeva S, 2008, CHEM BIOL, V15, P402, DOI 10.1016/j.chembiol.2008.03.007; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Sridharan S, 2007, J MOL BIOL, V366, P469, DOI 10.1016/j.jmb.2006.11.006; Sucipto H, 2015, CHEM SCI, V6, P5076, DOI 10.1039/c5sc01013f; Sucipto H, 2013, CHEMBIOCHEM, V14, P1581, DOI 10.1002/cbic.201300289; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3850, DOI 10.1128/AEM.00436-10; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3842, DOI 10.1128/AEM.00433-10; Theisen MJ, 2004, P NATL ACAD SCI USA, V101, P16442, DOI 10.1073/pnas.0405809101; Wackett L. P., 2015, DIRECT MICROBIAL CON, P442; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200	31	15	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26698	26706		10.1074/jbc.M116.760892	http://dx.doi.org/10.1074/jbc.M116.760892			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27815501	Green Published, hybrid			2022-12-28	WOS:000391571400010
J	Lee, H; Park, JJ; Nguyen, N; Park, JS; Hong, J; Kim, SH; Song, WY; Kim, HJ; Choi, K; Cho, S; Lee, JS; Kim, BW; Ko, YG				Lee, Hyun; Park, Jung-Jin; Nga Nguyen; Park, Jun Sub; Hong, Jin; Kim, Seung-Hyeob; Song, Woon Young; Kim, Hak Joong; Choi, Kwangman; Cho, Sungchan; Lee, Jae-Seon; Kim, Bong-Woo; Ko, Young-Gyu			MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) Interaction Disruptor Sensitizes Insulin Signaling in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE REPAIR; MUSCULAR-DYSTROPHY; MG53; INJURY; MYOGENESIS; OBESITY; KINASE; TRIM72	Mitsugumin 53 (MG53) is an E3 ligase that interacts with and ubiquitinates insulin receptor substrate-1 (IRS-1) in skeletal muscle; thus, an MG53-IRS-1 interaction disruptor (MID), which potentially sensitizes insulin signaling with an elevated level of IRS-1 in skeletal muscle, is an excellent candidate for treating insulin resistance. To screen for an MID, we developed a bimolecular luminescence complementation system using an N-terminal luciferase fragment fused with IRS-1 and a C-terminal luciferase fragment fused with an MG53 C14A mutant that binds to IRS-1 but does not have E3 ligase activity. An MID, which was discovered using the bimolecular luminescence complementation system, disrupted the molecular association of MG53 with IRS-1, thus abolishing MG53-mediated IRS-1 ubiquitination and degradation. Thus, the MID sensitized insulin signaling and increased insulin-elicited glucose uptake with an elevated level of IRS-1 in C2C12 myotubes. These data indicate that this MID holds promise as a drug candidate for treating insulin resistance.	[Lee, Hyun; Park, Jung-Jin; Nga Nguyen; Park, Jun Sub; Hong, Jin; Kim, Seung-Hyeob; Kim, Bong-Woo; Ko, Young-Gyu] Korea Univ, Div Life Sci, 145 Anam Ro, Seoul 02841, South Korea; [Song, Woon Young; Kim, Hak Joong] Korea Univ, Dept Chem, Seoul 02841, South Korea; [Choi, Kwangman; Cho, Sungchan] Korea Res Inst Biosci & Biotechnol, Targeted Med Res Ctr, Daejeon 34141, South Korea; [Lee, Jae-Seon] Inha Univ, Dept Biomed Sci, Coll Med, Inchon 22212, South Korea	Korea University; Korea University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Inha University	Ko, YG (corresponding author), Korea Univ, Div Life Sci, 145 Anam Ro, Seoul 02841, South Korea.; Kim, BW (corresponding author), Korea Univ, Tunneling Nanotube Res Ctr, 145 Anam Ro, Seoul 02841, South Korea.	kbw96@korea.ac.kr; ygko@korea.ac.kr	Song, Woon Young/AAC-5895-2019		Korea of Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health and Welfare, Republic of Korea [HI14C2739]; Korea University	Korea of Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea University	This work was supported by a grant from the Korea of Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HI14C2739; to Y.-G. K.). This work was also supported in part by a Korea University grant (to J.-J. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Duann P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010755; He B, 2012, MOL THER, V20, P727, DOI 10.1038/mt.2012.5; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Jia YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5387; Jung SY, 2010, BIOCHEM BIOPH RES CO, V396, P238, DOI 10.1016/j.bbrc.2010.04.072; Kim SC, 2014, AM J PHYSIOL-LUNG C, V307, pL449, DOI 10.1152/ajplung.00172.2014; Kim S, 2012, BMB REP, V45, P26, DOI 10.5483/BMBRep.2012.45.1.26; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Lee H, 2016, BMB REP, V49, P116, DOI 10.5483/BMBRep.2016.49.2.232; Lemckert FA, 2016, CARDIOVASC RES, V110, P178, DOI 10.1093/cvr/cvw017; Li HC, 2015, J BIOL CHEM, V290, P24592, DOI 10.1074/jbc.M115.680074; Lin PH, 2012, FASEB J, V26, P1875, DOI 10.1096/fj.11-188599; Nguyen N, 2014, J BIOL CHEM, V289, P3209, DOI 10.1074/jbc.M113.525154; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Tan T, 2016, BMB REP, V49, P414, DOI 10.5483/BMBRep.2016.49.8.079; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Yi JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3354; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440	25	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26627	26635		10.1074/jbc.M116.754424	http://dx.doi.org/10.1074/jbc.M116.754424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27810898	Green Published, hybrid			2022-12-28	WOS:000391571400004
J	Ko, YH; Domingo-Vidal, M; Roche, M; Lin, Z; Whitaker-Menezes, D; Seifert, E; Capparelli, C; Tuluc, M; Birbe, RC; Tassone, P; Curry, JM; Navarro-Sabate, A; Manzano, A; Bartrons, R; Caro, J; Martinez-Outschoorn, U				Ko, Ying-Hui; Domingo-Vidal, Marina; Roche, Megan; Lin, Zhao; Whitaker-Menezes, Diana; Seifert, Erin; Capparelli, Claudia; Tuluc, Madalina; Birbe, Ruth C.; Tassone, Patrick; Curry, Joseph M.; Navarro-Sabate, Aurea; Manzano, Anna; Bartrons, Ramon; Caro, Jaime; Martinez-Outschoorn, Ubaldo			TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-GROWTH; GLIOMA-CELLS; GLUCOSE-METABOLISM; FIBROBLASTS; AUTOPHAGY; HYPOXIA; PFKFB3; ROS; MITOCHONDRIA; MODULATION	A subgroup of breast cancers has several metabolic compartments. The mechanisms by which metabolic compartmentalization develop in tumors are poorly characterized. TP53 inducible glycolysis and apoptosis regulator (TIGAR) is a bisphosphatase that reduces glycolysis and is highly expressed in carcinoma cells in the majority of human breast cancers. Hence we set out to determine the effects of TIGAR expression on breast carcinoma and fibroblast glycolytic phenotype and tumor growth. The overexpression of this bisphosphatase in carcinoma cells induces expression of enzymes and transporters involved in the catabolism of lactate and glutamine. Carcinoma cells overexpressing TIGAR have higher oxygen consumption rates and ATP levels when exposed to glutamine, lactate, or the combination of glutamine and lactate. Coculture of TIGAR overexpressing carcinoma cells and fibroblasts compared with control cocultures induce more pronounced glycolytic differences between carcinoma and fibroblast cells. Carcinoma cells overexpressing TIGAR have reduced glucose uptake and lactate production. Conversely, fibroblasts in coculture with TIGAR overexpressing carcinoma cells induce HIF (hypoxia-inducible factor) activation with increased glucose uptake, increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3), and lactate dehydrogenase-A expression. We also studied the effect of this enzyme on tumor growth. TIGAR overexpression in carcinoma cells increases tumor growth in vivo with increased proliferation rates. However, a catalytically inactive variant of TIGAR did not induce tumor growth. Therefore, TIGAR expression in breast carcinoma cells promotes metabolic compartmentalization and tumor growth with a mitochondrial metabolic phenotype with lactate and glutamine catabolism. Targeting TIGAR warrants consideration as a potential therapy for breast cancer.	[Ko, Ying-Hui; Domingo-Vidal, Marina; Roche, Megan; Lin, Zhao; Whitaker-Menezes, Diana; Martinez-Outschoorn, Ubaldo] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA; [Seifert, Erin; Tuluc, Madalina] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Capparelli, Claudia] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Tassone, Patrick; Curry, Joseph M.] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Otolaryngol, Philadelphia, PA 19107 USA; [Birbe, Ruth C.] Cooper Univ Hosp, Dept Pathol, Camden, NJ 08103 USA; [Navarro-Sabate, Aurea; Manzano, Anna; Bartrons, Ramon] Univ Barcelona, Dept Physiol Sci, Barcelona 08907, Spain; [Caro, Jaime] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Dept Med, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Cooper University Hospital; University of Barcelona; Jefferson University	Martinez-Outschoorn, U (corresponding author), Sidney Kimmel Canc Ctr, Dept Med Oncol, 233 S 10th St Suite 909, Philadelphia, PA 19107 USA.	ubaldo.martinez-outschoorn@jefferson.edu	Tassone, Patrick/AAL-1306-2020; Navarro-Sabaté, Aurea/K-6329-2018; Manzano, Anna/ABG-3422-2020	Navarro-Sabaté, Aurea/0000-0002-8286-9732; Manzano, Anna/0000-0002-9106-3132; Birbe, Ruth/0000-0002-0651-2360; Curry, Joseph/0000-0001-9507-4237; Martinez-Outschoorn, Ubaldo/0000-0003-1483-4551	National Institutes of Health [NCI K08-CA175193, NCI 5 P30 CA 56036]; Instituto de Salud Carlos III-FIS [PI13/0096]; Fondo Europeo de Desarrollo Regional (FEDER); NATIONAL CANCER INSTITUTE [K08CA175193, P30CA056036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants NCI K08-CA175193 and NCI 5 P30 CA 56036. This work was also supported by Instituto de Salud Carlos III-FIS (PI13/0096) and Fondo Europeo de Desarrollo Regional (FEDER). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atsumi T, 2002, CANCER RES, V62, P5881; Augsten M, 2014, CANCER RES, V74, P2999, DOI 10.1158/0008-5472.CAN-13-2740; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Chen SS, 2015, CELL PHYSIOL BIOCHEM, V35, P997, DOI 10.1159/000369755; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Cheung EC, 2012, P NATL ACAD SCI USA, V109, P20491, DOI 10.1073/pnas.1206530109; Chiavarina B, 2012, CELL CYCLE, V11, P3280, DOI 10.4161/cc.21643; Curry JM, 2016, LARYNGOSCOPE, V126, P2410, DOI 10.1002/lary.25799; DeNicola GM, 2015, MOL CELL, V60, P514, DOI 10.1016/j.molcel.2015.10.018; Farmaki Elena, 2012, Genes Cancer, V3, P592, DOI 10.1177/1947601912474002; Gerin I, 2014, BIOCHEM J, V458, P439, DOI 10.1042/BJ20130841; Hanai J, 2002, J BIOL CHEM, V277, P16464, DOI 10.1074/jbc.M112274200; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kumar B, 2015, BIOCHIMIE, V118, P26, DOI 10.1016/j.biochi.2015.07.016; Lee P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.205; Lee P, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-1; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Lui VWY, 2011, ONCOGENE, V30, P1127, DOI 10.1038/onc.2010.490; Martinez-Outschoorn UE, 2015, NAT REV CANCER, V15, P225, DOI 10.1038/nrc3915; Martinez-Outschoorn UE, 2014, SEMIN CANCER BIOL, V25, P47, DOI 10.1016/j.semcancer.2014.01.005; Martinez-Outschoorn UE, 2012, CELL METAB, V15, P4, DOI 10.1016/j.cmet.2011.12.011; Martinez-Outschoorn UE, 2011, CANCER BIOL THER, V12, P924, DOI 10.4161/cbt.12.10.17780; Migneco G, 2010, CELL CYCLE, V9, P2412, DOI 10.4161/cc.9.12.11989; Novellasdemunt L, 2013, BIOCHEM J, V452, P531, DOI 10.1042/BJ20121886; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; OSBORNE CK, 1985, CANCER RES, V45, P584; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Pena-Rico MA, 2011, RADIOTHER ONCOL, V101, P132, DOI 10.1016/j.radonc.2011.07.002; Pusapati RV, 2016, CANCER CELL, V29, P548, DOI 10.1016/j.ccell.2016.02.018; Quaegebeur A, 2016, CELL METAB, V23, P280, DOI 10.1016/j.cmet.2015.12.007; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Sanchez-Alvarez R, 2013, CELL CYCLE, V12, P172, DOI 10.4161/cc.23058; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shekhar MPV, 2007, AM J PATHOL, V170, P1546, DOI 10.2353/ajpath.2007.061004; Simon-Molas H, 2016, FEBS LETT, V590, P2915, DOI 10.1002/1873-3468.12338; Sinha S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.128; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Sun ML, 2015, NEUROCHEM INT, V80, P99, DOI 10.1016/j.neuint.2014.09.006; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wanka C, 2012, J BIOL CHEM, V287, P33436, DOI 10.1074/jbc.M112.384578; Won KY, 2012, HUM PATHOL, V43, P221, DOI 10.1016/j.humpath.2011.04.021; Xie JM, 2014, CANCER RES, V74, P5127, DOI 10.1158/0008-5472.CAN-13-3517; Ye L, 2013, BIOCHEM BIOPH RES CO, V437, P300, DOI 10.1016/j.bbrc.2013.06.072; Zhao M, 2016, INT J ONCOL, V48, P756, DOI 10.3892/ijo.2015.3297; Zhou X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080576; Zou SB, 2012, MOL CELL BIOCHEM, V359, P17, DOI 10.1007/s11010-011-0993-0	53	46	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26291	26303		10.1074/jbc.M116.740209	http://dx.doi.org/10.1074/jbc.M116.740209			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27803158	Green Published, hybrid			2022-12-28	WOS:000391568200005
J	Kreko-Pierce, T; Azpurua, J; Mahoney, RE; Eaton, BA				Kreko-Pierce, Tabita; Azpurua, Jorge; Mahoney, Rebekah E.; Eaton, Benjamin A.			Extension of Health Span and Life Span in Drosophila by S107 Requires the calstabin Homologue FK506-BP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CALCIUM LEAK; OXIDATIVE DAMAGE THEORY; NAKED MOLE-RAT; CAENORHABDITIS-ELEGANS; SUPEROXIDE-DISMUTASE; RELEASE CHANNEL; STRESS; LONGEVITY; MELANOGASTER; RESVERATROL	The accumulation of oxidative damage is strongly linked to age-dependent declines in cell function, but the contribution of oxidative damage to morbidity is still debated. Many organisms seem to tolerate oxidative damage, and the extension of health span and life span by augmenting antioxidant activity has been inconsistent. Here we use the Drosophila model system to investigate the relationship among oxidative stress, health span, and life span. The oxidation-dependent dissociation of the Calstabin protein from the ryanodine receptor has been shown to result in reduced muscle function in mammals. The S107 molecule is able to reestablish this binding resulting in improved muscle function. We find that S107 is able to restore motor function in aging Drosophila to young levels, and this effect of S107 is absent in calstabin (FK506-BP2) mutants. Interestingly, FK506-BP2 mutant flies have reduced sensitivity to the effects of age and oxidative stress on motor function between 7 and 35 days of age. Muscle expression of FK506-BP2 in FK506-BP2 mutants completely restores the sensitivity of motor function to both age and oxidative stress, supporting the idea that the age-dependent decline in motor function in Drosophila requires FK506-BP2 function within the muscle. Although FK506-BP2 mutant flies are found to have less sensitivity to oxidative stress, FK506-BP2 mutants do not live longer than wild type. These results demonstrate that the deleterious effects of oxidation on motor function early in life are the result of a singular event that does not compromise survival.	[Kreko-Pierce, Tabita; Azpurua, Jorge; Mahoney, Rebekah E.; Eaton, Benjamin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Integrat & Cellular Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Eaton, BA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Integrat & Cellular Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	eatonb@uthscsa.edu			NIA, National Institutes of Health [P30-AG-013283]; National Institutes of Health [P40OD018537]	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge the Drosophila Aging Core of the Nathan Shock Center of Excellence in the Biology of Aging (which is supported in part by NIA, National Institutes of Health Grant P30-AG-013283) and the Bloomington Drosophila Stock Center (which is supported in part by National Institutes of Health Grant P40OD018537) for providing resources. Select immune reagents were also obtained from the Developmental Studies Hybridoma Bank, created by the NICHD, National Institutes of Health, and maintained at the University of Iowa Department of Biology.	Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Andziak B, 2005, MECH AGEING DEV, V126, P1206, DOI 10.1016/j.mad.2005.06.009; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6; Brunet-Rossinni AK, 2004, MECH AGEING DEV, V125, P11, DOI 10.1016/j.mad.2003.09.003; Canistro D, 2015, J GERONTOL A-BIOL, V70, P936, DOI 10.1093/gerona/glu160; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Duttaroy A, 2003, GENETICS, V165, P2295; Edrey YH, 2014, FREE RADICAL BIO MED, V71, P368, DOI 10.1016/j.freeradbiomed.2014.03.038; Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Gao SY, 2013, ANESTHESIOLOGY, V118, P587, DOI 10.1097/ALN.0b013e31827e52c6; Gems D, 2009, CELL CYCLE, V8, P1681, DOI 10.4161/cc.8.11.8595; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Grimes KM, 2014, AM J PHYSIOL-HEART C, V307, pH284, DOI 10.1152/ajpheart.00305.2014; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Krivoruchko A, 2010, OXID MED CELL LONGEV, V3, P186, DOI 10.4161/oxim.3.3.12356; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Lewis KN, 2013, ANTIOXID REDOX SIGN, V19, P1388, DOI 10.1089/ars.2012.4911; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Mahoney RE, 2014, J NEUROSCI, V34, P2111, DOI 10.1523/JNEUROSCI.3556-13.2014; Mei YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054208; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Montgomery MK, 2012, EXP GERONTOL, V47, P211, DOI 10.1016/j.exger.2011.11.014; Ondrias K, 1998, ANN NY ACAD SCI, V853, P149, DOI 10.1111/j.1749-6632.1998.tb08263.x; ORR WC, 1993, ARCH BIOCHEM BIOPHYS, V301, P34, DOI 10.1006/abbi.1993.1111; Parker JD, 2004, P NATL ACAD SCI USA, V101, P3486, DOI 10.1073/pnas.0400222101; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Rawson JM, 2012, AGING CELL, V11, P418, DOI 10.1111/j.1474-9726.2012.00799.x; Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102; Tong MM, 2016, CURR MOL PHARMACOL, V9, P48, DOI 10.2174/1874467208666150519113541; Toroser D, 2007, BIOCHEM BIOPH RES CO, V363, P418, DOI 10.1016/j.bbrc.2007.08.193; Umanskaya A, 2014, P NATL ACAD SCI USA, V111, P15250, DOI 10.1073/pnas.1412754111; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu SW, 2006, BRAIN, V129, P1470, DOI 10.1093/brain/awl077; Yan LJ, 2014, REDOX BIOL, V2, P165, DOI 10.1016/j.redox.2014.01.002; Zheng JY, 2005, AGING CELL, V4, P209, DOI 10.1111/j.1474-9726.2005.00159.x	49	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26045	26055		10.1074/jbc.M116.758839	http://dx.doi.org/10.1074/jbc.M116.758839			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803160	Green Published, hybrid			2022-12-28	WOS:000390345200024
J	Blackburn, PR; Tischer, A; Zimmermann, MT; Kemppainen, JL; Sastry, S; Knight Johnson, AE; Cousin, MA; Boczek, NJ; Oliver, G; Misra, VK; Gavrilova, RH; Lomberk, G; Auton, M; Urrutia, R; Klee, EW				Blackburn, Patrick R.; Tischer, Alexander; Zimmermann, Michael T.; Kemppainen, Jennifer L.; Sastry, Sujatha; Knight Johnson, Amy E.; Cousin, Margot A.; Boczek, Nicole J.; Oliver, Gavin; Misra, Vinod K.; Gavrilova, Ralitza H.; Lomberk, Gwen; Auton, Matthew; Urrutia, Raul; Klee, Eric W.			A Novel Kleefstra Syndrome-associated Variant That Affects the Conserved TPLX Motif within the Ankyrin Repeat of EHMT1 Leads to Abnormal Protein Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA sequencing; functional genomics; genetic disease; molecular dynamics; molecular modeling; 9q34 deletion syndrome; EHMT1; GLP; Kleefstra syndrome; functional validation	SUBTELOMERIC DELETION SYNDROME; MUTATIONS; RECOGNITION; P16(INK4A); PREDICTION; BEHAVIOR; FAMILY; GLP; G9A	Kleefstra syndrome (KS) (Mendelian Inheritance in Man (MIM) no. 610253), also known as 9q34 deletion syndrome, is an autosomal dominant disorder caused by haploinsufficiency of euchromatic histone methyltransferase-1 (EHMT1). The clinical phenotype of KS includes moderate to severe intellectual disability with absent speech, hypotonia, brachycephaly, congenital heart defects, and dysmorphic facial features with hypertelorism, synophrys, macroglossia, protruding tongue, and prognathism. Only a few cases of de novo missense mutations in EHMT1 giving rise to KS have been described. However, some EHMT1 variants have been described in individuals presenting with autism spectrum disorder or mild intellectual disability, suggesting that the phenotypic spectrum resulting from EHMT1 alterations may be quite broad. In this report, we describe two unrelated patients with complex medical histories consistent with KS in whom next generation sequencing identified the same novel c.2426C>T (p.P809L) missense variant in EHMT1. To examine the functional significance of this novel variant, we performed molecular dynamics simulations of the wild type and p.P809L variant, which predicted that the latter would have a propensity to misfold, leading to abnormal histone mark binding. Recombinant EHMT1 p.P809L was also studied using far UV circular dichroism spectroscopy and intrinsic protein fluorescence. These functional studies confirmed the model-based hypotheses and provided evidence for protein misfolding and aberrant target recognition as the underlying pathogenic mechanism for this novel KS-associated variant. This is the first report to suggest that missense variants in EHMT1 that lead to protein misfolding and disrupted histone mark binding can lead to KS.	[Blackburn, Patrick R.] Mayo Clin, Ctr Individualized Med, Jacksonville, FL 32224 USA; [Blackburn, Patrick R.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Tischer, Alexander; Auton, Matthew] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA; [Tischer, Alexander; Auton, Matthew] Mayo Clin, Div Hematol, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Zimmermann, Michael T.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Kemppainen, Jennifer L.; Gavrilova, Ralitza H.; Klee, Eric W.] Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA; [Kemppainen, Jennifer L.; Cousin, Margot A.; Boczek, Nicole J.; Oliver, Gavin; Klee, Eric W.] Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA; [Cousin, Margot A.; Boczek, Nicole J.; Klee, Eric W.] Mayo Clin, Dept Hlth Sci Res, 200 First St SW,Harwick 3-71, Rochester, MN 55905 USA; [Gavrilova, Ralitza H.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Lomberk, Gwen; Urrutia, Raul] Mayo Clin, Ctr Individualized Med, Epigen Translat Program, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Sastry, Sujatha; Misra, Vinod K.] Wayne State Univ, Sch Med, Dept Pediat, Div Genet & Metab Disorders, Detroit, MI 48201 USA; [Knight Johnson, Amy E.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Wayne State University; University of Chicago	Klee, EW (corresponding author), Mayo Clin, Dept Hlth Sci Res, 200 First St SW,Harwick 3-71, Rochester, MN 55905 USA.; Urrutia, R (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW,Guggenheim Bldg 10-42C, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu; klee.eric@mayo.edu	Cousin, Margot/AAD-4591-2019; Lomberk, Gwen/AAL-8490-2020	Cousin, Margot/0000-0002-6119-9346; Lomberk, Gwen/0000-0001-5463-789X; Zimmermann, Michael/0000-0001-7073-0525; Oliver, Gavin/0000-0002-9948-3799; Misra, Vinod/0000-0002-9566-5579	Mayo Clinic Center for Individualized Medicine through the Investigative and Functional Genomics Program; NIDDK; National Institutes of Health [RO1 52913, P30 084567, P50CA102701]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R01CA178627, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER	Mayo Clinic Center for Individualized Medicine through the Investigative and Functional Genomics Program; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Mayo Clinic Center for Individualized Medicine through the Investigative and Functional Genomics Program. This work was also supported by NIDDK, National Institutes of Health Grants RO1 52913, P30 084567, and P50CA102701 (to R. A. U.) and by the Mayo Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balemans MCM, 2013, HUM MOL GENET, V22, P852, DOI 10.1093/hmg/dds490; Balemans MCM, 2010, BEHAV BRAIN RES, V208, P47, DOI 10.1016/j.bbr.2009.11.008; Barrick D, 2008, CURR OPIN STRUC BIOL, V18, P27, DOI 10.1016/j.sbi.2007.12.004; Benevento M, 2016, NEURON, V91, P341, DOI 10.1016/j.neuron.2016.06.003; BIOVIA, 2017, DASS SYST BIOVIA DIS; Cammett TJ, 2003, J MOL BIOL, V327, P285, DOI 10.1016/S0022-2836(03)00043-3; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; He X, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000058; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kleefstra T, 2009, J MED GENET, V46, P598, DOI 10.1136/jmg.2008.062950; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; R Core Team, 2014, R FDN STAT COMP; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rump A, 2013, EUR J HUM GENET, V21, P887, DOI 10.1038/ejhg.2012.267; Samango-Sprouse C, 2016, AM J MED GENET A, V170, P1312, DOI 10.1002/ajmg.a.37575; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Urrutia R, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2357-7; Velez G, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-015-2874-z; Willemsen MH, 2011, MOL SYNDROMOL, V2, P202, DOI 10.1159/000335648; Willemsen MH, 2011, CLIN GENET, V80, P31, DOI 10.1111/j.1399-0004.2010.01607.x; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhang B, 2002, BIOCHEMISTRY-US, V41, P6293, DOI 10.1021/bi0117100	39	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3866	3876		10.1074/jbc.M116.770545	http://dx.doi.org/10.1074/jbc.M116.770545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28057753	Green Published, hybrid			2022-12-28	WOS:000395542500027
J	Gunera, J; Kindinger, F; Li, SM; Kolb, P				Gunera, Jakub; Kindinger, Florian; Li, Shu-Ming; Kolb, Peter			PrenDB, a Substrate Prediction Database to Enable Biocatalytic Use of Prenyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-FUMIGATUS; OVERPRODUCTION; PURIFICATION; GENERATION; DOCKING	Prenyltransferases of the dimethylallyltryptophan synthase (DMATS) superfamily catalyze the attachment of prenyl or prenyl-like moieties to diverse acceptor compounds. These acceptor molecules are generally aromatic in nature and mostly indole or indole-like. Their catalytic transformation represents a major skeletal diversification step in the biosynthesis of secondary metabolites, including the indole alkaloids. DMATS enzymes thus contribute significantly to the biological and pharmacological diversity of small molecule metabolites. Understanding the substrate specificity of these enzymes could create opportunities for their biocatalytic use in preparing complex synthetic scaffolds. However, there has been no framework to achieve this in a rational way. Here, we report a chemoinformatic pipeline to enable prenyltransferase substrate prediction. We systematically catalogued 32 unique prenyltransferases and 167 unique substrates to create possible reaction matrices and compiled these data into a browsable database named PrenDB. We then used a newly developed algorithm based on molecular fragmentation to automatically extract reactive chemical epitopes. The analysis of the collected data sheds light on the thus far explored substrate space of DMATS enzymes. To assess the predictive performance of our virtual reaction extraction tool, 38 potential substrates were tested as prenyl acceptors in assays with three prenyltransferases, and we were able to detect turnover in > 55% of the cases. The database, PrenDB (www. kolblab. org/prendb. php), enables the prediction of potential substrates for chemoenzymatic synthesis through substructure similarity and virtual chemical transformation techniques. It aims at making prenyltransferases and their highly regio-and stereoselective reactions accessible to the research community for integration in synthetic work flows.	[Gunera, Jakub; Kolb, Peter] Philipps Univ, Dept Pharmaceut Chem, D-35032 Marburg, Hesse, Germany; [Kindinger, Florian; Li, Shu-Ming] Philipps Univ, Inst Pharmaceut Biol & Biotechnol, D-35032 Marburg, Hesse, Germany; [Gunera, Jakub; Li, Shu-Ming; Kolb, Peter] Philipps Univ, LOEWE Ctr Synthet Microbiol, Synmikro, D-35043 Marburg, Hesse, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Kolb, P (corresponding author), Philipps Univ, Dept Pharmaceut Chem, D-35032 Marburg, Hesse, Germany.; Li, SM (corresponding author), Philipps Univ, Inst Pharmaceut Biol & Biotechnol, D-35032 Marburg, Hesse, Germany.; Li, SM; Kolb, P (corresponding author), Philipps Univ, LOEWE Ctr Synthet Microbiol, Synmikro, D-35043 Marburg, Hesse, Germany.	shuming.li@staff.uni-marburg.de; peter.kolb@uni-marburg.de	Kolb, Peter/A-3782-2008	Kolb, Peter/0000-0003-4089-614X	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Frank Balzer for help with making PrenDB available online and Christian Raab for data processing during the implementation. S.-M.L. acknowledges the Deutsche Forschungsgemeinschaft for funding the Bruker micrOTOF-Q III mass spectrometer.	Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241; Fan AL, 2015, APPL MICROBIOL BIOT, V99, P7399, DOI 10.1007/s00253-015-6813-9; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Gunera J, 2015, J COMPUT CHEM, V36, P1597, DOI 10.1002/jcc.23974; Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Li SM, 2010, NAT PROD REP, V27, P57, DOI 10.1039/b909987p; Liu AH, 2013, BIOORG MED CHEM LETT, V23, P2491, DOI 10.1016/j.bmcl.2013.03.038; Mai P, 2016, ADV SYNTH CATAL, V358, P1639, DOI 10.1002/adsc.201600064; McGann M, 2012, J COMPUT AID MOL DES, V26, P897, DOI 10.1007/s10822-012-9584-8; Oya A, 2015, J NAT PROD, V78, P258, DOI 10.1021/np500827h; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Schomburg K, 2010, J CHEM INF MODEL, V50, P1529, DOI 10.1021/ci100209a; Sunassee SN, 2012, NAT PROD REP, V29, P513, DOI 10.1039/c2np00086e; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Winkelblech J, 2015, APPL MICROBIOL BIOT, V99, P7379, DOI 10.1007/s00253-015-6811-y; Wollinsky B, 2012, BIOORG MED CHEM LETT, V22, P3866, DOI 10.1016/j.bmcl.2012.04.119; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Yin WB, 2007, CHEMBIOCHEM, V8, P1154, DOI 10.1002/cbic.200700079	22	4	4	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4003	4021		10.1074/jbc.M116.759118	http://dx.doi.org/10.1074/jbc.M116.759118			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	28007960	Green Published, hybrid			2022-12-28	WOS:000395837100005
J	Liu, YD; Liu, HO; Yang, L; Wu, Q; Liu, WS; Fu, Q; Zhang, WJ; Zhang, HJ; Xu, JJ; Gu, J				Liu, Yidong; Liu, Haiou; Yang, Liu; Wu, Qian; Liu, Weisi; Fu, Qiang; Zhang, Weijuan; Zhang, Haijian; Xu, Jiejie; Gu, Jianxin			Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anoikis; glycobiology; glycosyltransferase; hepatocellular carcinoma; microRNA (miRNA); migration; post-transcriptional regulation; GALNT4; Prognostic biomarker; microRNA-9	POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; VIRUS X PROTEIN; O-GLYCOSYLATION; PANCREATIC-CANCER; POOR-PROGNOSIS; EXPRESSION; CELLS; TRANSFERASES; INVASION; GROWTH	Deregulated expression of N-acetylgalactosaminyltransferases (GALNTs), which is responsible for the initial step of mucin-type O-glycosylation, could produce abnormal truncated O-glycans and thereby exert pivotal functions during malignant transformation. GALNT4 is one of the few isoforms preferring to catalyze partial GalNAc-glycosylated substrates and modify the sites not utilized by other known GALNTs. This study aims to evaluate the impact of GALNT4 expression on malignant transformation of hepatocellular carcinoma (HCC). Immunohistochemistry and in situ hybridization analysis were performed to assess GALNT4 and miR-9 level in clinical specimens, respectively. GALNT4 expression is markedly repressed in primary HCC tissues, and reduced expression of GALNT4 is significantly associated with adverse survival of patients with HCC. Functional investigations demonstrate that repressed GALNT4 could promote migration, invasion, anoikis resistance, and stemness of HCC cells in vitro as well as tumor growth in vivo. The wild-type GALNT4 could modify O-linked glycosylation on EGFR and thus modulate the activity of EGFR. A luciferase activity assay further identified microRNA-9 (miR-9) as the crucial specific arbitrator for GALNT4 expression in HCC cells. Furthermore, restoring GALNT4 expression attenuates miR-9-mediated oncogenic functions. Kaplan-Meier survival analysis indicates that the miR-9/GALNT4 expression signature yields promising prognostic significance to refine the risk stratification of patients with HCC. In conclusion, this study establishes the miR-9/GALNT4 axis as a potential adverse prognostic factor and therapeutic target for HCC patients.	[Liu, Yidong; Yang, Liu; Wu, Qian; Liu, Weisi; Fu, Qiang; Zhang, Haijian; Xu, Jiejie; Gu, Jianxin] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Zhang, Weijuan] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China; [Liu, Haiou] Fudan Univ, Hosp Obstet & Gynecol, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, JJ; Gu, J (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China.	jjxufdu@fudan.edu.cn; jxgu@shmu.edu.cn	Zhang, Weijuan/Q-1645-2019	Zhang, Weijuan/0000-0003-3494-3114; Zhang, Haijian/0000-0003-2516-4215; liu, weisi/0000-0002-4730-5448	National Key Projects for Infectious Diseases of China [2012ZX10002012-007, 2016ZX10002018-008]; National Natural Science Foundation of China [31100629, 31270863, 81401988, 81471621, 81472227, 31570803, 81572352]; Program for New Century Excellent Talents in University [NCET-13-0146]	National Key Projects for Infectious Diseases of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Key Projects for Infectious Diseases of China Grants 2012ZX10002012-007 and 2016ZX10002018-008; National Natural Science Foundation of China Grants 31100629, 31270863, 81401988, 81471621, 81472227, 31570803, and 81572352; and Program for New Century Excellent Talents in University Grant NCET-13-0146. The authors declare that they have no conflicts of interest with the contents of this article.	Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Drakaki A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1562-9; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Gu C, 2004, BRIT J CANCER, V90, P436, DOI 10.1038/sj.bjc.6601531; Gwak JM, 2014, BREAST CANCER RES TR, V147, P39, DOI 10.1007/s10549-014-3069-5; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Huang MJ, 2015, ONCOTARGET, V6, P5650, DOI 10.18632/oncotarget.3117; Kitada S, 2013, BRIT J CANCER, V109, P472, DOI 10.1038/bjc.2013.331; Li Z, 2011, BRIT J CANCER, V104, P1882, DOI 10.1038/bjc.2011.166; Liu HO, 2012, CANCER SCI, V103, P2072, DOI 10.1111/cas.12017; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Rountree CB, 2012, HEPATOLOGY, V55, P298, DOI 10.1002/hep.24762; Sun Z, 2013, MOL ONCOL, V7, P884, DOI 10.1016/j.molonc.2013.04.007; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wu Q, 2015, J BIOL CHEM, V290, P1170, DOI 10.1074/jbc.M114.601203; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yang NN, 2015, ADV DRUG DELIVER REV, V81, P62, DOI 10.1016/j.addr.2014.10.029	32	22	24	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3186	3200		10.1074/jbc.M116.751685	http://dx.doi.org/10.1074/jbc.M116.751685			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28062574	Green Published, hybrid			2022-12-28	WOS:000395538800012
J	Boros, E; Szabo, A; Zboray, K; Heja, D; Pal, G; Sahin-Toth, M				Boros, Eszter; Szabo, Andras; Zboray, Katalin; Heja, David; Pal, Gabor; Sahin-Toth, Miklos			Overlapping Specificity of Duplicated Human Pancreatic Elastase 3 Isoforms and Archetypal Porcine Elastase 1 Provides Clues to Evolution of Digestive Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LEUKOCYTE ELASTASE; CLONED MESSENGER-RNA; PROTEASE-E; ACTIVE-SITE; SEQUENCE-ANALYSIS; PHAGE-DISPLAY; PROCARBOXYPEPTIDASE-A; MOLECULAR-CLONING; ACID-SEQUENCES; CATHEPSIN-G	Chymotrypsin-like elastases (CELAs) are pancreatic serine proteinases that digest dietary proteins. CELAs are typically expressed in multiple isoforms that can vary among different species. The human pancreas does not express CELA1 but secretes two CELA3 isoforms, CELA3A and CELA3B. The reasons for the CELA3 duplication and the substrate preferences of the duplicated isoforms are unclear. Here, we tested whether CELA3A and CELA3B evolved unique substrate specificities to compensate for the loss of CELA1. We constructed a phage library displaying variants of the substrate-like Schistocerca gregaria proteinase inhibitor 2 (SGPI-2) to select reversible high affinity inhibitors of human CELA3A, CELA3B, and porcine CELA1. Based on the reactive loop sequences of the phage display selected inhibitors, we recombinantly expressed and purified 12 SGPI-2 variants and determined their binding affinities. Wefound that the primary specificity of CELA3A, CELA3B, and CELA1 was similar; all preferred aliphatic side chains at the socalled P1 position, the amino acid residue located directly N-terminal to the scissile peptide bond. P1 Met was an interesting exception that was preferred by CELA1 but weakly recognized by the CELA3 isoforms. The extended substrate specificity of CELA3A and CELA3B was comparable, whereas CELA1 exhibited unique interactions at several subsites. These observations indicated that the CELA1 and CELA3 paralogs have some different but also overlapping specificities and that the duplicated CELA3A and CELA3B isoforms did not evolve distinct substrate preferences. Thus, increased gene dosage rather than specificity divergence of the CELA3 isoforms may compensate for the loss of CELA1 digestive activity in the human pancreas.	[Boros, Eszter; Zboray, Katalin; Heja, David; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Ctr Exocrine Disorders, Boston, MA 02118 USA; [Boros, Eszter; Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA	Eotvos Lorand University; Boston University; Boston University	Pal, G (corresponding author), Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.; Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	gabor.pal@ttk.elte.hu; miklos@bu.edu	Pal, Gabor/A-6244-2009	Pal, Gabor/0000-0001-7868-7971; Boros, Eszter/0000-0002-0639-4739; Sahin-Toth, Miklos/0000-0003-4513-9922; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01DK095753, R01DK082412, R01DK058088]; National Research, Development and Innovation Office (NKFIH) [NK100769, K119386]; National Development Agency [KMOP-4.2.1/B-102011]; MedInProt Program of the Hungarian Academy of Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082412, R01DK058088, R01DK095753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research, Development and Innovation Office (NKFIH); National Development Agency; MedInProt Program of the Hungarian Academy of Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK095753, R01DK082412, and R01DK058088 (to M.S.T.), National Research, Development and Innovation Office (NKFIH) Grants NK100769 and K119386, National Development Agency Grant KMOP-4.2.1/B-102011, and the MedInProt Program of the Hungarian Academy of Sciences (to G.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARDELT W, 1974, BIOCHIM BIOPHYS ACTA, V341, P318, DOI 10.1016/0005-2744(74)90224-1; ARDELT W, 1979, ACTA BIOCHIM POL, V26, P267; ATLAS D, 1970, FEBS LETT, V11, P281, DOI 10.1016/0014-5793(70)80548-8; ATLAS D, 1975, J MOL BIOL, V93, P39, DOI 10.1016/0022-2836(75)90358-7; BALO J, 1950, BIOCHEM J, V46, P384, DOI 10.1042/bj0460384; BALO J, 1949, NATURE, V164, P491, DOI 10.1038/164491a0; BIETH J, 1973, BIOCHEM BIOPH RES CO, V53, P383, DOI 10.1016/0006-291X(73)90673-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DELMAR EG, 1980, BIOCHEMISTRY-US, V19, P468, DOI 10.1021/bi00544a011; EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002; FIGARELLA C, 1992, INT J PANCREATOL, V11, P213; FLETCHER TS, 1987, BIOCHEMISTRY-US, V26, P7256, DOI 10.1021/bi00397a010; GERTLER A, 1971, EUR J BIOCHEM, V20, P541, DOI 10.1111/j.1432-1033.1971.tb01425.x; GERTLER A, 1977, BIOCHEMISTRY-US, V16, P2709, DOI 10.1021/bi00631a019; Gestin M, 1997, COMP BIOCHEM PHYS B, V118, P181, DOI 10.1016/S0305-0491(97)00031-X; Gomis-Ruth FX, 1998, EUR J BIOCHEM, V251, P839, DOI 10.1046/j.1432-1327.1998.2510839.x; HARPER JW, 1984, BIOCHEMISTRY-US, V23, P2995, DOI 10.1021/bi00308a023; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; KASAFIREK E, 1976, EUR J BIOCHEM, V69, P1, DOI 10.1111/j.1432-1033.1976.tb10852.x; KAWASHIMA I, 1987, DNA-J MOLEC CELL BIO, V6, P163, DOI 10.1089/dna.1987.6.163; KERFELEC B, 1985, EUR J BIOCHEM, V151, P515, DOI 10.1111/j.1432-1033.1985.tb09132.x; KOBAYASHI R, 1981, J BIOL CHEM, V256, P2460; KOBAYASHI R, 1978, J BIOL CHEM, V253, P5526; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; LAMY F, 1961, J BIOL CHEM, V236, P86; LARGMAN C, 1976, BIOCHEMISTRY-US, V15, P2491, DOI 10.1021/bi00656a036; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; LEDOUX M, 1975, CAN J BIOCHEM CELL B, V53, P421, DOI 10.1139/o75-058; MACDONALD RJ, 1982, BIOCHEMISTRY-US, V21, P1453, DOI 10.1021/bi00535a053; MALLORY PA, 1975, BIOCHEMISTRY-US, V14, P722, DOI 10.1021/bi00675a012; NARAYANAN AS, 1969, BIOCHEM J, V114, P11, DOI 10.1042/bj1140011; NAUGHTON MA, 1961, BIOCHEM J, V78, P156, DOI 10.1042/bj0780156; Nozach H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-37; OHLSSON K, 1976, H-S Z PHYSIOL CHEM, V357, P1153, DOI 10.1515/bchm2.1976.357.2.1153; POWERS JC, 1977, BIOCHIM BIOPHYS ACTA, V485, P156, DOI 10.1016/0005-2744(77)90203-0; RENAUD A, 1983, J BIOL CHEM, V258, P8312; Rose SD, 1997, HUM MOL GENET, V6, P897, DOI 10.1093/hmg/6.6.897; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHELLENBERGER V, 1989, EUR J BIOCHEM, V179, P161, DOI 10.1111/j.1432-1033.1989.tb14534.x; SHEN W, 1987, BIOCHEMISTRY-US, V26, P3447, DOI 10.1021/bi00386a030; SHIRASU Y, 1987, J BIOCHEM-TOKYO, V102, P1555, DOI 10.1093/oxfordjournals.jbchem.a122204; SHIRASU Y, 1988, J BIOCHEM-TOKYO, V104, P259, DOI 10.1093/oxfordjournals.jbchem.a122454; SHOTTON D M, 1970, Nature (London), V225, P811, DOI 10.1038/225811a0; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Szabo A, 2016, J BIOL CHEM, V291, P17706, DOI 10.1074/jbc.M116.743237; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szenthe B, 2007, J MOL BIOL, V370, P63, DOI 10.1016/j.jmb.2007.04.029; Szepessy E, 2006, PANCREATOLOGY, V6, P117, DOI 10.1159/000090031; SZIEGOLEIT A, 1984, BIOCHEM J, V219, P735, DOI 10.1042/bj2190735; SZIEGOLEIT A, 1982, BIOCHEM J, V207, P573, DOI 10.1042/bj2070573; SZIEGOLEIT A, 1985, EUR J BIOCHEM, V151, P595, DOI 10.1111/j.1432-1033.1985.tb09145.x; TANI T, 1987, J BIOCHEM-TOKYO, V101, P591, DOI 10.1093/jb/101.3.591; TANI T, 1988, J BIOL CHEM, V263, P1231; URAM M, 1969, BIOCHIM BIOPHYS ACTA, V194, P102, DOI 10.1016/0005-2795(69)90185-8; VERED M, 1985, INT J PEPT PROT RES, V25, P76	56	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2690	2702		10.1074/jbc.M116.770560	http://dx.doi.org/10.1074/jbc.M116.770560			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28062577	Green Published, hybrid			2022-12-28	WOS:000395535100012
J	Calvez, P; Breukink, E; Roper, DI; Dib, M; Contreras-Martel, C; Zapun, A				Calvez, Philippe; Breukink, Eefjan; Roper, David I.; Dib, Melanie; Contreras-Martel, Carlos; Zapun, Andre			Substitutions in PBP2b from beta-Lactam-resistant Streptococcus pneumoniae Have Different Effects on Enzymatic Activity and Drug Reactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; THERMAL SHIFT ASSAYS; PEPTIDOGLYCAN SYNTHESIS; CRYSTAL-STRUCTURE; MECHANISM; MANAGEMENT; DIAGNOSIS; REVEALS; PBP1A; 2X	Pneumococcus resists beta-lactams by expressing variants of its target enzymes, the penicillin-binding proteins (PBPs), with many amino acid substitutions. Up to 10% of the sequence can be modified. These altered PBPs have a much reduced reactivity with the drugs but retain their physiological activity of crosslinking the peptidoglycan, the major constituent of the bacterial cell wall. However, because beta-lactams are chemical and structural mimics of the natural substrate, resistance mediated by altered PBPs raises the following paradox: how PBPs that react poorly with the drugs maintain a sufficient level of activity with the physiological substrate. This question is addressed for the first time in this study, which compares the peptidoglycan crosslinking activity of PBP2b from susceptible and resistant strains with their inhibition by different beta-lactams. Unexpectedly, the enzymatic activity of the variants did not correlate with their antibiotic reactivity. This finding indicates that some of the numerous amino acid substitutions were selected to restore a viable level of enzymatic activity by a compensatory molecular mechanism.	[Calvez, Philippe; Dib, Melanie; Contreras-Martel, Carlos; Zapun, Andre] Univ Grenoble Alpes, Inst Biol Struct, CEA, CNRS, F-38044 Grenoble, France; [Breukink, Eefjan] Univ Utrecht, Bijvoet Ctr Biomol Res, Inst Biomembranes, Dept Chem Biol & Organ Chem, NL-3584 CH Utrecht, Netherlands; [Roper, David I.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Utrecht University; University of Warwick	Zapun, A (corresponding author), Inst Biol Struct, 71 Ave Martyrs, F-38044 Grenoble, France.	andre.zapun@ibs.fr	Roper, David I/A-2323-2011; Breukink, Eefjan/I-3039-2016; Contreras-Martel, Carlos/AAA-1212-2021	Roper, David I/0000-0003-0009-621X; Breukink, Eefjan/0000-0002-7311-0660; Zapun, Andre/0000-0001-8953-4399	Agence Nationale de la Recherche [ORBiMP ANR-14-CE14-0003-01]; FRISBI [ANR-10-INSB-05-02]; GRAL Grant within the Grenoble Partnership for Structural Biology [ANR-10-LABX-49-01]; Biotechnology and Biological Sciences Research Council [BB/N003241/1] Funding Source: researchfish; Medical Research Council [G0500643] Funding Source: researchfish; BBSRC [BB/N003241/1] Funding Source: UKRI; MRC [G0500643] Funding Source: UKRI	Agence Nationale de la Recherche(French National Research Agency (ANR)); FRISBI; GRAL Grant within the Grenoble Partnership for Structural Biology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grant ORBiMP ANR-14-CE14-0003-01 from the Agence Nationale de la Recherche and used the platforms of the Grenoble Instruct Center (UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI Grant ANR-10-INSB-05-02 and GRAL Grant ANR-10-LABX-49-01 within the Grenoble Partnership for Structural Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Abrahams K. A., 2011, THESIS; [Anonymous], 2003, Weekly Epidemiological Record, V78, P110; Berg KH, 2013, J BACTERIOL, V195, P4342, DOI 10.1128/JB.00184-13; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Bui NK, 2012, ANAL BIOCHEM, V421, P657, DOI 10.1016/j.ab.2011.11.026; Carapito R, 2006, J BIOL CHEM, V281, P1771, DOI 10.1074/jbc.M511506200; Chesnel L, 2005, ANTIMICROB AGENTS CH, V49, P2895, DOI 10.1128/AAC.49.7.2895-2902.2005; Chesnel L, 2003, J BIOL CHEM, V278, P44448, DOI 10.1074/jbc.M305948200; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Contreras-Martel C, 2009, J MOL BIOL, V387, P899, DOI 10.1016/j.jmb.2009.02.024; Control for Disease Control and Prevention, 2015, ANT RES THREATS US; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel H, 2014, ANTIMICROB AGENTS CH, V58, P3934, DOI 10.1128/AAC.02547-14; Figueiredo TA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002508; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Filipe SR, 2002, P NATL ACAD SCI USA, V99, P1550, DOI 10.1073/pnas.032671699; GHUYSEN JM, 1986, BIOCHEM J, V235, P159, DOI 10.1042/bj2350159; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Graves-Woodward K, 1998, BIOCHEM J, V332, P755, DOI 10.1042/bj3320755; HAKENBECK R, 1987, J GEN MICROBIOL, V133, P755; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Helassa N, 2012, FEBS J, V279, P2071, DOI 10.1111/j.1742-4658.2012.08592.x; Job V, 2008, J BIOL CHEM, V283, P4886, DOI 10.1074/jbc.M706181200; Kardos N, 2011, APPL MICROBIOL BIOT, V92, P677, DOI 10.1007/s00253-011-3587-6; Kocaoglu O, 2015, ANTIMICROB AGENTS CH, V59, P3548, DOI 10.1128/AAC.05142-14; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noirclerc-Savoye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075522; Pagliero E, 2004, ANTIMICROB AGENTS CH, V48, P1848, DOI 10.1128/AAC.48.5.1848-1855.2004; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Philippe J, 2015, ANTIMICROB AGENTS CH, V59, P609, DOI 10.1128/AAC.04283-14; Sauerbier J, 2012, MOL MICROBIOL, V86, P692, DOI 10.1111/mmi.12009; Shapiro AB, 2013, ANAL BIOCHEM, V439, P37, DOI 10.1016/j.ab.2013.04.009; Shulman ST, 2012, CLIN INFECT DIS, V55, pE86, DOI 10.1093/cid/cis629; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; Tsui HCT, 2014, MOL MICROBIOL, V94, P21, DOI 10.1111/mmi.12745; Tsui HCT, 2016, MOL MICROBIOL, V100, P1039, DOI 10.1111/mmi.13366; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zapun A., 2016, ANTIBIOTICS, V5, pE35; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; Zapun A, 2013, ACS CHEM BIOL, V8, P2688, DOI 10.1021/cb400575t	47	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2854	2865		10.1074/jbc.M116.764696	http://dx.doi.org/10.1074/jbc.M116.764696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28062575	Green Published, hybrid			2022-12-28	WOS:000395535100025
J	Li, R; Yuan, FJ; Fu, W; Zhang, LY; Zhang, N; Wang, YA; Ma, K; Li, X; Wang, LN; Zhu, WG; Zhao, Y				Li, Ran; Yuan, Fengjie; Fu, Wan; Zhang, Luyao; Zhang, Nan; Wang, Yanan; Ma, Ke; Li, Xue; Wang, Lina; Zhu, Wei-Guo; Zhao, Ying			Serine/Threonine Kinase Unc-51-like Kinase-1 (Ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (Cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBIT AUTOPHAGY; ATG PROTEINS; COMPLEX; HSP90; GROWTH; DEGRADATION; ACTIVATION; BECLIN-1; AMPK; AKT	The serine/threonine kinase Unc-51-like kinase-1 (Ulk1) is thought to be essential for induction of autophagy, an intracellular bulk degradation process that is activated by various stresses. Although several proteins have been suggested as Ulk1 substrates during autophagic process, it still remains largely unknown about Ulk1's physiological substrates. Here, by performing in vitro and in vivo phosphorylation assay, we report that the co-chaperone cell division cycle protein 37 (Cdc37) is a Ulk1 substrate. Ulk1-mediated phosphorylation of Ser-339 in Cdc37 compromised the recruitment of client kinases to a complex comprising Cdc37 and heat shock protein 90 (Hsp90) but only modestly affected Cdc37 binding to Hsp90. Because the recruitment of protein kinase clients to the Hsp90 complex is essential for their stability and functions, Ser-339 phosphorylation of Cdc37 disrupts its ability as a co-chaperone to coordinate Hsp90. Hsp90 inhibitors are cancer chemotherapeutic agents by inducing depletion of clients, many of which are oncogenes. Upon treatment with an Hsp90 inhibitor in cancer cells, Ulk1 promoted the degradation of Hsp90-Cdc37 client kinases, resulting in increased cellular sensitivity to Hsp90 inhibitors. Thus, our study provides evidence for an anti-proliferative role of Ulk1 in response to Hsp90 inhibition in cancer cells.	[Li, Ran; Yuan, Fengjie; Fu, Wan; Zhang, Luyao; Zhang, Nan; Wang, Yanan; Ma, Ke; Li, Xue; Wang, Lina; Zhu, Wei-Guo; Zhao, Ying] Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Minist Educ, Dept Biochem & Mol Biol,Sch Basic Med Sci,Hlth Sc, Beijing 100191, Peoples R China; [Zhu, Wei-Guo] Peking Tsinghua Univ, Ctr Life Sci, Beijing 100871, Peoples R China; [Zhu, Wei-Guo] Shenzhen Univ, Sch Med, Dept Biochem & Mol Biol, Shenzhen 518060, Peoples R China	Peking University; Tsinghua University; Shenzhen University	Zhao, Y (corresponding author), Peking Univ, Beijing Key Lab Prot Posttranslat Modificat & Cel, Key Lab Carcinogenesis & Translat Res,Minist Educ, Dept Biochem & Mol Biol,Sch Basic Med Sci,Hlth Sc, Beijing 100191, Peoples R China.	zhaoying0812@bjmu.edu.cn		Zhu, Wei-Guo/0000-0001-8385-6581; Wang, Yanan/0000-0002-8050-3155	National Natural Science Foundation of China [81222028, 81621063, 81472581, 81672712, 91319302, 31261140372]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81222028, 81621063, 81472581, 81672712, 91319302, and 31261140372). The authors declare that they have no conflicts of interest with the contents of this article.	Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bestebroer J, 2013, TRAFFIC, V14, P1029, DOI 10.1111/tra.12091; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Ci Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.506; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Fremont S, 2013, EMBO REP, V14, P364, DOI 10.1038/embor.2013.23; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He W, 2016, INT J ONCOL, V48, P1710, DOI 10.3892/ijo.2016.3382; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Joo JH, 2016, MOL CELL, V62, P491, DOI 10.1016/j.molcel.2016.04.020; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Joshi A, 2016, CELL DEATH DIFFER, V23, P216, DOI 10.1038/cdd.2015.88; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Keramisanou D, 2016, MOL CELL, V62, P260, DOI 10.1016/j.molcel.2016.04.005; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee J, 2012, J BIOL CHEM, V287, P4033, DOI 10.1074/jbc.M111.280065; Li TY, 2016, MOL CELL, V62, P359, DOI 10.1016/j.molcel.2016.04.009; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Navone F, 2015, CELLS-BASEL, V4, P354, DOI 10.3390/cells4030354; Oberoi J, 2016, P NATL ACAD SCI USA, V113, P9009, DOI 10.1073/pnas.1603059113; Ramsey AJ, 2000, J BIOL CHEM, V275, P17857, DOI 10.1074/jbc.M001625200; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Xu WP, 2012, MOL CELL, V47, P434, DOI 10.1016/j.molcel.2012.05.015; Yan J, 1998, BIOCHEM BIOPH RES CO, V246, P222, DOI 10.1006/bbrc.1998.8546; Yan J, 1999, ONCOGENE, V18, P5850, DOI 10.1038/sj.onc.1202988; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009	49	11	13	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2830	2841		10.1074/jbc.M116.762443	http://dx.doi.org/10.1074/jbc.M116.762443			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28073914	Green Published, hybrid			2022-12-28	WOS:000395535100023
J	Kaburagi, T; Kizuka, Y; Kitazume, S; Taniguchi, N				Kaburagi, Tomoko; Kizuka, Yasuhiko; Kitazume, Shinobu; Taniguchi, Naoyuki			The Inhibitory Role of alpha 2,6-Sialylation in Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; EPIGENETIC REGULATION; GANGLIOSIDE GM3; DNA METHYLATION; GENE-EXPRESSION; N-GLYCOSYLATION; CELL-MIGRATION; VISCERAL FAT; ADIPOCYTE; DIFFERENTIATION	Adipose tissue plays critical roles in obesity and related diseases such as diabetes and cardiovascular diseases. Previous reports suggest that glycans, the most common posttranslational modifications, are involved in obesity-related diseases, but what type of glycan regulates adipogenesis during obesity remains unclear. In this study, we first quantified the mRNA levels of 167 genes (encoding 144 glycosyltransferases and 23 related enzymes) in visceral adipose tissues (VATs) from control mice and high-fat diet (HFD)-induced obese mice. We found that a gene encoding beta-galactoside alpha 2,6-sialyltransferase-1 (St6gal1), a key enzyme responsible for the biosynthesis of alpha 2,6-linked sialic acid in N-linked glycans, was most down-regulated in VATs from obese mice. We confirmed the reduction in alpha 2,6-sialic acid in VATs from obese mice and differentiated adipocyte model 3T3-L1 cells. Using proteomic analysis, integrin- beta 1 was identified as one of the target alpha 2,6-sialylated proteins in adipose tissues, and phosphorylation of its downstream molecule focal adhesion kinase was found to be decreased after HFD feeding. St6gal1 overexpression in differentiating 3T3-L1 cells inhibited adipogenesis with increased phosphorylation of focal adhesion kinase. Furthermore, St6gal1 knockout mice exhibited increased bodyweight and VAT weight after HFDfeeding. The down-regulation of St6gal1 during adipogenesis was canceled by treatment with a DNA methyltransferase inhibitor, suggesting an involvement of epigenetic DNA methylation in St6gal1 silencing. Our findings suggest that ST6GAL1 has an inhibitory role in adipogenesis through integrin-beta 1 activation, providing new insights into the roles and regulation mechanisms of glycans in adipocytes during obesity.	[Kaburagi, Tomoko] Daito Bunka Univ, Fac Sports & Hlth Sci, Dept Hlth Sci, 560 Iwadono, Higashi Matsuyama, Saitama 3558681, Japan; [Kaburagi, Tomoko; Kizuka, Yasuhiko; Kitazume, Shinobu; Taniguchi, Naoyuki] RIKEN, Max Planck Joint Res Ctr Syst Chem Biol, Syst Glycobiol Res Grp, Dis Glyc Team,Global Res Cluster, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	RIKEN	Kaburagi, T (corresponding author), Daito Bunka Univ, Fac Sports & Hlth Sci, Dept Hlth Sci, 560 Iwadono, Higashi Matsuyama, Saitama 3558681, Japan.; Kaburagi, T; Taniguchi, N (corresponding author), RIKEN, Max Planck Joint Res Ctr Syst Chem Biol, Syst Glycobiol Res Grp, Dis Glyc Team,Global Res Cluster, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	t-kabu@ic.daito.ac.jp; dglycotani@riken.jp	Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968; Kizuka, Yasuhiko/0000-0002-3181-9743	RIKEN (the Systems Glycobiology Research Project); Japan Society for the Promotion of Science [15K14481, 15H04700, 15K00885]; Grants-in-Aid for Scientific Research [15K00885] Funding Source: KAKEN	RIKEN (the Systems Glycobiology Research Project); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by RIKEN (the Systems Glycobiology Research Project) (to N. T.) and by Japan Society for the Promotion of Science Grant-in-Aid for Challenging Exploratory Research 15K14481 (to N. T.), Grant-in-Aid for Scientific Research (B) 15H04700 (to N. T.), and Grant-in-Aid for Scientific Research (C) 15K00885 (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Antony P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-901; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Boque N, 2013, MOL NUTR FOOD RES, V57, P1473, DOI 10.1002/mnfr.201200686; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Farnier C, 2003, INT J OBESITY, V27, P1178, DOI 10.1038/sj.ijo.0802399; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Fuentes P, 2010, J ENDOCRINOL, V206, P75, DOI 10.1677/JOE-10-0049; Gentile TL, 2013, MOL CELL BIOL, V33, P3864, DOI 10.1128/MCB.01495-12; Geurts L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7495; Haga Y, 2011, J BIOL CHEM, V286, P31320, DOI 10.1074/jbc.M111.253955; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hoffmann LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8235; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kawamura YI, 2008, GASTROENTEROLOGY, V135, P142, DOI 10.1053/j.gastro.2008.03.031; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Kitazume S, 2009, GLYCOBIOLOGY, V19, P479, DOI 10.1093/glycob/cwp003; Kizuka Y, 2016, PROTEOMICS, V16, P2854, DOI 10.1002/pmic.201600053; Kizuka Y, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020025; Kizuka Y, 2014, J BIOL CHEM, V289, P11253, DOI 10.1074/jbc.M114.554311; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kroes RA, 2016, GLYCOBIOLOGY, V26, P1271, DOI 10.1093/glycob/cww058; Lauc G, 2014, BBA-GEN SUBJECTS, V1840, P65, DOI 10.1016/j.bbagen.2013.08.017; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; Lipina C, 2015, FEBS LETT, V589, P3221, DOI 10.1016/j.febslet.2015.09.018; LISSNER L, 1995, EUR J CLIN NUTR, V49, P79; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Lu JS, 2016, J BIOL CHEM, V291, P5708, DOI 10.1074/jbc.M115.712836; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Marino JH, 2008, GLYCOBIOLOGY, V18, P719, DOI 10.1093/glycob/cwn051; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Minami A, 2013, J BIOL CHEM, V288, P11845, DOI 10.1074/jbc.M112.405993; Mito N, 2004, J ENDOCRINOL, V180, P167, DOI 10.1677/joe.0.1800167; Mito N, 2000, METABOLISM, V49, P1295, DOI 10.1053/meta.2000.9523; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Patrick CW, 2003, ANN BIOMED ENG, V31, P505, DOI 10.1114/1.1566446; Rellier N, 1999, LIFE SCI, V64, P1571, DOI 10.1016/S0024-3205(99)00094-6; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; SCOTT RE, 1982, P NATL ACAD SCI-BIOL, V79, P845, DOI 10.1073/pnas.79.3.845; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Shabana, 2016, EUR J HUM GENET, V24, P903, DOI 10.1038/ejhg.2015.212; SHIBUYA N, 1989, J BIOCHEM-TOKYO, V106, P1098, DOI 10.1093/oxfordjournals.jbchem.a122972; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Taniguchi N., 2014, HDB GLYCOSYLTRANSFER; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1089; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zaarour N, 2012, BIOCHEM J, V445, P265, DOI 10.1042/BJ20120232; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	68	18	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2278	2286		10.1074/jbc.M116.747667	http://dx.doi.org/10.1074/jbc.M116.747667			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031460	Green Published, hybrid			2022-12-28	WOS:000395530300020
J	Shiraishi, A; Uruno, T; Sanematsu, F; Ushijima, M; Sakata, D; Hara, T; Fukui, Y				Shiraishi, Akira; Uruno, Takehito; Sanematsu, Fumiyuki; Ushijima, Miho; Sakata, Daiji; Hara, Toshiro; Fukui, Yoshinori			DOCK8 Protein Regulates Macrophage Migration through Cdc42 Protein Activation and LRAP35a Protein Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELL-MIGRATION; RETROGRADE FLOW; RHO-GTPASES; MYOSIN-II; ACTIN; MUTATIONS; LOCALIZATION; POLARIZATION; DEDICATOR; MONOCYTES	DOCK8 is an atypical guanine nucleotide exchange factor for Cdc42, and its mutations cause combined immunodeficiency in humans. Accumulating evidence indicates that DOCK8 regulates the migration and activation of various subsets of leukocytes, but its regulatory mechanism is poorly understood. We here report that DOCK8-deficient macrophages exhibit a migration defect in a 2D setting. Although DOCK8 deficiency in macrophages did not affect the global Cdc42 activation induced by chemokine stimulation, rescue experiments revealed that the guanine nucleotide exchange factor activity of DOCK8 was required for macrophage migration. We found that DOCK8 associated with LRAP35a, an adaptor molecule that binds to the Cdc42 effector myotonic dystrophy kinase-related Cdc42-binding kinase, and facilitated its activity to phosphorylate myosin II regulatory light chain. When this interaction was disrupted in WT macrophages, they showed a migration defect, as seen in DOCK8-deficient macrophages. These results suggest that, during macrophage migration, DOCK8 links Cdc42 activation to actomyosin dynamics through the association with LRAP35a.	[Shiraishi, Akira; Uruno, Takehito; Sanematsu, Fumiyuki; Ushijima, Miho; Sakata, Daiji; Fukui, Yoshinori] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet, Fukuoka 8128582, Japan; [Shiraishi, Akira] Kyushu Univ, Dept Pediat, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Uruno, Takehito; Sanematsu, Fumiyuki; Fukui, Yoshinori] Kyushu Univ, Res Ctr Adv Immunol, Fukuoka 8128582, Japan; [Hara, Toshiro] Fukuoka Childrens Hosp, Fukuoka 8130017, Japan	Kyushu University; Kyushu University; Kyushu University	Fukui, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neuroscience, Div Immunogenet,Higashi Ku, Fukuoka 8128582, Japan.	fukui@bioreg.kyushu-u.ac.jp	Shiraishi, Akira/AAM-8444-2021; Uruno, Takehito/AAF-7998-2019	Uruno, Takehito/0000-0002-2812-9645; Fukui, Yoshinori/0000-0003-2335-8745	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Leading Advanced Projects for Medical Innovation; Research on Development of New Drugs from Japan Agency for Medical Research and Development	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Leading Advanced Projects for Medical Innovation; Research on Development of New Drugs from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by a grant-in-aid for scientific research on innovative areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; grants-in-aid for scientific research from the Japan Society for the Promotion of Science; the Leading Advanced Projects for Medical Innovation; and the Research on Development of New Drugs from Japan Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson TW, 2008, MOL BIOL CELL, V19, P5006, DOI 10.1091/mbc.E08-01-0034; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Crawford G, 2013, BLOOD, V122, P2052, DOI 10.1182/blood-2013-02-482331; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Jacobelli J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075151; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Lambe T, 2011, EUR J IMMUNOL, V41, P3423, DOI 10.1002/eji.201141759; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Maus UA, 2005, AM J PHYSIOL-LUNG C, V288, pL350, DOI 10.1152/ajplung.00061.2004; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; Mizesko MC, 2013, J ALLERGY CLIN IMMUN, V131, P840, DOI 10.1016/j.jaci.2012.12.1568; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhang Q, 2014, J EXP MED, V211, P2549, DOI 10.1084/jem.20141307; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhou YY, 2013, BIOCHEMISTRY-US, V52, P4354, DOI 10.1021/bi301688g	33	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2191	2202		10.1074/jbc.M116.736306	http://dx.doi.org/10.1074/jbc.M116.736306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028174	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000395530300013
J	van Lis, R; Popek, M; Coute, Y; Kosta, A; Drapier, D; Nitschke, W; Atteia, A				van Lis, Robert; Popek, Marion; Coute, Yohann; Kosta, Artemis; Drapier, Dominique; Nitschke, Wolfgang; Atteia, Ariane			Concerted Up-regulation of Aldehyde/Alcohol Dehydrogenase (ADHE) and Starch in Chlamydomonas reinhardtii Increases Survival under Dark Anoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-FORMATE-LYASE; ANAEROBIC ENERGY-METABOLISM; ALCOHOL-DEHYDROGENASE; ESCHERICHIA-COLI; FERREDOXIN OXIDOREDUCTASE; FERMENTATIVE METABOLISM; CONCENTRATING MECHANISM; HYDROGEN-PRODUCTION; GENE-EXPRESSION; PROTEIN	Aldehyde/alcohol dehydrogenases (ADHEs) are bifunctional enzymes that commonly produce ethanol from acetyl-CoA with acetaldehyde as intermediate and play a key role in anaerobic redox balance in many fermenting bacteria. ADHEs are also present in photosynthetic unicellular eukaryotes, where their physiological role and regulation are, however, largely unknown. Herein we provide the first molecular and enzymatic characterization of the ADHE from the photosynthetic microalga Chlamydomonas reinhardtii. Purified recombinant ADHE catalyzed the reversible NADH-mediated interconversions of acetyl-CoA, acetaldehyde, and ethanol but seemed to be poised toward the production of ethanol from acetaldehyde. Phylogenetic analysis of the algal fermentative enzyme supports a vertical inheritance from a cyanobacterial-related ancestor. ADHE was located in the chloroplast, where it associated in dimers and higher order oligomers. Electron microscopy analysis of ADHE-enriched stromal fractions revealed fine spiral structures, similar to bacterial ADHE spirosomes. Protein blots showed that ADHE is regulated under oxic conditions. Up-regulation is observed in cells exposed to diverse physiological stresses, including zinc deficiency, nitrogen starvation, and inhibition of carbon concentration/fixation capacity. Analyses of the overall proteome and fermentation profiles revealed that cells with increased ADHE abundance exhibit better survival under dark anoxia. This likely relates to the fact that greater ADHE abundance appeared to coincide with enhanced starch accumulation, which might reflect ADHE-mediated anticipation of anaerobic survival.	[van Lis, Robert; Popek, Marion; Nitschke, Wolfgang; Atteia, Ariane] Aix Marseille Univ, CNRS, BIP UMR 7281, F-13402 Marseille, France; [van Lis, Robert] INRA, LBE, F-11100 Narbonne, France; [Coute, Yohann] Univ Grenoble Alpes, BIG BGE, F-38000 Grenoble, France; [Coute, Yohann] Commissariat Energie Atom, BIG BGE, F-38000 Grenoble, France; [Coute, Yohann] INSERM, BGE, F-38000 Grenoble, France; [Kosta, Artemis] FR3479 Inst Microbiol Mediterranee, Microscopy Core Facil, F-13402 Marseille 20, France; [Drapier, Dominique] UPMC, Inst Biol Phys Chim, CNRS UMR7141, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Atteia, A (corresponding author), Aix Marseille Univ, CNRS, Unite Bioenerget & Ingn Prot UMR 7281, 31 Chemin Joseph Aiguier, F-13402 Marseille, France.	ariane.atteia@imm.cnrs.fr	Couté, Yohann/G-2695-2015; Nitschke, Wolfgang/C-4812-2012	Couté, Yohann/0000-0003-3896-6196; Kosta, Artemis/0000-0001-7115-4566; Nitschke, Wolfgang/0000-0003-2084-3032	Centre National de la Recherche Scientifique; Agence Nationale pour la Recherche [ANR-10-BIOE-0004]; ProFi Infrastructure [ANR-10-INBS-08-01]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); ProFi Infrastructure	This work was supported by the Centre National de la Recherche Scientifique and partly supported by Agence Nationale pour la Recherche Grant ANR-10-BIOE-0004 (to A. A., R.V.L., and M.P.), and ProFi Infrastructure Grant ANR-10-INBS-08-01 (to Y.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; Atteia A, 2003, PLANT MOL BIOL, V53, P175, DOI 10.1023/B:PLAN.0000009274.19340.36; Atteia A, 2013, BBA-BIOENERGETICS, V1827, P210, DOI 10.1016/j.bbabio.2012.08.002; BALL SG, 1990, PLANT SCI, V66, P1, DOI 10.1016/0168-9452(90)90162-H; Beckham KSH, 2014, MOL MICROBIOL, V93, P199, DOI 10.1111/mmi.12651; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Boxma B, 2004, MOL MICROBIOL, V51, P1389, DOI 10.1046/j.1365-2958.2003.03912.x; BRUCHHAUS I, 1994, BIOCHEM J, V303, P743, DOI 10.1042/bj3030743; Burgess SJ, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv167; CABISCOL E, 1994, J BIOL CHEM, V269, P6592; Catalanotti C, 2012, PLANT CELL, V24, P692, DOI 10.1105/tpc.111.093146; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; DRON M, 1983, PLASMID, V9, P321, DOI 10.1016/0147-619X(83)90009-4; Dubini A, 2009, J BIOL CHEM, V284, P7201, DOI 10.1074/jbc.M803917200; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; DURRANT I, 1990, NATURE, V346, P297, DOI 10.1038/346297a0; Fukuzawa H, 2001, P NATL ACAD SCI USA, V98, P5347, DOI 10.1073/pnas.081593498; GFELLER RP, 1984, PLANT PHYSIOL, V75, P212, DOI 10.1104/pp.75.1.212; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Hemschemeier A, 2008, EUKARYOT CELL, V7, P518, DOI 10.1128/EC.00368-07; Hoffmeister M, 2004, J BIOL CHEM, V279, P22422, DOI 10.1074/jbc.M400913200; Hsieh SI, 2013, MOL CELL PROTEOMICS, V12, P65, DOI 10.1074/mcp.M112.021840; Johnson X, 2014, PLANT PHYSIOL, V165, P438, DOI 10.1104/pp.113.233593; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Karlsson J, 1998, EMBO J, V17, P1208, DOI 10.1093/emboj/17.5.1208; KAWATA T, 1975, JPN J MICROBIOL, V19, P225, DOI 10.1111/j.1348-0421.1975.tb00872.x; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; KESSLER D, 1991, FEBS LETT, V281, P59, DOI 10.1016/0014-5793(91)80358-A; KREUZBERG K, 1984, PHYSIOL PLANTARUM, V61, P87, DOI 10.1111/j.1399-3054.1984.tb06105.x; KREUZBERG K, 1987, PHYSIOL PLANTARUM, V69, P481, DOI 10.1111/j.1399-3054.1987.tb09229.x; Kucho K, 2003, PLANT PHYSIOL, V133, P783, DOI 10.1104/pp.103.026492; Laurenceau R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004835; LEONARDO MR, 1993, J BACTERIOL, V175, P870, DOI 10.1128/JB.175.3.870-878.1993; Magneschi L, 2012, PLANT PHYSIOL, V158, P1293, DOI 10.1104/pp.111.191569; MAIONE TE, 1986, PLANT PHYSIOL, V80, P360, DOI 10.1104/pp.80.2.360; Malasarn D, 2013, J BIOL CHEM, V288, P10672, DOI 10.1074/jbc.M113.455105; McDonald KL, 2014, MICROSC MICROANAL, V20, P152, DOI 10.1017/S1431927613013846; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moezelaar R, 1996, APPL ENVIRON MICROB, V62, P1752, DOI 10.1128/AEM.62.5.1752-1758.1996; Montella C, 2005, J BACTERIOL, V187, P4957, DOI 10.1128/JB.187.14.4957-4966.2005; MORONEY JV, 1989, PLANT PHYSIOL, V89, P897, DOI 10.1104/pp.89.3.897; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Noth J, 2013, J BIOL CHEM, V288, P4368, DOI 10.1074/jbc.M112.429985; O'Toole ET, 2010, METHOD CELL BIOL, V96, P71, DOI 10.1016/S0091-679X(10)96004-4; OREN A, 1979, ARCH MICROBIOL, V122, P77, DOI 10.1007/BF00408049; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Philipps G, 2011, PLANT J, V66, P330, DOI 10.1111/j.1365-313X.2011.04494.x; Sanchez LB, 1998, ARCH BIOCHEM BIOPHYS, V354, P57, DOI 10.1006/abbi.1998.0664; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Shasmal M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19936; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; SPREITZER RJ, 1980, NATURE, V285, P114, DOI 10.1038/285114a0; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1016/S0168-6445(97)00056-9; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Valledor L, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0171-1; van Lis R, 2005, PLANT PHYSIOL, V139, P1946, DOI 10.1104/pp.105.069732; van Lis R, 2013, PLANT PHYSIOL, V161, P57, DOI 10.1104/pp.112.208181; Wang YJ, 2011, PHOTOSYNTH RES, V109, P115, DOI 10.1007/s11120-011-9643-3; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang WQ, 2014, PLANT CELL, V26, P4499, DOI 10.1105/tpc.114.129965; YANG WG, 1994, MOL BIOCHEM PARASIT, V64, P253, DOI 10.1016/0166-6851(93)00020-A; Zabawinski C, 2001, J BACTERIOL, V183, P1069, DOI 10.1128/JB.183.3.1069-1077.2001; Zheng TY, 2015, J BACTERIOL, V197, P2610, DOI 10.1128/JB.00232-15	70	19	19	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2395	2410		10.1074/jbc.M116.766048	http://dx.doi.org/10.1074/jbc.M116.766048			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28007962	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000395530300029
J	Klayman, LM; Wedegaertner, PB				Klayman, Lauren M.; Wedegaertner, Philip B.			Inducible Inhibition of G Reveals Localization-dependent Functions at the Plasma Membrane and Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; G protein; Golgi; intracellular trafficking; protein trafficking (Golgi); signal transduction	PROTEIN-KINASE-D; HETEROTRIMERIC G-PROTEINS; BETA-GAMMA-SUBUNITS; CELL-SURFACE; TRANSPORT CARRIERS; SPONGE METABOLITE; RECEPTOR KINASE; PKD; ILIMAQUINONE; COMPLEX	Heterotrimeric G proteins signal at a variety of endomembrane locations, in addition to their canonical function at the cytoplasmic surface of the plasma membrane (PM), where they are activated by cell surface G protein-coupled receptors. Here we focus on signaling at the Golgi, where activates a signaling cascade, ultimately resulting in vesicle fission from the trans-Golgi network (TGN). To develop a novel molecular tool for inhibiting endogenous in a spatial-temporal manner, we take advantage of a lipid association mutant of the widely used inhibitor GRK2ct (GRK2ct-KERE) and the FRB/FKBP heterodimerization system. We show that GRK2ct-KERE cannot inhibit function when expressed in cells, but recruitment to a specific membrane location recovers the ability of GRK2ct-KERE to inhibit signaling. PM-recruited GRK2ct-KERE inhibits lysophosphatidic acid-induced phosphorylation of Akt, whereas Golgi-recruited GRK2ct-KERE inhibits cargo transport from the TGN to the PM. Moreover, we show that Golgi-recruited GRK2ct-KERE inhibits model basolaterally targeted but not apically targeted cargo delivery, for both PM-destined and secretory cargo, providing the first evidence of selectivity in terms of cargo transport regulated by . Last, we show that Golgi fragmentation induced by ilimaquinone and nocodazole is blocked by inhibition, demonstrating that is a key regulator of multiple pathways that impact Golgi morphology. Thus, we have developed a new molecular tool, recruitable GRK2ct-KERE, to modulate signaling at specific subcellular locations, and we demonstrate novel cargo selectivity for regulation of TGN to PM transport and a novel role for in mediating Golgi fragmentation.	[Klayman, Lauren M.; Wedegaertner, Philip B.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,839 BLSB, Philadelphia, PA 19107 USA	Jefferson University	Wedegaertner, PB (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,839 BLSB, Philadelphia, PA 19107 USA.	Philip.Wedegaertner@jefferson.edu			National Institutes of Health [GM56444]; American Heart Association [14PRE19980023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056444, R56GM056444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56444 (to P.B.W.). This work was also supported by American Heart Association Grant 14PRE19980023 (to L.M.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anel A. M., 2007, BIOCHEM J, V406, P157; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Axelsson MAB, 2004, MOL BIOL CELL, V15, P1843, DOI 10.1091/mbc.E03-07-0459; Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023; Fuchs YF, 2009, TRAFFIC, V10, P858, DOI 10.1111/j.1600-0854.2009.00918.x; Giannotta M, 2012, EMBO J, V31, P2869, DOI 10.1038/emboj.2012.134; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Haase G, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00448; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Jensen DD, 2016, J BIOL CHEM, V291, P11285, DOI 10.1074/jbc.M115.710681; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kienzle C, 2013, MOL BIOL CELL, V24, P222, DOI 10.1091/mbc.E12-03-0198; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lee HY, 2015, MAR DRUGS, V13, P543, DOI 10.3390/md13010543; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lu PH, 2007, EUR J PHARMACOL, V556, P45, DOI 10.1016/j.ejphar.2006.10.061; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Montoya V, 2007, CELL MOTIL CYTOSKEL, V64, P936, DOI 10.1002/cm.20234; Musch A, 1996, J CELL BIOL, V133, P543, DOI 10.1083/jcb.133.3.543; O'Neill PR, 2014, MOL BIOL CELL, V25, P2305, DOI 10.1091/mbc.E14-04-0870; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Pandey KN, 2010, CURR OPIN BIOTECH, V21, P611, DOI 10.1016/j.copbio.2010.08.007; Riaz A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020215; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sonoda H, 2007, J BIOL CHEM, V282, P34085, DOI 10.1074/jbc.M705593200; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; VEIT B, 1993, J CELL BIOL, V122, P1197, DOI 10.1083/jcb.122.6.1197; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090	43	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1773	1784		10.1074/jbc.M116.750430	http://dx.doi.org/10.1074/jbc.M116.750430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994056	hybrid, Green Published			2022-12-28	WOS:000395515600019
J	Xi, G; Wai, C; White, MF; Clemmons, DR				Xi, Gang; Wai, Christine; White, Morris F.; Clemmons, David R.			Down-regulation of Insulin Receptor Substrate 1 during Hyperglycemia Induces Vascular Smooth Muscle Cell Dedifferentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; diabetes; insulin receptor substrate 1 (IRS-1); insulin resistance; myocardin; vascular smooth muscle cells	GROWTH-FACTOR-I; SERINE/THREONINE PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; OXIDIZED PHOSPHOLIPIDS; ENDOTHELIAL-CELLS; MAMMALIAN TARGET; ANGIOTENSIN-II; ACTIVATION; DIFFERENTIATION; RESISTANCE	Diabetes is a major risk factor for the development of atherosclerosis, but the mechanism by which hyperglycemia accelerates lesion development is not well defined. Insulin and insulin-like growth factor I (IGF-I) signal through the scaffold protein insulin receptor substrate 1 (IRS-1). In diabetes, IRS-1 is down-regulated, and cells become resistant to insulin. Under these conditions, the IGF-I receptor signals through an alternate scaffold protein, SHPS-1, resulting in pathophysiologic stimulation of vascular smooth muscle cell (VSMC) migration and proliferation. These studies were undertaken to determine whether IRS-1 is functioning constitutively to maintain VSMCs in their differentiated state and, thereby, inhibit aberrant signaling. Here we show that deletion of IRS-1 expression in VSMCs in non-diabetic mice results in dedifferentiation, SHPS-1 activation, and aberrant signaling and that these changes parallel those that occur in response to hyperglycemia. The mice showed enhanced sensitivity to IGF-I stimulation of VSMC proliferation and a hyperproliferative response to vascular injury. KLF4, a transcription factor that induces VSMC dedifferentiation, was up-regulated in IRS-1(-/-) mice, and the differentiation inducer myocardin was undetectable. Importantly, these changes were replicated in wild-type mice during hyperglycemia. These findings illuminate a new function of IRS-1: that of maintaining cells in their normal, differentiated state. Because IRS-1 is down-regulated in states of insulin resistance that occur in response to metabolic stresses such as obesity and cytokine stimulation, the findings provide a mechanism for understanding how patients with metabolic stress and/or diabetes are predisposed to developing vascular complications.	[Xi, Gang; Wai, Christine; Clemmons, David R.] Univ N Carolina, Div Endocrinol, Dept Med, Sch Med, Chapel Hill, NC 27599 USA; [White, Morris F.] Harvard Med Sch, Div Endocrinol, Dept Med, Childrens Hosp, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu			National Institutes of Health [AG02331, EY021943]; NATIONAL EYE INSTITUTE [R42EY021943, R41EY021943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG002331, R01AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG02331 and EY021943. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali MS, 2013, J CEREBR BLOOD F MET, V33, P1564, DOI 10.1038/jcbfm.2013.109; Berk BC, 2001, ANN NY ACAD SCI, V947, P93; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Cester N, 1996, EUR J CLIN INVEST, V26, P569, DOI 10.1046/j.1365-2362.1996.1750526.x; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Galkina EV, 2012, ARTERIOSCL THROM VAS, V32, P247, DOI 10.1161/ATVBAHA.111.240358; Garvey SM, 2010, J PHARMACOL EXP THER, V333, P34, DOI 10.1124/jpet.109.163949; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Lee J, 2010, AM J PHYSIOL-HEART C, V298, pH310, DOI 10.1152/ajpheart.00359.2009; Lee S, 2008, ENDOCRINOLOGY, V149, P2451, DOI 10.1210/en.2007-1595; Lightell DJ, 2011, ENDOCRINOLOGY, V152, P651, DOI 10.1210/en.2010-0722; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Longobardi L, 2009, GROWTH FACTORS, V27, P309, DOI 10.1080/08977190903138874; Maile LA, 2006, MOL ENDOCRINOL, V20, P405, DOI 10.1210/me.2005-0241; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Maile LA, 2007, ENDOCRINOLOGY, V148, P2435, DOI 10.1210/en.2006-1440; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nemoto S, 2014, ATHEROSCLEROSIS, V233, P64, DOI 10.1016/j.atherosclerosis.2013.12.032; Ordonez P, 2008, J STEROID BIOCHEM, V111, P287, DOI 10.1016/j.jsbmb.2008.07.001; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Radhakrishnan Y, 2011, MOL ENDOCRINOL, V25, P1636, DOI 10.1210/me.2011-0035; Raphel L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044052; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Salt IP, 2003, J BIOL CHEM, V278, P18791, DOI 10.1074/jbc.M210618200; Stohr O, 2011, BBA-MOL BASIS DIS, V1812, P573, DOI 10.1016/j.bbadis.2011.02.006; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Talasila A, 2013, ARTERIOSCL THROM VAS, V33, P2355, DOI 10.1161/ATVBAHA.112.301000; Taniyama Y, 2005, ARTERIOSCL THROM VAS, V25, P1142, DOI 10.1161/01.ATV.0000164313.17167.df; Thomas SS, 2013, KIDNEY INT, V84, P308, DOI 10.1038/ki.2013.97; Thum T, 2000, FASEB J, V14, P740, DOI 10.1096/fasebj.14.5.740; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Yoshida T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000230; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Yu Qiujun, 2014, Cardiovasc Res, V103, P238, DOI 10.1093/cvr/cvu132; Zhang H, 2000, J BIOL CHEM, V275, P22558, DOI 10.1074/jbc.M000412200; Zhao Y, 2011, AM J PHYSIOL-CELL PH, V300, pC1375, DOI 10.1152/ajpcell.00670.2008; Zheng XL, 2014, ARCH BIOCHEM BIOPHYS, V543, P48, DOI 10.1016/j.abb.2013.12.015	48	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2009	2020		10.1074/jbc.M116.758987	http://dx.doi.org/10.1074/jbc.M116.758987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28003360	Green Published, hybrid			2022-12-28	WOS:000395515600038
J	Han, XB; Shen, LQ; Wang, QJ; Cen, XF; Wang, J; Wu, M; Li, P; Zhao, W; Zhang, Y; Zhao, GP				Han, Xiaobiao; Shen, Liqiang; Wang, Qijun; Cen, Xufeng; Wang, Jin; Wu, Meng; Li, Peng; Zhao, Wei; Zhang, Yu; Zhao, Guoping			Cyclic AMP Inhibits the Activity and Promotes the Acetylation of Acetyl-CoA Synthetase through Competitive Binding to the ATP/AMP Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP; acetyl-CoA synthetase; acetylation; crystal structure; post-translational modification	COENZYME-A SYNTHETASE; ESCHERICHIA-COLI; RECEPTOR PROTEIN; RESPONSE REGULATOR; CAMP; ACTIVATION; IDENTIFICATION; TRANSCRIPTION; GROWTH; CHEY	The high-affinity biosynthetic pathway for converting acetate to acetyl-coenzyme A (acetyl-CoA) is catalyzed by the central metabolic enzyme acetyl-coenzymeAsynthetase (Acs), which is finely regulated both at the transcriptional level via cyclic AMP (cAMP)-driven trans-activation and at the post-translational level via acetylation inhibition. In this study, we discovered that cAMP directly binds to Salmonella enterica Acs (SeAcs) and inhibits its activity in a substrate-competitive manner. In addition, cAMP binding increases SeAcs acetylation by simultaneously promoting Pat-dependent acetylation and inhibiting CobB-dependent deacetylation, resulting in enhanced SeAcs inhibition. A crystal structure study and site-directed mutagenesis analyses confirmed that cAMP binds to the ATP/AMP pocket of SeAcs, and restrains SeAcs in an open conformation. The cAMP contact residues are well conserved from prokaryotes to eukaryotes, suggesting a general regulatory mechanism of cAMP on Acs.	[Han, Xiaobiao; Cen, Xufeng; Wang, Jin; Li, Peng; Zhao, Wei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Shen, Liqiang; Zhang, Yu; Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol,Ctr Excellence Mol Plant Sci, Shanghai 200032, Peoples R China; [Wang, Qijun] Shanghai Jiao Tong Univ, Sch Med, Dept Med Microbiol & Parasitol, Shanghai 200025, Peoples R China; [Wu, Meng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Zhao, Guoping] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Guoping] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Han, Xiaobiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhao, W (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.; Zhang, Y; Zhao, GP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol,Ctr Excellence Mol Plant Sci, Shanghai 200032, Peoples R China.; Zhao, GP (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.; Zhao, GP (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Inst Biomed Sci, Shanghai 200433, Peoples R China.; Zhao, GP (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China.; Zhao, GP (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China.; Zhao, GP (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China.	wzhao@sibs.ac.cn; zhang-yu@sibs.ac.cn; gpzhao@sibs.ac.cn	Wang, Jin/P-5458-2019; Zhang, Yu/AAV-5722-2021	Wang, Jin/0000-0003-4008-9284; Zhang, Yu/0000-0002-1778-8389; Zhao, Wei/0000-0002-2422-8398; Li, Peng/0000-0001-8262-7330; Zhao, Guo-Ping/0000-0002-7621-6620	Natural Science Foundation for Youth Grant [31400039]; Postdoctoral Science Foundation of China Grant [2012M510787]; Chinese Thousand Talents Program	Natural Science Foundation for Youth Grant; Postdoctoral Science Foundation of China Grant; Chinese Thousand Talents Program	This work was supported by Natural Science Foundation for Youth Grant 31400039, Postdoctoral Science Foundation of China Grant 2012M510787, and the Chinese Thousand Talents Program grant. The authors declare no conflict of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barak R, 2004, J MOL BIOL, V342, P383, DOI 10.1016/j.jmb.2004.07.020; Beatty CM, 2003, J BACTERIOL, V185, P5148, DOI 10.1128/JB.185.17.5148-5157.2003; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Browning DF, 2004, MOL MICROBIOL, V51, P241, DOI 10.1046/j.1365-2958.2003.03824.x; Castano-Cerezo S, 2011, MOL MICROBIOL, V82, P1110, DOI 10.1111/j.1365-2958.2011.07873.x; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Chan CH, 2011, MOL MICROBIOL, V80, P168, DOI 10.1111/j.1365-2958.2011.07566.x; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; DARI R, 1988, J BACTERIOL, V170, P65, DOI 10.1128/jb.170.1.65-70.1988; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DEATH A, 1994, J BACTERIOL, V176, P5101, DOI 10.1128/jb.176.16.5101-5107.1994; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; EPSTEIN W, 1975, P NATL ACAD SCI USA, V72, P2300, DOI 10.1073/pnas.72.6.2300; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Inada T, 1996, GENES CELLS, V1, P293, DOI 10.1046/j.1365-2443.1996.24025.x; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Lee HJ, 2012, NAT STRUCT MOL BIOL, V19, P811, DOI 10.1038/nsmb.2318; MAKMAN RS, 1965, J BIOL CHEM, V240, P1309; Malecki J, 2000, J BIOL CHEM, V275, P8480, DOI 10.1074/jbc.275.12.8480; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; NotleyMcRobb L, 1997, MICROBIOL-SGM, V143, P1909, DOI 10.1099/00221287-143-6-1909; Ortega-Martinez S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00046; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; SUTHERLA.EW, 1969, DIABETES, V18, P797, DOI 10.2337/diab.18.12.797; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TAKIO K, 1982, P NATL ACAD SCI-BIOL, V79, P2544, DOI 10.1073/pnas.79.8.2544; Tucker AC, 2014, J BIOL CHEM, V289, P36249, DOI 10.1074/jbc.M114.613901; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Villarreal JM, 2011, MICROBIOL-SGM, V157, P636, DOI 10.1099/mic.0.046045-0; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Yan JS, 2008, J MOL BIOL, V376, P1260, DOI 10.1016/j.jmb.2007.12.070; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	50	11	11	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1374	1384		10.1074/jbc.M116.753640	http://dx.doi.org/10.1074/jbc.M116.753640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27974467	Green Published, hybrid			2022-12-28	WOS:000393339800019
J	Keppel, TR; Sarpong, K; Murray, EM; Monsey, J; Zhu, J; Bose, R				Keppel, Theodore R.; Sarpong, Kwabena; Murray, Elisa M.; Monsey, John; Zhu, Jian; Bose, Ron			Biophysical Evidence for Intrinsic Disorder in the C-terminal Tails of the Epidermal Growth Factor Receptor (EGFR) and HER3 Receptor Tyrosine Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; STRUCTURAL-ANALYSIS; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; SCATTERING; DYNAMICS; MECHANISMS; REGIONS; DOMAIN	The epidermal growth factor receptor (EGFR)/ErbB family of receptor tyrosine kinases includes oncogenes important in the progression of breast and other cancers, and they are targets for many drug development strategies. Each member of the ErbB family possesses a unique, structurally uncharacterized C-terminal tail that plays an important role in autophosphorylation and signal propagation. To determine whether these C-terminal tails are intrinsically disordered regions, we conducted a battery of biophysical experiments on the EGFR and HER3 tails. Using hydrogen/deuterium exchange mass spectrometry, we measured the conformational dynamics of intracellular half constructs and compared the tails with the ordered kinase domains. The C-terminal tails demonstrate more rapid deuterium exchange behavior when compared with the kinase domains. Next, we expressed and purified EGFR and HER3 tail-only constructs. Results from circular dichroism spectroscopy, size exclusion chromatography with multiangle light scattering, dynamic light scattering, analytical ultracentrifugation, and small angle X-ray scattering each provide evidence that the EGFR and HER3 C-terminal tails are intrinsically disordered with extended, non-globular structure in solution. The intrinsic disorder and extended conformation of these tails may be important for their function by increasing the capture radius and reducing the thermodynamic barriers for binding of downstream signaling proteins.	[Keppel, Theodore R.; Sarpong, Kwabena; Murray, Elisa M.; Monsey, John; Bose, Ron] Washington Univ, Sch Med, Dept Med, Div Oncol, 660 South Euclid Ave,Campus Box 8076, St Louis, MO 63110 USA; [Zhu, Jian] Washington Univ, Sch Med, Dept Med, Div Hematol, 660 South Euclid Ave,Campus Box 8076, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Bose, R (corresponding author), Washington Univ, Sch Med, Dept Med, 660 South Euclid Ave,Campus Box 8076, St Louis, MO 63110 USA.	rbose@wustl.edu		Zhu, Jian/0000-0001-6679-8498	National Institutes of Health [R01 CA161001, 8P41 GM103422]; Cancer Biology Pathway Program at the Siteman Cancer Center through National Institutes of Health [5T32 CA113275]; NATIONAL CANCER INSTITUTE [R01CA161001, T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Biology Pathway Program at the Siteman Cancer Center through National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA161001 (to R. B.) and 8P41 GM103422 and by the Cancer Biology Pathway Program at the Siteman Cancer Center through National Institutes of Health Grant 5T32 CA113275. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Bae SH, 2009, J AM CHEM SOC, V131, P6814, DOI 10.1021/ja809687r; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Cantor, 1980, BIOPHYS CHEM; Collier TS, 2013, J BIOL CHEM, V288, P25254, DOI 10.1074/jbc.M113.474882; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Gajiwala KS, 2013, PROTEIN SCI, V22, P995, DOI 10.1002/pro.2283; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kathiriya JJ, 2014, MOL BIOSYST, V10, P2876, DOI 10.1039/c4mb00224e; Keppel TR, 2015, J AM SOC MASS SPECTR, V26, P547, DOI 10.1007/s13361-014-1033-6; Keppel TR, 2013, ANAL CHEM, V85, P5161, DOI 10.1021/ac4004979; Keppel TR, 2011, BIOCHEMISTRY-US, V50, P8722, DOI 10.1021/bi200875p; Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027; Koland JG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003435; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kovacs E, 2015, MOL CELL BIOL, V35, P3083, DOI 10.1128/MCB.00248-15; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; Lee NY, 2006, PROTEIN SCI, V15, P1142, DOI 10.1110/ps.052045306; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Liu JT, 2009, P NATL ACAD SCI USA, V106, P19819, DOI 10.1073/pnas.0907710106; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Manon F, 2010, ANONYMOUS INSTRUMENT, P431, DOI [DOI 10.1002/9780470602614CH15, 10.1002/9780470602614.ch15.]; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pines G, 2010, ONCOGENE, V29, P5850, DOI 10.1038/onc.2010.313; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Rob T, 2012, ANAL CHEM, V84, P3771, DOI 10.1021/ac300365u; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sapir T, 1999, EUR J BIOCHEM, V266, P1011, DOI 10.1046/j.1432-1327.1999.00942.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Tcherkasskaya O, 2001, PROTEINS, V44, P244, DOI 10.1002/prot.1089; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; UVERSKY VN, 1994, BIOCHEMISTRY-US, V33, P2782, DOI 10.1021/bi00176a006; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Xia Y, 2013, J AM CHEM SOC, V135, P18840, DOI 10.1021/ja407644b; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhou HX, 2012, PHYS CHEM CHEM PHYS, V14, P10466, DOI 10.1039/c2cp41196b	74	19	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					597	610		10.1074/jbc.M116.747485	http://dx.doi.org/10.1074/jbc.M116.747485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27872189	hybrid, Green Published			2022-12-28	WOS:000392316100016
J	Bowman, L; Zeden, MS; Schuster, CF; Kaever, V; Grundling, A				Bowman, Lisa; Zeden, Merve S.; Schuster, Christopher F.; Kaever, Volkhard; Grundling, Angelika			New Insights into the Cyclic Di-adenosine Monophosphate (c-di-AMP) Degradation Pathway and the Requirement of the Cyclic Dinucleotide for Acid Stress Resistance in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIME TRANSCRIPTION INITIATION; AFFECT BACTERIAL-GROWTH; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; ABC TRANSPORTER; GENE-EXPRESSION; PHOSPHODIESTERASE; NUCLEOTIDE; PROTEIN; OLIGORIBONUCLEASE	Nucleotide signaling networks are key to facilitate alterations in gene expression, protein function, and enzyme activity in response to diverse stimuli. Cyclic di-adenosine monophosphate (c-di-AMP) is an important secondary messenger molecule produced by the human pathogen Staphylococcus aureus and is involved in regulating a number of physiological processes including potassium transport. S. aureus must ensure tight control over its cellular levels as both high levels of the dinucleotide and its absence result in a number of detrimental phenotypes. Here we show that in addition to the membrane-bound Asp-His-His and Asp-His-His-associated (DHH/DHHA1) domain-containing phosphodiesterase (PDE) GdpP, S. aureus produces a second cytoplasmic DHH/DHHA1 PDE Pde2. Although capable of hydrolyzing c-di-AMP, Pde2 preferentially converts linear 5'-phosphadenylyl-adenosine (pApA) to AMP. Using a pde2 mutant strain, pApA was detected for the first time in S. aureus, leading us to speculate that this dinucleotide may have a regulatory role under certain conditions. Moreover, pApA is involved in a feedback inhibition loop that limits GdpP-dependent c-di-AMP hydrolysis. Another protein linked to the regulation of c-di-AMP levels in bacteria is the predicted regulator protein YbbR. Here, it is shown that a ybbR mutant S. aureus strain has increased acid sensitivity that can be bypassed by the acquisition of mutations in a number of genes, including the gene coding for the diadenylate cyclase DacA. We further show that c-di-AMP levels are slightly elevated in the ybbR suppressor strains tested as compared with the wild-type strain. With this, we not only identified a new role for YbbR in acid stress resistance in S. aureus but also provide further insight into how c-di-AMP levels impact acid tolerance in this organism.	[Bowman, Lisa; Zeden, Merve S.; Schuster, Christopher F.; Grundling, Angelika] Imperial Coll London, Microbiol Sect, Flowers Bldg,Rm 3-21, London SW7 2AZ, England; [Bowman, Lisa; Zeden, Merve S.; Schuster, Christopher F.; Grundling, Angelika] Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, D-306625 Hannover, Germany	Imperial College London; Imperial College London; Hannover Medical School	Grundling, A (corresponding author), Imperial Coll London, Microbiol Sect, Flowers Bldg,Rm 3-21, London SW7 2AZ, England.	a.grundling@imperial.ac.uk	Zeden, Merve/GXF-9824-2022; Schuster, Christopher/J-9904-2015; Kaever, Volkhard/G-3280-2013	Schuster, Christopher/0000-0002-4566-7226; Zeden, Merve Suzan/0000-0003-3636-700X; Grundling, Angelika/0000-0002-6235-8687	Biotechnology and Biological Sciences Research Council [BB/L024209/1]; BBSRC [BB/L024209/1] Funding Source: UKRI; MRC [MR/J006874/1] Funding Source: UKRI; Medical Research Council [MR/J006874/1, MR/J006874/1B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Andrew Ulijasz for providing the S. pneumoniae D39 DNA and Thomas Bernhardt and Jackson Buss for help with the Illumina sequencing of the S. aureus LAC*Delta ybbR mutant and suppressor strains as well as help with the genome sequence analysis. The Illumina sequencing of the LAC* strain was performed by MicrobesNG, which is supported by the Biotechnology and Biological Sciences Research Council Grant BB/L024209/1). We also thank Sanika Hakim for optimization of bacterial growth conditions for MIC determinations, Charlie Millership for purification of the DisA<INF>BT</INF> protein, Mikaila Jayaweera Bandara for construction of the E. coli YbbR overexpression strain, and Annette Garbe for the nucleotide analysis by mass spectrometry. Finally, we thank Manal AbuQun for the phenotype microarray experiments of the LAC* and LAC*Delta ybbR strains on Biolog plates.	Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0; Burhenne Heike, 2013, Methods Mol Biol, V1016, P27, DOI 10.1007/978-1-62703-441-8_3; Campeotto I, 2015, J BIOL CHEM, V290, P2888, DOI 10.1074/jbc.M114.621789; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Cohen D, 2015, P NATL ACAD SCI USA, V112, P11359, DOI 10.1073/pnas.1421450112; Commichau FM, 2015, MOL MICROBIOL, V97, P189, DOI 10.1111/mmi.13026; Corrigan RM, 2015, J BIOL CHEM, V290, P5826, DOI 10.1074/jbc.M114.598300; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Glanzmann P, 1999, ANTIMICROB AGENTS CH, V43, P240, DOI 10.1128/AAC.43.2.240; Goldman SR, 2011, MOL CELL, V42, P817, DOI 10.1016/j.molcel.2011.06.005; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Gundlach J, 2015, J BACTERIOL, V197, P3265, DOI 10.1128/JB.00564-15; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; He Q, 2016, J BIOL CHEM, V291, P14386, DOI [10.1074/jbc.A115.699801, 10.1074/jbc.M115.699801]; Heinrich J, 2008, MICROBIOL-SGM, V154, P1989, DOI 10.1099/mic.0.2008/018648-0; Huynh TN, 2015, P NATL ACAD SCI USA, V112, pE747, DOI 10.1073/pnas.1416485112; Jolly L, 1997, J BACTERIOL, V179, P5321, DOI 10.1128/jb.179.17.5321-5325.1997; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kitko RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010078; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuipers K, 2016, MOL MICROBIOL, V101, P12, DOI 10.1111/mmi.13312; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Leskela S, 1999, MOL MICROBIOL, V31, P533, DOI 10.1046/j.1365-2958.1999.01194.x; Manikandan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086096; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mechold U, 2007, NUCLEIC ACIDS RES, V35, P4552, DOI 10.1093/nar/gkm462; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; Monk IR, 2015, MBIO, V6, DOI 10.1128/mBio.00308-15; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Moscoso JA, 2016, J BACTERIOL, V198, P98, DOI 10.1128/JB.00480-15; Moses S, 2012, J BACTERIOL, V194, P745, DOI 10.1128/JB.06380-11; Nickels BE, 2011, J MOL BIOL, V412, P772, DOI 10.1016/j.jmb.2011.06.015; Orr MW, 2015, P NATL ACAD SCI USA, V112, pE5048, DOI 10.1073/pnas.1507245112; Pilonieta MC, 2012, MOL MICROBIOL, V84, P296, DOI 10.1111/j.1365-2958.2012.08022.x; Postic G, 2012, RNA, V18, P155, DOI 10.1261/rna.029132.111; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Rismondo J, 2016, J BACTERIOL, V198, P416, DOI 10.1128/JB.00845-15; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Schuster CF, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7279; Tang Q, 2015, INT J BIOL SCI, V11, P813, DOI 10.7150/ijbs.11797; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Huynh TN, 2016, MOL MICROBIOL, V102, P233, DOI 10.1111/mmi.13456; Huynh TN, 2016, CURR OPIN MICROBIOL, V30, P22, DOI 10.1016/j.mib.2015.12.007; Underwood AJ, 2014, J MICROBIOL METH, V107, P58, DOI 10.1016/j.mimet.2014.08.026; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Whiteley AT, 2015, CELL HOST MICROBE, V17, P788, DOI 10.1016/j.chom.2015.05.006; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14	67	53	57	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					26970	26986		10.1074/jbc.M116.747709	http://dx.doi.org/10.1074/jbc.M116.747709			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27834680	hybrid, Green Published			2022-12-28	WOS:000391576300003
J	Nigdelioglu, R; Hamanaka, RB; Meliton, AY; O'Leary, E; Witt, LJ; Cho, T; Sun, K; Bonham, C; Wu, D; Woods, PS; Husain, AN; Wolfgeher, D; Dulin, NO; Chandel, NS; Mutlu, GM				Nigdelioglu, Recep; Hamanaka, Robert B.; Meliton, Angelo Y.; O'Leary, Erin; Witt, Leah J.; Cho, Takugo; Sun, Kaitlyn; Bonham, Catherine; Wu, David; Woods, Parker S.; Husain, Aliya N.; Wolfgeher, Don; Dulin, Nickolai O.; Chandel, Navdeep S.; Mutlu, Gokhan M.			Transforming Growth Factor (TGF)-beta Promotes de Novo Serine Synthesis for Collagen Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOFIBROBLAST DIFFERENTIATION; PULMONARY; METABOLISM; MECHANISMS; INHIBITOR; SUPPORTS; FIBROSIS; GLYCINE	TGF-beta promotes excessive collagen deposition in fibrotic diseases such as idiopathic pulmonary fibrosis (IPF). The amino acid composition of collagen is unique due to its high (33%) glycine content. Here, we report that TGF-beta induces expression of glycolytic genes and increases glycolytic flux. TGF-beta also induces the expression of the enzymes of the de novo serine synthesis pathway (phosphoglycerate dehydrogenase (PHGDH), phosphoserine aminotransferase 1 (PSAT1), and phosphoserine phosphatase (PSPH)) and de novo glycine synthesis (serine hydroxymethyltransferase 2 (SHMT2)). Studies in fibroblasts with genetic attenuation of PHGDH or SHMT2 and pharmacologic inhibition of PHGDH showed that these enzymes are required for collagen synthesis. Furthermore, metabolic labeling experiments demonstrated carbon from glucose incorporated into collagen. Lungs from humans with IPF demonstrated increased expression of PHGDH and SHMT2. These results indicate that the de novo serine synthesis pathway is necessary for TGF-beta induced collagen production and suggest that this pathway may be a therapeutic target for treatment of fibrotic diseases including IPF.	[Nigdelioglu, Recep; Hamanaka, Robert B.; Meliton, Angelo Y.; O'Leary, Erin; Witt, Leah J.; Cho, Takugo; Sun, Kaitlyn; Bonham, Catherine; Wu, David; Woods, Parker S.; Dulin, Nickolai O.; Mutlu, Gokhan M.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Husain, Aliya N.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Wolfgeher, Don] Univ Chicago, Prote Core Facil, Chicago, IL 60637 USA; [Chandel, Navdeep S.] Northeastern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	University of Chicago; University of Chicago; University of Chicago	Mutlu, GM (corresponding author), Univ Chicago, Sect Pulm & Crit Care Med, 5841 S Maryland Ave,MC6026, Chicago, IL 60637 USA.	gmutlu@medicine.bsd.uchicago.edu	Mutlu, Gokhan/HIR-2545-2022	Wu, David/0000-0003-3162-3238; Bonham, Catherine/0000-0001-9132-4083; O'Leary, Erin/0000-0003-2220-2757	National Institutes of Health [R01 ES015024, R21 ES025644, K01 AR066579, R56 HL127395, F32 HL134288]; American Heart Association [15POST255900003]; NATIONAL CANCER INSTITUTE [T32CA070085, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL119995, R56HL127395, F32HL134288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR066579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025644, R01ES015024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES015024 and R21 ES025644 (to G. M. M.), K01 AR066579 (to R. B. H.), R56 HL127395 (to N. O. D.), and F32 HL134288 (to D. Wu) and American Heart Association Grant 15POST255900003 (to R. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Ducker GS, 2016, CELL METAB, V24, P640, DOI 10.1016/j.cmet.2016.09.011; FULMER JD, 1980, AM REV RESPIR DIS, V122, P289; Jain M, 2011, AM J RESP CRIT CARE, V183, P1490, DOI 10.1164/rccm.201009-1409OC; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; La J, 2016, AM J PHYSIOL-LUNG C, V310, pL815, DOI 10.1152/ajplung.00322.2015; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Maddocks ODK, 2016, MOL CELL, V61, P210, DOI 10.1016/j.molcel.2015.12.014; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mullarky E, 2016, P NATL ACAD SCI USA, V113, P1778, DOI 10.1073/pnas.1521548113; Mutlu GM, 2012, THORAX, V67, P139, DOI 10.1136/thoraxjnl-2011-200717; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rockey DC, 2015, NEW ENGL J MED, V373, P96, DOI 10.1056/NEJMc1504848; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012	27	69	72	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27239	27251		10.1074/jbc.M116.756247	http://dx.doi.org/10.1074/jbc.M116.756247			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27836973	Green Published, hybrid			2022-12-28	WOS:000391576300022
J	Calegari, VC; Torsoni, AS; Vanzela, EC; Araujo, EP; Morari, J; Zoppi, CC; Sbragia, L; Boschero, AC; Velloso, LA				Calegari, Vivian C.; Torsoni, Adriana S.; Vanzela, Emerielle C.; Araujo, Eliana P.; Morari, Joseane; Zoppi, Claudio C.; Sbragia, Lourenco; Boschero, Antonio C.; Velloso, Licio A.			Inflammation of the hypothalamus leads to defective pancreatic islet function (vol 286, pg 12870, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction							ENDOPLASMIC-RETICULUM STRESS						Morari Ricciardi de Aguiar, Joseane/AHE-2586-2022; Vanzela, Emerielle/AAJ-1679-2021; Araujo, EP/D-9231-2013	Araujo, EP/0000-0002-7539-8477; Vanzela, Emerielle C/0000-0001-8487-9320				Calegari VC, 2011, J BIOL CHEM, V286, P12870, DOI 10.1074/jbc.M110.173021; Coope A, 2012, J BIOL CHEM, V287, P15580, DOI 10.1074/jbc.M111.315218; Denis RG, 2010, NEUROSCIENCE, V170, P1035, DOI 10.1016/j.neuroscience.2010.08.013; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874	4	2	3	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26935	26935		10.1074/jbc.A110.173021	http://dx.doi.org/10.1074/jbc.A110.173021			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	28011877	Green Published, hybrid			2022-12-28	WOS:000391571400030
J	Survery, S; Moparthi, L; Kjellbom, P; Hogestatt, ED; Zygmunt, PM; Johanson, U				Survery, Sabeen; Moparthi, Lavanya; Kjellbom, Per; Hogestatt, Edward D.; Zygmunt, Peter M.; Johanson, Urban			The N-terminal Ankyrin Repeat Domain Is Not Required for Electrophile and Heat Activation of the Purified Mosquito TRPA1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; THERMAL SENSITIVITY; DICTATE SENSITIVITY; POTENTIAL CHANNELS; COLD; REVEALS; PAIN	Temperature sensors are crucial for animals to optimize living conditions. The temperature response of the ion channel transient receptor potential A1 (TRPA1) is intriguing; some orthologs have been reported to be activated by cold and others by heat, but the molecular mechanisms responsible for its activation remain elusive. Single-channel electrophysiological recordings of heterologously expressed and purified Anopheles gambiae TRPA1 (AgTRPA1), with and without the N-terminal ankyrin repeat domain, demonstrate that both proteins are functional because they responded to the electrophilic compounds allyl isothiocyanate and cinnamaldehyde as well as heat. The proteins' similar intrinsic fluorescence properties and corresponding quenching when activated by allyl isothiocyanate or heat suggest lipid bilayer-independent conformational changes outside the N-terminal domain. The results show that AgTRPA1 is an inherent thermo-and chemoreceptor, and analogous to what has been reported for the human TRPA1 ortholog, the N-terminal domain may tune the response but is not required for the activation by these stimuli.	[Survery, Sabeen; Moparthi, Lavanya; Kjellbom, Per; Johanson, Urban] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, SE-22100 Lund, Sweden; [Hogestatt, Edward D.; Zygmunt, Peter M.] Lund Univ, Dept Lab Med, Clin Chem & Pharmacol, SE-22185 Lund, Sweden	Lund University; Lund University	Johanson, U (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, SE-22100 Lund, Sweden.; Zygmunt, PM (corresponding author), Lund Univ, Dept Lab Med, Clin Chem & Pharmacol, SE-22185 Lund, Sweden.	peter.zygmunt@med.lu.se; urban.johanson@biochemistry.lu.se	Moparthi, Lavanya/AAX-1141-2020; Johanson, Urban/AHE-8231-2022	Moparthi, Lavanya/0000-0002-6030-3084; Johanson, Urban/0000-0001-8862-128X; Zygmunt, Peter/0000-0002-5102-8199; Survery, Sabeen/0000-0001-6740-5430	Vetenskapsradet Grants [2014-3801, 2010-5787, 2007-6110]; Svenska Forskningsradet Formas Grant [2007-718]; Research School of Pharmaceutical Sciences FLAK; Medicinska Fakulteten, Lunds Universitet	Vetenskapsradet Grants; Svenska Forskningsradet Formas Grant; Research School of Pharmaceutical Sciences FLAK; Medicinska Fakulteten, Lunds Universitet	This work was supported by Vetenskapsradet Grants 2014-3801, 2010-5787 (to P. M. Z. and E. D. H.), and 2007-6110 (to U. J.) and Svenska Forskningsradet Formas Grant 2007-718 (to P. M. Z., E. D. H., U. J., and P. K.); the Research School of Pharmaceutical Sciences FLAK (to U. J. and P. M. Z.); and the Medicinska Fakulteten, Lunds Universitet (to P. M. Z. and E. D. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Baez D, 2014, CURR TOP MEMBR, V74, P51, DOI 10.1016/B978-0-12-800181-3.00003-8; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; DeLano WL, 2010, PYMOL MOL GRAPH SYST; Gassmann O, 2009, J STRUCT BIOL, V168, P168, DOI 10.1016/j.jsb.2009.02.004; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hilton JK, 2015, BIOCHEMISTRY-US, V54, P2401, DOI 10.1021/acs.biochem.5b00071; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Jabba S, 2014, NEURON, V82, P1017, DOI 10.1016/j.neuron.2014.04.016; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6; Kreir M, 2008, LAB CHIP, V8, P587, DOI 10.1039/b713982a; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Latorre Ramon, 2007, P287; Laursen Willem J, 2015, Temperature (Austin), V2, P214, DOI 10.1080/23328940.2014.1000702; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072595; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Moparthi L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28763; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Norden K, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-47; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Panzano VC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3127pe22; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Sawada Y, 2007, BRAIN RES, V1160, P39, DOI 10.1016/j.brainres.2007.05.047; Shen C, 2008, PROTEINS, V71, P1744, DOI 10.1002/prot.21857; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Voets T, 2012, REV PHYSIOL BIOCH P, V162, P91, DOI 10.1007/112_2011_5; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; Wang H, 2013, J PHYSIOL-LONDON, V591, P185, DOI 10.1113/jphysiol.2012.242842; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zygmunt PM, 2014, HANDB EXP PHARMACOL, V222, P583, DOI 10.1007/978-3-642-54215-2_23	51	12	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26899	26912		10.1074/jbc.M116.743443	http://dx.doi.org/10.1074/jbc.M116.743443			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875296	Green Published, hybrid			2022-12-28	WOS:000391571400026
J	Yuan, ZQ; Kim, D; Shu, SK; Wu, JB; Guo, JP; Xiao, L; Kaneko, S; Coppola, D; Cheng, JQ				Yuan, Zengqiang; Kim, Donghwa; Shu, Shaokun; Wu, Junbing; Guo, Jianping; Xiao, Lei; Kaneko, Satoshi; Coppola, Domenico; Cheng, Jin Q.			Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120 (vol 285, pg 3815, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675	1	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22858	22858		10.1074/jbc.A109.059675	http://dx.doi.org/10.1074/jbc.A109.059675			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825096	hybrid, Green Published			2022-12-28	WOS:000386760600057
J	Thomson, SJ; Hansen, A; Sanguinetti, MC				Thomson, Steven J.; Hansen, Angela; Sanguinetti, Michael C.			Concerted all-or-none subunit interactions mediate slow deactivation of human ether-a-go-go-related gene K+ channels. (vol 289, pg 23428, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Sanguinetti, Michael/AAN-2615-2020					Thomson SJ, 2014, J BIOL CHEM, V289, P23428, DOI 10.1074/jbc.M114.582437	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21423	21423		10.1074/jbc.A114.582437	http://dx.doi.org/10.1074/jbc.A114.582437			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27825078	hybrid, Green Published			2022-12-28	WOS:000385999200010
J	Malara, A; Fresia, C; Di Buduo, CA; Soprano, PM; Moccia, F; Balduini, C; Zocchi, E; De Flora, A; Balduini, A				Malara, Alessandro; Fresia, Chiara; Di Buduo, Christian Andrea; Soprano, Paolo Maria; Moccia, Francesco; Balduini, Cesare; Zocchi, Elena; De Flora, Antonio; Balduini, Alessandra			The Plant Hormone Abscisic Acid Is a Prosurvival Factor in Human and Murine Megakaryocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						abscisic acid (ABA); B cell lymphoma 2 (Bcl-2) family; calcium; cyclic ADP Ribose (cADPR); ERK; PKA; megakaryocyte; thrombopoiesis	CYCLIC ADP-RIBOSE; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MESENCHYMAL STEM-CELLS; PLATELET PRODUCTION; SIGNALING PATHWAY; EX-VIVO; THROMBOPOIETIN; APOPTOSIS; CALCIUM	Abscisic acid (ABA) is a phytohormone involved in pivotal physiological functions in higher plants. Recently, ABA has been proven to be also secreted and active in mammals, where it stimulates the activity of innate immune cells, mesenchymal and hematopoietic stem cells, and insulin-releasing pancreatic cells through a signaling pathway involving the second messenger cyclic ADP-ribose (cADPR). In addition to behaving like an animal hormone, ABA also holds promise as a nutraceutical plant-derived compound in humans. Many biological functions of ABA in mammals are mediated by its binding to the LANCL-2 receptor protein. A putative binding of ABA to GRP78, a key regulator of endoplasmic reticulum stress, has also been proposed. Here we investigated the role of exogenous ABA in modulating thrombopoiesis, the process of platelet generation. Our results demonstrate that expression of both LANCL-2 and GRP78 is up-regulated during hematopoietic stem cell differentiation into mature megakaryocytes (Mks). Functional ABA receptors exist in mature Mks because ABA induces an intracellular Ca2+ increase ([Ca2+](i)) through PKA activation and subsequent cADPR generation. In vitro exposure of human or murine hematopoietic progenitor cells to 10 m ABA does not increase recombinant thrombopoietin (rTpo)-dependent Mk differentiation or platelet release. However, under conditions of cell stress induced by rTpo and serum deprivation, ABA stimulates, in a PKA- and cADPR-dependent fashion, the mitogen-activated kinase ERK 1/2, resulting in the modulation of lymphoma 2 (Bcl-2) family members, increased Mk survival, and higher rates of platelet production. In conclusion, we demonstrate that ABA is a prosurvival factor for Mks in a Tpo-independent manner.	[Malara, Alessandro; Di Buduo, Christian Andrea; Soprano, Paolo Maria; Balduini, Alessandra] Univ Pavia, IRCCS San Matteo Fdn, Dept Mol Med, Labs Biotechnol, Via Forlanini 6, I-27100 Pavia, Italy; [Moccia, Francesco; Balduini, Cesare] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Fresia, Chiara; Zocchi, Elena; De Flora, Antonio] Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	IRCCS Fondazione San Matteo; University of Pavia; University of Pavia; University of Genoa; Tufts University	Balduini, A (corresponding author), Univ Pavia, IRCCS San Matteo Fdn, Dept Mol Med, Labs Biotechnol, Via Forlanini 6, I-27100 Pavia, Italy.	alessandra.balduini@unipv.it	Moccia, Francesco/AAX-6447-2020; BALDUINI, ALESSANDRA/AAC-3363-2022; Di Buduo, Christian A/G-4771-2018; malara, alessandro/K-4027-2016	Moccia, Francesco/0000-0003-0010-0098; BALDUINI, ALESSANDRA/0000-0003-3145-1245; Di Buduo, Christian A/0000-0002-6472-2008; malara, alessandro/0000-0002-3396-3693; Soprano, Paolo Maria/0000-0001-6637-3852; FRESIA, CHIARA MARTA/0000-0002-9177-4655	Italian Ministry of University and Research FIRB [RBFR1299KO]	Italian Ministry of University and Research FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by Italian Ministry of University and Research FIRB Grant RBFR1299KO (to A. M. and C. F). The authors declare that they have no conflicts of interest with the contents of this article.	Ameri P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115992; Balduini A, 2016, THROMB HAEMOSTASIS, V115, P250, DOI 10.1160/TH15-07-0570; BALLEM PJ, 1987, J CLIN INVEST, V80, P33, DOI 10.1172/JCI113060; Bassaganya-Riera J, 2011, J BIOL CHEM, V286, P2504, DOI 10.1074/jbc.M110.160077; Bodrato N, 2009, J BIOL CHEM, V284, P14777, DOI 10.1074/jbc.M802604200; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.0.CO;2-0; Bruzzone S., 2012, MESSENGER, V1, P141; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140; Buckley S, 1999, AM J PHYSIOL-LUNG C, V277, pL159, DOI 10.1152/ajplung.1999.277.1.L159; Bunting S, 1997, BLOOD, V90, P3423, DOI 10.1182/blood.V90.9.3423; Cao SS, 2013, EXPERT OPIN THER TAR, V17, P437, DOI 10.1517/14728222.2013.756471; CHOI ES, 1995, BLOOD, V85, P402; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; De Flora A., 2014, MESSENGER, V3, P86, DOI DOI 10.1166/MSR.2014.1029; Debrincat MA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.97; Debrincat MA, 2012, BLOOD, V119, P5850, DOI 10.1182/blood-2011-12-398834; den Dekker E, 2001, THROMB HAEMOSTASIS, V86, P1106; Di Buduo CA, 2016, HAEMATOLOGICA, V101, P1479, DOI 10.3324/haematol.2016.146746; Di Buduo CA, 2015, BLOOD, V125, P2254, DOI 10.1182/blood-2014-08-595561; Di Buduo CA, 2014, HAEMATOLOGICA, V99, P769, DOI 10.3324/haematol.2013.096859; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Faouzi M, 2014, HANDB EXP PHARMACOL, V222, P403, DOI 10.1007/978-3-642-54215-2_16; Fresia C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26658; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Guri AJ, 2010, J NUTR BIOCHEM, V21, P1178, DOI 10.1016/j.jnutbio.2009.10.003; Guri AJ, 2010, CLIN NUTR, V29, P824, DOI 10.1016/j.clnu.2010.02.009; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Guse AH, 2015, BBA-PROTEINS PROTEOM, V1854, P1132, DOI 10.1016/j.bbapap.2014.12.015; Hong JH, 2013, PLANT CELL REP, V32, P971, DOI 10.1007/s00299-013-1439-9; Ishikawa T, 1998, J GASTROEN HEPATOL, V13, P907, DOI 10.1111/j.1440-1746.1998.tb00760.x; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Ito T, 1996, BRIT J HAEMATOL, V94, P387, DOI 10.1046/j.1365-2141.1996.d01-1813.x; Josefsson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4455; Kaushansky K, 2005, ANN NY ACAD SCI, V1044, P139, DOI 10.1196/annals.1349.018; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kaushansky K, 1997, STEM CELLS, V15, P97, DOI 10.1002/stem.5530150813; Kharenko OA, 2013, J BIOCHEM, V154, P383, DOI 10.1093/jb/mvt067; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Lopez JJ, 2013, ARTERIOSCL THROM VAS, V33, P2750, DOI 10.1161/ATVBAHA.113.302184; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Magnone M, 2015, FASEB J, V29, P4783, DOI 10.1096/fj.15-277731; Malara A, 2015, CELL MOL LIFE SCI, V72, P1517, DOI 10.1007/s00018-014-1813-y; Malara A, 2014, STEM CELLS, V32, P926, DOI 10.1002/stem.1626; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Osada M, 1999, EXP HEMATOL, V27, P131, DOI 10.1016/S0301-472X(98)00007-1; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scarfi S, 2009, STEM CELLS, V27, P2469, DOI 10.1002/stem.173; Scarfi S, 2008, STEM CELLS, V26, P2855, DOI 10.1634/stemcells.2008-0488; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sturla L, 2011, BIOCHEM BIOPH RES CO, V415, P390, DOI 10.1016/j.bbrc.2011.10.079; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Tao R, 2011, J CELL MOL MED, V15, P2684, DOI 10.1111/j.1582-4934.2011.01263.x; Trakala M, 2015, DEV CELL, V32, P155, DOI 10.1016/j.devcel.2014.12.015; UNEYAMA H, 1993, J BIOL CHEM, V268, P168; Vigliarolo T, 2016, INT J BIOCHEM CELL B, V75, P99, DOI 10.1016/j.biocel.2016.03.006; Vigliarolo T, 2015, J BIOL CHEM, V290, P13042, DOI 10.1074/jbc.M114.629501; Wang PC, 2013, P NATL ACAD SCI USA, V110, P11205, DOI 10.1073/pnas.1308974110; White MJ, 2012, BLOOD, V119, P4283, DOI 10.1182/blood-2011-11-394858; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zauli G, 1996, BRIT J HAEMATOL, V92, P711, DOI 10.1046/j.1365-2141.1996.367904.x; Zhou N, 2016, INT J CANCER, V138, P1947, DOI 10.1002/ijc.29935	70	13	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3239	3251		10.1074/jbc.M116.751693	http://dx.doi.org/10.1074/jbc.M116.751693			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28049729	hybrid, Green Published			2022-12-28	WOS:000395538800016
J	Vincent, MS; Canestrari, MJ; Leone, P; Stathopulos, J; Ize, B; Zoued, A; Cambillau, C; Kellenberger, C; Roussel, A; Cascales, E				Vincent, Maxence S.; Canestrari, Mickael J.; Leone, Philippe; Stathopulos, Julien; Ize, Berengere; Zoued, Abdelrahim; Cambillau, Christian; Kellenberger, Christine; Roussel, Alain; Cascales, Eric			Characterization of the Porphyromonas gingivalis Type IX Secretion Trans-envelope PorKLMNP Core Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; membrane protein; microbiology; protein assembly; protein complex; protein purification; protein secretion; secretion	ENTEROAGGREGATIVE ESCHERICHIA-COLI; TRANSMEMBRANE PROTEIN TOPOLOGY; BACTERIAL GLIDING MOTILITY; GRAM-NEGATIVE BACTERIA; C-TERMINAL DOMAIN; VI SECRETION; TANNERELLA-FORSYTHIA; 2-COMPONENT SYSTEM; SIGNAL PEPTIDES; IV SECRETION	The transport of proteins at the cell surface of Bacteroidetes depends on a secretory apparatus known as type IX secretion system (T9SS). This machine is responsible for the cell surface exposition of various proteins, such as adhesins, required for gliding motility in Flavobacterium, S-layer components in Tannerella forsythia, and tooth tissue-degrading enzymes in the oral pathogen Porphyromonas gingivalis. Although a number of subunits of the T9SS have been identified, we lack details on the architecture of this secretion apparatus. Here we provide evidence that five of the genes encoding the core complex of the T9SS are co-transcribed and that the gene products are distributed in the cell envelope. Protein-protein interaction studies then revealed that these proteins oligomerize and interact through a dense network of contacts.	[Vincent, Maxence S.; Canestrari, Mickael J.; Ize, Berengere; Zoued, Abdelrahim; Cascales, Eric] Aix Marseille Univ, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UMR 7255,CNRS, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France; [Leone, Philippe; Stathopulos, Julien; Cambillau, Christian; Kellenberger, Christine; Roussel, Alain] CNRS, UMR 7257, Architecture & Fonct Macromol Biol, Campus Luminy,Case 932, F-13288 Marseille 09, France; [Leone, Philippe; Stathopulos, Julien; Cambillau, Christian; Kellenberger, Christine; Roussel, Alain] Aix Marseille Univ, Architecture & Fonct Macromol Biol, UMR 7257, Campus Luminy,Case 932, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cascales, E (corresponding author), Aix Marseille Univ, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UMR 7255,CNRS, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	cascales@imm.cnrs.fr	kellenberger, christine/AAV-9304-2020; CASCALES, ERIC/G-7420-2011; IZE, Bérengère/GLQ-7207-2022	CASCALES, ERIC/0000-0003-0611-9179; IZE, Bérengère/0000-0001-9106-9254; Vincent, Maxence S./0000-0001-8431-7504; Zoued, Abdelrahim/0000-0002-6973-1755; Canestrari, Mickael/0000-0003-3501-7139	CNRS; Aix-Marseille Universite; Agence Nationale de la Recherche [ANR-15-CE11-0019-01]; French Ministere de la Recherche; Fondation pour la Recherche Medicale [FDT20140931060]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministere de la Recherche(Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the CNRS, the Aix-Marseille Universite, and a grant from the Agence Nationale de la Recherche (ANR-15-CE11-0019-01). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a doctoral fellowship from the French Ministere de la Recherche.; Supported by an end-of-thesis fellowship from the Fondation pour la Recherche Medicale (FDT20140931060).	Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Boisvert H, 2014, P NATL ACAD SCI USA, V111, P5355, DOI 10.1073/pnas.1402740111; Boisvert H, 2010, INFECT IMMUN, V78, P3616, DOI 10.1128/IAI.00187-10; Braun TF, 2005, J BACTERIOL, V187, P2628, DOI 10.1128/JB.187.8.2628-2637.2005; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; Flaugnatti N, 2016, MOL MICROBIOL, V99, P1099, DOI 10.1111/mmi.13292; Glew MD, 2014, J PROTEOMICS, V110, P72, DOI 10.1016/j.jprot.2014.07.033; Glew MD, 2012, J BIOL CHEM, V287, P24605, DOI 10.1074/jbc.M112.369223; Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200; Gorasia DG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005820; Goulas T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11969; Hasegawa Y, 2016, J DENT RES, V95, P1291, DOI 10.1177/0022034516655083; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kharade SS, 2015, J BACTERIOL, V197, P147, DOI 10.1128/JB.02085-14; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; Nakane D, 2013, P NATL ACAD SCI USA, V110, P11145, DOI 10.1073/pnas.1219753110; Nakayama K, 2015, J PERIODONTAL RES, V50, P1, DOI 10.1111/jre.12255; Narita Y, 2014, MICROBIOL-SGM, V160, P2295, DOI 10.1099/mic.0.080192-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Rhodes RG, 2011, J BACTERIOL, V193, P599, DOI 10.1128/JB.01203-10; Rocas IN, 2001, ORAL SURG ORAL MED O, V91, P468, DOI 10.1067/moe.2001.114379; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Sakamoto M, 2005, J PERIODONTAL RES, V40, P277, DOI 10.1111/j.1600-0765.2005.00793.x; Sato K, 2013, FEMS MICROBIOL LETT, V338, P68, DOI 10.1111/1574-6968.12028; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Shrivastava A, 2015, CURR OPIN MICROBIOL, V28, P93, DOI 10.1016/j.mib.2015.07.018; Shrivastava A, 2015, CURR BIOL, V25, P338, DOI 10.1016/j.cub.2014.11.045; Shrivastava A, 2013, J BACTERIOL, V195, P3201, DOI 10.1128/JB.00333-13; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108; Taguchi Y, 2016, INFECT IMMUN, V84, P230, DOI 10.1128/IAI.01308-15; Tomek MB, 2014, MOL ORAL MICROBIOL, V29, P307, DOI 10.1111/omi.12062; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Veith PD, 2013, J PROTEOME RES, V12, P4449, DOI 10.1021/pr400487b; Vincent MS, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00096; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zoued A, 2016, NATURE, V531, P59, DOI 10.1038/nature17182	60	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3252	3261		10.1074/jbc.M116.765081	http://dx.doi.org/10.1074/jbc.M116.765081			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28057754	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000395538800017
J	Levdikov, VM; Blagova, E; Young, VL; Belitsky, BR; Lebedev, A; Sonenshein, AL; Wilkinson, AJ				Levdikov, Vladimir M.; Blagova, Elena; Young, Vicki L.; Belitsky, Boris R.; Lebedev, Andrey; Sonenshein, Abraham L.; Wilkinson, Anthony J.			Structure of the Branched-chain Amino Acid and GTP-sensing Global Regulator, CodY, from Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; GRAM-POSITIVE BACTERIA; STATIONARY-PHASE; BINDING-SITES; MACROMOLECULAR STRUCTURES; STAPHYLOCOCCUS-AUREUS; DEPENDENT REGULATION; LACTOCOCCUS-LACTIS; TRANSCRIPTION; IDENTIFICATION	CodY is a branched-chain amino acid (BCAA) and GTP sensor and a global regulator of transcription in low G + C Grampositive bacteria. It controls the expression of over 100 genes and operons, principally by repressing during growth genes whose products are required for adaptations to nutrient limitation. However, the mechanism by which BCAA binding regulates transcriptional changes is not clear. It is known that CodY consists of a GAF (c (G) under bar MP-stimulated phosphodiesterases, (a) under bar denylate cyclases, (F) under bar hlA) domain that binds BCAAs and a winged helix-turn-helix (wHTH) domain that binds to DNA, but the way in which these domains interact and the structural basis of the BCAA dependence of this interaction are unknown. To gain new insights, we determined the crystal structure of unliganded CodY from Bacillus subtilis revealing a 10-turn alpha-helix linking otherwise discrete GAF and wHTH domains. The structure of CodY in complex with isoleucine revealed a reorganized GAF domain. In both complexes CodY was tetrameric. Size exclusion chromatography with multiangle laser light scattering (SEC-MALLS) experiments showed that CodY is a dimer at concentrations found in bacterial cells. Comparison of structures of dimers of unliganded CodY and CodYIle derived from the tetramers showed a splaying of the wHTH domains when Ile was bound; splaying is likely to account for the increased affinity of Ile-bound CodY for DNA. Electrophoretic mobility shift and SEC-MALLS analyses of CodY binding to 19-36-bp operator fragments are consistent with isoleucine dependent binding of two CodY dimers per duplex. The implications of these observations for effector control of CodY activity are discussed.	[Levdikov, Vladimir M.; Blagova, Elena; Young, Vicki L.; Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Belitsky, Boris R.; Sonenshein, Abraham L.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Lebedev, Andrey] STFC Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England	University of York - UK; Tufts University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Wilkinson, AJ (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	tony.wilkinson@york.ac.uk	Levdikov, Vladimir/AAA-6139-2022	Levdikov, Vladimir/0000-0003-3041-1049; Wilkinson, Anthony/0000-0003-4577-9479; Young, Vicki/0000-0002-9816-7858	National Institutes of Health [GM042219]; Biotechnology and Biological Sciences Research Council [BBS/B1213X]; Wellcome Trust [082829/Z/07/Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042219] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/1213X] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Institutes of Health Grant GM042219 from NIGMS, Biotechnology and Biological Sciences Research Council Grant BBS/B1213X, and Wellcome Trust Grant 082829/Z/07/Z. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; ATKINSON MR, 1990, J BACTERIOL, V172, P4758, DOI 10.1128/jb.172.9.4758-4765.1990; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; Belitsky BR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005600; Belitsky BR, 2015, J BACTERIOL, V197, P1330, DOI 10.1128/JB.02563-14; Belitsky BR, 2013, P NATL ACAD SCI USA, V110, P7026, DOI 10.1073/pnas.1300428110; Belitsky BR, 2011, J MOL BIOL, V413, P321, DOI 10.1016/j.jmb.2011.08.003; Belitsky BR, 2011, J MOL BIOL, V411, P729, DOI 10.1016/j.jmb.2011.06.012; Belitsky BR, 2011, J BACTERIOL, V193, P473, DOI 10.1128/JB.01151-10; Belitsky BR, 1998, J BACTERIOL, V180, P6298; Bennett HJ, 2007, MOL MICROBIOL, V63, P1453, DOI 10.1111/j.1365-2958.2007.05597.x; Blagova EV, 2003, ACTA CRYSTALLOGR D, V59, P155, DOI 10.1107/S0907444902018358; Brinsmade SR, 2014, P NATL ACAD SCI USA, V111, P8227, DOI 10.1073/pnas.1321308111; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; Dineen SS, 2010, J BACTERIOL, V192, P5350, DOI 10.1128/JB.00341-10; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fogg MJ, 2008, BIOCHEM SOC T, V36, P771, DOI 10.1042/BST0360771; FOUET A, 1990, J BACTERIOL, V172, P835, DOI 10.1128/jb.172.2.835-844.1990; Guedon E, 2005, MICROBIOL-SGM, V151, P3895, DOI 10.1099/mic.0.28186-0; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Han AR, 2016, NUCLEIC ACIDS RES, V44, P9483, DOI 10.1093/nar/gkw775; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Ji QJ, 2013, P NATL ACAD SCI USA, V110, P5010, DOI 10.1073/pnas.1219446110; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Levdikov VM, 2012, J MOL BIOL, V415, P343, DOI 10.1016/j.jmb.2011.11.017; Levdikov VM, 2009, J MOL BIOL, V390, P1007, DOI 10.1016/j.jmb.2009.05.077; Levdikov VM, 2006, J BIOL CHEM, V281, P11366, DOI 10.1074/jbc.M513015200; Lewis RJ, 2000, J MOL BIOL, V297, P757, DOI 10.1006/jmbi.2000.3598; Lobel L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002887; Maass S, 2014, MOL CELL PROTEOMICS, V13, P2260, DOI 10.1074/mcp.M113.035741; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Malke H, 2006, INT J MED MICROBIOL, V296, P259, DOI 10.1016/j.ijmm.2005.11.008; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miller J. H., 1972, EXPT MOL GENETICS, P433; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICOLAI T, 1987, J CHROMATOGR, V389, P286, DOI 10.1016/S0021-9673(01)94436-X; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Preis H, 2009, J BACTERIOL, V191, P5446, DOI 10.1128/JB.00602-09; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos JA, 2014, P NATL ACAD SCI USA, V111, pE2251, DOI 10.1073/pnas.1322728111; Shivers RP, 2006, MOL MICROBIOL, V62, P811, DOI 10.1111/j.1365-2958.2006.05410.x; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; SLACK FJ, 1995, MOL MICROBIOL, V15, P689, DOI 10.1111/j.1365-2958.1995.tb02378.x; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; van Schaik W, 2009, INFECT IMMUN, V77, P4437, DOI 10.1128/IAI.00716-09; Villapakkam AC, 2009, J BACTERIOL, V191, P6865, DOI 10.1128/JB.00818-09; Wen J, 2000, ANAL BIOCHEM, V280, P327, DOI 10.1006/abio.2000.4524; Wilkinson AJ, 1996, CHEM BIOL, V3, P519, DOI 10.1016/S1074-5521(96)90141-6; Wray LV, 2011, J BACTERIOL, V193, P4841, DOI 10.1128/JB.05258-11; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08	61	21	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2714	2728		10.1074/jbc.M116.754309	http://dx.doi.org/10.1074/jbc.M116.754309			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28011634	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000395535100014
J	Logashina, YA; Mosharova, IV; Korolkova, YV; Shelukhina, IV; Dyachenko, IA; Palikov, VA; Palikova, YA; Murashev, AN; Kozlov, SA; Stensvag, K; Andreev, YA				Logashina, Yulia A.; Mosharova, Irina V.; Korolkova, Yulia V.; Shelukhina, Irina V.; Dyachenko, Igor A.; Palikov, Victor A.; Palikova, Yulia A.; Murashev, Arkadii N.; Kozlov, Sergey A.; Stensvag, Klara; Andreev, Yaroslav A.			Peptide from Sea Anemone Metridium senile Affects Transient Receptor Potential Ankyrin-repeat 1 (TRPA1) Function and Produces Analgesic Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUE DISTRIBUTION ANALYSIS; ION-CHANNEL; MECHANICAL HYPERSENSITIVITY; NEUROGENIC INFLAMMATION; POLYPEPTIDE INHIBITOR; SENSORY NEURONS; C-FIBERS; ACTIVATION; PAIN; TRPV1	The transient receptor potential ankyrin-repeat 1 (TRPA1) is an important player in pain and inflammatory pathways. It is a prom-isingtargetfornoveldrugdevelopmentforthetreatmentofanum-ber of pathological states. A novel peptide producing a significant potentiating effect on allyl isothiocyanate-and diclofenac-induced currents of TRPA1 was isolated from the venom of sea anemone Metridium senile. It is a 35-amino acid peptide cross-linked by two disulfide bridges named tau-AnmTX Ms 9a-1 (short name Ms 9a-1) according to a structure similar to other sea anemone peptides belonging to structural group 9a. The structures of the two genes encoding the different precursor proteins of Ms 9a-1 were determined. PeptideMs9a-1 acted as a positive modulator of TRPA1 in vitro but did not cause pain or thermal hyperalgesia when injected into the hind paw of mice. Intravenous injection of Ms 9a-1 (0.3 mg/ kg) produced a significant decrease in the nociceptive and inflammatory response to allyl isothiocyanate (the agonist of TRPA1) and reversed CFA (Complete Freund's Adjuvant)-induced inflammation and thermal hyperalgesia. Taken together these data support the hypothesis that Ms 9a-1 potentiates the response of TRPA1 to endogenous agonists followed by persistent functional loss of TRPA1-expressing neurons. We can conclude that TRPA1 potentiating may be useful as a therapeutic approach as Ms 9a-1 produces significant analgesic and antiinflammatory effects in mice models of pain.	[Logashina, Yulia A.; Mosharova, Irina V.; Korolkova, Yulia V.; Shelukhina, Irina V.; Kozlov, Sergey A.; Andreev, Yaroslav A.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia; [Logashina, Yulia A.; Andreev, Yaroslav A.] Sechenov First Moscow State Med Univ, Inst Mol Med, Trubetskaya St 8,Bldg 2, Moscow 119991, Russia; [Dyachenko, Igor A.; Palikov, Victor A.; Palikova, Yulia A.; Murashev, Arkadii N.] Russian Acad Sci, Branch Shemyakin Ovchinnikov Inst Bioorgan Chem, 6 Nauki Ave, Moscow 142290, Russia; [Stensvag, Klara] Univ Tromso, Norwegian Coll Fishery Sci, N-9037 Tromso, Norway	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Sechenov First Moscow State Medical University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; UiT The Arctic University of Tromso	Andreev, YA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.; Andreev, YA (corresponding author), Sechenov First Moscow State Med Univ, Inst Mol Med, Trubetskaya St 8,Bldg 2, Moscow 119991, Russia.	ay@land.ru	Kozlov, Sergey A/D-1548-2012; Andreev, Yaroslav A/C-6627-2012; DI Igor, Dyachenko/K-9060-2017; Shelukhina, Irina/AHE-5496-2022; Palikova, Yuliya/Y-4228-2018	Kozlov, Sergey A/0000-0002-0242-4240; Shelukhina, Irina/0000-0003-3476-1441; Stensvag, Klara/0000-0002-4717-6711; Andreev, Yaroslav/0000-0002-7628-0980; Palikov, Victor/0000-0003-2989-4477; Palikova, Yuliya/0000-0001-9547-0686	Russian Science Foundation [16-15-00167]; Functional Genomics (FUGE) programme; Biotek 2021 programme of the Research Council of Norway [208546]	Russian Science Foundation(Russian Science Foundation (RSF)); Functional Genomics (FUGE) programme; Biotek 2021 programme of the Research Council of Norway	This work was supported by Russian Science Foundation Grant 16-15-00167, the Functional Genomics (FUGE) programme, and the Biotek 2021 programme of the Research Council of Norway, project XBioPepS (Grant 208546). The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Andersson DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046917; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Andre E, 2009, BRIT J PHARMACOL, V158, P1621, DOI 10.1111/j.1476-5381.2009.00438.x; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Andreev YA, 2009, DOKL BIOCHEM BIOPHYS, V424, P46, DOI 10.1134/S160767290901013X; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Andreev YA, 2013, MAR DRUGS, V11, P5100, DOI 10.3390/md11125100; Andreev YA, 2012, RECENT PATENTS INFLA, V6, P35, DOI 10.2174/187221312798889266; Andreev YA, 2010, ANAL BIOCHEM, V407, P144, DOI 10.1016/j.ab.2010.07.023; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Birrell MA, 2009, AM J RESP CRIT CARE, V180, P1042, DOI 10.1164/rccm.200905-0665OC; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; Brierley SM, 2011, J PHYSIOL-LONDON, V589, P3575, DOI 10.1113/jphysiol.2011.206789; Cassoli JS, 2013, J PROTEOMICS, V87, P89, DOI 10.1016/j.jprot.2013.05.022; Caterina MJ, 2007, NATURE, V445, P491, DOI 10.1038/nature05565; Chen J, 2011, PAIN, V152, P1165, DOI 10.1016/j.pain.2011.01.049; Chen Y, 2011, NEUROSCIENCE, V193, P440, DOI 10.1016/j.neuroscience.2011.06.085; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Cruz-Orengo L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-30; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Eid SR, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-48; Eilers H, 2010, ANESTHESIOLOGY, V112, P1452, DOI 10.1097/ALN.0b013e3181d94e00; Gui JH, 2014, CURR BIOL, V24, P473, DOI 10.1016/j.cub.2014.01.013; Honma T, 2005, TOXICON, V45, P33, DOI 10.1016/j.toxicon.2004.09.013; Honma T, 2008, PEPTIDES, V29, P536, DOI 10.1016/j.peptides.2007.12.010; Hu HZ, 2010, PFLUG ARCH EUR J PHY, V459, P579, DOI 10.1007/s00424-009-0749-9; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Jouiaei M, 2015, TOXINS, V7, P2251, DOI 10.3390/toxins7062251; Kojima R, 2014, EUR J PHARMACOL, V723, P288, DOI 10.1016/j.ejphar.2013.11.020; Kozlov S, 2005, TOXICON, V46, P672, DOI 10.1016/j.toxicon.2005.07.009; Kozlov S A, 2012, Bioorg Khim, V38, P653; Kozlov S, 2012, PEPTIDES, V33, P240, DOI 10.1016/j.peptides.2011.12.008; Kozlov S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-88; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Materazzi S, 2013, PAIN, V154, P2750, DOI 10.1016/j.pain.2013.08.002; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Namer B, 2005, NEUROREPORT, V16, P955, DOI 10.1097/00001756-200506210-00015; Osmakov DI, 2013, J BIOL CHEM, V288, P23116, DOI 10.1074/jbc.M113.485516; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Preti D, 2015, PHARM PAT ANAL, V4, P75, DOI [10.4155/ppa.14.60, 10.4155/PPA.14.60]; Raisinghani M, 2011, AM J PHYSIOL-CELL PH, V301, pC587, DOI 10.1152/ajpcell.00465.2010; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Satoh JI, 2009, J ANESTH, V23, P620, DOI 10.1007/s00540-009-0786-8; Schwartz ES, 2013, J NEUROSCI, V33, P5603, DOI 10.1523/JNEUROSCI.1806-12.2013; Shelukhina I, 2015, BRAIN STRUCT FUNCT, V220, P1885, DOI 10.1007/s00429-014-0762-4; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Taylor-Clark TE, 2008, J PHYSIOL-LONDON, V586, P3447, DOI 10.1113/jphysiol.2008.153585; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Taylor-Clark TE, 2009, MOL PHARMACOL, V75, P820, DOI 10.1124/mol.108.054445; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Utkina LL, 2013, FEBS J, V280, P3594, DOI 10.1111/febs.12349; Weng YQ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-75; Zaharenko AJ, 2008, COMP BIOCHEM PHYS D, V3, P219, DOI 10.1016/j.cbd.2008.04.002; Zhou YM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3399	62	28	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2992	3004		10.1074/jbc.M116.757369	http://dx.doi.org/10.1074/jbc.M116.757369			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28077580	hybrid, Green Published			2022-12-28	WOS:000395535100038
J	Zhao, WK; Tong, H; Huang, YK; Yan, Y; Teng, HJ; Xia, Y; Jiang, Q; Qin, JZ				Zhao, Wukui; Tong, Huan; Huang, Yikai; Yan, Yun; Teng, Huajian; Xia, Yin; Jiang, Qing; Qin, Jinzhong			Essential Role for Polycomb Group Protein Pcgf6 in Embryonic Stem Cell Maintenance and a Noncanonical Polycomb Repressive Complex 1 (PRC1) Integrity.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; SELF-RENEWAL; CHROMATIN-STRUCTURE; MOUSE DEVELOPMENT; NANOS PROTEINS; MICE; DIFFERENTIATION; RING1B; E2F6; ESCS	The Polycomb group (PcG) proteins have an important role in controlling the expression of key genes implicated in embryonic development, differentiation, and decision of cell fates. Emerging evidence suggests that Polycomb repressive complexes 1 (PRC1) is defined by the six Polycomb group RING finger protein (Pcgf) paralogs, and Pcgf proteins can assemble into noncanonical PRC1 complexes. However, little is known about the precise mechanisms of differently composed noncanonical PRC1 in the maintenance of the pluripotent cell state. Here we disrupt the Pcgf genes in mouse embryonic stem cells by CRISPR-Cas9 and find Pcgf6 null embryonic stem cells display severe defects in self-renewal and differentiation. Furthermore, Pcgf6 regulates genes mostly involved in differentiation and spermatogenesis by assembling a noncanonical PRC1 complex PRC1.6. Notably, Pcgf6 deletion causes a dramatic decrease in PRC1.6 binding to target genes and no loss of H2AK119ub1. Thus, Pcgf6 is essential for recruitment of PRC1.6 to chromatin. Our results reveal a previously uncharacterized, H2AK119ub1 independent chromatin assembly associated with PRC1.6 complex.	[Zhao, Wukui; Tong, Huan; Huang, Yikai; Yan, Yun; Teng, Huajian; Qin, Jinzhong] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing Biomed Res Inst, Nanjing 210061, Jiangsu, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Jiang, Qing] Nanjing Univ, Dept Sports Med & Adult Reconstruct Surg, Nanjing Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Chinese University of Hong Kong; Nanjing University	Qin, JZ (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	qinjz@nicemice.cn	zhao, wukui/AAI-9846-2020; Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532	National Natural Science Foundation of China [31471387, 31671532]; Shuangchuang Program of Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shuangchuang Program of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China (31471387 and 31671532) and by the 2015 Shuangchuang Program of Jiangsu Province (to J. Q.) The authors declare that they have no conflicts of interest with the contents of this article	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Akasaka T, 2002, GENES CELLS, V7, P835, DOI 10.1046/j.1365-2443.2002.00565.x; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Conacci-Sorrell Maralice, 2014, Cold Spring Harb Perspect Med, V4, pa014357, DOI 10.1101/cshperspect.a014357; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Illingworth RS, 2015, GENE DEV, V29, P1897, DOI 10.1101/gad.268151.115; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Kehoe SM, 2008, BIOL REPROD, V79, P921, DOI 10.1095/biolreprod.108.067645; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Maeda I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2780; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Luis NM, 2012, CELL STEM CELL, V11, P16, DOI 10.1016/j.stem.2012.06.005; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Qin JZ, 2010, J BIOL CHEM, V285, P27767, DOI 10.1074/jbc.M110.115410; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Storre J, 2005, J BIOL CHEM, V280, P41380, DOI 10.1074/jbc.M506797200; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; Suzuki A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11056; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Turner SA, 2013, CELL STEM CELL, V12, P145, DOI 10.1016/j.stem.2013.01.014; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Washkowitz AJ, 2015, DEVELOPMENT, V142, P31, DOI 10.1242/dev.111104; Wu H, 2011, CELL RES, V21, P365, DOI 10.1038/cr.2010.157; Yang CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep26899; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zdzieblo D, 2014, STEM CELLS, V32, P3112, DOI 10.1002/stem.1826	52	37	38	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2773	2784		10.1074/jbc.M116.763961	http://dx.doi.org/10.1074/jbc.M116.763961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049731	Green Published, hybrid			2022-12-28	WOS:000395535100018
J	Chen, J; Wu, XT; Yao, LK; Yan, L; Zhang, L; Qiu, JH; Liu, XF; Jia, SJ; Meng, AM				Chen, Jing; Wu, Xiaotong; Yao, Likun; Yan, Lu; Zhang, Lin; Qiu, Juhui; Liu, Xingfeng; Jia, Shunji; Meng, Anming			Impairment of Cargo Transportation Caused by gbf1 Mutation Disrupts Vascular Integrity and Causes Hemorrhage in Zebrafish Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; BREFELDIN-A; ENDOPLASMIC-RETICULUM; CELL-DEATH; IN-VIVO; INTRACELLULAR-TRANSPORT; LIPID DROPLETS; ARF PROTEINS; GOLGI; ER	ADP-ribosylation factor GTPases are activated by guanine nucleotide exchange factors including Gbf1 (Golgi brefeldin A-resistant factor 1) and play important roles in regulating organelle structure and cargo-selective vesicle trafficking. However, the developmental role of Gbf1 in vertebrates remains elusive. In this study, we report the zebrafish mutant line tsu3994 that arises from N-ethyl-N-nitrosourea (ENU)-mediated mutagenesis and is characterized by prominent intracerebral and trunk hemorrhage. The mutant embryos develop hemorrhage accompanied by fewer pigments and shorter caudal fin at day 2 of development. The hemorrhage phenotype is caused by vascular breakage in a cell autonomous fashion. Positional cloning identifies a T -> G nucleotide substitution in the 23rd exon of the gbf1 locus, resulting in a leucine -> arginine substitution (L1246R) in the HDS2 domain. The mutant phenotype is mimicked by gbf1 knockouts and morphants, suggesting a nature of loss of function. Experimental results in mammalian cells show that the mutant form Gbf1(L1246R) is unable to be recruited to the Golgi apparatus and fails to activate Arf1 for recruiting COPI complex. The hemorrhage in tsu3994 mutants can be prevented partially and temporally by treating with the endoplasmic reticulum stress/apoptosis inhibitor tauroursodeoxycholic acid or by knocking down the proapoptotic gene baxb. Therefore, endothelial endoplasmic reticulum stress and subsequent apoptosis induced by gbf1 deficiency may account for the vascular collapse and hemorrhage.	[Chen, Jing; Wu, Xiaotong; Yao, Likun; Yan, Lu; Zhang, Lin; Qiu, Juhui; Liu, Xingfeng; Jia, Shunji; Meng, Anming] Tsinghua Univ, Lab Mol Dev Biol, State Key Lab Membrane Biol, Tsinghua Peking Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University	Meng, AM (corresponding author), Tsinghua Univ, Lab Mol Dev Biol, State Key Lab Membrane Biol, Tsinghua Peking Ctr Life Sci,Sch Life Sci, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Wu, Xiaotong/AAH-4566-2021; Meng, Anming/A-4785-2012	Wu, Xiaotong/0000-0002-4109-9444; Chen, Jing/0000-0001-5540-0878; Meng, Anming/0000-0001-7228-3431; Yao, Likun/0000-0002-2798-7285	National Natural Science Foundation; China Grant [31330052]; Major Science Programs of the Ministry of Science and Technology of the People's Republic of China Grants [2012CB945101, 2011CB943800]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Grant; Major Science Programs of the Ministry of Science and Technology of the People's Republic of China Grants	This work was supported by National Natural Science Foundation of thus could serve as an anti-infection target. However, the China Grant 31330052 and Major Science Programs of the Ministry of Science and Technology of the People's Republic of China Grants 2012CB945101 and 2011CB943800. The authors declare that they have no conflicts of interest with the contents of this article.	Aridor M, 2002, TRAFFIC, V3, P781, DOI 10.1034/j.1600-0854.2002.31103.x; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Belov GA, 2010, CELL MICROBIOL, V12, P1463, DOI 10.1111/j.1462-5822.2010.01482.x; Bouvet S, 2013, J CELL SCI, V126, P4794, DOI 10.1242/jcs.134254; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cherfils J, 2005, BIOCHEM SOC T, V33, P635, DOI 10.1042/BST0330635; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Wilde AH, 2015, J VIROL, V89, P8318, DOI 10.1128/JVI.01029-15; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Jin P, 2004, CHINESE SCI BULL, V49, P2154, DOI 10.1360/982004-188; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu XF, 2016, METHODS MOL BIOL, V1344, P275, DOI 10.1007/978-1-4939-2966-5_17; Liu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2762; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Pyati UJ, 2011, DEV CELL, V21, P492, DOI 10.1016/j.devcel.2011.07.012; Quilty D, 2014, J CELL SCI, V127, P354, DOI 10.1242/jcs.130591; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Schimmoller F, 1997, CURR BIOL, V7, pR235, DOI 10.1016/S0960-9822(06)00109-6; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Toruno C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088151; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wang Su-Fang, 2012, Enzyme Res, V2012, P192867, DOI 10.1155/2012/192867; Wei AH, 2013, J DERMATOL, V40, P325, DOI 10.1111/1346-8138.12025; Wright J, 2014, CELL MOL LIFE SCI, V71, P3419, DOI 10.1007/s00018-014-1602-7; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Zhou Y, 2011, METHOD CELL BIOL, V104, P287, DOI 10.1016/B978-0-12-374814-0.00016-1	55	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2315	2327		10.1074/jbc.M116.767608	http://dx.doi.org/10.1074/jbc.M116.767608			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28003365	Green Published, hybrid			2022-12-28	WOS:000395530300023
J	Liu, MY; Pile, LA				Liu, Mengying; Pile, Lori A.			The Transcriptional Corepressor SIN3 Directly Regulates Genes Involved in Methionine Catabolism and Affects Histone Methylation, Linking Epigenetics and Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; gene transcription; histone acetylation; histone methylation; methionine; S-adenosylmethionine (SAM); SIN3	DROSOPHILA-MELANOGASTER; DEACETYLASE COMPLEX; S-ADENOSYLMETHIONINE; EXPRESSION; CELLS; DIFFERENTIATION; LOCALIZATION; RESISTANCE; VIABILITY; PROTEINS	Chromatin modification and cellular metabolism are tightly connected. Chromatin modifiers regulate the expression of genes involved in metabolism and, in turn, the levels of metabolites. The generated metabolites are utilized by chromatin modifiers to affect epigenetic modification. The mechanism for this cross-talk, however, remains incompletely understood. The corepressor SIN3 controls histone acetylation through association with the histone deacetylase RPD3. The SIN3 complex is known to regulate genes involved in a number of metabolic processes. Here, we find that Drosophila SIN3 binds to the promoter region of genes involved in methionine catabolism and that this binding affects histone modification, which in turn influences gene expression. Specifically, we observe that reduced expression of SIN3 leads to an increase in S-adenosylmethionine (SAM), which is the major cellular donor of methyl groups for protein modification. Additionally, Sin3A knockdown results in an increase in global histone H3K4me3 levels. Furthermore, decreased H3K4me3 caused by knockdown of either SAM synthetase (Sam-S) or the histone methyltransferase Set1 is restored to near normal levels when SIN3 is also reduced. Taken together, these results indicate that knockdown of Sin3A directly alters the expression of methionine metabolic genes to increase SAM, which in turn leads to an increase in global H3K4me3. Our study reveals that SIN3 is an important epigenetic regulator directly connecting methionine metabolism and histone modification.	[Liu, Mengying; Pile, Lori A.] Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall,Biological Sci Bldg, Detroit, MI 48202 USA	Wayne State University	Pile, LA (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall,Biological Sci Bldg, Detroit, MI 48202 USA.	loripile@wayne.edu			Wayne State University; NIGMS, National Institutes of Health [R01GM088886-01A2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088886] Funding Source: NIH RePORTER	Wayne State University; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Grants Plus Award from Wayne State University and NIGMS, National Institutes of Health Grant R01GM088886-01A2 (to L.A.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Barnes VL, 2014, AGING-US, V6, P645, DOI 10.18632/aging.100684; Barnes VL, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-26; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Caggese C, 1997, MOL GEN GENET, V253, P492, DOI 10.1007/s004380050348; Cheng P. G., 2011, J HUAZHONG AGR U SOC, V3, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022018; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Gajan A, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0053-9; Gan QA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r42; Gonneaud A, 2015, FEBS LETT, V589, P2776, DOI 10.1016/j.febslet.2015.08.009; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hallson G, 2012, GENETICS, V190, P91, DOI 10.1534/genetics.111.135863; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; LARSSON J, 1994, FEBS LETT, V342, P329, DOI 10.1016/0014-5793(94)80526-1; Li SS, 2015, MOL CELL, V60, P408, DOI 10.1016/j.molcel.2015.09.024; Liu MY, 2016, G3-GENES GENOM GENET, V6, P121, DOI 10.1534/g3.115.024273; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Neufeld TP, 1998, GENETICS, V148, P277; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Sadhu MJ, 2013, GENETICS, V195, P831, DOI 10.1534/genetics.113.153981; Saha N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2428-5; Sassone-Corsi P, 2013, SCIENCE, V339, P148, DOI 10.1126/science.1233423; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Spain MM, 2010, J BIOL CHEM, V285, P27457, DOI 10.1074/jbc.M110.130245; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Swaminathan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049563; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	42	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1970	1976		10.1074/jbc.M116.749754	http://dx.doi.org/10.1074/jbc.M116.749754			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28028175	hybrid, Green Published			2022-12-28	WOS:000395515600034
J	Kasho, K; Tanaka, H; Sakai, R; Katayama, T				Kasho, Kazutoshi; Tanaka, Hiroyuki; Sakai, Ryuji; Katayama, Tsutomu			Cooperative DnaA Binding to the Negatively Supercoiled datA Locus Stimulates DnaA-ATP Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI REPLICATION ORIGIN; OSMOTIC-STRESS RESPONSE; INTEGRATION HOST FACTOR; ESCHERICHIA-COLI; CHROMOSOMAL REPLICATION; INITIATION COMPLEX; STRUCTURAL BASIS; GENE-EXPRESSION; PROTEIN-BINDING; IN-VITRO	Timely initiation of replication in Escherichia coli requires functional regulation of the replication initiator, ATP-DnaA. The cellular level of ATP-DnaA increases just before initiation, after which its level decreases through hydrolysis of DnaA-bound ATP, yielding initiation-inactive ADP-DnaA. Previously, we reported a novel DnaA-ATP hydrolysis system involving the chromosomal locus datA and named it datA-dependent DnaA-ATP hydrolysis (DDAH). The datA locus contains a binding site for a nucleoid-associating factor integration host factor (IHF) and a cluster of three known DnaA-binding sites, which are important for DDAH. However, the mechanisms underlying the formation and regulation of the datA-IHF.DnaA complex remain unclear. We now demonstrate that a novel DnaA box within datA is essential for ATP-DnaA complex formation and DnaA-ATP hydrolysis. Specific DnaA residues, which are important for interaction with bound ATP and for head-to-tail inter-DnaA interaction, were also required for ATP-DnaA-specific oligomer formation on datA. Furthermore, we show that negative DNA supercoiling of datA stabilizes ATP-DnaA oligomers, and stimulates datA-IHF interaction and DnaA-ATP hydrolysis. Relaxation of DNA supercoiling by the addition of novobiocin, a DNA gyrase inhibitor, inhibits datA function in cells. On the basis of these results, we propose a mechanistic model of datA-IHF.DnaA complex formation and DNA supercoiling-dependent regulation for DDAH.	[Kasho, Kazutoshi; Tanaka, Hiroyuki; Sakai, Ryuji; Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka 8128582, Japan; [Tanaka, Hiroyuki] Hisamitsu Pharmaceut Co, Tosu, Saga 8410017, Japan	Kyushu University; Hisamitsu Pharmaceutical Co Ltd	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp		Kasho, Kazutoshi/0000-0003-0326-0740; Katayama, Tsutomu/0000-0001-9994-1684	Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 15K18479, 26291004, 26650127, 16H00775]; Japan Society for the Promotion of Science; Kyushu University Qdaijump Research Program (Former Interdisciplinary Programs in Education and Projects in Research Development) [26122, 28247]; Grants-in-Aid for Scientific Research [15K18479, 16H00775, 26291004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyushu University Qdaijump Research Program (Former Interdisciplinary Programs in Education and Projects in Research Development); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research KAKENHI 15K18479, 26291004, 26650127, and 16H00775 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Japan Society for the Promotion of Science and by the Kyushu University Qdaijump Research Program (Former Interdisciplinary Programs in Education and Projects in Research Development) (no. 26122 and 28247) and English/Japanese Proofreading Expenses Support. The authors declare that they have no conflict of interest of this article.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Aeling KA, 2006, J BIOL CHEM, V281, P39236, DOI 10.1074/jbc.M606363200; BAKER TA, 1988, CELL, V55, P113, DOI 10.1016/0092-8674(88)90014-1; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Cagliero C, 2013, NUCLEIC ACIDS RES, V41, P315, DOI 10.1093/nar/gks988; Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; Cameron ADS, 2011, MOL MICROBIOL, V80, P85, DOI 10.1111/j.1365-2958.2011.07560.x; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; COZZARELLI NR, 1980, SCIENCE, V207, P953, DOI 10.1126/science.6243420; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Donczew R, 2014, J MOL BIOL, V426, P2769, DOI 10.1016/j.jmb.2014.05.018; Dorman CJ, 1996, TRENDS MICROBIOL, V4, P214, DOI 10.1016/0966-842X(96)30015-2; DRLICA K, 1988, J BACTERIOL, V170, P4983, DOI 10.1128/jb.170.10.4983-4985.1988; Duggin IG, 2008, MOL MICROBIOL, V70, P1323, DOI 10.1111/j.1365-2958.2008.06500.x; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2008, J BACTERIOL, V190, P5368, DOI 10.1128/JB.00044-08; HOLLOMAN WK, 1976, P NATL ACAD SCI USA, V73, P3910, DOI 10.1073/pnas.73.11.3910; Inoue Y, 2016, GENES CELLS, V21, P1015, DOI 10.1111/gtc.12395; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Kasho K, 2014, NUCLEIC ACIDS RES, V42, P13134, DOI 10.1093/nar/gku1051; Kasho K, 2013, P NATL ACAD SCI USA, V110, P936, DOI 10.1073/pnas.1212070110; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Kawakami H, 2006, MOL MICROBIOL, V62, P1310, DOI 10.1111/j.1365-2958.2006.05450.x; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; Kitagawa R, 1996, MOL MICROBIOL, V19, P1137, DOI 10.1046/j.1365-2958.1996.453983.x; Krause M, 1997, J MOL BIOL, V274, P365, DOI 10.1006/jmbi.1997.1404; Leonard AC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00545; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Morigen, 2005, J BACTERIOL, V187, P3913, DOI 10.1128/JB.187.12.3913-3920.2005; Morigen M, 2014, MICROBIOL-SGM, V160, P703, DOI 10.1099/mic.0.074898-0; Nakamura K, 2010, MOL MICROBIOL, V76, P302, DOI 10.1111/j.1365-2958.2010.07074.x; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Noguchi Y, 2015, J BIOL CHEM, V290, P20295, DOI 10.1074/jbc.M115.662601; Nozaki S, 2009, GENES CELLS, V14, P329, DOI 10.1111/j.1365-2443.2008.01269.x; Ogawa T, 2002, MOL MICROBIOL, V44, P1367, DOI 10.1046/j.1365-2958.2002.02969.x; Okumura H, 2012, NUCLEIC ACIDS RES, V40, P220, DOI 10.1093/nar/gkr716; Ozaki S, 2012, J BIOL CHEM, V287, P37458, DOI 10.1074/jbc.M112.372052; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Riber L, 2016, FRONT MOL BIOSCI, V3, DOI [10.3389/fmollb.2016.00029, 10.3389/fmolb.2016.00029]; Rozgaja TA, 2011, MOL MICROBIOL, V82, P475, DOI 10.1111/j.1365-2958.2011.07827.x; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Sheridan SD, 1998, J BIOL CHEM, V273, P21298, DOI 10.1074/jbc.273.33.21298; SKARSTAD K, 1989, MOL GEN GENET, V218, P50, DOI 10.1007/BF00330564; SKARSTAD K, 1994, BBA-GENE STRUCT EXPR, V1217, P111, DOI 10.1016/0167-4781(94)90025-6; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; Smulczyk-Krawczyszyn A, 2006, J BACTERIOL, V188, P6184, DOI 10.1128/JB.00528-06; Stros M, 1998, EUR J BIOCHEM, V251, P427, DOI 10.1046/j.1432-1327.1998.2510427.x; Su'etsugu M, 2003, GENES CELLS, V8, P731, DOI 10.1046/j.1365-2443.2003.00671.x; Su'etsugu M, 2001, MOL MICROBIOL, V40, P376, DOI 10.1046/j.1365-2958.2001.02378.x; Teter B, 2000, PLASMID, V43, P73, DOI 10.1006/plas.1999.1443; Teyssier C, 1996, BIOCHEMISTRY-US, V35, P7954, DOI 10.1021/bi952414o; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; von Freiesleben U, 2000, MOL MICROBIOL, V37, P1087, DOI 10.1046/j.1365-2958.2000.02060.x; VONFREISLEBEN U, 1992, RES MICROBIOL, V143, P655, DOI 10.1016/0923-2508(92)90060-2; Weigel C, 1997, EMBO J, V16, P6574, DOI 10.1093/emboj/16.21.6574; Weigel C, 2001, MOL MICROBIOL, V40, P498, DOI 10.1046/j.1365-2958.2001.02409.x	64	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1251	1266		10.1074/jbc.M116.762815	http://dx.doi.org/10.1074/jbc.M116.762815			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27941026	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000393339800010
J	Llansola-Portoles, MJ; Sobotka, R; Kish, E; Shukla, MK; Pascal, AA; Polivka, T; Robert, B				Llansola-Portoles, Manuel J.; Sobotka, Roman; Kish, Elizabeth; Shukla, Mahendra Kumar; Pascal, Andrew A.; Polivka, Tomas; Robert, Bruno			Twisting a beta-Carotene, an Adaptive Trick from Nature for Dissipating Energy during Photoprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; RESONANCE RAMAN-SPECTRA; PHOTOSYSTEM-II; HIGHER-PLANTS; SPECTROSCOPIC PROPERTIES; ELECTRONIC ABSORPTION; ANTENNA PROTEINS; CHLOROPHYLL; BINDING; CONFIGURATION	Cyanobacteria possess a family of one-helix high light-inducible proteins (Hlips) that are homologous to light-harvesting antenna of plants and algae. An Hlip protein, high light-inducible protein D (HliD) purified as a small complex with the Ycf39 protein is evaluated using resonance Raman spectroscopy. We show that the HliD binds two different beta-carotenes, each present in two non-equivalent binding pockets with different conformations, having their (0,0) absorption maxima at 489 and 522 nm, respectively. Both populations of beta-carotene molecules were in all-trans configuration and the absorption position of the farthest blue-shifted beta-carotene was attributed entirely to the polarizability of the environment in its binding pocket. In contrast, the absorption maximum of the red-shifted beta-carotene was attributed to two different factors: the polarizability of the environment in its binding pocket and, more importantly, to the conformation of its beta-rings. This second beta-carotene has highly twisted beta-rings adopting a flat conformation, which implies that the effective conjugation length N is extended up to 10.5 modifying the energetic levels. This increase in N will also result in a lower S-1 energy state, which may provide a permanent energy dissipation channel. Analysis of the carbonyl stretching region for chlorophyll a excitations indicates that the HliD binds six chlorophyll a molecules in five non-equivalent binding sites, with at least one chlorophyll a presenting a slight distortion to its macrocycle. The binding modes and conformations of HliD-bound pigments are discussed with respect to the known structures of LHCII and CP29.	[Llansola-Portoles, Manuel J.; Kish, Elizabeth; Pascal, Andrew A.; Robert, Bruno] Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, F-91198 Gif Sur Yvette, France; [Sobotka, Roman; Shukla, Mahendra Kumar] Acad Sci Czech Republ, Inst Microbiol, Ctr Algatech, Trebon 37981, Czech Republic; [Polivka, Tomas] Univ South Bohemia, Fac Sci, Inst Phys & Biophys, Ceske Budejovice 37001, Czech Republic	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Llansola-Portoles, MJ (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, F-91198 Gif Sur Yvette, France.	manuel.llansola@cea.fr	Sobotka, Roman/J-3077-2014; Polivka, Tomas/G-9564-2014; pascal, andrew a/B-6186-2014; Llansola-Portoles, Manuel J./ABI-1060-2020; Robert, Bruno/D-1264-2012; Shukla, Mahendra Kumar/J-5994-2014	Sobotka, Roman/0000-0001-5909-3879; Polivka, Tomas/0000-0002-6176-0420; pascal, andrew a/0000-0002-1844-6065; Llansola-Portoles, Manuel J./0000-0002-8065-9459; Robert, Bruno/0000-0001-5999-4538; Shukla, Mahendra Kumar/0000-0002-6858-1441	French National Infrastructure for Integrated Structural Biology (FRISBI); Czech Science Foundation [P501/12/G055, 14-13967S]	French National Infrastructure for Integrated Structural Biology (FRISBI); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the French National Infrastructure for Integrated Structural Biology (FRISBI) and Grants P501/12/G055 and 14-13967S from the Czech Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Andreeva A, 2011, SPECTROCHIM ACTA A, V78, P1261, DOI 10.1016/j.saa.2010.12.071; Bhaya D, 2002, FEMS MICROBIOL LETT, V215, P209, DOI 10.1111/j.1574-6968.2002.tb11393.x; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; DemmigAdams B, 2014, NONPHOTOCHEMICAL QUE; DOLGANOV NAM, 1995, P NATL ACAD SCI USA, V92, P636, DOI 10.1073/pnas.92.2.636; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; FEILER U, 1994, J RAMAN SPECTROSC, V25, P365, DOI 10.1002/jrs.1250250513; Fuciman M, 2015, J PHYS CHEM B, V119, P1457, DOI 10.1021/jp512354r; FUJIWARA M, 1986, J PHYS CHEM-US, V90, P5646, DOI 10.1021/j100280a033; Gust D, 2008, MRS BULL, V33, P383, DOI 10.1557/mrs2008.78; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Knoppova J, 2014, PLANT CELL, V26, P1200, DOI 10.1105/tpc.114.123919; Komenda J, 2016, BBA-BIOENERGETICS, V1857, P288, DOI 10.1016/j.bbabio.2015.08.011; Koyama Y, 1999, ADV PHOTOSYNTH, V8, P161; KOYAMA Y, 1983, PHOTOBIOCH PHOTOBIOP, V5, P139; Lapouge K, 1998, J RAMAN SPECTROSC, V29, P977, DOI 10.1002/(SICI)1097-4555(199810/11)29:10/11<977::AID-JRS325>3.0.CO;2-K; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; LUTZ M, 1987, BIOCHIM BIOPHYS ACTA, V894, P423, DOI 10.1016/0005-2728(87)90121-6; LUTZ M, 1977, BIOCHIM BIOPHYS ACTA, V460, P408, DOI 10.1016/0005-2728(77)90081-0; Lutz M., 1991, CHLOROPHYLLS, P855; Macernis M, 2015, J PHYS CHEM A, V119, P56, DOI 10.1021/jp510426m; Macernis M, 2014, J PHYS CHEM A, V118, P1817, DOI 10.1021/jp406449c; Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r; Mendes-Pinto MM, 2013, J BIOL CHEM, V288, P18758, DOI 10.1074/jbc.M112.423681; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; Naveke A, 1997, J RAMAN SPECTROSC, V28, P599, DOI 10.1002/(SICI)1097-4555(199708)28:8<599::AID-JRS136>3.0.CO;2-C; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Niedzwiedzki DM, 2016, BBA-BIOENERGETICS, V1857, P1430, DOI 10.1016/j.bbabio.2016.04.280; Pascal A, 2000, J BIOL CHEM, V275, P22031, DOI 10.1074/jbc.M000658200; Pascoal AJ, 2014, COLOQUIO-LETRAS, P245; Polivka T, 2005, BIOCHEMISTRY-US, V44, P3994, DOI 10.1021/bi047473t; Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n; Polivka T, 2009, BIOPHYS J, V96, P2268, DOI 10.1016/j.bpj.2009.01.004; Robert B, 1999, ADV PHOTOSYNTH, V8, P189; Robert B., 1996, BIOPHYSICAL TECHNIQU, P161; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 2002, J BIOL CHEM, V277, P42937, DOI 10.1074/jbc.M207823200; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; Staleva H, 2015, NAT CHEM BIOL, V11, P287, DOI [10.1038/nchembio.1755, 10.1038/NCHEMBIO.1755]; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200	46	33	33	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1396	1403		10.1074/jbc.M116.753723	http://dx.doi.org/10.1074/jbc.M116.753723			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27994060	hybrid, Green Published			2022-12-28	WOS:000393339800021
J	Bloch, N; Glasker, S; Sitaram, P; Hofmann, H; Shepard, CN; Schultz, ML; Kim, B; Landau, NR				Bloch, Nicolin; Glasker, Sabine; Sitaram, Poojitha; Hofmann, Henning; Shepard, Caitlin N.; Schultz, Megan L.; Kim, Baek; Landau, Nathaniel R.			A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AICARDI-GOUTIERES SYNDROME; GMP-AMP SYNTHASE; HIV-1 RESTRICTION; ACCESSORY PROTEIN; ANTIRETROVIRAL ACTIVITY; ALLOSTERIC ACTIVATION; NUCLEASE ACTIVITY; DNTPASE ACTIVITY; STRUCTURAL BASIS	The triphosphohydrolase SAMHD1 ( sterile beta motif and histidine-aspartate domain-containing protein 1) restricts HIV-1 replication in nondividing myeloid cells by depleting the dNTP pool, preventing reverse transcription. SAMHD1 is also reported to have ribonuclease activity that degrades the virus genomic RNA. Human SAMHD1 is regulated by phosphorylation of its carboxyl terminus at Thr-592, which abrogates its antiviral function yet has only a small effect on its phosphohydrolase activity. In the mouse, SAMHD1 is expressed as two isoforms (ISF1 and ISF2) that differ at the carboxyl terminus due to alternative splicing of the last coding exon. In this study we characterized the biochemical and antiviral properties of the two mouse isoforms of SAMHD1. Both are antiviral in nondividing cells. Mass spectrometry analysis showed that SAMHD1 is phosphorylated at several amino acid residues, one of which (Thr-634) is homologous to Thr-592. Phosphomimetic mutation at Thr-634 of ISF1 ablates its antiviral activity yet has little effect on phosphohydrolase activity in vitro. dGTP caused ISF1 to tetramerize, activating its catalytic activity. In contrast, ISF2, which lacks the phosphorylation site, was significantly more active, tetramerized, and was active without added dGTP. Neither isoform nor human SAMHD1 had detectable RNase activity in vitro or affected HIV-1 genomic RNA stability in newly infected cells. These data support a model in which SAMHD1 catalytic activity is regulated through tetramer stabilization by the carboxyl-terminal tail, phosphorylation destabilizing the complexes and inactivating the enzyme. ISF2 may serve to reduce the dNTP pool to very low levels as a means of restricting virus replication.	[Bloch, Nicolin; Glasker, Sabine; Sitaram, Poojitha; Hofmann, Henning; Schultz, Megan L.; Landau, Nathaniel R.] New York Sch Med, Dept Microbiol, New York, NY 10016 USA; [Shepard, Caitlin N.; Kim, Baek] Emory Sch Med, Ctr Drug Discovery, Dept Pediat, Atlanta, GA 30322 USA; [Kim, Baek] Kyung Hee Univ, Sch Pharm, Seoul 02447, South Korea	Emory University; Kyung Hee University	Landau, NR (corresponding author), NYU Langone Med Ctr, Smilow Res Ctr, Dept Microbiol, 1003,550 First Ave, New York, NY 10016 USA.	nathaniel.landau@med.nyu.edu		Sitaram, Poojitha/0000-0003-3285-5057	National Institutes of Health [AI067059, AI058864, AI049781, GM104198]; Vilcek Fellowship Endowment Fund award; amfAR Mathilde Krim Fellowship in Basic Biomedical Research [108982-57-RKGN]; Deutsche Forschungs Gemeinschaft [HO 5262/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049781, R01AI067059, R01AI049781, R01AI058864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilcek Fellowship Endowment Fund award; amfAR Mathilde Krim Fellowship in Basic Biomedical Research; Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI067059 and AI058864 (to N. R. L.) and AI049781 and GM104198 (to B. K.). This work was also supported by a Vilcek Fellowship Endowment Fund award (to N. B.) and an amfAR Mathilde Krim Fellowship in Basic Biomedical Research (108982-57-RKGN) and a Deutsche Forschungs Gemeinschaft post-doctoral fellowship (HO 5262/1-1; to H. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Arnold LH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005194; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Bobadilla S, 2013, GENE THER, V20, P514, DOI 10.1038/gt.2012.61; Choi J, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0174-4; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Seamon KJ, 2015, NUCLEIC ACIDS RES, V43, P6486, DOI 10.1093/nar/gkv633; St Gelais C, 2014, J VIROL, V88, P7689, DOI 10.1128/JVI.01089-14; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Tang CX, 2015, J BIOL CHEM, V290, P26352, DOI 10.1074/jbc.M115.677435; Wang FF, 2016, VIROLOGY, V487, P273, DOI 10.1016/j.virol.2015.10.024; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Wittmann S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0229-6; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200; Yan JP, 2015, J BIOL CHEM, V290, P13279, DOI 10.1074/jbc.M115.646588; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhang RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089558; Zhu CF, 2015, ACTA CRYSTALLOGR D, V71, P516, DOI 10.1107/S1399004714027527	42	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1068	1080		10.1074/jbc.M116.743740	http://dx.doi.org/10.1074/jbc.M116.743740			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27920203	Green Published, hybrid			2022-12-28	WOS:000392318700026
J	Ludlow, MJ; Gaunt, HJ; Rubaiy, HN; Musialowski, KE; Blythe, NM; Vasudev, NS; Muraki, K; Beech, DJ				Ludlow, Melanie J.; Gaunt, Hannah J.; Rubaiy, Hussein N.; Musialowski, Katie E.; Blythe, Nicola M.; Vasudev, Naveen S.; Muraki, Katsuhiko; Beech, David J.			(-)-Englerin A-evoked Cytotoxicity Is Mediated by Na+ Influx and Counteracted by Na+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNELS; RENAL-CELL CARCINOMA; TRPC5; ENGLERIN; CANCER; NA,K-ATPASE; CELLMINER; SUBUNIT; BRAIN; PKC	(-)-Englerin A ((-)-EA) has a rapid and potent cytotoxic effect on several types of cancer cell that is mediated by plasma membrane ion channels containing transient receptor potential canonical 4 (TRPC4) protein. Because these channels are Ca2+-permeable, it was initially thought that the cytotoxicity arose as a consequence of Ca2+ overload. Here we show that this is not the case and that the effect of (-)-EA is mediated by a heteromer of TRPC4 and TRPC1 proteins. Both TRPC4 and TRPC1 were required for (-)-EA cytotoxicity; however, although TRPC4 was necessary for the (-)-EA-evoked Ca2+ elevation, TRPC1 was not. TRPC1 either had no role or was a negative regulator of Ca2+ entry. By contrast, both TRPC4 and TRPC1 were necessary for monovalent cation entry evoked by (-)-EA, and (-)-EA-evoked cell death was dependent upon entry of the monovalent cation Na+. We therefore hypothesized that Na+/K+-ATPase might act protectively by counteracting the Na+ load resulting from sustained Na+ entry. Indeed, inhibition of Na+/K+-ATPase by ouabain potently and strongly increased (-)-EA-evoked cytotoxicity. The data suggest that (-)-EA achieves cancer cell cytotoxicity by inducing sustained Na+ entry through heteromeric TRPC1/TRPC4 channels and that the cytotoxic effect of (-)-EA can be potentiated by Na+/K+ ATPase inhibition.	[Ludlow, Melanie J.; Gaunt, Hannah J.; Rubaiy, Hussein N.; Musialowski, Katie E.; Blythe, Nicola M.; Vasudev, Naveen S.; Beech, David J.] Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, Leeds LS2 9JT, W Yorkshire, England; [Muraki, Katsuhiko] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, 1-100 Kusumoto, Nagoya, Aichi 4648650, Japan	University of Leeds; Aichi Gakuin University	Beech, DJ (corresponding author), Univ Leeds, Sch Med, Leeds Inst Cardiovasc & Metab Med, LIGHT Labs, Leeds LS2 9JT, W Yorkshire, England.	D.J.Beech@leeds.ac.uk	- The Truth, HNR/AAO-2514-2020; Rubaiy, Hussein N./ABG-5191-2021	Rubaiy, Hussein N./0000-0002-1489-5576; Vasudev, Naveen/0000-0001-8470-7481; Ludlow, Melanie/0000-0002-0720-5581; Beech, David/0000-0002-7683-9422	Leeds Teaching Hospitals Trust Charitable Foundation; University of Leeds; British Heart Foundation [FS/14/22/30734] Funding Source: researchfish	Leeds Teaching Hospitals Trust Charitable Foundation; University of Leeds; British Heart Foundation(British Heart Foundation)	This work was supported by the Leeds Teaching Hospitals Trust Charitable Foundation and the University of Leeds. The authors declare that they have no conflicts of interest with the contents of this article.	Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Alevizopoulos K, 2014, CURR DRUG TARGETS, V15, P988, DOI 10.2174/1389450115666140908125025; Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Carson C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127498; Dietrich Alexander, 2014, Cells, V3, P939, DOI 10.3390/cells3040939; Engl E, 2015, J PHYSIOL-LONDON, V593, P3417, DOI 10.1113/jphysiol.2014.282517; Fash DM, 2016, BIOORG MED CHEM LETT, V26, P2641, DOI 10.1016/j.bmcl.2016.04.016; Kim J, 2014, PFLUG ARCH EUR J PHY, V466, P491, DOI 10.1007/s00424-013-1332-y; Li ZW, 2011, J AM CHEM SOC, V133, P6553, DOI 10.1021/ja201921j; Lopez-Suarez L, 2016, CHEMMEDCHEM, V11, P1003, DOI 10.1002/cmdc.201600040; Naylor J, 2016, BRIT J PHARMACOL, V173, P562, DOI 10.1111/bph.13387; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Radtke L, 2011, ANGEW CHEM INT EDIT, V50, P3998, DOI 10.1002/anie.201007790; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Ratnayake R, 2009, ORG LETT, V11, P57, DOI 10.1021/ol802339w; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Selvakumar P, 2014, EPIGENETICS-US, V9, P579, DOI 10.4161/epi.27795; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Shi J, 2012, FASEB J, V26, P409, DOI 10.1096/fj.11-185611; Sourbier C, 2013, CANCER CELL, V23, P228, DOI 10.1016/j.ccr.2012.12.007; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2	24	29	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					723	731		10.1074/jbc.M116.755678	http://dx.doi.org/10.1074/jbc.M116.755678			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27875305	Green Published, hybrid			2022-12-28	WOS:000392316100026
J	He, K; Hu, J; Yu, HY; Wang, LN; Tang, F; Gu, JJ; Ge, LX; Wang, HY; Li, S; Hu, P; Jin, Y				He, Ke; Hu, Jing; Yu, Hongyao; Wang, Lina; Tang, Fan; Gu, Junjie; Ge, Laixiang; Wang, Hongye; Li, Sheng; Hu, Ping; Jin, Ying			Serine/Threonine Kinase 40 (Stk40) Functions as a Novel Regulator of Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOGENIC DIFFERENTIATION; HISTONE DEACETYLASE-5; TRANSCRIPTION FACTOR; MEF2 PROTEINS; STEM-CELLS; REGENERATION; ENHANCER; ROLES; GENE; ACTIVATION	Skeletal muscle differentiation is a precisely coordinated process, and the molecular mechanism regulating the process remains incompletely understood. Here we report the identification of serine/threonine kinase 40 (Stk40) as a novel positive regulator of skeletal myoblast differentiation in culture and fetal skeletal muscle formation in vivo. We show that the expression level of Stk40 increases during skeletal muscle differentiation. Down-regulation and overexpression of Stk40 significantly decreases and increases myogenic differentiation of C2C12 myoblasts, respectively. In vivo, the number of myofibers and expression levels of myogenic markers are reduced in the fetal muscle of Stk40 knockout mice, indicating impaired fetal skeletal muscle formation. Mechanistically, Stk40 controls the protein level of histone deacetylase 5 (HDAC5) to maintain transcriptional activities of myocyte enhancer factor 2 (MEF2), a family of transcription factor important for skeletal myogenesis. Silencing of HDAC5 expression rescues the reduced myogenic gene expression caused by Stk40 deficiency. Together, our study reveals that Stk40 is required for fetal skeletal muscle development and provides molecular insights into the control of the HDAC5-MEF2 axis in skeletal myogenesis.	[He, Ke; Hu, Jing; Yu, Hongyao; Wang, Lina; Tang, Fan; Gu, Junjie; Ge, Laixiang; Jin, Ying] Shanghai Jiao Tong Univ, Sch Med, Lab Mol Dev Biol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Jin, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Ctr Excellence Mol Cell Sci,Inst Hlth Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Wang, Hongye; Li, Sheng; Hu, Ping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, 320 Yueyang Rd, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Lab Mol Dev Biol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn		Yu, Hongyao/0000-0003-3752-8442	Ministry of Science and Technology of China [2016YFA0100100, 2013CB966801]; National Natural Science Foundation [31301015, 91419309]; Chinese Academy of Sciences [XDB19020100]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the Ministry of Science and Technology of China (2016YFA0100100 and 2013CB966801), the National Natural Science Foundation (31301015 and 91419309), and the Chinese Academy of Sciences (XDB19020100). The authors declare that they have no conflicts of interest with the contents of this article.	Bailey P, 2001, CURR OPIN CELL BIOL, V13, P679, DOI 10.1016/S0955-0674(00)00271-4; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cripps RM, 2004, DEV BIOL, V267, P536, DOI 10.1016/j.ydbio.2003.12.004; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Li H S, 2009, J SAFETY SCI TECHNOL, V5, P5; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Swierczynski S, 2015, EXPERT OPIN BIOL TH, V15, P651, DOI 10.1517/14712598.2015.1025047; Tajbakhsh S, 2009, J INTERN MED, V266, P372, DOI 10.1111/j.1365-2796.2009.02158.x; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73; Weeks KL, 2015, J PHYSIOL-LONDON, V593, P1785, DOI 10.1113/jphysiol.2014.282442; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yu HY, 2015, J CELL SCI, V128, P2881, DOI 10.1242/jcs.170282; Yu HY, 2013, J BIOL CHEM, V288, P5342, DOI 10.1074/jbc.M112.409433	40	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					351	360		10.1074/jbc.M116.719849	http://dx.doi.org/10.1074/jbc.M116.719849			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27899448	Green Published, hybrid			2022-12-28	WOS:000391578000030
J	Hou, ST; Jiang, SX; Zaharia, LI; Han, XM; Benson, CL; Slinn, J; Abrams, SR				Hou, Sheng Tao; Jiang, Susan X.; Zaharia, L. Irina; Han, Xiumei; Benson, Chantel L.; Slinn, Jacqueline; Abrams, Suzanne R.			Phaseic Acid, an Endogenous and Reversible Inhibitor of Glutamate Receptors in Mouse Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEURONAL DEATH; CEREBRAL-ISCHEMIA; ABSCISIC-ACID; (+)-ABSCISIC ACID; RAT-BRAIN; IN-VIVO; ABA; NEUROPROTECTION; CALCIUM; RECOMMENDATIONS	Phaseic acid (PA) is a phytohormone regulating important physiological functions in higher plants. Here, we show the presence of naturally occurring (-)-PA in mouse and rat brains. (-)-PA is exclusively present in the choroid plexus and the cerebral vascular endothelial cells. Purified (-)-PA has no toxicity and protects cultured cortical neurons against glutamate toxicity through reversible inhibition of glutamate receptors. Focal occlusion of the middle cerebral artery elicited a significant induction in (-)-PA expression in the cerebrospinal fluid but not in the peripheral blood. Importantly, (-)-PA induction only occurred in the penumbra area, indicting a protective role of PA in the brain. Indeed, elevating the (-)-PA level in the brain reduced ischemic brain injury, whereas reducing the (-)-PA level using a monoclonal antibody against (-)-PA increased ischemic injury. Collectively, these studies showed for the first time that (-)-PA is an endogenous neuroprotective molecule capable of reversibly inhibiting glutamate receptors during ischemic brain injury.	[Hou, Sheng Tao] Southern Univ Sci & Technol, Brain Res Ctr, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China; [Hou, Sheng Tao] Southern Univ Sci & Technol, Dept Biol, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China; [Hou, Sheng Tao; Jiang, Susan X.; Slinn, Jacqueline] Natl Res Council Canada, Expt NeuroTherapeut, Human Hlth Therapeut Portfolio, 1200 Montreal Rd,Bldg M54, Ottawa, ON K1A 0R6, Canada; [Zaharia, L. Irina; Han, Xiumei; Benson, Chantel L.; Abrams, Suzanne R.] Natl Res Council Canada, Aquat & Crop Resource Dev, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada; [Hou, Sheng Tao] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Abrams, Suzanne R.] Univ Saskatchewan, Saskatchewan Struct Sci Ctr, Rm 190 Thorvaldson Bldg,110 Sci Pl, Saskatoon, SK S7N 5C9, Canada	Southern University of Science & Technology; Southern University of Science & Technology; National Research Council Canada; National Research Council Canada; University of Ottawa; University of Saskatchewan	Hou, ST (corresponding author), Southern Univ Sci & Technol, Brain Res Ctr, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China.; Hou, ST (corresponding author), Southern Univ Sci & Technol, Dept Biol, 1088 Xueyuan Blvd, Shenzhen 518055, Guangdong, Peoples R China.	hou.st@sustc.edu.cn	Hou, Sheng Tao/AAM-7756-2020; Hou, Sheng Tao/O-3202-2018	Hou, Sheng Tao/0000-0001-9736-342X	National Natural Science Foundation of China [81571287]; Shenzhen Science and Technology Innovation Committee Basic Science Research Grants [JCYJ20140417105742709, JCYJ20160301112230218]; State Key Laboratory of Neuroscience Open Competition Grant [SKLN-201403]; Southern University of Science and Technology (SUSTech) Peacock Program Start-up Fund Grant [22/Y01226109]; SUSTech Brain Research Centre Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Committee Basic Science Research Grants; State Key Laboratory of Neuroscience Open Competition Grant; Southern University of Science and Technology (SUSTech) Peacock Program Start-up Fund Grant; SUSTech Brain Research Centre Fund	This work was supported by National Natural Science Foundation of China Grant 81571287, Shenzhen Science and Technology Innovation Committee Basic Science Research Grants JCYJ20140417105742709 and JCYJ20160301112230218, State Key Laboratory of Neuroscience Open Competition Grant SKLN-201403, Southern University of Science and Technology (SUSTech) Peacock Program Start-up Fund Grant 22/Y01226109, and SUSTech Brain Research Centre Fund (to S. T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abrams S. R., 2013, J LABELLED COMPD RAD, V46, P273; BALSEVICH JJ, 1994, PLANT PHYSIOL, V106, P135, DOI 10.1104/pp.106.1.135; Brandt B, 2015, ELIFE, V4, DOI 10.7554/eLife.03599; Desikan R, 2004, J EXP BOT, V55, P205, DOI 10.1093/jxb/erh033; DeVos SL, 2013, JOVE-J VIS EXP, DOI 10.3791/50326; Diaz M, 2016, P NATL ACAD SCI USA, V113, pE396, DOI 10.1073/pnas.1512779113; EBERLE J, 1986, PLANT PHYSIOL, V81, P516, DOI 10.1104/pp.81.2.516; Edel KH, 2016, CURR OPIN PLANT BIOL, V33, P83, DOI 10.1016/j.pbi.2016.06.010; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GERGS U, 1993, BOT ACTA, V106, P404, DOI 10.1111/j.1438-8677.1993.tb00767.x; Hou ST, 2008, BIOCHEM BIOPH RES CO, V367, P109, DOI 10.1016/j.bbrc.2007.12.103; Hou ST, 2013, SCI REP-UK, V3, DOI 10.1038/srep01350; Hou ST, 2010, NEUROSCI RES, V66, P396, DOI 10.1016/j.neures.2009.12.010; Hou ST, 2009, J NEUROCHEM, V111, P870, DOI 10.1111/j.1471-4159.2009.06375.x; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Hou ST, 2002, INT REV CYTOL, V221, P93; Israelsson M, 2006, CURR OPIN PLANT BIOL, V9, P654, DOI 10.1016/j.pbi.2006.09.006; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; Jiang SX, 2007, MOL CELL BIOL, V27, P1696, DOI 10.1128/MCB.01760-06; Jiang SX, 2010, BIOCHEM BIOPH RES CO, V401, P435, DOI 10.1016/j.bbrc.2010.09.074; Jiang SX, 2005, J BIOL CHEM, V280, P33811, DOI 10.1074/jbc.M503113200; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Krochko JE, 1998, PLANT PHYSIOL, V118, P849, DOI 10.1104/pp.118.3.849; LEPAGEDEGIVRY MT, 1986, P NATL ACAD SCI USA, V83, P1155; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MACMANUS JP, 1994, NEUROREPORT, V5, P493, DOI 10.1097/00001756-199401120-00031; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Papadakis M, 2013, NAT MED, V19, P351, DOI 10.1038/nm.3097; Ross ARS, 2004, ANAL BIOCHEM, V329, P324, DOI 10.1016/j.ab.2004.02.026; Saver JL, 2009, STROKE, V40, P2594, DOI 10.1161/STROKEAHA.109.552554; Seiler C, 2011, J EXP BOT, V62, P2615, DOI 10.1093/jxb/erq446; Tu YH, 1998, J CEREBR BLOOD F MET, V18, P658, DOI 10.1097/00004647-199806000-00008; White PJ, 2000, BBA-BIOMEMBRANES, V1465, P171, DOI 10.1016/S0005-2736(00)00137-1; Zaharia LI, 2005, J PLANT GROWTH REGUL, V24, P274, DOI 10.1007/s00344-005-0066-2; Zaharia LI, 2005, J LABELLED COMPD RAD, V48, P435, DOI 10.1002/jlcr.939; Zaharia LI, 2004, PHYTOCHEMISTRY, V65, P3199, DOI 10.1016/j.phytochem.2004.09.007	38	11	11	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27007	27022		10.1074/jbc.M116.756429	http://dx.doi.org/10.1074/jbc.M116.756429			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864367	Green Published, hybrid			2022-12-28	WOS:000391576300005
J	Kasiappan, R; Jutooru, I; Karki, K; Hedrick, E; Safe, S				Kasiappan, Ravi; Jutooru, Indira; Karki, Keshav; Hedrick, Erik; Safe, Stephen			Benzyl Isothiocyanate (BITC) Induces Reactive Oxygen Species-dependent Repression of STAT3 Protein by Down-regulation of Specificity Proteins in Pancreatic Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP TRANSCRIPTION FACTORS; NF-KAPPA-B; BETA-PHENYLETHYL ISOTHIOCYANATE; CELL-CYCLE ARREST; TUMOR-GROWTH; SIGNAL TRANSDUCER; BREAST-CANCER; CRUCIFEROUS VEGETABLES; INDUCED APOPTOSIS; LUNG-CANCER	The antineoplastic agent benzyl isothiocyanate (BITC) acts by targeting multiple pro-oncogenic pathways/genes, including signal transducer and activator of transcription 3 (STAT3); however, the mechanism of action is not well known. As reported previously, BITC induced reactive oxygen species (ROS) in Panc1, MiaPaCa2, and L3.6pL pancreatic cancer cells. This was accompanied by induction of apoptosis and inhibition of cell growth and migration, and these responses were attenuated in cells cotreated with BITC plus glutathione (GSH). BITC also decreased expression of specificity proteins (Sp) Sp1, Sp3, and Sp4 transcription factors (TFs) and several pro-oncogenic Sp-regulated genes, including STAT3 and phospho-STAT3 (pSTAT3), and GSH attenuated these responses. Knockdown of Sp TFs by RNA interference also decreased STAT3/pSTAT3 expression. BITC-induced ROS activated a cascade of events that included down-regulation of c-Myc, and it was also demonstrated that c-Myc knockdown decreased expression of Sp TFs and STAT3. These results demonstrate that in pancreatic cancer cells, STAT3 is an Sp-regulated gene that can be targeted by BITC and other ROS inducers, thereby identifying a novel therapeutic approach for targeting STAT3.	[Kasiappan, Ravi; Jutooru, Indira; Karki, Keshav; Hedrick, Erik; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Jutooru, Indira] Covance Inc, 3301 Kinsman Blvd, Madison, WI 53704 USA	Texas A&M University System; Texas A&M University College Station; Covance	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	Karki, Keshav/AAR-2421-2021	Kasiappan, Ravi/0000-0002-5351-9098	National Institutes of Health [P30-ES023512]; College of Veterinary Science and Biomedical Sciences; Texas AgriLife Research and Sid Kyle endowment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Veterinary Science and Biomedical Sciences; Texas AgriLife Research and Sid Kyle endowment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant P30-ES023512 (to S. S.), a College of Veterinary Science and Biomedical Sciences postdoctoral research grant (to R. K.), and a Texas AgriLife Research and Sid Kyle endowment. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez James V, 2007, Transl Oncogenomics, V2, P99; Boreddy S, 2011, PLOS ONE, V6; Chadalapaka G, 2012, CARCINOGENESIS, V33, P886, DOI 10.1093/carcin/bgs102; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Chintharlapalli S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-371; Cohen JH, 2000, JNCI-J NATL CANCER I, V92, P61, DOI 10.1093/jnci/92.1.61; Edman P, 1975, PROTEIN SEQUENCE DET, P232; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Frank DA, 2013, J CLIN ONCOL, V31, P4560, DOI 10.1200/JCO.2013.52.8414; Gupta P, 2014, MOL NUTR FOOD RES, V58, P1685, DOI 10.1002/mnfr.201300684; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hedrick E, 2016, ONCOTARGET, V7, P22245, DOI 10.18632/oncotarget.7925; Hedrick E, 2015, MOL CANCER THER, V14, P2143, DOI 10.1158/1535-7163.MCT-15-0148; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hong D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5272; Huang C, 2012, NEOPLASMA, V59, P52, DOI 10.4149/neo_2012_007; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Jutooru I, 2014, MOL CELL BIOL, V34, P2382, DOI 10.1128/MCB.01602-13; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Jutooru I, 2010, EXP CELL RES, V316, P2174, DOI 10.1016/j.yexcr.2010.04.027; Karlsson I, 2016, SCI REP-UK, V6, DOI 10.1038/srep21203; Kato K, 2000, BBA-GENE STRUCT EXPR, V1493, P91, DOI 10.1016/S0167-4781(00)00168-8; Khan N, 2015, CANCER LETT, V359, P155, DOI 10.1016/j.canlet.2015.01.038; Kim JH, 2006, CARCINOGENESIS, V27, P475, DOI 10.1093/carcin/bgi272; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Kim SH, 2011, CARCINOGENESIS, V32, P359, DOI 10.1093/carcin/bgq267; Lai KC, 2010, J AGR FOOD CHEM, V58, P2935, DOI 10.1021/jf9036694; Lee J, 2009, APMIS, V117, P598, DOI 10.1111/j.1600-0463.2009.02512.x; Li MX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127356; Nakamura Y, 2000, CANCER RES, V60, P219; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Pathi SS, 2011, NUTR CANCER, V63, P1133, DOI 10.1080/01635581.2011.605984; Pathi SS, 2011, MOL CANCER RES, V9, P195, DOI 10.1158/1541-7786.MCR-10-0363; Rydberg P, 2002, CHEM RES TOXICOL, V15, P570, DOI 10.1021/tx000247+; Sahu RP, 2009, CARCINOGENESIS, V30, P1744, DOI 10.1093/carcin/bgp157; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Singh SV, 2012, CARCINOGENESIS, V33, P1833, DOI 10.1093/carcin/bgs216; Srivastava SK, 2003, CARCINOGENESIS, V24, P1665, DOI 10.1093/carcin/bgg123; Tang L, 2005, MOL CANCER THER, V4, P1250, DOI 10.1158/1535-7163.MCT-05-0041; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Wong AL, 2015, ANN ONCOL, V26, P998, DOI 10.1093/annonc/mdv026; Wu CL, 2011, J ORTHOP RES, V29, P1199, DOI 10.1002/jor.21350; Wu XA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-269; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Xiong H, 2012, J MOL MED, V90, P1037, DOI 10.1007/s00109-012-0869-0; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Yang MD, 2010, ANTICANCER RES, V30, P2135; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073803	52	38	39	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27122	27133		10.1074/jbc.M116.746339	http://dx.doi.org/10.1074/jbc.M116.746339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875298	hybrid, Green Published			2022-12-28	WOS:000391576300013
J	Malmlof, M; Roudier, E; Hogberg, J; Stenius, U				Malmlof, Maria; Roudier, Emilie; Hogberg, Johan; Stenius, Ulla			MEK-ERK-mediated phosphorylation of Mdm2 at Ser-166 in hepatocytes. Mdm2 IS ACTIVATED IN RESPONSE TO INHIBITED Akt SIGNALING (vol 282, pg 2288, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Malmlof M, 2007, J BIOL CHEM, V282, P2288, DOI 10.1074/jbc.M604953200	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26588	26588		10.1074/jbc.A116.604953	http://dx.doi.org/10.1074/jbc.A116.604953			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27986870	hybrid, Green Published			2022-12-28	WOS:000391568200031
J	Shu, SK; Liu, QY; Coppola, D; Cheng, JQ				Shu, Shao-Kun; Liu, Qiyuan; Coppola, Domenico; Cheng, Jin Q.			Phosphorylation and activation of androgen receptor by Aurora-A (vol 285, pg 33045, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Shu SK, 2010, J BIOL CHEM, V285, P33045, DOI 10.1074/jbc.M110.121129	1	0	0	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22854	22854		10.1074/jbc.A110.121129	http://dx.doi.org/10.1074/jbc.A110.121129			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825092	Green Published, hybrid			2022-12-28	WOS:000386760600053
J	Juan-Mateu, J; Rech, TH; Villate, O; Lizarraga-Mollinedo, E; Wendt, A; Turatsinze, JV; Brondani, LA; Nardelli, TR; Nogueira, TC; Esguerra, JLS; Alvelos, MI; Marchetti, P; Eliasson, L; Eizirik, DL				Juan-Mateu, Jonas; Rech, Tatiana H.; Villate, Olatz; Lizarraga-Mollinedo, Esther; Wendt, Anna; Turatsinze, Jean-Valery; Brondani, Leticia A.; Nardelli, Tarlliza R.; Nogueira, Tatiane C.; Esguerra, Jonathan L. S.; Alvelos, Maria Ines; Marchetti, Piero; Eliasson, Lena; Eizirik, Decio L.			Neuron-enriched RNA-binding Proteins Regulate Pancreatic Beta Cell Function and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; apoptosis; autoimmunity; beta cell (B-cell); diabetes; insulin secretion	ENDOPLASMIC-RETICULUM STRESS; SILENCING TRANSCRIPTION FACTOR; INSULIN-PRODUCING CELLS; KAPPA-B ACTIVATION; NERVOUS-SYSTEM; RESTRICTIVE SILENCER; SPLICING REGULATION; INDUCED APOPTOSIS; GENE-EXPRESSION; CANDIDATE GENE	Pancreatic beta cell failure is the central event leading to diabetes. Beta cells share many phenotypic traits with neurons, and proper beta cell function relies on the activation of several neuron-like transcription programs. Regulation of gene expression by alternative splicing plays a pivotal role in brain, where it affects neuronal development, function, and disease. The role of alternative splicing in beta cells remains unclear, but recent data indicate that splicing alterations modulated by both inflammation and susceptibility genes for diabetes contribute to beta cell dysfunction and death. Here we used RNA sequencing to compare the expression of splicing-regulatory RNA-binding proteins in human islets, brain, and other human tissues, and we identified a cluster of splicing regulators that are expressed in both beta cells and brain. Four of them, namely Elavl4, Nova2, Rbox1, and Rbfox2, were selected for subsequent functional studies in insulin-producing rat INS-1E, human EndoC-H1 cells, and in primary rat beta cells. Silencing of Elavl4 and Nova2 increased beta cell apoptosis, whereas silencing of Rbfox1 and Rbfox2 increased insulin content and secretion. Interestingly, Rbfox1 silencing modulates the splicing of the actin-remodeling protein gelsolin, increasing gelsolin expression and leading to faster glucose-induced actin depolymerization and increased insulin release. Taken together, these findings indicate that beta cells share common splicing regulators and programs with neurons. These splicing regulators play key roles in insulin release and beta cell survival, and their dysfunction may contribute to the loss of functional beta cell mass in diabetes.	[Juan-Mateu, Jonas; Rech, Tatiana H.; Villate, Olatz; Lizarraga-Mollinedo, Esther; Turatsinze, Jean-Valery; Brondani, Leticia A.; Nardelli, Tarlliza R.; Nogueira, Tatiane C.; Alvelos, Maria Ines; Eizirik, Decio L.] Univ Libre Bruxelles, ULB Ctr Diabet Res, Route Lennik 808, B-1070 Brussels, Belgium; [Wendt, Anna; Esguerra, Jonathan L. S.; Eliasson, Lena] Lund Univ, Dept Clin Sci Malmo, Unit Islets Cell Exocytosis, Ctr Diabet, SE-20502 Malmo, Sweden; [Marchetti, Piero] Univ Pisa, Dept Clin & Expt Med, Islet Cell Lab, I-56126 Pisa, Italy; [Eizirik, Decio L.] Univ Libre Bruxelles, Welbio, 808 Route Lennik,CP618, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Lund University; University of Pisa; Universite Libre de Bruxelles; WELBIO	Juan-Mateu, J; Eizirik, DL (corresponding author), Univ Libre Bruxelles, ULB Ctr Diabet Res, Route Lennik 808, B-1070 Brussels, Belgium.	mjuanmat@ulb.ac.be; deizirik@ulb.ac.be	de Araujo Nogueira, Tatiane/E-8510-2013; Eliasson, Lena/E-9294-2012; Lizárraga-Mollinedo, Esther/B-3867-2015; Esguerra, Jonathan/M-2366-2014; Rech, Tatiana/V-2711-2019	Eliasson, Lena/0000-0002-6467-5029; Lizárraga-Mollinedo, Esther/0000-0002-1059-8654; Esguerra, Jonathan/0000-0001-8454-6606; Juan-Mateu, Jonas/0000-0001-9749-6441; Villate, Olatz/0000-0002-5574-837X; Wendt, Anna/0000-0001-8807-5979	European Union of the European Commission; Fonds National de la Recherche Scientifique (FNRS) [T.0036.13]; FRFSWelbio [CR-2015A-06]; Swedish Research Council; Juvenile Diabetes Foundation; Helmsley Type 1 Diabetes Program; National Institutes of Health NIDDK-HIRN Consortium [1UC4DK104166-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104166] Funding Source: NIH RePORTER	European Union of the European Commission; Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); FRFSWelbio(WELBIO); Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); Helmsley Type 1 Diabetes Program; National Institutes of Health NIDDK-HIRN Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by European Union Project T2DSystems in the Horizon 2020 Programme of the European Commission; Fonds National de la Recherche Scientifique (FNRS) Grants T.0036.13 and FRFSWelbio CR-2015A-06, Belgium; the Swedish Research Council project grants (to L. E.); the Juvenile Diabetes Foundation; the Helmsley Type 1 Diabetes Program; and National Institutes of Health NIDDK-HIRN Consortium 1UC4DK104166-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Andersson LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120879; Arntfield ME, 2011, BIOESSAYS, V33, P582, DOI 10.1002/bies.201100015; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Bronicki LM, 2013, RNA, V19, P1019, DOI 10.1261/rna.039164.113; Brozzi F, 2016, UPSALA J MED SCI, V121, P133, DOI 10.3109/03009734.2015.1135217; Brozzi F, 2015, DIABETOLOGIA, V58, P2307, DOI 10.1007/s00125-015-3669-6; Calarco JA, 2011, RNA, V17, P775, DOI 10.1261/rna.2603911; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; DEVASKAR SU, 1994, J BIOL CHEM, V269, P8445; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; EIZIRIK DL, 1988, ENDOCRINOLOGY, V123, P1001, DOI 10.1210/endo-123-2-1001; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Gallagher TL, 2011, DEV BIOL, V359, P251, DOI 10.1016/j.ydbio.2011.08.025; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Giulietti M, 2013, NUCLEIC ACIDS RES, V41, pD125, DOI 10.1093/nar/gks997; Glatt SJ, 2011, AM J MED GENET B, V156B, P382, DOI 10.1002/ajmg.b.31181; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Hartenstein V, 2015, DEV CELL, V32, P390, DOI 10.1016/j.devcel.2015.02.004; Hayashi S, 2015, J NEUROSCI RES, V93, P399, DOI 10.1002/jnr.23496; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HENQUIN JC, 1984, ENDOCRINOLOGY, V115, P1125, DOI 10.1210/endo-115-3-1125; Hori Y, 2005, PLOS MED, V2, P347, DOI 10.1371/journal.pmed.0020103; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Juan-Mateu J, 2016, EUR J ENDOCRINOL, V174, pR225, DOI 10.1530/EJE-15-0916; Kalwat MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.73; Kalwat MA, 2012, MOL ENDOCRINOL, V26, P128, DOI 10.1210/me.2011-1112; Kim C, 2016, BBA-GENE REGUL MECH, V1859, P675, DOI 10.1016/j.bbagrm.2016.02.017; Kim C, 2014, J BIOL CHEM, V289, P112, DOI 10.1074/jbc.M113.474700; Lee CJ, 2003, BIOL PSYCHIAT, V54, P771, DOI 10.1016/S0006-3223(03)00375-5; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Leggere JC, 2016, ELIFE, V5, DOI 10.7554/eLife.14264; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marroqui L, 2015, EBIOMEDICINE, V2, P378, DOI 10.1016/j.ebiom.2015.03.012; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Martin D, 2008, DIABETOLOGIA, V51, P1429, DOI 10.1007/s00125-008-0984-1; Martin D, 2003, J BIOL CHEM, V278, P53082, DOI 10.1074/jbc.M306861200; Martin D, 2015, DEV BIOL, V405, P316, DOI 10.1016/j.ydbio.2015.07.002; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Pedrotti S, 2015, HUM MOL GENET, V24, P2360, DOI 10.1093/hmg/ddv003; Perrone-Bizzozero Nora, 2013, Front Biosci (Schol Ed), V5, P554; Raj B, 2015, NEURON, V87, P14, DOI 10.1016/j.neuron.2015.05.004; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; REGAZZI R, 1995, EMBO J, V14, P2723, DOI 10.1002/j.1460-2075.1995.tb07273.x; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; SADOUL K, 1995, J CELL BIOL, V128, P1019, DOI 10.1083/jcb.128.6.1019; Saito Y, 2016, ELIFE, V5, DOI 10.7554/eLife.14371; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Thiel G, 2015, CELL TISSUE RES, V359, P99, DOI 10.1007/s00441-014-1963-0; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Vikman J, 2006, J MOL ENDOCRINOL, V36, P503, DOI 10.1677/jme.1.01978; Villate O, 2014, NUCLEIC ACIDS RES, V42, P11818, DOI 10.1093/nar/gku861; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wang FF, 2015, P NATL ACAD SCI USA, V112, pE4995, DOI 10.1073/pnas.1513780112; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zheng S, 2013, TRENDS GENET, V29, P442, DOI 10.1016/j.tig.2013.04.003	80	34	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3466	3480		10.1074/jbc.M116.748335	http://dx.doi.org/10.1074/jbc.M116.748335			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28077579	Green Published, hybrid			2022-12-28	WOS:000395538800035
J	Rai, V; Thomas, DG; Beach, JR; Egelhoff, TT				Rai, Vandana; Thomas, Dustin G.; Beach, Jordan R.; Egelhoff, Thomas T.			Myosin IIA Heavy Chain Phosphorylation Mediates Adhesion Maturation and Protrusion in Three Dimensions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cytoskeleton; extracellular matrix; invasion; myosin	PROTEIN-KINASE-C; CELL-MIGRATION; CARCINOMA-CELLS; DYNAMICS; INVASION; MATRIX; MOTILITY; RECRUITMENT; GENERATION; PAXILLIN	Non-muscle myosin II (NMII) is a conserved force-producing cytoskeletal enzyme with important but poorly understood roles in cell migration. To investigate myosin heavy chain (MHC) phosphorylation roles in 3D migration, we expressed GFP-tagged NMIIA wild-type or mutant constructs in cells depleted of endogenous NMIIA protein. We find that individual mutation or double mutation of Ser-1916 or Ser-1943 to alanine potently blocks recruitment of GFP-NM-IIA filaments to leading edge protrusions in 2D, and this in turn blocks maturation of anterior focal adhesions. When placed in 3D collagen gels, cells expressing wild-type GFP MHC-IIA behave like parental cells, displaying robust and active formation and retraction of protrusions. However, cells depleted of NMIIA or cells expressing the mutant GFP MHC-IIA display severe defects in invasion and in stabilizing protrusions in 3D. These studies reveal an NMIIA-specific role in 3D invasion that requires competence for NMIIA phosphorylation at Ser-1916 and Ser-1943. In sum, these results demonstrate a critical and previously unrecognized role for NMIIA phosphorylation in 3D invasion.	[Rai, Vandana; Thomas, Dustin G.; Beach, Jordan R.; Egelhoff, Thomas T.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Egelhoff, TT (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.; Egelhoff, TT (corresponding author), Dept Cellular & Mol Med, 9500 Euclid Ave, Cleveland, OH 44106 USA.	tte@case.edu		Beach, Jordan/0000-0003-0633-4928	National Institutes of Health [GM50009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM50009. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelstein R S, 1989, Adv Exp Med Biol, V255, P289; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Babbin BA, 2009, AM J PATHOL, V174, P436, DOI 10.2353/ajpath.2009.080171; Beach JR, 2011, P NATL ACAD SCI USA, V108, P17991, DOI 10.1073/pnas.1106499108; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Betapudi V, 2011, J MOL BIOL, V407, P673, DOI 10.1016/j.jmb.2011.02.010; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720; Doyle AD, 2012, J CELL SCI, V125, P2244, DOI 10.1242/jcs.098806; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Dulyaninova Natalya G, 2013, Bioarchitecture, V3, P77; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Jorrisch MH, 2013, BIOL OPEN, V2, P368, DOI 10.1242/bio.20133707; KAWAMOTO S, 1989, J BIOL CHEM, V264, P2258; Kolega J, 1998, J CELL SCI, V111, P2085; Kubow KE, 2013, CURR BIOL, V23, P1607, DOI 10.1016/j.cub.2013.06.053; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LUDOWYKE RI, 1989, J BIOL CHEM, V264, P12492; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2015, CURR BIOL, V25, P175, DOI 10.1016/j.cub.2014.11.043; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Shih WT, 2010, BIOPHYS J, V98, pL29, DOI 10.1016/j.bpj.2010.02.028; Thomas DG, 2015, J CELL BIOL, V210, P583, DOI 10.1083/jcb.201502039; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2011, J CELL BIOL, V193, P381, DOI 10.1083/jcb.201012159; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094	47	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3099	3111		10.1074/jbc.M116.733402	http://dx.doi.org/10.1074/jbc.M116.733402			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28053086	hybrid, Green Published			2022-12-28	WOS:000395538800004
J	Liu, T; Chen, L; Zhou, Y; Jiang, X; Duan, YW; Yang, Q				Liu, Tian; Chen, Lei; Zhou, Yong; Jiang, Xi; Duan, Yanwei; Yang, Qing			Structure, Catalysis, and Inhibition of OfChi-h, the Lepidoptera-exclusive Insect Chitinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-III CHITINASE; CRYSTAL-STRUCTURES; BOMBYX-MORI; FUNCTIONAL EXPRESSION; AROMATIC RESIDUES; MOLECULAR-CLONING; BMCHI-H; CDNA; GENE; BACTERIAL	Chitinase-h (Chi-h) is of special interest among insect chitinases due to its exclusive distribution in lepidopteran insects and high sequence identity with bacterial and baculovirus homologs. Here OfChi-h, a Chi-h from Ostrinia furnacalis, was investigated. Crystal structures of both OfChi-h and its complex with chitoheptaose ((GlcN) 7) reveal that OfChi-h possesses a long and asymmetric substrate binding cleft, which is a typical characteristics of a processive exo-chitinase. The structural comparison between OfChi-h and its bacterial homolog SmChiA uncovered two phenylalanine-to-tryptophan site variants in OfChi-h at subsites +2 and possibly -7. The F232W/F396W double mutant endowedSmChiA with higher hydrolytic activities toward insoluble substrates, such as insect cuticle, alpha-chitin, and chitin nanowhisker. An enzymatic assay demonstrated that OfChi-h outperformed OfChtI, an insect endochitinase, toward the insoluble substrates, but showed lower activity toward the soluble substrate ethylene glycol chitin. Furthermore, OfChi-h was found to be inhibited by N, N',N"-trimethylglucosamine- N, N',N",N"'-tetraacetylchitotetraose (TMG(GlcNAc)(4)), a substrate analog which can be degraded into TMG-(GlcNAc)(1-2). Injection of TMG-(GlcNAc)(4) into 5th-instar O. furnacalis larvae led to severe defects in pupation. This work provides insights into a molting-indispensable insect chitinase that is phylogenetically closer to bacterial chitinases than insect chitinases.	[Liu, Tian; Chen, Lei; Zhou, Yong; Jiang, Xi; Duan, Yanwei; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, 2 Linggong Rd, Dalian 116024, Peoples R China; [Liu, Tian; Chen, Lei; Zhou, Yong; Jiang, Xi; Duan, Yanwei; Yang, Qing] Dalian Univ Technol, Sch Software, 2 Linggong Rd, Dalian 116024, Peoples R China; [Yang, Qing] Chinese Acad Agr Sci, Inst Plant Protect, 2 West Yuanmingyuan Rd, Beijing 100193, Peoples R China	Dalian University of Technology; Dalian University of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, 2 Linggong Rd, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Dalian Univ Technol, Sch Software, 2 Linggong Rd, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, 2 West Yuanmingyuan Rd, Beijing 100193, Peoples R China.	qingyang@dlut.edu.cn	Yang, Qing/GZK-2526-2022; Liu, Tian/E-2481-2012	Yang, Qing/0000-0001-8623-7532; Liu, Tian/0000-0001-9768-5496	Program for National Natural Science Funds for Distinguished Young Scholar [31425021]; Program for Liaoning Excellent Talents in University [LJQ2014006]; Fundamental Research Funds for the Central Universities [DUT16QY48, DUT16TD22]	Program for National Natural Science Funds for Distinguished Young Scholar; Program for Liaoning Excellent Talents in University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Program for National Natural Science Funds for Distinguished Young Scholar (31425021), the Program for Liaoning Excellent Talents in University (LJQ2014006), and the Fundamental Research Funds for the Central Universities (DUT16QY48, DUT16TD22). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmad T, 2003, BIOCHEM BIOPH RES CO, V310, P188, DOI 10.1016/j.bbrc.2003.08.136; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; Busby JN, 2012, J MOL BIOL, V415, P359, DOI 10.1016/j.jmb.2011.11.018; Cavada BS, 2006, FEBS J, V273, P3962, DOI 10.1111/j.1742-4658.2006.05400.x; Chen L, 2014, J BIOL CHEM, V289, P17932, DOI 10.1074/jbc.M114.564534; Chen L, 2014, ACTA CRYSTALLOGR D, V70, P932, DOI 10.1107/S1399004713033841; Daimon T, 2005, INSECT BIOCHEM MOLEC, V35, P1112, DOI 10.1016/j.ibmb.2005.05.005; Daimon T, 2003, INSECT BIOCHEM MOLEC, V33, P749, DOI 10.1016/S0965-1748(03)00084-5; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feix M, 2000, ARCH INSECT BIOCHEM, V45, P24, DOI 10.1002/1520-6327(200009)45:1&lt;24::AID-ARCH3&gt;3.0.CO;2-H; Fitches E, 2004, INSECT BIOCHEM MOLEC, V34, P1037, DOI 10.1016/j.ibmb.2004.06.012; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; Hill AD, 2007, J CHEM INF MODEL, V47, P1031, DOI 10.1021/ci600492e; Hollis T, 2000, PROTEIN SCI, V9, P544, DOI 10.1110/ps.9.3.544; Hsieh YC, 2010, J BIOL CHEM, V285, P31603, DOI 10.1074/jbc.M110.149310; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; Hurtado-Guerrero R, 2007, CHEM BIOL, V14, P589, DOI 10.1016/j.chembiol.2007.03.015; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Kim MG, 1998, INSECT BIOCHEM MOLEC, V28, P163, DOI 10.1016/S0965-1748(97)00112-4; Kitaoku Y, 2015, PLANTA, V242, P895, DOI 10.1007/s00425-015-2330-4; Koga D, 1998, BIOSCI BIOTECH BIOCH, V62, P1643, DOI 10.1271/bbb.62.1643; KRAMER KJ, 1993, INSECT BIOCHEM MOLEC, V23, P691, DOI 10.1016/0965-1748(93)90043-R; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008654; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Madhuprakash J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15657; Malecki PH, 2013, ACTA CRYSTALLOGR D, V69, P821, DOI 10.1107/S0907444913002011; Masuda T, 2015, BIOSCI BIOTECH BIOCH, V79, P45, DOI 10.1080/09168451.2014.962475; Matsumoto T, 1999, P JPN ACAD B-PHYS, V75, P269, DOI 10.2183/pjab.75.269; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Ohnuma T, 2011, PLANTA, V234, P123, DOI 10.1007/s00425-011-1390-3; Ohnuma T, 2011, PLANT MOL BIOL, V75, P291, DOI 10.1007/s11103-010-9727-z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paek A, 2012, MOL CELLS, V33, P439, DOI 10.1007/s10059-012-2133-4; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Qu MB, 2014, J PROTEOME RES, V13, P2931, DOI 10.1021/pr5000957; Rao FV, 2005, CHEM BIOL, V12, P65, DOI 10.1016/j.chembiol.2004.10.013; Schuttelkopf AW, 2010, BIOORGAN MED CHEM, V18, P8334, DOI 10.1016/j.bmc.2010.09.062; Shinoda T, 2001, INSECT BIOCHEM MOLEC, V31, P521, DOI 10.1016/S0965-1748(00)00133-8; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Sutherland TE, 2011, CHEM BIOL, V18, P569, DOI 10.1016/j.chembiol.2011.02.017; Tanaka T, 2001, J BIOL CHEM, V276, P35629, DOI 10.1074/jbc.M105919200; Tetreau G, 2015, INSECT BIOCHEM MOLEC, V62, P114, DOI 10.1016/j.ibmb.2015.01.006; Tsuji H, 2010, FEBS J, V277, P2683, DOI [10.1111/j.1742-464X.2010.07685.x, 10.1111/j.1742-4658.2010.07685.x]; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Umemoto N, 2015, PLANT J, V82, P54, DOI 10.1111/tpj.12785; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; Wu QY, 2013, INSECT SCI, V20, P147, DOI 10.1111/j.1744-7917.2012.01512.x; Yang JJ, 2010, EURASIP J IMAGE VIDE, DOI 10.1155/2010/461450; Yang Y, 2011, CHEMBIOCHEM, V12, P457, DOI 10.1002/cbic.201000561; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang DW, 2012, ARCH INSECT BIOCHEM, V79, P220, DOI 10.1002/arch.21018; Zhang JZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019899; Zheng Y, 2002, INSECT BIOCHEM MOLEC, V32, P1813, DOI 10.1016/S0965-1748(02)00166-2; Zhu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-248; Zhu KY, 2016, ANNU REV ENTOMOL, V61, P177, DOI 10.1146/annurev-ento-010715-023933; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105	64	48	57	9	52	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2080	2088		10.1074/jbc.M116.755330	http://dx.doi.org/10.1074/jbc.M116.755330			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28053084	Green Published, hybrid			2022-12-28	WOS:000395530300003
J	Martin, PM; Cifuentes-Diaz, C; Devaux, J; Garcia, M; Bureau, J; Thomasseau, S; Klingler, E; Girault, JA; Goutebroze, L				Martin, Pierre-Marie; Cifuentes-Diaz, Carmen; Devaux, Jerome; Garcia, Marta; Bureau, Jocelyne; Thomasseau, Sylvie; Klingler, Esther; Girault, Jean-Antoine; Goutebroze, Laurence			Schwannomin-interacting Protein 1 Isoform IQCJ-SCHIP1 Is a Multipartner Ankyrin- and Spectrin-binding Protein Involved in the Organization of Nodes of Ranvier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON INITIAL SEGMENTS; BETA-IV-SPECTRIN; SUBCORTICAL CYTOSKELETON PERIODICITY; TUMOR-SUPPRESSOR SCHWANNOMIN/MERLIN; PERIPHERAL NERVOUS-SYSTEM; MOLECULAR-ORGANIZATION; CHROMOSOME 3Q25-27; MYELINATED AXONS; SODIUM-CHANNELS; DOMAINS	The nodes of Ranvier are essential regions for action potential conduction in myelinated fibers. They are enriched in multimolecular complexes composed of voltage-gated Nav and Kv7 channels associated with cell adhesion molecules. Cytoskeletal proteins ankyrin-G (AnkG) and beta IV-spectrin control the organization of these complexes and provide mechanical support to the plasma membrane. IQCJ-SCHIP1 is a cytoplasmic protein present in axon initial segments and nodes of Ranvier. It interacts with AnkG and is absent from nodes and axon initial segments of beta IV-spectrin and AnkG mutant mice. Here, we show that IQCJ-SCHIP1 also interacts with beta IV-spectrin and Kv7.2/3 channels and self-associates, suggesting a scaffolding role in organizing nodal proteins. IQCJ-SCHIP1 binding requires a beta IV-spectrin-specific domain and Kv7 channel 1-5-10 calmodulin-binding motifs. We then investigate the role of IQCJ-SCHIP1 in vivo by studying peripheral myelinated fibers in Schip1 knock-out mutant mice. The major nodal proteins are normally enriched at nodes in these mice, indicating that IQCJ-SCHIP1 is not required for their nodal accumulation. However, morphometric and ultrastructural analyses show an altered shape of nodes similar to that observed in beta IV-spectrin mutant mice, revealing that IQCJ-SCHIP1 contributes to nodal membrane-associated cytoskeleton organization, likely through its interactions with the AnkG/beta IV-spectrin network. Our work reveals that IQCJ-SCHIP1 interacts with several major nodal proteins, and we suggest that it contributes to a higher organizational level of the AnkG/beta IV-spectrin network critical for node integrity.	[Martin, Pierre-Marie; Cifuentes-Diaz, Carmen; Garcia, Marta; Bureau, Jocelyne; Thomasseau, Sylvie; Klingler, Esther; Girault, Jean-Antoine] INSERM, UMR S 839, F-75005 Paris, France; [Martin, Pierre-Marie; Cifuentes-Diaz, Carmen; Garcia, Marta; Bureau, Jocelyne; Thomasseau, Sylvie; Klingler, Esther; Girault, Jean-Antoine; Goutebroze, Laurence] UPMC, Sorbonne Univ, UMR S 839, F-75005 Paris, France; [Martin, Pierre-Marie; Cifuentes-Diaz, Carmen; Garcia, Marta; Bureau, Jocelyne; Thomasseau, Sylvie; Klingler, Esther; Girault, Jean-Antoine; Goutebroze, Laurence] Inst Fer Moulin, F-75005 Paris, France; [Devaux, Jerome] Aix Marseille Univ, CNRS, CRN2M, F-13344 Marseille, France; [Klingler, Esther] Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva	Goutebroze, L (corresponding author), UPMC, INSERM, UMR S 839, Inst Fer Moulin, 17 Rue Fer Moulin, F-75005 Paris, France.	laurence.goutebroze@inserm.fr	Girault, Jean-Antoine/F-7518-2013; Devaux, jerome/X-8581-2019	Girault, Jean-Antoine/0000-0002-7900-1705; Devaux, jerome/0000-0001-6383-4334; Goutebroze, laurence/0000-0002-8712-000X; Cifuentes Diaz, Carmen/0000-0003-2563-2082; marta, garcia/0000-0003-1367-6459; Klingler, Esther/0000-0002-6577-1362	DIM NeRF from Region Ile-de-France (NERF) [10016908]; Fondation pour la Recherche Medicale/Rotary "Espoir en tete"	DIM NeRF from Region Ile-de-France (NERF)(Region Ile-de-France); Fondation pour la Recherche Medicale/Rotary "Espoir en tete"(Fondation pour la Recherche Medicale)	Equipment at the Institut du Fer a Moulin was supported in part by DIM NeRF from Region Ile-de-France (NERF, 10016908) and by the Fondation pour la Recherche Medicale/Rotary "Espoir en tete." We are grateful to R. Boukhari, N. Roblot, Y. Bertelle, A. Rousseau, M. Savariradjane, and T. Eirinopoulou (Institut du Fer a Moulin Cell and Tissue Imaging facility) for animal care and assistance with microscopes. The teams of J.-A.G. and L. G. are affiliated with the Paris School of Neuroscience (ENP) and the Bio-Psy laboratory of excellence.	Auranen M, 2003, MOL PSYCHIATR, V8, P879, DOI 10.1038/sj.mp.4001299; Bennett V, 2013, CURR TOP MEMBR, V72, P1, DOI 10.1016/B978-0-12-417027-8.00001-5; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Buttermore ED, 2013, J NEUROSCI RES, V91, P603, DOI 10.1002/jnr.23197; Chua JJE, 2012, P NATL ACAD SCI USA, V109, P5862, DOI 10.1073/pnas.1113819109; Chung HL, 2016, DEV CELL, V36, P511, DOI 10.1016/j.devcel.2016.02.004; Cifuentes-Diaz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025043; Coon H, 2005, HUM HERED, V60, P220, DOI 10.1159/000090546; D'Este E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22741; D'Este E, 2015, CELL REP, V10, P1246, DOI 10.1016/j.celrep.2015.02.007; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Denisenko N, 2008, J NEUROSCI, V28, P10472, DOI 10.1523/JNEUROSCI.2537-08.2008; Denisenko-Nehrbass N, 2003, J NEUROCHEM, V84, P209, DOI 10.1046/j.1471-4159.2003.01503.x; Devaux JJ, 2010, J PHYSIOL-LONDON, V588, P4719, DOI 10.1113/jphysiol.2010.196022; Fujita T, 2007, BIOCHEM BIOPH RES CO, V361, P605, DOI 10.1016/j.bbrc.2007.07.050; Goutebroze L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-29; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; Ho TSY, 2014, NAT NEUROSCI, V17, P1664, DOI 10.1038/nn.3859; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Ikuta J, 2007, BIOCHEM BIOPH RES CO, V353, P127, DOI 10.1016/j.bbrc.2006.11.142; Jenkins PM, 2015, P NATL ACAD SCI USA, V112, P957, DOI 10.1073/pnas.1416544112; Klingler E, 2015, DEVELOPMENT, V142, P2026, DOI 10.1242/dev.119248; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Kwasnicka-Crawford DA, 2006, BIOCHEM BIOPH RES CO, V350, P890, DOI 10.1016/j.bbrc.2006.09.136; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; Leterrier C, 2015, CELL REP, V13, P2781, DOI 10.1016/j.celrep.2015.11.051; Liu WJ, 2014, MOL CELL NEUROSCI, V58, P40, DOI 10.1016/j.mcn.2013.12.005; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; Martin PM, 2008, J NEUROSCI, V28, P6111, DOI 10.1523/JNEUROSCI.1044-08.2008; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Ozmen S, 2002, PLAST RECONSTR SURG, V109, P1760; Papandreou MJ, 2015, J NEUROCHEM, V134, P527, DOI 10.1111/jnc.13158; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Perisic L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122067; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Schulz A, 2014, BRAIN, V137, P420, DOI 10.1093/brain/awt327; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Tse WT, 2001, J BIOL CHEM, V276, P23974, DOI 10.1074/jbc.M009307200; Uemoto Y, 2007, J BIOL CHEM, V282, P6548, DOI 10.1074/jbc.M609223200; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Xu MX, 2015, J BIOL CHEM, V290, P16619, DOI 10.1074/jbc.M115.638932; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Zhang CS, 2016, CURR OPIN NEUROBIOL, V39, P116, DOI 10.1016/j.conb.2016.05.001; Zimmermann H, 1996, MICROSC RES TECHNIQ, V34, P462, DOI 10.1002/(SICI)1097-0029(19960801)34:5<462::AID-JEMT6>3.0.CO;2-O; Zollinger DR, 2015, ANNU REV CELL DEV BI, V31, P647, DOI 10.1146/annurev-cellbio-100913-013107	53	3	5	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2441	2456		10.1074/jbc.M116.758029	http://dx.doi.org/10.1074/jbc.M116.758029			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27979964	Green Published, hybrid			2022-12-28	WOS:000395530300032
J	Tsuji, T; Kurokawa, Y; Chiche, J; Pouyssegur, J; Sato, H; Fukuzawa, H; Nagao, M; Kambe, T				Tsuji, Tokuji; Kurokawa, Yayoi; Chiche, Johanna; Pouyssegur, Jacques; Sato, Hiroshi; Fukuzawa, Hideya; Nagao, Masaya; Kambe, Taiho			Dissecting the Process of Activation of Cancer-promoting Zinc-requiring Ectoenzymes by Zinc Metalation Mediated by ZNT Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-IX; TUMOR-CELL GROWTH; SECRETORY PATHWAY; BREAST-CANCER; ALKALINE-PHOSPHATASES; VERTEBRATE CELLS; SOLUBLE FORM; AUTOTAXIN; COMPLEXES; PROTEINS	Zinc-requiring ectoenzymes, including both secreted and membrane-bound enzymes, are considered to capture zinc in their active site for their activation in the early secretory pathway. This idea has been confirmed by our studies conducted using tissue-nonspecific alkaline phosphatase (TNAP), which is elaborately activated by means of a two-step mechanism by zinc transporter 5 (ZNT5)-ZNT6 heterodimers and ZNT7 homodimers, through protein stabilization followed by enzyme activation with zinc in the early secretory pathway. However, the molecular basis of the activation process in other zinc-requiring ectoenzymes remains largely unknown. In this study, we investigated this activation process by using three cancer- promoting zinc-requiring ectoenzymes, autotaxin (ATX), matrix metalloproteinase 9 (MMP9), and carbonic anhydrase IX (CAIX), and the chicken DT40 cell mutants that we generated; we specifically focused on clarifying whether the same or a similar activation mechanism operates in these ectoenzymes. ATX activation required ZNT5-ZNT6 heterodimers and ZNT7 homodimers in a manner similar to TNAP activation, although the protein stability of ATX was differently regulated from that of TNAP. MMP9 required ZNT5-ZNT6 heterodimers and ZNT7 homodimers for its activation as well as secretion; MMP9 was not secreted into the spent medium unless both zinc-transport complexes were present. Finally, CAIX activation by zinc was mediated not only by ZNT5-ZNT6 heterodimers and ZNT7 homodimers but also by ZNT4 homodimers; thus, these three zinc-transport complexes redundantly contribute to CAIX activation. Our results provide pivotal insights into the activation processes of zinc-requiring ectoenzymes, and furthermore, they offer novel insights for potential cancer therapy applications given the cancer-promoting potencies of ATX, MMP9, and CAIX.	[Tsuji, Tokuji; Kurokawa, Yayoi; Fukuzawa, Hideya; Nagao, Masaya; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan; [Chiche, Johanna] INSERM, Equipe Controle Metab Morts Cellulaires, Ctr Mediterraneen Med Mol C3M, U1065,Equipe 3, F-06204 Nice, France; [Pouyssegur, Jacques] Univ Nice Sophia Antipolis, Ctr A Lacassagne, Inst Res Canc & Aging, F-06189 Nice, France; [Pouyssegur, Jacques] Ctr Sci Monaco, Dept Med Biol, MC-98000 Monaco, Monaco; [Sato, Hiroshi] Kanazawa Univ, Canc Res Inst, Dept Mol Virol & Oncol, Kanazawa, Ishikawa 9201192, Japan	Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Kanazawa University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan.	kambe1@kais.kyoto-u.ac.jp	Chiche, Johanna/P-6382-2016; Fukuzawa, Hideya/I-5906-2018	Chiche, Johanna/0000-0001-5276-1125; Fukuzawa, Hideya/0000-0003-0963-5662; Kambe, Taiho/0000-0001-9757-063X	Japan Society for the Promotion of Science (KAKENHI) [26660086, 15H04501]; Fuji Foundation for Protein Research; Japan Foundation for Applied Enzymology; Foundation for the Promotion of Cancer Research in Japan; Suzuken Memorial Foundation; Salt Science Research Foundation	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Japan Foundation for Applied Enzymology; Foundation for the Promotion of Cancer Research in Japan; Suzuken Memorial Foundation; Salt Science Research Foundation	This work was supported in part by Grants-in-aid for Challenging Exploratory Research and Scientific Research (B) from the Japan Society for the Promotion of Science (KAKENHI) Grants 26660086 and 15H04501, the Fuji Foundation for Protein Research, the Japan Foundation for Applied Enzymology, the Foundation for the Promotion of Cancer Research in Japan, Suzuken Memorial Foundation, and the Salt Science Research Foundation (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreini C, 2012, J INORG BIOCHEM, V111, P150, DOI 10.1016/j.jinorgbio.2011.11.020; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Franz MC, 2013, MOL ASPECTS MED, V34, P735, DOI 10.1016/j.mam.2012.11.007; Fujimoto S, 2016, BIOCHEM J, V473, P2611, DOI 10.1042/BCJ20160324; Fujimoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077445; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Henry R.P., 1991, CARBONIC ANHYDRASES, P119, DOI [10.1007/978-1-4899-0750-98, DOI 10.1007/978-1-4899-0750-9_8]; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hogstrand C, 2013, BIOCHEM J, V455, P229, DOI 10.1042/BJ20130483; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Hyrsl L, 2009, NEOPLASMA, V56, P298, DOI 10.4149/neo_2009_04_29; IMAMURA S, 1978, J BIOCHEM-TOKYO, V83, P677, DOI 10.1093/oxfordjournals.jbchem.a131960; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Itsumura N, 2016, PEDIATR RES, V80, P586, DOI 10.1038/pr.2016.108; Kagara N, 2007, CANCER SCI, V98, P692, DOI 10.1111/j.1349-7006.2007.00446.x; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2016, ARCH BIOCHEM BIOPHYS, V611, P37, DOI 10.1016/j.abb.2016.03.035; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kambe T, 2014, METHOD ENZYMOL, V534, P77, DOI 10.1016/B978-0-12-397926-1.00005-6; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Kochanczyk T, 2015, METALLOMICS, V7, P244, DOI 10.1039/c4mt00094c; Kukic I, 2013, BIOCHEM J, V451, P155, DOI 10.1042/BJ20121506; Lee S, 2015, J BIOL CHEM, V290, P13064, DOI 10.1074/jbc.M115.637439; Li M, 2007, P NATL ACAD SCI USA, V104, P18636, DOI 10.1073/pnas.0709307104; Liao SY, 1997, CANCER RES, V57, P2827; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; MAREN TH, 1960, J PHARMACOL EXP THER, V130, P26; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Martin JE, 2016, J BACTERIOL, V198, P1066, DOI 10.1128/JB.00975-15; McCormick NH, 2012, AM J PHYSIOL-CELL PH, V303, pC291, DOI 10.1152/ajpcell.00443.2011; Miyai T, 2014, P NATL ACAD SCI USA, V111, P11780, DOI 10.1073/pnas.1323549111; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Reich R, 2015, J ENZYM INHIB MED CH, V30, P767, DOI 10.3109/14756366.2014.968146; Reich R, 2012, J MED CHEM, V55, P7875, DOI 10.1021/jm300981b; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Shin HJ, 2011, J CELL SCI, V124, P1077, DOI 10.1242/jcs.072207; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; TAMAOKU K, 1982, CHEM PHARM BULL, V30, P2492; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Taylor KM, 2016, BIOCHEM J, V473, P2531, DOI 10.1042/BCJ20160388; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Weaver Benjamin P, 2010, PLoS One, V5, DOI 10.1371/journal.pone.0013158; Zavada J, 2003, BRIT J CANCER, V89, P1067, DOI 10.1038/sj.bjc.6601264; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	59	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2159	2173		10.1074/jbc.M116.763946	http://dx.doi.org/10.1074/jbc.M116.763946			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028180	hybrid, Green Published			2022-12-28	WOS:000395530300010
J	Hwang, JS; Kwon, MY; Kim, KH; Lee, Y; Lyoo, IK; Kim, JE; Oh, ES; Han, IO				Hwang, Ji-Sun; Kwon, Mi-Youn; Kim, Kyung-Hong; Lee, Yunkyoung; Lyoo, In Kyoon; Kim, Jieun E.; Oh, Eok-Soo; Han, Inn-Oc			Lipopolysaccharide (LPS)-stimulated iNOS Induction Is Increased by Glucosamine under Normal Glucose Conditions but Is Inhibited by Glucosamine under High Glucose Conditions in Macrophage Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose; inflammation; NF-B; O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT)	NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; POSTTRANSCRIPTIONAL REGULATION; O-GLCNACYLATION; HEXOSAMINE BIOSYNTHESIS; INSULIN-RESISTANCE; INTERFERON-GAMMA; GENE-EXPRESSION; BINDING; INFLAMMATION	We investigated the regulatory effect of glucosamine (GlcN) for the production of nitric oxide (NO) and expression of inducible NO synthase (iNOS) under various glucose conditions in macrophage cells. At normal glucose concentrations, GlcN dose dependently increased LPS-stimulated production of NO/iNOS. However, GlcN suppressed NO/iNOS production under high glucose culture conditions. Moreover, GlcN suppressed LPS-induced up-regulation of COX-2, IL-6, and TNF- mRNAs under 25 mm glucose conditions yet did not inhibit up-regulation under 5 mm glucose conditions. Glucose itself dose dependently increased LPS-induced iNOS expression. LPS-induced MAPK and IB- phosphorylation did not significantly differ at normal and high glucose conditions. The activity of LPS-induced nuclear factor-B (NF-B) and DNA binding of c-Rel to the iNOS promoter were inhibited under high glucose conditions in comparison with no significant changes under normal glucose conditions. In addition, we found that the LPS-induced increase in O-GlcNAcylation as well as DNA binding of c-Rel to the iNOS promoter were further increased by GlcN under normal glucose conditions. However, both O-GlcNAcylation and DNA binding of c-Rel decreased under high glucose conditions. The NF-B inhibitor, pyrrolidine dithiocarbamate, inhibited LPS-induced iNOS expression under high glucose conditions but it did not influence iNOS induction under normal glucose conditions. In addition, pyrrolidine dithiocarbamate inhibited NF-B DNA binding and c-Rel O-GlcNAcylation only under high glucose conditions. By blocking transcription with actinomycin D, we found that stability of LPS-induced iNOS mRNA was increased by GlcN under normal glucose conditions. These results suggest that GlcN regulates inflammation by sensing energy states of normal and fuel excess.	[Hwang, Ji-Sun; Kwon, Mi-Youn; Kim, Kyung-Hong; Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Incheon 22212, South Korea; [Lee, Yunkyoung; Lyoo, In Kyoon; Kim, Jieun E.] Ewha Womans Univ, Dept Brain & Cognit Sci, Ewha Brain Inst, Coll Pharm, Seoul 03760, South Korea; [Oh, Eok-Soo; Han, Inn-Oc] Ewha Womans Univ, Dept Life Sci, Res Ctr Cellular Homeostasis, Seoul 03760, South Korea	Inha University; Ewha Womans University; Ewha Womans University	Han, IO (corresponding author), 100 Inha Ro, Incheon 22212, South Korea.	iohan@inha.ac.kr			National Research Federation of Korea [NRF-2013R1A1A2058244, NRF-2012R1A5A1048236]; Fire Fighting Safety; 119 Rescue Technology Research and Development Program - Ministry of Public Safety and Security [MPSS-Fire Fighting Safety-2016-86]	National Research Federation of Korea; Fire Fighting Safety; 119 Rescue Technology Research and Development Program - Ministry of Public Safety and Security	This work was supported by National Research Federation of Korea Grants NRF-2013R1A1A2058244 and NRF-2012R1A5A1048236 and The Fire Fighting Safety & 119 Rescue Technology Research and Development Program supported by the Ministry of Public Safety and Security (MPSS-Fire Fighting Safety-2016-86). The authors declare that they have no conflicts of interest with the contents of this article.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Anderson JW, 2005, FOOD CHEM TOXICOL, V43, P187, DOI 10.1016/j.fct.2004.11.006; Baudoin L, 2015, FRONT ENDOCRINOL, V5, DOI [10.3389/fendo.2014.00235, 10.3389/fendo.2016.00235]; Chen YJ, 2006, CELL BIOL INT, V30, P817, DOI 10.1016/j.cellbi.2006.06.003; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Eberhardt W, 1998, J IMMUNOL, V160, P4961; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gouze JN, 2002, FEBS LETT, V510, P166, DOI 10.1016/S0014-5793(01)03255-0; Han IO, 2002, NEUROSCI LETT, V325, P9, DOI 10.1016/S0304-3940(02)00218-5; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hua KF, 2012, INFLAMM RES, V61, P1107, DOI 10.1007/s00011-012-0503-1; Hwang JS, 2015, METABOLISM, V64, P368, DOI 10.1016/j.metabol.2014.11.005; Hwang SY, 2013, BRIT J PHARMACOL, V169, P1551, DOI 10.1111/bph.12223; Hwang SY, 2013, NITRIC OXIDE-BIOL CH, V31, P1, DOI 10.1016/j.niox.2013.02.082; Hwang SY, 2010, GLIA, V58, P1881, DOI 10.1002/glia.21058; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kengatharan M, 1996, BRIT J PHARMACOL, V117, P1163, DOI 10.1111/j.1476-5381.1996.tb16711.x; Khan MI, 2009, ANTIOXID REDOX SIGN, V11, P2289, DOI [10.1089/ars.2009.2569, 10.1089/ARS.2009.2569]; Korhonen R, 2007, MOL PHARMACOL, V71, P1427, DOI 10.1124/mol.106.033449; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Laroia G, 2002, P NATL ACAD SCI USA, V99, P1842, DOI 10.1073/pnas.042575699; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Ma JF, 2013, EXPERT REV PROTEOMIC, V10, P365, DOI 10.1586/14789450.2013.820536; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Marks-Konczalik J, 1998, J BIOL CHEM, V273, P22201, DOI 10.1074/jbc.273.35.22201; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Meininger CJ, 2000, BIOCHEM BIOPH RES CO, V279, P234, DOI 10.1006/bbrc.2000.3912; Mohanty P, 2000, J CLIN ENDOCR METAB, V85, P2970, DOI 10.1210/jc.85.8.2970; Monauni T, 2000, DIABETES, V49, P926, DOI 10.2337/diabetes.49.6.926; Moore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031062; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shikhman AR, 2009, OSTEOARTHR CARTILAGE, V17, P1022, DOI 10.1016/j.joca.2009.03.004; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; TRAXINGER RR, 1991, J BIOL CHEM, V266, P10148; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Won JS, 2003, J NEUROSCI, V23, P7470; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yi HA, 2005, CLIN EXP PHARMACOL P, V32, P1097, DOI 10.1111/j.1440-1681.2005.04305.x; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202; Zhang HF, 1998, BIOCHEM PHARMACOL, V55, P1873, DOI 10.1016/S0006-2952(98)00078-1	51	39	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1724	1736		10.1074/jbc.M116.737940	http://dx.doi.org/10.1074/jbc.M116.737940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27927986	Green Published, hybrid			2022-12-28	WOS:000395515600015
J	Tavares, CDJ; Giles, DH; Stancu, G; Chitjian, CA; Ferguson, SB; Wellmann, RM; Kaoud, TS; Ghose, R; Dalby, KN				Tavares, Clint D. J.; Giles, David H.; Stancu, Gabriel; Chitjian, Catrina A.; Ferguson, Scarlett B.; Wellmann, Rebecca M.; Kaoud, Tamer S.; Ghose, Ranajeet; Dalby, Kevin N.			Signal Integration at Elongation Factor 2 Kinase THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calmodulin (CaM); phosphorylation; translation; translation elongation factor; CaMK-III; S500D; Ser-500; Thr-348; eEF-2K	MR 100,000 SUBSTRATE; FACTOR-II KINASE; MAMMALIAN-CELLS; PROTEIN-KINASES; RABBIT RETICULOCYTES; MOLECULAR-MECHANISM; CRYSTAL-STRUCTURE; CHAIN ELONGATION; ALPHA-KINASES; ACTIVATION	Eukaryotic elongation factor 2 kinase (eEF-2K), the only calmodulin (CaM)-dependent member of the unique -kinase family, impedes protein synthesis by phosphorylating eEF-2. We recently identified Thr-348 and Ser-500 as two key autophosphorylation sites within eEF-2K that regulate its activity. eEF-2K is regulated by Ca2+ ions and multiple upstream signaling pathways, but how it integrates these signals into a coherent output, i.e. phosphorylation of eEF-2, is unclear. This study focuses on understanding how the post-translational phosphorylation of Ser-500 integrates with Ca2+ and CaM to regulate eEF-2K. CaM is shown to be absolutely necessary for efficient activity of eEF-2K, and Ca2+ is shown to enhance the affinity of CaM toward eEF-2K. Ser-500 is found to undergo autophosphorylation in cells treated with ionomycin and is likely also targeted by PKA. In vitro, autophosphorylation of Ser-500 is found to require Ca2+ and CaM and is inhibited by mutations that compromise binding of phosphorylated Thr-348 to an allosteric binding pocket on the kinase domain. A phosphomimetic Ser-500 to aspartic acid mutation (eEF-2K S500D) enhances the rate of activation (Thr-348 autophosphorylation) by 6-fold and lowers the EC50 for Ca2+/CaM binding to activated eEF-2K (Thr-348 phosphorylated) by 20-fold. This is predicted to result in an elevation of the cellular fraction of active eEF-2K. In support of this mechanism, eEF-2K knock-out MCF10A cells reconstituted with eEF-2K S500D display relatively high levels of phospho-eEF-2 under basal conditions. This study reports how phosphorylation of a regulatory site (Ser-500) integrates with Ca2+ and CaM to influence eEF-2K activity.	[Tavares, Clint D. J.; Chitjian, Catrina A.; Dalby, Kevin N.] Univ Texas Austin, Grad Program Cell & Mol Biol, Austin, TX 78712 USA; [Tavares, Clint D. J.; Giles, David H.; Stancu, Gabriel; Chitjian, Catrina A.; Ferguson, Scarlett B.; Wellmann, Rebecca M.; Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Div Chem Biol & Med Chem, Austin, TX 78712 USA; [Ghose, Ranajeet] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Ghose, Ranajeet] CUNY, Grad Ctr, New York, NY 10016 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Tavares, CDJ (corresponding author), Harvard Med Sch, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA.; Tavares, CDJ (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Dalby, KN (corresponding author), Univ Texas Austin, Div Chem Biol & Med Chem, Coll Pharm, 107 West Dean Keeton,Biomed Engn Bldg, Austin, TX 78712 USA.	clinttavares@utexas.edu; dalby@austin.utexas.edu	Dalby, Kevin N/A-1905-2013; Kaoud, Tamer S/C-3618-2019	Dalby, Kevin N/0000-0001-9272-5129; Kaoud, Tamer S/0000-0003-1298-8725	Welch Foundation [F-1390]; National Institutes of Health [GM59802]; NSF Division of Molecular and Cellular Biosciences Award [1657192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059802] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Division of Molecular and Cellular Biosciences Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Welch Foundation Grant F-1390 and National Institutes of Health Grant GM59802 (to K.N.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NSF Division of Molecular and Cellular Biosciences Award 1657192.	Abramczyk O, 2011, PROTEIN EXPRES PURIF, V79, P237, DOI 10.1016/j.pep.2011.05.005; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Cheng Y, 2016, ONCOGENE, V35, P6293, DOI 10.1038/onc.2016.166; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Devkota AK, 2012, BIOCHEMISTRY-US, V51, P2100, DOI 10.1021/bi201787p; Diggle TA, 1999, FEBS LETT, V457, P189, DOI 10.1016/S0014-5793(99)01034-0; Diggle TA, 1998, BIOCHEM J, V336, P525, DOI 10.1042/bj3360525; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; DUMONTMISCOPEIN A, 1994, FEBS LETT, V356, P283, DOI 10.1016/0014-5793(94)01272-5; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Hovland R, 1999, FEBS LETT, V444, P97, DOI 10.1016/S0014-5793(99)00039-3; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Knebel A, 2002, BIOCHEM J, V367, P525, DOI 10.1042/BJ20020916; Kristelly R, 2003, ACTA CRYSTALLOGR D, V59, P1859, DOI 10.1107/S0907444903018067; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Lee K, 2016, STRUCTURE, V24, P1441, DOI 10.1016/j.str.2016.06.015; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Meric-Bernstam F, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3343; MITSUI K, 1993, J BIOL CHEM, V268, P13422; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Moore CEJ, 2015, MOL CELL BIOL, V35, P1788, DOI 10.1128/MCB.01457-14; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; NAIRN AC, 1987, J BIOL CHEM, V262, P14265; PALFREY HC, 1987, J BIOL CHEM, V262, P9785; Pandey K, 2014, J PHYS CHEM B, V118, P5059, DOI 10.1021/jp501641r; Pavur KS, 2000, BIOCHEMISTRY-US, V39, P12216, DOI 10.1021/bi0007270; Pigott CR, 2012, BIOCHEM J, V442, P105, DOI 10.1042/BJ20111536; Pon CK, 2016, FASEB J, V30, P1144, DOI 10.1096/fj.15-277798; REDPATH NT, 1993, BIOCHEM J, V293, P31, DOI 10.1042/bj2930031; REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x; Ruys SPD, 2012, BIOCHEM J, V442, P681, DOI 10.1042/BJ20111530; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; RYAZANOV AG, 1988, BIOCHIMIE, V70, P619, DOI 10.1016/0300-9084(88)90245-3; Sanabria H, 2008, BIOPHYS J, V95, P6002, DOI 10.1529/biophysj.108.138974; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; TANAKA M, 1977, J BIOCHEM-TOKYO, V82, P1035, DOI 10.1093/oxfordjournals.jbchem.a131774; Tang SQ, 2017, CELL MOL IMMUNOL, V14, P180, DOI 10.1038/cmi.2015.59; Tavares CDJ, 2014, J BIOL CHEM, V289, P23901, DOI 10.1074/jbc.M114.577148; Tavares CDJ, 2012, BIOCHEMISTRY-US, V51, P2232, DOI 10.1021/bi201788e; Tekedereli I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041171; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wang XM, 2014, MOL CELL BIOL, V34, P4088, DOI 10.1128/MCB.01035-14; Wiseman SL, 2013, J BIOL CHEM, V288, P17803, DOI 10.1074/jbc.M113.477182; Xie JL, 2015, MOL CELL BIOL, V35, P1805, DOI 10.1128/MCB.00012-15; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Ye QL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000525	62	9	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2032	2045		10.1074/jbc.M116.753277	http://dx.doi.org/10.1074/jbc.M116.753277			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27956550	Green Published, hybrid			2022-12-28	WOS:000395515600040
J	Hammel, M; Yu, YP; Radhakrishnan, SK; Chokshi, C; Tsai, MS; Matsumoto, Y; Kuzdovich, M; Remesh, SG; Fang, SJ; Tomkinson, AE; Lees-Miller, SP; Tainer, JA				Hammel, Michal; Yu, Yaping; Radhakrishnan, Sarvan K.; Chokshi, Chirayu; Tsai, Miaw-Sheue; Matsumoto, Yoshihiro; Kuzdovich, Monica; Remesh, Soumya G.; Fang, Shujuan; Tomkinson, Alan E.; Lees-Miller, Susan P.; Tainer, John A.			An Intrinsically Disordered APLF Links Ku, DNA-PKcs, and XRCC4-DNA Ligase IV in an Extended Flexible Non-homologous End Joining Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; X-RAY-SCATTERING; SMALL-ANGLE SCATTERING; IONIZING-RADIATION; BIOLOGICAL MACROMOLECULES; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; DAMAGE RESPONSE; REPAIR PROTEINS	DNA double-strand break (DSB) repair by non-homologous end joining (NHEJ) in human cells is initiated by Ku heterodimer binding to a DSB, followed by recruitment of core NHEJ factors including DNA-dependent protein kinase catalytic subunit (DNA-PKcs), XRCC4-like factor (XLF), and XRCC4 (X4)-DNA ligase IV (L4). Ku also interacts with accessory factors such as aprataxin and polynucleotide kinase/phosphatase-like factor (APLF). Yet, how these factors interact to tether, process, and ligate DSB ends while allowing regulation and chromatin interactions remains enigmatic. Here, small angle X-ray scattering (SAXS) and mutational analyses show APLF is largely an intrinsically disordered protein that binds Ku, Ku/DNA-PKcs (DNA-PK), and X4L4 within an extended flexible NHEJ core complex. X4L4 assembles with Ku heterodimers linked to DNA-PKcs via flexible Ku80 C-terminal regions (Ku80CTR) in a complex stabilized through APLF interactions with Ku, DNA-PK, and X4L4. Collective results unveil the solution architecture of the six-protein complex and suggest cooperative assembly of an extended flexible NHEJ core complex that supports APLF accessibility while possibly providing flexible attachment of the core complex to chromatin. The resulting dynamic tethering furthermore, provides geometric access of L4 catalytic domains to the DNA ends during ligation and of DNA-PKcs for targeted phosphorylation of other NHEJ proteins as well as trans-phosphorylation of DNA-PKcs on the opposing DSB without disrupting the core ligation complex. Overall the results shed light on evolutionary conservation of Ku, X4, and L4 activities, while explaining the observation that Ku80CTR and DNA-PKcs only occur in a subset of higher eukaryotes.	[Hammel, Michal; Chokshi, Chirayu; Tsai, Miaw-Sheue; Kuzdovich, Monica; Remesh, Soumya G.; Tainer, John A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA; [Yu, Yaping; Radhakrishnan, Sarvan K.; Fang, Shujuan; Lees-Miller, Susan P.] Univ Calgary, Arnie Charbonneau Canc Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Matsumoto, Yoshihiro; Tomkinson, Alan E.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Tainer, John A.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Calgary; University of New Mexico; University of New Mexico's Health Sciences Center; University of Texas System; UTMD Anderson Cancer Center	Hammel, M; Tainer, JA (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA.; Lees-Miller, SP (corresponding author), Univ Calgary, Arnie Charbonneau Canc Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada.; Tainer, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	mailmhammel@lbl.gov; leesmill@ucalgary.ca; JATainer@LBL.gov	Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022; Remesh, Soumya G/I-3558-2019	Tainer, John/0000-0003-1659-2429; Hammel, Michal/0000-0002-5610-9289; Radhakrishnan, Sarvan Kumar/0000-0002-1618-7864; Matsumoto, Yoshihiro/0000-0001-6580-7188; Lees-Miller, Susan/0000-0001-5809-2516	National Institutes of Health MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering) [GM105404]; United States Department of Energy program Integrated Diffraction Analysis Technologies (IDAT); NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047251, R01GM105404] Funding Source: NIH RePORTER	National Institutes of Health MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy program Integrated Diffraction Analysis Technologies (IDAT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SAXS at the Advanced Light Source SIBYLS beamline is supported in part by the National Institutes of Health MINOS (Macromolecular Insights on Nucleic Acids Optimized by Scattering) Grant GM105404 and the United States Department of Energy program Integrated Diffraction Analysis Technologies (IDAT). We thank the Berkeley Lab Advanced Light Source and SIBYLS beam line staff at 12.3.1 for aiding solution scattering data collection, and Dr. M. Rey and L. Brechenmacher at the Southern Alberta Mass Spectrometry Centre for mass spectrometry.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Andres SN, 2012, NUCLEIC ACIDS RES, V40, P1868, DOI 10.1093/nar/gks022; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Brouwer I, 2016, NATURE, V535, P566, DOI 10.1038/nature18643; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Chen X, 2011, J BIOL CHEM, V286, P4931, DOI 10.1074/jbc.M110.195024; Cherry AL, 2015, DNA REPAIR, V35, P116, DOI 10.1016/j.dnarep.2015.10.002; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Cottarel J, 2013, J CELL BIOL, V200, P173, DOI 10.1083/jcb.201203128; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fenton AL, 2013, NUCLEIC ACIDS RES, V41, P4080, DOI 10.1093/nar/gkt134; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grob P, 2012, DNA REPAIR, V11, P74, DOI 10.1016/j.dnarep.2011.10.023; Grundy GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11242; Grundy GJ, 2013, EMBO J, V32, P112, DOI 10.1038/emboj.2012.304; Gu JF, 2008, GENE DEV, V22, P411, DOI 10.1101/gad.1646608; Hammel M, 2011, J BIOL CHEM, V286, P32638, DOI 10.1074/jbc.M111.272641; Hammel M, 2010, STRUCTURE, V18, P1431, DOI 10.1016/j.str.2010.09.009; Hammel M, 2010, J BIOL CHEM, V285, P1414, DOI 10.1074/jbc.M109.065615; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Jiang WX, 2015, MOL CELL, V58, P172, DOI 10.1016/j.molcel.2015.02.024; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lehman JA, 2008, BIOCHEMISTRY-US, V47, P4359, DOI 10.1021/bi702284c; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; Li M, 2013, GENE DEV, V27, P1752, DOI 10.1101/gad.226357.113; Li SC, 2011, J BIOL CHEM, V286, P36368, DOI 10.1074/jbc.M111.287797; Li YF, 2011, J THEOR BIOL, V283, P122, DOI 10.1016/j.jtbi.2011.05.015; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Macrae CJ, 2008, DNA REPAIR, V7, P292, DOI 10.1016/j.dnarep.2007.10.008; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mani RS, 2010, J BIOL CHEM, V285, P37619, DOI 10.1074/jbc.M109.058719; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Mehrotra PV, 2011, MOL CELL, V41, P46, DOI 10.1016/j.molcel.2010.12.008; Ochi T, 2012, STRUCTURE, V20, P1212, DOI 10.1016/j.str.2012.04.012; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Reid DA, 2015, P NATL ACAD SCI USA, V112, pE2575, DOI 10.1073/pnas.1420115112; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Rulten SL, 2011, MOL CELL, V41, P33, DOI 10.1016/j.molcel.2010.12.006; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shirodkar P, 2013, J BIOL CHEM, V288, P19604, DOI 10.1074/jbc.M112.440388; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tamura K, 2002, PLANT J, V29, P771, DOI 10.1046/j.1365-313X.2002.01258.x; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang C, 2013, INT J RADIAT ONCOL, V86, P440, DOI 10.1016/j.ijrobp.2013.01.011; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Williams GJ, 2014, DNA REPAIR, V17, P110, DOI 10.1016/j.dnarep.2014.02.009; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Wu Q, 2011, BIOCHEM SOC T, V39, P1387, DOI 10.1042/BST0391387; Yano K, 2008, CELL CYCLE, V7, P1321, DOI 10.4161/cc.7.10.5898; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679	73	42	44	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					26987	27006		10.1074/jbc.M116.751867	http://dx.doi.org/10.1074/jbc.M116.751867			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875301	Green Published, hybrid			2022-12-28	WOS:000391576300004
J	Aoun, J; Hayashi, M; Sheikh, IA; Sarkar, P; Saha, T; Ghosh, P; Bhowmick, R; Ghosh, D; Chatterjee, T; Chakrabarti, P; Chakrabarti, MK; Hoque, KM				Aoun, Joydeep; Hayashi, Mikio; Sheikh, Irshad Ali; Sarkar, Paramita; Saha, Tultul; Ghosh, Priyanka; Bhowmick, Rajsekhar; Ghosh, Dipanjan; Chatterjee, Tanaya; Chakrabarti, Pinak; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul			Anoctamin 6 Contributes to Cl- Secretion in Accessory Cholera Enterotoxin (Ace)-stimulated Diarrhea AN ESSENTIAL ROLE FOR PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE (PIP2) SIGNALING IN CHOLERA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNEL; TMEM16 PROTEIN FAMILY; SCRAMBLASE ACTIVITY; ION-CHANNEL; RHO GTPASES; EXPRESSION; ACE; MODULATION; 4-KINASE; DOMAIN	Accessory cholera enterotoxin (Ace) of Vibrio cholerae has been shown to contribute to diarrhea. However, the signaling mechanism and specific type of Cl- channel activated by Ace are still unknown. We have shown here that the recombinant Ace protein induced I-Cl of apical plasma membrane, which was inhibited by classical CaCC blockers. Surprisingly, an Ace-elicited rise of current was neither affected by ANO1 (TMEM16A)specific inhibitor T16A((inh))-AO1(TAO1) nor by the cystic fibrosis transmembrane conductance regulator (CFTR) blocker, CFTR inh-172. Ace stimulated whole-cell current in Caco-2 cells. However, the apical I-Cl was attenuated by knockdown of ANO6 (TMEM16F). This impaired phenotype was restored by re-expression of ANO6 in Caco-2 cells. Whole-cell patch clamp recordings of ANO currents in HEK293 cells transiently expressing mouse ANO1-mCherry or ANO6-GFP confirmed that Ace induced Cl- secretion. Application of Ace produced ANO6 but not the ANO1 currents. Ace was not able to induce a [Ca2+](i) rise in Caco-2 cells, but cellular abundance of phosphatidylinositol 4,5-bisphosphate (PIP2) increased. Identification of the PIP2-binding motif at the N-terminal sequence among human and mouse ANO6 variants along with binding of PIP2 directly to ANO6 in HEK293 cells indicate likely PIP2 regulation of ANO6. The biophysical and pharmacological properties of Ace stimulated Cl- current along with intestinal fluid accumulation, and binding of PIP2 to the proximal KR motif of channel proteins, whose mutagenesis correlates with altered binding of PIP2, is comparable with ANO6 stimulation. We conclude that ANO6 is predominantly expressed in intestinal epithelia, where it contributes secretory diarrhea by Ace stimulation in a calcium-independent mechanism of RhoA-ROCK-PIP2 signaling.	[Aoun, Joydeep; Sheikh, Irshad Ali; Sarkar, Paramita; Saha, Tultul; Ghosh, Priyanka; Bhowmick, Rajsekhar; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul] Natl Inst Cholera & Enter Dis, Mol Pathophysiol Div, P-33,CIT Rd, Kolkata 700010, India; [Hayashi, Mikio] Kansai Med Univ, Dept Physiol, 5-1,Shimmachi 2, Hirakata, Osaka 5731010, Japan; [Ghosh, Dipanjan] Univ Calcutta, Dept Biotechnol, Coll Sci & Technol, 35 Ballygunge Circular Rd, Kolkata 700019, India; [Chatterjee, Tanaya; Chakrabarti, Pinak] Bose Inst, Dept Biochem, P-1-12 CIT Rd, Kolkata 700054, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Kansai Medical University; University of Calcutta; Department of Science & Technology (India); Bose Institute	Hoque, KM (corresponding author), Natl Inst Cholera & Enter Dis, Mol Pathophysiol Div, P-33,CIT Rd, Kolkata 700010, India.	kmh_niced@yahoo.co.in	VELAYUTHAM, RAVICHANDIRAN/HGU-8028-2022; Sheikh, Irshad/AAD-6196-2022; Kazi, Mirajul Hoque/AAR-5291-2021	Aoun, Joydeep/0000-0003-1938-2830; Saha, Tultul/0000-0002-7913-9640	Government of India, Ministry of Science and Technology, Department of Biotechnology [BT/HRD/35/02/07/2009]; Japan Society for the Promotion of Science KAKENHI [24790226]; Indian Council of Medical Research, Government of India; Department of Science and Technology fellowship	Government of India, Ministry of Science and Technology, Department of Biotechnology; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Department of Science and Technology fellowship(Department of Science & Technology (India))	This work was supported in part by Government of India, Ministry of Science and Technology, Department of Biotechnology Grant BT/HRD/35/02/07/2009 (to K. M. H.), Japan Society for the Promotion of Science KAKENHI Grant 24790226 (to M. H.), Indian Council of Medical Research, Government of India (to I. A. S., J. A.), and a Department of Science and Technology fellowship (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1582, DOI 10.1111/bph.12446; Anvari S, 2012, CELL J, V14, P209; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bhattacharya M, 2004, BIOCHEM SOC T, V32, P1040, DOI 10.1042/BST0321040; BOIVIN D, 1995, AM J PHYSIOL-RENAL, V269, pF180, DOI 10.1152/ajprenal.1995.269.2.F180; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chatterjee T, 2011, BIOCHEMISTRY-US, V50, P2962, DOI 10.1021/bi101673x; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; Fasano A, 1997, J CLIN INVEST, V99, P1158, DOI 10.1172/JCI119271; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; Hoque KM, 2005, AM J PHYSIOL-GASTR L, V288, pG956, DOI 10.1152/ajpgi.00441.2004; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kunzelmann K, 2001, NEWS PHYSIOL SCI, V16, P167; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schultheiss G, 2005, PFLUG ARCH EUR J PHY, V449, P553, DOI 10.1007/s00424-004-1365-3; Scudieri P, 2015, J PHYSIOL-LONDON, V593, P3829, DOI 10.1113/JP270691; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; Sheikh IA, 2013, J BIOL CHEM, V288, P20404, DOI 10.1074/jbc.M113.467860; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; TRUCKSIS M, 1993, P NATL ACAD SCI USA, V90, P5267, DOI 10.1073/pnas.90.11.5267; Trucksis M, 2000, AM J PHYSIOL-CELL PH, V279, pC567, DOI 10.1152/ajpcell.2000.279.3.C567; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang SA, 2004, J BIOL CHEM, V279, P42331, DOI 10.1074/jbc.M404335200; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; YU FX, 1992, J BIOL CHEM, V267, P14616	50	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26816	26836		10.1074/jbc.M116.719823	http://dx.doi.org/10.1074/jbc.M116.719823			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27799301	hybrid, Green Published			2022-12-28	WOS:000391571400020
J	Collier, JB; Whitaker, RM; Eblen, ST; Schnellmann, RG				Collier, Justin B.; Whitaker, Ryan M.; Eblen, Scott T.; Schnellmann, Rick G.			Rapid Renal Regulation of Peroxisome Proliferator-activated Receptor gamma Coactivator-1 alpha by Extracellular Signal-Regulated Kinase 1/2 in Physiological and Pathological Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ACUTE KIDNEY INJURY; FOXO TRANSCRIPTION FACTORS; MITOCHONDRIAL DYSFUNCTION; FACTOR FKHR; IN-VITRO; PHOSPHORYLATION; CELLS; TRANSACTIVATION; PGC-1-ALPHA	Previous studies have shown that extracellular signal-regulated kinase 1/2 (ERK1/2) directly inhibits mitochondrial function during cellular injury. We evaluated the role of ERK1/2 on the expression of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene, a master regulator of mitochondrial function. The potent and specific MEK1/2 inhibitor trametinib rapidly blocked ERK1/2 phosphorylation, decreased cytosolic and nuclear FOXO3a/1 phosphorylation, and increased PGC-1 alpha gene expression and its downstream mitochondrial biogenesis (MB) targets under physiological conditions in the kidney cortex and in primary renal cell cultures. The epidermal growth factor receptor (EGFR) inhibitor erlotinib blocked ERK1/2 phosphorylation and increased PGC-1 alpha gene expression similar to treatment with trametinib, linking EGFR activation and FOXO3a/1 inactivation to the down-regulation of PGC-1 alpha and MB through ERK1/2. Pretreatment with trametinib blocked early ERK1/2 phosphorylation following ischemia/reperfusion kidney injury and attenuated the downregulation of PGC-1 alpha and downstream target genes. These results demonstrate that ERK1/2 rapidly regulates mitochondrial function through a novel pathway, EGFR/ERK1/2/FOXO3a/1/PGC-1 alpha, under physiological and pathological conditions. As such, ERK1/2 down-regulates mitochondrial function directly by phosphorylation of upstream regulators of PGC-1 alpha and subsequently decreasing MB.	[Collier, Justin B.; Whitaker, Ryan M.; Schnellmann, Rick G.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Eblen, Scott T.] Med Univ South Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Schnellmann, Rick G.] Ralph H Johnson Vet Adm Med Ctr, Charleston, SC 29425 USA; [Collier, Justin B.; Schnellmann, Rick G.] Univ Arizona, Drachman Hall,1295 N Martin Ave,POB 210202, Tucson, AZ 85721 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of Arizona	Schnellmann, RG (corresponding author), Univ Arizona, Drachman Hall,1295 N Martin Ave,POB 210202, Tucson, AZ 85721 USA.	schnell@pharmacy.arizona.edu	Collier, Justin/ABG-3467-2021	Collier, Justin/0000-0001-5302-2826	National Institutes of Health National Center for Research Resources [C06-RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455, UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK105782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084147, P20GM103542] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000851] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Animal facilities were funded by the National Institutes of Health National Center for Research Resources (Grant C06-RR015455).	Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Borniquel S, 2010, MOL CELL BIOL, V30, P4035, DOI 10.1128/MCB.00175-10; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Forrester SJ, 2016, ANNU REV PHARMACOL, V56, P627, DOI 10.1146/annurev-pharmtox-070115-095427; Friess T, 2006, ANTICANCER RES, V26, P3505; Funk JA, 2013, TOXICOL APPL PHARM, V273, P345, DOI 10.1016/j.taap.2013.09.026; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Ho KK, 2012, J BIOL CHEM, V287, P1545, DOI 10.1074/jbc.M111.284224; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Link W, 2009, J BIOL CHEM, V284, P28392, DOI 10.1074/jbc.M109.038984; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Nowak G, 1996, AM J PHYSIOL-CELL PH, V271, pC2072, DOI 10.1152/ajpcell.1996.271.6.C2072; Nowak G, 2006, AM J PHYSIOL-RENAL, V291, pF840, DOI 10.1152/ajprenal.00219.2005; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rayego-Mateos S, 2013, J PATHOL, V231, P480, DOI 10.1002/path.4250; Raymond E, 2000, DRUGS, V60, P15, DOI 10.2165/00003495-200060001-00002; Ripple MO, 2013, J BIOL CHEM, V288, P2933, DOI 10.1074/jbc.M112.430082; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Sabbatini M, 2006, AM J PHYSIOL-RENAL, V290, pF1408, DOI 10.1152/ajprenal.00304.2005; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schachter TN, 2012, AM J PHYSIOL-CELL PH, V303, pC977, DOI 10.1152/ajpcell.00027.2012; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Smith JA, 2015, J PHARMACOL EXP THER, V352, P346, DOI 10.1124/jpet.114.221085; Stallons L Jay, 2013, Curr Pathobiol Rep, V1, DOI 10.1007/s40139-013-0023-x; Tseng AHH, 2014, BIOCHEM J, V464, P157, DOI 10.1042/BJ20140213; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013; Zhuang SG, 2008, J PHARMACOL EXP THER, V325, P732, DOI 10.1124/jpet.108.136358	44	23	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26850	26859		10.1074/jbc.M116.754762	http://dx.doi.org/10.1074/jbc.M116.754762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875304	hybrid, Green Published			2022-12-28	WOS:000391571400022
J	Hirai, Y; Hirano, Y; Matsuda, A; Hiraoka, Y; Honda, T; Tomonaga, K				Hirai, Yuya; Hirano, Yasuhiro; Matsuda, Atsushi; Hiraoka, Yasushi; Honda, Tomoyuki; Tomonaga, Keizo			Borna Disease Virus Assembles Porous Cage-like Viral Factories in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURED-ILLUMINATION MICROSCOPY; INFECTED-CELLS; POLYMERASE COMPLEX; PROTEIN; RESOLUTION; NUCLEOPROTEIN; RNA; PHOSPHOPROTEIN; REPLICATION; LOCALIZATION	Animal-derived RNA viruses frequently generate viral factories in infected cells. However, the details of how RNA viruses build such intracellular structures are poorly understood. In this study, we examined the structure and formation of the viral factories, called viral speckle of transcripts (vSPOTs), that are produced in the nuclei of host cells by Borna disease virus (BDV). Super-resolution microscopic analysis showed that BDV assembled vSPOTs as intranuclear cage-like structures with 59-180-nm pores. The viral nucleoprotein formed the exoskeletons of vSPOTs, whereas the other viral proteins appeared to be mainly localized within these structures. In addition, stochastic optical reconstruction microscopy revealed that filamentous structures resembling viral ribonucleoprotein complexes (RNPs) appeared to protrude from the outer surfaces of the vSPOTs. We also found that vSPOTs disintegrated into RNPs concurrently with the breakdown of the nuclear envelope during mitosis. These observations demonstrated that BDV generates viral replication factories whose shape and formation are regulated, suggesting the mechanism of the integrity of RNA virus persistent infection in the nucleus.	[Hirai, Yuya] Osaka Dent Univ, Dept Biol, Hirakata, Osaka 5731121, Japan; [Hirai, Yuya; Honda, Tomoyuki; Tomonaga, Keizo] Kyoto Univ, Inst Frontier Life & Med Sci InFRONT, Dept Virus Res, Kyoto 6068507, Japan; [Tomonaga, Keizo] Kyoto Univ, Dept Mol Virol, Grad Sch Med, Kyoto 6068507, Japan; [Tomonaga, Keizo] Kyoto Univ, Mammalian Regulatory Network, Grad Sch Biostudies, Kyoto 6068507, Japan; [Hirano, Yasuhiro; Matsuda, Atsushi; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Matsuda, Atsushi; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo 6512492, Japan	Kyoto University; Kyoto University; Kyoto University; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan	Tomonaga, K (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci InFRONT, Dept Virus Res, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	tomonaga@virus.kyoto-u.ac.jp	Hirano, Yasuhiro/AAN-4617-2021; Hiraoka, Yasushi/B-5111-2009	Hiraoka, Yasushi/0000-0001-9407-8228; Hirano, Yasuhiro/0000-0001-7339-4053; Hirai, Yuya/0000-0001-8571-080X; Matsuda, Atsushi/0000-0003-0510-213X	Japan Society for the Promotion of Science (JSPS)/The Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [JP26253027, JP15H01259, JP16H06429, JP16K21723, JP16H06430, JP26870286, JP25840008, JP16H01440, JP15K14500, JP26116511]; JSPS Core-to-Core Program A, the Advanced Research Networks; Basic Science and Platform Technology Program for Innovative Biological Medicine; Japanese Agency for Medical Research and Development (AMED); Takeda Science Foundation; Grants-in-Aid for Scientific Research [16H01309, 15K14500, 16H01440] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)/The Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI; JSPS Core-to-Core Program A, the Advanced Research Networks(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Basic Science and Platform Technology Program for Innovative Biological Medicine; Japanese Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS)/The Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant Numbers JP26253027, JP15H01259, JP16H06429, JP16K21723, JP16H06430 (to K. T.), JP26870286 (to Y. Hirai), JP25840008 (to Y. Hirano), JP16H01440, JP15K14500 (to A. M.), and JP26116511 (to Y. Hiraoka), and JSPS Core-to-Core Program A, the Advanced Research Networks (to K. T.), the Basic Science and Platform Technology Program for Innovative Biological Medicine (to K. T.) from the Japanese Agency for Medical Research and Development (AMED), and a grant from the Takeda Science Foundation (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	BRIESE T, 1992, P NATL ACAD SCI USA, V89, P11486, DOI 10.1073/pnas.89.23.11486; Charlier CM, 2013, J VIROL, V87, P12339, DOI 10.1128/JVI.01127-13; Chase G, 2007, J VIROL, V81, P743, DOI 10.1128/JVI.01351-06; GARCIA J, 1993, VIROLOGY, V195, P243, DOI 10.1006/viro.1993.1366; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heinrich BS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000958; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hirai Y, 2015, J GEN VIROL, V96, P3198, DOI 10.1099/jgv.0.000273; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Knoops K, 2012, J VIROL, V86, P2474, DOI 10.1128/JVI.06677-11; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Kobayashi T, 2003, J VIROL, V77, P8099, DOI 10.1128/JVI.77.14.8099-8107.2003; Kobayashi T, 2001, J VIROL, V75, P3404, DOI 10.1128/JVI.75.7.3404-3412.2001; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; Lang T, 2010, PHYSIOLOGY, V25, P116, DOI 10.1152/physiol.00044.2009; Ludwig H, 2000, REV SCI TECH OIE, V19, P259, DOI 10.20506/rst.19.1.1217; Matsuda A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8753; Matsuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012768; Matsumoto Y, 2012, CELL HOST MICROBE, V11, P492, DOI 10.1016/j.chom.2012.04.009; Matsunaga S, 2012, CELL REP, V1, P299, DOI 10.1016/j.celrep.2012.02.005; Nakamura Y, 2000, J VIROL, V74, P4601, DOI 10.1128/JVI.74.10.4601-4611.2000; Nanbo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01206; Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32; Perez M, 2003, J GEN VIROL, V84, P3099, DOI 10.1099/vir.0.19467-0; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider U, 2005, VIRUS RES, V111, P148, DOI 10.1016/j.virusres.2005.04.006; Schneider U, 2003, J VIROL, V77, P11781, DOI 10.1128/JVI.77.21.11781-11789.2003; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]; Watanabe M, 2000, MICROBIOL IMMUNOL, V44, P765, DOI 10.1111/j.1348-0421.2000.tb02561.x; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; ZAJAC BA, 1970, J VIROL, V6, P243, DOI 10.1128/JVI.6.2.243-252.1970	35	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25789	25798		10.1074/jbc.M116.746396	http://dx.doi.org/10.1074/jbc.M116.746396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803166	Green Published, hybrid			2022-12-28	WOS:000390345200003
J	Young, PA; Migliorini, M; Strickland, DK				Young, Patricia A.; Migliorini, Mary; Strickland, Dudley K.			Evidence That Factor VIII Forms a Bivalent Complex with the Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) IDENTIFICATION OF CLUSTER IV ON LRP1 AS THE MAJOR BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; HIGH-AFFINITY BINDING; ALPHA-2-MACROGLOBULIN RECEPTOR; LIGAND-BINDING; FACTOR IXA; RAP COMPLEX; MOUSE MODEL; A2 DOMAIN; CHAPERONE; RESIDUES	Hemophilia A is a bleeding disorder caused by a deficiency in coagulation factor VIII (fVIII) that affects 1 in 5,000 males. Current prophylactic replacement therapy, although effective, is difficult to maintain due to the cost and frequency of injections. Hepatic clearance of fVIII is mediated by the LDL receptor-related protein 1 (LRP1), a member of the LDL receptor family. Although it is well established that fVIII binds LRP1, the molecular details of this interaction are unclear as most of the studies have been performed using fragments of fVIII and LRP1. In the current investigation, we examine the binding of intact fVIII to full-length LRP1 to gain insight into the molecular interaction. Chemical modification studies confirm the requirement for lysine residues in the interaction of fVIII with LRP1. Examination of the ionic strength dependence of the interaction of fVIII with LRP1 resulted in a Debye-Huckel plot with a slope of 1.8 +/- 0.5, suggesting the involvement of two critical charged residues in the interaction of fVIII with LRP1. Kinetic studies utilizing surface plasmon resonance techniques reveal that the high affinity of fVIII for LRP1 results from avidity effects mediated by the interactions of two sites in fVIII with complementary sites on LRP1 to form a bivalent fVIII.LRP1 complex. Furthermore, although fVIII bound avidly to soluble forms of clusters II and IV from LRP1, only soluble cluster IV competed with the binding of fVIII to full-length LRP1, revealing that cluster IV represents the major fVIII binding site in LRP1.	Univ Maryland, Ctr Vasc & Inflammatory Dis, Sch Med, Baltimore, MD 21201 USA; Univ Maryland, Dept Surg, Sch Med, Baltimore, MD 21201 USA; Univ Maryland, Dept Physiol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Strickland, DK (corresponding author), Ctr Vasc & Inflammatory Dis, Biopk 1,R219,800 W Baltimore St, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu			National Institutes of Health [HL114379, HL120388, T32 HL007698, F31 HL131283]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114379, R01HL120388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL114379 and HL120388 (to D. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grants T32 HL007698 and F31 HL131283.	ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Bloem E, 2013, J BIOL CHEM, V288, P29670, DOI 10.1074/jbc.M113.473116; Bovenschen N, 2006, J THROMB HAEMOST, V4, P1487, DOI 10.1111/j.1538-7836.2006.01965.x; Bovenschen N, 2005, BLOOD, V106, P906, DOI 10.1182/blood-2004-11-4230; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; Bovenschen N, 2003, BLOOD, V101, P3933, DOI 10.1182/blood-2002-07-2081; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Collins PW, 2009, J THROMB HAEMOST, V7, P413, DOI 10.1111/j.1538-7836.2008.03270.x; Doering CB, 2002, J BIOL CHEM, V277, P38345, DOI 10.1074/jbc.M206959200; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fischer K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006745; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; HEALEY JF, 1995, J BIOL CHEM, V270, P14505, DOI 10.1074/jbc.270.24.14505; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Kurasawa JH, 2015, BIOCHEMISTRY-US, V54, P481, DOI 10.1021/bi5011688; Lee D, 2007, PROTEIN SCI, V16, P1628, DOI 10.1110/ps.072865407; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; LIND P, 1995, EUR J BIOCHEM, V232, P19, DOI 10.1111/j.1432-1033.1995.tb20776.x; Makarova A, 2008, NEUROSCI LETT, V442, P91, DOI 10.1016/j.neulet.2008.06.070; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Pipe SW, 1999, BLOOD, V93, P176, DOI 10.1182/blood.V93.1.176.401k07_176_183; Prasad JM, 2016, J BIOL CHEM, V291, P18430, DOI 10.1074/jbc.M116.744904; Prasad JM, 2015, J BIOL CHEM, V290, P17262, DOI 10.1074/jbc.M115.660084; Rastegarlari G, 2012, BLOOD, V119, P2126, DOI 10.1182/blood-2011-08-373605; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Saenko EL, 1999, J BIOL CHEM, V274, P37685, DOI 10.1074/jbc.274.53.37685; Saenko EL, 2002, BRIT J HAEMATOL, V119, P323, DOI 10.1046/j.1365-2141.2002.03793.x; Sarafanov AG, 2006, BIOCHEMISTRY-US, V45, P1829, DOI 10.1021/bi0520380; Sarafanov AG, 2007, THROMB HAEMOSTASIS, V98, P1170, DOI 10.1160/TH07-05-0353; Schwarz HP, 2000, BLOOD, V95, P1703, DOI 10.1182/blood.V95.5.1703.005k20_1703_1708; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; Svensson LA, 2013, BIOL CHEM, V394, P761, DOI 10.1515/hsz-2012-0298; van den Biggelaar M, 2015, J BIOL CHEM, V290, P16463, DOI 10.1074/jbc.M115.650911; Vlot AJ, 1996, BLOOD, V87, P1809; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Wohner N, 2015, J THROMB HAEMOST, V13, P815, DOI 10.1111/jth.12885	51	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26035	26044		10.1074/jbc.M116.754622	http://dx.doi.org/10.1074/jbc.M116.754622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27794518	hybrid, Green Published			2022-12-28	WOS:000390345200023
J	Gerber, H; Wu, F; Dimitrov, M; Osuna, GMG; Fraering, PC				Gerber, Hermeto; Wu, Fang; Dimitrov, Mitko; Osuna, Guillermo M. Garcia; Fraering, Patrick C.			Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by -Secretase and Amyloid- Peptide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); amyloid- (AB); copper; intramembrane proteolysis; neurodegeneration; zinc; biometals	NUCLEOTIDE-BINDING SITE; ACTIVE GAMMA-SECRETASE; TARGETING A-BETA; ALZHEIMERS-DISEASE; THERAPEUTIC IMPLICATIONS; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; PLASMA-MEMBRANE; MEMORY DEFICITS; BRAIN-TISSUE	Recent evidence suggests involvement of biometal homeostasis in the pathological mechanisms in Alzheimer's disease (AD). For example, increased intracellular copper or zinc has been linked to a reduction in secreted levels of the AD-causing amyloid- peptide (A). However, little is known about whether these biometals modulate the generation of A. In the present study we demonstrate in both cell-free and cell-based assays that zinc and copper regulate A production by distinct molecular mechanisms affecting the processing by -secretase of its A precursor protein substrate APP-C99. We found that Zn2+ induces APP-C99 dimerization, which prevents its cleavage by -secretase and A production, with an IC50 value of 15 m. Importantly, at this concentration, Zn2+ also drastically raised the production of the aggregation-prone A43 found in the senile plaques of AD brains and elevated the A43:A40 ratio, a promising biomarker for neurotoxicity and AD. We further demonstrate that the APP-C99 histidine residues His-6, His-13, and His-14 control the Zn2+-dependent APP-C99 dimerization and inhibition of A production, whereas the increased A43:A40 ratio is substrate dimerization-independent and involves the known Zn2+ binding lysine Lys-28 residue that orientates the APP-C99 transmembrane domain within the lipid bilayer. Unlike zinc, copper inhibited A production by directly targeting the subunits presenilin and nicastrin in the -secretase complex. Altogether, our data demonstrate that zinc and copper differentially modulate A production. They further suggest that dimerization of APP-C99 or the specific targeting of individual residues regulating the production of the long, toxic A species, may offer two therapeutic strategies for preventing AD.	[Gerber, Hermeto; Fraering, Patrick C.] Fdn Eclos, CH-1228 Plan Les Ouates, Switzerland; [Gerber, Hermeto; Fraering, Patrick C.] Campus Biotech Innovat Pk, CH-1202 Geneva, Switzerland; [Gerber, Hermeto; Wu, Fang; Dimitrov, Mitko; Osuna, Guillermo M. Garcia; Fraering, Patrick C.] Swiss Fed Inst Technol EPFL, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Gerber, Hermeto; Wu, Fang; Dimitrov, Mitko; Osuna, Guillermo M. Garcia; Fraering, Patrick C.] Swiss Fed Inst Technol EPFL, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Gerber, Hermeto] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Wu, Fang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai 200240, Peoples R China	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Fribourg; Shanghai Jiao Tong University	Fraering, PC (corresponding author), Fdn Eclos, CH-1228 Plan Les Ouates, Switzerland.; Fraering, PC (corresponding author), Campus Biotech Innovat Pk, CH-1202 Geneva, Switzerland.; Fraering, PC (corresponding author), Swiss Fed Inst Technol EPFL, Brain Mind Inst, CH-1015 Lausanne, Switzerland.; Fraering, PC (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, CH-1015 Lausanne, Switzerland.	fraeringpatrick@hotmail.com	Wu, Fang/B-1945-2008; Gerber, Hermeto/I-8180-2018	Wu, Fang/0000-0002-4194-2243; Fraering, Patrick/0000-0002-5841-5327	Swiss National Science Foundation [31003A_152677/1]; Strauss Foundation; Foundation Eclosion; National Natural Science Foundation of China [31270853]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Strauss Foundation; Foundation Eclosion; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Swiss National Science Foundation (to H. G. and P. C. F., 31003A_152677/1), the Strauss Foundation (to H. G. and P. C. F.), the Foundation Eclosion (to H. G. and P. C. F.), and the National Natural Science Foundation of China (to F. W., 31270853). The authors declare that they have no conflicts of interest with the contents of this article.	Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Alattia JR, 2011, FASEB J, V25, P2287, DOI 10.1096/fj.10-174078; Alvarez HM, 2010, SCIENCE, V327, P331, DOI 10.1126/science.1179907; Arnal Nathalie, 2013, Int J Alzheimers Dis, V2013, P414817, DOI 10.1155/2013/414817; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Ayciriex S, 2016, BIOCHEM J, V473, P321, DOI 10.1042/BJ20150448; Ayton S, 2015, NEUROTHERAPEUTICS, V12, P109, DOI 10.1007/s13311-014-0312-z; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Bellingham SA, 2004, J NEUROCHEM, V91, P423, DOI 10.1111/j.1471-4159.2004.02731.x; Bonda DJ, 2011, METALLOMICS, V3, P267, DOI 10.1039/c0mt00074d; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; Bot N, 2011, J BIOL CHEM, V286, P2762, DOI 10.1074/jbc.M110.142521; BOUKAIBA N, 1993, AM J CLIN NUTR, V57, P566; Brewer GJ, 2000, P SOC EXP BIOL MED, V223, P39, DOI 10.1046/j.1525-1373.2000.22305.x; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011; Butterfield DA, 2003, CNS DRUGS, V17, P641, DOI 10.2165/00023210-200317090-00004; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Cacquevel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035133; Camakaris J, 1999, BIOCHEM BIOPH RES CO, V261, P225, DOI 10.1006/bbrc.1999.1073; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Danielsson J, 2007, FEBS J, V274, P46, DOI 10.1111/j.1742-4658.2006.05563.x; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Fraering PC, 2007, CURR GENOMICS, V8, P531, DOI 10.2174/138920207783769521; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; HARTTER DE, 1988, SYNAPSE, V2, P412, DOI 10.1002/syn.890020408; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hoke DE, 2005, FEBS J, V272, P5544, DOI 10.1111/j.1742-4658.2005.04950.x; Houacine J, 2012, NEUROBIOL AGING, V33, P2704, DOI 10.1016/j.neurobiolaging.2011.12.033; Hung YH, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00111; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; Hung YH, 2009, J BIOL CHEM, V284, P21899, DOI 10.1074/jbc.M109.019521; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; James SA, 2012, FREE RADICAL BIO MED, V52, P298, DOI 10.1016/j.freeradbiomed.2011.10.446; Jun SM, 2007, ANGEW CHEM INT EDIT, V46, P3959, DOI 10.1002/anie.200700318; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Kenche VB, 2011, BRIT J PHARMACOL, V163, P211, DOI 10.1111/j.1476-5381.2011.01221.x; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kukar TL, 2011, J BIOL CHEM, V286, P39804, DOI 10.1074/jbc.M111.274696; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Mithu VS, 2011, BIOPHYS J, V101, P2825, DOI 10.1016/j.bpj.2011.10.023; Noda Y, 2013, NEUROSCI LETT, V547, P10, DOI 10.1016/j.neulet.2013.04.057; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Pithadia AS, 2012, CURR OPIN CHEM BIOL, V16, P67, DOI 10.1016/j.cbpa.2012.01.016; Quagraine EK, 2001, J INORG BIOCHEM, V85, P23, DOI 10.1016/S0162-0134(00)00227-0; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Sandebring A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055847; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schlief ML, 2006, P NATL ACAD SCI USA, V103, P14919, DOI 10.1073/pnas.0605390103; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; She YM, 2003, MOL CELL PROTEOMICS, V2, P1306, DOI 10.1074/mcp.M300080-MCP200; Soragni A, 2008, BIOCHEMISTRY-US, V47, P10841, DOI 10.1021/bi8008856; Squitti R, 2014, NEUROBIOL AGING, V35, pS40, DOI 10.1016/j.neurobiolaging.2014.02.031; Squitti R, 2012, J ALZHEIMERS DIS, V29, P493, DOI 10.3233/JAD-2011-111991; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Takeda A, 2009, NEUROCHEM INT, V55, P376, DOI 10.1016/j.neuint.2009.04.006; Treiber C, 2004, J BIOL CHEM, V279, P51958, DOI 10.1074/jbc.M407410200; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wang YF, 2011, ADV NUTR, V2, P129, DOI 10.3945/an.110.000273; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922; Winkler E, 2015, BIOCHEMISTRY-US, V54, P6149, DOI 10.1021/acs.biochem.5b00986; Wu F, 2010, FASEB J, V24, P2464, DOI 10.1096/fj.09-148031; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhou LX, 2007, PEPTIDES, V28, P2229, DOI 10.1016/j.peptides.2007.08.022	92	50	52	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3751	3767		10.1074/jbc.M116.754101	http://dx.doi.org/10.1074/jbc.M116.754101			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28096459	Green Published, hybrid			2022-12-28	WOS:000395542500018
J	Noh, KT; Jung, ID; Cha, GS; Han, MK; Park, YM				Noh, Kyung Tae; Jung, In Duk; Cha, Gil Sun; Han, Myung-Kwan; Park, Yeong-Min			Platelet-activating Factor Mediates Endotoxin Tolerance by Regulating Indoleamine 2,3-Dioxygenase-dependent Expression of the Suppressor of Cytokine Signaling 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dendritic cell; endotoxin; glycogen synthase kinase 3 (GSK-3); immunosuppressor; indoleamine-pyrrole 2; 3-dioxygenase (IDO1)	UNITED-STATES; SEVERE SEPSIS; EPIDEMIOLOGY; ANTAGONIST	Indoleamine 2,3-dioxygenase (IDO) mediates immune tolerance, and suppressor of cytokine signaling 3 (SOCS3) negatively regulates the JAK/STAT signal transduction pathway. We determined previously that platelet-activating factor (PAF) protects mice against LPS-induced endotoxic shock, but its detailed mechanism of action was unknown. We performed survival experiments in IDO+/+ and IDO-/- mice using an LPS-induced endotoxemia model and rated organ injury (neutrophil infiltration and liver function). Using ELISA and Western blotting, we also investigated the mechanism of PAF-mediated endotoxin tolerance during endotoxemia. PAF-mediated endotoxin tolerance was dependent on IDO in vivo and in vitro and was not observed in IDO-/- mice. JAK/STAT signaling, crucial for SOCS3 expression, was also impaired in the absence of IDO. In an IDO- and STAT-dependent manner, PAF mediated a decrease in IL-12 and a dramatic increase in IL-10 and reduced mouse mortality. In addition, PAF attenuated LPS-mediated neutrophil infiltration into the lungs and interactions between neutrophil-like (THP-1) and endothelial cells (human umbilical vein endothelial cells). These results indicate that PAF-mediated endotoxin tolerance is initiated via IDO- and JAK/STAT-dependent expression of SOCS3. Our study has revealed a novel tolerogenic mechanism of IDO action and an important association between IDO and SOCS3 with respect to endotoxin tolerance.	[Noh, Kyung Tae] Armed Forces Med Res Inst, Dept Infect Dis, 90bun Jaunro, Daejeon 305878, South Korea; [Jung, In Duk; Cha, Gil Sun; Park, Yeong-Min] Konkuk Univ, Coll Med, Dept Immunol, 120 Neungdong Ro, Seoul 143701, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Dept Microbiol, Sch Med, Jeonju 561182, South Korea	Konkuk University; Konkuk University Medical Center; Jeonbuk National University	Park, YM (corresponding author), Konkuk Univ, Coll Med, Dept Immunol, 120 Neungdong Ro, Seoul 143701, South Korea.; Han, MK (corresponding author), Chonbuk Natl Univ, Dept Microbiol, Sch Med, Jeonju 561182, South Korea.	iamtom@chonbuk.ac.kr; immun3023@kku.ac.kr		Han, Myung-Kwan/0000-0003-1931-8898	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2014R1A1A2054999, 2014R1A2A1A10054634, 2015R1A2A1A13001713, 2013R1A4A1069575, 2016R1A5A2012284]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2014R1A1A2054999, 2014R1A2A1A10054634, 2015R1A2A1A13001713, 2013R1A4A1069575, and 2016R1A5A2012284). The authors declare that they have no conflicts of interest with the contents of this article.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; CASALSSTENZEL J, 1987, EUR J PHARMACOL, V135, P117, DOI 10.1016/0014-2999(87)90602-9; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Giral M, 1996, BRIT J PHARMACOL, V118, P1223, DOI 10.1111/j.1476-5381.1996.tb15527.x; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; IMAIZUMI TA, 1995, J INTERN MED, V238, P5, DOI 10.1111/j.1365-2796.1995.tb00894.x; Jeong YI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006503; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mathiak G, 1997, SHOCK, V7, P391, DOI 10.1097/00024382-199706000-00001; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2007, CURR CANCER DRUG TAR, V7, P31, DOI 10.2174/156800907780006896; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Noh KT, 2015, J BIOL CHEM, V290, P12394, DOI 10.1074/jbc.M114.628578; Noh KT, 2012, J BIOL CHEM, V287, P14226, DOI 10.1074/jbc.M111.308841; Peroval MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051243; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Walterscheid JP, 2002, J EXP MED, V195, P171, DOI 10.1084/jem.20011450; Yan CG, 2013, FASEB J, V27, P2967, DOI 10.1096/fj.12-225797; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084	25	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3290	3298		10.1074/jbc.M116.764464	http://dx.doi.org/10.1074/jbc.M116.764464			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28077574	Green Published, hybrid			2022-12-28	WOS:000395538800020
J	Mehta-D'souza, P; Klopocki, AG; Oganesyan, V; Terzyan, S; Mather, T; Li, ZH; Panicker, SR; Zhu, C; McEver, RP				Mehta-D'souza, Padmaja; Klopocki, Arkadiusz G.; Oganesyan, Vaheh; Terzyan, Simon; Mather, Timothy; Li, Zhenhai; Panicker, Sumith R.; Zhu, Cheng; McEver, Rodger P.			Glycan Bound to the Selectin Low Affinity State Engages Glu-88 to Stabilize the High Affinity State under Force	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH ENDOTHELIAL VENULES; LIGAND BINDING-KINETICS; P-SELECTIN; GLYCOPROTEIN LIGAND-1; LECTIN DOMAIN; CELL-ADHESION; CONFORMATION; REPLACEMENT; NEUTROPHILS; SOFTWARE	Selectin interactions with fucosylated glycan ligands mediate leukocyte rolling in the vasculature under shear forces. Crystal structures of P-and E-selectin suggest a two-state model in which ligand binding to the lectin domain closes loop 83-89 around the Ca2+ coordination site, enabling Glu-88 to engage Ca2+ and fucose. This triggers further allostery that opens the lectin/EGF domain hinge. The model posits that force accelerates transition from the bent (low affinity) to the extended (high affinity) state. However, transition intermediates have not been described, and the role of Glu-88 in force-assisted allostery has not been examined. Here we report the structure of the lectin and EGF domains of L-selectin bound to a fucose mimetic; that is, a terminal mannose on an N-glycan attached to a symmetry-related molecule. The structure is a transition intermediate where loop 83-89 closes to engage Ca2+ and mannose without triggering allostery that opens the lectin/EGF domain hinge. We used three complementary assays to compare ligand binding to WT selectins and to E88D selectins that replaced Glu-88 with Asp. Soluble P-selectinE88D bound with an similar to 9-fold lower affinity to PSGL-1, a physiological ligand, due to faster dissociation. Adhesion frequency experiments with a biomembrane force probe could not detect interactions of P-selectinE88D with PSGL-1. Cells expressing transmembrane P-selectinE88D or L-selectinE88D detached from immobilized ligands immediately after initiating flow. Cells expressing E-selectinE88D rolled but detached faster. Our data support a two-state model for selectins in which Glu-88 must engage ligand to trigger allostery that stabilizes the high affinity state under force.	[Mehta-D'souza, Padmaja; Klopocki, Arkadiusz G.; Oganesyan, Vaheh; Mather, Timothy; Panicker, Sumith R.; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Terzyan, Simon] Oklahoma Med Res Fdn, Crystallog Res Program, Oklahoma City, OK 73104 USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Li, Zhenhai; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	McEver, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org	Panicker, Sumith/X-8830-2019; Li, Zhenhai/B-2591-2018	Li, Zhenhai/0000-0002-0720-2807; Zhu, Cheng/0000-0002-1718-565X; Panicker, Sumith/0000-0001-8550-9436; McEver, Rodger/0000-0001-5343-2622	National Institutes of Health [HL034363, AI077343, HL085607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034363, R01HL034363, R01HL132019, P01HL085607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077343, R01AI077343, R01AI044902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL034363, AI077343, and HL085607. R.P.M. is a co-founder of Selexys Pharmaceutical Corp., now part of Novartis, and of Tetherex Pharmaceutical Corp. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Diacovo TG, 1996, SCIENCE, V273, P252, DOI 10.1126/science.273.5272.252; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; KISHIMOTO TK, 1991, BLOOD, V78, P805; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; McEver RP, 2015, CARDIOVASC RES, V107, P331, DOI 10.1093/cvr/cvv154; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta P, 1997, BLOOD, V90, P2381, DOI 10.1182/blood.V90.6.2381.2381_2381_2389; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Preston RC, 2016, J MOL CELL BIOL, V8, P62, DOI 10.1093/jmcb/mjv046; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; STOOLMAN LM, 1984, J CELL BIOL, V99, P1535, DOI 10.1083/jcb.99.4.1535; Turk D, 2013, ACTA CRYSTALLOGR D, V69, P1342, DOI 10.1107/S0907444913008408; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Waldron TT, 2009, P NATL ACAD SCI USA, V106, P85, DOI 10.1073/pnas.0810620105; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Yago T, 2010, P NATL ACAD SCI USA, V107, P9204, DOI 10.1073/pnas.1003110107; Yakovenko O, 2015, P NATL ACAD SCI USA, V112, P9884, DOI 10.1073/pnas.1503160112	35	21	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2510	2518		10.1074/jbc.M116.767186	http://dx.doi.org/10.1074/jbc.M116.767186			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011641	hybrid, Green Published			2022-12-28	WOS:000395530300037
J	Zhao, QJJ; Cai, WH; Zhang, X; Tian, S; Zhang, JW; Li, HB; Hou, CC; Ma, XL; Chen, H; Huang, BR; Chen, D				Zhao, Qiaojiajie; Cai, Weihua; Zhang, Xuan; Tian, Shuo; Zhang, Junwen; Li, Haibo; Hou, Congcong; Ma, Xiaoli; Chen, Hong; Huang, Bingren; Chen, Deng			RYBP Expression Is Regulated by KLF4 and Sp1 and Is Related to Hepatocellular Carcinoma Prognosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH EFFECTOR DOMAIN; TRANSCRIPTION FACTOR; SPECIFICITY PROTEIN-1; HEPATOBLASTOMA CELLS; POLYCOMB COMPLEX; APOPTOSIS; INTERACTS; ACTIVATION; SURVIVAL; TARGET	The expression of Ring1and YY1 binding protein (RYBP) is reduced in several human cancers, but the molecular mechanism( s) have remained elusive. In this study, we used human hepatocellular carcinoma (HCC) cell lines and tissue specimens to study the mechanism and herein report several new findings. First, we cloned and characterized the basal promoter region of the human RYBP gene. We found that the decreased RYBP expression in HCC tissues was not due to promoter sequence variation/polymorphisms orCpGdinucleotide methylation. Weidentified two transcription factors, KLF4 and Sp1, which directly bind the promoter region of RYBP to induce and suppress RYBP transcription, respectively. We mapped the binding sites of KLF4 and Sp1 on theRYBPpromoter. Studies in vitro showed that KLF4 suppresses whereas Sp1 promotesHCCcell growth through modulating RYBP expression. Deregulated KLF4 and Sp1 contributed to decreasedexpressionofRYBPinHCCtumortissues. Ourstudiesof human HCC tissues indicated that a diminished RYBP level in the tumor (in association with altered KLF4 and Sp1 expression) was statistically associated with a larger tumor size, poorer differentiation, and an increased susceptibility to distant metastasis. These findings help to clarifywhyRYBPis decreased inHCCand indicate that deregulated KLF4, Sp1, and RYBP may lead to a poorer prognosis. Our findings support the idea that RYBP may represent a target for cancer therapy and suggest that it may be useful as a prognostic biomarker for HCC, either alone or in combination with KLF4 and Sp1.	[Zhao, Qiaojiajie; Zhang, Xuan; Tian, Shuo; Zhang, Junwen; Hou, Congcong; Ma, Xiaoli; Chen, Hong; Huang, Bingren; Chen, Deng] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, State Key Lab Med Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Zhao, Qiaojiajie; Zhang, Xuan; Tian, Shuo; Zhang, Junwen; Hou, Congcong; Ma, Xiaoli; Chen, Hong; Huang, Bingren; Chen, Deng] Peking Union Med Coll, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China; [Cai, Weihua] Nantong Univ, Nantong Hosp 3, Dept Hepatobiliary Surg, Nantong 226006, Jiangsu, Peoples R China; [Li, Haibo] Nantong Maternal & Child Hlth Hosp, Dept Clin Lab Med, Nantong 226018, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nantong University	Huang, BR; Chen, D (corresponding author), Peking Union Med Coll, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hbr541@hotmail.com; chendeng2001@hotmail.com		Zhang, Junwen/0000-0003-3359-7213; Zhang, Xuan/0000-0002-1801-5855	Project of the National Natural Science Foundation of China [81272229]; State Key Laboratory of Medical Molecular Biology of China	Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Medical Molecular Biology of China	This work was supported by the Project of the National Natural Science Foundation of China (Grant 81272229) and the State Key Laboratory of Medical Molecular Biology of China. The authors declare that they have no conflicts of interest with the contents of this article.	Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Chen D, 2009, EMBO REP, V10, P166, DOI 10.1038/embor.2008.231; Cui JJ, 2013, CURR CANCER DRUG TAR, V13, P986, DOI 10.2174/15680096113136660104; Danen-van Oorschot AAAM, 2004, CELL DEATH DIFFER, V11, P564, DOI 10.1038/sj.cdd.4401391; Fowler CB, 2011, METHODS MOL BIOL, V724, P23, DOI 10.1007/978-1-61779-055-3_2; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Gonzalez I, 2009, CELL RES, V19, P747, DOI 10.1038/cr.2009.29; Hsiao CC, 2015, CANCER LETT, V368, P144, DOI 10.1016/j.canlet.2015.08.004; Hsu HT, 2014, INT J MOL SCI, V15, P9894, DOI 10.3390/ijms15069894; Kong LM, 2011, J CELL MOL MED, V15, P1415, DOI 10.1111/j.1582-4934.2010.01124.x; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; Li Q, 2012, GASTROENTEROLOGY, V143, P799, DOI 10.1053/j.gastro.2012.05.043; Ma W, 2016, CELL SIGNAL, V28, P779, DOI 10.1016/j.cellsig.2016.03.012; Majumdar G, 2003, AM J PHYSIOL-ENDOC M, V285, pE584, DOI 10.1152/ajpendo.00140.2003; Novak RL, 2008, CANCER GENE THER, V15, P713, DOI 10.1038/cgt.2008.25; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Safe S, 2014, EXPERT OPIN THER TAR, V18, P759, DOI 10.1517/14728222.2014.914173; Sawa C, 2002, J BIOL CHEM, V277, P22484, DOI 10.1074/jbc.M203060200; Schickling O, 2001, CELL DEATH DIFFER, V8, P1157, DOI 10.1038/sj.cdd.4400928; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Stanton SE, 2007, APOPTOSIS, V12, P2197, DOI 10.1007/s10495-007-0131-3; Sun HC, 2016, CLIN CANCER RES, V22, P502, DOI 10.1158/1078-0432.CCR-15-0528; Sung MT, 2015, ONCOL REP, V34, P439, DOI 10.3892/or.2015.3964; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tischoff I, 2008, WORLD J GASTROENTERO, V14, P1741, DOI 10.3748/wjg.14.1741; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Voruganti S, 2015, CANCER LETT, V369, P386, DOI 10.1016/j.canlet.2015.09.003; Wang W, 2014, ONCOTARGET, V5, P11604, DOI 10.18632/oncotarget.2598; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Yang JL, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-56; Yin X, 2013, ONCOL LETT, V5, P1155, DOI 10.3892/ol.2013.1151; Yumnam S, 2016, J CELL PHYSIOL, V231, P1261, DOI 10.1002/jcp.25222; Zeng XY, 2011, THEOR APPL MECH LETT, V1, DOI 10.1063/2.1103301; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200	37	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2143	2158		10.1074/jbc.M116.770727	http://dx.doi.org/10.1074/jbc.M116.770727			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028181	Green Published, hybrid			2022-12-28	WOS:000395530300009
J	Chenge, JT; Duyet, LV; Swami, S; McLean, KJ; Kavanagh, ME; Coyne, AG; Rigby, SEJ; Cheesman, MR; Girvan, HM; Levy, CW; Rupp, B; von Kries, JP; Abell, C; Leys, D; Munro, AW				Chenge, Jude T.; Le Van Duyet; Swami, Shalini; McLean, Kirsty J.; Kavanagh, Madeline E.; Coyne, Anthony G.; Rigby, Stephen E. J.; Cheesman, Myles R.; Girvan, Hazel M.; Levy, Colin W.; Rupp, Bernd; von Kries, Jens P.; Abell, Chris; Leys, David; Munro, Andrew W.			Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC CIRCULAR-DICHROISM; BIOPHYSICAL CHARACTERIZATION; CRYSTAL-STRUCTURE; AZOLE ANTIFUNGALS; PROTEIN COMPLEXES; P450; EXPRESSION; PURIFICATION; AGENTS; INHIBITORS	The Mycobacterium tuberculosis H37Rv genome encodes 20 cytochromes P450, including P450s crucial to infection and bacterial viability. Many M. tuberculosis P450s remain uncharacterized, suggesting that their further analysis may provide new insights into M. tuberculosis metabolic processes and new targets for drug discovery. CYP126A1 is representative of a P450 family widely distributed in mycobacteria and other bacteria. Here we explore the biochemical and structural properties of CYP126A1, including its interactions with new chemical ligands. A survey of azole antifungal drugs showed that CYP126A1 is inhibited strongly by azoles containing an imidazole ring but not by those tested containing a triazole ring. To further explore the molecular preferences of CYP126A1 and search for probes of enzyme function, we conducted a high throughput screen. Compounds containing three or more ring structures dominated the screening hits, including nitroaromatic compounds that induce substrate-like shifts in the heme spectrum of CYP126A1. Spectroelectrochemical measurements revealed a 155-mV increase in heme iron potential when bound to one of the newly identified nitroaromatic drugs. CYP126A1 dimers were observed in crystal structures of ligand-free CYP126A1 and for CYP126A1 bound to compounds discovered in the screen. However, ketoconazole binds in an orientation that disrupts the BC-loop regions at the P450 dimer interface and results in a CYP126A1 monomeric crystal form. Structural data also reveal that nitroaromatic ligands "moonlight" as substrates by displacing the CYP126A1 distal water but inhibit enzyme activity. The relatively polar active site of CYP126A1 distinguishes it from its most closely related sterol-binding P450s in M. tuberculosis, suggesting that further investigations will reveal its diverse substrate selectivity.	[Chenge, Jude T.; Le Van Duyet; Swami, Shalini; McLean, Kirsty J.; Rigby, Stephen E. J.; Girvan, Hazel M.; Levy, Colin W.; Leys, David; Munro, Andrew W.] Univ Manchester, Sch Chem, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England; [Kavanagh, Madeline E.; Coyne, Anthony G.; Abell, Chris] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Cheesman, Myles R.] Univ East Anglia, Sch Chem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Rupp, Bernd; von Kries, Jens P.] Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany	University of Manchester; University of Cambridge; University of East Anglia; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Munro, AW (corresponding author), Univ Manchester, Sch Chem, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Coyne, Anthony/O-2938-2019; McLean, Kirsty J/GXI-2853-2022; Munro, Andrew/G-5639-2019	Coyne, Anthony/0000-0003-0205-5630; Munro, Andrew/0000-0002-4642-180X; Girvan, Hazel/0000-0003-2299-8644; McLean, Kirsty/0000-0002-7193-5044; Rupp, Bernd/0000-0001-9447-9638; Kavanagh, Madeline E./0000-0002-4735-1559	Biotechnology and Biological Research Council (BBSRC) [BB/I019227/1, BB/I019669/1]; United States Department of Education William D. Ford Program; Vietnamese Government Ph.D. scholarship; National Overseas Ph.D. scholarship from the Ministry of Social Justice and Empowerment, Government of India (New Delhi); Commonwealth (University of Cambridge) Scholarship; Commonwealth Scholarship Commission in the United Kingdom; Cambridge Trusts; Royal Society Wolfson Merit Award; Biotechnology and Biological Sciences Research Council [BB/I019669/1, BB/E013007/1] Funding Source: researchfish; BBSRC [BB/I019669/1, BB/E013007/1] Funding Source: UKRI	Biotechnology and Biological Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United States Department of Education William D. Ford Program; Vietnamese Government Ph.D. scholarship; National Overseas Ph.D. scholarship from the Ministry of Social Justice and Empowerment, Government of India (New Delhi); Commonwealth (University of Cambridge) Scholarship; Commonwealth Scholarship Commission in the United Kingdom; Cambridge Trusts; Royal Society Wolfson Merit Award(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Research Council (BBSRC) Grants BB/I019227/1 (to A. W. M.) and BB/I019669/1 (to C. A.) underpinning this research program and supporting the research of A. J. C. and K. J. M. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Ph.D. studentship supported by funding from the United States Department of Education William D. Ford Program.r Recipient of a Vietnamese Government Ph.D. scholarship.r Recipient of a National Overseas Ph.D. scholarship from the Ministry of Social Justice and Empowerment, Government of India (New Delhi).r Supported by a Commonwealth (University of Cambridge) Scholarship, awarded jointly by the Commonwealth Scholarship Commission in the United Kingdom and the Cambridge Trusts.r Holder of a Royal Society Wolfson Merit Award.	Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Aoyama Y, 1998, J BIOCHEM-TOKYO, V124, P694; Banerjee S, 2012, INT J ANAL CHEM, V2012, DOI 10.1155/2012/282574; Belcher J, 2014, J BIOL CHEM, V289, P6535, DOI 10.1074/jbc.M113.527325; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Byrne ST, 2007, J MED MICROBIOL, V56, P1047, DOI 10.1099/jmm.0.47058-0; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Chenge J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26628; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cubrilovic D, 2013, ANAL CHEM, V85, P2724, DOI 10.1021/ac303197p; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Driscoll MD, 2011, BBA-PROTEINS PROTEOM, V1814, P76, DOI 10.1016/j.bbapap.2010.05.015; Duffell KM, 2013, ANAL CHEM, V85, P5707, DOI 10.1021/ac400236z; Dutton P L, 1978, Methods Enzymol, V54, P411; Esposito S, 2015, EXPERT OPIN PHARMACO, V16, P2319, DOI 10.1517/14656566.2015.1080240; Etienne G, 2005, MICROBIOL-SGM, V151, P2075, DOI 10.1099/mic.0.27869-0; Fernandez C., 2011, THESIS U NACL MAYOR; Green AJ, 2001, J BIOL INORG CHEM, V6, P523, DOI 10.1007/s007750100229; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Gustafsson MCU, 2004, BIOCHEMISTRY-US, V43, P5474, DOI 10.1021/bi035904m; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Hudson SA, 2014, CHEMBIOCHEM, V15, P549, DOI 10.1002/cbic.201300697; Hudson SA, 2013, CHEMMEDCHEM, V8, P1451, DOI 10.1002/cmdc.201300219; Hudson SA, 2012, ANGEW CHEM INT EDIT, V51, P9311, DOI 10.1002/anie.201202544; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; Kavanagh ME, 2016, J MED CHEM, V59, P3272, DOI 10.1021/acs.jmedchem.6b00007; Khatri Y, 2011, FEBS LETT, V585, P1506, DOI 10.1016/j.febslet.2011.04.035; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12410, DOI 10.1021/bi049132l; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; LIM HK, 1995, J MASS SPECTROM, V30, P708, DOI 10.1002/jms.1190300509; Lisurek M, 2010, MOL DIVERS, V14, P401, DOI 10.1007/s11030-009-9187-z; Loo JA, 1997, J AM SOC MASS SPECTR, V8, P234, DOI 10.1016/S1044-0305(96)00238-3; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lorenzen Kristina, 2010, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1712s62; Maple HJ, 2012, J MED CHEM, V55, P837, DOI 10.1021/jm201347k; Matsumoto M, 2007, CURR TOP MED CHEM, V7, P499, DOI 10.2174/156802607780059727; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCKNIGHT J, 1993, EUR J BIOCHEM, V213, P683, DOI 10.1111/j.1432-1033.1993.tb17808.x; McLean KJ, 2008, DRUG METAB REV, V40, P427, DOI 10.1080/03602530802186389 ; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Mukherjee P, 2014, CHEM SOC REV, V43, P6814, DOI 10.1039/c3cs60467e; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Nelson David R., 2009, Human Genomics, V4, P59; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Ouellet H, 2010, ARCH BIOCHEM BIOPHYS, V493, P82, DOI 10.1016/j.abb.2009.07.011; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; SIMPKIN D, 1989, BIOCHEMISTRY-US, V28, P8033, DOI 10.1021/bi00446a010; SLIGAR SG, 1976, BIOCHEMISTRY-US, V15, P5399, DOI 10.1021/bi00669a029; Sterling HJ, 2011, J AM SOC MASS SPECTR, V22, P1178, DOI 10.1007/s13361-011-0116-x; Tjernberg A, 2006, J BIOMOL SCREEN, V11, P131, DOI 10.1177/1087057105284218; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Warman AJ, 2012, FEBS J, V279, P1675, DOI 10.1111/j.1742-4658.2012.08543.x; WEBER C, 1987, P NATL ACAD SCI USA, V84, P6687, DOI 10.1073/pnas.84.19.6687; World Health Organization, 2015, GLOB TUB REP 2015; Zhu J, 2010, J MOL BIOL, V397, P835, DOI 10.1016/j.jmb.2010.01.041	73	11	11	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1310	1329		10.1074/jbc.M116.748822	http://dx.doi.org/10.1074/jbc.M116.748822			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27932461	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000393339800014
J	Gottier, P; Gonzalez-Salgado, A; Menon, AK; Liu, YC; Acosta-Serrano, A; Butikofer, P				Gottier, Petra; Gonzalez-Salgado, Amaia; Menon, Anant K.; Liu, Yuk-Chien; Acosta-Serrano, Alvaro; Butikofer, Peter			RFT1 Protein Affects Glycosylphosphatidylinositol (GPI) Anchor Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIANT SURFACE GLYCOPROTEIN; TRYPANOSOMA-BRUCEI OLIGOSACCHARYLTRANSFERASES; ACIDIC REPETITIVE PROTEIN; MEMBRANE; BIOSYNTHESIS; EXPRESSION; PROCYCLIN; IDENTIFICATION; PATHWAY; GLYCAN	The membrane protein RFT1 is essential for normal protein N- glycosylation, but its precise function is not known. RFT1 was originally proposed to translocate the glycolipid Man(5)GlcNAc(2)-PP-dolichol (needed to synthesize N-glycan precursors) across the endoplasmic reticulum membrane, but subsequent studies showed that it does not play a direct role in transport. In contrast to the situation in yeast, RFT1 is not essential for growth of the parasitic protozoan Trypanosoma brucei, enabling the study of its function in a null background. We now report that lack of T. brucei RFT1 (TbRFT1) not only affects protein N-glycosylation but also glycosylphosphatidylinositol (GPI) anchor side-chain modification. Analysis by immunoblotting, metabolic labeling, and mass spectrometry demonstrated that the major GPI-anchored proteins of T. brucei procyclic forms have truncated GPI anchor side chains in TbRFT1 null parasites when compared with wild-type cells, a defect that is corrected by expressing a tagged copy of TbRFT1 in the null background. In vivo and in vitro labeling experiments using radiolabeled GPI precursors showed that GPI underglycosylation was not the result of decreased formation of the GPI precursor lipid or defective galactosylation of GPI intermediates in the endoplasmic reticulum, but rather due to modifications that are expected to occur in the Golgi apparatus. Unexpectedly, immunofluorescence microscopy localized TbRFT1 to both the endoplasmic reticulum and the Golgi, consistent with the proposal that TbRFT1 plays a direct or indirect role in GPI anchor glycosylation in the Golgi apparatus. Our results implicate RFT1 in a wider range of glycosylation processes than previously appreciated.	[Gottier, Petra; Gonzalez-Salgado, Amaia; Butikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Gottier, Petra] Univ Bern, Grad Sch Cellular & Biochem Sci, CH-3012 Bern, Switzerland; [Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Liu, Yuk-Chien; Acosta-Serrano, Alvaro] Univ Liverpool Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Acosta-Serrano, Alvaro] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England	University of Bern; University of Bern; Cornell University; Liverpool School of Tropical Medicine; Liverpool School of Tropical Medicine	Butikofer, P (corresponding author), Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch	Acosta-Serrano, Alvaro/L-5503-2015; Menon, Anant/AAN-8663-2021	Acosta-Serrano, Alvaro/0000-0002-2576-7959; Menon, Anant/0000-0001-6924-2698	Swiss National Science Foundation [CRSII3_141913, 149353]; National Institutes of Health [R21NS093457]; GlycoPar-EU FP7 Marie Curie Initial Training Network Grant [GA. 608295]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS093457] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlycoPar-EU FP7 Marie Curie Initial Training Network Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by Swiss National Science Foundation Grants Sinergia CRSII3_141913 and 149353 (to P. B.), National Institutes of Health Grant R21NS093457 (to A. K. M.), and GlycoPar-EU FP7 Marie Curie Initial Training Network Grant GA. 608295 (to A. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Serrano A, 2004, EUKARYOT CELL, V3, P255, DOI 10.1128/EC.3.2.255-263.2004; Acosta-Serrano A, 1999, J BIOL CHEM, V274, P29763, DOI 10.1074/jbc.274.42.29763; Acosta-Serrano A, 2001, P NATL ACAD SCI USA, V98, P1513, DOI 10.1073/pnas.041611698; ALLEN G, 1982, J MOL BIOL, V157, P527, DOI 10.1016/0022-2836(82)90474-0; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Butikofer P, 1997, BIOCHEM J, V326, P415; Butikofer P, 1999, J CELL SCI, V112, P1785; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; CROSS GAM, 1977, AM J TROP MED HYG, V26, P240, DOI 10.4269/ajtmh.1977.26.240; Farine L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16787; Ferguson M. A. J., 1993, GLYCOBIOLOGY, P349; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1993, BIOCHEM J, V291, P51, DOI 10.1042/bj2910051; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FIELD MC, 1991, EMBO J, V10, P2731, DOI 10.1002/j.1460-2075.1991.tb07821.x; FIELD MC, 1991, J BIOL CHEM, V266, P8392; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Haeuptle MA, 2008, AM J HUM GENET, V82, P600, DOI 10.1016/j.ajhg.2007.12.021; Hall BS, 2005, EXP PARASITOL, V111, P160, DOI 10.1016/j.exppara.2005.07.005; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hong Y, 2009, KOREAN J PARASITOL, V47, P197, DOI 10.3347/kjp.2009.47.3.197; Hwa KY, 1999, GLYCOBIOLOGY, V9, P181, DOI 10.1093/glycob/9.2.181; Izquierdo L, 2009, MOL MICROBIOL, V71, P478, DOI 10.1111/j.1365-2958.2008.06542.x; Izquierdo L, 2015, GLYCOBIOLOGY, V25, P438, DOI 10.1093/glycob/cwu131; Izquierdo L, 2012, GLYCOBIOLOGY, V22, P696, DOI 10.1093/glycob/cws003; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Jelk J, 2013, J BIOL CHEM, V288, P20616, DOI 10.1074/jbc.M113.479642; KOERTE A, 1995, J BIOL CHEM, V270, P22556, DOI 10.1074/jbc.270.38.22556; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Leal S, 2004, J BIOL CHEM, V279, P28979, DOI 10.1074/jbc.M403479200; Liu L, 2013, J BIOL CHEM, V288, P10599, DOI 10.1074/jbc.M113.453597; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Martin KL, 2006, BIOCHEM J, V396, P287, DOI 10.1042/BJ20051825; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MAYOR S, 1992, J BIOL CHEM, V267, P754; MBAWA ZR, 1992, EUR J BIOCHEM, V204, P371, DOI 10.1111/j.1432-1033.1992.tb16646.x; MOWATT MR, 1988, MOL CELL BIOL, V8, P4055, DOI 10.1128/MCB.8.10.4055; Nakanishi M, 2014, PARASITOL INT, V63, P513, DOI 10.1016/j.parint.2014.01.007; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; RODITI I, 1987, NATURE, V325, P272, DOI 10.1038/325272a0; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; Rush JS, 2009, J BIOL CHEM, V284, P19835, DOI 10.1074/jbc.M109.000893; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Vassella E, 2000, GENE DEV, V14, P615	49	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1103	1111		10.1074/jbc.M116.758367	http://dx.doi.org/10.1074/jbc.M116.758367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27927990	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000392318700029
J	Liao, SH; Hu, HQ; Wang, T; Tu, XM; Li, ZY				Liao, Shanhui; Hu, Huiqing; Wang, Tao; Tu, Xiaoming; Li, Ziyin			The Protein Neddylation Pathway in Trypanosoma brucei FUNCTIONAL CHARACTERIZATION AND SUBSTRATE IDENTIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATTACHMENT ZONE FILAMENT; UBIQUITIN-LIKE PROTEIN; FLAGELLUM ATTACHMENT; CELL-CYCLE; CENTROSOME DUPLICATION; MODIFIER NEDD8; IN-VIVO; COMPLEX; LIGASE; CDT1	Protein posttranslational modifications such as neddylation play crucial roles in regulating protein function. Only a few neddylated substrates have been validated to date, and the role of neddylation remains poorly understood. Here, using Trypanosoma brucei as the model organism, we investigated the function and substrates of TbNedd8. TbNedd8 is distributed throughout the cytosol but enriched in the nucleus and the flagellum. Depletion of TbNedd8 by RNAi abolished global protein ubiquitination, caused DNA re-replication in postmitotic cells, impaired spindle assembly, and compromised the flagellum attachment zone filament, leading to flagellum detachment. Through affinity purification and mass spectrometry, we identified 70 TbNedd8-conjugated and -associated proteins, including known Nedd8-conjugated and -associated proteins, putative TbNedd8 conjugation system enzymes, proteins of diverse biological functions, and proteins of unknown function. Finally, we validated six Cullins as bona fide TbNedd8 substrates and identified the TbNedd8 conjugation site in three Cullins. This work lays the foundation for understanding the roles of protein neddylation in this early divergent parasitic protozoan.	[Liao, Shanhui; Tu, Xiaoming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Liao, Shanhui; Hu, Huiqing; Wang, Tao; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Wang, Tao] Chinese Acad Sci, High Field Magnet Lab, Hefei 230031, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Texas System; University of Texas Health Science Center Houston; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Tu, XM (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.; Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	xmtu@ustc.edu.cn; ziyin.li@uth.tmc.edu	Liao, Shanhui/N-1628-2018; Tu, Xiaoming/G-5090-2018	Liao, Shanhui/0000-0002-5083-667X; Li, Ziyin/0000-0002-3960-9716	National Natural Science Foundation of China [31270780, U1332137, 21272090, 31500601]; Fundamental Research Funds for the Central Universities [WK2070000020]; National Institutes of Health [R01AI101437, R01AI118736]; Chinese Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118736, R01AI101437] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China Grants 31270780, U1332137, and 21272090 (to X. T.) and 31500601 (to S. L.), Fundamental Research Funds for the Central Universities Grant WK2070000020 (to X. T.), and National Institutes of Health Grants R01AI101437 and R01AI118736 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by a scholarship from the Chinese Scholarship Council.	Dang HQ, 2011, J BIOL CHEM, V286, P32424, DOI 10.1074/jbc.M111.240143; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Hu HQ, 2012, J CELL SCI, V125, P4126, DOI 10.1242/jcs.106534; Hu L, 2012, MOL MICROBIOL, V83, P565, DOI 10.1111/j.1365-2958.2011.07951.x; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Koopmann R, 2009, AUTOPHAGY, V5, P1085, DOI 10.4161/auto.5.8.9611; Korzeniewski N, 2009, CANCER RES, V69, P6668, DOI 10.1158/0008-5472.CAN-09-1284; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Laplaza JM, 2004, BIOCHEM J, V377, P459, DOI 10.1042/BJ20030755; Li FJ, 2012, CELL MICROBIOL, V14, P1242, DOI 10.1111/j.1462-5822.2012.01795.x; Li TW, 2006, ARCH BIOCHEM BIOPHYS, V453, P70, DOI 10.1016/j.abb.2006.03.002; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EXP CELL RES, V312, P3504, DOI 10.1016/j.yexcr.2006.07.022; Li ZY, 2012, EUKARYOT CELL, V11, P1180, DOI 10.1128/EC.00145-12; Li ZY, 2002, J BIOL CHEM, V277, P42686, DOI 10.1074/jbc.M207183200; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liao SH, 2010, EXP CELL RES, V316, P704, DOI 10.1016/j.yexcr.2009.12.017; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Liu Y, 2013, MOL MICROBIOL, V90, P130, DOI 10.1111/mmi.12352; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Mutomba MC, 1997, MOL BIOCHEM PARASIT, V90, P491, DOI 10.1016/S0166-6851(97)00197-7; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Norman JA, 2006, BIOCHEMISTRY-US, V45, P3014, DOI 10.1021/bi052435a; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rotureau B, 2014, J CELL SCI, V127, P204, DOI 10.1242/jcs.136424; SASSE R, 1988, J CELL SCI, V90, P577; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; Tiengwe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032674; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wojcik EJ, 2000, CURR BIOL, V10, P1131, DOI 10.1016/S0960-9822(00)00703-X; Woods K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052846; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Zhang W, 2009, PROTEINS, V75, P781, DOI 10.1002/prot.22371; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	51	18	18	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1081	1091		10.1074/jbc.M116.766741	http://dx.doi.org/10.1074/jbc.M116.766741			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27956554	hybrid, Green Published			2022-12-28	WOS:000392318700027
J	Najjar, K; Erazo-Oliveras, A; Brock, DJ; Wang, TY; Pellois, JP				Najjar, Kristina; Erazo-Oliveras, Alfredo; Brock, Dakota J.; Wang, Ting-Yi; Pellois, Jean-Philippe			An L- to D-Amino Acid Conversion in an Endosomolytic Analog of the Cell- penetrating Peptide TAT Influences Proteolytic Stability, Endocytic Uptake, and Endosomal Escape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; INTRACELLULAR DELIVERY; LIVE CELLS; PROTEINS; MEMBRANE; RICH; MACROPINOCYTOSIS; INTERNALIZATION; PROTEOGLYCANS; BIOGENESIS	Cell-penetrating peptides (CPPs) are well established as delivery agents for otherwise cell-impermeable cargos. CPPs can also theoretically be used to modulate intracellular processes. However, their susceptibility to proteolytic degradation often limits their utility in these applications. Previous studies have explored the consequences for cellular uptake of converting the residues in CPPs from L-to D-stereochemistry, but conflicting results have been reported and specific steps en route to intracellular activity have not been explored. Here we use dimeric fluorescenceTATas a model CPP to explore the broader consequences of L-to D-stereochemical conversion. We show that inversion of chirality provides protease resistance without altering the overall mode of cellular entry, a process involving endocytic uptake followed by endosomal escape and cytosolic access. However, whereas inversion of chirality reduces endocytic uptake, the D-peptide, once in the endosome, is significantly more prone to escape than its L-counterpart. Moreover, the D-peptide is retained in the cytosol of cells for several days, whereas the L-peptide is degraded within hours. Notably, while the L-peptide is relatively innocuous to cells, the D-peptide exerts a prolonged antiproliferative activity. Together, our results establish connections between chirality, protease resistance, cellular penetration, and intracellular activity that may be useful for the development of future delivery agents with improved properties.	[Najjar, Kristina; Erazo-Oliveras, Alfredo; Brock, Dakota J.; Wang, Ting-Yi; Pellois, Jean-Philippe] Texas A&M Univ, Dept Biochem & Biophys, Biochem & Biophys Bldg,Rm 430,300 Olsen Blvd, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Pellois, JP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, Biochem & Biophys Bldg,Rm 430,300 Olsen Blvd, College Stn, TX 77843 USA.; Pellois, JP (corresponding author), Texas A&M Univ, Dept Chem, Biochem & Biophys Bldg,Rm 430,300 Olsen Blvd, College Stn, TX 77843 USA.	pellois@tamu.edu		Pellois, Jean-Philippe/0000-0001-8528-4652; Brock, Dakota/0000-0002-7115-6876; Wang, Ting-Yi/0000-0001-5536-925X	National Institutes of Health [R01GM110137]; Cancer Prevention and Research Institute of Texas [RP100819]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This article was supported by National Institutes of Health Grant R01GM110137 and Cancer Prevention and Research Institute of Texas Grant RP100819. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Colpitts TM, 2007, VIROLOGY, V369, P78, DOI 10.1016/j.virol.2007.07.012; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Elmquist A, 2003, BIOL CHEM, V384, P387, DOI 10.1515/BC.2003.044; Erazo-Oliveras A, 2016, CELL CHEM BIOL, V23, P598, DOI 10.1016/j.chembiol.2016.03.016; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2001, BIOL CHEM, V382, P483, DOI 10.1515/BC.2001.059; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Lee YJ, 2008, J AM CHEM SOC, V130, P2398, DOI 10.1021/ja7102026; Lindgren ME, 2004, BIOCHEM J, V377, P69, DOI 10.1042/BJ20030760; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Mueller J, 2008, BIOCONJUGATE CHEM, V19, P2363, DOI 10.1021/bc800194e; Munyendo WL, 2012, BIOMOLECULES, V2, P187, DOI 10.3390/biom2020187; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Palm C, 2007, BBA-BIOMEMBRANES, V1768, P1769, DOI 10.1016/j.bbamem.2007.03.029; Pan CY, 2010, MOL BIOL REP, V37, P2117, DOI 10.1007/s11033-009-9680-6; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Pujals S, 2007, BIOCHEM SOC T, V35, P794, DOI 10.1042/BST0350794; Pujals S, 2008, CHEMMEDCHEM, V3, P296, DOI 10.1002/cmdc.200700267; Rizzuti M, 2015, DRUG DISCOV TODAY, V20, P76, DOI 10.1016/j.drudis.2014.09.017; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968; Verdurmen WPR, 2011, CHEM BIOL, V18, P1000, DOI 10.1016/j.chembiol.2011.06.006; VIDARD L, 1991, J IMMUNOL, V147, P1786; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Youngblood DS, 2007, BIOCONJUGATE CHEM, V18, P50, DOI 10.1021/bc060138s; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	44	48	48	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					847	861		10.1074/jbc.M116.759837	http://dx.doi.org/10.1074/jbc.M116.759837			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27923812	Green Published, hybrid			2022-12-28	WOS:000392318700008
J	Rathore, S; Dass, S; Kandari, D; Kaur, I; Gupta, M; Sharma, YD				Rathore, Sumit; Dass, Sheena; Kandari, Divya; Kaur, Inderjeet; Gupta, Mayank; Sharma, Yagya D.			Basigin Interacts with Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 as a Second Erythrocyte Receptor to Promote Parasite Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURALLY ACQUIRED ANTIBODIES; PROTEIN-PROTEIN INTERACTIONS; MEROZOITE SURFACE PROTEIN-1; RED-BLOOD-CELLS; GLYCOPHORIN-A; BINDING LIGAND; SIALIC-ACID; INVASION; MALARIA; FALCIPARUM	Elucidating the molecular mechanisms of the host-parasite interaction during red cell invasion by Plasmodium is important for developing newer antimalarial therapeutics. Recently, we have characterized a Plasmodium vivax tryptophan-rich antigen PvTRAg38, which is expressed by its merozoites, binds to host erythrocytes, and interferes with parasite growth. Interaction of this parasite ligand with the host erythrocyte occurs through its two regions present at amino acid positions 167-178 (P-2) and 197-208 (P-4). Each region recognizes its own erythrocyte receptor. Previously, we identified band 3 as the chymotrypsin-sensitive erythrocyte receptor for the P-4 region, but the other receptor, binding to P-2 region, remained unknown. Here, we have identified basigin as the second erythrocyte receptor for PvTRAg38, which is resistant to chymotrypsin. The specificity of interaction between PvTRAg38 and basigin was confirmed by direct interaction where basigin was specifically recognized by P-2 and not by the P-4 region of this parasite ligand. Interaction between P-2 and basigin is stabilized through multiple amino acid residues, but Gly-171 and Leu-175 of P-2 were more critical. These two amino acids were also critical for parasite growth. Synthetic peptides P-2 and P-4 of PvTRAg38 interfered with the parasite growth independently but had an additive effect if combined together indicating involvement of both the receptors during red cell invasion. In conclusion, PvTRAg38 binds to two erythrocyte receptors basigin and band 3 through P-2 and P-4 regions, respectively, to facilitate parasite growth. This advancement in our knowledge on molecular mechanisms of host-parasite interaction can be exploited to develop therapeutics against P. vivax malaria.	[Rathore, Sumit; Dass, Sheena; Kandari, Divya; Sharma, Yagya D.] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Kaur, Inderjeet; Gupta, Mayank] Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi 110067, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Rathore, S; Sharma, YD (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	rathoresumit@gmail.com; ydsharma_aiims@yahoo.com		Kandari, Divya/0000-0002-9575-0263; Dass, Sheena/0000-0001-7694-8867; Kaur, Inderjeet/0000-0001-8778-1396	Indian Council of Medical Research [61/4/2012-BMS]; Department of Science and Technology-Indian National Science Academy INSPIRE Faculty Fellow Award from the Department of Science and Technology, Government of India [IFA12-LSBM42]; Department of Biotechnology, Government of India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology-Indian National Science Academy INSPIRE Faculty Fellow Award from the Department of Science and Technology, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by Indian Council of Medical Research Grant 61/4/2012-BMS and Department of Science and Technology-Indian National Science Academy INSPIRE Faculty Fellow Award IFA12-LSBM42 from the Department of Science and Technology, Government of India (to S. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of scholarships from the Department of Biotechnology, Government of India.	Abraham MJ, 2011, J COMPUT CHEM, V32, P2041, DOI 10.1002/jcc.21766; Alam MS, 2016, FEBS LETT, V590, P232, DOI 10.1002/1873-3468.12053; Alam MS, 2015, J BIOL CHEM, V290, P20257, DOI 10.1074/jbc.M115.644906; Bai Y, 2014, INT J MOL SCI, V15, P6356, DOI 10.3390/ijms15046356; Baldwin M, 2014, BBA-MOL CELL RES, V1843, P2855, DOI 10.1016/j.bbamcr.2014.08.008; Baldwin MR, 2015, BLOOD, V125, P2704, DOI 10.1182/blood-2014-11-611707; Bartholdson SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003031; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Chan ER, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003566; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Griffiths RE, 2012, AUTOPHAGY, V8, P1150, DOI 10.4161/auto.20648; Gunalan K, 2016, P NATL ACAD SCI USA, V113, P6271, DOI 10.1073/pnas.1606113113; Hostetler JB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004264; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu B, 2007, J AM CHEM SOC, V129, P12348, DOI 10.1021/ja072904r; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Mehndiratta S, 2013, J VECTOR DIS, V50, P71; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh S, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0103-4; Song F, 2011, ACTA BIOCH BIOPH SIN, V43, P900, DOI 10.1093/abbs/gmr060; SORETTE MP, 1991, BLOOD, V77, P628; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; Tyagi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151065; Tyagi RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050754; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Williams AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002991; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Zeeshan M, 2015, INFECT IMMUN, V83, P2018, DOI 10.1128/IAI.03095-14; Zeeshan M, 2015, J INFECT DIS, V211, P1111, DOI 10.1093/infdis/jiu558; Zeeshan M, 2013, J INFECT DIS, V207, P175, DOI 10.1093/infdis/jis650; Zenonos ZA, 2015, J EXP MED, V212, P1145, DOI 10.1084/jem.20150032; Zinzalla G, 2009, FUTURE MED CHEM, V1, P65, DOI [10.4155/fmc.09.12, 10.4155/FMC.09.12]	51	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					462	476		10.1074/jbc.M116.744367	http://dx.doi.org/10.1074/jbc.M116.744367			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27881677	Green Published, hybrid			2022-12-28	WOS:000392316100005
J	Coster, AD; Thorne, CA; Wu, LFN; Altschuler, SJ				Coster, Adam D.; Thorne, Curtis A.; Wu, Lani F.; Altschuler, Steven J.			Examining Crosstalk among Transforming Growth Factor beta, Bone Morphogenetic Protein, and Wnt Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL SIGNALING NETWORKS; TGF-BETA; EPITHELIAL-CELLS; SMAD1/5 PHOSPHORYLATION; CATENIN; TRANSCRIPTION; TRANSDUCTION; INFORMATION; COMPLEXES; BINDING	The integration of morphogenic signals by cells is not well understood. A growing body of literature suggests increasingly complex coupling among classically defined pathways. Given this apparent complexity, it is difficult to predict where, when, or even whether crosstalk occurs. Here, we investigated pairs of morphogenic pathways, previously reported to have multiple points of crosstalk, which either do not share (TGF beta and Wnt/beta-catenin) or share (TGF beta and bone morphogenetic protein (BMP)) core signaling components. Crosstalk was measured by the ability of one morphogenic pathway to cross-activate core transcription factors and/or target genes of another morphogenic pathway. In contrast to previous studies, we found a surprising absence of crosstalk between TGF beta and Wnt/beta-catenin. Further, we did not observe expected cross-pathway inhibition in between TGF beta and BMP, despite the fact that both use (or could compete) for the shared component SMAD4. Critical to our assays was a separation of timescales, which helped separate crosstalk due to initial signal transduction from subsequent post-transcriptional feedback events. Our study revealed fewer (and different) inter-morphogenic pathway crosstalk connections than expected; even pathways that share components can be insulated from one another.	[Coster, Adam D.; Thorne, Curtis A.; Wu, Lani F.; Altschuler, Steven J.] Univ Texas Southwestern Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Wu, Lani F.; Altschuler, Steven J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco	Wu, LFN; Altschuler, SJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.; Wu, LFN; Altschuler, SJ (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	Lani.Wu@ucsf.edu; Steven.Altschuler@ucsf.edu			Howard Hughes Medical Institute (HHMI) Medinto Grad (MIG) Scholars Program; Cancer Biology Training Grant [T32 CA124334]; American Cancer Society-Lakeshore Division Postdoctoral Fellowship; National Institute of Health [DK103126, GM112690, CA184984]; Institute of Computational Health Sciences (ICHS) at University of California, San Francisco; NATIONAL CANCER INSTITUTE [R01CA184984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK103126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112690] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI) Medinto Grad (MIG) Scholars Program; Cancer Biology Training Grant; American Cancer Society-Lakeshore Division Postdoctoral Fellowship; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Computational Health Sciences (ICHS) at University of California, San Francisco; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (HHMI) Medinto Grad (MIG) Scholars Program (to A. D. C.), Cancer Biology Training Grant T32 CA124334 (to C. A. T.), an American Cancer Society-Lakeshore Division Postdoctoral Fellowship (to C. A. T.), the National Institute of Health Grants DK103126 (to C. A. T.), GM112690 (to S. J. A.), and CA184984 (to L. F. W.), and the Institute of Computational Health Sciences (ICHS) at University of California, San Francisco (to S. J. A. and L. F. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Attisano Liliana, 2013, F1000Prime Rep, V5, P17, DOI 10.12703/P5-17; Candia AF, 1997, DEVELOPMENT, V124, P4467; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Coster AD, 2014, NAT METHODS, V11, P602, DOI 10.1038/nmeth.2971; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Freeman TJ, 2012, GASTROENTEROLOGY, V142, p[562, e2]; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Gronroos E, 2012, MOL CELL BIOL, V32, P2904, DOI 10.1128/MCB.00231-12; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Itasaki N, 2010, DEV DYNAM, V239, P16, DOI 10.1002/dvdy.22009; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Ku CJ, 2012, CELL, V149, P1073, DOI 10.1016/j.cell.2012.03.044; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Liu ZY, 2006, J BIOL CHEM, V281, P17156, DOI 10.1074/jbc.M513812200; Mamidi A, 2012, CELL DEATH DIFFER, V19, P1689, DOI 10.1038/cdd.2012.50; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Minoo P, 2010, INT J BIOCHEM CELL B, V42, P809, DOI 10.1016/j.biocel.2010.02.011; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Noselli S, 2000, SCIENCE, V290, P68, DOI 10.1126/science.290.5489.68; Oshimori N, 2012, CELL STEM CELL, V11, P751, DOI 10.1016/j.stem.2012.11.001; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; QUARONI A, 1978, P NATL ACAD SCI USA, V75, P5548, DOI 10.1073/pnas.75.11.5548; Rodriguez-Carballo E, 2011, J BONE MINER RES, V26, P718, DOI 10.1002/jbmr.260; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Song JF, 2014, P NATL ACAD SCI USA, V111, P7337, DOI 10.1073/pnas.1321764111; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang YQ, 2013, CELL REP, V3, P1607, DOI 10.1016/j.celrep.2013.04.009; Warmflash A, 2012, P NATL ACAD SCI USA, V109, pE1947, DOI 10.1073/pnas.1207607109; Warner D R, 2005, Orthod Craniofac Res, V8, P123; Warner DR, 2003, FEBS LETT, V539, P167, DOI 10.1016/S0014-5793(03)00155-8; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Zeng YA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003893; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zi ZK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000936; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22	62	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					244	250		10.1074/jbc.M116.759654	http://dx.doi.org/10.1074/jbc.M116.759654			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895117	Green Published, hybrid			2022-12-28	WOS:000391578000021
J	Iracheta-Vellve, A; Petrasek, J; Gyongyosi, B; Satishchandran, A; Lowe, P; Kodys, K; Catalano, D; Calenda, CD; Kurt-Jones, EA; Fitzgerald, KA; Szabo, G				Iracheta-Vellve, Arvin; Petrasek, Jan; Gyongyosi, Benedek; Satishchandran, Abhishek; Lowe, Patrick; Kodys, Karen; Catalano, Donna; Calenda, Charles D.; Kurt-Jones, Evelyn A.; Fitzgerald, Katherine A.; Szabo, Gyongyi			Endoplasmic Reticulum Stress-induced Hepatocellular Death Pathways Mediate Liver Injury and Fibrosis via Stimulator of Interferon Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; INNATE IMMUNITY; CARBON-TETRACHLORIDE; MOLECULAR-MECHANISMS; HEPATOCYTE APOPTOSIS; HEPATIC-FIBROSIS; DANGER SIGNALS; ER STRESS; RAT-LIVER; URIC-ACID	Fibrosis, driven by inflammation, marks the transition from benign to progressive stages of chronic liver diseases. Although inflammation promotes fibrogenesis, it is not known whether other events, such as hepatocyte death, are required for the development of fibrosis. Interferon regulatory factor 3 (IRF3) regulates hepatocyte apoptosis and production of type I IFNs. In the liver, IRF3 is activated via Toll-like receptor 4 (TLR4) signaling or the endoplasmic reticulum (ER) adapter, stimulator of interferon genes (STING). We hypothesized that IRF3-mediated hepatocyte death is an independent determinant of chemically induced liver fibrogenesis. To test this, we performed acute or chronic CCl4 administration to WT and IRF3-, Toll/Interleukin-1R (TIR) domain-containing adapter-inducing interferon-beta (TRIF)-, TRIF-related adaptor molecule (TRAM)-, and STING-deficient mice. We report that acute CCl4 administration to WT mice resulted in early ER stress, activation of IRF3, and type I IFNs, followed by hepatocyte apoptosis and liver injury, accompanied by liver fibrosis upon repeated administration of CCl4. Deficiency of IRF3 or STING prevented hepatocyte death and fibrosis both in acute or chronic CCl4. In contrast, mice deficient in type I IFN receptors or in TLR4 signaling adaptors, TRAM or TRIF, upstream of IRF3, were not protected from hepatocyte death and/or fibrosis, suggesting that the proapoptotic role of IRF3 is independent of TLR signaling in fibrosis. Hepatocyte death is required for liver fibrosis with causal involvement of STING and IRF3. Thus, our results identify that IRF3, by its association with STING in the presence of ER stress, couples hepatocyte apoptosis with liver fibrosis and indicate that innate immune signaling regulates outcomes of liver fibrosis via modulation of hepatocyte death in the liver.	[Iracheta-Vellve, Arvin; Petrasek, Jan; Gyongyosi, Benedek; Satishchandran, Abhishek; Lowe, Patrick; Kodys, Karen; Catalano, Donna; Calenda, Charles D.; Kurt-Jones, Evelyn A.; Fitzgerald, Katherine A.; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, LRB208,364 Plantat St, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, LRB208,364 Plantat St, Worcester, MA 01605 USA.	gyongyi.szabo@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Iracheta-Vellve, Arvin/K-6140-2014	Iracheta-Vellve, Arvin/0000-0002-6635-3904; Fitzgerald, Kate/0000-0003-3175-609X	National Institute on Alcohol Abuse and Alcoholism [AA017729, PA-12-149, F31AA025545]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA025545, R01AA020744, R01AA017729] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute on Alcohol Abuse and Alcoholism Grants AA017729 (to G. S.) and PA-12-149 (to A. I.-V.), and National Institute on Alcohol Abuse and Alcoholism Award F31AA025545 (to A. I.-V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chattopadhyay S, 2013, J VIROL, V87, P16, DOI 10.1128/JVI.01853-12; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deminice R, 2016, AMINO ACIDS, V48, P1983, DOI 10.1007/s00726-016-2183-6; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Hu FL, 2011, EUR J IMMUNOL, V41, P1086, DOI 10.1002/eji.201040831; Iracheta-Vellve A, 2015, J HEPATOL, V63, P1147, DOI 10.1016/j.jhep.2015.06.013; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Knockaert L, 2012, LAB INVEST, V92, P396, DOI 10.1038/labinvest.2011.193; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu YP, 2012, J IMMUNOL, V189, P4630, DOI 10.4049/jimmunol.1102737; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Petrasek J, 2015, J LEUKOCYTE BIOL, V98, P249, DOI 10.1189/jlb.3AB1214-590R; Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110; Petrasek J, 2011, HEPATOLOGY, V53, P649, DOI 10.1002/hep.24059; Plumb R, 2015, ELIFE, V4, DOI 10.7554/eLife.07426; Rivera CA, 2001, AM J PHYSIOL-GASTR L, V281, pG200, DOI 10.1152/ajpgi.2001.281.1.G200; Roh YS, 2014, HEPATOLOGY, V60, P237, DOI 10.1002/hep.26981; Roychowdhury S, 2012, ALCOHOL CLIN EXP RES, V36, P1139, DOI 10.1111/j.1530-0277.2011.01720.x; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Servant MJ, 2002, J INTERF CYTOK RES, V22, P49, DOI 10.1089/107999002753452656; Shi JL, 1998, AM J PATHOL, V153, P515, DOI 10.1016/S0002-9440(10)65594-0; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Soares JB, 2010, HEPATOL INT, V4, P659, DOI 10.1007/s12072-010-9219-x; Sun F, 2001, BBA-MOL BASIS DIS, V1535, P186, DOI 10.1016/S0925-4439(00)00098-3; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang X, 2011, CELL DEATH DIFFER, V18, P38, DOI 10.1038/cdd.2010.68; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Zakim D., 2002, HEPATOLOGY TXB LIVER, P746; Zhou Z, 2016, CELL MOL IMMUNOL, V13, P301, DOI 10.1038/cmi.2015.97	42	85	91	4	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26794	26805		10.1074/jbc.M116.736991	http://dx.doi.org/10.1074/jbc.M116.736991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27810900	Green Published, hybrid			2022-12-28	WOS:000391571400018
J	Niu, NN; Shao, R; Yan, G; Zou, WG				Niu, Ningning; Shao, Rui; Yan, Guang; Zou, Weiguo			Bromodomain and Extra-terminal (BET) Protein Inhibitors Suppress Chondrocyte Differentiation and Restrain Bone Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE-INHIBITION; THERAPEUTIC STRATEGY; STEM-CELLS; P-TEFB; CANCER; TRANSCRIPTION; BRD4; RESISTANCE; KINASE; MICE	Small molecule inhibitors for bromodomain and extra-terminal (BET) proteins have recently emerged as potential therapeutic agents in clinical trials for various cancers. However, to date, it is unknown whether these inhibitors have side effects on bone structures. Here, we report that inhibition of BET bromodomain proteins may suppress chondrocyte differentiation and restrain bone growth. We generated a luciferase reporter system using the chondrogenic cell line ATDC5 in which the luciferase gene was driven by the promoter of Col2a1, an elementary collagen of the chondrocyte. The Col2a1-luciferase ATDC5 system was used for rapidly screening both activators and repressors of human collagen Col2a1 gene expression, and we found that BET bromodomain inhibitors reduce the Col2a1-luciferase. Consistent with the luciferase assay, BET inhibitors decrease the expression of Col2a1. Furthermore, we constructed a zebrafish line in which the enhanced green fluorescent protein (EGFP) expression was driven by col2a1 promoter. The transgenic (col2a1-EGFP) zebrafish line demonstrated that BET inhibitors I-BET151 and (+)-JQ1 may affect EGFP expression in zebrafish. Furthermore, we found that I-BET151 and (+)-JQ1 may affect chondrocyte differentiation in vitro and inhibit zebrafish growth in vivo. Mechanistic analysis revealed that BET inhibitors influenced the depletion of RNA polymerase II from the Col2a1 promoter. Collectively, these results suggest that BET bromodomain inhibition may have side effects on skeletal bone structures.	[Niu, Ningning; Shao, Rui; Yan, Guang; Zou, Weiguo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol,Ctr Excellence Mol Cell S, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zou, WG (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, 320 Yue Yang Rd,SIBCB Bldg,Rm 1401, Shanghai 200031, Peoples R China.	zouwg94@sibcb.ac.cn		Yan, Guang/0000-0001-6784-0010	973 Program from the Chinese Ministry of Science and Technology [2015CB964503, 2014CB964704]; National Natural Science Foundation of China [31371463, 31501170]; National Science Fund for Excellent Young Scholars [81322027]	973 Program from the Chinese Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars	This work was supported in part by 973 Program from the Chinese Ministry of Science and Technology Grants 2015CB964503 and 2014CB964704 and National Natural Science Foundation of China Grants 31371463 and 31501170. The authors declare that they have no conflicts of interest with the contents of this article.; A scholar of the National 1000 Young Talents Program of China and the National Science Fund for Excellent Young Scholars (Grant 81322027). To whom correspondence should be addressed: Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue Yang Rd., SIBCB Bldg., Rm. 1401, Shanghai 200031, China. Tel.: 86-21-54921320; Fax: 86-21-54921279; E-mail: zouwg94@sibcb.ac.cn.	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bianco P, 1998, MATRIX BIOL, V17, P185, DOI 10.1016/S0945-053X(98)90057-9; Ceribelli M, 2014, P NATL ACAD SCI USA, V111, P11365, DOI 10.1073/pnas.1411701111; Chaidos A, 2014, BLOOD, V123, P697, DOI 10.1182/blood-2013-01-478420; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fenaroli F, 2014, ACS NANO, V8, P7014, DOI 10.1021/nn5019126; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; Fiskus W, 2014, MOL CANCER THER, V13, P2315, DOI 10.1158/1535-7163.MCT-14-0258; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Fu LL, 2015, ONCOTARGET, V6, P5501, DOI 10.18632/oncotarget.3551; Huang MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23770; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Kan A, 2009, ARTHRITIS RHEUM-US, V60, P3314, DOI 10.1002/art.24878; Korb E, 2015, NAT NEUROSCI, V18, P1464, DOI 10.1038/nn.4095; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamoureux F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4511; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Liu Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11149; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Montenegro RC, 2016, ONCOTARGET, V7, P43997, DOI 10.18632/oncotarget.9766; Park-Min KH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6418; Seghatoleslami MR, 1995, MATRIX BIOL, V14, P753, DOI 10.1016/S0945-053X(05)80018-6; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Sullivan JM, 2015, J EXP MED, V212, P1771, DOI 10.1084/jem.20151271; Tang YJ, 2014, NAT MED, V20, P732, DOI 10.1038/nm.3613; Wei X, 2016, J DENT RES, V95, P1221, DOI 10.1177/0022034516651823; Wein MN, 2012, P NATL ACAD SCI USA, V109, P8173, DOI 10.1073/pnas.1205848109; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yapp C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1053-7; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zhou G, 1998, J BIOL CHEM, V273, P14989, DOI 10.1074/jbc.273.24.14989	40	14	14	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26647	26657		10.1074/jbc.M116.749697	http://dx.doi.org/10.1074/jbc.M116.749697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27821592	Green Published, hybrid			2022-12-28	WOS:000391571400006
J	Wang, X; Jia, YY; Fei, C; Song, XM; Li, L				Wang, Xin; Jia, Yingying; Fei, Cong; Song, Xiaomin; Li, Lin			Activation/Proliferation-associated Protein 2 (Caprin-2) Positively Regulates CDK14/Cyclin Y-mediated Lipoprotein Receptor-related Protein 5 and 6 (LRP5/6) Constitutive Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; LRP6 PHOSPHORYLATION; BETA-CATENIN; WNT PATHWAY; STEM-CELLS; IDENTIFICATION; ACTIVATION; EXPRESSION; STABILIZATION; DROSOPHILA	Low-density lipoprotein receptor-related proteins 5 and 6 (LRP5/6) are co-receptors for Wnt ligands. Upon ligand binding, LRP5/6 undergo glycogen synthase kinase 3 (GSK3)/casein kinase I (CKI)-mediated phosphorylation at multiple PPP(S/T) P motifs in the intracellular domain, which is essential for canonical Wnt signal transduction. On the other hand, in the Wnt-off state, the mitosis-specific CDK14-Cyclin Y kinase complex phosphorylates Ser-1490 of LRP5/6 at G(2)/M, thereby priming the receptor for Wnt-induced phosphorylation. However, it remains unclear how CDK14/Cyclin Y is recruited to LRP5/6 and whether there are other cofactors involved in this process. Previously, we identified Caprin-2 as a positive regulator of canonical Wnt signaling by promoting GSK3-depedent LRP5/6 phosphorylation upon Wnt stimulation. Here we uncovered that Caprin-2 positively regulates constitutive LRP5/6 Ser-1490 phosphorylation by complexing with CDK14/Cyclin Y. Caprin-2-mediated LRP5/6 phosphorylation is cell cycle-dependent in a pattern similar to that of CDK14/Cyclin Y-dependent LRP5/6 phosphorylation. Moreover, knockdown of Caprin-2 disrupts not only the interaction between CDK14 and Cyclin Y but also the interaction between CDK14/Cyclin Y and LRP6. Overall, our findings revealed an unrecognized role of Caprin-2 in facilitating LRP5/6 constitutive phosphorylation at G(2)/M through forming a quaternary complex with CDK14, Cyclin Y, and LRP5/6.	[Wang, Xin; Jia, Yingying; Fei, Cong; Song, Xiaomin; Li, Lin] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Innovat Ctr Cell Signaling Network, State Key Lab Mol Biol,Inst Biochem & Cell Biol,S, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, XM; Li, L (corresponding author), Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Innovat Ctr Cell Signaling Network, State Key Lab Mol Biol,Inst Biochem & Cell Biol,S, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	li, li/HII-4157-2022; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022		National Natural Science Foundation of China [31530094, 31230044, 31100532]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000, XDA12010301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (Grants 31530094, 31230044 and 31100532) and the Strategic Priority Research Program of the Chinese Academy of Sciences (Grants XDB19000000 and XDA12010301). The authors declare that they have no conflicts of interest with the contents of this article.	Acebron SP, 2014, MOL CELL, V54, P663, DOI 10.1016/j.molcel.2014.04.014; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Ding Y, 2008, J CELL BIOL, V182, P865, DOI 10.1083/jcb.200803147; Feng Q, 2015, J CELL PHYSIOL, V230, P1170, DOI 10.1002/jcp.24853; Hadjihannas MV, 2012, EMBO REP, V13, P347, DOI 10.1038/embor.2012.12; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Huang YL, 2015, P NATL ACAD SCI USA, V112, P5732, DOI 10.1073/pnas.1423533112; Jiang M, 2009, FEBS LETT, V583, P2171, DOI 10.1016/j.febslet.2009.06.010; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Koch S, 2015, CELL, V163, P1225, DOI 10.1016/j.cell.2015.10.029; Li M, 2010, J BIOL CHEM, V285, P13397, DOI 10.1074/jbc.M109.083246; Liu DM, 2010, GENETICS, V184, P1025, DOI 10.1534/genetics.110.114017; Loren CE, 2009, DIFFERENTIATION, V77, P386, DOI 10.1016/j.diff.2008.11.003; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Miao HF, 2014, J BIOL CHEM, V289, P34104, DOI 10.1074/jbc.M114.591636; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Shiina N, 2010, J BIOL CHEM, V285, P24260, DOI 10.1074/jbc.M110.108944; Stolz A, 2015, EMBO REP, V16, P490, DOI 10.15252/embr.201439410; Stowers RS, 2000, DEV BIOL, V221, P23, DOI 10.1006/dbio.2000.9685; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Verkaar F, 2011, DRUG DISCOV TODAY, V16, P35, DOI 10.1016/j.drudis.2010.11.007; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yang T, 2001, GENE, V267, P165, DOI 10.1016/S0378-1119(01)00391-2; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zi ZZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005485	38	11	15	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26427	26434		10.1074/jbc.M116.744607	http://dx.doi.org/10.1074/jbc.M116.744607			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27821587	Green Published, hybrid			2022-12-28	WOS:000391568200016
J	Dunne, A; Carpenter, S; Brikos, C; Gray, P; Strelow, A; Wesche, H; Morrice, N; O'Neill, LAJ				Dunne, Aisling; Carpenter, Susan; Brikos, Constantinos; Gray, Pearl; Strelow, Astrid; Wesche, Holger; Morrice, Nick; O'Neill, Luke A. J.			IRAK1 and IRAK4 promote phosphorylation, ubiquitination, and degradation of MyD88 adaptor-like (Mal) (vol 285, pg 18276, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														O'Neill, Luke/0000-0002-4333-2748; dunne, aisling/0000-0002-2342-9518				Dunne A, 2010, J BIOL CHEM, V285, P18276, DOI 10.1074/jbc.M109.098137	1	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24802	24802		10.1074/jbc.A109.098137	http://dx.doi.org/10.1074/jbc.A109.098137			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27864528	Green Published, hybrid			2022-12-28	WOS:000388875500039
J	Ruel, L; Stambolic, V; Ali, A; Manoukian, AS; Woodgett, JR				Ruel, Laurent; Stambolic, Vuk; Ali, Adnan; Manoukian, Armen S.; Woodgett, James R.			RETRACTION: Regulation of the protein kinase activity of Shaggy(Zeste-white3) by components of the Wingless pathway in Drosophila cells and embryos (Retraction of Vol 274, Pg 21790, 1999)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797				Ruel L, 1999, J BIOL CHEM, V274, P21790, DOI 10.1074/jbc.274.31.21790	1	0	0	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23364	23364		10.1074/jbc.A116.121790	http://dx.doi.org/10.1074/jbc.A116.121790			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27825099	Green Published, hybrid			2022-12-28	WOS:000387224800043
J	Kaneko, S; Feldman, RI; Yu, L; Wu, ZG; Gritsko, T; Shelley, SA; Nicosia, SV; Nobori, T; Cheng, JQ				Kaneko, Satoshi; Feldman, Richard I.; Yu, Lu; Wu, Zhenguo; Gritsko, Tatiana; Shelley, Sue A.; Nicosia, Santo V.; Nobori, Tsutomu; Cheng, Jin Q.			Positive feedback regulation between Akt2 and MyoD during muscle differentiation. CLONING OF Akt2 PROMOTER (vol 277, pg 23230, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Wu, Zhenguo/AAB-8679-2021					Kaneko S, 2002, J BIOL CHEM, V277, P23230, DOI 10.1074/jbc.M201733200	1	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22850	22850		10.1074/jbc.A116.201733	http://dx.doi.org/10.1074/jbc.A116.201733			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825088	Green Published, hybrid			2022-12-28	WOS:000386760600049
J	Munkacsi, AB; Hammond, N; Schneider, RT; Senanayake, DS; Higaki, K; Lagutin, K; Bloor, SJ; Ory, DS; Maue, RA; Chen, FW; Hernandez-Ono, A; Dahlson, N; Repa, JJ; Ginsberg, HN; Ioannou, YA; Sturleyj, SL				Munkacsi, Andrew B.; Hammond, Natalie; Schneider, Remy T.; Senanayake, Dinindu S.; Higaki, Katsumi; Lagutin, Kirill; Bloor, Stephen J.; Ory, Daniel S.; Maue, Robert A.; Chen, Fannie W.; Hernandez-Ono, Antonio; Dahlson, Nicole; Repa, Joyce J.; Ginsberg, Henry N.; Ioannou, Yiannis A.; Sturleyj, Stephen L.			Normalization of Hepatic Homeostasis in the Npc1(nmf164) Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL ACCUMULATION; FATTY-ACIDS; LIVER; GENE; EXPRESSION; TARGET; MURINE; BIOMARKERS; SECRETION; DATABASE	Niemann-Pick type C (NP-C) disease is a fatal genetic lipidosis for which there is no Food and Drug Administration (FDA)approved therapy. Vorinostat, an FDA-approved inhibitor of histone deacetylases, ameliorates lysosomal lipid accumulation in cultured NP-C patient fibroblasts. To assess the therapeutic potential of histone deacetylase inhibition, we pursued these in vitro observations in two murine models of NP-C disease. Npc1(nmf164) mice, which express a missense mutation in the Npc1 gene, were treated intraperitoneally, from weaning, with the maximum tolerated dose of vorinostat (150 mg/kg, 5 days/week). Disease progression was measured via gene expression, liver function and pathology, serum and tissue lipid levels, body weight, and life span. Transcriptome analyses of treated livers indicated multiple changes consistent with reversal of liver dysfunction that typifies NP-C disease. Significant improvements in liver pathology and function were achieved by this treatment regimen; however, NPC1 protein maturation and levels, disease progression, weight loss, and animal morbidity were not detectably altered. Vorinostat concentrations were > 200 mu M in the plasma compartment of treated animals but were almost 100fold lower in brain tissue. Apolipoprotein B metabolism and the expression of key components of lipid homeostasis in primary hepatocytes from null (Npc1(-/-)) and missense (Npc1(nmf164)) mutant mice were altered by vorinostat treatment, consistent with a response by these cells independent of the status of the Npc1 locus. These results suggest that HDAC inhibitors have utility to treat visceral NP-C disease. However, it is clear that improved blood-brain barrier penetration will be required to alleviate the neurological symptoms of human NP-C disease.	[Munkacsi, Andrew B.; Hammond, Natalie; Schneider, Remy T.; Senanayake, Dinindu S.] Victoria Univ Wellington, Sch Biol Sci, Alan MacDiarmid Bldg,Rm 322, Wellington 6012, New Zealand; [Munkacsi, Andrew B.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington 6012, New Zealand; [Higaki, Katsumi] Tottori Univ, Res Ctr Biosci & Technol, Div Funct Genom, Yonago, Tottori 6838503, Japan; [Lagutin, Kirill; Bloor, Stephen J.] Callaghan Innovat, Lower Hutt 5040, New Zealand; [Ory, Daniel S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Maue, Robert A.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Hanover, NH 03755 USA; [Maue, Robert A.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Chen, Fannie W.; Ioannou, Yiannis A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Dahlson, Nicole; Repa, Joyce J.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Dahlson, Nicole; Repa, Joyce J.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Ginsberg, Henry N.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Sturleyj, Stephen L.] Columbia Univ, Dept Genet & Dev, Med Ctr, 630 W 168th St, New York, NY 10032 USA	Victoria University Wellington; Victoria University Wellington; Tottori University; Callaghan Innovation; Washington University (WUSTL); Dartmouth College; Dartmouth College; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; Columbia University	Munkacsi, AB (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Alan MacDiarmid Bldg,Rm 322, Wellington 6012, New Zealand.; Sturleyj, SL (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, 630 W 168th St, New York, NY 10032 USA.	andrew.munkacsi@vuw.ac.nz; sls37@columbia.edu		Lagutin, Kirill/0000-0001-5276-844X; Repa, Joyce/0000-0001-5740-1954; Munkacsi, Andrew/0000-0003-3033-395X	Ara Parseghian Medical Research Foundation; Dana's Angels Research Trust; National Institutes of Health [DK54320, DK082712, NS092653, HL55638]; Victoria University of Wellington University Research Fund; Ministry of Education, Culture, Science, Sports, and Technology of Japan [20790728];  [T32 HL07343]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090260] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK082712, R01DK054320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092653] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17K10051] Funding Source: KAKEN	Ara Parseghian Medical Research Foundation; Dana's Angels Research Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victoria University of Wellington University Research Fund; Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ara Parseghian Medical Research Foundation (to S. L. S. and J. J. R.) and Dana's Angels Research Trust (to S. L. S.) and by National Institutes of Health Grants DK54320 (to S. L. S.), DK082712 (to Y. A. I.), NS092653 (to D. S. O.), and HL55638 (to H. N. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported as a Peter Pentchev Research Fellow of the National Niemann-Pick Disease Foundation, a Senior Fellow in Biomedical Sciences of the Charles Revson Foundation, and a National Institutes of Health Postdoctoral Fellow in Arteriosclerosis (Grant T32 HL07343) and recipient of support from the Victoria University of Wellington University Research Fund. To whom correspondence may be addressed: School of Biological Sciences, Victoria University of Wellington, Alan MacDiarmid Bldg., Rm. 322, Wellington 6012, NewZealand. Tel.: 64-463-5171; Fax: 64-463-5331; E-mail: andrew.munkacsi@vuw.ac.nz.; Supported by Ministry of Education, Culture, Science, Sports, and Technology of Japan Grant 20790728.	Alam MS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9407; Alam MS, 2014, J BIOL CHEM, V289, P8051, DOI 10.1074/jbc.M113.526392; Alam MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048273; Aqul A, 2011, J NEUROSCI, V31, P9404, DOI 10.1523/JNEUROSCI.1317-11.2011; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Butovich IA, 2009, J LIPID RES, V50, P501, DOI 10.1194/jlr.M800426-JLR200; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Chuang JC, 2008, MOL ENDOCRINOL, V22, P2353, DOI 10.1210/me.2007-0568; Claerhout S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024662; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Conlon DM, 2016, J CLIN INVEST, V126, P3852, DOI 10.1172/JCI86028; Davidson CD, 2016, ANN CLIN TRANSL NEUR, V3, P366, DOI 10.1002/acn3.306; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; DIXON JL, 1991, J BIOL CHEM, V266, P5080; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fan M, 2013, J LIPID RES, V54, P2800, DOI 10.1194/jlr.M040618; Garver WS, 2007, AM J MED GENET A, V143A, P1204, DOI 10.1002/ajmg.a.31735; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Halsall JA, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0021-9; Han YP, 2013, J GASTROEN HEPATOL, V28, P49, DOI 10.1111/jgh.12016; Hanson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069964; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Kulinski A, 2007, J BIOL CHEM, V282, P1627, DOI 10.1074/jbc.M610001200; Li JZ, 2012, J CLIN INVEST, V122, P4130, DOI 10.1172/JCI65179; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Liu YB, 2013, TOXICOL LETT, V221, P23, DOI 10.1016/j.toxlet.2013.05.643; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lopez ME, 2013, DIS MODEL MECH, V6, P1089, DOI 10.1242/dmm.012385; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Munkacsi AB, 2007, FUTURE LIPIDOL, V2, P357, DOI 10.2217/17460875.2.3.357; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; Nunes MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053394; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Palmieri D, 2009, CLIN CANCER RES, V15, P6148, DOI 10.1158/1078-0432.CCR-09-1039; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Pontikis CC, 2013, J INHERIT METAB DIS, V36, P491, DOI 10.1007/s10545-012-9583-x; Praggastis M, 2015, J NEUROSCI, V35, P8091, DOI 10.1523/JNEUROSCI.4173-14.2015; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Runz H, 2008, HUM MUTAT, V29, P345, DOI 10.1002/humu.20636; Sandhu Punam, 2007, Drug Metab Lett, V1, P153, DOI 10.2174/187231207780363642; Sayre NL, 2010, J LIPID RES, V51, P2372, DOI 10.1194/jlr.M007211; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; Stampfer M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-35; Stimson L, 2009, CANCER LETT, V280, P177, DOI 10.1016/j.canlet.2009.03.016; Su L, 2010, ONCOGENE, V29, P4352, DOI 10.1038/onc.2010.204; Taylor AM, 2012, J LIPID RES, V53, P2331, DOI 10.1194/jlr.M028241; Tian J, 2016, P NATL ACAD SCI USA, V113, P8182, DOI 10.1073/pnas.1608987113; Van den Bossche J, 2014, BIOCHEM BIOPH RES CO, V455, P396, DOI 10.1016/j.bbrc.2014.11.029; Vance DE, 2009, J LIPID RES, V50, pS132, DOI 10.1194/jlr.R800048-JLR200; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; Wehrmann ZT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048561; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Yang H, 2015, NAT METHODS, V12, P841, DOI [10.1038/NMETH.3484, 10.1038/nmeth.3484]; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yu Y, 2010, GENOMICS, V96, P281, DOI 10.1016/j.ygeno.2010.08.003	74	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4395	4410		10.1074/jbc.M116.770578	http://dx.doi.org/10.1074/jbc.M116.770578			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28031458	hybrid, Green Published			2022-12-28	WOS:000397585100002
J	Jiang, C; Kawabe, H; Rotin, D				Jiang, Chong; Kawabe, Hiroshi; Rotin, Daniela			The Ubiquitin Ligase Nedd4L Regulates the Na/K/2Cl Co-transporter NKCC1/SLC12A2 in the Colon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; E3 ubiquitin ligase; epithelial sodium channel (ENaC); gene knockout; intestine; membrane transport; ubiquitin	EPITHELIAL NA+ CHANNEL; CELL-SURFACE EXPRESSION; CL-COTRANSPORTER; LIDDLE-SYNDROME; PY MOTIF; TRANSPORT; SUBUNITS; SODIUM; ENAC; HYPERTENSION	The ubiquitin ligase Nedd4-like (Nedd4L, or Nedd4-2) binds to and regulates stability of the epithelial Na+ channel (ENaC) in salt-absorbing epithelia in the kidney, lung, and other tissues. Its role in the distal colon, which also absorbs salt and fluid and expresses ENaC, is unknown. Using a conditional knock-out approach to knock out Nedd4L in mice intestinal epithelium (Nedd4L(f/f);Vil-Cre(ERT2)) we show here that Nedd4L depletion leads to a higher steady-state short circuit current (Isc) in mouse distal colon tissue relative to controls. This higher Isc was partially reduced by the addition of apical amiloride and strongly reduced by basolateral bumetanide as well as by depletion of basolateral Cl-, suggesting that Na+/K+/2Cl(-) (NKCC1/SLC12A2) co-transporter and ENaC are targets of Nedd4L in the colon. In accordance, NKCC1 (and ENaC) protein abundance in the colon of the Nedd4L knock-out animals was increased, indicating that Nedd4L normally suppresses these proteins. However, we did not observe co-immunoprecipitation between Nedd4L and NKCC1, suggesting that Nedd4L indirectly suppresses NKCC1 expression. Low salt diet resulted in a strong increase in and (but not ) ENaC mRNA and protein expression and ENaC activity. Although salt restriction also increased NKCC1 protein and mRNA abundance, it did not lead to its elevated activity (Isc). These results identify NKCC1 as a novel target for Nedd4L-mediated down-regulation in vivo, which modulates ion and fluid transport in the distal colon together with ENaC.	[Jiang, Chong; Rotin, Daniela] Hosp Sick Children, PGCRL 19-9715,686 Bay St, Toronto, ON M5G 0A4, Canada; [Jiang, Chong; Rotin, Daniela] Univ Toronto, Toronto, ON M5G 0A4, Canada; [Kawabe, Hiroshi] Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3D, D-37075 Gottingen, Germany	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Max Planck Society	Rotin, D (corresponding author), Hosp Sick Children, PGCRL 19-9715,686 Bay St, Toronto, ON M5G 0A4, Canada.	drotin@sickkids.ca	Kawabe, Hiroshi/U-7325-2018	Kawabe, Hiroshi/0000-0001-5650-8696	Canadian Institute of Health Research [CIHR MOP-130422]; Cystic Fibrosis Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada	This work was supported by the Canadian Institute of Health Research (CIHR MOP-130422) and by Cystic Fibrosis Canada (to D. R.). The authors declare that they have no conflict of interests with the content of this article.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Frindt G, 2008, J GEN PHYSIOL, V131, P617, DOI 10.1085/jgp.200809989; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lagnaz D, 2014, AM J PHYSIOL-RENAL, V307, pF275, DOI 10.1152/ajprenal.00574.2013; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Loffing J, 2000, AM J PHYSIOL-RENAL, V279, pF252, DOI 10.1152/ajprenal.2000.279.2.F252; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malsure S, 2014, J AM SOC NEPHROL, V25, P1453, DOI 10.1681/ASN.2013090936; Markadieu N, 2014, PFLUG ARCH EUR J PHY, V466, P91, DOI 10.1007/s00424-013-1370-5; No YR, 2014, J BIOL CHEM, V289, P18360, DOI 10.1074/jbc.M113.541706; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; Rotin D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00212; Roy A, 2015, J CLIN INVEST, V125, P3433, DOI 10.1172/JCI75245; Rozansky DJ, 2002, AM J PHYSIOL-RENAL, V283, pF105, DOI 10.1152/ajprenal.00176.2001; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Susa K, 2012, CLIN EXP NEPHROL, V16, P530, DOI 10.1007/s10157-012-0590-x; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Wu JJ, 2013, HUM GENET, V132, P179, DOI 10.1007/s00439-012-1238-3; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	36	18	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3137	3145		10.1074/jbc.M116.770065	http://dx.doi.org/10.1074/jbc.M116.770065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28087701	hybrid, Green Published			2022-12-28	WOS:000395538800007
J	Morgenstern, J; Fleming, T; Schumacher, D; Eckstein, V; Freichel, M; Herzig, S; Nawroth, P				Morgenstern, Jakob; Fleming, Thomas; Schumacher, Dagmar; Eckstein, Volker; Freichel, Marc; Herzig, Stephan; Nawroth, Peter			Loss of Glyoxalase 1 Induces Compensatory Mechanism to Achieve Dicarbonyl Detoxification in Mammalian Schwann Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell metabolism; CRISPR; Cas; diabetes; enzyme kinetics; glycation; toxicity; aldose reductase; diabetic neuropathy; glyoxalase system; methylglyoxal	GLYCATION END-PRODUCTS; ALDOSE REDUCTASE INHIBITOR; DIABETIC-NEUROPATHY; NITRIC-OXIDE; ENDOTHELIAL-CELLS; MASS-SPECTROMETRY; METHYLGLYOXAL; SYSTEM; COMPLICATIONS; PROTEINS	The glyoxalase system is a highly specific enzyme system existing in all mammalian cells that is responsible for the detoxification of dicarbonyl species, primarily methylglyoxal (MG). It has been implicated to play an essential role in preventing the increased formation of advanced glycation end products under certain pathological conditions. We have established the first glyoxalase 1 knock-out model (GLO1(-/-)) in mammalian Schwann cells using the CRISPR/Cas9 technique to investigate compensatory mechanisms. Neither elevated concentrations of MG nor associated protein modifications were observed in GLO1(-/-) cells. Alternative detoxification of MG in GLO1(-/-) is achieved by increased catalytic efficiency of aldose reductase toward hemithioacetal (product of glutathione and MG), which is most likely caused by S-nitrosylation of aldose reductase. The hemithioacetal is mainly converted into lactaldehyde, which is paralleled by a loss of reduced glutathione. Inhibition of aldose reductase in GLO1(-/-) cells is associated with an increased sensitivity against MG, elevated intracellular MG levels, associated modifications, as well as increased oxidative stress. Our data suggest that aldose reductase can compensate for the loss of GLO1. This might be of clinical importance within the context of neuronal diseases caused by an impaired glyoxalase system and elevated levels of dicarbonyl species, such as MG.	[Morgenstern, Jakob; Fleming, Thomas; Nawroth, Peter] Univ Heidelberg Hosp, Dept Internal Med & Clin Chem, Neuenheimer Feld 410, D-69120 Heidelberg, Germany; [Eckstein, Volker] Univ Heidelberg Hosp, Dept Med 5, Neuenheimer Feld 410, Heidelberg, Germany; [Schumacher, Dagmar; Freichel, Marc] Heidelberg Univ, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany; [Herzig, Stephan; Nawroth, Peter] German Inst Diabet & Canc IDC, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Fleming, Thomas; Herzig, Stephan; Nawroth, Peter] German Ctr Diabet Res DZD, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Morgenstern, J (corresponding author), Univ Heidelberg Hosp, Dept Internal Med & Clin Chem, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	jakob.morgenstern@med.uni-heidelberg.de		Morgenstern, Jakob/0000-0001-7227-8958	Deutsche Forschungsgemeinschaft [SFB1118]; GRK [1874-DIAMICOM]; DietmarHopp Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); GRK(German Research Foundation (DFG)); DietmarHopp Foundation	This work was supported in whole or part by Deutsche Forschungsgemeinschaft Grants SFB1118 and GRK 1874-DIAMICOM and The DietmarHopp Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Allaman I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00023; Baba SP, 2009, DIABETES, V58, P2486, DOI 10.2337/db09-0375; Baba SP, 2009, CHEM-BIOL INTERACT, V178, P250, DOI 10.1016/j.cbi.2008.11.007; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Beilin E, 2008, J PHARMACEUT BIOMED, V46, P316, DOI 10.1016/j.jpba.2007.10.022; Belanger M, 2011, J NEUROSCI, V31, P18338, DOI 10.1523/JNEUROSCI.1249-11.2011; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouwers O, 2011, J BIOL CHEM, V286, P1374, DOI 10.1074/jbc.M110.144097; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; CLELLAND JD, 1990, J LABELLED COMPD RAD, V28, P1455, DOI 10.1002/jlcr.2580281215; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Freeman OJ, 2016, DIABETES, V65, P228, DOI 10.2337/db15-0835; Giacco F, 2014, DIABETES, V63, P291, DOI 10.2337/db13-0316; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Hidmark A, 2014, EXP CLIN ENDOCR DIAB, V122, P201, DOI 10.1055/s-0034-1367023; Hu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087096; Izaguirre G, 1998, COMP BIOCHEM PHYS B, V119, P747, DOI 10.1016/S0305-0491(98)00051-0; Jack MM, 2011, DIABETOLOGIA, V54, P2174, DOI 10.1007/s00125-011-2196-3; Kaiserova K, 2008, J BIOL CHEM, V283, P9101, DOI 10.1074/jbc.M709671200; KERN TS, 1982, HISTOCHEM J, V14, P507, DOI 10.1007/BF01011860; KWON NS, 1994, FASEB J, V8, P529, DOI 10.1096/fasebj.8.8.8181671; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; MCLELLAN AC, 1989, MECH AGEING DEV, V48, P63, DOI 10.1016/0047-6374(89)90026-2; Mizisin Andrew P, 2014, Handb Clin Neurol, V126, P401, DOI 10.1016/B978-0-444-53480-4.00029-1; Peters AS, 2016, J VASC SURG, V64, P990, DOI 10.1016/j.jvs.2016.04.025; PHILLIPS SA, 1993, BIOCHEM PHARMACOL, V46, P805, DOI 10.1016/0006-2952(93)90488-I; Qu Z, 2014, J PROTEOME RES, V13, P3200, DOI 10.1021/pr401179v; Rabbani N, 2014, NAT PROTOC, V9, P1969, DOI 10.1038/nprot.2014.129; Rabbani N, 2014, DIABETES, V63, P50, DOI 10.2337/db13-1606; RAE C, 1990, EUR J BIOCHEM, V193, P83, DOI 10.1111/j.1432-1033.1990.tb19307.x; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ramirez MA, 2008, PHARMACOTHERAPY, V28, P646, DOI 10.1592/phco.28.5.646; Schemmel KE, 2010, J DIABETES COMPLICAT, V24, P354, DOI 10.1016/j.jdiacomp.2009.07.005; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Skapare E, 2013, J DIABETES COMPLICAT, V27, P262, DOI 10.1016/j.jdiacomp.2012.12.002; Srivastava S, 1999, BIOCHEMISTRY-US, V38, P42, DOI 10.1021/bi981794l; Su Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-134; Thornalley PJ, 2014, BBA-GEN SUBJECTS, V1840, P818, DOI 10.1016/j.bbagen.2013.03.025; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Turkseven Saadet, 2014, Journal of Basic and Clinical Physiology and Pharmacology, V25, P109, DOI 10.1515/jbcpp-2013-0095; Vander Jagt D. L., 1989, GLUTATHIONE CHEM B A, P598; Vander Jagt DL, 2003, CHEM-BIOL INTERACT, V143, P341, DOI 10.1016/S0009-2797(02)00212-0; Vander Jagt DL, 2001, CHEM-BIOL INTERACT, V130, P549, DOI 10.1016/S0009-2797(00)00298-2; VANDERJAGT DL, 1992, J BIOL CHEM, V267, P4364; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Wang TN, 2012, J AM CHEM SOC, V134, P8958, DOI 10.1021/ja301994d; Watabe, 2014, J MOL GENET MED S, VS1, P12; Xue MZ, 2016, DIABETES, V65, P2282, DOI 10.2337/db16-0153; Xue MZ, 2012, BIOCHEM J, V443, P213, DOI 10.1042/BJ20111648	62	52	53	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3224	3238		10.1074/jbc.M116.760132	http://dx.doi.org/10.1074/jbc.M116.760132			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	27956549	Green Published, hybrid			2022-12-28	WOS:000395538800015
J	Leech, CA; Kopp, RF; Nelson, HA; Nandi, J; Roe, MW				Leech, Colin A.; Kopp, Richard F.; Nelson, Heather A.; Nandi, Jyotirmoy; Roe, Michael W.			Stromal Interaction Molecule 1 (STIM1) Regulates ATP-sensitive Potassium (K-ATP) and Store-operated Ca2+ Channels in MIN6 beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFONYLUREA RECEPTOR 1; ENDOPLASMIC-RETICULUM; INSULIN-SECRETION; ION CHANNELS; INTRACELLULAR CA2+; SLOW OSCILLATIONS; TRPC CHANNELS; CALCIUM; ENTRY; ORAI1	Stromal interaction molecule 1 (STIM1) regulates store-operated Ca2+ entry (SOCE) and other ion channels either as an endoplasmic reticulum Ca2+-sensing protein or when present in the plasma membrane. However, the role of STIM1 in insul-insecreting beta-cells is unresolved. We report that lowering expression of STIM1, the gene that encodes STIM1, in insulin-secreting MIN6 beta-cells with RNA interference inhibits SOCE and ATP-sensitive K+ (KATP) channel activation. The effects of STIM1 knockdown were reversed by transduction of MIN6 cells with an adenovirus gene shuttle vector that expressed human STIM1. Immunoprecipitation studies revealed that STIM1 binds to nucleotide binding fold-1 (NBF1) of the sulfonylurea receptor 1 (SUR1) subunit of the K-ATP channel. Binding of STIM1 to SUR1 was enhanced by poly-lysine. Our data indicate that SOCE and K-ATP channel activity are regulated by STIM1. This suggests that STIM1 is a multifunctional signaling effector that participates in the control of membrane excitability and Ca2+ signaling events in beta-cells.	[Leech, Colin A.; Kopp, Richard F.; Nandi, Jyotirmoy; Roe, Michael W.] SUNY Upstate Med Univ, Dept Med, 505 Irving Ave, Syracuse, NY 13210 USA; [Nelson, Heather A.; Roe, Michael W.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Roe, MW (corresponding author), SUNY Upstate Med Univ, Dept Med, 505 Irving Ave, Syracuse, NY 13210 USA.	roem@upstate.edu		Nelson, Heather/0000-0002-4622-2923; Kopp, Richard/0000-0001-8190-1748	National Institutes of Health [R01DK074966, R01DK092616]; American Diabetes Association [1-12-BS-109]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074966, R01DK092616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK074966 (to M. W. R.) and R01DK092616 (to M. W. R.). This work was also supported by American Diabetes Association Research Grant 1-12-BS-109 (to C. A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health National Institutes of Health/NIDDK or the American Diabetes Association.	Ambily A, 2014, CELL SIGNAL, V26, P502, DOI 10.1016/j.cellsig.2013.11.025; Ambudkar IS, 2007, PFLUG ARCH EUR J PHY, V455, P187, DOI 10.1007/s00424-007-0252-0; Berna-Erro A, 2012, ADV EXP MED BIOL, V740, P349, DOI 10.1007/978-94-007-2888-2_15; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Carrillo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120431; Chang N, 2011, J BIOL CHEM, V286, P23308, DOI 10.1074/jbc.M111.217950; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Darbellay B, 2011, J CELL BIOL, V194, P335, DOI 10.1083/jcb.201012157; Dionisio N, 2015, BBA-MOL CELL RES, V1853, P1145, DOI 10.1016/j.bbamcr.2015.02.014; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; Enklaar T, 2010, ISLETS, V2, P337, DOI 10.4161/isl.2.5.13140; Furman B, 2010, ADV EXP MED BIOL, V654, P281, DOI 10.1007/978-90-481-3271-3_13; Gomez-Lagunas F, 2003, P NATL ACAD SCI USA, V100, P347, DOI 10.1073/pnas.0237122100; Harbeck Mark C, 2006, Sci STKE, V2006, ppl6, DOI 10.1126/stke.3532006pl6; Hartzell CA, 2016, ELIFE, V5, DOI 10.7554/eLife.14850; Harvey J, 2000, J PHYSIOL-LONDON, V527, P95, DOI 10.1111/j.1469-7793.2000.00095.x; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Hodeify R, 2015, J CELL SCI, V128, P3143, DOI 10.1242/jcs.172320; Hogan PG, 2015, CELL CALCIUM, V58, P357, DOI 10.1016/j.ceca.2015.07.001; Hooper R, 2013, PFLUG ARCH EUR J PHY, V465, P1383, DOI 10.1007/s00424-013-1270-8; Horinouchi T, 2012, BIOCHEM BIOPH RES CO, V428, P252, DOI 10.1016/j.bbrc.2012.10.034; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Huang YS, 2009, LASERS ELECTRO-OPT R, P1; Islam MS, 2011, ADV EXP MED BIOL, V704, P811, DOI 10.1007/978-94-007-0265-3_42; Jacobson D. A., 2007, V179, P409; Jairaman A, 2013, CHANNELS, V7, P402, DOI 10.4161/chan.25292; Jardin I, 2008, CHANNELS, V2, P401, DOI 10.4161/chan.2.6.7055; Kang YH, 2011, J BIOL CHEM, V286, P5876, DOI 10.1074/jbc.M109.089607; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Klein A, 2005, BRIT J PHARMACOL, V145, P907, DOI 10.1038/sj.bjp.0706252; Koriyama N, 2000, DIABETES, V49, P1830, DOI 10.2337/diabetes.49.11.1830; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Leech C. A., 2014, ISLETS OF LANGERHANS, P337; LEECH CA, 1994, ENDOCRINOLOGY, V135, P365, DOI 10.1210/en.135.1.365; Leech CA, 2011, PROG BIOPHYS MOL BIO, V107, P236, DOI 10.1016/j.pbiomolbio.2011.07.005; Liang T, 2014, J BIOL CHEM, V289, P6028, DOI 10.1074/jbc.M113.511808; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Liu WJ, 2013, MATH BIOSCI, V243, P240, DOI 10.1016/j.mbs.2013.03.004; Lopez JJ, 2016, BBA-MOL CELL RES, V1863, P2037, DOI 10.1016/j.bbamcr.2016.04.024; Maechler P, 1999, J BIOL CHEM, V274, P12583, DOI 10.1074/jbc.274.18.12583; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Marigo V, 2009, MOL CELL ENDOCRINOL, V299, P194, DOI 10.1016/j.mce.2008.11.011; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; Masia R, 2007, CHANNELS, V1, P315, DOI 10.4161/chan.5083; McNally BA, 2012, J PHYSIOL-LONDON, V590, P4179, DOI 10.1113/jphysiol.2012.233098; Mears D, 2004, J MEMBRANE BIOL, V197, P59, DOI 10.1007/s00232-003-0642-y; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Moccia F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00153; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Redondo PC, 2015, INT REV CEL MOL BIO, V316, P183, DOI 10.1016/bs.ircmb.2015.01.007; Ren JH, 2013, AM J PHYSIOL-ENDOC M, V305, pE805, DOI 10.1152/ajpendo.00046.2013; ROE MW, 1994, AM J PHYSIOL, V266, pE852, DOI 10.1152/ajpendo.1994.266.6.E852; Roe MW, 1998, J BIOL CHEM, V273, P10402, DOI 10.1074/jbc.273.17.10402; Saitoh N, 2011, J CELL BIOCHEM, V112, P147, DOI 10.1002/jcb.22910; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Sivaprasadarao A, 2007, BIOCHEM SOC T, V35, P1055, DOI 10.1042/BST0351055; SMITH PA, 1993, J GEN PHYSIOL, V101, P767, DOI 10.1085/jgp.101.5.767; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Tanahashi Y, 2016, J VET MED SCI, V78, P203, DOI 10.1292/jvms.15-0346; Tengholm A, 1999, J BIOL CHEM, V274, P36883, DOI 10.1074/jbc.274.52.36883; Tian G, 2012, J BIOL CHEM, V287, P9862, DOI 10.1074/jbc.M111.292854; Varadi A, 2002, DIABETES, V51, pS190, DOI 10.2337/diabetes.51.2007.S190; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wang Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1089; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; WORLEY JF, 1994, J BIOL CHEM, V269, P32055; Yang SN, 2014, CELL MOL LIFE SCI, V71, P4149, DOI 10.1007/s00018-014-1680-6; Yeung-Yam-Wah V, 2010, CELL CALCIUM, V47, P77, DOI 10.1016/j.ceca.2009.11.007; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	79	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2266	2277		10.1074/jbc.M116.767681	http://dx.doi.org/10.1074/jbc.M116.767681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28003364	Green Published, hybrid			2022-12-28	WOS:000395530300019
J	Fourati, Z; Ruza, RR; Laverty, D; Drege, E; Delarue-Cochin, S; Joseph, D; Koehl, P; Smart, T; Delarue, M				Fourati, Zaineb; Ruza, Reinis Reinholds; Laverty, Duncan; Drege, Emmanuelle; Delarue-Cochin, Sandrine; Joseph, Delphine; Koehl, Patrice; Smart, Trevor; Delarue, Marc			Barbiturates Bind in the GLIC Ion Channel Pore and Cause Inhibition by Stabilizing a Closed State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anesthesia; crystallography; electrophysiology; membrane protein; structural biology; x-ray crystallography; ligand-gated ion channels; barbiturates	NICOTINIC ACETYLCHOLINE-RECEPTOR; GLOEOBACTER-VIOLACEUS; GENERAL-ANESTHETICS; GABA(A) RECEPTORS; MECHANISM; PROPOFOL; BEAMLINE; CONFORMATION; SITES	Barbiturates induce anesthesia by modulating the activity of anionic and cationic pentameric ligand-gated ion channels (pLGICs). Despite more than a century of use in clinical practice, the prototypic binding site for this class of drugs within pLGICs is yet to be described. In this study, we present the first X-ray structures of barbiturates bound to GLIC, a cationic prokaryotic pLGIC with excellent structural homology to other relevant channels sensitive to general anesthetics and, as shown here, to barbiturates, at clinically relevant concentrations. Several derivatives of barbiturates containing anomalous scatterers were synthesized, and these derivatives helped us unambiguously identify a unique barbiturate binding site within the central ion channel pore in a closed conformation. In addition, docking calculations around the observed binding site for all three states of the receptor, including a model of the desensitized state, showed that barbiturates preferentially stabilize the closed state. The identification of this pore binding site sheds light on the mechanism of barbiturate inhibition of cationic pLGICs and allows the rationalization of several structural and functional features previously observed for barbiturates.	[Fourati, Zaineb; Ruza, Reinis Reinholds; Delarue, Marc] CNRS, UMR 3528, Inst Pasteur, Unite Dynam Struct Macromol, F-75015 Paris, France; [Laverty, Duncan; Smart, Trevor] UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England; [Drege, Emmanuelle; Delarue-Cochin, Sandrine; Joseph, Delphine] Univ Paris Sud, CNRS, UMR 8076, BioCIS,Fac Pharm, F-92296 Chatenay Malabry, France; [Koehl, Patrice] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis	Smart, T (corresponding author), UCL, Gower St, London WC1E 6BT, England.; Delarue, M (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75015 Paris, France.	t.smart@ucl.ac.uk; delarue@pasteur.fr		Ruza, Reinis/0000-0002-0509-3512; Fourati, Zaineb/0000-0002-2316-4142	'Agence Nationale de la Recherche' grant "Pentagate"; Medical Research Council [1068348] Funding Source: researchfish	'Agence Nationale de la Recherche' grant "Pentagate"(French National Research Agency (ANR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the 'Agence Nationale de la Recherche' grant "Pentagate" (to M.D. and D.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Arias HR, 2001, MOL PHARMACOL, V60, P497; Ascone I, 2007, AIP CONF PROC, V882, P872; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiara DC, 2014, BIOCHEMISTRY-US, V53, P135, DOI 10.1021/bi401492k; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; Dent JA, 2010, ADV EXP MED BIOL, V683, P11; Duran D., 2013, Journal of Physics: Conference Series, V425, DOI 10.1088/1742-6596/425/1/012005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Franks NP, 2015, ANESTHESIOLOGY, V122, P787, DOI 10.1097/ALN.0000000000000588; Gingrich KJ, 2009, J GEN PHYSIOL, V133, P171, DOI 10.1085/jgp.200810081; Gonzalez-Gutierrez G, 2013, P NATL ACAD SCI USA, V110, P18716, DOI 10.1073/pnas.1313156110; Hadipour-Jahromy M, 2003, EUR J PHARMACOL, V477, P81, DOI 10.1016/j.ejphar.2003.08.017; Hamouda AK, 2014, MOL PHARMACOL, V85, P735, DOI 10.1124/mol.113.090985; Jenkins A, 1996, BRIT J PHARMACOL, V117, P1507, DOI 10.1111/j.1476-5381.1996.tb15314.x; Johnson WD, 2012, J PHARMACOL EXP THER, V340, P445, DOI 10.1124/jpet.111.188037; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Laurent B, 2016, STRUCTURE, V24, P595, DOI 10.1016/j.str.2016.02.014; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Lehmann H E, 1972, Curr Psychiatr Ther, V12, P70; Loscher W, 2012, EPILEPSIA, V53, P12, DOI 10.1111/epi.12025; Lopez-Munoz Francisco, 2005, Neuropsychiatr Dis Treat, V1, P329; Lopez-Munoz Francisco, 2005, Ann Clin Psychiatry, V17, P113, DOI 10.1080/10401230591002002; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Murphy JA, 2007, ORG LETT, V9, P3233, DOI 10.1021/ol071049d; Nardou R, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00016; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Oakley S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032070; OLSEN RW, 1986, LIFE SCI, V39, P1969, DOI 10.1016/0024-3205(86)90320-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Sauguet L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149795; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Schober A, 2010, BRIT J PHARMACOL, V161, P365, DOI 10.1111/j.1476-5381.2010.00886.x; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YOST CS, 1993, CELL MOL NEUROBIOL, V13, P159, DOI 10.1007/BF00735372; Zeller A., 2008, V182, P31, DOI 10.1007/978-3-540-74806-9_2; Zhou Cheng, 2012, World J Crit Care Med, V1, P80, DOI 10.5492/wjccm.v1.i3.80	49	15	15	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1550	1558		10.1074/jbc.M116.766964	http://dx.doi.org/10.1074/jbc.M116.766964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27986812	Green Published, hybrid			2022-12-28	WOS:000395515600002
J	Cole, DK; van den Berg, HA; Lloyd, A; Crowther, MD; Beck, K; Ekeruche-Makinde, J; Miles, JJ; Bulek, AM; Dolton, G; Schauenburg, AJ; Wall, A; Fuller, A; Clement, M; Laugel, B; Rizkallah, PJ; Wooldridge, L; Sewell, AK				Cole, David K.; van den Berg, Hugo A.; Lloyd, Angharad; Crowther, Michael D.; Beck, Konrad; Ekeruche-Makinde, Julia; Miles, John J.; Bulek, Anna M.; Dolton, Garry; Schauenburg, Andrea J.; Wall, Aaron; Fuller, Anna; Clement, Mathew; Laugel, Bruno; Rizkallah, Pierre J.; Wooldridge, Linda; Sewell, Andrew K.			Structural Mechanism Underpinning Cross-reactivity of a CD8(+) T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I; CARDIOVASCULAR TOXICITY; RECEPTOR RECOGNITION; ANTIGEN RECOGNITION; BETA-CELLS; AFFINITY; BINDING; TCR; SPECIFICITY	T-cell cross-reactivity is essential for effective immune surveillance but has also been implicated as a pathway to autoimmunity. Previous studies have demonstrated that T-cell receptors (TCRs) that focus on a minimal motif within the peptide are able to facilitate a high level of T-cell cross-reactivity. However, the structural database shows that most TCRs exhibit less focused antigen binding involving contact with more peptide residues. To further explore the structural features that allow the clonally expressed TCR to functionally engage with multiple peptide-major histocompatibility complexes (pMHCs), we examined the ILA1 CD8(+) T-cell clone that responds to a peptide sequence derived from human telomerase reverse transcriptase. The ILA1 TCR contacted its pMHC with a broad peptide binding footprint encompassing spatially distant peptide residues. Despite the lack of focused TCR-peptide binding, the ILA1 T-cell clone was still cross-reactive. Overall, the TCR-peptide contacts apparent in the structure correlated well with the level of degeneracy at different peptide positions. Thus, the ILA1 TCR was less tolerant of changes at peptide residues that were at, or adjacent to, key contact sites. This study provides new insights into the molecular mechanisms that control T-cell cross-reactivity with important implications for pathogen surveillance, autoimmunity, and transplant rejection.	[Cole, David K.; Lloyd, Angharad; Crowther, Michael D.; Ekeruche-Makinde, Julia; Miles, John J.; Bulek, Anna M.; Dolton, Garry; Schauenburg, Andrea J.; Wall, Aaron; Fuller, Anna; Clement, Mathew; Laugel, Bruno; Rizkallah, Pierre J.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Cole, David K.; Lloyd, Angharad; Crowther, Michael D.; Ekeruche-Makinde, Julia; Miles, John J.; Bulek, Anna M.; Dolton, Garry; Schauenburg, Andrea J.; Wall, Aaron; Fuller, Anna; Clement, Mathew; Laugel, Bruno; Rizkallah, Pierre J.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Syst Immun Res Inst, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [van den Berg, Hugo A.] Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; [Beck, Konrad] Cardiff Univ, Sch Dent, Heath Pk, Cardiff CF14 4XY, S Glam, Wales; [Miles, John J.] Queensland Inst Med Res, Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Miles, John J.] James Cook Univ, Cairns, Qld 4870, Australia; [Wooldridge, Linda] Univ Bristol, Fac Hlth Sci, Bristol BS8 1TD, Avon, England	Cardiff University; Cardiff University; University of Warwick; Cardiff University; QIMR Berghofer Medical Research Institute; James Cook University; University of Bristol	Cole, DK; Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.; Cole, DK; Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Syst Immun Res Inst, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	coledk@cf.ac.uk; sewellak@cf.ac.uk	Sewell, Andrew/GPT-4220-2022; Rizkallah, Pierre J/A-5367-2012; Miles, John J/ABC-1105-2020; Beck, Konrad/AAX-1351-2020	Sewell, Andrew/0000-0003-3194-3135; Rizkallah, Pierre J/0000-0002-9290-0369; Miles, John J/0000-0001-5506-6304; Beck, Konrad/0000-0001-5098-9484; Cole, David/0000-0003-0028-9396; Wooldridge, Linda/0000-0002-6213-347X; Makinde, Julia/0000-0002-9906-7437; Fuller, Anna/0000-0002-8655-6741; van den Berg, Hugo/0000-0002-8230-6227; Crowther, Michael Douglas/0000-0003-4765-2818	United Kingdom Biotechnology and Biological Sciences Research Council [BB/H001085/1]; Wellcome Trust [WT079848MA, WT095767]; Research Councils UK fellowship; BBSRC [BB/H001085/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Wellcome Trust [100327/Z/12/Z] Funding Source: researchfish; Health and Care Research Wales [HS-14-23] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Research Councils UK fellowship(UK Research & Innovation (UKRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Health and Care Research Wales	This work was supported in part by United Kingdom Biotechnology and Biological Sciences Research Council Grant BB/H001085/1 and Wellcome Trust Intermediate Clinical Fellowship WT079848MA (to L.W.). The authors declare that they have no conflicts of interest with the contents of this article.; A Wellcome Trust Research Career Development Fellow (Grant WT095767). To whom correspondence may be addressed. E-mail:coledk@cf.ac.uk.; Supported by a Research Councils UK fellowship.	Adams JJ, 2016, NAT IMMUNOL, V17, P87, DOI 10.1038/ni.3310; Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Bulek AM, 2012, J IMMUNOL METHODS, V382, P203, DOI 10.1016/j.jim.2012.06.007; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2007, PROTEINS, V67, P65, DOI 10.1002/prot.21176; Cole DK, 2016, J CLIN INVEST, V126, P2191, DOI 10.1172/JCI85679; Cole DK, 2014, J BIOL CHEM, V289, P628, DOI 10.1074/jbc.M113.522110; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DeLano W.L, PYMOL MOL GRAPHICS S; Ekeruche-Makinde J, 2013, BLOOD, V121, P1112, DOI 10.1182/blood-2012-06-437202; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282; Kloverpris HN, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0149-5; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Laugel B, 2007, EUR J IMMUNOL, V37, P905, DOI 10.1002/eji.200636718; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Madura F, 2015, EUR J IMMUNOL, V45, P584, DOI 10.1002/eji.201445114; Madura F, 2013, J BIOL CHEM, V288, P18766, DOI 10.1074/jbc.M113.464560; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melenhorst JJ, 2008, J IMMUNOL METHODS, V338, P31, DOI 10.1016/j.jim.2008.07.008; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Miles KM, 2011, MOL IMMUNOL, V48, P728, DOI 10.1016/j.molimm.2010.11.004; Motozono C, 2015, J BIOL CHEM, V290, P18924, DOI 10.1074/jbc.M114.622522; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Raman MCC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18851; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sethi DK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3623; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; van den Berg HA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00250; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480	50	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					802	813		10.1074/jbc.M116.741603	http://dx.doi.org/10.1074/jbc.M116.741603			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27903649	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000392318700004
J	Kilroy, G; Burk, DH; Floyd, ZE				Kilroy, Gail; Burk, David H.; Floyd, Z. Elizabeth			Siah2 Protein Mediates Early Events in Commitment to an Adipogenic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; BONE MORPHOGENETIC PROTEINS; EMBRYONIC STEM-CELLS; ADIPOSE-TISSUE; BETA-CATENIN; CANONICAL WNT; ADIPOCYTE DIFFERENTIATION; PREADIPOCYTE COMMITMENT; PROGENITOR CELLS; IN-VITRO	Adipose tissue expansion occurs by increasing the size of existing adipocytes or by increasing the number of adipocytes via adipogenesis. Adipose tissue dysfunction in obesity is associated with adipocyte hypertrophy and impaired adipogenesis. We recently demonstrated that deletion of the ubiquitin ligase Siah2 is associated with enlarged adipocytes in lean or obese mice. In this study, we find that adipogenesis is impaired in 3T3-L1 preadipocytes stably transfected with Siah2 shRNA and that overexpression of Siah2 in non-precursor fibroblasts promotes adipogenesis. In the 3T3-L1 model, loss of Siah2 is associated with sustained beta-catenin expression post-induction, but depletion of beta-catenin only partially restores PPAR gamma expression and adipocyte formation. Using wild-type and Siah2(-/-) adipose tissue and adipose stromal vascular cells, we observe that Siah2 influences the expression of several factors that control adipogenesis, including Wnt pathway genes, beta-catenin, Zfp432, and Bmp-4. Consistent with increased beta-catenin levels in shSiah2 preadipocytes, Wnt10b is elevated in Siah2(-/-) adipose tissue and remains elevated in Siah2(-/-) primary stromal cells after addition of the induction mixture. However, addition of BMP-4 to Siah2(-/-) stromal cells reduces Wnt10b expression, reduces Zfp521 protein levels, and increases expression of Zfp423, a transcriptional regulator of peroxisome proliferator-activated receptor gamma expression that controls commitment to adipogenesis and is repressed by Zfp521. These results indicate that Siah2 acts upstream of BMP-4 to regulate factors that control the commitment of adipocyte progenitors to an adipogenic pathway. Our findings reveal an essential role for Siah2 in the early events that signal undifferentiated progenitor cells to become mature adipocytes.	[Kilroy, Gail; Burk, David H.; Floyd, Z. Elizabeth] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Floyd, ZE (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	Elizabeth.Floyd@pbrc.edu	Floyd, Elizabeth/W-2758-2019; Floyd, Elizabeth/N-1962-2017; Burk, David/D-2056-2009	Floyd, Elizabeth/0000-0002-3002-6186; Floyd, Elizabeth/0000-0002-3002-6186; 	COBRE [NIH 8P20-GM103528]; NORC center grants from the National Institutes of Health [NIH 2P30-DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099625, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	COBRE; NORC center grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work used the Cell Biology and Bioimaging Core and the Genomics Core facilities at Pennington Biomedical Research Center, which are supported in part by COBRE (NIH 8P20-GM103528) and NORC (NIH 2P30-DK072476) center grants from the National Institutes of Health.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Addison WN, 2014, MOL CELL BIOL, V34, P3076, DOI 10.1128/MCB.00185-14; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Atkinson SP, 2012, STEM CELLS, V30, P1373, DOI 10.1002/stem.1113; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Buckley SM, 2012, CELL STEM CELL, V11, P783, DOI 10.1016/j.stem.2012.09.011; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Dani C, 1997, J CELL SCI, V110, P1279; Floyd ZE, 2003, DIABETES, V52, P308, DOI 10.2337/diabetes.52.2.308; Gao Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3656; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grunberg JR, 2014, J BIOL CHEM, V289, P6899, DOI 10.1074/jbc.M113.511964; Grundy SM, 2000, ENDOCRINE, V13, P155, DOI 10.1385/ENDO:13:2:155; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Gustafson B, 2013, DIABETES, V62, P2997, DOI 10.2337/db13-0473; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kilroy G, 2015, OBESITY, V23, P2223, DOI 10.1002/oby.21220; Kilroy G, 2012, ENDOCRINOLOGY, V153, P1206, DOI 10.1210/en.2011-1725; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Lundgren M, 2007, DIABETOLOGIA, V50, P625, DOI 10.1007/s00125-006-0572-1; Masserdotti G, 2010, J BIOL CHEM, V285, P30814, DOI 10.1074/jbc.M110.142869; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Moran-Crusio K, 2012, TRENDS IMMUNOL, V33, P357, DOI 10.1016/j.it.2012.01.009; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Naujokat C, 2007, STEM CELLS, V25, P2408, DOI 10.1634/stemcells.2007-0255; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Pal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065330; REDDI AH, 1993, J BONE MINER RES, V8, pS499; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746; Severe N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.217; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; STERN JS, 1972, LANCET, V2, P948; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Watanabe M, 2015, ELIFE, V4, DOI 10.7554/eLife.05615; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yu G, 2011, METHODS MOL BIOL, V702, P29, DOI 10.1007/978-1-61737-960-4_3	50	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27289	27297		10.1074/jbc.M116.744672	http://dx.doi.org/10.1074/jbc.M116.744672			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27864366	Green Published, hybrid			2022-12-28	WOS:000391576300026
J	Zhang, D; Goldberg, MV; Chiu, ML				Zhang, Di; Goldberg, Monica V.; Chiu, Mark L.			Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA RECEPTOR ENGAGEMENT; MONOCLONAL-ANTIBODY; CANCER-IMMUNOTHERAPY; ANTITUMOR ACTIVITIES; TUMOR-IMMUNITY; TNF RECEPTOR; KAPPA-B; CELLS; OX40; ACTIVATION	Agonistic antibodies directed against immunostimulatory receptors belonging to the tumor necrosis factor receptor (TNFR) superfamily are emerging as promising cancer immunotherapies. Several Fc engineering approaches discovered recently can augment the anti-tumor activities of TNFR antibodies by enhancing their agonistic activities and/or effector functions. In this study, we compared these approaches for their effects on an anti-OX40 antibody. Both S267E/L328F and V12 mutations facilitated enhanced binding to Fc gamma RIIB and thus increased Fc gamma RIIB cross-linking mediated agonist activity. However, both mutations abrogated the binding to Fc gamma RIIIA and thereby decreasing the antibody-dependent cellular cytotoxicity activities. In contrast, the E345R mutation, which can promote antibody multimerization upon receptor binding, facilitated anti-OX40 antibody to have increased agonism by promoting the clustering of OX40 receptors without the dependence on Fc gamma RIIB cross-linking. Nonetheless, cross-linking to Fc gamma RIIB can lead to a further boost of the agonism of the anti-OX40 antibody with IgG1 Fc but not with the silent IgG2 sigma Fc. The antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity activities of the anti-OX40 antibody with the E345R mutation were affected by the choice of IgG subtypes. However, there was little change in the antibody-dependent cellular phagocytosis activity. In summary, different Fc engineering approaches can guide the design of engineered antibodies to OX40 and other TNFR with improved anti-tumor activity.	[Zhang, Di; Goldberg, Monica V.; Chiu, Mark L.] Janssen Res & Dev LLC, Spring House, PA 19477 USA; [Goldberg, Monica V.] Bristol Myers Squibb, Lawrence, NJ 08648 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Bristol-Myers Squibb	Zhang, D (corresponding author), Janssen R&D LLC, Dept Biol Res, 1400 McKean Rd,POB 776, Spring House, PA 19477 USA.	dzhang53@its.jnj.com	chiu, mark/AAK-2756-2021	Chiu, Mark/0000-0001-6300-404X				Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Bulliard Y, 2014, IMMUNOL CELL BIOL, V92, P475, DOI 10.1038/icb.2014.26; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chu SY, 2008, MOL IMMUNOL, V45, P3926, DOI 10.1016/j.molimm.2008.06.027; de Jong RN, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002344; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; He LZ, 2013, J IMMUNOL, V191, P4174, DOI 10.4049/jimmunol.1300409; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; Khalil Magi, 2007, Update Cancer Ther, V2, P61, DOI 10.1016/j.uct.2007.06.001; Li FB, 2012, CELL CYCLE, V11, P3343, DOI 10.4161/cc.21842; Li FB, 2012, P NATL ACAD SCI USA, V109, P10966, DOI 10.1073/pnas.1208698109; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Luo Y, 2009, MABS-AUSTIN, V1, P491, DOI 10.4161/mabs.1.5.9631; Mangsbo SM, 2015, CLIN CANCER RES, V21, P1115, DOI 10.1158/1078-0432.CCR-14-0913; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mimoto F, 2013, PROTEIN ENG DES SEL, V26, P589, DOI 10.1093/protein/gzt022; Moran AE, 2013, CURR OPIN IMMUNOL, V25, P230, DOI 10.1016/j.coi.2013.01.004; Morris NP, 2007, MOL IMMUNOL, V44, P3112, DOI 10.1016/j.molimm.2007.02.004; POLLOK KE, 1993, J IMMUNOL, V150, P771; Ramakrishna V, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0080-2; Rankin CT, 2006, BLOOD, V108, P2384, DOI 10.1182/blood-2006-05-020602; Schaer DA, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-7; Simons PJ, 2014, Patent US, Patent No. [20140377284 A1, WO 2014/ 148895 A1, 20140377284]; Veri MC, 2007, IMMUNOLOGY, V121, P392, DOI 10.1111/j.1365-2567.2007.02588.x; White AL, 2015, CANCER CELL, V27, P138, DOI 10.1016/j.ccell.2014.11.001; White AL, 2011, J IMMUNOL, V187, P1754, DOI 10.4049/jimmunol.1101135; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Xu YY, 2003, J IMMUNOL, V171, P562, DOI 10.4049/jimmunol.171.2.562	34	38	45	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27134	27146		10.1074/jbc.M116.757773	http://dx.doi.org/10.1074/jbc.M116.757773			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27856634	hybrid, Green Published			2022-12-28	WOS:000391576300014
J	Howitt, J; Hill, AF				Howitt, Jason; Hill, Andrew F.			Exosomes in the Pathology of Neurodegenerative Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CREUTZFELDT-JAKOB-DISEASE; PRION-LIKE TRANSMISSION; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; AMYLOID-BETA; EXTRACELLULAR VESICLES; TUNNELING NANOTUBES; TAU-PROTEIN; IN-VIVO	More than 30 years ago, two unexpected findings were discovered that challenged conventional thinking in biology. The first was the identification of a misfolded protein with transmissible properties associated with a group of neurodegenerative diseases known as transmissible spongiform encephalopathies. The second was the discovery of a new pathway used for the extracellular release of biomolecules, including extracellular vesicles called exosomes. Two decades later, the convergence of these pathways was shown when exosomes were found to play a significant role in both the transmission and propagation of protein aggregates in disease. Recent research has now revealed that the majority of proteins involved in neurodegenerative diseases are transported in exosomes, and that external stresses due to age-related impairment of protein quality control mechanisms can promote the transcellular flux of these proteins in exosomes. Significantly, exosomes provide an environment that can induce the conformational conversion of native proteins into aggregates that can be transmitted to otherwise aggregate-free cells in the brain. Here we review the current roles of exosomes in the pathology of neurodegenerative diseases.	[Howitt, Jason] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Hill, Andrew F.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; La Trobe University	Howitt, J (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.; Hill, AF (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia.	jason.howitt@florey.edu.au; andrew.hill@latrobe.edu.au	Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020	Hill, Andrew F./0000-0001-5581-2354; Howitt, Jason/0000-0001-9922-7931				Abounit S, 2016, EMBO J, V35, P2120, DOI 10.15252/embj.201593411; Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Arellano-Anaya ZE, 2015, CELL MOL LIFE SCI, V72, P1185, DOI 10.1007/s00018-014-1735-8; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Boluda S, 2015, ACTA NEUROPATHOL, V129, P221, DOI 10.1007/s00401-014-1373-0; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Breda C, 2015, HUM MOL GENET, V24, P1077, DOI 10.1093/hmg/ddu521; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Costanzo M, 2013, J CELL SCI, V126, P3678, DOI 10.1242/jcs.126086; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; DIVRY PAUL, 1927, JOUR NEUROL ET PSYCHIATR, V27, P643; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Grad LI, 2014, PRION, V8, P331, DOI 10.4161/19336896.2014.983398; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Hasegawa T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.015204; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; KITAMOTO T, 1989, J GEN VIROL, V70, P3371, DOI 10.1099/0022-1317-70-12-3371; Kong SMY, 2014, HUM MOL GENET, V23, P2816, DOI 10.1093/hmg/ddu099; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kunadt M, 2015, ACTA NEUROPATHOL, V129, P695, DOI 10.1007/s00401-015-1408-1; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lee HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.45; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lewy F. H., 1912, LEWANDOWSKYS HDB, VIII, P920; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Pearce MMP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7768; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Polanco JC, 2016, J BIOL CHEM, V291, P12445, DOI 10.1074/jbc.M115.709485; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sacino AN, 2014, J NEUROSCI, V34, P12368, DOI 10.1523/JNEUROSCI.2102-14.2014; Sacino AN, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-38; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; SCHUBERT D, 1989, P NATL ACAD SCI USA, V86, P2066, DOI 10.1073/pnas.86.6.2066; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shi M, 2014, ACTA NEUROPATHOL, V128, P639, DOI 10.1007/s00401-014-1314-y; Son SM, 2012, DIABETES, V61, P3126, DOI 10.2337/db11-1735; Stuendl A, 2016, BRAIN, V139, P481, DOI 10.1093/brain/awv346; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Tardivel M, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0386-4; Tsunemi T, 2014, J NEUROSCI, V34, P15281, DOI 10.1523/JNEUROSCI.1629-14.2014; VANDERMEEREN M, 1993, J NEUROCHEM, V61, P1828, DOI 10.1111/j.1471-4159.1993.tb09823.x; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; Yuyama K, 2008, J NEUROCHEM, V105, P217, DOI 10.1111/j.1471-4159.2007.05128.x; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594; Zomer A, 2015, CELL, V161, P1046, DOI 10.1016/j.cell.2015.04.042	99	135	137	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26589	26597		10.1074/jbc.R116.757955	http://dx.doi.org/10.1074/jbc.R116.757955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27852825	hybrid, Green Published			2022-12-28	WOS:000391571400001
J	Sugiyama, Y; Nakamura, A; Matsumoto, M; Kanbe, A; Sakanaka, M; Higashi, K; Igarashi, K; Katayama, T; Suzuki, H; Kurihara, S				Sugiyama, Yuta; Nakamura, Atsuo; Matsumoto, Mitsuharu; Kanbe, Ayaka; Sakanaka, Mikiyasu; Higashi, Kyohei; Igarashi, Kazuei; Katayama, Takane; Suzuki, Hideyuki; Kurihara, Shin			A Novel Putrescine Exporter SapBCDF of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; UTILIZATION PATHWAY; GAMMA-AMINOBUTYRATE; POTASSIUM CHANNEL; TRANSPORT-SYSTEM; POLYAMINES; K-12; SPERMIDINE; PROTEIN; CONTRIBUTES	Recent research has suggested that polyamines (putrescine, spermidine, and spermine) in the intestinal tract impact the health of animals either negatively or positively. The concentration of polyamines in the intestinal tract results from the balance of uptake and export of the intestinal bacteria. However, the mechanism of polyamine export from bacterial cells to the intestinal lumen is still unclear. In Escherichia coli, PotE was previously identified as a transporter responsible for putrescine excretion in an acidic growth environment. We observed putrescine concentration in the culture supernatant was increased from 0 to 50 mu M during growth of E. coli under neutral conditions. Screening for the unidentified putrescine exporter was performed using a gene knock-out collection of E. coli, and deletion of sapBCDF significantly decreased putrescine levels in the culture supernatant. Complementation of the deletion mutant with the sapBCDF genes restored putrescine levels in the culture supernatant. Additionally, the Delta sapBCDF strain did not facilitate uptake of putrescine from the culture supernatant. Quantification of stable isotope-labeled putrescine derived from stable isotope-labeled arginine supplemented in the medium revealed that SapBCDF exported putrescine from E. coli cells to the culture supernatant. It was previously reported that SapABCDF of Salmonella enterica sv. typhimurium and Haemophilus influenzae conferred resistance to antimicrobial peptides; however, the E. coli Delta sapBCDF strain did not affect resistance to antimicrobial peptide LL-37. These results strongly suggest that the natural function of the SapBCDF proteins is the export of putrescine.	[Sugiyama, Yuta; Sakanaka, Mikiyasu; Katayama, Takane; Kurihara, Shin] Ishikawa Prefectural Univ, Grad Sch Bioresources & Environm Sci, Div Appl Life Sci, Nonoichi, Ishikawa 9218836, Japan; [Nakamura, Atsuo; Matsumoto, Mitsuharu] Kyodo Milk Ind Co Ltd, Dairy Sci & Technol Inst, Tokyo 1900182, Japan; [Kanbe, Ayaka; Suzuki, Hideyuki] Kyoto Inst Technol, Div Appl Biol, Kyoto 6068585, Japan; [Higashi, Kyohei] Chiba Univ, Grad Sch Pharmaceut Sci, Div Biopharmaceut Sci, Chiba 2608675, Japan; [Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Innovat Plaza, Chiba 2600856, Japan; [Katayama, Takane] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Ishikawa Prefecture University; Kyoto Institute of Technology; Chiba University; Chiba University; Kyoto University	Kurihara, S (corresponding author), Ishikawa Prefectural Univ, 1-308 Suematsu, Nonoichi, Ishikawa 9218836, Japan.	kuri711@ishikawa-pu.ac.jp	Matsumoto, Mitsuharu/AHB-4023-2022	Higashi, Kyohei/0000-0002-2622-4825; Matsumoto, Mitsuharu/0000-0002-0378-3077; Igarashi, Kazuei/0000-0003-3751-3187	Institute for Fermentation, Osaka, Japan; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan	Institute for Fermentation, Osaka, Japan(Institute for Fermentation (IFO)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan	This work was supported by grants-in-aid from the Institute for Fermentation, Osaka, Japan, and in part by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry by the Bio-oriented Technology Research Advancement Institution (BRAIN), Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babbar N, 2011, RECENT RESULTS CANC, V188, P49, DOI 10.1007/978-3-642-10858-7_4; Chen GG, 2009, J MASS SPECTROM, V44, P1203, DOI 10.1002/jms.1597; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; Harms C, 2001, MICROBIOL-SGM, V147, P2991, DOI 10.1099/00221287-147-11-2991; HARWIG SSL, 1994, METHOD ENZYMOL, V236, P160; Higashi K, 2008, J BACTERIOL, V190, P872, DOI 10.1128/JB.01505-07; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; KASHIWAGI K, 1991, J BIOL CHEM, V266, P20922; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Kibe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04548; Kurihara S, 2006, FEMS MICROBIOL LETT, V256, P318, DOI 10.1111/j.1574-6968.2006.00137.x; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Kurihara S, 2008, J BIOL CHEM, V283, P19981, DOI 10.1074/jbc.M800133200; Kurihara S, 2013, J BIOL CHEM, V288, P15668, DOI 10.1074/jbc.M113.454090; Kurihara S, 2010, J BACTERIOL, V192, P4582, DOI 10.1128/JB.00308-10; Kurihara S, 2009, J BACTERIOL, V191, P2776, DOI 10.1128/JB.01314-08; Leuzzi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136744; Liu K, 2000, PLANT PHYSIOL, V124, P1315, DOI 10.1104/pp.124.3.1315; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Mason KM, 2006, MOL MICROBIOL, V62, P1357, DOI 10.1111/j.1365-2958.2006.05460.x; Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Miller J. H., 1972, SHORT COURSE BACTERI, p[263, 437]; Nemoto N, 2012, J BACTERIOL, V194, P3437, DOI 10.1128/JB.00097-12; PARRALOPEZ C, 1993, EMBO J, V12, P4053, DOI 10.1002/j.1460-2075.1993.tb06089.x; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; Sakanaka M, 2016, AMINO ACIDS, V48, P2443, DOI 10.1007/s00726-016-2233-0; Sasahara A, 2011, J BIOL CHEM, V286, P29044, DOI 10.1074/jbc.M111.260224; Schiller D, 2000, J BACTERIOL, V182, P6247, DOI 10.1128/JB.182.21.6247-6249.2000; Shelton CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002360; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Thompson PA, 2010, GASTROENTEROLOGY, V139, P797, DOI 10.1053/j.gastro.2010.06.005; Tiburcio AF, 2014, PLANTA, V240, P1, DOI 10.1007/s00425-014-2055-9; Vandenberg CA, 2008, P NATL ACAD SCI USA, V105, P7109, DOI 10.1073/pnas.0803231105; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106	46	32	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26343	26351		10.1074/jbc.M116.762450	http://dx.doi.org/10.1074/jbc.M116.762450			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27803167	hybrid, Green Published			2022-12-28	WOS:000391568200009
J	Kim, GW; Li, L; Ghorbani, M; You, LY; Yang, XJ				Kim, Go-Woon; Li, Lin; Ghorbani, Mohammad; You, Linya; Yang, Xiang-Jiao			Mice lacking alpha-tubulin acetyltransferase 1 are viable but display alpha-tubulin acetylation deficiency and dentate gyrus distortion (vol 291, pg 25279, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Kim GW, 2016, J BIOL CHEM, V291, P25279, DOI 10.1074/jbc.A113.464792	1	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25279	25279		10.1074/jbc.A113.464792	http://dx.doi.org/10.1074/jbc.A113.464792			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27888237	Green Published, hybrid			2022-12-28	WOS:000388880100042
J	Takeuchi, T; Harada, Y; Moriyama, S; Furuta, K; Tanaka, S; Miyaji, T; Omote, H; Moriyama, Y; Hiasa, M				Takeuchi, Tomoya; Harada, Yuika; Moriyama, Satomi; Furuta, Kazuyuki; Tanaka, Satoshi; Miyaji, Takaaki; Omote, Hiroshi; Moriyama, Yoshinori; Hiasa, Miki			Vesicular Polyamine Transporter Mediates Vesicular Storage and Release of Polyamine from Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histamine; mast cell; polyamine; transporter; vesicles; secretory granules; spermine; vesicular polyamine transporter	INDUCED HISTAMINE-RELEASE; MEMBRANE-PROTEIN; NEUROTRANSMITTER TRANSPORTERS; L-GLUTAMATE; EXOCYTOSIS; SECRETION; RECEPTOR; ACTIVATION; IDENTIFICATION; CHROMATOGRAPHY	Mast cells are secretory cells that play an important role in host defense by discharging various intragranular contents, such as histamine and serotonin, upon stimulation of Fc receptors. The granules also contain spermine and spermidine, which can act as modulators of mast cell function, although the mechanism underlying vesicular storage remains unknown. Vesicular polyamine transporter (VPAT), the fourth member of the SLC18 transporter family, is an active transporter responsible for vesicular storage of spermine and spermidine in neurons. In the present study, we investigated whether VPAT functions in mast cells. RT-PCR and Western blotting indicated VPAT expression in murine bone marrow-derived mast cells (BMMCs). Immunohistochemical analysis indicated that VPAT is colocalized with VAMP3 but not with histamine, serotonin, cathepsin D, VAMP2, or VAMP7. Membrane vesicles from BMMCs accumulated spermidine upon the addition of ATP in a reserpine- and bafilomycin A(1)-sensitive manner. BMMCs secreted spermine and spermidine upon the addition of either antigen or A23187 in the presence of Ca2+, and the antigen-mediated release, which was shown to be temperature-dependent and sensitive to bafilomycin A(1) and tetanus toxin, was significantly suppressed by VPAT gene RNA interference. Under these conditions, expression of vesicular monoamine transporter 2 was unaffected, but antigen-dependent histamine release was significantly suppressed, which was recovered by the addition of 1 mm spermine. These results strongly suggest that VPAT is expressed and is responsible for vesicular storage of spermine and spermidine in novel secretory granules that differ from histamine- and serotonin-containing granules and is involved in vesicular release of these polyamines from mast cells.	[Takeuchi, Tomoya; Harada, Yuika; Moriyama, Satomi; Omote, Hiroshi; Moriyama, Yoshinori; Hiasa, Miki] Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Furuta, Kazuyuki; Tanaka, Satoshi] Okayama Univ, Grad Sch Med Dent, Dept Immunobiol, Okayama 7008530, Japan; [Miyaji, Takaaki] Okayama Univ, Adv Sci Res Ctr, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University	Moriyama, Y; Hiasa, M (corresponding author), Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	moriyama@pharm.okayama-u.ac.jp; hiasa@okayama-u.ac.jp	Tanaka, Satoshi/H-6800-2019; TANAKA, Satoshi/B-1624-2011	Tanaka, Satoshi/0000-0002-3468-7694; TANAKA, Satoshi/0000-0002-3468-7694; Miyaji, Takaaki/0000-0002-7257-7621	Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan [22790067, 25253008, 16K08230]; Uehara Memorial Foundation; Smoking Research Foundation; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders	Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Smoking Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology of Japan 22790067 (to T. M.), 25253008 (to H. O. and Y. M.), and 16K08230 (to M. H.); by the Uehara Memorial Foundation and the Smoking Research Foundation (to T. M.); and by the Takeda Science Foundation and the Astellas Foundation for Research on Metabolic Disorders (to T. M. and M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Anlauf M, 2004, J HISTOCHEM CYTOCHEM, V52, P779, DOI 10.1369/jhc.4A6264.2004; BUEB JL, 1991, AGENTS ACTIONS, V33, P84, DOI 10.1007/BF01993133; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Garcia-Faroldi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015071; Garcia-Faroldi G, 2009, J CELL BIOCHEM, V108, P261, DOI 10.1002/jcb.22246; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Hiasa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06836; INAGAKI N, 1994, LIFE SCI, V54, P1403, DOI 10.1016/0024-3205(94)00595-8; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kanerva K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006858; KUROSAWA M, 1991, ALLERGY, V46, P349, DOI 10.1111/j.1398-9995.1991.tb00597.x; LAGUNOFF D, 1983, ANNU REV PHARMACOL, V23, P331, DOI 10.1146/annurev.pa.23.040183.001555; Lorentz A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00143; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MORIYAMA Y, 1995, J BIOL CHEM, V270, P22314, DOI 10.1074/jbc.270.38.22314; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Omote H, 2016, ANNU REV PHARMACOL, V56, P385, DOI 10.1146/annurev-pharmtox-010814-124816; Omote H, 2013, PHYSIOLOGY, V28, P39, DOI 10.1152/physiol.00033.2012; Omote H, 2011, BIOCHEMISTRY-US, V50, P5558, DOI 10.1021/bi200567k; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; PURCELL WM, 1994, BIOCHEM SOC T, V22, pS398, DOI 10.1042/bst022398s; Purcell WM, 1996, J NEUROIMMUNOL, V65, P49, DOI 10.1016/0165-5728(95)00182-4; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; READ GW, 1982, J PHARMACOL EXP THER, V222, P652; ROTTEM M, 1993, J IMMUNOL, V151, P4950; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SJOERDSMA A, 1957, SCIENCE, V125, P1201; SMITH MA, 1985, PLANT PHYSIOL, V78, P89, DOI 10.1104/pp.78.1.89; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; THEOHARIDES TC, 1982, NATURE, V297, P229, DOI 10.1038/297229a0; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Vliagoftis H, 1999, INT J IMMUNOPHARMACO, V21, P547, DOI 10.1016/S0192-0561(99)00031-4; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; YAMATODANI A, 1985, J CHROMATOGR, V344, P115, DOI 10.1016/S0378-4347(00)82012-5	41	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3909	3918		10.1074/jbc.M116.756197	http://dx.doi.org/10.1074/jbc.M116.756197			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28082679	Green Published, hybrid			2022-12-28	WOS:000395542500031
J	Bruck, I; Dhingra, N; Kaplan, DL				Bruck, Irina; Dhingra, Nalini; Kaplan, Daniel L.			A Positive Amplification Mechanism Involving a Kinase and Replication Initiation Factor Helps Assemble the Replication Fork Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; DNA helicase; DNA replication; DNA-protein interaction; phosphorylation	EUKARYOTIC DNA-REPLICATION; SINGLE-STRANDED-DNA; CELL-CYCLE CHECKPOINT; S-PHASE PROGRESSION; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MCM2-7 HELICASE; PROTEIN; GINS; PHOSPHORYLATION	The assembly of the replication fork helicase during S phase is key to the initiation of DNA replication in eukaryotic cells. One step in this assembly in budding yeast is the association of Cdc45 with the Mcm2-7 heterohexameric ATPase, and a second step is the assembly of the tetrameric GINS (GG-Ichi-Nii-San) complex with Mcm2-7. Dbf4-dependent kinase (DDK) and S-phase cyclin-dependent kinase (S-CDK) are two S phase-specific kinases that phosphorylate replication proteins during S phase, and Dpb11, Sld2, Sld3, Pol E, and Mcm10 are factors that are also required for replication initiation. However, the exact roles of these initiation factors in assembly of the replication fork helicase remain unclear. We show here that Dpb11 stimulates DDK phosphorylation of the minichromosome maintenance complex protein Mcm4 alone and also of the Mcm2-7 complex and the dsDNA-loaded Mcm2-7 complex. We further demonstrate that Dpb11 can directly recruit DDK to Mcm4. A DDK phosphomimetic mutant of Mcm4 bound Dpb11 with substantially higher affinity than wild-type Mcm4, suggesting a mechanism to recruit Dpb11 to DDK-phosphorylated Mcm2-7. Furthermore, dsDNA-loaded Mcm2-7 harboring the DDK phosphomimetic Mcm4 mutant bound GINS in the presence of Dpb11, suggesting a mechanism for how GINS is recruited to Mcm2-7. We isolated a mutant of Dpb11 that is specifically defective for binding to Mcm4. This mutant, when expressed in budding yeast, diminished cell growth and DNA replication, substantially decreased Mcm4 phosphorylation, and decreased association of GINS with replication origins. We conclude that Dpb11 functions with DDK and Mcm4 in a positive amplification mechanism to trigger the assembly of the replication fork helicase.	[Bruck, Irina; Dhingra, Nalini; Kaplan, Daniel L.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA; [Bruck, Irina] Sloan Kettering Mem Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA	State University System of Florida; Florida State University; Memorial Sloan Kettering Cancer Center	Kaplan, DL (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA.	Daniel.Kaplan@med.fsu.edu		Kaplan, Daniel/0000-0003-2760-7745; Dhingra, Nalini/0000-0003-0949-883X	NIGMS, National Institutes of Health [R15GM113167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM113167] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R15GM113167 (to D.L.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Bruck I, 2015, J BIOL CHEM, V290, P27414, DOI 10.1074/jbc.M115.688424; Bruck I, 2015, P NATL ACAD SCI USA, V112, P11223, DOI 10.1073/pnas.1509608112; Bruck I, 2015, J BIOL CHEM, V290, P1210, DOI 10.1074/jbc.M114.608232; Bruck I, 2014, J BIOL CHEM, V289, P1948, DOI 10.1074/jbc.M113.532085; Bruck I, 2013, J BIOL CHEM, V288, P7550, DOI 10.1074/jbc.M112.440941; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Deegan TD, 2016, EMBO J, V35, P961, DOI 10.15252/embj.201593552; Dhingra N, 2015, J BIOL CHEM, V290, P7586, DOI 10.1074/jbc.M115.640383; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Homesley L, 2000, GENE DEV, V14, P913; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Lindsey-Boltz LA, 2011, J BIOL CHEM, V286, P19229, DOI 10.1074/jbc.M111.237958; Mantiero D, 2011, EMBO J, V30, P4805, DOI 10.1038/emboj.2011.404; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Perez-Arnaiz P, 2016, NUCLEIC ACIDS RES, V44, P315, DOI 10.1093/nar/gkv1260; Ramer MD, 2013, J BIOL CHEM, V288, P14926, DOI 10.1074/jbc.M112.392910; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2013, MOL CELL BIOL, V33, P2614, DOI 10.1128/MCB.00431-13; Tognetti S, 2015, CHROMOSOMA, V124, P13, DOI 10.1007/s00412-014-0489-2; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	54	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3062	3073		10.1074/jbc.M116.772368	http://dx.doi.org/10.1074/jbc.M116.772368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082681	hybrid, Green Published			2022-12-28	WOS:000395538800001
J	Gajsiewicz, JM; Smith, SA; Morrissey, JH				Gajsiewicz, Joshua M.; Smith, Stephanie A.; Morrissey, James H.			Polyphosphate and RNA Differentially Modulate the Contact Pathway of Blood Clotting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coagulation factor; hemostasis; nucleic acid; RNA; thrombosis	MOLECULAR-WEIGHT KININOGEN; COAGULATION-FACTOR-XII; THROMBUS FORMATION; PLASMA PREKALLIKREIN; MYOCARDIAL-INFARCTION; HAGEMAN-FACTOR; IN-VIVO; ACTIVATION; INFLAMMATION; MECHANISMS	The contact pathway of the plasma clotting cascade is dispensable for normal hemostasis, but contributes to thrombosis and serves as a bridge between inflammation and coagulation. This pathway is triggered upon exposure of plasma to certain anionic polymers and artificial surfaces. Recently, extracellular nucleic acids and inorganic polyphosphate (polyP) have been implicated as being important (patho)physiologically relevant activators of this pathway. However, mechanistic details regarding how nucleic acids or polyP modulate the individual reactions of the contact pathway have been lacking. In this study, we investigate the ability of RNA homopolymers and polyP to bind the primary constituents of the contact pathway: factor XIa, factor XIIa, and plasma kallikrein, in the presence and absence of high molecular weight kininogen (HK), an important cofactor in this pathway. We examine seven proteolytic activation reactions within the contact pathway and report that polyP greatly enhances the rate of all seven, while RNA is effective in supporting only a subset of these reactions. HK both enhances and suppresses these proteolytic activation reactions, depending on the specific reaction evaluated. Overall, we find that polyP is a potent mediator of contact pathway activation reactions in general, that RNA secondary structure may be important to its procoagulant activity, and that nucleic acids versus polyP may differentially modulate specific enzyme activation events within the contact pathway.	[Gajsiewicz, Joshua M.; Smith, Stephanie A.; Morrissey, James H.] Univ Illinois, Dept Biochem, 323 Roger Adams Lab,MC-712,600 S Mathews Ave, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Morrissey, JH (corresponding author), Univ Illinois, Dept Biochem, 323 Roger Adams Lab,MC-712,600 S Mathews Ave, Urbana, IL 61801 USA.	jhmorris@illinois.edu	Morrissey, James H./GLR-5645-2022; Morrissey, James H/H-4933-2011	Morrissey, James H/0000-0002-1570-1569	NHLBI of the National Institutes of Health [R01 HL047014, UM1HL120877]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047014, UM1HL120877] Funding Source: NIH RePORTER	NHLBI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grants R01 HL047014 and UM1HL120877 from the NHLBI of the National Institutes of Health. S.A.S. and J.H.M. are inventors on patents and pending patent applications on medical uses of polyP and polyP inhibitors. The research laboratory of J.H.M. receives revenues from sales of polyP and polyP derivatives through Kerafast, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BERNARDO MM, 1993, J BIOL CHEM, V268, P12477; Bhagirath VC, 2015, SHOCK, V44, P265, DOI 10.1097/SHK.0000000000000397; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811; Choi SH, 2010, BIOCHEMISTRY-US, V49, P9935, DOI 10.1021/bi1014437; Doggen CJM, 2006, BLOOD, V108, P4045, DOI 10.1182/blood-2005-12-023697; Engel R, 2014, J THROMB HAEMOST, V12, P1513, DOI 10.1111/jth.12663; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gansler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050399; Geng Y, 2013, J THROMB HAEMOST, V11, P2020, DOI 10.1111/jth.12414; Geng YP, 2013, BLOOD, V121, P3962, DOI 10.1182/blood-2012-12-473629; Gould TJ, 2014, ARTERIOSCL THROM VAS, V34, P1977, DOI 10.1161/ATVBAHA.114.304114; GRIFFIN JH, 1976, P NATL ACAD SCI USA, V73, P2554, DOI 10.1073/pnas.73.8.2554; Grundt H, 2004, AM HEART J, V147, P260, DOI 10.1016/j.ahj.2003.07.012; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kokoye Y, 2016, THROMB RES, V140, P118, DOI 10.1016/j.thromres.2016.02.020; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; LEVISON PR, 1982, BIOCHEM J, V205, P529, DOI 10.1042/bj2050529; Long AT, 2016, J THROMB HAEMOST, V14, P427, DOI 10.1111/jth.13235; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Matafonov A, 2014, BLOOD, V123, P1739, DOI 10.1182/blood-2013-04-499111; Merlo C, 2002, ATHEROSCLEROSIS, V161, P261, DOI 10.1016/S0021-9150(01)00666-9; MILLER G, 1980, BIOCHEM BIOPH RES CO, V92, P803, DOI 10.1016/0006-291X(80)90774-3; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; MORRISSEY JH, 1993, BLOOD, V81, P734; Muller F, 2008, CURR OPIN HEMATOL, V15, P516, DOI 10.1097/MOH.0b013e328309ec85; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; NAITO K, 1991, J BIOL CHEM, V266, P7353; Petrovic AG, 2008, J PHYS CHEM B, V112, P2255, DOI 10.1021/jp075873v; RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Renne Thomas, 2007, Expert Rev Cardiovasc Ther, V5, P733, DOI 10.1586/14779072.5.4.733; Revenko AS, 2011, BLOOD, V118, P5302, DOI 10.1182/blood-2011-05-355248; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2012, BLOOD, V120, P5103, DOI 10.1182/blood-2012-07-444935; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; TANKERSLEY DL, 1984, BIOCHEMISTRY-US, V23, P273, DOI 10.1021/bi00297a016; TANS G, 1987, J BIOL CHEM, V262, P11308; Travers RJ, 2014, BLOOD, V124, P3183, DOI 10.1182/blood-2014-05-577932; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; Vu TT, 2013, THROMB HAEMOSTASIS, V109, P421, DOI 10.1160/TH12-07-0465	46	26	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1808	1814		10.1074/jbc.M116.754325	http://dx.doi.org/10.1074/jbc.M116.754325			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28007958	Green Published, hybrid			2022-12-28	WOS:000395515600022
J	Geng, QD; Xhabija, B; Knuckle, C; Bonham, CA; Vacratsis, PO				Geng, Qiudi; Xhabija, Besa; Knuckle, Colleen; Bonham, Christopher A.; Vacratsis, Panayiotis O.			The Atypical Dual Specificity Phosphatase hYVH1 Associates with Multiple Ribonucleoprotein Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTAL-RETARDATION PROTEIN; STRESS GRANULES; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; YVH1; TRANSLATION; PHOSPHORYLATION; IDENTIFICATION; REPRESSION; REGULATORS	Human YVH1 (hYVH1), also known as dual specificity phosphatase 12 (DUSP12), is a poorly characterized atypical dual specificity phosphatase widely conserved throughout evolution. Recent findings have demonstrated that hYVH1 expression affects cellular DNA content and is a novel cell survival phosphatase preventing both thermal and oxidative stress-induced cell death, whereas studies in yeast have established YVH1 as a novel 60S ribosome biogenesis factor. In this study, we have isolated novel hYVH1-associating proteins from human U2OS osteosarcoma cells using affinity chromatography coupled to mass spectrometry employing ion mobility separation. Numerous ribosomal proteins were identified, confirming the work done in yeast. Furthermore, proteins known to be present on additional RNP particles were identified, including Y box-binding protein 1 (YB-1) and fragile X mental retardation protein, proteins that function in translational repression and stress granule regulation. Follow-up studies demonstrated that hYVH1 co-localizes with YB-1 and fragile X mental retardation protein on stress granules in response to arsenic treatment. Interestingly, hYVH1-positive stress granules were significantly smaller, whereas knocking down hYVH1 expression attenuated stress granule breakdown during recovery from arsenite stress, indicating a possible role for hYVH1 in stress granule disassembly. These results propagate a role for dual specificity phosphatases at RNP particles and suggest that hYVH1 may affect a variety of fundamental cellular processes by regulating messenger ribonucleoprotein (mRNP) dynamics.	[Geng, Qiudi; Xhabija, Besa; Knuckle, Colleen; Bonham, Christopher A.; Vacratsis, Panayiotis O.] Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada	University of Windsor	Vacratsis, PO (corresponding author), Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	vacratsi@uwindsor.ca	Xhabija, Besa/GOP-2447-2022	Xhabija, Besa/0000-0002-4784-2454	Natural Sciences and Engineering Research Council of Canada (NSERC) [298468]; Seeds4Hope grant; NSERC CGS; Ontario Trillium award; Ontario Graduate Scholarship program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Seeds4Hope grant; NSERC CGS(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Trillium award; Ontario Graduate Scholarship program(Ontario Graduate Scholarship)	This work was supported by a Discovery Grant (298468) from the Natural Sciences and Engineering Research Council of Canada (NSERC) (to P. O. V.), a Seeds4Hope grant (to P. O. V.), and an NSERC CGS (to C. A. B. and C. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Ontario Trillium award.; Supported by the Ontario Graduate Scholarship program.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A., 2003, PROTEIN PHOSPHATASES, P333; Antrobus R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018218; Beeser AE, 2000, J BACTERIOL, V182, P3517, DOI 10.1128/JB.182.12.3517-3528.2000; Biernacki MA, 2010, CANCER RES, V70, P906, DOI 10.1158/0008-5472.CAN-09-2303; Bonham CA, 2009, J BIOL CHEM, V284, P22853, DOI 10.1074/jbc.M109.038612; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cain EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018677; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Franklin NE, 2013, J CELL SCI, V126, P1333, DOI 10.1242/jcs.113928; Franklin NE, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209122; Fritzsche R, 2013, CELL REP, V5, P1749, DOI 10.1016/j.celrep.2013.11.023; GUAN K, 1992, P NATL ACAD SCI USA, V89, P12175, DOI 10.1073/pnas.89.24.12175; Harada M, 2014, GENES CELLS, V19, P504, DOI 10.1111/gtc.12150; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kemmler S, 2009, J CELL BIOL, V186, P863, DOI 10.1083/jcb.200904111; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Kozarova A, 2011, CELL CYCLE, V10, P1669, DOI 10.4161/cc.10.10.15641; Kresse SH, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-39; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; LIN A, 1990, P NATL ACAD SCI USA, V87, P8565, DOI 10.1073/pnas.87.21.8565; Liu W, 2012, HUM MOL GENET, V21, P4655, DOI 10.1093/hmg/dds307; Liu Y, 2009, GENETICS, V181, P907, DOI 10.1534/genetics.108.100099; Lo KY, 2009, J CELL BIOL, V186, P849, DOI 10.1083/jcb.200904110; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363; Muda M, 1999, J BIOL CHEM, V274, P23991, DOI 10.1074/jbc.274.34.23991; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Sadatomi D, 2013, INT J MOL SCI, V14, P4596, DOI 10.3390/ijms14034596; Sharda PR, 2009, BIOCHEM J, V418, P391, DOI 10.1042/BJ20081484; Somasekharan SP, 2015, J CELL BIOL, V208, P913, DOI 10.1083/jcb.201411047; Walters RW, 2015, RNA, V21, P1660, DOI 10.1261/rna.053116.115; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526	42	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					539	550		10.1074/jbc.M116.715607	http://dx.doi.org/10.1074/jbc.M116.715607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27856639	hybrid, Green Published			2022-12-28	WOS:000392316100011
J	Mymrikov, EV; Daake, M; Richter, B; Haslbeck, M; Buchner, J				Mymrikov, Evgeny V.; Daake, Marina; Richter, Bettina; Haslbeck, Martin; Buchner, Johannes			The Chaperone Activity and Substrate Spectrum of Human Small Heat Shock Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; MOLECULAR CHAPERONES; SKELETAL-MUSCLE; AGGREGATION; HSPB8; EXPRESSION; HSP20; TRANSITIONS; ASSEMBLIES; STRESS	Small heat shock proteins (sHsps) are a ubiquitous family of molecular chaperones that suppress the unspecific aggregation of miscellaneous proteins. Multicellular organisms contain a large number of different sHsps, raising questions as to whether they function redundantly or are specialized in terms of substrates and mechanism. To gain insight into this issue, we undertook a comparative analysis of the eight major human sHsps on the aggregation of both model proteins and cytosolic lysates under standardized conditions. We discovered that sHsps, which form large oligomers (HspB1/Hsp27, HspB3, HspB4/alpha A-crystallin, and HspB5/alpha B-crystallin) are promiscuous chaperones, whereas the chaperone activity of the other sHsps is more substrate-dependent. However, all human sHsps analyzed except HspB7 suppressed the aggregation of cytosolic proteins of HEK293 cells. We identified similar to 1100 heat-sensitive HEK293 proteins, 12% of which could be isolated in complexes with sHsps. Analysis of their biochemical properties revealed that most of the sHsp substrates have a molecular mass from 50 to 100 kDa and a slightly acidic pI (5.4-6.8). The potency of the sHsps to suppress aggregation of model substrates is correlated with their ability to form stable substrate complexes; especially HspB1 and HspB5, but also B3, bind tightly to a variety of proteins, whereas fewer substrates were detected in complex with the other sHsps, although these were also efficient in preventing the aggregation of cytosolic proteins.	[Mymrikov, Evgeny V.; Daake, Marina; Richter, Bettina; Haslbeck, Martin; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85748 Garching, Germany; [Mymrikov, Evgeny V.] Univ Freiburg, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany	Technical University of Munich; University of Freiburg	Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85748 Garching, Germany.	johannes.buchner@tum.de	Haslbeck, Martin/A-4413-2013; Buchner, Johannes/A-2651-2010	Mymrikov, Evgeny/0000-0003-4817-6278; Buchner, Johannes/0000-0003-1282-7737	Deutsche Forschungsgemeinschaft [SFB 1035]; CIPSM; Peter und Traudl Engelhorn Stiftung post-doctoral fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM; Peter und Traudl Engelhorn Stiftung post-doctoral fellowship	The work was supported by the Deutsche Forschungsgemeinschaft (SFB 1035) and CIPSM. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Peter und Traudl Engelhorn Stiftung post-doctoral fellowship. Present address: Institute for Biochemistry and Molecular Biology, University of Freiburg, Stefan- Meier-Strasse 17, 79104 Freiburg, Germany.	Asthana A, 2012, CELL BIOCHEM BIOPHYS, V64, P61, DOI 10.1007/s12013-012-9366-x; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Bukach OV, 2004, EUR J BIOCHEM, V271, P291, DOI 10.1046/j.1432-1033.2003.03928.x; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Carra S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0409; Chalova AS, 2014, CELL STRESS CHAPERON, V19, P963, DOI 10.1007/s12192-014-0520-9; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Cox D, 2016, J BIOL CHEM, V291, P22618, DOI 10.1074/jbc.M116.739250; Dashivets T, 2009, CHEMBIOCHEM, V10, P869, DOI 10.1002/cbic.200800697; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Ehrnsperger M, 2000, METH MOL B, V99, P421; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Fleckenstein T, 2015, MOL CELL, V58, P1067, DOI 10.1016/j.molcel.2015.04.019; Fu XM, 2014, PROTEIN SCI, V23, P229, DOI 10.1002/pro.2404; GASTMANN O, 1993, MOL REPROD DEV, V36, P407, DOI 10.1002/mrd.1080360402; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2015, METHODS MOL BIOL, V1292, P39, DOI 10.1007/978-1-4939-2522-3_3; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Hristozova N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161970; Huntley MA, 2006, MOL BIOL EVOL, V23, P2017, DOI 10.1093/molbev/msl073; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kappe G, 2001, BBA-GENE STRUCT EXPR, V1520, P1, DOI 10.1016/S0167-4781(01)00237-8; KATO K, 1994, J BIOL CHEM, V269, P15302; KATO K, 1992, J BIOL CHEM, V267, P7718; Khanova HA, 2007, BIOPHYS CHEM, V125, P521, DOI 10.1016/j.bpc.2006.11.002; Kim MV, 2004, BIOCHEM BIOPH RES CO, V315, P796, DOI 10.1016/j.bbrc.2004.01.130; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Morrow G, 2012, INT J BIOCHEM CELL B, V44, P1613, DOI 10.1016/j.biocel.2012.03.009; Mymrikov EV, 2015, EXPERT REV PROTEOMIC, V12, P295, DOI 10.1586/14789450.2015.1039993; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Mymrikov EV, 2010, CELL STRESS CHAPERON, V15, P365, DOI 10.1007/s12192-009-0151-8; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Numoto N, 2012, BIOCHEM BIOPH RES CO, V425, P601, DOI 10.1016/j.bbrc.2012.07.138; Panasenko OO, 2002, BBA-PROTEINS PROTEOM, V1601, P64, DOI 10.1016/S1570-9639(02)00430-2; Patel S, 2014, BIOPHYS J, V106, P2644, DOI 10.1016/j.bpj.2014.04.048; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Prabhu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029810; Quinlan RA, 2015, SCIENCE, V350, P636, DOI 10.1126/science.aad6303; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; SWAMY MS, 1991, CURR EYE RES, V10, P213, DOI 10.3109/02713689109003443; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Verschuure P, 2003, EUR J CELL BIOL, V82, P523, DOI 10.1078/0171-9335-00337; Vos MJ, 2011, AUTOPHAGY, V7, P101, DOI 10.4161/auto.7.1.13935; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704	68	84	85	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					672	684		10.1074/jbc.M116.760413	http://dx.doi.org/10.1074/jbc.M116.760413			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909051	Green Published, hybrid			2022-12-28	WOS:000392316100022
J	Chun, H; Sharma, AK; Lee, J; Chan, J; Jia, S; Kim, BE				Chun, Haarin; Sharma, Anuj Kumar; Lee, Jaekwon; Chan, Jefferson; Jia, Shang; Kim, Byung-Eun			The Intestinal Copper Exporter CUA-1 Is Required for Systemic Copper Homeostasis in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOME-RELATED ORGANELLES; TRANSCRIPTION FACTOR MTF-1; CELL-SPECIFIC EXPRESSION; C. ELEGANS; IRON-METABOLISM; SUPEROXIDE-DISMUTASE; FLUORESCENT-PROBES; DROSOPHILA MODEL; MENKES PROTEIN; ZINC	Copper plays key catalytic and regulatory roles in biochemical processes essential for normal growth, development, and health. Defects in copper metabolism cause Menkes and Wilson's disease, myeloneuropathy, and cardiovascular disease and are associated with other pathophysiological states. Consequently, it is critical to understand the mechanisms by which organisms control the acquisition, distribution, and utilization of copper. The intestinal enterocyte is a key regulatory point for copper absorption into the body; however, the mechanisms by which intestinal cells transport copper to maintain organismal copper homeostasis are poorly understood. Here, we identify a mechanism by which organismal copper homeostasis is maintained by intestinal copper exporter trafficking that is coordinated with extraintestinal copper levels in Caenorhabditis elegans. Specifically, we show that CUA-1, the C. elegans homolog of ATP7A/B, localizes to lysosome-like organelles (gut granules) in the intestine under copper overload conditions for copper detoxification, whereas copper deficiency results in a redistribution of CUA-1 to basolateral membranes for copper efflux to peripheral tissues. Worms defective in gut granule biogenesis exhibit defects in copper sequestration and increased susceptibility to toxic copper levels. Interestingly, however, a splice isoform CUA-1.2 that lacks a portion of the N-terminal domain is targeted constitutively to the basolateral membrane irrespective of dietary copper concentration. Our studies establish that CUA-1 is a key intestinal copper exporter and that its trafficking is regulated to maintain systemic copper homeostasis. C. elegans could therefore be exploited as a whole-animal model system to study regulation of intra-and intercellular copper trafficking pathways.	[Chun, Haarin; Sharma, Anuj Kumar; Kim, Byung-Eun] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Kim, Byung-Eun] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA; [Chan, Jefferson; Jia, Shang] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Berkeley	Kim, BE (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.; Kim, BE (corresponding author), Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA.	bekim@umd.edu	Sharma, Anuj/G-3043-2011; 贾, 上/P-7344-2019	Sharma, Anuj/0000-0001-5061-9731; 贾, 上/0000-0001-6285-8959; Chun, Haarin/0000-0002-2668-6296	National Institutes of Health [DK074797]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Kim laboratory for helpful suggestions, technical assistance, and critical reading of this manuscript. We thank members of Dr. Iqbal Hamza's laboratory (University of Maryland, College Park) for technical assistance and expertise in C. elegans genetics and cell biology as well as for discussions regarding the work, and Dr. Tamara Korolnek for critical reading of this manuscript. We thank Dr. Stephen G. Kaler (National Institutes of Health, Bethesda) for the anti-ATP7A antibody, and Dr. Michael J. Petris (University of Missouri, Columbia) for ATP7A knock-out MEFs. We thank Dr. Christopher J. Chang (University of California, Berkeley) for discussion and help in providing and using the CF4 and Control-CF4 probes. The worm strain expressing MANS:: mCherry was generously provided by Dr. Christopher Rongo (Rutgers The State University of New Jersey). The COPAS Biosort instrument was purchased from funds supported by a supplement to National Institutes of Health Grant DK074797 (to I. H.).	Anderson CP, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00113; Aron AT, 2015, ACCOUNTS CHEM RES, V48, P2434, DOI 10.1021/acs.accounts.5b00221; Bahadorani S, 2010, DIS MODEL MECH, V3, P84, DOI 10.1242/dmm.002642; Barstead R, 2012, G3-GENES GENOM GENET, V2, P1415, DOI 10.1534/g3.112.003830; Bertinato J, 2003, J BIOL CHEM, V278, P35071, DOI 10.1074/jbc.M302242200; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Cheli VT, 2010, TRAFFIC, V11, P579, DOI 10.1111/j.1600-0854.2010.01044.x; Cheli VT, 2010, HUM MOL GENET, V19, P861, DOI 10.1093/hmg/ddp555; Chen B, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/263685; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; Chew YL, 2015, AGING CELL, V14, P148, DOI 10.1111/acel.12285; Cotruvo JA, 2015, CHEM SOC REV, V44, P4400, DOI 10.1039/c4cs00346b; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; Dodani SC, 2014, P NATL ACAD SCI USA, V111, P16280, DOI 10.1073/pnas.1409796111; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Edgley Mark L, 2006, WormBook, P1; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hermann GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043043; Hong-Hermesdorf A, 2014, NAT CHEM BIOL, V10, P1034, DOI 10.1038/nchembio.1662; Hung WL, 2014, DEVELOPMENT, V141, P1767, DOI 10.1242/dev.103846; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kostich M, 2000, J CELL SCI, V113, P2595; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Maduro MF, 2002, DEV BIOL, V246, P68, DOI 10.1006/dbio.2002.0655; Mak HY, 2012, J LIPID RES, V53, P28, DOI 10.1194/jlr.R021006; McGhee James D, 2007, WormBook, P1; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meredith D, 2000, CELL MOL LIFE SCI, V57, P754, DOI 10.1007/s000180050040; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Muckenthaler MU, 2008, CELL METAB, V8, P1, DOI 10.1016/j.cmet.2008.06.009; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Noble T, 2013, CELL METAB, V18, P672, DOI 10.1016/j.cmet.2013.09.007; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Palgunow D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046198; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Roh HC, 2015, NUCLEIC ACIDS RES, V43, P803, DOI 10.1093/nar/gku1360; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Romney SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002394; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Sambongi Y, 1997, J BIOCHEM-TOKYO, V121, P1169, DOI 10.1093/oxfordjournals.jbchem.a021711; Schroeder LK, 2007, MOL BIOL CELL, V18, P995, DOI 10.1091/mbc.E06-08-0685; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; SIMON TC, 1995, CURR OPIN GENET DEV, V5, P577, DOI 10.1016/0959-437X(95)80026-3; Southon A, 2004, BIOCHEM J, V383, P303, DOI 10.1042/BJ20040745; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; Wakabayashi T, 1998, FEBS LETT, V440, P141, DOI 10.1016/S0014-5793(98)01431-8; Wang YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043039; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001	64	16	16	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					1	14		10.1074/jbc.M116.760876	http://dx.doi.org/10.1074/jbc.M116.760876			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27881675	Green Published, hybrid			2022-12-28	WOS:000391578000001
J	Panagoulias, I; Georgakopoulos, T; Aggeletopoulou, I; Agelopoulos, M; Thanos, D; Mouzaki, A				Panagoulias, Ioannis; Georgakopoulos, Tassos; Aggeletopoulou, Ioanna; Agelopoulos, Marios; Thanos, Dimitris; Mouzaki, Athanasia			Transcription Factor Ets-2 Acts as a Preinduction Repressor of Interleukin-2 (IL-2) Transcription in Naive T Helper Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CELL-ACTIVATION; PROMOTER; PROLIFERATION; PROTEINS; FAMILY; ARCHITECTURE; SPECIFICITY; MODULATION; APOPTOSIS	IL-2 is the first cytokine produced when naive T helper (Th) cells are activated and differentiate into dividing pre-Th0 proliferating precursors. IL-2 expression is blocked in naive, but not activated or memory, Th cells by the transcription factor Ets-2 that binds to the antigen receptor response element (ARRE)-2 of the proximal IL-2 promoter. Ets-2 acts as an independent pre-induction repressor in naive Th cells and does not interact physically with the transcription factor NFAT (nuclear factor of activated T-cells) that binds to the ARRE-2 in activated Th cells. In naive Th cells, Ets-2 mRNA expression, Ets-2 protein levels, and Ets-2 binding to ARRE-2 decrease upon cell activation followed by the concomitant expression of IL-2. Cyclosporine Astabilizes Ets-2 mRNA and protein when the cells are activated. Ets-2 silences directly constitutive or induced IL-2 expression through the ARRE-2. Conversely, Ets-2 silencing allows for constitutive IL-2 expression in unstimulated cells. Ets-2 binding to ARRE-2 in chromatin is stronger in naive compared with activated or memory Th cells; in the latter, Ets-2 participates in a change of the IL-2 promoter architecture, possibly to facilitate a quick response when the cells re-encounter antigen. We propose that Ets-2 expression and protein binding to the ARRE-2 of the IL-2 promoter are part of a strictly regulated process that results in a physiological transition of naive Th cells to Th0 cells upon antigenic stimulation. Malfunction of such a repression mechanism at the molecular level could lead to a disturbance of later events in Th cell plasticity, leading to autoimmune diseases or other pathological conditions.	[Panagoulias, Ioannis; Georgakopoulos, Tassos; Aggeletopoulou, Ioanna; Mouzaki, Athanasia] Univ Patras, Fac Med, Dept Internal Med, Div Hematol, GR-26500 Patras, Greece; [Agelopoulos, Marios; Thanos, Dimitris] Acad Athens, Biomed Res Fdn, Inst Mol Biol Genet & Biotechnol, GR-11527 Athens, Greece	University of Patras; Academy of Athens	Mouzaki, A (corresponding author), Univ Patras, Sch Hlth Sci, Fac Med, Lab Immunohematol,Div Hematol,Dept Internal Med, GR-26500 Patras, Greece.	mouzaki@upatras.gr	panagoulias, ioannis/ABA-7915-2020; Thanos, Dimitris/AAE-5720-2019; aggeletopoulou, ioanna/P-4129-2016	Aggeletopoulou, Ioanna/0000-0003-4489-1485	European Union (European Social Fund); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program Heracleitus II Grant [D.276.001.020]; K. Karatheodoris Grant, University of Patras [B407]	European Union (European Social Fund)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program Heracleitus II Grant; K. Karatheodoris Grant, University of Patras	This work was co-supported by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program Heracleitus II Grant D.276.001.020 and K. Karatheodoris Grant B407, University of Patras (to A. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson MK, 1999, DEVELOPMENT, V126, P3131; Argyropoulos C, 2004, GENES IMMUN, V5, P16, DOI 10.1038/sj.gene.6364034; Baker KM, 2003, J BIOL CHEM, V278, P17876, DOI 10.1074/jbc.M209480200; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; Blumenthal SG, 1999, J BIOL CHEM, V274, P12910, DOI 10.1074/jbc.274.18.12910; Bunting K, 2006, VITAM HORM, V74, P105, DOI 10.1016/S0083-6729(06)74005-5; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FIRPO EJ, 1994, MOL CELL BIOL, V14, P4889, DOI 10.1128/MCB.14.7.4889; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Irvin BJ, 2003, J BIOL CHEM, V278, P46378, DOI 10.1074/jbc.M305189200; Jia Y., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0097999; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Liu Jun O, 2005, Sci STKE, V2005, pre1; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; MOUZAKI A, 1994, BLOOD, V84, P2612; MOUZAKI A, 1991, EMBO J, V10, P1399, DOI 10.1002/j.1460-2075.1991.tb07660.x; Mouzaki A, 2002, BLOOD, V100, P1774, DOI 10.1182/blood.V100.5.1774.h81702001774_1774_1779; Mouzaki A, 2000, MOL MED, V6, P377, DOI 10.1007/BF03401782; MOUZAKI A, 1993, EUR J IMMUNOL, V23, P1469, DOI 10.1002/eji.1830230711; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Savignac M, 2005, EMBO J, V24, P3555, DOI 10.1038/sj.emboj.7600810; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Shore P, 1996, MOL CELL BIOL, V16, P3338; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; THOMPSON CB, 1992, MOL CELL BIOL, V12, P1043, DOI 10.1128/MCB.12.3.1043; Travers P., 2001, IMMUNOBIOLOGY IMMUNE, P323; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Wolvetang EJ, 2003, HUM MOL GENET, V12, P247, DOI 10.1093/hmg/ddg015; Yamanaka Y, 2008, J ORTHOP RES, V26, P1577, DOI 10.1002/jor.20714; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zaldumbide A, 2002, J IMMUNOL, V169, P4873, DOI 10.4049/jimmunol.169.9.4873	38	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26707	26721		10.1074/jbc.M116.762179	http://dx.doi.org/10.1074/jbc.M116.762179			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27815505	Green Published, hybrid			2022-12-28	WOS:000391571400011
J	Kong, W; He, LL; Coppola, M; Guo, JP; Esposito, NN; Coppola, D; Cheng, JQ				Kong, William; He, Lili; Coppola, Marc; Guo, Jianping; Esposito, Nicole N.; Coppola, Domenico; Cheng, Jin Q.			MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer (vol 285, pg 17869, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055	1	21	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22855	22855		10.1074/jbc.A110.101055	http://dx.doi.org/10.1074/jbc.A110.101055			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825093	hybrid, Green Published			2022-12-28	WOS:000386760600054
J	Park, S; Kim, D; Dan, HC; Chen, HH; Testa, JR; Cheng, JQ				Park, Sungman; Kim, Donghwa; Dan, Han C.; Chen, Huihua; Testa, Joseph R.; Cheng, Jin Q.			Identification of Akt interaction protein PHF20/TZP that transcriptionally regulates p53 (vol 287, pg 11151, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Park S, 2012, J BIOL CHEM, V287, P11151, DOI 10.1074/jbc.M111.333922	1	1	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22852	22852		10.1074/jbc.A111.333922	http://dx.doi.org/10.1074/jbc.A111.333922			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825090	Green Published, hybrid			2022-12-28	WOS:000386760600051
J	Wang, JB; Galvao, J; Beach, KM; Luo, WJ; Urrutia, RA; Goldberg, JL; Otteson, DC				Wang, Jianbo; Galvao, Joana; Beach, Krista M.; Luo, Weijia; Urrutia, Raul A.; Goldberg, Jeffrey L.; Otteson, Deborah C.			Novel roles and mechanism for Kruppel-like factor 16 (KLF16) regulation of neurite outgrowth and ephrin receptor A5 (EphA5) expression in retinal ganglion cells (vol 291, pg 18084, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NIDDK NIH HHS [R01 DK052913] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Wang JB, 2016, J BIOL CHEM, V291, P18084, DOI 10.1074/jbc.M116.732339	1	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21422	21422		10.1074/jbc.A116.732339	http://dx.doi.org/10.1074/jbc.A116.732339			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27825077	Green Published, hybrid			2022-12-28	WOS:000385999200009
J	Mojumdar, A; De March, M; Marino, F; Onesti, S				Mojumdar, Aditya; De March, Matteo; Marino, Francesca; Onesti, Silvia			The Human RecQ4 Helicase Contains a Functional RecQ C-terminal Region (RQC) That Is Essential for Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; SMALL-ANGLE SCATTERING; ESCHERICHIA-COLI RECQ; ZINC-BINDING DOMAIN; WINGED-HELIX DOMAIN; DNA HELICASE; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL MECHANISMS; BLOOMS-SYNDROME; RNA HELICASE	RecQ helicases are essential in the maintenance of genome stability. Five paralogues (RecQ1, Bloom, Werner, RecQ4, and RecQ5) are found in human cells, with distinct but overlapping roles. Mutations in human RecQ4 give rise to three distinct genetic disorders (Rothmund-Thomson, RAPADILINO, and Baller-Gerold syndromes), characterized by genetic instability, growth deficiency, and predisposition to cancer. Previous studies suggested that RecQ4 was unique because it did not seem to contain a RecQ C-terminal region (RQC) found in the other RecQ paralogues; such a region consists of a zinc domain and a winged helix domain and plays an important role in enzyme activity. However, our recent bioinformatic analysis identified in RecQ4 a putative RQC. To experimentally confirm this hypothesis, we report the purification and characterization of the catalytic core of human RecQ4. Inductively coupled plasmaatomic emission spectrometry detected the unusual presence of two zinc clusters within the zinc domain, consistent with the bioinformatic prediction. Analysis of site-directed mutants, targeting key RQC residues (putative zinc ligands and the aromatic residue predicted to be at the tip of the winged helix beta- hairpin), showed a decrease in DNA binding, unwinding, and annealing, as expected for a functional RQC domain. Low resolution structural information obtained by small angle X- ray scattering data suggests that RecQ4 interacts with DNA in a manner similar to RecQ1, whereas the winged helix domain may assume alternative conformations, as seen in the bacterial enzymes. These combined results experimentally confirm the presence of a functional RQC domain in human RecQ4.	[Mojumdar, Aditya; De March, Matteo; Marino, Francesca; Onesti, Silvia] Elettra Sincrotrone Trieste, Struct Biol Lab, I-34149 Trieste, Italy; [Mojumdar, Aditya] Univ Trieste, Dipartimento Scienze Vita, I-34127 Trieste, Italy	Elettra Sincrotrone Trieste; University of Trieste	Onesti, S (corresponding author), Elettra Sincrotrone Trieste, SS 14-km 163,5 AREA Sci Pk, I-34149 Trieste, Italy.	silvia.onesti@elettra.eu		Onesti, Silvia/0000-0002-0612-7948; Mojumdar, Aditya/0000-0003-0254-6958; De March, Matteo/0000-0002-3447-957X	Associazione Italiana per la Ricerca sul Cancro Grants [IG10646, IG14718]; ICTP TRIL fellowship programme; Cross-Border Cooperation Programme Italy-Slovenia by the European Regional Development Fund; national funds (PROTEO); European Community [283570]	Associazione Italiana per la Ricerca sul Cancro Grants(Fondazione AIRC per la ricerca sul cancro); ICTP TRIL fellowship programme; Cross-Border Cooperation Programme Italy-Slovenia by the European Regional Development Fund; national funds (PROTEO); European Community(European Commission)	This work was supported by Associazione Italiana per la Ricerca sul Cancro Grants IG10646 and IG14718, the ICTP TRIL fellowship programme, the Cross-Border Cooperation Programme Italy-Slovenia 2007-2013 by the European Regional Development Fund and national funds (PROTEO), and the European Community's Seventh Framework Programme (2007-2013) under BioStruct-X Grant Agreement 283570. The authors declare that they have no conflicts of interest with the contents of this article.	Arora A, 2016, J PATHOL, V238, P495, DOI 10.1002/path.4681; Bhattacharyya B, 2014, PROTEIN SCI, V23, P1498, DOI 10.1002/pro.2533; Capp C, 2009, J BIOL CHEM, V284, P30845, DOI 10.1074/jbc.M109.008052; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; de Renty C, 2017, AGEING RES REV, V33, P36, DOI 10.1016/j.arr.2016.05.010; Fang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069600; Fourme R., 2004, 8 INT C BIOL SYNCHR; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Guo RB, 2005, NUCLEIC ACIDS RES, V33, P3109, DOI 10.1093/nar/gki619; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Keijzers G, 2014, CRIT REV BIOCHEM MOL, V49, P463, DOI 10.3109/10409238.2014.942450; Kitano K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00366; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Larizza L, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-2; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Liu JL, 2004, J BIOL CHEM, V279, P42794, DOI 10.1074/jbc.M405008200; Lucic B, 2011, NUCLEIC ACIDS RES, V39, P1703, DOI 10.1093/nar/gkq1031; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Marino F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21501; Marino F, 2013, BIOPHYS CHEM, V177, P34, DOI 10.1016/j.bpc.2013.02.009; Mo DL, 2016, CANCER RES, V76, P3057, DOI 10.1158/0008-5472.CAN-15-2361; Oshima J., 2016, AGEING RES REV; Pike ACW, 2015, P NATL ACAD SCI USA, V112, P4286, DOI 10.1073/pnas.1417594112; Rossi ML, 2010, DNA REPAIR, V9, P796, DOI 10.1016/j.dnarep.2010.04.003; Sami F, 2016, MUTAT RES-FUND MOL M, V790, P8, DOI 10.1016/j.mrfmmm.2016.05.005; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su YR, 2010, CANCER RES, V70, P9207, DOI 10.1158/0008-5472.CAN-10-1743; Suhasini AN, 2013, ADV EXP MED BIOL, V973, P123, DOI 10.1007/978-1-4614-5037-5_6; Suzuki T, 2009, J BIOCHEM, V146, P327, DOI 10.1093/jb/mvp074; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tani H, 2010, BIOCHEM BIOPH RES CO, V393, P131, DOI 10.1016/j.bbrc.2010.01.100; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269	40	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2017	292	10					4176	4184		10.1074/jbc.M116.767954	http://dx.doi.org/10.1074/jbc.M116.767954			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EN2JZ	27998982	Green Published, hybrid			2022-12-28	WOS:000395837100016
J	Maeda, R; Tamashiro, H; Takano, K; Takahashi, H; Suzuki, H; Saito, S; Kojima, W; Adachi, N; Ura, K; Endo, T; Tamura, T				Maeda, Ryo; Tamashiro, Hiroyuki; Takano, Kazunori; Takahashi, Hiro; Suzuki, Hidefumi; Saito, Shinta; Kojima, Waka; Adachi, Noritaka; Ura, Kiyoe; Endo, Takeshi; Tamura, Taka-aki			TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell growth; p53; protein stability; transcription factor	TATA-BINDING PROTEIN; TRANSCRIPTION-FACTOR; NUCLEAR EXPORT; CANCER GENOMICS; MDM2 PROTEIN; DNA-BINDING; PHOSPHORYLATION; DEGRADATION; REPRESSION; DOMAINS	Stress-induced activation of p53 is an essential cellular response to prevent aberrant cell proliferation and cancer development. The ubiquitin ligase MDM2 promotes p53 degradation and limits the duration of p53 activation. It remains unclear, however, how p53 persistently escapes MDM2-mediated negative control for making appropriate cell fate decisions. Here we report that TBP-like protein (TLP), a member of the TBP family, is a new regulatory factor for the p53-MDM2 interplay and thus for p53 activation. We found that TLP acts to stabilize p53 protein to ensure long-lasting p53 activation, leading to potentiation of p53-induced apoptosis and senescence after genotoxic stress. Mechanistically, TLP interferes with MDM2 binding and ubiquitination of p53. Moreover, single cell imaging analysis shows that TLP depletion accelerates MDM2-mediated nuclear export of p53. We further show that a cervical cancer-derived TLP mutant has less p53 binding ability and lacks a proliferation-repressive function. Our findings uncover a role of TLP as a competitive MDM2 blocker, proposing a novel mechanism by which p53 escapes the p53-MDM2 negative feedback loop to modulate cell fate decisions.	[Maeda, Ryo; Tamashiro, Hiroyuki; Takano, Kazunori; Suzuki, Hidefumi; Kojima, Waka; Ura, Kiyoe; Endo, Takeshi; Tamura, Taka-aki] Chiba Univ, Grad Sch Sci, Dept Biol, Chiba 2638522, Japan; [Takahashi, Hiro] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan; [Saito, Shinta; Adachi, Noritaka] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan; [Adachi, Noritaka] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan; [Kojima, Waka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Tokyo 2770882, Japan	Chiba University; Chiba University; Yokohama City University; Yokohama City University; University of Tokyo	Maeda, R (corresponding author), Chiba Univ, Grad Sch Sci, Dept Biol, Chiba 2638522, Japan.	rmaeda@chiba-u.jp	Suzuki, Hidefumi/GRR-9474-2022; Takahashi, Hiro/E-6746-2013	Takahashi, Hiro/0000-0002-8230-9524	Japan Society for the Promotion of Science [272670, 26114703, 254583, 24570193]; Grants-in-Aid for Scientific Research [15J02670, 15H04323, 15H04348] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (272670 (to R. M.), 26114703 (to H. Tamashiro), 254583 (to H. S.), and 24570193 (to T. T.)). The authors declare that they have no conflicts of interest with the contents of this article.	Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHEN XB, 1993, GENE DEV, V7, P1837, DOI 10.1101/gad.7.10.1837; Cross B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228981; Fischer M, 2014, CELL CYCLE, V13, P3037, DOI 10.4161/15384101.2014.949083; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Freedman DA, 1997, MOL MED, V3, P248, DOI 10.1007/BF03401678; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Goldman SC, 1996, AM J PATHOL, V148, P1381; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Maeda R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090190; Mizuno S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-17; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Suenaga Y, 2009, J BIOL CHEM, V284, P35433, DOI 10.1074/jbc.M109.050047; Suzuki H, 2015, NUCLEIC ACIDS RES, V43, P6285, DOI 10.1093/nar/gkv576; Suzuki H, 2012, J BIOL CHEM, V287, P19792, DOI 10.1074/jbc.M112.369629; Tanaka Y, 2007, BIOCHEM BIOPH RES CO, V352, P21, DOI 10.1016/j.bbrc.2006.10.175; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Towers CG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10077; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang YL, 2014, GENE DEV, V28, P1550, DOI 10.1101/gad.245662.114; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu Y, 2014, MOL CELL, V53, P63, DOI 10.1016/j.molcel.2013.10.031; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Zehavi Y, 2015, TRANSCR-AUSTIN, V6, P1, DOI 10.1080/21541264.2015.1004980	48	6	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3201	3212		10.1074/jbc.M116.763318	http://dx.doi.org/10.1074/jbc.M116.763318			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082682	Green Published, hybrid			2022-12-28	WOS:000395538800013
J	Hu, ZW; Ma, MR; Chen, YX; Zhao, YF; Qiang, W; Li, YM				Hu, Zhi-Wen; Ma, Meng-Rong; Chen, Yong-Xiang; Zhao, Yu-Fen; Qiang, Wei; Li, Yan-Mei			Phosphorylation at Ser(8) as an Intrinsic Regulatory Switch to Regulate the Morphologies and Structures of Alzheimer's 40-residue beta-Amyloid (A beta 40) Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRION-LIKE MECHANISMS; A-BETA; ALKALINE-PHOSPHATASE; PROTEIN; STRAINS; TAU; STATE; POLYMORPHISM; PEPTIDE; PROPAGATION	Polymorphism of amyloid-beta (A beta) fibrils, implying different fibril structures, may play important pathological roles in Alzheimer's disease (AD). Morphologies of A beta fibrils were found to be sensitive to fibrillation conditions. Herein, the Ser(8)-phosphorylated A beta (pA beta), which is assumed to specially associate with symptomatic AD, is reported to modify the morphology, biophysical properties, cellular toxicity, and structures of A beta fibrils. Under the same fibrillation conditions, pA beta favors the formation of fibrils (F-p beta), which are different from the wild-type A beta fibrils (F-beta). Both F-beta and F-p beta fibrils show single predominant morphologies. Compared with F-beta, F-p beta exhibits higher propagation efficiency and higher neuronal cell toxicity. The residue-specific structural differences between the F-beta- and F-p beta-seeded A beta fibrils were identified using magic angle spin NMR. Our results suggest a potential regulatory mechanism of phosphorylation on A beta fibril formation in AD and imply that the posttranslationally modified A beta, especially the phosphorylated A beta, may be an important target for the diagnosis or treatment of AD at specific stages.	[Hu, Zhi-Wen; Ma, Meng-Rong; Chen, Yong-Xiang; Zhao, Yu-Fen; Li, Yan-Mei] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorous Chem & Chem Biol, Beijing 100084, Peoples R China; [Qiang, Wei] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Li, Yan-Mei] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Tsinghua University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Qiang, W (corresponding author), SUNY Binghamton, B28B,Sci 2,4400 Vestal Pkwy East, Binghamton, NY 13902 USA.; Li, YM (corresponding author), Tsinghua Univ, Dept Chem, Rm 331,New Life Sci Bldg, Beijing 100084, Peoples R China.	wqiang@binghamton.edu; liym@mail.tsinghua.edu.cn	CHEN, YONG-XIANG/D-4792-2017	CHEN, YONG-XIANG/0000-0003-3518-0139; Hu, zhiwen/0000-0002-2615-4900	Major State Basic Research Development Program of China [2013CB910700]; National Natural Science Foundation of China [21472109, 81661148047]; Binghamton University; National Science Foundation Major Research Instrumentation Grant [0922815]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Binghamton University; National Science Foundation Major Research Instrumentation Grant(National Science Foundation (NSF))	This work was supported by Major State Basic Research Development Program of China Grant 2013CB910700, National Natural Science Foundation of China Grants 21472109 and 81661148047, a start-up fund from Binghamton University (to W.Q.), and National Science Foundation Major Research Instrumentation Grant 0922815. The authors declare that they have no conflicts of interest with the contents of this article.	Abelein A, 2016, J AM CHEM SOC, V138, P6893, DOI 10.1021/jacs.6b04511; Akinlolu RD, 2015, BIOCHEMISTRY-US, V54, P3416, DOI 10.1021/acs.biochem.5b00321; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Chaudhuri G, 2013, INDIAN J BIOCHEM BIO, V50, P64; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen M, 2016, PRION, V10, P9, DOI 10.1080/19336896.2015.1123371; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; Du JT, 2007, FEBS J, V274, P5012, DOI 10.1111/j.1742-4658.2007.06018.x; Du JT, 2005, J AM CHEM SOC, V127, P16350, DOI 10.1021/ja054568p; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gandhi NS, 2015, ANGEW CHEM INT EDIT, V54, P6819, DOI 10.1002/anie.201501898; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jawhar S, 2011, J BIOL CHEM, V286, P38825, DOI 10.1074/jbc.R111.288308; Julien O, 2014, NAT CHEM BIOL, V10, P969, DOI [10.1038/nchembio.1639, 10.1038/NCHEMBIO.1639]; Kalapothakis JMD, 2015, BIOPHYS J, V108, P2300, DOI 10.1016/j.bpj.2015.03.021; Kardos J, 2015, J PHYS CHEM B, V119, P2946, DOI 10.1021/jp5124234; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kumar S, 2013, ACTA NEUROPATHOL, V125, P699, DOI 10.1007/s00401-013-1107-8; Kumar S, 2012, J BIOL CHEM, V287, P8641, DOI 10.1074/jbc.M111.279133; Kumar S, 2011, AGING-US, V3, P803, DOI 10.18632/aging.100362; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Ma MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37130; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Matsuzaki K, 2014, ACCOUNTS CHEM RES, V47, P2397, DOI 10.1021/ar500127z; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Milton NGN, 2005, SUB CELL BIOCHEM, V38, P381; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; O'Brien EP, 2009, J PHYS CHEM B, V113, P14421, DOI 10.1021/jp9050098; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Rahman MM, 2015, ACS CHEM BIOL, V10, P766, DOI 10.1021/cb5008663; Rezaei-Ghaleh N, 2016, J BIOL CHEM, V291, P16059, DOI 10.1074/jbc.M116.728956; Rezaei-Ghaleh N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11359; Rezaei-Ghaleh N, 2014, J AM CHEM SOC, V136, P4913, DOI 10.1021/ja411707y; Sanders DW, 2016, NEURON, V89, P433, DOI 10.1016/j.neuron.2016.01.026; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sgourakis NG, 2015, STRUCTURE, V23, P216, DOI 10.1016/j.str.2014.10.022; Shim SH, 2009, P NATL ACAD SCI USA, V106, P6614, DOI 10.1073/pnas.0805957106; Spirig T, 2014, NEURODEGENER DIS, V14, P151, DOI 10.1159/000363623; Stohr J, 2014, P NATL ACAD SCI USA, V111, P10329, DOI 10.1073/pnas.1408968111; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tanaka M, 2015, NAT CHEM BIOL, V11, P373, DOI 10.1038/nchembio.1818; Tycko R, 2015, NEURON, V86, P632, DOI 10.1016/j.neuron.2015.03.017; Upadhaya AR, 2014, BRAIN, V137, P887, DOI 10.1093/brain/awt362; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Xu F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13527; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yin RH, 2014, CURR ALZHEIMER RES, V11, P755, DOI 10.2174/156720501108140910121425; Zalatan JG, 2006, J AM CHEM SOC, V128, P1293, DOI 10.1021/ja056528r; Zhang S, 2013, P NATL ACAD SCI USA, V110, P2798, DOI 10.1073/pnas.1209955110; Zhou LX, 2006, BIOCHEM BIOPH RES CO, V348, P637, DOI 10.1016/j.bbrc.2006.07.099; Zorn JA, 2011, J AM CHEM SOC, V133, P19630, DOI 10.1021/ja208350u	79	20	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2611	2623		10.1074/jbc.M116.757179	http://dx.doi.org/10.1074/jbc.M116.757179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28031462	Green Published, hybrid			2022-12-28	WOS:000395535100005
J	Rahman, A; Haugh, JM				Rahman, Anisur; Haugh, Jason M.			Kinetic Modeling and Analysis of the Akt/Mechanistic Target of Rapamycin Complex 1 (mTORC1) Signaling Axis Reveals Cooperative, Feedforward Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TSC2 GAP ACTIVITY; TUBEROUS SCLEROSIS; CELL-GROWTH; RHEB; PHOSPHORYLATION; ACTIVATION; PROTEIN; KINASE; ERK; BINDING	Mechanistic target of rapamycin complex 1)mTORC1) controls biosynthesis and has been implicated in uncontrolled cell growth in cancer. Although many details of mTORC1 regulation are well understood, a systems- level, predictive framework synthesizing those details is currently lacking. We constructed various mathematical models of mTORC1 activation mediated by Akt and aligned the model outputs to kinetic data acquired for growth factor- stimulated cells. A model based on a putative feedforward loop orchestrated by Akt consistently predicted how the pathway was altered by depletion of key regulatory proteins. Analysis of the successful model also elucidates two dynamical motifs: neutralization of a negative regulator, which characterizes how Akt indirectly activates mTORC1, and seesaw enzyme regulation, which describes how activated and inhibited states of mTORC1 are controlled in concert to produce a nonlinear, ultrasensitive response. Such insights lend quantitative understanding of signaling networks and their precise manipulation in various contexts.	[Rahman, Anisur; Haugh, Jason M.] North Carolina State Univ, Dept Chem & Biomol Engn, Campus Box 7905, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Haugh, JM (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Campus Box 7905, Raleigh, NC 27695 USA.	jason_haugh@ncsu.edu		Haugh, Jason/0000-0002-2476-4027	National Institutes of Health [R01-GM088987]; National Science Foundation [1330746]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01-GM088987 (to J.M.H.) and National Science Foundation Grant 1330746. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; Everett RD, 2010, J VIROL, V84, P3695, DOI 10.1128/JVI.00021-10; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Janes KA, 2013, J CELL SCI, V126, P1913, DOI 10.1242/jcs.112045; Kolch W, 2015, NAT REV CANCER, V15, P515, DOI 10.1038/nrc3983; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nascimento EBM, 2010, CELL SIGNAL, V22, P961, DOI 10.1016/j.cellsig.2010.02.002; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rahman A, 2014, BIOPHYS J, V107, pL29, DOI 10.1016/j.bpj.2014.10.003; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang XM, 2011, J MOL CELL BIOL, V3, P206, DOI 10.1093/jmcb/mjq038	31	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2866	2872		10.1074/jbc.M116.761205	http://dx.doi.org/10.1074/jbc.M116.761205			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28069808	Green Published, hybrid			2022-12-28	WOS:000395535100026
J	Toksoy, A; Sennefelder, H; Adam, C; Hofmann, S; Trautmann, A; Goebeler, M; Schmidt, M				Toksoy, Atiye; Sennefelder, Helga; Adam, Christian; Hofmann, Sonja; Trautmann, Axel; Goebeler, Matthias; Schmidt, Marc			Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLERGIC CONTACT-DERMATITIS; HYPERSENSITIVITY REACTIONS; NALP3 INFLAMMASOME; GENE-EXPRESSION; PEPTIDE REPERTOIRE; INNATE IMMUNITY; MECHANISMS; SELF; INDUCTION; MONOCYTES	There is experimental and clinical evidence that some exanthematous allergic drug hypersensitivity reactions are mediated by drug- specific T cells. We hypothesized that the capacity of certain drugs to directly stimulate the innate immune system may contribute to generate drug- specific T cells. Here we analyzed whether abacavir, an HIV-1 reverse transcriptase inhibitor often inducing severe delayed- type drug hypersensitivity, can trigger innate immune activation that may contribute to its allergic potential. We show that abacavir fails to generate direct innate immune activation in human monocytes but potently triggers IL- 1 beta release upon pro- inflammatory priming with phorbol ester or Toll- like receptor stimulation. IL- 1 beta processing and secretion were sensitive to Caspase-1 inhibition, NLRP3 knockdown, and K+ efflux inhibition and were not observed with other non-allergenic nucleoside reverse transcriptase inhibitors, identifying abacavir as a specific inflammasome activator. It further correlated with dose-dependent mitochondrial reactive oxygen species production and cytotoxicity, indicating that inflammasome activation resulted from mitochondrial damage. However, both NLRP3 depletion and inhibition of K+ efflux mitigated abacavir-induced mitochondrial reactive oxygen species production and cytotoxicity, suggesting that these processes were secondary to NLRP3 activation. Instead, depletion of cardiolipin synthase 1 abolished abacavir-induced IL-1 beta secretion, suggesting that mitochondrial cardiolipin release may trigger abacavir-induced inflammasome activation. Our data identify abacavir as a novel inflammasome-stimulating drug allergen. They implicate a potential contribution of innate immune activation to medication-induced delayed-type hypersensitivity, which may stimulate new concepts for treatment and prevention of drug allergies.	[Toksoy, Atiye; Sennefelder, Helga; Adam, Christian; Hofmann, Sonja; Trautmann, Axel; Goebeler, Matthias; Schmidt, Marc] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Josef Schneider Str 2, D-97080 Wurzburg, Germany	University of Wurzburg	Schmidt, M (corresponding author), Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	schmidt_M11@ukw.de	Schmidt, Marc/E-8821-2010	Schmidt, Marc/0000-0002-8643-1615; Adam, Christian/0000-0001-7721-4144	Department of Dermatology, University Hospital Wurzburg, Germany	Department of Dermatology, University Hospital Wurzburg, Germany	This work was supported by the Department of Dermatology, University Hospital Wurzburg, Germany. The authors declare that they have no conflicts of interest with the contents of this article.	Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Cutrell AG, 2004, ANN PHARMACOTHER, V38, P2171, DOI 10.1345/aph.1E202; Czymai T, 2010, J BIOL CHEM, V285, P10163, DOI 10.1074/jbc.M109.056663; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; FENTON MJ, 1988, J IMMUNOL, V140, P2267; Fowler BJ, 2014, SCIENCE, V346, P1000, DOI 10.1126/science.1261754; Guo HT, 2014, J BIOL CHEM, V289, P21716, DOI 10.1074/jbc.M114.566620; Hernandez JC, 2014, INTERVIROLOGY, V57, P36, DOI 10.1159/000353902; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lucas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117160; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Martin SF, 2011, ALLERGY, V66, P1152, DOI 10.1111/j.1398-9995.2011.02652.x; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; Pavlos R, 2015, ANNU REV MED, V66, P439, DOI 10.1146/annurev-med-050913-022745; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Schmidt M, 2015, J DTSCH DERMATOL GES, V13, P653, DOI 10.1111/ddg.12673; Schrijvers R, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0073-8; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Weston JK, 2014, CHEM RES TOXICOL, V27, P949, DOI 10.1021/tx5001333; White KD, 2015, J ALLERGY CLIN IMMUN, V136, P219, DOI 10.1016/j.jaci.2015.05.050; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	41	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2805	2814	7	10.1074/jbc.M116.749473	http://dx.doi.org/10.1074/jbc.M116.749473			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28057759	Green Published, hybrid			2022-12-28	WOS:000395535100021
J	Halmo, SM; Singh, D; Patel, S; Wang, S; Edlin, M; Boons, GJ; Moremen, KW; Live, D; Wells, L				Halmo, Stephanie M.; Singh, Danish; Patel, Sneha; Wang, Shuo; Edlin, Melanie; Boons, Geert-Jan; Moremen, Kelley W.; Live, David; Wells, Lance			Protein O-Linked Mannose beta-1,4-N-Acetylglucosaminyl-transferase 2 (POMGNT2) Is a Gatekeeper Enzyme for Functional Glycosylation of alpha-Dystroglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSYLATION PATHWAY; MUSCULAR-DYSTROPHY; GLYCAN STRUCTURES; LAMININ-BINDING; SKELETAL-MUSCLE; EXPRESSION; SEQUENCE; IDENTIFICATION; SUBSTRATE	Disruption of theO-mannosylation pathway involved in functional glycosylation of alpha-dystroglycan gives rise to congenital muscular dystrophies. Protein O-linked mannose beta-1,4-Nacetylglucosaminyltransferase 2 (POMGNT2) catalyzes the first step toward the functional matriglycan structure on alpha-dystroglycan that is responsible for binding extracellular matrix proteins and certain arenaviruses. Alternatively, protein O-linked mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGNT1) catalyzes the first step toward other various glycan structures present on alpha-dystroglycan of unknown function. Here, we demonstrate that POMGNT1 is promiscuous for O-mannosylated peptides, whereas POMGNT2 displays significant primary amino acid selectivity near the site of O-mannosylation. We define a POMGNT2 acceptor motif, conserved among 59 vertebrate species, in alpha-dystroglycan that when engineered into a POMGNT1-only site is sufficient to convert the O-mannosylated peptide to a substrate for POMGNT2. Additionally, an acceptor glycopeptide is a less efficient substrate forPOMGNT2 when two of the conserved amino acids are replaced. These findings begin to define the selectivity of POMGNT2 and suggest that this enzyme functions as a gatekeeper enzyme to prevent the vast majority of O-mannosylated sites on proteins from becoming modified with glycan structures functional for binding laminin globular domain-containing proteins.	[Halmo, Stephanie M.; Singh, Danish; Patel, Sneha; Wang, Shuo; Edlin, Melanie; Boons, Geert-Jan; Moremen, Kelley W.; Live, David; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Halmo, Stephanie M.; Singh, Danish; Moremen, Kelley W.; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Edlin, Melanie; Boons, Geert-Jan] Univ Georgia, Dept Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Wells, L (corresponding author), Univ Georgia, Dept Biochem, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu	Boons, Geert-Jan P H/J-3211-2016; Moremen, Kelley/AAD-4661-2019	Boons, Geert-Jan P H/0000-0003-3111-5954; Halmo, Stephanie/0000-0001-8369-3620; Wells, Lance/0000-0003-4956-5363	National Institutes of Health [R01GM111939, P01GM107012, P41GM103490, P41GM103390, S10RR027155]; National Institutes of Health Training Grant [T32GM107004]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, P41GM103490, R01GM111939, P01GM107012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM111939 (to D. L. and L. W.), P01GM107012 (to G.-J. B., K. W. M., and L. W.), P41GM103490 (to K. W. M. and L. W.), P41GM103390 (to K. W. M. and D. L.), and S10RR027155 for purchase of the peptide synthesizer (to D. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health Training Grant T32GM107004.	Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Lee JK, 2012, J BIOL CHEM, V287, P28526, DOI 10.1074/jbc.M112.367565; Liu MA, 2008, BIOPOLYMERS, V90, P358, DOI 10.1002/bip.20847; Live D, 2013, CHEMBIOCHEM, V14, P2392, DOI 10.1002/cbic.201300417; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Mo KF, 2011, J AM CHEM SOC, V133, P14418, DOI 10.1021/ja205473q; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Praissman JL, 2014, BIOCHEMISTRY-US, V53, P3066, DOI 10.1021/bi500153y; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Takahashi S, 2001, GLYCOBIOLOGY, V11, P37, DOI 10.1093/glycob/11.1.37; Vandersall-Nairn AS, 1998, GLYCOBIOLOGY, V8, P1183, DOI 10.1093/glycob/8.12.1183; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Voglmeir J, 2011, BIOCHEM J, V436, P447, DOI 10.1042/BJ20101059; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978; Yagi H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03288; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	38	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2101	2109		10.1074/jbc.M116.764712	http://dx.doi.org/10.1074/jbc.M116.764712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27932460	Green Published, hybrid			2022-12-28	WOS:000395530300005
J	Hantouche, C; Williamson, B; Valinsky, WC; Solomon, J; Shrier, A; Young, JC				Hantouche, Christine; Williamson, Brittany; Valinsky, William C.; Solomon, Joshua; Shrier, Alvin; Young, Jason C.			Bag1 Co-chaperone Promotes TRC8 E3 Ligase-dependent Degradation of Misfolded Human Ether a Go-Go-related Gene (hERG) Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; SIGNAL PEPTIDE PEPTIDASE; UBIQUITIN LIGASE; QUALITY-CONTROL; RING FINGER; K+ CHANNELS; PROTEIN; HSP70; GP78; TRAFFICKING	Cardiac long QT syndrome type 2 is caused by mutations in the human ether a go-go-related gene (hERG) potassium channel, many of which cause misfolding and degradation at the endoplasmic reticulum instead of normal trafficking to the cell surface. The Hsc70/Hsp70 chaperones assist the folding of the hERG cytosolic domains. Here, we demonstrate that the Hsp70 nucleotide exchange factor Bag1 promotes hERG degradation by the ubiquitin-proteasome system at the endoplasmic reticulum to regulate hERG levels and channel activity. Dissociation of hERG complexes containing Hsp70 and the E3 ubiquitin ligase CHIP requires the interaction of Bag1 with Hsp70, but this does not involve the Bag1 ubiquitin-like domain. The interaction with Bag1 then shifts hERG degradation to the membrane-anchored E3 ligase TRC8 and its E2-conjugating enzyme Ube2g2, as determined by siRNA screening. TRC8 interacts through the transmembrane region with hERG and decreases hERG functional expression. TRC8 also mediates degradation of the mis-folded hERG-G601S disease mutant, but pharmacological stabilization of the mutant structure prevents degradation. Our results identify TRC8 as a previously unknown Hsp70-independent quality control E3 ligase for hERG.	[Hantouche, Christine; Valinsky, William C.; Solomon, Joshua; Shrier, Alvin] McGill Univ, Dept Physiol, Montreal, PQ H3G 0B1, Canada; [Williamson, Brittany; Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Hantouche, Christine; Williamson, Brittany; Valinsky, William C.; Solomon, Joshua; Shrier, Alvin; Young, Jason C.] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University; McGill University	Shrier, A (corresponding author), McGill Univ, Dept Physiol, 3649 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.; Young, JC (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler,Rm 467, Montreal, PQ H3G 1Y6, Canada.	alvin.shrier@mcgill.ca; jason.young2@mcgill.ca		Valinsky, Corey/0000-0001-7736-9146	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by the Canadian Institutes of Health Research.	Aizawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11379; Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Apaja PM, 2013, MOL BIOL CELL, V24, P3787, DOI 10.1091/mbc.E13-07-0417; Baaklini I, 2012, J BIOL CHEM, V287, P41939, DOI 10.1074/jbc.M112.413278; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Brauweiler A, 2007, ONCOGENE, V26, P2263, DOI 10.1038/sj.onc.1210017; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen CY, 2014, EMBO J, V33, P2492, DOI 10.15252/embj.201488208; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057282; Gemmill RM, 2002, ONCOGENE, V21, P3507, DOI 10.1038/sj.onc.1205437; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Hsu JL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004811; Jehle J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.77; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kanelakis KC, 1999, J BIOL CHEM, V274, P34134, DOI 10.1074/jbc.274.48.34134; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Knapp RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085415; Knapp RT, 2012, BIOCHEM J, V441, P297, DOI 10.1042/BJ20111456; Li PL, 2015, J MOL CELL CARDIOL, V86, P138, DOI 10.1016/j.yjmcc.2015.07.018; Li PL, 2011, CIRC RES, V108, P458, DOI 10.1161/CIRCRESAHA.110.227835; Lin PH, 2013, ONCOGENE, V32, P2325, DOI 10.1038/onc.2012.244; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Mata-Greenwood E, 2013, ARTERIOSCL THROM VAS, V33, P1046, DOI 10.1161/ATVBAHA.113.301247; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Sroka K, 2009, J NEUROCHEM, V111, P801, DOI 10.1111/j.1471-4159.2009.06363.x; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Sultana R, 2013, FEBS OPEN BIO, V3, P394, DOI 10.1016/j.fob.2013.09.003; Sultana R, 2012, EXP CELL RES, V318, P53, DOI 10.1016/j.yexcr.2011.09.010; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Taldone T, 2014, TRENDS PHARMACOL SCI, V35, P48, DOI 10.1016/j.tips.2014.09.001; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	64	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2287	2300		10.1074/jbc.M116.752618	http://dx.doi.org/10.1074/jbc.M116.752618			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27998983	Green Published, hybrid			2022-12-28	WOS:000395530300021
J	Hichino, A; Okamoto, M; Taga, S; Akizuki, R; Endo, S; Matsunaga, T; Ikari, A				Hichino, Asami; Okamoto, Miki; Taga, Saeko; Akizuki, Risa; Endo, Satoshi; Matsunaga, Toshiyuki; Ikari, Akira			Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CANCER-CELLS; TIGHT JUNCTIONS; GASTRIC CARCINOGENESIS; UP-REGULATION; GROWTH; PROGNOSIS; CARCINOMA; PROMOTES; PATHWAY	Claudin-2 is highly expressed in lung adenocarcinoma tissues and increases proliferation in adenocarcinoma cells. The chemicals that reduce claudin-2 expression may have anti-cancer effects, but such therapeutic medicines have not been developed. We found that azacitidine (AZA), a DNA methylation inhibitor, and trichostatin A (TSA) and sodium butyrate (NaB), histone deacetylase (HDAC) inhibitors, decrease claudin-2 levels. The effect of AZA was mediated by the inhibition of phosphorylated Akt and NF-kappa B. LY-294002, an inhibitor of phosphatidylinositol 3-kinase (PI3K), and BAY 11-7082, an NF-kappa B inhibitor, decreased claudin-2 levels. The reporter activity of claudin-2 was decreased by AZA and LY-294002, which was blocked by the mutation in a putative NF-kappa B-binding site. NF-kappa B bound to the promoter region of claudin-2, which was inhibited by AZA and LY-294002. AZA is suggested to decrease the claudin-2 mRNA level mediated by the inhibition of a PI3K/Akt/NF-kappa B pathway. TSA and NaB did not change phosphorylated Akt and NF-kappa B levels. Furthermore, these inhibitors did not change the reporter activity of claudin-2 but decreased the stability of claudin-2 mRNA mediated by the elevation of miR-497 microRNA. The binding of histone H3 to the promoter region of miR-497 was inhibited by TSA and NaB, whereas that of claudin-2 was not. These results suggest that HDAC inhibitors decrease claudin-2 levels mediated by the elevation of miR-497 expression. Cell proliferation was additively decreased by AZA, TSA, and NaB, which was partially rescued by ectopic expression of claudin-2. We suggest that epigenetic inhibitors suppress the abnormal proliferation of lung adenocarcinoma cells highly expressing claudin-2.	[Hichino, Asami; Okamoto, Miki; Taga, Saeko; Akizuki, Risa; Endo, Satoshi; Matsunaga, Toshiyuki; Ikari, Akira] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan	Gifu Pharmaceutical University	Ikari, A (corresponding author), Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	ikari@gifu-pu.ac.jp	Endo, Satoshi/F-8059-2011	Endo, Satoshi/0000-0003-0578-9672				Agarwal R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008002; Ansari J, 2016, TRANSL LUNG CANCER R, V5, P155, DOI 10.21037/tlcr.2016.02.02; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Buurman R, 2012, GASTROENTEROLOGY, V143, P811, DOI 10.1053/j.gastro.2012.05.033; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Di Cello F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068630; Flores AR, 2014, J COMP PATHOL, V150, P169, DOI 10.1016/j.jcpa.2013.09.004; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Guo ST, 2013, ONCOGENE, V32, P1910, DOI 10.1038/onc.2012.214; Halasz J, 2006, HUM PATHOL, V37, P555, DOI 10.1016/j.humpath.2005.12.015; Hamm CA, 2015, PHARMACOL THERAPEUT, V151, P72, DOI 10.1016/j.pharmthera.2015.03.003; Han ZY, 2015, ONCOTARGET, V6, P13149, DOI 10.18632/oncotarget.3693; Ikari A, 2014, BBA-MOL CELL RES, V1843, P2079, DOI 10.1016/j.bbamcr.2014.05.017; Ikari A, 2012, BBA-MOL CELL RES, V1823, P1110, DOI 10.1016/j.bbamcr.2012.04.005; Ikari A, 2011, LIFE SCI, V88, P628, DOI 10.1016/j.lfs.2011.02.002; Kim HS, 2012, PATHOBIOLOGY, V79, P84, DOI 10.1159/000334340; Kinugasa T, 2007, ANTICANCER RES, V27, P3729; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Nakayama F, 2008, PATHOBIOLOGY, V75, P177, DOI 10.1159/000124978; Nguyen TTP, 2011, BREAST CANCER RES TR, V130, P73, DOI 10.1007/s10549-010-1304-2; Park YJ, 2011, PROG DRUG RES, V67, P25, DOI 10.1007/978-3-7643-8989-5_2; Patonai A, 2011, VIRCHOWS ARCH, V458, P679, DOI 10.1007/s00428-011-1077-y; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Sampath D, 2012, BLOOD, V119, P1162, DOI 10.1182/blood-2011-05-351510; Schnermann J, 2013, AM J PHYSIOL-RENAL, V305, pF1352, DOI 10.1152/ajprenal.00342.2013; Song X, 2008, HISTOL HISTOPATHOL, V23, P673, DOI 10.14670/HH-23.673; Sonoki H, 2015, NUTRIENTS, V7, P4578, DOI 10.3390/nu7064578; Tabaries S, 2011, ONCOGENE, V30, P1318, DOI 10.1038/onc.2010.518; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Valente S, 2014, J MED CHEM, V57, P6259, DOI 10.1021/jm500303u; Valente S, 2013, CHEMMEDCHEM, V8, P800, DOI 10.1002/cmdc.201300005; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Xin S, 2007, ONCOLOGY-BASEL, V73, P357, DOI 10.1159/000135351; Yang G, 2016, ONCOTARGET, V7, P55900, DOI 10.18632/oncotarget.10152; Zhao WY, 2013, BIOCHEM BIOPH RES CO, V435, P466, DOI 10.1016/j.bbrc.2013.05.010; Zochbauer-Muller S, 2001, CANCER RES, V61, P249	48	26	28	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2411	2421		10.1074/jbc.M116.762807	http://dx.doi.org/10.1074/jbc.M116.762807			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28057758	Green Published, hybrid			2022-12-28	WOS:000395530300030
J	Battram, AM; Durrant, TN; Agbani, EO; Heesom, KJ; Paul, DS; Piatt, R; Poole, AW; Cullen, PJ; Bergmeier, W; Moore, SF; Hers, I				Battram, Anthony M.; Durrant, Tom N.; Agbani, Ejaife O.; Heesom, Kate J.; Paul, David S.; Piatt, Raymond; Poole, Alastair W.; Cullen, Peter J.; Bergmeier, Wolfgang; Moore, Samantha F.; Hers, Ingeborg			The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3) Binder Rasa3 Regulates Phosphoinositide 3-kinase (PI3K)-dependent Integrin alpha(II)b beta(3) Outside-in Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; integrin; phosphatidylinositide 3-kinase (PI3K); platelet; Ras-related protein 1 (Rap1); GAP1IP4BP; Rasa3	VON-WILLEBRAND-FACTOR; PROTEIN-KINASE-C; HUMAN PLATELETS; THROMBUS FORMATION; GAP1 FAMILY; ACTIVATION; PHOSPHORYLATION; RAP1B; GAP1(IP4BP); FIBRINOGEN	The class I PI3K family of lipid kinases plays an important role in integrin (IIb3) function, thereby supporting thrombus growth and consolidation. Here, we identify Ras/Rap1GAP Rasa3 (GAP1(IP4BP)) as a major phosphatidylinositol 3,4,5-trisphosphate-binding protein in human platelets and a key regulator of integrin (IIb3) outside-in signaling. We demonstrate that cytosolic Rasa3 translocates to the plasma membrane in a PI3K-dependent manner upon activation of human platelets. Expression of wild-type Rasa3 in integrin (IIb3)-expressing CHO cells blocked Rap1 activity and integrin (IIb3)-mediated spreading on fibrinogen. In contrast, Rap1GAP-deficient (P489V) and Ras/Rap1GAP-deficient (R371Q) Rasa3 had no effect. We furthermore show that two Rasa3 mutants (H794L and G125V), which are expressed in different mouse models of thrombocytopenia, lack both Ras and Rap1GAP activity and do not affect integrin (IIb3)-mediated spreading of CHO cells on fibrinogen. Platelets from thrombocytopenic mice expressing GAP-deficient Rasa3 (H794L) show increased spreading on fibrinogen, which in contrast to wild-type platelets is insensitive to PI3K inhibitors. Together, these results support an important role for Rasa3 in PI3K-dependent integrin (IIb3)-mediated outside-in signaling and cell spreading.	[Battram, Anthony M.; Durrant, Tom N.; Agbani, Ejaife O.; Poole, Alastair W.; Moore, Samantha F.; Hers, Ingeborg] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Heesom, Kate J.; Cullen, Peter J.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Paul, David S.; Piatt, Raymond; Bergmeier, Wolfgang] Univ North Carolina Chapel Hill, McAllister Heart Inst, Chapel Hill, NC 27514 USA; [Bergmeier, Wolfgang] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA	University of Bristol; University of Bristol; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hers, I (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	i.hers@bristol.ac.uk	Hers, Ingeborg/ABG-3357-2020; Battram, Anthony/AAC-8243-2020; Agbani, Ejaife O./AAC-9418-2020	Battram, Anthony/0000-0002-9179-0639; Moore, Samantha/0000-0003-0944-7055; Cullen, Peter/0000-0002-9070-8349; Durrant, Tom N/0000-0002-0503-9364; Hers, Ingeborg/0000-0002-6467-5715; Poole, Alastair/0000-0002-0868-297X	British Heart Foundation [FS/12/22/29510, PG/12/79/29884, PG/13/11/30016, PG/14/3/30565]; National Institutes of Health [R01 HL121650]; British Heart Foundation [PG/16/3/31833, PG/16/21/32083] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121650] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by British Heart Foundation Grants FS/12/22/29510, PG/12/79/29884, PG/13/11/30016, and PG/14/3/30565 and National Institutes of Health Grant R01 HL121650. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Blair TA, 2014, ARTERIOSCL THROM VAS, V34, P1681, DOI 10.1161/ATVBAHA.114.303954; Blanc L, 2012, P NATL ACAD SCI USA, V109, P12099, DOI 10.1073/pnas.1204948109; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Canault M, 2014, J EXP MED, V211, P1346, DOI 10.1084/jem.20130477; Canobbio I, 2009, BLOOD, V114, P2193, DOI 10.1182/blood-2009-03-208074; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Consonni A, 2012, BLOOD, V119, P847, DOI 10.1182/blood-2011-07-364992; Cozier GE, 2000, J BIOL CHEM, V275, P28261; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; CULLEN PJ, 1995, BIOCHEM J, V305, P139, DOI 10.1042/bj3050139; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Gilio K, 2009, J BIOL CHEM, V284, P33750, DOI 10.1074/jbc.M109.048439; Goggs R, 2013, J BIOL CHEM, V288, P34217, DOI 10.1074/jbc.M113.504100; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Guidetti Gianni Francesco, 2012, J Signal Transduct, V2012, P412089, DOI 10.1155/2012/412089; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Heraud JM, 1998, J BIOL CHEM, V273, P17817, DOI 10.1074/jbc.273.28.17817; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Iwashita S, 2007, J BIOL CHEM, V282, P3413, DOI 10.1074/jbc.C600293200; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; JACKSON SP, 1994, J BIOL CHEM, V269, P27093; Ji P, 1999, BBA-MOL CELL RES, V1448, P543, DOI 10.1016/S0167-4889(98)00160-8; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Kupzig S, 2009, MOL CELL BIOL, V29, P3929, DOI 10.1128/MCB.00427-09; Laurent Pierre-Alexandre, 2014, Advances in Biological Regulation, V54, P162, DOI 10.1016/j.jbior.2013.09.006; Lockyer PJ, 1997, CURR BIOL, V7, P1007, DOI 10.1016/S0960-9822(06)00423-4; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; Molina-Ortiz P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004420; Moore SF, 2013, BLOOD, V121, P1209, DOI 10.1182/blood-2012-05-431288; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; Shock DD, 1997, BIOCHEM J, V321, P525, DOI 10.1042/bj3210525; Stefanini L, 2015, J CLIN INVEST, V125, P1419, DOI 10.1172/JCI77993; Stefanini L, 2012, ARTERIOSCL THROM VAS, V32, P434, DOI 10.1161/ATVBAHA.111.239194; Tulasne D, 2002, EUR J BIOCHEM, V269, P1511, DOI 10.1046/j.1432-1033.2002.02798.x; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Williams CM, 2014, PLATELETS, V25, P62, DOI 10.3109/09537104.2012.761686; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Yi WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102394; Zhang GY, 2011, J BIOL CHEM, V286, P39466, DOI 10.1074/jbc.M111.239608	46	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1691	1704		10.1074/jbc.M116.746867	http://dx.doi.org/10.1074/jbc.M116.746867			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27903653	Green Published, hybrid			2022-12-28	WOS:000395515600013
J	Szczyrba, J; Niesen, A; Wagner, M; Wandernoth, PM; Aumuller, G; Wennemuth, G				Szczyrba, Jaroslaw; Niesen, Anne; Wagner, Mathias; Wandernoth, Petra M.; Aumueller, Gerhard; Wennemuth, Gunther			Neuroendocrine Cells of the Prostate Derive from the Neural Crest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; neuroendocrinology; neurogenesis; prostate; Wnt pathway; neural crest; neuroendocrine cells; WNT1	UROGENITAL DUCT SYSTEM; REGIONAL-DISTRIBUTION; ENDOCRINE-CELLS; CHROMOGRANIN-A; MALE-RAT; DIFFERENTIATION; ORIGIN; CANCER; CALCITONIN; PEPTIDE	The histogenesis of prostatic neuroendocrine cells is controversial: a stem cell hypothesis with a urogenital sinus-derived progeny of all prostatic epithelial cells is opposed by a dual origin hypothesis, favoring the derivation of neuroendocrine cells from the neural crest, with the secretory and basal cells being of urogenital sinus origin. A computer-assisted 3D reconstruction was used to analyze the distribution of chromogranin A immunoreactive cells in serial sections of human fetal prostate specimens (gestation weeks 18 and 25). Immunohistochemical double labeling studies with YFP and serotonin antisera combined with electron microscopy were carried out on double-transgenic Wnt1-Cre/ROSA26-YFP mice showing stable YFP expression in all neural crest-derived cell populations despite loss of Wnt1 expression. 3D reconstruction of the distribution pattern of neuroendocrine cells in the human fetal prostate indicates a migration of paraganglionic cells passing the stroma and reaching the prostate ducts. Double-transgenic mice showed 55% double labeling of periurethral neuroendocrine cells expressing both serotonin and YFP, whereas single serotonin labeling was observed in 36% and exclusive YFP labeling in 9%. The results favor the assumption of a major fraction of neural crest-derived neuroendocrine cells in both the human and murine prostates.	[Szczyrba, Jaroslaw; Niesen, Anne; Wandernoth, Petra M.; Wennemuth, Gunther] Univ Duisburg Essen, Univ Hosp, Inst Anat, D-45147 Essen, Germany; [Wagner, Mathias] Univ Saarland, Sch Med, Inst Pathol, D-66421 Homburg, Germany; [Aumueller, Gerhard] Philipps Univ Marburg, Dept Anat & Cell Biol, Robert Koch Str 8, D-35037 Marburg, Germany	University of Duisburg Essen; Saarland University; Philipps University Marburg	Wennemuth, G (corresponding author), Univ Duisburg Essen, Univ Hosp, Inst Anat, D-45147 Essen, Germany.	gunther.wennemuth@uk-essen.de	Dankert, Jaroslaw Thomas/A-2400-2017; Dankert, Jaroslaw Thomas/GWV-8070-2022	Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Wennemuth, Gunther/0000-0003-3313-2475				ABRAHAMSSON PA, 1989, PROSTATE, V14, P71, DOI 10.1002/pros.2990140109; Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; ABRAHAMSSON PA, 1989, PATHOL RES PRACT, V185, P373, DOI 10.1016/S0344-0338(89)80016-0; Aumuller G, 2012, PROSTATE, V72, P326, DOI 10.1002/pros.21437; Aumuller G, 2001, PROSTATE, V46, P108, DOI 10.1002/1097-0045(20010201)46:2<108::AID-PROS1014>3.0.CO;2-9; Aumuller G, 1999, UROLOGY, V53, P1041, DOI 10.1016/S0090-4295(98)00631-1; Aumuller G., 1979, HDB MIKROSKOPISCHEN, P1; Bjerknes M, 2012, DEV BIOL, V362, P194, DOI 10.1016/j.ydbio.2011.12.009; Bonkhoff H, 1996, PROSTATE, V28, P98; BONKHOFF H, 1995, HUM PATHOL, V26, P167, DOI 10.1016/0046-8177(95)90033-0; Cassiman D, 2006, J HEPATOL, V44, P1098, DOI 10.1016/j.jhep.2005.09.023; Deckmann K, 2015, INT IMMUNOPHARMACOL, V29, P51, DOI 10.1016/j.intimp.2015.05.038; Deeble PD, 2007, CANCER RES, V67, P3663, DOI 10.1158/0008-5472.CAN-06-2616; di, 1992, CANCER, V70, P254; DISANTAGNESE PA, 1985, ARCH PATHOL LAB MED, V109, P607; DISANTAGNESE PA, 1989, ARCH PATHOL LAB MED, V113, P790; DISANTAGNESE PA, 1984, ARCH PATHOL LAB MED, V108, P693; Diwakar G, 2015, GLYCOCONJUGATE J, V32, P413, DOI 10.1007/s10719-015-9605-7; Erasmus CE, 2002, CAN J NEUROL SCI, V29, P375, DOI 10.1017/S0317167100002250; Fixemer T, 2002, PROSTATE, V53, P118, DOI 10.1002/pros.10133; GNESSI L, 1984, BIOCHEM BIOPH RES CO, V125, P199, DOI 10.1016/S0006-291X(84)80354-X; Harris ML, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003644; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P462, DOI 10.1111/j.1755-148X.2011.00845.x; Ivanov VN, 2015, APOPTOSIS, V20, P996, DOI 10.1007/s10495-015-1131-3; Johansson E, 2015, DEVELOPMENT, V142, P3519, DOI 10.1242/dev.126581; KIRKLAND SC, 1988, CANCER, V61, P1359, DOI 10.1002/1097-0142(19880401)61:7<1359::AID-CNCR2820610714>3.0.CO;2-0; KRIJNEN JLM, 1993, HISTOCHEMISTRY, V100, P393, DOI 10.1007/BF00268938; Krivova YS, 2014, B EXP BIOL MED+, V156, P865, DOI 10.1007/s10517-014-2471-7; Larue L, 2013, CELL MOL LIFE SCI, V70, P1067, DOI 10.1007/s00018-012-1112-4; Miskovic J, 2015, ACTA HISTOCHEM, V117, P451, DOI 10.1016/j.acthis.2015.02.002; Murai H, 2015, DEV GROWTH DIFFER, V57, P232, DOI 10.1111/dgd.12201; Murase D, 2015, BIOL OPEN, V4, P1213, DOI 10.1242/bio.011973; Rovasio RA, 2012, EUR J CELL BIOL, V91, P375, DOI 10.1016/j.ejcb.2011.12.007; SJOBERG HE, 1980, ACTA PHYSIOL SCAND, V110, P101, DOI 10.1111/j.1748-1716.1980.tb06636.x; SUNDAY ME, 1988, LAB INVEST, V59, P5; Szeder V, 2003, DEV BIOL, V253, P258, DOI 10.1016/S0012-1606(02)00015-5; Uchida K, 2006, PROSTATE, V66, P536, DOI 10.1002/pros.20369; Vashchenko N, 2005, EUR UROL, V47, P147, DOI 10.1016/j.eururo.2004.09.007; Wakui S, 2015, PROSTATE, V75, P646, DOI 10.1002/pros.22948; Xing NZ, 2001, PROSTATE, V48, P7, DOI 10.1002/pros.1076; Yang J, 2014, EXP CELL RES, V320, P54, DOI 10.1016/j.yexcr.2013.09.017	41	25	25	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2021	2031		10.1074/jbc.M116.755082	http://dx.doi.org/10.1074/jbc.M116.755082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28003366	Green Published, hybrid			2022-12-28	WOS:000395515600039
J	Abbott, RK; Silva, M; Labuda, J; Thayer, M; Cain, DW; Philbrook, P; Sethumadhavan, S; Hatfield, S; Ohta, A; Sitkovsky, M				Abbott, Robert K.; Silva, Murillo; Labuda, Jasmine; Thayer, Molly; Cain, Derek W.; Philbrook, Phaethon; Sethumadhavan, Shalini; Hatfield, Stephen; Ohta, Akio; Sitkovsky, Michail			The GS Protein-coupled A2a Adenosine Receptor Controls T Cell Help in the Germinal Center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE DEAMINASE AID; CLASS SWITCH RECOMBINATION; CENTER B-CELLS; FOLLICULAR HELPER; IMMUNE-RESPONSES; DENDRITIC CELLS; HYPOXIA; DIFFERENTIATION; INFLAMMATION; CONFINEMENT	T follicular helper (TFH) cells have been shown to be critically required for the germinal center (GC) reaction where B cells undergo class switch recombination and clonal selection to generate high affinity neutralizing antibodies. However, detailed knowledge of the physiological cues within the GC microenvironment that regulate T cell help is limited. The cAMP-elevating, Gs protein-coupled A2a adenosine receptor (A2aR) is an evolutionarily conserved receptor that limits and redirects cellular immunity. However, the role of A2aR in humoral immunity and B cell differentiation is unknown. We hypothesized that the hypoxic microenvironment within the GC facilitates an extracellular adenosine-rich milieu, which serves to limit TFH frequency and function, and also promotes immunosuppressive T follicular regulatory cells (TFR). In support of this hypothesis, we found that following immunization, mice lacking A2aR (A2aRKO) exhibited a significant expansion of T follicular cells, as well as increases in TFH to TFR ratio, GCT cell frequency, GC B cell frequency, and class switching of GC B cells to IgG1. Transfer of CD4 T cells from A2aRKO or wild type donors into T cell-deficient hosts revealed that these increases were largely T cell-intrinsic. Finally, injection of A2aR agonist, CGS21680, following immunization suppressed T follicular differentiation, GC B cell frequency, and class switching of GC B cells to IgG1. Taken together, these observations point to a previously unappreciated role of GS protein-coupled A2aR in regulating humoral immunity, which may be pharmacologically targeted during vaccination or pathological states in which GC-derived autoantibodies contribute to the pathology.	[Abbott, Robert K.; Silva, Murillo; Labuda, Jasmine; Thayer, Molly; Philbrook, Phaethon; Sethumadhavan, Shalini; Hatfield, Stephen; Ohta, Akio; Sitkovsky, Michail] Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA; [Cain, Derek W.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA	Northeastern University; Duke University	Abbott, RK; Sitkovsky, M (corresponding author), Northeastern Univ, Dept Biol, 360 Huntington Ave,Mugar Bldg,Rm 312, Boston, MA 02115 USA.	robertkabbott@gmail.com; m.sitkovsky@neu.edu	Silva, Murillo/I-4863-2017	Silva, Murillo/0000-0003-4668-6290; Abbott, Robert/0000-0003-0335-1175	National Institutes of Health [U19 AI 091693, R01 CA 111985]; NATIONAL CANCER INSTITUTE [R01CA111985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants U19 AI 091693 and R01 CA 111985 (to M. Sitkovsky). The authors R. K. A., S. H., and M. Sitkovsky have filed a patent partially based on this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott RK, 2016, J IMMUNOL, V197, P4014, DOI 10.4049/jimmunol.1601401; Bullen JW, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf0583; Choi JY, 2015, ARTHRITIS RHEUMATOL, V67, P988, DOI 10.1002/art.39020; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Hatfield SM, 2014, J MOL MED, V92, P1283, DOI 10.1007/s00109-014-1189-3; Hynes Thomas R, 2015, J Mol Signal, V10, P2, DOI 10.5334/1750-2187-10-2; Iskandrian AE, 2007, J NUCL CARDIOL, V14, P645, DOI 10.1016/j.nuclcard.2007.06.114; Iyer SS, 2013, EUR J IMMUNOL, V43, P3219, DOI 10.1002/eji.201343469; Koshiba M, 1999, MOL PHARMACOL, V55, P614; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; Muppidi JR, 2015, J EXP MED, V212, P2213, DOI 10.1084/jem.20151250; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navarro G, 2016, NEUROPHARMACOLOGY, V104, P161, DOI 10.1016/j.neuropharm.2015.07.024; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Ohta A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00304; Preite S, 2015, EUR J IMMUNOL, V45, P3010, DOI 10.1002/eji.201545920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thompson CA, 2008, AM J HEALTH-SYST PH, V65, P890, DOI 10.2146/news080038; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Xu S, 2013, NEURO-ONCOLOGY, V15, P1160, DOI 10.1093/neuonc/not067	42	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1211	1217		10.1074/jbc.C116.764043	http://dx.doi.org/10.1074/jbc.C116.764043			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27974461	Green Published, hybrid			2022-12-28	WOS:000393339800006
J	Xiao, Y; Ma, HX; Wan, P; Qin, DD; Wang, XX; Zhang, XX; Xiang, YL; Liu, WB; Chen, J; Yi, ZH; Li, L				Xiao, Yi; Ma, Haixia; Wan, Ping; Qin, Dandan; Wang, Xiaoxiao; Zhang, Xiaoxin; Xiang, Yunlong; Liu, Wenbo; Chen, Jiong; Yi, Zhaohong; Li, Lei			Trp-Asp (WD) Repeat Domain 1 Is Essential for Mouse Peri-implantation Development and Regulates Cofilin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN DYNAMICS; LIM-KINASE; FUNCTIONAL ROLES; CELL-MIGRATION; IN-VITRO; ADF/COFILIN; PROTEIN; CYTOSKELETON; MECHANISMS; FILAMENTS	Trp-Asp (WD) repeat domain 1 (WDR1) is a highly conserved actin-binding protein across all eukaryotes and is involved in numerous actin-based processes by accelerating Cofilin severing actin filament. However, the function and the mechanism of WDR1 in mammalian early development are still largely unclear. We now report that WDR1 is essential for mouse peri-implantation development and regulates Cofilin phosphorylation in mouse cells. The disruption of maternal WDR1 does not obviously affect ovulation and female fertility. However, depletion of zygotic WDR1 results in embryonic lethality at the peri-implantation stage. In WDR1 knock-out cells, we found that WDR1 regulates Cofilin phosphorylation. Interestingly, WDR1 is overdosed to regulate Cofilin phosphorylation in mouse cells. Furthermore, we showed that WDR1 interacts with Lim domain kinase 1 (LIMK1), a well known phosphorylation kinase of Cofilin. Altogether, our results provide new insights into the role and mechanism of WDR1 in physiological conditions.	[Xiao, Yi; Ma, Haixia; Qin, Dandan; Wang, Xiaoxiao; Zhang, Xiaoxin; Xiang, Yunlong; Liu, Wenbo; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Xiao, Yi; Ma, Haixia; Qin, Dandan; Wang, Xiaoxiao; Li, Lei] Univ Chinese Acad Sci, Inst Zool, Beijing 100049, Peoples R China; [Wan, Ping; Chen, Jiong] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China; [Wan, Ping; Chen, Jiong] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Yi, Zhaohong] Beijing Agr Univ, Coll Biol Sci & Engn, Minist Agr, Key Lab Urban Agr North, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Chinese Academy of Sciences, CAS; Nanjing University; Nanjing University; Beijing University of Agriculture; Ministry of Agriculture & Rural Affairs	Li, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Li, L (corresponding author), Univ Chinese Acad Sci, Inst Zool, Beijing 100049, Peoples R China.; Chen, J (corresponding author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China.; Chen, J (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China.; Yi, ZH (corresponding author), Beijing Agr Univ, Coll Biol Sci & Engn, Minist Agr, Key Lab Urban Agr North, Beijing 102206, Peoples R China.	chenjiong@nju.edu.cn; yizhaoh2009@163.com; lil@ioz.ac.cn	Ma, Haixia/ABC-4707-2021	Ma, Haixia/0000-0001-9080-2004; Chen, Jiong/0000-0001-5252-3936; Li, Lei/0000-0001-5478-5681; Wan, Ping/0000-0001-6888-4701	National Natural Science Foundation of China [31590832, 31471353]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01010103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 31590832 and 31471353 and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01010103. The authors declare that they have no conflicts of interest with the contents of this article.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bedzhov I, 2014, NAT PROTOC, V9, P2732, DOI 10.1038/nprot.2014.186; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Brieher W, 2013, MOL BIOL CELL, V24, P2299, DOI 10.1091/mbc.E12-09-0694; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Chen Q, 2015, J BIOL CHEM, V290, P2289, DOI 10.1074/jbc.M114.612978; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Doppler H, 2013, J BIOL CHEM, V288, P455, DOI 10.1074/jbc.M112.397448; Edwards DC, 1999, J BIOL CHEM, V274, P11352, DOI 10.1074/jbc.274.16.11352; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Gerisch G, 2004, CELL MOTIL CYTOSKEL, V57, P18, DOI 10.1002/cm.10150; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Gorovoy M, 2005, J BIOL CHEM, V280, P26533, DOI 10.1074/jbc.M502921200; Gressin L, 2015, CURR BIOL, V25, P1437, DOI 10.1016/j.cub.2015.04.011; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heller E, 2015, J CELL BIOL, V211, P219, DOI 10.1083/jcb.201506106; HSU YC, 1971, NATURE, V231, P100, DOI 10.1038/231100a0; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Kuhns DB, 2016, BLOOD, V128, P2135, DOI 10.1182/blood-2016-03-706028; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Liang QX, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.122127; Liu LJ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027381; Luxenburg C, 2015, NAT CELL BIOL, V17, P592, DOI 10.1038/ncb3146; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Nomura K, 2016, J BIOL CHEM, V291, P5146, DOI 10.1074/jbc.M115.713495; Ohashi K, 2015, DEV GROWTH DIFFER, V57, P275, DOI 10.1111/dgd.12213; Oleinik NV, 2014, J BIOL CHEM, V289, P26383, DOI 10.1074/jbc.M114.569657; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Pollard T.D, 2016, COLD SPRING HARBOR P, V8; Qi DC, 2015, MOL MED REP, V12, P2570, DOI 10.3892/mmr.2015.3773; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Xu HC, 2016, AM J TRANSL RES, V8, P1253; Xu J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.182; Yae K, 2006, MOL CELL BIOL, V26, P6185, DOI 10.1128/MCB.00018-06; Yuan BY, 2014, AM J PATHOL, V184, P1967, DOI 10.1016/j.ajpath.2014.04.007; Zhao ZA, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150092	52	7	7	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1438	1448		10.1074/jbc.M116.759886	http://dx.doi.org/10.1074/jbc.M116.759886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27994054	Green Published, hybrid			2022-12-28	WOS:000393339800025
J	Tang, R; Zhang, G; Chen, SY				Tang, Rui; Zhang, Gui; Chen, Shi-You			Smooth Muscle Cell Proangiogenic Phenotype Induced by Cyclopentenyl Cytosine Promotes Endothelial Cell Proliferation and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE RECEPTORS; TGF-BETA; CAROTID ARTERIES; LESION FORMATION; ANGIOGENESIS; PDGF; INHIBITION; PLASTICITY; PERICYTES; GROWTH	Vascular smooth muscle cells (SMCs) and endothelial cells (ECs) are in close contact with blood vessels. SMC phenotypes can be altered during pathological vascular remodeling. However, how SMC phenotypes affect EC properties remains largely unknown. In this study, we found that PDGF-BB-induced synthetic SMCs suppressed EC proliferation and migration while exhibiting increased expression of anti-angiogenic factors, such as endostatin, and decreased pro-angiogenic factors, including CXC motif ligand 1 (CXCL1). Cyclopentenyl cytosine (CPEC), a CTP synthase inhibitor that has been reported previously to inhibit SMC proliferation and injury-induced neointima formation, induced SMC redifferentiation. Interestingly, CPEC-conditioned SMC culture medium promoted EC proliferation and migration because of an increase in CXCL1 along with decreased endostatin production in SMCs. Addition of recombinant endostatin protein or blockade of CXCL1 with a neutralizing antibody suppressed the EC proliferation and migration induced by CPEC-conditioned SMC medium. Mechanistically, CPEC functions as a cytosine derivate to stimulate adenosine receptors A1 and A2a, which further activate downstream cAMP and Akt signaling, leading to the phosphorylation of cAMP response element binding protein and, consequently, SMC redifferentiation. These data provided proof of a novel concept that synthetic SMC exhibits an anti-angiogenic SMC phenotype, whereas contractile SMC shows a pro-angiogenic phenotype. CPEC appears to be a potent stimulator for switching the anti-angiogenic SMC phenotype to the pro-angiogenic phenotype, which may be essential for CPEC to accelerate re-endothelialization for vascular repair during injury-induced vascular wall remodeling.	[Tang, Rui; Zhang, Gui; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu			National Institute of Health [HL123302, HL119053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123302, R01HL119053] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Health Grants HL123302 and HL119053. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Beech DJ, 2007, BIOCHEM SOC T, V35, P890, DOI 10.1042/BST0350890; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chang SF, 2014, P NATL ACAD SCI USA, V111, P1855, DOI 10.1073/pnas.1323761111; Cidad P, 2010, ARTERIOSCL THROM VAS, V30, P1203, DOI 10.1161/ATVBAHA.110.205187; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Feoktistov I, 2004, HYPERTENSION, V44, P649, DOI 10.1161/01.HYP.0000144800.21037.a5; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Fillinger MF, 1997, J SURG RES, V67, P169, DOI 10.1006/jsre.1996.4978; FINGERLE J, 1990, ARTERIOSCLEROSIS, V10, P1082, DOI 10.1161/01.ATV.10.6.1082; FISHMAN JA, 1975, LAB INVEST, V32, P339; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Halka AT, 2008, CARDIOVASC PATHOL, V17, P98, DOI 10.1016/j.carpath.2007.03.001; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; HOOVER GA, 1989, ARTERIOSCLEROSIS, V9, P76, DOI 10.1161/01.ATV.9.1.76; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Jaschke B, 2005, CARDIOVASC RES, V68, P483, DOI 10.1016/j.cardiores.2005.06.029; JONZON B, 1985, J CELL PHYSIOL, V124, P451, DOI 10.1002/jcp.1041240314; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Miyake M, 2013, LAB INVEST, V93, P768, DOI 10.1038/labinvest.2013.71; Miyazawa K, 1995, ATHEROSCLEROSIS, V118, P213, DOI 10.1016/0021-9150(95)05607-6; MOTRO B, 1990, P NATL ACAD SCI USA, V87, P3092, DOI 10.1073/pnas.87.8.3092; Nadal JA, 2002, AM J PHYSIOL-HEART C, V282, pH739, DOI 10.1152/ajpheart.00656.2001; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; REIDY MA, 1981, LAB INVEST, V44, P301; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Sakao S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-95; Shigematsu Satoshi, 1999, Endocrine Journal, V46, pS59, DOI 10.1507/endocrj.46.Suppl_S59; Shryock JC, 1997, AM J CARDIOL, V79, P2, DOI 10.1016/S0002-9149(97)00256-7; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Tang R, 2013, ARTERIOSCL THROM VAS, V33, P2336, DOI 10.1161/ATVBAHA.113.301561; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tuszynski GP, 1996, BIOESSAYS, V18, P71, DOI 10.1002/bies.950180113; Virmani R, 1999, CURR OPIN LIPIDOL, V10, P499, DOI 10.1097/00041433-199912000-00004; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706; Wong J, 1997, CIRCULATION, V96, P1631, DOI 10.1161/01.CIR.96.5.1631; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Yilmaz MS, 2008, EUR J PHARMACOL, V584, P125, DOI 10.1016/j.ejphar.2008.01.044; Zhong HY, 2004, AM J RESP CELL MOL, V30, P118, DOI 10.1165/rcmb.2003-0118OC	55	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26913	26921		10.1074/jbc.M116.741967	http://dx.doi.org/10.1074/jbc.M116.741967			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27821588	Green Published, hybrid			2022-12-28	WOS:000391571400027
J	St Gelais, C; Kim, SH; Ding, LM; Yount, JS; Ivanov, D; Spearman, P; Wu, L				St Gelais, Corine; Kim, Sun Hee; Ding, Lingmei; Yount, Jacob S.; Ivanov, Dmitri; Spearman, Paul; Wu, Li			A Putative Cyclin-binding Motif in Human SAMHD1 Contributes to Protein Phosphorylation, Localization, and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; RESTRICTION FACTOR SAMHD1; DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE; IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; HIV-1 RESTRICTION; DENDRITIC CELLS; RIBONUCLEASE-ACTIVITY; DEPENDENT KINASES; NUCLEASE ACTIVITY	SAMHD1 (sterile alpha motif and HD domain-containing protein 1) is a mammalian protein that regulates intracellular dNTP levels through its hydrolysis of dNTPs. SAMHD1 functions as an important retroviral restriction factor through a mechanism relying on its dNTPase activity. We and others have reported that human SAMHD1 interacts with the cell cycle regulatory proteins cyclin A, CDK1, and CDK2, which mediates phosphorylation of SAMHD1 at threonine 592, a post-translational modification that has been implicated in abrogating SAMHD1 restriction function and ability to form stable tetramers. Utilizing co-immunoprecipitation and co-localization approaches, we show that endogenous SAMHD1 is able to interact with the cyclin A-CDK1-CDK2 complex in monocytic THP-1 cells and primary monocyte-derived macrophages. Sequence analysis of SAMHD1 identifies a putative cyclin-binding motif found in many cyclin-CDK complex substrates. Using a mutagenesis-based approach, we demonstrate that the conserved residues in the putative cyclin-binding motif are important for protein expression, protein half-life, and optimal phosphorylation of SAMHD1 at Thr(592). Furthermore, we observed that SAMHD1 mutants of the cyclin-binding motif mislocalized to a nuclear compartment and had reduced ability to interact with cyclin A-CDK complexes and to form the tetramer. These findings help define the mechanisms by which SAMHD1 is phosphorylated and suggest the contribution of cyclin binding to SAMHD1 expression and stability in dividing cells.	[St Gelais, Corine; Kim, Sun Hee; Wu, Li] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, 1900 Coffey Rd, Columbus, OH 43210 USA; [Yount, Jacob S.; Wu, Li] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Ding, Lingmei; Spearman, Paul] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Spearman, Paul] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Ivanov, Dmitri] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Emory University; Children's Healthcare of Atlanta (CHOA); University of Texas System; University of Texas Health San Antonio	Wu, L (corresponding author), Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, 1900 Coffey Rd, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011; Ivanov, Dmitri/B-4600-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Yount, Jacob/0000-0002-6128-4575	National Institutes of Health [GM111027, AI104483, CA181997, AI120209, AI127667]; Public Health Preparedness for Infectious Diseases Program of the Ohio State University; NATIONAL CANCER INSTITUTE [R21CA181997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104476, R01AI104483, R56AI127667, R01AI120209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Preparedness for Infectious Diseases Program of the Ohio State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM111027 (to P. S.) and AI104483, CA181997, AI120209, and AI127667 (to L. W.) and in part by the Public Health Preparedness for Infectious Diseases Program of the Ohio State University (to L. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Antonucci JM, 2016, NAT MED, V22, P1072, DOI 10.1038/nm.4163; Arnold LH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005194; Arnold LH, 2015, ANTIMICROB AGENTS CH, V59, P186, DOI 10.1128/AAC.03903-14; Badia R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005829; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Bonifati S, 2016, VIROLOGY, V495, P92, DOI 10.1016/j.virol.2016.05.002; Brandariz-Nunez A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-131; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Chen ZM, 2014, BIOCHEM BIOPH RES CO, V450, P1462, DOI 10.1016/j.bbrc.2014.07.023; Choi J, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0174-4; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Gelais CS, 2014, J VIROL, V88, P5834, DOI 10.1128/JVI.00155-14; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Goutieres F, 2005, BRAIN DEV-JPN, V27, P201, DOI 10.1016/j.braindev.2003.12.011; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Kohnken R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0446-6; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Kyei GB, 2015, CELL HOST MICROBE, V17, P98, DOI 10.1016/j.chom.2014.11.009; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Liu F, 1999, MOL CELL BIOL, V19, P5113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma TL, 1999, P NATL ACAD SCI USA, V96, P382, DOI 10.1073/pnas.96.2.382; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ruiz A, 2015, CELL CYCLE, V14, P1657, DOI 10.1080/15384101.2015.1030558; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Seamon KJ, 2015, NUCLEIC ACIDS RES, V43, P6486, DOI 10.1093/nar/gkv633; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Tang CX, 2015, J BIOL CHEM, V290, P26352, DOI 10.1074/jbc.M115.677435; Tungler V, 2013, J MOL MED, V91, P759, DOI 10.1007/s00109-013-0995-3; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Wittmann S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0229-6; Wohlschlegel JA, 2001, MOL CELL BIOL, V21, P4868, DOI 10.1128/MCB.21.15.4868-4874.2001; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Yan JP, 2015, J BIOL CHEM, V290, P13279, DOI 10.1074/jbc.M115.646588; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhou Pengbo, 2004, Methods Mol Biol, V284, P67; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	56	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26332	26342		10.1074/jbc.M116.753947	http://dx.doi.org/10.1074/jbc.M116.753947			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27815502	Green Published, hybrid			2022-12-28	WOS:000391568200008
J	Chen, YL; Guo, HF; Terajima, M; Banerjee, P; Liu, X; Yu, J; Momin, AA; Katayama, H; Hanash, SM; Burns, AR; Fields, GB; Yamauchi, M; Kurie, JM				Chen, Yulong; Guo, Houfu; Terajima, Masahiko; Banerjee, Priyam; Liu, Xin; Yu, Jiang; Momin, Amin A.; Katayama, Hiroyuki; Hanash, Samir M.; Burns, Alan R.; Fields, Gregg B.; Yamauchi, Mitsuo; Kurie, Jonathan M.			Lysyl Hydroxylase 2 Is Secreted by Tumor Cells and Can Modify Collagen in the Extracellular Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME-OSTEOGENESIS IMPERFECTA; BRUCK-SYNDROME; CROSS-LINKING; LYSINE HYDROXYLATION; FKBP10 CAUSE; I COLLAGEN; MUTATIONS; TISSUE; METASTASIS; EXPRESSION	Lysyl hydroxylase 2 (LH2) catalyzes the hydroxylation of lysine residues in the telopeptides of fibrillar collagens, which leads to the formation of stable collagen cross-links. Recently we reported that LH2 enhances the metastatic propensity of lung cancer by increasing the amount of stable hydroxylysine aldehyde-derived collagen cross-links (HLCCs), which generate a stiffer tumor stroma (Chen, Y., et al. (2015) J. Clin. Invest. 125, 125, 1147-1162). It is generally accepted that LH2 modifies procollagen alpha chains on the endoplasmic reticulum before the formation of triple helical procollagen molecules. Herein, we report that LH2 is also secreted and modifies collagen in the extracellular space. Analyses of lung cancer cell lines demonstrated that LH2 is present in the cell lysates and the conditioned media in a dimeric, active form in both compartments. LH2 co-localized with collagen fibrils in the extracellular space in human lung cancer specimens and in orthotopic lung tumors generated by injection of a LH2-expressing human lung cancer cell line into nude mice. LH2 depletion in MC3T3 osteoblastic cells impaired the formation of HLCCs, resulting in an increase in the unmodified lysine aldehyde-derived collagen cross-link (LCC), and the addition of recombinant LH2 to the media of LH2-deficient MC3T3 cells was sufficient to rescue HLCC formation in the extracellular matrix. The finding that LH2 modifies collagen in the extracellular space challenges the current view that LH2 functions solely on the endoplasmic reticulum and could also have important implications for cancer biology.	[Chen, Yulong; Guo, Houfu; Banerjee, Priyam; Liu, Xin; Yu, Jiang; Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Terajima, Masahiko; Yamauchi, Mitsuo] Univ N Carolina, Sch Dent, Oral & Craniofacial Hlth Sci, Chapel Hill, NC 27599 USA; [Momin, Amin A.; Katayama, Hiroyuki; Hanash, Samir M.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77004 USA; [Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Jupiter, FL 33458 USA	University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; State University System of Florida; Florida Atlantic University	Yamauchi, M (corresponding author), Univ N Carolina, Sch Dent, Oral & Craniofacial Hlth Sci, Chapel Hill, NC 27599 USA.; Kurie, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mitsuo_yamauchi@unc.edu; jkurie@mdanderson.org	Banerjee, Priyam/D-2363-2011	Banerjee, Priyam/0000-0001-9398-9345; Guo, Hou-Fu/0000-0002-3659-9399	National Institutes of Health [R21AR060978, R01CA105155]; Elza A. and Ina S. Freeman Professorship in Lung Cancer; MD Anderson Cancer Center [CA016672]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elza A. and Ina S. Freeman Professorship in Lung Cancer; MD Anderson Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grants R21AR060978 (NIAMS; to M. Y.) and R01CA105155 (NCI; to J. M. K. and M. Y.). This work was also supported by the Elza A. and Ina S. Freeman Professorship in Lung Cancer (to J. M. K.) and MD Anderson Cancer Center Support Grant CA016672. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blanco MA, 2012, CELL RES, V22, P1339, DOI 10.1038/cr.2012.89; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Chen YL, 2015, J CLIN INVEST, V125, P1147, DOI 10.1172/JCI74725; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Eisinger-Mathason TSK, 2013, CANCER DISCOV, V3, P1190, DOI 10.1158/2159-8290.CD-13-0118; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; Heikkinen J, 2011, MATRIX BIOL, V30, P27, DOI 10.1016/j.matbio.2010.10.002; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kelley BP, 2011, J BONE MINER RES, V26, P666, DOI 10.1002/jbmr.250; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Mercer DK, 2003, BIOCHEM BIOPH RES CO, V307, P803, DOI 10.1016/S0006-291X(03)01262-2; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pornprasertsuk S, 2005, J BONE MINER RES, V20, P81, DOI 10.1359/JBMR.041026; Pornprasertsuk S, 2004, J BONE MINER RES, V19, P1349, DOI 10.1359/JBMR.040323; Remst DFG, 2013, OSTEOARTHR CARTILAGE, V21, P157, DOI 10.1016/j.joca.2012.10.002; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Robertson D, 2011, METHODS MOL BIOL, V724, P69, DOI 10.1007/978-1-61779-055-3_4; Sada M, 2016, CANCER LETT, V372, P210, DOI 10.1016/j.canlet.2016.01.016; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2006, MATRIX BIOL, V25, P475, DOI 10.1016/j.matbio.2006.08.260; Schliekelman MJ, 2015, CANCER RES, V75, P1789, DOI 10.1158/0008-5472.CAN-14-2535; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Shaheen R, 2011, AM J MED GENET A, V155A, P1448, DOI 10.1002/ajmg.a.34025; SIEGEL RC, 1974, P NATL ACAD SCI USA, V71, P4826, DOI 10.1073/pnas.71.12.4826; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Suokas M, 2000, J BIOL CHEM, V275, P17863, DOI 10.1074/jbc.M908025199; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; TANZER ML, 1973, J BIOL CHEM, V248, P393; Puig-Hervas MT, 2012, HUM MUTAT, V33, P1444, DOI 10.1002/humu.22133; Uzawa K, 1999, J BONE MINER RES, V14, P1272, DOI 10.1359/jbmr.1999.14.8.1272; Valtavaara M, 1997, J BIOL CHEM, V272, P6831, DOI 10.1074/jbc.272.11.6831; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Wang CG, 2012, J CELL PHYSIOL, V227, P668, DOI 10.1002/jcp.22774; YAMAUCHI M, 1987, J BIOL CHEM, V262, P11428; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/bse0520113, 10.1042/BSE0520113]	40	46	46	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25799	25808		10.1074/jbc.M116.759803	http://dx.doi.org/10.1074/jbc.M116.759803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803159	Green Published, hybrid			2022-12-28	WOS:000390345200004
J	Chawla, B; Hedman, AC; Sayedyahossein, S; Erdemir, HH; Li, ZG; Sacks, DB				Chawla, Bhavna; Hedman, Andrew C.; Sayedyahossein, Samar; Erdemir, Huseyin H.; Li, Zhigang; Sacks, David B.			Absence of IQGAP1 Protein Leads to Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; insulin; insulin receptor; insulin receptor substrate 1 (IRS-1); insulin resistance; mitogen-activated protein kinase (MAPK); phosphatidylinositide 3-kinase (PI 3-kinase); IQGAP1	PLECKSTRIN-HOMOLOGY DOMAIN; HEPATOCELLULAR-CARCINOMA; MICE LACKING; PTB DOMAIN; IQ MOTIFS; RECEPTOR; IRS-1; SCAFFOLD; BINDING; ACTIVATION	Insulin binds to the insulin receptor (IR) and induces tyrosine phosphorylation of the receptor and insulin receptor substrate-1 (IRS-1), leading to activation of the PKB/Akt and MAPK/ERK pathways. IQGAP1 is a scaffold protein that interacts with multiple binding partners and integrates diverse signaling cascades. Here we show that IQGAP1 associates with both IR and IRS-1 and influences insulin action. In vitro analysis with pure proteins revealed that the IQ region of IQGAP1 binds directly to the intracellular domain of IR. Similarly, the phosphotyrosine-binding domain of IRS-1 mediates a direct interaction with the C-terminal tail of IQGAP1. Consistent with these observations, both IR and IRS-1 co-immunoprecipitated with IQGAP1 from cells. Investigation of the functional effects of the interactions revealed that in the absence of IQGAP1, insulin-stimulated phosphorylation of Akt and ERK, as well as the association of phosphatidylinositol 3-kinase with IRS-1, were significantly decreased. Importantly, loss of IQGAP1 results in impaired insulin signaling and glucose homeostasis in vivo. Collectively, these data reveal that IQGAP1 is a scaffold for IR and IRS-1 and implicate IQGAP1 as a participant in insulin signaling.	[Chawla, Bhavna; Hedman, Andrew C.; Sayedyahossein, Samar; Erdemir, Huseyin H.; Li, Zhigang; Sacks, David B.] NIH, Dept Lab Med, 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA; [Chawla, Bhavna] US FDA, Ctr Biol Evaluat & Res, Div Emerging & Transfus Transmitted Dis, Silver Spring, MD 20993 USA; [Erdemir, Huseyin H.] Cleveland Clin, Dept Pediat Hematol Oncol, Cleveland, OH 44195 USA; [Erdemir, Huseyin H.] Cleveland Clin, BMT, Cleveland, OH 44195 USA	National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA); Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sacks, DB (corresponding author), NIH, Dept Lab Med, 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA.	david.sacks2@nih.gov		Sayedyahossein, Samar/0000-0003-1773-4740; Sacks, David/0000-0003-3100-0735	National Institutes of Health Intramural Research Program; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This work was supported by the National Institutes of Health Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Algenstaedt PM, 1997, J BIOL CHEM, V272, P23696, DOI 10.1074/jbc.272.38.23696; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Backer JM, 1997, EUR J BIOCHEM, V245, P91, DOI 10.1111/j.1432-1033.1997.t01-1-00091.x; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Chen F, 2010, EXP MOL MED, V42, P477, DOI 10.3858/emm.2010.42.7.049; Chiariello CS, 2012, REGUL PEPTIDES, V173, P36, DOI 10.1016/j.regpep.2011.09.003; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Dinchuk JE, 2010, ENDOCRINOLOGY, V151, P4123, DOI 10.1210/en.2010-0032; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Erdemir HH, 2014, J BIOL CHEM, V289, P9100, DOI 10.1074/jbc.M114.553511; Geetha T, 2012, J BIOL CHEM, V287, P29672, DOI 10.1074/jbc.M111.322404; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Kim H, 2011, BIOCHEM J, V440, P309, DOI 10.1042/BJ20110419; Kohno T, 2013, AM J PHYSIOL-CELL PH, V305, pC591, DOI 10.1152/ajpcell.00011.2013; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Kriauciunas KM, 2000, MOL CELL BIOL, V20, P6849, DOI 10.1128/MCB.20.18.6849-6859.2000; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Munshi HG, 1996, BIOCHEMISTRY-US, V35, P15883, DOI 10.1021/bi962107y; Ramos RR, 2007, P NATL ACAD SCI USA, V104, P10470, DOI 10.1073/pnas.0701114104; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Smith MJ, 2010, EMBO J, V29, P884, DOI 10.1038/emboj.2009.399; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ueki K, 2000, J CLIN INVEST, V105, P1437, DOI 10.1172/JCI7656; VANOBBERGHEN E, 1994, DIABETOLOGIA, V37, pS125, DOI 10.1007/BF00400836; VanRenterghem B, 1998, J BIOL CHEM, V273, P29942, DOI 10.1074/jbc.273.45.29942; Wagner MJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008987; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2011, J BIOL CHEM, V286, P29734, DOI 10.1074/jbc.M111.220939; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; WOLF G, 1995, J BIOL CHEM, V270, P27407, DOI 10.1074/jbc.270.46.27407; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300	53	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3273	3289		10.1074/jbc.M116.752642	http://dx.doi.org/10.1074/jbc.M116.752642			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28082684	Green Published, hybrid			2022-12-28	WOS:000395538800019
J	Du, CY; Cao, SY; Shi, XY; Nie, XT; Zheng, JS; Deng, Y; Ruan, LF; Peng, DH; Sun, M				Du, Cuiying; Cao, Shiyun; Shi, Xiangyu; Nie, Xiangtao; Zheng, Jinshui; Deng, Yun; Ruan, Lifang; Peng, Donghai; Sun, Ming			Genetic and Biochemical Characterization of a Gene Operon for trans-Aconitic Acid, a Novel Nematicide from Bacillus thuringiensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial genetics; bacterial toxin; biosynthesis; small molecule; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); Bacillus thuringiensis; aconitate isomerase; membrane transporter; nematicidal factor; trans-aconitic acid	ROOT-KNOT NEMATODE; COMPLETE GENOME SEQUENCE; CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; SECONDARY METABOLITE; VIRULENCE FACTORS; ISOCITRATE LYASE; PROTEIN; ISOMERASE; PLANT	trans-Aconitic acid (TAA) is an isomer of cis-aconitic acid (CAA), an intermediate of the tricarboxylic acid cycle that is synthesized by aconitase. Although TAA production has been detected in bacteria and plants for many years and is known to be a potent inhibitor of aconitase, its biosynthetic origins and the physiological relevance of its activity have remained unclear. We have serendipitously uncovered key information relevant to both of these questions. Specifically, in a search for novel nematicidal factors from Bacillus thuringiensis, a significant nematode pathogen harboring many protein virulence factors, we discovered a high yielding component that showed activity against the plant-parasitic nematode Meloidogyne incognita and surprisingly identified it as TAA. Comparison with CAA, which displayed a much weaker nematicidal effect, suggested that TAA is specifically synthesized by B. thuringiensis as a virulence factor. Analysis of mutants deficient in plasmids that were anticipated to encode virulence factors allowed us to isolate a TAA biosynthesis-related (tbr) operon consisting of two genes, tbrA and tbrB. We expressed the corresponding proteins, TbrA and TbrB, and characterized them as an aconitate isomerase and TAA transporter, respectively. Bioinformatics analysis of the TAA biosynthetic gene cluster revealed the association of the TAA genes with transposable elements relevant for horizontal gene transfer as well as a distribution across B. cereus bacteria and other B. thuringiensis strains, suggesting a general role for TAA in the interactions of B. cereus group bacteria with nematode hosts in the soil environment. This study reveals new bioactivity for TAA and the TAA biosynthetic pathway, improving our understanding of virulence factors employed by B. thuringiensis pathogenesis and providing potential implications for nematode management applications.	[Du, Cuiying; Cao, Shiyun; Shi, Xiangyu; Nie, Xiangtao; Zheng, Jinshui; Deng, Yun; Ruan, Lifang; Peng, Donghai; Sun, Ming] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Cao, Shiyun] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	Huazhong Agricultural University; State University System of Florida; University of Florida	Sun, M (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	m98sun@mail.hzau.edu.cn	Ming, Sun/Q-1497-2015	Ming, Sun/0000-0001-5465-5983	China 948 Program of the Ministry of Agriculture [2016-X21]; National Natural Science Foundation of China [31670085, 31171901]; National Key Research and Development Program of China [2017YFC204521201]	China 948 Program of the Ministry of Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by the China 948 Program of the Ministry of Agriculture (Grant 2016-X21), National Natural Science Foundation of China Grants 31670085 and 31171901, and National Key Research and Development Program of China Grant 2017YFC204521201. The authors declare that they have no conflicts of interest with the contents of this article.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ALTEKAR WW, 1963, J BACTERIOL, V85, P604, DOI 10.1128/JB.85.3.604-613.1963; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Bernheim F, 1928, BIOCHEM J, V22, P1178, DOI 10.1042/bj0221178; Blin K, 2017, NUCLEIC ACIDS RES, V45, pD555, DOI 10.1093/nar/gkw960; BRAUER D, 1981, PLANT PHYSIOL, V68, P1406, DOI 10.1104/pp.68.6.1406; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Cai H, 1999, J BIOL CHEM, V274, P13470, DOI 10.1074/jbc.274.19.13470; Chen S. T., 2015, U. S. Patent, Patent No. 20150104531; Cordes T, 2015, ANNU REV NUTR, V35, P451, DOI 10.1146/annurev-nutr-071714-034243; Garcia ED, 2010, PHYTOMEDICINE, V18, P80, DOI 10.1016/j.phymed.2010.05.008; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Garvey GS, 2007, PROTEIN SCI, V16, P1274, DOI 10.1110/ps.072801907; Grimek TL, 2004, J BACTERIOL, V186, P454, DOI 10.1128/JB.186.2.454-462.2004; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; He J, 2011, J BACTERIOL, V193, P3407, DOI 10.1128/JB.05085-11; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Hu Y, 2010, P NATL ACAD SCI USA, V107, P5955, DOI 10.1073/pnas.0912327107; Iatsenko I, 2014, TOXINS, V6, P2050, DOI 10.3390/toxins6072050; Iatsenko I, 2014, APPL ENVIRON MICROB, V80, P3266, DOI 10.1128/AEM.00464-14; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Jouzani GS, 2008, CAN J MICROBIOL, V54, P812, DOI [10.1139/W08-074, 10.1139/w08-074]; KAR S, 1993, ANTIMICROB AGENTS CH, V37, P2459, DOI 10.1128/AAC.37.11.2459; KIM M, 1976, Applied Entomology and Zoology, V11, P53; KLINMAN JP, 1971, BIOCHEMISTRY-US, V10, P2259, DOI 10.1021/bi00788a012; KLINMAN JP, 1971, BIOCHEMISTRY-US, V10, P2253, DOI 10.1021/bi00788a011; Lenane IJ, 2008, FEMS MICROBIOL LETT, V278, P115, DOI 10.1111/j.1574-6968.2007.00987.x; Li XQ, 2008, BIOL CONTROL, V47, P97, DOI 10.1016/j.biocontrol.2008.06.007; Li XQ, 2007, PLANT BIOTECHNOL J, V5, P455, DOI 10.1111/j.1467-7652.2007.00257.x; Liu XY, 2010, J BIOL CHEM, V285, P39191, DOI 10.1074/jbc.M110.148387; Liu XY, 2014, TOXINS, V6, P2229, DOI 10.3390/toxins6082229; Liu YY, 2014, STAND GENOMIC SCI, V9, DOI 10.4056/sigs.4738557; Lourenco-Tessutti IT, 2015, PHYTOPATHOLOGY, V105, P628, DOI 10.1094/PHYTO-09-14-0237-R; Luo H, 2013, APPL MICROBIOL BIOT, V97, P10135, DOI 10.1007/s00253-013-5249-3; Luo XX, 2013, APPL ENVIRON MICROB, V79, P460, DOI 10.1128/AEM.02551-12; Luo Y, 2011, ANTIMICROB AGENTS CH, V55, P4161, DOI 10.1128/AAC.00111-11; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MIDDENDORF PJ, 1993, J NEMATOL, V25, P573; MILLER RE, 1951, ADV CARBOHYD CHEM, V6, P231; MISRA S, 1989, BIOCHEM MED METAB B, V42, P171, DOI 10.1016/0885-4505(89)90052-2; NOEL GR, 1990, J NEMATOL, V22, P763; Peng DH, 2016, ENVIRON MICROBIOL, V18, P846, DOI 10.1111/1462-2920.13069; RAGHAVEN.M, 1961, BIOCHEM BIOPH RES CO, V4, P101, DOI 10.1016/0006-291X(61)90355-2; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; Ruan LF, 2015, ENVIRON MICROBIOL, V17, P4547, DOI 10.1111/1462-2920.12968; Ruan LF, 2015, TRENDS MICROBIOL, V23, P341, DOI 10.1016/j.tim.2015.02.011; SAFFRAN M, 1949, J BIOL CHEM, V180, P1301; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sugimoto T, 2014, J BIOSCI BIOENG, V117, P563, DOI 10.1016/j.jbiosc.2013.10.020; Sun M, 1996, Wei Sheng Wu Xue Bao, V36, P303; TATE CG, 1993, J BIOL CHEM, V268, P26850; TATE CG, 1992, J BIOL CHEM, V267, P6923; THOMPSON JF, 1990, ANAL BIOCHEM, V184, P39, DOI 10.1016/0003-2697(90)90008-W; Thompson JF, 1997, J AGR FOOD CHEM, V45, P3684, DOI 10.1021/jf970131s; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Zhang LL, 2014, J ECON ENTOMOL, V107, P551, DOI 10.1603/EC13201; Zheng JS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0942; Zheng ZQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31341; Zhou JH, 2011, J HAZARD MATER, V192, P1243, DOI 10.1016/j.jhazmat.2011.06.035; Zhu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14129	63	22	26	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3517	3530		10.1074/jbc.M116.762666	http://dx.doi.org/10.1074/jbc.M116.762666			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28087696	Green Published, hybrid			2022-12-28	WOS:000395538800039
J	Sommese, RF; Ritt, M; Swanson, CJ; Sivaramakrishnan, S				Sommese, Ruth F.; Ritt, Michael; Swanson, Carter J.; Sivaramakrishnan, Sivaraj			The Role of Regulatory Domains in Maintaining Autoinhibition in the Multidomain Kinase PKC alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C BETA-II; PROTEIN-KINASE; ACTIVATION; NUCLEOTIDES; INHIBITION; MECHANISMS; EVOLUTION; ISOFORMS; AFFINITY; POCKET	Resolving the conformational dynamics of large multidomain proteins has proven to be a significant challenge. Here we use a variety of techniques to dissect the roles of individual protein kinase C alpha (PKC alpha) regulatory domains in maintaining catalytic autoinhibition. We find that whereas the pseudosubstrate domain is necessary for autoinhibition it is not sufficient. Instead, each regulatory domain (C1a, C1b, and C2) appears to strengthen the pseudosubstrate- catalytic domain interaction in a nucleotide- dependent manner. The pseudosubstrate and C1a domains, however, are minimally essential for maintaining the inactivated state. Furthermore, disrupting known interactions between the C1a and other regulatory domains releases the autoinhibited interaction and increases basal activity. Modulating this interaction between the catalytic and regulatory domains reveals a direct correlation between autoinhibition and membrane translocation following PKC activation.	[Sommese, Ruth F.; Ritt, Michael; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Swanson, Carter J.] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan	Sivaramakrishnan, S (corresponding author), Univ Minnesota, 4-124 MCB,420 Washington Ave SE, Twin Cities Minneapolis, MN 55455 USA.	sivaraj@umn.edu			American Heart Association Scientist Development Grant [13SDG14270009]; National Institutes of Health [1DP2 CA186752-01, 1-R01-GM-105646-01-A1]; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105646] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Heart Association Scientist Development Grant 13SDG14270009 and National Institutes of Health Grants 1DP2 CA186752-01 and 1-R01-GM-105646-01-A1 (to S.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Antal CE, 2015, CELL REP, V12, P1252, DOI 10.1016/j.celrep.2015.07.039; Autry JM, 2012, J BIOL CHEM, V287, P39070, DOI 10.1074/jbc.M112.404434; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HERBERG FW, 1993, BIOCHEMISTRY-US, V32, P14015, DOI 10.1021/bi00213a035; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Huang SM, 1999, BIOCHEMISTRY-US, V38, P12020, DOI 10.1021/bi990594m; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Igumenova TI, 2015, BIOCHEMISTRY-US, V54, P4953, DOI 10.1021/acs.biochem.5b00565; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kirwan AF, 2003, BIOCHEM J, V373, P571, DOI 10.1042/BJ20030011; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Leonard TA, 2011, CURR OPIN STRUC BIOL, V21, P785, DOI 10.1016/j.sbi.2011.07.006; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; Lucic I, 2016, J MOL BIOL, V428, P121, DOI 10.1016/j.jmb.2015.11.001; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Sommese RF, 2016, J BIOL CHEM, V291, P21963, DOI 10.1074/jbc.M116.737601; Srivastava J, 2002, FEBS LETT, V516, P265, DOI 10.1016/S0014-5793(02)02500-0; Stahelin RV, 2005, J BIOL CHEM, V280, P36452, DOI 10.1074/jbc.M506224200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Swanson CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162331; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Swanson CJ, 2014, J BIOL CHEM, V289, P17812, DOI 10.1074/jbc.M113.534750; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107	37	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2873	2880		10.1074/jbc.M116.768457	http://dx.doi.org/10.1074/jbc.M116.768457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049730	hybrid, Green Published			2022-12-28	WOS:000395535100027
J	Bisse, E; Schaeffer-Reiss, C; Van Dorsselaer, A; Alayi, TD; Epting, T; Winkler, K; Cardenas, ASB; Soman, J; Birukou, I; Samuel, PP; Olson, JS				Bisse, Emmanuel; Schaeffer-Reiss, Christine; Van Dorsselaer, Alain; Alayi, Tchilabalo Dilezitoko; Epting, Thomas; Winkler, Karl; Cardenas, Andres S. Benitez; Soman, Jayashree; Birukou, Ivan; Samuel, Premila P.; Olson, John S.			Hemoglobin Kirklareli (alpha H58L), a New Variant Associated with Iron Deficiency and Increased CO Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURES; LIGAND-BINDING; RATE CONSTANTS; CARBOXYHEMOGLOBIN LEVELS; HEMIN DISSOCIATION; CARBON-MONOXIDE; ZURICH BETA-63; HB ZURICH; M-BOSTON; R-STATE	Mutations in hemoglobin can cause a wide range of phenotypic outcomes, including anemia due to protein instability and red cell lysis. Uncovering the biochemical basis for these phenotypes can provide new insights into hemoglobin structure and function as well as identify new therapeutic opportunities. We report here a new hemoglobin alpha chain variant in a female patient with mild anemia, whose father also carries the trait and is from the Turkish city of Kirklareli. Both the patient and her father had a His-58(E7) -> Leu mutation in alpha 1. Surprisingly, the patient's father is not anemic, but he is a smoker with high levels of HbCO (similar to 16%). To understand these phenotypes, we examined recombinant human Hb (rHb) Kirklareli containing the alpha H58L replacement. Mutant alpha subunits containing Leu-58(E7) autoxidize similar to 8 times and lose hemin similar to 200 times more rapidly than native alpha subunits, causing the oxygenated form of rHb Kirklareli to denature very rapidly under physiological conditions. The crystal structure of rHb Kirklareli shows that the alpha H58L replacement creates a completely apolar active site, which prevents electrostatic stabilization of bound O-2, promotes autoxidation, and enhances hemin dissociation by inhibiting water coordination to the Fe(III) atom. At the same time, the mutant alpha subunit has an similar to 80,000-fold higher affinity for CO than O-2, causing it to rapidly take up and retain carbon monoxide, which prevents denaturation both in vitro and in vivo and explains the phenotypic differences between the father, who is a smoker, and his daughter.	[Bisse, Emmanuel; Epting, Thomas; Winkler, Karl] Univ Med Ctr, Inst Clin Chem & Lab Med, Hugstetterstr 55, D-79106 Freiburg, Germany; [Schaeffer-Reiss, Christine; Van Dorsselaer, Alain; Alayi, Tchilabalo Dilezitoko] Univ Strasbourg, BioOrgan Mass Spectrometry Lab LSMBO, IPHC, 25 Rue Becquerel, F-67087 Strasbourg, France; [Schaeffer-Reiss, Christine; Van Dorsselaer, Alain; Alayi, Tchilabalo Dilezitoko] CNRS, IPHC, UMR7178, F-67087 Strasbourg, France; [Cardenas, Andres S. Benitez; Soman, Jayashree; Birukou, Ivan; Samuel, Premila P.; Olson, John S.] Rice Univ, Dept Biosci, Houston, TX 77281 USA; [Birukou, Ivan] Syngenta Crop Protect LLC, 9 Davis Dr, Res Triangle Pk, NC 27709 USA	University of Freiburg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Rice University; Syngenta	Olson, JS (corresponding author), Rice Univ, BioSci Rice, MS 140,6100 Main St, Houston, TX 77005 USA.	olson@rice.edu	Alayi, Tchilabalo Dilezitoko/X-7191-2018	Alayi, Tchilabalo Dilezitoko/0000-0002-7291-531X; Samuel, Premila/0000-0001-6690-0886	Robert A. Welch Foundation [C-0612]; National Institutes of Health [P01 HL110900]; Ministry of Science and Arts, Baden-Wurttemberg, Germany; Fondation pour la Recherche Medicale; Proteomic French Infrastructure (ProFI) [ANR-10-INSB-08-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900] Funding Source: NIH RePORTER	Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Arts, Baden-Wurttemberg, Germany; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Proteomic French Infrastructure (ProFI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant C-0612 from Robert A. Welch Foundation (to J. S. O.), National Institutes of Health Grant P01 HL110900 (to J. S. O.), the Ministry of Science and Arts, Baden-Wurttemberg, Germany (to University Medical Center, Freiburg, Germany (to E.B., T.E., and K.W.)), the Fondation pour la Recherche Medicale, and the Proteomic French Infrastructure (ProFI) Grant ANR-10-INSB-08-03 (to C.S.-R., A.D., and T.D.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alayi TD, 2014, HEMOGLOBIN, V38, P133, DOI 10.3109/03630269.2014.880063; [Anonymous], 1968, J CRYST GROWTH, DOI [rg/10.1016/00220248(68)900717, DOI 10.1016/0022-0248(68)90071-7]; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Beutler E., 1975, MANUAL BIOCH METHODS, P3; Bevington P.R., 1969, DATA REDUCTION ERROR; Birukou I., 2011, THESIS; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Bisse E, 2000, J BIOL CHEM, V275, P21380, DOI 10.1074/jbc.M001827200; Bisse E, 2011, J CHROMATOGR B, V879, P2952, DOI 10.1016/j.jchromb.2011.08.016; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brucker EA, 2000, ACTA CRYSTALLOGR D, V56, P812, DOI 10.1107/S0907444900006557; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOC MG, 1981, J BIOL CHEM, V256, P1831; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; DIIORIO EE, 1984, EUR J BIOCHEM, V145, P549; DIVOKY V, 1992, BIOCHIM BIOPHYS ACTA, V1180, P173, DOI 10.1016/0925-4439(92)90065-U; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; GIACOMETTI GM, 1980, J BIOL CHEM, V255, P6160; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Hardison RC, 1998, HEMOGLOBIN, V22, P113, DOI 10.3109/03630269809092136; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11300, DOI 10.1021/bi960372d; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Huisman T. H., 1977, HEMOGLOBINOPATHIES T, P70; HUISMAN TH, 1961, CLIN CHIM ACTA, V6, P347, DOI 10.1016/0009-8981(61)90061-4; IMAI K, 1970, Biochimica et Biophysica Acta, V200, P189, DOI 10.1016/0005-2795(70)90163-7; LIEINJO LE, 1973, AM J HUM GENET, V25, P382; Liu YT, 2000, BRIT J HAEMATOL, V108, P295; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; Maillett D. H. J., 2003, THESIS; Manning LR, 2007, PROTEIN SCI, V16, P1641, DOI 10.1110/ps.072891007; Manning LR, 1999, METHOD ENZYMOL, V306, P113; Manning LR, 1996, PROTEIN SCI, V5, P775; MATHEWS AJ, 1989, J BIOL CHEM, V264, P16573; MATHEWS AJ, 1994, METHOD ENZYMOL, V232, P363; Mollan TL, 2014, FREE RADICAL BIO MED, V69, P265, DOI 10.1016/j.freeradbiomed.2014.01.030; Nagatomo S, 2002, BIOPHYS CHEM, V98, P217, DOI 10.1016/S0301-4622(02)00103-5; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 2003, METH MOLEC MED, V82, P65; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PERUTZ MF, 1968, NATURE, V219, P902, DOI 10.1038/219902a0; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; PHILLIPS SEV, 1981, J MOL BIOL, V150, P137, DOI 10.1016/0022-2836(81)90329-6; PIK C, 1964, CLIN CHIM ACTA, V10, P90, DOI 10.1016/0009-8981(64)90220-7; PULSINELLI PD, 1973, P NATL ACAD SCI USA, V70, P3870, DOI 10.1073/pnas.70.12.3870; Qadah T, 2015, HEMOGLOBIN, V39, P340, DOI 10.3109/03630269.2015.1062393; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Samuel PP, 2015, J BIOL CHEM, V290, P23479, DOI 10.1074/jbc.M115.672204; SANGUANSERMSRI T, 1979, HEMOGLOBIN, V3, P161, DOI 10.3109/03630267908998911; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Schaer DJ, 2010, ANTIOXID REDOX SIGN, V12, P181, DOI 10.1089/ars.2009.2923; Schweers R., 2003, THESIS; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; SHIMADA H, 1989, BIOCHEM BIOPH RES CO, V158, P110, DOI 10.1016/S0006-291X(89)80184-6; So CC, 2009, J CLIN PATHOL, V62, P1107, DOI 10.1136/jcp.2009.067538; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; Thom C. S., 2015, NATHAN OSKIS HEMATOL, P630; TUCKER PW, 1978, P NATL ACAD SCI USA, V75, P1076, DOI 10.1073/pnas.75.3.1076; Unzai S, 1998, J BIOL CHEM, V273, P23150, DOI 10.1074/jbc.273.36.23150; VIRSHUP DM, 1983, AM J HEMATOL, V14, P315, DOI 10.1002/ajh.2830140402; WALLACE WJ, 1976, BIOCHEM BIOPH RES CO, V68, P1379, DOI 10.1016/0006-291X(76)90348-X; ZHANG L, 1991, J BIOL CHEM, V266, P24698; ZINKHAM WH, 1983, AM J MED, V74, P23, DOI 10.1016/0002-9343(83)91113-0; ZINKHAM WH, 1980, SCIENCE, V209, P406, DOI 10.1126/science.7384813	73	7	7	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2542	2555		10.1074/jbc.M116.764274	http://dx.doi.org/10.1074/jbc.M116.764274			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011635	hybrid, Green Published			2022-12-28	WOS:000395530300040
J	Qin, HM; Miyakawa, T; Inoue, A; Nishiyama, R; Nakamura, A; Asano, A; Sawano, Y; Ojima, T; Tanokura, M				Qin, Hui-Min; Miyakawa, Takuya; Inoue, Akira; Nishiyama, Ryuji; Nakamura, Akira; Asano, Atsuko; Sawano, Yoriko; Ojima, Takao; Tanokura, Masaru			Structure and Polymannuronate Specificity of a Eukaryotic Member of Polysaccharide Lyase Family 14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALIOTIS-DISCUS-HANNAI; ALGINATE LYASE; CRYSTAL-STRUCTURE; CDNA CLONING; ABALONE; RESIDUES; ACID	Alginate is an abundant algal polysaccharide, composed of beta-D-mannuronate and its C5 epimer alpha-L-guluronate, that is a useful biomaterial in cell biology and tissue engineering, with applications in cancer and aging research. The alginate lyase (EC 4.2.2.3) from Aplysia kurodai, AkAly30, is a eukaryotic member of the polysaccharide lyase 14 (PL-14) family and degrades alginate by cleaving the glycosidic bond through a beta-elimination reaction. Here, we present the structural basis for the substrate specificity, with a preference for polymannuronate, of AkAly30. The crystal structure of AkAly30 at a 1.77 angstrom resolution and the putative substrate-binding model show that the enzyme adopts a beta-jelly roll fold at the core of the structure and that Lys-99, Tyr-140, and Tyr-142 form catalytic residues in the active site. Their arrangements allow the carboxyl group of mannuronate residues at subsite +1 to form ionic bonds with Lys-99. The coupled tyrosine forms a hydrogen bond network with the glycosidic bond, and the hydroxy group of Tyr-140 is located near the C5 atom of the mannuronate residue. These interactions could promote the beta-elimination of the mannuronate residue at subsite +1. More interestingly, Gly-118 and the disulfide bond formed by Cys-115 and Cys-124 control the conformation of an active-site loop, which makes the space suitable for substrate entry into subsite -1. The cleavage efficiency of AkAly30 is enhanced relative to that of mutants lacking either Gly-118 or the Cys-115-Cys-124 disulfide bond. The putative binding model and mutagenesis studies provide a novel substrate recognition mode explaining the polymannuronate specificity of PL-14 alginate lyases.	[Qin, Hui-Min; Miyakawa, Takuya; Nakamura, Akira; Asano, Atsuko; Sawano, Yoriko; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Qin, Hui-Min] Tianjin Univ Sci & Technol, Coll Biotechnol, 29,13th Ave, Tianjin 300457, Peoples R China; [Inoue, Akira; Nishiyama, Ryuji; Ojima, Takao] Hokkaido Univ, Grad Sch Fisheries Sci, Lab Marine Biotechnol & Microbiol, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan; [Sawano, Yoriko] Tokyo Med & Dent Univ, Coll Liberal Arts & Sci, Chem Lab, 2-8-30 Kounodai, Ichikawa, Chiba 2720827, Japan	University of Tokyo; Tianjin University Science & Technology; Hokkaido University; Tokyo Medical & Dental University (TMDU)	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp	Nakamura, Akira/K-2982-2019	Nakamura, Akira/0000-0001-7733-4007; Tanokura, Masaru/0000-0001-5072-2480	Tohoku Marine Science Project of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; overseas High-level Talents Program of Tianjin University of Science and Technology, China	Tohoku Marine Science Project of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; overseas High-level Talents Program of Tianjin University of Science and Technology, China	This work was supported by the Tohoku Marine Science Project of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, and the overseas High-level Talents Program of Tianjin University of Science and Technology, China. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Chaki T, 2007, BIOSCI BIOTECH BIOCH, V71, P1819, DOI 10.1271/bbb.60620; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; ELYAKOVA LA, 1974, BIOCHIM BIOPHYS ACTA, V358, P341, DOI 10.1016/0005-2744(74)90464-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GACESA P, 1990, APPL ENVIRON MICROB, V56, P2265, DOI 10.1128/AEM.56.7.2265-2267.1990; Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hashimoto W, 2003, J BIOL CHEM, V278, P7663, DOI 10.1074/jbc.M208100200; Hata M, 2009, FISHERIES SCI, V75, P755, DOI 10.1007/s12562-009-0079-z; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Inoue A, 2016, J BIOL CHEM, V291, P15551, DOI 10.1074/jbc.M115.713230; Inoue A, 2011, MAR BIOTECHNOL, V13, P256, DOI 10.1007/s10126-010-9290-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kumagai Y, 2009, COMP BIOCHEM PHYS B, V154, P113, DOI 10.1016/j.cbpb.2009.05.005; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Mochizuki S, 2015, J BIOL CHEM, V290, P30962, DOI 10.1074/jbc.M115.686725; Muramatsu T, 1996, J PROTEIN CHEM, V15, P709, DOI 10.1007/BF01887144; Nishida Y, 2007, BIOCHIMIE, V89, P1002, DOI 10.1016/j.biochi.2007.03.015; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Ootsuka S, 2006, J BIOTECHNOL, V125, P269, DOI 10.1016/j.jbiotec.2006.03.008; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Park D, 2014, J BIOL CHEM, V289, P8645, DOI 10.1074/jbc.M113.531111; Rahman MM, 2012, CARBOHYD RES, V360, P69, DOI 10.1016/j.carres.2012.05.019; Rahman MM, 2011, BIOCHIMIE, V93, P1720, DOI 10.1016/j.biochi.2011.06.004; Rahman MM, 2010, COMP BIOCHEM PHYS B, V157, P317, DOI 10.1016/j.cbpb.2010.07.006; Sawabe T, 2003, AQUACULTURE, V219, P671, DOI 10.1016/S0044-8486(02)00618-X; Shimizu E, 2003, CARBOHYD RES, V338, P2841, DOI 10.1016/j.carres.2003.08.009; Suda K, 1999, FEMS MICROBIOL LETT, V180, P45, DOI 10.1016/S0378-1097(99)00459-0; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Suzuki K., 2004, MAR BIOTECHNOL, V6, pS502; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Wang L, 2012, FISHERIES SCI, V78, P889, DOI 10.1007/s12562-012-0517-1; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509	46	23	24	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2182	2190		10.1074/jbc.M116.749929	http://dx.doi.org/10.1074/jbc.M116.749929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011642	Green Published, hybrid			2022-12-28	WOS:000395530300012
J	Chan, CM; Macdonald, CD; Litherland, GJ; Wilkinson, DJ; Skelton, A; Europe-Finner, GN; Rowan, AD				Chan, Chun Ming; Macdonald, Christopher D.; Litherland, Gary J.; Wilkinson, David J.; Skelton, Andrew; Europe-Finner, G. Nicholas; Rowan, Andrew D.			Cytokine-induced MMP13 Expression in Human Chondrocytes Is Dependent on Activating Transcription Factor 3 (ATF3) Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP-1); arthritis; cell signaling; chondrocyte; inflammation; matrix metalloproteinase (MMP)	MATRIX-METALLOPROTEINASE 13; TUMOR-NECROSIS-FACTOR; HUMAN OSTEOARTHRITIC CHONDROCYTES; CARTILAGE COLLAGEN BREAKDOWN; ONCOSTATIN-M; GENE-EXPRESSION; RESPONSE ELEMENT; PARATHYROID-HORMONE; PROINFLAMMATORY CYTOKINES; INTERSTITIAL COLLAGENASE	Irreversible breakdown of cartilage extracellular matrix (ECM) by the collagenase matrix metalloproteinase 13 (MMP13) represents a key event in osteoarthritis (OA) progression. Although inflammation is most commonly associated with inflammatory joint diseases, it also occurs in OA and is thus relevant to the prevalent tissue destruction. Here, inflammation generates a cFOS AP-1 early response that indirectly affects MMP13 gene expression. To ascertain a more direct effect on prolonged MMP13 production we examined the potential molecular events occurring between the rapid, transient expression of cFOS and the subsequent MMP13 induction. Importantly, we show MMP13 mRNA expression is mirrored by nascent hnRNA transcription. Employing ChIP assays, cFOS recruitment to the MMP13 promoter occurs at an early stage prior to gene transcription and that recruitment of transcriptional initiation markers also correlated with MMP13 expression. Moreover, protein synthesis inhibition following early FOS expression resulted in a significant decrease in MMP13 expression thus indicating a role for different regulatory factors modulating expression of the gene. Subsequent mRNA transcriptome analyses highlighted several genes induced soon after FOS that could contribute to MMP13 expression. Specific small interfering RNA-mediated silencing highlighted that ATF3 was as highly selective for MMP13 as cFOS. Moreover, ATF3 expression was AP-1(cFOS/cJUN)-dependent and expression levels were maintained after the early transient cFOS response. Furthermore, ATF3 bound the proximal MMP13 AP-1 motif in stimulated chondrocytes at time points that no longer supported binding of FOS. Consequently, these findings support roles for both cFOS (indirect) and ATF3 (direct) in effecting MMP13 transcription in human chondrocytes.	[Chan, Chun Ming; Macdonald, Christopher D.; Litherland, Gary J.; Wilkinson, David J.; Skelton, Andrew; Europe-Finner, G. Nicholas; Rowan, Andrew D.] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Macdonald, Christopher D.] Arthrit Res UK, 41 Portland Pl,4th Floor, London W1B 1QH, England; [Litherland, Gary J.] Univ West Scotland, Sch Sci & Sport, Inst Biomed & Environm Hlth Res, Paisley Campus, Paisley PA1 2BE, Renfrew, Scotland; [Skelton, Andrew] Newcastle Univ, Bioinformat Support Unit, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Europe-Finner, G. Nicholas] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK; University of West Scotland; Newcastle University - UK; Newcastle University - UK	Rowan, AD (corresponding author), Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	drew.rowan@ncl.ac.uk	Litherland, Gary J/K-9755-2015	Wilkinson, David/0000-0002-6262-3575; Litherland, Gary/0000-0001-5264-0219	Nuffield Foundation (Oliver Bird Rheumatism Programme); JGW Patterson Foundation; United Kingdom National Institute for Health Research Biomedical Research Centre for Ageing and Age-related disease award; Arthritis Research Campaign [18726, 19322, 19485]	Nuffield Foundation (Oliver Bird Rheumatism Programme); JGW Patterson Foundation; United Kingdom National Institute for Health Research Biomedical Research Centre for Ageing and Age-related disease award; Arthritis Research Campaign(Versus Arthritis)	This work was supported by the Nuffield Foundation (Oliver Bird Rheumatism Programme), the JGW Patterson Foundation, Arthritis Research Campaign Grants 18726, 19322, and 19485, and a United Kingdom National Institute for Health Research Biomedical Research Centre for Ageing and Age-related disease award to the Newcastle upon Tyne Hospitals National Health Service Foundation Trust. The authors declare that they have no conflicts of interest with the contents of this article. The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Dept. of Health.	AUBLE DT, 1991, BIOCHEMISTRY-US, V30, P4629, DOI 10.1021/bi00232a039; Bailey J, 2002, J CLIN ENDOCR METAB, V87, P1717, DOI 10.1210/jcem.87.4.8360; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Benderdour M, 2002, J RHEUMATOL, V29, P1262; Bui C, 2012, FASEB J, V26, P3000, DOI 10.1096/fj.12-206367; Catterall JB, 2001, ARTHRITIS RHEUM-US, V44, P2296, DOI 10.1002/1529-0131(200110)44:10<2296::AID-ART392>3.0.CO;2-9; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; Durigova M, 2011, EUR CELLS MATER, V21, P31, DOI 10.22203/eCM.v021a03; Fukasawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30918; Gellersen B, 1997, MOL ENDOCRINOL, V11, P97, DOI 10.1210/me.11.1.97; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Hai T, 1999, GENE EXPRESSION, V7, P321; Hashimoto K, 2013, J BIOL CHEM, V288, P10061, DOI 10.1074/jbc.M112.421156; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Hui W, 2003, ANN RHEUM DIS, V62, P172, DOI 10.1136/ard.62.2.172; Iezaki T, 2016, J PATHOL, V239, P426, DOI 10.1002/path.4739; James CG, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-30; Karsdal MA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2434; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Little CB, 2005, OSTEOARTHR CARTILAGE, V13, P162, DOI 10.1016/j.joca.2004.10.014; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Nilsson M, 1997, CELL GROWTH DIFFER, V8, P913; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Radwan M, 2013, ARTHRITIS RHEUM-US, V65, P1290, DOI 10.1002/art.37868; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Rowan AD, 2003, AM J PATHOL, V162, P1975, DOI 10.1016/S0002-9440(10)64330-1; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Rowan AD, 2008, EXPERT OPIN THER TAR, V12, P1, DOI 10.1517/14728222.12.1.1; Schmucker AC, 2012, J BIOL CHEM, V287, P1189, DOI 10.1074/jbc.M111.264077; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Staunton D, 1998, PROTEIN ENG, V11, P1093, DOI 10.1093/protein/11.11.1093; Thalayasingam N, 2011, BEST PRACT RES CL RH, V25, P549, DOI 10.1016/j.berh.2011.10.004; Uchida M, 2001, J BONE MINER RES, V16, P221, DOI 10.1359/jbmr.2001.16.2.221; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; Yue CM, 2008, PHYSIOL GENOMICS, V35, P231, DOI 10.1152/physiolgenomics.90218.2008; Zhang Q, 2008, ANN RHEUM DIS, V67, P1633, DOI 10.1136/ard.2007.079574	50	33	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1625	1636		10.1074/jbc.M116.756601	http://dx.doi.org/10.1074/jbc.M116.756601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27956552	hybrid, Green Published			2022-12-28	WOS:000395515600008
J	Del Piccolo, N; Sarabipour, S; Hristova, K				Del Piccolo, Nuala; Sarabipour, Sarvenaz; Hristova, Kalina			A New Method to Study Heterodimerization of Membrane Proteins and Its Application to Fibroblast Growth Factor Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; TRANSMEMBRANE HELIX DIMERIZATION; PLASMA-MEMBRANE; TYROSINE KINASES; EGF RECEPTOR; THANATOPHORIC DYSPLASIA; JUXTAMEMBRANE REGION; FLUORESCENT PROTEINS; EXTRACELLULAR DOMAIN; SKELETAL DYSPLASIAS	The activity of receptor tyrosine kinases (RTKs) is controlled through their lateral association in the plasma membrane. RTKs are believed to form both homodimers and heterodimers, and the different dimers are believed to play unique roles in cell signaling. However, RTK heterodimers remain poorly characterized, as compared with homodimers, because of limitations in current experimental methods. Here, we develop a FRET-based methodology to assess the thermodynamics of hetero-interactions in the plasma membrane. To demonstrate the utility of the methodology, we use it to study the hetero-interactions between three fibroblast growth factor receptors-FGFR1, FGFR2, and FGFR3-in the absence of ligand. Our results show that all possible FGFR heterodimers form, suggesting that the biological roles of FGFR heterodimers may be as significant as the homodimer roles. We further investigate the effect of two pathogenic point mutations in FGFR3 (A391E and G380R) on heterodimerization. We show that each of these mutations stabilize most of the heterodimers, with the largest effects observed for FGFR3 wild-type/mutant heterodimers. We thus demonstrate that the methodology presented here can yield new knowledge about RTK interactions and can further our understanding of signal transduction across the plasma membrane.	[Del Piccolo, Nuala; Sarabipour, Sarvenaz; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	kh@jhu.edu	Sarabipour, Sarvenaz/H-2992-2015	Sarabipour, Sarvenaz/0000-0001-5097-5509; Del Piccolo, Nuala/0000-0002-5104-7322	National Institutes of Health [GM095930, GM068619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619, R01GM095930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM095930 and GM068619. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad I, 2012, BBA-MOL CELL RES, V1823, P850, DOI 10.1016/j.bbamcr.2012.01.004; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; Chen FH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056521; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Cunningham ML, 2007, ORTHOD CRANIOFAC RES, V10, P67, DOI 10.1111/j.1601-6343.2007.00389.x; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; Del Piccolo N, 2015, BIOPHYS J, V108, P272, DOI 10.1016/j.bpj.2014.11.3460; Del Piccolo N, 2012, ANAL CHEM, V84, P8650, DOI [10.1021/ac301776j, 10.1021/ac301776J]; Delezoide AL, 1998, MECH DEVELOP, V77, P19, DOI 10.1016/S0925-4773(98)00133-6; Dietz MS, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-6; Drevs J, 2003, CURR DRUG TARGETS, V4, P113, DOI 10.2174/1389450033346885; Duneau JP, 2007, BIOCHEMISTRY-US, V46, P2010, DOI 10.1021/bi061436f; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Foldynova-Trantirkova S, 2012, HUM MUTAT, V33, P29, DOI 10.1002/humu.21636; Gerber D, 2004, J BIOL CHEM, V279, P21177, DOI 10.1074/jbc.M400847200; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044; He LJ, 2011, J BIOL CHEM, V286, P13272, DOI 10.1074/jbc.M110.205583; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; JOHNSON ML, 1992, METHOD ENZYMOL, V210, P1; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Khadria AS, 2013, BIOCHEMISTRY-US, V52, P7542, DOI 10.1021/bi4009837; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; King C, 2014, BIOPHYS J, V106, P1309, DOI 10.1016/j.bpj.2014.01.039; Krejci P, 2014, MUTAT RES-REV MUTAT, V759, P40, DOI 10.1016/j.mrrev.2013.11.001; Lazar J, 2011, NAT METHODS, V8, P684, DOI [10.1038/NMETH.1643, 10.1038/nmeth.1643]; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li E, 2005, BIOCHEMISTRY-US, V44, P352, DOI 10.1021/bi048480k; Li E, 2008, ANAL CHEM, V80, P5976, DOI 10.1021/ac800616u; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Merzlyakov M, 2006, J MOL BIOL, V358, P1, DOI 10.1016/j.jmb.2006.01.086; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pantaleo MA, 2008, INT J ONCOL, V33, P443, DOI 10.3892/ijo_00000026; Placone J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046678; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Sarabipour S, 2016, BBA-BIOMEMBRANES, V1858, P1436, DOI 10.1016/j.bbamem.2016.03.027; Sarabipour S, 2016, ELIFE, V5, DOI 10.7554/eLife.13876; Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262; Sarabipour S, 2015, ACCOUNTS CHEM RES, V48, P2262, DOI 10.1021/acs.accounts.5b00238; Sarabipour S, 2015, BBA-BIOMEMBRANES, V1848, P1591, DOI 10.1016/j.bbamem.2015.04.002; Sarabipour S, 2015, J MOL BIOL, V427, P1705, DOI 10.1016/j.jmb.2015.02.013; Sarabipour S, 2014, ANAL BIOCHEM, V449, P155, DOI 10.1016/j.ab.2013.12.027; Sarabipour S, 2013, BIOPHYS J, V105, P165, DOI 10.1016/j.bpj.2013.05.053; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Soumana OS, 2008, EUR BIOPHYS J BIOPHY, V37, P851, DOI 10.1007/s00249-008-0293-0; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Tamagaki H, 2014, BIOCHEMISTRY-US, V53, P5000, DOI 10.1021/bi500327q; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; UENO H, 1992, J BIOL CHEM, V267, P1470; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; von Heijne G, 1999, J MOL BIOL, V293, P367, DOI 10.1006/jmbi.1999.2998; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1; You M, 2005, ANAL BIOCHEM, V340, P154, DOI 10.1016/j.ab.2005.01.035	73	24	24	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1288	1301		10.1074/jbc.M116.755777	http://dx.doi.org/10.1074/jbc.M116.755777			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27927983	hybrid, Green Published			2022-12-28	WOS:000393339800012
J	Beg, I; Minton, AP; Islam, A; Hassan, MI; Ahmad, F				Beg, Ilyas; Minton, Allen P.; Islam, Asimul; Hassan, Md. Imtaiyaz; Ahmad, Faizan			The pH Dependence of Saccharides' Influence on Thermal Denaturation of Two Model Proteins Supports an Excluded Volume Model for Stabilization Generalized to Allow for Intramolecular Electrostatic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANIDINE-HYDROCHLORIDE; TREHALOSE SYNTHESIS; ORGANIC OSMOLYTES; CHARGE-DENSITY; IN-VITRO; STABILITY; THERMOTOLERANCE; POLYELECTROLYTE; ACQUISITION; EQUILIBRIA	The reversible thermal denaturation of apo alpha-lactalbumin (alpha-LA) and lysozyme was measured in the absence and presence of multiple concentrations of each of seven saccharides (glucose, galactose, fructose, sucrose, trehalose, raffinose, and stachyose) at multiple pH values. It was observed that with increasing pH, the absolute stability of alpha-LA decreased, whereas the stabilizing effect per mole of all saccharides increased, and that the absolute stability of lysozyme increased, whereas the stabilizing effect per mole of all saccharides decreased. All of the data may be accounted for quantitatively by straightforward electrostatic generalization of a previously introduced coarse-grained model for stabilization of proteins by sugars.	[Beg, Ilyas; Islam, Asimul; Hassan, Md. Imtaiyaz; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Minton, Allen P.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	Jamia Millia Islamia; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ahmad, F (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.; Minton, AP (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.	minton@helix.nih.gov; fahmad@jmi.ac.in	Hassan, Imtaiyaz/ABF-6485-2020; BEG, ILYAS/AAS-2307-2020; Islam, Asimul/V-4526-2019; Hassan, Md Imtaiyaz/G-7072-2017; Hassan, Mohammad/GZA-7507-2022; Ahmad, Faizan/AGH-4493-2022	Hassan, Imtaiyaz/0000-0002-3663-4940; BEG, ILYAS/0000-0002-2008-2619; Islam, Asimul/0000-0001-9060-7970; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004; Ahmad, Faizan/0000-0001-7021-7502; Minton, Allen/0000-0001-8459-1247	Council of Scientific and Industrial Research, India [37(1603)/13/EMRII, 37(1604)/13/EMRII)]; National Institutes of Health Intramural Research Program of the NIDDK	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); National Institutes of Health Intramural Research Program of the NIDDK	This work was supported by Council of Scientific and Industrial Research, India, Research Grants 37(1603)/13/EMRII and 37(1604)/13/EMRII) (to F. A. and A. I.) and the National Institutes of Health Intramural Research Program of the NIDDK (to A. P. M). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ATTFIELD PV, 1987, FEBS LETT, V225, P259, DOI 10.1016/0014-5793(87)81170-5; Auton M, 2011, BIOPHYS CHEM, V159, P90, DOI 10.1016/j.bpc.2011.05.012; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Beg I, 2015, BIOCHEMISTRY-US, V54, P3594, DOI 10.1021/acs.biochem.5b00415; Bolen D W, 2001, Methods Mol Biol, V168, P17; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Davis-Searles PR, 2001, ANNU REV BIOPH BIOM, V30, P271, DOI 10.1146/annurev.biophys.30.1.271; DEVIRGILIO C, 1994, EUR J BIOCHEM, V219, P179; Dou SC, 2006, J POLYM SCI POL PHYS, V44, P2001, DOI 10.1002/polb.20853; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; HOTTIGER T, 1994, EUR J BIOCHEM, V219, P187, DOI 10.1111/j.1432-1033.1994.tb19929.x; JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Kim WK, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051926; Kirwan LJ, 2004, NANO LETT, V4, P149, DOI 10.1021/nl034912l; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Minton AP, 2000, BIOPHYS J, V78, P101, DOI 10.1016/S0006-3495(00)76576-3; Pace C N, 1986, Methods Enzymol, V131, P266; Pace CN, 2000, PROTEIN SCI, V9, P1395; Poddar NK, 2008, BIOPHYS CHEM, V138, P120, DOI 10.1016/j.bpc.2008.09.013; Senske M, 2014, J AM CHEM SOC, V136, P9036, DOI 10.1021/ja503205y; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Singh LR, 2011, J IRAN CHEM SOC, V8, P1; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; Tanford C., 1961, PHYS CHEM MACROMOLEC; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; Timasheff SN, 2002, BIOCHEMISTRY-US, V41, P13473, DOI 10.1021/bi020316e; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Weast R.C., 1972, HDB CHEM PHYS, V53rd ed.; Welsh DT, 2000, FEMS MICROBIOL REV, V24, P263, DOI 10.1111/j.1574-6976.2000.tb00542.x; Xie GF, 1997, BIOPHYS CHEM, V64, P25, DOI 10.1016/S0301-4622(96)02222-3; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	35	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					505	511		10.1074/jbc.M116.757302	http://dx.doi.org/10.1074/jbc.M116.757302			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909048	Green Published, hybrid			2022-12-28	WOS:000392316100008
J	Allen, JW; DiRusso, CC; Black, PN				Allen, James W.; DiRusso, Concetta C.; Black, Paul N.			Carbon and Acyl Chain Flux during Stress-induced Triglyceride Accumulation by Stable Isotopic Labeling of the Polar Microalga Coccomyxa subellipsoidea C169	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIATOM PHAEODACTYLUM-TRICORNUTUM; FATTY-ACID DESATURATION; CHLAMYDOMONAS-REINHARDTII; NITROGEN DEPRIVATION; LIPID-ACCUMULATION; TRIACYLGLYCEROL SYNTHESIS; PHOTOSYNTHETIC APPARATUS; ARABIDOPSIS-THALIANA; MEMBRANE-LIPIDS; ALGAL BIOFUELS	Deriving biofuels and other lipoid products from algae is a promising future technology directly addressing global issues of atmospheric CO2 balance. To better understand the metabolism of triglyceride synthesis in algae, we examined their metabolic origins in the model species, Coccomyxa subellipsoidea C169, using stable isotopic labeling. Labeling patterns arising from [U-C-13]glucose, (CO2)-C-13, or D2O supplementation were analyzed by GC-MS and/or LC-MSover time courses during nitrogen starvation to address the roles of catabolic carbon recycling, acylchain redistribution, and de novo fatty acid(FA) synthesis during the expansion of the lipid bodies. The metabolic origin of stress-induced triglyceride was found to be a continuous 8: 2 ratio between de novo synthesized FA and acyl chain transfer from pre-stressed membrane lipids with little input from lipid remodeling. Membrane lipids were continually synthesized with associated acyl chain editing during nitrogen stress, in contrast to an overall decrease in total membrane lipid. The incorporation rates of de novo synthesized FA into lipid classes were measured over a time course of nitrogen starvation. The synthesis of triglycerides, phospholipids, and galactolipids followed a two-stage pattern where nitrogen starvation resulted in a 2.5-fold increase followed by a gradual decline. Acyl chain flux into membrane lipids was dominant in the first stage followed by triglycerides. These data indicate that the level of metabolic control that determines acyl chain flux between membrane lipids and triglycerides during nitrogen stress relies primarily on the Kennedy pathway and de novo FA synthesis with limited, defined input from acyl editing reactions.	[Allen, James W.; DiRusso, Concetta C.; Black, Paul N.] Univ Nebraska, Dept Biochem, N200 George W Beadle Ctr,1901 Vine St, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Black, PN (corresponding author), Univ Nebraska, Dept Biochem, N200 George W Beadle Ctr,1901 Vine St, Lincoln, NE 68588 USA.	pblack2@unl.edu	Allen, James/AAG-6465-2019	DiRusso, Concetta/0000-0001-7388-9152; Black, Paul/0000-0002-6272-6881	National Science Foundation [EPS-1004094, 1264409]; Nebraska Center for Energy Sciences Research	National Science Foundation(National Science Foundation (NSF)); Nebraska Center for Energy Sciences Research	This work was supported by Grants EPS-1004094 (to P. N. B. and C. C. D.) and 1264409 (to C. C. D.) from the National Science Foundation and by a grant from the Nebraska Center for Energy Sciences Research (to P. N. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alipanah L, 2015, J EXP BOT, V66, P6281, DOI 10.1093/jxb/erv340; Allen JW, 2015, ALGAL RES, V10, P110, DOI 10.1016/j.algal.2015.04.019; Allen JW, 2014, ALGAL RES, V5, P23, DOI 10.1016/j.algal.2014.04.003; Bates PD, 2012, PLANT PHYSIOL, V160, P1530, DOI 10.1104/pp.112.204438; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Burrows EH, 2012, BIOENERG RES, V5, P876, DOI 10.1007/s12155-012-9201-7; Chader S, 2009, INT J HYDROGEN ENERG, V34, P4941, DOI 10.1016/j.ijhydene.2008.10.058; Chisti Y, 2013, J BIOTECHNOL, V167, P201, DOI 10.1016/j.jbiotec.2013.07.020; Chisti Y, 2011, APPL ENERG, V88, P3277, DOI 10.1016/j.apenergy.2011.04.038; CHORNEY W, 1960, BIOCHIM BIOPHYS ACTA, V37, P280, DOI 10.1016/0006-3002(60)90235-3; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; Deme B, 2014, FASEB J, V28, P3373, DOI 10.1096/fj.13-247395; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Georgianna DR, 2012, NATURE, V488, P329, DOI 10.1038/nature11479; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Guerzoni ME, 1997, CAN J MICROBIOL, V43, P569, DOI 10.1139/m97-080; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; HARWOOD J, 1989, CRIT REV PLANT SCI, V8, P1, DOI 10.1080/07352680490273310; Hu ZH, 2012, PLANT PHYSIOL, V158, P1944, DOI 10.1104/pp.111.192153; Huard K, 2015, J MED CHEM, V58, P7164, DOI 10.1021/acs.jmedchem.5b01008; HUPPE HC, 1994, PLANT PHYSIOL, V105, P1043, DOI 10.1104/pp.105.4.1043; Ikaran Z, 2015, ALGAL RES, V10, P134, DOI 10.1016/j.algal.2015.04.023; Juergens MT, 2015, PLANT PHYSIOL, V167, P558, DOI 10.1104/pp.114.250530; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lee SJ, 2011, BIOTECHNOL BIOPROC E, V16, P561, DOI 10.1007/s12257-010-0360-0; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; Li-Beisson Y, 2015, PLANT J, V82, P504, DOI 10.1111/tpj.12787; Lu YD, 2009, EXTREMOPHILES, V13, P875, DOI 10.1007/s00792-009-0275-x; Lv HX, 2013, GENOMICS, V101, P229, DOI 10.1016/j.ygeno.2013.01.004; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Nakamura Y, 2005, J BIOL CHEM, V280, P7469, DOI 10.1074/jbc.M408799200; Nicolo MS, 2010, J BIOTECHNOL, V150, pS163, DOI 10.1016/j.jbiotec.2010.08.423; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pancha I, 2014, BIORESOURCE TECHNOL, V156, P146, DOI 10.1016/j.biortech.2014.01.025; PATTON GM, 1979, BIOCHEMISTRY-US, V18, P3186, DOI 10.1021/bi00581a042; Pollard M, 2015, PHYTOCHEMISTRY, V118, P192, DOI 10.1016/j.phytochem.2015.07.021; Preininger E, 2015, PHOTOSYNTHETICA, V53, P369, DOI 10.1007/s11099-015-0129-y; Ras M, 2013, REV ENVIRON SCI BIO, V12, P153, DOI 10.1007/s11157-013-9310-6; Roston RL, 2014, J BIOL CHEM, V289, P26089, DOI 10.1074/jbc.M114.576694; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Shen YX, 2013, J CHROMATOGR B, V930, P36, DOI 10.1016/j.jchromb.2013.04.034; Simionato D, 2013, EUKARYOT CELL, V12, P665, DOI 10.1128/EC.00363-12; Solovchenko AE, 2013, RUSS J PLANT PHYSL+, V60, P1, DOI 10.1134/S1021443713010081; Solovchenko AE, 2012, RUSS J PLANT PHYSL+, V59, P167, DOI 10.1134/S1021443712020161; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Tang HY, 2011, BIOTECHNOL BIOENG, V108, P2280, DOI 10.1002/bit.23160; Tevatia R, 2014, BIORESOURCE TECHNOL, V170, P152, DOI 10.1016/j.biortech.2014.07.043; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; Tjellstroem H, 2012, PLANT PHYSIOL, V158, P601, DOI 10.1104/pp.111.186122; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Urzica EI, 2013, J BIOL CHEM, V288, P30246, DOI 10.1074/jbc.M113.490425; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Wase N, 2014, J PROTEOME RES, V13, P1373, DOI 10.1021/pr400952z; Wen QX, 2013, BIOENERG RES, V6, P877, DOI 10.1007/s12155-013-9308-5; Wickramarathna AD, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0156-6; Yoon K, 2012, PLANT CELL, V24, P3708, DOI 10.1105/tpc.112.100701; Yurchenko OP, 2009, PLANT BIOTECHNOL J, V7, P602, DOI 10.1111/j.1467-7652.2009.00427.x; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x	65	20	21	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					361	374		10.1074/jbc.M116.760843	http://dx.doi.org/10.1074/jbc.M116.760843			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27903654	Green Published, hybrid			2022-12-28	WOS:000391578000031
J	Endo, A; Ly, T; Pippa, R; Bensaddek, D; Nicolas, A; Lamond, AI				Endo, Akinori; Ly, Tony; Pippa, Raffaella; Bensaddek, Dalila; Nicolas, Armel; Lamond, Angus I.			The Chromatin Assembly Factor Complex 1 (CAF1) and 5-Azacytidine (5-AzaC) Affect Cell Motility in Src-transformed Human Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; BREAST-CANCER; FACTOR-I; MESENCHYMAL TRANSITION; ONCOGENE; LINK; FIBROBLASTS; INHERITANCE; METABOLISM; SENESCENCE	Tumor invasion into surrounding stromal tissue is a hallmark of high grade, metastatic cancers. Oncogenic transformation of human epithelial cells in culture can be triggered by activation of v-Src kinase, resulting in increased cell motility, invasiveness, and tumorigenicity and provides a valuable model for studying how changes in gene expression cause cancer phenotypes. Here, we show that epithelial cells transformed by activated Src show increased levels of DNA methylation and that the methylation inhibitor 5-azacytidine (5-AzaC) potently blocks the increased cell motility and invasiveness induced by Src activation. A proteomic screen for chromatin regulators acting downstream of activated Src identified the replication-dependent histone chaperone CAF1 as an important factor for Src-mediated increased cell motility and invasion. We show that Src causes a 5-AzaC-sensitive decrease in both mRNA and protein levels of the p150 (CHAF1A) and p60 (CHAF1B), subunits of CAF1. Depletion of CAF1 in untransformed epithelial cells using siRNA was sufficient to recapitulate the increased motility and invasive phenotypes characteristic of transformed cells without activation of Src. Maintaining high levels of CAF1 by exogenous expression suppressed the increased cell motility and invasiveness phenotypes when Src was activated. These data identify a critical role of CAF1 in the dysregulation of cell invasion and motility phenotypes seen in transformed cells and also highlight an important role for epigenetic remodeling through DNA methylation for Src-mediated induction of cancer phenotypes.	[Endo, Akinori; Ly, Tony; Pippa, Raffaella; Bensaddek, Dalila; Nicolas, Armel; Lamond, Angus I.] Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dow St, Dundee DD1 5EH, Scotland	University of Dundee	Lamond, AI (corresponding author), Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dow St, Dundee DD1 5EH, Scotland.	a.i.lamond@dundee.ac.uk	Pippa, Raffaella/J-4566-2012; Pippa, Raffaella/AAH-8047-2020	Pippa, Raffaella/0000-0002-1028-6511; Pippa, Raffaella/0000-0002-1028-6511	Wellcome Trust [073980/Z/03/Z, 105024/Z/14/Z, 098503/E/12/Z, BB/K003801/1]; Seventh Framework Programme Grant [HEALTH-F4-2010-257082]; Gene Regulation and Expression Strategic Award [097945/B/11/Z]	Wellcome Trust(Wellcome TrustEuropean Commission); Seventh Framework Programme Grant; Gene Regulation and Expression Strategic Award	This work was supported by Wellcome Trust Grants 073980/Z/03/Z, 105024/Z/14/Z, 098503/E/12/Z, and BB/K003801/1 (to A. I. L.), Seventh Framework Programme Grant HEALTH-F4-2010-257082 (to A. I. L.), and Gene Regulation and Expression Strategic Award 097945/B/11/Z. The authors declare that they have no conflicts of interest with the contents of this article.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Cheloufi S, 2015, NATURE, V528, P218, DOI 10.1038/nature15749; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Elsberger B, 2014, CRIT REV ONCOL HEMAT, V89, P343, DOI 10.1016/j.critrevonc.2013.12.009; Exner V, 2006, DEVELOPMENT, V133, P4163, DOI 10.1242/dev.02599; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Hart PC, 2016, ONCOTARGET, V7, P308, DOI 10.18632/oncotarget.5687; Heimann R, 2000, EUR J CANCER, V36, P1631, DOI 10.1016/S0959-8049(00)00151-9; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Hunter T, 2015, P NATL ACAD SCI USA, V112, P7877, DOI 10.1073/pnas.1508223112; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kustatscher G, 2014, NAT PROTOC, V9, P2090, DOI 10.1038/nprot.2014.142; Larance M, 2013, MOL CELL PROTEOMICS, V12, P638, DOI 10.1074/mcp.M112.024547; Ly T, 2015, ELIFE, V4, DOI 10.7554/eLife.04534; Ly T, 2014, ELIFE, V3, DOI 10.7554/eLife.01630; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Petty RD, 2006, J CLIN ONCOL, V24, P1729, DOI 10.1200/JCO.2005.03.3399; Pippa R., 2016, ONCOTARGET, V5, DOI 10.18632/oncotarget.9840; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Polo SE, 2004, CANCER RES, V64, P2371, DOI 10.1158/0008-5472.CAN-03-2893; Ridgway P, 2000, J CELL SCI, V113, P2647; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Santini V, 2001, ANN INTERN MED, V134, P573, DOI 10.7326/0003-4819-134-7-200104030-00011; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SORM F, 1964, EXPERIENTIA, V20, P202, DOI 10.1007/BF02135399; SOULE HD, 1990, CANCER RES, V50, P6075; Staibano S, 2007, HISTOPATHOLOGY, V50, P911, DOI 10.1111/j.1365-2559.2007.02698.x; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; WANG E, 1976, P NATL ACAD SCI USA, V73, P4065, DOI 10.1073/pnas.73.11.4065; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	40	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					172	184		10.1074/jbc.M116.751024	http://dx.doi.org/10.1074/jbc.M116.751024			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27872192	Green Published, hybrid			2022-12-28	WOS:000391578000015
J	Romanatto, T; Roman, EA; Arruda, AP; Denis, RG; Solon, C; Milanski, M; Moraes, JC; Bonfleur, ML; Degasperi, GR; Picardi, PK; Hirabara, S; Boschero, AC; Curi, R; Velloso, LA				Romanatto, Talita; Roman, Erika A.; Arruda, Ana P.; Denis, Raphael G.; Solon, Carina; Milanski, Marciane; Moraes, Juliana C.; Bonfleur, Maria L.; Degasperi, Giovanna R.; Picardi, Paty K.; Hirabara, Sandro; Boschero, Antonio C.; Curi, Rui; Velloso, Licio A.			RETRACTION: Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis (Retraction of Vol 284, Pg 36213, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Velloso, Licio/AAJ-3778-2020; Bonfleur, M. L./A-2610-2013; Vercesi, Aníbal E/C-8767-2012; Denis, Raphael/ABE-1758-2020; Curi, Rui/AAT-7970-2021	Denis, Raphael/0000-0002-7677-7460; Curi, Rui/0000-0001-5095-9154				Romanatto Talita, 2009, J Biol Chem, V284, P36213, DOI 10.1074/jbc.M109.030874	1	3	3	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26934	26934		10.1074/jbc.A109.030874	http://dx.doi.org/10.1074/jbc.A109.030874			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	28011876	Green Published, hybrid			2022-12-28	WOS:000391571400029
J	Arkadash, V; Yosef, G; Shirian, J; Cohen, I; Horev, Y; Grossman, M; Sagi, I; Radisky, ES; Shifman, JM; Papo, N				Arkadash, Valeria; Yosef, Gal; Shirian, Jason; Cohen, Itay; Horev, Yuval; Grossman, Moran; Sagi, Irit; Radisky, Evette S.; Shifman, Julia M.; Papo, Niv			Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						directed evolution; metastasis; protease inhibitor; protein-protein interaction; proteolysis; binding affinity; computational protein design; matrix metalloproteinases; yeast surface display	HUMAN TISSUE INHIBITOR; CRYSTAL-STRUCTURE; BREAST-CANCER; 1-MATRIX METALLOPROTEINASE; SELECTIVE-INHIBITION; CATALYTIC DOMAIN; TUMOR-GROWTH; BINDING; ANTIBODIES; COMPLEX	Degradation of the extracellular matrices in the human body is controlled by matrix metalloproteinases (MMPs), a family of more than 20 homologous enzymes. Imbalance in MMP activity can result in many diseases, such as arthritis, cardiovascular diseases, neurological disorders, fibrosis, and cancers. Thus, MMPs present attractive targets for drug design and have been a focus for inhibitor design for as long as 3 decades. Yet, to date, all MMP inhibitors have failed in clinical trials because of their broad activity against numerous MMP family members and the serious side effects of the proposed treatment. In this study, we integrated a computational method and a yeast surface display technique to obtain highly specific inhibitors of MMP-14 by modifying the natural non-specific broad MMP inhibitor protein N-TIMP2 to interact optimally with MMP-14. We identified an N-TIMP2 mutant, with five mutations in its interface, that has an MMP-14 inhibition constant (K-i) of 0.9 pm, the strongest MMP-14 inhibitor reported so far. Compared with wild-type N-TIMP2, this variant displays approximate to 900-fold improved affinity toward MMP-14 and up to 16,000-fold greater specificity toward MMP-14 relative to other MMPs. In an in vitro and cell-based model of MMP-dependent breast cancer cellular invasiveness, this N-TIMP2 mutant acted as a functional inhibitor. Thus, our study demonstrates the enormous potential of a combined computational/directed evolution approach to protein engineering. Furthermore, it offers fundamental clues into the molecular basis of MMP regulation by N-TIMP2 and identifies a promising MMP-14 inhibitor as a starting point for the development of protein-based anticancer therapeutics.	[Arkadash, Valeria; Yosef, Gal; Cohen, Itay; Horev, Yuval; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Arkadash, Valeria; Yosef, Gal; Cohen, Itay; Horev, Yuval; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Shirian, Jason; Shifman, Julia M.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Grossman, Moran; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Radisky, Evette S.] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Weizmann Institute of Science; Mayo Clinic	Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.; Papo, N (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.; Shifman, JM (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	jshifman@mail.huji.ac.il; papo@bgu.ac.il	Radisky, Evette S/C-8526-2012; Papo, Niv/R-3946-2017	Radisky, Evette S/0000-0003-3121-109X; 	European Research Council [ERC-2013-StG, 336041]; NATIONAL CANCER INSTITUTE [R21CA205471, R01CA154387] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by European Research Council "Ideas Program" ERC-2013-StG by Contract Grant 336041 (to N. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GP, 2013, ANAL CHIM ACTA, V786, P132, DOI 10.1016/j.aca.2013.05.010; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Bartolome RA, 2009, AM J PATHOL, V174, P602, DOI 10.2353/ajpath.2009.080636; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Dufayard JF, 2005, BIOINFORMATICS, V21, P2596, DOI 10.1093/bioinformatics/bti325; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Fromer M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000627; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Graff CP, 2004, PROTEIN ENG DES SEL, V17, P293, DOI 10.1093/protein/gzh038; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Jiang WG, 2006, INT J MOL MED, V17, P583; Kveiborg M, 2010, BIOCHEM J, V430, P79, DOI 10.1042/BJ20100649; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; McCamish M, 2011, MABS-AUSTIN, V3, P209, DOI 10.4161/mabs.3.2.15005; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Ogata H, 2014, ACTA CRYSTALLOGR F, V70, P232, DOI 10.1107/S2053230X13034857; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Reddy N Ravindra, 2012, J Indian Soc Periodontol, V16, P549, DOI 10.4103/0972-124X.106907; Reich R, 2005, CLIN CANCER RES, V11, P3925, DOI 10.1158/1078-0432.CCR-04-1985; Romer T, 2011, CURR OPIN BIOTECH, V22, P882, DOI 10.1016/j.copbio.2011.06.007; Roque ACA, 2004, BIOTECHNOL PROGR, V20, P639, DOI 10.1021/bp030070k; Rosenfeld L, 2016, TRENDS BIOCHEM SCI, V41, P421, DOI 10.1016/j.tibs.2016.03.002; Seiki M, 1999, APMIS, V107, P137, DOI 10.1111/j.1699-0463.1999.tb01536.x; Sela-Passwell NA, 2012, NAT MED, V18, P143, DOI 10.1038/nm.2582; Sharabi O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093712; Sharabi O, 2013, BIOCHEM SOC T, V41, P1166, DOI 10.1042/BST20130121; Sharabi O, 2013, METHOD ENZYMOL, V523, P41, DOI 10.1016/B978-0-12-394292-0.00003-5; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Suojanen J, 2009, CANCER BIOL THER, V8, P2362, DOI 10.4161/cbt.8.24.10139; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Tetu B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1503; Thurber GM, 2008, TRENDS PHARMACOL SCI, V29, P57, DOI 10.1016/j.tips.2007.11.004; Udi Y, 2015, STRUCTURE, V23, P104, DOI 10.1016/j.str.2014.10.012; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Vanhoutte D, 2010, J MOL CELL CARDIOL, V48, P445, DOI 10.1016/j.yjmcc.2009.09.013; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Williamson RA, 1996, EUR J BIOCHEM, V241, P476, DOI 10.1111/j.1432-1033.1996.00476.x; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Yan TH, 2015, AM J TRANSL RES, V7, P950; Yang JK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15001; Yu Q, 2000, GENE DEV, V14, P163; Zhang HY, 2009, EUR ARCH OTO-RHINO-L, V266, P1427, DOI 10.1007/s00405-009-0943-6; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200	75	38	40	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3481	3495		10.1074/jbc.M116.756718	http://dx.doi.org/10.1074/jbc.M116.756718			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28087697	hybrid, Green Published			2022-12-28	WOS:000395538800036
J	Qiu, YL; Zhang, YY; Hu, N; Dong, F				Qiu, Yaling; Zhang, Yangyang; Hu, Nan; Dong, Fan			A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell differentiation; cell surface receptor; leukemia; neutrophil	SEVERE CONGENITAL NEUTROPENIA; DISTINCT CYTOPLASMIC REGIONS; UNFOLDED PROTEIN RESPONSE; PLURIPOTENT STEM-CELLS; ACUTE MYELOID-LEUKEMIA; PREMATURE APOPTOSIS; MUTATIONS; ACTIVATION; GENE; MICE	Mutations in ELANE encoding neutrophil elastase (NE) have been identified in the majority of patients with severe congenital neutropenia (SCN). The NE mutants have been shown to activate unfolded protein response and induce premature apoptosis in myeloid cells. Patients with SCN are predisposed to acute myeloid leukemia (AML), and progression from SCN to AML is accompanied by mutations in CSF3R encoding the granulocyte colony-stimulating factor receptor (G-CSFR) in approximate to 80% of patients. The mutations result in the expression of C-terminally truncated G-CSFRs that promote strong cell proliferation and survival. It is unknown why the CSF3R mutations, which are rare in de novo AML, are so prevalent in SCN/AML. We show here that a G-CSFR mutant, d715, derived from an SCN patient inhibited G-CSF-induced expression of NE in a dominant negative manner. Furthermore, G-CSFR d715 suppressed unfolded protein response and apoptosis induced by an SCN-derived NE mutant, which was associated with sustained activation of AKT and STAT5, and augmented expression of BCL-XL. Thus, the truncated G-CSFRs associated with SCN/AML may protect myeloid precursor cells from apoptosis induced by the NE mutants. We propose that acquisition of CSF3R mutations may represent a mechanism by which myeloid precursor cells carrying the ELANE mutations evade the proapoptotic activity of the NE mutants in SCN patients.	[Qiu, Yaling; Zhang, Yangyang; Hu, Nan; Dong, Fan] Univ Toledo, Dept Biol Sci, 2801 West Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Dong, F (corresponding author), Univ Toledo, Dept Biol Sci, 2801 West Bancroft St, Toledo, OH 43606 USA.	fan.dong@utoledo.edu	zhang, yangyang/GZG-7467-2022		National Institutes of Health [R15HL112183]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL112183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant R15HL112183 (to F. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aprikyan AAG, 2003, EXP HEMATOL, V31, P372, DOI 10.1016/S0301-472X(03)00048-1; Beel K, 2009, HAEMATOL-HEMATOL J, V94, P1449, DOI 10.3324/haematol.2009.009001; Bellanne-Chantelot C, 2004, BLOOD, V103, P4119, DOI 10.1182/blood-2003-10-3518; Carapeti M, 1997, LEUKEMIA, V11, P1005, DOI 10.1038/sj.leu.2400697; Cassinat B, 2004, LEUKEMIA, V18, P1553, DOI 10.1038/sj.leu.2403431; Debierre-Grockiego F, 2004, APOPTOSIS, V9, P717, DOI 10.1023/B:APPT.0000045785.65546.a2; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Dong F, 2000, BLOOD, V95, P1656, DOI 10.1182/blood.V95.5.1656.005k29_1656_1662; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Dong F, 1997, LEUKEMIA, V11, P120, DOI 10.1038/sj.leu.2400537; Dong F, 1998, J IMMUNOL, V161, P6503; DONG F, 1994, P NATL ACAD SCI USA, V91, P4480, DOI 10.1073/pnas.91.10.4480; Dong F, 2001, J IMMUNOL, V167, P6447, DOI 10.4049/jimmunol.167.11.6447; DONG F, 1993, MOL CELL BIOL, V13, P7774, DOI 10.1128/MCB.13.12.7774; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Gits J, 2006, LEUKEMIA, V20, P2111, DOI 10.1038/sj.leu.2404448; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Grenda DS, 2002, BLOOD, V100, P3221, DOI 10.1182/blood-2002-05-1372; Hermans MHA, 1999, J EXP MED, V189, P683, DOI 10.1084/jem.189.4.683; Hiramoto T, 2013, P NATL ACAD SCI USA, V110, P3023, DOI 10.1073/pnas.1217039110; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Hu N, 2015, J BIOL CHEM, V290, P24561, DOI 10.1074/jbc.M115.668871; Hunter MG, 2000, BLOOD, V95, P2132, DOI 10.1182/blood.V95.6.2132; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Klimiankou M, 2016, BLOOD, V127, P2638, DOI 10.1182/blood-2015-12-685784; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Lavallee VP, 2016, BLOOD, V127, P3054, DOI 10.1182/blood-2016-03-705053; Li FQ, 2001, J BIOL CHEM, V276, P14230, DOI 10.1074/jbc.M010279200; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Liu H, 2006, J IMMUNOL, V176, P2407, DOI 10.4049/jimmunol.176.4.2407; Massullo P, 2005, BLOOD, V105, P3397, DOI 10.1182/blood-2004-07-2618; Maxson JE, 2016, BLOOD, V127, P3094, DOI 10.1182/blood-2016-04-709899; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; McLemore ML, 1998, J CLIN INVEST, V102, P483, DOI 10.1172/JCI3216; Mitsui T, 2003, BLOOD, V101, P2990, DOI 10.1182/blood.V101.8.2990; Nanua S, 2011, BLOOD, V117, P3539, DOI 10.1182/blood-2010-10-311704; Nayak RC, 2015, J CLIN INVEST, V125, P3103, DOI 10.1172/JCI80924; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Rosenberg PS, 2006, BLOOD, V107, P4628, DOI 10.1182/blood-2005-11-4370; Sano H, 2015, BRIT J HAEMATOL, V170, P391, DOI 10.1111/bjh.13439; Sehgal Pravin B, 2013, JAKSTAT, V2, pe24860, DOI 10.4161/jkst.24860; Tidow N, 1997, BLOOD, V89, P2369, DOI 10.1182/blood.V89.7.2369; Tidwell T, 2014, BLOOD, V123, P562, DOI 10.1182/blood-2013-07-513242; Xia J, 2009, BRIT J HAEMATOL, V147, P535, DOI 10.1111/j.1365-2141.2009.07888.x; Zeidler C, 2009, BRIT J HAEMATOL, V144, P459, DOI 10.1111/j.1365-2141.2008.07425.x; Zhuang DZ, 2006, J BIOL CHEM, V281, P10745, DOI 10.1074/jbc.M510924200; Zhuang DZ, 2005, J LEUKOCYTE BIOL, V78, P1008, DOI 10.1189/jlb.0105032	50	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3496	3505		10.1074/jbc.M116.755157	http://dx.doi.org/10.1074/jbc.M116.755157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28073911	hybrid, Green Published			2022-12-28	WOS:000395538800037
J	Tuz, K; Li, C; Fang, X; Raba, DA; Liang, PD; Minh, DDL; Juarez, O				Tuz, Karina; Li, Chen; Fang, Xuan; Raba, Daniel A.; Liang, Pingdong; Minh, David D. L.; Juarez, Oscar			Identification of the Catalytic Ubiquinone-binding Site of Vibrio cholerae Sodium-dependent NADH Dehydrogenase A NOVEL UBIQUINONE-BINDING MOTIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-TRANSLOCATING NADH; PUMPING NADHQUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; ELECTRON-TRANSFER; NADHUBIQUINONE OXIDOREDUCTASE; NADH/QUINONE OXIDOREDUCTASE; RHODOBACTER-SPHAEROIDES; PROSTHETIC GROUPS; REDOX PROPERTIES; SUBUNIT B	The sodium-dependent NADH dehydrogenase (Na+-NQR) is a key component of the respiratory chain of diverse prokaryotic species, including pathogenic bacteria. Na+-NQR uses the energy released by electron transfer between NADH and ubiquinone (UQ) to pump sodium, producing a gradient that sustains many essential homeostatic processes as well as virulence factor secretion and the elimination of drugs. The location of the UQ binding site has been controversial, with two main hypotheses that suggest that this site could be located in the cytosolic subunit A or in the membrane-bound subunit B. In this work, we performed alanine scanning mutagenesis of aromatic residues located in transmembrane helices II, IV, and V of subunit B, near glycine residues 140 and 141. These two critical glycine residues form part of the structures that regulate the site's accessibility. Our results indicate that the elimination of phenylalanine residue 211 or 213 abolishes the UQ-dependent activity, produces a leak of electrons to oxygen, and completely blocks the binding of UQ and the inhibitor HQNO. Molecular docking calculations predict that UQ interacts with phenylalanine 211 and pinpoints the location of the binding site in the interface of subunits B and D. The mutagenesis and structural analysis allow us to propose a novel UQ-binding motif, which is completely different compared with the sites of other respiratory photosynthetic complexes. These results are essential to understanding the electron transfer pathways and mechanism of Na+-NQR catalysis.	IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Li, Chen; Minh, David D. L.] IIT, Dept Chem, Chicago, IL 60616 USA	Illinois Institute of Technology; Illinois Institute of Technology	Juarez, O (corresponding author), IIT, Life Sci Bldg,3101 S Dearborn St, Chicago, IL 60616 USA.	ojuarez@iit.edu	Fang, Xuan/CAG-5381-2022; Minh, David/A-4655-2009	Fang, Xuan/0000-0001-6394-4015; Minh, David/0000-0002-4802-2618; Tuz, Karina/0000-0002-1669-4612; Liang, Pingdong/0000-0002-8950-5755; Juarez, Oscar/0000-0002-2915-8413	Illinois Institute of Technology start up funds; National Institutes of Health [R15GM114781]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM114781] Funding Source: NIH RePORTER	Illinois Institute of Technology start up funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Illinois Institute of Technology start up funds (to O. J. and D. D. L. M.) and by National Institutes of Health Grant R15GM114781 (to D. D. L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afri M, 2004, CHEM PHYS LIPIDS, V131, P123, DOI 10.1016/j.chemphyslip.2004.04.006; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2009, J BIOL CHEM, V284, P5533, DOI 10.1074/jbc.M808984200; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; CRAMER CJ, 1992, J COMPUT AID MOL DES, V6, P629, DOI 10.1007/BF00126219; CROFTS A, 1992, BIOCHIM BIOPHYS ACTA, V1101, P162, DOI 10.1016/S0005-2728(05)80009-X; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hauss T, 2005, BBA-BIOENERGETICS, V1710, P57, DOI 10.1016/j.bbabio.2005.08.007; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; KLESS H, 1995, J MOL BIOL, V246, P120, DOI 10.1006/jmbi.1994.0071; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shea ME, 2015, BIOCHEMISTRY-US, V54, P490, DOI 10.1021/bi501266e; Shea ME, 2013, J BIOL CHEM, V288, P31241, DOI 10.1074/jbc.M113.510776; Steuber J, 2015, BIOL CHEM, V396, P1015, DOI 10.1515/hsz-2015-0128; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Strickland M, 2014, J BIOL CHEM, V289, P23723, DOI 10.1074/jbc.M114.574640; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Tuz K, 2015, J BIOL CHEM, V290, P20009, DOI 10.1074/jbc.M115.658773; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; Yoshikawa K, 1999, J ANTIBIOT, V52, P182, DOI 10.7164/antibiotics.52.182	50	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3039	3048		10.1074/jbc.M116.770982	http://dx.doi.org/10.1074/jbc.M116.770982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28053088	Green Published, hybrid			2022-12-28	WOS:000395535100042
J	Motoyama, K; Unno, H; Hattori, A; Takaoka, T; Ishikita, H; Kawaide, H; Yoshimura, T; Hemmi, H				Motoyama, Kento; Unno, Hideaki; Hattori, Ai; Takaoka, Tomohiro; Ishikita, Hiroshi; Kawaide, Hiroshi; Yoshimura, Tohru; Hemmi, Hisashi			A Single Amino Acid Mutation Converts (R)-5-Diphosphomevalonate Decarboxylase into a Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEVALONATE DIPHOSPHATE DECARBOXYLASE; ARCHAEON SULFOLOBUS-SOLFATARICUS; PANCREATIC RIBONUCLEASE-A; CRYSTAL-STRUCTURES; HISTIDINE-RESIDUES; DIFFRACTION DATA; IMIDAZOLE RING; PATHWAY; BINDING; MODEL	The biosynthesis of isopentenyl diphosphate, a fundamental precursor for isoprenoids, via the mevalonate pathway is completed by diphosphomevalonate decarboxylase. This enzyme catalyzes the formation of isopentenyl diphosphate through the ATP-dependent phosphorylation of the 3-hydroxyl group of (R)-5-diphosphomevalonate followed by decarboxylation coupled with the elimination of the 3-phosphate group. In this reaction, a conserved aspartate residue has been proposed to be involved in the phosphorylation step as the general base catalyst that abstracts a proton from the 3-hydroxyl group. In this study, the catalytic mechanism of this rare type of decarboxylase is re-investigated by structural and mutagenic studies on the enzyme from a thermoacidophilic archaeon Sulfolobus solfataricus. The crystal structures of the archaeal enzyme in complex with (R)-5-diphosphomevalonate and adenosine 5'-O-(3-thio) triphosphate or with (R)-5-diphosphomevalonate and ADP are newly solved, and theoretical analysis based on the structure suggests the inability of proton abstraction by the conserved aspartate residue, Asp-281. Site-directed mutagenesis on Asp-281 creates mutants that only show diphosphomevalonate 3-kinase activity, demonstrating that the residue is required in the process of phosphate elimination/decarboxylation, rather than in the preceding phosphorylation step. These results enable discussion of the catalytic roles of the aspartate residue and provide clear proof of the involvement of a long predicted intermediate, (R)-3-phospho-5-diphosphomevalonate, in the reaction of the enzyme.	[Motoyama, Kento; Hattori, Ai; Yoshimura, Tohru; Hemmi, Hisashi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Unno, Hideaki] Nagasaki Univ, Grad Sch Engn, Bunkyo Machi, Nagasaki, Nagasaki 8528521, Japan; [Takaoka, Tomohiro; Ishikita, Hiroshi] Univ Tokyo, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan; [Ishikita, Hiroshi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Komaba 4-6-1, Tokyo 1538904, Japan; [Kawaide, Hiroshi] Tokyo Univ Agr & Technol, Inst Agr, Saiwaicho 3-5-8, Fuchu, Tokyo 1838509, Japan	Nagoya University; Nagasaki University; University of Tokyo; University of Tokyo; Tokyo University of Agriculture & Technology	Hemmi, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hhemmi@agr.nagoya-u.ac.jp	Hideaki, UNNO/ABG-9471-2020; Hemmi, Hisashi/I-6868-2014; Ishikita, Hiroshi/G-9864-2018; Kawaide, Hiroshi/F-9243-2013	Hideaki, UNNO/0000-0001-5917-269X; Hemmi, Hisashi/0000-0002-9538-809X; Ishikita, Hiroshi/0000-0002-5849-8150; Kawaide, Hiroshi/0000-0001-6693-1332	Japan Society for the Promotion of Science KAKENHI Grants [25108712, 16K14882, 15H00864, 26711008]; Takeda Science Foundation; Japan Science and Technology Agency CREST; Materials Integration for Engineering Polymers of Cross-ministerial Strategic Innovation Promotion Program(SIP); Interdisciplinary Computational Science Program in CCS, University of Tsukuba; Grants-in-Aid for Scientific Research [15K06977, 15K21719, 26105001, 26711008] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Science and Technology Agency CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Materials Integration for Engineering Polymers of Cross-ministerial Strategic Innovation Promotion Program(SIP); Interdisciplinary Computational Science Program in CCS, University of Tsukuba; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 25108712 and 16K14882 (to H. H.) and Grants 15H00864, 26105012, and 26711008 (to H. I.), Takeda Science Foundation (to H. H.), Japan Science and Technology Agency CREST (to H. I.), Materials Integration for Engineering Polymers of Cross-ministerial Strategic Innovation Promotion Program(SIP) (to H. I.), and the Interdisciplinary Computational Science Program in CCS, University of Tsukuba. The authors declare that they have no conflicts of interest with the contents of this article.	Azami Y, 2014, J BIOL CHEM, V289, P15957, DOI 10.1074/jbc.M114.562686; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barta ML, 2012, BIOCHEMISTRY-US, V51, P5611, DOI 10.1021/bi300591x; Barta ML, 2011, J BIOL CHEM, V286, P23900, DOI 10.1074/jbc.M111.242016; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bertoldi M, 2014, ARCH BIOCHEM BIOPHYS, V546, P1, DOI 10.1016/j.abb.2013.12.020; Bjerrum J., 1958, STABILITY CONSTANTS; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Bochevarov AD, 2013, INT J QUANTUM CHEM, V113, P2110, DOI 10.1002/qua.24481; Bonanno JB, 2001, P NATL ACAD SCI USA, V98, P12896, DOI 10.1073/pnas.181466998; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Byres E, 2007, J MOL BIOL, V371, P540, DOI 10.1016/j.jmb.2007.05.094; CORNFORTH JW, 1966, J BIOL CHEM, V241, P3970; Dellas N, 2013, ELIFE, V2, DOI 10.7554/eLife.00672; DHEPAGANON S, 1994, BIOCHEMISTRY-US, V33, P13355, DOI 10.1021/bi00249a023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Froese DS, 2013, STRUCTURE, V21, P1182, DOI 10.1016/j.str.2013.05.001; Hattori A, 2015, J BACTERIOL, V197, P3463, DOI 10.1128/JB.00352-15; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; Kutter S, 2006, FEBS J, V273, P4199, DOI 10.1111/j.1742-4658.2006.05415.x; Kuzuyama T, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P493; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lefurgy ST, 2010, J BIOL CHEM, V285, P20654, DOI 10.1074/jbc.M109.098350; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li TF, 2012, BIOORG CHEM, V43, P2, DOI 10.1016/j.bioorg.2012.03.001; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAVE JF, 1985, BIOCHEM J, V227, P247, DOI 10.1042/bj2270247; Nishimura H, 2013, J BIOCHEM, V153, P415, DOI 10.1093/jb/mvt006; NOZAKI Y, 1967, J AM CHEM SOC, V89, P736, DOI 10.1021/ja00980a002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne KAP, 2015, NATURE, V522, P497, DOI 10.1038/nature14560; Rabenstein B, 2001, BIOPHYS J, V80, P1141, DOI 10.1016/S0006-3495(01)76091-2; REEVE W, 1979, CAN J CHEM, V57, P2747, DOI 10.1139/v79-444; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Styer L., 1988, BIOCHEMISTRY-US, P1046; Sugai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P128, DOI 10.1271/bbb.100733; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P586, DOI 10.1016/0167-4838(83)90277-7; TANOKURA M, 1983, J BIOCHEM-TOKYO, V94, P51, DOI 10.1093/oxfordjournals.jbchem.a134353; VanNice JC, 2014, J BACTERIOL, V196, P1055, DOI 10.1128/JB.01230-13; Vinokur JM, 2015, PROTEIN SCI, V24, P212, DOI 10.1002/pro.2607; Vinokur JM, 2014, BIOCHEMISTRY-US, V53, P4161, DOI 10.1021/bi500566q; Voynova NE, 2008, ARCH BIOCHEM BIOPHYS, V480, P58, DOI 10.1016/j.abb.2008.08.024; Yang JM, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0236-2	48	8	9	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2457	2469		10.1074/jbc.M116.752535	http://dx.doi.org/10.1074/jbc.M116.752535			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28003359	Green Published, hybrid			2022-12-28	WOS:000395530300033
J	Roehrich, AD; Bordignon, E; Mode, S; Shen, DK; Liu, X; Pain, M; Murillo, I; Martinez-Argudo, I; Sessions, RB; Blocker, AJ				Roehrich, A. Dorothea; Bordignon, Enrica; Mode, Selma; Shen, Da-Kang; Liu, Xia; Pain, Maria; Murillo, Isabel; Martinez-Argudo, Isabel; Sessions, Richard B.; Blocker, Ariel J.			Steps for Shigella Gatekeeper Protein MxiC Function in Hierarchical Type III Secretion Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; cellular regulation; electron paramagnetic resonance (EPR); Gram-negative bacteria; molecular genetics; protein secretion; type III secretion system (T3SS); MxiC; Shigella	SYSTEM NEEDLE TIP; B-CELL EPITOPES; YERSINIA-PESTIS; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; GENE-EXPRESSION; YOP SECRETION; FLEXNERI; IPAB; APPARATUS	Type III secretion systems are complex nanomachines used for injection of proteins from Gram-negative bacteria into eukaryotic cells. Although they are assembled when the environmental conditions are appropriate, they only start secreting upon contact with a host cell. Secretion is hierarchical. First, the pore-forming translocators are released. Second, effector proteins are injected. Hierarchy between these protein classes is mediated by a conserved gatekeeper protein, MxiC, in Shigella. As its molecular mechanism of action is still poorly understood, we used its structure to guide site-directed mutagenesis and to dissect its function. We identified mutants predominantly affecting all known features of MxiC regulation as follows: secretion of translocators, MxiC and/or effectors. Using molecular genetics, we then mapped at which point in the regulatory cascade the mutants were affected. Analysis of some of these mutants led us to a set of electron paramagnetic resonance experiments that provide evidence that MxiC interacts directly with IpaD. We suggest how this interaction regulates a switch in its conformation that is key to its functions.	[Roehrich, A. Dorothea; Mode, Selma; Shen, Da-Kang; Liu, Xia; Pain, Maria; Murillo, Isabel; Martinez-Argudo, Isabel; Sessions, Richard B.; Blocker, Ariel J.] Univ Bristol, Sch Cellular & Mol Med, Fac Med & Vet Sci, Med Sci Bldg, Bristol BS8 1TD, Avon, England; [Roehrich, A. Dorothea; Mode, Selma; Shen, Da-Kang; Liu, Xia; Pain, Maria; Murillo, Isabel; Martinez-Argudo, Isabel; Sessions, Richard B.; Blocker, Ariel J.] Univ Bristol, Sch Biochem, Fac Med & Vet Sci, Med Sci Bldg, Bristol BS8 1TD, Avon, England; [Bordignon, Enrica] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany; [Martinez-Argudo, Isabel] Univ Castilla La Mancha, Area Genet, Fac Ciencias Ambientales & Bioquim, E-45071 Toledo, Spain; [Roehrich, A. Dorothea] Testo AG, Testostr 1, D-79853 Lenzkirch, Germany	University of Bristol; University of Bristol; Free University of Berlin; Universidad de Castilla-La Mancha	Blocker, AJ (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Univ Walk, Bristol BS8 1TD, Avon, England.	ariel.blocker@bristol.ac.uk	Martinez, Isabel/R-4803-2019	Martinez, Isabel/0000-0001-5067-1791; Blocker, Ariel/0000-0002-8705-2641; Sessions, Richard/0000-0003-0320-0895; Bordignon, Enrica/0000-0003-2450-5161	Centenary Postgraduate Fund at the University of Bristol; United Kingdom Wellcome Trust [WT088266]; UK Medical Research Council [MR-J002097-1]; Universite Pierre et Marie Curie (Paris 6); MRC [MR/J002097/1] Funding Source: UKRI; Medical Research Council [MR/J002097/1] Funding Source: researchfish	Centenary Postgraduate Fund at the University of Bristol; United Kingdom Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Universite Pierre et Marie Curie (Paris 6); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Studentship from the Centenary Postgraduate Fund at the University of Bristol (to A.D.R.), Project Grant WT088266 from the United Kingdom Wellcome Trust (to A.J.B. and I.M.A.), Project Grant MR-J002097-1 from the UK Medical Research Council (to A.J.B., also supporting D.S. and M.P.), and two short Master 1-Level work-experience scholarships from the Universite Pierre et Marie Curie (Paris 6) (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Archuleta TL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004498; Archuleta TL, 2011, J BIOL CHEM, V286, P33992, DOI 10.1074/jbc.M111.258426; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; BARZU S, 1993, INFECT IMMUN, V61, P3825, DOI 10.1128/IAI.61.9.3825-3831.1993; Birket SE, 2007, BIOCHEMISTRY-US, V46, P8128, DOI 10.1021/bi700099c; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Bordignon Enrica, 2013, Methods Mol Biol, V974, P329, DOI 10.1007/978-1-62703-275-9_15; Botteaux A, 2009, MOL MICROBIOL, V71, P449, DOI 10.1111/j.1365-2958.2008.06537.x; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Burkinshaw BJ, 2015, ACTA CRYSTALLOGR F, V71, P1300, DOI 10.1107/S2053230X15016064; Cherradi Y, 2013, MOL MICROBIOL, V87, P1183, DOI 10.1111/mmi.12158; Cheung M, 2015, MOL MICROBIOL, V95, P31, DOI 10.1111/mmi.12843; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x; Deane JE, 2008, J MOL BIOL, V377, P985, DOI 10.1016/j.jmb.2008.01.072; Diepold A, 2014, FEMS MICROBIOL REV, V38, P802, DOI 10.1111/1574-6976.12061; Ferracci F, 2005, MOL MICROBIOL, V57, P970, DOI 10.1111/j.1365-2958.2005.04738.x; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Jackson MW, 1998, J BACTERIOL, V180, P4912, DOI 10.1128/JB.180.18.4912-4921.1998; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Johnson S, 2006, ACTA CRYSTALLOGR F, V62, P865, DOI 10.1107/S1744309106027047; Joseph SS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00001; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kosek M, 2010, CURR OPIN INFECT DIS, V23, P475, DOI 10.1097/QCO.0b013e32833da204; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Lee PC, 2014, P NATL ACAD SCI USA, V111, pE2027, DOI 10.1073/pnas.1402658111; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; Lillington JED, 2011, J MOL BIOL, V405, P427, DOI 10.1016/j.jmb.2010.10.053; Martinez-Argudo I, 2010, MOL MICROBIOL, V78, P1365, DOI 10.1111/j.1365-2958.2010.07413.x; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Page AL, 2001, MOL MICROBIOL, V42, P1133, DOI 10.1046/j.1365-2958.2001.02715.x; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Roehrich A. D., 2013, THESIS; Roehrich AD, 2013, MOL MICROBIOL, V87, P690, DOI 10.1111/mmi.12124; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Shen DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155141; Shen DK, 2010, INFECT IMMUN, V78, P4999, DOI 10.1128/IAI.00470-10; Silva-Herzog E, 2011, J BACTERIOL, V193, P3490, DOI 10.1128/JB.00203-11; Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x; Wang DP, 2008, SYNLETT, P69, DOI 10.1055/s-2007-992409; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wei HL, 2012, MOL MICROBIOL, V85, P195, DOI 10.1111/j.1365-2958.2012.08119.x; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	57	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1705	1723		10.1074/jbc.M116.746826	http://dx.doi.org/10.1074/jbc.M116.746826			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27974466	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000395515600014
J	Rulifson, IC; Collins, P; Miao, L; Nojima, D; Lee, KJ; Hardy, M; Gupte, J; Hensley, K; Samayoa, K; Cam, C; Rottman, JB; Ollmann, M; Richards, WG; Li, Y				Rulifson, Ingrid C.; Collins, Patrick; Miao, Li; Nojima, Dana; Lee, Ki Jeong; Hardy, Miki; Gupte, Jamila; Hensley, Kelly; Samayoa, Kim; Cam, Cynthia; Rottman, James B.; Ollmann, Mike; Richards, William G.; Li, Yang			In Vitro and in Vivo Analyses Reveal Profound Effects of Fibroblast Growth Factor 16 as a Metabolic Regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipogenesis; bile acid; fibroblast growth factor (FGF); fibroblast growth factor receptor (FGFR); intestinal metabolism; metabolism	BROWN ADIPOSE-TISSUE; SUPPRESSES OSTEOGENIC DIFFERENTIATION; LINKED RECESSIVE FUSION; PROMOTES PROLIFERATION; FGF16; OBESITY; MICE; FAT; IDENTIFICATION; MUTATIONS	The discovery of brown adipose tissue (BAT) as a key regulator of energy expenditure has sparked interest in identifying novel soluble factors capable of activating inducible BAT (iBAT) to combat obesity. Using a high content cell-based screen, we identified fibroblast growth factor 16 (FGF16) as a potent inducer of several physical and transcriptional characteristics analogous to those of both "classical" BAT and iBAT. Overexpression of Fgf16 in vivo recapitulated several of our in vitro findings, specifically the significant induction of the Ucp1 gene and UCP1 protein expression in inguinal white adipose tissue (iWAT), a common site for emergent active iBAT. Despite significant UCP1 up-regulation in iWAT and dramatic weight loss, the metabolic improvements observed due to Fgf16 overexpression in vivo were not the result of increased energy expenditure, as measured by indirect calorimetric assessment. Instead, a pattern of reduced food and water intake, combined with feces replete with lipid and bile acid, indicated a phenotype more akin to that of starvation and intestinal malabsorption. Gene expression analysis of the liver and ileum indicated alterations in several steps of bile acid metabolism, including hepatic synthesis and reabsorption. Histological analysis of intestinal tissue revealed profound abnormalities in support of this conclusion. The in vivo data, together with FGF receptor binding analysis, indicate that the in vivo outcome observed is the likely result of both direct and indirect mechanisms and probably involves multiple receptors. These results highlight the complexity of FGF signaling in the regulation of various metabolic processes.	[Rulifson, Ingrid C.; Miao, Li; Gupte, Jamila; Li, Yang] Amgen Inc, Dept Cardiometabol Disorders, 1120 Vet Blvd, South San Francisco, CA 94080 USA; [Collins, Patrick; Nojima, Dana; Hardy, Miki; Ollmann, Mike] Amgen Inc, Genome Anal Unit, South San Francisco, CA 94080 USA; [Hensley, Kelly; Samayoa, Kim] Amgen Inc, Dept Pathol, South San Francisco, CA 94080 USA; [Cam, Cynthia] Amgen Inc, Dept Comparat Anim Res, South San Francisco, CA 94080 USA; [Lee, Ki Jeong] Amgen Inc, Genome Anal Unit, Thousand Oaks, CA 91320 USA; [Richards, William G.] Amgen Inc, Dept Cardiometabol Disorders, Thousand Oaks, CA 91320 USA; [Rottman, James B.] Amgen Inc, Dept Pathol, Cambridge, MA 02142 USA	Amgen; Amgen; Amgen; Amgen; Amgen; Amgen; Amgen	Rulifson, IC; Li, Y (corresponding author), Amgen Inc, Dept Cardiometabol Disorders, 1120 Vet Blvd, South San Francisco, CA 94080 USA.	ingridr@amgen.com; yangl@amgen.com		Collins, Patrick/0000-0002-7141-7503; , Ki Jeong/0000-0002-8039-7436				Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Cypess AM, 2010, CURR OPIN PEDIATR, V22, P478, DOI 10.1097/MOP.0b013e32833a8d6e; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Elsen M, 2014, AM J PHYSIOL-CELL PH, V306, pC431, DOI 10.1152/ajpcell.00290.2013; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Ge HF, 2014, J BIOL CHEM, V289, P30470, DOI 10.1074/jbc.M114.592022; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hotta Y, 2008, DEV DYNAM, V237, P2947, DOI 10.1002/dvdy.21726; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Itoh N, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00154; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jamsheer A, 2014, BIRTH DEFECTS RES A, V100, P314, DOI 10.1002/bdra.23239; Jamsheer A, 2013, J MED GENET, V50, P579, DOI 10.1136/jmedgenet-2013-101659; Jones B, 2014, CLIN DYSMORPHOL, V23, P95, DOI 10.1097/MCD.0000000000000043; Konishi M, 2000, J BIOL CHEM, V275, P12119, DOI 10.1074/jbc.275.16.12119; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Laurell T, 2014, MOL GENET GENOM MED, V2, P402, DOI 10.1002/mgg3.81; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Lu SY, 2008, BIOCHEM BIOPH RES CO, V373, P270, DOI 10.1016/j.bbrc.2008.06.029; Matsumoto E, 2013, GENES CELLS, V18, P544, DOI 10.1111/gtc.12055; Miyake A, 1998, BIOCHEM BIOPH RES CO, V243, P148, DOI 10.1006/bbrc.1998.8073; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research (US) and National Academies Press (US), 2011, GUIDE CARE USE LAB A; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Pandol S. J., 2010, EXOCRINE PANCREAS; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yu W, 2016, DEVELOPMENT, V143, P936, DOI 10.1242/dev.130971; Zhang J, 2014, DRUG DISCOV TODAY, V19, P579, DOI 10.1016/j.drudis.2013.10.021; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	44	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1951	1969		10.1074/jbc.M116.751404	http://dx.doi.org/10.1074/jbc.M116.751404			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28011645	Green Published, hybrid			2022-12-28	WOS:000395515600033
J	Bhagat, TD; Zou, YY; Huang, SZ; Park, J; Palmer, MB; Hu, C; Li, WJ; Shenoy, N; Giricz, O; Choudhary, G; Yu, YT; Ko, YA; Izquierdo, MC; Park, ASD; Vallumsetla, N; Laurence, R; Lopez, R; Suzuki, M; Pullman, J; Kaner, J; Gartrell, B; Hakimi, AA; Greally, JM; Patel, B; Benhadji, K; Pradhan, K; Verma, A; Susztak, K				Bhagat, Tushar D.; Zou, Yiyu; Huang, Shizheng; Park, Jihwan; Palmer, Matthew B.; Hu, Caroline; Li, Weijuan; Shenoy, Niraj; Giricz, Orsolya; Choudhary, Gaurav; Yu, Yiting; Ko, Yi-An; Izquierdo, Maria C.; Park, Ae Seo Deok; Vallumsetla, Nishanth; Laurence, Remi; Lopez, Robert; Suzuki, Masako; Pullman, James; Kaner, Justin; Gartrell, Benjamin; Hakimi, A. Ari; Greally, John M.; Patel, Bharvin; Benhadji, Karim; Pradhan, Kith; Verma, Amit; Susztak, Katalin			Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY; METHYLATION	Clear cell renal cell carcinoma (CCRCC) is an incurable malignancy in advanced stages and needs newer therapeutic targets. Transcriptomic analysis of CCRCCs and matched microdissected renal tubular controls revealed overexpression of NOTCH ligands and receptors in tumor tissues. Examination of theTCGARNA- seq data set also revealed widespread activation of NOTCH pathway in a large cohort of CCRCC samples. Samples with NOTCH pathway activation were also clinically distinct and were associated with better overall survival. Parallel DNA methylation and copy number analysis demonstrated that both genetic and epigenetic alterations led to NOTCH pathway activation in CCRCC. NOTCH ligand JAGGED1 was overexpressed and associated with loss of CpG methylation of H3K4me1- associated enhancer regions. JAGGED2 was also overexpressed and associated with gene amplification in distinct CCRCC samples. Transgenic expression of intracellular NOTCH1 in mice with tubule- specific deletion of VHL led to dysplastic hyperproliferation of tubular epithelial cells, confirming the procarcinogenic role of NOTCH in vivo. Alteration of cell cycle pathways was seen in murine renal tubular cells with NOTCH overexpression, and molecular similarity to human tumors was observed, demonstrating that human CCRCC recapitulates features and gene expression changes observed in mice with transgenic overexpression of the Notch intracellular domain. Treatment with the gamma-secretase inhibitor LY3039478 led to inhibition of CCRCC cells in vitro and in vivo. In sum- mary, these data reveal the mechanistic basis of NOTCH pathway activation in CCRCC and demonstrate this pathway to a potential therapeutic target.	[Bhagat, Tushar D.; Zou, Yiyu; Hu, Caroline; Li, Weijuan; Shenoy, Niraj; Giricz, Orsolya; Choudhary, Gaurav; Yu, Yiting; Vallumsetla, Nishanth; Laurence, Remi; Lopez, Robert; Suzuki, Masako; Kaner, Justin; Gartrell, Benjamin; Greally, John M.; Pradhan, Kith; Verma, Amit] Albert Einstein Coll Med, 1300 Morris Pk Ave,Chanin 302B, Bronx, NY 10461 USA; [Huang, Shizheng; Park, Jihwan; Palmer, Matthew B.; Ko, Yi-An; Izquierdo, Maria C.; Park, Ae Seo Deok; Susztak, Katalin] Univ Penn, Perelman Sch Med, Dept Med & Genet, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Pullman, James] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA; [Hakimi, A. Ari] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Patel, Bharvin; Benhadji, Karim] Eli Lilly, Indianapolis, IN 46221 USA	Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; Eli Lilly	Verma, A (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave,Chanin 302B, Bronx, NY 10461 USA.; Susztak, K (corresponding author), Univ Penn, Perelman Sch Med, 415 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	amit.verma@einstein.yu.edu; ksusztak@mail.med.upenn.edu	Susztak, Katalin/ABE-7474-2021; Greally, John/AAF-9540-2019; Suzuki, Masako/ABF-6497-2020; Choudhary, Gaurav S./C-3673-2019	Susztak, Katalin/0000-0002-1005-3726; Greally, John/0000-0001-6069-7960; Suzuki, Masako/0000-0003-0605-9225; Choudhary, Gaurav S./0000-0001-5365-6706; Benhadji, Karim/0000-0001-9883-6970; Shenoy, Niraj/0000-0003-2074-1108; Huang, Shizheng/0000-0002-9240-1578; IZQUIERDO, MARIA CONCEPCION/0000-0002-8690-0151	National Institutes of Health [R01DK087635, R01076077, DP3 DK108220]; NYSTEM; Albert Einstein Stem Cell Institute grant; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, DP3DK108220, R01DK087635, R01DK076077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Albert Einstein Stem Cell Institute grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK087635, R01076077, and DP3 DK108220 (to K. S.) and a NYSTEM grant and an Albert Einstein Stem Cell Institute grant (to T. D. B.). B. P. and K. B. are employees of Eli Lilly. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Choi K, 2009, J BIOL CHEM, V284, P17766, DOI 10.1074/jbc.M109.003111; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Figueroa ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001882; Hakimi AA, 2013, NAT GENET, V45, P849, DOI 10.1038/ng.2708; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hu CY, 2014, CLIN CANCER RES, V20, P4349, DOI 10.1158/1078-0432.CCR-14-0494; Huang QB, 2014, ONCOTARGET, V5, P3066, DOI 10.18632/oncotarget.1827; Kinney SRM, 2013, ADV EXP MED BIOL, V754, P57, DOI 10.1007/978-1-4419-9967-2_3; Lamprecht B, 2010, CELL CYCLE, V9, P4276, DOI 10.4161/cc.9.21.13682; Massard C., 2015, J CLIN ONCOL, V33; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Oda M, 2009, NUCLEIC ACIDS RES, V37, P3829, DOI 10.1093/nar/gkp260; Pietras A, 2011, MOL CANCER RES, V9, P626, DOI 10.1158/1541-7786.MCR-10-0508; Powles T, 2011, BRIT J CANCER, V104, P741, DOI 10.1038/sj.bjc.6606061; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Sjolund J, 2005, EUR J CANCER, V41, P2620, DOI 10.1016/j.ejca.2005.06.025; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Sjolund J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023057; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Wu KR, 2011, JPN J CLIN ONCOL, V41, P411, DOI 10.1093/jjco/hyq205	30	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					837	846		10.1074/jbc.M116.745208	http://dx.doi.org/10.1074/jbc.M116.745208			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27909050	hybrid, Green Published			2022-12-28	WOS:000392318700007
J	De Nardis, C; Lossl, P; van den Biggelaar, M; Madoori, PK; Leloup, N; Mertens, K; Heck, AJR; Gros, P				De Nardis, Camilla; Lossl, Philip; van den Biggelaar, Maartje; Madoori, Pramod K.; Leloup, Nadia; Mertens, Koen; Heck, Albert J. R.; Gros, Piet			Recombinant Expression of the Full-length Ectodomain of LDL Receptor-related Protein 1 (LRP1) Unravels pHdependent Conformational Changes and the Stoichiometry of Binding with Receptor- associated Protein ( RAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; CRITICAL LYSINE RESIDUES; NMR SOLUTION STRUCTURE; LIGAND-BINDING; ALPHA-2-MACROGLOBULIN RECEPTOR; MASS-SPECTROMETRY; HUMAN ALPHA(2)-MACROGLOBULIN; MOLECULAR CHAPERONE; 39-KDA PROTEIN; CROSS-LINKING	LDL receptor-related protein 1 (LRP1) is a highly modular protein and the largest known mammalian endocytic receptor. LRP1 binds and internalizes many plasma components, playing multiple crucial roles as a scavenger and signaling molecule. One major challenge to studying LRP1 has been that it is difficult to express such a large, highly glycosylated, and cysteinerich protein, limiting structural studies to LRP1 fragments. Here, we report the first recombinant expression of the complete 61 domains of the full-length LRP1 ectodomain. This advance was achieved with a multistep cloning approach and by using DNA dilutions to improve protein yields. We investigated the binding properties of LRP1 using receptor-associated protein (RAP) as a model ligand due to its tight binding interaction. The LRP1 conformation was studied in its bound and unbound state using mass spectrometry, small-angle X-ray scattering, and negative-stain electron microscopy at neutral and acidic pH. Our findings revealed a pH-dependent release of the ligand associated with a conformational change of the receptor. In summary, this investigation of the complete LRP1 ectodomain significantly advances our understanding of this important receptor and provides the basis for further elucidating the mechanism of action of LRP1 in a whole and integrated system.	[De Nardis, Camilla; Madoori, Pramod K.; Leloup, Nadia; Gros, Piet] Univ Utrecht, Bijvoet Ctr Biomol Res, Crystal & Struct Chem Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Lossl, Philip; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, NL-3584 CH Utrecht, Netherlands; [Lossl, Philip; Heck, Albert J. R.] Univ Utrecht, Netherlands Prote Ctr, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Lossl, Philip; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [van den Biggelaar, Maartje; Mertens, Koen] Sanquin Res, Dept Plasma Proteins, NL-1006 AN Amsterdam, Netherlands; [Mertens, Koen] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University; Utrecht University	Gros, P (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Crystal & Struct Chem Grp, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	p.gros@uu.nl	Leloup, Nadia/W-9748-2019; Gros, Piet/AAD-6452-2019; Heck, Albert/D-7098-2011	Leloup, Nadia/0000-0002-1504-3690; Gros, Piet/0000-0002-7782-2585; Heck, Albert/0000-0002-2405-4404; Lossl, Philip/0000-0001-5062-7723	ManiFold project in the European Union [317371]; BioStruct-X in the European Union [283570]; Roadmap Initiative Proteins@Work - Netherlands Organisation for Scientific Research (NWO) [184.032.201]; Landsteiner Foundation for Blood Transfusion Research (LSBR) [1517]	ManiFold project in the European Union; BioStruct-X in the European Union; Roadmap Initiative Proteins@Work - Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Landsteiner Foundation for Blood Transfusion Research (LSBR)	This work was supported by the ManiFold project (Grant 317371) and the BioStruct-X (Grant 283570) embedded in the European Union's Seventh Framework Programme (FP7/2007-2013), the Roadmap Initiative Proteins@Work (Project 184.032.201) funded by The Netherlands Organisation for Scientific Research (NWO), and The Landsteiner Foundation for Blood Transfusion Research (LSBR Fellowship 1517 (to M. v. d. B)). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen OM, 2001, BIOCHEMISTRY-US, V40, P15408, DOI 10.1021/bi0110692; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Bloem E, 2015, BIOCHEM J, V468, P65, DOI 10.1042/BJ20140977; Brennich ME, 2016, J APPL CRYSTALLOGR, V49, P203, DOI 10.1107/S1600576715024462; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; DELAIN E, 1994, ANN NY ACAD SCI, V737, P202, DOI 10.1111/j.1749-6632.1994.tb44313.x; Dolmer K, 2000, J BIOL CHEM, V275, P3264, DOI 10.1074/jbc.275.5.3264; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Guo X, 2008, ANAL CHEM, V80, P951, DOI 10.1021/ac701636w; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Halff EF, 2014, PROTEIN EXPRES PURIF, V99, P27, DOI 10.1016/j.pep.2014.03.010; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; IADONATO SP, 1993, BIOCHEM J, V296, P867, DOI 10.1042/bj2960867; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; Laatsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029385; Lazic A, 2006, ARCH BIOCHEM BIOPHYS, V450, P167, DOI 10.1016/j.abb.2006.04.007; Lee D, 2007, PROTEIN SCI, V16, P1628, DOI 10.1110/ps.072865407; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu F, 2015, NAT METHODS, V12, P1179, DOI 10.1038/nmeth.3603; Lossl P, 2016, ACS CENTRAL SCI, V2, P445, DOI 10.1021/acscentsci.6b00053; Lossl P, 2016, EMBO J, V35, P2634, DOI 10.15252/embj.201694818; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Peng WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083110; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; Snijder J, 2014, J AM CHEM SOC, V136, P7295, DOI 10.1021/ja502616y; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Strickland DK, 2014, ARTERIOSCL THROM VAS, V34, P487, DOI 10.1161/ATVBAHA.113.301924; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van den Biggelaar M, 2015, J BIOL CHEM, V290, P16463, DOI 10.1074/jbc.M115.650911; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827	55	38	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					912	924		10.1074/jbc.M116.758862	http://dx.doi.org/10.1074/jbc.M116.758862			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27956551	Green Published, hybrid			2022-12-28	WOS:000392318700013
J	Hata, S; Kitamura, F; Yamaguchi, M; Shitara, H; Murakami, M; Sorimachi, H				Hata, Shoji; Kitamura, Fujiko; Yamaguchi, Midori; Shitara, Hiroshi; Murakami, Makoto; Sorimachi, Hiroyuki			A Gastrointestinal Calpain Complex, G-calpain, Is a Heterodimer of CAPN8 and CAPN9 Calpain Isoforms, Which Play Catalytic and Regulatory Roles, Respectively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC CALPAIN; EFFICIENT GENE ACTIVATION; STOMACH-SPECIFIC CALPAIN; 5TH EF-HAND; CRYSTAL-STRUCTURE; EMBRYONIC-DEVELOPMENT; DIGESTIVE-TRACT; CRE RECOMBINASE; MU-CALPAIN; SUBUNIT	Calpains (CAPN) are a family of Ca2+-dependent cysteine proteases that regulate various cellular functions by cleaving diverse substrates. Of the 15 mammalian calpains, CAPN8 and CAPN9 are two that are expressed predominantly in the gastrointestinal tract, where they interact to form a protease complex, termed G-calpain. However, because native G-calpain exhibits a highly restricted expression pattern, it has never been purified, and the interactions between CAPN8 and CAPN9 have not been characterized. Here, we clarified the molecular nature of G-calpain by using recombinant proteins and transgenic mice expressing FLAG-tagged CAPN8 (CAPN8-FLAG). Recombinant mouse CAPN8 and CAPN9 co-expressed in eukaryotic expression systems exhibited the same mobility as native mouse G-calpain in Blue Native-PAGE gels, and CAPN8-FLAG immunoprecipitation from stomach homogenates of the transgenic mice showed that CAPN9 was the only protein that associated with CAPN8-FLAG. These results indicated that G-calpain is a heterodimer of CAPN8 and CAPN9. In addition, active recombinant G-calpain was expressed and purified using an in vitro translation system, and the purified protease exhibited enzymatic properties that were comparable with that of calpain-2. Wefound that an active-site mutant of CAPN8, but not CAPN9, compromised G-calpain's substrate cleavage activity, and that the N-terminal helix region of CAPN8 and the C-terminal EF-hands of CAPN8 and CAPN9 were involved in CAPN8/9 dimerization. Furthermore, CAPN8 protein in Capn9(-/-) mice was almost completely lost, whereas CAPN9 was only partially lost in Capn8(-/-) mice. Collectively, these results demonstrated that CAPN8 and CAPN9 function as catalytic and chaperone-like subunits, respectively, in G-calpain.	[Hata, Shoji; Kitamura, Fujiko; Sorimachi, Hiroyuki] Tokyo Metropolitan Inst Med Sci IGAKUKEN, Dept Adv Sci Biomol, Calpain Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Murakami, Makoto] Tokyo Metropolitan Inst Med Sci IGAKUKEN, Dept Adv Sci Biomol, Lipid Metab Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Yamaguchi, Midori; Shitara, Hiroshi] Tokyo Metropolitan Inst Med Sci IGAKUKEN, Ctr Basic Technol Res, Lab Transgen Technol, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan		Hata, S (corresponding author), Tokyo Metropolitan Inst Med Sci IGAKUKEN, Dept Adv Sci Biomol, Calpain Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	hata-sj@igakuken.or.jp	Sorimachi, Hiroyuki/C-6448-2009	Sorimachi, Hiroyuki/0000-0001-9509-6727	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants [JP26450172, JP23780152, JP15H02389, JP23247021]; Kato Memorial Bioscience Foundation; SUNTORY research grant; JSPS; Takeda Science Foundation; Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for creating next-generation agriculture, forestry and fisheries; Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization (NARO); Naito Foundation; Grants-in-Aid for Scientific Research [15H02389] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants; Kato Memorial Bioscience Foundation; SUNTORY research grant; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for creating next-generation agriculture, forestry and fisheries; Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization (NARO); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants JP26450172 and JP23780152 (to S. H.) and JP15H02389 and JP23247021 (to H. Sorimachi), a Kato Memorial Bioscience Foundation research grant (to S. H.), a SUNTORY research grant (to S. H.), Open Partnership Joint Projects of the JSPS Bilateral Joint Research Projects (to H. Sorimachi), a Takeda Science Foundation research grant (to H. Sorimachi), the Council for Science, Technology and Innovation (CSTI), the Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: the Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization (NARO)) (to H. Sorimachi), and a research grant of The Naito Foundation (to H. Sorimachi). The authors declare that they have no conflicts of interest with the contents of this article.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Chou JS, 2011, BBA-PROTEINS PROTEOM, V1814, P864, DOI 10.1016/j.bbapap.2011.04.007; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Davis TL, 2007, J MOL BIOL, V366, P216, DOI 10.1016/j.jmb.2006.11.037; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hata S, 2006, J BIOL CHEM, V281, P11214, DOI 10.1074/jbc.M509244200; Hata S, 2001, FEBS LETT, V501, P111, DOI 10.1016/S0014-5793(01)02611-4; Hata S, 2007, J BIOL CHEM, V282, P27847, DOI 10.1074/jbc.M703168200; Hata S, 2012, J BIOCHEM, V151, P417, DOI 10.1093/jb/mvs002; Hata S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001040; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Kitaura Y, 2002, ARCH BIOCHEM BIOPHYS, V399, P12, DOI 10.1006/abbi.2001.2736; Lee HJ, 1998, BIOL CHEM, V379, P175, DOI 10.1515/bchm.1998.379.2.175; Lee HJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P22, DOI 10.1006/abbi.1998.1021; Liu KY, 2000, J BIOL CHEM, V275, P31093, DOI 10.1074/jbc.M005451200; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Nakagawa K, 2001, J BIOCHEM-TOKYO, V130, P605, DOI 10.1093/oxfordjournals.jbchem.a003025; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ojima K, 2011, J MOL BIOL, V407, P439, DOI 10.1016/j.jmb.2011.01.057; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Partha SK, 2014, FEBS J, V281, P3138, DOI 10.1111/febs.12849; Ravulapalli R, 2009, FEBS J, V276, P973, DOI 10.1111/j.1742-4658.2008.06833.x; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; SORIMACHI H, 1993, J BIOL CHEM, V268, P19476; Sorimachi H, 2011, J BIOCHEM, V150, P23, DOI 10.1093/jb/mvr070; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06; Tonami K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003668; Tonami K, 2011, J CELL SCI, V124, P1214, DOI 10.1242/jcs.072561; Weisz OA, 2003, INT REV CYTOL, V226, P259, DOI 10.1016/S0074-7696(03)01005-2; Yamada M, 2009, NAT MED, V15, P1202, DOI 10.1038/nm.2023; Yoshikawa Y, 2000, JPN J CANCER RES, V91, P459, DOI 10.1111/j.1349-7006.2000.tb00967.x	47	9	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27313	27322		10.1074/jbc.M116.763912	http://dx.doi.org/10.1074/jbc.M116.763912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27881674	hybrid, Green Published			2022-12-28	WOS:000391576300028
J	Palczewska, G; Maeda, A; Golczak, M; Arai, E; Dong, ZQ; Perusek, L; Kevany, B; Palczewski, K				Palczewska, Grazyna; Maeda, Akiko; Golczak, Marcin; Arai, Eisuke; Dong, Zhiqian; Perusek, Lindsay; Kevany, Brian; Palczewski, Krzysztof			Receptor MER Tyrosine Kinase Proto-oncogene (MERTK) Is Not Required for Transfer of Bis-retinoids to the Retinal Pigmented Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; ROD OUTER SEGMENTS; VISUAL CYCLE; RCS RAT; MOUSE MODEL; FUNDUS AUTOFLUORESCENCE; ADIPONECTIN RECEPTORS; MACULAR DEGENERATION; DYSTROPHY PHENOTYPE; BINDING PROTEIN	Accumulation of bis-retinoids in the retinal pigmented epithelium (RPE) is a hallmark of aging and retinal disorders such as Stargardt disease and age-related macular degeneration. These aberrant fluorescent condensation products, including di-retinoid-pyridinium-ethanolamine (A2E), are thought to be transferred to RPE cells primarily through phagocytosis of the photoreceptor outer segments. However, we observed by two-photon microscopy that mouse retinas incapable of phagocytosis due to a deficiency of the c-Mer proto-oncogene tyrosine kinase (Mertk) nonetheless contained fluorescent retinoid condensation material in their RPE. Primary RPE cells from Mertk(-/-) mice also accumulated fluorescent products in vitro. Finally, quantification of A2E demonstrated the acquisition of retinal condensation products in Mertk(-/-) mouse RPE prior to retinal degeneration. In these mice, we identified activated microglial cells that likely were recruited to transport A2E-like condensation products to the RPE and dispose of the dying photoreceptor cells. These observations demonstrate a novel transport mechanism between photoreceptor cells and RPE that does not involve canonical Mertk-dependent phagocytosis.	[Palczewska, Grazyna; Dong, Zhiqian] Polgenix Inc, Cleveland, OH USA; [Maeda, Akiko; Arai, Eisuke; Perusek, Lindsay] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Golczak, Marcin; Kevany, Brian; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Golczak, Marcin; Kevany, Brian; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Maeda, A (corresponding author), Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.; Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	aam19@case.edu; kxp65@case.edu		DONG, ZHIQIAN/0000-0002-8748-4532	National Institutes of Health [EY022326, U01 EY025451, R24 EY024864, EY022658, EY023948]; VSRC CORE Grant [P30 EY011373]; Arnold and Mabel Beckman Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [P30EY011373, R01EY022658, R01EY022326, R01EY023948, U01EY025451, R24EY024864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VSRC CORE Grant; Arnold and Mabel Beckman Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants EY022326, U01 EY025451, and R24 EY024864 (to K. P.), EY022658 (to A. M.), and EY023948 (to M. G.), VSRC CORE Grant P30 EY011373, the Arnold and Mabel Beckman Foundation, and the Foundation Fighting Blindness. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; BOK D, 1993, J CELL SCI, P189; Bruban J, 2011, NEUROBIOL DIS, V42, P55, DOI 10.1016/j.nbd.2011.01.004; CHAITIN MH, 1983, INVEST OPHTH VIS SCI, V24, P812; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; EDWARDS RB, 1977, SCIENCE, V197, P1001, DOI 10.1126/science.560718; Fujioka H, 2014, ULTRASTRUCT PATHOL, V38, P204, DOI 10.3109/01913123.2014.888114; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gliem M, 2016, JAMA OPHTHALMOL, V134, P817, DOI 10.1001/jamaophthalmol.2016.1475; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Hu SJ, 2015, J NEUROSCI, V35, P6987, DOI 10.1523/JNEUROSCI.3955-14.2015; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Katz ML, 2001, INVEST OPHTH VIS SCI, V42, P3023; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim SR, 2006, EXP EYE RES, V82, P828, DOI 10.1016/j.exer.2005.10.004; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; LaVail MM, 2016, ADV EXP MED BIOL, V854, P487, DOI 10.1007/978-3-319-17121-0_65; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2014, P NATL ACAD SCI USA, V111, pE1428, DOI 10.1073/pnas.1317986111; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Molday RS, 2015, PROG MOL BIOL TRANSL, V134, P415, DOI 10.1016/bs.pmbts.2015.06.008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Palczewska G, 2014, NAT MED, V20, P785, DOI 10.1038/nm.3590; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rice DS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7228; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Tanabe H, 2015, NATURE, V520, P312, DOI 10.1038/nature14301; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Vollrath D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005723; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	57	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26937	26949		10.1074/jbc.M116.764563	http://dx.doi.org/10.1074/jbc.M116.764563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875314	Green Published, hybrid			2022-12-28	WOS:000391571400032
J	Cahill, TJ; Leo, V; Kelly, M; Stockenhuber, A; Kennedy, NW; Bao, L; Cereghetti, GM; Harper, AR; Czibik, G; Liao, C; Bellahcene, M; Steeples, V; Ghaffari, S; Yavari, A; Mayer, A; Poulton, J; Ferguson, DJP; Scorrano, L; Hettiarachchi, NT; Peers, C; Boyle, J; Hill, RB; Simmons, A; Watkins, H; Dear, TN; Ashrafian, H				Cahill, Thomas J.; Leo, Vincenzo; Kelly, Matthew; Stockenhuber, Alexander; Kennedy, Nolan W.; Bao, Leyuan; Cereghetti, Grazia M.; Harper, Andrew R.; Czibik, Gabor; Liao, Chunyan; Bellahcene, Mohammed; Steeples, Violetta; Ghaffari, Sahar; Yavari, Arash; Mayer, Alice; Poulton, Joanna; Ferguson, David J. P.; Scorrano, Luca; Hettiarachchi, Nishani T.; Peers, Chris; Boyle, John; Hill, R. Blake; Simmons, Alison; Watkins, Hugh; Dear, T. Neil; Ashrafian, Houman			Resistance of dynamin-related protein 1 oligomers to disassembly impairs mitophagy, resulting in myocardial inflammation and heart failure (vol 290, pg 25907, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Poulton, Joanna/AAB-4828-2021; Czibik, Gabor/U-9295-2018; Harper, Andrew/B-7044-2017	Czibik, Gabor/0000-0002-4914-6794; Hill, Blake/0000-0001-6228-3905; Stockenhuber, Alexander/0000-0002-5523-6673; Kennedy, Nolan/0000-0002-2944-5439; Harper, Andrew/0000-0001-5327-0328; Simmons, Alison/0000-0003-3454-0710; Peers, Chris/0000-0002-8354-346X; Poulton, Joanna/0000-0002-2460-5587	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067180] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/012/24110] Funding Source: Medline; Medical Research Council [MC_UU_12010/7, MR/J010448/1] Funding Source: Medline; NIGMS NIH HHS [R01 GM067180] Funding Source: Medline; Department of Health [NIHR-RP-R3-12-026] Funding Source: Medline; National Institute for Health Research [NIHR-RP-R3-12-026] Funding Source: researchfish; MRC [MC_UU_12010/7, MR/J010448/1] Funding Source: UKRI	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cahill TJ, 2015, J BIOL CHEM, V290, P25907, DOI 10.1074/jbc.M115.665695	1	11	11	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25762	25762		10.1074/jbc.A115.665695	http://dx.doi.org/10.1074/jbc.A115.665695			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27913663	Green Published, hybrid			2022-12-28	WOS:000390095300041
J	Zwick, M; Esposito, C; Hellstern, M; Seelig, A				Zwick, Matthias; Esposito, Cinzia; Hellstern, Manuel; Seelig, Anna			How phosphorylation and ATPase activity regulate anion flux through the cystic fibrosis transmembrane conductance regulator (CFTR) (vol 291, pg 14483, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Zwick M, 2016, J BIOL CHEM, V291, P14483, DOI 10.1074/jbc.M116.721415	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23928	23928		10.1074/jbc.A116.721415	http://dx.doi.org/10.1074/jbc.A116.721415			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27837011	Green Published, hybrid			2022-12-28	WOS:000388498100009
J	Fancy, RM; Wang, LY; Schmid, T; Zeng, QH; Wang, H; Zhou, T; Buchsbaum, DJ; Song, YH				Fancy, Romone M.; Wang, Lingyun; Schmid, Thomas; Zeng, Qinghua; Wang, Hong; Zhou, Tong; Buchsbaum, Donald J.; Song, Yuhua			Characterization of the interactions between calmodulin and death receptor 5 in triple-negative and estrogen receptor-positive breast cancer cells. AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY (vol 291, pg 12862, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Fancy RM, 2016, J BIOL CHEM, V291, P12862, DOI 10.1074/jbc.M116.727727	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23489	23489		10.1074/jbc.A116.727727	http://dx.doi.org/10.1074/jbc.A116.727727			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27815452	Green Published, hybrid			2022-12-28	WOS:000387884400011
J	Takatsu, H; Tanaka, G; Segawa, K; Suzuki, J; Nagata, S; Nakayama, K; Shin, HW				Takatsu, Hiroyuki; Tanaka, Gaku; Segawa, Katsumori; Suzuki, Jun; Nagata, Shigekazu; Nakayama, Kazuhisa; Shin, Hye-Won			Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane (vol 289, pg 33543, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Nakayama, Kazuhisa/ABF-2924-2020; Shin, Hye-Won/P-5398-2018	Shin, Hye-Won/0000-0002-9138-9554; Nakayama, Kazuhisa/0000-0001-7701-7183; Nagata, Shigekazu/0000-0001-9758-8426				Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012	1	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21421	21421		10.1074/jbc.A114.593012	http://dx.doi.org/10.1074/jbc.A114.593012			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27825076	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000385999200008
J	Kim, HS; Nickoloff, JA; Wu, YH; Williamson, EA; Sidhu, GS; Reinert, BL; Jaiswal, AS; Srinivasan, G; Patel, B; Kong, K; Burma, S; Lee, SH; Hromas, RA				Kim, Hyun-Suk; Nickoloff, Jac A.; Wu, Yuehan; Williamson, Elizabeth A.; Sidhu, Gurjit Singh; Reinert, Brian L.; Jaiswal, Aruna S.; Srinivasan, Gayathri; Patel, Bhavita; Kong, Kimi; Burma, Sandeep; Lee, Suk-Hee; Hromas, Robert A.			Endonuclease EEPD1 Is a Gatekeeper for Repair of Stressed Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA END RESECTION; HOMOLOGOUS RECOMBINATION; GENOME INSTABILITY; RESTART; NUCLEASES; ROLES; EXO1; MECHANISM; PATHWAYS	Replication is not as continuous as once thought, with DNA damage frequently stalling replication forks. Aberrant repair of stressed replication forks can result in cell death or genome instability and resulting transformation to malignancy. Stressed replication forks are most commonly repaired via homologous recombination (HR), which begins with 5 ' end resection, mediated by exonuclease complexes, one of which contains Exo1. However, Exo1 requires free 5 ' -DNA ends upon which to act, and these are not commonly present in non-reversed stalled replication forks. To generate a free 5 ' end, stalled replication forks must therefore be cleaved. Although several candidate endonucleases have been implicated in cleavage of stalled replication forks to permit end resection, the identity of such an endonuclease remains elusive. Here we show that the 5 ' -endonuclease EEPD1 cleaves replication forks at the junction between the lagging parental strand and the unreplicated DNA parental double strands. This cleavage creates the structure that Exo1 requires for 5 ' end resection and HR initiation. We observed that EEPD1 and Exo1 interact constitutively, and Exo1 repairs stalled replication forks poorly without EEPD1. Thus, EEPD1 performs a gatekeeper function for replication fork repair by mediating the fork cleavage that permits initiation of HR-mediated repair and restart of stressed forks.	[Kim, Hyun-Suk; Lee, Suk-Hee] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Nickoloff, Jac A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Wu, Yuehan; Williamson, Elizabeth A.; Sidhu, Gurjit Singh; Reinert, Brian L.; Jaiswal, Aruna S.; Srinivasan, Gayathri; Patel, Bhavita; Kong, Kimi; Hromas, Robert A.] Univ Florida Hlth, Dept Med, Gainesville, FL 32610 USA; [Wu, Yuehan; Williamson, Elizabeth A.; Sidhu, Gurjit Singh; Reinert, Brian L.; Jaiswal, Aruna S.; Srinivasan, Gayathri; Patel, Bhavita; Kong, Kimi; Hromas, Robert A.] Univ Florida Hlth, Ctr Canc, Gainesville, FL 32610 USA; [Burma, Sandeep] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Indiana University System; Indiana University Bloomington; Colorado State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lee, SH (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.; Hromas, RA (corresponding author), Univ Florida Hlth, Dept Med, Gainesville, FL 32610 USA.; Hromas, RA (corresponding author), Univ Florida Hlth, Ctr Canc, Gainesville, FL 32610 USA.	slee@iupui.edu; robert.hromas@medicine.ufl.edu			National Institutes of Health Grants [R01 GM109645, CA139429, CA205224, R01 CA152367, R01 GM084020, RO1CA149461, RO1CA197796, R21CA202403]; National Aeronautics and Space Administration Grant [NNX16AD78G]; Leukemia and Lymphoma Society Grants [6253-13, 8995-14]; Florida BankheadColey program; NATIONAL CANCER INSTITUTE [R01CA151367, R01CA139429, R01CA149461, R01CA197796, R01CA205224, R21CA202403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084020, R01GM109645] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration Grant; Leukemia and Lymphoma Society Grants(Leukemia and Lymphoma Society); Florida BankheadColey program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM109645, CA139429, and CA205224 (to R. H.); R01 CA152367 (to S. H. L.); R01 GM084020 (to J. A. N., E. A. W., and R. H.); and RO1CA149461, RO1CA197796, and R21CA202403 and the National Aeronautics and Space Administration Grant NNX16AD78G (to S. B.); and the Leukemia and Lymphoma Society Grants 6253-13 and 8995-14 and the Florida BankheadColey program (to R. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Berti M, 2016, NAT STRUCT MOL BIOL, V23, P103, DOI 10.1038/nsmb.3163; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Carr AM, 2013, J MOL BIOL, V425, P4733, DOI 10.1016/j.jmb.2013.04.023; Chan YW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5844; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Costes A, 2013, BIOMOLECULES, V3, P39, DOI 10.3390/biom3010039; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Kakarougkas A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130685; Keijzers G, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150058; Kim HS, 2014, J BIOL CHEM, V289, P10930, DOI 10.1074/jbc.M113.533216; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Makharashvili N, 2014, MOL CELL, V54, P1022, DOI 10.1016/j.molcel.2014.04.011; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Rass U, 2013, CHROMOSOMA, V122, P499, DOI 10.1007/s00412-013-0431-z; Sarbajna S, 2014, GENE DEV, V28, P1124, DOI 10.1101/gad.238303.114; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; Syeda AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016550; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tay YD, 2010, J BIOL CHEM, V285, P11427, DOI 10.1074/jbc.M110.108399; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Wray J, 2013, BLOOD, V121, P4359, DOI 10.1182/blood-2012-10-460527; Wu YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005675; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang Y, 2011, NAT STRUCT MOL BIOL, V18, P80, DOI 10.1038/nsmb.1940; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	43	20	20	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2795	2804		10.1074/jbc.M116.758235	http://dx.doi.org/10.1074/jbc.M116.758235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049724	hybrid, Green Published			2022-12-28	WOS:000395535100020
J	Ticha, A; Stanchev, S; Skerle, J; Began, J; Ingr, M; Svehlova, K; Polovinkin, L; Ruzicka, M; Bednarova, L; Hadravova, R; Polachova, E; Rampirova, P; Brezinova, J; Kasicka, V; Majer, P; Strisovsky, K				Ticha, Anezka; Stanchev, Stancho; Skerle, Jan; Began, Jakub; Ingr, Marek; Svehlova, Katerina; Polovinkin, Lucie; Ruzicka, Martin; Bednarova, Lucie; Hadravova, Romana; Polachova, Edita; Rampirova, Petra; Brezinova, Jana; Kasicka, Vaclav; Majer, Pavel; Strisovsky, Kvido			Sensitive Versatile Fluorogenic Transmembrane Peptide Substrates for Rhomboid Intramembrane Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; MEMBRANE; PROTEOLYSIS; SELECTIVITY; DETERGENTS; ACTIVATION	Rhomboid proteases are increasingly being explored as potential drug targets, but their potent and specific inhibitors are not available, and strategies for inhibitor development are hampered by the lack of widely usable and easily modifiable in vitro activity assays. Here we address this bottleneck and report on the development of new fluorogenic transmembrane peptide substrates, which are cleaved by several unrelated rhomboid proteases, can be used both in detergent micelles and in liposomes, and contain red-shifted fluorophores that are suitable for high-throughput screening of compound libraries. We show that nearly the entire transmembrane domain of the substrate is important for efficient cleavage, implying that it extensively interacts with the enzyme. Importantly, we demonstrate that in the detergent micelle system, commonly used for the enzymatic analyses of intramembrane proteolysis, the cleavage rate strongly depends on detergent concentration, because the reaction proceeds only in the micelles. Furthermore, we show that the catalytic efficiency and selectivity toward a rhomboid substrate can be dramatically improved by targeted modification of the sequence of its P5 to P1 region. The fluorogenic substrates that we describe and their sequence variants should find wide use in the detection of activity and development of inhibitors of rhomboid proteases.	[Ticha, Anezka; Stanchev, Stancho; Skerle, Jan; Began, Jakub; Svehlova, Katerina; Polovinkin, Lucie; Ruzicka, Martin; Bednarova, Lucie; Hadravova, Romana; Polachova, Edita; Rampirova, Petra; Brezinova, Jana; Kasicka, Vaclav; Majer, Pavel; Strisovsky, Kvido] Czech Acad Sci, Inst Organ Chem & Biochem, Flemingovo 2, Prague, Czech Republic; [Skerle, Jan; Ingr, Marek; Polovinkin, Lucie; Ruzicka, Martin] Charles Univ Prague, Dept Biochem, Fac Sci, Hlavova 2030-8, Prague 12843, Czech Republic; [Began, Jakub] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Vinicna 5, CR-12844 Prague, Czech Republic; [Ticha, Anezka] Charles Univ Prague, Fac Med 1, Katerinska 32, Prague 12108, Czech Republic; [Ingr, Marek] Tomas Bata Univ Zlin, Dept Phys & Mat Engn, Fac Technol, Nam TG Masaryka 5555, Zlin 76001, Czech Republic; [Polovinkin, Lucie] Inst Biol Struct, 71 Ave Martyrs, F-38044 Grenoble, France	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Charles University Prague; Tomas Bata University Zlin; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Strisovsky, K (corresponding author), Inst Organ Chem & Biochem, Flemingovo 2, Prague 16610, Czech Republic.	kvido.strisovsky@uochb.cas.cz	Strisovsky, Kvido/H-6284-2014; Brezinova, Jana/G-5594-2014; Majer, Pavel/G-1141-2019; Poláchová, Edita/AAH-2532-2020; Ingr, Marek/E-2478-2015; Skerle, Jan/G-5904-2014; Bednarova, Lucie/E-7622-2012; Tichá, Anežka/H-1657-2014; Růžička, Martin/G-5695-2014; Polovinkin, Lucie/AAB-9056-2019; Began, Jakub/G-6290-2014	Strisovsky, Kvido/0000-0003-3677-0907; Brezinova, Jana/0000-0002-2076-9891; Poláchová, Edita/0000-0002-4740-1114; Ingr, Marek/0000-0001-6741-9955; Skerle, Jan/0000-0002-7838-8418; Tichá, Anežka/0000-0002-2517-2488; Růžička, Martin/0000-0002-0245-487X; Svehlova, Katerina/0000-0002-5687-9574; Stanchev, Stancho/0000-0002-4880-0539; Began, Jakub/0000-0003-3934-3767	EMBO Installation Grant [2329]; Ministry of Education, Youth and Sports of the Czech Republic Projects [LK11206, LO1302]; National Subvention for Development of Research Organizations [RVO: 61388963]; Marie Curie Career Integration Grant [304154]	EMBO Installation Grant; Ministry of Education, Youth and Sports of the Czech Republic Projects(Ministry of Education, Youth & Sports - Czech Republic); National Subvention for Development of Research Organizations; Marie Curie Career Integration Grant	This work was supported by EMBO Installation Grant 2329, Ministry of Education, Youth and Sports of the Czech Republic Projects LK11206 and LO1302, Marie Curie Career Integration Grant Project 304154 (to K. S.), and National Subvention for Development of Research Organizations RVO: 61388963 to the Institute of Organic Chemistry and Biochemistry. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1983, BIOCHEM J, V213, P561; Chan EYL, 2013, BBA-BIOMEMBRANES, V1828, P2916, DOI 10.1016/j.bbamem.2013.05.012; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Etheridge SL, 2013, CELL TISSUE RES, V351, P301, DOI 10.1007/s00441-012-1542-1; Fenyo David, 2007, J Vis Exp, P192, DOI 10.3791/192; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Haedke U, 2013, CURR OPIN CHEM BIOL, V17, P102, DOI 10.1016/j.cbpa.2012.11.024; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INTERNATIONAL UNION OF BIOCHEMISTRY NOMENCLATURE COMMITTEE., 1979, European Journal of Biochemistry, V97, P319, DOI 10.1111/j.1432-1033.1979.tb13116.x; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MONGAY C, 1974, ANN CHIM-ROME, V64, P409; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; PARRY G, 1976, FEBS LETT, V67, P123, DOI 10.1016/0014-5793(76)80348-1; Pierrat OA, 2011, ACS CHEM BIOL, V6, P325, DOI 10.1021/cb100314y; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rath A, 2013, METHODS MOL BIOL, V1063, P197, DOI 10.1007/978-1-62703-583-5_11; Riestra AM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005294; SCHEEL G, 1982, EUR J BIOCHEM, V127, P245, DOI 10.1111/j.1432-1033.1982.tb06862.x; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Solinova V, 2004, J CHROMATOGR B, V808, P75, DOI 10.1016/j.jchromb.2004.01.062; Song W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9022; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Strisovsky K, 2016, FEBS J, V283, P1837, DOI 10.1111/febs.13638; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urbani A, 2005, ANAL BIOCHEM, V336, P117, DOI 10.1016/j.ab.2004.09.040; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; Vosyka O, 2013, P NATL ACAD SCI USA, V110, P2472, DOI 10.1073/pnas.1215076110; Wolf EV, 2015, ACS CHEM BIOL, V10, P2325, DOI 10.1021/acschembio.5b00514; Wolf EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072307; Zoll S, 2014, EMBO J, V33, P2408, DOI 10.15252/embj.201489367	37	16	16	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2703	2713		10.1074/jbc.M116.762849	http://dx.doi.org/10.1074/jbc.M116.762849			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28069810	Green Published, hybrid			2022-12-28	WOS:000395535100013
J	Peng, GQ; Yang, Y; Pasquarella, JR; Xu, LQ; Qian, ZH; Holmes, KV; Li, F				Peng, Guiqing; Yang, Yang; Pasquarella, Joseph R.; Xu, Liqing; Qian, Zhaohui; Holmes, Kathryn V.; Li, Fang			Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOEMBRYONIC ANTIGEN FAMILY; RESPIRATORY SYNDROME CORONAVIRUS; VIRUS-BINDING ACTIVITY; HEPATITIS-VIRUS; CRYSTAL-STRUCTURE; SPIKE PROTEIN; AMINOPEPTIDASE N; MHV RECEPTOR; AMINO-ACIDS; CELL ENTRY	Hosts and pathogens are locked in an evolutionary arms race. To infect mice, mouse hepatitis coronavirus (MHV) has evolved to recognize mouse CEACAM1a (mCEACAM1a) as its receptor. To elude MHV infections, mice may have evolved a variant allele from the Ceacam1a gene, called Ceacam1b, producing mCEACAM1b, which is a much poorer MHV receptor than mCEACAM1a. Previous studies showed that sequence differences between mCEACAM1a and mCEACAM1b in a critical MHV-binding CC' loop partially account for the low receptor activity of mCEACAM1b, but detailed structural and molecular mechanisms for the differential MHV receptor activities of mCEACAM1a and mCEACAM1b remained elusive. Here we have determined the crystal structure of mCEACAM1b and identified the structural differences and additional residue differences betweenmCEACAM1a and mCEACAM1b that affect MHV binding and entry. These differences include conformational alterations of the CC' loop as well as residue variations in other MHV-binding regions, including beta-strands C' and C '' and loop C'C ''. Using pseudovirus entry and protein-protein binding assays, we show that substituting the structural and residue features from mCEACAM1b into mCEACAM1a reduced the viral receptor activity of mCEACAM1a, whereas substituting the reverse changes from mCEACAM1a into mCEACAM1b increased the viral receptor activity of mCEACAM1b. These results elucidate the detailed molecular mechanism for how mice may have kept pace in the evolutionary arms race with MHV by undergoing structural and residue changes in the MHV receptor, providing insight into this possible example of pathogen-driven evolution of a host receptor protein.	[Peng, Guiqing; Yang, Yang; Pasquarella, Joseph R.; Xu, Liqing; Li, Fang] Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA; [Peng, Guiqing] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Xu, Liqing] Huazhong Agr Univ, Key Lab Hort Plant Biol, Wuhan 430070, Peoples R China; [Qian, Zhaohui] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Qian, Zhaohui] Peking Union Med Coll, Beijing 100730, Peoples R China; [Qian, Zhaohui; Holmes, Kathryn V.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA	University of Minnesota System; University of Minnesota Twin Cities; Huazhong Agricultural University; Huazhong Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, F (corresponding author), Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA.	lifang@umn.edu	Qian, Zhaohui/AFR-9488-2022; Yang, Yang/R-7215-2016	Yang, Yang/0000-0001-9061-3828; Qian, Zhaohui/0000-0003-4116-4450	National Institutes of Health [R01AI089728]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01AI089728. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], PYMOL MOL GRAPH SYST; Beauchemin N, 1999, EXP CELL RES, V252, P243; BOYLE JF, 1987, J VIROL, V61, P185, DOI 10.1128/JVI.61.1.185-189.1987; CAVANAGH D, 1986, J GEN VIROL, V67, P1443, DOI 10.1099/0022-1317-67-7-1443; Chen L, 2012, P NATL ACAD SCI USA, V109, P17966, DOI 10.1073/pnas.1210123109; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Chen YQ, 2013, J VIROL, V87, P10777, DOI 10.1128/JVI.01756-13; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GODFRAIND C, 1995, LAB INVEST, V73, P615; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hirai A, 2010, J VIROL, V84, P6654, DOI 10.1128/JVI.02680-09; Homberger FR, 1997, LAB ANIM, V31, P97, DOI 10.1258/002367797780600189; Jacoby RO, 1997, FASEB J, V11, P609, DOI 10.1096/fasebj.11.8.9240962; Kammerer R, 2004, GENE, V339, P99, DOI 10.1016/j.gene.2004.06.023; Krempl C, 1997, J VIROL, V71, P3285, DOI 10.1128/JVI.71.4.3285-3287.1997; KUBO H, 1994, J VIROL, V68, P5403, DOI 10.1128/JVI.68.9.5403-5410.1994; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Liu C, 2015, J VIROL, V89, P6121, DOI 10.1128/JVI.00430-15; Liu C, 2014, J BIOL CHEM, V289, P34520, DOI 10.1074/jbc.M114.566802; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Miura HS, 2004, J VIROL, V78, P216, DOI 10.1128/JVI.78.1.216-223.2004; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Ohtsuka N, 1997, J VIROL, V71, P8860, DOI 10.1128/JVI.71.11.8860-8863.1997; Ohtsuka N, 1996, J GEN VIROL, V77, P1683, DOI 10.1099/0022-1317-77-8-1683; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng GQ, 2012, J BIOL CHEM, V287, P41931, DOI 10.1074/jbc.M112.418210; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Promkuntod N, 2014, VIROLOGY, V448, P26, DOI 10.1016/j.virol.2013.09.018; Rao PV, 1997, VIROLOGY, V229, P336, DOI 10.1006/viro.1997.8446; Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859; SCHULTZE B, 1992, VIROLOGY, V189, P792, DOI 10.1016/0042-6822(92)90608-R; Schwegmann-Wessels C, 2006, GLYCOCONJUGATE J, V23, P51, DOI 10.1007/s10719-006-5437-9; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toleman M, 2001, CELL MICROBIOL, V3, P33, DOI 10.1046/j.1462-5822.2001.00089.x; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988; Wang NS, 2013, CELL RES, V23, P986, DOI 10.1038/cr.2013.92; Wessner DR, 1998, J VIROL, V72, P1941, DOI 10.1128/JVI.72.3.1941-1948.1998; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; Yang Y, 2014, P NATL ACAD SCI USA, V111, P12516, DOI 10.1073/pnas.1405889111	50	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2174	2181		10.1074/jbc.M116.764266	http://dx.doi.org/10.1074/jbc.M116.764266			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28035001	Green Published, hybrid			2022-12-28	WOS:000395530300011
J	Zhang, J; Jiang, HY; Zhang, LK; Xu, WL; Qiao, YT; Zhu, XG; Liu, W; Zheng, QQ; Hua, ZC				Zhang, Jing; Jiang, Heng-yi; Zhang, Lin-kai; Xu, Wen-ling; Qiao, Yi-ting; Zhu, Xu-guo; Liu, Wan; Zheng, Qian-qian; Hua, Zi-Chun			C-FLIPL Modulated Wnt/beta-Catenin Activation via Association with TIP49 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEX; NF-KAPPA-B; RUVB DNA HELICASE; CANCER CELL-DEATH; BETA-CATENIN; NUCLEAR-LOCALIZATION; APOPTOSIS; TRANSCRIPTION; TIP60; GENE	Cellular FLICE-like inhibitory protein (c-FLIPL) is a key inhibitory protein in the extrinsic apoptotic pathway. Recent studies showed that c-FLIPL could translocate into the nucleus and might be involved in the Wnt signaling pathway. The nuclear function of c-FLIPL was still unclear. Here we found a novel c-FLIPL-associated protein TIP49, which is a nuclear protein identified as a cofactor in the transcriptional regulation of beta-catenin. They had co-localization in the nucleus and the DED domain of c-FLIPL was required for the association with TIP49. By performing ChIP experiments, C-FLIPL was detected in the ITF-2 locus and facilitated TIP49 accumulation in the formation of complexes at the T-cell-specific transcription factor site of human ITF-2 promoter. When TIP49 knockdown, c-FLIP(L)driven Wnt activation, and cell proliferation were inhibited, suggesting that a role of nuclear c-FLIPL involved in modulation of theWntpathway was in a TIP49-dependent manner. Elevated expression of c-FLIPL and TIP49 that coincided in human lung cancers were analyzed in silico using the Oncomine database. Their high expressions were reconfirmed in six lung cancer cell lines and correlated with cell growth. The association of c-FLIPL and TIP49 provided an additional mechanism involved in c-FLIPL-mediated functions, including Wnt activation.	[Zhang, Jing; Jiang, Heng-yi; Zhang, Lin-kai; Xu, Wen-ling; Qiao, Yi-ting; Zhu, Xu-guo; Liu, Wan; Zheng, Qian-qian; Hua, Zi-Chun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China; [Zhang, Jing; Hua, Zi-Chun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou 213164, Jiangsu, Peoples R China; [Zhang, Jing; Hua, Zi-Chun] Jiangsu Target Pharma Labs Inc, Changzhou 213164, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Zhang, J; Hua, ZC (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.; Zhang, J (corresponding author), Nanjing Univ, Changzhou High Tech Res Inst, Changzhou 213164, Jiangsu, Peoples R China.; Zhang, J (corresponding author), Jiangsu Target Pharma Labs Inc, Changzhou 213164, Jiangsu, Peoples R China.	jzhang08@nju.edu.cn; zchua@nju.edu.cn			Chinese National Natural Sciences Foundation [81421091]; Doctoral Station Science Foundation from the Chinese Ministry of Education Grant [20130091130003]; Jiangsu Provincial Nature Science Foundation [BK20161477, BE2013630]; Open Project Programs from the State Key Laboratory of Natural and Biomimetic Drugs [K20140201]; Bureau of Science and Technology of Changzhou [CZ20130011, CE20135013]	Chinese National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Doctoral Station Science Foundation from the Chinese Ministry of Education Grant; Jiangsu Provincial Nature Science Foundation; Open Project Programs from the State Key Laboratory of Natural and Biomimetic Drugs; Bureau of Science and Technology of Changzhou	This work was supported by Chinese National Natural Sciences Foundation Grant 81421091, Doctoral Station Science Foundation from the Chinese Ministry of Education Grant 20130091130003, Jiangsu Provincial Nature Science Foundation Grants BK20161477 and BE2013630, Open Project Programs from the State Key Laboratory of Natural and Biomimetic Drugs Grant K20140201, and Bureau of Science and Technology of Changzhou Grants CZ20130011 and CE20135013. The authors declare that they have no conflicts of interest with the contents of this article.	Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Chau H, 2005, J EXP MED, V202, P405, DOI 10.1084/jem.20050118; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Dugan KA, 2002, ONCOGENE, V21, P5835, DOI 10.1038/sj.onc.1205763; Feng Y, 2003, CANCER RES, V63, P8726; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Gohshi T, 1999, J BIOCHEM, V125, P939, DOI 10.1093/oxfordjournals.jbchem.a022372; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Katayama R, 2010, J CELL SCI, V123, P23, DOI 10.1242/jcs.058602; Kikuchi N, 1999, J BIOCHEM, V125, P487, DOI 10.1093/oxfordjournals.jbchem.a022312; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Naito M, 2004, MOL CELL BIOL, V24, P8418, DOI 10.1128/MCB.24.19.8418-8427.2004; Nakagiri S, 2005, MOL CELL BIOL, V25, P9249, DOI 10.1128/MCB.25.21.9249-9258.2005; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Riley JS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.481; Safa A. R., 2012, Experimental Oncology, V34, P176; Safa A. R., 2013, J CARCINOG MUTAGEN, V6; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Zhang J, 2009, INT J BIOCHEM CELL B, V41, P1678, DOI 10.1016/j.biocel.2009.02.008; Zhang N, 2005, J EXP MED, V202, P395, DOI 10.1084/jem.20050117	37	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2132	2142		10.1074/jbc.M116.753251	http://dx.doi.org/10.1074/jbc.M116.753251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028178	hybrid, Green Published			2022-12-28	WOS:000395530300008
J	Mallette, E; Kimber, MS				Mallette, Evan; Kimber, Matthew S.			A Complete Structural Inventory of the Mycobacterial Microcompartment Shell Proteins Constrains Models of Global Architecture and Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL MICROCOMPARTMENT; CARBOXYSOME SHELL; PDU MICROCOMPARTMENT; BETA-CARBOXYSOME; ORGANELLES; ENZYME; SOFTWARE	Bacterial microcompartments are bacterial analogs of eukaryotic organelles in that they spatially segregate aspects of cellular metabolism, but they do so by building not a lipid membrane but a thin polyhedral protein shell. Although multiple shell protein structures are known for several microcompartment types, additional uncharacterized components complicate systematic investigations of shell architecture. We report here the structures of all four proteins proposed to form the shell of an uncharacterized microcompartment designated the Rhodococcus and Mycobacterium microcompartment (RMM), which, along with crystal interactions and docking studies, suggests possible models for the particle's vertex and edge organization. MSM0272 is a typical hexameric beta-sandwich shell protein thought to form the bulk of the facet. MSM0273 is a pentameric beta-barrel shell protein that likely plugs the vertex of the particle. MSM0271is an unusual double-ringed bacterial microcompartment shell protein whose rings are organized in an offset position relative to all known related proteins. MSM0275 is related to MSM0271 but self-organizes as linear strips that may line the facet edge; here, the presence of a novel extendable loop may help ameliorate poor packing geometry of the rigid main particle at the angled edges. In contrast to previously characterized homologs, both of these proteins show closed pores at both ends. This suggests a model where key interactions at the vertex and edges are mediated at the inner layer of the shell by MSM0271 (encircling MSM0273) and MSM0275, and the facet is built from MSM0272 hexamers tiling in the outer layer of the shell.	[Mallette, Evan; Kimber, Matthew S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Kimber, MS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	mkimber@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586	Natural Sciences and Engineering Research Council of Canada [04045-2015]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant 04045-2015 (to M. S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; Cai F, 2013, J BIOL CHEM, V288, P16055, DOI 10.1074/jbc.M113.456897; Chowdhury C, 2015, P NATL ACAD SCI USA, V112, P2990, DOI 10.1073/pnas.1423672112; Chowdhury C, 2014, MICROBIOL MOL BIOL R, V78, P438, DOI 10.1128/MMBR.00009-14; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; Dryden KA, 2009, PROTEIN SCI, V18, P2629, DOI 10.1002/pro.272; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Heinhorst S., 2014, NANOMICROBIOLOGY, DOI [10.1007/978-1-4939-1667-2_4, DOI 10.1007/978-1-4939-1667-2_4]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huseby DL, 2013, J BACTERIOL, V195, P2864, DOI 10.1128/JB.02179-12; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kataoka M, 2006, LETT APPL MICROBIOL, V43, P430, DOI 10.1111/j.1472-765X.2006.01970.x; Keeling TJ, 2014, PHOTOSYNTH RES, V121, P125, DOI 10.1007/s11120-014-9973-z; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2015, TRENDS MICROBIOL, V23, P22, DOI 10.1016/j.tim.2014.10.003; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/nchembio.1141, 10.1038/NCHEMBIO.1141]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pang A, 2012, ACTA CRYSTALLOGR D, V68, P1642, DOI 10.1107/S0907444912039315; Pitts AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048360; Rae BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043871; Samborska B, 2012, STRUCTURE, V20, P1353, DOI 10.1016/j.str.2012.05.013; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Sinha S, 2014, J MOL BIOL, V426, P2328, DOI 10.1016/j.jmb.2014.04.012; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tsai YS, 2009, ACTA CRYSTALLOGR D, V65, P980, DOI 10.1107/S0907444909025153; Urano N, 2011, APPL MICROBIOL BIOT, V89, P739, DOI 10.1007/s00253-010-2924-5; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wheatley NM, 2013, PROTEIN SCI, V22, P660, DOI 10.1002/pro.2246; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeates TO, 2013, J MOL MICROB BIOTECH, V23, P290, DOI 10.1159/000351347; Zarzycki J, 2013, J EXP BOT, V64, P787, DOI 10.1093/jxb/ers294	41	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1197	1210		10.1074/jbc.M116.754093	http://dx.doi.org/10.1074/jbc.M116.754093			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27927988	Green Published, hybrid			2022-12-28	WOS:000393339800005
J	Shah, R; Ohashi, T; Erickson, HP; Oas, TG				Shah, Riddhi; Ohashi, Tomoo; Erickson, Harold P.; Oas, Terrence G.			Spontaneous Unfolding-Refolding of Fibronectin Type III Domains Assayed by Thiol Exchange THERMODYNAMIC STABILITY CORRELATES WITH RATES OF UNFOLDING RATHER THAN FOLDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOGLYCERATE KINASE; DISULFIDE EXCHANGE; CRYSTAL-STRUCTURE; PROTEINS; ELASTICITY; KINETICS; MATRIX; TENASCIN; STATE; ACCESSIBILITY	Globular proteins are not permanently folded but spontaneously unfold and refold on time scales that can span orders of magnitude for different proteins. A longstanding debate in the protein- folding field is whether unfolding rates or folding rates correlate to the stability of a protein. In the present study, we have determined the unfolding and folding kinetics of 10 FNIII domains. FNIII domains are one of the most common protein folds and are present in 2% of animal proteins. FNIII domains are ideal for this study because they have an identical sevenstrand beta-sandwich structure, but they vary widely in sequence and thermodynamic stability. We assayed thermodynamic stability of each domain by equilibrium denaturation in urea. We then assayed the kinetics of domain opening and closing by a technique known as thiol exchange. For this we introduced a buried Cys at the identical location in each FNIII domain and measured the kinetics of labeling with DTNB over a range of urea concentrations. A global fit of the kinetics data gave the kinetics of spontaneous unfolding and refolding in zero urea. We found that the folding rates were relatively similar, similar to 0.1-1 s(- 1), for the different domains. The unfolding rates varied widely and correlated with thermodynamic stability. Our study is the first to address this question using a set of domains that are structurally homologous but evolved with widely varying sequence identity and thermodynamic stability. These data add new evidence that thermodynamic stability correlates primarily with unfolding rate rather than folding rate. The study also has implications for the question of whether opening of FNIII domains contributes to the stretching of fibronectin matrix fibrils.	[Shah, Riddhi; Erickson, Harold P.; Oas, Terrence G.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Ohashi, Tomoo; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Erickson, HP (corresponding author), Duke Univ, Dept Cell Biol, 412 Nanaline Duke Bldg, Durham, NC 27710 USA.; Erickson, HP; Oas, TG (corresponding author), Duke Univ, Dept Biochem, 412 Nanaline Duke Bldg, Durham, NC 27710 USA.	h.erickson@cellbio.duke.edu; oas@duke.edu			National Institutes of Health [CA 47056]; NATIONAL CANCER INSTITUTE [R01CA047056, R37CA047056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant CA 47056 (to H. P. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AUKHIL I, 1993, J BIOL CHEM, V268, P2542; BALLERY N, 1993, BIOCHEMISTRY-US, V32, P708, DOI 10.1021/bi00053a040; BALLERY N, 1990, PROTEIN ENG, V3, P199, DOI 10.1093/protein/3.3.199; Broom A, 2015, PROTEIN SCI, V24, P580, DOI 10.1002/pro.2606; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Clarke J, 1997, J MOL BIOL, V270, P771, DOI 10.1006/jmbi.1997.1147; Cota E, 2000, J MOL BIOL, V302, P713, DOI 10.1006/jmbi.2000.4053; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; ERICKSON HP, 1983, J BIOL CHEM, V258, P4539; Erickson HP, 2002, J MUSCLE RES CELL M, V23, P575, DOI 10.1023/A:1023427026818; Feng ZY, 2001, J MOL BIOL, V314, P153, DOI 10.1006/jmbi.2001.5117; Gualfetti PJ, 1999, PROTEIN SCI, V8, P1623, DOI 10.1110/ps.8.8.1623; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jensen KS, 2014, BIOCHEMISTRY-US, V53, P2533, DOI 10.1021/bi4016633; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Lemmon CA, 2011, J BIOL CHEM, V286, P26375, DOI 10.1074/jbc.M111.240028; Malhotra P, 2014, BIOCHEMISTRY-US, V53, P3608, DOI 10.1021/bi401493t; Maurer LM, 2016, CRIT REV BIOCHEM MOL, V51, P213, DOI 10.1080/10409238.2016.1184224; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153; Plaxco KW, 1997, J MOL BIOL, V270, P763, DOI 10.1006/jmbi.1997.1148; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Pogliani L, 1996, J MATH CHEM, V20, P193, DOI 10.1007/BF01165164; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Sivakumar P, 2006, J CELL SCI, V119, P1350, DOI 10.1242/jcs.02830; SKORSTENGAARD K, 1986, EUR J BIOCHEM, V161, P441, DOI 10.1111/j.1432-1033.1986.tb10464.x; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; SNYDER GH, 1981, BIOCHEMISTRY-US, V20, P6509, DOI 10.1021/bi00526a001; SOTERIOU A, 1993, P ROY SOC B-BIOL SCI, V254, P83, DOI 10.1098/rspb.1993.0130; Sridevi K, 2002, BIOCHEMISTRY-US, V41, P1568, DOI 10.1021/bi011494v; Stine JM, 2015, BIOCHEMISTRY-US, V54, P6724, DOI 10.1021/acs.biochem.5b00818; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Walters J, 2009, METHOD ENZYMOL, V455, P1, DOI 10.1016/S0076-6879(08)04201-8	40	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					955	966		10.1074/jbc.M116.760371	http://dx.doi.org/10.1074/jbc.M116.760371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27909052	Green Published, hybrid			2022-12-28	WOS:000392318700017
J	Yan, ZC; Fang, Q; Liu, Y; Xiao, S; Yang, L; Wang, F; An, CJ; Werren, JH; Ye, GY				Yan, Zhichao; Fang, Qi; Liu, Yang; Xiao, Shan; Yang, Lei; Wang, Fei; An, Chunju; Werren, John H.; Ye, Gongyin			A Venom Serpin Splicing Isoform of the Endoparasitoid Wasp Pteromalus puparum Suppresses Host Prophenoloxidase Cascade by Forming Complexes with Host Hemolymph Proteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANDUCA-SEXTA HEMOLYMPH; CELLULAR IMMUNE-RESPONSES; PIERIS-RAPAE LEPIDOPTERA; PARASITOID-WASP; ACTIVATING PROTEINASE; OSTRINIA-FURNACALIS; SERINE PROTEASES; INSECT IMMUNITY; INNATE IMMUNITY; DROSOPHILA	To ensure successful parasitism, parasitoid wasps inject venom along with their eggs into their hosts. The venom serves to suppress host immune responses, including melanization. Venom from Pteromalus puparum, a pupal endoparasitoid, inhibits melanization of host hemolymph in vitro in a dose- dependent manner. Using assay- guided fractionation, a serpin splicing isoform with phenoloxidase inhibitory activity was identified as P. puparum serpin- 1, venom isoform (PpS1V). This serpin gene has 16 predicted splicing isoforms that differ only in the C- terminal region. RT- PCR results show that the specific serpin isoform is differentially expressed in the venom gland. Recombinant PpS1V (rPpS1V) suppresses host prophenoloxidase (PPO) activation rather than inhibiting the phenoloxidase directly. Pulldown assays show that PpS1V forms complexes with two host hemolymph proteins, here named Pieris rapae hemolymph proteinase 8 (PrHP8) and P. rapae prophenoloxidase- activating proteinase 1 (PrPAP1), based on gene sequence blasting and phylogenetic analysis. The role of rPrPAP1 in the PPO activation cascade and its interaction with rPpS1V were confirmed. The stoichiometry of inhibition of PrPAP1 by PpS1V is 2.3. PpS1V also inhibits PPO activation in a non- natural host, Ostrinia furnacalis, through forming a complex with O. furnacalis serine protease 13 (OfSP13), an ortholog to PrPAP1. Our results identify a venom- enriched serpin isoform in P. puparum that inhibits host PPO activation, probably by forming a complex with host hemolymph proteinase PrPAP1.	[Yan, Zhichao; Fang, Qi; Liu, Yang; Xiao, Shan; Yang, Lei; Wang, Fei; Ye, Gongyin] Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Yan, Zhichao; Fang, Qi; Liu, Yang; Xiao, Shan; Yang, Lei; Wang, Fei; Ye, Gongyin] Zhejiang Univ, Minist Agr, Key Lab Agr Entomol, Inst Insect Sci, Hangzhou 310058, Zhejiang, Peoples R China; [An, Chunju] China Agr Univ, Coll Agr & Biotechnol, Dept Entomol, Beijing 100193, Peoples R China; [Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; China Agricultural University; University of Rochester	Ye, GY (corresponding author), Zhejiang Univ, Inst Insect Sci, C1152 Agrobio Complex, Hangzhou 310058, Zhejiang, Peoples R China.	chu@zju.edu.cn	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022	Yan, Zhichao/0000-0001-9140-2926	National Natural Science Foundation of China [31272098, 31472038]; Major International (Regional) Joint Research Project of National Natural Science Foundation [31620103915]; China National Science Fund for Distinguished Young Scholars [31025021]; National Institutes of Health [RO1GM098667]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098667] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major International (Regional) Joint Research Project of National Natural Science Foundation; China National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grants 31272098 and 31472038, Major International (Regional) Joint Research Project of National Natural Science Foundation Grant 31620103915, and China National Science Fund for Distinguished Young Scholars Grant 31025021 and by National Institutes of Health Grant RO1GM098667(to J. H. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An CJ, 2011, DEV COMP IMMUNOL, V35, P135, DOI 10.1016/j.dci.2010.09.004; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Asgari S, 2003, INSECT BIOCHEM MOLEC, V33, P1017, DOI 10.1016/S0965-1748(03)00116-4; Asgari S, 2003, ARCH INSECT BIOCHEM, V53, P92, DOI 10.1002/arch.10088; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Bangham J, 2006, IMMUNITY, V25, P1, DOI 10.1016/j.immuni.2006.07.002; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke GR, 2014, MOL ECOL, V23, P890, DOI 10.1111/mec.12648; Cai J, 2004, J INSECT PHYSIOL, V50, P315, DOI 10.1016/j.jinsphys.2004.01.007; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Celli J, 2002, TRENDS MICROBIOL, V10, P232, DOI 10.1016/S0966-842X(02)02343-0; Chu Y, 2015, J INVERTEBR PATHOL, V128, P64, DOI 10.1016/j.jip.2015.02.010; Chu Y, 2015, INSECT BIOCHEM MOLEC, V61, P53, DOI 10.1016/j.ibmb.2015.03.007; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; Colinet D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-342; Colinet D, 2011, J BIOL CHEM, V286, P40110, DOI 10.1074/jbc.M111.288845; Dillman AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002527; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Fang Q, 2011, INSECT BIOCHEM MOLEC, V41, P852, DOI 10.1016/j.ibmb.2011.07.001; Fang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-484; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Goecks J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064125; Gubb D, 2010, BIOCHIMIE, V92, P1749, DOI 10.1016/j.biochi.2010.09.004; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gulley MM, 2013, J INSECT PHYSIOL, V59, P138, DOI 10.1016/j.jinsphys.2012.08.015; Heraty John, 2009, P445, DOI 10.1002/9781444308211.ch19; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang HB, 1996, J BIOL CHEM, V271, P28017, DOI 10.1074/jbc.271.45.28017; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003; Kanost MR, 1997, ADV EXP MED BIOL, V425, P155; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Liu Yu-Qiang, 2014, J Anal Methods Chem, V2014, P617367, DOI 10.1155/2014/617367; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Martinson EO, 2016, MOL BIOL EVOL, V33, P1042, DOI 10.1093/molbev/msv348; Mortimer NT, 2013, P NATL ACAD SCI USA, V110, P9427, DOI 10.1073/pnas.1222351110; Mrinalini A., 2016, EVOLUTION VENOMOUS A, P1, DOI [DOI 10.1007/978-94-007-6727-0_2-2, 10.1007/978-94-007-6727-0_2-2]; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nappi AJ, 2005, J INSECT PHYSIOL, V51, P197, DOI 10.1016/j.jinsphys.2004.10.013; Nielsen-LeRoux C, 2012, CURR OPIN MICROBIOL, V15, P220, DOI 10.1016/j.mib.2012.04.006; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poirie M, 2009, CR BIOL, V332, P311, DOI 10.1016/j.crvi.2008.09.004; Ragan EJ, 2010, J BIOL CHEM, V285, P29642, DOI 10.1074/jbc.M110.125419; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schmidt O, 2001, BIOESSAYS, V23, P344, DOI 10.1002/bies.1049; Siigur E, 2001, GENE, V263, P199, DOI 10.1016/S0378-1119(00)00571-0; Soderhall I, 2009, J BIOL CHEM, V284, P6301, DOI 10.1074/jbc.M806764200; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; Takahashi D, 2015, P NATL ACAD SCI USA, V112, P13856, DOI 10.1073/pnas.1517236112; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Vaiyapuri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021532; Vavricka CJ, 2010, PROTEIN CELL, V1, P830, DOI 10.1007/s13238-010-0109-8; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wong ESW, 2012, GENE, V496, P1, DOI 10.1016/j.gene.2012.01.009; Yan ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19604; Zhang GM, 2004, INSECT BIOCHEM MOLEC, V34, P477, DOI 10.1016/j.ibmb.2004.02.009; Zhang Z, 2005, TOXICON, V46, P337, DOI 10.1016/j.toxicon.2005.05.005; Zheng YP, 2009, COMP BIOCHEM PHYS B, V154, P165, DOI 10.1016/j.cbpb.2009.05.016; Zhu JY, 2008, MICRON, V39, P926, DOI 10.1016/j.micron.2007.11.005; Zhu JY, 2009, ARCH INSECT BIOCHEM, V71, P45, DOI 10.1002/arch.20304; Zhu Y, 2015, ARCH INSECT BIOCHEM, V90, P140, DOI 10.1002/arch.21250; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	79	29	36	5	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1038	1051		10.1074/jbc.M116.739565	http://dx.doi.org/10.1074/jbc.M116.739565			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27913622	Green Published, hybrid			2022-12-28	WOS:000392318700023
J	Kang, I; Harten, IA; Chang, MY; Braun, KR; Sheih, A; Nivison, MP; Johnson, PY; Workman, G; Kaber, G; Evanko, SP; Chan, CK; Merrilees, MJ; Ziegler, SF; Kinsella, MG; Frevert, CW; Wight, TN				Kang, Inkyung; Harten, Ingrid A.; Chang, Mary Y.; Braun, Kathleen R.; Sheih, Alyssa; Nivison, Mary P.; Johnson, Pamela Y.; Workman, Gail; Kaber, Gernot; Evanko, Stephen P.; Chan, Christina K.; Merrilees, Mervyn J.; Ziegler, Steven F.; Kinsella, Michael G.; Frevert, Charles W.; Wight, Thomas N.			Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY SMOOTH-MUSCLE; NF-KAPPA-B; CHONDROITIN SULFATE PROTEOGLYCANS; DOUBLE-STRANDED-RNA; HYALURONAN SYNTHESIS; TOLL-LIKE; PATTERN-RECOGNITION; NLRP3 INFLAMMASOME; CELLS; ASTHMA	Viral infection is an exacerbating factor contributing to chronic airway diseases, such as asthma, via mechanisms that are still unclear. Polyinosine-polycytidylic acid (poly(I:C)), a Toll-like receptor 3 (TLR3) agonist used as a mimetic to study viral infection, has been shown to elicit inflammatory responses in lungs and to exacerbate pulmonary allergic reactions in animal models. Previously, we have shown that poly(I:C) stimulates lung fibroblasts to accumulate an extracellular matrix (ECM), enriched in hyaluronan (HA) and its binding partner versican, which promotes monocyte adhesion. In the current study, we aimed to determine the in vivo role of versican in mediating inflammatory responses in poly(I:C)-induced lung inflammation using a tamoxifen-inducible versican-deficient mouse model (Vcan(-/-) mice). In C57Bl/6 mice, poly(I:C) instillation significantly increased accumulation of versican and HA, especially in the perivascular and peribronchial regions, which were enriched in infiltrating leukocytes. In contrast, versican-deficient (Vcan(-/-)) lungs did not exhibit increases in versican or HA in these regions and had strikingly reduced numbers of leukocytes in the bronchoalveolar lavage fluid and lower expression of inflammatory chemokines and cytokines. Poly(I:C) stimulation of lung fibroblasts isolated from control mice generated HA-enriched cable structures in the ECM, providing a substrate for monocytic cells in vitro, whereas lung fibroblasts from Vcan(-/-) mice did not. Moreover, increases in proinflammatory cytokine expression were also greatly attenuated in the Vcan(-/-) lung fibroblasts. These findings provide strong evidence that versican is a critical inflammatory mediator during poly(I:C)induced acute lung injury and, in association with HA, generates an ECM that promotes leukocyte infiltration and adhesion.	[Kang, Inkyung; Harten, Ingrid A.; Braun, Kathleen R.; Nivison, Mary P.; Johnson, Pamela Y.; Workman, Gail; Kaber, Gernot; Evanko, Stephen P.; Chan, Christina K.; Kinsella, Michael G.; Wight, Thomas N.] Benaroya Res Inst, Matrix Biol Program, Seattle, WA 98101 USA; [Sheih, Alyssa; Ziegler, Steven F.] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [Chang, Mary Y.; Frevert, Charles W.; Wight, Thomas N.] Univ Washington, Dept Comparat Med, Seattle, WA 98109 USA; [Chang, Mary Y.; Frevert, Charles W.; Wight, Thomas N.] Univ Washington, Ctr Lung Biol, Seattle, WA 98109 USA; [Merrilees, Mervyn J.] Univ Auckland, Sch Med Sci, Dept Anat & Med Imaging, Auckland 1010, New Zealand; [Nivison, Mary P.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Kaber, Gernot] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Benaroya Research Institute; Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Auckland; University of Washington; University of Washington Seattle; Stanford University	Wight, TN (corresponding author), Benaroya Res Inst Virginia Mason, Matrix Biol Program, 1201 Ninth Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org			National Institutes of Health [P30 DK17047]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR030249] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068731, U19AI125378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Richard D. Palmiter (Howard Hughes Medical Institute and University of Washington) and Robert J. Hunter (University of Washington) for expert guidance in the development of Vcan e4<SUP>fl/fl</SUP> mice and Dr. Virginia M. Green for careful reading and editing of the manuscript. National Institutes of Health Grant P30 DK17047 (University of Washington Diabetes Research Center) provided Core support.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Andersson-Sjoland A, 2015, GLYCOBIOLOGY, V25, P243, DOI 10.1093/glycob/cwu120; Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807; Ayars AG, 2013, INT ARCH ALLERGY IMM, V161, P65, DOI 10.1159/000343031; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bensadoun ES, 1996, AM J RESP CRIT CARE, V154, P1819, DOI 10.1164/ajrccm.154.6.8970376; Bogels M, 2012, ONCOIMMUNOLOGY, V1, P798, DOI 10.4161/onci.20427; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Chang MY, 2014, MATRIX BIOL, V34, P1, DOI 10.1016/j.matbio.2014.01.011; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; Clarke DL, 2014, CLIN SCI, V126, P567, DOI 10.1042/CS20130149; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Evanko SP, 2009, J HISTOCHEM CYTOCHEM, V57, P1041, DOI 10.1369/jhc.2009.953802; Faggian J, 2007, AM J PHYSIOL-REG I, V293, pR784, DOI 10.1152/ajpregu.00801.2006; Fanhchaksai K, 2016, INT J CANCER, V138, P630, DOI 10.1002/ijc.29804; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Han Hongwei, 2013, Bio Protoc, V3; Hascall V. C., 2002, HYALURONAN CHEM BIOC, P381; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Hope C, 2014, BLOOD, V123, P3305, DOI 10.1182/blood-2014-02-554071; Huang J, 1999, AM J RESP CRIT CARE, V160, P725, DOI 10.1164/ajrccm.160.2.9809040; Johnson PRA, 2001, CLIN EXP PHARMACOL P, V28, P233, DOI 10.1046/j.1440-1681.2001.03426.x; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Kang I, 2014, J BIOL CHEM, V289, P15393, DOI 10.1074/jbc.M113.544338; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kurai D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00293; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lauer ME, 2009, J BIOL CHEM, V284, P5299, DOI 10.1074/jbc.M807965200; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Li D, 2013, 2013 INTERNATIONAL CONFERENCE ON VIRTUAL REALITY AND VISUALIZATION (ICVRV 2013), P37, DOI 10.1109/ICVRV.2013.14; Lowry MH, 2008, AM J RESP CELL MOL, V38, P509, DOI 10.1165/rcmb.2007-0128OC; Ludwig MS, 2004, CLIN EXP ALLERGY, V34, P926, DOI 10.1111/j.1365-2222.2004.01980.x; Malmstrom J, 2002, PROTEOMICS, V2, P394, DOI 10.1002/1615-9861(200204)2:4<394::AID-PROT394>3.0.CO;2-6; Masuda A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4251; Matsushita MD, 2005, J PATHOL, V207, P102, DOI 10.1002/path.1818; Merrilees MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-41; Merrilees MJ, 2004, J PATHOL, V203, P653, DOI 10.1002/path.1577; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Morales MMB, 2011, CRIT CARE, V15, DOI 10.1186/cc9401; Moreth K, 2014, MATRIX BIOL, V35, P143, DOI 10.1016/j.matbio.2014.01.010; Ohkawa T, 1999, BBA-MOL CELL RES, V1448, P416, DOI 10.1016/S0167-4889(98)00155-4; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Potter-Perigo S, 2010, AM J RESP CELL MOL, V43, P109, DOI 10.1165/rcmb.2009-0081OC; Reeves SR, 2016, J HISTOCHEM CYTOCHEM, V64, P364, DOI 10.1369/0022155416642989; ROBERTS CR, 1995, CHEST, V107, pS111, DOI 10.1378/chest.107.3_Supplement.111S; Said N, 2012, ONCOIMMUNOLOGY, V1, P1175, DOI 10.4161/onci.20594; Said N, 2012, J CLIN INVEST, V122, P1503, DOI 10.1172/JCI61392; Saraya T, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00226; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schonherr E, 1997, ARCH BIOCHEM BIOPHYS, V339, P353, DOI 10.1006/abbi.1996.9854; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Shannon JM, 2003, AM J PHYSIOL-LUNG C, V285, pL1323, DOI 10.1152/ajplung.00226.2003; Shibata T, 2014, J IMMUNOL, V192, P3569, DOI 10.4049/jimmunol.1302766; Shih SC, 2005, EXP MOL PATHOL, V79, P14, DOI 10.1016/j.yexmp.2005.03.004; Snyder JM, 2015, J HISTOCHEM CYTOCHEM, V63, P952, DOI 10.1369/0022155415610383; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Tan WC, 2005, CURR OPIN PULM MED, V11, P21; Tang M, 2015, CELL REP, V13, P2851, DOI 10.1016/j.celrep.2015.11.053; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang W, 2009, ARCH MED RES, V40, P321, DOI 10.1016/j.arcmed.2009.04.005; Weitoft M, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-67; Westergren-Thorsson G, 2002, INT J BIOCHEM CELL B, V34, P1256, DOI 10.1016/S1357-2725(02)00058-4; Wight TN, 2014, MATRIX BIOL, V35, P152, DOI 10.1016/j.matbio.2014.01.015; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; Zhang ZW, 2012, INT J MOL SCI, V13, P6873, DOI 10.3390/ijms13066873; Zhu Z, 2002, J IMMUNOL, V168, P2953, DOI 10.4049/jimmunol.168.6.2953	77	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					51	63		10.1074/jbc.M116.753186	http://dx.doi.org/10.1074/jbc.M116.753186			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895126	Green Published, hybrid			2022-12-28	WOS:000391578000005
J	Makins, C; Ghosh, S; Roman-Melendez, GD; Malec, PA; Kennedy, RT; Marsh, ENG				Makins, Caitlyn; Ghosh, Soumi; Roman-Melendez, Gabriel D.; Malec, Paige A.; Kennedy, Robert T.; Marsh, E. Neil G.			Does Viperin Function as a Radical S-Adenosyl-L-methionine-dependent Enzyme in Regulating Farnesylpyrophosphate Synthase Expression and Activity?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-INDUCIBLE PROTEIN; ADENOSYLMETHIONINE ENZYMES; VIRUS-REPLICATION; SAM SUPERFAMILY; BOND FORMATION; BIOSYNTHESIS; ELONGATOR; MECHANISM; INFECTION; DOMAIN	Viperin is an endoplasmic reticulum-associated antiviral responsive protein that is highly up-regulated in eukaryotic cells upon viral infection through both interferon-dependent and independent pathways. Viperin is predicted to be a radical S-adenosyl-L-methionine (SAM) enzyme, but it is unknown whether viperin actually exploits radical SAM chemistry to exert its antiviral activity. We have investigated the interaction of viperin with its most firmly established cellular target, farnesyl pyrophosphate synthase (FPPS). Numerous enveloped viruses utilize cholesterol-rich lipid rafts to bud from the host cell membrane, and it is thought that by inhibiting FPPS activity (and therefore cholesterol synthesis), viperin retards viral budding from infected cells. We demonstrate that, consistent with this hypothesis, overexpression of viperin in human embryonic kidney cells reduces the intracellular rate of accumulation of FPPS but does not inhibit or inactivate FPPS. The endoplasmic reticulum-localizing, N-terminal amphipathic helix of viperin is specifically required for viperin to reduce cellular FPPS levels. However, although viperin reductively cleaves SAM to form 5'-deoxyadenosine in a slow, uncoupled reaction characteristic of radical SAM enzymes, this cleavage reaction is independent of FPPS. Furthermore, mutation of key cysteinyl residues ligating the catalytic [Fe4S4] cluster in the radical SAM domain, surprisingly, does not abolish the inhibitory activity of viperin against FPPS; indeed, some mutations potentiate viperin activity. These observations imply that viperin does not act as a radical SAM enzyme in regulating FPPS.	[Makins, Caitlyn; Ghosh, Soumi; Roman-Melendez, Gabriel D.; Malec, Paige A.; Kennedy, Robert T.; Marsh, E. Neil G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Makins, Caitlyn; Marsh, E. Neil G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Marsh, ENG (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	nmarsh@umich.edu		Malec, Paige/0000-0002-9853-6078; Ghosh, Soumi/0000-0001-6101-0147	National Institutes of Health [GM 093088, DK 046960]; Natural Sciences and Engineering Research Council of Canada; National Science Foundation Award [DBI-0959823]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046960, R37DK046960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM 093088 (to E. N. G. M.) and DK 046960 (to R. T. K.), a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (to C. M.), and National Science Foundation Award DBI-0959823 (to the SMART Center of the University of Michigan). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BALLINGER MD, 1992, BIOCHEMISTRY-US, V31, P949, DOI 10.1021/bi00119a001; Bonissone S, 2013, MOL CELL PROTEOMICS, V12, P14, DOI 10.1074/mcp.M112.019075; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Coquille S, 2013, J STRUCT BIOL, V184, P438, DOI 10.1016/j.jsb.2013.10.005; Davidson VL, 2012, BBA-PROTEINS PROTEOM, V1824, P1299, DOI 10.1016/j.bbapap.2012.01.008; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Fluhe L, 2013, CURR OPIN CHEM BIOL, V17, P605, DOI 10.1016/j.cbpa.2013.06.031; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Fugate CJ, 2012, BBA-PROTEINS PROTEOM, V1824, P1213, DOI 10.1016/j.bbapap.2012.01.010; Fujimori DG, 2013, CURR OPIN CHEM BIOL, V17, P597, DOI 10.1016/j.cbpa.2013.05.032; Greenwood C, 2009, J BIOL CHEM, V284, P141, DOI 10.1074/jbc.M805312200; Haldar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031797; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Marsh ENG, 2010, CHEMBIOCHEM, V11, P604, DOI 10.1002/cbic.200900777; Miskiewicz K, 2011, NEURON, V72, P776, DOI 10.1016/j.neuron.2011.10.010; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Roach PL, 2011, CURR OPIN CHEM BIOL, V15, P267, DOI 10.1016/j.cbpa.2010.11.015; Ruszczycky MW, 2012, BBA-PROTEINS PROTEOM, V1824, P1231, DOI 10.1016/j.bbapap.2011.11.006; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Selvadurai K, 2014, NAT CHEM BIOL, V10, P810, DOI [10.1038/nchembio.1610, 10.1038/NCHEMBIO.1610]; Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Tsoumpra MK, 2015, BONE, V81, P478, DOI 10.1016/j.bone.2015.08.020; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wong JMT, 2016, J CHROMATOGR A, V1446, P78, DOI 10.1016/j.chroma.2016.04.006; Yang LL, 2012, BIOCHEMISTRY-US, V51, P7173, DOI 10.1021/bi3010945; Young AP, 2013, CURR OPIN CHEM BIOL, V17, P613, DOI 10.1016/j.cbpa.2013.05.035; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	39	23	23	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26806	26815		10.1074/jbc.M116.751040	http://dx.doi.org/10.1074/jbc.M116.751040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27834682	hybrid, Green Published			2022-12-28	WOS:000391571400019
J	Chen, H; Dutta, T; Deutscher, MP				Chen, Hua; Dutta, Tanmay; Deutscher, Murray P.			Growth Phase-dependent Variation of RNase BN/Z Affects Small RNAs REGULATION OF 6S RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; 6S RNA; BACILLUS-SUBTILIS; BN/RNASE Z; PROCESSING ENZYME; MESSENGER-RNA; IN-VIVO; POLYMERASE; SEQUENCE; TRANSCRIPTION	RNase BN, the RNase Z family member in E. coli, can participate in the processing of tRNA precursors. However, this function only becomes apparent when other processing enzymes are absent, raising the question of its primary physiological role. Here, we show that RNase BN itself is subject to growth phase-dependent regulation, because both rbn mRNA and RNase BN protein are at their highest levels in early exponential phase, but then decrease dramatically and are essentially absent in stationary phase. As a consequence of this variation, certain small RNAs, such as 6S RNA, remain low in exponential phase cells, and increase greatly in stationary phase. RNase BN affects 6S RNA abundance by decreasing its stability in exponential phase. RNase BN levels increase rapidly as cells exit stationary phase and are primarily responsible for the decrease in 6S RNA that accompanies this process. Purified RNase BN directly cleaves 6S RNA as shown by in vitro assays, and the 6S RNA: pRNA duplex is an even more favorable substrate of RNase BN. The exoribonuclease activity of RNase BN is unnecessary because all its action on 6S RNA is due to endonucleolytic cleavages. These data indicate that RNase BN plays an important role in determining levels of the global transcription regulator, 6S RNA, throughout the growth cycle.	[Chen, Hua; Dutta, Tanmay; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	m.deutscher@med.miami.edu	Dutta, Tanmay/ABH-2431-2021		National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM16317 (to M. P. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; Beckmann BM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq437; Beckmann BM, 2012, EMBO J, V31, P1727, DOI 10.1038/emboj.2012.23; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cavanagh AT, 2014, ANNU REV MICROBIOL, V68, P45, DOI 10.1146/annurev-micro-092611-150135; Cavanagh AT, 2012, NUCLEIC ACIDS RES, V40, P2234, DOI 10.1093/nar/gkr1003; Chen CL, 2010, RNA, V16, P667, DOI 10.1261/rna.1981010; Deutscher MP, 2015, FEMS MICROBIOL REV, V39, P350, DOI 10.1093/femsre/fuv012; Dutta T, 2013, J BIOL CHEM, V288, P30636, DOI 10.1074/jbc.M113.514570; Dutta T, 2012, J BIOL CHEM, V287, P35747, DOI 10.1074/jbc.M112.407403; Dutta T, 2010, J BIOL CHEM, V285, P22872, DOI 10.1074/jbc.M110.141101; Fadouloglou VE, 2015, FEBS J, V282, P4548, DOI 10.1111/febs.13516; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; Kim KS, 2004, NUCLEIC ACIDS RES, V32, P6057, DOI 10.1093/nar/gkh939; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lee JY, 2013, MOL CELLS, V36, P227, DOI 10.1007/s10059-013-0082-1; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Perwez T, 2006, MOL MICROBIOL, V60, P723, DOI 10.1111/j.1365-2958.2006.05124.x; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Saramago M, 2014, CURR OPIN MICROBIOL, V18, P105, DOI 10.1016/j.mib.2014.02.009; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Song LM, 2016, NUCLEIC ACIDS RES, V44, P1979, DOI 10.1093/nar/gkw053; Stead MB, 2011, NUCLEIC ACIDS RES, V39, P3188, DOI 10.1093/nar/gkq1242; Viegas SC, 2008, RNA BIOL, V5, P230, DOI 10.4161/rna.6915; Wassarman KM, 2006, SCIENCE, V314, P1601, DOI 10.1126/science.1134830; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Zhou H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5884; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	34	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26435	26442		10.1074/jbc.M116.757450	http://dx.doi.org/10.1074/jbc.M116.757450			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27875308	hybrid, Green Published			2022-12-28	WOS:000391568200017
J	Lopata, A; Leveles, I; Bendes, AA; Viskolcz, B; Vertessy, BG; Jojart, B; Toth, J				Lopata, Anna; Leveles, Ibolya; Bendes, Abris Adam; Viskolcz, Bela; Vertessy, Beata G.; Jojart, Balazs; Toth, Judit			A Hidden Active Site in the Potential Drug Target Mycobacterium tuberculosis dUTPase Is Accessible through Small Amplitude Protein Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PHOSPHATE ESTER HYDROLYSIS; INFECTIOUS-ANEMIA VIRUS; ESCHERICHIA-COLI; CATALYTIC MECHANISM; RANDOM ACCELERATION; C-TERMINUS; CYTOCHROME P450CAM; TRIMERIC DUTPASES; COUPLED RECEPTOR	dUTPases catalyze the hydrolysis of dUTP into dUMP and pyrophosphate to maintain the proper nucleotide pool for DNA metabolism. Recent evidence suggests that dUTPases may also represent a selective drug target in mycobacteria because of the crucial role of these enzymes in maintaining DNA integrity. Nucleotide-hydrolyzing enzymes typically harbor a buried ligand-binding pocket at interdomain or intersubunit clefts, facilitating proper solvent shielding for the catalyzed reaction. The mechanism by which substrate binds this hidden pocket and product is released in dUTPases is unresolved because of conflicting crystallographic and spectroscopic data. We sought to resolve this conflict by using a combination of random acceleration molecular dynamics (RAMD) methodology and structural and biochemical methods to study the dUTPase from Mycobacterium tuberculosis. In particular, the RAMD approach used in this study provided invaluable insights into the nucleotide dissociation process that reconciles all previous experimental observations. Specifically, our data suggest that nucleotide binding takes place as a small stretch of amino acids transiently slides away and partially uncovers the active site. The in silico data further revealed a new dUTPase conformation on the pathway to a relatively open active site. To probe this model, we developed the Trp(21) reporter and collected crystallographic, spectroscopic, and kinetic data that confirmed the interaction of Trp(21) with the active site shielding C-terminal arm, suggesting that the RAMD method is effective. In summary, our computational simulations and spectroscopic results support the idea that small loop movements in dUTPase allow the shuttling of the nucleotides between the binding pocket and the solvent.	[Lopata, Anna; Leveles, Ibolya; Bendes, Abris Adam; Vertessy, Beata G.; Toth, Judit] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary; [Viskolcz, Bela] Univ Miskolc, Inst Chem, H-3529 Miskolc, Hungary; [Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol, H-1111 Budapest, Hungary; [Jojart, Balazs] Univ Szeged, Dept Chem Informat, H-6725 Szeged, Hungary; [Lopata, Anna] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Lopata, Anna] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Bendes, Abris Adam] Univ Oulu, Fac Biochem & Mol Med, Oulu 90014, Finland; [Bendes, Abris Adam] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Miskolc; Budapest University of Technology & Economics; Szeged University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Leeds; University of Oulu; University of Oulu	Toth, J (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary.	toth.judit@ttk.mta.hu	Viskolcz, Bela/R-3927-2017; Viskolcz, Béla/Q-6225-2019; Vertessy, Beata G/H-6202-2012	Viskolcz, Bela/0000-0002-0777-9569; Viskolcz, Béla/0000-0002-0777-9569; Vertessy, Beata G./0000-0002-1288-2982; Bendes, Abris Adam/0000-0002-1335-6183	National Institutes of Health [1R01TW008130]; National Research, Development and Innovation Office Hungarian Scientific Research Fund Grants OTKA [K109486, K115993, K119493]; Hungarian Academy of Sciences MedInProt Program; International Centre for Genetic Engineering and Biotechnology (ICGEB) Research Grant [CRP/HUN14-01]; Hungarian Scientific Research Funds; Hungarian Academy of Sciences; FOGARTY INTERNATIONAL CENTER [R01TW008130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research, Development and Innovation Office Hungarian Scientific Research Fund Grants OTKA; Hungarian Academy of Sciences MedInProt Program; International Centre for Genetic Engineering and Biotechnology (ICGEB) Research Grant; Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Institutes of Health Grant 1R01TW008130; National Research, Development and Innovation Office Hungarian Scientific Research Fund Grants OTKA K109486, K115993, and K119493; the Hungarian Academy of Sciences MedInProt Program; International Centre for Genetic Engineering and Biotechnology (ICGEB) Research Grant CRP/HUN14-01; and Hungarian Scientific Research Funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. To whom correspondence should be addressed: Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudosok korutja 2, Budapest, Hungary, H1117. Tel.: 36-1-3826707; Fax: 36-1-4631401; E-mail: toth.judit@ttk.mta.hu.	Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Barabas O, 2004, J BIOL CHEM, V279, P42907, DOI 10.1074/jbc.M406135200; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Chan S, 2004, J MOL BIOL, V341, P503, DOI 10.1016/j.jmb.2004.06.028; Cojocaru V, 2012, CURR DRUG METAB, V13, P143, DOI 10.2174/138920012798918462; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fiser A, 2000, BIOCHEM BIOPH RES CO, V279, P534, DOI 10.1006/bbrc.2000.3994; Freeman L, 2009, J BIOL CHEM, V284, P25280, DOI 10.1074/jbc.M109.019315; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Garcia-Nafria J, 2010, ACTA CRYSTALLOGR D, V66, P953, DOI 10.1107/S0907444910026272; Gervasio FL, 2006, J MOL BIOL, V361, P390, DOI 10.1016/j.jmb.2006.06.034; Gonzalez A, 2001, ACTA CRYSTALLOGR D, V57, P767, DOI 10.1107/S0907444901004255; Grazioso G, 2012, J AM CHEM SOC, V134, P453, DOI 10.1021/ja208485w; Hill RLL, 2016, J MOL BIOL, V428, P142, DOI 10.1016/j.jmb.2015.11.009; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalyaanamoorthy S, 2012, J CHEM INF MODEL, V52, P589, DOI 10.1021/ci200584f; Klvana M, 2009, J MOL BIOL, V392, P1339, DOI 10.1016/j.jmb.2009.06.076; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Ludemann SK, 2000, J MOL BIOL, V303, P813, DOI 10.1006/jmbi.2000.4155; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mol CD, 1996, STRUCTURE, V4, P1077, DOI 10.1016/S0969-2126(96)00114-1; Muha V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002738; Nemeth-Pongracz V, 2007, NUCLEIC ACIDS RES, V35, P495, DOI 10.1093/nar/gkl1074; Niu YZ, 2016, PHYS CHEM CHEM PHYS, V18, P5622, DOI 10.1039/c5cp06257h; Nord J, 2001, FEBS LETT, V492, P228, DOI 10.1016/S0014-5793(01)02257-8; Nord J, 2000, FEBS LETT, V472, P312, DOI 10.1016/S0014-5793(00)01453-8; Pecsi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037461; Pecsi I, 2011, P NATL ACAD SCI USA, V108, P14437, DOI 10.1073/pnas.1013872108; Pecsi I, 2010, NUCLEIC ACIDS RES, V38, P7179, DOI 10.1093/nar/gkq584; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pietra F, 2013, CHEM BIODIVERS, V10, P556, DOI 10.1002/cbdv.201200434; Prasad GS, 2000, ACTA CRYSTALLOGR D, V56, P1100, DOI 10.1107/S0907444900009197; Sablin EP, 2001, CURR OPIN STRUC BIOL, V11, P716, DOI 10.1016/S0959-440X(01)00265-2; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Shao H, 1997, BBA-PROTEIN STRUCT M, V1339, P181, DOI 10.1016/S0167-4838(96)00229-4; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Szabo JE, 2014, NUCLEIC ACIDS RES, V42, P11912, DOI 10.1093/nar/gku882; Takacs E, 2010, FEBS LETT, V584, P3047, DOI 10.1016/j.febslet.2010.05.018; Takacs E, 2009, FEBS LETT, V583, P865, DOI 10.1016/j.febslet.2009.02.011; Tarbouriech N, 2005, STRUCTURE, V13, P1299, DOI 10.1016/j.str.2005.06.009; Thomas T, 2016, J CHEM INF MODEL, V56, P308, DOI 10.1021/acs.jcim.5b00457; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Vertessy BG, 1997, PROTEINS, V28, P568, DOI 10.1002/(SICI)1097-0134(199708)28:4<568::AID-PROT10>3.0.CO;2-E; Vertessy BG, 1998, FEBS LETT, V421, P83, DOI 10.1016/S0014-5793(97)01545-7; Wang T, 2007, J AM CHEM SOC, V129, P6970, DOI 10.1021/ja0691977; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang SW, 2016, BBA-PROTEINS PROTEOM, V1864, P42, DOI 10.1016/j.bbapap.2015.10.007; Zhang JQ, 2015, SOFT MATTER, V11, P6633, DOI 10.1039/c5sm01028d; Zhuang SL, 2013, J MOL GRAPH MODEL, V44, P155, DOI 10.1016/j.jmgm.2013.06.001	66	7	7	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26320	26331		10.1074/jbc.M116.734012	http://dx.doi.org/10.1074/jbc.M116.734012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27815500	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000391568200007
J	Gray, P; Dunne, A; Brikos, C; Jefferies, CA; Doyle, SL; O'Neill, LAJ				Gray, Pearl; Dunne, Aisling; Brikos, Constantinos; Jefferies, Caroline A.; Doyle, Sarah L.; O'Neill, Luke A. J.			MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction (vol 281, pg 10489, 2006)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Jefferies, Caroline/AAI-1543-2021	Jefferies, Caroline/0000-0002-8879-6722; dunne, aisling/0000-0002-2342-9518; O'Neill, Luke/0000-0002-4333-2748				Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200	1	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26240	26240		10.1074/jbc.A116.508892	http://dx.doi.org/10.1074/jbc.A116.508892			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27941071	hybrid, Green Published			2022-12-28	WOS:000390345200040
J	Zaganelli, S; Rebelo-Guiomar, P; Maundrell, K; Rozanska, A; Pierredon, S; Powell, CA; Jourdain, AA; Hulo, N; Lightowlers, RN; Chrzanowska-Lightowlers, ZM; Minczuk, M; Martinou, JC				Zaganelli, Sofia; Rebelo-Guiomar, Pedro; Maundrell, Kinsey; Rozanska, Agata; Pierredon, Sandra; Powell, Christopher A.; Jourdain, Alexis A.; Hulo, Nicolas; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M.; Minczuk, Michal; Martinou, Jean-Claude			The Pseudouridine Synthase RPUSD4 Is an Essential Component of Mitochondrial RNA Granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MESSENGER-RNA; NUCLEOTIDE RESOLUTION; LARGE SUBUNIT; HUMAN-CELLS; MUTATIONS; PROTEINS; RIBOSOME; BIOGENESIS; RESIDUES	Mitochondrial gene expression is a fundamental process that is largely dependent on nuclear-encoded proteins. Several steps of mitochondrial RNA processing and maturation, including RNA post-transcriptional modification, appear to be spatially organized into distinct foci, which we have previously termed mitochondrial RNA granules (MRGs). Although an increasing number of proteins have been localized to MRGs, a comprehensive analysis of the proteome of these structures is still lacking. Here, we have applied a microscopy-based approach that has allowed us to identify novel components of the MRG proteome. Among these, we have focused our attention on RPUSD4, an uncharacterized mitochondrial putative pseudouridine synthase. We show that RPUSD4 depletion leads to a severe reduction of the steady-state level of the 16S mitochondrial (mt) rRNA with defects in the biogenesis of the mito ribosome large subunit and consequently in mitochondrial translation. We report that RPUSD4 binds 16S mt-rRNA, mttRNA(Met), and mt-tRNA(Phe), and we demonstrate that it is responsible for pseudouridylation of the latter. These data provide new insights into the relevance of RNA pseudouridylation in mitochondrial gene expression.	[Zaganelli, Sofia; Maundrell, Kinsey; Pierredon, Sandra; Jourdain, Alexis A.; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland; [Rebelo-Guiomar, Pedro; Powell, Christopher A.; Minczuk, Michal] Med Res Council Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England; [Rebelo-Guiomar, Pedro] Univ Porto, Grad Program Areas Basic & Appl Biol GABBA, P-4200135 Oporto, Portugal; [Rozanska, Agata; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Hulo, Nicolas] Univ Geneva, Inst Genet & Genom Geneva, CH-1211 Geneva 4, Switzerland; [Jourdain, Alexis A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	University of Geneva; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Universidade do Porto; Newcastle University - UK; University of Geneva; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Martinou, JC (corresponding author), Univ Geneva, Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jean-claude.martinou@unige.ch	Jourdain, Alexis A./ABF-4838-2020; Rebelo-Guiomar, Pedro/AAT-3575-2021; Minczuk, Michal/G-1638-2014	Rebelo-Guiomar, Pedro/0000-0002-5060-7519; Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152; Powell, Christopher/0000-0001-7501-0586; Minczuk, Michal/0000-0001-8242-1420; martinou, Jean-claude/0000-0002-9847-2051; Jourdain, Alexis A./0000-0001-5321-6938; ZAGANELLI, SOFIA/0000-0002-2815-3231; Jourdain, Alexis/0000-0002-1721-8394	Swiss National Science Foundation [SNF310030B_160257/1]; Wellcome Trust [096919/Z/11/Z]; Medical Research Council, UK; Medical Research Council [MC_U105697135, MC_UU_00015/4] Funding Source: researchfish; MRC [MC_UU_00015/4, MC_U105697135] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Swiss National Science Foundation Grant SNF310030B_160257/1, Wellcome Trust Grant 096919/Z/11/Z, and core funding of Medical Research Council, UK. The authors declare that they have no conflicts of interest with the contents of this article.	Antonicka H, 2017, EMBO REP, V18, P28, DOI 10.15252/embr.201643391; Antonicka H, 2015, CELL REP, V10, P920, DOI 10.1016/j.celrep.2015.01.030; Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; Bakin AV, 1998, METH MOL B, V77, P297; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Barrientos A, 2015, ONCOTARGET, V6, P16800, DOI 10.18632/oncotarget.4646; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Dennerlein S, 2010, BIOCHEM J, V430, P551, DOI 10.1042/BJ20100757; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252; Ge JH, 2013, TRENDS BIOCHEM SCI, V38, P210, DOI 10.1016/j.tibs.2013.01.002; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Hallberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Hoang C, 2006, MOL CELL, V24, P535, DOI 10.1016/j.molcel.2006.09.017; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jourdain AA, 2015, CELL REP, V10, P1110, DOI 10.1016/j.celrep.2015.01.063; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Lee KW, 2013, J BIOL CHEM, V288, P31386, DOI 10.1074/jbc.M113.515692; Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200; Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011; Powell CA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00079; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Spenkuch F, 2014, RNA BIOL, V11, P1540, DOI 10.4161/15476286.2014.992278; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wilson WC, 2014, HUM MOL GENET, V23, P6345, DOI 10.1093/hmg/ddu352	38	47	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4519	4532		10.1074/jbc.M116.771105	http://dx.doi.org/10.1074/jbc.M116.771105			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28082677	Green Published, hybrid			2022-12-28	WOS:000397585100011
J	Papaioannou, G; Petit, ET; Liu, ES; Baccarini, M; Pritchard, C; Demay, MB				Papaioannou, Garyfallia; Petit, Elizabeth T.; Liu, Eva S.; Baccarini, Manuela; Pritchard, Catrin; Demay, Marie B.			Raf Kinases Are Essential for Phosphate Induction of ERK1/2 Phosphorylation in Hypertrophic Chondrocytes and Normal Endochondral Bone Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; caspase; chondrocyte; growth plate; Raf kinase; phosphate; rickets	B-RAF; GROWTH-PLATE; PROTEIN-KINASE; CONSTITUTIVE ACTIVATION; CELL-PROLIFERATION; TRANSGENIC MICE; A-RAF; APOPTOSIS; DIFFERENTIATION; EXPRESSION	Hypophosphatemia causes rickets by impairing hypertrophic chondrocyte apoptosis. Phosphate induction of MEK1/2-ERK1/2 phosphorylation in hypertrophic chondrocytes is required for phosphate-mediated apoptosis and growth plate maturation. MEK1/2 can be activated by numerous molecules including Raf isoforms. A- and B-Raf ablation in chondrocytes does not alter skeletal development, whereas ablation of C-Raf decreases hypertrophic chondrocyte apoptosis and impairs vascularization of the growth plate. However, ablation of C-Raf does not impair phosphate-induced ERK1/2 phosphorylation in vitro, but leads to rickets by decreasing VEGF protein stability. To determine whether Raf isoforms are required for phosphate-induced hypertrophic chondrocyte apoptosis, mice lacking all three Raf isoforms in chondrocytes were generated. Raf deletion caused neonatal death and a significant expansion of the hypertrophic chondrocyte layer of the growth plate, accompanied by decreased cleaved caspase-9. This was associated with decreased phospho-ERK1/2 immunoreactivity in the hypertrophic chondrocyte layer and impaired vascular invasion. These data further demonstrated that Raf kinases are required for phosphate-induced ERK1/2 phosphorylation in cultured hypertrophic chondrocytes and perform essential, but partially redundant roles in growth plate maturation.	[Papaioannou, Garyfallia; Petit, Elizabeth T.; Liu, Eva S.; Demay, Marie B.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Papaioannou, Garyfallia; Liu, Eva S.; Demay, Marie B.] Harvard Med Sch, Boston, MA 02115 USA; [Liu, Eva S.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Baccarini, Manuela] Univ Vienna, Dept Microbiol Immunobiol & Genet, Ctr Mol Biol, Max F Perutz Labs, Doktor Bohr Gasse 9, A-1030 Vienna, Austria; [Pritchard, Catrin] Univ Leicester, Dept Mol & Cell Biol, Univ Rd, Leicester LE1 7RH, Leics, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Leicester	Demay, MB (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.; Demay, MB (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	demay@helix.mgh.harvard.edu	; Baccarini, Manuela/B-6481-2014	Pritchard, Catrin/0000-0003-1859-4487; Baccarini, Manuela/0000-0002-3033-391X	National Institutes of Health [P30 AR061313, R01 AR061376]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR067854, P30AR066261, R01AR061376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046974, T32DK007529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P30 AR061313 and R01 AR061376 (to M. B. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Carlevaro MF, 2000, J CELL SCI, V113, P59; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chen ZJ, 2015, J BONE MINER RES, V30, P765, DOI 10.1002/jbmr.2409; Donohue MM, 2002, ENDOCRINOLOGY, V143, P3691, DOI 10.1210/en.2002-220454; Emons JAM, 2006, PEDIATR RES, V60, P288, DOI 10.1203/01.pdr.0000232790.53527.c6; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Jesenberger V, 2001, J EXP MED, V193, P353, DOI 10.1084/jem.193.3.353; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; KANEKO Y, 1994, CALCIFIED TISSUE INT, V54, P426, DOI 10.1007/BF00305531; Kerkhoff E, 1997, MOL CELL BIOL, V17, P2576, DOI 10.1128/MCB.17.5.2576; Kern F, 2013, ONCOGENE, V32, P2483, DOI 10.1038/onc.2012.254; Ko FC, 2016, J BONE MINER RES, V31, P2204, DOI 10.1002/jbmr.2891; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Liu ES, 2016, DEVELOPMENT, V143, P348, DOI 10.1242/dev.127142; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Magudia K, 2012, J CELL BIOL, V198, P185, DOI 10.1083/jcb.201202108; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; Miedlich SU, 2010, J BIOL CHEM, V285, P18270, DOI 10.1074/jbc.M109.098616; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Papaioannou G, 2013, P NATL ACAD SCI USA, V110, pE3291, DOI 10.1073/pnas.1302797110; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; Provot S, 2008, MOL CELL BIOL, V28, P344, DOI 10.1128/MCB.00617-07; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Sebastian A, 2011, J ORTHOP RES, V29, P375, DOI 10.1002/jor.21262; Spirli C, 2012, HEPATOLOGY, V56, P2363, DOI 10.1002/hep.25872; Thiel G, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-8; Urosevic J, 2011, P NATL ACAD SCI USA, V108, P5015, DOI 10.1073/pnas.1016933108; Usmani SE, 2012, BONE, V51, P131, DOI 10.1016/j.bone.2012.04.012; Vakana E., 2016, ONCOTARGET, DOI 10.18632/oncotarget.14002; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7; Yadav V, 2012, J BIOL CHEM, V287, P28087, DOI 10.1074/jbc.M112.377218; Zalutskaya AA, 2009, J CELL BIOCHEM, V108, P668, DOI 10.1002/jcb.22302; Zhang XR, 2011, J BONE MINER RES, V26, P2622, DOI 10.1002/jbmr.502; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820	42	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3164	3171		10.1074/jbc.M116.763342	http://dx.doi.org/10.1074/jbc.M116.763342			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28073913	hybrid, Green Published			2022-12-28	WOS:000395538800010
J	Braganza, A; Li, JF; Zeng, XM; Yates, NA; Dey, NB; Andrews, J; Clark, J; Zamani, L; Wang, XH; St Croix, C; O'Sullivan, R; Garcia-Exposito, L; Brodsky, JL; Sobol, RW				Braganza, Andrea; Li, Jianfeng; Zeng, Xuemei; Yates, Nathan A.; Dey, Nupur B.; Andrews, Joel; Clark, Jennifer; Zamani, Leila; Wang, Xiao-Hong; St Croix, Claudette; O'Sullivan, Roderick; Garcia-Exposito, Laura; Brodsky, Jeffrey L.; Sobol, Robert W.			UBE3B Is a Calmodulin-regulated, Mitochondrion-associated E3 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAUFMAN OCULOCEREBROFACIAL SYNDROME; BASE EXCISION-REPAIR; DNA-POLYMERASE-BETA; INTERACTING PROTEINS; IQ DOMAIN; PROTEASOME; FUSION; MITOPHAGY; SYSTEM; DEGRADATION	Recent genome-wide studies found that patients with hypotonia, developmental delay, intellectual disability, congenital anomalies, characteristic facial dysmorphic features, and low cholesterol levels suffer from Kaufman oculocerebrofacial syndrome (KOS, also reported as blepharophimosis-ptosis-intellectual disability syndrome). The primary cause of KOS is autosomal recessive mutations in the gene UBE3B. However, to date, there are no studies that have determined the cellular or enzymatic function of UBE3B. Here, we report that UBE3B is a mitochondrion-associated protein with homologous to the E6-AP C terminus (HECT) E3 ubiquitin ligase activity. Mutating the catalytic cysteine (C1036A) or deleting the entire HECT domain (amino acids 758-1068) results in loss of UBE3B's ubiquitylation activity. Knockdown of UBE3B in human cells induces changes in mitochondrial morphology and physiology, a decrease in mitochondrial volume, and a severe suppression of cellular proliferation. We also discovered that UBE3B interacts with calmodulin via its N-terminal isoleucine-glutamine (IQ) motif. Deletion of the IQ motif (amino acids 29-58) results in loss of calmodulin binding and a significant increase in the in vitro ubiquitylation activity of UBE3B. In addition, we found that changes in calcium levels in vitro disrupt the calmodulin-UBE3B interaction. These studies demonstrate that UBE3B is an E3 ubiquitin ligase and reveal that the enzyme is regulated by calmodulin. Furthermore, the modulation of UBE3B via calmodulin and calcium implicates a role for calcium signaling in mitochondrial protein ubiquitylation, protein turnover, and disease.	[Braganza, Andrea; O'Sullivan, Roderick; Garcia-Exposito, Laura; Sobol, Robert W.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Braganza, Andrea; Yates, Nathan A.; Wang, Xiao-Hong; O'Sullivan, Roderick; Garcia-Exposito, Laura; Sobol, Robert W.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Zeng, Xuemei; Yates, Nathan A.] Univ Pittsburgh, Sch Hlth Sci, Biomed Mass Spectrometry Ctr, Pittsburgh, PA 15213 USA; [St Croix, Claudette] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15213 USA; [Li, Jianfeng; Dey, Nupur B.; Andrews, Joel; Clark, Jennifer; Zamani, Leila; Sobol, Robert W.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Yates, Nathan A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of South Alabama; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sobol, RW (corresponding author), Univ S Alabama, Mitchell Canc Inst, 1660 Springhill Ave, Mobile, AL 36604 USA.	rwsobol@health.southalabama.edu	St Croix, Claudette/AAA-3338-2022; Sobol, Robert W./E-4125-2013	Sobol, Robert W./0000-0001-7385-3563; Braganza Jardini, Andrea/0000-0002-7391-3658; Garcia Exposito, Laura/0000-0002-8172-7986	National Institutes of Health Cancer Center Support Grant [CA047904]; Abraham A. Mitchell Distinguished Investigator award; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA148629, R01CA207209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM087798, R43GM087798, R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abraham A. Mitchell Distinguished Investigator award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. David Svilar for valuable comments during the preparation of this manuscript and Dr. Qingming Fang, Dr. Elise Fouquerrel, Zhongxun Yu, Ashley Brown, Sandy Schamus, and Morgan Jessup for technical help. The recombinant human ubiquitin expression vector (wild type) was a generous gift from Drs. Fumika Koyano and Noriyuki Matsuda (Tokyo Metropolitan Institute of Medical Science). Support for the University of Pittsburgh Cancer Institute Lentiviral Facility, the Biomedical Mass Spectrometry Center, and the University of Pittsburgh Cancer Institute Cancer Proteomics Facility was provided by the National Institutes of Health Cancer Center Support Grant CA047904. Support for the MCI Gene Expression, Editing, and Discovery Facility was provided by funds from the Abraham A. Mitchell Distinguished Investigator award.	Basel-Vanagaite L, 2014, HUM GENET, V133, P939, DOI 10.1007/s00439-014-1436-2; Basel-Vanagaite L, 2012, AM J HUM GENET, V91, P998, DOI 10.1016/j.ajhg.2012.10.011; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Escobar-Henriques M, 2006, J CELL BIOL, V173, P645, DOI 10.1083/jcb.200512079; Fang QM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6513; Ferree AW, 2013, AUTOPHAGY, V9, P1887, DOI 10.4161/auto.26503; Findeisen F, 2013, J MOL BIOL, V425, P3217, DOI 10.1016/j.jmb.2013.06.024; Fischer C, 2013, PLANT CELL PHYSIOL, V54, P573, DOI 10.1093/pcp/pct021; Flex E, 2013, J MED GENET, V50, P493, DOI 10.1136/jmedgenet-2012-101405; Fouquerel E, 2014, CELL REP, V8, P1819, DOI 10.1016/j.celrep.2014.08.036; Franz A, 2015, CURR OPIN CELL BIOL, V37, P18, DOI 10.1016/j.ceb.2015.08.004; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Goellner EM, 2011, CANCER RES, V71, P2308, DOI 10.1158/0008-5472.CAN-10-3213; Gong TWL, 2003, GENOMICS, V82, P143, DOI 10.1016/S0888-7543(03)00111-3; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang H., 2012, ISPRS, V1-3, P377; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Jang DJ, 2011, MOL CELLS, V32, P511, DOI 10.1007/s10059-011-0109-4; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Laker RC, 2014, J BIOL CHEM, V289, P12005, DOI 10.1074/jbc.M113.530527; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YY, 2015, CELL PROLIFERAT, V48, P338, DOI 10.1111/cpr.12184; Lu Q, 2015, NAT STRUCT MOL BIOL, V22, P81, DOI 10.1038/nsmb.2923; Miedel MT, 2014, METHODS, V68, P536, DOI 10.1016/j.ymeth.2014.04.019; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; Neutzner Albert, 2007, Novartis Found Symp, V287, P4; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; Pedurupillay CRJ, 2015, AM J MED GENET A, V167, P657, DOI 10.1002/ajmg.a.36944; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374; Svilar D, 2012, MOL CANCER RES, V10, P1580, DOI 10.1158/1541-7786.MCR-12-0168; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tang JB, 2010, MOL CANCER RES, V8, P67, DOI 10.1158/1541-7786.MCR-09-0411; Theivanthiran B, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005903; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Venhoranta H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-890; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wen JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115622; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Xu S, 2016, MOL BIOL CELL, V27, P349, DOI 10.1091/mbc.E15-09-0678	63	19	19	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2470	2484		10.1074/jbc.M116.766824	http://dx.doi.org/10.1074/jbc.M116.766824			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28003368	Green Published, hybrid			2022-12-28	WOS:000395530300034
J	Pereira, N; Cardone, C; Lassoued, S; Galloux, M; Fix, J; Assrir, N; Lescop, E; Bontems, F; Eleouet, JF; Sizun, C				Pereira, Nelson; Cardone, Christophe; Lassoued, Safa; Galloux, Marie; Fix, Jenna; Assrir, Nadine; Lescop, Ewen; Bontems, Francois; Eleouet, Jean-Francois; Sizun, Christina			New Insights into Structural Disorder in Human Respiratory Syncytial Virus Phosphoprotein and Implications for Binding of Protein Partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARAMAGNETIC RELAXATION ENHANCEMENT; MULTIPLE SEQUENCE ALIGNMENTS; P-PROTEIN; N-PROTEIN; FUNCTIONAL-CHARACTERIZATION; POLYMERASE COMPLEX; INFECTED CELLS; M2-1 PROTEIN; RNA; IDENTIFICATION	Phosphoprotein is the main cofactor of the viral RNA polymerase of Mononegavirales. It is involved in multiple interactions that are essential for the polymerase function. Most prominently it positions the polymerase complex onto the nucleocapsid, but also acts as a chaperone for the nucleoprotein. Mononegavirales phosphoproteins lack sequence conservation, but contain all large disordered regions. We show here that Nand Cterminal intrinsically disordered regions account for 80% of the phosphoprotein of the respiratory syncytial virus. But these regions display marked dynamic heterogeneity. Whereas almost stable helices are formed C terminally to the oligomerization domain, extremely transient helices are present in the N terminal region. They all mediate internal long range contacts in this non globular protein. Transient secondary elements together with fully disordered regions also provide protein binding sites recognized by the respiratory syncytial virus nucleoprotein and compatible with weak interactions required for the processivity of the polymerase.	[Pereira, Nelson; Cardone, Christophe; Lassoued, Safa; Assrir, Nadine; Lescop, Ewen; Bontems, Francois; Sizun, Christina] Univ Paris Saclay, CNRS, UPR2301, Inst Chim Subst Nat, F-91190 Gif Sur Yvette, France; [Galloux, Marie; Fix, Jenna; Eleouet, Jean-Francois] INRA, UR892, Unite Virol & Immunol Mol, F-78350 Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Sizun, C (corresponding author), CNRS, ICSN, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	christina.sizun@cnrs.fr	Lescop, Ewen/AAA-8700-2019; Eléouët, Jean-François/AAD-1994-2019	ELeouet, Jean-Francois/0000-0002-7361-4885; ASSRIR, Nadine/0000-0003-1693-7263; Lescop, Ewen/0000-0002-2623-9365; Sizun, Christina/0000-0002-5760-2614	Agence Nationale de la Recherche [ANR-11-BSV8-024-02, ANR-13-ISV3-0007-04]; Institut de Chimie des Substances Naturelles; Region Ile-de-France DIM Malinf	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut de Chimie des Substances Naturelles; Region Ile-de-France DIM Malinf(Region Ile-de-France)	This work was supported by Agence Nationale de la Recherche Grants ANR-11-BSV8-024-02 and ANR-13-ISV3-0007-04 and doctoral fellowships from Institut de Chimie des Substances Naturelles (to N. P.) and Region Ile-de-France DIM Malinf (to S. L. and C. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; Asenjo A, 2008, VIRUS RES, V132, P160, DOI 10.1016/j.virusres.2007.11.013; Asenjo A, 2006, J GEN VIROL, V87, P3637, DOI 10.1099/vir.0.82165-0; Asenjo A, 2016, VIRUS RES, V211, P117, DOI 10.1016/j.virusres.2015.10.011; Bakker SE, 2013, J GEN VIROL, V94, P1734, DOI 10.1099/vir.0.053025-0; Blondot ML, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002734; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Castagne N, 2004, J GEN VIROL, V85, P1643, DOI 10.1099/vir.0.79830-0; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Collins P.L., 2013, FIELDS VIROLOGY, P1086; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Cox R, 2016, EXPERT OPIN DRUG DIS, V11, P543, DOI 10.1517/17460441.2016.1174212; Cox R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00459; Cox R, 2014, P NATL ACAD SCI USA, V111, P15208, DOI 10.1073/pnas.1413268111; Cox R, 2013, J VIROL, V87, P7558, DOI 10.1128/JVI.00653-13; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; Galloux M, 2015, J VIROL, V89, P3484, DOI 10.1128/JVI.03666-14; Galloux M, 2012, J VIROL, V86, P8375, DOI 10.1128/JVI.00058-12; GARCIA J, 1993, VIROLOGY, V195, P243, DOI 10.1006/viro.1993.1366; GarciaBarreno B, 1996, J VIROL, V70, P801; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GROSFELD H, 1995, J VIROL, V69, P5677, DOI 10.1128/JVI.69.9.5677-5686.1995; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Heinrich BS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000958; Karlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031719; Khattar SK, 2001, J GEN VIROL, V82, P775, DOI 10.1099/0022-1317-82-4-775; Kosol S, 2013, MOLECULES, V18, P10802, DOI 10.3390/molecules180910802; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Leyrat C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080371; Lietzow MA, 2002, J MOL BIOL, V322, P655, DOI 10.1016/S0022-2836(02)00847-1; Llorente MT, 2008, PROTEINS, V72, P946, DOI 10.1002/prot.21988; Llorente MT, 2006, J GEN VIROL, V87, P159, DOI 10.1099/vir.0.81430-0; Lu B, 2002, J VIROL, V76, P2871, DOI 10.1128/JVI.76.6.2871-2880.2002; Mason SW, 2003, J VIROL, V77, P10670, DOI 10.1128/JVI.77.19.10670-10676.2003; Mazur N, 2015, LANCET RESP MED, V3, P888, DOI 10.1016/S2213-2600(15)00255-6; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Munday DC, 2015, J VIROL, V89, P917, DOI 10.1128/JVI.01783-14; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Noval MG, 2016, BIOCHEMISTRY-US, V55, P1441, DOI 10.1021/acs.biochem.5b01332; Ouizougun-Oubari M, 2015, J VIROL, V89, P11129, DOI 10.1128/JVI.01612-15; Renner M, 2016, ELIFE, V5, DOI 10.7554/eLife.12627; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger L., 2010, AXPYMOL MOL GRPHICS; Shapiro AB, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0191-2; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simabuco FM, 2011, BRAZ J MICROBIOL, V42, P340, DOI 10.1590/S1517-83822011000100043; Slack MS, 1998, VIRUS RES, V55, P167, DOI 10.1016/S0168-1702(98)00042-2; Sourimant J, 2015, J VIROL, V89, P4421, DOI 10.1128/JVI.03619-14; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tran TL, 2009, J VIROL, V83, P6363, DOI 10.1128/JVI.00335-09; Villanueva N, 2000, J GEN VIROL, V81, P129, DOI 10.1099/0022-1317-81-1-129; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; YU QZ, 1995, J VIROL, V69, P2412, DOI 10.1128/JVI.69.4.2412-2419.1995	58	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2120	2131		10.1074/jbc.M116.765958	http://dx.doi.org/10.1074/jbc.M116.765958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031463	Green Published, hybrid			2022-12-28	WOS:000395530300007
J	Srivastava, S; Katorcha, E; Daus, ML; Lasch, P; Beekes, M; Baskakov, IV				Srivastava, Saurabh; Katorcha, Elizaveta; Daus, Martin L.; Lasch, Peter; Beekes, Michael; Baskakov, Ilia V.			Sialylation Controls Prion Fate in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICULAR DENDRITIC CELLS; SIALIC ACIDS; MASS-SPECTROMETRY; LYMPHOID-TISSUES; SCRAPIE AGENT; FACTOR-H; PROTEIN; INFECTIVITY; CLEARANCE; GLYCANS	Prions or PrPSc are proteinaceous infectious agents that consist of misfolded, self-replicating states of a sialoglycoprotein called the prion protein or PrPC. The current work tests a new hypothesis that sialylation determines the fate of prions in an organism. To begin, we produced control PrPSc from PrPC using protein misfolding cyclic amplification with beads (PMCAb), and also generated PrPSc with reduced sialylation levels using the same method but with partially desialylated PrPC as a substrate (dsPMCAb). Syrian hamsters were inoculated intraperitoneally with brain-derived PrPSc or PrPSc produced in PMCAb or dsPMCAb and then monitored for disease. Animals inoculated with brain-or PMCAb-derived PrPSc developed prion disease, whereas administration of dsPMCAb-derived PrPSc with reduced sialylation did not cause prion disease. Animals inoculated with dsPMCAb-derived material were not subclinical carriers of scrapie, as no PrPSc was detected in brains or spleen of these animals by either Western blotting or after amplification by serial PMCAb. In subsequent experiments, trafficking of brain-, PMCAb-, and dsPMCAb-derived PrPSc to secondary lymphoid organs was monitored in wild type mice. PrPSc sialylation was found to be critical for effective trafficking of PrPSc to secondary lymphoid organs. By 6 hours after inoculation, brain-and PMCAb- derived PrPSc were found in spleen and lymph nodes, whereas dsPMCAb-derived PrPSc was found predominantly in liver. This study demonstrates that the outcome of prion transmission to a wild type host is determined by the sialylation status of the inoculated PrPSc. Furthermore, this work suggests that the sialylation status of PrPSc plays an important role in prion lymphotropism.	[Srivastava, Saurabh; Katorcha, Elizaveta; Baskakov, Ilia V.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, 111 S Penn St, Baltimore, MD 21201 USA; [Srivastava, Saurabh; Katorcha, Elizaveta; Baskakov, Ilia V.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Daus, Martin L.; Lasch, Peter; Beekes, Michael] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, D-13353 Berlin, Germany	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Robert Koch Institute	Baskakov, IV (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, 111 S Penn St, Baltimore, MD 21201 USA.	Baskakov@umaryland.edu	Beekes, Michael/S-1975-2018; Srivastava, Saurabh/L-1188-2017	Beekes, Michael/0000-0002-6454-6657; Srivastava, Saurabh/0000-0003-3159-7826; Lasch, Peter/0000-0001-6193-3144	National Institutes of Health [R01 NS045585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS045585 (to I.V.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; AMINOFF D, 1977, P NATL ACAD SCI USA, V74, P1521, DOI 10.1073/pnas.74.4.1521; Baskakov IV, 2007, BBA-MOL BASIS DIS, V1772, P692, DOI 10.1016/j.bbadis.2006.07.007; Baskakov IV, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3389/fnins.2076.00358, 10.3389/fnins.2016.00358]; Beringue V, 2000, J PATHOL, V190, P495, DOI 10.1002/(SICI)1096-9896(200003)190:4&lt;495::AID-PATH535&gt;3.0.CO;2-T; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; Boerner S, 2013, LAB ANIM-UK, V47, P106, DOI 10.1177/0023677213476856; BOLTON DC, 1985, J VIROL, V53, P596, DOI 10.1128/JVI.53.2.596-606.1985; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; Brown P, 1991, Curr Top Microbiol Immunol, V172, P1; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; CARP RI, 1981, INTERVIROLOGY, V16, P8, DOI 10.1159/000149241; Castro-Seoane R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002538; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Daus ML, 2013, J BIOL CHEM, V288, P35068, DOI 10.1074/jbc.M113.497131; DINI L, 1992, FEBS LETT, V296, P174, DOI 10.1016/0014-5793(92)80373-O; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; Gonzalez-Montalban N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041210; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Halliez S, 2014, J VIROL, V88, P8678, DOI 10.1128/JVI.01118-14; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Jansen AJG, 2012, BLOOD, V119, P1263, DOI 10.1182/blood-2011-05-355628; Jin JK, 2007, NEUROSCI LETT, V420, P138, DOI 10.1016/j.neulet.2007.04.069; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Katorcha E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33119; Katorcha E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143218; Katorcha E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16912; Katorcha E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004366; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; Klingeborn M, 2011, P NATL ACAD SCI USA, V108, pE1244, DOI 10.1073/pnas.1111255108; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2012, PRION, V6, P322, DOI 10.4161/pri.20676; Makarava N, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0248-5; Makarava N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1730; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; McCulloch L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002402; Michel B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00440; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Mok SWF, 2007, BIOCHEM BIOPH RES CO, V359, P672, DOI 10.1016/j.bbrc.2007.05.163; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; O'Sullivan JM, 2016, J THROMB HAEMOST, V14, P2446, DOI 10.1111/jth.13537; Pangburn MK, 2000, J IMMUNOL, V164, P4742, DOI 10.4049/jimmunol.164.9.4742; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Sassa Y, 2010, MICROBIOL IMMUNOL, V54, P763, DOI 10.1111/j.1348-0421.2010.00272.x; Sassa Y, 2010, VET IMMUNOL IMMUNOP, V133, P33, DOI 10.1016/j.vetimm.2009.06.018; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Spassov S, 2006, BBA-GEN SUBJECTS, V1760, P1138, DOI 10.1016/j.bbagen.2006.02.018; Srivastava S, 2015, P NATL ACAD SCI USA, V112, pE6654, DOI 10.1073/pnas.1517993112; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; Takakura I, 2011, AM J PATHOL, V179, P1301, DOI 10.1016/j.ajpath.2011.05.058; Tanaka K, 2010, ANGEW CHEM INT EDIT, V49, P8195, DOI 10.1002/anie.201000892; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Wang SJ, 2015, TUMOR BIOL, V36, P885, DOI 10.1007/s13277-014-2638-x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	70	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2359	2368		10.1074/jbc.M116.768010	http://dx.doi.org/10.1074/jbc.M116.768010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27998976	Green Published, hybrid			2022-12-28	WOS:000395530300026
J	Singh, V; Finke-Isami, J; Hopper-Chidlaw, AC; Schwerk, P; Thompson, A; Tedin, K				Singh, Vikash; Finke-Isami, Johannes; Hopper-Chidlaw, Amanda C.; Schwerk, Peter; Thompson, Arthur; Tedin, Karsten			Salmonella Co-opts Host Cell Chaperone-mediated Autophagy for Intracellular Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; bacterial metabolism; bacterial pathogenesis; intracellular trafficking; Salmonella enterica	ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; CONTAINING VACUOLES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ANTIMICROBIAL RESISTANCE; BACTERIAL PATHOGENS; SELECTIVE UPTAKE; TYPHOID-FEVER; TRANSPORT; LIVER	Salmonella enterica are invasive intracellular pathogens that replicate within a membrane-bound compartment inside infected host cells known as the Salmonella-containing vacuole. How Salmonella obtains nutrients for growth within this intracellular niche despite the apparent isolation is currently not known. Recent studies have indicated the importance of glucose and related carbon sources for tissue colonization and intracellular proliferation within host cells during Salmonella infections, although none have been found to be essential. We found that wild-type Salmonella are capable of replicating within infected host cells in the absence of both exogenous sugars and/or amino acids. Furthermore, mutants defective in glucose uptake or dependent upon peptides for growth also showed no significant loss in intracellular replication, suggesting host-derived peptides can supply both carbon units and amino acids. Here, we show that intracellular Salmonella recruit the host proteins LAMP-2A and Hsc73, key components of the host protein turnover pathway known as chaperone-mediated autophagy involved in transport of cytosolic proteins to the lysosome for degradation. Host-derived peptides are shown to provide a significant contribution toward the intracellular growth of Salmonella. The results reveal a means whereby intracellular Salmonella gain access to the host cell cytosol from within its membrane-bound compartment to acquire nutrients. Furthermore, this study provides an explanation as to how Salmonella evades activation of autophagy mechanisms as part of the innate immune response.	[Singh, Vikash; Finke-Isami, Johannes; Schwerk, Peter; Tedin, Karsten] Free Univ Berlin, Inst Microbiol & Epizoot, Ctr Infect Med, Robert von Ostertag Str 7-13, D-14163 Berlin, Germany; [Hopper-Chidlaw, Amanda C.; Thompson, Arthur] Inst Food Res, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England; [Singh, Vikash] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Finke-Isami, Johannes] Cargill Deutschland GmbH & Co KG, D-20539 Hamburg, Germany	Free University of Berlin; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Cambridge	Tedin, K (corresponding author), Free Univ Berlin, Inst Microbiol & Epizoot, Ctr Infect Med, Robert von Ostertag Str 7-13, D-14163 Berlin, Germany.	karsten.tedin@fu-berlin.de		SINGH, VIKASH/0000-0002-6904-1199	Deutsche Forschungsgemeinschaft (DFG) through Priority Program [TE416/1-1]; Graduate Research Training [GRK1121]; Biotechnology and Biological Sciences Research Council [BB/D004810/1]; BBSRC [BB/D004810/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG) through Priority Program(German Research Foundation (DFG)); Graduate Research Training; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) through Priority Program SPP1136 Grant TE416/1-1, Graduate Research Training Grant GRK1121 ( to K.T. and V.S.), and Biotechnology and Biological Sciences Research Council Grant BB/D004810/1 ( to A.T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Alcaine SD, 2007, J FOOD PROTECT, V70, P780, DOI 10.4315/0362-028X-70.3.780; ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Beuzon CR, 2002, MICROBIOL-SGM, V148, P2705, DOI 10.1099/00221287-148-9-2705; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Bowden SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096266; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Brumell JH, 2002, INFECT IMMUN, V70, P3264, DOI 10.1128/IAI.70.6.3264-3270.2002; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Chai LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036201; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Clemente L, 2015, RES MICROBIOL, V166, P574, DOI 10.1016/j.resmic.2015.05.007; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Daniel H, 2015, EXP PHYSIOL, V100, P1441, DOI 10.1113/EP085029; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Garcia-Del Portillo F, 2000, INFECT IMMUN, V68, P2985, DOI 10.1128/IAI.68.5.2985-2991.2000; Garcia-Gutierrez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150687; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; Gopinath S, 2012, TRENDS MICROBIOL, V20, P320, DOI 10.1016/j.tim.2012.04.004; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HOLMES R, 1989, GUT, V30, P1667, DOI 10.1136/gut.30.12.1667; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Kariuki S, 2015, VACCINE, V33, pS21, DOI 10.1016/j.vaccine.2015.03.102; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Keeney KM, 2011, CURR OPIN MICROBIOL, V14, P92, DOI 10.1016/j.mib.2010.12.012; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Kleeb AC, 2007, P NATL ACAD SCI USA, V104, P13907, DOI 10.1073/pnas.0705379104; Klose KE, 1997, INFECT IMMUN, V65, P587, DOI 10.1128/IAI.65.2.587-596.1997; Knodler LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084681; Krieger V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004374; Kuhle V, 2006, TRAFFIC, V7, P716, DOI 10.1111/j.1600-0854.2006.00422.x; Malik-Kale P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038732; McGourty K, 2012, SCIENCE, V338, P963, DOI 10.1126/science.1227037; Miner-Williams WM, 2014, NUTR RES REV, V27, P308, DOI 10.1017/S0954422414000225; Mostowy S, 2012, TRENDS CELL BIOL, V22, P283, DOI 10.1016/j.tcb.2012.03.006; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Orenstein SJ, 2010, SEMIN CELL DEV BIOL, V21, P719, DOI 10.1016/j.semcdb.2010.02.005; PANG T, 1995, TRENDS MICROBIOL, V3, P253, DOI 10.1016/S0966-842X(00)88937-4; Pang T, 1998, TRENDS MICROBIOL, V6, P131, DOI 10.1016/S0966-842X(98)01236-0; PAYNE JW, 1994, ADV MICROB PHYSIOL, V36, P1, DOI 10.1016/S0065-2911(08)60176-9; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Roark EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003538; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Schroeder N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001002; Scott CC, 2002, J BIOL CHEM, V277, P12770, DOI 10.1074/jbc.M110399200; Seki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031232; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Staib L, 2014, MICROBIOL-SGM, V160, P1020, DOI 10.1099/mic.0.078105-0; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Strugnell RA, 2014, CURR OPIN MICROBIOL, V17, P99, DOI 10.1016/j.mib.2013.12.004; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Tennant SM, 2015, VACCINE, V33, pC36, DOI 10.1016/j.vaccine.2015.04.029; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Verbrugghe E, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-118; VIRGILIO R, 1981, CAN J MICROBIOL, V27, P1272, DOI 10.1139/m81-195; Vorwerk S, 2015, MOL CELL PROTEOMICS, V14, P81, DOI 10.1074/mcp.M114.041145; WING SS, 1991, BIOCHEM J, V275, P165, DOI 10.1042/bj2750165; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006; Yu HB, 2014, MBIO, V5, DOI 10.1128/mBio.00865-14; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	77	23	23	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1847	1864		10.1074/jbc.M116.759456	http://dx.doi.org/10.1074/jbc.M116.759456			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27932462	hybrid, Green Published			2022-12-28	WOS:000395515600025
J	Raja, V; Joshi, AS; Li, GL; Maddipati, KR; Greenberg, ML				Raja, Vaishnavi; Joshi, Amit S.; Li, Guiling; Maddipati, Krishna Rao; Greenberg, Miriam L.			Loss of Cardiolipin Leads to Perturbation of Acetyl-CoA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE BYPASS; SUPPRESSES TEMPERATURE SENSITIVITY; COENZYME-A SYNTHETASE; SACCHAROMYCES-CEREVISIAE; BARTH-SYNDROME; SUPEROXIDE-DISMUTASE; MITOCHONDRIAL-DNA; RESPIRATORY-CHAIN; YEAST FRATAXIN; UP-REGULATION	Cardiolipin (CL), the signature phospholipid of mitochondrial membranes, plays an important role in mitochondrial processes and bioenergetics. CL is synthesized de novo and undergoes remodeling in the mitochondrial membranes. Perturbation of CL remodeling leads to the rare X-linked genetic disorder Barth syndrome, which shows disparities in clinical presentation. Touncover biochemical modifiers that exacerbate CL deficiency, we carried out a synthetic genetic array screen to identify synthetic lethal interactions with the yeast CL synthase mutant crd1 Delta. The results indicated that crd1 Delta is synthetically lethal with mutants in pyruvate dehydrogenase (PDH), which catalyzes the conversion of pyruvate to acetyl-CoA. Acetyl-CoA levels were decreased in the mutant. The synthesis of acetylCoA depends primarily on the PDH-catalyzed conversion of pyruvate in the mitochondria and on the PDH bypass in the cytosol, which synthesizes acetyl-CoA from acetate. Consistent with perturbation of the PDH bypass, crd1 Delta cells grown on acetate as the sole carbon source exhibited decreased growth, decreased acetyl-CoA, and increased intracellular acetate levels resulting from decreased acetyl-CoA synthetase activity. PDH mRNA and protein levels were up-regulated in crd1 Delta cells, but PDH enzyme activity was not increased, indicating that PDH up-regulation did not compensate for defects in the PDH bypass. These findings demonstrate for the first time that CL is required for acetyl-CoA synthesis, which is decreased in CL-deficient cells as a result of a defective PDH bypass pathway.	[Raja, Vaishnavi; Joshi, Amit S.; Li, Guiling; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Maddipati, Krishna Rao] Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Pathol,Bioact Lipids Res Program, Detroit, MI 48202 USA; [Joshi, Amit S.] NIDDK, NIH, Bethesda, MD 20892 USA; [Li, Guiling] Jimei Univ, Coll Food & Biol Engn, Xiamen 361021, Fujian, Peoples R China	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Jimei University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mgreenberg@wayne.edu	Maddipati, Krishna Rao/H-3569-2019; Maddipati, Krishna Rao/G-1859-2011	Maddipati, Krishna Rao/0000-0003-1445-791X; Maddipati, Krishna Rao/0000-0003-1445-791X	National Institutes of Health [HL117880]; Barth Syndrome Foundation; Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL117880, the Barth Syndrome Foundation (to M. L. G.), and the Graduate School of Wayne State University (to V. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alrob OA, 2014, BIOCHEM SOC T, V42, P1043, DOI 10.1042/BST20140094; Armando JW, 2012, LETT APPL MICROBIOL, V54, P140, DOI 10.1111/j.1472-765X.2011.03184.x; Avidan O, 2015, J EXP BOT, V66, P7287, DOI 10.1093/jxb/erv424; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; BARTH KH, 1981, PEDIATRICS, V67, P675; Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; BISACCIA F, 1984, BIOCHIM BIOPHYS ACTA, V766, P386, DOI 10.1016/0005-2728(84)90254-8; Bleyl SB, 1997, AM J MED GENET, V72, P257, DOI 10.1002/(SICI)1096-8628(19971031)72:3<257::AID-AJMG2>3.3.CO;2-F; Boubekeur S, 1999, J BIOL CHEM, V274, P21044, DOI 10.1074/jbc.274.30.21044; Branda SS, 1999, HUM MOL GENET, V8, P1099, DOI 10.1093/hmg/8.6.1099; BRIQUET M, 1977, BIOCHIM BIOPHYS ACTA, V459, P290, DOI 10.1016/0005-2728(77)90029-9; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; DESTEENSMA HY, 1990, EUR J BIOCHEM, V191, P769, DOI 10.1111/j.1432-1033.1990.tb19186.x; DEVIRGILIO C, 1992, YEAST, V8, P1043, DOI 10.1002/yea.320081207; Dickinson FM, 1996, BIOCHEM J, V315, P393, DOI 10.1042/bj3150393; DICKINSON JR, 1986, MOL GEN GENET, V204, P103; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; EPHRUSSI B, 1955, NATURE, V176, P1207, DOI 10.1038/1761207b0; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; GUEST JR, 1989, ANN N Y ACAD SCI, V573, P76; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; JAKOVCIC S, 1971, J CELL BIOL, V48, P490, DOI 10.1083/jcb.48.3.490; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Johnston J, 1997, AM J HUM GENET, V61, P1053, DOI 10.1086/301604; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; Joshi AS, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow019; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Kozak BU, 2014, MBIO, V5, DOI 10.1128/mBio.01696-14; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P2834, DOI 10.1021/bi00225a015; Meaden PG, 1997, YEAST, V13, P1319, DOI 10.1002/(SICI)1097-0061(199711)13:14<1319::AID-YEA183>3.0.CO;2-T; MIRAN SG, 1993, P NATL ACAD SCI USA, V90, P1252, DOI 10.1073/pnas.90.4.1252; NALECZ MJ, 1991, BIOCHIM BIOPHYS ACTA, V1079, P87, DOI 10.1016/0167-4838(91)90028-X; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; NIU XD, 1988, P NATL ACAD SCI USA, V85, P7546, DOI 10.1073/pnas.85.20.7546; PANGBORN MC, 1947, J BIOL CHEM, V168, P351; PAQUIN CE, 1986, MOL CELL BIOL, V6, P70, DOI 10.1128/MCB.6.1.70; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Remize F, 2000, APPL ENVIRON MICROB, V66, P3151, DOI 10.1128/AEM.66.8.3151-3159.2000; ROEMER T, 1991, P NATL ACAD SCI USA, V88, P11295, DOI 10.1073/pnas.88.24.11295; Saffi J, 2006, REDOX REP, V11, P179, DOI 10.1179/135100006X116691; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Shiba Y, 2007, METAB ENG, V9, P160, DOI 10.1016/j.ymben.2006.10.005; Stacpoole PW, 1997, ARCH DIS CHILD, V77, P535, DOI 10.1136/adc.77.6.535; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Trotter PJ, 2001, ANNU REV NUTR, V21, P97, DOI 10.1146/annurev.nutr.21.1.97; UHLINGER DJ, 1986, BIOCHEMISTRY-US, V25, P5673, DOI 10.1021/bi00367a049; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; VANDENBERG MA, 1995, EUR J BIOCHEM, V231, P704; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; Vorapreeda T, 2012, MICROBIOL-SGM, V158, P217, DOI 10.1099/mic.0.051946-0; Wei YL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-7; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200	80	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1092	1102		10.1074/jbc.M116.753624	http://dx.doi.org/10.1074/jbc.M116.753624			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27941023	Green Published, hybrid			2022-12-28	WOS:000392318700028
J	Alexander, PB; Chen, R; Gong, C; Yuan, LF; Jasper, JS; Ding, Y; Markowitz, GJ; Yang, PY; Xu, X; McDonnell, DP; Song, EW; Wang, XF				Alexander, Peter B.; Chen, Rui; Gong, Chang; Yuan, Lifeng; Jasper, Jeff S.; Ding, Yi; Markowitz, Geoffrey J.; Yang, Pengyuan; Xu, Xin; McDonnell, Donald P.; Song, Erwei; Wang, Xiao-Fan			Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PHASE-II TRIAL; IMATINIB MESYLATE; PROMOTER METHYLATION; MOLECULAR-MECHANISMS; GROWTH; TRASTUZUMAB; SENESCENCE; INHIBITOR; THERAPY	Targeted inhibitors of the human epidermal growth factor receptor 2 (HER2), such as trastuzumab and lapatinib, are among the first examples of molecularly targeted cancer therapy and have proven largely effective for the treatment of HER2-positive breast cancers. However, approximately half of those patients either do not respond to these therapies or develop secondary resistance. Although a few signaling pathways have been implicated, a comprehensive understanding of mechanisms underlying HER2 inhibitor drug resistance is still lacking. To address this critical question, we undertook a concerted approach using patient expression data sets, HER2-positive cell lines, and tumor samples biopsied both before and after trastuzumab treatment. Together, these methods revealed that high expression and activation of a specific subset of receptor tyrosine kinases (RTKs) was strongly associated with poor clinical prognosis and the development of resistance. Mechanistically, these RTKs are capable of maintaining downstream signal transduction to promote tumor growth via the suppression of cellular senescence. Consequently, these findings provide the rationale for the design of therapeutic strategies for overcoming drug resistance in breast cancer via combinational inhibition of the limited number of targets from this specific subset of RTKs.	[Alexander, Peter B.; Chen, Rui; Yuan, Lifeng; Jasper, Jeff S.; Ding, Yi; Markowitz, Geoffrey J.; Yang, Pengyuan; Xu, Xin; McDonnell, Donald P.; Wang, Xiao-Fan] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, C218 LSRC Bldg,308 Res Dr, Durham, NC 27710 USA; [Gong, Chang; Song, Erwei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Guangdong, Peoples R China	Duke University; Sun Yat Sen University	Wang, XF (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, C218 LSRC Bldg,308 Res Dr, Durham, NC 27710 USA.	xiao.fan.wang@duke.edu	Yuan, Lifeng/AAG-4363-2021	Yuan, Lifeng/0000-0002-5367-7512; Markowitz, Geoffrey/0000-0003-3915-8078; Jasper, Jeff/0000-0003-3941-0018	National Institutes of Health [CA154586, CA186800, CA174643, CA059365]; Department of Defense [BC151189]; 973 Projects from the Ministry of Science and Technology of China [2010CB912800, 2011CB504203]; Natural Science Foundation of China [81672594, 81230060, 81261140373, 81272893, 81472466]; National SAMP;T Major Special Project on New Drug Innovation of China [2011ZX09102-010-02]; Guangdong Province [2014A03036003, S2012030006287, 2014A030310378, 2016A050502018]; NATIONAL CANCER INSTITUTE [R21CA186800, R01CA154586, T32CA059365, R01CA174643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); 973 Projects from the Ministry of Science and Technology of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National SAMP;T Major Special Project on New Drug Innovation of China; Guangdong Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA154586 and CA186800 (to X.-F. W.), CA174643 (to D. P. M.), and CA059365 (to P. B. A.) and Department of Defense Grant BC151189 (to X.-F. W.). This work was also supported by 973 Projects 2010CB912800 and 2011CB504203 from the Ministry of Science and Technology of China; Natural Science Foundation of China Grants 81672594, 81230060, 81261140373, 81272893, and 81472466; National S&T Major Special Project on New Drug Innovation of China Grant 2011ZX09102-010-02); and Guangdong Province Grants 2014A03036003, S2012030006287, 2014A030310378, and 2016A050502018 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander PB, 2015, FRONT MED-PRC, V9, P134, DOI 10.1007/s11684-015-0396-9; Alexander PB, 2015, CELL RES, V25, P135, DOI 10.1038/cr.2014.141; Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Groenendijk FH, 2014, MOL ONCOL, V8, P1067, DOI 10.1016/j.molonc.2014.05.004; Harris LN, 2007, CLIN CANCER RES, V13, P1198, DOI 10.1158/1078-0432.CCR-06-1304; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kastner K, 2014, CHEM-EUR J, V20, P12269, DOI 10.1002/chem.201403592; Kawasaki T, 2007, NEOPLASIA, V9, P1091, DOI 10.1593/neo.07760; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; Kojima H, 2012, CELL CYCLE, V11, P730, DOI 10.4161/cc.11.4.19172; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lu YH, 2004, INT J CANCER, V108, P334, DOI 10.1002/ijc.11445; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Modi S, 2005, BREAST CANCER RES TR, V90, P157, DOI 10.1007/s10549-004-3974-0; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Rivenbark AG, 2006, EPIGENETICS-US, V1, P32, DOI 10.4161/epi.1.1.2358; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Roskoski R, 2007, BIOCHEM BIOPH RES CO, V356, P323, DOI 10.1016/j.bbrc.2007.02.156; Salt MB, 2014, CANCER DISCOV, V4, P186, DOI 10.1158/2159-8290.CD-13-0520; Schilder RJ, 2008, J CLIN ONCOL, V26, P3418, DOI 10.1200/JCO.2007.14.3420; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Thompson CA, 2015, AM J HEALTH-SYST PH, V72, P592, DOI 10.2146/news150028; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; Wang QR, 2013, CANCER LETT, V340, P43, DOI 10.1016/j.canlet.2013.06.022; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Xia W, 2006, P NATL ACAD SCI USA, V103, P7795, DOI 10.1073/pnas.0602468103; Yardley DA, 2009, CLIN BREAST CANCER, V9, P237, DOI 10.3816/CBC.2009.n.040; Zhou J, 2015, ONCOTARGET, V6, P44332, DOI 10.18632/oncotarget.6293	53	22	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					748	759		10.1074/jbc.M116.754960	http://dx.doi.org/10.1074/jbc.M116.754960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27903634	Green Published, hybrid			2022-12-28	WOS:000392316100028
J	Ayuso, MI; Martinez-Alonso, E; Regidor, I; Alcazar, A				Ayuso, Maria I.; Martinez-Alonso, Emma; Regidor, Ignacio; Alcazar, Alberto			Stress Granule Induction after Brain Ischemia Is Independent of Eukaryotic Translation Initiation Factor (eIF) 2 alpha Phosphorylation and Is Correlated with a Decrease in eIF4B and eIF4E Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELAYED NEURONAL DEATH; RNA-BINDING PROTEINS; CEREBRAL-ISCHEMIA; CELL-DEATH; GENE-EXPRESSION; RAT-BRAIN; INHIBITION; AGGREGATION; REPERFUSION; TIA-1	Stress granules (SGs) are cytoplasmic ribonucleoprotein aggregates that are directly connected with the translation initiation arrest response to cellular stresses. Translation inhibition (TI) is observed in transient brain ischemia, a condition that induces persistent TI even after reperfusion, i.e. when blood flow is restored, and causes delayed neuronal death (DND) in selective vulnerable regions. We previously described a connection between TI and DND in the hippocampal cornu ammonis 1 (CA1) in an animal model of transient brain ischemia. To link the formation of SGs to TI and DND after brain ischemia, we investigated SG induction in brain regions with differential vulnerabilities to ischemia-reperfusion (IR) in this animal model. SG formation is triggered by both eukaryotic translation initiation factor (eIF) 2 alpha phosphorylation and eIF4F complex dysfunction. We analyzed SGs by immunofluorescence colocalization of granule-associated protein T-cell internal antigen-1 with eIF3b, eIF4E, and ribosomal protein S6 and studied eIF2 and eIF4F complex. The results showed that IR stress induced SG formation in the CA1 region after 3-day reperfusion, consistent with TI and DND in CA1. SGs were formed independently of eIF2 alpha phosphorylation, and their appearance was correlated with a decrease in the levels of eIF4F compounds, the cap-binding protein eIF4E, and eIF4B, suggesting that remodeling of the eIF4F complex was required for SG formation. Finally, pharmacological protection of CA1 ischemic neurons with cycloheximide decreased the formation of SGs and restored eIF4E and eIF4B levels in CA1. These findings link changes in eIF4B and eIF4E to SG induction in regions vulnerable to death after IR.	[Ayuso, Maria I.; Martinez-Alonso, Emma; Alcazar, Alberto] Hosp Ramon & Cajal, Inst Ramon & Cajal Invest Sanitaria, Dept Invest, E-28034 Madrid, Spain; [Regidor, Ignacio] Hosp Ramon & Cajal, Inst Ramon & Cajal Invest Sanitaria, Dept Neurophysiol, E-28034 Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal	Ayuso, MI (corresponding author), Inst Biomed Sevilla, Neurovasc Res Grp, Ave Manuel Siurot S-N, E-41013 Seville, Spain.; Alcazar, A (corresponding author), Hosp Ramon & Cajal, Ctra Colmenar Km 9-1, E-28034 Madrid, Spain.	mayuso-ibis@us.es; alberto.alcazar@hrc.es	IBiS, Neurovascular/P-5842-2016; Ayuso, Maria Irene/C-9435-2015	IBiS, Neurovascular/0000-0001-9511-0672; Ayuso, Maria Irene/0000-0003-0046-3657	Instituto de Salud Carlos III Grant from the Spanish Ministry of Economy and Competitiveness [PI14/00705]; Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III Grant from the Spanish Ministry of Economy and Competitiveness; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This work was supported by Instituto de Salud Carlos III Grant PI14/00705 from the Spanish Ministry of Economy and Competitiveness and Fondo Europeo de Desarrollo Regional (FEDER) (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Ayuso MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121958; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; COOPER HK, 1977, J NEUROCHEM, V28, P929, DOI 10.1111/j.1471-4159.1977.tb10652.x; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; de la Vega CM, 2001, NEUROREPORT, V12, P1021, DOI 10.1097/00001756-200104170-00031; DeGracia DJ, 2007, NEUROSCIENCE, V146, P562, DOI 10.1016/j.neuroscience.2007.01.050; DeGracia DJ, 2008, J NEUROCHEM, V106, P2288, DOI 10.1111/j.1471-4159.2008.05561.x; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Fujimura K, 2012, NUCLEIC ACIDS RES, V40, P8099, DOI 10.1093/nar/gks566; Garcia-Bonilla L, 2007, J NEUROCHEM, V103, P1368, DOI 10.1111/j.1471-4159.2007.04844.x; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; GONZALEZ CI, 2007, TRANSLATIONAL CONTRO, P719; GOTO K, 1990, BRAIN RES, V534, P299, DOI 10.1016/0006-8993(90)90144-Z; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Hata R, 2000, J CEREBR BLOOD F MET, V20, P306, DOI 10.1097/00004647-200002000-00012; Hermann DM, 2001, NEUROSCIENCE, V104, P947, DOI 10.1016/S0306-4522(01)00125-7; Higashi S, 2013, J NEUROCHEM, V126, P288, DOI 10.1111/jnc.12194; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Ayuso MI, 2013, J CEREBR BLOOD F MET, V33, P1173, DOI 10.1038/jcbfm.2013.60; Jamison JT, 2008, NEUROSCIENCE, V154, P504, DOI 10.1016/j.neuroscience.2008.03.057; Jamison JT, 2011, NEUROSCIENCE, V199, P394, DOI 10.1016/j.neuroscience.2011.09.015; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu CL, 2005, NEUROSCIENCE, V134, P1273, DOI 10.1016/j.neuroscience.2005.05.015; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; PAPAS S, 1992, EUR J NEUROSCI, V4, P758, DOI 10.1111/j.1460-9568.1992.tb00185.x; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Raught B., 2007, TRANSLATIONAL CONTRO, P369; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; THILMANN R, 1986, ACTA NEUROPATHOL, V71, P88, DOI 10.1007/BF00687967; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wolozin B, 2015, ADV EXP MED BIOL, V822, P11, DOI 10.1007/978-3-319-08927-0_3; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Zhang F, 2006, J NEUROCHEM, V98, P102, DOI 10.1111/j.1471-4159.2006.03838.x	46	16	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27252	27264		10.1074/jbc.M116.738989	http://dx.doi.org/10.1074/jbc.M116.738989			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27836976	hybrid, Green Published			2022-12-28	WOS:000391576300023
J	Entingh, AJ; Taniguchi, CM; Kahn, CR				Entingh, Amelia J.; Taniguchi, Cullen M.; Kahn, C. Ronald			RETRACTION: Bi-directional regulation of brown fat adipogenesis by the insulin receptor (Retraction of Vol 278, Pg 33377, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228				ENTINGH AJ, 2003, THE JOURNAL OF BIOLO, V278, P33377, DOI DOI 10.1074/JBC.A116.303056	1	2	2	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27434	27434		10.1074/jbc.A116.303056	http://dx.doi.org/10.1074/jbc.A116.303056			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	28039334	Green Published, hybrid			2022-12-28	WOS:000391576300039
J	Law, NC; White, MF; Hunzicker-Dunn, ME				Law, Nathan C.; White, Morris F.; Hunzicker-Dunn, Mary E.			G protein-coupled receptors (GPCRs) That Signal via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the phosphatidylinositol 3-kinase (PI3K)/AKT Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; PHOSPHOINOSITIDE 3-KINASE; SERINE/THREONINE PHOSPHORYLATION; TARGETED DISRUPTION; CELL-PROLIFERATION; REGULATORY SUBUNIT; SMOOTH-MUSCLE; IN-VITRO; FSH; BETA	G protein-coupled receptors (GPCRs) activate PI3K/v-AKT thymoma viral oncoprotein (AKT) to regulate many cellular functions that promote cell survival, proliferation, and growth. However, the mechanism by which GPCRs activate PI3K/AKT remains poorly understood. We used ovarian preantral granulosa cells (GCs) to elucidate the mechanism by which the GPCR agonist FSH via PKA activates the PI3K/AKT cascade. Insulinlike growth factor 1 (IGF1) is secreted in an autocrine/paracrine manner by GCs and activates the IGF1 receptor (IGF1R) but, in the absence of FSH, fails to stimulate YXXM phosphorylation of IRS1 (insulin receptor substrate 1) required for PI3K/AKT activation. We show that PKA directly phosphorylates the protein phosphatase 1 (PP1) regulatory subunit myosin phosphatase targeting subunit 1 (MYPT1) to activate PP1 associated with the IGF1R-IRS1 complex. Activated PP1 is sufficient to dephosphorylate at least four IRS1 Ser residues, Ser(318), Ser(346), Ser(612), and Ser(789), and promotes IRS1 YXXM phosphorylation by the IGF1R to activate the PI3K/AKT cascade. Additional experiments indicate that this mechanism also occurs in breast cancer, thyroid, and preovulatory granulosa cells, suggesting that the PKA-dependent dephosphorylation of IRS1 Ser/Thr residues is a conserved mechanism by which GPCRs signal to activate the PI3K/AKT pathway downstream of the IGF1R.	[Law, Nathan C.; Hunzicker-Dunn, Mary E.] Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci Bldg,Rm 233, Pullman, WA 99164 USA; [White, Morris F.] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Div Endocrinol, Boston, MA 02115 USA	Washington State University; Harvard University; Boston Children's Hospital; Harvard Medical School	Hunzicker-Dunn, ME (corresponding author), Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci Bldg,Rm 233, Pullman, WA 99164 USA.	mehd@wsu.edu			National Institute of Health [R01HD065859, R01HD062053, T32GM083864, R01DK098655-01, R01DK038712-22]; Fund for Science; Poncin Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062053, R01HD065859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098655, R01DK038712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864, P50GM021700] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Science; Poncin Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institute of Health Grants R01HD065859 and R01HD062053 (to M. E. H. D.), T32GM083864 (to N. C. L), and R01DK098655-01 and R01DK038712-22 (to M. F. W.). Additional funding was provided by The Fund for Science (to M. E. H. D.) and the Poncin Scholarship Fund (to N. C. L). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Arcaro A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00030; Baumgarten SC, 2014, J CLIN ENDOCR METAB, V99, P2995, DOI 10.1210/jc.2014-1139; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Butler T, 2013, AM J PHYSIOL-CELL PH, V304, pC485, DOI 10.1152/ajpcell.00161.2012; Chen XL, 2007, CHEM REV, V107, P1777, DOI 10.1021/cr050029r; CHENG HC, 1986, J BIOL CHEM, V261, P989; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; Donaubauer EM, 2016, J BIOL CHEM, V291, P19701, DOI 10.1074/jbc.M116.733972; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Flynn MP, 2016, J CELL SCI, V129, P2983, DOI 10.1242/jcs.190397; Fontal OI, 1999, ANAL BIOCHEM, V269, P289, DOI 10.1006/abio.1999.3099; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Geetha T, 2011, J AM SOC MASS SPECTR, V22, P457, DOI 10.1007/s13361-010-0051-2; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Hartog H, 2007, EUR J CANCER, V43, P1895, DOI 10.1016/j.ejca.2007.05.021; Herndon MK, 2016, MOL CELL ENDOCRINOL, V434, P116, DOI 10.1016/j.mce.2016.06.020; Herrema H, 2014, BIOCHEM BIOPH RES CO, V443, P689, DOI 10.1016/j.bbrc.2013.12.023; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Hunzicker-Dunn M, 2015, PHYSL REPROD, P895; Hunzicker-Dunn ME, 2012, P NATL ACAD SCI USA, V109, pE2979, DOI 10.1073/pnas.1205661109; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Kirschner LS, 2009, ENDOCR-RELAT CANCER, V16, P773, DOI 10.1677/ERC-09-0068; Klempner SJ, 2013, CANCER DISCOV, V3, P1345, DOI 10.1158/2159-8290.CD-13-0063; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Law NC, 2016, J BIOL CHEM, V291, P4547, DOI 10.1074/jbc.M115.698761; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; Lei ZM, 2001, MOL ENDOCRINOL, V15, P184, DOI 10.1210/me.15.1.184; Li Q, 2013, MOL ENDOCRINOL, V27, P1468, DOI 10.1210/me.2013-1082; Liu ZL, 2015, MOL ENDOCRINOL, V29, P1006, DOI 10.1210/me.2015-1103; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Luo ML, 2005, ENDOCRINOLOGY, V146, P4410, DOI 10.1210/en.2005-0260; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; Machida K, 2005, AM J PHYSIOL-LUNG C, V288, pL860, DOI 10.1152/ajplung.00131.2004; Mani AM, 2010, REPRODUCTION, V139, P139, DOI 10.1530/REP-09-0050; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Medina DL, 2000, EUR J ENDOCRINOL, V143, P161, DOI 10.1530/eje.0.1430161; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Ni L, 2007, ASSAY DRUG DEV TECHN, V5, P645, DOI 10.1089/adt.2007.079; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Puri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28132; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; Swingle Mark, 2007, V365, P23; Torella D, 2009, AM J PHYSIOL-HEART C, V297, pH2015, DOI 10.1152/ajpheart.00738.2009; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang XL, 2012, J BIOL CHEM, V287, P10166, DOI 10.1074/jbc.M111.293274; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zeleznik AJ, 2003, ENDOCRINOLOGY, V144, P3985, DOI 10.1210/en.2003-0293; Zhang XM, 2014, J PROTEOMICS, V109, P63, DOI 10.1016/j.jprot.2014.06.010	76	34	40	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27160	27169		10.1074/jbc.M116.763235	http://dx.doi.org/10.1074/jbc.M116.763235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27856640	Green Published, hybrid			2022-12-28	WOS:000391576300016
J	Zhu, F; Zhang, H; Yang, TD; Haslam, SM; Dell, A; Wu, H				Zhu, Fan; Zhang, Hua; Yang, Tiandi; Haslam, Stuart M.; Dell, Anne; Wu, Hui			Engineering and Dissecting the Glycosylation Pathway of a Streptococcal Serine-rich Repeat Adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL PROTEIN GLYCOSYLATION; FIMBRIA-ASSOCIATED ADHESIN; GDP-D-RHAMNOSE; BIOFILM FORMATION; UNKNOWN FUNCTION; FUNCTIONAL-CHARACTERIZATION; STAPHYLOCOCCUS-AUREUS; MOLECULAR CHAPERONE; CONSERVED DOMAIN; SURFACE PROTEIN	Serine-rich repeat glycoproteins (SRRPs) are conserved in Gram-positive bacteria. They are crucial for modulating biofilm formation and bacterial-host interactions. Glycosylation of SRRPs plays a pivotal role in the process; thus understanding the glycosyl-transferases involved is key to identifying new therapeutic drug targets. The glycosylation of Fap1, an SRRP of Streptococcus parasanguinis, is mediated by a gene cluster consisting of six genes: gtf1, gtf2, gly, gtf3, dGT1, and galT2. Mature Fap1 glycan possesses the sequence of Rha1-3Glc1-(Glc1-3GlcNAc1)-2,6-Glc1-6GlcNAc. Gtf12, Gtf3, and dGT1 are responsible for the first four steps of the Fap1 glycosylation, catalyzing the transfer of GlcNAc, Glc, Glc, and GlcNAc residues to the protein backbone sequentially. The role of GalT2 and Gly in the Fap1 glycosylation is unknown. In the present study, we synthesized the fully modified Fap1 glycan in Escherichia coli by incorporating all six genes from the cluster. This study represents the first reconstitution of an exogenous stepwise O-glycosylation synthetic pathway in E. coli. In addition, we have determined that GalT2 mediates the fifth step of the Fap1 glycosylation by adding a rhamnose residue, and Gly mediates the final glycosylation step by transferring glucosyl residues. Furthermore, inactivation of each glycosyltransferase gene resulted in differentially impaired biofilms of S. parasanguinis, demonstrating the importance of Fap1 glycosylation in the biofilm formation. The Fap1 glycosylation system offers an excellent model to engineer glycans using different permutations of glycosyltransferases and to investigate biosynthetic pathways of SRRPs because SRRP genetic loci are highly conserved.	[Zhu, Fan; Zhang, Hua; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent, 1919 7th Ave S, Birmingham, AL 35244 USA; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Microbiol, 1919 7th Ave S, Birmingham, AL 35244 USA; [Zhu, Fan; Zhang, Hua; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Pediat Dent, 1919 7th Ave S, Birmingham, AL 35244 USA; [Zhu, Fan; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Microbiol, 1919 7th Ave S, Birmingham, AL 35244 USA; [Yang, Tiandi; Haslam, Stuart M.; Dell, Anne] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Imperial College London	Wu, H (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent, 1919 7th Ave S, Birmingham, AL 35244 USA.; Wu, H (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Microbiol, 1919 7th Ave S, Birmingham, AL 35244 USA.; Wu, H (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Pediat Dent, 1919 7th Ave S, Birmingham, AL 35244 USA.; Wu, H (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Microbiol, 1919 7th Ave S, Birmingham, AL 35244 USA.; Haslam, SM (corresponding author), Imperial Coll London, Dept Life Sci, London SW7 2AZ, England.	s.haslam@imperial.ac.uk; hwu@uab.edu			National Institutes of Health NIDCR [R01DE17954, F33DE022215]; Biotechnology and Biological Sciences Research Council [BB/K016164/1]; Core Support for Collaborative Research; Wellcome Trust; BBSRC [BB/K016164/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954, F33DE022215] Funding Source: NIH RePORTER	National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Core Support for Collaborative Research; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health NIDCR Grants R01DE17954 and F33DE022215 (to H. W.), Biotechnology and Biological Sciences Research Council Grant BB/K016164/1 (to S. M. H. and A. D.), Core Support for Collaborative Research (to A. D. and S. M. H.), and a Wellcome Trust Senior Investigator Award (to A. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Cuccui J, 2015, J PHARM PHARMACOL, V67, P338, DOI 10.1111/jphp.12321; Cuccui J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130002; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Echlin H., 2014, THESIS; Echlin H, 2013, J BACTERIOL, V195, P2166, DOI 10.1128/JB.02255-12; Elhenawy W, 2016, GLYCOBIOLOGY, V26, P301, DOI 10.1093/glycob/cwv098; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Garcia-Quintanilla F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00381; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; James DBA, 2013, J BACTERIOL, V195, P5469, DOI 10.1128/JB.00715-13; Kampf MM, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0195-7; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Kremer BHA, 2001, J BACTERIOL, V183, P2543, DOI 10.1128/JB.183.8.2543-2552.2001; Lee IC, 2014, J BACTERIOL, V196, P1671, DOI 10.1128/JB.01401-13; Li YR, 2014, CURR MICROBIOL, V69, P121, DOI 10.1007/s00284-014-0563-2; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Lu QH, 2015, TRENDS MICROBIOL, V23, P630, DOI 10.1016/j.tim.2015.07.003; Nothaft H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26511; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Pan C, 2016, MBIO, V7, DOI 10.1128/mBio.00443-16; Peng Z, 2008, ORAL MICROBIOL IMMUN, V23, P70, DOI 10.1111/j.1399-302X.2007.00401.x; Rahim R, 2001, MOL MICROBIOL, V40, P708, DOI 10.1046/j.1365-2958.2001.02420.x; Ravenscroft N, 2016, GLYCOBIOLOGY, V26, P51, DOI 10.1093/glycob/cwv077; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Schmid J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00182; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Tan FYY, 2015, TRENDS BIOCHEM SCI, V40, P342, DOI 10.1016/j.tibs.2015.03.016; Theilacker C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-67; Valguarnera E, 2016, J MOL BIOL, V428, P3206, DOI 10.1016/j.jmb.2016.04.013; Wacker M, 2014, J INFECT DIS, V209, P1551, DOI 10.1093/infdis/jit800; Walter J, 2008, MICROBIOL-SGM, V154, P72, DOI 10.1099/mic.0.2007/010637-0; Wang S, 2015, J BACTERIOL, V197, P2012, DOI 10.1128/JB.02590-14; Wang S, 2013, BIOORG MED CHEM LETT, V23, P3491, DOI 10.1016/j.bmcl.2013.04.051; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Wu R, 2011, J BIOL CHEM, V286, P34923, DOI 10.1074/jbc.M111.239350; Wu R, 2010, APPL ENVIRON MICROB, V76, P7966, DOI 10.1128/AEM.01434-10; Zegzouti H, 2013, GLYCOBIOLOGY, V23, P1340; Zhang H, 2016, J BIOL CHEM, V291, P22106, DOI 10.1074/jbc.M116.731695; Zhang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5339; Zhang H, 2013, ACTA CRYSTALLOGR F, V69, P520, DOI 10.1107/S1744309113007161; Zhou MX, 2008, INFECT IMMUN, V76, P5624, DOI 10.1128/IAI.00534-08; Zhou M, 2008, J MICROBIOL METH, V72, P249, DOI 10.1016/j.mimet.2007.12.002; Zhou MX, 2012, MOL MICROBIOL, V83, P866, DOI 10.1111/j.1365-2958.2012.07970.x; Zhou MX, 2011, J BACTERIOL, V193, P6560, DOI 10.1128/JB.05668-11; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0; Zhu F, 2015, J DENT RES, V94, P659, DOI 10.1177/0022034515574865; Zhu F, 2016, SCI CHINA LIFE SCI, V59, P11, DOI 10.1007/s11427-015-4980-7; Zhu F, 2011, J BIOL CHEM, V286, P27048, DOI 10.1074/jbc.M110.208629	66	22	22	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27354	27363		10.1074/jbc.M116.752998	http://dx.doi.org/10.1074/jbc.M116.752998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	28039332	Green Published, hybrid			2022-12-28	WOS:000391576300032
J	Chiara, DC; Jounaidi, Y; Zhou, XJ; Savechenkov, PY; Bruzik, KS; Miller, KW; Cohen, JB				Chiara, David C.; Jounaidi, Youssef; Zhou, Xiaojuan; Savechenkov, Pavel Y.; Bruzik, Karol S.; Miller, Keith W.; Cohen, Jonathan B.			General Anesthetic Binding Sites in Human alpha 4 beta 3 delta gamma-Aminobutyric Acid Type A Receptors (GABAARs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRASYNAPTIC GABA(A) RECEPTORS; DELTA-SUBUNIT; INTRAVENOUS ANESTHETICS; TRANSMEMBRANE DOMAIN; ALLOSTERIC MODULATION; FUNCTIONAL-PROPERTIES; ETOMIDATE; STOICHIOMETRY; PROPOFOL; ALPHA-1-BETA-3-DELTA	Extrasynaptic gamma-aminobutyric acid type A receptors (GABA(A)Rs), which contribute generalized inhibitory tone to the mammalian brain, are major targets for general anesthetics. To identify anesthetic binding sites in an extrasynaptic GABA(A)R, we photolabeled human alpha 4 beta 3 delta GABA(A)Rs purified in detergent with [H-3]azietomidate and a barbiturate, [H-3]R-mTFD-MPAB, photoreactive anesthetics that bind with high selectivity to distinct but homologous intersubunit binding sites in the transmembrane domain of synaptic alpha 1 beta 3 gamma 2 GABA(A)Rs. Based upon H-3 incorporation into receptor subunits resolved by SDS-PAGE, there was etomidate-inhibitable labeling by [H-3] azietomidate in the alpha 4 and beta 3 subunits and barbiturate-inhibitable labeling by [H-3] R-mTFD-MPAB in the beta 3 subunit. These sites did not bind the anesthetic steroid alphaxalone, which enhanced photolabeling, or DS-2, a delta subunit-selective positive allosteric modulator, which neither enhanced nor inhibited photolabeling. The amino acids labeled by [H-3] azietomidate or [H-3] R-mTFD-MPAB were identified by N-terminal sequencing of fragments isolated by HPLC fractionation of enzymatically digested subunits. No evidence was found for a delta subunit contribution to an anesthetic binding site. [H-3] azietomidate photolabeling of beta 3Met-286 in beta M3 and alpha 4Met-269 in alpha M1 that was inhibited by etomidate but not by R-mTFD-MPAB established that etomidate binds to a site at the alpha 3(+)-alpha 4(-) interface equivalent to its site in alpha 1 beta 3 gamma 2 GABA(A)Rs. [H-3] Azietomidate and [H-3] R-mTFD-MPAB photolabeling of beta 3Met-227 in beta M1 established that these anesthetics also bind to a homologous site, most likely at the beta 3(+)-beta 3(-) interface, which suggests a subunit arrangement of beta 3 alpha 4 beta 3 delta beta 3.	[Chiara, David C.; Cohen, Jonathan B.] Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA; [Miller, Keith W.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jounaidi, Youssef; Zhou, Xiaojuan; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Savechenkov, Pavel Y.; Bruzik, Karol S.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cohen, JB (corresponding author), Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu			National Institutes of Health [GM-58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-58448. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amlong CA, 2016, ANESTH ANALG, V123, P1241, DOI 10.1213/ANE.0000000000001358; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bieda MC, 2009, ANESTH ANALG, V108, P484, DOI 10.1213/ane.0b013e3181904571; Botzolakis EJ, 2016, J BIOL CHEM, V291, P20440, DOI 10.1074/jbc.M115.698860; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Dostalova Z, 2014, PROTEIN SCI, V23, P157, DOI 10.1002/pro.2401; Drexler B, 2011, CAN J ANESTH, V58, P178, DOI 10.1007/s12630-010-9414-1; Eaton MM, 2014, MOL PHARMACOL, V86, P647, DOI 10.1124/mol.114.094813; Estrada-Mondragon A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00055; Feng HJ, 2014, BRIT J PHARMACOL, V171, P789, DOI 10.1111/bph.12507; Feng HJ, 2010, J BIOL CHEM, V285, P23614, DOI 10.1074/jbc.M110.122564; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Hartiadi LY, 2016, BIOCHEM PHARMACOL, V103, P98, DOI 10.1016/j.bcp.2015.12.021; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Jayakar SS, 2015, J BIOL CHEM, V290, P23432, DOI 10.1074/jbc.M115.672006; Jayakar SS, 2014, J BIOL CHEM, V289, P27456, DOI 10.1074/jbc.M114.581728; Jensen ML, 2013, BRIT J PHARMACOL, V168, P1118, DOI 10.1111/bph.12001; Jia F, 2008, J PHARMACOL EXP THER, V324, P1127, DOI 10.1124/jpet.107.134569; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Kretschmannova K, 2013, J NEUROSCI, V33, P7264, DOI 10.1523/JNEUROSCI.5475-12.2013; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liao M, 2005, ANESTH ANALG, V101, P131, DOI 10.1213/01.ANE.0000153011.64764.6F; Maldifassi MC, 2016, NEUROPHARMACOLOGY, V105, P207, DOI 10.1016/j.neuropharm.2016.01.003; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Nourmahnad A, 2016, ANESTHESIOLOGY, V125, P1144, DOI 10.1097/ALN.0000000000001390; Patel B, 2014, BRIT J PHARMACOL, V171, P985, DOI 10.1111/bph.12514; Patel P.M., 2011, GOODMAN GILMANS PHAR, P527; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Puthenkalam R, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00044; Reynolds DS, 2003, J NEUROSCI, V23, P8608; Sauguet L, 2015, BBA-GEN SUBJECTS, V1850, P511, DOI 10.1016/j.bbagen.2014.05.007; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Sigel E., 2005, BENZODIAZEPINE RECOG; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Stewart DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111470; Stewart DS, 2013, J BIOL CHEM, V288, P30373, DOI 10.1074/jbc.M113.494583; Wagoner KR, 2010, J BIOL CHEM, V285, P14187, DOI 10.1074/jbc.M110.104257; Wongsamitkul N, 2016, J BIOL CHEM, V291, P18474, DOI 10.1074/jbc.M116.738906; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	50	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26529	26539		10.1074/jbc.M116.753335	http://dx.doi.org/10.1074/jbc.M116.753335			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27821594	Green Published, hybrid			2022-12-28	WOS:000391568200025
J	Duan, HQ; Wang, CL; Wang, M; Gao, XJ; Yan, MM; Akram, S; Peng, W; Zou, HF; Wang, D; Zhou, JJ; Chu, YJ; Dou, Z; Barrett, G; Green, HN; Wang, FJ; Tian, RJ; He, P; Wang, WW; Liu, X; Yao, XB				Duan, Hequan; Wang, Chunli; Wang, Ming; Gao, Xinjiao; Yan, Maomao; Akram, Saima; Peng, Wei; Zou, Hanfa; Wang, Dong; Zhou, Jiajia; Chu, Youjun; Dou, Zhen; Barrett, Gregory; Green, Hadiyah-Nicole; Wang, Fangjun; Tian, Ruijun; He, Ping; Wang, Wenwen; Liu, Xing; Yao, Xuebiao			Phosphorylation of PP1 regulator Sds22 by PLK1 ensures accurate chromosome segregation (vol 291, pg 21123, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Liu, Xing/H-2989-2018; Yao, Xuebiao/P-5771-2014	Liu, Xing/0000-0002-7480-5085; Fangjun, Wang/0000-0002-8118-7019				Duan HQ, 2016, J BIOL CHEM, V291, P21123, DOI 10.1074/jbc.M116.745372	1	1	1	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26239	26239		10.1074/jbc.A116.745372	http://dx.doi.org/10.1074/jbc.A116.745372			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27941070	Green Published, hybrid			2022-12-28	WOS:000390345200039
J	Guo, JP; Coppola, D; Cheng, JQ				Guo, Jian-Ping; Coppola, Domenico; Cheng, Jin Q.			IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation (vol 286, pg 37389, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433	1	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22853	22853		10.1074/jbc.A111.287433	http://dx.doi.org/10.1074/jbc.A111.287433			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825091	hybrid, Green Published			2022-12-28	WOS:000386760600052
J	Wesener, DA; Levengood, MR; Kiessling, LL				Wesener, Darryl A.; Levengood, Matthew R.; Kiessling, Laura L.			Comparing Galactan Biosynthesis in Mycobacterium tuberculosis and Corynebacterium diphtheriae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-GALACTOPYRANOSE MUTASE; WALL ARABINAN BIOSYNTHESIS; CHAIN-LENGTH; POLYSACCHARIDE BIOSYNTHESIS; STREPTOCOCCUS-PNEUMONIAE; CAPSULAR POLYSACCHARIDE; STRUCTURAL FEATURES; MASS-SPECTROMETRY; OUTER-MEMBRANE; CELL-ENVELOPE	The suborder Corynebacterineae encompasses species like Corynebacterium glutamicum, which has been harnessed for industrial production of amino acids, as well as Corynebacterium diphtheriae and Mycobacterium tuberculosis, which cause devastating human diseases. A distinctive component of the Corynebacterineae cell envelope is the mycolyl-arabinogalactan (mAG) complex. The mAG is composed of lipid mycolic acids, and arabinofuranose (Araf) and galactofuranose (Galf) carbohydrate residues. Elucidating microbe-specific differences inmAG composition could advance biotechnological applications and lead to new antimicrobial targets. To this end, we compare and contrast galactan biosynthesis in C. diphtheriae and M. tuberculosis. In each species, the galactan is constructed from uridine 5'-diphosphate-alpha-D-galactofuranose (UDP-Galf), which is generated by the enzyme UDP-galactopyranose mutase (UGM or Glf). UGM and the galactan are essential in M. tuberculosis, but their importance in Corynebacterium species was not known. We show that small molecule inhibitors ofUGMimpede C. glutamicum growth, suggesting that the galactan is critical in corynebacteria. Previous cell wall analysis data suggest the galactan polymer is longer in mycobacterial species than corynebacterial species. To explore the source of galactan length variation, a C. diphtheriae ortholog of the M. tuberculosis carbohydrate polymerase responsible for the bulk of galactan polymerization, GlfT2, was produced, and its catalytic activity was evaluated. The C. diphtheriae GlfT2 gave rise to shorter polysaccharides than those obtained with the M. tuberculosis GlfT2. These data suggest that GlfT2 alone can influence galactan length. Our results provide tools, both small molecule and genetic, for probing and perturbing the assembly of the Corynebacterineae cell envelope.	[Wesener, Darryl A.; Kiessling, Laura L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Levengood, Matthew R.; Kiessling, Laura L.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kiessling, LL (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	kiessling@chem.wisc.edu		Kiessling, Laura/0000-0001-6829-1500; Wesener, Darryl/0000-0002-8132-7018	National Institutes of Health [S10 RR13790]; UW-Madison; National Science Foundation [BIR-9512577]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024601, S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI126592, R01AI063596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW-Madison; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MALDI-TOF mass spectrometry data were obtained at the University of Wisconsin (UW)-Madison Chemistry Instrument Center Mass Spectrometry Facility on a Bruker Ultraflex III Instrument that was supported by the National Institutes of Health (Center for Research Resources 1S10RR024601). Additional experiments were carried out at the UW-Madison Biophysics Instrumentation Facility, which is supported by UW-Madison, National Science Foundation Grant BIR-9512577 and National Institutes of Health Grant S10 RR13790. We acknowledge R.A. Splain for synthesis of the synthetic acceptor substrates used in this study and M.A. Martinez Farias for synthesis of the FP probes. We thank H.L. Hodges and A.M. Justen for helpful discussion and help preparing the manuscript.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Angala SK, 2014, CRIT REV BIOCHEM MOL, V49, P361, DOI 10.3109/10409238.2014.925420; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; Berg S, 2005, J BIOL CHEM, V280, P5651, DOI 10.1074/jbc.M411418200; BESRA GS, 1995, BIOCHEMISTRY-US, V34, P4257, DOI 10.1021/bi00013a015; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Birch HL, 2009, J BACTERIOL, V191, P4879, DOI 10.1128/JB.00296-09; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Brown CD, 2012, J AM CHEM SOC, V134, P6552, DOI 10.1021/ja301723p; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chad JM, 2007, BIOCHEMISTRY-US, V46, P6723, DOI 10.1021/bi7002795; COYLE MB, 1990, CLIN MICROBIOL REV, V3, P227, DOI 10.1128/CMR.3.3.227-246.1990; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; DAFFE M, 1990, J BIOL CHEM, V265, P6734; DAFFE M, 1993, CARBOHYD RES, V249, P383, DOI 10.1016/0008-6215(93)84102-C; Dover LG, 2004, FEMS MICROBIOL REV, V28, P225, DOI 10.1016/j.femsre.2003.10.001; Dykhuizen EC, 2008, J AM CHEM SOC, V130, P6706, DOI 10.1021/ja8018687; Dykhuizen EC, 2009, ORG LETT, V11, P193, DOI 10.1021/ol802094p; Farias MAM, 2014, J AM CHEM SOC, V136, P8492, DOI 10.1021/ja500622v; Forsee WT, 2009, J BIOL CHEM, V284, P11836, DOI 10.1074/jbc.M900379200; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Goude R, 2009, ANTIMICROB AGENTS CH, V53, P4138, DOI 10.1128/AAC.00162-09; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; Hermann T, 2003, J BIOTECHNOL, V104, P155, DOI 10.1016/S0168-1656(03)00149-4; Horsburgh CR, 2015, NEW ENGL J MED, V373, P2149, DOI 10.1056/NEJMra1413919; Jankute M, 2015, ANNU REV MICROBIOL, V69, P405, DOI 10.1146/annurev-micro-091014-104121; Jankute M, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0013-2013; Kacem R, 2004, MICROBIOL-SGM, V150, P73, DOI 10.1099/mic.0.26583-0; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kincaid VA, 2015, ACS CHEM BIOL, V10, P2209, DOI 10.1021/acschembio.5b00370; Krawczyk J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp453; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Lee R, 1996, ANAL BIOCHEM, V242, P1, DOI 10.1006/abio.1996.0419; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Levengood MR, 2011, J AM CHEM SOC, V133, P12758, DOI 10.1021/ja204448t; Marlow AL, 2001, ORG LETT, V3, P2517, DOI 10.1021/ol016170d; May JF, 2012, BIOCHEMISTRY-US, V51, P1148, DOI 10.1021/bi201820p; May JF, 2009, P NATL ACAD SCI USA, V106, P11851, DOI 10.1073/pnas.0901407106; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; Mikusova K, 2006, J BACTERIOL, V188, P6592, DOI 10.1128/JB.00489-06; Minnikin D. E., 1982, BIOL MYCOBACTERIA, P95; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Partha SK, 2010, J MOL BIOL, V403, P578, DOI 10.1016/j.jmb.2010.08.053; Paulsen IT, 1997, MICROBIOL-SGM, V143, P2685, DOI 10.1099/00221287-143-8-2685; Peltier P, 2010, CHEM BIOL, V17, P1356, DOI 10.1016/j.chembiol.2010.10.014; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rose NL, 2008, CARBOHYD RES, V343, P2130, DOI 10.1016/j.carres.2008.03.023; Rose NL, 2006, J AM CHEM SOC, V128, P6721, DOI 10.1021/ja058254d; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Seidel M, 2007, GLYCOBIOLOGY, V17, P210, DOI 10.1093/glycob/cwl066; Soltero-Higgin M, 2004, J AM CHEM SOC, V126, P10532, DOI 10.1021/ja048017v; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Szczepina MG, 2009, CHEMBIOCHEM, V10, P2052, DOI 10.1002/cbic.200900202; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; Ventura CL, 2006, MOL MICROBIOL, V61, P723, DOI 10.1111/j.1365-2958.2006.05259.x; Wang TSA, 2008, J AM CHEM SOC, V130, P14068, DOI 10.1021/ja806016y; Wesener DA, 2013, BIOCHEMISTRY-US, V52, P4391, DOI 10.1021/bi400264d; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; Wheatley RW, 2012, J BIOL CHEM, V287, P28132, DOI 10.1074/jbc.M112.347484; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Yamatsugu K, 2016, J AM CHEM SOC, V138, P9205, DOI 10.1021/jacs.6b04481; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944; Zhang QB, 2000, J AM CHEM SOC, V122, P9065, DOI 10.1021/ja001333z; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	73	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2944	2955		10.1074/jbc.M116.759340	http://dx.doi.org/10.1074/jbc.M116.759340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28039359	hybrid, Green Published			2022-12-28	WOS:000395535100034
J	Takahashi, M; Li, YP; Dillon, TJ; Stork, PJS				Takahashi, Maho; Li, Yanping; Dillon, Tara J.; Stork, Philip J. S.			Phosphorylation of Rap1 by cAMP-dependent Protein Kinase (PKA) Creates a Binding Site for KSR to Sustain ERK Activation by cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASES; B-RAF; CYCLIC-AMP; CELL-PROLIFERATION; MELANOMA-CELLS; MAP KINASE; PATHWAY; SUPPRESSOR; SCAFFOLD; CALCIUM	Cyclic adenosine monophosphate (cAMP) is an important mediator of hormonal stimulation of cell growth and differentiation through its activation of the extracellular signal-regulated kinase (ERK) cascade. Two small G proteins, Ras and Rap1 have been proposed to mediate this activation. Using HEK293 cells as a model system, we have recently shown that both Ras and Rap1 are required for cAMP signaling to ERKs. However, cAMP-dependent Ras signaling to ERKs is transient and rapidly terminated by PKA phosphorylation of the Raf isoforms C-Raf and B-Raf. In contrast, cAMP-dependent Rap1 signaling to ERKs and Rap1 is potentiated by PKA. We show that this is due to sustained binding of B-Raf to Rap1. One of the targets of PKA is Rap1 itself, directly phosphorylating Rap1a on serine 180 and Rap1b on serine 179. We show that these phosphorylations create potential binding sites for the adaptor protein 14-3-3 that links Rap1 to the scaffold protein KSR. These results suggest that Rap1 activation of ERKs requiresPKAphosphorylation and KSR binding. Because KSR and B-Raf exist as heterodimers within the cell, this binding also brings B-Raf to Rap1, allowing Rap1 to couple to ERKs through B-Raf binding to Rap1 independently of its Ras-binding domain.	[Takahashi, Maho; Li, Yanping; Dillon, Tara J.; Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Stork, PJS (corresponding author), Oregon Hlth & Sci Univ, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	stork@ohsu.edu	li, yan/GTI-4638-2022		National Institutes of Health [R01 DK090309, R21 CA191392-01]; NATIONAL CANCER INSTITUTE [T32CA106195, R21CA191392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK090309 and R21 CA191392-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alleaume C, 2003, NEUROPEPTIDES, V37, P98, DOI 10.1016/S0143-4179(03)00020-9; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Dugan LL, 1999, J BIOL CHEM, V274, P25842, DOI 10.1074/jbc.274.36.25842; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Edreira MM, 2009, J BIOL CHEM, V284, P27480, DOI 10.1074/jbc.M109.011312; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fernandez MR, 2012, MOL CELL BIOL, V32, P3718, DOI 10.1128/MCB.06754-11; FISCHER TH, 1991, FEBS LETT, V283, P173, DOI 10.1016/0014-5793(91)80581-M; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Jagemann LR, 2008, J BIOL CHEM, V283, P17450, DOI 10.1074/jbc.M709185200; Karhoff D, 2007, NEUROENDOCRINOLOGY, V85, P45, DOI 10.1159/000100508; Kortum RL, 2006, MOL CELL BIOL, V26, P2202, DOI 10.1128/MCB.26.6.2202-2214.2006; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kuroda S, 1996, J BIOL CHEM, V271, P14680, DOI 10.1074/jbc.271.25.14680; Le Pechon-Vallee C, 2000, NEUROENDOCRINOLOGY, V72, P46, DOI 10.1159/000054570; Li YP, 2016, J BIOL CHEM, V291, P21584, DOI 10.1074/jbc.M116.730978; Li YP, 2013, J BIOL CHEM, V288, P27646, DOI 10.1074/jbc.M113.463067; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; McKay Melissa M, 2011, Small GTPases, V2, P276; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Monaghan TK, 2008, J NEUROCHEM, V104, P74, DOI 10.1111/j.1471-4159.2007.05018.x; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; Qiu WS, 2000, J BIOL CHEM, V275, P31921, DOI 10.1074/jbc.M003327200; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Romano D, 2003, J BIOL CHEM, V278, P51386, DOI 10.1074/jbc.M308372200; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Van Kolen K, 2010, NEUROPHARMACOLOGY, V58, P135, DOI 10.1016/j.neuropharm.2009.06.022; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Zeiller C, 2012, CELL SIGNAL, V24, P2237, DOI 10.1016/j.cellsig.2012.08.006; Zhou M, 2002, J MOL BIOL, V315, P435, DOI 10.1006/jmbi.2001.5263	68	30	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1449	1461		10.1074/jbc.M116.768986	http://dx.doi.org/10.1074/jbc.M116.768986			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	28003362	Green Published, hybrid			2022-12-28	WOS:000393339800026
J	Hanske, J; Schulze, J; Aretz, J; McBride, R; Loll, B; Schmidt, H; Knirel, Y; Rabsch, W; Wahl, MC; Paulson, JC; Rademacher, C				Hanske, Jonas; Schulze, Jessica; Aretz, Jonas; McBride, Ryan; Loll, Bernhard; Schmidt, Henrik; Knirel, Yuriy; Rabsch, Wolfgang; Wahl, Markus C.; Paulson, James C.; Rademacher, Christoph			Bacterial Polysaccharide Specificity of the Pattern Recognition Receptor Langerin Is Highly Species- dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; CARBOHYDRATE-RECOGNITION; STRUCTURAL BASIS; DC-SIGN; BINDING; PROTEIN; CELLS; DIVERSITY; PATHOGEN; ANTIGENS	The recognition of pathogen surface polysaccharides by glycan- binding proteins is a cornerstone of innate host defense. Many members of the C-type lectin receptor family serve as pattern recognition receptors facilitating pathogen uptake, antigen processing, and immunomodulation. Despite the high evolutionary pressure in host-pathogen interactions, it is still widely assumed that genetic homology conveys similar specificities. Here, we investigate the ligand specificities of the human and murine forms of the myeloid C-type lectin receptor langerin for simple and complex ligands augmented by structural insight into murine langerin. Although the two homologs share the same three-dimensional structure and recognize simple ligands identically, a screening of more than 300 bacterial polysaccharides revealed highly diverging avidity and selectivity for larger and more complex glycans. Structural and evolutionary conservation analysis identified a highly variable surface adjacent to the canonic binding site, potentially forming a secondary site of interaction for large glycans.	[Hanske, Jonas; Schulze, Jessica; Aretz, Jonas; Schmidt, Henrik; Rademacher, Christoph] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Wissensch Pk Golm,Muhlenberg 1, D-14424 Potsdam, Germany; [Hanske, Jonas; Schulze, Jessica; Aretz, Jonas; Loll, Bernhard; Schmidt, Henrik; Wahl, Markus C.; Rademacher, Christoph] Free Univ Berlin, Dept Biol Chem & Pharm, D-14195 Berlin, Germany; [McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Immunol & Microbial Sci, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Knirel, Yuriy] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia; [Rabsch, Wolfgang] Robert Koch Inst, Wernigerode Branch, Natl Reference Ctr Salmonellae & Other Bacterial, D-38855 Wernigerode, Germany	Max Planck Society; Free University of Berlin; Scripps Research Institute; Scripps Research Institute; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; Robert Koch Institute	Rademacher, C (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Wissensch Pk Golm,Muhlenberg 1, D-14424 Potsdam, Germany.	Christoph.Rademacher@mpikg.mpg.de	Rademacher, Christoph/H-3101-2012; Knirel, Yuriy A/E-2058-2014; Loll, Bernhard/J-4815-2019; McBride, Ryan/E-6812-2011; Wahl, Markus C./D-6365-2017; Aretz, Jonas/AAL-4829-2020; Paulson, James/AAG-3565-2019	Rademacher, Christoph/0000-0001-7082-7239; Loll, Bernhard/0000-0001-7928-4488; Wahl, Markus C./0000-0002-2811-5307; Aretz, Jonas/0000-0002-4623-5820; Hanske, Jonas/0000-0002-8854-3012	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Daniel Varon Silva for generously providing alpha-methyl-(alpha-1,2)-mannobiose and Willie Vann for granting access to polysialic acid structures. J. H. thanks Daniel Tesolin for help with optimizing protein expression and labeling. We acknowledge Claudia Alings for excellent technical support. C. R. and J. H. thank Peter Seeberger for providing the research environment and fruitful discussions. We accessed beamlines of the BESSY II (Berliner Elektronenspeicherring-Gesellschaft fur Synchrotronstrahlung II) storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien und Energie, the Freie Universitat Berlin, the Humboldt-Universitat zu Berlin, the Max-Delbruck Centrum, and the Leibniz-Institut fur Molekulare Pharmakologie. We acknowledge beamtime and support at the EMBL beamline P14 of PETRA III (Deutsches Elektronen Synchrotron, Hamburg, Germany).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aretz J, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00323; Chabrol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050722; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; de Jong MAWP, 2010, MOL IMMUNOL, V47, P1216, DOI 10.1016/j.molimm.2009.12.016; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; DRICKAMER K, 1995, CURR OPIN STRUC BIOL, V5, P612, DOI 10.1016/0959-440X(95)80052-2; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Feinberg H, 2013, J BIOL CHEM, V288, P36762, DOI 10.1074/jbc.M113.528000; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Forni D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004189; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Garcia-Vallejo JJ, 2013, TRENDS IMMUNOL, V34, P482, DOI 10.1016/j.it.2013.03.001; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Horan N, 1999, P NATL ACAD SCI USA, V96, P11782, DOI 10.1073/pnas.96.21.11782; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Mayer M, 2004, J AM CHEM SOC, V126, P4453, DOI 10.1021/ja0398870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Munoz-Garcia JC, 2015, J AM CHEM SOC, V137, P4100, DOI 10.1021/ja511529x; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Stowell SR, 2014, NAT CHEM BIOL, V10, P470, DOI [10.1038/nchembio.1525, 10.1038/NCHEMBIO.1525]; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; van den Berg LM, 2015, J IMMUNOL, V195, P1763, DOI 10.4049/jimmunol.1402356; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	44	25	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					862	871		10.1074/jbc.M116.751750	http://dx.doi.org/10.1074/jbc.M116.751750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27903635	hybrid, Green Published			2022-12-28	WOS:000392318700009
J	Nishina, T; Deguchi, Y; Miura, R; Yamazaki, S; Shinkai, Y; Kojima, Y; Okumura, K; Kumagai, Y; Nakano, H				Nishina, Takashi; Deguchi, Yutaka; Miura, Ryosuke; Yamazaki, Soh; Shinkai, Yasuhiro; Kojima, Yuko; Okumura, Ko; Kumagai, Yoshito; Nakano, Hiroyasu			Critical Contribution of Nuclear Factor Erythroid 2-related Factor 2 (NRF2) to Electrophile-induced Interleukin-11 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; SIGNAL TRANSDUCER; BINDING-SITES; PROTEIN; STRESS; ACTIVATION; RECEPTOR; CANCER; GENE; 1,2-NAPHTHOQUINONE	Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that plays a crucial role in protection of cells from electrophile-induced toxicity through up-regulating phase II detoxifying enzymes and phase III transporters. We previously reported that oxidative stress induces up-regulation of interleukin-11 (IL-11), a member of the IL-6 family that ameliorates acetaminophen-induced liver toxicity. However, a role for IL-11 in protection of cells from electrophile-induced toxicity remains unclear. Here we show that an environmental electrophile, 1,2-naphthoquinone (1,2-NQ), but not 15d-prostaglandin J(2) (PGJ(2)) or tert-butylhydroxyquinone (tBHQ), induced IL-11 production. Consistent with a crucial role for prolonged ERK activation in H2O2-induced IL-11 production, 1,2-NQ, but not 15d-PGJ(2) or tBHQ, elicited prolonged ERK activation. Conversely, inhibition of the ERK pathway by a MEK inhibitor completely blocked 1,2-NQ-induced IL-11 production at both protein and mRNA levels, further substantiating an intimate cross-talk between ERK activation and 1,2-NQ-induced IL-11 production. Promoter analysis of the Il11 gene revealed that two AP-1 sites were essential for 1,2-NQ-induced promoter activities. Among various members of the AP-1 family, Fra-1 was upregulated by 1,2-NQ, and its up-regulation was blocked by a MEK inhibitor. Although NRF2 was not required for H2O2-in-duced IL11 up-regulation, NRF2 was essential for 1,2-NQ-induced IL11 up-regulation by increasing Fra-1 proteins possibly through promoting mRNA translation of FOSL1. Finally, intraperitoneal administration of 1,2-NQ induced body weight loss in wild-type mice, which was further exacerbated in Il11ra1(-/-) mice compared with Il11ra1(+/-) mice. Together, both Fra-1 and NRF2 play crucial roles in IL-11 production that protects cells from 1,2-NQ intestinal toxicity.	[Nishina, Takashi; Deguchi, Yutaka; Miura, Ryosuke; Yamazaki, Soh; Nakano, Hiroyasu] Toho Univ, Sch Med, Dept Biochem, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan; [Miura, Ryosuke] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Lab Mol Biol & Immunol,Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan; [Shinkai, Yasuhiro; Kumagai, Yoshito] Univ Tsukuba, Fac Med, Environm Biol Lab, Tsukuba, Ibaraki 3058575, Japan; [Kojima, Yuko] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Lab Morphol & Image Anal, Tokyo 1138421, Japan; [Okumura, Ko] Juntendo Univ, Grad Sch Med, Atopy Res Ctr, Tokyo 1138421, Japan	Toho University; Tokyo University of Science; University of Tsukuba; Juntendo University; Juntendo University	Nakano, H (corresponding author), Toho Univ, Sch Med, Dept Biochem, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	hiroyasu.nakano@med.toho-u.ac.jp	Shinkai, Yasuhiro/F-9941-2013; Nishina, Takashi/AAQ-3942-2021	Nishina, Takashi/0000-0003-2301-9874; Nakano, Hiroyasu/0000-0003-4843-1427; Yamazaki, Soh/0000-0001-5038-1567; Miura, Ryosuke/0000-0003-1249-7803	Japan Society for the Promotion of Science (JSPS) [24390100, 26460397, 24790328, 25670167]; MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan [26110003]; Fund for the Advancement of Science in commemoration of Toho University's 60th anniversary; Project Research Grant of Toho University School of Medicine [28-3]; NOVARTIS Foundation for the Promotion of Science; Naito Science Foundation; Uehara Science Foundation; Takeda Science Foundation; JSPS Fellowship [13J10995]; Grants-in-Aid for Scientific Research [16K01378] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fund for the Advancement of Science in commemoration of Toho University's 60th anniversary; Project Research Grant of Toho University School of Medicine; NOVARTIS Foundation for the Promotion of Science; Naito Science Foundation; Uehara Science Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) 24390100 (to H. N.) and Scientific Research (C) 26460397 (to T. N.) and Grant-in-Aid for Young Scientists (B) 24790328 (to T. N.), and Challenging Exploratory Research 25670167 (to H. N.) from the Japan Society for the Promotion of Science (JSPS). This work was also supported by Grant-in-Aid for Scientific Research on Innovative Areas 26110003 (to H. N.) from the MEXT (Ministry of Education, Culture, Sports, Science, and Technology), Japan, the Fund for the Advancement of Science in commemoration of Toho University's 60th anniversary (to T. N.), and Project Research Grant of Toho University School of Medicine 28-3 (to T. N.). This work was also supported by research grants from the NOVARTIS Foundation for the Promotion of Science (to H. N.), the Naito Science Foundation (to H. N.), the Uehara Science Foundation (to H. N.), and the Takeda Science Foundation (to H. N.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by JSPS Fellowship 13J10995.	Beei C, 2013, J TOXICOL SCI, V38, P793; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; FRILING RS, 1992, P NATL ACAD SCI USA, V89, P668, DOI 10.1073/pnas.89.2.668; Fujii S, 2016, ARCH BIOCHEM BIOPHYS, V595, P140, DOI 10.1016/j.abb.2015.11.008; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038; Katsuoka F, 2005, J BIOL CHEM, V280, P4483, DOI 10.1074/jbc.M411451200; Kumagai Y, 2012, ANNU REV PHARMACOL, V52, P221, DOI 10.1146/annurev-pharmtox-010611-134517; Lorchner H, 2015, NAT MED, V21, P353, DOI 10.1038/nm.3816; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Menegon S, 2016, TRENDS MOL MED, V22, P578, DOI 10.1016/j.molmed.2016.05.002; Miura T, 2011, CHEM RES TOXICOL, V24, P1836, DOI 10.1021/tx200025y; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nishina T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002056; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Putoczki TL, 2015, IMMUNOTHERAPY-UK, V7, P441, DOI [10.2217/IMT.15.17, 10.2217/imt.15.17]; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Wages PA, 2015, CHEM RES TOXICOL, V28, P2411, DOI 10.1021/acs.chemrestox.5b00424	26	16	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					205	216		10.1074/jbc.M116.744755	http://dx.doi.org/10.1074/jbc.M116.744755			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27872193	Green Published, hybrid			2022-12-28	WOS:000391578000018
J	Van de Velde, LA; Subramanian, C; Smith, AM; Barron, L; Qualls, JE; Neale, G; Alfonso-Pecchio, A; Jackowski, S; Rock, CO; Wynn, TA; Murray, PJ				Van de Velde, Lee-Ann; Subramanian, Chitra; Smith, Amber M.; Barron, Luke; Qualls, Joseph E.; Neale, Geoffrey; Alfonso-Pecchio, Adolfo; Jackowski, Suzanne; Rock, Charles O.; Wynn, Thomas A.; Murray, Peter J.			T Cells Encountering Myeloid Cells Programmed for Amino Acid-dependent Immunosuppression Use Rictor/mTORC2 Protein for Proliferative Checkpoint Decisions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE-SYNTHASE; L-ARGININE METABOLISM; DENDRITIC CELLS; ACTIVATION; MTOR; MACROPHAGES; INTERLEUKIN-2; SCHISTOSOMIASIS; DIFFERENTIATION; AVAILABILITY	Modulation of T cell proliferation and function by immunoregulatory myeloid cells are an essential means of preventing self-reactivity and restoring tissue homeostasis. Consumption of amino acids such as arginine and tryptophan by immunoregulatory macrophages is one pathway that suppresses local T cell proliferation. Using a reduced complexity in vitro macrophage-T cell co-culture system, we show that macrophage arginase-1 is the only factor required by M2 macrophages to block T cells in G1, and this effect is mediated by L-arginine elimination rather than metabolite generation. Tracking how T cells adjust their metabolism when deprived of arginine revealed the significance of macrophage-mediated arginine deprivation to T cells. We found mTORC1 activity was unaffected in the initial G1 block. After 2 days of arginine deprivation, mTORC1 activity declined paralleling a selective down-regulation of SREBP target gene expression, whereas mRNAs involved in glycolysis, gluconeogenesis, and T cell activation were unaffected. Cell cycle arrest was reversible at any point by exogenous arginine, suggesting starved T cells remain poised awaiting nutrients. Arginine deprivation-induced cell cycle arrest was mediated in part by Rictor/mTORC2, providing evidence that this nutrient recognition pathway is a central component of how T cells measure environmental arginine.	[Van de Velde, Lee-Ann; Subramanian, Chitra; Smith, Amber M.; Qualls, Joseph E.; Alfonso-Pecchio, Adolfo; Jackowski, Suzanne; Rock, Charles O.; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, Mail Stop 320,262 Danny Thomas Pl, Memphis, TN 38105 USA; [Van de Velde, Lee-Ann; Smith, Amber M.; Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Barron, Luke; Wynn, Thomas A.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Qualls, Joseph E.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Mail Stop 320,262 Danny Thomas Pl, Memphis, TN 38105 USA.	peter.murray@stjude.org	Chitra, S/GPX-8113-2022; Subramanian, Chitra/N-9210-2018; Jackowski, Suzanne/N-8168-2018; Murray, Peter J/K-4725-2018; Wynn, Thomas A/AAO-3523-2021	Subramanian, Chitra/0000-0003-1101-5307; Jackowski, Suzanne/0000-0002-6855-1429; Murray, Peter J/0000-0001-6329-9802; Wynn, Thomas A/0000-0002-7244-8731; Qualls, Joseph/0000-0002-0113-2166	National Institutes of Health [AI062921, CA138064]; Cancer Center Core Grant [P30 CA21765]; American Lebanese Syrian Associated Charities; National Institutes of Health Intramural Program; NATIONAL CANCER INSTITUTE [F32CA138064, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000829, R01AI062921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Core Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); National Institutes of Health Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI062921 (to P. J. M.) and CA138064 (to J. E. Q.), Cancer Center Core Grant P30 CA21765, the American Lebanese Syrian Associated Charities, and the National Institutes of Health Intramural Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barron L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061961; Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Carroll B, 2016, ELIFE, V5, DOI 10.7554/eLife.11058; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; CHUANG JC, 1990, CLIN EXP IMMUNOL, V81, P173; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; CURRIE GA, 1979, BRIT J CANCER, V39, P613, DOI 10.1038/bjc.1979.112; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; El-Gayar S, 2003, J IMMUNOL, V171, P4561, DOI 10.4049/jimmunol.171.9.4561; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009; Hogan LH, 2002, J IMMUNOL, V169, P6386, DOI 10.4049/jimmunol.169.11.6386; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Manner CK, 2003, J NEUROCHEM, V85, P476, DOI 10.1046/j.1471-4159.2003.01695.x; Marigo I, 2016, CANCER CELL, V30, P377, DOI 10.1016/j.ccell.2016.08.004; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nascimento M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004282; Njau F, 2009, MICROBES INFECT, V11, P1002, DOI 10.1016/j.micinf.2009.07.006; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Offman MN, 2011, BLOOD, V117, P1614, DOI 10.1182/blood-2010-07-298422; Panda K, 2002, J BIOL CHEM, V277, P31020, DOI 10.1074/jbc.M203749200; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Qualls JE, 2012, CELL HOST MICROBE, V12, P313, DOI 10.1016/j.chom.2012.07.012; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Ross SH, 2016, IMMUNITY, V45, P685, DOI 10.1016/j.immuni.2016.07.022; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Saxton RA, 2016, NATURE, V536, P229, DOI 10.1038/nature19079; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; TURNER JM, 1993, INT IMMUNOL, V5, P1199, DOI 10.1093/intimm/5.10.1199; Van De Velde LA, 2016, CELL REP, V17, P2247, DOI 10.1016/j.celrep.2016.10.079; Van de Velde LA, 2016, J BIOL CHEM, V291, P25815, DOI 10.1074/jbc.C116.763623; Vannella KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004372; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Waysbort N, 2013, J IMMUNOL, V191, P5822, DOI 10.4049/jimmunol.1301575; Werner A, 2016, EUR J IMMUNOL, V46, P92, DOI 10.1002/eji.201546047; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068	60	39	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					15	30		10.1074/jbc.M116.766238	http://dx.doi.org/10.1074/jbc.M116.766238			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27903651	hybrid, Green Published			2022-12-28	WOS:000391578000002
J	Weider, E; Susan-Resiga, D; Essalmani, R; Hamelin, J; Asselin, MC; Nimesh, S; Ashraf, Y; Wycoff, KL; Zhang, JB; Prat, A; Seidah, NG				Weider, Elodie; Susan-Resiga, Delia; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Nimesh, Surendra; Ashraf, Yahya; Wycoff, Keith L.; Zhang, Jianbing; Prat, Annik; Seidah, Nabil G.			Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation (vol 291, pg 16659, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Seidah, Nabil/I-3596-2013; Prat, Annik/S-6757-2018; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017	Seidah, Nabil/0000-0001-6503-9342; Prat, Annik/0000-0002-8007-5277; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X				Weider E, 2016, J BIOL CHEM, V291, P16659, DOI 10.1074/jbc.M116.717736	1	4	4	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26586	26586		10.1074/jbc.A116.717736	http://dx.doi.org/10.1074/jbc.A116.717736			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27986868	Green Published, hybrid			2022-12-28	WOS:000391568200029
J	Yoshimoto, FK; Gonzalez, E; Auchus, RJ; Guengerich, FP				Yoshimoto, Francis K.; Gonzalez, Eric; Auchus, Richard J.; Guengerich, F. Peter			Mechanism of 17 alpha,20-lyase and new hydroxylation reactions of human cytochrome P450 17A1. O-18 LABELING AND OXYGEN SURROGATE EVIDENCE FOR A ROLE OF A PERFERRYL OXYGEN (vol 291, 17143, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NIGMS NIH HHS [R25 GM062459] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966	1	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26587	26587		10.1074/jbc.A116.732966	http://dx.doi.org/10.1074/jbc.A116.732966			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27986869	hybrid, Green Published			2022-12-28	WOS:000391568200030
J	Bouillet, S; Genest, O; Jourlin-Castelli, C; Fons, M; Mejean, V; Iobbi-Nivol, C				Bouillet, Sophie; Genest, Olivier; Jourlin-Castelli, Cecile; Fons, Michel; Mejean, Vincent; Iobbi-Nivol, Chantal			The General Stress Response sigma(S) Is Regulated by a Partner Switch in the Gram-negative Bacterium Shewanella oneidensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; RNA-POLYMERASE; III SECRETION; RPOS; RSSB; STABILITY; COLONIZATION; DEGRADATION; SYSTEM	Here, we show that a partner-switching system of the aquatic Proteobacterium Shewanella oneidensis regulates post-translationally sigma(S) (also called RpoS), the general stress response sigma factor. Genes SO2118 and SO2119 encode CrsA and CrsR, respectively. CrsR is a three-domain protein comprising a receiver, a phosphatase, and a kinase/anti-sigma domains, and CrsA is an anti-sigma antagonist. In vitro, CrsR sequesters sigma(S) and possesses kinase and phosphatase activities toward CrsA. In turn, dephosphorylated CrsA binds the anti-sigma domain of CrsR to allow the release of sigma(S). This study reveals a novel pathway that post-translationally regulates the general stress response sigma factor differently than what was described for other proteobacteria like Escherichia coli. We argue that this pathway allows probably a rapid bacterial adaptation.	[Bouillet, Sophie; Genest, Olivier; Jourlin-Castelli, Cecile; Fons, Michel; Mejean, Vincent; Iobbi-Nivol, Chantal] Aix Marseille Univ, CNRS, BIP UMR7281, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Iobbi-Nivol, C (corresponding author), CNRS, BIP IMM, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	iobbi@imm.cnrs.fr	Genest, Olivier/GQZ-3215-2022	Genest, Olivier/0000-0003-1240-2827; Fons, Michel/0000-0001-8263-3669; Mejean, Vincent/0000-0001-6533-5846	Centre National de la Recherche Scientifique; Aix-Marseille Universite; Ministere de l'enseignement superieur et de la recherche fellowship	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Ministere de l'enseignement superieur et de la recherche fellowship	This work was supported by the Centre National de la Recherche Scientifique and Aix-Marseille Universite. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Ministere de l'enseignement superieur et de la recherche fellowship and Aix-Marseille Universite.	ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Baraquet C, 2009, MOL MICROBIOL, V73, P278, DOI 10.1111/j.1365-2958.2009.06770.x; Battesti A, 2012, J BACTERIOL, V194, P2470, DOI 10.1128/JB.00132-12; Battesti A, 2015, P NATL ACAD SCI USA, V112, P5159, DOI 10.1073/pnas.1504639112; Battesti A, 2013, GENE DEV, V27, P2722, DOI 10.1101/gad.229617.113; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Becker G, 2000, MOL MICROBIOL, V35, P657, DOI 10.1046/j.1365-2958.2000.01736.x; Bhuwan M, 2012, J BIOL CHEM, V287, P1903, DOI 10.1074/jbc.M111.256586; Bordi C, 2003, J BACTERIOL, V185, P2042, DOI 10.1128/JB.185.6.2042-2045.2003; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; de Been M, 2011, MICROBIOL-SGM, V157, P3, DOI 10.1099/mic.0.045740-0; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; Dufour A, 1996, J BACTERIOL, V178, P3701, DOI 10.1128/jb.178.13.3701-9sigma.1996; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fiebig A, 2015, ANNU REV GENET, V49, P603, DOI 10.1146/annurev-genet-112414-054813; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fimlaid KA, 2015, CURR OPIN MICROBIOL, V24, P88, DOI 10.1016/j.mib.2015.01.006; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Gottesman S, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P59; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Houot L, 2012, MICROBIOL-SGM, V158, P1964, DOI 10.1099/mic.0.057059-0; Hryckowian AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01043-14; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kozak NA, 2005, J BACTERIOL, V187, P5665, DOI 10.1128/JB.187.16.5665-5676.2005; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Landini P, 2014, ENV MICROBIOL REP, V6, P1, DOI 10.1111/1758-2229.12112; Larsen MR, 2001, PROTEOMICS, V1, P223; Lucchini S, 2009, MOL MICROBIOL, V74, P1169, DOI 10.1111/j.1365-2958.2009.06929.x; Magnin T, 1997, J BACTERIOL, V179, P3922, DOI 10.1128/jb.179.12.3922-3927.1997; Mattoo S, 2004, MOL MICROBIOL, V52, P1201, DOI 10.1111/j.1365-2958.2004.04053.x; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; Mika F, 2014, RNA BIOL, V11, P494, DOI 10.4161/rna.28867; Moreno M, 2000, J MOL MICROB BIOTECH, V2, P245; Morris AR, 2013, MOL MICROBIOL, V87, P509, DOI 10.1111/mmi.12109; Morris AR, 2011, MOL MICROBIOL, V82, P114, DOI 10.1111/j.1365-2958.2011.07800.x; Morris AR, 2010, ENVIRON MICROBIOL, V12, P2051, DOI 10.1111/j.1462-2920.2010.02269.x; Muffler A, 1996, EMBO J, V15, P1333, DOI 10.1002/j.1460-2075.1996.tb00475.x; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Park YH, 2013, P NATL ACAD SCI USA, V110, P21142, DOI 10.1073/pnas.1316629111; Pesavento C, 2012, NUCLEIC ACIDS RES, V40, P4783, DOI 10.1093/nar/gks055; Pratt LA, 1996, P NATL ACAD SCI USA, V93, P2488, DOI 10.1073/pnas.93.6.2488; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; Sharma AK, 2011, CELL PHYSIOL BIOCHEM, V28, P407, DOI 10.1159/000335104; Sheldon JR, 2012, APPL ENVIRON MICROB, V78, P8331, DOI 10.1128/AEM.02149-12; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Thompson CC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005125; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	61	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26151	26163		10.1074/jbc.M116.751933	http://dx.doi.org/10.1074/jbc.M116.751933			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27810894	Green Published, hybrid			2022-12-28	WOS:000390345200032
J	Jakobs, A; Steinmann, S; Henrich, SM; Schmidt, TJ; Klempnauer, KH				Jakobs, Anke; Steinmann, Simone; Henrich, Sarah Marie; Schmidt, Thomas J.; Klempnauer, Karl-Heinz			Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein beta (C/EBP beta) and Co-activator p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-MYB; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MIM-1 GENE; SYNERGISTIC ACTIVATION; MESSENGER-RNA; MYELOID GENES; CANCER CELLS; KAPPA-B; NF-M	Recent work has demonstrated pro-oncogenic functions of the transcription factor CCAAT box/enhancer-binding protein beta (C/EBP beta) in various tumors, implicating C/EBP beta as an interesting target for the development of small-molecule inhibitors. We have previously discovered that the sesquiterpene lactone helenalin acetate, a natural compound known to inhibit NF-kappa B, is a potent C/EBP beta inhibitor. We have now examined the inhibitory mechanism of helenalin acetate in more detail. We demonstrate that helenalin acetate is a significantly more potent inhibitor of C/EBP beta than of NF-kappa B. Our work shows that helenalin acetate inhibits C/EBP beta by binding to the N-terminal part of C/EBP beta, thereby disrupting the cooperation of C/EBP beta with the co-activator p300. C/EBP beta is expressed in several isoforms from alternative translational start codons. We have previously demonstrated that helenalin acetate selectively inhibits only the full-length (liver-enriched activating protein* (LAP*)) isoform but not the slightly shorter (LAP) isoform. Consistent with this, helenalin acetate binds to the LAP* but not to the LAP isoform, explaining why its inhibitory activity is selective for LAP*. Although helenalin acetate contains reactive groups that are able to interact covalently with cysteine residues, as exemplified by its effect on NF-kappa B, the inhibition of C/EBP beta by helenalin acetate is not due to irreversible reaction with cysteine residues of C/EBP beta. In summary, helenalin acetate is the first highly active small-molecule C/EBP beta inhibitor that inhibits C/EBP beta by a direct binding mechanism. Its selectivity for the LAP* isoform also makes helenalin acetate an interesting tool to dissect the functions of the LAP* and LAP isoforms.	[Jakobs, Anke; Steinmann, Simone; Henrich, Sarah Marie; Klempnauer, Karl-Heinz] Westfal Wilhelms Univ, Inst Biochem, D-48149 Munster, Germany; [Schmidt, Thomas J.] Westfal Wilhelms Univ, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany	University of Munster; University of Munster	Klempnauer, KH (corresponding author), Westfal Wilhelms Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de	Schmidt, Thomas J/M-1678-2016	Schmidt, Thomas J/0000-0003-2634-9705	Deutsche Krebshilfe; Graduate School of Chemistry at the University of Munster (GSC-MS)	Deutsche Krebshilfe(Deutsche Krebshilfe); Graduate School of Chemistry at the University of Munster (GSC-MS)	This work was supported by the Deutsche Krebshilfe. This work was also supported by a fellowship from the Graduate School of Chemistry at the University of Munster (GSC-MS) (to S. M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Morante D, 2011, NEUROSCIENCE, V176, P110, DOI 10.1016/j.neuroscience.2010.12.025; Aguilar-Morante D, 2015, ONCOTARGET, V6, P4369, DOI 10.18632/oncotarget.2976; Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; Bhaumik P, 2014, ACTA CRYSTALLOGR D, V70, P1914, DOI 10.1107/S1399004714009262; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buchele B, 2010, ANAL BIOCHEM, V401, P30, DOI 10.1016/j.ab.2010.02.020; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; Calkhoven CF, 2000, GENE DEV, V14, P1920; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chayka O, 2005, MOL CELL BIOL, V25, P499, DOI 10.1128/MCB.25.1.499-511.2005; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Hadaschik D, 2003, J VIROL, V77, P5253, DOI 10.1128/JVI.77.9.5253-5265.2003; Homma J, 2006, ONCOL REP, V15, P595; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Jakobs A, 2016, LEUKEMIA, V30, P1612, DOI 10.1038/leu.2016.16; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Joo M, 2004, J BIOL CHEM, V279, P6658, DOI 10.1074/jbc.M306267200; Kim MH, 2009, PROSTATE, V69, P1435, DOI 10.1002/pros.20993; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Mink S, 1996, MOL CELL BIOL, V16, P1316; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Schmidt TJ, 1997, BIOORGAN MED CHEM, V5, P645, DOI 10.1016/S0968-0896(97)00003-5; Schmidt TJ, 1999, BIOORGAN MED CHEM, V7, P2849, DOI 10.1016/S0968-0896(99)00234-5; Schomburg C, 2013, EUR J MED CHEM, V63, P313, DOI 10.1016/j.ejmech.2013.02.018; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Steinmann S, 2009, ONCOGENE, V28, P2446, DOI 10.1038/onc.2009.90; Steinmann S, 2013, J BIOL CHEM, V288, P22257, DOI 10.1074/jbc.M113.487769; Su WC, 2003, J BIOL CHEM, V278, P51150, DOI 10.1074/jbc.M305501200; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094	49	24	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					26098	26108		10.1074/jbc.M116.748129	http://dx.doi.org/10.1074/jbc.M116.748129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803164	hybrid, Green Published			2022-12-28	WOS:000390345200028
J	Richards, EJ; Zhang, G; Li, ZP; Permuth-Wey, J; Challa, S; Li, YJ; Kong, W; Dan, S; Bui, MM; Coppola, D; Mao, WM; Sellers, TA; Cheng, JQ				Richards, Edward J.; Zhang, Gu; Li, Zhu-Peng; Permuth-Wey, Jennifer; Challa, Sridevi; Li, Yajuan; Kong, William; Dan, Su; Bui, Marilyn M.; Coppola, Domenico; Mao, Wei-Min; Sellers, Thomas A.; Cheng, Jin Q.			Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) . LncRNA-HIT-MEDIATED TGF-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY EPITHELIA (vol 290, pg 6857, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Richards EJ, 2015, J BIOL CHEM, V290, P6857, DOI 10.1074/jbc.M114.610915	1	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22860	22860		10.1074/jbc.A114.610915	http://dx.doi.org/10.1074/jbc.A114.610915			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825098	hybrid, Green Published			2022-12-28	WOS:000386760600059
J	Mason, AR; Elia, LP; Finkbeiner, S				Mason, Amanda R.; Elia, Lisa P.; Finkbeiner, Steven			The Receptor-interacting Serine/Threonine Protein Kinase 1 (RIPK1) Regulates Progranulin Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; neurobiology; neurodegeneration; neurodegenerative disease; neurological disease; Ripk1; frontotemporal dementia; progranulin	FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; GENE-EXPRESSION; CELL-DEATH; INFLAMMATION; DEMENTIA; MUTATIONS; NEUROINFLAMMATION; POLYMORPHISM; NECROPTOSIS	Progranulin (PGRN), a secreted growth factor, is a key regulator of inflammation and is genetically linked to two common and devastating neurodegenerative diseases. Haploinsufficiency mutations in GRN, the gene encoding PGRN, cause frontotemporal dementia (FTD), and a GRN SNP confers significantly increased risk for Alzheimer's disease (AD). Because cellular and animal data indicate that increasing PGRN can reverse phenotypes of both FTD and AD, modulating PGRN level has been proposed as a therapeutic strategy for both diseases. However, little is known about the regulation of PGRN levels. In this study, we performed an siRNA-based screen of the kinome to identify genetic regulators of PGRN levels in a rodent cell-based model system. We found that knocking down receptor-interacting serine/threonine protein kinase 1 (Ripk1) increased both intracellular and extracellular PGRN protein levels by increasing the translation rate of PGRN without affecting mRNA levels. We observed this effect in Neuro2a cells, wild-type primary mouse neurons, and Grn-haploinsufficient primary neurons from an FTD mouse model. We found that the effect of RIPK1 on PGRN is independent of the kinase activity of RIPK1 and occurs through a novel signaling pathway. These data suggest that targeting RIPK1 may be a therapeutic strategy in both AD and FTD.	[Mason, Amanda R.; Elia, Lisa P.; Finkbeiner, Steven] Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA; [Mason, Amanda R.; Elia, Lisa P.; Finkbeiner, Steven] Taube Koret Ctr Neurodegenerat Dis Res, San Francisco, CA 94158 USA; [Mason, Amanda R.] Univ Calif San Francisco, Dev & Stem Cell Biol Grad Program, San Francisco, CA 94158 USA; [Mason, Amanda R.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	sfinkbeiner@gladstone.ucsf.edu			National Institutes of Health [3R01 NS039074, R21 NS093236]; California Institute for Regenerative Medicine (CIRM) [TG2-01153, RB4-06079, T32 HD007470, T32 GM007618]; Consortium for Frontotemporal Dementia Research; Taube/Koret Center for Neurodegenerative Disease Research; Hellman Foundation Program in Alzheimer's Disease Research; J. David Gladstone Institutes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS093236, R01NS039074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Consortium for Frontotemporal Dementia Research; Taube/Koret Center for Neurodegenerative Disease Research; Hellman Foundation Program in Alzheimer's Disease Research; J. David Gladstone Institutes(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants 3R01 NS039074, R21 NS093236; California Institute for Regenerative Medicine (CIRM) Grants TG2-01153, RB4-06079, T32 HD007470, and T32 GM007618; the Consortium for Frontotemporal Dementia Research; the Taube/Koret Center for Neurodegenerative Disease Research; the Hellman Foundation Program in Alzheimer's Disease Research; and the J. David Gladstone Institutes. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Capell A, 2014, J BIOL CHEM, V289, P25879, DOI 10.1074/jbc.M114.560128; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cuevas-Antonio R, 2010, CANCER INVEST, V28, P452, DOI 10.3109/07357900903346455; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; De Muynck L, 2011, J MOL NEUROSCI, V45, P549, DOI 10.1007/s12031-011-9553-z; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Demorrow Sharon, 2013, Transl Gastrointest Cancer, V2, P145; Elia L., 2014, OMICS APPL NEUROSCIE, P114; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Gass J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-33; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Hsiung GYR, 2011, J NEUROL SCI, V300, P28, DOI 10.1016/j.jns.2010.10.009; Ionis Pharmaceuticals, 2016, BIOG ION PHARM REP N; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Kalai M, 2007, CELL DEATH DIFFER, V14, P1050, DOI 10.1038/sj.cdd.4402110; Knopman DS, 2011, J MOL NEUROSCI, V45, P330, DOI 10.1007/s12031-011-9538-y; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Lee TH, 2003, MOL CELL BIOL, V23, P8377, DOI 10.1128/MCB.23.22.8377-8385.2003; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Moriwaki K, 2014, CYTOKINE GROWTH F R, V25, P167, DOI 10.1016/j.cytogfr.2013.12.013; Nguyen AD, 2013, J BIOL CHEM, V288, P8627, DOI 10.1074/jbc.M112.441949; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S1474-4422(07)70221-1; Serrero G, 2003, HUM PATHOL, V34, P1148, DOI 10.1016/S0046-8177(03)00425-8; Sheng JH, 2014, GENE, V542, P141, DOI 10.1016/j.gene.2014.03.041; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; World Health Organization and Alzheimers Disease International, 2012, DEM PUBL HLTH PRIOR; Zhang DW, 2010, CELL MOL IMMUNOL, V7, P243, DOI 10.1038/cmi.2010.10	42	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3262	3272		10.1074/jbc.M116.752006	http://dx.doi.org/10.1074/jbc.M116.752006			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28069809	Green Published, hybrid			2022-12-28	WOS:000395538800018
J	Lentucci, C; Belkina, AC; Cederquist, CT; Chan, M; Johnson, HE; Prasad, S; Lopacinski, A; Nikolajczyk, BS; Monti, S; Snyder-Cappione, J; Tanasa, B; Cardamone, MD; Perissi, V				Lentucci, Claudia; Belkina, Anna C.; Cederquist, Carly T.; Chan, Michelle; Johnson, Holly E.; Prasad, Sherry; Lopacinski, Amanda; Nikolajczyk, Barbara S.; Monti, Stefano; Snyder-Cappione, Jennifer; Tanasa, Bogdan; Cardamone, M. Dafne; Perissi, Valentina			Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CONJUGATING ENZYME; G-PROTEIN; T-CELL; TRANSCRIPTION FACTOR; STRUCTURAL BASIS; MOLECULAR-BASIS; C-JUN; ACTIVATION; PATHWAY	Non-proteolytic ubiquitin signaling mediated by Lys(63) ubiquitin chains plays a critical role in multiple pathways that are key to the development and activation of immune cells. Our previous work indicates that GPS2 (G-protein Pathway Suppressor 2) is a multifunctional protein regulating TNF alpha signaling and lipid metabolism in the adipose tissue through modulation of Lys63 ubiquitination events. However, the full extent of GPS2-mediated regulation of ubiquitination and the underlying molecular mechanisms are unknown. Here, we report that GPS2 is required for restricting the activation of TLR and BCR signaling pathways and the AKT/FOXO1 pathway in immune cells based on direct inhibition of Ubc13 enzymatic activity. Relevance of this regulatory strategy is confirmed in vivo by B cell-targeted deletion of GPS2, resulting in developmental defects at multiple stages of B cell differentiation. Together, these findings reveal that GPS2 genomic and non-genomic functions are critical for the development and cellular homeostasis of B cells.	[Lentucci, Claudia; Cederquist, Carly T.; Chan, Michelle; Johnson, Holly E.; Prasad, Sherry; Lopacinski, Amanda; Cardamone, M. Dafne; Perissi, Valentina] Boston Univ, Sch Med, Dept Biochem, Silvio Conte Bldg, Boston, MA 02118 USA; [Belkina, Anna C.; Nikolajczyk, Barbara S.; Snyder-Cappione, Jennifer] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Monti, Stefano] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Belkina, Anna C.; Snyder-Cappione, Jennifer] Boston Univ, Sch Med, Flow Cytometry Core Facil, Boston, MA 02118 USA; [Tanasa, Bogdan] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Boston University; Boston University; Boston University; Boston University; Stanford University	Perissi, V (corresponding author), Boston Univ, Sch Med, Dept Biochem, Silvio Conte Bldg, Boston, MA 02118 USA.	vperissi@bu.edu	Belkina, Anna C/F-4816-2014	Belkina, Anna C/0000-0001-7967-6254; Nikolajczyk, Barbara/0000-0001-5647-5740; Monti, Stefano/0000-0002-9376-0660; Cardamone, Maria/0000-0003-4591-3447; Perissi, Valentina/0000-0002-3716-0003	Grunebaum Cancer Foundation; National Institutes of Health Grant [R01DK100422]; Medicine Department at Boston University School of Medicine; National Research Service Award (NRSA) Individual Predoctoral Fellowship from the National Institutes of Health [F31DK108571]; Genomic Science Institute at Boston University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK108571, R01DK100422] Funding Source: NIH RePORTER	Grunebaum Cancer Foundation; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medicine Department at Boston University School of Medicine; National Research Service Award (NRSA) Individual Predoctoral Fellowship from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genomic Science Institute at Boston University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by awards from the Grunebaum Cancer Foundation and the Genomic Science Institute at Boston University and National Institutes of Health Grant R01DK100422 (to V. P.) and by a seed grant from the Medicine Department at Boston University School of Medicine (to V. P. and S. M.). This work was also supported by a National Research Service Award (NRSA) Individual Predoctoral Fellowship from the National Institutes of Health (F31DK108571) (to C. T. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Cederquist CT, 2017, MOL METAB, V6, P125, DOI 10.1016/j.molmet.2016.10.007; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Chow KT, 2013, J EXP MED, V210, P1621, DOI 10.1084/jem.20130498; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Chun ACS, 2000, AIDS RES HUM RETROV, V16, P1689, DOI 10.1089/08892220050193155; Cilloni D, 2007, HAEMATOLOGICA, V92, P1224, DOI 10.3324/haematol.11199; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Fabris S, 2008, GENE CHROMOSOME CANC, V47, P781, DOI 10.1002/gcc.20579; Fan RR, 2016, NAT MED, V22, P780, DOI 10.1038/nm.4114; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Giltiay NV, 2013, J EXP MED, V210, P2773, DOI 10.1084/jem.20122798; Guo C, 2015, J BIOL CHEM, V290, P3666, DOI 10.1074/jbc.M114.598797; Habelhah Hasem, 2010, Genes Cancer, V1, P735; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ho YK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005102; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Jiang XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13755; Jiang XX, 2011, IMMUNITY, V35, P883, DOI 10.1016/j.immuni.2011.11.010; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Jin W, 2007, J BIOL CHEM, V282, P15884, DOI 10.1074/jbc.M609952200; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Katz EJ, 2010, BIOCHEM SOC T, V38, P21, DOI 10.1042/BST0380021; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004736; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Landmann R, 1996, INFECT IMMUN, V64, P1762, DOI 10.1128/IAI.64.5.1762-1769.1996; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee TH, 2006, DNA REPAIR, V5, P32, DOI 10.1016/j.dnarep.2005.07.004; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lino AC, 2013, BLOOD, V122, P209, DOI 10.1182/blood-2012-08-447136; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; MARCHANT A, 1992, EUR J IMMUNOL, V22, P1663, DOI 10.1002/eji.1830220650; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Moran ST, 2007, J IMMUNOL, V179, P195, DOI 10.4049/jimmunol.179.1.195; Nagy V, 2010, BIOL CHEM, V391, P163, DOI 10.1515/bc.2010.021; Notley CA, 2010, J IMMUNOL, V184, P3386, DOI 10.4049/jimmunol.0902640; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ori D, 2013, J IMMUNOL, V190, P4037, DOI 10.4049/jimmunol.1300173; Panda S, 2015, IMMUNITY, V43, P647, DOI 10.1016/j.immuni.2015.09.010; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Peng YC, 2000, J VIROL, V74, P5872, DOI 10.1128/JVI.74.13.5872-5879.2000; Peng YC, 2001, MOL CELL BIOL, V21, P5913, DOI 10.1128/MCB.21.17.5913-5924.2001; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Piper RC, 2011, CELL CYCLE, V10, P3067, DOI 10.4161/cc.10.18.17191; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Pulvino M, 2012, BLOOD, V120, P1668, DOI 10.1182/blood-2012-02-406074; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Sato Y, 2012, J BIOL CHEM, V287, P25860, DOI 10.1074/jbc.M112.364752; Schmidt-Supprian M, 2007, TRANSGENIC RES, V16, P657, DOI 10.1007/s11248-007-9100-4; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Szydlowski M, 2014, INT REV IMMUNOL, V33, P146, DOI 10.3109/08830185.2014.885022; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Touma M, 2011, J IMMUNOL, V187, P3942, DOI 10.4049/jimmunol.1002109; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; WASSERMAN R, 1995, J IMMUNOL, V155, P644; Weigert O, 2012, BLOOD, V120, P2553, DOI 10.1182/blood-2012-05-414995; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Wu XF, 2015, IMMUNOL REV, V266, P161, DOI 10.1111/imr.12310; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang YB, 2015, IMMUNOL REV, V263, P240, DOI 10.1111/imr.12247; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zhang DH, 2008, J BIOL CHEM, V283, P8580, DOI 10.1074/jbc.M708209200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang XM, 2013, CELL MOL IMMUNOL, V10, P113, DOI 10.1038/cmi.2012.63	111	13	15	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2754	2772		10.1074/jbc.M116.755132	http://dx.doi.org/10.1074/jbc.M116.755132			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28039360	hybrid, Green Published			2022-12-28	WOS:000395535100017
J	Naito-Matsui, Y; Davies, LRL; Takematsu, H; Chou, HH; Tangvoranuntakul, P; Carlin, AF; Verhagen, A; Heyser, CJ; Yoo, SW; Choudhury, B; Paton, JC; Paton, AW; Varki, NM; Schnaar, RL; Varki, A				Naito-Matsui, Yuko; Davies, Leela R. L.; Takematsu, Hiromu; Chou, Hsun-Hua; Tangvoranuntakul, Pam; Carlin, Aaron F.; Verhagen, Andrea; Heyser, Charles J.; Yoo, Seung-Wan; Choudhury, Biswa; Paton, James C.; Paton, Adrienne W.; Varki, Nissi M.; Schnaar, Ronald L.; Varki, Ajit			Physiological Exploration of the Long Term Evolutionary Selection against Expression of N-Glycolylneuraminic Acid in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; CELL-ADHESION MOLECULE; LACKING COMPLEX GANGLIOSIDES; POLYSIALIC ACID; NERVOUS-SYSTEM; ACETYLNEURAMINIC ACID; RECOGNITION MEMORY; PERIRHINAL CORTEX; TRANSGENIC MICE; SIALIC ACIDS	All vertebrate cell surfaces display a dense glycan layer often terminated with sialic acids, which have multiple functions due to their location and diverse modifications. The major sialic acids in most mammalian tissues are N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), the latter being derived from Neu5Ac via addition of one oxygen atom at the sugar nucleotide level by CMP-Neu5Ac hydroxylase (Cmah). Contrasting with other organs that express various ratios of Neu5Ac and Neu5Gc depending on the variable expression of Cmah, Neu5Gc expression in the brain is extremely low in all vertebrates studied to date, suggesting that neural expression is detrimental to animals. However, physiological exploration of the reasons for this long term evolutionary selection has been lacking. To explore the consequences of forced expression of Neu5Gc in the brain, we have established brain-specific Cmah transgenic mice. Such Neu5Gc overexpression in the brain resulted in abnormal locomotor activity, impaired object recognition memory, and abnormal axon myelination. Brain-specific Cmah transgenic mice were also lethally sensitive to a Neu5Gc-preferring bacterial toxin, even though Neu5Gc was overexpressed only in the brain and other organs maintained endogenous Neu5Gc expression, as in wild-type mice. Therefore, the unusually strict evolutionary suppression of Neu5Gc expression in the vertebrate brain may be explained by evasion of negative effects on neural functions and by selection against pathogens.	[Naito-Matsui, Yuko; Davies, Leela R. L.; Takematsu, Hiromu; Chou, Hsun-Hua; Tangvoranuntakul, Pam; Carlin, Aaron F.; Verhagen, Andrea; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Naito-Matsui, Yuko; Davies, Leela R. L.; Takematsu, Hiromu; Chou, Hsun-Hua; Tangvoranuntakul, Pam; Carlin, Aaron F.; Verhagen, Andrea; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Heyser, Charles J.] Univ Calif San Diego, Neurosci Behav Testing Core, La Jolla, CA 92093 USA; [Choudhury, Biswa; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Varki, Nissi M.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Takematsu, Hiromu] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan; [Yoo, Seung-Wan] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Neurosci, Baltimore, MD 21205 USA; [Paton, James C.; Paton, Adrienne W.] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Naito-Matsui, Yuko] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Kyoto University; Johns Hopkins University; Johns Hopkins University; University of Adelaide; Kobe Pharmaceutical University	Varki, A (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	Cheng, Pam/AAY-8063-2021; Carlin, Aaron/AAK-3806-2021	Takematsu, Hiromu/0000-0003-1689-9500	National Institutes of Health [R01GM32373, R37NS037096]; Mathers Foundation of New York; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation of New York; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01GM32373 (to A. Varki) and R37NS037096 (to R.S.), the Mathers Foundation of New York (to A. Varki), and by a fellowship from the Japan Society for the Promotion of Science (to Y.N.-M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bernimoulin MP, 2003, J BIOL CHEM, V278, P37, DOI 10.1074/jbc.M204360200; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; BRINSTER RL, 1982, NATURE, V296, P39, DOI 10.1038/296039a0; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chiavegatto S, 2000, EXP NEUROL, V166, P227, DOI 10.1006/exnr.2000.7504; Collins BE, 2000, GLYCOBIOLOGY, V10, P11, DOI 10.1093/glycob/10.1.11; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Davies LRL, 2015, TOP CURR CHEM, V366, P31, DOI 10.1007/128_2013_419; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Diaz SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004241; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; HIGA HH, 1985, J BIOL CHEM, V260, P8838; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; HOESCHE C, 1993, J BIOL CHEM, V268, P26494; Inoue S, 2001, J BIOL CHEM, V276, P31863, DOI 10.1074/jbc.M103336200; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Kamien B, 2014, AM J MED GENET A, V164, P782, DOI 10.1002/ajmg.a.36345; Kannagi R, 2002, CURR OPIN STRUC BIOL, V12, P599, DOI 10.1016/S0959-440X(02)00365-2; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LEPERS A, 1990, EUR J BIOCHEM, V193, P715, DOI 10.1111/j.1432-1033.1990.tb19391.x; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Muto J, 2014, J CLIN INVEST, V124, P1309, DOI 10.1172/JCI67947; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Sato C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00061; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schnaar RL, 2009, J NEUROSCI RES, V87, P3267, DOI 10.1002/jnr.21992; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Shaw AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092556; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Stencel-Baerenwald JE, 2014, NAT REV MICROBIOL, V12, P739, DOI 10.1038/nrmicro3346; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; Sumida M, 2015, J BIOL CHEM, V290, P13202, DOI 10.1074/jbc.M115.638759; Sun J, 2004, GLYCOBIOLOGY, V14, P851, DOI 10.1093/glycob/cwh107; SVENNERHOLM L, 1956, NATURE, V177, P524, DOI 10.1038/177524b0; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; TAKEMATSU H, 1994, J BIOCHEM-TOKYO, V115, P381, DOI 10.1093/oxfordjournals.jbchem.a124347; TETTAMANTI G, 1965, NATURE, V206, P192, DOI 10.1038/206192a0; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wan HM, 1999, J NEUROSCI, V19, P1142; Willems AP, 2016, BBA-GEN SUBJECTS, V1860, P1640, DOI 10.1016/j.bbagen.2015.12.017; Xiao C, 2013, J ALZHEIMERS DIS, V35, P777, DOI 10.3233/JAD-122419; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	60	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2557	2570		10.1074/jbc.M116.768531	http://dx.doi.org/10.1074/jbc.M116.768531			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049733	Green Published, hybrid			2022-12-28	WOS:000395535100001
J	Sunami, Y; Araki, M; Kan, S; Ito, A; Hironaka, Y; Imai, M; Morishita, S; Ohsaka, A; Komatsu, N				Sunami, Yoshitaka; Araki, Marito; Kan, Shin; Ito, Akihiro; Hironaka, Yumi; Imai, Misa; Morishita, Soji; Ohsaka, Akimichi; Komatsu, Norio			Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-trans-retinoic Acid-induced Granulocytic Differentiation in Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; PML-RAR-ALPHA; GENE-EXPRESSION; NONHISTONE PROTEINS; TYROSINE KINASES; PROSTATE-CANCER; DOWN-REGULATION; HL-60 CELLS; ACETYLATION	Differentiation therapy with all-trans-retinoic acid (ATRA) improves the treatment outcome of acute promyelocytic leukemia (APL); however, the molecular mechanism by which ATRA induces granulocytic differentiation remains unclear. We previously reported that the inhibition of the NAD-dependent histone deacetylase (HDAC) SIRT2 induces granulocytic differentiation in leukemia cells, suggesting the involvement of protein acetylation in ATRA- induced leukemia cell differentiation. Herein, we show that p300/CREB- binding proteinassociated factor (PCAF), a histone acetyltransferase (HAT), is a prerequisite for ATRA- induced granulocytic differentiation in leukemia cells. We found that PCAF expression was markedly increased in leukemia cell lines (NB4 and HL-60) and primary APL cells during ATRA- induced granulocytic differentiation. Consistent with these results, the expression of PCAF was markedly up- regulated in the bone marrow cells of APL patients who received ATRA- containing chemotherapy. The knockdown of PCAF inhibited ATRA- induced granulocytic differentiation in leukemia cell lines and primary APL cells. Conversely, the overexpression of PCAF induced the expression of the granulocytic differentiation marker CD11b at the mRNA level. Acetylome analysis identified the acetylated proteins after ATRA treatment, and we found that histone H3, a known PCAF acetylation substrate, was preferentially acetylated by the ATRA treatment. Furthermore, we have demonstrated that PCAF is required for the acetylation of histone H3 on the promoter of ATRA target genes, such as CCL2 and FGR, and for the expression of these genes in ATRA- treated leukemia cells. These results strongly support our hypothesis that PCAF is induced and activated by ATRA, and the subsequent acetylation of PCAF substrates promotes granulocytic differentiation in leukemia cells. Targeting PCAF and its downstream acetylation targets could serve as a novel therapeutic strategy to overcome all subtypes of AML.	[Sunami, Yoshitaka; Kan, Shin; Hironaka, Yumi; Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Araki, Marito; Morishita, Soji; Ohsaka, Akimichi] Juntendo Univ, Sch Med, Dept Transfus Med & Stem Cell Regulat, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Kan, Shin; Imai, Misa] Juntendo Univ, Sch Med, Leading Ctr Dev & Res Canc Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Ito, Akihiro] RIKEN, Chem Genet Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	Juntendo University; Juntendo University; Juntendo University; RIKEN	Komatsu, N (corresponding author), Juntendo Univ, Sch Med, Dept Hematol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	komatsun@juntendo.ac.jp	Araki, Marito/T-4283-2019	Araki, Marito/0000-0002-3502-5000	Japan Society for the Promotion of Science (JSPS) KAKENHI [26893264, 25118725]; Juntendo University Young investigator joint project award [2608]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); MEXT Promotion Plan for the Platform of Human Resource Development for Cancer project	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Juntendo University Young investigator joint project award; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT Promotion Plan for the Platform of Human Resource Development for Cancer project	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 26893264 and 25118725; the Juntendo University Young investigator joint project award 2014 (Grant 2608); and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)-supported Program for the Strategic Research Foundation at Private Universities, and the MEXT Promotion Plan for the Platform of Human Resource Development for Cancer project. The authors declare that they have no conflicts of interest with the contents of this article.	Ablain J, 2014, NAT MED, V20, P167, DOI 10.1038/nm.3441; Ablain J, 2011, BLOOD, V117, P5795, DOI 10.1182/blood-2011-02-329367; Araki M, 2016, BLOOD, V127, P1307, DOI 10.1182/blood-2015-09-671172; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; BURN TC, 1994, BLOOD, V84, P2776; Cang SD, 2009, INT J ONCOL, V35, P1417, DOI 10.3892/ijo_00000459; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Bellis F, 2014, CANCER RES, V74, P2328, DOI 10.1158/0008-5472.CAN-13-2568; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Fantuzzi L, 1999, BLOOD, V94, P875, DOI 10.1182/blood.V94.3.875.415k28_875_883; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gocek Elzbieta, 2011, Cancers (Basel), V3, P2402, DOI 10.3390/cancers3022402; Grimwade D, 2016, BLOOD, V127, P29, DOI 10.1182/blood-2015-07-604496; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Ishfaq M, 2012, FEBS LETT, V586, P3236, DOI 10.1016/j.febslet.2012.06.042; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jing YK, 2004, LEUKEMIA LYMPHOMA, V45, P639, DOI 10.1080/10428190310001609933; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; Katagiri K, 1996, J BIOL CHEM, V271, P11557, DOI 10.1074/jbc.271.19.11557; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kitamura K, 1997, LEUKEMIA, V11, P1950, DOI 10.1038/sj.leu.2400837; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kosono S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131169; Kumar P, 2014, MOL PHARMACOL, V85, P946, DOI 10.1124/mol.114.092221; LANOTTE M, 1991, BLOOD, V77, P1080; Lee KH, 2002, BIOCHEM BIOPH RES CO, V296, P1125, DOI 10.1016/S0006-291X(02)02043-0; Lee SM, 2007, J PHARMACOL EXP THER, V322, P1084, DOI 10.1124/jpet.107.124461; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Leiva M, 2012, LEUKEMIA, V26, P1630, DOI 10.1038/leu.2012.39; Lin ZH, 2013, CHEM BIOL, V20, P253, DOI 10.1016/j.chembiol.2013.01.002; Liu L, 1999, MOL CELL BIOL, V19, P1202; Liu TX, 2000, BLOOD, V96, P1496, DOI 10.1182/blood.V96.4.1496.h8001496_1496_1504; Miller WH, 2002, ONCOGENE, V21, P3496, DOI 10.1038/sj/onc/1205328; Miranda MB, 2007, LEUKEMIA, V21, P1363, DOI 10.1038/sj.leu.2404690; Modak R, 2013, ACS CHEM BIOL, V8, P1311, DOI 10.1021/cb4000597; Mori J, 1999, JPN J CANCER RES, V90, P660, DOI 10.1111/j.1349-7006.1999.tb00798.x; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Muraoka M, 1996, ONCOGENE, V12, P1565; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Roth SY, 1996, CELL, V87, P5, DOI 10.1016/S0092-8674(00)81316-1; Sakuma T, 2006, INT J ONCOL, V29, P117; Schaible AM, 2013, BIOCHEM PHARMACOL, V86, P476, DOI 10.1016/j.bcp.2013.04.015; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Su R, 2015, ONCOGENE, V34, P3226, DOI 10.1038/onc.2014.274; Sun WJ, 2012, ACTA BIOCH BIOPH SIN, V44, P80, DOI 10.1093/abbs/gmr113; Sunami Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057633; Waxman S, 2000, LEUKEMIA, V14, P491, DOI 10.1038/sj.leu.2401714; Wei S, 2015, NAT MED, V21, P457, DOI 10.1038/nm.3839; WILLMAN CL, 1991, BLOOD, V77, P726; Xiao LY, 2010, ACTA HAEMATOL-BASEL, V123, P71, DOI 10.1159/000264628; Xu G, 2003, BLOOD, V102, P2960, DOI 10.1182/blood-2003-02-0390; Zeisig BB, 2007, CANCER CELL, V12, P36, DOI 10.1016/j.ccr.2007.06.006; Zhao J, 2012, J IMMUNOL, V188, P1266, DOI 10.4049/jimmunol.1101976	64	14	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2815	2829		10.1074/jbc.M116.745398	http://dx.doi.org/10.1074/jbc.M116.745398			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28053092	Green Published, hybrid			2022-12-28	WOS:000395535100022
J	Plugis, NM; Palanski, BA; Weng, CH; Albertelli, M; Khosla, C				Plugis, Nicholas M.; Palanski, Brad A.; Weng, Chih-Hisang; Albertelli, Megan; Khosla, Chaitan			Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine IMPLICATIONS FOR CELIAC DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; disulfide; intestine; thioredoxin; transglutaminase	ALLOSTERIC DISULFIDE BOND; HUMAN MACROPHAGES; REDOX REGULATION; T-CELLS; DOMAIN; INACTIVATION; INHIBITION; REDUCTION; CD4	Transglutaminase 2 (TG2) catalyzes transamidation or deamidation of its substrates and is ordinarily maintained in a catalytically inactive state in the intestine and other organs. Aberrant TG2 activity is thought to play a role in celiac disease, suggesting that a better understanding of TG2 regulation could help to elucidate the mechanistic basis of this malady. Structural and biochemical analysis has led to the hypothesis that extracellular TG2 activation involves reduction of an allosteric disulfide bond by thioredoxin-1 (TRX), but cellular and in vivo evidence for this proposal is lacking. To test the physiological relevance of this hypothesis, we first showed that macrophages exposed to pro-inflammatory stimuli released TRX in sufficient quantities to activate their extracellular pools of TG2. By using the C35S mutant of TRX, which formed a metastable mixed disulfide bond with TG2, we demonstrated that these proteins specifically recognized each other in the extracellular matrix of fibroblasts. When injected into mice and visualized with antibodies, we observed the C35S TRX mutant bound to endogenous TG2 as its principal protein partner in the small intestine. Control experiments showed no labeling of TG2 knock-out mice. Intravenous administration of recombinant TRX in wild-type mice, but not TG2 knock-out mice, led to a rapid rise in intestinal transglutaminase activity in a manner that could be inhibited by small molecules targeting TG2 or TRX. Our findings support the potential pathophysiological relevance of TRX in celiac disease and establish the Cys(370)-Cys(371) disulfide bond of TG2 as one of clearest examples of an allosteric disulfide bond in mammals.	[Plugis, Nicholas M.; Palanski, Brad A.; Weng, Chih-Hisang; Khosla, Chaitan] Stanford Univ, Dept Chem, 443 Via Ortega,Rm. 269, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Chem Engn, 443 Via Ortega,Rm. 269, Stanford, CA 94305 USA; [Albertelli, Megan] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Weng, Chih-Hisang] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Weng, Chih-Hisang] Stanford Univ, Dept Med Sci Training Program, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Khosla, C (corresponding author), Stanford Univ, Dept Chem, 443 Via Ortega,Rm. 269, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, 443 Via Ortega,Rm. 269, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Stanford ChEM H, Shriram Ctr Bioengn & Chem Engn, 443 Via Ortega,Rm. 269, Stanford, CA 94305 USA.	khosla@stanford.edu	Albertelli, Megan/C-7650-2011	Albertelli, Megan/0000-0001-9433-229X; Khosla, Chaitan/0000-0001-6529-495X	National Institutes of Health [R01 DK063158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK063158 (to C.K.). C.K. is an advisor to and shareholder of Sitari Pharmaceuticals, a company that is developing drugs that target transglutaminase 2. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamczyk M, 2015, J CELL SCI, V128, P4615, DOI 10.1242/jcs.175968; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Azimi I, 2010, J BIOL CHEM, V285, P40072, DOI 10.1074/jbc.M110.185371; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; BOOTHE RL, 1969, J BIOL CHEM, V244, P399; Checconi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127086; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; CONNELLAN JM, 1969, J BIOL CHEM, V244, P3173; Dafik L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030642; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; DiRaimondo TR, 2014, ACS CHEM BIOL, V9, P266, DOI 10.1021/cb4006408; DiRaimondo TR, 2013, J MED CHEM, V56, P1301, DOI 10.1021/jm301775s; Ganderton T, 2007, J THROMB HAEMOST, V5, P204, DOI 10.1111/j.1538-7836.2006.02292.x; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Hofer S, 2009, CRIT CARE MED, V37, P2155, DOI 10.1097/CCM.0b013e31819fff67; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Klock C, 2012, SEMIN IMMUNOPATHOL, V34, P513, DOI 10.1007/s00281-012-0305-0; Klock C, 2014, J MED CHEM, V57, P9042, DOI 10.1021/jm501145a; Klock C, 2012, PROTEIN SCI, V21, P1781, DOI 10.1002/pro.2162; Krudysz-Amblo J, 2013, BBA-GEN SUBJECTS, V1830, P3489, DOI 10.1016/j.bbagen.2013.02.013; Kumar S, 2013, AMINO ACIDS, V44, P81, DOI 10.1007/s00726-011-1139-0; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Matsuo Y, 2013, CYTOKINE GROWTH F R, V24, P345, DOI 10.1016/j.cytogfr.2013.01.001; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Nadalutti CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077277; Nadella V, 2015, BBA-MOL CELL RES, V1853, P201, DOI 10.1016/j.bbamcr.2014.09.020; Nakamura H, 2004, ANTIOXID REDOX SIGN, V6, P15, DOI 10.1089/152308604771978309; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P2688, DOI 10.1073/pnas.041624998; Nakamura H, 2009, ADV DRUG DELIVER REV, V61, P303, DOI 10.1016/j.addr.2009.01.003; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Owen GR, 2016, BIOCHEMISTRY-US, V55, P2227, DOI 10.1021/acs.biochem.6b00154; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Seluanov A., 2010, J VIS EXP; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; van de Wal Y, 1998, J IMMUNOL, V161, P1585; Wang P, 2013, J BIOL CHEM, V288, P3346, DOI 10.1074/jbc.M112.418046; Wu CG, 2014, MOL CELL PROTEOMICS, V13, P3507, DOI 10.1074/mcp.M114.040931; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yi MC, 2015, BIOORG MED CHEM LETT, V25, P4922, DOI 10.1016/j.bmcl.2015.05.006; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zucker M, 2016, J THROMB HAEMOST, V14, P2202, DOI 10.1111/jth.13488	53	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					2000	2008		10.1074/jbc.M116.767988	http://dx.doi.org/10.1074/jbc.M116.767988			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28003361	Green Published, hybrid			2022-12-28	WOS:000395515600037
J	Yang, ZF; Kim, S; Mahajan, S; Zamani, A; Faccio, R				Yang, Zhengfeng; Kim, Seokho; Mahajan, Sahil; Zamani, Ali; Faccio, Roberta			Phospholipase C gamma 1 (PLC gamma 1) Controls Osteoclast Numbers via Colony-stimulating Factor 1 (CSF-1)-dependent Diacylglycerol/beta-Catenin/CyclinD1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-GAMMA; BONE HOMEOSTASIS; CELL DEVELOPMENT; MURINE MODEL; M-CSF; SURVIVAL; ALPHA(V)BETA(3); PROLIFERATION; ACTIVATION; PRECURSORS	Phospholipases C gamma (PLC gamma) 1 and 2 are a class of highly homologous enzymes modulating a variety of cellular pathways through production of inositol 1,4,5-trisphosphate and diacylglycerol (DAG). Our previous studies demonstrated the importance of PLC gamma 2 in osteoclast (OC) differentiation by modulating inositol 1,4,5-trisphosphate-mediated calcium oscillations and the up-regulation of the transcription factor NFATc1. Surprisingly, despite being expressed throughout osteoclastogenesis, PLC gamma 1 did not compensate for PLC gamma 2 deficiency. Because both isoforms are activated during osteoclastogenesis, it is plausible that PLC gamma 1 modulates OC development independently of PLC gamma 2. Here, we utilized PLC gamma 1-specific shRNAs to delete PLC gamma 1 in OC precursors derived from wild type (WT) mice. Differently from PLC gamma 2, we found that PLC gamma 1 shRNA significantly suppresses OC differentiation by limiting colony-stimulating factor 1 (CSF-1)-dependent proliferation and beta-catenin/cyclinD1 levels. Confirming the specificity toward CSF-1 signaling, PLC gamma 1 is recruited to the CSF-1 receptor following exposure to the cytokine. To understand how PLC gamma 1 controls cell proliferation, we turned to its downstream effector, DAG. By utilizing cells lacking the DAG kinase zeta, which have increased DAG levels, we demonstrate that DAG modulates CSF-1-dependent proliferation and beta-catenin/cyclinD1 levels in OC precursors. Most importantly, the proliferation and osteoclastogenesis defects observed in the absence of PLC gamma 1 are normalized in PLC gamma 1/DAG kinase zeta double null cells. Taken together, our study shows that PLC gamma 1 controls OC numbers via a CSF-1-dependent DAG/beta-catenin/cyclinD1 pathway.	[Yang, Zhengfeng; Kim, Seokho; Mahajan, Sahil; Zamani, Ali; Faccio, Roberta] Washington Univ, Sch Med, Dept Orthopaed, St Louis, MO 63110 USA; [Kim, Seokho] Korea Res Inst Biosci & Biotechnol, Aging Res Inst, Daejeon 34141, South Korea; [Zamani, Ali] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Faccio, Roberta] Washington Univ, Sch Med, Dept Orthopaed Surg, Box 8233,660 S Euclid, St Louis, MO 63110 USA	Washington University (WUSTL); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Pennsylvania; Washington University (WUSTL)	Faccio, R (corresponding author), Washington Univ, Sch Med, Dept Orthopaed, St Louis, MO 63110 USA.; Faccio, R (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, Box 8233,660 S Euclid, St Louis, MO 63110 USA.	faccior@wustl.edu	Yang, Zhengfeng/AAA-7014-2020		Broad Institute RNAi Consortium (TRC); Children's Discovery Institute (CDI); Genome Institute at Washington University (TGI); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066551, R01AR053628] Funding Source: NIH RePORTER	Broad Institute RNAi Consortium (TRC); Children's Discovery Institute (CDI); Genome Institute at Washington University (TGI); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We gratefully thank Dr. Gary Koretzky (Weill Cornell Medical College, Ithaca, NY) for the DGK zeta<SUP>-/-</SUP> mice. The shPlcg1 plasmids were provided by Washington University RNAi core, supported by the Broad Institute RNAi Consortium (TRC), the Children's Discovery Institute (CDI), and the Genome Institute at Washington University (TGI).	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Chen YB, 2008, J BIOL CHEM, V283, P29593, DOI 10.1074/jbc.M802493200; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Cremasco V, 2008, ARTHRITIS RHEUM-US, V58, P2712, DOI 10.1002/art.23757; Cremasco V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008909; Decker CE, 2015, P NATL ACAD SCI USA, V112, P15654, DOI 10.1073/pnas.1511285112; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Faccio R, 2010, ANN NY ACAD SCI, V1192, P124, DOI 10.1111/j.1749-6632.2009.05217.x; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Glantschnig H, 2003, CELL DEATH DIFFER, V10, P1165, DOI 10.1038/sj.cdd.4401285; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Ichise H, 2009, DEVELOPMENT, V136, P191, DOI 10.1242/dev.025353; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Koss H, 2014, TRENDS BIOCHEM SCI, V39, P603, DOI 10.1016/j.tibs.2014.09.004; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Maeda K, 2013, J MOL MED, V91, P15, DOI 10.1007/s00109-012-0974-0; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; Otero K, 2012, J IMMUNOL, V188, P2612, DOI 10.4049/jimmunol.1102836; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Qiang YW, 2010, BRIT J HAEMATOL, V148, P726, DOI 10.1111/j.1365-2141.2009.08009.x; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Scholtysek C, 2013, NAT MED, V19, P608, DOI 10.1038/nm.3146; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Yang K, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-32; Yang Yong Ryoul, 2012, Adv Biol Regul, V52, P138; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zamani A, 2015, J BONE MINER RES, V30, P1852, DOI 10.1002/jbmr.2533; Zheng YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119739; Zhou P, 2006, J IMMUNOL, V177, P8777, DOI 10.4049/jimmunol.177.12.8777	44	6	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1178	1186		10.1074/jbc.M116.764928	http://dx.doi.org/10.1074/jbc.M116.764928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27941021	Green Published, hybrid			2022-12-28	WOS:000393339800003
J	Haggie, PM; Phuan, PW; Tan, JA; Xu, HJ; Avramescu, RG; Perdomo, D; Zlock, L; Nielson, DW; Finkbeiner, WE; Lukacs, GL; Verkman, AS				Haggie, Peter M.; Phuan, Puay-Wah; Tan, Joseph-Anthony; Xu, Haijin; Avramescu, Radu G.; Perdomo, Doranda; Zlock, Lorna; Nielson, Dennis W.; Finkbeiner, Walter E.; Lukacs, Gergely L.; Verkman, Alan S.			Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator ( CFTR) Translation Product*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; CYSTIC-FIBROSIS; CONDUCTANCE REGULATOR; EPITHELIAL-CELLS; NONSENSE MUTATIONS; ROCK INHIBITOR; BIOAVAILABILITY; DOMAIN; TERMINATION; RESTORATION	W1282X is the fifth most common cystic fibrosis transmembrane regulator (CFTR) mutation that causes cystic fibrosis. Here, we investigated the utility of a small molecule corrector/potentiator strategy, as used for Delta F508-CFTR, to produce functional rescue of the truncated translation product of the W1282X mutation, CFTR1281, without the need for readthrough. In transfected cell systems, certain potentiators and correctors, including VX-809 and VX-770, increased CFTR1281 activity. To identify novel correctors and potentiators with potentially greater efficacy on CFTR1281, functional screens were done of similar to 30,000 synthetic small molecules and drugs/nutraceuticals in CFTR1281-transfected cells. Corrector scaffolds of 1-arylpyrazole-4-arylsulfonyl-piperazine and spiro-piperidine-quinazolinone classes were identified with up to similar to 5-fold greater efficacy than VX-809, some of which were selective for CFTR1281, whereas others also corrected Delta F508-CFTR. Several novel potentiator scaffolds were identified with efficacy comparable with VX-770; remarkably, a phenylsulfonamide-pyrrolopyridine acted synergistically with VX-770 to increaseCFTR(1281) function similar to 8-fold over that of VX-770 alone, normalizing CFTR1281 channel activity to that of wild type CFTR. Corrector and potentiator combinations were tested in primary cultures and conditionally reprogrammed cells generated from nasal brushings from one W1282X homozygous subject. Although robust chloride conductance was seen with correctors and potentiators in homozygous Delta F508 cells, increased chloride conductance was not found in W1282X cells despite the presence of adequate transcript levels. Notwithstanding the negative data inW1282Xcells from one human subject, we speculate that corrector and potentiator combinations may have therapeutic efficacy in cystic fibrosis caused by the W1282X mutation, although additional studies are needed on human cells from W1282X subjects.	[Haggie, Peter M.; Phuan, Puay-Wah; Tan, Joseph-Anthony; Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Haggie, Peter M.; Phuan, Puay-Wah; Tan, Joseph-Anthony; Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Zlock, Lorna; Finkbeiner, Walter E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Nielson, Dennis W.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Xu, Haijin; Avramescu, Radu G.; Perdomo, Doranda; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; McGill University	Haggie, PM; Verkman, AS (corresponding author), Univ Calif San Francisco, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.; Lukacs, GL (corresponding author), McIntyre Med Sci Bldg,Rm 1006, Montreal, PQ H3G 1Y6, Canada.	peter.haggie@ucsf.edu; gergely.lukacs@mcgill.ca; alan.verkman@ucsf.edu		Lukacs, Gergely/0000-0003-0900-0675; Perdomo, Doranda/0000-0001-9949-751X	Cystic Fibrosis Foundation (The Cystic Fibrosis Foundation Therapeutics); National Institutes of Health [P30 CA082103]; NATIONAL CANCER INSTITUTE [P30CA082103, R44CA091661] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK099803, R01DK075302, P30DK072517] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation (The Cystic Fibrosis Foundation Therapeutics); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Robert Bridges, Rosalind Franklin University of Medicine and Science, for providing compounds through the CFTR Compound Program, CFFT. This compound repository is supported by the Cystic Fibrosis Foundation (The Cystic Fibrosis Foundation Therapeutics). The University of California at San Francisco Helen Diller Cancer Center Genome Analysis Core is supported by the National Institutes of Health Grant P30 CA082103.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Benharouga M, 2003, J BIOL CHEM, V278, P22079, DOI 10.1074/jbc.M301030200; Bowden M., 2014, Patent, Patent No. [WO/2014/167530, 2014167530]; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Davies JC, 2015, CURR OPIN PULM MED, V21, P579, DOI 10.1097/MCP.0000000000000211; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Ehrhardt C, 2006, CELL TISSUE RES, V323, P405, DOI 10.1007/s00441-005-0062-7; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Gentzsch M, 2002, BIOCHEM J, V366, P541, DOI 10.1042/BJ20020511; Gentzsch M, 2001, J BIOL CHEM, V276, P1291, DOI 10.1074/jbc.M003672200; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Gonzalez-Hilarion S, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-58; Gradolatto A, 2005, DRUG METAB DISPOS, V33, P49, DOI 10.1124/dmd.104.000893; Haggie PM, 2015, PEDIATR PULM, V50, P264; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Kerem E, 2014, LANCET RESP MED, V2, P539, DOI 10.1016/S2213-2600(14)70100-6; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; McElroy SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001593; Meyer H, 2006, ANN NUTR METAB, V50, P167, DOI 10.1159/000090736; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Palechor-Ceron N, 2013, AM J PATHOL, V183, P1862, DOI 10.1016/j.ajpath.2013.08.009; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Phuan PW, 2015, MOL PHARMACOL, V88, P791, DOI 10.1124/mol.115.099689; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Phuan PW, 2014, MOL PHARMACOL, V86, P42, DOI 10.1124/mol.114.092478; Quon BS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i859; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Rowe SM, 2007, AM J RESP CELL MOL, V37, P347, DOI 10.1165/rcmb.2006-0176OC; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sun DQ, 2008, BIOORG MED CHEM LETT, V18, P3513, DOI 10.1016/j.bmcl.2008.05.025; Sun HP, 2014, EUR J MED CHEM, V79, P399, DOI 10.1016/j.ejmech.2014.03.061; Tawada H, 1998, Preparation of 1-benzoyl-4-naphthalenesulfonylpiperazines and related compounds as inhibitors of activated coagulation factor X, Patent No. [WO 9854164A1, 9854164]; Valentine CD, 2012, J BIOL CHEM, V287, P43630, DOI 10.1074/jbc.M112.421172; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Veit G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002462; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Veit G, 2012, MOL BIOL CELL, V23, P4188, DOI 10.1091/mbc.E12-06-0424; Wang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152232; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC	53	54	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					771	785		10.1074/jbc.M116.764720	http://dx.doi.org/10.1074/jbc.M116.764720			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27895116	hybrid, Green Published			2022-12-28	WOS:000392318700002
J	Shen, ZX; Chen, XQ; Sun, XN; Sun, JY; Zhang, WC; Zheng, XJ; Zhang, YY; Shi, HJ; Zhang, JW; Li, C; Wang, J; Liu, X; Duan, SZ				Shen, Zhu-Xia; Chen, Xiao-Qing; Sun, Xue-Nan; Sun, Jian-Yong; Zhang, Wu-Chang; Zheng, Xiao-Jun; Zhang, Yu-Yao; Shi, Huan-Jing; Zhang, Jia-Wei; Li, Chao; Wang, Jun; Liu, Xu; Duan, Sheng-Zhong			Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Atherosclerosis by Affecting Foam Cell Formation and Efferocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE ALDOSTERONE BLOCKER; ANGIOTENSIN-II; PPAR-ALPHA; KEY ROLE; EPLERENONE; DELETION; HEART; ACCUMULATION; INFLAMMATION; PHENOTYPE	Mineralocorticoid receptor (MR) has been considered as a potential target for treating atherosclerosis. However, the cellular and molecular mechanisms are not completely understood. We aim to explore the functions and mechanisms of macrophage MR in atherosclerosis. Atherosclerosis-susceptible LDLRKO chimeric mice with bone marrow cells from floxed control mice or from myeloid MR knock-out (MRKO) mice were generated and fed with high cholesterol diet. Oil red O staining showed that MRKO decreased atherosclerotic lesion area in LDLRKO mice. In another mouse model of atherosclerosis, MRKO/APOEKO mice and floxed control/APOEKO mice were generated and treated with angiotensin II. Similarly, MRKO inhibited the atherosclerotic lesion area in APOEKO mice. Histological analysis showed that MRKO increased collagen coverage and decreased necrosis and macrophage accumulation in the lesions. In vitro results demonstrated that MRKO suppressed macrophage foam cell formation and up-regulated the expression of genes involved in cholesterol efflux. Furthermore, MRKOdecreased accumulation of apoptotic cells and increased effective efferocytosis in atherosclerotic lesions. In vitro study further revealed that MRKO increased the phagocytic index of macrophages without affecting their apoptosis. In conclusion, MRKOreduces high cholesterol-or angiotensin II-induced atherosclerosis and favorably changes plaque composition, likely improving plaque stability. Mechanistically, MR deficiency suppresses macrophage foam cell formation and up-regulates expression of genes related to cholesterol efflux, as well as increases effective efferocytosis and phagocytic capacity of macrophages.	[Shen, Zhu-Xia; Sun, Xue-Nan; Zhang, Wu-Chang; Zheng, Xiao-Jun; Zhang, Yu-Yao; Li, Chao; Duan, Sheng-Zhong] Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai Res Inst Stomatol,Sch Med, Shanghai Key Lab Stomatol,Sch Stomatol,Lab Oral M, Shanghai 200011, Peoples R China; [Shen, Zhu-Xia; Wang, Jun] Fudan Univ, Dept Cardiol, Jingan Dist Ctr Hosp Shanghai, Huashan Hosp,Jingan Branch, Shanghai 200040, Peoples R China; [Shen, Zhu-Xia; Sun, Xue-Nan; Sun, Jian-Yong; Zheng, Xiao-Jun; Zhang, Yu-Yao; Shi, Huan-Jing; Zhang, Jia-Wei; Li, Chao] Univ Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Chinese Acad Sci, Shanghai 200031, Peoples R China; [Chen, Xiao-Qing; Liu, Xu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Dept Cardiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University	Duan, SZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	duansz@shsmu.edu.cn	chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022; Zhang, Jiawei/AAY-4922-2020	Zhang, Jiawei/0000-0002-5782-5543	National Natural Science Foundation of China [31671181, 31400987, 91339110, 31371153]; Science and Technology Commission of Shanghai Municipality [15140904400]; Shanghai Summit & Plateau Discipline Developing Projects	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Summit & Plateau Discipline Developing Projects	This work was supported by National Natural Science Foundation of China Grants 31671181, 31400987, 91339110, and 31371153; Science and Technology Commission of Shanghai Municipality Grant 15140904400; and the Shanghai Summit & Plateau Discipline Developing Projects. The authors declare that they have no conflicts of interest with the contents of this article.	Bienvenu LA, 2012, ENDOCRINOLOGY, V153, P3416, DOI 10.1210/en.2011-2098; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Duivenvoorden R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4065; Ferrario CM, 2015, CIRC RES, V116, P206, DOI 10.1161/CIRCRESAHA.116.302706; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Heo KS, 2014, CIRCULATION, V130, P180, DOI 10.1161/CIRCULATIONAHA.113.005991; Keidar S, 2005, CIRC RES, V97, P946, DOI 10.1161/01.RES.0000187500.24964.7A; Keidar S, 2004, CIRCULATION, V109, P2213, DOI 10.1161/01.CIR.0000127949.05756.9D; Keidar S, 2003, J CARDIOVASC PHARM, V41, P955, DOI 10.1097/00005344-200306000-00019; Kojima Y, 2014, J CLIN INVEST, V124, P1083, DOI 10.1172/JCI70391; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Lewis DR, 2015, P NATL ACAD SCI USA, V112, P2693, DOI 10.1073/pnas.1424594112; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110950; Libby P, 2016, CIRC RES, V118, P531, DOI 10.1161/CIRCRESAHA.116.308334; Lother A, 2015, ANNU REV PHARMACOL, V55, P289, DOI 10.1146/annurev-pharmtox-010814-124302; MacRitchie N, 2012, ARTERIOSCL THROM VAS, V32, P2569, DOI 10.1161/ATVBAHA.112.251314; McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moss ME, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00153; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rajagopalan S, 2002, CIRCULATION, V105, P2212, DOI 10.1161/01.CIR.0000015854.60710.10; Raz-Pasteur A, 2014, J RENIN-ANGIO-ALDO S, V15, P228, DOI 10.1177/1470320312467558; Rickard AJ, 2009, HYPERTENSION, V54, P537, DOI 10.1161/HYPERTENSIONAHA.109.131110; Rousselle A, 2013, J CLIN INVEST, V123, P1343, DOI 10.1172/JCI66580; Sun JY, 2016, ARTERIOSCL THROM VAS, V36, P874, DOI 10.1161/ATVBAHA.115.307031; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Takai S, 2005, HYPERTENSION, V46, P1135, DOI 10.1161/01.HYP.0000184640.81730.22; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Van Vre EA, 2012, ARTERIOSCL THROM VAS, V32, P887, DOI 10.1161/ATVBAHA.111.224873; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	43	32	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					925	935		10.1074/jbc.M116.739243	http://dx.doi.org/10.1074/jbc.M116.739243			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27881672	hybrid, Green Published			2022-12-28	WOS:000392318700014
J	Singh, C; Glaab, E; Linster, CL				Singh, Charandeep; Glaab, Enrico; Linster, Carole L.			Molecular Identification of D-Ribulokinase in Budding Yeast and Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-XYLULOSE; ESCHERICHIA-COLI; RIBITOL-PHOSPHATE; INBORN ERROR; D-ARABINITOL; D-RIBULOSE; METABOLOMICS; PURIFICATION; DEFICIENCY; GENES	Proteomes of even well characterized organisms still contain a high percentage of proteins with unknown or uncertain molecular and/ or biological function. A significant fraction of those proteins is predicted to have catalytic properties. Here we aimed at identifying the function of the Saccharomyces cerevisiae Ydr109c protein and its human homolog FGGY, both of which belong to the broadly conserved FGGY family of carbohydrate kinases. Functionally identified members of this family phosphorylate 3- to 7-carbon sugars or sugar derivatives, but the endogenous substrate of S. cerevisiae Ydr109c and human FGGY has remained unknown. Untargeted metabolomics analysis of an S. cerevisiae deletion mutant of YDR109C revealed ribulose as one of the metabolites with the most significantly changed intracellular concentration as compared with a wildtype strain. In human HEK293 cells, ribulose could only be detected when ribitol was added to the cultivation medium, and under this condition, FGGY silencing led to ribulose accumulation. Biochemical characterization of the recombinant purified Ydr109c and FGGY proteins showed a clear substrate preference of both kinases for D-ribulose over a range of other sugars and sugar derivatives tested, including L-ribulose. Detailed sequence and structural analyses of Ydr109c and FGGY as well as homologs thereof furthermore allowed the definition of a 5-residue D-ribulokinase signature motif (TCSLV). The physiological role of the herein identified eukaryotic D-ribulokinase remains unclear, but we speculate that S. cerevisiae Ydr109c and human FGGY could act as metabolite repair enzymes, serving to re-phosphorylate free D-ribulose generated by promiscuous phosphatases from D-ribulose 5-phosphate. In human cells, FGGY can additionally participate in ribitol metabolism.	[Singh, Charandeep; Glaab, Enrico; Linster, Carole L.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Campus Belval,7 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg	University of Luxembourg	Linster, CL (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Campus Belval,7 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg.	carole.linster@uni.lu	Glaab, Enrico/A-9136-2012	Glaab, Enrico/0000-0003-3977-7469; Linster, Carole/0000-0001-7143-0719; Singh, Charandeep/0000-0003-4015-0591	Fonds National de la Recherche Luxembourg AFR Ph.D. Grant [6885527]; Fondation du Pelican de Mie et Pierre Hippert-Faber Scholarship	Fonds National de la Recherche Luxembourg AFR Ph.D. Grant(Luxembourg National Research Fund); Fondation du Pelican de Mie et Pierre Hippert-Faber Scholarship	This work was supported by the Fonds National de la Recherche Luxembourg AFR Ph.D. Grant 6885527 and a Fondation du Pelican de Mie et Pierre Hippert-Faber Scholarship (to C. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Berg J. M., 2007, BIOCHEMISTRY-US, P467; BERNARD EM, 1981, J CLIN MICROBIOL, V14, P189, DOI 10.1128/JCM.14.2.189-194.1981; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; BROWN AD, 1974, J BACTERIOL, V118, P769, DOI 10.1128/JB.118.3.769-777.1974; Bueschl C, 2014, METABOLOMICS, V10, P754, DOI 10.1007/s11306-013-0611-0; Bueschl C, 2012, BIOINFORMATICS, V28, P736, DOI 10.1093/bioinformatics/bts012; Cai B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.018; CANH DS, 1975, FOLIA MICROBIOL, V20, P320, DOI 10.1007/BF02878113; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Chen YP, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.06.004; Chio A, 2009, HUM MOL GENET, V18, P1524, DOI 10.1093/hmg/ddp059; Clasquin MF, 2011, CELL, V145, P969, DOI 10.1016/j.cell.2011.05.022; Creek DJ, 2011, ANAL CHEM, V83, P8703, DOI 10.1021/ac2021823; Daoud H, 2010, AMYOTROPH LATERAL SC, V11, P389, DOI 10.3109/17482960903358857; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; ELSINGHORST EA, 1988, J BACTERIOL, V170, P5423, DOI 10.1128/jb.170.12.5423-5432.1988; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ewald JC, 2013, MOL BIOSYST, V9, P440, DOI 10.1039/c2mb25423a; Fernandez-Santiago R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.04.018; Follens A, 1999, J BACTERIOL, V181, P2001, DOI 10.1128/JB.181.7.2001-2007.1999; FUTTERMAN S, 1955, J BIOL CHEM, V215, P257; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Gibney PA, 2013, P NATL ACAD SCI USA, V110, pE4393, DOI 10.1073/pnas.1318100110; Glaab E, 2016, BRIEF BIOINFORM, V17, P352, DOI 10.1093/bib/bbv037; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Heuel H, 1998, MICROBIOL-SGM, V144, P1631, DOI 10.1099/00221287-144-6-1631; Hewitt JE, 2009, BBA-MOL BASIS DIS, V1792, P853, DOI 10.1016/j.bbadis.2009.06.003; HOLLMANN S, 1957, J BIOL CHEM, V225, P87; Huck JHJ, 2004, AM J HUM GENET, V74, P745, DOI 10.1086/383204; Huck JHJ, 2004, MOL GENET METAB, V82, P231, DOI 10.1016/j.ymgme.2004.05.003; INGRAM JM, 1965, J BACTERIOL, V89, P1186, DOI 10.1128/JB.89.5.1186-1194.1965; Ishikura S, 2005, J BIOCHEM, V137, P303, DOI 10.1093/jb/mvi033; Jewison T, 2012, NUCLEIC ACIDS RES, V40, pD815, DOI 10.1093/nar/gkr916; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KAGAWA Y, 1960, BIOCHIM BIOPHYS ACTA, V44, P205, DOI 10.1016/0006-3002(60)91553-5; KAMEYAMA T, 1965, J BIOCHEM-TOKYO, V57, P339, DOI 10.1093/oxfordjournals.jbchem.a128087; KAMEYAMA T, 1962, BIOCHIM BIOPHYS ACTA, V64, P180, DOI 10.1016/0006-3002(62)90773-4; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Kerner Berit, 2013, Front Psychiatry, V4, P154, DOI 10.3389/fpsyt.2013.00154; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Kuznetsova E, 2015, J BIOL CHEM, V290, P18678, DOI 10.1074/jbc.M115.657916; Lee LV, 2001, ARCH BIOCHEM BIOPHYS, V396, P219, DOI 10.1006/abbi.2001.2613; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/nchembio.1141, 10.1038/NCHEMBIO.1141]; MCCORKINDALE J, 1954, BIOCHEM J, V57, P518, DOI 10.1042/bj0570518; NEUBERGER MS, 1981, BIOCHEM J, V193, P513, DOI 10.1042/bj1930513; Niehaus TD, 2015, PLANT PHYSIOL, V169, P1436, DOI 10.1104/pp.15.00959; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Peng J, 2011, PROTEINS, V79, P161, DOI 10.1002/prot.23175; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; QUONG MW, 1993, BIOCHEM BIOPH RES CO, V196, P1323, DOI 10.1006/bbrc.1993.2397; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; REINER AM, 1975, J BACTERIOL, V123, P530, DOI 10.1128/JB.123.2.530-536.1975; Riemersma M, 2015, CHEM BIOL, V22, P1643, DOI 10.1016/j.chembiol.2015.10.014; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Schneider N, 2012, J COMPUT AID MOL DES, V26, P701, DOI 10.1007/s10822-011-9531-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMILEY JD, 1961, J BIOL CHEM, V236, P357; STAYTON MM, 1979, J BIOL CHEM, V254, P3765; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Treusch S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004913; Van Es MA, 2009, AMYOTROPH LATERAL SC, V10, P441, DOI 10.3109/17482960802673042; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Verhoeven NM, 2001, AM J HUM GENET, V68, P1086, DOI 10.1086/320108; Wamelink MMC, 2008, HUM MUTAT, V29, P532, DOI 10.1002/humu.20685; WINKELMAN J, 1961, BIOCHIM BIOPHYS ACTA, V52, P170, DOI 10.1016/0006-3002(61)90914-3; WONG B, 1993, J BACTERIOL, V175, P6314, DOI 10.1128/JB.175.19.6314-6320.1993; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yeh JI, 2004, BIOCHEMISTRY-US, V43, P362, DOI 10.1021/bi034258o; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002318	80	11	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1005	1028		10.1074/jbc.M116.760744	http://dx.doi.org/10.1074/jbc.M116.760744			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27909055	hybrid, Green Published			2022-12-28	WOS:000392318700021
J	Minsky, N; Roeder, RG				Minsky, Neri; Roeder, Robert G.			Control of Secreted Protein Gene Expression and the Mammalian Secretome by the Metabolic Regulator PGC-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGC-1 COACTIVATORS; ENERGY-METABOLISM; THERMOGENESIS; EXERCISE; MICE	Secreted proteins serve pivotal roles in the development of multicellular organisms, acting as structural matrix, extracellular enzymes, and signal molecules. However, how the secretome is regulated remains incompletely understood. Here we demonstrate, unexpectedly, that peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha), a critical transcriptional co-activator of metabolic gene expression, functions to down-regulate the expression of diverse genes encoding secreted molecules and extracellular matrix components to modulate the secretome. Using cell lines, primary cells, and mice, we show that both endogenous and exogenous PGC-1 alpha down-regulate the expression of numerous genes encoding secreted molecules. Mechanistically, results obtained using mRNA stability measurements as well as intronic RNA expression analysis are consistent with a transcriptional effect of PGC-1 alpha on the expression of genes encoding secreted proteins. Interestingly, PGC-1 alpha requires the central heat shock response regulator heat shock factor protein 1 (HSF1) to affect some of its targets, and both factors co-reside on several target genes encoding secreted molecules in cells. Finally, using a mass spectrometric analysis of secreted proteins, we demonstrate that PGC-1 alpha modulates the secretome of mouse embryonic fibroblasts. Our results define a link between a key pathway controlling metabolic regulation and the regulation of the mammalian secretome.	[Minsky, Neri; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA	Rockefeller University	Minsky, N; Roeder, RG (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA.	nminsky@rockefeller.edu; roeder@rockefeller.edu			Sohn Conferences Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	Sohn Conferences Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Bruce Spiegelman for the PGC-1 alpha KO and WT immortalized brown preadipocytes, Daniel Kelly for the PGC-1 alpha KO and WT primary MEFs, Ivor J. Benjamin for the HSF1 knock-out MEFs, and Scott Friedman for the LX2 cells. The Proteomics Resource Center at The Rockefeller University acknowledges funding for mass spectrometer instrumentations from the Sohn Conferences Foundation.	Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Minsky N, 2015, P NATL ACAD SCI USA, V112, pE5669, DOI 10.1073/pnas.1516219112; Olesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032222; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Scherz-Shouval R, 2014, CELL, V158, P564, DOI 10.1016/j.cell.2014.05.045; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Wang GX, 2015, TRENDS ENDOCRIN MET, V26, P231, DOI 10.1016/j.tem.2015.03.002; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	19	1	1	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					43	50		10.1074/jbc.C116.761049	http://dx.doi.org/10.1074/jbc.C116.761049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27909049	hybrid, Green Published			2022-12-28	WOS:000391578000004
J	Prantner, D; Perkins, DJ; Vogel, SN				Prantner, Daniel; Perkins, Darren J.; Vogel, Stefanie N.			AMP-activated Kinase (AMPK) Promotes Innate Immunity and Antiviral Defense through Modulation of Stimulator of Interferon Genes (STING) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC GMP-AMP; NF-KAPPA-B; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DEPENDENT PROTEIN-KINASE; I INTERFERON; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; AIRWAY INFLAMMATION; UPSTREAM KINASE	The host protein Stimulator of Interferon Genes (STING) has been shown to be essential for recognition of both viral and intracellular bacterial pathogens, but its regulation remains unclear. Previously, we reported that mitochondrial membrane potential regulates STING-dependent IFN-beta induction independently of ATP synthesis. Because mitochondrial membrane potential controls calcium homeostasis, and AMP-activated protein kinase (AMPK) is regulated, in part, by intracellular calcium, we postulated that AMPK participates in STING activation; however, its role has yet to be been defined. Addition of an intracellular calcium chelator or an AMPK inhibitor to either mouse macrophages or mouse embryonic fibroblasts (MEFs) suppressed IFN-beta and TNF-alpha induction following stimulation with the STING-dependent ligand 5,6-dimethyl xanthnone-4-acetic acid (DMXAA). These pharmacological findings were corroborated by showing that MEFs lacking AMPK activity also failed to up-regulate IFN-beta and TNF-alpha after treatment with DMXAA or the natural STING ligand cyclic GMP-AMP (cGAMP). As a result, AMPK-deficient MEFs exhibit impaired control of vesicular stomatitis virus (VSV), a virus sensed by STING that can cause an influenza-like illness in humans. This impairment could be overcome by pretreatment of AMPK-deficient MEFs with type I IFN, illustrating that de novo production of IFN-beta in response to VSV plays a key role in antiviral defense during infection. Loss of AMPK also led to dephosphorylation at Ser-555 of the known STING regulator, UNC-51-like kinase 1 (ULK1). However, ULK1-deficient cells responded normally to DMXAA, indicating that AMPK promotes STING-dependent signaling independent of ULK1 in mouse cells.	[Prantner, Daniel; Perkins, Darren J.; Vogel, Stefanie N.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Vogel, SN (corresponding author), 685 W Baltimore St,Rm 380, Baltimore, MD 21201 USA.	svogel@som.umaryland.edu			National Institutes of Health [AI018797]; Ruth L. Kirschstein National Research Service Award [F32AI098167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123371, F32AI098167, R01AI018797, R56AI018797, R37AI018797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI018797 (to S. N. V.) and Ruth L. Kirschstein National Research Service Award F32AI098167 (to D. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Carroll KC, 2013, J LEUKOCYTE BIOL, V94, P1113, DOI 10.1189/jlb.0313157; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Almeida LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023135; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dorsey FC, 2009, J PROTEOME RES, V8, P5253, DOI 10.1021/pr900583m; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Katerelos M, 2010, IMMUNOL CELL BIOL, V88, P754, DOI 10.1038/icb.2010.44; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Kim Young Sook, 2011, Evid Based Complement Alternat Med, V2011, P761859, DOI 10.1093/ecam/nep078; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13; Li L, 2014, FOOD CHEM TOXICOL, V63, P166, DOI 10.1016/j.fct.2013.08.036; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Lo AKF, 2013, J PATHOL, V230, P336, DOI 10.1002/path.4201; Ma Z, 2015, P NATL ACAD SCI USA, V112, pE4306, DOI 10.1073/pnas.1503831112; Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; Moser TS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002661; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Nakashima K, 2011, MICROBIOL IMMUNOL, V55, P774, DOI 10.1111/j.1348-0421.2011.00382.x; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Park SJ, 2012, INFLAMM RES, V61, P1069, DOI 10.1007/s00011-012-0499-6; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Prasad R, 2006, J NEUROSCI RES, V84, P614, DOI 10.1002/jnr.20953; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tian WL, 2015, FEBS LETT, V589, P1847, DOI 10.1016/j.febslet.2015.05.020; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; YEH LA, 1980, J BIOL CHEM, V255, P2308; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zheng LY, 2013, CLIN CANCER RES, V19, P5372, DOI 10.1158/1078-0432.CCR-13-0203; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	78	49	50	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					292	304		10.1074/jbc.M116.763268	http://dx.doi.org/10.1074/jbc.M116.763268			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27879319	Green Published, hybrid			2022-12-28	WOS:000391578000025
J	Xing, LJ; An, Y; Shi, GS; Yan, J; Xie, PC; Qu, ZP; Zhang, ZH; Liu, ZW; Pan, DJ; Xu, Y				Xing, Lijuan; An, Yang; Shi, Guangsen; Yan, Jie; Xie, Pancheng; Qu, Zhipeng; Zhang, Zhihui; Liu, Zhiwei; Pan, Dejing; Xu, Ying			Correlated evolution between CK1 delta Protein and the Serine-rich Motif Contributes to Regulating the Mammalian Circadian Clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN-KINASE-I; SLEEP PHASE SYNDROME; DROSOPHILA CLOCK; DOUBLE-TIME; CKI-EPSILON; PHOSPHORYLATION; PERIOD; MUTATION; BINDING; GENE	Understanding the mechanism underlying the physiological divergence of species is a long-standing issue in evolutionary biology. The circadian clock is a highly conserved system existing in almost all organisms that regulates a wide range of physiological and behavioral events to adapt to the day-night cycle. Here, the interactions between hCK1 epsilon/delta/DBT (Drosophila ortholog of CK1 delta/epsilon) and serine-rich (SR) motifs from hPER2 (ortholog of Drosophila per) were reconstructed in a Drosophila circadian system. The results indicated that in Drosophila, the SR mutant form hPER2(S662G) does not recapitulate the mouse or human mutant phenotype. However, introducing hCK1 delta (but not DBT) shortened the circadian period and restored the SR motif function. We found that hCK1 delta is catalytically more efficient than DBT in phosphorylating the SR motif, which demonstrates that the evolution of CK1 delta activity is required for SR motif modulation. Moreover, an abundance of phosphorylatable SR motifs and the striking emergence of putative SR motifs in vertebrate proteins were observed, which provides further evidence that the correlated evolution between kinase activity and its substrates set the stage for functional diversity in vertebrates. It is possible that such correlated evolution may serve as a biomarker associated with the adaptive benefits of diverse organisms. These results also provide a concrete example of how functional synthesis can be achieved through introducing evolutionary partners in vivo.	[Xing, Lijuan; Shi, Guangsen; Yan, Jie; Liu, Zhiwei; Pan, Dejing; Xu, Ying] Soochow Univ, Cambridge Suda Genom Resource Ctr, 199 Renai Rd, Suzhou 215123, Peoples R China; [An, Yang; Xie, Pancheng; Qu, Zhipeng; Zhang, Zhihui; Xu, Ying] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China	Soochow University - China; Nanjing University	Pan, DJ; Xu, Y (corresponding author), Soochow Univ, Cambridge Suda Genom Resource Ctr, 199 Renai Rd, Suzhou 215123, Peoples R China.; Xu, Y (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	pandejing@suda.edu.cn; yingxu@suda.edu.cn	Xu, Ying/AAF-3081-2019	Xu, Ying/0000-0002-6689-7768; PAN, DEJING/0000-0002-4316-2849	National Science Foundation of China [31230049]; Royal Society-Newton Advanced Fellowship [NA150373]; Priority Academic Development Program of the Jiangsu Higher Education Institutions	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society-Newton Advanced Fellowship; Priority Academic Development Program of the Jiangsu Higher Education Institutions	This work was supported by grants from the National Science Foundation of China (31230049) (to Y. X), Royal Society-Newton Advanced Fellowship (NA150373) (to Y. X), and a project funded by the Priority Academic Development Program of the Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Akashi M, 2006, MOL BIOL CELL, V17, P555, DOI 10.1091/mbc.E05-05-0396; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Chiu JC, 2011, CELL, V145, P357, DOI 10.1016/j.cell.2011.04.002; Coyle SM, 2013, CELL, V154, P875, DOI 10.1016/j.cell.2013.07.019; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Emery Patrick, 2007, Methods Mol Biol, V362, P375; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Li S., 2011, COMMUN INF SCI MANAG, V1, P1, DOI DOI 10.5812/K0WSAR.1735143X.771; Liu ZM, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/959386; MARIN O, 1994, BIOCHEM BIOPH RES CO, V198, P898, DOI 10.1006/bbrc.1994.1128; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Pfeiffenberger C, 2010, COLD SPRING HARB PRO, V2010, DOI [10.1101/pdb.prot5519, DOI 10.1101/PDB.PROT5519]; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Schlosser A, 2005, ANAL CHEM, V77, P5243, DOI 10.1021/ac050232m; Sekine T, 2008, J BIOL RHYTHM, V23, P3, DOI 10.1177/0748730407311652; Shi GS, 2016, CELL REP, V14, P823, DOI 10.1016/j.celrep.2015.12.076; Studer RA, 2009, TRENDS GENET, V25, P210, DOI 10.1016/j.tig.2009.03.004; Suri V, 2000, J NEUROSCI, V20, P7547; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yu WJ, 2011, CURR BIOL, V21, P756, DOI 10.1016/j.cub.2011.02.037; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	46	1	1	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					161	171		10.1074/jbc.M116.751214	http://dx.doi.org/10.1074/jbc.M116.751214			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27879317	Green Published, hybrid			2022-12-28	WOS:000391578000014
J	Zhang, Y; Agrebi, R; Bellows, LE; Collet, JF; Kaever, V; Grundling, A				Zhang, Yong; Agrebi, Rym; Bellows, Lauren E.; Collet, Jean-Francois; Kaever, Volkhard; Grundling, Angelika			Evolutionary Adaptation of the Essential tRNA Methyltransferase TrmD to the Signaling Molecule 3 ',5 '-cAMP in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADENOSINE-MONOPHOSPHATE; MULTIPLE SEQUENCE ALIGNMENTS; IV ADENYLYL-CYCLASE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; THIAMINE TRIPHOSPHATASE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; BINDING-SITE; ACTIVE-SITE	The nucleotide signaling molecule 3',5'-cyclic adenosine monophosphate (3',5'-cAMP) plays important physiological roles, ranging from carbon catabolite repression in bacteria to mediating the action of hormones in higher eukaryotes, including human. However, it remains unclear whether 3',5'-cAMP is universally present in the Firmicutes group of bacteria. We hypothesized that searching for proteins that bind 3',5'-cAMP might provide new insight into this question. Accordingly, we performed a genome-wide screen and identified the essential Staphylococcus aureus tRNA m(1)G37 methyltransferase enzyme TrmD, which is conserved in all three domains of life as a tight 3',5'-cAMP-binding protein. TrmD enzymes are known to use S-adenosyl-L-methionine (AdoMet) as substrate; we have shown that 3',5'-cAMP binds competitively with AdoMet to the S. aureus TrmD protein, indicating an overlapping binding site. However, the physiological relevance of this discovery remained unclear, as we were unable to identify a functional adenylate cyclase in S. aureus and only detected 2',3' -cAMP but not 3',5'-cAMP in cellular extracts. Interestingly, TrmD proteins from Escherichia coli and Mycobacterium tuberculosis, organisms known to synthesize 3',5'-cAMP, did not bind this signaling nucleotide. Comparative bioinformatics, mutagenesis, and biochemical analyses revealed that the highly conserved Tyr-86 residue in E. coli TrmD is essential to discriminate between 3',5'-cAMP and the native substrate AdoMet. Combined with a phylogenetic analysis, these results suggest that amino acids in the substrate binding pocket of TrmD underwent an adaptive evolution to accommodate the emergence of adenylate cyclases and thus the signaling molecule 3',5'-cAMP. Altogether this further indicates that S. aureus does not produce 3',5'-cAMP, which would otherwise competitively inhibit an essential enzyme.	[Zhang, Yong; Bellows, Lauren E.; Grundling, Angelika] Imperial Coll London, Sect Microbiol, London SW7 2AZ, England; [Zhang, Yong; Bellows, Lauren E.; Grundling, Angelika] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Agrebi, Rym; Collet, Jean-Francois] WELBIO, Ave Hippocrate 75, B-1200 Brussels, Belgium; [Agrebi, Rym; Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Zhang, Yong] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Imperial College London; Imperial College London; WELBIO; Universite Catholique Louvain; Hannover Medical School; University of Copenhagen	Grundling, A (corresponding author), Imperial Coll London, Sect Microbiol, London SW7 2AZ, England.	a.grundling@imperial.ac.uk	Kaever, Volkhard/G-3280-2013; ZHANG, YONG/J-3689-2019; ZHANG, YONG/H-1959-2011	ZHANG, YONG/0000-0003-2968-0081; ZHANG, YONG/0000-0003-2968-0081; Grundling, Angelika/0000-0002-6235-8687; Collet, Jean-Francois/0000-0001-8069-7036	Wellcome Trust [100289]; European Research Council [260371]; EMBO long-term fellowship [ALTF 721-2013]; MRC [MR/J006874/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 100289 and European Research Council Grant 260371 (to A. G.) and EMBO long-term fellowship ALTF 721-2013 (to Y. Z.). The authors declare that they have no conflict of interest with the contents of this article.	Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Ahuja N, 2004, CRIT REV MICROBIOL, V30, P187, DOI 10.1080/10408410490468795; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bahre H, 2014, J CHROMATOGR B, V964, P208, DOI 10.1016/j.jchromb.2014.02.046; Bettendorff L, 2013, FEBS J, V280, P6443, DOI 10.1111/febs.12498; Bjork GR, 2003, J BACTERIOL, V185, P750, DOI 10.1128/JB.185.3.750-759.2003; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; BYSTROM AS, 1982, MOL GEN GENET, V188, P447, DOI 10.1007/BF00330047; Campeotto I, 2015, J BIOL CHEM, V290, P2888, DOI 10.1074/jbc.M114.621789; Corrigan RM, 2016, P NATL ACAD SCI USA, V113, pE1710, DOI 10.1073/pnas.1522179113; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Cotta MA, 1998, FEMS MICROBIOL LETT, V164, P257, DOI 10.1111/j.1574-6968.1998.tb13095.x; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Delvaux D, 2011, J BIOL CHEM, V286, P34023, DOI 10.1074/jbc.M111.233585; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Gallagher DT, 2006, J MOL BIOL, V362, P114, DOI 10.1016/j.jmb.2006.07.008; Gallagher DT, 2011, J MOL BIOL, V405, P787, DOI 10.1016/j.jmb.2010.11.026; Galperin MY, 2010, MOL BIOSYST, V6, P721, DOI 10.1039/b908047c; Gancedo JM, 2013, BIOL REV, V88, P645, DOI 10.1111/brv.12020; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gonzalez-Pinzon R, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001965; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAGERVALL TG, 1993, J MOL BIOL, V232, P756, DOI 10.1006/jmbi.1993.1429; HARMAN JG, 1983, J BACTERIOL, V153, P191, DOI 10.1128/JB.153.1.191-199.1983; Hill PJ, 2013, J MED CHEM, V56, P7278, DOI 10.1021/jm400718n; Ito T, 2015, P NATL ACAD SCI USA, V112, pE4197, DOI 10.1073/pnas.1422981112; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jackson EK, 2011, AM J PHYSIOL-RENAL, V301, pF1160, DOI 10.1152/ajprenal.00450.2011; Jankovic I, 2007, J MOL MICROB BIOTECH, V12, P114, DOI 10.1159/000096466; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lahoud G, 2011, RNA, V17, P1236, DOI 10.1261/rna.2706011; Leulliot N, 2008, NUCLEIC ACIDS RES, V36, P629, DOI 10.1093/nar/gkm1074; Linder JU, 2008, BIOCHEM J, V415, P449, DOI 10.1042/BJ20080350; MACH H, 1984, FEMS MICROBIOL LETT, V22, P27; MACH H, 1988, FEMS MICROBIOL LETT, V52, P189, DOI 10.1111/j.1574-6968.1988.tb02593.x; Makhlin J, 2007, J BACTERIOL, V189, P5976, DOI 10.1128/JB.00592-07; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Schuster CF, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7279; Shih ACC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-63; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sismeiro O, 1998, J BACTERIOL, V180, P3339, DOI 10.1128/JB.180.13.3339-3344.1998; Taylor AB, 2008, NUCLEIC ACIDS RES, V36, P1542, DOI 10.1093/nar/gkm1172; Tellez-Sosa J, 2002, J BACTERIOL, V184, P3560, DOI 10.1128/JB.184.13.3560-3568.2002; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Van Damme T, 2014, PHYTOCHEMISTRY, V103, P59, DOI 10.1016/j.phytochem.2014.03.013; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White TA, 2004, COMP FUNCT GENOM, V5, P304, DOI 10.1002/cfg.411	54	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					313	327		10.1074/jbc.M116.758896	http://dx.doi.org/10.1074/jbc.M116.758896			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27881678	hybrid, Green Published			2022-12-28	WOS:000391578000027
J	Zhang, Y; Xu, S; Liang, KY; Li, K; Zou, ZP; Yang, CL; Tan, K; Cao, X; Jiang, Y; Gao, TM; Bai, XC				Zhang, Yue; Xu, Song; Liang, Kang-yan; Li, Kai; Zou, Zhi-peng; Yang, Cui-lan; Tan, Kang; Cao, Xiong; Jiang, Yu; Gao, Tian-ming; Bai, Xiao-chun			Neuronal mTORC1 Is Required for Maintaining the Nonreactive State of Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; FIBROBLAST GROWTH FACTOR-2; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; BRAIN-INJURY; REACTIVE ASTROCYTES; SIGNALING PATHWAY; ACTIVATION; EPILEPSY; PROLIFERATION	Astrocytes respond to CNS insults through reactive astrogliosis, but the underlying mechanisms are unclear. In this study, we show that inactivation of mechanistic target of rapamycin complex (mTORC1) signaling in postnatal neurons induces reactive astrogliosis in mice. Ablation of Raptor (an mTORC1-specific component) in postmitotic neurons abolished mTORC1 activity and produced neurons with smaller soma and fewer dendrites, resulting in microcephaly and aberrant behavior in adult mice. Interestingly, extensive astrogliosis without significant astrocyte proliferation and glial scar formation was observed in these mice. The inhibition of neuronal mTORC1 may activate astrogliosis by reducing neuron-derived fibroblast growth factor 2 (FGF-2), which might trigger FGF receptor signaling in astrocytes to maintain their nonreactive state, and FGF-2 injection successfully prevented astrogliosis in Raptor knock-out mice. This study demonstrates that neuronal mTORC1 inhibits reactive astrogliosis and plays an important role in CNS pathologies.	[Zhang, Yue; Xu, Song; Bai, Xiao-chun] Southern Med Univ, Affiliated Hosp 3, Acad Orthoped, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Yue; Xu, Song; Liang, Kang-yan; Li, Kai; Zou, Zhi-peng; Yang, Cui-lan; Tan, Kang; Bai, Xiao-chun] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China; [Cao, Xiong; Gao, Tian-ming] Southern Med Univ, Sch Basic Med Sci, Dept Neurobiol, Guangzhou 510515, Guangdong, Peoples R China; [Cao, Xiong] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bai, XC (corresponding author), Southern Med Univ, Affiliated Hosp 3, Acad Orthoped, Guangzhou 510515, Guangdong, Peoples R China.; Bai, XC (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China.	baixc15@smu.edu.cn		zhang, yue/0000-0002-6612-8002; Cao, Xiong/0000-0002-1889-4255	State Key Development Program for Basic Research of China [2013CB945203, 2015CB55360]; National Natural Sciences Foundation of China [U1301222, 81530070, 31600964, 81270080]; National Science Fund for Distinguished Young Scholars [81625015]; GDHVPS	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); GDHVPS	This work was supported by the State Key Development Program for Basic Research of China (Grants 2013CB945203 and 2015CB55360), National Natural Sciences Foundation of China (Grants U1301222, 81530070, 31600964, and 81270080), The National Science Fund for Distinguished Young Scholars (Grant 81625015), and GDHVPS (2011). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal A, 2014, NEURON, V83, P255, DOI 10.1016/j.neuron.2014.07.005; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Chuang JH, 2013, STEM CELL RES, V11, P1117, DOI 10.1016/j.scr.2013.08.003; Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013; Costa-Mattioli M, 2013, NAT NEUROSCI, V16, P1537, DOI 10.1038/nn.3546; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Goddard DR, 2002, J ANAT, V200, P57, DOI 10.1046/j.0021-8782.2001.00002.x; Habas A, 2013, P NATL ACAD SCI USA, V110, P18291, DOI 10.1073/pnas.1208764110; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Kang K, 2014, GLIA, V62, P1328, DOI 10.1002/glia.22684; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Kassai H, 2014, CELL REP, V7, P1626, DOI 10.1016/j.celrep.2014.04.048; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Lee JH, 2015, NEURON, V85, P303, DOI 10.1016/j.neuron.2014.12.019; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008; McLean JR, 2005, GLIA, V52, P59, DOI 10.1002/glia.20218; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neary Joseph T, 2006, Novartis Found Symp, V276, P131; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Nobuta H, 2012, ANN NEUROL, V72, P750, DOI 10.1002/ana.23670; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Perea G, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ncel.2014.00378, 10.3389/fncel.2014.00378]; Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628; Pun RYK, 2012, NEURON, V75, P1022, DOI 10.1016/j.neuron.2012.08.002; Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Russo E, 2012, MOL NEUROBIOL, V46, P662, DOI 10.1007/s12035-012-8314-5; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stork T, 2014, NEURON, V83, P388, DOI 10.1016/j.neuron.2014.06.026; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; WINDLE WF, 1950, J COMP NEUROL, V93, P241, DOI 10.1002/cne.900930206; Zhang BL, 2006, J BIOL CHEM, V281, P905, DOI 10.1074/jbc.M503945200; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	47	14	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					100	111		10.1074/jbc.M116.744482	http://dx.doi.org/10.1074/jbc.M116.744482			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895121	hybrid, Green Published			2022-12-28	WOS:000391578000009
J	Nuth, M; Guan, HC; Ricciardi, RP				Nuth, Manunya; Guan, Hancheng; Ricciardi, Robert P.			A Conserved Tripeptide Sequence at the C Terminus of the Poxvirus DNA Processivity Factor D4 Is Essential for Protein Integrity and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; CRYSTAL-STRUCTURE; A20R PROTEIN; IN-VITRO; POLYMERASE; GLYCOSYLASE; REPLICATION; BINDING; IDENTIFICATION; INHIBITORS	Vaccinia virus (VACV) is a poxvirus, and the VACV D4 protein serves both as a uracil-DNA glycosylase and as an essential component required for processive DNA synthesis. The VACV A20 protein has no known catalytic function itself but associates with D4 to form the D4-A20 heterodimer that functions as the poxvirus DNA processivity factor. The heterodimer enables the DNA polymerase to efficiently synthesize extended strands of DNA. Upon characterizing the interaction between D4 and A20, we observed that the C terminus of D4 is susceptible to perturbation. Further analysis demonstrated that a conserved hexapeptide stretch at the extreme C terminus of D4 is essential for maintaining protein integrity, as assessed by its requirement for the production of soluble recombinant protein that is functional in processive DNA synthesis. From the known crystal structures of D4, the C-terminal hexapeptide is shown to make intramolecular contact with residues spanning the inner core of the protein. Our mutational analysis revealed that a tripeptide motif ((215)GFI(217)) within the hexapeptide comprises apparent residues necessary for the contact. Prediction of protein disorder identified the hexapeptide and several regions upstream of Gly(215) that comprise residues of the interface surfaces of the D4-A20 heterodimer. Our study suggests that (215)GFI(217) anchors these potentially dynamic upstream regions of the protein to maintain protein integrity. Unlike uracil-DNA glycosylases from diverse sources, where the C termini are disordered and do not form comparable intramolecular contacts, this feature may be unique to orthopoxviruses.	[Nuth, Manunya; Guan, Hancheng; Ricciardi, Robert P.] Univ Penn, Sch Dent Med, Dept Microbiol, 221 Levy Res Bldg,4010 Locust St, Philadelphia, PA 19104 USA; [Ricciardi, Robert P.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Ricciardi, RP (corresponding author), Univ Penn, Sch Dent Med, Dept Microbiol, 221 Levy Res Bldg,4010 Locust St, Philadelphia, PA 19104 USA.	ricciard@upenn.edu		Nuth, Manunya/0000-0002-3457-8201	National Institutes of Health [5U01-A1082211, 1R44AI115759-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI115759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants 5U01-A1082211 and 1R44AI115759-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGULNICK AD, 1993, J GEN VIROL, V74, P1003, DOI 10.1099/0022-1317-74-6-1003; Aravind L, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-4-RESEARCH0007; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; Boyle KA, 2011, J BIOL CHEM, V286, P24702, DOI 10.1074/jbc.M111.222216; Burmeister WP, 2015, J BIOL CHEM, V290, P17923, DOI 10.1074/jbc.M115.648352; Contesto-Richefeu C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003978; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ellison V, 2001, CELL, V106, P655, DOI 10.1016/S0092-8674(01)00498-6; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; Ishii K, 2002, VIROLOGY, V303, P232, DOI 10.1006/viro.2002.1721; Ishii K, 2001, J VIROL, V75, P1656, DOI 10.1128/JVI.75.4.1656-1663.2001; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; KIEHL A, 1991, VIROLOGY, V184, P330, DOI 10.1016/0042-6822(91)90849-7; Klemperer N, 2001, J VIROL, V75, P12298, DOI 10.1128/JVI.75.24.12298-12307.2001; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lin K, 2000, J VIROL METHODS, V88, P219, DOI 10.1016/S0166-0934(00)00190-7; Lin K, 1998, J VIROL, V72, P6228, DOI 10.1128/JVI.72.7.6228-6232.1998; Lin K, 1998, VIROLOGY, V250, P210, DOI 10.1006/viro.1998.9348; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; MILLNS AK, 1994, VIROLOGY, V198, P504, DOI 10.1006/viro.1994.1061; Moss B., 2013, COLD SPRING HARBOR P, V5, P1; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nuth M, 2013, J MED CHEM, V56, P3235, DOI 10.1021/jm301735k; Nuth M, 2011, J MED CHEM, V54, P3260, DOI 10.1021/jm101554k; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rachofsky EL, 2001, BIOCHEMISTRY-US, V40, P957, DOI 10.1021/bi001665g; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Schormann N, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-45; Schormann N, 2015, BMC STRUCT BIOL, V15, DOI 10.1186/s12900-015-0037-1; Sele C, 2013, J VIROL, V87, P1679, DOI 10.1128/JVI.01533-12; Shudofsky AMD, 2010, J VIROL, V84, P12325, DOI 10.1128/JVI.01435-10; SKLENAR V, 1993, J AM CHEM SOC, V115, P12181, DOI 10.1021/ja00078a073; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stanitsa ES, 2006, J BIOL CHEM, V281, P3439, DOI 10.1074/jbc.M511239200; STUART DT, 1993, J VIROL, V67, P2503, DOI 10.1128/JVI.67.5.2503-2512.1993; TSURUMI T, 1993, J VIROL, V67, P7648, DOI 10.1128/JVI.67.12.7648-7653.1993; UPTON C, 1993, P NATL ACAD SCI USA, V90, P4518, DOI 10.1073/pnas.90.10.4518; WEILAND KL, 1994, VIRUS RES, V34, P191, DOI 10.1016/0168-1702(94)90124-4; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	49	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27087	27097		10.1074/jbc.M116.761908	http://dx.doi.org/10.1074/jbc.M116.761908			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27836975	hybrid, Green Published			2022-12-28	WOS:000391576300010
J	Imamura, M; Tabeta, N; Kato, N; Matsuura, Y; Iwamaru, Y; Yokoyama, T; Murayama, Y				Imamura, Morikazu; Tabeta, Naoko; Kato, Nobuko; Matsuura, Yuichi; Iwamaru, Yoshifumi; Yokoyama, Takashi; Murayama, Yuichi			Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRESYMPTOMATIC DETECTION; CHONDROITIN SULFATE; ALZHEIMERS-DISEASE; CULTURED-CELLS; SCRAPIE; AGGREGATION; BRAIN; PRPSC; GLYCOSAMINOGLYCAN	The precise mechanism underlying the conversion of normal prion protein (PrPC) into abnormal prion protein (PrPSc) remains unclear. Protein misfolding cyclic amplification (PMCA), an in vitro technique used for amplifying PrPSc, results in PrPSc replication that preserves the strain-specific characteristics of the input PrPSc; thus, PMCA mimics the process of in vivo PrPSc replication. Previous work has demonstrated that in PMCA, nucleic acids are critical for PrPSc amplification, but little information has been reported on glycosaminoglycan (GAG) participation in PrPSc replication in vitro. Here, we investigated whether GAGs play a role in the faithful replication of PrPSc by using a modified PMCA performed with baculovirus-derived recombinant PrP (Bac-PrP) as a substrate. The addition of heparan sulfate (HS) or its analog heparin (HP) restored the conversion efficiency in PMCA that was inhibited through nucleic acid depletion. Moreover, the PMCA products obtained under these conditions were infectious and preserved the properties of the input PrPSc. These data suggest that HS and HP play the same role as nucleic acids in facilitating faithful replication of prions in PMCA. Furthermore, we showed that HP binds to both Bac-PrP and Bac-PrPSc through the sulfated groups present on HP and that the N-terminal domain of Bac-PrPSc might potentially not be involved in the binding to HP. These results suggest that the interaction of GAGs such as HS and HP with PrPC and/or PrPSc through their sulfate groups is critical for the faithful replication of prions.	[Imamura, Morikazu; Tabeta, Naoko; Kato, Nobuko; Matsuura, Yuichi; Iwamaru, Yoshifumi; Yokoyama, Takashi; Murayama, Yuichi] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Imamura, M (corresponding author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Tsukuba, Ibaraki 3050856, Japan.	imamuram@affrc.go.jp	Matsuura, Yuichi/AAF-3170-2021	Matsuura, Yuichi/0000-0003-3383-7918	JSPS [25460575]; BSE Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BSE Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by JSPS KAKENHI Grant 25460575 and a grant-in-aid from the BSE Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040; Aono S, 2006, ADV PHARMACOL, V53, P323, DOI 10.1016/S1054-3589(05)53015-1; Avram S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/642798; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Ellett LJ, 2015, GLYCOBIOLOGY, V25, P745, DOI 10.1093/glycob/cwv014; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Imamura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082538; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V339, P577, DOI 10.1016/j.bbrc.2005.11.053; Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004; Lawson VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012351; Leucht C, 2003, EMBO REP, V4, P290, DOI 10.1038/sj.embor.embor768; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Mayer-Sonnenfeld T, 2005, NEUROBIOL DIS, V20, P738, DOI 10.1016/j.nbd.2005.05.009; Mays CE, 2010, FASEB J, V24, P5102, DOI 10.1096/fj.10-163600; Murayama Y, 2016, BIOCHEM BIOPH RES CO, V470, P563, DOI 10.1016/j.bbrc.2016.01.105; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; PERLMUTTER LS, 1991, J NEUROSCI RES, V30, P673, DOI 10.1002/jnr.490300411; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; SNOW AD, 1994, AM J PATHOL, V144, P337; SNOW AD, 1990, LAB INVEST, V63, P601; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072	40	19	19	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26478	26486		10.1074/jbc.M116.745851	http://dx.doi.org/10.1074/jbc.M116.745851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27821590	Green Published, hybrid			2022-12-28	WOS:000391568200021
J	Qiu, YX; Hassaninasab, A; Han, GS; Carman, GM				Qiu, Yixuan; Hassaninasab, Azam; Han, Gil-Soo; Carman, George M.			Phosphorylation of Dgk1 Diacylglycerol Kinase by Casein Kinase II Regulates Phosphatidic Acid Production in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; NUCLEAR-MEMBRANE GROWTH; PHOSPHOLIPID-SYNTHESIS; LIPID-METABOLISM; SIGNALING FUNCTIONS; BETA-SUBUNIT; PROTEIN-PHOSPHORYLATION; MEDIATED REGULATION; ORTHOLOGUE PAH1P	In the yeast Saccharomyces cerevisiae, Dgk1 diacylglycerol (DAG) kinase catalyzes the CTP-dependent phosphorylation of DAG to form phosphatidic acid (PA). The enzyme in conjunction with Pah1 PA phosphatase controls the levels of PA and DAG for the synthesis of triacylglycerol and membrane phospholipids, the growth of the nuclear/endoplasmic reticulum membrane, and the formation of lipid droplets. Little is known about how DAG kinase activity is regulated by posttranslational modification. In this work, we examined the phosphorylation of Dgk1 DAG kinase by casein kinase II (CKII). When phosphate groups were globally reduced using nonspecific alkaline phosphatase, Triton X-100-solubilized membranes from DGK1-overexpressing cells showed a 7.7-fold reduction in DAG kinase activity; the reduced enzyme activity could be increased 5.5-fold by treatment with CKII. Dgk1(1-77) expressed heterologously in Escherichia coli was phosphorylated by CKII on a serine residue, and its phosphorylation was dependent on time as well as on the concentrations of CKII, ATP, and Dgk1(177). We used site-specific mutagenesis, coupled with phosphorylation analysis and phosphopeptide mapping, to identify Ser-45 and Ser-46 of Dgk1 as the CKII target sites, with Ser-46 being the major phosphorylation site. In vivo, the S46A and S45A/S46A mutations of Dgk1 abolished the stationary phase-dependent stimulation of DAG kinase activity. Inaddition, the phosphorylation-deficientmutations decreased Dgk1 function in PA production and in eliciting pah1 Delta phenotypes, such as the expansion of the nuclear/endoplasmic reticulum membrane, reduced lipid droplet formation, and temperature sensitivity. This work demonstrates that the CKII-mediated phosphorylation of Dgk1 regulates its function in the production of PA.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA.	gcarman@rutgers.edu			National Institutes of Health from the United States Public Health Service [GM028140, GM050679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140, R01GM050679] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM028140 and GM050679 from the United States Public Health Service. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramovici H, 2003, MOL BIOL CELL, V14, P4499, DOI 10.1091/mbc.E03-03-0190; Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; ALFEEL W, 1992, P NATL ACAD SCI USA, V89, P4534, DOI 10.1073/pnas.89.10.4534; Baldanzi G, 2008, ONCOGENE, V27, P942, DOI 10.1038/sj.onc.1210717; Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chang YF, 2006, J BIOL CHEM, V281, P4754, DOI 10.1074/jbc.M513064200; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Connerth M, 2009, METHODS MOL BIOL, V579, P359, DOI 10.1007/978-1-60761-322-0_18; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JU QD, 1990, MOL CELL BIOL, V10, P5226, DOI 10.1128/MCB.10.10.5226; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Krishna S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00178; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lussier M, 1997, GENETICS, V147, P435; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; PADMANABHA R, 1987, J BIOL CHEM, V262, P1829; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Qiu YX, 2013, J BIOL CHEM, V288, P29124, DOI 10.1074/jbc.M113.507392; Raben DM, 2008, FRONT BIOSCI-LANDMRK, V13, P590, DOI 10.2741/2704; REED JC, 1994, J BIOL CHEM, V269, P18192; Rincon E, 2012, PROG LIPID RES, V51, P1, DOI 10.1016/j.plipres.2011.10.001; Ruiz C, 1999, YEAST, V15, P1001; Sakane F, 2008, CURR DRUG TARGETS, V9, P626, DOI 10.2174/138945008785132394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Tu-Sekine B, 2011, CRIT REV BIOCHEM MOL, V46, P353, DOI 10.3109/10409238.2011.577761; van Baal J, 2005, J BIOL CHEM, V280, P9870, DOI 10.1074/jbc.M409301200; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WITTERS LA, 1990, BIOCHEM BIOPH RES CO, V169, P369, DOI 10.1016/0006-291X(90)90341-J; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Yamaguchi Y, 2006, J BIOL CHEM, V281, P31627, DOI 10.1074/jbc.M606992200; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	124	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26455	26467		10.1074/jbc.M116.763839	http://dx.doi.org/10.1074/jbc.M116.763839			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27834677	hybrid, Green Published			2022-12-28	WOS:000391568200019
J	Ha, SD; Reid, C; Meshkibaf, S; Kim, SO				Ha, Soon-Duck; Reid, Chantelle; Meshkibaf, Shahab; Kim, Sung Ouk			Inhibition of interleukin 1 beta (IL-1 beta) expression by anthrax lethal toxin (LeTx) is reversed by histone deacetylase 8 (HDAC8) inhibition in murine macrophages (vol 291, pg 8745, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													KIM, Sung Ouk/A-1309-2008; Kim, Sung Ouk/AAO-1795-2020	Kim, Sung Ouk/0000-0002-0282-6661				Ha SD, 2016, J BIOL CHEM, V291, P8745, DOI 10.1074/jbc.M115.695809	1	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23363	23363		10.1074/jbc.A115.695809	http://dx.doi.org/10.1074/jbc.A115.695809			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27794103	hybrid, Green Published			2022-12-28	WOS:000387224800042
J	Yuan, ZQ; Kim, D; Kaneko, S; Sussman, M; Bokoch, GM; Kruh, GD; Nicosia, SV; Testa, JR; Cheng, JQ				Yuan, Zeng-qiang; Kim, Donghwa; Kaneko, Satoshi; Sussman, Melissa; Bokoch, Gary M.; Kruh, Gary D.; Nicosia, Santo V.; Testa, Joseph R.; Cheng, Jin Q.			ArgBP2 gamma interacts with Akt and p21-activated kinase-1 and promotes cell survival (vol 280, pg 21483, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Yuan ZQ, 2005, J BIOL CHEM, V280, P21483, DOI 10.1074/jbc.M500097200	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22845	22845		10.1074/jbc.A116.500097	http://dx.doi.org/10.1074/jbc.A116.500097			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825083	hybrid, Green Published			2022-12-28	WOS:000386760600044
J	Tessmer, MH; Anderson, DM; Buchaklian, A; Frank, DW; Feix, JB				Tessmer, Maxx H.; Anderson, David M.; Buchaklian, Adam; Frank, Dara W.; Feix, Jimmy B.			Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A(2) (PLA(2)) Enzyme, ExoU	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron paramagnetic resonance (EPR); phospholipase; protein structure; Pseudomonas aeruginosa (P; aeruginosa); ubiquitin	AERUGINOSA CYTOTOXIN EXOU; III PROTEIN SECRETION; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; EXOENZYME S; C2 DOMAIN; SPIN; DYNAMICS; IDENTIFICATION	The ExoU type III secretion enzyme is a potent phospholipase A(2) secreted by the Gram-negative opportunistic pathogen, Pseudomonas aeruginosa. Activation of phospholipase activity is induced by protein-protein interactions with ubiquitin in the cytosol of a targeted eukaryotic cell, leading to destruction of host cell membranes. Previous work in our laboratory suggested that conformational changes within a C-terminal domain of the toxin might be involved in the activation mechanism. In this study, we use site-directed spin-labeling electron paramagnetic resonance spectroscopy to investigate conformational changes in a C-terminal four-helical bundle region of ExoU as it interacts with lipid substrates and ubiquitin, and to examine the localization of this domain with respect to the lipid bilayer. In the absence of ubiquitin or substrate liposomes, the overall structure of the C-terminal domain is in good agreement with crystallographic models derived from ExoU in complex with its chaperone, SpcU. Significant conformational changes are observed throughout the domain in the presence of ubiquitin and liposomes combined that are not observed with either liposomes or ubiquitin alone. In the presence of ubiquitin, two interhelical loops of the C-terminal four-helix bundle appear to penetrate the membrane bilayer, stabilizing ExoU-membrane association. Thus, ubiquitin and the substrate lipid bilayer act synergistically to induce a conformational rearrangement in the C-terminal domain of ExoU.	[Tessmer, Maxx H.; Anderson, David M.; Frank, Dara W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Tessmer, Maxx H.; Anderson, David M.; Frank, Dara W.; Feix, Jimmy B.] Med Coll Wisconsin, Ctr Infect Dis Res, Milwaukee, WI 53226 USA; [Buchaklian, Adam; Feix, Jimmy B.] Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Feix, Jimmy B.] Med Coll Wisconsin, Natl Biomed EPR Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Anderson, David M.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Vanderbilt University	Feix, JB (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Feix, JB (corresponding author), Med Coll Wisconsin, Natl Biomed EPR Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jfeix@mcw.edu			National Institutes of Health [GM114234, AI104922]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM114234 (to J. B. F.) and AI104922 (to D. W. F). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Anderson DM, 2015, J BACTERIOL, V197, P529, DOI 10.1128/JB.02402-14; Anderson DM, 2013, J BIOL CHEM, V288, P26741, DOI 10.1074/jbc.M113.478529; Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; Benson MA, 2011, BIOPHYS J, V100, P1335, DOI 10.1016/j.bpj.2011.01.056; Benson MA, 2010, CLIN CHIM ACTA, V411, P190, DOI 10.1016/j.cca.2009.10.025; Bucher D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003156; Cao J, 2013, J BIOL CHEM, V288, P1806, DOI 10.1074/jbc.R112.421909; Columbus L, 2004, BIOCHEMISTRY-US, V43, P7273, DOI 10.1021/bi0497906; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Ellena JF, 2004, BIOPHYS J, V87, P3221, DOI 10.1529/biophysj.104.046748; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Gendrin C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002637; Halavaty AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049388; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Isas JM, 2002, BIOCHEMISTRY-US, V41, P1464, DOI 10.1021/bi011856z; Klug CS, 2008, METHOD CELL BIOL, V84, P617, DOI 10.1016/S0091-679X(07)84020-9; Klug CS, 1997, BIOCHEMISTRY-US, V36, P13027, DOI 10.1021/bi971232m; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-25; Malmberg NJ, 2003, BIOCHEMISTRY-US, V42, P13227, DOI 10.1021/bi035119+; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mouchlis VD, 2015, P NATL ACAD SCI USA, V112, pE516, DOI 10.1073/pnas.1424651112; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Phillips RM, 2003, J BIOL CHEM, V278, P41326, DOI 10.1074/jbc.M302472200; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rabin SDP, 2006, INFECT IMMUN, V74, P2552, DOI 10.1128/IAI.74.5.2552-2561.2006; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sato H, 2005, J BACTERIOL, V187, P1192, DOI 10.1128/JB.187.3.1192-1195.2005; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103127; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Stirling FR, 2006, CELL MICROBIOL, V8, P1294, DOI 10.1111/j.1462-5822.2006.00710.x; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Tamura M, 2004, BIOCHEM BIOPH RES CO, V316, P323, DOI 10.1016/j.bbrc.2004.02.050; Tyson GH, 2013, INFECT IMMUN, V81, P2873, DOI 10.1128/IAI.00414-13; Veesenmeyer JL, 2010, INFECT IMMUN, V78, P3346, DOI 10.1128/IAI.00223-10; Victor KG, 2001, BIOPHYS J, V81, P2241, DOI 10.1016/S0006-3495(01)75871-7; Yahr TL, 1996, MOL MICROBIOL, V22, P991, DOI 10.1046/j.1365-2958.1996.01554.x; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yahr TL, 1997, J BACTERIOL, V179, P7165, DOI 10.1128/jb.179.22.7165-7168.1997; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200	51	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3411	3419		10.1074/jbc.M116.760074	http://dx.doi.org/10.1074/jbc.M116.760074			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28069812	Green Published, hybrid			2022-12-28	WOS:000395538800030
J	Chitty, JL; Tatzenko, TL; Williams, SJ; Koh, YQAE; Corfield, EC; Butler, MS; Robertson, AAB; Cooper, MA; Kappler, U; Kobe, B; Fraser, JA				Chitty, Jessica L.; Tatzenko, Tayla L.; Williams, Simon J.; Koh, Y. Q. Andre E.; Corfield, Elizabeth C.; Butler, Mark S.; Robertson, Avril A. B.; Cooper, Matthew A.; Kappler, Ulrike; Kobe, Bostjan; Fraser, James A.			GMP Synthase Is Required for Virulence Factor Production and Infection by Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; XANTHOSINE 5-PHOSPHATE; CEREBROSPINAL-FLUID; BIOSYNTHESIS; SYNTHETASE; PURINE; AIDS; PHARMACOLOGY; INHIBITORS; HIV	Over the last four decades the HIV pandemic and advances in medical treatments that also cause immunosuppression have produced an ever-growing cohort of individuals susceptible to opportunistic pathogens. Of these, AIDS patients are particularly vulnerable to infection by the encapsulated yeast Cryptococcus neoformans. Most commonly found in the environment in purine-rich bird guano, C. neoformans experiences a drastic change in nutrient availability during host infection, ultimately disseminating to colonize the purine-poor central nervous system. Investigating the consequences of this challenge, we have characterized C. neoformans GMP synthase, the second enzyme in the guanylate branch of de novo purine biosynthesis. We show that in the absence of GMP synthase, C. neoformans becomes a guanine auxotroph, the production of key virulence factors is compromised, and the ability to infect nematodes and mice is abolished. Activity assays performed using recombinant protein unveiled differences in substrate binding between the C. neoformans and human enzymes, with structural insights into these kinetic differences acquired via homology modeling. Collectively, these data highlight the potential of GMP synthase to be exploited in the development of new therapeutic agents for the treatment of disseminated, life-threatening fungal infections.	[Chitty, Jessica L.; Tatzenko, Tayla L.; Williams, Simon J.; Koh, Y. Q. Andre E.; Corfield, Elizabeth C.; Cooper, Matthew A.; Kappler, Ulrike; Kobe, Bostjan; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia; [Chitty, Jessica L.; Butler, Mark S.; Robertson, Avril A. B.; Cooper, Matthew A.; Fraser, James A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Kappler, Ulrike] Univ Queensland, Ctr Met Biol, St Lucia, Qld 4072, Australia; [Williams, Simon J.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia	University of Queensland; University of Queensland; University of Queensland; Australian National University	Fraser, JA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.	jafraser@uq.edu.au	Robertson, Avril/A-4043-2012; Corfield, Elizabeth C/M-7086-2017; Cooper, Matthew A./C-7988-2009; Fraser, James A/B-4918-2012; Butler, Mark S./D-9973-2011; Chitty, Jessica/U-6619-2019; Williams, Simon/F-7447-2011; Kappler, Ulrike/A-9483-2013; Kobe, Bostjan/D-1292-2009	Robertson, Avril/0000-0002-9652-8357; Corfield, Elizabeth C/0000-0002-0119-157X; Cooper, Matthew A./0000-0003-3147-3460; Fraser, James A/0000-0001-5724-5285; Butler, Mark S./0000-0001-6689-4236; Chitty, Jessica/0000-0003-1776-1618; Williams, Simon/0000-0003-4781-6261; Kappler, Ulrike/0000-0002-2642-1319; Kobe, Bostjan/0000-0001-9413-9166; Tatzenko, Tayla/0000-0002-3525-4356	National Health and Medical Research Council [APP1049716]; Queensland Medical Research Scholarship; National Health and Medical Research Council Principle Research Fellowships [1003325, 1110971]; National Health and Medical Research Council Principle Research Fellowship [GNT1059354]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland Medical Research Scholarship; National Health and Medical Research Council Principle Research Fellowships; National Health and Medical Research Council Principle Research Fellowship	This work was supported by National Health and Medical Research Council Grant APP1049716 (to J. A. F. and M. S. B.), a Queensland Medical Research Scholarship (to J. C.), National Health and Medical Research Council Principle Research Fellowships 1003325 and 1110971 (to B. K.), and National Health and Medical Research Council Principle Research Fellowship GNT1059354 (to M. A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott JL, 2006, PROTEIN J, V25, P483, DOI 10.1007/s10930-006-9032-5; ABRAMS R, 1955, ARCH BIOCHEM BIOPHYS, V56, P184, DOI 10.1016/0003-9861(55)90347-7; Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; [Anonymous], 1982, Morbidity and Mortality Weekly Report, V31, P507; Ballut L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9930; Bhat JY, 2008, BIOCHEM J, V409, P263, DOI 10.1042/BJ20070996; Bicanic T, 2006, CLIN INFECT DIS, V43, P1069, DOI 10.1086/507895; Blundell RD, 2016, ACS INFECT DIS, V2, P651, DOI 10.1021/acsinfecdis.6b00121; BRENNER S, 1974, GENETICS, V77, P71; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P507; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305; Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P465; Cervantes-Madrid D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/690492; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; COGGIN JH, 1965, J BACTERIOL, V89, P1348, DOI 10.1128/JB.89.5.1348-1353.1965; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; DUJARDIN G, 1994, GENE, V139, P127, DOI 10.1016/0378-1119(94)90535-5; EELLS JT, 1983, NEUROCHEM RES, V8, P1451; ELION GB, 1989, BIOSCIENCE REP, V9, P509, DOI 10.1007/BF01119794; ELION GB, 1985, ADV ENZYME REGUL, V24, P323, DOI 10.1016/0065-2571(85)90084-6; Franco TMA, 2012, ARCH BIOCHEM BIOPHYS, V517, P1, DOI 10.1016/j.abb.2011.11.013; Franklin MC, 2015, PROTEINS, V83, P2124, DOI 10.1002/prot.24841; FRANKLIN TJ, 1969, BIOCHEM J, V113, P515, DOI 10.1042/bj1130515; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; FUKUYAMA TT, 1966, J BIOL CHEM, V241, P4745; GARDNER WJE, 1979, CAN J MICROBIOL, V25, P380, DOI 10.1139/m79-059; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; HITCHINGS GH, 1948, FED PROC, V7, P160; HYMES KB, 1981, LANCET, V2, P598; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Jiang LH, 2010, FEMS YEAST RES, V10, P199, DOI 10.1111/j.1567-1364.2009.00600.x; Jongwutiwes U, 2008, JPN J INFECT DIS, V61, P111; Kuracka L, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/759808; LAGERKVIST U, 1958, J BIOL CHEM, V233, P143; LEE BH, 1974, BIOCHEM BIOPH RES CO, V60, P918, DOI 10.1016/0006-291X(74)90402-1; Li M, 2012, BRAZ J INFECT DIS, V16, P175, DOI 10.1016/S1413-8670(12)70301-X; Maruoka S, 2010, J MOL BIOL, V395, P417, DOI 10.1016/j.jmb.2009.10.053; MARX JL, 1984, SCIENCE, V224, P475, DOI 10.1126/science.6324344; Mendelsohn LG, 1996, INVEST NEW DRUG, V14, P287, DOI 10.1007/BF00194532; Morrow CA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002957; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; NAKAMURA J, 1995, J BIOL CHEM, V270, P7347, DOI 10.1074/jbc.270.13.7347; Oliver JC, 2014, ARCH BIOCHEM BIOPHYS, V545, P22, DOI 10.1016/j.abb.2014.01.004; Oliver JC, 2013, BIOCHEMISTRY-US, V52, P5225, DOI 10.1021/bi3017075; Perfect JR, 2014, J CLIN INVEST, V124, P1893, DOI 10.1172/JCI75241; RAHMAN A, 1985, INVEST NEW DRUG, V3, P369; RIESENBERG DE, 1985, JAMA-J AM MED ASSOC, V254, P2521, DOI 10.1001/jama.254.18.2521; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roberts B D, 1994, J Insur Med, V26, P13; Rodriguez-Suarez R, 2007, CHEM BIOL, V14, P1163, DOI 10.1016/j.chembiol.2007.09.009; RODRIGUEZNUNEZ A, 1993, ACTA PAEDIATR, V82, P849, DOI 10.1111/j.1651-2227.1993.tb12577.x; SAKAMOTO N, 1972, J BIOL CHEM, V247, P5880; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SKIPPER HE, 1954, CANCER RES, V14, P294; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; SWEENEY MJ, 1972, CANCER RES, V32, P1803; Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74; Thakur AS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001091; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; VONDERSAAL W, 1985, BIOCHEMISTRY-US, V24, P5343, DOI 10.1021/bi00341a011; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Welin M, 2013, J MOL BIOL, V425, P4323, DOI 10.1016/j.jmb.2013.06.032; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; World Health Organization, 2016, GLOB HLTH OBS GHO DA; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M; YARCHOAN R, 1986, LANCET, V1, P575; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	73	14	14	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					3049	3059		10.1074/jbc.M116.767533	http://dx.doi.org/10.1074/jbc.M116.767533			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28062578	hybrid, Green Published			2022-12-28	WOS:000395535100043
J	Posse, V; Gustafsson, CM				Posse, Viktor; Gustafsson, Claes M.			Human Mitochondrial Transcription Factor B2 Is Required for Promoter Melting during Initiation of Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; IN-VITRO; DNA; TFAM; SPECIFICITY; COMPLEXES; COMPONENT; BINDING; PROTEIN; LIGHT	The mitochondrial transcription initiation machinery in humans consists of three proteins: the RNA polymerase (POLRMT) and two accessory factors, transcription factors A and B2 (TFAM and TFB2M, respectively). This machinery is required for the expression of mitochondrial DNA and the biogenesis of the oxidative phosphorylation system. Previous experiments suggested that TFB2M is required for promoter melting, but conclusive experimental proof for this effect has not been presented. Moreover, the role of TFB2M in promoter unwinding has not been discriminated from that of TFAM. Here we used potassium permanganate footprinting, DNase I footprinting, and in vitro transcription from the mitochondrial light-strand promoter to study the role of TFB2M in transcription initiation. We demonstrate that a complex composed of TFAM and POLRMT was readily formed at the promoter but alone was insufficient for promoter melting, which only occurred when TFB2M joined the complex. We also show that mismatch bubble templates could circumvent the requirement of TFB2M, but TFAM was still required for efficient initiation. Our findings support a model in which TFAM first recruits POLRMT to the promoter, followed by TFB2M binding and induction of promoter melting.	[Posse, Viktor; Gustafsson, Claes M.] Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden	University of Gothenburg	Gustafsson, CM (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.	claes.gustafsson@medkem.gu.se		Posse, Viktor/0000-0003-4936-4967; Gustafsson, Claes/0000-0003-3531-8468	Swedish Research Council [2012-2583]; Swedish Cancer Foundation [CAN 2013/855]; European Research Council [268897]; IngaBritt and Arne Lundberg Foundation; Knut and Alice Wallenbergs Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; European Research Council(European Research Council (ERC)European Commission); IngaBritt and Arne Lundberg Foundation; Knut and Alice Wallenbergs Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by Swedish Research Council Grant 2012-2583; Swedish Cancer Foundation Grant CAN 2013/855; European Research Council Grant 268897; the IngaBritt and Arne Lundberg Foundation; and the Knut and Alice Wallenbergs Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; CHAN B, 1990, FEBS LETT, V267, P46, DOI 10.1016/0014-5793(90)80284-P; DAIRAGHI DJ, 1995, BBA-MOL BASIS DIS, V1271, P127, DOI 10.1016/0925-4439(95)00019-Z; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Morozov YI, 2016, J BIOL CHEM, V291, P13432, DOI 10.1074/jbc.C116.727966; Morozov YI, 2015, NUCLEIC ACIDS RES, V43, P3726, DOI 10.1093/nar/gkv235; Morozov YI, 2014, NUCLEIC ACIDS RES, V42, P3884, DOI 10.1093/nar/gkt1356; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Paratkar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228023; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Posse V, 2015, NUCLEIC ACIDS RES, V43, P2615, DOI 10.1093/nar/gkv105; Posse V, 2014, NUCLEIC ACIDS RES, V42, P3638, DOI 10.1093/nar/gkt1397; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; RUBIN CM, 1980, NUCLEIC ACIDS RES, V8, P4613, DOI 10.1093/nar/8.20.4613; Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160; Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; XU BJ, 1992, NUCLEIC ACIDS RES, V20, P1053, DOI 10.1093/nar/20.5.1053	30	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2637	2645		10.1074/jbc.M116.751008	http://dx.doi.org/10.1074/jbc.M116.751008			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28028173	Green Published, hybrid			2022-12-28	WOS:000395535100007
J	Baker, ST; Grill, B				Baker, Scott T.; Grill, Brock			Defining Minimal Binding Regions in Regulator of Presynaptic Morphology 1 (RPM-1) Using Caenorhabditis elegans Neurons Reveals Differential Signaling Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE COMPLEX; SYNAPTIC TERMINAL GROWTH; MAP KINASE PATHWAY; PHR PROTEIN RPM-1; C-ELEGANS; AXON TERMINATION; GENE-TRANSFER; HIGHWIRE; DROSOPHILA; SYNAPTOGENESIS	The intracellular signaling protein regulator of presynaptic morphology 1 (RPM-1) is a conserved regulator of synapse formation and axon termination in Caenorhabditis elegans. RPM-1 functions in a ubiquitin ligase complex with the F-box protein FSN-1 and functions through the microtubule binding protein RAE-1. Using a structure-function approach and positive selection for transgenic C. elegans, we explored the biochemical relationship between RPM-1, FSN-1, and RAE-1. This led to the identification of two new domains in RPM-1 that are sufficient for binding to FSN-1, called FSN-1 binding domain 2 (FBD2) and FBD3. Furthermore, we map the RAE-1 binding domain to a much smaller region of RPM-1. Point mutations in RPM-1 that reduce binding to RAE-1 did not affect FSN-1 binding, indicating that RPM-1 utilizes different biochemical mechanisms to bind these molecules. Analysis of RPM-1 protein complexes in the neurons of C. elegans elucidated two further discoveries: FSN-1 binds to RAE-1, and this interaction is not mediated by RPM-1, and RPM-1 binding to FSN-1 and RAE-1 reduces FSN-1.RAE-1 complex formation. These results indicate that RPM-1 uses different mechanisms to recruit FSN-1 and RAE-1 into independent signaling complexes in neurons.	[Baker, Scott T.; Grill, Brock] Scripps Florida, Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida	Grill, B (corresponding author), Scripps Florida, Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	bgrill@scripps.edu		Grill, Brock/0000-0002-0379-3267	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072129] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the C. elegans knockout consortium for generating alleles and the C. elegans Genetics Center for providing strains (National Institutes of Health Office of Research Infrastructure Programs, P40 OD010440).	Abrams B, 2008, DEV DYNAM, V237, P630, DOI 10.1002/dvdy.21446; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Baker ST, 2015, GENETICS, V199, P151, DOI 10.1534/genetics.114.170589; Baker ST, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004297; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Brace EJ, 2014, J NEUROSCI, V34, P8398, DOI 10.1523/JNEUROSCI.4715-13.2014; BRENNER S, 1974, GENETICS, V77, P71; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Giles AC, 2015, G3-GENES GENOM GENET, V5, P2745, DOI 10.1534/g3.115.021410; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Grill B, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0063-0; Grill B, 2012, J NEUROSCI, V32, P2628, DOI 10.1523/JNEUROSCI.2901-11.2012; Huntwork-Rodriguez S, 2013, J CELL BIOL, V202, P747, DOI 10.1083/jcb.201303066; Kim JH, 2013, NEURON, V78, P827, DOI 10.1016/j.neuron.2013.05.020; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Li H.T., 2008, INT WORKSH EARTH OBS, V1, P1, DOI DOI 10.1117/1.2943286; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Opperman KJ, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-10; Po MD, 2010, CURR OPIN NEUROBIOL, V20, P100, DOI 10.1016/j.conb.2009.12.007; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Sharma J, 2014, J BIOL CHEM, V289, P34654, DOI 10.1074/jbc.M114.614065; Shin JE, 2011, J NEUROSCI, V31, P17689, DOI 10.1523/JNEUROSCI.3902-11.2011; Tian XL, 2011, NAT NEUROSCI, V14, P1267, DOI 10.1038/nn.2922; Tulgren ED, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004481; Tulgren ED, 2011, GENETICS, V189, P1297, DOI 10.1534/genetics.111.134791; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Xiong X, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001440; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	35	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2519	2530		10.1074/jbc.M116.748004	http://dx.doi.org/10.1074/jbc.M116.748004			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	27979965	hybrid, Green Published			2022-12-28	WOS:000395530300038
J	Juillan-Binard, C; Picciocchi, A; Andrieu, JP; Dupuy, J; Petit-Hartlein, I; Caux-Thang, C; Vives, C; Niviere, V; Fieschi, F				Juillan-Binard, Celine; Picciocchi, Antoine; Andrieu, Jean-Pierre; Dupuy, Jerome; Petit-Hartlein, Isabelle; Caux-Thang, Christelle; Vives, Corinne; Niviere, Vincent; Fieschi, Franck			A Two-component NADPH Oxidase (NOX)-like System in Bacteria Is Involved in the Electron Transfer Chain to the Methionine Sulfoxide Reductase MsrP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN-STRUCTURE; FAMILY; OXIDOREDUCTASE; BINDING; HEME; IDENTIFICATION; ACTIVATION; DOMAIN; IRON	MsrPQ is a newly identified methionine sulfoxide reductase system found in bacteria, which appears to be specifically involved in the repair of periplasmic proteins oxidized by hypochlorous acid. It involves two proteins: a periplasmic one, MsrP, previously named YedY, carrying out the Msr activity, and MsrQ, an integral b-type heme membrane-spanning protein, which acts as the specific electron donor to MsrP. MsrQ, previously named YedZ, was mainly characterized by bioinformatics as a member of the FRD superfamily of heme-containing membrane proteins, which include the NADPH oxidase proteins (NOX/DUOX). Here we report a detailed biochemical characterization of the MsrQ protein from Escherichia coli. We optimized conditions for the overexpression and membrane solubilization of an MsrQ-GFP fusion and set up a purification scheme allowing the production of pure MsrQ. Combining UV-visible spectroscopy, heme quantification, and site-directed mutagenesis of histidine residues, we demonstrated that MsrQ is able to bind two b-type hemes through the histidine residues conserved between the MsrQ and NOX protein families. In addition, we identify the E. coli flavin reductase Fre, which is related to the dehydrogenase domain of eukaryotic NOX enzymes, as an efficient cytosolic electron donor to the MsrQ heme moieties. Cross-linking experiments as well as surface Plasmon resonance showed that Fre interacts with MsrQ to form a specific complex. Taken together, these data support the identification of the first prokaryotic two-component protein system related to the eukaryotic NOX family and involved in the reduction of periplasmic oxidized proteins.	[Juillan-Binard, Celine; Picciocchi, Antoine; Andrieu, Jean-Pierre; Dupuy, Jerome; Petit-Hartlein, Isabelle; Vives, Corinne; Fieschi, Franck] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Juillan-Binard, Celine; Picciocchi, Antoine; Andrieu, Jean-Pierre; Dupuy, Jerome; Petit-Hartlein, Isabelle; Vives, Corinne; Fieschi, Franck] CEA, IBS, F-38027 Grenoble, France; [Juillan-Binard, Celine; Picciocchi, Antoine; Andrieu, Jean-Pierre; Dupuy, Jerome; Petit-Hartlein, Isabelle; Vives, Corinne; Fieschi, Franck] CNRS, IBS, F-38027 Grenoble, France; [Caux-Thang, Christelle; Niviere, Vincent] Univ Grenoble Alpes, Grenoble, France; [Caux-Thang, Christelle; Niviere, Vincent] CNRS, LCBM, UMR 5249, Grenoble, France; [Caux-Thang, Christelle; Niviere, Vincent] CEA, DRF, BIG, Lab Chim & Biol Metaux, 17 Rue Martyrs, F-38054 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Fieschi, F (corresponding author), Inst Biol Struct, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	fieschi@ibs.fr	Fieschi, Franck/W-2748-2019; Dupuy, Jerome/AAD-3438-2020	Dupuy, Jerome/0000-0002-2721-5365; Niviere, Vincent/0000-0002-5132-457X; FIESCHI, Franck/0000-0003-1194-8107	FRISBI within the Grenoble Partnership for Structural Biology (PSB) [ANR-10INSB-05-02]; GRAL within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	FRISBI within the Grenoble Partnership for Structural Biology (PSB); GRAL within the Grenoble Partnership for Structural Biology (PSB)	We thank Jan Willem de Gier for the gift of the pET28-YedZ-GFP plasmid. This work used the MP3, the Robiomol, and the SPR platforms of the Grenoble Instruct Center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	BIANCHI V, 1993, J BACTERIOL, V175, P1590, DOI 10.1128/JB.175.6.1590-1595.1993; Biberstine-Kinkade KJ, 2001, J BIOL CHEM, V276, P31105, DOI 10.1074/jbc.M103327200; BLASCHKOWSKI HP, 1982, EUR J BIOCHEM, V123, P563; Boschi-Muller S, 2014, BIOORG CHEM, V57, P222, DOI 10.1016/j.bioorg.2014.07.002; Brokx SJ, 2005, BIOCHEMISTRY-US, V44, P10339, DOI 10.1021/bi050621a; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gennaris A, 2015, NATURE, V528, P409, DOI 10.1038/nature15764; Gray MJ, 2013, ANNU REV MICROBIOL, V67, P141, DOI 10.1146/annurev-micro-102912-142520; Havelius KGV, 2011, INORG CHEM, V50, P741, DOI 10.1021/ic101291j; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Kleven MD, 2015, J BIOL CHEM, V290, P22558, DOI 10.1074/jbc.M115.664565; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; Loschi L, 2004, J BIOL CHEM, V279, P50391, DOI 10.1074/jbc.M408876200; Melnyk RA, 2015, MBIO, V6, DOI 10.1128/mBio.00233-15; Niviere V, 1999, J BIOL CHEM, V274, P18252, DOI 10.1074/jbc.274.26.18252; Niviere V, 1996, J BIOL CHEM, V271, P16656, DOI 10.1074/jbc.271.28.16656; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Pushie MJ, 2011, INORG CHEM, V50, P732, DOI 10.1021/ic101280m; Rieske JS, 1967, METHOD ENZYMOL, V10, P488, DOI DOI 10.1016/0076-6879(67)10081-5; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; SEGAL AW, 1978, NATURE, V276, P515, DOI 10.1038/276515a0; Sucharitakul J, 2014, ARCH BIOCHEM BIOPHYS, V555, P33, DOI 10.1016/j.abb.2014.05.009; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; von Rozycki T, 2004, J MOL MICROB BIOTECH, V8, P129, DOI 10.1159/000085786; Workun GJ, 2008, MICROBIOL MOL BIOL R, V72, P228, DOI 10.1128/MMBR.00041-07; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058126	35	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2485	2494		10.1074/jbc.M116.752014	http://dx.doi.org/10.1074/jbc.M116.752014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028176	Green Published, hybrid			2022-12-28	WOS:000395530300035
J	Liang, T; Qin, TR; Xie, L; Dolai, S; Zhu, D; Prentice, KJ; Wheeler, M; Kang, YH; Osborne, L; Gaisano, HY				Liang, Tao; Qin, Tairan; Xie, Li; Dolai, Subhankar; Zhu, Dan; Prentice, Kacey J.; Wheeler, Michael; Kang, Youhou; Osborne, Lucy; Gaisano, Herbert Y.			New Roles of Syntaxin-1A in Insulin Granule Exocytosis and Replenishment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; KNOCK-OUT MICE; MEDIATES EXOCYTOSIS; PROTEIN EXPRESSION; HPC-1/SYNTAXIN 1A; SECRETION; SNARE; DOCKING; FUSION; 1ST-PHASE	In type-2 diabetes (T2D), severely reduced islet syntaxin-1A (Syn-1A) levels contribute to insulin secretory deficiency. We generated beta-cell-specific Syn-1A-KO (Syn-1A-beta KO) mice to mimic beta-cell Syn-1A deficiency in T2D. Glucose tolerance tests showed that Syn-1A-beta KO mice exhibited blood glucose elevation corresponding to reduced blood insulin levels. Perifusion of Syn-1A-beta KO islets showed impaired first-and second-phase glucose-stimulated insulin secretion (GSIS) resulting from reduction in readily releasable pool and granule pool refilling. To unequivocally determine the beta-cell exocytotic defects caused by Syn-1A deletion, EM and total internal reflection fluorescence microscopy showed that Syn-1A-KO beta-cells had a severe reduction in the number of secretory granules (SGs) docked onto the plasma membrane (PM) at rest and reduced SG recruitment to the PM after glucose stimulation, the latter indicating defects in replenishment of releasable pools required to sustain second-phase GSIS. Whereas reduced predocked SG fusion accounted for reduced first-phase GSIS, selective reduction of exocytosis of short-dock (but not no-dock) newcomer SGs accounted for the reduced second-phase GSIS. These Syn-1A actions on newcomer SGs were partly mediated by Syn-1A interactions with newcomer SG VAMP8.	[Liang, Tao; Qin, Tairan; Xie, Li; Dolai, Subhankar; Zhu, Dan; Kang, Youhou; Osborne, Lucy; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Osborne, Lucy] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Liang, Tao; Qin, Tairan; Xie, Li; Dolai, Subhankar; Zhu, Dan; Prentice, Kacey J.; Wheeler, Michael; Kang, Youhou; Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Gaisano, HY (corresponding author), Univ Toronto, 1 Kings Coll Circle,Rm 7368, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes of Health Research [MOP 89889]; 3D (Diet, Digestive Tract, and Disease) Centre - Canadian Foundation for Innovation and Ontario Research Fund [19442]; Banting and Best Diabetes Center of the University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); 3D (Diet, Digestive Tract, and Disease) Centre - Canadian Foundation for Innovation and Ontario Research Fund; Banting and Best Diabetes Center of the University of Toronto	Some equipment used in this study was supported by the 3D (Diet, Digestive Tract, and Disease) Centre funded by the Canadian Foundation for Innovation and Ontario Research Fund, project number 19442, and the Banting and Best Diabetes Center of the University of Toronto.	Andersson SA, 2012, MOL CELL ENDOCRINOL, V364, P36, DOI 10.1016/j.mce.2012.08.009; Andersson SA, 2011, PFLUG ARCH EUR J PHY, V462, P443, DOI 10.1007/s00424-011-0979-5; Chan CB, 1999, DIABETES, V48, P997, DOI 10.2337/diabetes.48.5.997; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Dolai S, 2016, DIABETES, V65, P1962, DOI 10.2337/db15-1436; Fex M, 2007, J ENDOCRINOL, V194, P551, DOI 10.1677/JOE-07-0161; Fujiwara T, 2011, J NEUROENDOCRINOL, V23, P1222, DOI 10.1111/j.1365-2826.2011.02214.x; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Gaisano HY, 2012, DIABETOLOGIA, V55, P877, DOI 10.1007/s00125-012-2483-7; Gaisano HY, 2014, TRENDS ENDOCRIN MET, V25, P381, DOI 10.1016/j.tem.2014.03.005; Gaisano HY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00349; Gaisano HY, 2002, ENDOCRINOLOGY, V143, P4218, DOI 10.1210/en.2002-220237; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Holz GG, 2013, DIABETES, V62, P2665, DOI 10.2337/db13-0796; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Hoppa MB, 2012, DIABETOLOGIA, V55, P1001, DOI 10.1007/s00125-011-2400-5; HOSKER JP, 1989, METABOLISM, V38, P767, DOI 10.1016/0026-0495(89)90064-4; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Kwan EP, 2005, DIABETES, V54, P2734, DOI 10.2337/diabetes.54.9.2734; Lam PPL, 2013, DIABETES, V62, P2416, DOI 10.2337/db12-1380; Lam PPL, 2005, DIABETES, V54, P2744, DOI 10.2337/diabetes.54.9.2744; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Mishima T, 2012, J NEUROSCI, V32, P381, DOI 10.1523/JNEUROSCI.2911-11.2012; Oh E, 2012, J BIOL CHEM, V287, P25821, DOI 10.1074/jbc.M112.361501; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takahashi N, 2004, J CELL BIOL, V165, P255, DOI 10.1083/jcb.200312033; Takahashi N, 2010, CELL METAB, V12, P19, DOI 10.1016/j.cmet.2010.05.013; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xie L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147862; Xie L, 2015, DIABETOLOGIA, V58, P1250, DOI 10.1007/s00125-015-3545-4; Yasuda T, 2010, CELL METAB, V12, P117, DOI 10.1016/j.cmet.2010.05.017; Zhu D, 2013, DIABETOLOGIA, V56, P359, DOI 10.1007/s00125-012-2757-0; Zhu D, 2015, MOL METAB, V4, P418, DOI 10.1016/j.molmet.2015.02.004; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	46	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2203	2216		10.1074/jbc.M116.769885	http://dx.doi.org/10.1074/jbc.M116.769885			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28031464	hybrid, Green Published			2022-12-28	WOS:000395530300014
J	Schauwecker, SM; Kim, JJ; Licht, JD; Clevenger, CV				Schauwecker, Suzanne M.; Kim, J. Julie; Licht, Jonathan D.; Clevenger, Charles V.			Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND DEVELOPMENT; PLASMA PROLACTIN; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; TRANSACTIVATION DOMAIN; CHROMATIN COMPACTION; ACTIVATION; RECEPTOR; VARIANTS; BINDING	The hormone prolactin (PRL) contributes to breast cancer pathogenesis through various signaling pathways, one of the most notable being the JAK2/signal transducer and activator of transcription 5 (STAT5) pathway. PRL-induced activation of the transcription factor STAT5 results in the up-regulation of numerous genes implicated in breast cancer pathogenesis. However, the molecular mechanisms that enable STAT5 to access the promoters of these genes are not well understood. Here, we show thatPRLsignaling induces chromatin decompaction at promoter DNA, corresponding with STAT5 binding. The chromatin-modifying protein high mobility group nucleosomal binding domain 2 (HMGN2) specifically promotes STAT5 accessibility at promoter DNA by facilitating the dissociation of the linker histone H1 in response to PRL. Knockdown of H1 rescues the decrease in PRL-induced transcription following HMGN2 knockdown, and it does so by allowing increased STAT5 recruitment. Moreover, H1 and STAT5 are shown to function antagonistically in regulating PRL-induced transcription as well as breast cancer cell biology. While reduced STAT5 activation results in decreased PRL-induced transcription and cell proliferation, knockdown of H1 rescues both of these effects. Taken together, we elucidate a novel mechanism whereby the linker histone H1 prevents STAT5 binding at promoter DNA, and the PRL-induced dissociation of H1 mediated by HMGN2 is necessary to allow full STAT5 recruitment and promote the biological effects of PRL signaling.	[Schauwecker, Suzanne M.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Kim, J. Julie] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Div Reprod Sci Med,Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Licht, Jonathan D.] Univ Florida, Hlth Canc Ctr, Dept Med, Div Hematol & Oncol, Gainesville, FL 32610 USA; [Clevenger, Charles V.] Virginia Commonwealth Univ, Dept Pathol, 1101 E Marshall St,Sanger 4-006A,POB 980662, Richmond, VA 23298 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; State University System of Florida; University of Florida; Virginia Commonwealth University	Clevenger, CV (corresponding author), Virginia Commonwealth Univ, Dept Pathol, 1101 E Marshall St,Sanger 4-006A,POB 980662, Richmond, VA 23298 USA.	charles.clevenger@vcuhealth.org	Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020	Licht, Jonathan/0000-0002-3942-1369; Kim, J Julie/0000-0001-9834-8213	NCI, National Institutes of Health [R01CA173305]; National Research Service Award [F30CA171858]; Lynn Sage Foundation; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE [R01CA173305, P30CA060553, F30CA171858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008152] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lynn Sage Foundation; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health, Grant R01CA173305 (to C.V.C.) and National Research Service Award F30CA171858 (to S.M.S.), by grants from the Lynn Sage Foundation (to C.V.C.), and by a Malkin Scholar Award from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (to S.M.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; ALFONSO PJ, 1994, J MOL BIOL, V236, P189, DOI 10.1006/jmbi.1994.1128; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Cao Kaixiang, 2013, PLoS Genet, V9, pe1003417, DOI 10.1371/journal.pgen.1003417; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Deng T, 2017, NUCLEIC ACIDS RES, V45, P3031, DOI 10.1093/nar/gkw1222; Deng T, 2015, GENOME RES, V25, P1295, DOI 10.1101/gr.192229.115; Ding HF, 1997, MOL CELL BIOL, V17, P5843, DOI 10.1128/MCB.17.10.5843; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eliassen AH, 2007, INT J CANCER, V120, P1536, DOI 10.1002/ijc.22482; Fang F, 2010, J MOL ENDOCRINOL, V44, P319, DOI 10.1677/JME-09-0140; Fang F, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-11; Fiorillo AA, 2013, AM J PATHOL, V182, P217, DOI 10.1016/j.ajpath.2012.09.021; Fiorillo AA, 2011, MOL ENDOCRINOL, V25, P1550, DOI 10.1210/me.2011-0106; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gervais AL, 2010, NUCLEIC ACIDS RES, V38, pW308, DOI 10.1093/nar/gkq485; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hankinson SE, 1999, J NATL CANCER I, V91, P629, DOI 10.1093/jnci/91.7.629; Harshman SW, 2014, J PROTEOME RES, V13, P2453, DOI 10.1021/pr401248f; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Hodge LS, 2014, BLOOD, V123, P1055, DOI 10.1182/blood-2013-08-521963; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Iavnilovitch E, 2004, INT J CANCER, V112, P607, DOI 10.1002/ijc.20484; Iwafuchi-Doi M, 2016, MOL CELL, V62, P79, DOI 10.1016/j.molcel.2016.03.001; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kang K, 2014, MOL CELL BIOL, V34, P464, DOI 10.1128/MCB.00988-13; Kim JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16714; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; LEBRUN JJ, 1994, J BIOL CHEM, V269, P14021; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Maus MV, 1999, ENDOCRINOLOGY, V140, P5447, DOI 10.1210/en.140.11.5447; Medler TR, 2016, MOL CANCER RES, V14, P994, DOI 10.1158/1541-7786.MCR-16-0109; Metser G, 2016, NUCLEIC ACIDS RES, V44, P1052, DOI 10.1093/nar/gkv999; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Moon HG, 2015, BREAST CANCER RES TR, V154, P13, DOI 10.1007/s10549-015-3585-y; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Ormandy CJ, 1997, J MAMMARY GLAND BIOL, V2, P355, DOI 10.1023/A:1026395229025; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Perks CC, 2004, BRIT J CANCER, V91, P305, DOI 10.1038/sj.bjc.6601947; Pezet A, 1997, J BIOL CHEM, V272, P25043, DOI 10.1074/jbc.272.40.25043; Pinz S, 2015, NUCLEIC ACIDS RES, V43, P3524, DOI 10.1093/nar/gkv188; Raccurt M, 2003, BRIT J CANCER, V89, P524, DOI 10.1038/sj.bjc.6601115; Rasmussen LM, 2010, ENDOCR-RELAT CANCER, V17, P809, DOI 10.1677/ERC-09-0326; Ren SX, 2002, ONCOGENE, V21, P4335, DOI 10.1038/sj.onc.1205484; Rijnkels M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053270; Rose-Hellekant TA, 2003, ONCOGENE, V22, P4664, DOI 10.1038/sj.onc.1206619; RUI H, 1994, J BIOL CHEM, V269, P5364; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Sato T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-59; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Shan L, 2014, ONCOGENE, V33, P3205, DOI 10.1038/onc.2013.270; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Nacht AS, 2016, EMBO J, V35, P1822, DOI 10.15252/embj.201593260; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sugathan A, 2013, MOL CELL BIOL, V33, P3594, DOI 10.1128/MCB.00280-13; Tang JZ, 2010, ENDOCRINOLOGY, V151, P43, DOI 10.1210/en.2009-0651; Tworoger SS, 2007, J CLIN ONCOL, V25, P1482, DOI 10.1200/JCO.2006.07.6356; Tworoger SS, 2013, CANCER RES, V73, P4810, DOI 10.1158/0008-5472.CAN-13-0665; Ueda T, 2006, J BIOL CHEM, V281, P10182, DOI 10.1074/jbc.M600821200; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Vomachka AJ, 2000, ONCOGENE, V19, P1077, DOI 10.1038/sj.onc.1203348; WAKAO H, 1995, EMBO J, V14, P854, DOI 10.1002/j.1460-2075.1995.tb07064.x; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yang CW, 2006, CANCER RES, V66, P11649, DOI 10.1158/0008-5472.CAN-06-1645	68	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2237	2254		10.1074/jbc.M116.764233	http://dx.doi.org/10.1074/jbc.M116.764233			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28035005	hybrid, Green Published			2022-12-28	WOS:000395530300017
J	Zhai, XH; Gao, YG; Mishra, SK; Simanshu, DK; Boldyrev, IA; Benson, LM; Bergen, HR; Malinina, L; Mundy, J; Molotkovsky, JG; Patel, DJ; Brown, RE				Zhai, Xiuhong; Gao, Yong-Guang; Mishra, Shrawan K.; Simanshu, Dhirendra K.; Boldyrev, Ivan A.; Benson, Linda M.; Bergen, H. Robert, III; Malinina, Lucy; Mundy, John; Molotkovsky, Julian G.; Patel, Dinshaw J.; Brown, Rhoderick E.			Phosphatidylserine Stimulates Ceramide 1-Phosphate (C1P) Intermembrane Transfer by C1P Transfer Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLIPID TRANSFER PROTEIN; OXYSTEROL-BINDING PROTEINS; PROGRAMMED CELL-DEATH; AMPHITROPIC PROTEINS; MEMBRANE INTERACTION; GLYCOSPHINGOLIPID SYNTHESIS; TRANSBILAYER DISTRIBUTION; TRYPTOPHAN FLUORESCENCE; PHOSPHOLIPID-BINDING; MEDIATED TRANSFER	Genetic models for studying localized cell suicide that halt the spread of pathogen infection and immune response activation in plants include Arabidopsis accelerated-cell-death 11 mutant (acd11). In this mutant, sphingolipid homeostasis is disrupted via depletion of ACD11, a lipid transfer protein that is specific for ceramide 1-phosphate (C1P) and phyto-C1P. The C1P binding site in ACD11 and in human ceramide-1-phosphate transfer protein (CPTP) is surrounded by cationic residues. Here, we investigated the functional regulation of ACD11 and CPTP by anionic phosphoglycerides and found that 1-palmitoyl-2-oleoyl-phosphatidic acid or 1-palmitoyl-2-oleoyl-phosphatidylglycerol (<= 15 mol %) in C1P source vesicles depressed C1P intermembrane transfer. Bycontrast, replacement with 1-palmitoyl-2-oleoyl-phosphatidylserine stimulated C1P transfer by ACD11 and CPTP. Notably, "soluble" phosphatidylserine (dihexanoyl-phosphatidylserine) failed to stimulate C1P transfer. Also, none of the anionic phosphoglycerides affected transfer action by human glycolipid lipid transfer protein (GLTP), which is glycolipid-specific and has few cationic residues near its glycolipid binding site. These findings provide the first evidence for a potential phosphoglyceride headgroup-specific regulatory interaction site(s) existing on the surface of any GLTP-fold and delineate new differences between GLTP superfamily members that are specific for C1P versus glycolipid.	[Zhai, Xiuhong; Gao, Yong-Guang; Mishra, Shrawan K.; Malinina, Lucy; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Boldyrev, Ivan A.; Molotkovsky, Julian G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Benson, Linda M.; Bergen, H. Robert, III] Mayo Fdn, Med Genom Facil, Prote Core, Rochester, MN 55905 USA; [Mundy, John] Univ Copenhagen, BioCtr, Dept Biol, DK-2200 Copenhagen N, Denmark; [Simanshu, Dhirendra K.] NCI Frederick, Frederick Natl Lab Canc Res, NIH, 8560 Progress Dr,C1012, Frederick, MD 21702 USA	University of Minnesota System; Memorial Sloan Kettering Cancer Center; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Mayo Clinic; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Zhai, XH; Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zhai@hi.umn.edu; reb@umn.edu	Mishra, Shrawan K/J-7972-2013; mundy, john/A-2361-2013; Gao, Yongguang/B-8546-2012; Boldyrev, Ivan/L-7879-2017; Mishra, Shrawan/N-1592-2019	mundy, john/0000-0001-7490-4588; Gao, Yongguang/0000-0002-9359-4252; Mishra, Shrawan/0000-0001-5513-9876; Simanshu, Dhirendra/0000-0002-9717-4618; Malinina, Lucy/0000-0001-7973-1831; Brown, Rhoderick/0000-0002-7337-3604	NIGMS, National Institutes of Health (NIH) [GM45928]; NHLBI, NIH [HL125353, NCI CA121493]; Russian Foundation for Basic Research [015-04-07415]; Danish Strategic Research Council [09-067148]; Abby Rockefeller Mauze Trust; Maloris and Hormel Foundations; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA121493, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Abby Rockefeller Mauze Trust; Maloris and Hormel Foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by NIGMS, National Institutes of Health (NIH), Grant GM45928 and NHLBI, NIH, Grants HL125353 and NCI CA121493; Russian Foundation for Basic Research Grant 015-04-07415; Danish Strategic Research Council Grant 09-067148; the Abby Rockefeller Mauze Trust; and the Maloris and Hormel Foundations. Portions of this work were presented at the 2015 American Chemical Society and 2015 American Society for Biochemistry and Molecular Biology Annual Meetings. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; BERGELSON LD, 1985, CHEM PHYS LIPIDS, V37, P165, DOI 10.1016/0009-3084(85)90083-0; Berkey R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00068; Boldyrev IA, 2013, RUSS J BIOORG CHEM+, V39, P539, DOI 10.1134/S106816201305004X; Boscia AL, 2014, CHEM PHYS LIPIDS, V178, P1, DOI 10.1016/j.chemphyslip.2013.12.010; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Brown R E, 1990, Subcell Biochem, V16, P333; BROWN RE, 1992, BIOCHIM BIOPHYS ACTA, V1113, P375, DOI 10.1016/0304-4157(92)90007-W; BROWN RE, 1990, BIOCHIM BIOPHYS ACTA, V1044, P77, DOI 10.1016/0005-2760(90)90221-I; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Drin G, 2014, ANNU REV BIOCHEM, V83, P51, DOI 10.1146/annurev-biochem-060713-035307; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Kamlekar RK, 2013, BBA-MOL CELL BIOL L, V1831, P417, DOI 10.1016/j.bbalip.2012.10.010; Kamlekar RK, 2010, BIOPHYS J, V99, P2626, DOI 10.1016/j.bpj.2010.08.038; Kenoth R, 2010, J BIOL CHEM, V285, P13066, DOI 10.1074/jbc.M109.093203; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Koppaka V, 1996, BIOCHEMISTRY-US, V35, P7482, DOI 10.1021/bi952063d; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Li LB, 2013, J PHYS CHEM B, V117, P11906, DOI 10.1021/jp405418y; Li XM, 2004, BIOCHEMISTRY-US, V43, P10285, DOI 10.1021/bi0495432; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; MacCallum JL, 2011, TRENDS BIOCHEM SCI, V36, P653, DOI 10.1016/j.tibs.2011.08.003; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malewicz B, 2005, BIOPHYS J, V88, P2670, DOI 10.1529/biophysj.104.057059; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Malinina L, 2015, Q REV BIOPHYS, V48, P281, DOI 10.1017/S003358351400016X; Mattjus P, 2003, BIOCHEMISTRY-US, V42, P535, DOI 10.1021/bi026896x; Mattjus P, 1999, ANAL BIOCHEM, V268, P297, DOI 10.1006/abio.1998.3065; Mattjus P, 2000, BIOCHEMISTRY-US, V39, P1067, DOI 10.1021/bi991810u; Mattjus P, 2002, J BIOL CHEM, V277, P19476, DOI 10.1074/jbc.M201305200; MOLOTKOVSKY JG, 1991, CHEM PHYS LIPIDS, V58, P199, DOI 10.1016/0009-3084(91)90093-Q; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; NORDLUND JR, 1981, BIOCHEMISTRY-US, V20, P6415, DOI 10.1021/bi00525a020; Nylund M, 2007, LANGMUIR, V23, P11726, DOI 10.1021/la701927u; Ohvo-Rekila H, 2011, BBA-BIOMEMBRANES, V1808, P47, DOI 10.1016/j.bbamem.2010.08.018; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Olkkonen VM, 2013, MOLECULES, V18, P13666, DOI 10.3390/molecules181113666; Petersen NHT, 2008, FEBS J, V275, P4378, DOI 10.1111/j.1742-4658.2008.06584.x; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Rao CS, 2004, BIOCHEMISTRY-US, V43, P13805, DOI 10.1021/bi0492197; Samygina VR, 2011, STRUCTURE, V19, P1644, DOI 10.1016/j.str.2011.09.011; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Simanshu DK, 2014, CELL REP, V6, P388, DOI 10.1016/j.celrep.2013.12.023; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Stahelin RV, 2014, CHEM PHYS LIPIDS, V182, P3, DOI 10.1016/j.chemphyslip.2014.02.002; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhai XH, 2009, J BIOL CHEM, V284, P13620, DOI 10.1074/jbc.M809089200; Zou XQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-72	73	16	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2531	2541		10.1074/jbc.M116.760256	http://dx.doi.org/10.1074/jbc.M116.760256			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28011644	Green Published, hybrid			2022-12-28	WOS:000395530300039
J	Qin, Z; Yang, SQ; Zhao, LM; You, X; Yan, QJ; Jiang, ZQ				Qin, Zhen; Yang, Shaoqing; Zhao, Liming; You, Xin; Yan, Qiaojuan; Jiang, Zhengqiang			Catalytic Mechanism of a Novel Glycoside Hydrolase Family 16 "Elongating" -Transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mechanism; enzyme structure; glycoside hydrolase; protein crystallization	CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; LAMINARINASE 16A; IN-VITRO; GLYCOSYNTHASE; OLIGOSACCHARIDES; AMYLOSUCRASE; RECOGNITION; EFFICIENT; COMPLEX	Carbohydrates are complex macromolecules in biological metabolism. Enzymatic synthesis of carbohydrates is recognized as a powerful tool to overcome the problems associated with large scale synthesis of carbohydrates. Novel enzymes with significant transglycosylation ability are still in great demand in glycobiology studies. Here we report a novel glycoside hydrolase family 16 elongating -transglycosylase from Paecilomyces thermophila (PtBgt16A), which efficiently catalyzes the synthesis of higher polymeric oligosaccharides using -1,3/1,4-oligosaccharides as donor/acceptor substrates. Further structural information reveals that PtBgt16A has a binding pocket around the -1 subsite. The catalytic mechanism of PtBgt16A is partly similar to an exo-glycoside hydrolase, which cleaves the substrate from the non-reducing end one by one. However, PtBgt16A releases the reducing end product and uses the remainder glucosyl as a transglycosylation donor. This catalytic mechanism has similarity with the catalytic mode of amylosucrase, which catalyzes the transglycosylation products gradually extend by one glucose unit. PtBgt16A thus has the potential to be a tool enzyme for the enzymatic synthesis of new -oligosaccharides and glycoconjugates.	[Qin, Zhen; Yang, Shaoqing; Jiang, Zhengqiang] Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [You, Xin; Yan, Qiaojuan] China Agr Univ, Coll Engn, Bioresource Utilizat Lab, Beijing 100083, Peoples R China; [Zhao, Liming] East China Univ Sci & Technol, Sch Biotechnol, Res & Dev Ctr Separat & Extract Technol Fermentat, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	China Agricultural University; East China University of Science & Technology	Jiang, ZQ (corresponding author), China Agr Univ, POB 294,17 Qinghua Donglu, Beijing 100083, Peoples R China.	zhqjiang@cau.edu.cn		qin, zhen/0000-0003-2133-8572	National Science Fund for Distinguished Young Scholars [31325021]; Program for Changjiang Scholars [T2014055]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by National Science Fund for Distinguished Young Scholars Grant 31325021 and Program for Changjiang Scholars Grant T2014055. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bissaro B, 2015, BIOCHEM J, V467, P17, DOI 10.1042/BJ20141412; Blanco N, 2015, FEBS J, V282, P715, DOI 10.1111/febs.13176; Campbell P, 1999, PLANT J, V18, P371, DOI 10.1046/j.1365-313X.1999.00459.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng YS, 2014, BBA-PROTEINS PROTEOM, V1844, P366, DOI 10.1016/j.bbapap.2013.11.005; Cobucci-Ponzano B, 2012, NAT PROD REP, V29, P697, DOI 10.1039/c2np20032e; Cobucci-Ponzano B, 2011, ADV SYNTH CATAL, V353, P2284, DOI 10.1002/adsc.201100461; Diez-Municio M, 2014, MICROB BIOTECHNOL, V7, P315, DOI 10.1111/1751-7915.12124; Dobruchowska JM, 2016, GLYCOBIOLOGY, V26, P1157, DOI 10.1093/glycob/cww074; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng HY, 2005, J BIOL CHEM, V280, P37088, DOI 10.1074/jbc.M502873200; Furtado GP, 2011, PROCESS BIOCHEM, V46, P1202, DOI 10.1016/j.procbio.2011.01.037; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hrmova M, 2002, J BIOL CHEM, V277, P30102, DOI 10.1074/jbc.M203971200; Hua CW, 2010, APPL MICROBIOL BIOT, V88, P509, DOI 10.1007/s00253-010-2759-0; Ilari A, 2009, FEBS J, V276, P1048, DOI 10.1111/j.1742-4658.2008.06848.x; Jeng WY, 2011, J BIOL CHEM, V286, P45030, DOI 10.1074/jbc.M111.271213; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Labourel A, 2014, J BIOL CHEM, V289, P2027, DOI 10.1074/jbc.M113.538843; Li TZ, 2016, J BIOL CHEM, V291, P16508, DOI 10.1074/jbc.M116.738765; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lundemo P, 2017, APPL MICROBIOL BIOT, V101, P1121, DOI 10.1007/s00253-016-7833-9; Magee AS, 2015, BIOPOLYMERS, V103, P665, DOI 10.1002/bip.22685; Matsuzawa T, 2016, FEBS J, V283, P2340, DOI 10.1111/febs.13743; Meng DD, 2016, APPL MICROBIOL BIOT, V100, P4923, DOI 10.1007/s00253-016-7334-x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mouyna I, 1998, MICROBIOL-SGM, V144, P3171, DOI 10.1099/00221287-144-11-3171; Mouyna I, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00081; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Perez X, 2011, BIOMACROMOLECULES, V12, P494, DOI 10.1021/bm1013537; Qin Z, 2016, APPL MICROBIOL BIOT, V100, P1765, DOI 10.1007/s00253-015-7057-4; Qin Z, 2015, ACTA CRYSTALLOGR D, V71, P1714, DOI 10.1107/S1399004715011037; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Seibel J, 2006, BIOCATAL BIOTRANSFOR, V24, P157, DOI 10.1080/10242420500538274; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; Spadiut O, 2011, J AM CHEM SOC, V133, P10892, DOI 10.1021/ja202788q; Teze D, 2014, PROTEIN ENG DES SEL, V27, P13, DOI 10.1093/protein/gzt057; Vasur J, 2010, J AM CHEM SOC, V132, P1724, DOI 10.1021/ja909129b; Vasur J, 2009, FEBS J, V276, P4282, DOI 10.1111/j.1742-4658.2009.07099.x; Wei JH, 2013, EUR J ORG CHEM, V2013, P2414, DOI 10.1002/ejoc.201201507; Yang SQ, 2008, J AGR FOOD CHEM, V56, P5345, DOI 10.1021/jf800303b	44	15	15	3	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1666	1678		10.1074/jbc.M116.762419	http://dx.doi.org/10.1074/jbc.M116.762419			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27956553	Green Published, hybrid			2022-12-28	WOS:000395515600011
J	Xu, K; Chen, X; Yang, H; Xu, YW; He, YL; Wang, CF; Huang, H; Liu, BD; Liu, WQ; Li, JY; Kou, XC; Zhao, YH; Zhao, K; Zhang, LF; Hou, ZZ; Wang, H; Wang, HL; Li, J; Fan, HY; Wang, FC; Gao, YW; Zhang, Y; Chen, JY; Gao, SR				Xu, Kai; Chen, Xia; Yang, Hui; Xu, Yiwen; He, Yuanlin; Wang, Chenfei; Huang, Hua; Liu, Baodong; Liu, Wenqiang; Li, Jingyi; Kou, Xiaochen; Zhao, Yanhong; Zhao, Kun; Zhang, Linfeng; Hou, Zhenzhen; Wang, Hong; Wang, Hailin; Li, Jing; Fan, Hengyu; Wang, Fengchao; Gao, Yawei; Zhang, Yong; Chen, Jiayu; Gao, Shaorong			Maternal Sall4 Is Indispensable for Epigenetic Maturation of Mouse Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA methylation; embryo; histone methylation; meiosis; oocyte	EMBRYONIC STEM-CELLS; HISTONE MODIFICATIONS; OKIHIRO-SYNDROME; GENE; TRANSCRIPTION; PLURIPOTENCY; METHYLATION; MEIOSIS; GROWTH; PLZF	Sall4 (Splat-like 4) plays important roles in maintaining pluripotency of embryonic stem cells and in various developmental processes. Here, we find that Sall4 is highly expressed in oocytes and early embryos. To investigate the roles of SALL4 in oogenesis, we generated Sall4 maternal specific knock-out mice by using CRISPR/Cas9 system, and we find that the maternal deletion of Sall4 causes developmental arrest of oocytes at germinal vesicle stage with non-surrounded nucleus, and the subsequent meiosis resumption is prohibited. We further discover that the loss of maternal Sall4 causes failure in establishment of DNA methylation in oocytes. Furthermore, we find that Sall4 modulates H3K4me3 and H3K27me3 modifications by regulating the expression of key histone demethylases coding genes Kdm5b, Kdm6a, and Kdm6b in oocytes. Moreover, we demonstrate that the aberrant H3K4me3 and H3K27me3 cause mis-expression of genes that are critical for oocytes maturation and meiosis resumption. Taken together, our study explores a pivotal role of Sall4 in regulating epigenetic maturation of mouse oocytes.	[Xu, Kai; Chen, Xia; Yang, Hui; Wang, Chenfei; Liu, Wenqiang; Li, Jingyi; Kou, Xiaochen; Zhao, Yanhong; Zhao, Kun; Zhang, Linfeng; Hou, Zhenzhen; Wang, Hong; Gao, Yawei; Zhang, Yong; Chen, Jiayu; Gao, Shaorong] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Shanghai Matern & Infant, Shanghai 200092, Peoples R China; [Xu, Yiwen; Fan, Hengyu] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Yiwen; Fan, Hengyu] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [He, Yuanlin; Li, Jing] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Huang, Hua; Liu, Baodong; Wang, Hailin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China; [Wang, Fengchao] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Tongji University; Zhejiang University; Zhejiang University; Nanjing Medical University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); National Institute of Biological Sciences, Beijing	Chen, JY; Gao, SR (corresponding author), 1239 Siping Rd, Shanghai 200092, Peoples R China.	chenjiayu@tongji.edu.cn; gaoshaorong@tongji.edu.cn	Chen, Jiayu/ABF-3722-2021; Zhang, Yong/B-4838-2011; zhao, yan/GWC-9174-2022; gao, yawei/AAS-3512-2021	Chen, Jiayu/0000-0003-4755-8901; Zhang, Yong/0000-0001-6316-2734; gao, yawei/0000-0001-8946-9697; Wang, Chenfei/0000-0001-7573-3768; huang, hua/0000-0002-9881-4197; Yang, Hui/0000-0003-0043-8793	National Natural Science Foundation of China [31401247, 81630035, 31325019, 31430056, 31471392, 31401266, 31501196, 31501197, 31501183]; Ministry of Science and Technology of China [2016YFA0100400, 2015CB964503, 2015CB964800, 2014CB964601]; Science and Technology Commission of Shanghai Municipality [15XD1503500, YF1403900, 16YF140940, 14CG16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China Grants 31401247, 81630035, 31325019, 31430056, 31471392, 31401266, 31501196, 31501197, and 31501183; Ministry of Science and Technology of China Grants 2016YFA0100400, 2015CB964503, 2015CB964800, and 2014CB964601; and the Science and Technology Commission of Shanghai Municipality Grants 15XD1503500, YF1403900, 16YF140940 and 14CG16. The authors declare that they have no conflicts of interest with the contents of this article.	Agopiantz M, 2017, REPROD FERT DEVELOP, V29, P824, DOI 10.1071/RD15367; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brind'Amour J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7033; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Dole G, 2008, REPRODUCTION, V135, P671, DOI 10.1530/REP-07-0405; Gu L, 2010, CELL CYCLE, V9, P1942, DOI 10.4161/cc.9.10.11599; Guo HS, 2015, NAT PROTOC, V10, P645, DOI 10.1038/nprot.2015.039; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Huntriss J, 2006, MOL HUM REPROD, V12, P283, DOI 10.1093/molehr/gal035; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kawamura K, 2008, DEV BIOL, V315, P189, DOI 10.1016/j.ydbio.2007.12.029; Lopez E, 2015, THROMB HAEMOSTASIS, V114, P969, DOI 10.1160/TH14-09-0727; Lovelace DL, 2016, DEVELOPMENT, V143, P1893, DOI 10.1242/dev.132761; Ma PP, 2015, CELL REP, V13, P1552, DOI 10.1016/j.celrep.2015.10.031; Ma PP, 2012, P NATL ACAD SCI USA, V109, pE481, DOI 10.1073/pnas.1118403109; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pfender S, 2015, NATURE, V524, P239, DOI 10.1038/nature14568; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Sleer LS, 2007, BIOL REPROD, V76, P391, DOI 10.1095/biolreprod.106.053934; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Stewart KR, 2015, GENE DEV, V29, P2449, DOI 10.1101/gad.271353.115; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van den Hurk R, 2005, THERIOGENOLOGY, V63, P1717, DOI 10.1016/j.theriogenology.2004.08.005; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Yamaguchi YL, 2015, STEM CELLS, V33, P289, DOI 10.1002/stem.1853; Yang JC, 2012, J BIOL CHEM, V287, P1996, DOI 10.1074/jbc.M111.308734; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	35	24	27	3	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1798	1807		10.1074/jbc.M116.767061	http://dx.doi.org/10.1074/jbc.M116.767061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28031467	Green Published, hybrid			2022-12-28	WOS:000395515600021
J	Lebeau, P; Al-Hashimi, A; Sood, S; Lhotak, S; Yu, P; Gyulay, G; Pare, G; Chen, SRW; Trigatti, B; Prat, A; Seidah, NG; Austin, RC				Lebeau, Paul; Al-Hashimi, Ali; Sood, Sudesh; Lhotak, Sarka; Yu, Pei; Gyulay, Gabriel; Pare, Guillaume; Chen, S. R. Wayne; Trigatti, Bernardo; Prat, Annik; Seidah, Nabil G.; Austin, Richard C.			Endoplasmic Reticulum Stress and Ca2+ Depletion Differentially Modulate the Sterol Regulatory Protein PCSK9 to Control Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; CONVERTASE SUBTILISIN/KEXIN TYPE-9; CARDIAC RYANODINE RECEPTOR; MICE LACKING PCSK9; LDL RECEPTOR; VENTRICULAR-TACHYCARDIA; LIVER-REGENERATION; CHOLESTEROL EFFLUX	Accumulating evidence implicates endoplasmic reticulum (ER) stress as a mediator of impaired lipid metabolism, thereby contributing to fatty liver disease and atherosclerosis. Previous studies demonstrated that ER stress can activate the sterol regulatory element-binding protein-2 (SREBP2), an ER-localized transcription factor that directly up-regulates sterol regulatory genes, including PCSK9. Given that PCSK9 contributes to atherosclerosis by targeting low density lipoprotein (LDL) receptor (LDLR) degradation, this study investigates a novel mechanism by which ER stress plays a role in lipid metabolism by examining its ability to modulate PCSK9 expression. Herein, we demonstrate the existence of two independent effects of ER stress on PCSK9 expression and secretion. In cultured HuH7 and HepG2 cells, agents or conditions that cause ER Ca2+ depletion, including thapsigargin, induced SREBP2-dependent up-regulation of PCSK9 expression. In contrast, a significant reduction in the secreted form of PCSK9 protein was observed in the media from both thapsigargin-and tunicamycin (TM)-treated HuH7 cells, mouse primary hepatocytes, and in the plasma of TM-treated C57BL/6 mice. Furthermore, TM significantly increased hepatic LDLR expression and reduced plasma LDL concentrations in mice. Based on these findings, we propose a model in which ER Ca2+ depletion promotes the activation of SREBP2 and subsequent transcription of PCSK9. However, conditions that cause ER stress regardless of their ability to dysregulate ER Ca2+ inhibit PCSK9 secretion, thereby reducing PCSK9-mediated LDLR degradation and promoting LDLR-dependent hepatic cholesterol uptake. Taken together, our studies provide evidence that the retention of PCSK9 in the ER may serve as a potential strategy for lowering LDL cholesterol levels.	[Lebeau, Paul; Al-Hashimi, Ali; Sood, Sudesh; Lhotak, Sarka; Gyulay, Gabriel; Austin, Richard C.] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON L8N 4A6, Canada; [Lebeau, Paul; Al-Hashimi, Ali; Sood, Sudesh; Lhotak, Sarka; Gyulay, Gabriel; Austin, Richard C.] St Josephs Hamilton Healthcare & Hamilton Ctr Kid, Hamilton, ON L8N 4A6, Canada; [Yu, Pei; Trigatti, Bernardo; Austin, Richard C.] Hamilton Hlth Sci, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada; [Yu, Pei; Trigatti, Bernardo; Austin, Richard C.] McMaster Univ, Hamilton, ON L8L 2X2, Canada; [Yu, Pei; Trigatti, Bernardo] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Pare, Guillaume] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Pare, Guillaume] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; [Pare, Guillaume] McMaster Univ, Dept Epidemiol, Hamilton, ON L8L 2X2, Canada; [Pare, Guillaume] McMaster Univ, Dept Pathol, Hamilton, ON L8L 2X2, Canada; [Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 2T9, Canada; [Prat, Annik; Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; Libin Cardiovascular Institute Of Alberta; University of Calgary; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Austin, RC (corresponding author), 50 Charlton Ave East,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Prat, Annik/S-6757-2018; Pare, Guillaume/T-9631-2018; Seidah, Nabil/I-3596-2013	Prat, Annik/0000-0002-8007-5277; Pare, Guillaume/0000-0002-6795-4760; Trigatti, Bernardo (Dino) L./0000-0002-4556-119X; Seidah, Nabil/0000-0001-6503-9342	Heart and Stroke Foundation of Ontario Research Grant [T-6146]; Canadian Institutes of Health Research Grant [MOP-74477]; Ontario Research and Development Challenge Fund; Canadian Institute of Health Research; Leducq Foundation [13 CVD 03]; Canada Research Chair [216684]; St. Joseph's Healthcare Hamilton; Canadian Institutes of Health Research Team Grant in Thromboembolism [FRN-79846]	Heart and Stroke Foundation of Ontario Research Grant; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Ontario Research and Development Challenge Fund(General Electric); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Leducq Foundation(Leducq Foundation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); St. Joseph's Healthcare Hamilton; Canadian Institutes of Health Research Team Grant in Thromboembolism(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Heart and Stroke Foundation of Ontario Research Grant T-6146 (to R. C. A.), Canadian Institutes of Health Research Grant MOP-74477, the Ontario Research and Development Challenge Fund, the Canadian Institute of Health Research (to S. R. W. C.), Leducq Foundation Grant 13 CVD 03 (to N. G. S. and A. P.), Canada Research Chair 216684 (to N. G. S.), St. Joseph's Healthcare Hamilton and the Canadian Institutes of Health Research Team Grant in Thromboembolism FRN-79846. The authors declare that they have no conflicts of interest with the contents of this article.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Amodio G, 2013, FEBS LETT, V587, P3261, DOI 10.1016/j.febslet.2013.08.021; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Biswas C, 2007, BIOCHEM J, V405, P233, DOI 10.1042/BJ20061867; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chen Chang-fu, 2015, China Journal of Highway and Transport, V28, P1; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Choi SB, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-112; Chorba JS, 2014, J BIOL CHEM, V289, P29030, DOI 10.1074/jbc.M114.594861; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279; Fuller M, 2014, ARTERIOSCL THROM VAS, V34, P2394, DOI 10.1161/ATVBAHA.114.304200; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GONZALEZGRONOW M, 1993, J BIOL CHEM, V268, P20791; GREEVE J, 1993, J LIPID RES, V34, P1367; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Higgins ME, 2001, J LIPID RES, V42, P1939; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; INUI M, 1988, METHOD ENZYMOL, V157, P490; INUI M, 1987, J BIOL CHEM, V262, P1740; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jiang DW, 2010, CHANNELS, V4, P302, DOI 10.4161/chan.4.4.12666; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lamb HK, 2006, J BIOL CHEM, V281, P8796, DOI 10.1074/jbc.M503964200; Lauressergues E, 2012, NEUROPHARMACOLOGY, V62, P784, DOI 10.1016/j.neuropharm.2011.08.048; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lhotak S, 2012, AM J PHYSIOL-RENAL, V303, pF266, DOI 10.1152/ajprenal.00482.2011; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Pai JT, 1996, P NATL ACAD SCI USA, V93, P5437, DOI 10.1073/pnas.93.11.5437; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2015, CELL REP, V13, P2064, DOI 10.1016/j.celrep.2015.11.006; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rohrl C, 2014, J LIPID RES, V55, P94, DOI 10.1194/jlr.M043299; Roubtsova A, 2015, J LIPID RES, V56, P2133, DOI 10.1194/jlr.M061952; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 2015, J GLOBAL CARDIOLOGY, V59, P1; Song YF, 2016, CHEMOSPHERE, V144, P2443, DOI 10.1016/j.chemosphere.2015.11.031; Strom TB, 2014, BIOCHEM J, V457, P99, DOI 10.1042/BJ20130930; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tong JF, 1999, J BIOL CHEM, V274, P693, DOI 10.1074/jbc.274.2.693; Tran H, 2003, J LIPID RES, V44, P1859, DOI 10.1194/jlr.M200487-JLR200; Vig S, 2015, CELL CYCLE, V14, P2274, DOI 10.1080/15384101.2015.1046654; VOLPE JJ, 1983, J BIOL CHEM, V258, P9220; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	85	27	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1510	1523		10.1074/jbc.M116.744235	http://dx.doi.org/10.1074/jbc.M116.744235			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27909053	Green Published, hybrid			2022-12-28	WOS:000393339800030
J	Li, JJ; Sun, ZJ; Yuan, YM; Yin, FF; Bian, YG; Long, LY; Zhang, XL; Xie, D				Li, Jing-Jing; Sun, Zhi-Jian; Yuan, Yan-Mei; Yin, Fen-Fen; Bian, Yao-Gang; Long, Ling-Yun; Zhang, Xue-li; Xie, Dong			EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; RECEPTOR TYROSINE KINASES; MEMBRANE PROTRUSION; TUMOR-METASTASIS; MULTIPLE ROLES; GROWTH-FACTOR; RHO-GTPASES; CARCINOMA; ADHESION; EPHRINS	Eph receptors, the largest subfamily of transmembrane tyrosine kinase receptors, have been increasingly implicated in various physiologic and pathologic processes, and the roles of the Eph family members during tumorigenesis have recently attracted growing attentions. In the present study, we explored the function of EphB3, one member of Eph family, in papillary thyroid cancer (PTC). We found that the expression of EphB3 was significantly elevated in PTC. Either overexpression of EphB3 or activation of EphB3 by EfnB1-Fc/EfnB2-Fc stimulated in vitro migration of PTC cells. In contrast, siRNA-mediated knockdown of EphB3 or EphB3-Fc treatment, which only blocked EphB3-mediated forward signaling, inhibited migration and metastasis of PTC cells. A mechanism study revealed that EphB3 knockdown led to suppressed activity of Rac1 and enhanced activity of RhoA. Moreover, we found that Vav2, an important regulator of Rho family GTPases, was activated by EphB3 in a kinase-dependent manner. Altogether, our work suggested that EphB3 acted as a tumor promoter in PTC by increasing the in vitro migration as well as the in vivo metastasis of PTC cells through regulating the activities of Vav2 and Rho GTPases in a kinase-dependent manner.	[Li, Jing-Jing; Sun, Zhi-Jian; Yuan, Yan-Mei; Yin, Fen-Fen; Long, Ling-Yun; Xie, Dong] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Bian, Yao-Gang; Zhang, Xue-li] Southern Med Univ, Dept Gen Surg, Fengxian Hosp, 6600 Nanfeng Rd, Shanghai 201499, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Southern Medical University - China	Zhang, XL (corresponding author), Southern Med Univ, Dept Gen Surg, Fengxian Hosp, 6600 Nanfeng Rd, Shanghai 201499, Peoples R China.; Xie, D (corresponding author), Chinese Acad Sci, Mol Oncol Lab, Inst Nutr Sci, Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	lejing1996@aliyun.com; dxie@sibs.ac.cn	Long, Lingyun/C-2455-2019	Long, Lingyun/0000-0002-8565-4948; Xie, Dong/0000-0002-1150-8657; Xie, Dong/0000-0003-2804-8578	National Basic Research Program of China [2010CB912102]; Ministry of Science and Technology Key Program [2012ZX10002009-017]; National Natural Science Foundation of China [81230058, 81321062, 30930023, 31100551, 31201046, 81021002, 31520103907]; CAS/SAFEA International Partnership Program for Creative Research Teams; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [SIBS2012004]; Technology Commission of Shanghai Municipality [12XD1405600]; National Science Foundation of China [31201046]; Sanofi-Aventis-Sibs Scholarship Program	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology Key Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sanofi-Aventis-Sibs Scholarship Program	This work was supported by the National Basic Research Program of China (2010CB912102), Ministry of Science and Technology Key Program (2012ZX10002009-017), the National Natural Science Foundation of China (81230058, 81321062, 30930023, 31100551, 31201046, 81021002, 31520103907), CAS/SAFEA International Partnership Program for Creative Research Teams, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2012004), and Technology Commission of Shanghai Municipality (12XD1405600) (to D. X.). This work was also supported by Young Scientist Fund of National Science Foundation of China (31201046) and Sanofi-Aventis-Sibs Scholarship Program (2011) (to J.-J.L.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1997, Cell, V90, P403; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x; Brambilla R, 1996, MOL CELL NEUROSCI, V8, P199, DOI 10.1006/mcne.1996.0057; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cantisani MC, 2016, ONCOTARGET, V7, P28510, DOI 10.18632/oncotarget.8577; Caron E, 2003, NAT CELL BIOL, V5, P185, DOI 10.1038/ncb0303-185; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Castellone MD, 2008, BEST PRACT RES CL EN, V22, P1023, DOI 10.1016/j.beem.2008.09.012; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DULGEROFF AJ, 1994, ENDOCR REV, V15, P500, DOI 10.1210/edrv-15-4-500; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eustatia-Rutten CFA, 2006, J CLIN ENDOCR METAB, V91, P313, DOI 10.1210/jc.2005-1322; Farivar RS, 2003, J SURG RES, V115, P219, DOI 10.1016/S0022-4804(03)00246-4; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gimm O, 2001, CANCER LETT, V163, P143, DOI 10.1016/S0304-3835(00)00697-2; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang J, 2014, ONCOGENE, V33, P2737, DOI 10.1038/onc.2013.238; Hundahl SA, 2000, CANCER-AM CANCER SOC, V89, P202, DOI 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A; Hunter SG, 2006, MOL CELL BIOL, V26, P4830, DOI 10.1128/MCB.02215-05; Ji XD, 2011, CANCER RES, V71, P1156, DOI 10.1158/0008-5472.CAN-10-0717; Karidis NP, 2011, MED SCI MONITOR, V17, pBR257, DOI 10.12659/MSM.881929; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Lang BHH, 2007, ANN SURG ONCOL, V14, P730, DOI 10.1245/s10434-006-9207-5; Liu DP, 2007, INT J ONCOL, V30, P865; von Zangen IL, 2007, ACTA NEUROPATHOL, V113, P325, DOI 10.1007/s00401-006-0190-5; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Meyer S, 2005, INT J ONCOL, V27, P1197; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Parri M, 2007, J BIOL CHEM, V282, P19619, DOI 10.1074/jbc.M701319200; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Sherman SI, 1998, CANCER-AM CANCER SOC, V83, P1012; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Tamas P, 2001, CELL SIGNAL, V13, P475, DOI 10.1016/S0898-6568(01)00172-3; Wang HY, 2014, INT J CLIN EXP PATHO, V7, P313; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wimmer-Kleikamp SH, 2005, IUBMB LIFE, V57, P421, DOI 10.1080/15216540500138337; Wu B, 2016, ANTICANCER RES, V36, P1211; Yin H, 2013, CANCER BIOMARK, V13, P261, DOI 10.3233/CBM-130356	52	12	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1112	1121		10.1074/jbc.M116.750349	http://dx.doi.org/10.1074/jbc.M116.750349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27986811	hybrid, Green Published			2022-12-28	WOS:000392318700030
J	Nair, HAS; Periasamy, S; Yang, L; Kjelleberg, S; Rice, SA				Nair, Harikrishnan A. S.; Periasamy, Saravanan; Yang, Liang; Kjelleberg, Staffan; Rice, Scott A.			Real Time, Spatial, and Temporal Mapping of the Distribution of c-di-GMP during Biofilm Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS; GREEN FLUORESCENT PROTEIN; PSEUDOMONAS-AERUGINOSA; BACTERIAL BIOFILM; OXYGEN; CELLS; DIFFERENTIATION; 2ND-MESSENGER; MICROSCOPY; STARVATION	Bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-diGMP) is a dynamic intracellular signaling molecule that plays a central role in the biofilm life cycle. Current methodologies for the quantification of c-di-GMP are typically based on chemical extraction, representing end point measurements. Chemical methodologies also fail to take into consideration the physiological heterogeneity of the biofilm and thus represent an average c-di-GMP concentration across the entire biofilm. To address these problems, a ratiometric, image-based quantification method has been developed based on expression of the green fluorescence protein (GFP) under the control of the c-di-GMP-responsive cdrA promoter (Rybtke, M. T., Borlee, B. R., Murakami, K., Irie, Y., Hentzer, M., Nielsen, T. E., Givskov, M., Parsek, M. R., and Tolker-Nielsen, T. (2012) Appl. Environ. Microbiol. 78, 5060-5069). The methodology uses the cyan fluorescent protein (CFP) as a biomass indicator and the GFP as a c-di-GMP reporter. Thus, the CFP/GFP ratio gives the effective c-di-GMP per biomass. A binary mask was applied to alleviate background fluorescence, and fluorescence was calibrated against known c-di-GMP concentrations. Using flow cells for biofilm formation, c-di-GMP showed a non-uniform distribution across the biofilm, with concentrated hot spots of c-diGMP. Additionally, c-di-GMP was found to be localized at the outer boundary of mature colonies in contrast to a uniform distribution in early stage, small colonies. These data demonstrate the application of a method for the in situ, real time quantification of c-di-GMP and show that the amount of this biofilm-regulating second messenger was dynamic with time and colony size, reflecting the extent of biofilm heterogeneity in real time.	[Nair, Harikrishnan A. S.; Periasamy, Saravanan; Yang, Liang; Kjelleberg, Staffan; Rice, Scott A.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Nair, Harikrishnan A. S.] Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore 637551, Singapore; [Yang, Liang; Kjelleberg, Staffan; Rice, Scott A.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Periasamy, Saravanan] Rajalakshmi Engn Coll, Madras 602105, Tamil Nadu, India	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Rajalakshmi Engineering College	Rice, SA (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore.; Rice, SA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	rscott@ntu.edu.sg	Rice, Scott/A-6084-2019; periasamy, saravanan/AAF-2860-2020; Kjelleberg, Staffan/C-9229-2015; Kjelleberg, Staffan/AAB-4641-2020; Yang, Liang/C-8487-2011	Rice, Scott/0000-0002-9486-2343; Kjelleberg, Staffan/0000-0003-4271-6413; Kjelleberg, Staffan/0000-0003-4271-6413; Yang, Liang/0000-0002-2362-0128	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Program; Nanyang Technological University; Australian Research Council [DP140102192]	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Program(Ministry of Education, Singapore); Nanyang Technological University(Nanyang Technological University); Australian Research Council(Australian Research Council)	This work was supported by the National Research Foundation and Ministry of Education Singapore under its Research Centre of Excellence Program and a Nanyang Technological University research scholarship for the years 2012-2016. This work was also supported by Australian Research Council Grant DP140102192. The authors declare that they have no conflicts of interest with the contents of this article.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Almblad H, 2015, J BACTERIOL, V197, P2190, DOI 10.1128/JB.00193-15; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Chou SH, 2016, J BACTERIOL, V198, P32, DOI 10.1128/JB.00333-15; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Chua SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10052; Chua SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5462; Conibear TCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006289; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004; Hwang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep32841; Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109; Jacobson AR, 2007, ENVIRON SCI TECHNOL, V41, P6343, DOI 10.1021/es070707m; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kikuchi K, 2004, CURR OPIN CHEM BIOL, V8, P182, DOI 10.1016/j.cbpa.2004.02.007; Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0; Koh KS, 2007, J BACTERIOL, V189, P119, DOI 10.1128/JB.00930-06; Lee KWK, 2016, ISME J, V10, P846, DOI 10.1038/ismej.2015.159; North AJ, 2006, J CELL BIOL, V172, P9, DOI 10.1083/jcb.200507103; Purevdorj-Gage B, 2005, MICROBIOL-SGM, V151, P1569, DOI 10.1099/mic.0.27536-0; Rani SA, 2005, ANTIMICROB AGENTS CH, V49, P728, DOI 10.1128/AAC.49.2.728-732.2005; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Rybtke MT, 2012, APPL ENVIRON MICROB, V78, P5060, DOI 10.1128/AEM.00414-12; SILVER RA, 1990, NATURE, V343, P751, DOI 10.1038/343751a0; Stewart PS, 2007, LETT APPL MICROBIOL, V44, P454, DOI 10.1111/j.1472-765X.2007.02112.x; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Taki M, 2004, J AM CHEM SOC, V126, P712, DOI 10.1021/ja039073j; Tolker-Nielsen T., 2011, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259, DOI 10.1002/9780471729259]; Wang DL, 2005, SPEECH SEPARATION BY HUMANS AND MACHINES, P181, DOI 10.1007/0-387-22794-6_12	40	19	22	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					477	487		10.1074/jbc.M116.746743	http://dx.doi.org/10.1074/jbc.M116.746743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27899451	hybrid, Green Published			2022-12-28	WOS:000392316100006
J	Wittwer, M; Luo, Q; Kaila, VRI; Dames, SA				Wittwer, Matthias; Luo, Qi; Kaila, Ville R. I.; Dames, Sonja A.			Oxidative Unfolding of the Rubredoxin Domain and the Natively Disordered N-terminal Region Regulate the Catalytic Activity of Mycobacterium tuberculosis Protein Kinase G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENIC MYCOBACTERIA; MOLECULAR-DYNAMICS; DIPOLAR COUPLINGS; STRUCTURAL BASIS; STRESS-RESPONSE; AMINO-ACIDS; NMR; SURVIVAL; ZINC; PKNG	Mycobacterium tuberculosis escapes killing in human macrophages by secreting protein kinase G (PknG). PknG intercepts host signaling to prevent fusion of the phagosome engulfing the mycobacteria with the lysosome and, thus, their degradation. The N-terminal NORS (no regulatory secondary structure) region of PknG (approximately residues 1-75) has been shown to play a role in PknG regulation by (auto) phosphorylation, whereas the following rubredoxin-like metal-binding motif (RD, residues similar to 74-147) has been shown to interact tightly with the subsequent catalytic domain (approximately residues 148-420) to mediate its redox regulation. Deletions or mutations in NORS or the redox-sensitive RD significantly decrease PknG survival function. Based on combined NMR spectroscopy, in vitro kinase assay, and molecular dynamics simulation data, we provide novel insights into the regulatory roles of the N-terminal regions. The NORS region is indeed natively disordered and rather dynamic. Consistent with most earlier data, autophosphorylation occurs in our assays only when the NORS region is present and, thus, in the NORS region. Phosphorylation of it results only in local conformational changes and does not induce interactions with the subsequent RD. Although the reduced, metal-bound RD makes tight interactions with the following catalytic domain in the published crystal structures, it can also fold in its absence. Our data further suggest that oxidation-induced unfolding of the RD regulates substrate access to the catalytic domain and, thereby, PknG function under different redox conditions, e.g. when exposed to increased levels of reactive oxidative species in host macrophages.	[Wittwer, Matthias; Dames, Sonja A.] Tech Univ Munich, Dept Chem, Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany; [Luo, Qi; Kaila, Ville R. I.] Tech Univ Munich, Dept Chem, Computat Biocatalysis, Lichtenbergstr 4, D-85747 Garching, Germany; [Luo, Qi] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310027, Zhejiang, Peoples R China; [Luo, Qi] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China; [Dames, Sonja A.] Helmholtz Zentrum Munchen, Inst Biol Struct, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany	Technical University of Munich; Technical University of Munich; Zhejiang University; Zhejiang University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.; Dames, SA (corresponding author), Helmholtz Zentrum Munchen, Inst Biol Struct, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	sonja.dames@tum.de	Kaila, Ville R. I./E-1449-2014	Kaila, Ville/0000-0003-4464-6324; Dames, Sonja/0000-0001-7495-6943	German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB1035]; Gauss Centre for Supercomputing/Leibniz Supercomputing Centre [pr84pa]; China Scholarship Council; Technische Universitat Munchen (TUM) Diversity and Talent Management Office; Helmholtz portfolio theme "Metabolic Dysfunction and Common Disease" of the Helmholtz Zentrum Munchen	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Gauss Centre for Supercomputing/Leibniz Supercomputing Centre; China Scholarship Council(China Scholarship Council); Technische Universitat Munchen (TUM) Diversity and Talent Management Office; Helmholtz portfolio theme "Metabolic Dysfunction and Common Disease" of the Helmholtz Zentrum Munchen	This work was supported by grants from the German Research Foundation (Deutsche Forschungsgemeinschaft) (SFB1035, Project B04 and SFB1035, Project B12) (to S. A. D. and V. R. I. K., respectively). Computer resources were provided in part by the Gauss Centre for Supercomputing/Leibniz Supercomputing Centre (Grant pr84pa to V. R. I. K.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the China Scholarship Council.r Supported by the Technische Universitat Munchen (TUM) Diversity and Talent Management Office and the Helmholtz portfolio theme "Metabolic Dysfunction and Common Disease" of the Helmholtz Zentrum Munchen.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; Bourles E, 2011, CHEM-EUR J, V17, P13762, DOI 10.1002/chem.201101913; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Chaurasiya SK, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-271; Chim N, 2014, J INORG BIOCHEM, V133, P118, DOI 10.1016/j.jinorgbio.2013.11.003; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dames SA, 2011, J BIOL CHEM, V286, P36907, DOI 10.1074/jbc.M111.225052; Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h; Dauter Z, 1996, P NATL ACAD SCI USA, V93, P8836, DOI 10.1073/pnas.93.17.8836; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2015, SEMIN CELL DEV BIOL, V37, P44, DOI 10.1016/j.semcdb.2014.09.025; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gamiz-Hernandez AP, 2009, J CHEM THEORY COMPUT, V5, P2898, DOI 10.1021/ct900328c; Gil M, 2013, FREE RADICAL BIO MED, V65, P150, DOI 10.1016/j.freeradbiomed.2013.06.021; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iannuzzi C, 2014, PROTEIN SCI, V23, P1208, DOI 10.1002/pro.2501; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Li J, 2000, J CELL SCI, V113, P4143; Lisa MN, 2015, STRUCTURE, V23, P1039, DOI 10.1016/j.str.2015.04.001; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; SIEKER LC, 1994, METHOD ENZYMOL, V243, P203; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Thakur KG, 2010, J MOL BIOL, V397, P1199, DOI 10.1016/j.jmb.2010.02.026; Tharun IM, 2015, ACS CHEM BIOL, V10, P475, DOI 10.1021/cb5007097; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Walsh JD, 2010, BIOPHYS J, V99, P2636, DOI 10.1016/j.bpj.2010.08.036; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wittwer M, 2016, BIOMOL NMR ASSIGN, V10, P401, DOI 10.1007/s12104-016-9708-5; Wittwer M, 2015, PROTEIN EXPRES PURIF, V111, P68, DOI 10.1016/j.pep.2015.03.015; Zdanowski K, 2006, BIOCHEMISTRY-US, V45, P8294, DOI 10.1021/bi060711v; Zheng P, 2014, ANGEW CHEM INT EDIT, V53, P14060, DOI 10.1002/anie.201408105; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	52	14	12	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27062	27072		10.1074/jbc.M116.747089	http://dx.doi.org/10.1074/jbc.M116.747089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27810897	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000391576300008
J	Zhao, JW; Liu, JJ; Lee, JF; Zhang, WL; Kandouz, M; VanHecke, GC; Chen, SY; Ahn, YH; Lonardo, F; Lee, MJ				Zhao, Jiawei; Liu, Jingjing; Lee, Jen-Fu; Zhang, Wenliang; Kandouz, Mustapha; VanHecke, Garrett C.; Chen, Shiyou; Ahn, Young-Hoon; Lonardo, Fulvio; Lee, Menq-Jer			TGF-beta/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; PULMONARY-FIBROSIS; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; TUMOR PROGRESSION; MUTATION ANALYSIS	Previously, we showed that levels of sphingosine-1 phosphate receptor 3 (S1PR3) are increased in a panel of cultured human lung adenocarcinoma cell lines, and that S1PR3-mediated signaling pathways regulate proliferation, soft agar growth, and invasion of human lung adenocarcinoma cells in vitro. In the present study, we examine S1PR3 levels in human lung adenocarcinoma specimens. cDNA array and tumor microarray analysis shows that mRNA and protein levels of S1PR3 are significantly increased in human lung adenocarcinomas when compared with normal lung epithelial cells. Promoter analysis shows 16 candidate SMAD3 binding sites in the promoter region of S1PR3. ChIP indicates that TGF-beta treatment stimulates the binding of SMAD3 to the promoter region of S1PR3. Luciferase reporter assay demonstrates that SMAD3 transactivates S1PR3 promoter. TGF-beta stimulation or ectopic expression of TGF-beta up-regulates S1PR3 levels in vitro and ex vivo. Pharmacologic inhibition of TGF-beta receptor or SMAD3 abrogates the TGF-beta-stimulated S1PR3 up-regulation. Moreover, S1PR3 knockdown dramatically inhibits tumor growth and lung metastasis, whereas ectopic expression of S1PR3 promotes the growth of human lung adenocarcinoma cells in animals. Pharmacological inhibition of S1PR3 profoundly inhibits the growth of lung carcinoma in mice. Our studies suggest that levels of S1PR3 are up-regulated in human lung adenocarcinomas, at least in part due to the TGF-beta/SMAD3 signaling axis. Furthermore, S1PR3 activity promotes the progression of human lung adenocarcinomas. Therefore, S1PR3 may represent a novel therapeutic target for the treatment of deadly lung adenocarcinomas.	[Zhao, Jiawei; Liu, Jingjing; Lee, Jen-Fu; Zhang, Wenliang; Kandouz, Mustapha; Lonardo, Fulvio; Lee, Menq-Jer] Wayne State Univ, Sch Med, Dept Pathol, 540 East Canfield Ave,Scott Hall,Rm 9215, Detroit, MI 48201 USA; [VanHecke, Garrett C.; Ahn, Young-Hoon] Wayne State Univ, Sch Med, Dept Chem, Detroit, MI 48201 USA; [Lonardo, Fulvio; Lee, Menq-Jer] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Lee, Menq-Jer] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA; [Chen, Shiyou] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University System of Georgia; University of Georgia	Lee, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, 540 East Canfield Ave,Scott Hall,Rm 9215, Detroit, MI 48201 USA.	menqjer.lee@wayne.edu	LEE, JEN-FU/GRO-3670-2022		Department of Defense [W81XWH-14-1-0346]; Wayne State University; Strategic Research Initiative Grant (SRIG) award of the Karmanos Cancer Institute; National Institutes of Health [HL123302, HL119053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119053, R01HL123302] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Wayne State University; Strategic Research Initiative Grant (SRIG) award of the Karmanos Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Department of Defense Grant W81XWH-14-1-0346, a funding support of Wayne State University, a Strategic Research Initiative Grant (SRIG) award of the Karmanos Cancer Institute (to M. L.), and National Institutes of Health Grants HL123302 and HL119053 (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; An SZ, 1998, J CELL BIOCHEM, P147; Aoyagi T, 2012, LYMPHAT RES BIOL, V10, P97, DOI 10.1089/lrb.2012.0010; Barthelemy-Brichant N, 2002, EUR J CLIN INVEST, V32, P193, DOI 10.1046/j.1365-2362.2002.00956.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Chen MF, 2012, CLIN SCI, V122, P459, DOI 10.1042/CS20110434; Cui Y, 2011, INT J BIOCHEM CELL B, V43, P1122, DOI 10.1016/j.biocel.2011.04.005; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Decologne N, 2007, J IMMUNOL, V179, P6043, DOI 10.4049/jimmunol.179.9.6043; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dornagafa-Kulawik J, 2006, ARCH IMMUNOL THER EX, V54, P143, DOI 10.1007/s00005-006-0016-0; Estrada R, 2008, J BIOL CHEM, V283, P30363, DOI 10.1074/jbc.M804392200; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Fuxe J, 2012, SEMIN CANCER BIOL, V22, P455, DOI 10.1016/j.semcancer.2012.05.004; Gauldie J, 2008, AM J PHYSIOL-LUNG C, V294, pL151, DOI 10.1152/ajplung.00520.2007; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hasegawa Y, 2001, CANCER-AM CANCER SOC, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O; Haura EB, 2006, CLIN LUNG CANCER, V7, P273, DOI 10.3816/CLC.2006.n.006; Hirata N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5806; Hong S, 2010, WORLD J GASTROENTERO, V16, P2080, DOI 10.3748/wjg.v16.i17.2080; Hsu A, 2012, INT J ONCOL, V40, P1619, DOI 10.3892/ijo.2012.1379; Ivanova MM, 2009, MOL CELL ENDOCRINOL, V305, P12, DOI 10.1016/j.mce.2009.01.021; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Miller AV, 2008, MOL CELL BIOL, V28, P4142, DOI 10.1128/MCB.01465-07; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Naber HPH, 2008, CURR CANCER DRUG TAR, V8, P466, DOI 10.2174/156800908785699342; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Nalluri SM, 2015, CYTOSKELETON, V72, P557, DOI 10.1002/cm.21263; Nowrin K, 2014, EXPERT REV RESP MED, V8, P547, DOI 10.1586/17476348.2014.948853; Nussbaum C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7416; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Olejniczak ET, 2007, MOL CANCER RES, V5, P331, DOI 10.1158/1541-7786.MCR-06-0367; Papageorgis P, 2015, J ONCOL, V2015, DOI 10.1155/2015/587193; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Rak J, 1995, CANCER METAST REV, V14, P263, DOI 10.1007/BF00690598; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Saito H, 1999, CANCER, V86, P1455, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1455::AID-CNCR11>3.0.CO;2-L; Saitoh M, 2015, CANCER SCI, V106, P481, DOI 10.1111/cas.12630; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Sholl LM, 2015, J THORAC ONCOL, V10, P768, DOI 10.1097/JTO.0000000000000516; Siow DL, 2011, ADV ENZYME REGUL, V51, P229, DOI 10.1016/j.advenzreg.2010.09.004; Tian MZ, 2011, CELL SIGNAL, V23, P951, DOI 10.1016/j.cellsig.2010.10.015; Tsushima H, 1996, GASTROENTEROLOGY, V110, P375, DOI 10.1053/gast.1996.v110.pm8566583; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yamamoto H, 2009, LUNG CANCER, V63, P315, DOI 10.1016/j.lungcan.2008.06.021; Yamanaka M, 2004, J BIOL CHEM, V279, P53994, DOI 10.1074/jbc.M410144200; YANAGAWA H, 1995, BRIT J CANCER, V71, P1095, DOI 10.1038/bjc.1995.212; Yang L, 2010, CANCER METAST REV, V29, P263, DOI 10.1007/s10555-010-9226-3; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yester JW, 2011, CANCER METAST REV, V30, P577, DOI 10.1007/s10555-011-9305-0; Yu H, 2015, NEOPLASMA, V62, P1, DOI 10.4149/neo_2015_002; Zhang WL, 2014, J BIOL CHEM, V289, P32178, DOI 10.1074/jbc.M114.601096; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001; Zhang WL, 2013, J BIOL CHEM, V288, P32126, DOI 10.1074/jbc.M113.495218; Zhao P, 2013, ONCOGENE, V32, P5186, DOI 10.1038/onc.2012.542	75	27	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27343	27353		10.1074/jbc.M116.740084	http://dx.doi.org/10.1074/jbc.M116.740084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27856637	Green Published, hybrid			2022-12-28	WOS:000391576300031
J	Berchtold, MW; Zacharias, T; Kulej, K; Wang, K; Torggler, R; Jespersen, T; Chen, JN; Larsen, MR; la Cour, JM				Berchtold, Martin W.; Zacharias, Triantafyllos; Kulej, Katarzyna; Wang, Kevin; Torggler, Raffaela; Jespersen, Thomas; Chen, Jau-Nian; Larsen, Martin R.; la Cour, Jonas M.			The Arrhythmogenic Calmodulin Mutation D129G Dysregulates Cell Growth, Calmodulin-dependent Kinase II Activity, and Cardiac Function in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; PROTEIN-KINASE; HEART-FAILURE; CAMKII ACTIVITY; CALCIUM; ION; DEATH; CALM1; CA2+/CALMODULIN; CHROMATOGRAPHY	Calmodulin (CaM) is a Ca2+ binding protein modulating multiple targets, several of which are associated with cardiac pathophysiology. Recently, CaM mutations were linked to heart arrhythmia. CaM is crucial for cell growth and viability, yet the effect of the arrhythmogenic CaM mutations on cell viability, as well as heart rhythm, remains unknown, and only a few targets with relevance for heart physiology have been analyzed for their response to mutant CaM. We show that the arrhythmia-associated CaM mutants support growth and viability of DT40 cells in the absence of WT CaM except for the long QT syndrome mutant CaM D129G. Of the six CaM mutants tested (N53I, F89L, D95V, N97S, D129G, and F141L), three showed a decreased activation of Ca2+/CaM-dependent kinase II, most prominently the D129G CaM mutation, which was incapable of stimulating Thr(286) autophosphorylation. Furthermore, the CaM D129G mutation led to bradycardia in zebrafish and an arrhythmic phenotype in a subset of the analyzed zebrafish.	[Berchtold, Martin W.; Zacharias, Triantafyllos; Torggler, Raffaela; la Cour, Jonas M.] Univ Copenhagen, Dept Biol, Univ Pk 13, DK-2100 Copenhagen, Denmark; [Jespersen, Thomas] Univ Copenhagen, Danish Arrhythmia Res Ctr, DK-2100 Copenhagen, Denmark; [Kulej, Katarzyna; Larsen, Martin R.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Wang, Kevin; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of Copenhagen; University of Copenhagen; University of Southern Denmark; University of California System; University of California Los Angeles	Berchtold, MW; la Cour, JM (corresponding author), Univ Copenhagen, Dept Biol, Univ Pk 13, DK-2100 Copenhagen, Denmark.	mabe@bio.ku.dk; jonas@bio.ku.dk	Chen, Jau-Nian/AAM-7808-2020; Berchtold, Martin W./L-1695-2014; la Cour, Jonas/M-5088-2016	Berchtold, Martin W./0000-0001-8995-9047; Jespersen, Thomas/0000-0001-6575-360X; la Cour, Jonas/0000-0002-1588-0608	Danish Heart Foundation; AP Moller Laegefonden; Nilssons Foundation; Marshall Foundation; Willumsen Foundation; Danielsen Foundation; Danish Research Council [FSS4004-00560]; Villum Fonden [00007292] Funding Source: researchfish	Danish Heart Foundation; AP Moller Laegefonden; Nilssons Foundation; Marshall Foundation; Willumsen Foundation; Danielsen Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	This work was supported by funds from the Danish Heart Foundation (to J. M. L. C. and M. W. B.), AP Moller Laegefonden (to J. M. L. C.), and the Nilssons, Marshall, Willumsen, and Danielsen Foundations (to M. W. B.) and by Danish Research Council Grant FSS4004-00560 (to M. W. B. and J. M. L. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Barcomb K, 2014, FASEB J, V28, P3810, DOI 10.1096/fj.14-250407; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BERCHTOLD MW, 1993, GENOMICS, V16, P461, DOI 10.1006/geno.1993.1211; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bers DM, 2011, HEART RHYTHM, V8, P1101, DOI 10.1016/j.hrthm.2011.01.030; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; Boczek NJ, 2016, CIRC-CARDIOVASC GENE, V9, P136, DOI 10.1161/CIRCGENETICS.115.001323; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; DeGrande S, 2012, HEART RHYTHM, V9, P2034, DOI 10.1016/j.hrthm.2012.08.026; Engholm-Keller K, 2011, J PROTEOME RES, V10, P5383, DOI 10.1021/pr200641x; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Gomez-Hurtado N, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004161; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Hund TJ, 2015, TRENDS CARDIOVAS MED, V25, P392, DOI 10.1016/j.tcm.2014.12.001; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Kopp R, 2005, J EXP BIOL, V208, P2123, DOI 10.1242/jeb.01620; Kwok S, 2008, BIOCHEM BIOPH RES CO, V369, P519, DOI 10.1016/j.bbrc.2008.02.070; Langenbacher AD, 2012, DEV BIOL, V362, P263, DOI 10.1016/j.ydbio.2011.12.004; Leong IUS, 2010, BIOCHEM BIOPH RES CO, V396, P817, DOI 10.1016/j.bbrc.2010.04.157; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Marsman RF, 2014, J AM COLL CARDIOL, V63, P259, DOI 10.1016/j.jacc.2013.07.091; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Mower AF, 2011, P NATL ACAD SCI USA, V108, P21241, DOI 10.1073/pnas.1108261109; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Panina S, 2012, J BIOL CHEM, V287, P18173, DOI 10.1074/jbc.M112.339382; Pipilas DC, 2016, HEART RHYTHM, V13, P2012, DOI 10.1016/j.hrthm.2016.06.038; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Reed GJ, 2015, HEART RHYTHM, V12, P419, DOI 10.1016/j.hrthm.2014.10.035; Roden DM, 2006, CIRC RES, V98, P979, DOI 10.1161/01.RES.0000221822.22971.8c; Schmalzigaug R, 2001, IMMUNOLOGY, V103, P332, DOI 10.1046/j.1365-2567.2001.01259.x; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Shimizu J, 2016, RHEUMATOLOGY, V55, P583, DOI 10.1093/rheumatology/kev320; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Toutenhoofd SL, 2002, BBA-PROTEINS PROTEOM, V1600, P95, DOI 10.1016/S1570-9639(02)00449-1; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	48	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26636	26646		10.1074/jbc.M116.758680	http://dx.doi.org/10.1074/jbc.M116.758680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27815504	Green Published, hybrid			2022-12-28	WOS:000391571400005
J	Yang, Y; Davis, I; Ha, U; Wang, YF; Shin, I; Liu, AM				Yang, Yu; Davis, Ian; Ha, Uyen; Wang, Yifan; Shin, Inchul; Liu, Aimin			A Pitcher-and-Catcher Mechanism Drives Endogenous Substrate Isomerization by a Dehydrogenase in Kynurenine Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; 4-OXALOCROTONATE TAUTOMERASE; DECARBOXYLASE ACMSD; CRYSTAL-STRUCTURE; ACTIVE-SITE; TRYPTOPHAN; PATHWAY; ACID; DEGRADATION; CATALYSIS	Aldehyde dehydrogenase typically performs oxidation of aldehydes to their corresponding carboxylic acid while reducing NAD(P)(+) to NAD(P) H via covalent catalysis mediated by an active-site cysteine residue. One member of this superfamily, the enzyme 2-aminomuconate-6-semialdehyde dehydrogenase (AMSDH), is a component of the kynurenine pathway, which catabolizes tryptophan in mammals and certain bacteria. AMSDH catalyzes the NAD(+)-dependent oxidation of 2-aminomuconate semialdehyde to 2-aminomuconate. We recently determined the first crystal structure of AMSDH and several catalytic cycle intermediates. A conserved asparagine in the oxyanion hole, Asn-169, is found to be H-bonded to substrate-derived intermediates in the active site of AMSDH during catalysis, including both the covalently bound thiohemiacetal and thioacyl intermediates. To better interrogate the significance of the hydrogen bond provided by Asn-169 to the reaction mechanism of AMSDH, we created Ala, Ser, Asp, and Gln mutants and studied them using biochemical, kinetic, crystallographic, and computational studies. The in crystallo chemical reaction of the primary substrate with the co-crystalized complex of the N169D mutant and NAD(+) led to the successful trapping of a new catalytic intermediate that was not previously seen. The structural and computational data are consistent with a substrate imine/enol tautomer intermediate being formed prior to the formation of the covalent bond between the substrate and the active-site cysteine. Thus, AMSDH surprisingly includes an isomerization process within its known catalytic mechanism. These data establish a hidden intrinsic isomerization activity of the dehydrogenase and allow us to propose a pitcher-catcher type of catalytic mechanism for the isomerization.	[Yang, Yu; Davis, Ian; Wang, Yifan; Shin, Inchul; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Davis, Ian; Ha, Uyen; Liu, Aimin] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University of Texas System; University of Texas at San Antonio (UTSA); University System of Georgia; Georgia State University	Liu, AM (corresponding author), Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA.; Liu, AM (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	Feradical@utsa.edu	Liu, Aimin/C-1572-2017	Liu, Aimin/0000-0002-4182-8176; Wang, Yifan/0000-0003-0378-2469; Yang, Yu/0000-0001-5305-2435; Davis, Ian/0000-0002-1566-4972	National Institutes of Health [MH107985]; National Science Foundation [CHE-1623856]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107985] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1623856] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Institutes of Health Grant MH107985 and the National Science Foundation Grant CHE-1623856. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Burks EA, 2011, BIOCHEMISTRY-US, V50, P7600, DOI 10.1021/bi200947w; Burks EA, 2010, BIOCHEMISTRY-US, V49, P5016, DOI 10.1021/bi100502z; CHEN LH, 1992, J BIOL CHEM, V267, P17716; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; Colabroy KL, 2005, J AM CHEM SOC, V127, P840, DOI 10.1021/ja0446395; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Davis I, 2015, EXPERT REV NEUROTHER, V15, P719, DOI 10.1586/14737175.2015.1049999; Dazzi C, 2001, J CHROMATOGR B, V751, P61, DOI 10.1016/S0378-4347(00)00450-3; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Frisch M.J., 2016, GAUSSIAN16 REV B01; Huddleston JP, 2014, ARCH BIOCHEM BIOPHYS, V564, P189, DOI 10.1016/j.abb.2014.08.019; Huo L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6935; Huo L, 2015, PROTEINS, V83, P178, DOI 10.1002/prot.24722; Huo L, 2013, J BIOL CHEM, V288, P30862, DOI 10.1074/jbc.M113.496869; ICHIYAMA A, 1965, J BIOL CHEM, V240, P740; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2007, J AM CHEM SOC, V129, P9278, DOI 10.1021/ja073648l; Li TF, 2006, BIOCHEMISTRY-US, V45, P6628, DOI 10.1021/bi060108c; Metanis N, 2004, J AM CHEM SOC, V126, P12726, DOI 10.1021/ja0463841; Muraki T, 2003, APPL ENVIRON MICROB, V69, P1564, DOI 10.1128/AEM.69.3.1564-1572.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park J, 2013, J BIOL CHEM, V288, P15760, DOI 10.1074/jbc.M113.460428; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Taylor AB, 1998, BIOCHEMISTRY-US, V37, P14692, DOI 10.1021/bi981607j; Terrell CR, 2013, ARCH BIOCHEM BIOPHYS, V537, P113, DOI 10.1016/j.abb.2013.06.016; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028	34	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26252	26261		10.1074/jbc.M116.759712	http://dx.doi.org/10.1074/jbc.M116.759712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27810899	hybrid, Green Published			2022-12-28	WOS:000391568200002
J	Zeng, J; Deng, SW; Wang, YP; Li, P; Tang, L; Pang, YF				Zeng, Jia; Deng, Senwen; Wang, Yiping; Li, Ping; Tang, Lian; Pang, Yefeng			Specific Inhibition of Acyl-CoA Oxidase-1 by an Acetylenic Acid Improves Hepatic Lipid and Reactive Oxygen Species (ROS) Metabolism in Rats Fed a High Fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); fatty acid; fatty acid metabolism; fatty acid oxidation; inhibitor; metabolism	PEROXISOMAL BETA-OXIDATION; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; INSULIN-RESISTANCE; LIVER; MICE; DISEASE; CLOFIBRATE; EXPRESSION; OBESITY	A chronic high fat diet results in hepatic mitochondrial dysfunction and induction of peroxisomal fatty acid oxidation (FAO); whether specific inhibition of peroxisomal FAO benefits mitochondrial FAO and reactive oxygen species (ROS) metabolism remains unclear. In this study a specific inhibitor for the rate-limiting enzyme involved in peroxisomal FAO, acyl-CoA oxidase-1 (ACOX1) was developed and used for the investigation of peroxisomal FAO inhibition upon mitochondrial FAO and ROS metabolism. Specific inhibition of ACOX1 by 10,12-tricosadiynoic acid increased hepatic mitochondrial FAO via activation of the SIRT1-AMPK (adenosine 5-monophosphate-activated protein kinase) pathway and proliferator activator receptor and reduced hydrogen peroxide accumulation in high fat diet-fed rats, which significantly decreased hepatic lipid and ROS contents, reduced body weight gain, and decreased serum triglyceride and insulin levels. Inhibition of ACOX1 is a novel and effective approach for the treatment of high fat diet- or obesity-induced metabolic diseases by improving mitochondrial lipid and ROS metabolism.	[Zeng, Jia; Deng, Senwen; Wang, Yiping; Li, Ping; Tang, Lian; Pang, Yefeng] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan 411201, Hunan, Peoples R China	Hunan University of Science & Technology	Zeng, J (corresponding author), Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan 411201, Hunan, Peoples R China.	zengj@hnu.edu.cn			National Natural Science Fund of China [30900024]; Doctoral Program of Ministry of Education of China [200805331034]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Fund of China (30900024) and the Doctoral Program of Ministry of Education of China (200805331034). The authors declare that they have no conflicts of interest with the contents of this article.	DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Fatope MO, 2000, J AGR FOOD CHEM, V48, P1872, DOI 10.1021/jf990550k; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; GOEL SK, 1986, CANCER RES, V46, P1324; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huang JS, 2012, FASEB J, V26, P628, DOI 10.1096/fj.11-194019; Huang JS, 2011, AM J PATHOL, V179, P703, DOI 10.1016/j.ajpath.2011.04.030; Ishiyama H, 1997, J ORG CHEM, V62, P3831, DOI 10.1021/jo970206r; Jia Z, 2004, PROTEIN EXPRES PURIF, V38, P153, DOI 10.1016/j.pep.2004.08.013; Kasumov T, 2005, BIOCHEM J, V389, P397, DOI 10.1042/BJ20050144; Kuklev DV, 2013, PHYTOMEDICINE, V20, P1145, DOI 10.1016/j.phymed.2013.06.009; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; Lee YH, 2015, J AGR FOOD CHEM, V63, P7361, DOI 10.1021/acs.jafc.5b02876; Li D, 1999, J AM CHEM SOC, V121, P9034, DOI 10.1021/ja991908w; Li YX, 2000, DNA CELL BIOL, V19, P113, DOI 10.1089/104454900314627; Luo YS, 2000, ARCH BIOCHEM BIOPHYS, V384, P1, DOI 10.1006/abbi.2000.2079; Mari M, 2010, ANTIOXID REDOX SIGN, V12, P1295, DOI 10.1089/ars.2009.2634; Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004; NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369; Nilakantan V, 1998, CARCINOGENESIS, V19, P631, DOI 10.1093/carcin/19.4.631; Nsiah-Sefaa A, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150295; NUGTEREN DH, 1987, PROSTAGLANDINS, V33, P403, DOI 10.1016/0090-6980(87)90022-0; PARDRIDGE WM, 1980, J CLIN INVEST, V66, P88, DOI 10.1172/JCI109839; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Reszko AE, 2004, J BIOL CHEM, V279, P19574, DOI 10.1074/jbc.M400162200; ROGNSTAD R, 1991, BIOCHEM J, V279, P147, DOI 10.1042/bj2790147; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Shin M, 1998, BIOCHEM PHARMACOL, V55, P367, DOI 10.1016/S0006-2952(97)00507-8; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; THOMAS H, 1989, BIOCHEM PHARMACOL, V38, P4291, DOI 10.1016/0006-2952(89)90528-5; THOMASSEN MS, 1982, BIOCHEM J, V206, P195, DOI 10.1042/bj2060195; Turecky L, 2014, PHYSIOL RES, V63, pS585, DOI 10.33549/physiolres.932918; Walton PA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00108; Zeng J, 2006, BBA-GEN SUBJECTS, V1760, P78, DOI 10.1016/j.bbagen.2005.09.010; Zeng J, 2008, ORG LETT, V10, P4287, DOI 10.1021/ol801571n; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	40	54	55	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3800	3809		10.1074/jbc.M116.763532	http://dx.doi.org/10.1074/jbc.M116.763532			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28077576	hybrid, Green Published			2022-12-28	WOS:000395542500022
J	Hatami, A; Monjazeb, S; Milton, S; Glabe, CG				Hatami, Asa; Monjazeb, Sanaz; Milton, Saskia; Glabe, Charles G.			Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-beta Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; Alzheimer disease; amyloid- (A); monoclonal antibody; peptide conformation	SMOOTH-MUSCLE-CELLS; A-BETA; MONOCLONAL-ANTIBODIES; PROTOFIBRIL FORMATION; PRESENILIN MUTATIONS; CEREBRAL-HEMORRHAGE; THIOFLAVIN-T; TOTTORI D7N; ENGLISH H6R; ANGIOPATHY	Most cases of Alzheimer's disease (AD) are sporadic, but a small percentage of AD cases, called familial AD (FAD), are associated with mutations in presenilin 1, presenilin 2, or the amyloid precursor protein. Amyloid precursor protein mutations falling within the amyloid- (A) sequence lead to a wide range of disease phenotypes. There is increasing evidence that distinct amyloid structures distinguished by amyloid conformation-dependent monoclonal antibodies have similarly distinct roles in pathology. It is possible that this phenotypic diversity of FAD associated with mutations within the A sequence is due to differences in the conformations adopted by mutant A peptides, but the effects of FAD mutations on aggregation kinetics and conformational and morphological changes of the A peptide are poorly defined. To gain more insight into this possibility, we therefore investigated the effects of 11 FAD mutations on the aggregation kinetics of A, as well as its ability to form distinct conformations recognized by a panel of amyloid conformation-specific monoclonal antibodies. We found that most FAD mutations increased the rate of aggregation of A. The FAD mutations also led to the adoption of alternative amyloid conformations distinguished by monoclonal antibodies and resulted in the formation of distinct aggregate morphologies as determined by transmission electron microscopy. In addition, several of the mutant peptides displayed a large reduction in thioflavin T fluorescence, despite forming abundant fibrils indicating that thioflavin T is a probe of conformational polymorphisms rather than a reliable indicator of fibrillization. Taken together, these results indicate that FAD mutations falling within the A sequence lead to dramatic changes in aggregation kinetics and influence the ability of A to form immunologically and morphologically distinct amyloid structures.	[Hatami, Asa; Monjazeb, Sanaz; Milton, Saskia; Glabe, Charles G.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Hatami, Asa] UCLA, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Glabe, Charles G.] King Abdulaziz Univ, King Fahd Med Res Ctr, Dept Biochem, Fac Sci, Jeddah 23218, Saudi Arabia; [Glabe, Charles G.] King Abdulaziz Univ, King Fahd Med Res Ctr, Expt Biochem Unit, Jeddah 23218, Saudi Arabia	University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; King Abdulaziz University; King Abdulaziz University	Glabe, CG (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	cglabe@uci.edu			National Institutes of Health [AG033069, AG00538]; Cure Alzheimer's fund; NATIONAL INSTITUTE ON AGING [R01AG033069, P01AG000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG033069 and AG00538 and a grant from the Cure Alzheimer's fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Chatani E, 2005, BBA-PROTEINS PROTEOM, V1753, P64, DOI 10.1016/j.bbapap.2005.08.002; Cloe AL, 2011, BIOCHEMISTRY-US, V50, P2026, DOI 10.1021/bi1016217; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Di Fede G, 2013, FRONT BIOSCI-LANDMRK, V18, P1202, DOI 10.2741/4173; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Duboisset J, 2013, J PHYS CHEM B, V117, P784, DOI 10.1021/jp309528f; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elkins MR, 2016, J AM CHEM SOC, V138, P9840, DOI 10.1021/jacs.6b03715; Fawzi NL, 2008, BIOPHYS J, V94, P2007, DOI 10.1529/biophysj.107.121467; Fossati S, 2010, FASEB J, V24, P229, DOI 10.1096/fj.09-139584; Gessel MM, 2012, ACS CHEM NEUROSCI, V3, P909, DOI 10.1021/cn300050d; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Handoko M, 2013, JAMA NEUROL, V70, P594, DOI 10.1001/jamaneurol.2013.48; Hatami A, 2014, J BIOL CHEM, V289, P32131, DOI 10.1074/jbc.M114.594846; Hernandez-Guillamon M, 2010, J BIOL CHEM, V285, P27144, DOI 10.1074/jbc.M110.135228; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Kaden D, 2012, EMBO MOL MED, V4, P647, DOI 10.1002/emmm.201200239; Kalimo H, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-60; Kassler K, 2010, J MOL MODEL, V16, P1011, DOI 10.1007/s00894-009-0611-1; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kutoku Y, 2015, INTERNAL MED, V54, P205, DOI 10.2169/internalmedicine.54.3021; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LUYENDIJK W, 1988, J NEUROL SCI, V85, P267, DOI 10.1016/0022-510X(88)90186-4; Maia LF, 2007, J NEUROL SCI, V257, P23, DOI 10.1016/j.jns.2007.01.054; Masuda Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2170, DOI 10.1271/bbb.80250; Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411; McLean D, 2013, ACS CHEM NEUROSCI, V4, P613, DOI 10.1021/cn300226q; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nishitsuji K, 2009, AM J PATHOL, V174, P957, DOI 10.2353/ajpath.2009.080480; Nussbaum JM, 2013, PRION, V7, P14, DOI 10.4161/pri.22118; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Obici L, 2005, ANN NEUROL, V58, P639, DOI 10.1002/ana.20571; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Ovchinnikova OY, 2011, J MOL BIOL, V408, P780, DOI 10.1016/j.jmb.2011.02.049; Pasalar P, 2002, NEUROLOGY, V58, P1574, DOI 10.1212/WNL.58.10.1574; Pensalfini A, 2014, NEUROBIOL DIS, V71, P53, DOI 10.1016/j.nbd.2014.07.011; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; Pezzini A, 2009, CURR MED CHEM, V16, P2498, DOI 10.2174/092986709788682047; Reinke AA, 2011, CHEM BIOL DRUG DES, V77, P399, DOI 10.1111/j.1747-0285.2011.01110.x; Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8; Shimada H, 2011, DEMENT GERIATR COGN, V32, P45, DOI 10.1159/000330017; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; Van Nostrand WE, 1998, J NEUROCHEM, V70, P216; Van Nostrand WE, 2002, ANN NY ACAD SCI, V977, P258; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wang ZZ, 2000, STROKE, V31, P534, DOI 10.1161/01.STR.31.2.534; Weggen S, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt107; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x	64	79	80	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3172	3185		10.1074/jbc.M116.755264	http://dx.doi.org/10.1074/jbc.M116.755264			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28049728	Green Published, hybrid			2022-12-28	WOS:000395538800011
J	Ketkar, A; Voehler, M; Mukiza, T; Eoff, RL				Ketkar, Amit; Voehler, Markus; Mukiza, Tresor; Eoff, Robert L.			Residues in the RecQ C-terminal Domain of the Human Werner Syndrome Helicase Are Involved in Unwinding G-quadruplex DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA repair; DNA replication; enzyme mechanism; G-quadruplex; Werner syndrome helicase	SYNDROME PROTEIN; STRAND SEPARATION; GENE-EXPRESSION; S-PHASE; REPLICATION; FANCJ; CELLS; WRN; RECOGNITION; STABILITY	The structural and biophysical properties typically associated with G-quadruplex (G4) structures render them a significant block for DNA replication, which must be overcome for cell division to occur. The Werner syndrome protein (WRN) is a RecQ family helicase that has been implicated in the efficient processing of G4 DNA structures. The aim of this study was to identify the residues of WRN involved in the binding and ATPase-driven unwinding of G4 DNA. Using a c-Myc G4 DNA model sequence and recombinant WRN, we have determined that the RecQ-C-terminal (RQC) domain of WRN imparts a 2-fold preference for binding to G4 DNA relative to non-G4 DNA substrates. NMR studies identified residues involved specifically in interactions with G4 DNA. Three of the amino acids in the WRN RQC domain that exhibited the largest G4-specific changes in NMR signal were then mutated alone or in combination. Mutating individual residues implicated in G4 binding had a modest effect on WRN binding to DNA, decreasing the preference for G4 substrates by approximate to 25%. Mutating two G4-interacting residues (T1024G and T1086G) abrogated preferential binding of WRN to G4 DNA. Very modest decreases in G4 DNA-stimulated ATPase activity were observed for the mutant enzymes. Most strikingly, G4 unwinding by WRN was inhibited approximate to 50% for all three point mutants and >90% for the WRN double mutant (T1024G/T1086G) relative to normal B-form dsDNA substrates. Our work has helped to identify residues in the WRN RQC domain that are involved specifically in the interaction with G4 DNA.	[Ketkar, Amit; Mukiza, Tresor; Eoff, Robert L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Voehler, Markus] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA	University of Arkansas System; University of Arkansas Medical Sciences; Vanderbilt University	Eoff, RL (corresponding author), Univ Arkansas Med Sci, Biomed Res Ctr 1, Rm B421E,4301 W Markham St, Little Rock, AR 72205 USA.	rleoff@uams.edu	Ketkar, Amit/H-8022-2019; Mukiza, Tresor/AAS-3093-2021	Mukiza, Tresor/0000-0002-4785-9432; ketkar, amit/0000-0002-6536-7415	National Institutes of Health from USPHS [GM084460, CA183895]; University of Arkansas for Medical Sciences Translational Research Institute CTSA [UL1TR000039]; NATIONAL CANCER INSTITUTE [R01CA183895] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM084460, R00GM084460] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; University of Arkansas for Medical Sciences Translational Research Institute CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM084460 and CA183895 from USPHS (to R. L. E.) and by University of Arkansas for Medical Sciences Translational Research Institute CTSA Grant Award UL1TR000039. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Bohr VA, 2000, EXP GERONTOL, V35, P695, DOI 10.1016/S0531-5565(00)00145-5; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Chatterjee S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6556; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Dai JX, 2011, J AM CHEM SOC, V133, P17673, DOI 10.1021/ja205646q; Damerla RR, 2012, CELL CYCLE, V11, P3036, DOI 10.4161/cc.21399; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Eddy S, 2014, NUCLEIC ACIDS RES, V42, P3272, DOI 10.1093/nar/gkt1314; Eoff RL, 2005, BIOCHEM SOC T, V33, P1474, DOI 10.1042/BST0331474; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Gray RD, 2014, J MOL BIOL, V426, P1629, DOI 10.1016/j.jmb.2014.01.009; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Hu JS, 2005, P NATL ACAD SCI USA, V102, P18379, DOI 10.1073/pnas.0509380102; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100; Lee JW, 2005, J BIOL CHEM, V280, P39627, DOI 10.1074/jbc.M506112200; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Mathad RI, 2011, NUCLEIC ACIDS RES, V39, P9023, DOI 10.1093/nar/gkr612; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Moser MJ, 2000, CANCER RES, V60, P2492; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; Poot M, 1999, HUM GENET, V104, P10, DOI 10.1007/s004390050903; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Tang WL, 2016, HUM MOL GENET, V25, P2060, DOI 10.1093/hmg/ddw079; Tippana R, 2016, P NATL ACAD SCI USA, V113, P8448, DOI 10.1073/pnas.1603724113; Wu CG, 2016, NUCLEIC ACIDS RES, V44, P8742, DOI 10.1093/nar/gkw574; Wu CG, 2013, ADV EXP MED BIOL, V973, P1, DOI 10.1007/978-1-4614-5037-5_1	36	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2017	292	8					3154	3163		10.1074/jbc.M116.767699	http://dx.doi.org/10.1074/jbc.M116.767699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8CM	28069813	hybrid, Green Published			2022-12-28	WOS:000395538800009
J	Meng, FL; Cang, XH; Peng, YY; Li, RH; Zhang, ZY; Li, FS; Fan, QQ; Guan, AS; Fischel-Ghosian, N; Zhao, XL; Guan, MX				Meng, Feilong; Cang, Xiaohui; Peng, Yanyan; Li, Ronghua; Zhang, Zhengyue; Li, Fushan; Fan, Qingqing; Guan, Anna S.; Fischel-Ghosian, Nathan; Zhao, Xiaoli; Guan, Min-Xin			Biochemical Evidence for a Nuclear Modifier Allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) Related to Mitochondrial tRNA Modification in the Phenotypic Manifestation of Deafness-associated 12S rRNA Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY OPTIC NEUROPATHY; NONSYNDROMIC DEAFNESS; OXIDATIVE STRESS; C1494T MUTATION; GENE; AMINOACYLATION; EXPRESSION; TRANSLATION; SYNTHETASE; DISEASES	Nuclear modifier gene(s) was proposed to modulate the phenotypic expression of mitochondrial DNA mutation(s). Our previous investigations revealed that a nuclear modifier allele (A10S) in TRMU(methylaminomethyl-2-thiouridylate-methyltransferase) related to tRNA modification interacts with 12S rRNA 1555A3 -> G mutation to cause deafness. The A10S mutation resided at a highly conserved residue of the N-terminal sequence. It was hypothesized that the A10S mutation altered the structure and function of TRMU, thereby causing mitochondrial dysfunction. Using molecular dynamics simulations, we showed that the A10S mutation introduced the Ser(10) dynamic electrostatic interaction with the Lys(106) residue of helix 4 within the catalytic domain of TRMU. The Western blotting analysis displayed the reduced levels of TRMU in mutant cells carrying the A10S mutation. The thermal shift assay revealed the T-m value of mutant TRMU protein, lower than that of the wild-type counterpart. The A10S mutation caused marked decreases in 2-thiouridine modification of U34 of tRNALys, tRNAGlu and tRNAGln. However, the A10S mutation mildly increased the aminoacylated efficiency of tRNAs. The altered 2-thiouridine modification worsened the impairment of mitochondrial translation associated with the m. 1555A -> Gmutation. The defective translation resulted in the reduced activities of mitochondrial respiration chains. The respiratory deficiency caused the reduction of mitochondrial ATP production and elevated the production of reactive oxidative species. As a result, mutated TRMU worsened mitochondrial dysfunctions associated with m. 1555A3 -> G mutation, exceeding the threshold for expressing a deafness phenotype. Our findings provided new insights into the pathophysiology of maternally inherited deafness that was manifested by interaction between mtDNA mutation and nuclear modifier gene.	[Meng, Feilong; Cang, Xiaohui; Guan, Min-Xin] Zhejiang Univ, Sch Med, Zhejiang Childrens Hosp, Div Med Genet & Gen, Hangzhou 310058, Zhejiang, Peoples R China; [Meng, Feilong; Cang, Xiaohui; Peng, Yanyan; Zhang, Zhengyue; Li, Fushan; Fan, Qingqing; Zhao, Xiaoli; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Peng, Yanyan] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Li, Ronghua] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30307 USA; [Guan, Anna S.; Fischel-Ghosian, Nathan] UCLA Sch Med, Ahmanson Dept Pediat, Cedars Sinai Med Ctr, Los Angeles, CA 90095 USA; [Guan, Min-Xin] Zhejiang Univ, Joining Inst Genet & Genom Med, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Univ Toronto, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Cincinnati Children's Hospital Medical Center; Emory University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Zhejiang University; University of Toronto	Zhao, XL (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.	zhaoxiaoli@zju.edu.cn; gminxin88@zju.edu.cn		Guan, Min-Xin/0000-0001-5067-6736	National Natural Science Foundation of China [81330024, 31400709]; National Basic Research Priorities Program of China [2014CB541704, 2012CB967902]; NIDCD National Institutes of Health [RO1DC05230, RO1DC07696]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007696, R01DC005230] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Priorities Program of China(National Basic Research Program of China); NIDCD National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Natural Science Foundation of China Grant 81330024, National Basic Research Priorities Program of China Grant 2014CB541704, NIDCD National Institutes of Health Grants RO1DC05230 and RO1DC07696 (to M.-X.G.), National Natural Science Foundation of China Grant 31400709 (to X.C.), and National Basic Research Priorities Program of China Grant 2012CB967902 (to X.Z.). The MD simulations were carried out at National Supercomputer Center in Tianjin, China. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allner O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Belostotsky R, 2012, RNA BIOL, V9, P33, DOI 10.4161/rna.9.1.18009; Boczonadi V, 2013, HUM MOL GENET, V22, P4602, DOI 10.1093/hmg/ddt309; Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009; Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Armengod ME, 2014, RNA BIOL, V11, P1495, DOI 10.4161/15476286.2014.992269; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Iwanicka-Pronicka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044054; Jacobs HT, 2003, HUM MOL GENET, V12, pR293, DOI 10.1093/hmg/ddg285; James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; KING MP, 1993, J BIOL CHEM, V268, P10228; Kruger MK, 1998, J MOL BIOL, V284, P609, DOI 10.1006/jmbi.1998.2197; Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Qian YP, 2011, MITOCHONDRION, V11, P871, DOI 10.1016/j.mito.2011.06.006; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rotig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010; Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018; Sasarman F, 2011, HUM MOL GENET, V20, P4634, DOI 10.1093/hmg/ddr397; Sathiamoorthy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047259; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200; Simon M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005097; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; SYLVERS LA, 1993, BIOCHEMISTRY-US, V32, P3836, DOI 10.1021/bi00066a002; Tang XW, 2015, MITOCHONDRION, V23, P17, DOI 10.1016/j.mito.2015.05.001; Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002; Yan QF, 2006, BIOCHEM BIOPH RES CO, V342, P1130, DOI 10.1016/j.bbrc.2006.02.078; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Yan QF, 2004, BBA-GENE STRUCT EXPR, V1676, P119, DOI 10.1016/j.bbaexp.2003.11.010; Yu JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114650; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004; Zhao H, 2005, NUCLEIC ACIDS RES, V33, P1132, DOI 10.1093/nar/gki262; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001	73	36	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2881	2892		10.1074/jbc.M116.749374	http://dx.doi.org/10.1074/jbc.M116.749374			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049726	Green Published, hybrid			2022-12-28	WOS:000395535100028
J	Parasuraman, P; Mulligan, P; Walker, JA; Li, BH; Boukhali, M; Haas, W; Bernards, A				Parasuraman, Prasanna; Mulligan, Peter; Walker, James A.; Li, Bihua; Boukhali, Myriam; Haas, Wilhelm; Bernards, Andre			Interaction of p190A RhoGAP with eIF3A and Other Translation Preinitiation Factors Suggests a Role in Protein Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; INITIATION-FACTOR 3; RNA-POLYMERASE-II; MASS-SPECTROMETRY; TYROSINE KINASES; PHOSPHORYLATION; P190RHOGAP; DOMAINS; RAS; COMPLEX	The negative regulator of Rho family GTPases, p190A RhoGAP, is one of six mammalian proteins harboring so-called FF motifs. To explore the function of these and other p190A segments, we identified interacting proteins by tandem mass spectrometry. Here we report that endogenous human p190A, but not its 50% identical p190B paralog, associates with all 13 eIF3 subunits and several other translational preinitiation factors. The interaction involves the first FF motif of p190A and the winged helix/PCI domain of eIF3A, is enhanced by serum stimulation and reduced by phosphatase treatment. The p190A/eIF3A interaction is unaffected by mutating phosphorylated p190A-Tyr(308), but disrupted by a S296A mutation, targeting the only other known phosphorylated residue in the first FF domain. The p190A-eIF3 complex is distinct from eIF3 complexes containing S6K1 or mammalian target of rapamycin (mTOR), and appears to represent an incomplete preinitiation complex lacking several subunits. Based on these findings we propose that p190A may affect protein translation by controlling the assembly of functional preinitiation complexes. Whether such a role helps to explain why, unique among the large family of RhoGAPs, p190A exhibits a significantly increased mutation rate in cancer remains to be determined.	Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Harvard Med Sch, Charlestown, MA 02129 USA; [Mulligan, Peter] Univ Lyon, Epigenet & Canc Team, Ctr Cancerol Lyon, INSERM U1052,CNRS UMR5286,Ctr Leon Berard, F-69008 Lyon, France	Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Bernards, A (corresponding author), 149 13th St, Charlestown, MA 02129 USA.	abernards@partners.org		Mulligan, Peter/0000-0003-0737-2328	National Institutes of Health NIGMS [1R01GM087386]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087386] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Grant 1R01GM087386 (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bedford MT, 1999, TRENDS BIOCHEM SCI, V24, P264, DOI 10.1016/S0968-0004(99)01417-6; Bernards A, 2005, GROWTH FACTORS, V23, P143, DOI 10.1080/08977190500130480; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bernards A, 2007, GROWTH FACTORS, V25, P355, DOI 10.1080/08977190701830375; Biname F, 2016, J CELL BIOL, V214, P859, DOI 10.1083/jcb.201601063; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008994; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; des Georges A, 2015, NATURE, V525, P491, DOI 10.1038/nature14891; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Ellisdon Andrew M, 2012, Bioarchitecture, V2, P118, DOI 10.4161/bioa.21131; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FOSTER R, 1994, MOL CELL BIOL, V14, P7173, DOI 10.1128/MCB.14.11.7173; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kusama T, 2006, CANCER SCI, V97, P848, DOI 10.1111/j.1349-7006.2006.00242.x; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Levay M, 2013, CELL SIGNAL, V25, P1388, DOI 10.1016/j.cellsig.2013.03.004; Levay M, 2009, BIOCHEMISTRY-US, V48, P8615, DOI 10.1021/bi900667y; Liu JX, 2013, J BIOL CHEM, V288, P10890, DOI 10.1074/jbc.M113.460238; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; Pincheira R, 2001, EUR J CELL BIOL, V80, P410, DOI 10.1078/0171-9335-00176; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Wang DZM, 1997, CANCER RES, V57, P2478; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wolf RM, 2003, GENE DEV, V17, P476, DOI 10.1101/gad.1040003; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	48	9	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2679	2689		10.1074/jbc.M116.769216	http://dx.doi.org/10.1074/jbc.M116.769216			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28007963	Green Published, hybrid			2022-12-28	WOS:000395535100011
J	Wheaton, K; Sarkari, F; Johns, BS; Davarinejad, H; Egorova, O; Kaustov, L; Raught, B; Saridakis, V; Sheng, Y				Wheaton, Keith; Sarkari, Feroz; Johns, Beena Stanly; Davarinejad, Hossein; Egorova, Olga; Kaustov, Lilia; Raught, Brian; Saridakis, Vivian; Sheng, Yi			UbE2E1/UBCH6 Is a Critical in Vivo E2 for the PRC1-catalyzed Ubiquitination of H2A at Lys-119	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCOMB GROUP PROTEINS; CELL-CYCLE PROGRESSION; INK4A TUMOR-SUPPRESSOR; EMBRYONIC STEM-CELLS; HISTONE H2A; LIGASE COMPLEX; X-INACTIVATION; CANCER; RING1B; LOCUS	UbE2E1/ UbcH6 is an E2 ubiquitin- conjugating enzyme that is regulated by USP7. We identified UbE2E1 as a novel component of Polycomb repressive complex 1 (PRC1), the E3 ligase complex responsible for histone H2A ubiquitination and gene silencing. We demonstrate that UbE2E1 is critical for the monoubiquitination of H2A at residue Lys- 119 ( uH2AK119) through its association with the PRC1 complex. UbE2E1 interacts with PRC1 subunits including Ring1A and Ring1B. Overexpression of UbE2E1 results in increased levels of uH2AK119, whereas overexpression of catalytically inactive UbE2E1_ C131A or UbE2E1 knockdown results in decreased levels of uH2AK119. The down- regulation of H2A ubiquitination by loss of function of UbE2E1 is correlated with alleviated p16(INK4a) promoter repression and induced growth inhibition in HCT116 cells. These results are specific to UbE2E1 as knockdown of UbE2D E2s does not show any effect on uH2AK119. We extended the UbE2E1 regulation of uH2AK119 to USP7 and showed that USP7 is also a key regulator for monoubiquitination at H2A Lys-119 as both knockdown and deletion of USP7 results in decreased levels of uH2AK119. This study reveals that UbE2E1 is an in vivo E2 for the PRC1 ligase complex and thus plays an important role in the regulation of H2A Lys- 119 monoubiquitination.	[Wheaton, Keith; Sarkari, Feroz; Johns, Beena Stanly; Davarinejad, Hossein; Egorova, Olga; Saridakis, Vivian; Sheng, Yi] York Univ, Dept Biol, Toronto, ON M3J1P3, Canada; [Kaustov, Lilia; Raught, Brian] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada	York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Sheng, Y (corresponding author), York Univ, Dept Biol, Toronto, ON M3J1P3, Canada.	yisheng@yorku.ca	Wheaton, Keith/AAF-1561-2021	Davarinejad, Hossein/0000-0002-6049-1492; Kaustov, Lilia/0000-0002-8474-559X	Canadian Institute of Health Research [106583]; York University startup funds; Canada Foundation for Innovation Leaders Opportunity Fund (CFI-LOF) Program [12939]; Ontario Research Fund Research Infrastructure Program (ORF-RI)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); York University startup funds; Canada Foundation for Innovation Leaders Opportunity Fund (CFI-LOF) Program; Ontario Research Fund Research Infrastructure Program (ORF-RI)	This work was support by Canadian Institute of Health Research operating Grant 106583 (to V.S. and Y.S.) and York University startup funds (to V.S. and Y.S.). Infrastructure was funded by the Canada Foundation for Innovation Leaders Opportunity Fund (CFI-LOF) Program Grant 12939 and the Ontario Research Fund Research Infrastructure Program (ORF-RI) (to V.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Benitz S, 2016, ONCOTARGET, V7, P11424, DOI 10.18632/oncotarget.6717; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cai SY, 1999, P NATL ACAD SCI USA, V96, P2828, DOI 10.1073/pnas.96.6.2828; Calses C, 2008, MOL CELL BIOL, V28, P1018, DOI 10.1128/MCB.01136-07; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; de Bie P, 2010, BIOCHEM BIOPH RES CO, V400, P389, DOI 10.1016/j.bbrc.2010.08.082; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Gehrke SG, 2003, BLOOD, V101, P3288, DOI 10.1182/blood-2002-07-2192; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Lecona E, 2015, MOL CELL BIOL, V35, P1157, DOI 10.1128/MCB.01197-14; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Sahtoe DD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10292; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sarkari F, 2013, J BIOL CHEM, V288, P16975, DOI 10.1074/jbc.M113.469262; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; SWERDLOW PS, 1990, MOL CELL BIOL, V10, P4905, DOI 10.1128/MCB.10.9.4905; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	47	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2893	2902		10.1074/jbc.M116.749564	http://dx.doi.org/10.1074/jbc.M116.749564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28073915	hybrid, Green Published			2022-12-28	WOS:000395535100029
J	Susan-Resiga, D; Girard, E; Kiss, RS; Essalmani, R; Hamelin, J; Asselin, MC; Awan, Z; Butkinaree, C; Fleury, A; Soldera, A; Dory, YL; Baass, A; Seidah, NG				Susan-Resiga, Delia; Girard, Emmanuelle; Kiss, Robert Scott; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Awan, Zuhier; Butkinaree, Chutikarn; Fleury, Alexandre; Soldera, Armand; Dory, Yves L.; Baass, Alexis; Seidah, Nabil G.			The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cholesterol metabolism; low density lipoprotein (LDL); lysosome; proprotein convertase subtilisin; kexin type 9 (PCSK9); familial hypercholesterolemia; human natural mutations; LDL receptor; subcellular localization; loss-of-function	AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; LDL-RECEPTOR; RECYCLING RECEPTORS; LIVER-REGENERATION; MOLECULAR-DYNAMICS; PCSK9; DEGRADATION; CHOLESTEROL; GENE; DOMAIN	Familial hypercholesterolemia (FH) is characterized by severely elevated low density lipoprotein (LDL) cholesterol. Herein, we identified an FH patient presenting novel compound heterozygote mutations R410S and G592E of the LDL receptor (LDLR). The patient responded modestly to maximum rosuvastatin plus ezetimibe therapy, even in combination with a PCSK9 monoclonal antibody injection. Using cell biology and molecular dynamics simulations, we aimed to define the underlying mechanism(s) by which these LDLR mutations affect LDL metabolism and lead to hypercholesterolemia. Our data showed that the LDLR-G592E is a class 2b mutant, because it mostly failed to exit the endoplasmic reticulum and was degraded. Even though LDLR-R410S and LDLR-WT were similar in levels of cell surface and total receptor and bound equally well to LDL or extracellular PCSK9, the LDLR-R410S was resistant to exogenous PCSK9-mediated degradation in endosomes/lysosomes and showed reduced LDL internalization and degradation relative to LDLR-WT. Evidence is provided for a tighter association of LDL with LDLR-R410S at acidic pH, a reduced LDL delivery to late endosomes/lysosomes, and an increased release in the medium of the bound/internalized LDL, as compared with LDLR-WT. These data suggested that LDLR-R410S recycles loaded with its LDL-cargo. Our findings demonstrate that LDLR-R410S represents an LDLR loss-of-function through a novel class 8 FH-causing mechanism, thereby rationalizing the observed phenotype.	[Asselin, Marie-Claude; Awan, Zuhier; Butkinaree, Chutikarn; Seidah, Nabil G.] Univ Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Baass, Alexis] Univ Montreal, Inst Rech Clin Montreal, Nutr Metab & Atherosclerosis Clin, Montreal, PQ H2W 1R7, Canada; [Kiss, Robert Scott] McGill Univ, Dept Med, Montreal, PQ H3G 2M1, Canada; [Fleury, Alexandre; Soldera, Armand; Dory, Yves L.] Univ Sherbrooke, Dept Chem, Lab Supramol Chem, Sherbrooke, PQ J1K 2R1, Canada; [Asselin, Marie-Claude] Culture Collect European Collect Authenticated Ce, Porton Down SP4 0JG, England; [Awan, Zuhier] King Abdulaziz Univ, Jeddah 22254, Saudi Arabia; [Butkinaree, Chutikarn] Chulabhorn Grad Inst, Bangkok 10210, Thailand	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; University of Sherbrooke; King Abdulaziz University; Chulabhorn Graduate Institute	Seidah, NG (corresponding author), Inst Rech Clin Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Soldera, Armand/K-2808-2019; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017; Soldera, Armand/I-7007-2013; Seidah, Nabil/I-3596-2013	Soldera, Armand/0000-0001-5467-5714; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Soldera, Armand/0000-0001-5467-5714; Seidah, Nabil/0000-0001-6503-9342; Girard, Emmanuelle/0000-0001-8375-7970; Awan, Zuhier/0000-0002-4176-335X	Canadian Institutes of Health Research Foundation [148363]; Canada Research Chair [216684]; Pfizer Aspire CV IIR [W1207162]; Fondation Leducq [13CVD03]	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Pfizer Aspire CV IIR; Fondation Leducq(Leducq Foundation)	This work was supported in part by Canadian Institutes of Health Research Foundation Grant 148363 and Canada Research Chair 216684 and in part by Pfizer Aspire CV IIR Grant W1207162 and Fondation Leducq Grant 13CVD03 (to N. G. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2012, ATHEROSCLEROSIS, V223, P394, DOI 10.1016/j.atherosclerosis.2012.04.006; AULINSKAS TH, 1985, ARTERIOSCLEROSIS, V5, P45, DOI 10.1161/01.ATV.5.1.45; Awan Z, 2014, CLIN BIOCHEM, V47, P1033, DOI 10.1016/j.clinbiochem.2014.03.022; Awan Z, 2012, CLIN CHEM, V58, P183, DOI 10.1373/clinchem.2011.172932; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertolini S, 2013, ATHEROSCLEROSIS, V227, P342, DOI 10.1016/j.atherosclerosis.2013.01.007; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Butkinaree C, 2015, J BIOL CHEM, V290, P18609, DOI 10.1074/jbc.M115.647180; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; Denis N, 2011, J PROTEOME RES, V10, P2011, DOI 10.1021/pr2000072; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Etxebarria A, 2015, HUM MUTAT, V36, P129, DOI 10.1002/humu.22721; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Huijgen R, 2012, EUR HEART J, V33, P2325, DOI 10.1093/eurheartj/ehs038; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koivisto UM, 2001, CELL, V105, P575, DOI 10.1016/S0092-8674(01)00371-3; Kuzmanic A, 2010, BIOPHYS J, V98, P861, DOI 10.1016/j.bpj.2009.11.011; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Langslet G, 2015, EXPERT REV CARDIOVAS, V13, P477, DOI 10.1586/14779072.2015.1030395; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lind S, 2004, J INTERN MED, V256, P406, DOI 10.1111/j.1365-2796.2004.01401.x; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pedersen NB, 2014, J BIOL CHEM, V289, P17312, DOI 10.1074/jbc.M113.545053; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157230; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Raal F, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000028; Rader DJ, 2014, CIRCULATION, V129, P1022, DOI 10.1161/CIRCULATIONAHA.113.001292; Ranheim T, 2006, CLIN CHEM, V52, P1469, DOI 10.1373/clinchem.2006.068627; Roubtsova A, 2015, J LIPID RES, V56, P2133, DOI 10.1194/jlr.M061952; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; Stein EA, 2014, ANNU REV MED, V65, P417, DOI 10.1146/annurev-med-022613-090402; Tavori H, 2013, CIRCULATION, V127, P2403, DOI 10.1161/CIRCULATIONAHA.113.001592; Topchiy E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155030; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VASSILIOU G, 1994, J BIOL CHEM, V269, P15172; Vendome J, 2011, NAT STRUCT MOL BIOL, V18, P693, DOI 10.1038/nsmb.2051; Weider E, 2016, J BIOL CHEM, V291, P16659, DOI 10.1074/jbc.M116.717736; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	71	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1573	1590		10.1074/jbc.M116.769430	http://dx.doi.org/10.1074/jbc.M116.769430			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27998977	Green Published, hybrid			2022-12-28	WOS:000395515600004
J	Turell, L; Vitturi, DA; Coitino, EL; Lebrato, L; Moller, MN; Sagasti, C; Salvatore, SR; Woodcock, SR; Alvarez, B; Schopfer, FJ				Turell, Lucia; Vitturi, Dario A.; Laura Coitino, E.; Lebrato, Lourdes; Moller, Matias N.; Sagasti, Camila; Salvatore, Sonia R.; Woodcock, Steven R.; Alvarez, Beatriz; Schopfer, Francisco J.			The Chemical Basis of Thiol Addition to Nitro-conjugated Linoleic Acid, a Protective Cell-signaling Lipid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACEBO-CONTROLLED PHASE-3; PROTON-TRANSFER REACTIONS; HUMAN SERUM-ALBUMIN; FATTY-ACIDS; NUCLEOPHILIC ADDITIONS; MULTIPLE-SCLEROSIS; MICHAEL ADDITION; ORBITAL METHODS; SULFENIC ACID; ORAL BG-12	Nitroalkene fatty acids are formed in vivo and exert protective and anti-inflammatory effects via reversible Michael addition to thiol-containing proteins in key signaling pathways. Nitro-conjugated linoleic acid (NO2-CLA) is preferentially formed, constitutes the most abundant nitrated fatty acid in humans, and contains two carbons that could potentially react with thiols, modulating signaling actions and levels. In this work, we examined the reactions of NO2-CLA with low molecular weight thiols (glutathione, cysteine, homocysteine, cysteinylglycine, and beta-mercaptoethanol) and human serum albumin. Reactions followed reversible biphasic kinetics, consistent with the presence of two electrophilic centers in NO2-CLA located on the beta- and delta-carbons with respect to the nitro group. The differential reactivity was confirmed by computational modeling of the electronic structure. The rates (k(on) and k(off)) and equilibrium constants for both reactions were determined for different thiols. LC-UV-Visible and LC-MS analyses showed that the fast reaction corresponds to beta-adduct formation (the kinetic product), while the slow reaction corresponds to the formation of the beta-adduct (the thermodynamic product). The pH dependence of the rate constants, the correlation between intrinsic reactivity and thiol pK(a), and the absence of deuterium solvent kinetic isotope effects suggested stepwise mechanisms with thiolate attack on NO2-CLA as rate-controlling step. Computational modeling supported the mechanism and revealed additional features of the transition states, anionic intermediates, and final neutral products. Importantly, the detection of cysteine-delta-adducts in human urine provided evidence for the biological relevance of this reaction. Finally, human serum albumin was found to bind NO2-CLA both non-covalently and to form covalent adducts at Cys-34, suggesting potential modes for systemic distribution. These results provide new insights into the chemical basis of NO2-CLA signaling actions.	[Turell, Lucia; Lebrato, Lourdes; Alvarez, Beatriz] Univ Republica, Lab Enzimol, Inst Quim Biol, Fac Ciencias, Montevideo 11400, Uruguay; [Laura Coitino, E.; Sagasti, Camila] Univ Republica, Lab Quim Teor & Computac, Inst Quim Biol, Fac Ciencias, Montevideo 11400, Uruguay; [Moller, Matias N.] Univ Republica, Lab Fisicoquim Biol, Fac Ciencias, Inst Quim Biol, Montevideo 11400, Uruguay; [Turell, Lucia; Lebrato, Lourdes; Moller, Matias N.; Alvarez, Beatriz] Univ Republica, Ctr Free Rad & Biomed Res, Montevideo 11400, Uruguay; [Vitturi, Dario A.; Salvatore, Sonia R.; Woodcock, Steven R.; Schopfer, Francisco J.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Alvarez, B (corresponding author), Fac Ciencias, Lab Enzimol, Igua 4225, Montevideo 11400, Uruguay.; Schopfer, FJ (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Thomas E Starzl Biomed Sci Tower E1340, Pittsburgh, PA 15213 USA.	beatriz.alvarez@fcien.edu.uy; fjs2@pitt.edu	Schopfer, Francisco/AAW-6505-2021; Woodcock, Steven/AAE-9199-2020; Schopfer, Francisco Jose/AAE-8125-2020; Vitturi, Dario/Z-3469-2019; Coitino, E. Laura/A-8101-2016	Schopfer, Francisco Jose/0000-0001-9526-695X; Turell, Lucia/0000-0002-6660-0784; Salvatore, Sonia/0000-0002-9942-3905; Vitturi, Dario/0000-0003-0354-4567; Coitino, E. Laura/0000-0002-6214-2413; Moller, Matias N./0000-0002-3486-8217; Alvarez, Beatriz/0000-0001-6911-3132	Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); National Institutes of Health [K01-HL133331, R01-AT006822]; American Heart Association [14GRNT20170024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL133331] Funding Source: NIH RePORTER	Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants and fellowships from Comision Sectorial de Investigacion Cientifica (Universidad de la Republica, Uruguay) (to L. T., M. N. M., and B. A.), Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay) (to L. L.), National Institutes of Health Grants K01-HL133331 (to D. A. V.) and R01-AT006822 (to F. J. S.), and American Heart Association Grant in Aid 14GRNT20170024 (to F. J. S.). D. A. V., S. R. W., and F. J. S. acknowledge financial interest in Complexa Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Alvarez B, 2010, METHOD ENZYMOL, V473, P117, DOI 10.1016/S0076-6879(10)73005-6; Ando K, 2011, J ORG CHEM, V76, P3937, DOI 10.1021/jo200383f; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; BEDNAR RA, 1990, BIOCHEMISTRY-US, V29, P3684, DOI 10.1021/bi00467a014; BELL RP, 1966, PROC R SOC LON SER-A, V294, P273, DOI 10.1098/rspa.1966.0207; Bernasconi C. F., 1991, ADV PHYS ORGANIC CHE, P119; BERNASCONI CF, 1988, J AM CHEM SOC, V110, P7506, DOI 10.1021/ja00230a038; BERNASCONI CF, 1988, J ORG CHEM, V53, P3342, DOI 10.1021/jo00249a040; Bonacci G, 2012, J BIOL CHEM, V287, P44071, DOI 10.1074/jbc.M112.401356; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; CANN PF, 1974, J CHEM SOC PERK T 2, P820, DOI 10.1039/p29740000820; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; Charles RL, 2014, P NATL ACAD SCI USA, V111, P8167, DOI 10.1073/pnas.1402965111; CHEN RF, 1967, J BIOL CHEM, V242, P173; Delmastro-Greenwood M, 2015, FREE RADICAL BIO MED, V89, P333, DOI 10.1016/j.freeradbiomed.2015.07.149; Delmastro-Greenwood M, 2014, ANNU REV PHYSIOL, V76, P79, DOI 10.1146/annurev-physiol-021113-170341; Dennington R., 2009, GAUSSVIEW VERSION 5; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Espenson J. H., 1995, CHEM KINETICS REACTI, P142; Fazzari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084884; Fersht A., 1999, STRUCTURE MECH PROTE, P150; FIERKE CA, 1995, METHOD ENZYMOL, V249, P3; FISHBEIN JC, 1988, J AM CHEM SOC, V110, P5075, DOI 10.1021/ja00223a028; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; FRIEDMAN M, 1965, J AM CHEM SOC, V87, P3672, DOI 10.1021/ja01094a025; Frisch M.J, 2016, GAUSSIAN16 REVISON A; FUKUI K, 1981, ACCOUNTS CHEM RES, V14, P363, DOI 10.1021/ar00072a001; Geerlings P, 2003, CHEM REV, V103, P1793, DOI 10.1021/cr990029p; Glendening ED, 2012, WIRES COMPUT MOL SCI, V2, P1, DOI 10.1002/wcms.51; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hratchian HP, 2005, J CHEM THEORY COMPUT, V1, P61, DOI 10.1021/ct0499783; JENCKS WP, 1971, J AM CHEM SOC, V93, P4433, DOI 10.1021/ja00747a016; Kelley EE, 2014, CARDIOVASC RES, V101, P352, DOI 10.1093/cvr/cvt341; Krenske EH, 2011, J ORG CHEM, V76, P5074, DOI 10.1021/jo200761w; Krishnan S, 2014, J AM CHEM SOC, V136, P12624, DOI 10.1021/ja505194w; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Moutiers G, 1997, J CHEM SOC PERK T 2, P1479, DOI 10.1039/a700737j; Mulliner D, 2011, ORG BIOMOL CHEM, V9, P8400, DOI 10.1039/c1ob06065a; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Peters Jr T., 1996, ALL ALBUMIN BIOCH GE, p[79, 228, 251, 260, 283, 305]; Portillo-Ledesma S, 2014, BIOCHEMISTRY-US, V53, P6113, DOI 10.1021/bi500389m; Ramsay EE, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00181; Requejo R, 2010, FEBS J, V277, P1465, DOI 10.1111/j.1742-4658.2010.07576.x; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Rudolph TK, 2010, ARTERIOSCL THROM VAS, V30, P938, DOI 10.1161/ATVBAHA.109.201582; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Salvatore SR, 2013, J LIPID RES, V54, P1998, DOI 10.1194/jlr.M037804; Sato M, 2009, J ORG CHEM, V74, P1268, DOI 10.1021/jo8023939; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Smith JM, 2013, J CHEM THEORY COMPUT, V9, P4860, DOI 10.1021/ct400773k; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Thomas BE, 1995, J ORG CHEM, V60, P8375, DOI 10.1021/jo00131a012; Tomasi J, 2011, WIRES COMPUT MOL SCI, V1, P855, DOI 10.1002/wcms.54; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Turell L, 2013, FREE RADICAL BIO MED, V65, P244, DOI 10.1016/j.freeradbiomed.2013.05.050; Villacorta L, 2013, CARDIOVASC RES, V98, P116, DOI 10.1093/cvr/cvt002; Vitturi DA, 2015, NAT CHEM BIOL, V11, P504, DOI [10.1038/NCHEMBIO.1814, 10.1038/nchembio.1814]; Vitturi DA, 2013, J BIOL CHEM, V288, P25626, DOI 10.1074/jbc.M113.486282; Wang HP, 2010, AM J PHYSIOL-RENAL, V298, pF754, DOI 10.1152/ajprenal.00439.2009; WIBERG KB, 1968, TETRAHEDRON, V24, P1083, DOI 10.1016/0040-4020(68)88057-3; Woodcock SR, 2014, J ORG CHEM, V79, P25, DOI 10.1021/jo4021562; Woodcock SR, 2013, FREE RADICAL BIO MED, V59, P14, DOI 10.1016/j.freeradbiomed.2012.11.015; YANG W, 1986, J AM CHEM SOC, V108, P5708, DOI 10.1021/ja00279a008	71	36	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1145	1159		10.1074/jbc.M116.756288	http://dx.doi.org/10.1074/jbc.M116.756288			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27923813	Green Published, hybrid			2022-12-28	WOS:000393339800001
J	Lee, HW; Khan, SQ; Khaliqdina, S; Altintas, MM; Grahammer, F; Zhao, JL; Koh, KH; Tardi, NJ; Faridi, MH; Geraghty, T; Cimbaluk, DJ; Susztak, K; Moita, LF; Baltimore, D; Tharaux, PL; Huber, TB; Kretzler, M; Bitzer, M; Reiser, J; Gupta, V				Lee, Ha Won; Khan, Samia Q.; Khaliqdina, Shehryar; Altintas, Mehmet M.; Grahammer, Florian; Zhao, Jimmy L.; Koh, Kwi Hye; Tardi, Nicholas J.; Faridi, Mohd. Hafeez; Geraghty, Terese; Cimbaluk, David J.; Susztak, Katalin; Moita, Luis F.; Baltimore, David; Tharaux, Pierre-Louis; Huber, Tobias B.; Kretzler, Matthias; Bitzer, Markus; Reiser, Jochen; Gupta, Vineet			Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; TGF-BETA; KIDNEY DEVELOPMENT; MICRORNA-146A; NEPHROPATHY; PROGRESSION; INHIBITION; DISEASE; INJURY; ACTIVATION	Podocyte injury is an early event in diabetic kidney disease and is a hallmark of glomerulopathy. MicroRNA-146a (miR-146a) is highly expressed in many cell types under homeostatic conditions, and plays an important anti-inflammatory role in myeloid cells. However, its role in podocytes is unclear. Here, we show that miR-146a expression levels decrease in the glomeruli of patients with type 2 diabetes (T2D), which correlates with increased albuminuria and glomerular damage. miR-146a levels are also significantly reduced in the glomeruli of albuminuric BTBR ob/ob mice, indicating its significant role in maintaining podocyte health. miR-146a-deficient mice (miR-146a(-/-)) showed accelerated development of glomerulopathy and albuminuria upon streptozotocin (STZ)-induced hyperglycemia. The miR-146a targets, Notch-1 and ErbB4, were also significantly up-regulated in the glomeruli of diabetic patients and mice, suggesting induction of the downstream TGF beta signaling. Treatment with a pan-ErbB kinase inhibitor erlotinib with nanomolar activity against ErbB4 significantly suppressed diabetic glomerular injury and albuminuria in both WT and miR146a(-/-) animals. Treatment of podocytes in vitro with TGF-beta 1 resulted in increased expression of Notch-1, ErbB4, pErbB4, and pEGFR, the heterodimerization partner of ErbB4, suggesting increased ErbB4/EGFR signaling. TGF-beta 1 also increased levels of inflammatory cytokine monocyte chemoattractant protein-1 (MCP-1) and MCP-1 induced protein-1 (MCPIP1), a suppressor of miR-146a, suggesting an autocrine loop. Inhibition of ErbB4/EGFR with erlotinib co-treatment of podocytes suppressed this signaling. Our findings suggest a novel role for miR-146a in protecting against diabetic glomerulopathy and podocyte injury. They also point to ErbB4/EGFR as a novel, druggable target for therapeutic intervention, especially because several pan-ErbB inhibitors are clinically available.	[Lee, Ha Won; Khan, Samia Q.; Khaliqdina, Shehryar; Altintas, Mehmet M.; Koh, Kwi Hye; Tardi, Nicholas J.; Faridi, Mohd. Hafeez; Geraghty, Terese; Reiser, Jochen; Gupta, Vineet] Rush Univ, Med Ctr, Dept Internal Med, Cohn 222, Chicago, IL 60026 USA; [Cimbaluk, David J.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Grahammer, Florian; Huber, Tobias B.] Univ Freiburg, Fac Med, Med Ctr, Dept Med 4, D-79106 Freiburg, Germany; [Zhao, Jimmy L.] New York Presbyterian Weill Cornell Med Ctr, Dept Med, New York, NY 10065 USA; [Zhao, Jimmy L.; Baltimore, David] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Susztak, Katalin] Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA; [Moita, Luis F.] Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal; [Tharaux, Pierre-Louis] INSERM, Paris Cardiovasc Ctr PARCC, F-75015 Paris, France; [Tharaux, Pierre-Louis] Univ Paris 05, Sorbonne Paris Cite, F-75270 Paris, France; [Huber, Tobias B.] Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ, FRIAS, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ, ZBSA Ctr Syst Biol, D-79104 Freiburg, Germany; [Kretzler, Matthias; Bitzer, Markus] Univ Michigan, Div Nephrol, Ann Arbor, MI 48109 USA	Rush University; Rush University; University of Freiburg; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; California Institute of Technology; University of Pennsylvania; Pennsylvania Medicine; Instituto Gulbenkian de Ciencia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; University of Freiburg; University of Freiburg; University of Michigan System; University of Michigan	Gupta, V (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Cohn 222, Chicago, IL 60026 USA.	vineet_gupta@rush.edu	Lee, Hawon/ABQ-4063-2022; Altintas, Mehmet Mete/ABI-5904-2020; Moita, Luis F./L-1296-2013; Altintas, Mehmet Mete/T-5333-2018; Tharaux, Pierre-Louis/A-9155-2009; Grahammer, Florian/ABB-7775-2021; Moita, Luis/HCI-2793-2022; Susztak, Katalin/ABE-7474-2021	Lee, Hawon/0000-0001-5382-9646; Moita, Luis F./0000-0003-0707-315X; Altintas, Mehmet Mete/0000-0002-1871-6985; Tharaux, Pierre-Louis/0000-0002-6062-5905; Moita, Luis/0000-0003-0707-315X; Susztak, Katalin/0000-0002-1005-3726; Huber, Tobias B./0000-0001-7175-5062; Bitzer, Markus/0000-0002-3711-2984	National Institutes of Health [R01DK084195, R01HL109582, R01DK106512, R01DK107984]; Nephcure Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK081943, R01DK107984, R01DK106512, R01DK076077, R01DK084195, R01DK100449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nephcure Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK084195 and R01HL109582 (to V. G.) and R01DK106512 and R01DK107984 (to V. G. and J. R.), the Nephcure Foundation and resources from the Rush University Medical Center. V. G. and J. R. are inventors on pending patent applications related to this study. These authors and the Rush University Medical Center have the potential for financial benefit from their future commercialization. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Advani A, 2011, NEPHROLOGY, V16, P573, DOI 10.1111/j.1440-1797.2011.01451.x; Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; [Anonymous], 2003, Am J Kidney Dis, V42, P1; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Barak H, 2012, ADV EXP MED BIOL, V727, P99, DOI 10.1007/978-1-4614-0899-4_8; Ben-Dov IZ, 2012, TRANSPLANTATION, V94, P1086, DOI 10.1097/TP.0b013e3182751efd; Bhatt K, 2016, J AM SOC NEPHROL, V27, P2277, DOI 10.1681/ASN.2015010111; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; BREYER MD, 1990, AM J PHYSIOL, V259, pF553, DOI 10.1152/ajprenal.1990.259.4.F553; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Chandrasekaran K, 2012, KIDNEY INT, V81, P617, DOI 10.1038/ki.2011.448; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen HQ, 2009, DRUG METAB DISPOS, V37, P1841, DOI 10.1124/dmd.109.026609; Chen JC, 2015, J AM SOC NEPHROL, V26, P1115, DOI 10.1681/ASN.2014020192; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Coaxum SD, 2009, BBA-MOL CELL RES, V1793, P1174, DOI 10.1016/j.bbamcr.2009.03.006; Coward RJM, 2005, DIABETES, V54, P3095, DOI 10.2337/diabetes.54.11.3095; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Farazi TA, 2012, METHODS, V58, P171, DOI 10.1016/j.ymeth.2012.07.020; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Halkein J, 2013, J CLIN INVEST, V123, P2143, DOI 10.1172/JCI64365; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Ho J, 2012, J AM SOC NEPHROL, V23, P400, DOI 10.1681/ASN.2011080797; Horie T, 2010, CARDIOVASC RES, V87, P656, DOI 10.1093/cvr/cvq148; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Ichii O, 2012, KIDNEY INT, V81, P280, DOI 10.1038/ki.2011.345; Kato M, 2012, EXP CELL RES, V318, P993, DOI 10.1016/j.yexcr.2012.02.034; Lai JY, 2015, J AM SOC NEPHROL, V26, P805, DOI 10.1681/ASN.2013121274; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee EY, 2009, AM J PHYSIOL-RENAL, V297, pF85, DOI 10.1152/ajprenal.90642.2008; Lee HW, 2015, J AM SOC NEPHROL, V26, P2741, DOI 10.1681/ASN.2014090859; Li JYZ, 2010, NEPHROLOGY, V15, P599, DOI 10.1111/j.1440-1797.2010.01363.x; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; MOGENSEN CE, 1985, UREMIA INVEST, V9, P85, DOI 10.3109/08860228509088195; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Qu B, 2015, ARTHRITIS RHEUMATOL, V67, P3209, DOI 10.1002/art.39398; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Remuzzi G, 2006, J AM SOC NEPHROL, V17, pS90, DOI 10.1681/ASN.2005121324; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Sirin Y, 2012, J PATHOL, V226, P394, DOI 10.1002/path.2967; Spurney RF, 2008, J AM SOC NEPHROL, V19, P2035, DOI 10.1681/ASN.2008090955; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Veikkolainen V, 2012, J AM SOC NEPHROL, V23, P112, DOI 10.1681/ASN.2011020160; Waters AM, 2008, J AM SOC NEPHROL, V19, P1139, DOI 10.1681/ASN.2007050596; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Weil EJ, 2013, DIABETES, V62, P3224, DOI 10.2337/db12-1512; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Wu DT, 2005, J AM SOC NEPHROL, V16, P3211, DOI 10.1681/ASN.2004121055; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Zeng F, 2007, MOL BIOL CELL, V18, P4446, DOI 10.1091/mbc.E07-03-0223; Zeng FH, 2014, KIDNEY INT, V86, P538, DOI 10.1038/ki.2014.84; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	82	60	64	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					732	747		10.1074/jbc.M116.753822	http://dx.doi.org/10.1074/jbc.M116.753822			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27913625	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000392316100027
J	O'Shea, C; Staby, L; Bendsen, SK; Tidemand, FG; Redsted, A; Willemoes, M; Kragelund, BB; Skriver, K				O'Shea, Charlotte; Staby, Lasse; Bendsen, Sidsel Krogh; Tidemand, Frederik Gronbaek; Redsted, Andreas; Willemoes, Martin; Kragelund, Birthe B.; Skriver, Karen			Structures and Short Linear Motif of Disordered Transcription Factor Regions Provide Clues to the Interactome of the Cellular Hub Protein Radical-induced Cell Death1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; STRUCTURE PREDICTION; SECONDARY STRUCTURE; INTRINSIC DISORDER; STRESS RESPONSES; OXIDATIVE STRESS; LEAF SENESCENCE; BINDING; RESOURCE; DOMAIN	Intrinsically disordered protein regions (IDRs) lack a well defined three-dimensional structure but often facilitate key protein functions. Some interactions between IDRs and folded protein domains rely on short linear motifs (SLiMs). These motifs are challenging to identify, but once found they can point to larger networks of interactions, such as with proteins that serve as hubs for essential cellular functions. The stress-associated plant protein radical-induced cell death1 (RCD1) is one such hub, interacting with many transcription factors via their flexible IDRs. To identify the SLiM bound by RCD1, we analyzed the IDRs in three protein partners, DREB2A (dehydration-responsive element-binding protein 2A), ANAC013, and ANAC046, considering parameters such as disorder, context, charges, and pI. Using a combined bioinformatics and experimental approach, we have identified the bipartite RCD1-binding SLiM as (DE) X(1,2)(YF) X(1,4)(DE)L, with essential contributions from conserved aromatic, acidic, and leucine residues. Detailed thermodynamic analysis revealed both favorable and unfavorable contributions from the IDRs surrounding the SLiM to the interactions with RCD1, and the SLiM affinities ranged from low nanomolar to 50 times higher K-d values. Specifically, although the SLiM was surrounded by IDRs, individual intrinsic alpha-helix propensities varied as shown by CD spectroscopy. NMR spectroscopy further demonstrated that DREB2A underwent coupled folding and binding with alpha-helix formation upon interaction with RCD1, whereas peptides from ANAC013 and ANAC046 formed different structures or were fuzzy in the complexes. These findings allow us to present a model of the stress-associated RCD1-transcription factor interactome and to contribute to the emerging understanding of the interactions between folded hubs and their intrinsically disordered partners.	[O'Shea, Charlotte; Staby, Lasse; Bendsen, Sidsel Krogh; Tidemand, Frederik Gronbaek; Redsted, Andreas; Willemoes, Martin; Kragelund, Birthe B.; Skriver, Karen] Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr Prot Sci, 5 Ole Maaloes Vej, DK-2200 Copenhagen, Denmark	University of Copenhagen	Skriver, K (corresponding author), Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr Prot Sci, 5 Ole Maaloes Vej, DK-2200 Copenhagen, Denmark.	kskriver@bio.ku.dk	Skriver, Karen/K-9860-2014; Kragelund, Birthe/M-3927-2014; Willemoes, Martin/K-4359-2014; Tidemand, Frederik/N-2396-2016	Skriver, Karen/0000-0003-2225-4012; Kragelund, Birthe/0000-0002-7454-1761; Willemoes, Martin/0000-0003-1689-2712; Tidemand, Frederik/0000-0001-8914-9626; Staby, Lasse/0000-0002-5588-5163	Danish Research Councils [4181-00344]	Danish Research Councils(Det Frie Forskningsrad (DFF))	This work was supported by Danish Research Councils Grant 4181-00344 (to B. B. K. and K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098575; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balsa-Canto E, 2016, BIOINFORMATICS, V32, P3357, DOI 10.1093/bioinformatics/btw411; Bienkiewicz EA, 2002, BIOCHEMISTRY-US, V41, P752, DOI 10.1021/bi015763t; Brosche M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004112; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cino EA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02305; Das RK, 2016, P NATL ACAD SCI USA, V113, P5616, DOI 10.1073/pnas.1516277113; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dunlap TB, 2013, PROTEINS, V81, P607, DOI 10.1002/prot.24215; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gibson TJ, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0121-y; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Heller GT, 2015, TRENDS BIOCHEM SCI, V40, P491, DOI 10.1016/j.tibs.2015.07.004; Hiltscher H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00475; Jaspers P, 2010, PLANT SIGNAL BEHAV, V5, P78, DOI 10.4161/psb.5.1.10293; Jaspers P, 2009, PLANT J, V60, P268, DOI 10.1111/j.1365-313X.2009.03951.x; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Kim YS, 2013, PLANT CELL PHYSIOL, V54, P1660, DOI 10.1093/pcp/pct113; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Kjaersgaard T, 2011, J BIOL CHEM, V286, P35418, DOI 10.1074/jbc.M111.247221; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Kragelund BB, 2012, TRENDS PLANT SCI, V17, P625, DOI 10.1016/j.tplants.2012.06.010; Ladbury JE, 2010, BIOCHEM SOC T, V38, P888, DOI 10.1042/BST0380888; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; Mukherjee SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001647; Munoz V, 1996, FOLD DES, V1, P167, DOI 10.1016/S1359-0278(96)00029-6; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Ng S, 2013, PLANT CELL, V25, P3450, DOI 10.1105/tpc.113.113985; O'Shea C, 2015, BIOCHEM J, V465, P281, DOI 10.1042/BJ20141045; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sakuraba Y, 2015, PLANT CELL, V27, P1771, DOI 10.1105/tpc.15.00222; Song JH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003239; SPERA S, 1991, Journal of Biomolecular NMR, V1, P155, DOI 10.1007/BF01877227; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Stender EG, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1010967; Teotia S, 2009, PLANT PHYSIOL, V151, P180, DOI 10.1104/pp.109.142786; Tiwari SB, 2012, PLANT J, V70, P855, DOI 10.1111/j.1365-313X.2012.04935.x; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; Vermeirssen V, 2014, PLANT CELL, V26, P4656, DOI 10.1105/tpc.114.131417; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Wong ETC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003192; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zhou HX, 2012, TRENDS BIOCHEM SCI, V37, P43, DOI 10.1016/j.tibs.2011.11.002	64	36	36	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					512	527		10.1074/jbc.M116.753426	http://dx.doi.org/10.1074/jbc.M116.753426			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27881680	Green Published, hybrid			2022-12-28	WOS:000392316100009
J	Primo, C; Ferri-Blazquez, A; Loewith, R; Yenush, L				Primo, Cecilia; Ferri-Blazquez, Alba; Loewith, Robbie; Yenush, Lynne			Reciprocal Regulation of Target of Rapamycin Complex 1 and Potassium Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP1 PERMEASE UBIQUITYLATION; PPZ PROTEIN PHOSPHATASES; CELL-GROWTH CONTROL; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; SIGNALING PATHWAY; UBIQUITIN LIGASE; SALT TOLERANCE; H+-ATPASE; NITROGEN-UPTAKE	The proper maintenance of potassium homeostasis is crucial for cell viability. Among the major determinants of potassium uptake in the model organism Saccharomyces cerevisiae are the Trk1 high affinity potassium transporter and the functionally redundant Hal4 (Sat4) and Hal5 protein kinases. These kinases are required for the plasma membrane accumulation of not only Trk1 but also several nutrient permeases. Here, we show that overexpression of the target of rapamycin complex 1 (TORC1) effector NPR1 improves hal4 hal5 growth defects by stabilizing nutrient permeases at the plasma membrane. We subsequently found that internal potassium levels and TORC1 activity are linked. Specifically, growth under limiting potassium alters the activities of Npr1 and another TORC1 effector kinase, Sch9; hal4 hal5 and trk1 trk2 mutants display hypersensitivity to rapamycin, and reciprocally, TORC1 inhibition reduces potassium accumulation. Our results demonstrate that in addition to carbon and nitrogen, TORC1 also responds to and regulates potassium fluxes.	[Primo, Cecilia; Ferri-Blazquez, Alba; Yenush, Lynne] Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, Avd Naranjos S-N, E-46022 Valencia, Spain; [Loewith, Robbie] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Loewith, Robbie] Univ Geneva, Inst Genet & Genom Geneva IGE3, Swiss Natl Ctr Competence Res Chem Biol, CH-1211 Geneva, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Geneva; University of Geneva	Yenush, L (corresponding author), Inst Biol Mol & Celular Plantas, C Vera S-N, Valencia 46022, Spain.	lynne@ibmcp.upv.es	Primo, Cecilia/AAT-8561-2021; Primo Planta, Cecilia/AAU-1204-2021; Yenush, Lynne/J-8815-2014; Loewith, Robbie/S-6289-2016	Primo Planta, Cecilia/0000-0002-3305-5150; Yenush, Lynne/0000-0001-8589-7002; Loewith, Robbie/0000-0002-2482-603X; Ferri-Blazquez, Alba/0000-0002-4533-5117	Spanish Ministry of Science and Innovation (Madrid, Spain) [BFU2011-30197-C03-03]; Spanish Research Council (Consejo Superior de Investigaciones Cientificas); Swiss National Science Foundation; European Research Council; Canton of Geneva	Spanish Ministry of Science and Innovation (Madrid, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Research Council (Consejo Superior de Investigaciones Cientificas); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Canton of Geneva	This work was supported by Spanish Ministry of Science and Innovation (Madrid, Spain) Grant BFU2011-30197-C03-03 (to L. Y.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a pre-doctoral fellowship from the Spanish Research Council (Consejo Superior de Investigaciones Cientificas).; Supported by the Swiss National Science Foundation, the European Research Council, and the Canton of Geneva.	Aubry L, 2013, PROG MOL BIOL TRANSL, V118, P21, DOI 10.1016/B978-0-12-394440-5.00002-4; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Bihler H, 1998, FEBS LETT, V432, P59, DOI 10.1016/S0014-5793(98)00832-1; Bihler H, 2002, BBA-BIOMEMBRANES, V1558, P109, DOI 10.1016/S0005-2736(01)00414-X; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Brachmann CB, 1998, YEAST, V14, P115; Crapeau M, 2014, J BIOL CHEM, V289, P22103, DOI 10.1074/jbc.M114.582320; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Dechant R, 2014, MOL CELL, V55, P409, DOI 10.1016/j.molcel.2014.06.002; Eraso P, 2006, BBA-BIOMEMBRANES, V1758, P164, DOI 10.1016/j.bbamem.2006.01.010; Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; GRENSON M, 1982, EUR J BIOCHEM, V121, P643, DOI 10.1111/j.1432-1033.1982.tb05834.x; Hallett JEH, 2014, GENETICS, V198, P773, DOI 10.1534/genetics.114.168369; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hirasaki M, 2011, J BIOSCI BIOENG, V111, P249, DOI 10.1016/j.jbiosc.2010.11.013; Hoshikawa C, 2003, P NATL ACAD SCI USA, V100, P11505, DOI 10.1073/pnas.1933153100; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KO CH, 1993, MOL CELL BIOL, V13, P638, DOI 10.1128/MCB.13.1.638; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; LUBIN M, 1964, BIOCHIM BIOPHYS ACTA, V80, P614, DOI 10.1016/0926-6550(64)90306-8; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Navarrete C, 2010, FEMS YEAST RES, V10, P508, DOI 10.1111/j.1567-1364.2010.00630.x; Novoselova TV, 2012, EUKARYOT CELL, V11, P463, DOI 10.1128/EC.00009-12; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Omura F, 2004, FEMS MICROBIOL LETT, V230, P227, DOI 10.1016/S0378-1097(03)00918-2; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Perez-Valle J, 2007, MOL CELL BIOL, V27, P5725, DOI 10.1128/MCB.01375-06; Perez-Valle J, 2010, EUKARYOT CELL, V9, P1881, DOI 10.1128/EC.00184-10; Petrezselyova S, 2010, FUNGAL BIOL-UK, V114, P144, DOI 10.1016/j.funbio.2009.11.002; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; Stefan CP, 2013, EUKARYOT CELL, V12, P204, DOI 10.1128/EC.00299-12; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vargas RC, 2007, EUKARYOT CELL, V6, P134, DOI 10.1128/EC.00290-06; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wright MB, 1997, J BIOL CHEM, V272, P13647, DOI 10.1074/jbc.272.21.13647; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920; Zeng L, 2013, ELECTROPHORESIS, V34, P2234, DOI 10.1002/elps.201300140; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	57	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					563	574		10.1074/jbc.M116.746982	http://dx.doi.org/10.1074/jbc.M116.746982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27895122	Green Published, hybrid			2022-12-28	WOS:000392316100013
J	Mauricio, RPM; Jeffries, CM; Svergun, DI; Deane, JE				Mauricio, Rui P. M.; Jeffries, Cy M.; Svergun, Dmitri I.; Deane, Janet E.			The Shigella Virulence Factor IcsA Relieves N-WASP Autoinhibition by Displacing the Verprolin Homology/Cofilin/Acidic (VCA) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED MOTILITY; WISKOTT-ALDRICH-SYNDROME; X-RAY-SCATTERING; SMALL-ANGLE SCATTERING; I-TASSER SERVER; ESCHERICHIA-COLI; SYNDROME PROTEIN; INTRACELLULAR MOTILITY; AUTOTRANSPORTER ICSA; LIGAND INTERACTIONS	Shigella flexneri is a bacterial pathogen that invades cells of the gastrointestinal tract, causing severe dysentery. Shigella mediates intracellular motility and spreading via actin comet tail formation. This process is dependent on the surface-exposed, membrane-embedded virulence factor IcsA, which recruits the host actin regulator N-WASP. Although it is clear that Shigella requires N-WASP for this process, the molecular details of this interaction and the mechanism of N-WASP activation remain poorly understood. Here, we show that co-expression of full-length IcsA and the Shigella membrane protease IcsP yields highly pure IcsA passenger domain (residues 53-758). We show that IcsA is monomeric and describe the solution structure of the passenger domain obtained by small-angle X-ray scattering (SAXS) analysis. The SAXS-derived models suggest that IcsA has an elongated shape but, unlike most other autotransporter proteins, possesses a central kink revealing a distinctly curved structure. Pull-down experiments show direct binding of the IcsA passenger domain to both the WASP homology 1 (WH1) domain and the GTPase binding domain (GBD) of N-WASP and no binding to the verprolin homology/cofilin/acidic (VCA) region. Using fluorescence polarization experiments, we demonstrate that IcsA binding to the GBD region displaces the VCA peptide and that this effect is synergistically enhanced upon IcsA binding to the WH1 region. Additionally, domain mapping of the IcsA interaction interface reveals that different regions of IcsA bind to the WH1 and GBD domains of N-WASP. Taken together, our data support a model where IcsA and N-WASP form a tight complex releasing the N-WASP VCA domain to recruit the host cell machinery for actin tail formation.	[Mauricio, Rui P. M.; Deane, Janet E.] Univ Cambridge, Dept Pathol, Cambridge Inst Med Res, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England; [Jeffries, Cy M.; Svergun, Dmitri I.] DESY, Hamburg Outstn, European Mol Biol Lab, D-22067 Hamburg, Germany	University of Cambridge; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Deane, JE (corresponding author), Univ Cambridge, Dept Pathol, Cambridge Inst Med Res, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England.	jed55@cam.ac.uk		Svergun, Dmitri/0000-0003-0830-5696; Deane, Janet/0000-0002-4863-0330; /0000-0002-8718-7343	Wellcome Trust Strategic Award [100140]	Wellcome Trust Strategic Award(Wellcome Trust)	We thank Stephen Graham for helpful discussions and advice, Nele Dieckmann and Tom O'Loughlin for early contributions to this work, and Robin Antrobus for carrying out mass spectrometry experiments. The Cambridge Institute for Medical Research is supported by Wellcome Trust Strategic Award 100140.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Cheng HC, 2008, NATURE, V454, P1009, DOI 10.1038/nature07160; dHauteville H, 1996, INFECT IMMUN, V64, P511, DOI 10.1128/IAI.64.2.511-517.1996; Egile C, 1997, MOL MICROBIOL, V23, P1063, DOI 10.1046/j.1365-2958.1997.2871652.x; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; FUKUDA I, 1995, J BACTERIOL, V177, P1719, DOI 10.1128/jb.177.7.1719-1726.1995; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; Graewert MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10734; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Heras B, 2014, P NATL ACAD SCI USA, V111, P457, DOI 10.1073/pnas.1311592111; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; KOCKS C, 1995, MOL MICROBIOL, V18, P413, DOI 10.1111/j.1365-2958.1995.mmi_18030413.x; Kuhnel K, 2011, J BACTERIOL, V193, P2042, DOI 10.1128/JB.00790-10; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Mounier J, 1999, J CELL SCI, V112, P2069; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Panjkovich A, 2016, PHYS CHEM CHEM PHYS, V18, P5707, DOI 10.1039/c5cp04540a; Petoukhov MV, 2015, ACTA CRYSTALLOGR D, V71, P1051, DOI 10.1107/S1399004715002576; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Robbins JR, 2001, MOL MICROBIOL, V41, P861, DOI 10.1046/j.1365-2958.2001.02552.x; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sallee NA, 2008, NATURE, V454, P1005, DOI 10.1038/nature07170; Shere KD, 1997, MOL MICROBIOL, V25, P451, DOI 10.1046/j.1365-2958.1997.4681827.x; Shibata T, 2002, CURR BIOL, V12, P341, DOI 10.1016/S0960-9822(02)00689-9; Suzuki T, 1995, J BIOL CHEM, V270, P30874, DOI 10.1074/jbc.270.52.30874; Suzuki T, 1996, J BIOL CHEM, V271, P21878, DOI 10.1074/jbc.271.36.21878; Suzuki T, 1998, JPN J MED SCI BIOL, V51, pS63, DOI 10.7883/yoken1952.51.Supplement1_S63; Suzuki T, 2002, CELL MICROBIOL, V4, P223, DOI 10.1046/j.1462-5822.2002.00185.x; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagner JK, 2009, J BACTERIOL, V191, P815, DOI 10.1128/JB.00989-08; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	53	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					134	145		10.1074/jbc.M116.758003	http://dx.doi.org/10.1074/jbc.M116.758003			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27881679	Green Published, hybrid			2022-12-28	WOS:000391578000012
J	Liu, YH; Wang, YH; Chen, Y; Li, XH; Yang, J; Liu, Y; Shen, AG				Liu, Yonghua; Wang, Youhua; Chen, Ying; Li, Xiaohong; Yang, Jiao; Liu, Yang; Shen, Aiguo			RETRACTION: Spy1 protein mediates phosphorylation and degradation of SCG10 protein in axonal degeneration (Retraction of Vol 290, Pg 13888, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022					Liu YH, 2015, J BIOL CHEM, V290, P13888, DOI 10.1074/jbc.M114.611574	1	0	1	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23365	23365		10.1074/jbc.A114.611574	http://dx.doi.org/10.1074/jbc.A114.611574			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27794104	hybrid, Green Published			2022-12-28	WOS:000387224800044
J	Fayyad-Kazan, H; Rouas, R; Merimi, M; El Zein, N; Lewalle, P; Jebbawi, F; Mourtada, M; Badran, H; Ezzeddine, M; Salaun, B; Romero, P; Burny, A; Martiat, P; Badran, B				Fayyad-Kazan, Hussein; Rouas, Redouane; Merimi, Makram; El Zein, Nabil; Lewalle, Philippe; Jebbawi, Fadi; Mourtada, Mohamad; Badran, Hussein; Ezzeddine, Mohamad; Salaun, Bruno; Romero, Pedro; Burny, Arsene; Martiat, Philippe; Badran, Bassam			Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase (vol 285, pg 20481, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Fayyad-Kazan, Hussein; Rouas, Redouane; Merimi, Makram; El Zein, Nabil; Lewalle, Philippe; Jebbawi, Fadi; Mourtada, Mohamad; Badran, Hussein; Ezzeddine, Mohamad; Salaun, Bruno; Romero, Pedro; Burny, Arsene; Martiat, Philippe; Badran, Bassam] Lebanese Univ, EDST PRASE, Immunol Lab, Fac Sci,Dept Biochem, Hadath Beirut 657314, Lebanon	Lebanese University	Badran, B (corresponding author), Lebanese Univ, EDST PRASE, Immunol Lab, Fac Sci,Dept Biochem, Hadath Beirut 657314, Lebanon.		Jebbawi, Fadi/AAD-6063-2020	Fayyad-Kazan, Hussein/0000-0002-3465-4630				Fayyad-Kazan H, 2010, J BIOL CHEM, V285, P20481, DOI 10.1074/jbc.M110.119628	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5934	5934		10.1074/jbc.A110.119628	http://dx.doi.org/10.1074/jbc.A110.119628			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	27805804	Green Published, hybrid			2022-12-28	WOS:000287230600102
J	Porter, EG; Dykhuizen, EC				Porter, Elizabeth G.; Dykhuizen, Emily C.			Individual Bromodomains of Polybromo-1 Contribute to Chromatin Association and Tumor Suppression in Clear Cell Renal Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H4; RECOGNITION; MUTATIONS; COMPLEX; H3	The architecture of chromatin is governed, in part, by ATP-dependent chromatin remodelers. These multiprotein complexes contain targeting domains that recognize post-translational marks on histones. One such targeting domain is the bromodomain (BD), which recognizes acetyl-lysines and recruits proteins to sites of acetylation across the genome. Polybromo1 (PBRM1), a subunit of the Polybromo-associated BRG1- or hBRM-associated factors (PBAF) chromatin remodeler, contains six tandem BDs and is frequently mutated in clear cell renal cell carcinoma (ccRCC). Mutations in the PBRM1 gene often lead to the loss of protein expression; however, missense mutations in PBRM1 have been identified and tend to cluster in the BDs, particularly BD2 and BD4, suggesting that individual BDs are critical for PBRM1 function. To study the role of these six BDs, we inactivated each of the six BDs of PBRM1 and re-expressed these mutants in Caki2 cells (ccRCC cells with the loss of function mutation in PBRM1). Four of the six BDs abrogated PBRM1 tumor suppressor function, gene regulation, and chromatin affinity with the degree of importance correlating strongly to the rate of missense mutations in patients. Furthermore, we identified BD2 as the most critical for PBRM1 and confirmed BD2-mediated association to histone H3 peptides acetylated at lysine 14 (H3K14Ac), validating the importance of this specific acetylation mark for PBRM1 binding. From these data, we conclude that four of the BDs act together to target PBRM1 to sites on chromatin; when a single BD is mutated, PBRM1 no longer controls gene expression properly, leading to increased cell proliferation.	[Porter, Elizabeth G.; Dykhuizen, Emily C.] Purdue Univ, Dept Med Chem & Mol Pharmacol, HANS105,201 S Univ St, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dykhuizen, EC (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, HANS105,201 S Univ St, W Lafayette, IN 47907 USA.	edykhui@purdue.edu		dykhuizen, emily/0000-0003-3072-1469	National Institutes of Health [P30 CA023168]; NATIONAL CANCER INSTITUTE [U01CA207532, P30CA023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Sanger sequencing data were acquired by the Purdue Genomics Facility supported by National Institutes of Health Grant P30 CA023168. We thank Laura Deemer for assistance with cloning and mutagenesis, and Brian Smith from Medical College of Wisconsin for helpful discussion.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chandrasekaran R, 2007, BIOCHEM BIOPH RES CO, V355, P661, DOI 10.1016/j.bbrc.2007.01.193; Charlop-Powers Z, 2010, CELL RES, V20, P529, DOI 10.1038/cr.2010.43; Chowdhury B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153718; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Ji X, 2015, P NATL ACAD SCI USA, V112, P3841, DOI 10.1073/pnas.1502971112; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Jung M, 2014, J BIOL CHEM, V289, P9304, DOI 10.1074/jbc.M113.523019; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Myrianthopoulos V, 2016, J MED CHEM, V59, P8787, DOI 10.1021/acs.jmedchem.6b00355; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Sanchez OF, 2015, TALANTA, V140, P212, DOI 10.1016/j.talanta.2015.03.046; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Thompson M, 2009, BIOCHIMIE, V91, P309, DOI 10.1016/j.biochi.2008.10.019; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vivoli M, 2014, JOVE-J VIS EXP, DOI 10.3791/51809; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Yang N, 2013, CRIT REV BIOCHEM MOL, V48, P211, DOI 10.3109/10409238.2012.742035; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	31	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2601	2610		10.1074/jbc.M116.746875	http://dx.doi.org/10.1074/jbc.M116.746875			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28053089	hybrid, Green Published			2022-12-28	WOS:000395535100004
J	Zhao, JF; Li, BW; Huang, XC; Morelli, X; Shi, N				Zhao, Jianfeng; Li, Bowen; Huang, Xiaochen; Morelli, Xavier; Shi, Ning			Structural Basis for the Interaction between Golgi Reassembly-stacking Protein GRASP55 and Golgin45	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL SECRETION; COMPLEX; GROWTH; LOCALIZATION; EXPRESSION; GM130; JEM-1; ER	Golgin45 is required for normal Golgi structure and the transportation of protein from the ER. It forms a specific complex with GRASP55 in vivo. Little is known regarding the molecular details of this interaction and its structural role in stacking of the Golgi complex. Here, we present the crystal structure of the GRASP domains of GRASP55 in complex with the Golgin45 C-terminal peptide, determined at 1.33 a resolutn. Similar to the structure of GRASP65 bound to GM130 reported recently, this structure reveals more than one interacting site and involves both PDZ1 and PDZ2 domains of the GRASP simultaneously. The C-terminal peptides of Golgin45 and GM130 present a conserved PDZ domain binding motif sequence and recognize the canonical PDZ-peptide binding groove of the PDZ1 domains of GRASP55 and GRASP65. A main difference in this recognition process resides in a structural rearrangement of GRASP65-GM130 that does not occur for the GRASP55-Golgin45 complex. The binding site at the cleft between the PDZ1 and PDZ2 domains of GRASP65 is dominated by hydrophobic interactions with GM130 that are not observed in the GRASP55-Golgin45 complex. In addition, a unique zinc finger structure is revealed in the GRASP55-Golgin45 complex crystal structure. Mutagenesis experiments support these structural observations and demonstrate that two of these sites are required to form a stable complex. Finally, a novel Golgi stacking model is proposed according to these structural findings.	[Zhao, Jianfeng; Li, Bowen; Huang, Xiaochen; Shi, Ning] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China; [Morelli, Xavier] Aix Marseille Univ, CRCM, INSERM, CNRS,Inst Paoli Calmettes, F-13009 Marseille, France	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Shi, N (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, 155 Yangqiao Rd W, Fuzhou 350002, Peoples R China.	shining@fjirsm.ac.cn	morelli, xavier/A-9218-2016	morelli, xavier/0000-0001-8101-7901	National Natural Science Foundation of China [31370738]; Hundred Talents Program of the Chinese Academy of Sciences; Agence Nationale de la Recherche [NR-15-CE18-0023]; Campus France [26203WD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Agence Nationale de la Recherche(French National Research Agency (ANR)); Campus France	This work was supported by National Natural Science Foundation of China Grant 31370738 and Hundred Talents Program of the Chinese Academy of Sciences and Campus France (Partenariats Hubert Curien CAI YUANPEI 2013 International program between France and China) Project 26203WD. This work was also supported by the Agence Nationale de la Recherche Grant NR-15-CE18-0023. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; Duprez E, 1997, ONCOGENE, V14, P1563, DOI 10.1038/sj.onc.1200995; Ekkapongpisit M, 2007, J MED VIROL, V79, P552, DOI 10.1002/jmv.20806; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng YB, 2013, J BIOL CHEM, V288, P28418, DOI 10.1074/jbc.M113.478024; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; He P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040435; Hu F, 2015, J BIOL CHEM, V290, P26373, DOI 10.1074/jbc.M115.657940; Huang RY, 2015, BIOCHEM BIOPH RES CO, V467, P602, DOI 10.1016/j.bbrc.2015.08.119; Kim J, 2016, TRAFFIC, V17, P733, DOI 10.1111/tra.12403; Koldehoff M, 2008, INT J HEMATOL, V87, P39, DOI 10.1007/s12185-007-0013-z; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Lee I, 2014, P NATL ACAD SCI USA, V111, P1849, DOI 10.1073/pnas.1323895111; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Pacaud R, 2014, BIOCHIMIE, V104, P36, DOI 10.1016/j.biochi.2014.05.005; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; Rabouille C, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00001; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Stein MF, 2015, BIOCHEM BIOPH RES CO, V459, P42, DOI 10.1016/j.bbrc.2015.02.057; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; Tang DM, 2012, BIOL OPEN, V1, P1204, DOI 10.1242/bio.20122659; Tong JH, 1999, LEUKEMIA, V13, P1982, DOI 10.1038/sj.leu.2401560; Truschel ST, 2012, J BIOL CHEM, V287, P19870, DOI 10.1074/jbc.M111.326256; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhang XY, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00084; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	38	23	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2956	2965		10.1074/jbc.M116.765990	http://dx.doi.org/10.1074/jbc.M116.765990			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28049725	hybrid, Green Published			2022-12-28	WOS:000395535100035
J	Ferreira, RC; Popova, EY; James, J; Briones, MRS; Zhang, SS; Barnstable, CJ				Ferreira, Renata C.; Popova, Evgenya Y.; James, Jessica; Briones, Marcelo R. S.; Zhang, Samuel S.; Barnstable, Colin J.			Histone Deacetylase 1 Is Essential for Rod Photoreceptor Differentiation by Regulating Acetylation at Histone H3 Lysine 9 and Histone H4 Lysine 12 in the Mouse Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME PCR DATA; SODIUM-BUTYRATE; CLASS-I; NEURONAL DIFFERENTIATION; STAT3 ACTIVATION; GENE-EXPRESSION; CELL FATE; ROLES; INHIBITION; PROLIFERATION	Histone acetylation has a regulatory role in gene expression and is necessary for proper tissue development. To investigate the specific roles of histone deacetylases (HDACs) in rod differentiation in neonatal mouse retinas, we used a pharmacological approach that showed that inhibition of class I but not class IIa HDACs caused the same phenotypic changes seen with broad spectrum HDAC inhibitors, most notably a block in the differentiation of rod photoreceptors. Inhibition of HDAC1 resulted in increase of acetylation of lysine 9 of histone 3 (H3K9) and lysine 12 of histone 4 (H4K12) but not lysine 27 of histone 3 (H3K27) and led to maintained expression of progenitor-specific genes such as Vsx2 and Hes1 with concomitant block of expression of rod-specific genes. ChiP experiments confirmed these changes in the promoters of a group of progenitor genes. Based on our results, we suggest that HDAC1-specific inhibition prevents progenitor cells of the retina from exiting the cell cycle and differentiating. HDAC1 may be an essential epigenetic regulator of the transition from progenitor cells to terminally differentiated photoreceptors.	[Ferreira, Renata C.; Popova, Evgenya Y.; James, Jessica; Zhang, Samuel S.; Barnstable, Colin J.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, 500 Univ Dr, Hershey, PA 17033 USA; [Popova, Evgenya Y.; Zhang, Samuel S.; Barnstable, Colin J.] Penn State Hershey Eye Ctr, Hershey, PA 17033 USA; [Ferreira, Renata C.; Briones, Marcelo R. S.] Univ Fed Sao Paulo, Escola Paulista Med, Lab Evolutionary Genom & Biocomplex, BR-04039032 Sao Paulo, Brazil	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Universidade Federal de Sao Paulo (UNIFESP)	Barnstable, CJ (corresponding author), Penn State Univ, Coll Med, Dept Neural & Behav Sci, 500 Univ Dr, Hershey, PA 17033 USA.	cbarnstable@hmc.psu.edu	Barnstable, Colin/ABB-4822-2021; Briones, Marcelo RS/C-5760-2013; Barnstable, Colin/GLU-9219-2022; Ferreira, Renata/S-7590-2019	Carmona e Ferreira, Renata/0000-0003-1481-2926; Briones, Marcelo/0000-0001-8045-2477; Barnstable, Colin/0000-0002-7011-4068	National Council for Scientific and Technological Development of Brazil [206445/2014-8]; Sao Paulo Research Foundation (FAPESP) [2013/078380, 2014/256026]; Macula Vision Research Foundation	National Council for Scientific and Technological Development of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Macula Vision Research Foundation	Supported by Fellowship 206445/2014-8 from the National Council for Scientific and Technological Development of Brazil.; Supported by Sao Paulo Research Foundation (FAPESP) Fellowships 2013/078380 and 2014/256026.; Supported by a grant from Macula Vision Research Foundation.	Anderson KW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126592; Balasubramaniyan V, 2006, NEUROSCIENCE, V143, P939, DOI 10.1016/j.neuroscience.2006.08.082; BARNSTABLE CJ, 1980, NATURE, V286, P231, DOI 10.1038/286231a0; Barrios AP, 2014, MOL CELL BIOL, V34, P2760, DOI 10.1128/MCB.00083-14; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Chen B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-78; Cho Y, 2014, CURR OPIN NEUROBIOL, V27, P118, DOI 10.1016/j.conb.2014.03.008; Colletti SL, 2001, BIOORG MED CHEM LETT, V11, P107, DOI 10.1016/S0960-894X(00)00604-1; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; DarkinRattray SJ, 1996, P NATL ACAD SCI USA, V93, P13143, DOI 10.1073/pnas.93.23.13143; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; DAVIE JR, 1978, P NATL ACAD SCI USA, V75, P3574, DOI 10.1073/pnas.75.8.3574; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Saez JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131760; Fan J, 2016, EXP EYE RES, V146, P269, DOI 10.1016/j.exer.2016.03.026; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Furumai R, 2002, CANCER RES, V62, P4916; Galletti M, 2014, BIOCHEM PHARMACOL, V91, P181, DOI 10.1016/j.bcp.2014.07.011; Greene TT, 2016, ELIFE, V5, DOI 10.7554/eLife.14749; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HAGUE A, 1993, INT J CANCER, V55, P498, DOI 10.1002/ijc.2910550329; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hojo M, 2000, DEVELOPMENT, V127, P2515; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jung M, 1999, J MED CHEM, V42, P4669, DOI 10.1021/jm991091h; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lamb TD, 2013, PROG RETIN EYE RES, V36, P52, DOI 10.1016/j.preteyeres.2013.06.001; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Liu Mu-Gen, 2008, J Ocul Biol Dis Infor, V1, P59, DOI 10.1007/s12177-008-9009-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mitrousis N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00483; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Morris MJ, 2013, INT J DEV NEUROSCI, V31, P370, DOI 10.1016/j.ijdevneu.2013.02.005; Mu XQ, 2008, P NATL ACAD SCI USA, V105, P6942, DOI 10.1073/pnas.0802627105; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nambiar RM, 2007, MECH DEVELOP, V124, P682, DOI 10.1016/j.mod.2007.07.003; Newbold A, 2008, MOL CANCER THER, V7, P1066, DOI 10.1158/1535-7163.MCT-07-2256; Ozawa Y, 2004, MOL CELL NEUROSCI, V26, P258, DOI 10.1016/j.mcn.2004.02.001; Pinzon-Guzman C, 2011, J NEUROSCI, V31, P18606, DOI 10.1523/JNEUROSCI.2578-11.2011; POGO BGT, 1968, P NATL ACAD SCI USA, V59, P1337, DOI 10.1073/pnas.59.4.1337; Popova EY, 2016, MOL NEUROBIOL, V53, P4563, DOI 10.1007/s12035-015-9395-8; Popova EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046867; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scognamiglio A, 2008, BBA-MOL CELL RES, V1783, P2030, DOI 10.1016/j.bbamcr.2008.07.007; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun GQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/835968; Tatamiya Takayuki, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P567; Tiwari P, 2015, CHEM-BIOL INTERACT, V226, P1, DOI 10.1016/j.cbi.2014.11.018; Tiwari S, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-30; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; Tummala P, 2010, MOL VIS, V16, P252; VanderMolen KM, 2011, J ANTIBIOT, V64, P525, DOI 10.1038/ja.2011.35; Wallace DM, 2006, INVEST OPHTH VIS SCI, V47, P2765, DOI 10.1167/iovs.05-1383; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wilken MS, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-8; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; Zhang SSM, 2005, EXP EYE RES, V81, P103, DOI 10.1016/j.exer.2005.01.016; Zhang SSM, 2004, INVEST OPHTH VIS SCI, V45, P2407, DOI 10.1167/iovs.04-0003; Zhang SSM, 2002, METHODS, V28, P439, DOI 10.1016/S1046-2023(02)00263-3	82	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2422	2440		10.1074/jbc.M116.756643	http://dx.doi.org/10.1074/jbc.M116.756643			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28028172	Green Published, hybrid			2022-12-28	WOS:000395530300031
J	Hayakawa, M; Hayakawa, H; Petrova, T; Ritprajak, P; Sutavani, RV; Jimenez-Andrade, GY; Sano, Y; Choo, MK; Seavitt, J; Venigalla, RKC; Otsu, K; Georgopoulos, K; Arthur, JSC; Park, JM				Hayakawa, Morisada; Hayakawa, Hiroko; Petrova, Tsvetana; Ritprajak, Patcharee; Sutavani, Ruhcha V.; Jimenez-Andrade, Guillermina Yanek; Sano, Yasuyo; Choo, Min-Kyung; Seavitt, John; Venigalla, Ram K. C.; Otsu, Kinya; Georgopoulos, Katia; Arthur, J. Simon C.; Park, Jin Mo			Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; mouse; p38; signal transduction; T-cell	ACTIVATED PROTEIN-KINASE; IN-VIVO; GENE-EXPRESSION; DENDRITIC CELLS; INNATE IMMUNITY; P38-ALPHA; RECEPTOR; PATHWAY; PHOSPHORYLATION; MAPK	The evolutionarily conserved protein kinase p38 mediates innate resistance to environmental stress and microbial infection. Four p38 isoforms exist in mammals and may have been co-opted for new roles in adaptive immunity. Murine T cells deficient in p38, the ubiquitously expressed p38 isoform, showed no readily apparent cell-autonomous defects while expressing elevated amounts of another isoform, p38. Mice with T cells simultaneously lacking p38 and p38 displayed lymphoid atrophy and elevated Foxp3(+) regulatory T cell frequencies. Double deficiency of p38 and p38 in naive CD4(+) T cells resulted in an attenuation of MAPK-activated protein kinase (MK)-dependent mTOR signaling after T cell receptor engagement, and enhanced their differentiation into regulatory T cells under appropriate inducing conditions. Pharmacological inhibition of the p38-MK-mTOR signaling module produced similar effects, revealing potential for therapeutic applications.	[Hayakawa, Morisada; Hayakawa, Hiroko; Ritprajak, Patcharee; Jimenez-Andrade, Guillermina Yanek; Sano, Yasuyo; Choo, Min-Kyung; Seavitt, John; Georgopoulos, Katia; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149 13th St, Charlestown, MA 02129 USA; [Hayakawa, Morisada; Hayakawa, Hiroko; Ritprajak, Patcharee; Jimenez-Andrade, Guillermina Yanek; Sano, Yasuyo; Choo, Min-Kyung; Seavitt, John; Georgopoulos, Katia; Park, Jin Mo] Harvard Med Sch, 149 13th St, Charlestown, MA 02129 USA; [Hayakawa, Morisada; Hayakawa, Hiroko] Jichi Med Univ, Dept Biochem, Shimotsuke, Tochigi 3290498, Japan; [Petrova, Tsvetana; Sutavani, Ruhcha V.; Arthur, J. Simon C.] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Wellcome Trust Bldg, Dundee DD1 5EH, Scotland; [Venigalla, Ram K. C.] Univ Dundee, Prot Phosphorylat Unit, MRC, Sch Life Sci,Sir James Black Ctr, Dundee DD1 5EH, Scotland; [Ritprajak, Patcharee] Chulalongkorn Univ, Dept Microbiol & Immunol, Fac Dent, Bangkok 10330, Thailand; [Ritprajak, Patcharee] Chulalongkorn Univ, Res Unit Oral Microbiol, Fac Dent, Bangkok 10330, Thailand; [Otsu, Kinya] Kings Coll London, Div Cardiovasc, London SE5 9NU, England	Harvard University; Massachusetts General Hospital; Jichi Medical University; University of Dundee; University of Dundee; Chulalongkorn University; Chulalongkorn University; University of London; King's College London	Park, JM (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, 149 13th St, Charlestown, MA 02129 USA.; Park, JM (corresponding author), Harvard Med Sch, 149 13th St, Charlestown, MA 02129 USA.	jmpark@cbrc2.mgh.harvard.edu		Petrova, Tsvetana/0000-0003-2425-2459; Hayakawa, Morisada/0000-0002-1869-2450; Arthur, Simon/0000-0002-8135-1958	National Institutes of Health [AI074957]; Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health Grant AI074957 (to J.M.P.) and by a Medical Research Council grant (to J.S.C.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam MS, 2014, J EXP MED, V211, P1257, DOI 10.1084/jem.20131917; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Atherly LO, 2006, J IMMUNOL, V176, P1571, DOI 10.4049/jimmunol.176.3.1571; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Berenson LS, 2006, J IMMUNOL, V176, P4616, DOI 10.4049/jimmunol.176.8.4616; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Caballero-Franco C, 2013, J BIOL CHEM, V288, P23788, DOI 10.1074/jbc.M113.452029; Chang X, 2011, IMMUNITY, V34, P201, DOI 10.1016/j.immuni.2011.01.017; Degols G, 1996, MOL CELL BIOL, V16, P2870; Barrantes IDB, 2011, P NATL ACAD SCI USA, V108, P12764, DOI 10.1073/pnas.1015013108; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Diehl NL, 2000, J EXP MED, V191, P321, DOI 10.1084/jem.191.2.321; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Hale KK, 1999, J IMMUNOL, V162, P4246; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Hernandez G, 2011, EXP CELL RES, V317, P2938, DOI 10.1016/j.yexcr.2011.09.011; Hsu SC, 2003, BLOOD, V101, P970, DOI 10.1182/blood-2002-03-0744; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jirmanova L, 2011, BLOOD, V118, P3280, DOI 10.1182/blood-2011-01-333039; Jirmanova L, 2009, BLOOD, V113, P2229, DOI 10.1182/blood-2008-04-153304; Katholnig K, 2013, J IMMUNOL, V190, P1519, DOI 10.4049/jimmunol.1202683; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim JM, 2005, J IMMUNOL, V174, P1239, DOI 10.4049/jimmunol.174.3.1239; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; McGuire VA, 2013, MOL CELL BIOL, V33, P4152, DOI 10.1128/MCB.01691-12; Merritt C, 2000, MOL CELL BIOL, V20, P936, DOI 10.1128/MCB.20.3.936-946.2000; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Otsuka M, 2010, GASTROENTEROLOGY, V138, P1255, DOI 10.1053/j.gastro.2010.01.005; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Ritprajak P, 2012, P NATL ACAD SCI USA, V109, P9089, DOI 10.1073/pnas.1202984109; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sano Y, 2014, J INVEST DERMATOL, V134, P2231, DOI 10.1038/jid.2014.153; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Tanaka N, 2002, EMBO REP, V3, P785, DOI 10.1093/embo-reports/kvf153; Wu XN, 2011, J BIOL CHEM, V286, P31501, DOI 10.1074/jbc.M111.233122; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	49	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1762	1772		10.1074/jbc.M116.764548	http://dx.doi.org/10.1074/jbc.M116.764548			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	28011639	Green Published, hybrid			2022-12-28	WOS:000395515600018
J	Mathieu, C; Bui, LC; Petit, E; Haddad, I; Agbulut, O; Vinh, J; Dupret, JM; Rodrigues-Lima, F				Mathieu, Cecile; Bui, Linh-Chi; Petit, Emile; Haddad, Iman; Agbulut, Onnik; Vinh, Joelle; Dupret, Jean-Marie; Rodrigues-Lima, Fernando			Molecular Mechanisms of Allosteric Inhibition of Brain Glycogen Phosphorylase by Neurotoxic Dithiocarbamate Chemicals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; brain metabolism; carbohydrate metabolism; disulfide; glycogen; glycogen storage disease; Parkinson disease; toxicology	ETHYLENE-BIS-DITHIOCARBAMATE; ALDEHYDE DEHYDROGENASE; GLUCOSE-METABOLISM; CHRONIC EXPOSURE; FUNGICIDE MANEB; DISULFIRAM; RAT; DISEASE; DIETHYLDITHIOCARBAMATE; IDENTIFICATION	Dithiocarbamates (DTCs) are important industrial chemicals used extensively as pesticides and in a variety of therapeutic applications. However, they have also been associated with neurotoxic effects and in particular with the development of Parkinson-like neuropathy. Although different pathways and enzymes (such as ubiquitin ligases or the proteasome) have been identified as potential targets of DTCs in the brain, the molecular mechanisms underlying their neurotoxicity remain poorly understood. There is increasing evidence that alteration of glycogen metabolism in the brain contributes to neurodegenerative processes. Interestingly, recent studies with N,N-diethyldithiocarbamate suggest that brain glycogen phosphorylase (bGP) and glycogen metabolism could be altered by DTCs. Here, we provide molecular and mechanistic evidence that bGP is a target of DTCs. To examine this system, we first tested thiram, a DTC pesticide known to display neurotoxic effects, observing that it can react rapidly with bGP and readily inhibits its glycogenolytic activity (k(inact) = 1.4 x 10(5)m(-1) s(-1)). Using cysteine chemical labeling, mass spectrometry, and site-directed mutagenesis approaches, we show that thiram (and certain of its metabolites) alters the activity of bGP through the formation of an intramolecular disulfide bond (Cys(318)-Cys(326)), known to act as a redox switch that precludes the allosteric activation of bGP by AMP. Given the key role of glycogen metabolism in brain functions and neurodegeneration, impairment of the glycogenolytic activity of bGP by DTCs such as thiram may be a new mechanism by which certain DTCs exert their neurotoxic effects.	[Mathieu, Cecile; Bui, Linh-Chi; Petit, Emile; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, CNRS, UMR 8251, Sorbonne Paris Cite,Unite BFA, F-75013 Paris, France; [Haddad, Iman] Univ Paris Sci & Lettres, CNRS, USR,ESPCI ParisTech, Lab Spectrometrie Masse Biol & Prote, F-3149 Paris, France; [Agbulut, Onnik] UPMC Univ Paris 06, Sorbonne Univ,Inst Biol Paris Seine, CNRS, UMR 8256,Biol Adaptat & Ageing, F-75005 Paris, France; [Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, CNRS, UMR 8251, Sorbonne Paris Cite,Unite BFA, F-75013 Paris, France.; Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France.	fernando.rodrigues-lima@univ-paris-diderot.fr	Vinh, Joelle/K-1347-2015	Vinh, Joelle/0000-0001-7184-2668; Agbulut, Onnik/0000-0003-1923-8871	University Paris Diderot; University Paris Diderot (Ecole Doctorale BioSPC); CNRS	University Paris Diderot; University Paris Diderot (Ecole Doctorale BioSPC); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by University Paris Diderot, CNRS, and a Ph.D. fellowship from University Paris Diderot (Ecole Doctorale BioSPC; to C.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Amici M, 2002, J BIOL INORG CHEM, V7, P750, DOI 10.1007/s00775-002-0352-4; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; Domico LM, 2007, NEUROTOXICOLOGY, V28, P1079, DOI 10.1016/j.neuro.2007.04.008; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; FERRAZ HB, 1988, NEUROLOGY, V38, P550, DOI 10.1212/WNL.38.4.550; GERTZ HJ, 1985, MECH AGEING DEV, V31, P25, DOI 10.1016/0047-6374(85)90024-7; Gibbs ME, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00070; Gould NS, 2015, CHEM BIOL, V22, P965, DOI 10.1016/j.chembiol.2015.06.010; IQBAL J, 1991, FREE RADICAL BIO MED, V10, P69, DOI 10.1016/0891-5849(91)90023-V; Kona FR, 2011, CURR CANCER DRUG TAR, V11, P338; MADAN A, 1995, DRUG METAB DISPOS, V23, P1153; Madan A, 1998, ALCOHOL CLIN EXP RES, V22, P1212, DOI 10.1111/j.1530-0277.1998.tb03901.x; MADDAIAH VT, 1966, J BIOL CHEM, V241, P3873; Malka F, 2009, FEBS J, V276, P4900, DOI 10.1111/j.1742-4658.2009.07189.x; Mathieu C, 2016, J BIOL CHEM, V291, P23842, DOI 10.1074/jbc.M116.757062; Mathieu C, 2016, J BIOL CHEM, V291, P18072, DOI 10.1074/jbc.M116.738898; Mathieu C, 2015, EXPERT OPIN DRUG MET, V11, P81, DOI 10.1517/17425255.2015.975691; MECO G, 1994, SCAND J WORK ENV HEA, V20, P301, DOI 10.5271/sjweh.1394; MILLER DB, 1982, NEUROBEH TOXICOL TER, V4, P779; Nobel CSI, 1997, CHEM RES TOXICOL, V10, P1319, DOI 10.1021/tx970131m; de la Cruz VP, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/494316; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Pratt-Hyatt M, 2010, DRUG METAB DISPOS, V38, P2286, DOI 10.1124/dmd.110.034710; Rahman MA, 1997, PHARMACOL BIOCHEM BE, V56, P409, DOI 10.1016/S0091-3057(96)00222-5; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Sato N, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3339/fnagi.2015,00199, 10.3389/fnagi.2015.00199]; Shen ML, 2000, BIOCHEM PHARMACOL, V60, P947, DOI 10.1016/S0006-2952(00)00435-4; Sickmann HM, 2012, NEUROCHEM INT, V60, P267, DOI 10.1016/j.neuint.2011.12.019; Sook Han M, 2003, NEUROTOXICOLOGY, V24, P425; STROMME JH, 1963, BIOCHEM PHARMACOL, V12, P705, DOI 10.1016/0006-2952(63)90046-7; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Vaccari A, 1999, J PHARMACOL EXP THER, V288, P1; Veverka KA, 1997, BIOCHEM PHARMACOL, V53, P511, DOI 10.1016/S0006-2952(96)00767-8; Viquez OM, 2012, CHEM RES TOXICOL, V25, P2310, DOI 10.1021/tx300198h; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472	46	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1603	1612		10.1074/jbc.M116.766725	http://dx.doi.org/10.1074/jbc.M116.766725			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27965358	Green Published, hybrid			2022-12-28	WOS:000395515600006
J	Vitrac, H; MacLean, DM; Karlstaedt, A; Taegtmeyer, H; Jayaraman, V; Bogdanov, M; Dowhan, W				Vitrac, Heidi; MacLean, David M.; Karlstaedt, Anja; Taegtmeyer, Heinrich; Jayaraman, Vasanthi; Bogdanov, Mikhail; Dowhan, William			Dynamic Lipid-dependent Modulation of Protein Topology by Post-translational Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); glycerophospholipid; lipid-protein interaction; membrane protein; phosphorylation; post-translational modification (PTM)	POLYTOPIC MEMBRANE-PROTEIN; ESCHERICHIA-COLI; LACTOSE PERMEASE; DUAL-TOPOLOGY; TRANSMEMBRANE SEGMENTS; TOPOGENIC SIGNALS; ORIENTATION; DETERMINANTS; CHOLESTEROL; INSERTION	Membrane protein topology and folding are governed by structural principles and topogenic signals that are recognized and decoded by the protein insertion and translocation machineries at the time of initial membrane insertion and folding. We previously demonstrated that the lipid environment is also a determinant of initial protein topology, which is dynamically responsive to post-assembly changes in membrane lipid composition. However, the effect on protein topology of post-assembly phosphorylation of amino acids localized within initially cytoplasmically oriented extramembrane domains has never been investigated. Here, we show in a controlled in vitro system that phosphorylation of a membrane protein can trigger a change in topological arrangement. The rate of change occurred on a scale of seconds, comparable with the rates observed upon changes in the protein lipid environment. The rate and extent of topological rearrangement were dependent on the charges of extramembrane domains and the lipid bilayer surface. Using model membranes mimicking the lipid compositions of eukaryotic organelles, we determined that anionic lipids, cholesterol, sphingomyelin, and membrane fluidity play critical roles in these processes. Our results demonstrate how post-translational modifications may influence membrane protein topology in a lipid-dependent manner, both along the organelle trafficking pathway and at their final destination. The results provide further evidence that membrane protein topology is dynamic, integrating for the first time the effect of changes in lipid composition and regulators of cellular processes. The discovery of a new topology regulatory mechanism opens additional avenues for understanding unexplored structure-function relationships and the development of optimized topology prediction tools.	[Vitrac, Heidi; MacLean, David M.; Jayaraman, Vasanthi; Bogdanov, Mikhail; Dowhan, William] Univ Texas Houston, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,Ste 6 200, Houston, TX 77030 USA; [Vitrac, Heidi; MacLean, David M.; Jayaraman, Vasanthi; Bogdanov, Mikhail; Dowhan, William] Univ Texas Houston, McGovern Med Sch, Ctr Membrane Biol, Houston, TX 77030 USA; [Karlstaedt, Anja; Taegtmeyer, Heinrich] Univ Texas Houston, McGovern Med Sch, Div Cardiol, Dept Internal Med, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Vitrac, H; Dowhan, W (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,Ste 6 200, Houston, TX 77030 USA.	Heidi.Vitrac@uth.tmc.edu; william.dowhan@uth.tmc.edu	Karlstaedt, Anja/N-6557-2019; Bogdanov, Mikhail/J-3695-2017; Vitrac, Heidi/R-7117-2018	Karlstaedt, Anja/0000-0001-5689-3571; Vitrac, Heidi/0000-0002-8858-4914; MacLean, David/0000-0001-8294-6075	National Institutes of Health [R37 GM 20478, K99 NS 094761, R01 GM 113212, R01 GM 094246-04, R01 HL 61483]; Roderick MacDonald Research Fund; John Dunn Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, R01GM113212, R01GM094246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS094761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roderick MacDonald Research Fund; John Dunn Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R37 GM 20478 (to W.D.), K99 NS 094761 (to D.M.M.), R01 GM 113212 and R01 GM 094246-04 (to V.J.), and R01 HL 61483 (to H.T.), the Roderick MacDonald Research Fund (to A.K.), and the John Dunn Research Foundation (to W.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Binder WH, 2003, ANGEW CHEM INT EDIT, V42, P5802, DOI 10.1002/anie.200300586; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov M, 2014, BBA-MOL CELL RES, V1843, P1475, DOI 10.1016/j.bbamcr.2013.12.007; Bogdanov M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404103; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Bowie JU, 2013, SCIENCE, V339, P398, DOI 10.1126/science.1228655; Bowie JU, 2005, NATURE, V433, P367, DOI 10.1038/433367a; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Goder V, 2000, EMBO J, V19, P6704, DOI 10.1093/emboj/19.24.6704; Hansen AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003403; Harley CA, 1998, J BIOL CHEM, V273, P24963, DOI 10.1074/jbc.273.38.24963; Hedin LE, 2010, J MOL BIOL, V396, P221, DOI 10.1016/j.jmb.2009.11.036; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; Herate C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145617; Hickey KD, 2011, J LIPIDS, V2011, DOI 10.1155/2011/208457; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; Kaiser HJ, 2011, J BIOL CHEM, V286, P40631, DOI 10.1074/jbc.M111.276444; Kolbusz MA, 2012, BIOCHEMISTRY-US, V51, P8867, DOI 10.1021/bi300854c; KRISHTALIK LI, 1995, FEBS LETT, V369, P140, DOI 10.1016/0014-5793(95)00756-Y; Kwaw I, 2001, BIOCHEMISTRY-US, V40, P10491, DOI 10.1021/bi010866x; LeBarron J, 2016, LANGMUIR, V32, P10752, DOI 10.1021/acs.langmuir.6b02597; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Monne M, 2005, FEBS J, V272, P28, DOI 10.1111/j.1432-1033.2004.04394.x; Nilsson IM, 2001, J BIOL CHEM, V276, P41748, DOI 10.1074/jbc.M105823200; Popot JL, 2016, BIOCHEMISTRY-US, V55, P5, DOI 10.1021/acs.biochem.5b01134; Prange R, 2004, J GEN VIROL, V85, P1221, DOI 10.1099/vir.0.19737-0; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; Schlebach JP, 2015, J MEMBRANE BIOL, V248, P371, DOI 10.1007/s00232-014-9726-0; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Serdiuk T, 2015, STRUCTURE, V23, P754, DOI 10.1016/j.str.2015.02.009; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Stott BM, 2008, J LIPID RES, V49, P1202, DOI 10.1194/jlr.M700479-JLR200; Su MG, 2014, NUCLEIC ACIDS RES, V42, pD537, DOI 10.1093/nar/gkt1221; Tsaousis GN, 2014, BBA-PROTEINS PROTEOM, V1844, P316, DOI 10.1016/j.bbapap.2013.11.001; Tu LW, 2010, J MOL BIOL, V396, P1346, DOI 10.1016/j.jmb.2009.12.059; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; Vitrac H, 2015, P NATL ACAD SCI USA, V112, P13874, DOI 10.1073/pnas.1512994112; Vitrac H, 2013, P NATL ACAD SCI USA, V110, P9338, DOI 10.1073/pnas.1304375110; Vitrac H, 2011, J BIOL CHEM, V286, P15182, DOI 10.1074/jbc.M110.214387; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; White SH, 2005, BIOCHEM SOC T, V33, P1012, DOI 10.1042/BST0331012; WHITLEY P, 1994, NAT STRUCT BIOL, V1, P858, DOI 10.1038/nsb1294-858; Yamamoto H, 2012, BIOCHEMISTRY-US, V51, P3596, DOI 10.1021/bi2018915; Zhao YJ, 2015, BBA-MOL CELL RES, V1853, P2095, DOI 10.1016/j.bbamcr.2014.10.028; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700	61	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1613	1624		10.1074/jbc.M116.765719	http://dx.doi.org/10.1074/jbc.M116.765719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27974465	Green Published, hybrid			2022-12-28	WOS:000395515600007
J	Kim, HS; Williamson, EA; Nickoloff, JA; Hromas, RA; Lee, SH				Kim, Hyun-Suk; Williamson, Elizabeth A.; Nickoloff, Jac A.; Hromas, Robert A.; Lee, Suk-Hee			Metnase Mediates Loading of Exonuclease 1 onto Single Strand Overhang DNA for End Resection at Stalled Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR PATHWAY CHOICE; HOMOLOGOUS RECOMBINATION; HUMAN-CELLS; GENOME INSTABILITY; BREAK REPAIR; BIOCHEMICAL-CHARACTERIZATION; MAMMALIAN-CELLS; NHEJ REPAIR; EXO1; RESTART	Stalling at DNA replication forks generates stretches of single- stranded (ss) DNA on both strands that are exposed to nucleolytic degradation, potentially compromising genome stability. One enzyme crucial for DNA replication fork repair and restart of stalled forks in human is Metnase (also known as SETMAR), a chimeric fusion protein consisting of a su(var) 3-9, enhancer-of-zeste and trithorax (SET) histone methylase and transposase nuclease domain. We previously showed that Metnase possesses a unique fork cleavage activity necessary for its function in replication restart and that its SET domain is essential for recovery from hydroxyurea-induced DNA damage. However, its exact role in replication restart is unclear. In this study, we show that Metnase associates with exonuclease 1 (Exo1), a 5' -exonuclease crucial for 5' -end resection to mediate DNA processing at stalled forks. Metnase DNA cleavage activity was not required for Exo1 5' -exonuclease activity on the lagging strand daughter DNA, but its DNA binding activity mediated loading of Exo1 onto ssDNA overhangs. Metnase-induced enhancement of Exo1-mediated DNA strand resection required the presence of these overhangs but did not require Metnase's DNA cleavage activity. These results suggest that Metnase enhances Exo1-mediated exonuclease activity on the lagging strand DNA by facilitating Exo1 loading onto a single strand gap at the stalled replication fork.	[Kim, Hyun-Suk; Lee, Suk-Hee] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Williamson, Elizabeth A.; Hromas, Robert A.] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Williamson, Elizabeth A.; Hromas, Robert A.] Shands Hlth Care Syst, Gainesville, FL 32610 USA; [Nickoloff, Jac A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Colorado State University	Lee, SH (corresponding author), Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	slee@iu.edu			National Institutes of Health [R01 CA151367, R01 GM084020, R01 CA139429]; Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE [R01CA151367, R01CA139429, R01CA205224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109645, R01GM084020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA151367 (to S.-H. L.), R01 GM084020 (to J. A. N. and R. A. H.), and R01 CA139429 (to R. A. H.) and by the Indiana University Simon Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; [Anonymous], 1980, BASIC LIFE SCI, V15, P1; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Carr AM, 2013, J MOL BIOL, V425, P4733, DOI 10.1016/j.jmb.2013.04.023; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costes A, 2013, BIOMOLECULES, V3, P39, DOI 10.3390/biom3010039; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; El-Shemerly M, 2005, CANCER RES, V65, P3604, DOI 10.1158/0008-5472.CAN-04-4069; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hromas R, 2012, ONCOGENE, V31, P4245, DOI 10.1038/onc.2011.586; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Kakarougkas A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130685; Karanja KK, 2012, CELL CYCLE, V11, P3983, DOI 10.4161/cc.22215; Kim HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139418; Kim HS, 2014, J BIOL CHEM, V289, P10930, DOI 10.1074/jbc.M113.533216; Lambert S, 2013, CURR OPIN GENET DEV, V23, P132, DOI 10.1016/j.gde.2012.11.009; Lambert S, 2013, CHROMOSOMA, V122, P33, DOI 10.1007/s00412-013-0398-9; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Murti KG, 1996, EXP CELL RES, V223, P279, DOI 10.1006/excr.1996.0083; Ngo GHP, 2014, NUCLEIC ACIDS RES, V42, P10516, DOI 10.1093/nar/gku746; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Rass U, 2013, CHROMOSOMA, V122, P499, DOI 10.1007/s00412-013-0431-z; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Warmerdam DO, 2009, CELL CYCLE, V8, P1765, DOI 10.4161/cc.8.11.8721; Wu YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005675; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhou Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1309; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	67	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1414	1425		10.1074/jbc.M116.745646	http://dx.doi.org/10.1074/jbc.M116.745646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27974460	Green Published, hybrid			2022-12-28	WOS:000393339800023
J	Guo, YY; An, LW; Ng, HM; Sy, SMH; Huen, MSY				Guo, Yingying; An, Liwei; Ng, Hoi-Man; Sy, Shirley M. H.; Huen, Michael S. Y.			An E2-guided E3 Screen Identifies the RNF17-UBE2U Pair as Regulator of the Radiosensitivity, Immunodeficiency, Dysmorphic Features, and Learning Difficulties (RIDDLE) Syndrome Protein RNF168	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; RING-FINGER PROTEIN; UBIQUITIN STRUCTURES; STRUCTURAL BASIS; PIWI PROTEINS; HISTONE H2AX; UBIQUITYLATION; REPAIR; DOMAIN	Protein ubiquitination has emerged as a pivotal regulatory reaction that promotes cellular responses toDNAdamage. With a goal to delineate theDNAdamage signal transduction cascade, we systematically analyzed the human E2 ubiquitin-and ubiquitin-like-conjugating enzymes for their ability to mobilize the DNA damage marker 53BP1 onto ionizing radiation-induced DNA double strand breaks. An RNAi-based screen identified UBE2U as a candidate regulator of chromatin responses at double strand breaks. Further mining of the UBE2U interactome uncovered its cognate E3 RNF17 as a novel factor that, via the radiosensitivity, immunodeficiency, dysmorphic features, and learning difficulties (RIDDLE) syndrome protein RNF168, enforces DNA damage responses. Our screen allowed us to uncover new players in the mammalian DNA damage response and highlights the instrumental roles of ubiquitin machineries in promoting cell responses to genotoxic stress.	[Guo, Yingying; An, Liwei; Ng, Hoi-Man; Sy, Shirley M. H.; Huen, Michael S. Y.] Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Sy, SMH; Huen, MSY (corresponding author), Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.; Huen, MSY (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.	mhsy@hku.hk; huen.michael@hku.hk		Sy, Ming Hui/0000-0002-2731-6692; An, Liwei/0000-0003-4514-5476; Huen, Michael Shing-Yan/0000-0003-1774-2425; guo, yingying/0000-0002-7829-6935	Research Grants Council Hong Kong [17104215]; The University of Hong Kong	Research Grants Council Hong Kong(Hong Kong Research Grants Council); The University of Hong Kong(University of Hong Kong)	This work was supported by Research Grants Council Hong Kong Project 17104215 and by the Outstanding Young Researcher Award (The University of Hong Kong) (to M. S. Y. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bohgaki M, 2013, P NATL ACAD SCI USA, V110, P20982, DOI 10.1073/pnas.1320302111; Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Chen C, 2009, P NATL ACAD SCI USA, V106, P20336, DOI 10.1073/pnas.0911640106; Dantuma NP, 2016, EMBO J, V35, P6, DOI 10.15252/embj.201592595; Devgan SS, 2011, CELL DEATH DIFFER, V18, P1500, DOI 10.1038/cdd.2011.18; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gatti M, 2015, CELL REP, V10, P226, DOI 10.1016/j.celrep.2014.12.021; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; Hodge C. D., 2016, ONCOTARGET, DOI 10.18632/oncotarget.10948; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Leung JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004178; Li TT, 2014, J CELL SCI, V127, P2238, DOI 10.1242/jcs.138891; Liu C, 2013, J CELL SCI, V126, P2042, DOI 10.1242/jcs.122945; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Pan JY, 2005, DEVELOPMENT, V132, P4029, DOI 10.1242/dev.02003; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Schmidt CK, 2015, NAT CELL BIOL, V17, P1458, DOI 10.1038/ncb3260; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Sy SMH, 2013, NUCLEIC ACIDS RES, V41, P8572, DOI 10.1093/nar/gkt622; Sy SMH, 2011, J BIOL CHEM, V286, P22355, DOI 10.1074/jbc.M111.232041; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Wasik KA, 2015, GENE DEV, V29, P1403, DOI 10.1101/gad.265215.115; Wilson MD, 2016, NATURE, V536, P100, DOI 10.1038/nature18951; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yin XY, 1999, ONCOGENE, V18, P6621, DOI 10.1038/sj.onc.1203097; Yin XY, 2001, ONCOGENE, V20, P2908, DOI 10.1038/sj.onc.1204417; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Yu M, 2016, J BIOL CHEM, V291, P959, DOI 10.1074/jbc.M114.624478; Zhang XQ, 2013, CELL CYCLE, V12, P312, DOI 10.4161/cc.23104; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhu QZ, 2015, CELL CYCLE, V14, P1413, DOI 10.1080/15384101.2015.1007785	57	6	6	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					967	978		10.1074/jbc.M116.758854	http://dx.doi.org/10.1074/jbc.M116.758854			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27903633	hybrid, Green Published			2022-12-28	WOS:000392318700018
J	Alvarez-Curto, E; Inoue, A; Jenkins, L; Raihan, SZ; Prihandoko, R; Tobin, AB; Milligan, G				Alvarez-Curto, Elisa; Inoue, Asuka; Jenkins, Laura; Raihan, Sheikh Zahir; Prihandoko, Rudi; Tobin, Andrew B.; Milligan, Graeme			Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; ERK1/2 ACTIVATION; HORMONE RECEPTOR; 4 FFA4/GPR120; PHOSPHORYLATION; AGONIST; INTERNALIZATION; DESENSITIZATION; MECHANISMS; HISTORY	G protein-coupled receptors (GPCRs) can initiate intracellular signaling cascades by coupling to an array of heterotrimeric G proteins and arrestin adaptor proteins. Understanding the contribution of each of these coupling options to GPCR signaling has been hampered by a paucity of tools to selectively perturb receptor function. Here we employ CRISPR/Cas9 genome editing to eliminate selected G proteins (G alpha(q) and G alpha(11)) or arrestin2 and arrestin3 from HEK293 cells together with the elimination of receptor phosphorylation sites to define the relative contribution of G proteins, arrestins, and receptor phosphorylation to the signaling outcomes of the free fatty acid receptor 4 (FFA4). A lack of FFA4-mediated elevation of intracellular Ca2+ in G alpha q/G alpha(11)-null cells and agonist-mediated receptor internalization in arrestin2/3-null cells confirmed previously reported canonical signaling features of this receptor, thereby validating the genome-edited HEK293 cells. FFA4-mediated ERK1/2 activation was totally dependent on G(q)/(11) but intriguingly was substantially enhanced for FFA4 receptors lacking sites of regulated phosphorylation. This was not due to a simple lack of desensitization of G(q)/(11) signaling because the G(q)/(11)-dependent calcium response was desensitized by both receptor phosphorylation and arrestin-dependent mechanisms, whereas a substantially enhanced ERK1/2 response was only observed for receptors lacking phosphorylation sites and not in arrestin2/3-null cells. In conclusion, we validate CRISPR/Cas9 engineered HEK293 cells lacking G(q)/(11) or arrestin2/3 as systems for GPCR signaling research and employ these cells to reveal a previously unappreciated interplay of signaling pathways where receptor phosphorylation can impact on ERK1/2 signaling through a mechanism that is likely independent of arrestins.	[Alvarez-Curto, Elisa; Jenkins, Laura; Raihan, Sheikh Zahir; Prihandoko, Rudi; Tobin, Andrew B.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow G12 8QQ, Lanark, Scotland; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy JST, Precursory Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Glasgow; Tohoku University; Japan Science & Technology Agency (JST)	Alvarez-Curto, E; Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Elisa.Alvarez-Curto@glasgow.ac.uk; Graeme.Milligan@glasgow.ac.uk		Milligan, Graeme/0000-0002-6946-3519	Biotechnology and Biological Sciences Research Council [BB/K019864/1, BB/K019856/1]; PRESTO, Japan Science and Technology Agency; BBSRC [BB/K019864/1, BB/L02781X/1, BB/K019856/1, BB/K019856/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K019856/2, BB/L02781X/1, 1653478] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/K019864/1 (to G. M.) and BB/K019856/1 (to A. B. T.) and PRESTO, Japan Science and Technology Agency (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Birdsong WT, 2013, J NEUROSCI, V33, P4118, DOI 10.1523/JNEUROSCI.4187-12.2013; Burns RN, 2014, BIOCHEM PHARMACOL, V87, P650, DOI 10.1016/j.bcp.2013.12.016; Butcher AJ, 2016, J BIOL CHEM, V291, P8862, DOI 10.1074/jbc.M115.681726; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Charest PG, 2007, CELL SIGNAL, V19, P32, DOI 10.1016/j.cellsig.2006.05.020; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gurevich V. V., 2015, PROG MOL BIOL TRANSL, V132, P1; Hudson BD, 2014, J BIOL CHEM, V289, P20345, DOI 10.1074/jbc.M114.561449; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Kriz V, 2014, J BIOL CHEM, V289, P1128, DOI 10.1074/jbc.M113.498444; Kuhar JR, 2015, CELL SIGNAL, V27, P1799, DOI 10.1016/j.cellsig.2015.05.019; LEE CH, 1992, J BIOL CHEM, V267, P16044; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Li Z, 2016, EXPERT OPIN INV DRUG, V25, P871, DOI 10.1080/13543784.2016.1189530; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Milasta S, 2005, BIOCHEM J, V387, P573, DOI 10.1042/BJ20041745; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Milligan G, 2017, CHEM REV, V117, P67, DOI 10.1021/acs.chemrev.6b00056; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Peng RX, 2016, FEBS J, V283, P1218, DOI 10.1111/febs.13586; Prihandoko R, 2016, MOL PHARMACOL, V89, P505, DOI 10.1124/mol.115.101949; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid CL, 2009, PHARMACOL THERAPEUT, V121, P285, DOI 10.1016/j.pharmthera.2008.11.005; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Srivastava A, 2015, TRENDS ENDOCRIN MET, V26, P628, DOI 10.1016/j.tem.2015.09.001; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stone VM, 2014, DIABETOLOGIA, V57, P1182, DOI 10.1007/s00125-014-3213-0; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Yu R, 1999, J BIOL CHEM, V274, P15745, DOI 10.1074/jbc.274.22.15745; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhou L, 2014, CURR OPIN CELL BIOL, V27, P102, DOI 10.1016/j.ceb.2013.11.010	43	94	94	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27147	27159		10.1074/jbc.M116.754887	http://dx.doi.org/10.1074/jbc.M116.754887			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27852822	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000391576300015
J	Janevska, S; Arndt, B; Niehaus, EM; Burkhardt, I; Rosler, SM; Brock, NL; Humpf, HU; Dickschat, JS; Tudzynski, B				Janevska, Slavica; Arndt, Birgit; Niehaus, Eva-Maria; Burkhardt, Immo; Roesler, Sarah M.; Brock, Nelson L.; Humpf, Hans-Ulrich; Dickschat, Jeroen S.; Tudzynski, Bettina			Gibepyrone Biosynthesis in the Rice Pathogen Fusarium fujikuroi Is Facilitated by a Small Polyketide Synthase Gene Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIBBERELLA-FUJIKUROI; SECONDARY METABOLISM; ENDOPHYTIC FUNGUS; SACCHAROMYCES-CEREVISIAE; TRICHODERMA-HARZIANUM; TRANSCRIPTION FACTORS; BIOLOGICAL-ACTIVITY; MASS-SPECTROMETRY; NATURAL-PRODUCTS; SPECIES COMPLEX	The 2H-pyran-2-one gibepyrone A and its oxidized derivatives gibepyrones B-F have been isolated from the rice pathogenic fungus Fusarium fujikuroi already more than 20 years ago. However, these products have not been linked to the respective biosynthetic genes, and therefore, their biosynthesis has not yet been analyzed on a molecular level. Feeding experiments with isotopically labeled precursors clearly supported a polyketide origin for the formal monoterpenoid gibepyrone A, whereas the terpenoid pathway could be excluded. Targeted gene deletion verified that the F. fujikuroi polyketide synthase PKS13, designated Gpy1, is responsible for gibepyrone A biosynthesis. Next to Gpy1, the ATP-binding cassette transporter Gpy2 is encoded by the gibepyrone gene cluster. Gpy2 was shown to have only a minor impact on the actual efflux of gibepyrone A out of the cell. Instead, we obtained evidence that Gpy2 is involved in gene regulation as it represses GPY1 gene expression. Thus, GPY1 was up-regulated and gibepyrone A production was enhanced both extra-and intracellularly in Delta gpy2 mutants. Furthermore, expression of GPY genes is strictly repressed by members of the fungus-specific velvet complex, Vel1, Vel2, and Lae1, whereas Sge1, a major regulator of secondary metabolism in F. fujikuroi, affects gibepyrone biosynthesis in a positive manner. The gibepyrone A derivatives gibepyrones B and D were shown to be produced by cluster-independent P450 monooxygenases, probably to protect the fungus from the toxic product. In contrast, the formation of gibepyrones E and F from gibepyrone A is a spontaneous process and independent of enzymatic activity.	[Janevska, Slavica; Niehaus, Eva-Maria; Roesler, Sarah M.; Tudzynski, Bettina] Westfal Wilhelms Univ Munster, Inst Biol & Biotechnol Pflanzen, Schlosspl 8, D-48143 Munster, Germany; [Arndt, Birgit; Roesler, Sarah M.; Humpf, Hans-Ulrich] Westfal Wilhelms Univ Munster, Inst Lebensmittelchem, Corrensstr 45, D-48149 Munster, Germany; [Burkhardt, Immo; Brock, Nelson L.; Dickschat, Jeroen S.] Rhein Friedrich Wilhelms Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany	University of Munster; University of Munster; University of Bonn	Tudzynski, B (corresponding author), Westfal Wilhelms Univ Munster, Inst Biol & Biotechnol Pflanzen, Schlosspl 8, D-48143 Munster, Germany.; Dickschat, JS (corresponding author), Rhein Friedrich Wilhelms Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	dickschat@uni-bonn.de; tudzynsb@uni-muenster.de	Humpf, Hans-Ulrich/AAV-4845-2020	Janevska, Slavica/0000-0001-7361-495X; Humpf, Hans-Ulrich/0000-0003-3296-3058	German Research Foundation [TU101/16-2, HU730/9-3]; Collaborative Research Centre "Chemistry at Spin Centres" [SFB 813]	German Research Foundation(German Research Foundation (DFG)); Collaborative Research Centre "Chemistry at Spin Centres"	This work was supported by the German Research Foundation (projects TU101/16-2 and HU730/9-3) and by the Collaborative Research Centre SFB 813 "Chemistry at Spin Centres." The authors declare that they have no conflicts of interest with the contents of this article.	ABBAS HK, 1992, MYCOPATHOLOGIA, V118, P115, DOI 10.1007/BF00442540; ABRAHAM WR, 1990, PHYTOCHEMISTRY, V29, P2877, DOI 10.1016/0031-9422(90)87095-C; ABRAHAM WR, 1988, PHYTOCHEMISTRY, V27, P3310, DOI 10.1016/0031-9422(88)80051-7; ABRELL LM, 1994, TETRAHEDRON LETT, V35, P9159, DOI 10.1016/0040-4039(94)88453-6; Ahmed YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001750; Arndt B, 2015, FUNGAL GENET BIOL, V84, P26, DOI 10.1016/j.fgb.2015.09.006; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; AVENT AG, 1992, PHYTOCHEMISTRY, V31, P3447, DOI 10.1016/0031-9422(92)83704-3; BARRERO AF, 1993, TETRAHEDRON, V49, P141, DOI 10.1016/S0040-4020(01)80514-7; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; BENTLEY R, 1967, J AM CHEM SOC, V89, P676, DOI 10.1021/ja00979a036; Bertrand S, 2014, MOL BIOSYST, V10, P2289, DOI 10.1039/c4mb00223g; Bomke C, 2009, PHYTOCHEMISTRY, V70, P1876, DOI 10.1016/j.phytochem.2009.05.020; Bok JW, 2006, MOL MICROBIOL, V61, P1636, DOI 10.1111/j.1365-2958.2006.05330.x; Brock NL, 2013, CHEMBIOCHEM, V14, P311, DOI 10.1002/cbic.201200695; Brock NL, 2011, CHEMBIOCHEM, V12, P2667, DOI 10.1002/cbic.201100516; Burkhardt I, 2016, ANGEW CHEM INT EDIT, V55, P8748, DOI 10.1002/anie.201603782; Cacho RA, 2015, J AM CHEM SOC, V137, P15688, DOI 10.1021/jacs.5b11814; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CLAYDON N, 1987, T BRIT MYCOL SOC, V88, P503, DOI 10.1016/S0007-1536(87)80034-7; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; COLLINS RP, 1972, J AGR FOOD CHEM, V20, P437, DOI 10.1021/jf60180a010; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cook RJ., 1981, FUSARIUM DIS BIOL TA, P104; Cooney JM, 1997, J NAT PROD, V60, P1242, DOI 10.1021/np970337n; Crutcher FK, 2015, MICROBIOL-SGM, V161, P875, DOI 10.1099/mic.0.000043; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; DICKINSON JM, 1993, NAT PROD REP, V10, P71, DOI 10.1039/np9931000071; Dickschat JS, 2014, NAT PROD REP, V31, P838, DOI 10.1039/c3np70080a; Dickschat JS, 2011, EUR J ORG CHEM, V2011, P3339, DOI 10.1002/ejoc.201100188; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Evidente Antonio, 1994, Natural Toxins, V2, P4, DOI 10.1002/nt.2620020103; Gardiner DM, 2005, FUNGAL GENET BIOL, V42, P257, DOI 10.1016/j.fgb.2004.12.001; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; GHISALBERTI EL, 1990, PLANT SOIL, V121, P287, DOI 10.1007/BF00012323; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; JOFFE AZ, 1969, J STORED PROD RES, V5, P211, DOI 10.1016/0022-474X(69)90035-6; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; LEE JC, 1995, CHEM BIOL, V2, P721, DOI 10.1016/1074-5521(95)90100-0; Leslie J F, 2006, Mycotoxin Res, V22, P73, DOI 10.1007/BF02956766; LIGHT RJ, 1966, BIOCHEMISTRY-US, V5, P4037, DOI 10.1021/bi00876a038; Liu D, 2013, HELV CHIM ACTA, V96, P437, DOI 10.1002/hlca.201200195; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; McGlacken GP, 2005, NAT PROD REP, V22, P369, DOI 10.1039/b416651p; Menke J, 2012, MOL PLANT MICROBE IN, V25, P1408, DOI 10.1094/MPMI-04-12-0081-R; Michielse CB, 2015, ENVIRON MICROBIOL, V17, P2690, DOI 10.1111/1462-2920.12592; MOSS MO, 1975, PHYTOCHEMISTRY, V14, P2706, DOI 10.1016/0031-9422(75)85255-1; NAIR MSR, 1975, TETRAHEDRON LETT, P1655; Nguyen VQ, 2008, P NATL ACAD SCI USA, V105, P4880, DOI 10.1073/pnas.0710448105; Niehaus EM, 2016, ENVIRON MICROBIOL, V18, P4282, DOI 10.1111/1462-2920.13576; Niehaus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103336; Niehaus EM, 2014, APPL MICROBIOL BIOT, V98, P1749, DOI 10.1007/s00253-013-5453-1; Niehaus EM, 2013, CHEM BIOL, V20, P1055, DOI 10.1016/j.chembiol.2013.07.004; Nirenberg HI, 1998, MYCOLOGIA, V90, P434, DOI 10.2307/3761403; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Rosler SM, 2016, APPL MICROBIOL BIOT, V100, P5869, DOI 10.1007/s00253-016-7426-7; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Shimizu BI, 2005, Z NATURFORSCH C, V60, P862; Short DPG, 2013, FUNGAL GENET BIOL, V53, P59, DOI 10.1016/j.fgb.2013.01.004; Skellam EJ, 2010, MOL BIOSYST, V6, P680, DOI 10.1039/b923990a; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Studt L, 2016, ENVIRON MICROBIOL, V18, P936, DOI 10.1111/1462-2920.13150; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Tang SG, 2012, REC NAT PROD, V6, P398; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Tudzynski B, 1998, FUNGAL GENET BIOL, V25, P157, DOI 10.1006/fgbi.1998.1095; Turkkan M, 2011, PHYTOPATHOL MEDITERR, V50, P154; UMBREIT MA, 1977, J AM CHEM SOC, V99, P5526, DOI 10.1021/ja00458a072; VENKATASUBBAIAH P, 1991, PHYTOCHEMISTRY, V30, P1471, DOI 10.1016/0031-9422(91)84189-Y; VISCONTI A, 1994, J NAT PROD, V57, P695, DOI 10.1021/np50108a002; Wang DN, 2014, MED MYCOL, V52, P504, DOI 10.1093/mmy/myu007; Wang QX, 2011, FITOTERAPIA, V82, P777, DOI 10.1016/j.fitote.2011.04.002; Wickel SM, 2013, EUR J ORG CHEM, V2013, P2906, DOI 10.1002/ejoc.201300049; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wiemann P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037519; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Yu FG, 2005, FEMS MICROBIOL LETT, V248, P257, DOI 10.1016/j.femsle.2005.05.053	89	29	31	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27403	27420		10.1074/jbc.M116.753053	http://dx.doi.org/10.1074/jbc.M116.753053			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27856636	hybrid, Green Published			2022-12-28	WOS:000391576300036
J	Hu, H; Luo, C; Zheng, YG				Hu, Hao; Luo, Cheng; Zheng, Y. George			Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC DIMETHYLARGININE; SUBSTRATE-SPECIFICITY; FUNCTIONAL INSIGHTS; MOLECULAR-MECHANISM; CRYSTAL-STRUCTURE; KIDNEY-DISEASE; PRMT1; METHYLATION; INHIBITORS; CARM1	Protein arginine methyltransferases (PRMTs) are the enzymes responsible for posttranslational methylation of protein arginine residues in eukaryotic cells, particularly within the histone tails. A detailed mechanistic model of PRMT-catalyzed methylation is currently lacking, but it is essential for understanding the functions of PRMTs in various cellular pathways and for efficient design of PRMT inhibitors as potential treatments for a range of human diseases. In this work, we used stopped-flow fluorescence in combination with global kinetic simulation to dissect the transient kinetics of PRMT1, the predominant type I arginine methyltransferase. Several important mechanistic insights were revealed. The cofactor and the peptide substrate bound to PRMT1 in a random manner and then followed a kinetically preferred pathway to generate the catalytic enzyme-cofactor-substrate ternary complex. Product release proceeded in an ordered fashion, with peptide dissociation followed by release of the byproduct S-adenosylhomocysteine. Importantly, the dissociation rate of the monomethylated intermediate from the ternary complex was much faster than the methyl transfer. Such a result provided direct evidence for distributive arginine dimethylation, which means the monomethylated substrate has to be released to solution and rebind with PRMT1 before it undergoes further methylation. In addition, cofactor binding involved a conformational transition, likely an open-to-closed conversion of the active site pocket. Further, the histone H4 peptide bound to the two active sites of the PRMT1 homodimer with differential affinities, suggesting a negative cooperativity mechanism of substrate binding. These findings provide a new mechanistic understanding of how PRMTs interact with their substrates and transfer methyl groups.	[Hu, Hao; Zheng, Y. George] Univ Georgia, Dept Pharmaceut & Biomed Sci, 250 W Green St, Athens, GA 30602 USA; [Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	University System of Georgia; University of Georgia; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zheng, YG (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, 250 W Green St, Athens, GA 30602 USA.	yzheng@uga.edu	Stefanadis, Christodoulos/ABH-2232-2020; Hu, Hao/AAJ-8523-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Hu, Hao/0000-0003-1365-0267	American Heart Association [12GRNT12070056]; National Institutes of Health [R01 GM086717]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086717] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 12GRNT12070056 and National Institutes of Health Grant R01 GM086717. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bonnefond L, 2015, J STRUCT BIOL, V191, P175, DOI 10.1016/j.jsb.2015.06.017; Boriack-Sjodin PA, 2016, ACS CHEM BIOL, V11, P763, DOI 10.1021/acschembio.5b00773; Bouras G, 2013, CURR TOP MED CHEM, V13, P180, DOI 10.2174/1568026611313020007; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Copeland RA, 2004, ENZYMES PRACTICAL IN; Cura V, 2014, ACTA CRYSTALLOGR D, V70, P2401, DOI 10.1107/S1399004714014278; Cvetkovic T, 2012, J MED BIOCHEM, V31, P301, DOI 10.2478/v10011-012-0029-7; Da LT, 2014, ADV EXP MED BIOL, V805, P29, DOI 10.1007/978-3-319-02970-2_2; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; Feng Y, 2009, BIOCHEM BIOPH RES CO, V379, P567, DOI 10.1016/j.bbrc.2008.12.119; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Gui SY, 2013, BIOCHEMISTRY-US, V52, P199, DOI 10.1021/bi301283t; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Hu H, 2016, EXPERT OPIN INV DRUG, V25, P335, DOI 10.1517/13543784.2016.1144747; Hu H, 2015, J MED CHEM, V58, P1228, DOI 10.1021/jm501452j; Jacques SL, 2016, BIOCHEMISTRY-US, V55, P1635, DOI 10.1021/acs.biochem.5b01071; Johnson K. A., 1992, ENZYMES, P1; Johnson KA, 2013, FEBS LETT, V587, P2753, DOI 10.1016/j.febslet.2013.07.012; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kolbel K, 2009, J BIOL CHEM, V284, P8274, DOI 10.1074/jbc.M809547200; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Larsen SC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7329; Le Romancer M, 2010, STEROIDS, V75, P560, DOI 10.1016/j.steroids.2010.01.013; Lee WC, 2015, BIOCHEMISTRY-US, V54, P7514, DOI 10.1021/acs.biochem.5b00995; Matsuguma K, 2006, J AM SOC NEPHROL, V17, P2176, DOI 10.1681/ASN.2005121379; Morales Y, 2016, ARCH BIOCHEM BIOPHYS, V590, P138, DOI 10.1016/j.abb.2015.11.030; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Obianyo O, 2012, J BIOL CHEM, V287, P6062, DOI 10.1074/jbc.M111.333609; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Raptis V, 2013, NEPHROLOGY, V18, P11, DOI 10.1111/j.1440-1797.2012.01659.x; Sack JS, 2011, BIOCHEM J, V436, P331, DOI 10.1042/BJ20102161; Schapira M, 2014, MEDCHEMCOMM, V5, P1779, DOI 10.1039/c4md00269e; Segel IH., 1993, ENZYME KINETICS BEHA; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Shia WJ, 2012, BLOOD, V119, P4953, DOI 10.1182/blood-2011-04-347476; Sinha SH, 2012, EUR J MED CHEM, V54, P647, DOI 10.1016/j.ejmech.2012.06.017; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P14977, DOI 10.1021/bi050988f; T Hart P, 2012, MEDCHEMCOMM, V3, P1235; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Tymoczko J. L., 2011, BIOCH SHORT COURSE, P606; Wang CY, 2014, STRUCTURE, V22, P756, DOI 10.1016/j.str.2014.03.003; Wang M, 2014, BIOCHEMISTRY-US, V53, P7884, DOI 10.1021/bi501279g; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Wu J, 2012, J BIOMOL SCREEN, V17, P237, DOI 10.1177/1087057111414903; Xie N, 2009, BIOCONJUGATE CHEM, V20, P360, DOI 10.1021/bc800467a; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zheng YG, 2008, MED RES REV, V28, P645, DOI 10.1002/med.20120; Zhou R, 2015, J CHEM INF MODEL, V55, P2623, DOI 10.1021/acs.jcim.5b00454	60	20	20	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26722	26738		10.1074/jbc.M116.757625	http://dx.doi.org/10.1074/jbc.M116.757625			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27834681	Green Published, hybrid			2022-12-28	WOS:000391571400012
J	Liu, Q; Tang, Y; Chen, L; Liu, N; Lang, FF; Liu, H; Wang, P; Sun, XL				Liu, Qiang; Tang, Yu; Chen, Long; Liu, Na; Lang, Fangfang; Liu, Heng; Wang, Pin; Sun, Xiulian			E3 Ligase SCF beta TrCP-induced DYRK1A Protein Degradation Is Essential for Cell Cycle Progression in HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME PROTEOLYTIC PATHWAY; DOWN-SYNDROME; UBIQUITIN LIGASE; KINASE DYRK1A; NEURONAL DIFFERENTIATION; INHIBITS PROLIFERATION; DEPENDENT DEGRADATION; COGNITIVE DEFICITS; ALZHEIMER-DISEASE; FUNCTIONAL-LINK	DYRK1A, located on the Down syndrome (DS) critical region of chromosome 21, was found to be overexpressed in brains of DS and Alzheimer's disease individuals. DYRK1A was considered to play important roles in the pathogenesis of DS and Alzheimer's disease; however, the degradation mechanism of DYRK1A was still unclear. In this study, we found that DYRK1A was degraded through the ubiquitin-proteasome pathway in HEK293 cells. The N terminus of DYRK1A that was highly unstable in HEK293 cells contributed to proteolysis of DYRK1A. E3 ligase SCF beta TrCP mediated ubiquitination and promoted degradation of DYRK1A through an unconserved binding motif ((49)SDQQVSALS(57)) lying in the N terminus. Any Ser-Ala substitution in this motif could decrease the binding between DYRK1A and beta-transducin repeat containing protein (beta TrCP), resulting in stabilization of DYRK1A. We also found DYRK1Aprotein was elevated in theG0/G1 phase and decreased in the S and G(2)/M phase, which was negatively correlated to beta TrCP levels in the HEK293 cell cycle. Knockdown of beta TrCP caused arrest of the G(0)/G(1) phase, which could be partly rescued by down-regulation of DYRK1A. Our study uncovered a new regulatory mechanism of DYRK1A degradation by SCF beta TrCP in HEK293 cell cycle progression.	[Liu, Qiang; Sun, Xiulian] Shandong Univ, Qilu Hosp, Brain Res Inst, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Tang, Yu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250012, Peoples R China; [Chen, Long; Liu, Heng; Wang, Pin; Sun, Xiulian] Shandong Univ, Qilu Hosp, Natl Key Lab Otolaryngol, Jinan 250012, Peoples R China; [Liu, Na] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Peoples R China; [Liu, Qiang] Shandong Univ, Shandong Prov Qianfoshan Hosp, Med Res Ctr, 10766 Jingshi Rd, Jinan 250014, Peoples R China; [Lang, Fangfang] Shandong Univ, Jinan Cent Hosp, Dept Gynecol & Obstet, 105 Jiefang Rd, Jinan 250013, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Sun, XL (corresponding author), Shandong Univ, Qilu Hosp, Brain Res Inst, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	xiulians@gmail.com			National Natural Science Foundation of China [81171030]; Fundamental Research Funds of Shandong University [2015JC035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of Shandong University	This work was supported by National Natural Science Foundation of China Grant 81171030 (to X. S.) and Fundamental Research Funds of Shandong University Grant 2015JC035 (to X. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Chen JY, 2013, MOL CELL, V52, P87, DOI 10.1016/j.molcel.2013.09.009; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Ferron SR, 2010, CELL STEM CELL, V7, P367, DOI 10.1016/j.stem.2010.06.021; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; Hattori K, 1999, J BIOL CHEM, V274, P29641, DOI 10.1074/jbc.274.42.29641; Ishihara K, 2010, CEREB CORTEX, V20, P1131, DOI 10.1093/cercor/bhp176; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Larsen KB, 2008, ANN ANAT, V190, P421, DOI 10.1016/j.aanat.2008.05.007; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Limon-Mortes MC, 2008, J CELL SCI, V121, P1825, DOI 10.1242/jcs.020552; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Liu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098853; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Low TY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005882; Lu M, 2011, J BIOL CHEM, V286, P10755, DOI 10.1074/jbc.M110.174540; Park J, 2010, J BIOL CHEM, V285, P31895, DOI 10.1074/jbc.M110.147520; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Song YC, 2004, BIOCHEM BIOPH RES CO, V317, P128, DOI 10.1016/j.bbrc.2004.03.019; Soppa U, 2014, CELL CYCLE, V13, P2084, DOI 10.4161/cc.29104; Tanzi RE, 1996, NAT MED, V2, P31, DOI 10.1038/nm0196-31; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; Uchida S, 2011, J CELL SCI, V124, P2816, DOI 10.1242/jcs.083931; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Vicari S, 2006, BEHAV GENET, V36, P355, DOI 10.1007/s10519-006-9057-8; Vingtdeux V, 2005, NEUROBIOL DIS, V20, P625, DOI 10.1016/j.nbd.2005.05.004; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; WISNIEWSKI KE, 1990, AM J MED GENET, P274; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010	53	11	12	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26399	26409		10.1074/jbc.M116.717553	http://dx.doi.org/10.1074/jbc.M116.717553			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27807027	Green Published, hybrid			2022-12-28	WOS:000391568200014
J	Van de Velde, LA; Murray, PJ				Van de Velde, Lee-Ann; Murray, Peter J.			Proliferating Helper T Cells Require Rictor/mTORC2 Complex to Integrate Signals from Limiting Environmental Amino Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; CYCLE PROGRESSION; MAMMALIAN TARGET; GLUTAMINE UPTAKE; LEUCINE SENSOR; MTORC1 PATHWAY; ACTIVATION; DIFFERENTIATION; METABOLISM; MECHANISM	Antigen-stimulated T cells require elevated importation of essential and non-essential amino acids to generate large numbers of daughter cells necessary for effective immunity to pathogens. When amino acids are limiting, T cells arrest in the G(1) phase of the cell cycle, suggesting that they have specific sensing mechanisms to ensure sufficient amino acids are available for multiple rounds of daughter generation. We found that activation of mTORC1, which is regulated by amino acid amounts, was uncoupled from limiting amino acids in the G(1) phase of the cell cycle. Instead, we found that Rictor/mTORC2 has an essential role in T cell amino acid sensing. In the absence of Rictor, CD4(+) T cells proliferate normally in limiting arginine or leucine. Our data suggest that Rictor/mTORC2 controls an amino acid-sensitive checkpoint that allows T cells to determine whether the microenvironment contains sufficient resources for daughter cell generation.	[Van de Velde, Lee-Ann; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Van de Velde, Lee-Ann; Murray, Peter J.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.; Murray, PJ (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.murray@stjude.org	Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802	National Institutes of Health [CA189990]; Cancer Center [P30 CA21765]; American Lebanese Syrian Associated Charities	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by National Institutes of Health Grant CA189990 and Cancer Center Core Grant P30 CA21765 (to P. J. M.) and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Carroll B, 2016, ELIFE, V5, DOI 10.7554/eLife.11058; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dyachok J, 2016, J BIOL CHEM, V291, P22414, DOI 10.1074/jbc.M116.732511; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hwang LN, 2006, CANCER RES, V66, P1132, DOI 10.1158/0008-5472.CAN-05-1679; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kinjyo I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7301; Lee JH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2885; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Murray PJ, 2016, NAT IMMUNOL, V17, P132, DOI 10.1038/ni.3323; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Ross SH, 2016, IMMUNITY, V45, P685, DOI 10.1016/j.immuni.2016.07.022; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2016, NATURE, V536, P229, DOI 10.1038/nature19079; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Tato I, 2011, J BIOL CHEM, V286, P6128, DOI 10.1074/jbc.M110.166991; Taylor DK, 2006, J IMMUNOL, V177, P2216, DOI 10.4049/jimmunol.177.4.2216; Van de Velde L. A., 2016, CELL REP IN PRESS; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Werner A, 2016, EUR J IMMUNOL, V46, P92, DOI 10.1002/eji.201546047; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yoon MS, 2016, CELL REP, V16, P1510, DOI 10.1016/j.celrep.2016.07.008	38	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25815	25822		10.1074/jbc.C116.763623	http://dx.doi.org/10.1074/jbc.C116.763623			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27799302	hybrid, Green Published			2022-12-28	WOS:000390345200006
J	Dan, HC; Sun, M; Yang, L; Feldman, RI; Sui, XM; Ou, CC; Nellist, M; Yeung, RS; Halley, DJJ; Nicosia, SV; Pledger, WJ; Cheng, JQ				Dan, Han C.; Sun, Mei; Yang, Lin; Feldman, Richard I.; Sui, Xue-Mei; Ou, Chien Chen; Nellist, Mark; Yeung, Raymond S.; Halley, Dicky J. J.; Nicosia, Santo V.; Pledger, Warren J.; Cheng, Jin Q.			Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin (vol 277, pg 35364, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200	1	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22848	22848		10.1074/jbc.A116.205838	http://dx.doi.org/10.1074/jbc.A116.205838			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825086	Green Published, hybrid			2022-12-28	WOS:000386760600047
J	Guo, JP; Shu, SK; Esposito, NN; Coppola, D; Koomen, JM; Cheng, JQ				Guo, Jian-Ping; Shu, Shao-Kun; Esposito, Nicole N.; Coppola, Domenico; Koomen, John M.; Cheng, Jin Q.			IKK epsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer (vol 285, pg 3676, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Guo JP, 2010, J BIOL CHEM, V285, P3676, DOI 10.1074/jbc.M109.078212	1	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22857	22857		10.1074/jbc.A109.078212	http://dx.doi.org/10.1074/jbc.A109.078212			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825095	Green Published, hybrid			2022-12-28	WOS:000386760600056
J	Yuan, ZQ; Feldman, RI; Sun, M; Olashaw, NE; Coppola, D; Sussman, GE; Shelley, SA; Nicosia, SV; Cheng, JQ				Yuan, Zeng-qiang; Feldman, Richard I.; Sun, Mei; Olashaw, Nancy E.; Coppola, Domenico; Sussman, Gene E.; Shelley, Sue A.; Nicosia, Santo V.; Cheng, Jin Q.			Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial cells (vol 277, pg 29973, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Yuan ZQ, 2002, J BIOL CHEM, V277, P29973, DOI 10.1074/jbc.M203636200	1	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22849	22849		10.1074/jbc.A116.203636	http://dx.doi.org/10.1074/jbc.A116.203636			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825087	Green Published, hybrid			2022-12-28	WOS:000386760600048
J	Li, L; Zhang, QJ; Yang, HQ; Zou, QJ; Lai, CD; Jiang, F; Zhao, P; Luo, ZW; Yang, JY; Chen, Q; Wang, Y; Newsome, PN; Frampton, J; Maxwell, PH; Li, WJ; Chen, SH; Wang, DY; Siu, TS; Tam, S; Tse, HF; Qin, BM; Bao, XC; Esteban, MA; Lai, LX				Li, Li; Zhang, Quanjun; Yang, Huaqiang; Zou, Qingjian; Lai, Chengdan; Jiang, Fei; Zhao, Ping; Luo, Zhiwei; Yang, Jiayin; Chen, Qian; Wang, Yan; Newsome, Philip N.; Frampton, Jon; Maxwell, Patrick H.; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Siu, Tak-Shing; Tam, Sidney; Tse, Hung-Fat; Qin, Baoming; Bao, Xichen; Esteban, Miguel A.; Lai, Liangxue			Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER NUCLEASES; EMBRYONIC STEM-CELLS; LARGE-ANIMAL-MODEL; LIVER REPOPULATION; CARBOCYANINE DYE; RAT BLASTOCYSTS; PIGS; MICROINJECTION; GENERATION; HEPATOCYTES	From the (a)CAS Key Laboratory of Regenerative Biology, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China, and Guangzhou Medical University, Guangzhou 511436, China, (b)CAS Key Laboratory of Regenerative Biology and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China, (c)Laboratory of RNA, Chromatin, and Human Disease, CAS Key Laboratory of Regenerative Biology and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China, (d)Cardiology Division, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China, (e)Hong Kong-Guangdong Stem Cell and Regenerative Medicine Research Centre, The University of Hong Kong and Guangzhou Institutes of Biomedicine and Health, Hong Kong SAR, China, (f)Department of Ophthalmology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China, (g)State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial Research Center for Liver Fibrosis, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital and (h)Biomedical Research Center, Southern Medical University, Guangzhou 510515, China, (i)Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, (j)National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit and Centre for Liver Research, and (k)Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom, (l)Cambridge Institute for Medical Research, Wellcome Trust/Medical Research Council (MRC) Building, Cambridge CB2 0XY, United Kingdom, mDepartment of Clinical Biochemistry Unit, Queen Mary Hospital, Hong Kong SAR, China, (n)Department of Medicine, University of Hong Kong-Shenzhen Hospital, Shenzhen 518053, Guangdong, China, and (o)Laboratory of Metabolism and Cell Fate, CAS Key Laboratory of Regenerative Biology and Guangdong Provincial Key Laboratory of Stem Cells and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, Guangdong, China	[Li, Li; Zhang, Quanjun; Yang, Huaqiang; Zou, Qingjian; Lai, Chengdan; Jiang, Fei; Zhao, Ping; Luo, Zhiwei; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Qin, Baoming; Bao, Xichen; Esteban, Miguel A.; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Joint Sch Life Sci, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Li, Li; Zhang, Quanjun; Yang, Huaqiang; Zou, Qingjian; Lai, Chengdan; Jiang, Fei; Zhao, Ping; Luo, Zhiwei; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Qin, Baoming; Bao, Xichen; Esteban, Miguel A.; Lai, Liangxue] Guangzhou Med Univ, Guangzhou 511436, Guangdong, Peoples R China; [Li, Li; Zhang, Quanjun; Yang, Huaqiang; Zou, Qingjian; Lai, Chengdan; Jiang, Fei; Zhao, Ping; Luo, Zhiwei; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Qin, Baoming; Bao, Xichen; Esteban, Miguel A.; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Li, Li; Zhang, Quanjun; Yang, Huaqiang; Zou, Qingjian; Lai, Chengdan; Jiang, Fei; Zhao, Ping; Luo, Zhiwei; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Qin, Baoming; Bao, Xichen; Esteban, Miguel A.; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cells & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Zhao, Ping; Luo, Zhiwei; Li, Wenjuan; Chen, Shuhan; Wang, Dongye; Bao, Xichen; Esteban, Miguel A.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Lab RNA Chromatin & Human Dis, Guangzhou 510530, Guangdong, Peoples R China; [Yang, Jiayin; Tse, Hung-Fat] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Yang, Jiayin; Tse, Hung-Fat; Esteban, Miguel A.] Univ Hong Kong, Hong Kong Guangdong Stem Cell & Regenerat Med Re, Hong Kong, Hong Kong, Peoples R China; [Yang, Jiayin; Tse, Hung-Fat; Esteban, Miguel A.] Guangzhou Inst Biomed & Hlth, Hong Kong, Hong Kong, Peoples R China; [Chen, Qian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou 510630, Guangdong, Peoples R China; [Wang, Yan] Nanfang Hosp, Dept Infect Dis,State Key Lab Organ Failure Res, Guangdong Prov Res Ctr Liver Fibrosis, Guangdong Prov Key Lab Viral Hepatitis Res, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Yan] Nanfang Hosp, Hepatol Unit, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Yan] Southern Med Univ, Biomed Res Ctr, Guangzhou 510515, Guangdong, Peoples R China; [Newsome, Philip N.] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England; [Newsome, Philip N.] Univ Birmingham, Birmingham Liver Biomed Res Unit, Natl Inst Hlth Res NIHR, Birmingham B15 2TT, W Midlands, England; [Newsome, Philip N.] Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England; [Frampton, Jon] Univ Birmingham, Coll Med & Dent Sci, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Maxwell, Patrick H.] Wellcome Trust Med Res Council MRC Bldg, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Siu, Tak-Shing; Tam, Sidney] Queen Mary Hosp, Dept Clin Biochem Unit, Hong Kong, Hong Kong, Peoples R China; [Tse, Hung-Fat] Univ Hong Kong Shenzhen Hosp, Dept Med, Shenzhen 518053, Guangdong, Peoples R China; [Qin, Baoming] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Lab Metab & Cell Fate, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Medical University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Sun Yat Sen University; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Cambridge; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Esteban, MA; Lai, LX (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Joint Sch Life Sci, CAS Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.; Esteban, MA; Lai, LX (corresponding author), Guangzhou Med Univ, Guangzhou 511436, Guangdong, Peoples R China.	miguel@gibh.ac.cn; lai_liangxue@gibh.ac.cn	Yang, Huaqiang/AAU-6402-2021; Tse, Hung-Fat/C-4426-2009; Newsome, Philip N/D-4495-2018; Maxwell, Patrick H/C-5557-2008	Tse, Hung-Fat/0000-0002-9578-7808; Newsome, Philip N/0000-0001-6085-3652; Maxwell, Patrick H/0000-0002-0338-2679; Tse, Hung Fat/0000-0003-4665-7887; Yang, Huaqiang/0000-0002-4287-0026	National Key Research and Development Program of China [2016YFA0100102]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020106]; National Natural Science Foundation of China (NSFC) [31401275]; Guangdong Province Science and Technology Program [2013B050800010, 2013B060300017, 2014030304010, 2014B030301058, 2014A030312001, 2015B020229002, 2016B030229007]; Guangzhou Science and Technology Cooperation Program [2012J5100040, 201508030027]; Key Deployment Project of the Chinese Academy of Sciences [KSZDEW-Z-005-003-002]; Pearl River Science and Technology Nova Program of Guangzhou [201610010107]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2015294]; Wellcome Trust Senior Investigator Award [096956/Z/11/Z]; NSFC and Hong Kong Research Grants Council Joint Research Fund [81261160506, N-HKU 730/12]; Medical Research Council [MR/K008781/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10122] Funding Source: researchfish; Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish; MRC [MR/K008781/1] Funding Source: UKRI	National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Program; Guangzhou Science and Technology Cooperation Program; Key Deployment Project of the Chinese Academy of Sciences; Pearl River Science and Technology Nova Program of Guangzhou; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Wellcome Trust Senior Investigator Award(Wellcome Trust); NSFC and Hong Kong Research Grants Council Joint Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Key Research and Development Program of China Grant 2016YFA0100102; Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01020106; National Natural Science Foundation of China (NSFC) Grant 31401275; Guangdong Province Science and Technology Program Grants 2013B050800010, 2013B060300017, 2014030304010, 2014B030301058, 2014A030312001, 2015B020229002, and 2016B030229007; Guangzhou Science and Technology Cooperation Program Grants 2012J5100040 and 201508030027; Key Deployment Project of the Chinese Academy of Sciences Grant KSZDEW-Z-005-003-002; Pearl River Science and Technology Nova Program of Guangzhou Grant 201610010107; Youth Innovation Promotion Association of the Chinese Academy of Sciences Grant 2015294; Wellcome Trust Senior Investigator Award 096956/Z/11/Z (to P. H. M.); and NSFC and Hong Kong Research Grants Council Joint Research Fund Grants 81261160506 and N-HKU 730/12. The authors declare that they have no conflicts of interest with the contents of this article.	Ashorn Merja, 2006, Paediatr Drugs, V8, P47, DOI 10.2165/00148581-200608010-00004; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bosze Z, 2006, WORLD RABBIT SCI, V14, P1; BREM G, 1985, ZUCHTHYGIENE, V20, P251; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Elgilani F, 2017, AM J PATHOL, V187, P33, DOI 10.1016/j.ajpath.2016.09.013; Ferrari A, 2001, J BIOMED MATER RES, V56, P361, DOI 10.1002/1097-4636(20010905)56:3<361::AID-JBM1104>3.0.CO;2-4; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gissen P, 2003, J INHERIT METAB DIS, V26, P13, DOI 10.1023/A:1024011110116; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Grompe M, 2001, SEMIN LIVER DIS, V21, P563, DOI 10.1055/s-2001-19035; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Hickey RD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3838; Hickey RD, 2014, STEM CELL RES, V13, P144, DOI 10.1016/j.scr.2014.05.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ji DN, 2015, TRANSGENIC RES, V24, P227, DOI 10.1007/s11248-014-9834-8; Kuijk EW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22154; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; Macsai MS, 2001, AM J OPHTHALMOL, V132, P522, DOI 10.1016/S0002-9394(01)01160-6; Nakamura K, 2007, J NUTR, V137, p1556S, DOI 10.1093/jn/137.6.1556S; REESE JA, 1981, IN VITRO CELL DEV B, V17, P935; RUSSO P, 1990, AM J HUM GENET, V47, P317; Schauwvlieghe PP, 2013, CORNEA, V32, P91, DOI 10.1097/ICO.0b013e318243e474; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; Tian J, 2012, REPROD DOMEST ANIM, V47, P544, DOI 10.1111/j.1439-0531.2011.01915.x; Trautwein C, 1998, J CLIN INVEST, V101, P1960, DOI 10.1172/JCI504; Vogel A, 2004, HEPATOLOGY, V39, P433, DOI 10.1002/hep.20077; Wang Yu, 2014, Cell Regen, V3, P3, DOI 10.1186/2045-9769-3-3; Wu MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24360; Yan Quanmei, 2014, Cell Regen, V3, P12, DOI 10.1186/2045-9769-3-12; Yang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25161; Yang DS, 2011, CELL RES, V21, P979, DOI 10.1038/cr.2011.70; Yuan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22024; Zhang LD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31460; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020; Zou QJ, 2015, J MOL CELL BIOL, V7, P580, DOI 10.1093/jmcb/mjv061	47	13	14	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 10	2017	292	11					4755	4763		10.1074/jbc.M116.764787	http://dx.doi.org/10.1074/jbc.M116.764787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP7VK	28053091	Green Published, hybrid			2022-12-28	WOS:000397585100031
J	Swenson, AM; Tang, WJ; Blair, CA; Fetrow, CM; Unrath, WC; Previs, MJ; Campbell, KS; Yengo, CM				Swenson, Anja M.; Tang, Wanjian; Blair, Cheavar A.; Fetrow, Christopher M.; Unrath, William C.; Previs, Michael J.; Campbell, Kenneth S.; Yengo, Christopher M.			Omecamtiv Mecarbil Enhances the Duty Ratio of Human -Cardiac Myosin Resulting in Increased Calcium Sensitivity and Slowed Force Development in Cardiac Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cardiac muscle; contractile protein; molecular motor; myosin; calcium sensitivity	SYSTOLIC HEART-FAILURE; BINDING PROTEIN-C; CONTRACTILE PROPERTIES; MOTILE PROPERTIES; ATPASE ACTIVITY; STEP-SIZE; ACTIN; ACTIVATOR; MOTOR; CARDIOMYOPATHY	The small molecule drug omecamtiv mecarbil (OM) specifically targets cardiac muscle myosin and is known to enhance cardiac muscle performance, yet its impact on human cardiac myosin motor function is unclear. We expressed and purified human -cardiac myosin subfragment 1 (M2-S1) containing a C-terminal Avi tag. We demonstrate that the maximum actin-activated ATPase activity of M2-S1 is slowed more than 4-fold in the presence of OM, whereas the actin concentration required for half-maximal ATPase was reduced dramatically (30-fold). We find OM does not change the overall actin affinity. Transient kinetic experiments suggest that there are two kinetic pathways in the presence of OM. The dominant pathway results in a slow transition between actomyosinADP states and increases the time myosin is strongly bound to actin. However, OM also traps a population of myosin heads in a weak actin affinity state with slow product release. We demonstrate that OM can reduce the actin sliding velocity more than 100-fold in the in vitro motility assay. The ionic strength dependence of in vitro motility suggests the inhibition may be at least partially due to drag forces from weakly attached myosin heads. OM causes an increase in duty ratio examined in the motility assay. Experiments with permeabilized human myocardium demonstrate that OM increases calcium sensitivity and slows force development (k(tr)) in a concentration-dependent manner, whereas the maximally activated force is unchanged. We propose that OM increases the myosin duty ratio, which results in enhanced calcium sensitivity but slower force development in human myocardium.	[Swenson, Anja M.; Tang, Wanjian; Fetrow, Christopher M.; Unrath, William C.; Yengo, Christopher M.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA; [Blair, Cheavar A.; Campbell, Kenneth S.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Blair, Cheavar A.; Campbell, Kenneth S.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40536 USA; [Previs, Michael J.] Univ Vermont, Cardiovasc Res Inst, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Kentucky; University of Kentucky; University of Vermont	Yengo, CM (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	cmy11@psu.edu		Touma, Anja/0000-0001-9953-9695; Blair, Cheavar/0000-0002-0289-439X; Tang, Wanjian/0000-0001-7374-6442	American Heart Association [14GRNT20380068, 15GRNT25460003]; National Institutes of Health [R01HL127699, UL1TR000117, R00HL124041]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127699, R00HL124041] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 14GRNT20380068 and National Institutes of Health Grant R01HL127699 (to C. M. Y.), American Heart Association Grant 15GRNT25460003 and National Institutes of Health Grant UL1TR000117 (to K. S. C.), and National Institutes of Health Grant R00HL124041 (to M. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksel T, 2015, CELL REP, V11, P910, DOI 10.1016/j.celrep.2015.04.006; Albet-Torres N, 2009, J BIOL CHEM, V284, P22926, DOI 10.1074/jbc.M109.019232; Bakkehaug JP, 2015, CIRC-HEART FAIL, V8, P766, DOI 10.1161/CIRCHEARTFAILURE.114.002152; Batters C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00090; Blair C. A., 2016, VAD J, V2, P12, DOI 10.13023/VAD.2016.12; Braunwald E, 2013, CIRC RES, V113, P633, DOI 10.1161/CIRCRESAHA.113.302254; Brizendine RK, 2015, P NATL ACAD SCI USA, V112, P11235, DOI 10.1073/pnas.1510241112; Campbell KS, 2003, AM J PHYSIOL-HEART C, V285, pH2857, DOI 10.1152/ajpheart.00295.2003; CHALOVICH JM, 1984, BIOCHEMISTRY-US, V23, P4885, DOI 10.1021/bi00316a011; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Fewell JG, 1998, J CLIN INVEST, V101, P2630, DOI 10.1172/JCI2825; Geeves MA, 2016, BIOPOLYMERS, V105, P483, DOI 10.1002/bip.22853; Greenberg BH, 2015, JACC-HEART FAIL, V3, P22, DOI 10.1016/j.jchf.2014.07.009; GREENE LE, 1978, P NATL ACAD SCI USA, V75, P54, DOI 10.1073/pnas.75.1.54; Haldeman BD, 2014, J BIOL CHEM, V289, P21055, DOI 10.1074/jbc.M114.564740; Haynes P, 2014, J MOL CELL CARDIOL, V72, P1, DOI 10.1016/j.yjmcc.2014.02.008; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; Kron S. J., 1991, METH ENZYMOL, V196, P399, DOI [10.1016/0076-6879(91)96035-P, DOI 10.1016/0076-6879(91)96035-P]; Lin TM, 2005, J BIOL CHEM, V280, P41562, DOI 10.1074/jbc.M508653200; Liu YY, 2015, BIOCHEMISTRY-US, V54, P1963, DOI 10.1021/bi5015166; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Malnasi-Csizmadia A, 2010, TRENDS BIOCHEM SCI, V35, P684, DOI 10.1016/j.tibs.2010.07.012; Mamidi R, 2015, J MOL CELL CARDIOL, V85, P262, DOI 10.1016/j.yjmcc.2015.06.011; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Moss RL, 2015, CIRC RES, V116, P183, DOI 10.1161/CIRCRESAHA.116.300561; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Nag S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500511; Nagy L., 2015, BRIT J PHARMACOL, V2015; Noguchi T, 2003, J MOL CELL CARDIOL, V35, P91, DOI 10.1016/S0022-2828(02)00282-1; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Petersen John W, 2008, Crit Care Med, V36, pS106, DOI 10.1097/01.CCM.0000296273.72952.39; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Quintero OA, 2010, J BIOL CHEM, V285, P35770, DOI 10.1074/jbc.M110.144360; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sheikh F, 2014, TRENDS CARDIOVAS MED, V24, P133, DOI 10.1016/j.tcm.2013.07.004; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SMITH DA, 1995, BIOPHYS J, V69, P524, DOI 10.1016/S0006-3495(95)79926-X; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Teerlink JR, 2016, J AM COLL CARDIOL, V67, P1444, DOI 10.1016/j.jacc.2016.01.031; Teerlink JR, 2009, HEART FAIL REV, V14, P243, DOI 10.1007/s10741-009-9153-y; Trivedi DV, 2015, P NATL ACAD SCI USA, V112, P14593, DOI 10.1073/pnas.1517566112; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; Utter MS, 2015, J CARDIOVASC PHARM, V66, P347, DOI 10.1097/FJC.0000000000000286; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Van Dijk J, 1998, BIOCHEMISTRY-US, V37, P8385, DOI 10.1021/bi980139a; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wang YH, 2014, BIOCHEMISTRY-US, V53, P5298, DOI 10.1021/bi500730t; Winkelmann DA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8974; Wulf SF, 2016, P NATL ACAD SCI USA, V113, pE1844, DOI 10.1073/pnas.1516598113	58	53	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 3	2017	292	9					3768	3778		10.1074/jbc.M116.748780	http://dx.doi.org/10.1074/jbc.M116.748780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8DW	28082673	Green Published, hybrid			2022-12-28	WOS:000395542500019
J	Du, KY; Murakami, S; Sun, YM; Kilpatrick, CL; Luscher, B				Du, Keyong; Murakami, Shoko; Sun, Yingmin; Kilpatrick, Casey L.; Luscher, Bernhard			DHHC7 Palmitoylates Glucose Transporter 4 (Glut4) and Regulates Glut4 Membrane Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER DOMAIN; SERTOLI-CELL GENE; PROTEIN PALMITOYLATION; GLUCOSE-TRANSPORTER; GABA(A) RECEPTORS; INSULIN; IDENTIFICATION; PHOSPHORYLATION; TRAFFICKING; ASSOCIATION	Insulin-dependent translocation of glucose transporter 4 (Glut4) to the plasma membrane plays a key role in the dynamic regulation of glucose homeostasis. Werecently showed that this process is critically dependent on palmitoylation of Glut4 at Cys-223. To gain further insights into the regulation of Glut4 palmitoylation, we set out to identify the palmitoyl acyltransferase (PAT) involved. Here we report that among 23 mammalian DHHC proteins, DHHC7 is the major Glut4 PAT, based on evidence that ectopic expression of DHHC7 increased Glut4 palmitoylation, whereas DHHC7 knockdown in 3T3-L1 adipocytes andDHHC7KOin adipose tissue and muscle decreased Glut4 palmitoylation. Moreover, inactivation of DHHC7 suppressed insulin-dependent Glut4 membrane translocation in both 3T3-L1 adipocytes and primary adipocytes. Finally, DHHC7 KO mice developed hyperglycemia and glucose intolerance, thereby confirming that DHHC7 represents the principal PAT for Glut4 and that this mechanism is essential for insulin- regulated glucose homeostasis.	[Du, Keyong; Sun, Yingmin] Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA; [Murakami, Shoko; Kilpatrick, Casey L.; Luscher, Bernhard] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Kilpatrick, Casey L.; Luscher, Bernhard] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Kilpatrick, Casey L.; Luscher, Bernhard] Penn State Univ, Ctr Mol Invest Neurol Disorders, University Pk, PA 16802 USA	Tufts Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Du, KY (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA.	kdu@tuftsmedicalcenter.org	Luscher, Bernhard/C-3528-2009	Luscher, Bernhard/0000-0003-1375-1906	National Institutes of Health [DK084319, MH062391, MH083911]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084319, R56DK084319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH062391, RC1MH089111, R01MH083911, R01MH062391, R01MH099851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants DK084319 (NIDDK; to K.D.) and MH062391 and MH083911 (to B.L.). This work was also supported by a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chaudhary J, 2002, ENDOCRINOLOGY, V143, P426, DOI 10.1210/en.143.2.426; Cheatham B, 2000, TRENDS ENDOCRIN MET, V11, P356, DOI 10.1016/S1043-2760(00)00308-8; Ding JX, 2009, MOL CELL BIOL, V29, P1459, DOI 10.1128/MCB.00754-08; Du KY, 2015, ADIPOCYTE, V4, P286, DOI 10.1080/21623945.2015.1048051; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; EBINA Y, 1985, P NATL ACAD SCI USA, V82, P8014, DOI 10.1073/pnas.82.23.8014; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gonzalez Montoro A, 2013, BIOCHEM J, V454, P427, DOI 10.1042/BJ20121693; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, BIOCHEM SOC T, V38, P522, DOI 10.1042/BST0380522; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hoffman NJ, 2011, TRENDS ENDOCRIN MET, V22, P110, DOI 10.1016/j.tem.2010.12.001; Hornemann T, 2015, J INHERIT METAB DIS, V38, P179, DOI 10.1007/s10545-014-9753-0; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Kilpatrick CL, 2016, J BIOL CHEM, V291, P27371, DOI 10.1074/jbc.M116.732768; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Lai JB, 2013, J BIOL CHEM, V288, P22862, DOI 10.1074/jbc.M113.458794; Lampson MA, 2000, J CELL SCI, V113, P4065; Lievens PMJ, 2016, MOL CELL BIOL, V36, P2208, DOI 10.1128/MCB.00144-16; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Martin BR, 2013, BIOCHEM SOC T, V41, P43, DOI 10.1042/BST20120271; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2012, J BIOL CHEM, V287, P34337, DOI 10.1074/jbc.M112.379297; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Omata W, 1997, BIOCHEM BIOPH RES CO, V241, P401, DOI 10.1006/bbrc.1997.7810; POULIOT JF, 1995, BBA-BIOMEMBRANES, V1234, P191, DOI 10.1016/0005-2736(94)00272-Q; Ren WY, 2015, BIOCHEM BIOPH RES CO, V460, P709, DOI 10.1016/j.bbrc.2015.03.094; Ren WY, 2013, MOL CELL BIOL, V33, P4255, DOI 10.1128/MCB.00527-13; Ren WY, 2013, ADIPOCYTE, V2, P17, DOI 10.4161/adip.22117; Ren WY, 2013, J BIOL CHEM, V288, P10902, DOI 10.1074/jbc.M112.369371; Ren WY, 2012, J BIOL CHEM, V287, P26890, DOI 10.1074/jbc.M112.357699; Ross SA, 1997, BIOCHEM BIOPH RES CO, V239, P247, DOI 10.1006/bbrc.1997.7459; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sorek N, 2009, CURR OPIN PLANT BIOL, V12, P714, DOI 10.1016/j.pbi.2009.09.003; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Wei XC, 2014, ARTERIOSCL THROM VAS, V34, P346, DOI 10.1161/ATVBAHA.113.302848; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200	55	33	33	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2979	2991		10.1074/jbc.M116.747139	http://dx.doi.org/10.1074/jbc.M116.747139			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28057756	hybrid, Green Published			2022-12-28	WOS:000395535100037
J	Shen, ZN; Li, YR; Gasparski, AN; Abeliovich, H; Greenberg, ML				Shen, Zheni; Li, Yiran; Gasparski, Alexander N.; Abeliovich, Hagai; Greenberg, Miriam L.			Cardiolipin Regulates Mitophagy through the Protein Kinase C Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-AUTOPHAGOSOMAL STRUCTURE; SUPPRESSES TEMPERATURE SENSITIVITY; SACCHAROMYCES-CEREVISIAE; BARTH-SYNDROME; STATIONARY-PHASE; UP-REGULATION; YEAST; MITOCHONDRIAL; PHOSPHORYLATION; COMPLEX	Cardiolipin (CL), the signature phospholipid of mitochondrial membranes, is important for cardiovascular health, and perturbation of CL metabolism is implicated in cardiovascular disease. Although the role of CL in mitochondrial function, biogenesis, and genome stability has been studied, recent findings indicate that it is essential for functions apart from mitochondrial bioenergetics. In this study, we report that mitophagy is perturbed in CL-deficient yeast cells. Mutants of autophagy/ mitophagy genes ATG8, ATG18, and ATG32 synthetically interact with CL synthase mutant crd1 Delta. CL-deficient cells exhibited decreased GFP-tagged mitochondrial proteins inside the vacuole and decreased free GFP, consistent with decreased mitophagy. Both PKC and high osmolarity glycerol (HOG) MAPK pathways were shown previously to be required for mitophagy. Activation of both MAPKs was defective in CL-deficient cells. Deletion of HOG pathway genes SHO1, SSK1, STE50, and HOG1 exacerbated crd1 Delta growth. 1 M sorbitol and 0.2 M NaCl, which induce the HOG pathway, rescued growth of the mutant. Activation of the MAPK Slt2p was defective in crd1 Delta cells, and up-regulation of the PKC pathway by expression of the PKC1(R398P) gene, which encodes constitutively activated Pkc1p, rescued crd1 Delta growth and mitophagy defects. These findings indicate that loss of CL impairs MAPK pathway activation, and decreased activation of thePKCpathway leads to defective mitophagy.	[Shen, Zheni; Li, Yiran; Gasparski, Alexander N.; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA; [Abeliovich, Hagai] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel	Wayne State University; Hebrew University of Jerusalem	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mgreenberg@wayne.edu	Gasparski, Alexander/K-7918-2019	Gasparski, Alexander/0000-0002-6012-4887	National Institutes of Health [R01 HL117880]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01 HL117880. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Baba M, 1995, CELL STRUCT FUNCT, V20, P465, DOI 10.1247/csf.20.465; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Bessa C, 2013, FEMS YEAST RES, V13, P700, DOI 10.1111/1567-1364.12069; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Conboy MJ, 2000, MOL BIOL CELL, V11, P2429, DOI 10.1091/mbc.11.7.2429; Farre JC, 2013, EMBO REP, V14, P441, DOI 10.1038/embor.2013.40; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Gaspard GJ, 2015, J BIOL CHEM, V290, P9284, DOI 10.1074/jbc.M115.641878; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Hage-Sleiman R, 2016, IMMUNOL RES, V64, P869, DOI 10.1007/s12026-016-8787-9; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; Hsu P, 2015, AUTOPHAGY, V11, P643, DOI 10.1080/15548627.2015.1023984; Huwiler A, 1996, P NATL ACAD SCI USA, V93, P6959, DOI 10.1073/pnas.93.14.6959; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Journo D, 2009, J BIOL CHEM, V284, P35885, DOI 10.1074/jbc.M109.048140; Kanki T, 2009, AUTOPHAGY, V5, P1186, DOI 10.4161/auto.5.8.9854; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kofinger J, 2015, STRUCTURE, V23, P809, DOI 10.1016/j.str.2015.02.012; Li SC, 2012, EUKARYOT CELL, V11, P282, DOI 10.1128/EC.05198-11; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Sakoh-Nakatogawa M, 2015, FEBS LETT, V589, P744, DOI 10.1016/j.febslet.2015.02.003; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Shen ZN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/891707; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Valianpour F, 2002, J PEDIATR-US, V141, P729, DOI 10.1067/mpd.2002.129174; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200; Zhou JM, 2009, J BIOL CHEM, V284, P18106, DOI 10.1074/jbc.M109.003236	55	48	49	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2916	2923		10.1074/jbc.M116.753574	http://dx.doi.org/10.1074/jbc.M116.753574			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28062576	Green Published, hybrid			2022-12-28	WOS:000395535100031
J	Mir, S; Cai, WK; Andres, DA				Mir, Sajad; Cai, Weikang; Andres, Douglas A.			RIT1 GTPase Regulates Sox2 Transcriptional Activity and Hippocampal Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; ELEMENT-BINDING PROTEIN; ADULT NEUROGENESIS; NEURONAL DIFFERENTIATION; MOUSE FIBROBLASTS; DIRECT CONVERSION; BRAIN; ACTIVATION; MAINTENANCE; ASTROCYTES	Adult neurogenesis, the process of generating mature neurons from neuronal progenitor cells, makes critical contributions to neural circuitry and brain function in both healthy and disease states. Neurogenesis is a highly regulated process in which diverse environmental and physiological stimuli are relayed to resident neural stem cell populations to control the transcription of genes involved in self-renewal and differentiation. Understanding the molecular mechanisms governing neurogenesis is necessary for the development of translational strategies to harness this process for neuronal repair. Here we report that the Ras-related GTPase RIT1 serves to control the sequential proliferation and differentiation of adult hippocampal neural progenitor cells, with in vivo expression of active RIT1 driving robust adult neurogenesis. Gene expression profiling analysis demonstrates increased expression of a specific set of transcription factors known to govern adult neurogenesis in response to active RIT1 expression in the hippocampus, including sex-determining region Y-related HMG box 2 (Sox2), a well established regulator of stem cell self-renewal and neurogenesis. In adult hippocampal neuronal precursor cells, RIT1 controls an Akt-dependent signaling cascade, resulting in the stabilization and transcriptional activation of phosphorylated Sox2. This study supports a role for RIT1 in relaying niche-derived signals to neural/stem progenitor cells to control transcription of genes involved in self-renewal and differentiation.	[Mir, Sajad; Cai, Weikang; Andres, Douglas A.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, B283 BBSRB,741 S Limestone St, Lexington, KY 40536 USA; [Cai, Weikang] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02215 USA	University of Kentucky; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Andres, DA (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, B283 BBSRB,741 S Limestone St, Lexington, KY 40536 USA.	dandres@uky.edu	Cai, Weikang/K-2394-2019	Cai, Weikang/0000-0001-5638-0805	NINDS, National Institutes of Health [R01 NS045103]; Kentucky Spinal Cord and Head Injury Research Trust Grant [12-1A]; Kentucky Lung Cancer research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045103] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Kentucky Spinal Cord and Head Injury Research Trust Grant; Kentucky Lung Cancer research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NINDS, National Institutes of Health Grant R01 NS045103, Kentucky Spinal Cord and Head Injury Research Trust Grant 12-1A, and a Kentucky Lung Cancer research grant. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Alunni A, 2016, DEVELOPMENT, V143, P741, DOI 10.1242/dev.122796; Amador-Arjona A, 2015, P NATL ACAD SCI USA, V112, pE1936, DOI 10.1073/pnas.1421480112; Archer TC, 2011, DEV BIOL, V350, P429, DOI 10.1016/j.ydbio.2010.12.013; Berger AH, 2014, ONCOGENE, V33, P4418, DOI 10.1038/onc.2013.581; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115602; Cai WK, 2012, J NEUROSCI, V32, P9887, DOI 10.1523/JNEUROSCI.0375-12.2012; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Conover JC, 2008, CELL TISSUE RES, V331, P211, DOI 10.1007/s00441-007-0503-6; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep22490; Gotz M., 2016, COLD SPRING HARB PER, V8, P1; Guo WX, 2012, NAT PROTOC, V7, P2005, DOI 10.1038/nprot.2012.123; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Heinrich C, 2014, STEM CELL REP, V3, P1000, DOI 10.1016/j.stemcr.2014.10.007; Heng JCD, 2010, ADV EXP MED BIOL, V695, P76, DOI 10.1007/978-1-4419-7037-4_6; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lee CHJ, 1996, J NEUROSCI, V16, P6784; Lein PJ, 2007, J NEUROSCI, V27, P4725, DOI 10.1523/JNEUROSCI.5633-06.2007; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mir S, 2014, MOL CELL, V56, P786, DOI 10.1016/j.molcel.2014.10.019; Miyagi S, 2009, CELL MOL LIFE SCI, V66, P3675, DOI 10.1007/s00018-009-0097-0; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Niu WZ, 2015, STEM CELL REP, V4, P780, DOI 10.1016/j.stemcr.2015.03.006; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Park DH, 2014, CELL REP, V8, P1290, DOI 10.1016/j.celrep.2014.07.060; Poulou M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00127; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shi GX, 2013, CELL SIGNAL, V25, P2060, DOI 10.1016/j.cellsig.2013.06.002; Shi GX, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.384248; Shi GX, 2011, MOL CELL BIOL, V31, P1938, DOI 10.1128/MCB.01380-10; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telley L, 2016, SCIENCE, V351, P1443, DOI 10.1126/science.aad8361; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Wang J, 2016, CELL DEATH DIFFER, V23, P393, DOI 10.1038/cdd.2015.106; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	57	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2017	292	6					2054	2064		10.1074/jbc.M116.749770	http://dx.doi.org/10.1074/jbc.M116.749770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7ZG	28007959	Green Published, hybrid			2022-12-28	WOS:000395530300001
J	Back, CR; Sztukowska, MN; Till, M; Lamont, RJ; Jenkinson, HF; Nobbs, AH; Race, PR				Back, Catherine R.; Sztukowska, Maryta N.; Till, Marisa; Lamont, Richard J.; Jenkinson, Howard F.; Nobbs, Angela H.; Race, Paul R.			The Streptococcus gordonii Adhesin CshA Protein Binds Host Fibronectin via a Catch-Clamp Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; bacterial pathogenesis; intrinsically disordered protein; microbiology; small-angle X-ray scattering (SAXS); X-ray crystallography	CELL-SURFACE; SECONDARY STRUCTURE; ANTIGEN-I/II; SWISS-MODEL; CRYSTAL-STRUCTURE; V-REGION; PREDICTION; HYDROPHOBICITY; DETERMINANTS; POLYPEPTIDES	Adherence of bacteria to biotic or abiotic surfaces is a prerequisite for host colonization and represents an important step in microbial pathogenicity. This attachment is facilitated by bacterial adhesins at the cell surface. Because of their size and often elaborate multidomain architectures, these polypeptides represent challenging targets for detailed structural and functional characterization. The multifunctional fibrillar adhesin CshA, which mediates binding to both host molecules and other microorganisms, is an important determinant of colonization by Streptococcus gordonii, an oral commensal and opportunistic pathogen of animals and humans. CshA binds the high-molecular-weight glycoprotein fibronectin (Fn) via an N-terminal non-repetitive region, and this protein-protein interaction has been proposed to promote S. gordonii colonization at multiple sites within the host. However, the molecular details of how these two proteins interact have yet to be established. Here we present a structural description of the Fn binding N-terminal region of CshA, derived from a combination of X-ray crystallography, small angle X-ray scattering, and complementary biophysical methods. In vitro binding studies support a previously unreported two-state catch-clamp mechanism of Fn binding by CshA, in which the disordered N-terminal domain of CshA acts to catch Fn, via formation of a rapidly assembled but also readily dissociable pre-complex, enabling its neighboring ligand binding domain to tightly clamp the two polypeptides together. This study presents a new paradigm for target binding by a bacterial adhesin, the identification of which will inform future efforts toward the development of anti-adhesive agents that target S. gordonii and related streptococci.	[Back, Catherine R.; Jenkinson, Howard F.; Nobbs, Angela H.] Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England; [Sztukowska, Maryta N.; Lamont, Richard J.] Univ Louisville, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA; [Sztukowska, Maryta N.] Univ Informat Technol & Management, Dept Dent, PL-35225 Rzeszow, Poland; [Till, Marisa; Race, Paul R.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Till, Marisa; Race, Paul R.] Univ Bristol, BrisSynBio Synthet Biol Res Ctr, Life Sci Bldg,Tyndall Ave, Bristol BS8 1TQ, Avon, England	University of Bristol; University of Louisville; University of Information Technology & Management Rzeszow; University of Bristol; University of Bristol	Nobbs, AH (corresponding author), Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England.; Race, PR (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	Angela.Nobbs@bristol.ac.uk; paul.race@bristol.ac.uk	Nobbs, Angela/AAS-3926-2020; Jenkinson, Howard/AAD-9282-2022; Jenkinson, Howard/ABI-1842-2020	Nobbs, Angela/0000-0003-3813-4410; Sztukowska, Maryta/0000-0002-5774-5092	National Institutes of Health Grants [DE016690, DE012505]; Biotechnology and Biological Sciences Research Council Grant [BB/I006478/1]; Royal Society University Research Fellowship Award [UF080534]; BBSRC [BB/I006478/1, BB/L01386X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L01386X/1, BB/I006478/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012505, R01DE016690] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University Research Fellowship Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health Grants DE016690 (to H. F. J. and R. J. L.) and DE012505 (to R. J. L.), Biotechnology and Biological Sciences Research Council Grant BB/I006478/1 (to P. R. R.), and Royal Society University Research Fellowship Award UF080534 (to P. R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Attwood TK, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas019; Back CR, 2015, MOL ORAL MICROBIOL, V30, P411, DOI 10.1111/omi.12106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Brittan JL, 2015, MICROBES INFECT, V17, P360, DOI 10.1016/j.micinf.2014.12.013; Bryson K, 2007, CURR PROTEIN PEPT SC, V8, P181, DOI 10.2174/138920307780363415; Cid M, 2010, J BIOL CHEM, V285, P35999, DOI 10.1074/jbc.M110.166330; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Demuyser L, 2014, PATHOG DIS, V70, P219, DOI 10.1111/2049-632X.12123; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Forsgren N, 2009, PROTEIN SCI, V18, P1896, DOI 10.1002/pro.200; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Giomarelli B, 2006, FEMS MICROBIOL LETT, V265, P172, DOI 10.1111/j.1574-6968.2006.00479.x; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Gruszka DT, 2012, P NATL ACAD SCI USA, V109, pE1011, DOI 10.1073/pnas.1119456109; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hirt H, 2000, J BACTERIOL, V182, P2299, DOI 10.1128/JB.182.8.2299-2306.2000; Holmes AR, 1996, INFECT IMMUN, V64, P4680, DOI 10.1128/IAI.64.11.4680-4685.1996; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Jakubovics NS, 2009, MICROBIOL-SGM, V155, P3572, DOI 10.1099/mic.0.032078-0; Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005; JENKINSON HF, 1987, J GEN MICROBIOL, V133, P1909; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lofling J, 2011, CELL MICROBIOL, V13, P186, DOI 10.1111/j.1462-5822.2010.01560.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCNAB R, 1994, MOL MICROBIOL, V14, P743, DOI 10.1111/j.1365-2958.1994.tb01311.x; McNab R, 1996, INFECT IMMUN, V64, P4204, DOI 10.1128/IAI.64.10.4204-4210.1996; McNab R, 1999, J BACTERIOL, V181, P3087, DOI 10.1128/JB.181.10.3087-3095.1999; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moschioni M, 2010, MICROB BIOTECHNOL, V3, P370, DOI 10.1111/j.1751-7915.2009.00138.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nylander A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063768; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Plewczynski D, 2007, POLYMER, V48, P5493, DOI 10.1016/j.polymer.2007.07.039; Rego S, 2016, J BIOL CHEM, V291, P15985, DOI 10.1074/jbc.M116.726562; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; Uversky VN, 2015, FEBS J, V282, P1182, DOI 10.1111/febs.13202; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011	73	17	17	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1538	1549		10.1074/jbc.M116.760975	http://dx.doi.org/10.1074/jbc.M116.760975			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27920201	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000395515600001
J	Ran, YC; Thibodeau, PH				Ran, Yanchao; Thibodeau, Patrick H.			Stabilization of Nucleotide Binding Domain Dimers Rescues ABCC6 Mutants Associated with Pseudoxanthoma Elasticum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; biosynthesis; calcification; protein stability; protein structure; abcc6; pseudoxanthoma elasticum	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS MUTATION; INTRACELLULAR TRAFFICKING; ECTOPIC MINERALIZATION; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; P-GLYCOPROTEIN; IN-VIVO; CFTR; TRANSPORTER	ABC transporters are polytopic membrane proteins that utilize ATP binding and hydrolysis to facilitate transport across biological membranes. Forty-eight human ABC transporters have been identified in the genome, and the majority of these are linked to heritable disease. Mutations in the ABCC6 (ATP binding cassette transporter C6) ABC transporter are associated with pseudoxanthoma elasticum, a disease of altered elastic properties in multiple tissues. Although similar to 200 mutations have been identified in pseudoxanthoma elasticum patients, the underlying structural defects associated with the majority of these are poorly understood. To evaluate the structural consequences of these missense mutations, a combination of biophysical and cell biological approaches were applied to evaluate the local and global folding and assembly of the ABCC6 protein. Structural and bioinformatic analyses suggested that a cluster of mutations, representing roughly 20% of the patient population with identified missense mutations, are located in the interface between the transmembrane domain and the C-terminal nucleotide binding domain. Biochemical and cell biological analyses demonstrate these mutations influence multiple steps in the biosynthetic pathway, minimally altering local domain structure but adversely impacting ABCC6 assembly and trafficking. The differential impacts on local and global protein structure are consistent with hierarchical folding and assembly of ABCC6. Stabilization of specific domain-domain interactions via targeted amino acid substitution in the catalytic site of the C-terminal nucleotide binding domain restored proper protein trafficking and cell surface localization of multiple biosynthetic mutants. This rescue provides a specific mechanism by which chemical chaperones could be developed for the correction of ABCC6 biosynthetic defects.	[Ran, Yanchao; Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, 450 Technol Dr,517 Bridgeside Point 2, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thibodeau, PH (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, 450 Technol Dr,517 Bridgeside Point 2, Pittsburgh, PA 15219 USA.	thibodea@pitt.edu			NIDDK; National Institutes of Health Grant [DK083284]; Cystic Fibrosis Foundation Therapeutics Grant [THIBOD13XX0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083284, R56DK083284] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIDDK, National Institutes of Health Grant DK083284 (to P. H. T.). This work was also supported by Cystic Fibrosis Foundation Therapeutics Grant THIBOD13XX0 (to P. H. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aleksandrov LA, 2015, PROTEIN EXPRES PURIF, V116, P159, DOI 10.1016/j.pep.2015.09.018; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai J, 2002, BIOCHEMISTRY-US, V41, P8058, DOI 10.1021/bi012082p; Chan KM, 2000, J GEN PHYSIOL, V116, P163, DOI 10.1085/jgp.116.2.163; Chaptal V., 2014, BIOCHEM PHARMACOL, V3, P150; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; GOODMAN RM, 1963, MEDICINE, V42, P297, DOI 10.1097/00005792-196309000-00001; Gorgels TGMF, 2005, HUM MOL GENET, V14, P1763, DOI 10.1093/hmg/ddi183; Gyimesi G, 2012, HUM MUTAT, V33, P1547, DOI 10.1002/humu.22138; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hirai M, 2011, BLOOD, V117, P500, DOI 10.1182/blood-2010-05-284737; Hosen MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102779; Ilias A, 2002, J BIOL CHEM, V277, P16860, DOI 10.1074/jbc.M110918200; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jiang QJ, 2009, J INVEST DERMATOL, V129, P348, DOI 10.1038/jid.2008.212; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Klement JF, 2005, MOL CELL BIOL, V25, P8299, DOI 10.1128/MCB.25.18.8299-8310.2005; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Marconi B, 2015, INTRACTABLE RARE DIS, V4, P113, DOI 10.5582/irdr.2015.01014; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Plomp AS, 2008, MOL VIS, V14, P118; Pollet JF, 2000, BBA-MOL BASIS DIS, V1500, P59, DOI 10.1016/S0925-4439(99)00088-5; Pomozi V, 2014, J INVEST DERMATOL, V134, P946, DOI 10.1038/jid.2013.482; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; Uitto J, 2014, EXPERT OPIN ORPHAN D, V2, P567, DOI 10.1517/21678707.2014.908702; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Xue P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097360; YANG YP, 1993, HUM MOL GENET, V2, P1253, DOI 10.1093/hmg/2.8.1253; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	59	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1559	1572		10.1074/jbc.M116.759811	http://dx.doi.org/10.1074/jbc.M116.759811			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994049	Green Published, hybrid			2022-12-28	WOS:000395515600003
J	Stam, NJ; Wilkens, S				Stam, Nicholas J.; Wilkens, Stephan			Structure of the Lipid Nanodisc-reconstituted Vacuolar ATPase Proton Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						EM; isothermal titration calorimetry (ITC); protein structure; proton transport; vacuolar ATPase; V-o proton channel; lipid nanodisc	RENAL TUBULAR-ACIDOSIS; YEAST V-ATPASE; H+-ATPASE; CRYSTAL-STRUCTURE; SUBUNIT; ACIDIFICATION; CELLS; V-1; PUMP; PURIFICATION	Eukaryotic vacuolar H+-ATPase (V-ATPase) is a multisub-unit enzyme complex that acidifies subcellular organelles and the extracellular space. V-ATPase consists of soluble V-1-ATPase and membrane-integral V-o proton channel sectors. To investigate the mechanism of V-ATPase regulation by reversible disassembly, we recently determined a cryo-EM reconstruction of yeast V-o. The structure indicated that, when V-1 is released from V-o, the N-terminal cytoplasmic domain of subunit a (a(NT)) changes conformation to bind rotor subunit d. However, insufficient resolution precluded a precise definition of the a(NT)-d interface. Here we reconstituted V-o into lipid nanodiscs for single-particle EM. 3D reconstructions calculated at similar to 15-angstrom resolution revealed two sites of contact between a(NT) and d that are mediated by highly conserved charged residues. Alanine mutagenesis of some of these residues disrupted the a(NT)-d interaction, as shown by isothermal titration calorimetry and gel filtration of recombinant subunits. A recent cryo-EM study of holo V-ATPase revealed three major conformations corresponding to three rotational states of the central rotor of the enzyme. Comparison of the three V-ATPase conformations with the structure of nanodisc-bound V-o revealed that V-o is halted in rotational state 3. Combined with our prior work that showed autoinhibited V-1-ATPase to be arrested in state 2, we propose a model in which the conformational mismatch between free V-1 and V-o functions to prevent unintended reassembly of holo V-ATPase when activity is not needed.	[Stam, Nicholas J.; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [GM058600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM058600 (to S.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; Brown D, 1997, J EXP BIOL, V200, P257; Chung JH, 2003, J BIOL CHEM, V278, P28872, DOI 10.1074/jbc.M300943200; Couoh-Cardel S, 2015, J BIOL CHEM, V290, P27959, DOI 10.1074/jbc.M115.662494; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Diab HI, 2013, J BIOL CHEM, V288, P11366, DOI 10.1074/jbc.M112.419259; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Inoue H, 1999, BBA-BIOENERGETICS, V1413, P130, DOI 10.1016/S0005-2728(99)00096-1; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kartner N, 2014, EXPERT OPIN DRUG DIS, V9, P505, DOI 10.1517/17460441.2014.902155; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Muench SP, 2014, J MOL BIOL, V426, P286, DOI 10.1016/j.jmb.2013.09.018; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Oot RA, 2016, EMBO J, V35, P1694, DOI 10.15252/embj.201593447; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Smardon AM, 2015, J BIOL CHEM, V290, P27511, DOI 10.1074/jbc.M115.667634; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Thudium CS, 2012, CURR PROTEIN PEPT SC, V13, P141; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vavassori S, 2014, J CELL BIOL, V205, P7, DOI 10.1083/jcb.201403040; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Williamson W Ryan, 2010, Commun Integr Biol, V3, P604, DOI 10.4161/cib.3.6.13364; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Xu YQ, 2012, J BIOL CHEM, V287, P26409, DOI 10.1074/jbc.M112.352229; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001; ZHANG JM, 1994, J BIOL CHEM, V269, P23518; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	53	15	15	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1749	1761		10.1074/jbc.M116.766790	http://dx.doi.org/10.1074/jbc.M116.766790			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27965356	Green Published, hybrid			2022-12-28	WOS:000395515600017
J	Inaba, S; Numoto, N; Ogawa, S; Morii, H; Ikura, T; Abe, R; Ito, N; Oda, M				Inaba, Satomi; Numoto, Nobutaka; Ogawa, Shuhei; Morii, Hisayuki; Ikura, Teikichi; Abe, Ryo; Ito, Nobutoshi; Oda, Masayuki			Crystal Structures and Thermodynamic Analysis Reveal Distinct Mechanisms of CD28 Phosphopeptide Binding to the Src Homology 2 (SH2) Domains of Three Adaptor Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRB2; GADS; CORECEPTOR; ACTIVATION; 3-KINASE; SURFACE; SLP-76; ICOS	Full activation of T cells and differentiation into effector T cells are essential for many immune responses and require costimulatory signaling via the CD28 receptor. Extracellular ligand binding to CD28 recruits protein-tyrosine kinases to its cytoplasmictail, whichcontainsaYMNMmotif. Followingphosphorylation of the tyrosine, the proteins growth factor receptorbound protein 2 (Grb2), Grb2-related adaptor downstream of Shc (Gads), and p85 subunit of phosphoinositide 3-kinase may bind to pYMNM (where pY is phosphotyrosine) via their Src homology 2 (SH2) domains, leading to downstream signaling to distinct immune pathways. These three adaptor proteins bind to the same site on CD28 with variable affinity, and all are important for CD28-mediated co-stimulatory function. However, the mechanism of how these proteins recognize and compete for CD28 is unclear. To visualize their interactions with CD28, we have determined the crystal structures of Gads SH2 and two p85 SH2 domains in complex with a CD28-derived phosphopeptide. The high resolution structures obtained revealed that, whereas the CD28 phosphopeptide bound to Gads SH2 is in a bent conformation similar to that when bound to Grb2 SH2, it adopts a more extended conformation when bound to the N- and C-terminal SH2 domains of p85. These differences observed in the peptide-protein interactions correlated well with the affinity and other thermodynamic parameters for each interaction determined by isothermal titration calorimetry. The detailed insight into these interactions reported here may inform the development of compounds that specifically inhibit the association of CD28 with these adaptor proteins to suppress excessive T cell responses, such as in allergies and autoimmune diseases.	[Inaba, Satomi; Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan; [Numoto, Nobutaka; Ikura, Teikichi; Ito, Nobutoshi] Tokyo Med & Dent Univ, Med Res Inst, Tokyo 1138510, Japan; [Ogawa, Shuhei; Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba 2780022, Japan; [Morii, Hisayuki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Ibaraki 3050074, Japan	Kyoto Prefectural University; Tokyo Medical & Dental University (TMDU); Tokyo University of Science; National Institute of Advanced Industrial Science & Technology (AIST)	Ito, N (corresponding author), Tokyo Med & Dent Univ, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.; Oda, M (corresponding author), Kyoto Prefectural Univ, Sakyo Ku, 1-5 Hangi Cho, Kyoto, Kyoto 6068522, Japan.	ito.str@tmd.ac.jp; oda@kpu.ac.jp	Ikura, Teikichi/T-5912-2019	Inoue, Satomi/0000-0002-6939-1324; Oda, Masayuki/0000-0002-8568-4223	Medical Research Institute, Tokyo Medical and Dental University	Medical Research Institute, Tokyo Medical and Dental University	This work was supported by the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Harada Y, 2003, J EXP MED, V197, P257, DOI 10.1084/jem.20021305; Harada Y, 2001, J BIOL CHEM, V276, P9003, DOI 10.1074/jbc.M005051200; Higo K, 2014, IMMUNOL INVEST, V43, P278, DOI 10.3109/08820139.2013.875039; Higo K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074482; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kraskouskaya D, 2013, CHEM SOC REV, V42, P3337, DOI 10.1039/c3cs35449k; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Law CL, 1999, J EXP MED, V189, P1243, DOI 10.1084/jem.189.8.1243; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Liu BA, 2012, FEBS LETT, V586, P2597, DOI 10.1016/j.febslet.2012.04.054; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNemar C, 1997, BIOCHEMISTRY-US, V36, P10006, DOI 10.1021/bi9704360; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; O'Brien R, 2000, PROTEIN SCI, V9, P570; Oda M, 1998, J MOL BIOL, V276, P571, DOI 10.1006/jmbi.1997.1564; Oda M, 2000, MOL IMMUNOL, V37, P1111, DOI 10.1016/S0161-5890(01)00028-1; Ogawa S, 2013, INT IMMUNOL, V25, P671, DOI 10.1093/intimm/dxt028; Ogura K, 1997, J BIOMOL NMR, V10, P273, DOI 10.1023/A:1018340506337; Papaioannou D, 2016, PROTEIN SCI, V25, P627, DOI 10.1002/pro.2856; Pauptit RA, 2001, ACTA CRYSTALLOGR D, V57, P1397, DOI 10.1107/S0907444901012434; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; Schneider H, 2008, BIOCHEM BIOPH RES CO, V369, P616, DOI 10.1016/j.bbrc.2008.02.068; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Takeda K, 2008, INT IMMUNOL, V20, P1507, DOI 10.1093/intimm/dxn108; Teichmann LL, 2015, IMMUNITY, V42, P552, DOI 10.1016/j.immuni.2015.02.015; Watanabe R, 2006, J IMMUNOL, V177, P1085, DOI 10.4049/jimmunol.177.2.1085; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	15	15	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					1052	1060		10.1074/jbc.M116.755173	http://dx.doi.org/10.1074/jbc.M116.755173			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27927989	hybrid, Green Published			2022-12-28	WOS:000392318700024
J	Pfaff, DH; Fleming, T; Nawroth, P; Teleman, AA				Pfaff, Daniel H.; Fleming, Thomas; Nawroth, Peter; Teleman, Aurelio A.			Evidence Against a Role for the Parkinsonism-associated Protein DJ-1 in Methylglyoxal Detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DJ-1; OXIDATIVE STRESS; GLYOXAL; MUTANTS; GLYCATION; DISEASE	Methylglyoxal (MG) is a reactive metabolite that forms adducts on cysteine, lysine and arginine residues of proteins, thereby affecting their function. Methylglyoxal is detoxified by the Glyoxalase system, consisting of two enzymes, Glo1 and Glo2, that act sequentially to convert MG into D-lactate. Recently, the Parkinsonism-associated protein DJ-1 was described in vitro to have glyoxalase activity, thereby detoxifying the MG metabolite, or deglycase activity, thereby removing the adduct formed by MG on proteins. Since Drosophila is an established model system to study signaling, neurodegeneration, and metabolic regulation in vivo, we asked whether DJ-1 contributes to MG detoxification in vivo. Using both DJ-1 knockdown in Drosophila cells in culture, and DJ-1 beta knock-out flies, we could detect no contribution of DJ-1 to survival to MG challenge or to accumulation of MG protein adducts. Furthermore, we provide data suggesting that the previously reported deglycation activity of DJ-1 can be ascribed to a TRIS buffer artifact.	[Pfaff, Daniel H.; Teleman, Aurelio A.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Pfaff, Daniel H.; Fleming, Thomas; Nawroth, Peter] Univ Heidelberg Hosp, Dept Internal Med & Clin Chem 1, D-69120 Heidelberg, Germany; [Nawroth, Peter] German Ctr Diabet Res DZD, D-85764 Munich, Germany; [Nawroth, Peter] Helmholtz Zentrum, Joint Heidelberg IDC Translat Diabet Program, D-85764 Munich, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association	Teleman, AA (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.; Nawroth, P (corresponding author), Univ Heidelberg Hosp, Dept Internal Med & Clin Chem 1, D-69120 Heidelberg, Germany.; Nawroth, P (corresponding author), German Ctr Diabet Res DZD, D-85764 Munich, Germany.; Nawroth, P (corresponding author), Helmholtz Zentrum, Joint Heidelberg IDC Translat Diabet Program, D-85764 Munich, Germany.	Peter.Nawroth@med.uni-heidelberg.de; a.teleman@dkfz.de	Teleman, Aurelio A/E-6864-2013; Teleman, Aurelio/V-8470-2019	Teleman, Aurelio A/0000-0002-4237-9368; Teleman, Aurelio/0000-0002-4237-9368	DFG [SFB1118]; Helmholtz Portfolio Topic "Metabolic Dysfunction"; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Helmholtz Portfolio Topic "Metabolic Dysfunction"; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the DFG SFB1118 and by the Helmholtz Portfolio Topic "Metabolic Dysfunction." The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2012, INT SCHOLARLY RES NO; Berlanga J, 2005, CLIN SCI, V109, P83, DOI 10.1042/CS20050026; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Golej J, 1998, LIFE SCI, V63, P801, DOI 10.1016/S0024-3205(98)00336-1; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Lavara-Culebras E, 2007, GENE, V400, P158, DOI 10.1016/j.gene.2007.06.013; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Mihoub M, 2015, BIOCHEM BIOPH RES CO, V463, P1305, DOI 10.1016/j.bbrc.2015.06.111; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; Raninga Prahlad V, 2014, Oncoscience, V1, P95; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Richarme G, 2015, J BIOL CHEM, V290, P1885, DOI 10.1074/jbc.M114.597815; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3	18	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					685	690		10.1074/jbc.M116.743823	http://dx.doi.org/10.1074/jbc.M116.743823			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27903648	hybrid, Green Published			2022-12-28	WOS:000392316100023
J	Taylor, A				Taylor, Alexandra			Improving on Nature: James Travis' Work on Recombinant Human alpha(1)-Proteinase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Taylor, Alexandra] Johns Hopkins Univ, Sci & Med Writing, Baltimore, MD 21218 USA	Johns Hopkins University	Taylor, A (corresponding author), Johns Hopkins Univ, Sci & Med Writing, Baltimore, MD 21218 USA.	alexandraataylor@gmail.com						TRAVIS J, 1985, J BIOL CHEM, V260, P4384	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					80	+		10.1074/jbc.O117.000001	http://dx.doi.org/10.1074/jbc.O117.000001			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	28062687	hybrid, Green Published			2022-12-28	WOS:000391578000007
J	Chhum, P; Yu, HT; An, B; Doyon, BR; Lin, YS; Brodsky, B				Chhum, Panharith; Yu, Hongtao; An, Bo; Doyon, Brian R.; Lin, Yu-Shan; Brodsky, Barbara			Consequences of Glycine Mutations in the Fibronectin-binding Sequence of Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I COLLAGEN; TRIPLE-HELIX; OSTEOGENESIS IMPERFECTA; MOLECULAR-DYNAMICS; STRUCTURAL-ANALYSIS; MUTANT COLLAGEN; MODEL PEPTIDES; FORCE-FIELD; PROTEIN; SITES	Collagen and fibronectin (Fn) are two key extracellular matrix proteins, which are known to interact and jointly shape matrix structure and function. Most proteins that interact with collagen bind only to the native triple-helical form, whereas Fn is unusual in binding strongly to denatured collagen and more weakly to native collagen. The consequences of replacing a Gly by Ser at each position in the required (Gly-Xaa-Yaa)(6) Fn-binding sequence are probed here, using model peptides and a recombinant bacterial collagen system. Fluorescence polarization and solid-state assays indicated that Gly replacements at four sites within the Fn-binding sequence led to decreased Fn binding to denatured collagen. Molecular dynamics simulations showed these Gly replacements interfered with the interaction of a collagen beta-strand with the beta-sheet structure of Fn modules seen in the high resolution crystal structure. Whereas previous studies showed that Gly to Ser mutations within an integrin-binding site caused no major structural perturbations, mutations within the Fn-binding site caused the triple helix to become highly sensitive to trypsin digestion. This trypsin susceptibility is consistent with the significant local unfolding and loss of hydrogen bonding seen in molecular dynamics simulations. Protease sensitivity resulting from mutations in the Fn-binding sequence could lead to degradation of type I collagen, early embryonic lethality, and the scarcity of reported osteogenesis imperfecta mutations in this region.	[Chhum, Panharith; Yu, Hongtao; An, Bo; Doyon, Brian R.; Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Yu, Hongtao; Lin, Yu-Shan] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [An, Bo] CSL Behring LLC, Res & Dev, Kankakee, IL 60901 USA; [Doyon, Brian R.] Novartis Inst Biomed Res Inc, 22 Windsor St, Cambridge, MA 02139 USA	Tufts University; Tufts University; CSL; Novartis	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.; Lin, YS (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	Yu-Shan.Lin@tufts.edu; Barbara.Brodsky@tufts.edu	Lin, Yu-Shan/E-2198-2013	Lin, Yu-Shan/0000-0001-6460-2877	National Institutes of Health [GM 60048]; Tufts start-up fund; Knez Family Faculty Investment Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts start-up fund; Knez Family Faculty Investment Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 60048 (to B. B.), the Tufts start-up fund (to Y.-S. L.), and the Knez Family Faculty Investment Fund (to Y.-S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen M. P., 1987, COMPUTER SIMULATION, P64; An B, 2016, ADV DRUG DELIVER REV, V97, P69, DOI 10.1016/j.addr.2015.11.013; An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Brown AM, 2012, BIOCHEMISTRY-US, V51, P5041, DOI 10.1021/bi3002924; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Chellgren BW, 2004, BIOCHEMISTRY-US, V43, P5864, DOI 10.1021/bi049922v; Cheng AL, 1996, J PHYS CHEM-US, V100, P1927, DOI 10.1021/jp951968y; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; DESSAU W, 1978, BIOCHEM J, V169, P55, DOI 10.1042/bj1690055; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; INGHAM KC, 1988, J BIOL CHEM, V263, P4624; Ito H, 2005, J MOL BIOL, V352, P382, DOI 10.1016/j.jmb.2005.07.019; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lingenheil M, 2008, J CHEM THEORY COMPUT, V4, P1293, DOI 10.1021/ct8000365; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Mooney SD, 2001, BIOPOLYMERS, V58, P347, DOI 10.1002/1097-0282(200103)58:3<347::AID-BIP1011>3.0.CO;2-M; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickford AR, 2004, CHEM REV, V104, P3557, DOI 10.1021/cr0304018; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; Rainey JK, 2004, BIOINFORMATICS, V20, P2458, DOI 10.1093/bioinformatics/bth247; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Squeglia F, 2014, J BIOL CHEM, V289, P5122, DOI 10.1074/jbc.M113.523597; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; TANGEMANN K, 1995, FEBS LETT, V358, P179, DOI 10.1016/0014-5793(94)01411-S; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yigit S, 2016, J BIOL CHEM, V291, P19196, DOI 10.1074/jbc.M116.726182; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134	54	15	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27073	27086		10.1074/jbc.M116.753566	http://dx.doi.org/10.1074/jbc.M116.753566			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27799304	Green Published, hybrid			2022-12-28	WOS:000391576300009
J	Vijaykrishna, N; Melangath, G; Kumar, R; Khandelia, P; Bawa, P; Varadarajan, R; Vijayraghavan, U				Vijaykrishna, Nagampalli; Melangath, Geetha; Kumar, Rakesh; Khandelia, Piyush; Bawa, Pushpinder; Varadarajan, Raghavan; Vijayraghavan, Usha			The Fission Yeast Pre-mRNA-processing Factor 18 (prp18(+)) Has Intron-specific Splicing Functions with Links to G(1)-S Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTANTS; AMINO-ACID-SEQUENCE; SCHIZOSACCHAROMYCES-POMBE; 2ND STEP; SACCHAROMYCES-CEREVISIAE; U5 SNRNA; ALLELES MODULATE; CATALYTIC STEPS; BUDDING YEAST; PROTEIN	The fission yeast genome, which contains numerous short introns, is an apt model for studies on fungal splicing mechanisms and splicing by intron definition. Here we perform a domain analysis of the evolutionarily conserved Schizosaccharomyces pombe pre-mRNA-processing factor, SpPrp18. Our mutational and biophysical analyses of the C-terminal alpha-helical bundle reveal critical roles for the conserved region as well as helix five. We generate a novel conditional missense mutant, spprp18-5. To assess the role of SpPrp18, we performed global splicing analyses on cells depleted of prp18(+) and the conditional spprp18-5 mutant, which show widespread but intron-specific defects. In the absence of functional SpPrp18, primer extension analyses on a tfIId(+) intron 1-containing minitranscript show accumulated pre-mRNA, whereas the lariat intron-exon 2 splicing intermediate was undetectable. These phenotypes also occurred in cells lacking both SpPrp18 and SpDbr1 (lariat debranching enzyme), a genetic background suitable for detection of lariat RNAs. These data indicate a major precatalytic splicing arrest that is corroborated by the genetic interaction between spprp18-5 and spprp2-1, a mutant in the early acting U2AF59 protein. Interestingly, SpPrp18 depletion caused cell cycle arrest before S phase. The compromised splicing of transcripts coding for G(1)-S regulators, such as Res2, a transcription factor, and Skp1, a regulated proteolysis factor, are shown. The cumulative effects of SpPrp18-dependent intron splicing partly explain the G1 arrest upon the loss of SpPrp18. Our study using conditional depletion of spprp18(+) and the spprp18-5 mutant uncovers an intron-specific splicing function and early spliceosomal interactions and suggests links with cell cycle progression.	[Vijaykrishna, Nagampalli; Melangath, Geetha; Kumar, Rakesh; Khandelia, Piyush; Bawa, Pushpinder; Vijayraghavan, Usha] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Vijaykrishna, Nagampalli] Cleveland Clin, Genom Med Inst, Lerner Res Inst, 9500 Euclid Ave,NC-22, Cleveland, OH 44195 USA; [Khandelia, Piyush] Singapore Inst Clin Sci, Brenner Ctr Mol Med, 30 Med Dr, Singapore 117609, Singapore	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Cleveland Clinic Foundation; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Vijayraghavan, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	uvr@mcbl.iisc.ernet.in	Bawa, Pushpinder Singh/AAV-4265-2021; NAGAMPALLI, VIJAY/J-8568-2019; Bawa, Pushpinder/AAH-2397-2021; Kumar, Rakesh/AAJ-3616-2020	Bawa, Pushpinder Singh/0000-0002-8370-3638; NAGAMPALLI, VIJAY/0000-0002-0917-3093; Kumar, Rakesh/0000-0001-6852-2655	Department of Biotechnology [BT/PR10725/AGR/36/574/2008]; Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	Department of Biotechnology; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology Grant BT/PR10725/AGR/36/574/2008 (to U. V. R. and R. V.) and infrastructure support from the DBT-IISc Partnership Programme for Advanced Research in Biosciences and Bioengineering, Government of India, Department of Science and Technology-FIST, and University of Grants Commission-Centre for Advanced Studies. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a scholarship from the Council of Scientific and Industrial Research, Government of India.r Recipient of a Research Associate fellowship from the Department of Biotechnology, Government of India.	Alvarez CJ, 2001, RNA, V7, P342, DOI 10.1017/S1355838201002448; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aronova A, 2007, RNA, V13, P1437, DOI 10.1261/rna.572807; AYTE J, 1995, MOL CELL BIOL, V15, P2589; Bacikova D, 2005, MOL CELL BIOL, V25, P2107, DOI 10.1128/MCB.25.6.2107-2116.2005; Bacikova D, 2002, RNA, V8, P1280, DOI 10.1017/S1355838202023099; Banerjee S, 2013, MOL CELL BIOL, V33, P3125, DOI 10.1128/MCB.00007-13; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Burge CB, 1999, RNA WORLD, P525; Carpy A, 2014, MOL CELL PROTEOMICS, V13, P1925, DOI 10.1074/mcp.M113.035824; Chakshusmathi G, 2004, P NATL ACAD SCI USA, V101, P7925, DOI 10.1073/pnas.0402222101; Chawla G, 2003, NUCLEIC ACIDS RES, V31, P2333, DOI 10.1093/nar/gkg333; Chua K, 1999, GENE DEV, V13, P841, DOI 10.1101/gad.13.7.841; Crotti LB, 2007, GENE DEV, V21, P1204, DOI 10.1101/gad.1538207; Crotti LB, 2009, P NATL ACAD SCI USA, V106, P18954, DOI 10.1073/pnas.0907948106; Eckert D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005768; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Habara Y, 2001, RNA, V7, P671, DOI 10.1017/S1355838201001200; Horowitz DS, 2012, WIRES RNA, V3, P331, DOI 10.1002/wrna.112; Horowitz DS, 1997, GENE DEV, V11, P139, DOI 10.1101/gad.11.1.139; HOROWITZ DS, 1993, MOL CELL BIOL, V13, P2959, DOI 10.1128/MCB.13.5.2959; Huang T, 2002, EMBO J, V21, P5516, DOI 10.1093/emboj/cdf555; James SA, 2002, RNA, V8, P1068, DOI 10.1017/S1355838202022033; Jiang JZ, 2000, P NATL ACAD SCI USA, V97, P3022, DOI 10.1073/pnas.97.7.3022; Kaufer NF, 2000, NUCLEIC ACIDS RES, V28, P3003, DOI 10.1093/nar/28.16.3003; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kuhn AN, 2003, CURR GENET, V42, P241, DOI 10.1007/s00294-002-0355-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Liu L, 2007, NAT STRUCT MOL BIOL, V14, P519, DOI 10.1038/nsmb1240; Livesay SB, 2013, EUKARYOT CELL, V12, P1472, DOI 10.1128/EC.00140-13; Lundgren K, 1996, MOL BIOL CELL, V7, P1083, DOI 10.1091/mbc.7.7.1083; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Mishra SK, 2011, NATURE, V474, P173, DOI 10.1038/nature10143; MIYAMOTO M, 1994, EMBO J, V13, P1873, DOI 10.1002/j.1460-2075.1994.tb06456.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moser BA, 2000, CURR OPIN MICROBIOL, V3, P631, DOI 10.1016/S1369-5274(00)00152-1; Munding EM, 2013, MOL CELL, V51, P338, DOI 10.1016/j.molcel.2013.06.012; Nam K, 1997, MOL CELL BIOL, V17, P809, DOI 10.1128/MCB.17.2.809; Patrick KL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005074; POTASHKIN J, 1993, SCIENCE, V262, P573, DOI 10.1126/science.8211184; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Query CC, 2012, RNA, V18, P1001, DOI 10.1261/rna.029421.111; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Romfo CM, 1997, NUCLEIC ACIDS RES, V25, P4658, DOI 10.1093/nar/25.22.4658; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Saha D, 2012, BIOCHEM BIOPH RES CO, V424, P579, DOI 10.1016/j.bbrc.2012.06.156; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sapra AK, 2004, J BIOL CHEM, V279, P52437, DOI 10.1074/jbc.M408815200; Schwelnus W, 2001, EMBO REP, V2, P35, DOI 10.1093/embo-reports/kve009; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; SHEA JE, 1994, NUCLEIC ACIDS RES, V22, P5555, DOI 10.1093/nar/22.25.5555; Sridharan V, 2011, MOL CELL BIOL, V31, P652, DOI 10.1128/MCB.01000-10; Toda T, 1999, PHILOS T ROY SOC B, V354, P1551, DOI 10.1098/rstb.1999.0498; Umen JG, 1995, RNA, V1, P869; Urushiyama S, 1996, MOL GEN GENET, V253, P118, DOI 10.1007/s004380050304; Varadarajan R, 1996, P NATL ACAD SCI USA, V93, P13908, DOI 10.1073/pnas.93.24.13908; VIJAYRAGHAVAN U, 1990, MOL CELL BIOL, V10, P324, DOI 10.1128/MCB.10.1.324; Will CL, 2006, COLD SPRING HARB MON, V43, P369; Zhang XP, 1997, NUCLEIC ACIDS RES, V25, P2146, DOI 10.1093/nar/25.11.2146; Zhou ZL, 1998, EMBO J, V17, P2095, DOI 10.1093/emboj/17.7.2095	65	7	7	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27387	27402		10.1074/jbc.M116.751289	http://dx.doi.org/10.1074/jbc.M116.751289			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27875300	Green Published, hybrid			2022-12-28	WOS:000391576300035
J	Lin, ZJ; Zhang, YG; Xia, YL; Xu, XL; Jiao, XA; Sun, J				Lin, Zhijie; Zhang, Yong-Guo; Xia, Yinglin; Xu, Xiulong; Jiao, Xinan; Sun, Jun			Salmonella enteritidis Effector AvrA Stabilizes Intestinal Tight Junctions via the JNK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; ENTERICA SEROVAR ENTERITIDIS; EPITHELIAL BARRIER FUNCTION; INVASIVE SALMONELLA; UNITED-STATES; CELLS; INFLAMMATION; INFECTION; PROTEINS; RECEPTOR	Salmonella pathogenesis studies to date have focused on Salmonella typhimurium, and the pathogenesis of a second major serotype, Salmonella enteritidis, is poorly understood. Salmonella spp. possess effector proteins that display biochemical activities and modulate host functions. Here, we generated a deletion mutant of the effector AvrA, S.E-AvrA(-), and a plasmid-mediated complementary strain, S.E-AvrA(-)/pAvrA(+) (S.E-AvrA(+)), in S. Enteritidis. Using in vitro and in vivo infection models, we showed that AvrA stabilizes epithelial tight junction (TJ) proteins, such as ZO-1, in human intestinal epithelial cells. Transepithelial electrical resistance was significantly higher in cells infected with S.E-AvrA(+) than in cells infected with S.E-AvrA(-). Inhibition of the JNK pathway suppresses the disassembly of TJ proteins; we found that enteritidis AvrA inhibited JNK activity in cells infected with wild type or S.E-AvrA(+) strains. Therefore, Enteritidis AvrA-induced ZO-1 stability is achieved via suppression of the JNK pathway. Furthermore, the S.E-AvrA(-) strain led to enhanced bacterial invasion, both in vitro and in vivo. Taken together, our data reveal a novel role for AvrA in S. Enteritidis: Enteritidis AvrA stabilizes intestinal TJs and attenuates bacterial invasion. The manipulation of JNK activity and TJs in microbial-epithelial interactions may be a novel therapeutic approach for the treatment of infectious diseases.	[Lin, Zhijie; Xu, Xiulong; Jiao, Xinan; Sun, Jun] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Jiangsu Key Lab Zoonosis, Yangzhou 225009, Jiangsu, Peoples R China; [Xu, Xiulong] Yangzhou Univ, Coll Vet Med, Ctr Comparat Med, Anim Infect Dis Lab, Yangzhou 225009, Jiangsu, Peoples R China; [Lin, Zhijie; Zhang, Yong-Guo; Xia, Yinglin; Sun, Jun] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA; [Xu, Xiulong] Univ Illinois, Dept Anat & Cell Biol, Med Ctr, Chicago, IL 60612 USA	Yangzhou University; Yangzhou University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sun, J (corresponding author), Univ Illinois, Div Gastroenterol & Hepatol, Dept Med, 840 S Wood St,Rm 704 CSB, Chicago, IL 60612 USA.	junsun7@uic.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	NIDDK; National Institutes of Health [1R01DK105118-01]; Swim Across America Cancer Research Award; University of Illinois at Chicago Cancer Center; Projects of International Cooperation and Exchanges National Natural Science Foundation of China [31320103907]; Graduate Research and Innovation Project of Jiangsu Province [KYZZ_0368]; International Program for Ph.D. students from Yangzhou University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105118] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swim Across America Cancer Research Award; University of Illinois at Chicago Cancer Center; Projects of International Cooperation and Exchanges National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Research and Innovation Project of Jiangsu Province; International Program for Ph.D. students from Yangzhou University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant 1R01DK105118-01, a Swim Across America Cancer Research Award, the University of Illinois at Chicago Cancer Center (to J. S.), and Projects of International Cooperation and Exchanges National Natural Science Foundation of China Grant 31320103907. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Graduate Research and Innovation Project of Jiangsu Province Grant KYZZ_0368 and the International Program for Ph.D. students from Yangzhou University.	Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Boyle EC, 2006, CELL MICROBIOL, V8, P1946, DOI 10.1111/j.1462-5822.2006.00762.x; Braden CR, 2006, CLIN INFECT DIS, V43, P512, DOI 10.1086/505973; Carrozzino F, 2009, AM J PHYSIOL-CELL PH, V297, pC775, DOI 10.1152/ajpcell.00084.2009; Chen ML, 2006, INFECT IMMUN, V74, P6581, DOI 10.1128/IAI.00958-06; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Dalbey RE, 2012, FEMS MICROBIOL REV, V36, P1023, DOI 10.1111/j.1574-6976.2012.00327.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Ghosh TS, 2006, AM J INFECT CONTROL, V34, P348, DOI 10.1016/j.ajic.2005.09.010; Ghule VV, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-40; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; GUMBINER BM, 1993, J CELL BIOL, V123, P1631, DOI 10.1083/jcb.123.6.1631; Guppy D., 2007, Morbidity and Mortality Weekly Report, V56, P877; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hubert A, 2004, BIOCHIMIE, V86, P533, DOI 10.1016/j.biochi.2004.07.009; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Katsenos Chrisostomos, 2008, Cases J, V1, P5, DOI 10.1186/1757-1626-1-5; Kobayashi H, 2009, INT J INFECT DIS, V13, pE463, DOI 10.1016/j.ijid.2008.12.015; Kojima T, 2001, J HISTOCHEM CYTOCHEM, V49, P333, DOI 10.1177/002215540104900307; Kojima T, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24894; Kojima T, 2010, J CELL PHYSIOL, V225, P720, DOI 10.1002/jcp.22273; Konno T, 2015, HISTOCHEM CELL BIOL, V143, P471, DOI 10.1007/s00418-014-1300-4; Lane CR, 2014, EMERG INFECT DIS, V20, P1097, DOI 10.3201/eid2007.121850; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Liu Q, 2016, J BIOL CHEM, V291, P4779, DOI 10.1074/jbc.M115.683052; Liu XY, 2011, AM J PHYSIOL-GASTR L, V301, pG992, DOI 10.1152/ajpgi.00080.2011; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131; Misselwitz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002810; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Muramatsu R, 2015, J BIOL CHEM, V290, P11515, DOI 10.1074/jbc.M114.587253; Mutlu H, 2009, J AM SOC ECHOCARDIOG, V22, DOI 10.1016/j.echo.2008.11.017; Naydenov NG, 2009, CELL CYCLE, V8, P2110, DOI 10.4161/cc.8.13.8928; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Ramos-Morales F., 2012, ISRN CELL BIOL, V2012, P1, DOI [10.5402/2012/787934, DOI 10.5402/2012/787934]; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Shaked H, 2012, P NATL ACAD SCI USA, V109, P14007, DOI 10.1073/pnas.1211509109; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Tena D, 2007, J INFECTION, V54, P245, DOI 10.1016/j.jinf.2006.05.007; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Uto T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11273; Van de Walle J, 2010, TOXICOL APPL PHARM, V245, P291, DOI 10.1016/j.taap.2010.03.012; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; Wu SP, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12356; Wu SP, 2015, GUT, V64, P1082, DOI 10.1136/gutjnl-2014-307436; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058606; Zhang YG, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688362.2014.972849	59	34	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26837	26849		10.1074/jbc.M116.757393	http://dx.doi.org/10.1074/jbc.M116.757393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875307	Green Published, hybrid			2022-12-28	WOS:000391571400021
J	Ojelabi, OA; Lloyd, KP; Simon, AH; De Zutter, JK; Carruthers, A				Ojelabi, Ogooluwa A.; Lloyd, Kenneth P.; Simon, Andrew H.; De Zutter, Julie K.; Carruthers, Anthony			WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE GLUCOSE-TRANSPORT; HEXOSE TRANSFER SYSTEM; DEFICIENCY SYNDROME; HUMAN ERYTHROCYTES; MONOSACCHARIDE TRANSPORT; SEQUENCE DETERMINANTS; CYTOCHALASIN-B; CANCER; METABOLISM; GLYCOLYSIS	WZB117 (2-fluoro-6-(m-hydroxybenzoyloxy) phenyl m-hydroxybenzoate) inhibits passive sugar transport in human erythrocytes and cancer cell lines and, by limiting glycolysis, inhibits tumor growth in mice. This study explores how WZB117 inhibits the erythrocyte sugar transporter glucose transport protein 1 (GLUT1) and examines the transporter isoform specificity of inhibition. WZB117 reversibly and competitively inhibits erythrocyte 3-O-methylglucose (3MG) uptake with K-i(app) = 6 mu M but is a noncompetitive inhibitor of sugar exit. Cytochalasin B (CB) is a reversible, noncompetitive inhibitor of 3MG uptake with K-i(app) = 0.3 mu M but is a competitive inhibitor of sugar exit indicating that WZB117 and CB bind at exofacial and endofacial sugar binding sites, respectively. WZB117 inhibition of GLUTs expressed in HEK293 cells follows the order of potency: insulin-regulated GLUT4 >> GLUT1 approximate to neuronal GLUT3. This may explain WZB117-induced murine lipodystrophy. Molecular docking suggests the following. 1) The WZB117 binding envelopes of exofacial GLUT1 and GLUT4 conformers differ significantly. 2) GLUT1 and GLUT4 exofacial conformers present multiple, adjacent glucose binding sites that overlap with WZB117 binding envelopes. 3) The GLUT1 exofacial conformer lacks a CB binding site. 4) The inward GLUT1 conformer presents overlapping endofacial WZB117, D-glucose, and CB binding envelopes. Interrogating the GLUT1 mechanism using WZB117 reveals that subsaturating WZB117 and CB stimulate erythrocyte 3MG uptake. Extracellular WZB117 does not affect CB binding to GLUT1, but intracellular WZB117 inhibits CB binding. These findings are incompatible with the alternating conformer carrier for glucose transport but are consistent with either a multisubunit, allosteric transporter, or a transporter in which each subunit presents multiple, interacting ligand binding sites.	[Ojelabi, Ogooluwa A.; Lloyd, Kenneth P.; Simon, Andrew H.; De Zutter, Julie K.; Carruthers, Anthony] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Room 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK036081, DK044888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044888, R01DK036081, R56DK036081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK036081 and DK044888. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAKER GF, 1978, J PHYSIOL-LONDON, V278, P377, DOI 10.1113/jphysiol.1978.sp012310; Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006; BARNETT JEG, 1973, BIOCHEM J, V131, P211, DOI 10.1042/bj1310211; BARNETT JEG, 1975, BIOCHEM J, V145, P417, DOI 10.1042/bj1450417a; BASKETTER DA, 1978, J PHYSIOL-LONDON, V278, P389, DOI 10.1113/jphysiol.1978.sp012311; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3898, DOI 10.1021/bi00230a014; CARRUTHERS A, 1986, BIOCHEMISTRY-US, V25, P3592, DOI 10.1021/bi00360a018; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Cloherty EK, 2001, BIOCHEMISTRY-US, V40, P15549, DOI 10.1021/bi015586w; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; Cunningham P, 2014, J MEMBRANE BIOL, V247, P1161, DOI 10.1007/s00232-014-9711-7; Cunningham P, 2013, J MEMBRANE BIOL, V246, P495, DOI 10.1007/s00232-013-9564-5; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; De Giorgis V, 2013, SEIZURE-EUR J EPILEP, V22, P803, DOI 10.1016/j.seizure.2013.07.003; De Vivo DC, 2002, J CHILD NEUROL, V17, pS15; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; DEVES R, 1978, BIOCHIM BIOPHYS ACTA, V510, P339, DOI 10.1016/0005-2736(78)90034-2; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; GORGA FR, 1982, BIOCHEMISTRY-US, V21, P1905, DOI 10.1021/bi00537a031; Graybill C, 2006, BIOCHEMISTRY-US, V45, P8096, DOI 10.1021/bi060398x; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HELGERSON AL, 1987, J BIOL CHEM, V262, P5464; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Klepper J, 2008, EPILEPSIA, V49, P46, DOI 10.1111/j.1528-1167.2008.01833.x; KRUPKA RM, 1981, J BIOL CHEM, V256, P5410; Leitch JM, 2009, AM J PHYSIOL-CELL PH, V296, pC151, DOI 10.1152/ajpcell.00359.2008; Li Q, 2004, AM J PHYSIOL-GASTR L, V287, pG236, DOI 10.1152/ajpgi.00396.2003; LIEB WR, 1974, BIOCHIM BIOPHYS ACTA, V373, P178, DOI 10.1016/0005-2736(74)90144-8; Liu Y, 2012, MOL CANCER THER, V11, P1672, DOI 10.1158/1535-7163.MCT-12-0131; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Naftalin RJ, 2003, BRIT J PHARMACOL, V140, P487, DOI 10.1038/sj.bjp.0705460; Palorini R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.257; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Sage JM, 2015, AM J PHYSIOL-CELL PH, V308, pC827, DOI 10.1152/ajpcell.00001.2015; Sage JM, 2014, AM J PHYSIOL-CELL PH, V306, pC910, DOI 10.1152/ajpcell.00044.2014; Segel I. H., 1975, ENZYME KINETICS, P355; Shibuya K, 2015, ONCOTARGET, V6, P651, DOI 10.18632/oncotarget.2892; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Vollers SS, 2012, J BIOL CHEM, V287, P42533, DOI 10.1074/jbc.M112.369587; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Xintaropoulou C, 2015, ONCOTARGET, V6, P25677, DOI 10.18632/oncotarget.4499; Zhang WH, 2010, BIOORG MED CHEM LETT, V20, P2191, DOI 10.1016/j.bmcl.2010.02.027; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	60	54	55	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26762	26772		10.1074/jbc.M116.759175	http://dx.doi.org/10.1074/jbc.M116.759175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27836974	Green Published, hybrid			2022-12-28	WOS:000391571400015
J	Yap, CC; Digilio, L; McMahon, L; Roszkowska, M; Bott, CJ; Kruczek, K; Winckler, B				Yap, Chan Choo; Digilio, Laura; McMahon, Lloyd; Roszkowska, Matylda; Bott, Christopher J.; Kruczek, Kamil; Winckler, Bettina			Different Doublecortin (DCX) Patient Alleles Show Distinct Phenotypes in Cultured Neurons EVIDENCE FOR DIVERGENT LOSS-OF-FUNCTION AND "OFF-PATHWAY" CELLULAR MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; FAMILY PROTEINS; MIGRATION; KINASE; MICE; MICROTUBULE; MUTATIONS; DOMAIN; DEPHOSPHORYLATION; NEUROFASCIN	Doublecortin on the X-chromosome (DCX) is a neuronal microtubule-binding protein with a multitude of roles in neuro-development. In humans, DCX is a major genetic locus for X-linked lissencephaly. The best studied defects are in neuronal migration during corticogenesis and in the hippocampus, as well as axon and dendrite growth defects. Much effort has been directed at understanding the molecular and cellular bases of DCX-linked lissencephaly. The focus has been in particular on defects in microtubule assembly and bundling, using knock-out mice and expression of WT and mutant Dcx in non-neuronal cells. Dcx also binds other proteins besides microtubules, such as spinophilin (abbreviated spn; gene name Ppp1r9b protein phosphatase 1 regulatory subunit 9b) and the clathrin adaptors AP-1 and AP-2. Even though many non-sense and missense mutations of Dcx are known, their molecular and cellular defects are still only incompletely understood. It is also largely unknown how neurons are affected by expression of DCX patient alleles. We have now characterized several patient DCX alleles (DCX-R89G, DCX-R59H, DCX-246X, DCX-272X, and DCX-303X) using a gain-of-function dendrite growth assay in cultured rat neurons in combination with the determination of molecular binding activities and subcellular localization in non-neuronal and neuronal cells. First, we find that several mutants (Dcx-R89G and Dcx-272X) were loss-of-function alleles (as had been postulated) but surprisingly acted via different cellular mechanisms. Second, one allele (Dcx-R59H) formed cytoplasmic aggregates, which contained Hspa1B (heat shock protein 1B hsp70) and ubiquitinated proteins, trapped other cytoskeletal proteins, including spinophilin, and led to increased autophagy. This allele could thus be categorized as "off-pathway"/possibly neomorph. Our findings thus suggested that distinct DCX alleles caused dysfunction by different mechanisms.	[Yap, Chan Choo; Digilio, Laura; McMahon, Lloyd; Roszkowska, Matylda; Bott, Christopher J.; Kruczek, Kamil; Winckler, Bettina] Univ Virginia, Dept Cell Biol, 3703B Pinn Hall,1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA	University of Virginia	Winckler, B (corresponding author), Univ Virginia, Dept Cell Biol, 3703B Pinn Hall,1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	bwinckler@virginia.edu	Roszkowska, Matylda/HGC-4112-2022	Roszkowska, Matylda/0000-0001-9280-8063; Winckler, Bettina/0000-0002-7924-9313	National Institutes of Health [R01NS081674]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS081674 (to B. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Bahi-Buisson N, 2013, BRAIN, V136, P223, DOI 10.1093/brain/aws323; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bazelot M, 2012, EUR J NEUROSCI, V35, P244, DOI 10.1111/j.1460-9568.2011.07962.x; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Cohen D, 2008, DEV NEUROSCI-BASEL, V30, P187, DOI 10.1159/000109862; Corbo JC, 2002, J NEUROSCI, V22, P7548; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dixon-Salazar TJ, 2010, ANN NY ACAD SCI, V1214, P156, DOI 10.1111/j.1749-6632.2010.05819.x; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Friocourt G, 2007, J NEUROSCI, V27, P3875, DOI 10.1523/JNEUROSCI.4530-06.2007; Friocourt G, 2011, ACTA NEUROPATHOL, V121, P149, DOI 10.1007/s00401-010-0768-9; Fu XQ, 2013, J NEUROSCI, V33, P709, DOI 10.1523/JNEUROSCI.4603-12.2013; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Jean DC, 2012, HUM MOL GENET, V21, P5511, DOI 10.1093/hmg/dds395; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Kerjan G, 2009, P NATL ACAD SCI USA, V106, P6766, DOI 10.1073/pnas.0812687106; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Nawabi H, 2015, NEURON, V88, P704, DOI 10.1016/j.neuron.2015.10.005; Pramparo T, 2010, J NEUROSCI, V30, P3002, DOI 10.1523/JNEUROSCI.4851-09.2010; Santra M, 2006, CANCER RES, V66, P11726, DOI 10.1158/0008-5472.CAN-06-1978; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; Shin E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2443; Shmueli A, 2006, MOL CELL NEUROSCI, V32, P15, DOI 10.1016/j.mcn.2006.01.014; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2006, CEREB CORTEX, V16, pI69, DOI 10.1093/cercor/bhk005; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Toriyama M, 2012, J BIOL CHEM, V287, P12691, DOI 10.1074/jbc.M111.316307; Tsukada M, 2003, MECH DEVELOP, V120, P1033, DOI 10.1016/S0925-4773(03)00177-1; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Yap CC, 2012, J NEUROSCI, V32, P7439, DOI 10.1523/JNEUROSCI.5318-11.2012	37	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26613	26626		10.1074/jbc.M116.760777	http://dx.doi.org/10.1074/jbc.M116.760777			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27799303	Green Published, hybrid			2022-12-28	WOS:000391571400003
J	Shu, ST; Emert-Sedlak, LA; Smithgall, TE				Shu, Sherry T.; Emert-Sedlak, Lori A.; Smithgall, Thomas E.			Cell-based Fluorescence Complementation Reveals a Role for HIV-1 Nef Protein Dimerization in AP-2 Adaptor Recruitment and CD4 Co-receptor Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 NEF; CRYSTAL-STRUCTURE; SH3 DOMAIN; T-LYMPHOCYTES; INFECTION; SURFACE; REPLICATION; DETERMINANT; BINDING; AIDS	The HIV-1 Nef accessory factor enhances viral infectivity, immune evasion, and AIDS progression. Nef triggers rapid down-regulation of CD4 via the endocytic adaptor protein 2 ( AP-2) complex, a process linked to enhanced viral infectivity and immune escape. Here, we describe a bimolecular fluorescence complementation ( BiFC) assay to visualize the interaction of Nef with AP-2 and CD4 in living cells. Interacting protein pairs were fused to complementary non-fluorescent fragments of YFP and co-expressed in 293T cells. Nef interactions with both CD4 and AP-2 resulted in complementation of YFP and a bright fluorescent signal by confocal microcopy that localized to the cell periphery. Co-expression of the AP-2 alpha subunit enhanced the Nef.AP-2 sigma 2 subunit BiFC signal and vice versa, suggesting that the AP-2 alpha-sigma 2 hemicomplex interacts cooperatively with Nef. Mutagenesis of Nef amino acids Arg-134, Glu-174, and Asp-175, which stabilize Nef for AP-2 alpha-sigma 2 binding in a recent co-crystal structure, substantially reduced AP-2 interaction without affecting CD4 binding. A dimerization-defective mutant of Nef failed to interact with either CD4 or AP-2 in the BiFC assay, indicating that Nef quaternary structure is required for CD4 and AP-2 recruitment as well as CD4 down-regulation. A small molecule previously shown to bind the Nef dimerization interface also reduced Nef interactions with AP-2 and CD4 and restored CD4 expression to the surface of HIV-infected cells. Our findings provide a mechanistic explanation for previous observations that dimerization-defective Nef mutants fail to down-regulate CD4 and validate the Nef dimerization interface as a target site for antiretroviral drug development.	[Shu, Sherry T.; Emert-Sedlak, Lori A.; Smithgall, Thomas E.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Bridgeside Point 2,Ste 523,450 Technol Dr, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Bridgeside Point 2,Ste 523,450 Technol Dr, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu			National Institutes of Health [AI057083, AI102704, K01 OD018431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102724, R01AI057083] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD018431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants AI057083 and AI102704 (to T.E.S.) and K01 OD018431 (to S.T.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alvarado JJ, 2014, J BIOL CHEM, V289, P28539, DOI 10.1074/jbc.M114.600031; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Doria M, 2011, CURR HIV RES, V9, P490, DOI 10.2174/157016211798842125; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Gondim MV, 2015, J VIROL, V89, P12518, DOI 10.1128/JVI.01838-15; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Jolicoeur P, 2011, CURR HIV RES, V9, P524, DOI 10.2174/157016211798842062; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Paczkowski JE, 2015, TRENDS CELL BIOL, V25, P408, DOI 10.1016/j.tcb.2015.02.005; Pawlak EN, 2015, BBA-GEN SUBJECTS, V1850, P733, DOI 10.1016/j.bbagen.2015.01.003; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Poe JA, 2014, J BIOMOL SCREEN, V19, P556, DOI 10.1177/1087057113513640; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; Richard J, 2015, P NATL ACAD SCI USA, V112, pE2687, DOI 10.1073/pnas.1506755112; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Saksela K, 2011, CURR HIV RES, V9, P531, DOI 10.2174/157016211798842107; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Sloan RD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-44; Smithgall T. E., 2013, DRUG DISCOV TODAY TE, V10, P523; Tarafdar S, 2014, J BIOL CHEM, V289, P15718, DOI 10.1074/jbc.M114.572099; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Watkins RL, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0187-z; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	41	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2017	292	7					2670	2678		10.1074/jbc.M116.770016	http://dx.doi.org/10.1074/jbc.M116.770016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM8BB	28031466	Green Published, hybrid			2022-12-28	WOS:000395535100010
J	Moretti, S; Menicali, E; Nucci, N; Voce, P; Colella, R; Melillo, RM; Liotti, F; Morelli, S; Fallarino, F; Macchiarulo, A; Santoro, M; Avenia, N; Puxeddu, E				Moretti, Sonia; Menicali, Elisa; Nucci, Nicole; Voce, Pasquale; Colella, Renato; Melillo, Rosa Marina; Liotti, Federica; Morelli, Silvia; Fallarino, Francesca; Macchiarulo, Antonio; Santoro, Massimo; Avenia, Nicola; Puxeddu, Efisio			Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell signaling; indoleamine-pyrrole 2; 3-dioxygenase (IDO1); interferon regulatory factor (IRF); signal transducers and activators of transcription 1 (STAT1)	NF-KAPPA-B; THYROID PCCL3 CELLS; KINASE-C-DELTA; DENDRITIC CELLS; GENE-EXPRESSION; STAT1; IDO; PHOSPHORYLATION; RESISTANCE	Indoleamine 2,3-dioxygenase 1 (IDO1) is a single chain oxidoreductase that catalyzes tryptophan degradation to kynurenine. In cancer, it exerts an immunosuppressive function as part of an acquired mechanism of immune escape. Recently, we demonstrated that IDO1 expression is significantly higher in all thyroid cancer histotypes compared with normal thyroid and that its expression levels correlate with T regulatory (Treg) lymphocyte densities in the tumor microenvironment. BRAF(V600E)- and RET/PTC3-expressing PcCL3 cells were used as cellular models for the evaluation of IDO1 expression in thyroid carcinoma cells and for the study of involved signal transduction pathways. BRAF(V600E)-expressing PcCL3 cells did not show IDO1 expression. Conversely, RET/PTC3-expressing cells were characterized by a high IDO1 expression. Moreover, we found that, the STAT1-IRF1 pathway was instrumental for IDO1 expression in RET/PTC3 expressing cells. In detail, RET/PTC3 induced STAT1 overexpression and phosphorylation at Ser-727 and Tyr-701. STAT1 transcriptional regulation appeared to require activation of the canonical NF-B pathway. Conversely, activation of the MAPK and PI3K-AKT pathways primarily regulated Ser-727 phosphorylation, whereas a physical interaction between RET/PTC3 and STAT1, followed by a direct tyrosine phosphorylation event, was necessary for STAT1 Tyr-701 phosphorylation. These data provide the first evidence of a direct link between IDO1 expression and the oncogenic activation of RET in thyroid carcinoma and describe the involved signal transduction pathways. Moreover, they suggest possible novel molecular targets for the abrogation of tumor microenvironment immunosuppression. The detection of those targets is becoming increasingly important to yield the full function of novel immune checkpoint inhibitors.	[Moretti, Sonia; Menicali, Elisa; Nucci, Nicole; Voce, Pasquale; Morelli, Silvia; Puxeddu, Efisio] Univ Perugia, Dept Med, I-06100 Perugia, Italy; [Colella, Renato; Fallarino, Francesca] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Macchiarulo, Antonio] Univ Perugia, Dept Pharmaceut Sci, I-06100 Perugia, Italy; [Avenia, Nicola] Univ Perugia, Dept Surg & Biomed Sci, I-06100 Perugia, Italy; [Moretti, Sonia; Menicali, Elisa; Nucci, Nicole; Voce, Pasquale; Morelli, Silvia; Avenia, Nicola; Puxeddu, Efisio] Univ Perugia, Res Ctr Thyroid Prote & Genom CRiProGeT, I-05100 Terni, Italy; [Melillo, Rosa Marina; Liotti, Federica; Santoro, Massimo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Melillo, Rosa Marina] CNR, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy	University of Perugia; University of Perugia; University of Perugia; University of Perugia; University of Perugia; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Puxeddu, E (corresponding author), Edificio D,Piano 2,Piazza L Severi 1, I-06132 Perugia, Italy.	efisio.puxeddu@unipg.it	Liotti, Federica/AAC-1614-2019; Macchiarulo, Antonio/L-2846-2017; Avenia, Nicola/AAL-4546-2021; melillo, rosa marina/O-5255-2015; Fallarino, Francesca/O-3358-2013	Liotti, Federica/0000-0002-0145-988X; Macchiarulo, Antonio/0000-0001-9535-4183; Fallarino, Francesca/0000-0002-8501-2136	Fondazione Cassa di Risparmio di Perugia; Associazione Italiana per la Ricerca sul Cancro [IG 9338]; Beadle Family Foundation; Brunello Cucinelli Foundation	Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Beadle Family Foundation; Brunello Cucinelli Foundation	This work was supported by grants from the Fondazione Cassa di Risparmio di Perugia, Associazione Italiana per la Ricerca sul Cancro (IG 9338), and a liberal contribution from the Beadle Family Foundation (San Antonio, TX) and the Brunello Cucinelli Foundation (Corciano, Italy) (all to E.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Carlomagno F, 2004, ONCOGENE, V23, P6056, DOI 10.1038/sj.onc.1207810; Carlomagno F, 2002, CANCER RES, V62, P1077; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Hwang ES, 2004, MOL ENDOCRINOL, V18, P2672, DOI 10.1210/me.2004-0168; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Menicali Elisa, 2012, Front Endocrinol (Lausanne), V3, P67, DOI 10.3389/fendo.2012.00067; Mitsutake N, 2006, ENDOCRINOLOGY, V147, P1014, DOI 10.1210/en.2005-0280; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Moretti S, 2014, J CLIN ENDOCR METAB, V99, pE832, DOI 10.1210/jc.2013-3351; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Neely RJ, 2011, ONCOGENE, V30, P87, DOI 10.1038/onc.2010.396; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogasawara N, 2009, J CELL BIOCHEM, V108, P716, DOI 10.1002/jcb.22308; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Puxeddu E, 2005, ENDOCR-RELAT CANCER, V12, P319, DOI 10.1677/erc.1.00947; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wang JW, 2003, MOL ENDOCRINOL, V17, P1425, DOI 10.1210/me.2003-0041	32	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1785	1797		10.1074/jbc.M116.745448	http://dx.doi.org/10.1074/jbc.M116.745448			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27994058	hybrid, Green Published			2022-12-28	WOS:000395515600020
J	Taylor, NG; Swenson, S; Harris, NJ; Germany, EM; Fox, JL; Khalimonchuk, O				Taylor, Nicholas G.; Swenson, Samantha; Harris, Nicholas J.; Germany, Edward M.; Fox, Jennifer L.; Khalimonchuk, Oleh			The Assembly Factor Pet117 Couples Heme a Synthase Activity to Cytochrome Oxidase Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c oxidase (Complex IV); heme; mitochondria; mitochondrial disease; oligomerization; Cox15; Pet117	SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL FERREDOXIN; COX1 MATURATION; YEAST; PROTEIN; BIOGENESIS; CENTERS; MSS51P; OMA1; COA2	Heme a is an essential metalloporphyrin cofactor of the mitochondrial respiratory enzyme cytochrome c oxidase (CcO). Its synthesis from heme b requires several enzymes, including the evolutionarily conserved heme a synthase (Cox15). Oligomerization of Cox15 appears to be important for the process of heme a biosynthesis and transfer to maturing CcO. However, the details of this process remain elusive, and the roles of any additional CcO assembly factors that may be involved remain unclear. Here we report the systematic analysis of one such uncharacterized assembly factor, Pet117, and demonstrate in Saccharomyces cerevisiae that this evolutionarily conserved protein is necessary for Cox15 oligomerization and function. Pet117 is shown to reside in the mitochondrial matrix, where it is associated with the inner membrane. Pet117 functions at the later maturation stages of the core CcO subunit Cox1 that precede Cox1 hemylation. Pet117 also physically interacts with Cox15 and specifically mediates the stability of Cox15 oligomeric complexes. This Cox15-Pet117 interaction observed by co-immunoprecipitation persists in the absence of heme a synthase activity, is dependent upon Cox1 synthesis and early maturation steps, and is further dependent upon the presence of the matrix-exposed, unstructured linker region of Cox15 needed for Cox15 oligomerization, suggesting that this region mediates the interaction or that the interaction is lost when Cox15 is unable to oligomerize. Based on these findings, it was concluded that Pet117 mediates coupling of heme a synthesis to the CcO assembly process in eukaryotes.	[Taylor, Nicholas G.; Harris, Nicholas J.; Fox, Jennifer L.] Coll Charleston, Dept Chem & Biochem, 66 George St, Charleston, SC 29424 USA; [Swenson, Samantha; Germany, Edward M.; Khalimonchuk, Oleh] Univ Nebraska, Dept Biochem, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA; [Swenson, Samantha; Germany, Edward M.; Khalimonchuk, Oleh] Univ Nebraska, Nebraska Redox Biol Ctr, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA	College of Charleston; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Fox, JL (corresponding author), Coll Charleston, Dept Chem & Biochem, 66 George St, Charleston, SC 29424 USA.; Khalimonchuk, O (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA.; Khalimonchuk, O (corresponding author), Univ Nebraska, Nebraska Redox Biol Ctr, 1901 Vine St,N230 BEAD, Lincoln, NE 68588 USA.	foxjl@cofc.edu; okhalimonchuk2@unl.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678; Swenson, Samantha/0000-0002-5650-3841	National Institutes of Health [P30GM103335, R01GM108975, T32 GM107001-01A1,, 5 P20 RR016461, 8 P20 GM103499]; Research Corporation for Science Advancement [22643]; NSF-Major Research Instrumentation [CHE1229559]; College of Charleston Summer Undergraduate Research with Faculty; Howard Hughes Medical Institute through the Pre-college and Undergraduate Science Education Program [52007537]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK110858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, R01GM108975, P20GM103499, T32GM107001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Corporation for Science Advancement(Research Corporation for Science Advancement); NSF-Major Research Instrumentation(National Science Foundation (NSF)); College of Charleston Summer Undergraduate Research with Faculty; Howard Hughes Medical Institute through the Pre-college and Undergraduate Science Education Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P30GM103335 (to the Nebraska Redox Biology Center), R01GM108975 (to O.K.), T32 GM107001-01A1, 5 P20 RR016461, and 8 P20 GM103499; Cottrell College Science Award 22643 (to J. L.F.) from the Research Corporation for Science Advancement; NSF-Major Research Instrumentation Grant CHE1229559 (to J.L.F. as co- principal investigator); College of Charleston Summer Undergraduate Research with Faculty grants (to J.L.F., N.G.T., and N.J.H.); and Howard Hughes Medical Institute Grant 52007537 through the Pre-college and Undergraduate Science Education Program (to the College of Charleston). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atkinson A, 2010, J BIOL CHEM, V285, P19450, DOI 10.1074/jbc.M110.109793; Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barros MH, 2002, J BIOL CHEM, V277, P9997, DOI 10.1074/jbc.M112025200; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bestwick M, 2010, MOL CELL BIOL, V30, P172, DOI 10.1128/MCB.00869-09; Bohovych I, 2014, J BIOL CHEM, V289, P13259, DOI 10.1074/jbc.M113.542910; Broadley SA, 2001, MOL CELL BIOL, V21, P7663, DOI 10.1128/MCB.21.22.7663-7672.2001; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khalimonchuk E, 2005, MITOCHONDRION, V5, P363, DOI 10.1016/j.mito.2005.08.002; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2006, EUKARYOT CELL, V5, P997, DOI 10.1128/EC.00092-06; Khalimonchuk O, 2012, J BIOL CHEM, V287, P26715, DOI 10.1074/jbc.M112.377200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; Kim HJ, 2012, BBA-MOL CELL RES, V1823, P1604, DOI 10.1016/j.bbamcr.2012.04.008; MCEWEN JE, 1993, CURR GENET, V23, P9, DOI 10.1007/BF00336742; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Swenson S, 2016, J BIOL CHEM, V291, P10411, DOI 10.1074/jbc.M115.707539; Veniamin S, 2011, FREE RADICAL BIO MED, V51, P1589, DOI 10.1016/j.freeradbiomed.2011.06.024	37	27	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1815	1825		10.1074/jbc.M116.766980	http://dx.doi.org/10.1074/jbc.M116.766980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27998984	Green Published, hybrid			2022-12-28	WOS:000395515600023
J	Ueda, F; Tago, K; Tamura, H; Funakoshi-Tago, M				Ueda, Fumihito; Tago, Kenji; Tamura, Hiroomi; Funakoshi-Tago, Megumi			Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erythropoietin; Janus kinase (JAK); mutant; STAT transcription factor; tumor; Janus kinase 2 (JAK2); V617F mutant; erythropoietin receptor (EpoR); myeloproliferative neoplasms (MPN); signal transducer and activator of transcription 5 (STAT5)	ERYTHROID PROGENITOR CELLS; POLYCYTHEMIA-VERA; EPO RECEPTOR; FERM DOMAIN; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; BINDING-SITES; DNA-BINDING; STAT5; JAK2	The erythropoietin receptor (EpoR) regulates development of blood cells, and its full activation normally requires the cytokine erythropoietin (Epo). In the case of myeloproliferative neoplasms (MPN), Epo-independent signaling through EpoR can be caused by a point mutation, V617F, in the EpoR-interacting tyrosine kinase Janus kinase 2 (JAK2). In cells expressing the JAK2 V617F mutant, eight tyrosine residues in the intracellular domain of EpoR are phosphorylated, but the functional role of these phosphorylations in oncogenic signaling is incompletely understood. Here, to evaluate the functional consequences of the phosphorylation of these tyrosine residues, we constructed an EpoR-8YF mutant in which we substituted all eight tyrosine residues with phenylalanine. Co-expression of EpoR-8YF with the JAK2 V617F mutant failed to induce cytokine-independent cell proliferation and tumorigenesis, indicating that JAK2-mediated EpoR phosphorylation is the reason for JAK2 V617F mutant-induced oncogenic signaling. An exhaustive mutational analysis of the eight EpoR tyrosine residues indicated that three of these residues, Tyr-343, Tyr-460, and Tyr-464, are required for the JAK2 V617F mutant to exhibit its oncogenic activity. We also showed that phosphorylation at these three residues was necessary for full activation of the transcription factor STAT5, which is a critical downstream factor of JAK2 V617F-induced oncogenic signaling. In contrast, Epo stimulation could moderately stimulate the proliferation of cells expressing wild type JAK2 and EpoR-8YF, suggesting that the requirement of the phosphorylation of these three tyrosine residues seems to be specific for the oncogenic proliferation provoked by V617F mutation. Collectively, these results have revealed that phosphorylation of Tyr-343, Tyr-460, and Tyr-464 in EpoR underlies JAK2 V617F mutant-induced tumorigenesis. We propose that the targeted disruption of this pathway has therapeutic utility for managing MPN.	[Ueda, Fumihito; Tamura, Hiroomi; Funakoshi-Tago, Megumi] Keio Univ, Fac Pharm, Div Hygien Chem, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan; [Tago, Kenji] Jichi Med Univ, Dept Biochem, Div Struct Biochem, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan	Keio University; Jichi Medical University	Funakoshi-Tago, M (corresponding author), Keio Univ, Fac Pharm, Div Hygien Chem, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	tago-mg@pha.keio.ac.jp		Ueda, Fumihito/0000-0003-1241-1643	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23790096]; Takeda Science Foundation; Uehara Memorial Foundation; Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research	This work was supported in part by Grant 23790096 from Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Takeda Science Foundation, Uehara Memorial Foundation, and Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research. Theauthorsdeclare that they have no conflicts of interest with the contents of this article	Abe M, 2009, INT IMMUNOPHARMACOL, V9, P870, DOI 10.1016/j.intimp.2009.03.011; Arai A, 2001, J BIOL CHEM, V276, P33282, DOI 10.1074/jbc.M102924200; Berger A, 2014, LEUKEMIA, V28, P629, DOI 10.1038/leu.2013.351; Chin H, 1996, BLOOD, V88, P4415, DOI 10.1182/blood.V88.12.4415.bloodjournal88124415; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Funakoshi-Tago M, 2006, EMBO J, V25, P4763, DOI 10.1038/sj.emboj.7601365; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Halupa A, 2005, EXP CELL RES, V309, P1, DOI 10.1016/j.yexcr.2005.04.030; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kashii Y, 2000, BLOOD, V96, P941, DOI 10.1182/blood.V96.3.941.015k14_941_949; Ketteler R, 2003, J BIOL CHEM, V278, P2654, DOI 10.1074/jbc.M211236200; Kirito K, 2002, BLOOD, V99, P102, DOI 10.1182/blood.V99.1.102; Kirken Robert A., 1994, Progress in Growth Factor Research, V5, P195, DOI 10.1016/0955-2235(94)90005-1; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Klingmuller U, 1997, P NATL ACAD SCI USA, V94, P3016, DOI 10.1073/pnas.94.7.3016; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li K, 2003, BLOOD, V102, P3147, DOI 10.1182/blood-2003-01-0078; Li K, 2003, J BIOL CHEM, V278, P40702, DOI 10.1074/jbc.M307182200; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Liu L, 1997, LEUKEMIA, V11, P181, DOI 10.1038/sj.leu.2400559; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Mason JM, 2000, J BIOL CHEM, V275, P4398, DOI 10.1074/jbc.275.6.4398; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Meyer WKH, 1997, J BIOL CHEM, V272, P31821, DOI 10.1074/jbc.272.50.31821; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Nakaya Y, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.73; Pardanani A, 2011, LEUKEMIA, V25, P218, DOI 10.1038/leu.2010.269; Pircher TJ, 1999, MOL ENDOCRINOL, V13, P555, DOI 10.1210/mend.13.4.0263; Ram PA, 1996, J BIOL CHEM, V271, P5929, DOI 10.1074/jbc.271.10.5929; RAVICHANDRAN KS, 1995, MOL CELL BIOL, V15, P593; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Tauchi T, 1996, BLOOD, V87, P4495, DOI 10.1182/blood.V87.11.4495.bloodjournal87114495; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Uddin S, 2000, BIOCHEM BIOPH RES CO, V275, P16, DOI 10.1006/bbrc.2000.3266; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; WOJCHOWSKI DM, 1993, STEM CELLS, V11, P381, DOI 10.1002/stem.5530110505; Wu H, 1997, P NATL ACAD SCI USA, V94, P1806, DOI 10.1073/pnas.94.5.1806	47	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2017	292	5					1826	1846		10.1074/jbc.M116.749465	http://dx.doi.org/10.1074/jbc.M116.749465			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM7TQ	27998978	hybrid, Green Published			2022-12-28	WOS:000395515600024
J	Virtue, A; Johnson, C; Lopez-Pastrana, J; Shao, Y; Fu, HF; Li, XY; Li, YF; Yin, Y; Mai, JT; Rizzo, V; Tordoff, M; Bagi, Z; Shan, HM; Jiang, XH; Wang, H; Yang, XF				Virtue, Anthony; Johnson, Candice; Lopez-Pastrana, Jahaira; Shao, Ying; Fu, Hangfei; Li, Xinyuan; Li, Ya-Feng; Yin, Ying; Mai, Jietang; Rizzo, Victor; Tordoff, Michael; Bagi, Zsolt; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng			MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease A NOVEL MOUSE MODEL OF OBESITY PARADOX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY MONOCYTE DIFFERENTIATION; PERCUTANEOUS CORONARY INTERVENTION; BODY-MASS INDEX; METABOLIC SYNDROME; APOLIPOPROTEIN-E; EXPRESSION; IMPACT; CELLS; MECHANISMS; MICE	Obesity paradox (OP) describes a widely observed clinical finding of improved cardiovascular fitness and survival in some overweight or obese patients. The molecular mechanisms underlying OP remain enigmatic partly due to a lack of animal models mirroring OP in patients. Using apolipoprotein E knockout (ApoE(-/-)) mice on high-fat (HF) diet as an atherosclerotic obesity model, we demonstrated: 1) microRNA-155 (miRNA-155, miR-155) is significantly upregulated in aortas of ApoE(-/-) mice; and miR-155 deficiency in ApoE(-/-) mice inhibits atherosclerosis; 2) ApoE(-/-)/miR-155(-/-) (DKO) mice show HF diet-induced obesity, adipocyte hypertrophy and present with nonalcoholic fatty liver disease (NAFLD); 3) DKO mice demonstrate HF diet-induced elevations of plasma leptin, resistin, fed-state and fasting insulin, increased expression of adipogenic transcription factors, but lack glucose intolerance and insulin resistance. Our results are the first to present an OP model using DKO mice with features of decreased atherosclerosis, increased obesity and NAFLD. Our findings suggest the mechanistic role of reduced miR-155 expression in OP and present a new OP working model based on a single miRNA deficiency in diet-induced obese atherogenic mice. Furthermore, our results serve as a breakthrough in understanding the potential mechanism underlying OP and provide a new biomarker and novel therapeutic target for OP-related metabolic diseases.	[Virtue, Anthony; Johnson, Candice; Lopez-Pastrana, Jahaira; Shao, Ying; Fu, Hangfei; Li, Xinyuan; Li, Ya-Feng; Yin, Ying; Mai, Jietang; Rizzo, Victor; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Ctr Metab Dis Res, Philadelphia, PA 19140 USA; [Virtue, Anthony; Johnson, Candice; Lopez-Pastrana, Jahaira; Shao, Ying; Fu, Hangfei; Li, Xinyuan; Li, Ya-Feng; Yin, Ying; Mai, Jietang; Rizzo, Victor; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Ctr Cardiovasc Res, Philadelphia, PA 19140 USA; [Virtue, Anthony; Johnson, Candice; Lopez-Pastrana, Jahaira; Shao, Ying; Fu, Hangfei; Li, Xinyuan; Li, Ya-Feng; Yin, Ying; Mai, Jietang; Rizzo, Victor; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Ctr Thrombosis Res, Philadelphia, PA 19140 USA; [Tordoff, Michael] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Bagi, Zsolt] Augusta Univ, Vasc Biol Ctr, Augusta, GA 30912 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Monell Chemical Senses Center; University System of Georgia; Augusta University	Yang, XF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Metab Dis Res, 3500 North Broad St,MERB-1059, Philadelphia, PA 19140 USA.; Yang, XF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Cardiovasc Res, 3500 North Broad St,MERB-1059, Philadelphia, PA 19140 USA.	xfyang@temple.edu	Li, Xinyuan/B-1139-2015; Li, Xinyuan/Z-6299-2019; Li, YaFeng/J-6247-2013	Li, Xinyuan/0000-0002-6746-8367; Li, Xinyuan/0000-0002-6746-8367; Li, YaFeng/0000-0002-7500-0959; Bagi, Zsolt/0000-0001-8755-2980	National Institutes of Health [U24-DK093000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132399, R01HL116917, R01HL138749, R01HL117654, R01HL108910, R01HL131460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104116, U24DK093000, R01DK113775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Part of this work was performed at the National Mouse Metabolic Phenotyping Center at University of Massachusetts Medical School funded by National Institutes of Health Grant U24-DK093000.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bjorndal B, 2011, J OBES, V2011, DOI 10.1155/2011/490650; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Cheng WW, 2011, INT J MOL MED, V27, P393, DOI 10.3892/ijmm.2011.598; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Coppieters KT, 2014, MOL METAB, V3, P275, DOI 10.1016/j.molmet.2013.12.005; Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808; Deiuliis JA, 2016, INT J OBESITY, V40, P88, DOI 10.1038/ijo.2015.170; Dixon JB, 2015, INT J OBESITY, V39, P82, DOI 10.1038/ijo.2014.59; Doherty TM, 2005, ARTERIOSCL THROM VAS, V25, pE38, DOI 10.1161/01.ATV.0000161318.83751.08; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; Du F, 2014, ARTERIOSCL THROM VAS, V34, P759, DOI 10.1161/ATVBAHA.113.302701; Economou EK, 2015, ATHEROSCLEROSIS, V241, P624, DOI 10.1016/j.atherosclerosis.2015.06.037; Fang P, 2014, DIABETES, V63, P4275, DOI 10.2337/db14-0809; Ferreira DMS, 2014, FEBS J, V281, P2503, DOI 10.1111/febs.12806; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Gurm HS, 2002, AM J CARDIOL, V90, P42, DOI 10.1016/S0002-9149(02)02384-6; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hosin AA, 2014, J VASC RES, V51, P338, DOI 10.1159/000368193; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Khattab AA, 2008, AM J CARDIOL, V101, P1550, DOI 10.1016/j.amjcard.2008.02.034; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Kortelainen ML, 2011, AM J FOREN MED PATH, V32, P372, DOI 10.1097/PAF.0b013e318219cd89; Lakner AM, 2011, WORLD J GASTROENTERO, V17, P2536, DOI 10.3748/wjg.v17.i20.2536; Lavie CJ, 2015, NAT REV ENDOCRINOL, V11, P55, DOI 10.1038/nrendo.2014.165; Lavie CJ, 2013, JACC-HEART FAIL, V1, P93, DOI 10.1016/j.jchf.2013.01.006; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Miller AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072324; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Niedziela J, 2014, EUR J EPIDEMIOL, V29, P801, DOI 10.1007/s10654-014-9961-9; Nogueras S, 2008, AM J PHYSIOL-HEART C, V294, pH708, DOI 10.1152/ajpheart.00466.2007; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883; Pulkkinen KH, 2011, FREE RADICAL BIO MED, V51, P2124, DOI 10.1016/j.freeradbiomed.2011.09.014; Raitoharju E, 2013, CLIN CHEM, V59, P1708, DOI 10.1373/clinchem.2013.204917; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sha XJ, 2015, J BIOL CHEM, V290, P19307, DOI 10.1074/jbc.M115.663286; Skarn M, 2012, STEM CELLS DEV, V21, P873, DOI 10.1089/scd.2010.0503; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sun HX, 2012, HYPERTENSION, V60, P1407, DOI 10.1161/HYPERTENSIONAHA.112.197301; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Virtue A, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-66; Virtue A, 2011, FRONT BIOSCI-LANDMRK, V16, P3133, DOI 10.2741/3901; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Wang F, 2013, VITAM HORM, V91, P49, DOI 10.1016/B978-0-12-407766-9.00003-1; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xiong Z, 2008, FRONT BIOSCI-LANDMRK, V13, P7143, DOI 10.2741/3217; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yin Y, 2015, ARTERIOSCL THROM VAS, V35, P804, DOI 10.1161/ATVBAHA.115.305282; Zhang DQ, 2012, CIRC RES, V111, P37, DOI [10.1161/CIRCRESAHA.112.269472, 10.1161/circresaha.112.269472]; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046551; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	69	68	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1267	1287		10.1074/jbc.M116.739839	http://dx.doi.org/10.1074/jbc.M116.739839			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27856635	Green Published, hybrid			2022-12-28	WOS:000393339800011
J	King, DT; Wasney, GA; Nosella, M; Fong, A; Strynadka, NCJ				King, Dustin T.; Wasney, Gregory A.; Nosella, Michael; Fong, Anita; Strynadka, Natalie C. J.			Structural Insights into Inhibition of Escherichia coli Penicillin-binding Protein 1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN GLYCOSYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; BETA-LACTAMASE; BACTERIAL PEPTIDOGLYCAN; CATALYZED-HYDROLYSIS; PBP1B; CEPHALOSPORINS; MOENOMYCIN; TRANSGLYCOSYLASE	In Escherichia coli, the peptidoglycan cell wall is synthesized by bifunctional penicillin-binding proteins such as PBP1b that have both transpeptidase and transglycosylase activities. The PBP1b transpeptidase domain is a major target of beta-lactams, and therefore it is important to attain a detailed understanding of its inhibition. The peptidoglycan glycosyltransferase domain of PBP1b is also considered an excellent antibiotic target yet is not exploited by any clinically approved antibacterials. Herein, we adapt a pyrophosphate sensor assay to monitor PBP1b-catalyzed glycosyltransfer and present an improved crystallographic model for inhibition of the PBP1b glycosyltransferase domain by the potent substrate analog moenomycin. We elucidate the structure of a previously disordered region in the glycosyltransferase active site and discuss its implications with regards to peptidoglycan polymerization. Furthermore, we solve the crystal structures of E. coli PBP1b bound to multiple different beta-lactams in the transpeptidase active site and complement these data with gel-based competition assays to provide a detailed structural understanding of its inhibition. Taken together, these biochemical and structural data allow us to propose new insights into inhibition of both enzymatic domains in PBP1b.	Univ British Columbia, Dept Biochem & Mol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca		King, Dustin/0000-0003-1775-2885	Canadian Institutes of Health Research; Howard Hughes Medical Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Canadian Institutes of Health Research and Howard Hughes Medical Institute International Scholar Program and infrastructure support from the Canadian Foundation for Innovation, British Columbia Knowledge Development Fund, and the Canada Research Chair Programs to (N. C. J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Bebrone C, 2001, ANTIMICROB AGENTS CH, V45, P1868, DOI 10.1128/AAC.45.6.1868-1871.2001; BOYD DB, 1985, J ORG CHEM, V50, P886, DOI 10.1021/jo00206a034; Bury D, 2015, BIOCHEM PHARMACOL, V93, P141, DOI 10.1016/j.bcp.2014.11.003; DeLano W. L., 2012, PYMOL MOL GRAPH SYST; Denome SA, 1999, J BACTERIOL, V181, P3981, DOI 10.1128/JB.181.13.3981-3993.1999; Egan AJF, 2014, P NATL ACAD SCI USA, V111, P8197, DOI 10.1073/pnas.1400376111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng H, 2014, J AM CHEM SOC, V136, P14694, DOI 10.1021/ja508388e; Gale RT, 2014, CHEM SCI, V5, P3823, DOI 10.1039/c4sc00802b; Goldman RC, 2000, CURR MED CHEM, V7, P801; Han S, 2010, P NATL ACAD SCI USA, V107, P22002, DOI 10.1073/pnas.1013092107; Heaslet H, 2009, J STRUCT BIOL, V167, P129, DOI 10.1016/j.jsb.2009.04.010; Huang CY, 2012, P NATL ACAD SCI USA, V109, P6496, DOI 10.1073/pnas.1203900109; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P355, DOI 10.1124/dmd.30.4.355; Jha RK, 2006, J BIOMOL SCREEN, V11, P1005, DOI 10.1177/1087057106294364; JOHNSON DH, 1995, MED CLIN N AM, V79, P733, DOI 10.1016/S0025-7125(16)30036-0; King DT, 2014, J BIOL CHEM, V289, P19245, DOI 10.1074/jbc.M114.565879; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; KOHLRAUSCH U, 1991, FEMS MICROBIOL LETT, V78, P253; Kurz M, 1998, EUR J BIOCHEM, V252, P500, DOI 10.1046/j.1432-1327.1998.2520500.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Lovering AL, 2008, J MOL BIOL, V383, P167, DOI 10.1016/j.jmb.2008.08.020; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Macheboeuf P, 2011, BIOCHEM BIOPH RES CO, V405, P107, DOI 10.1016/j.bbrc.2011.01.003; Martin SF, 2013, ANNU REV BIOCHEM, V82, P267, DOI 10.1146/annurev-biochem-060410-105819; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; MOBASHERY S, 1986, J BIOL CHEM, V261, P7879; Offant J, 2010, FEBS J, V277, P4290, DOI 10.1111/j.1742-4658.2010.07817.x; Ostash B, 2010, NAT PROD REP, V27, P1594, DOI 10.1039/c001461n; PAGE MI, 1984, J AM CHEM SOC, V106, P3820, DOI 10.1021/ja00325a019; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Pepper ED, 2006, FEMS MICROBIOL LETT, V263, P61, DOI 10.1111/j.1574-6968.2006.00418.x; Perlstein DL, 2010, J AM CHEM SOC, V132, P48, DOI 10.1021/ja909325m; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRATT RF, 1986, J AM CHEM SOC, V108, P5328, DOI 10.1021/ja00277a044; Rafailidis PI, 2007, DRUGS, V67, P1829, DOI 10.2165/00003495-200767130-00003; Sarkar SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048598; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz B, 2002, BIOCHEMISTRY-US, V41, P12552, DOI 10.1021/bi026205x; Sobhanifar S, 2013, CURR OPIN STRUC BIOL, V23, P695, DOI 10.1016/j.sbi.2013.07.008; Sung MT, 2009, P NATL ACAD SCI USA, V106, P8824, DOI 10.1073/pnas.0904030106; SYKES RB, 1985, REV INFECT DIS, V7, pS579; Terrak M, 2008, J BIOL CHEM, V283, P28464, DOI 10.1074/jbc.M803223200; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vilanova B., 1997, J CHEM SOC PERK T, V2, P2439; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; WRIGHT DB, 1986, DRUG INTEL CLIN PHAR, V20, P845, DOI 10.1177/106002808602001104; Yuan YQ, 2008, ACS CHEM BIOL, V3, P429, DOI 10.1021/cb800078a; Yuan YQ, 2007, P NATL ACAD SCI USA, V104, P5348, DOI 10.1073/pnas.0701160104; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	57	31	32	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					979	993		10.1074/jbc.M116.718403	http://dx.doi.org/10.1074/jbc.M116.718403			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27899450	Green Published, hybrid			2022-12-28	WOS:000392318700019
J	Patel, D; Salloum, D; Saqcena, M; Chatterjee, A; Mroz, V; Ohh, M; Foster, DA				Patel, Deven; Salloum, Darin; Saqcena, Mahesh; Chatterjee, Amrita; Mroz, Victoria; Ohh, Michael; Foster, David A.			A Late G(1) Lipid Checkpoint That Is Dysregulated in Clear Cell Renal Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; RESTRICTION POINT; PHOSPHATIDIC-ACID; TRANSFORMED-CELLS; GROWTH-FACTOR; CANCER-CELLS; S-PHASE; CYCLE; RAPAMYCIN; PROLIFERATION	Lipids are important nutrients that proliferating cells require to maintain energy homeostasis as well as to build plasma membranes for newly synthesized cells. Previously, we identified nutrient-sensing checkpoints that exist in the latter part of the G1 phase of the cell cycle that are dependent upon essential amino acids, Gln, and finally, a checkpoint mediated by mammalian target of rapamycin (mTOR), which integrates signals from both nutrients and growth factors. In this study, we have identified and temporally mapped a lipid-mediated G1 checkpoint. This checkpoint is located after the Gln checkpoint and before the mTOR-mediated cell cycle checkpoint. Intriguingly, clear cell renal cell carcinoma cells (ccRCC) have a dysregulated lipid-mediated checkpoint due in part to defective phosphatase and tensin homologue (PTEN). Whendeprived of lipids, instead of arresting in G1, these cells continue to cycle and utilize lipid droplets as a source of lipids. Lipid droplets have been known to maintain endoplasmic reticulum homeostasis and prevent cytotoxic endoplasmic reticulum stress in ccRCC. Dysregulation of the lipid-mediated checkpoint forces these cells to utilize lipid droplets, which could potentially lead to therapeutic opportunities that exploit this property of ccRCC.	[Patel, Deven; Salloum, Darin; Saqcena, Mahesh; Chatterjee, Amrita; Mroz, Victoria; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Patel, Deven; Saqcena, Mahesh; Foster, David A.] CUNY, Grad Ctr, Biochem Program, New York, NY 10016 USA; [Salloum, Darin; Chatterjee, Amrita; Foster, David A.] CUNY, Grad Ctr, Biol Program, New York, NY 10016 USA; [Foster, David A.] Weill Cornell Med, Dept Pharmacol, New York, NY 10021 USA; [Ohh, Michael] Univ Toronto, Dept Lab Med & Pathobiol, Fac Med, Toronto, ON M5S 1A8, Canada	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Cornell University; University of Toronto	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 413 E 69th St, New York, NY 10021 USA.	foster@genectr.hunter.cuny.edu	Patel, Deven/J-4886-2019; Saqcena, Mahesh/U-5973-2017	Saqcena, Mahesh/0000-0002-2210-3444	National Center for Research Resources of the National Institutes of Health [RR-03039]; NATIONAL CANCER INSTITUTE [R01CA046677, R01CA179542] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research Centers in Minority Institutions Award RR-03039 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Biological Sciences Department at Hunter College, is acknowledged.	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Blaskovich MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078632; Brenner W, 2002, INT J CANCER, V99, P53, DOI 10.1002/ijc.10303; Chatterjee A, 2015, CANCER LETT, V360, P134, DOI 10.1016/j.canlet.2015.01.043; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster DA, 2014, J BIOL CHEM, V289, P22583, DOI 10.1074/jbc.R114.566091; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Gan W., 2015, CELL CYCLE, P1; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Johnson A, 2013, CURR OPIN CELL BIOL, V25, P717, DOI 10.1016/j.ceb.2013.07.010; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kearney AY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135962; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Patel D, 2016, J BIOL CHEM, V291, P9322, DOI 10.1074/jbc.M115.710145; PlanasSilva MD, 1997, CURR OPIN CELL BIOL, V9, P768, DOI 10.1016/S0955-0674(97)80076-2; Qiu B, 2015, CANCER DISCOV, V5, P652, DOI 10.1158/2159-8290.CD-14-1507; Robinson CM, 2014, FEBS LETT, V588, P2704, DOI 10.1016/j.febslet.2014.02.026; Salloum D, 2014, MOL CANCER THER, V13, P733, DOI 10.1158/1535-7163.MCT-13-0762; Saqcena M, 2015, ONCOGENE, V34, P2672, DOI 10.1038/onc.2014.207; Saqcena M, 2015, CELL CYCLE, V14, P2285, DOI 10.1080/15384101.2015.1046653; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Schneider E, 2011, INT J ONCOL, V38, P823, DOI 10.3892/ijo.2010.893; Schonenberger D, 2016, CANCER RES, V76, P2025, DOI 10.1158/0008-5472.CAN-15-1859; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	36	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2017	292	3					936	944		10.1074/jbc.M116.757864	http://dx.doi.org/10.1074/jbc.M116.757864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2LL	27956548	Green Published, hybrid			2022-12-28	WOS:000392318700015
J	Halabi, S; Sekine, E; Verstak, B; Gay, NJ; Moncrieffe, MC				Halabi, Samer; Sekine, Eiki; Verstak, Brett; Gay, Nicholas J.; Moncrieffe, Martin C.			Structure of the Toll/Interleukin-1 Receptor (TIR) Domain of the B-cell Adaptor That Links Phosphoinositide Metabolism with the Negative Regulation of the Toll-like Receptor (TLR) Signalosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TYROSINE PHOSPHORYLATION; 3-KINASE; BCAP; ACTIVATION; TRANSDUCTION; MACROPHAGES; REVEALS; CALCIUM; PI3K	Ligand binding to Toll-like receptors (TLRs) results in dimerization of their cytosolic Toll/interleukin-1 receptor (TIR) domains and recruitment of post-receptor signal transducers into a complex signalosome. TLR activation leads to the production of transcription factors and pro-inflammatory molecules and the activation of phosphoinositide 3-kinases (PI3K) in a process that requires the multimodular B-cell adaptor for phosphoinositide 3-kinase (BCAP). BCAP has a sequence previously proposed as a "cryptic" TIR domain. Here, we present the structure of the N-terminal region of human BCAP and show that it possesses a canonical TIR fold. Dimeric BCAP associates with the TIR domains of TLR2/4 and MAL/TIRAP, suggesting that it is recruited to the TLR signalosome by multitypic TIR-TIR interactions. BCAP also interacts with the p85 subunit of PI3K and phospholipase C gamma, enzymes that deplete plasma-membrane phosphatidylinositol 4,5-bisphosphate (PIP2), and these interactions provide a molecular explanation for BCAP-mediated down-regulation of inflammatory signaling.	[Halabi, Samer; Sekine, Eiki; Verstak, Brett; Gay, Nicholas J.; Moncrieffe, Martin C.] Univ Cambridge, Dept Biochem, Sanger Bldg,80 Tennis Court Rd, Cambridge CB2 1GA, England	University of Cambridge	Gay, NJ; Moncrieffe, MC (corresponding author), Univ Cambridge, Dept Biochem, Sanger Bldg,80 Tennis Court Rd, Cambridge CB2 1GA, England.	njg11@cam.ac.uk; mcm35@cam.ac.uk		Sekine, Eiki/0000-0001-6555-7879	UK Medical Research Council [G1000133]; Wellcome Investigator award [WT100321/z/12/Z]; Islamic Development Bank (Jeddah, Kingdom of Saudi Arabia); Cambridge Trust (Cambridge, UK)	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Investigator award; Islamic Development Bank (Jeddah, Kingdom of Saudi Arabia); Cambridge Trust (Cambridge, UK)	This work was supported by a program grant from the UK Medical Research Council (G1000133) and a Wellcome Investigator award (WT100321/z/12/Z to N. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Islamic Development Bank (Jeddah, Kingdom of Saudi Arabia) and the Cambridge Trust (Cambridge, UK).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Arsenault RJ, 2013, CELL SIGNAL, V25, P2246, DOI 10.1016/j.cellsig.2013.07.014; Battersby A, 2003, J MOL BIOL, V329, P479, DOI 10.1016/S0022-2836(03)00489-3; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Inabe K, 2002, BLOOD, V99, P584, DOI 10.1182/blood.V99.2.584; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kim YJ, 2004, MOL CELL BIOL, V24, P9986, DOI 10.1128/MCB.24.22.9986-9999.2004; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; MacFarlane AW, 2008, BLOOD, V112, P131, DOI 10.1182/blood-2007-08-107847; Matsumura T, 2010, BIOCHEM BIOPH RES CO, V400, P265, DOI 10.1016/j.bbrc.2010.08.055; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; Ni MJ, 2012, P NATL ACAD SCI USA, V109, P267, DOI 10.1073/pnas.1111957108; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Snyder GA, 2014, J BIOL CHEM, V289, P669, DOI 10.1074/jbc.M113.523407; Song S, 2011, J IMMUNOL, V187, P619, DOI 10.4049/jimmunol.0903425; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Troutman TD, 2012, P NATL ACAD SCI USA, V109, P273, DOI 10.1073/pnas.1118579109; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Verstak B, 2013, J IMMUNOL, V191, P6101, DOI 10.4049/jimmunol.1300849; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wu YY, 2013, J IMMUNOL, V191, P6110, DOI 10.4049/jimmunol.1301203; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang YX, 2011, GENET MOL RES, V10, P7, DOI 10.4238/vol10-1gmr980; Zhou XY, 2006, J BIOL CHEM, V281, P31337, DOI 10.1074/jbc.M602739200	54	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					652	660		10.1074/jbc.M116.761528	http://dx.doi.org/10.1074/jbc.M116.761528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909057	Green Published, hybrid			2022-12-28	WOS:000392316100020
J	Sarmento, OF; Svingen, PA; Xiong, YN; Sun, ZF; Bamidele, AO; Mathison, AJ; Smyrk, TC; Nair, AA; Gonzalez, MM; Sagstetter, MR; Baheti, S; McGovern, DPB; Friton, JJ; Papadakis, KA; Gautam, G; Xavier, RJ; Urrutia, RA; Faubion, WA				Sarmento, Olga F.; Svingen, Phyllis A.; Xiong, Yuning; Sun, Zhifu; Bamidele, Adebowale O.; Mathison, Angela J.; Smyrk, Thomas C.; Nair, Asha A.; Gonzalez, Michelle M.; Sagstetter, Mary R.; Baheti, Saurabh; McGovern, Dermot P. B.; Friton, Jessica J.; Papadakis, Konstantinos A.; Gautam, Goel; Xavier, Ramnik J.; Urrutia, Raul A.; Faubion, William A.			The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; GENE-EXPRESSION; FOXP3; DIFFERENTIATION; PHOSPHORYLATION; TRANSCRIPTION; METHYLATION; REPRESSION; PLASTICITY; STABILITY	Regulatory T (Treg) cells expressing the transcription factor FOXP3 play a pivotal role in maintaining immunologic self-tolerance. We and others have shown previously that EZH2 is recruited to the FOXP3 promoter and its targets in Treg cells. To further address the role for EZH2 in Treg cellular function, we have now generated mice that lack EZH2 specifically in Treg cells (EZH2(Delta/Delta) FOXP3(+)). We find that EZH2 deficiency in FOXP3(+) T cells results in lethal multiorgan autoimmunity. We further demonstrate that EZH2(Delta/Delta)FOXP3(+) T cells lack a regulatory phenotype in vitro and secrete proinflammatory cytokines. Of special interest, EZH2(Delta/Delta)FOXP3(+) mice develop spontaneous inflammatory bowel disease. Guided by these results, we assessed the FOXP3 and EZH2 gene networks by RNA sequencing in isolated intestinal CD4(+) T cells from patients with Crohn's disease. Gene network analysis demonstrates that these CD4(+) T cells display a Th1/Th17-like phenotype with an enrichment of gene targets shared by FOXP3 and EZH2. Combined, these results suggest that the inflammatory milieu found in Crohn's disease could lead to or result from deregulation of FOXP3/EZH2-enforced T cell gene networks contributing to the underlying intestinal inflammation.	[Sarmento, Olga F.; Svingen, Phyllis A.; Xiong, Yuning; Bamidele, Adebowale O.; Mathison, Angela J.; Gonzalez, Michelle M.; Sagstetter, Mary R.; Friton, Jessica J.; Papadakis, Konstantinos A.; Urrutia, Raul A.; Faubion, William A.] Mayo Clin, Div Gastroenterol & Hepatol, Epigenet & Chromatin Dynam Lab, Rochester, MN 55905 USA; [Sarmento, Olga F.; Svingen, Phyllis A.; Xiong, Yuning; Bamidele, Adebowale O.; Mathison, Angela J.; Gonzalez, Michelle M.; Sagstetter, Mary R.; Friton, Jessica J.; Papadakis, Konstantinos A.; Urrutia, Raul A.; Faubion, William A.] Mayo Clin, Translat Epigen Program, Ctr Individualized Med, Rochester, MN 55905 USA; [Sun, Zhifu; Nair, Asha A.; Baheti, Saurabh] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Smyrk, Thomas C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [McGovern, Dermot P. B.] Cedars Sinai Med Ctr, F Widjaja Fdn, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Gautam, Goel; Xavier, Ramnik J.] Harvard Med Sch, Gastrointestinal Unit, Boston, MA 02114 USA; [Gautam, Goel; Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Gautam, Goel; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Ctr Computat & Integrat Biol, Cambridge, MA 02142 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Cedars Sinai Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Faubion, WA (corresponding author), 200 First St SW, Rochester, MN 55905 USA.	Faubion.william@mayo.edu	Bamidele, Adebowale O./AAZ-2453-2020	Bamidele, Adebowale O./0000-0002-9547-2195; Sun, Zhifu/0000-0001-8461-7523; Mathison, Angela/0000-0002-6763-2710	Crohn's and Colitis Foundation of America [271332, 401661]; Mayo Clinic Foundation; National Institutes of Health [RO1DK52913]; Career Developmental Award Mayo Clinic SPORE in Pancreatic Cancer; Career Developmental Award Mayo Clinic Center for Cell Signaling in Gastroenterology; NIAID, National Institutes of Health [RO1 AI089714]; Leona Helmsley Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, P30DK084567, P30DK043351] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Mayo Clinic Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Developmental Award Mayo Clinic SPORE in Pancreatic Cancer; Career Developmental Award Mayo Clinic Center for Cell Signaling in Gastroenterology; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Leona Helmsley Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Crohn's and Colitis Foundation of America Fellowship award 271332 and Career Development Award 401661 (to O. F. S.); the Mayo Clinic Foundation (to K. A. P.); National Institutes of Health Grant RO1DK52913 (to R. A. U.); Career Developmental Award Mayo Clinic SPORE in Pancreatic Cancer and Career Developmental Award Mayo Clinic Center for Cell Signaling in Gastroenterology (to G. A. L.); and NIAID, National Institutes of Health Grant RO1 AI089714 and the Leona Helmsley Charitable Trust (to W. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bantug GR, 2016, NAT IMMUNOL, V17, P41, DOI 10.1038/ni.3346; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen BL, 2013, CELL CYCLE, V12, P112, DOI 10.4161/cc.23030; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Duijvestein M, 2011, STEM CELLS, V29, P1549, DOI 10.1002/stem.698; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Faubion WA, 2004, GASTROENTEROLOGY, V126, P1759, DOI 10.1053/j.gastro.2004.03.015; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Harms PW., 2014, HUM PATHOL, V1, P21, DOI DOI 10.1016/J.EHPC.2014.07.002; Hovhannisyan Z, 2011, GASTROENTEROLOGY, V140, P957, DOI 10.1053/j.gastro.2010.12.002; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jacob E, 2008, J BIOL CHEM, V283, P13471, DOI 10.1074/jbc.M709886200; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Kornete M, 2012, J IMMUNOL, V188, P1064, DOI 10.4049/jimmunol.1101303; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Michels AW, 2010, NAT REV ENDOCRINOL, V6, P270, DOI 10.1038/nrendo.2010.40; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Meara MM, 2012, CHROMOSOMA, V121, P221, DOI 10.1007/s00412-012-0361-1; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Rahman MK, 2010, J IMMUNOL, V184, P7247, DOI 10.4049/jimmunol.0901479; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saeidi K, 2016, CRIT REV ONCOL HEMAT, V98, P375, DOI 10.1016/j.critrevonc.2015.11.004; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Shi LH, 2014, J IMMUNOL, V192, P3057, DOI 10.4049/jimmunol.1302063; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tartar DM, 2010, J IMMUNOL, V184, P3377, DOI 10.4049/jimmunol.0903324; Tone Y, 2014, J IMMUNOL, V192, P3915, DOI 10.4049/jimmunol.1302174; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Ueno A, 2013, INFLAMM BOWEL DIS, V19, P2522, DOI 10.1097/MIB.0b013e3182a85709; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wan JH, 2015, NUCLEIC ACIDS RES, V43, P3591, DOI 10.1093/nar/gkv238; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Xiong YN, 2012, J BIOL CHEM, V287, P34372, DOI 10.1074/jbc.M111.325332; Xu BW, 2015, EXP HEMATOL, V43, P698, DOI 10.1016/j.exphem.2015.05.001; Yang XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10643; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zhang H, 2013, J ALLERGY CLIN IMMUN, V132, P1005, DOI 10.1016/j.jaci.2013.05.033; Zhang YX, 2014, BLOOD, V124, P737, DOI 10.1182/blood-2013-12-544106; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	60	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					706	722		10.1074/jbc.M116.749663	http://dx.doi.org/10.1074/jbc.M116.749663			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27909059	Green Published, hybrid			2022-12-28	WOS:000392316100025
J	Yasuda, H; Oh, CD; Chen, D; de Crombrugghe, B; Kim, JH				Yasuda, Hideyo; Oh, Chun-do; Chen, Di; de Crombrugghe, Benoit; Kim, Jin-Hoi			A Novel Regulatory Mechanism of Type II Collagen Expression via a SOX9-dependent Enhancer in Intron 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE-SPECIFIC ENHANCER; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; SOX9; CHONDROGENESIS; MUTATIONS; CARTILAGE; COL2A1; DIFFERENTIATION	Type II collagen alpha 1 is specific for cartilaginous tissues, and mutations in its gene are associated with skeletal diseases. Its expression has been shown to be dependent on SOX9, a master transcription factor required for chondrogenesis that binds to an enhancer region in intron 1. However, ChIP sequencing revealed that SOX9 does not strongly bind to intron 1, but rather it binds to intron 6 and a site 30 kb upstream of the transcription start site. Here, we aimed to determine the role of the novel SOX9-binding site in intron 6. We prepared reporter constructs that contain a Col2a1 promoter, intron 1 with or without intron 6, and the luciferase gene. Although the reporter constructs were not activated by SOX9 alone, the construct that contained both introns 1 and 6 was activated 5-10-fold by the SOX9/SOX5 or the SOX9/SOX6 combination in transient-transfection assays in 293T cells. This enhancement was also observed in rat chondrosarcoma cells that stably expressed the construct. CRISPR/Cas9-induced deletion of intron 6 in RCS cells revealed that a 10-bp region of intron 6 is necessary both for Col2a1 expression and SOX9 binding. Furthermore, SOX9, but not SOX5, binds to this region as demonstrated in an electrophoretic mobility shift assay, although both SOX9 and SOX5 bind to a larger 325-bp fragment of intron 6 containing this small sequence. These findings suggest a novel mechanism of action of SOX5/6; namely, the SOX9/5/6 combination enhances Col2a1 transcription through a novel enhancer in intron 6 together with the enhancer in intron 1.	[Yasuda, Hideyo; Kim, Jin-Hoi] Konkuk Univ, Dept Stem Cell & Regenerat Biol, Seoul 05029, South Korea; [Yasuda, Hideyo; Oh, Chun-do; de Crombrugghe, Benoit] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Oh, Chun-do; Chen, Di] Rush Univ, Dept Biochem, Med Ctr, Chicago, IL 60612 USA	Konkuk University; University of Texas System; UTMD Anderson Cancer Center; Rush University	Yasuda, H; Kim, JH (corresponding author), Konkuk Univ, Dept Stem Cell & Regenerat Biol, Seoul 05029, South Korea.; Yasuda, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	h-yasuda@yk9.so-net.ne.jp; jhkim541@konkuk.ac.kr	Chen, Di/AAJ-3665-2021	Oh, Chundo/0000-0002-5419-8011; kim, jin-hoi/0000-0003-1232-5307	Science Research Center from the National Research Foundation of Korea, Republic of Korea [2015R1A 5A1009701]	Science Research Center from the National Research Foundation of Korea, Republic of Korea	This work was supported by the Science Research Center (2015R1A 5A1009701) from the National Research Foundation of Korea, Republic of Korea. The authors declare that they have no conflict of interest with the contents of this article.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Bi Q, 2001, APPL BIOCHEM BIOTECH, V95, P23, DOI 10.1385/ABAB:95:1:23; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Coustry F, 2010, NUCLEIC ACIDS RES, V38, P6018, DOI 10.1093/nar/gkq417; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hattori T, 2008, NUCLEIC ACIDS RES, V36, P3011, DOI 10.1093/nar/gkn150; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hattori T, 2013, J BIOL CHEM, V288, P35138, DOI 10.1074/jbc.M113.486795; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kist R, 2002, GENESIS, V32, P121, DOI 10.1002/gene.10050; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Oh CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143156; Oh CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107577; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richards AJ, 2000, BRIT J OPHTHALMOL, V84, P364, DOI 10.1136/bjo.84.4.364; Shinomura T, 2012, J BIOCHEM, V152, P565, DOI 10.1093/jb/mvs110; Su PQ, 2008, ARTHRITIS RHEUM-US, V58, P1701, DOI 10.1002/art.23491; Takigawa Y, 2010, J CELL SCI, V123, P3780, DOI 10.1242/jcs.071373; VANDENBERG P, 1991, P NATL ACAD SCI USA, V88, P7640, DOI 10.1073/pnas.88.17.7640; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Yasuda H, 2016, J GENET GENOMICS, V43, P705, DOI 10.1016/j.jgg.2016.10.006	33	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					528	538		10.1074/jbc.M116.758425	http://dx.doi.org/10.1074/jbc.M116.758425			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27881681	hybrid, Green Published			2022-12-28	WOS:000392316100010
J	Klemens, CA; Edinger, RS; Kightlinger, L; Liu, XN; Butterworth, MB				Klemens, Christine A.; Edinger, Robert S.; Kightlinger, Lindsay; Liu, Xiaoning; Butterworth, Michael B.			Ankyrin G Expression Regulates Apical Delivery of the Epithelial Sodium Channel (ENaC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL INITIAL SEGMENT; VOLTAGE-GATED SODIUM; COLLECTING DUCT; LATERAL MEMBRANE; NA+ CHANNEL; INTERCALATED DISC; PROTEIN-KINASE; ALPHA-SUBUNIT; BETA-SUBUNIT; E-CADHERIN	The epithelial sodium channel (ENaC) is the limiting entry point for Na+ reabsorption in the distal kidney nephron and is regulated by numerous hormones, including the mineralocorticoid hormone aldosterone. Previously we identified ankyrin G (AnkG), a cytoskeletal protein involved in vesicular transport, as a novel aldosterone-induced protein that can alter Na+ transport in mouse cortical collecting duct cells. However, the mechanisms underlying AnkG regulation of Na+ transport were unknown. Here we report that AnkG expression directly regulates Na+ transport by altering ENaC activity in the apical membrane. Increasing AnkG expression increased ENaC activity while depleting AnkG reduced ENaC-mediated Na+ transport. These changes were due to a change in ENaC directly rather than through alterations to the Na+ driving force created by Na+ /K+-ATPase. Using a constitutively open mutant of ENaC, we demonstrate that the augmentation of Na+ transport is caused predominantly by increasing the number of ENaCs at the surface. To determine the mechanism of AnkG action on ENaC surface number, changes in rates of internalization, recycling, and membrane delivery were investigated. AnkG did not alter ENaC delivery to the membrane from biosynthetic pathways or removal by endocytosis. However, AnkG did alter ENaC insertion from constitutive recycling pathways. These findings provide a mechanism to account for the role of AnkG in the regulation of Na+ transport in the distal kidney nephron.	[Klemens, Christine A.; Edinger, Robert S.; Kightlinger, Lindsay; Liu, Xiaoning; Butterworth, Michael B.] Univ Pittsburgh, Dept Cell Biol, Sch Med, S314 BST,200 Lothrop St, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Butterworth, MB (corresponding author), Univ Pittsburgh, Dept Cell Biol, Sch Med, S314 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.	michael7@pitt.edu	Klemens, Christine Anne/GXG-6739-2022; Klemens, Christine A./U-5520-2019	Klemens, Christine A./0000-0002-0812-824X	NIDDK, National Institutes of Health [DK102843]; American Heart Association [PRE25680068]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK102843] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant DK102843 (to M. B. B.) and Predoctoral Grant PRE25680068 from the American Heart Association (to C. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barry J, 2014, DEV CELL, V28, P117, DOI 10.1016/j.devcel.2013.11.023; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Cooper EC, 2011, SEMIN CELL DEV BIOL, V22, P185, DOI 10.1016/j.semcdb.2010.10.001; Copeland SJ, 2001, AM J PHYSIOL-CELL PH, V281, pC231, DOI 10.1152/ajpcell.2001.281.1.C231; Doctor RB, 1998, AM J PHYSIOL-RENAL, V274, pF129, DOI 10.1152/ajprenal.1998.274.1.F129; Edinger RS, 2014, J AM SOC NEPHROL, V25, P2445, DOI 10.1681/ASN.2013090931; Edinger RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046593; Erlij D, 1999, PFLUG ARCH EUR J PHY, V438, P195, DOI 10.1007/s004240050898; GARVIN JL, 1985, J MEMBRANE BIOL, V87, P45, DOI 10.1007/BF01870698; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ilatovskaya DV, 2011, FASEB J, V25, P2688, DOI 10.1096/fj.10-167262; Jenkins PM, 2013, J BIOL CHEM, V288, P14018, DOI 10.1074/jbc.M113.454439; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Liu X, 2008, J BIOL CHEM, V283, P11461, DOI 10.1074/jbc.M706942200; Loo CS, 2013, P NATL ACAD SCI USA, V110, P17119, DOI 10.1073/pnas.1309219110; Lopez C, 2005, J BIOL CHEM, V280, P8221, DOI 10.1074/jbc.M413351200; Lorenzo DN, 2014, J CELL BIOL, V207, P735, DOI 10.1083/jcb.201407063; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Luft Friedrich C, 2003, Clin Med Res, V1, P291; Makara MA, 2014, CIRC RES, V115, P929, DOI 10.1161/CIRCRESAHA.115.305154; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Montersino A, 2014, J NEUROCHEM, V131, P33, DOI 10.1111/jnc.12785; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Piepenhagen PA, 1995, AM J PHYSIOL-CELL PH, V269, pC1417, DOI 10.1152/ajpcell.1995.269.6.C1417; Reifenberger MS, 2014, AM J PHYSIOL-RENAL, V307, pF86, DOI 10.1152/ajprenal.00251.2013; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; ROTIN D, 1994, AM J PHYSIOL, V267, pL263, DOI 10.1152/ajplung.1994.267.3.L263; San-Cristobal P, 2014, KIDNEY INT, V85, P94, DOI 10.1038/ki.2013.280; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V344, P651, DOI 10.1016/j.bbrc.2006.03.160; Schafer JA, 2002, AM J PHYSIOL-RENAL, V283, pF221, DOI 10.1152/ajprenal.00068.2002; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; SHIBAYAMA T, 1993, CELL STRUCT FUNCT, V18, P79, DOI 10.1247/csf.18.79; SMITH PR, 1991, P NATL ACAD SCI USA, V88, P6971, DOI 10.1073/pnas.88.16.6971; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Stabach PR, 2008, AM J PHYSIOL-CELL PH, V295, pC1202, DOI 10.1152/ajpcell.00273.2008; Stankewich MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0142687; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Thevananther S, 1998, J BIOL CHEM, V273, P23952, DOI 10.1074/jbc.273.37.23952; Xu MX, 2015, J BIOL CHEM, V290, P16619, DOI 10.1074/jbc.M115.638932; Zhang ZS, 1998, J BIOL CHEM, V273, P18681, DOI 10.1074/jbc.273.30.18681	64	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					375	385		10.1074/jbc.M116.753616	http://dx.doi.org/10.1074/jbc.M116.753616			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27895120	Green Published, hybrid			2022-12-28	WOS:000391578000032
J	Lin, SC; Lu, S; Mulaj, M; Fang, B; Keeley, T; Wan, LX; Hao, JH; Muschol, M; Sun, JW; Yang, SY				Lin, Shengchen; Lu, Shuang; Mulaj, Mentor; Fang, Bin; Keeley, Tyler; Wan, Lixin; Hao, Jihui; Muschol, Martin; Sun, Jianwei; Yang, Shengyu			Monoubiquitination Inhibits the Actin Bundling Activity of Fascin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT PROGNOSTIC VALUE; BREAST-CANCER; CROSS-LINKER; FSCN2 GENE; PROTEIN; IMMUNOREACTIVITY; EXPRESSION; MECHANISM; INVASION; MOTILITY	Fascin is an actin bundling protein that cross-links individual actin filaments into straight, compact, and stiff bundles, which are crucial for the formation of filopodia, stereocillia, and other finger-like membrane protrusions. The dysregulation of fascin has been implicated in cancer metastasis, hearing loss, and blindness. Here we identified monoubiquitination as a novel mechanism that regulates fascin bundling activity and dynamics. The monoubiquitination sites were identified to be Lys247 and Lys250, two residues located in a positive charge patch at the actin binding site 2 of fascin. Using a chemical ubiquitination method, we synthesized chemically monoubiquitinated fascin and determined the effects of monoubiquitination on fascin bundling activity and dynamics. Our data demonstrated that monoubiquitination decreased the fascin bundling EC50, delayed the initiation of bundle assembly, and accelerated the disassembly of existing bundles. By analyzing the electrostatic properties on the solvent-accessible surface of fascin, we proposed that monoubiquitination introduced steric hindrance to interfere with the interaction between actin filaments and the positively charged patch at actin binding site 2. We also identified Smurf1 as a E3 ligase regulating the monoubiquitination of fascin. Our findings revealed a previously unidentified regulatory mechanism for fascin, which will have important implications for the understanding of actin bundle regulation under physiological and pathological conditions.	[Lin, Shengchen; Lu, Shuang; Keeley, Tyler; Sun, Jianwei; Yang, Shengyu] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Wan, Lixin] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Fang, Bin; Muschol, Martin] H Lee Moffitt Canc Ctr & Res Inst, Dept Prote, Tampa, FL 33612 USA; [Mulaj, Mentor] Univ S Florida, Dept Phys, Tampa, FL 33620 USA; [Keeley, Tyler] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33620 USA; [Sun, Jianwei] South China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China; [Hao, Jihui] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Dept Pancreat Canc, Tianjin 300060, Peoples R China; [Lin, Shengchen; Yang, Shengyu] Penn State Coll Med, Dept Cellular & Mol Physiol, MC H166,500 Univ Dr, Hershey, PA 17033 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; South China Agricultural University; Tianjin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yang, SY (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, MC H166,500 Univ Dr, Hershey, PA 17033 USA.; Sun, JW (corresponding author), 483 Wushan Rd, Guangzhou 510642, Guangdong, Peoples R China.	jwsun@scau.edu.cn; syang2@hmc.psu.edu	wan, li/GRY-7634-2022; Lin, Shengchen/T-3529-2018	Lin, Shengchen/0000-0003-1488-8680; Muschol, Martin/0000-0002-6488-0049	National Institutes of Health [R01CA175741]; National Natural Science Foundation of China [81572618, 31671448]; National Cancer Institute [P30 CA076292]; NATIONAL CANCER INSTITUTE [R01CA175741, P30CA076292, R00CA183914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Institutes of Health Grant R01CA175741 and National Natural Science Foundation of China Grants 81572618 and 31671448. The core facilities at the Moffitt Cancer Center are supported in part by the Cancer Center Support Grant P30 CA076292 from the National Cancer Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Hashimoto Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-241; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Hwang P, 2015, CELL REP, V13, P1287, DOI 10.1016/j.celrep.2015.10.003; Jansen S, 2011, J BIOL CHEM, V286, P30087, DOI 10.1074/jbc.M111.251439; Kanda Y, 2014, PROTEOMICS, V14, P1031, DOI 10.1002/pmic.201300414; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Li A, 2014, GASTROENTEROLOGY, V146, P1386, DOI 10.1053/j.gastro.2014.01.046; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lin-Jones J, 2007, INVEST OPHTH VIS SCI, V48, P1380, DOI 10.1167/iovs.06-0763; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Mulaj M, 2014, J AM CHEM SOC, V136, P8947, DOI 10.1021/ja502529m; Ono S, 1997, J BIOL CHEM, V272, P2527; Pelosi G, 2003, LUNG CANCER-J IASLC, V42, P203, DOI 10.1016/S0169-5002(03)00294-0; Pelosi G, 2003, BRIT J CANCER, V88, P537, DOI 10.1038/sj.bjc.6600731; Perrin BJ, 2013, J NEUROSCI, V33, P8114, DOI 10.1523/JNEUROSCI.0238-13.2013; Puppa G, 2007, BRIT J CANCER, V96, P1118, DOI 10.1038/sj.bjc.6603690; Sedeh RS, 2010, J MOL BIOL, V400, P589, DOI 10.1016/j.jmb.2010.04.043; Shin JB, 2010, J NEUROSCI, V30, P9683, DOI 10.1523/JNEUROSCI.1541-10.2010; Sun JW, 2013, J BIOL CHEM, V288, P36971, DOI 10.1074/jbc.M113.506535; Sun JW, 2011, J BIOL CHEM, V286, P38865, DOI 10.1074/jbc.M111.270413; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wada Y, 2003, ARCH OPHTHALMOL-CHIC, V121, P1613, DOI 10.1001/archopht.121.11.1613; Wada Y, 2001, INVEST OPHTH VIS SCI, V42, P2395; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Yang SY, 2013, J BIOL CHEM, V288, P274, DOI 10.1074/jbc.M112.427971; Yang Shengyu, 2012, Methods Mol Biol, V928, P221, DOI 10.1007/978-1-62703-008-3_17; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Yokokura S, 2005, INVEST OPHTH VIS SCI, V46, P2905, DOI 10.1167/iovs.04-0856; Zhao X, 2014, CANCER RES, V74, P2455, DOI 10.1158/0008-5472.CAN-13-3009	40	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27323	27333		10.1074/jbc.M116.767640	http://dx.doi.org/10.1074/jbc.M116.767640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27879315	hybrid, Green Published			2022-12-28	WOS:000391576300029
J	Baehr, CA; Huntoon, CJ; Hoang, SM; Jerde, CR; Karnitz, LM				Baehr, Carly A.; Huntoon, Catherine J.; Hoang, Song-My; Jerde, Calvin R.; Karnitz, Larry M.			Glycogen Synthase Kinase 3 (GSK-3)-mediated Phosphorylation of Uracil N-Glycosylase 2 (UNG2) Facilitates the Repair of Floxuridine-induced DNA Lesions and Promotes Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; REPLICATION; 5-FLUOROURACIL; CANCER; DEGRADATION; EXPRESSION; BETA; LOCALIZATION; ASSOCIATION; SEPARATION	Uracil N-glycosylase 2 (UNG2), the nuclear isoform of UNG, catalyzes the removal of uracil or 5-fluorouracil lesions that accumulate in DNA following treatment with the anticancer agents 5-fluorouracil and 5-fluorodeoxyuridine (floxuridine), a 5-fluorouracil metabolite. By repairing these DNA lesions before they can cause cell death, UNG2 promotes cancer cell survival and is therefore critically involved in tumor resistance to these agents. However, the mechanisms by which UNG2 is regulated remain unclear. Several phosphorylation sites within the N-terminal regulatory domain of UNG2 have been identified, although the effects of these modifications on UNG2 function have not been fully explored, nor have the identities of the kinases involved been determined. Here we show that glycogen synthase kinase 3 (GSK-3) interacts with and phosphorylates UNG2 at Thr(60) and that Thr(60) phosphorylation requires a Ser(64) priming phosphorylation event. We also show that mutating Thr(60) or Ser(64) to Ala increases the half-life of UNG2, reduces the rate of in vitro uracil excision, and slows UNG2 dissociation from chromatin after DNA replication. Using an UNG2-deficient ovarian cancer cell line that is hypersensitive to floxuridine, we show that GSK-3 phosphorylation facilitates UNG2-dependent repair of floxuridine-induced DNA lesions and promotes tumor cell survival following exposure to this agent. These data suggest that GSK-3 regulates UNG2 and promotes DNA damage repair.	[Baehr, Carly A.; Huntoon, Catherine J.; Hoang, Song-My; Jerde, Calvin R.; Karnitz, Larry M.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Karnitz, Larry M.] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA; [Huntoon, Catherine J.; Karnitz, Larry M.] Mayo Clin, Div Oncol Res, Gonda 19-300,200 First St SW, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Karnitz, LM (corresponding author), Mayo Clin, Div Oncol Res, Gonda 19-300,200 First St SW, Rochester, MN 55905 USA.	karnitz.larry@mayo.edu	Jerde, Calvin/Q-6890-2017	Jerde, Calvin/0000-0003-3138-4759; Baehr, Carly/0000-0002-3395-6776	National Institutes of Health T32 Training Grant [GM72474]; Mayo Clinic Ovarian Cancer SPORE Grant [P50 CA136393]; Fred C. and Katherine B. Andersen Foundation; NATIONAL CANCER INSTITUTE [P50CA136393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	National Institutes of Health T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Ovarian Cancer SPORE Grant; Fred C. and Katherine B. Andersen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health T32 Training Grant GM72474, Mayo Clinic Ovarian Cancer SPORE Grant P50 CA136393, and a grant from the Fred C. and Katherine B. Andersen Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akbari M, 2010, DNA REPAIR, V9, P785, DOI 10.1016/j.dnarep.2010.04.002; Al-Zain A, 2015, MOL BIOL CELL, V26, P2609, DOI 10.1091/mbc.E14-07-1213; An Q, 2007, CANCER RES, V67, P940, DOI 10.1158/0008-5472.CAN-06-2960; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Bulgar AD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.135; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Carey DC, 1999, BIOCHEMISTRY-US, V38, P16553, DOI 10.1021/bi9907429; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Dong QM, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150234; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Fan JS, 2005, FREE RADICAL BIO MED, V38, P1121, DOI 10.1016/j.freeradbiomed.2005.01.012; Fischer JA, 2004, DNA REPAIR, V3, P505, DOI 10.1016/j.dnarep.2004.01.012; Fu YF, 2014, ONCOTARGETS THER, V7, P1159, DOI 10.2147/OTT.S62158; Geng LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028862; Grogan BC, 2011, BIOCHEMISTRY-US, V50, P618, DOI 10.1021/bi102046h; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Huehls AM, 2016, MOL PHARMACOL, V89, P53, DOI 10.1124/mol.115.100164; Huehls AM, 2011, CANCER RES, V71, P4944, DOI 10.1158/0008-5472.CAN-11-0814; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Li DS, 2006, CELL RES, V16, P609, DOI 10.1038/sj.cr.7310082; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Luo Y, 2008, DNA REPAIR, V7, P162, DOI 10.1016/j.dnarep.2007.09.001; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Nagaria P, 2013, MUTAT RES-FUND MOL M, V743, P26, DOI 10.1016/j.mrfmmm.2012.12.001; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Oh M, 2009, J BIOL CHEM, V284, P28579, DOI 10.1074/jbc.M109.002659; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Pettersen HS, 2011, NUCLEIC ACIDS RES, V39, P8430, DOI 10.1093/nar/gkr563; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Schormann N, 2014, PROTEIN SCI, V23, P1667, DOI 10.1002/pro.2554; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; Weeks LD, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.477; Weeks LD, 2013, MOL CANCER THER, V12, P2248, DOI 10.1158/1535-7163.MCT-13-0172; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Welcker M, 2011, MOL CELL BIOL, V31, P1214, DOI 10.1128/MCB.01347-10; Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017	48	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26875	26885		10.1074/jbc.M116.746081	http://dx.doi.org/10.1074/jbc.M116.746081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27875297	hybrid, Green Published			2022-12-28	WOS:000391571400024
J	Samanta, D; Widom, J; Borbat, PP; Freed, JH; Crane, BR				Samanta, Dipanjan; Widom, Joanne; Borbat, Peter P.; Freed, Jack H.; Crane, Brian R.			Bacterial Energy Sensor Aer Modulates the Activity of the Chemotaxis Kinase CheA Based on the Redox State of the Flavin Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; AEROTAXIS RECEPTOR AER; PAIR DISTANCE DISTRIBUTIONS; ESCHERICHIA-COLI; TIKHONOV REGULARIZATION; MEMBRANE-PROTEINS; SIGNAL TRANSDUCER; PULSED ESR; PAS DOMAIN; CHEMORECEPTOR	Flagellated bacteria modulate their swimming behavior in response to environmental cues through the CheA/CheY signaling pathway. In addition to responding to external chemicals, bacteria also monitor internal conditions that reflect the availability of oxygen, light, and reducing equivalents, in a process termed "energy taxis." In Escherichia coli, the transmembrane receptor Aer is the primary energy sensor for motility. Genetic and physiological data suggest that Aer monitors the electron transport chain through the redox state of its FAD cofactor. However, direct biochemical data correlating FAD redox chemistry with CheA kinase activity have been lacking. Here, we test this hypothesis via functional reconstitution of Aer into nanodiscs. As purified, Aer contains fully oxidized FAD, which can be chemically reduced to the anionic semiquinone (ASQ). Oxidized Aer activates CheA, whereas ASQ Aer reversibly inhibits CheA. Under these conditions, Aer cannot be further reduced to the hydroquinone, in contrast to the proposed Aer signaling model. Pulse ESR spectroscopy of the ASQ corroborates a potential mechanism for signaling in that the resulting distance between the two flavin-binding PAS (Per-Arnt-Sim) domains implies that they tightly sandwich the signal-transducing HAMP domain in the kinase-off state. Aer appears to follow oligomerization patterns observed for related chemoreceptors, as higher loading of Aer dimers into nanodiscs increases kinase activity. These results provide a new methodological platform to study Aer function along with new mechanistic details into its signal transduction process.	[Samanta, Dipanjan; Widom, Joanne; Borbat, Peter P.; Freed, Jack H.; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Samanta, Dipanjan; Borbat, Peter P.; Freed, Jack H.] Cornell Univ, Natl Biomed Ctr Adv ESR Technol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Crane, BR (corresponding author), Cornell Univ, Phys Sci Bldg, Ithaca, NY 14853 USA.	bc69@cornell.edu	Borbat, Petr P/A-8658-2014; borbat, peter/B-1616-2016		National Institutes of Health [GM066775, P41GM103521, R01EB003150]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123779, R01GM066775, P41GM103521, P41GM103485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM066775 (to B. R. C.) and P41GM103521 and R01EB003150 (to J. H. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Airola MV, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001479; Amin DN, 2007, J BACTERIOL, V189, P7206, DOI 10.1128/JB.00871-07; Amin DN, 2012, J BIOL CHEM, V287, P41697, DOI 10.1074/jbc.M112.415588; Amin DN, 2010, J BACTERIOL, V192, P1193, DOI 10.1128/JB.01391-09; Amin DN, 2006, J BACTERIOL, V188, P894, DOI 10.1128/JB.188.3.894-901.2006; Barnakov AN, 1998, J BACTERIOL, V180, P6713, DOI 10.1128/JB.180.24.6713-6718.1998; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; Bhatnagar J, 2012, BIOPHYS J, V102, P2192, DOI 10.1016/j.bpj.2012.03.038; Bibikov SI, 2000, P NATL ACAD SCI USA, V97, P5830, DOI 10.1073/pnas.100118697; Bibikov SI, 2004, J BACTERIOL, V186, P3730, DOI 10.1128/JB.186.12.3730-3737.2004; Bibikov SI, 1997, J BACTERIOL, V179, P4075, DOI 10.1128/jb.179.12.4075-4079.1997; Boldog T, 2007, METHOD ENZYMOL, V423, P317, DOI 10.1016/S0076-6879(07)23014-9; Boldog T, 2006, P NATL ACAD SCI USA, V103, P11509, DOI 10.1073/pnas.0604988103; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Chiang YW, 2005, J MAGN RESON, V177, P184, DOI 10.1016/j.jmr.2005.07.021; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Feng XH, 1997, J BACTERIOL, V179, P6714, DOI 10.1128/jb.179.21.6714-6720.1997; Garcia D, 2016, MOL MICROBIOL, V100, P156, DOI 10.1111/mmi.13308; Gosink KK, 2006, J BACTERIOL, V188, P3487, DOI 10.1128/JB.188.10.3487-3493.2006; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hill S, 1996, P NATL ACAD SCI USA, V93, P2143, DOI 10.1073/pnas.93.5.2143; Karasawa A, 2013, J BIOL CHEM, V288, P29862, DOI 10.1074/jbc.M113.499327; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Macheroux P, 1998, BIOCHEM J, V332, P413, DOI 10.1042/bj3320413; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Parkinson JS, 2015, TRENDS MICROBIOL, V23, P257, DOI 10.1016/j.tim.2015.03.003; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; Rebbapragada A, 1997, P NATL ACAD SCI USA, V94, P10541, DOI 10.1073/pnas.94.20.10541; Repik A, 2000, MOL MICROBIOL, V36, P806, DOI 10.1046/j.1365-2958.2000.01910.x; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Samanta D, 2015, P NATL ACAD SCI USA, V112, P2455, DOI 10.1073/pnas.1414155112; Srivastava M, 2016, IEEE ACCESS, V4, P3862, DOI 10.1109/ACCESS.2016.2587581; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Taylor BL, 2007, MOL MICROBIOL, V65, P1415, DOI 10.1111/j.1365-2958.2007.05889.x; Taylor BL, 1999, ANNU REV MICROBIOL, V53, P103, DOI 10.1146/annurev.micro.53.1.103; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Taylor BL, 2001, ANTIOXID REDOX SIGN, V3, P867, DOI 10.1089/15230860152665037; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524	42	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25809	25814		10.1074/jbc.C116.757492	http://dx.doi.org/10.1074/jbc.C116.757492			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27803157	Green Published, hybrid			2022-12-28	WOS:000390345200005
J	Dan, HC; Sun, M; Kaneko, S; Feldman, RI; Nicosia, SV; Wang, HG; Tsang, BK; Cheng, JQ				Dan, Han C.; Sun, Mei; Kaneko, Satoshi; Feldman, Richard I.; Nicosia, Santo V.; Wang, Hong-Gang; Tsang, Benjamin K.; Cheng, Jin Q.			Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP) (vol 279, pg 5405, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Tsang, Benjamin K./0000-0003-1213-3946				Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200	1	11	12	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22846	22846		10.1074/jbc.A116.312044	http://dx.doi.org/10.1074/jbc.A116.312044			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27825084	Green Published, hybrid			2022-12-28	WOS:000386760600045
J	Weston, C; Winfield, I; Harris, M; Hodgson, R; Shah, A; Dowell, SJ; Mobarec, JC; Woodlock, DA; Reynolds, CA; Poyner, DR; Watkins, HA; Ladds, G				Weston, Cathryn; Winfield, Ian; Harris, Matthew; Hodgson, Rose; Shah, Archna; Dowell, Simon J.; Mobarec, Juan Carlos; Woodlock, David A.; Reynolds, Christopher A.; Poyner, David R.; Watkins, Harriet A.; Ladds, Graham			Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); molecular dynamics; molecular modeling; signal transduction; yeast; adrenomedullin; adrenomedullin 2; CGRP; RAMP; signal bias	COUPLED RECEPTORS; CGRP RECEPTOR; ADRENOMEDULLIN; PHARMACOLOGY; DYNAMICS; ACTIVATION; INTERMEDIN; PATHWAYS; AMYLIN; CELLS	The calcitonin gene-related peptide (CGRP) family of G protein-coupled receptors (GPCRs) is formed through the association of the calcitonin receptor-like receptor (CLR) and one of three receptor activity-modifying proteins (RAMPs). Binding of one of the three peptide ligands, CGRP, adrenomedullin (AM), and intermedin/adrenomedullin 2 (AM2), is well known to result in a G(s)-mediated increase in cAMP. Here we used modified yeast strains that couple receptor activation to cell growth, via chimeric yeast/G subunits, and HEK-293 cells to characterize the effect of different RAMP and ligand combinations on this pathway. We not only demonstrate functional couplings to both G(s) and G(q) but also identify a G(i) component to CLR signaling in both yeast and HEK-293 cells, which is absent in HEK-293S cells. We show that the CGRP family of receptors displays both ligand- and RAMP-dependent signaling bias among the G(s), G(i), and G(q/11) pathways. The results are discussed in the context of RAMP interactions probed through molecular modeling and molecular dynamics simulations of the RAMP-GPCR-G protein complexes. This study further highlights the importance of RAMPs to CLR pharmacology and to bias in general, as well as identifying the importance of choosing an appropriate model system for the study of GPCR pharmacology.	[Weston, Cathryn; Winfield, Ian; Hodgson, Rose; Shah, Archna] Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England; [Winfield, Ian; Harris, Matthew; Ladds, Graham] Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England; [Dowell, Simon J.] GlaxoSmithkline, Dept Platform Technol & Sci, Stevenage SG1 2NY, Herts, England; [Mobarec, Juan Carlos; Woodlock, David A.; Reynolds, Christopher A.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Poyner, David R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Watkins, Harriet A.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Watkins, Harriet A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand	University of Warwick; University of Cambridge; GlaxoSmithKline; University of Essex; Aston University; University of Auckland; University of Auckland	Ladds, G (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	grl30@cam.ac.uk	Harris, Matt/AAV-1471-2021; Reynolds, Christopher/G-1036-2010	Harris, Matt/0000-0002-7918-5735; Dowell, Simon/0000-0001-6499-7573; Reynolds, Christopher/0000-0001-9267-5141; Mobarec, Juan Carlos/0000-0001-9482-4294; Ladds, Graham/0000-0001-7320-9612; Poyner, David R/0000-0003-1590-112X	National Heart Foundation of New Zealand; School of Biological Sciences, University of Auckland [BB/M00015X/1, BB/M000176/1, BB/M006883/1]; BBSRC; BBSRC Doctoral Training Partnership Grant [BB/JO14540/1]; MRC Doctoral Training Partnership [MR/J003964/1]; Warwick Impact Fund; Warwick Research Development Fund [RD13301]; Warwick Undergraduate Research Scholarship Scheme; Biotechnology and Biological Sciences Research Council [BB/M00015X/1, BB/M007529/1, BB/M000176/1, BB/M00015X/2, BB/M006883/1, 1643678] Funding Source: researchfish; Medical Research Council [1361423] Funding Source: researchfish; BBSRC [1643678, BB/M00015X/1, BB/M00015X/2, BB/M007529/1, BB/M006883/1, BB/M000176/1] Funding Source: UKRI	National Heart Foundation of New Zealand; School of Biological Sciences, University of Auckland(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Doctoral Training Partnership Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Doctoral Training Partnership(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Warwick Impact Fund; Warwick Research Development Fund; Warwick Undergraduate Research Scholarship Scheme; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the National Heart Foundation of New Zealand (to H. A. W.), the School of Biological Sciences, University of Auckland seed fund (to H. A. W.), Grants BB/M00015X/1 (to G. L.), BB/M000176/1 (to D. R. P.), and BB/M006883/1 (to C. A. R.) from the BBSRC, BBSRC Doctoral Training Partnership Grant BB/JO14540/1 (to M. H.), MRC Doctoral Training Partnership MR/J003964/1 (to I. W.), the Warwick Impact Fund (to C. W. and G. L.), Grant RD13301 from the Warwick Research Development Fund (to C. W. and G. L.), and the Warwick Undergraduate Research Scholarship Scheme (to A. S. and R. H). The authors declare they have no conflicts of interest with the contents of this article.	Aiyar N, 1999, MOL CELL BIOCHEM, V197, P179, DOI 10.1023/A:1006962221332; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Case D. A., 2016, AMBER 2016; Christopoulos G, 1999, MOL PHARMACOL, V56, P235, DOI 10.1124/mol.56.1.235; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Disa J, 2000, NEUROPEPTIDES, V34, P229, DOI 10.1054/npep.2000.0810; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Edvinsson L, 2013, CURR PROTEIN PEPT SC, V14, P386, DOI 10.2174/13892037113149990055; Figueroa KW, 2009, J PHARMACOL EXP THER, V328, P331, DOI 10.1124/jpet.108.145219; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gingell JJ, 2010, PEPTIDES, V31, P1400, DOI 10.1016/j.peptides.2010.03.027; Harikumar KG, 2009, BIOCHEMISTRY-US, V48, P11773, DOI 10.1021/bi901326k; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Hay DL, 2016, BIOCHEM SOC T, V44, P568, DOI 10.1042/BST20150237; Hay DL, 2003, REGUL PEPTIDES, V112, P139, DOI 10.1016/S0167-0115(03)00032-6; Hoang HN, 2015, J MED CHEM, V58, P4080, DOI 10.1021/acs.jmedchem.5b00166; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Holmes D, 2013, CURR PROTEIN PEPT SC, V14, P294, DOI 10.2174/13892037113149990049; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kataoka Y, 2010, J CARDIOVASC PHARM, V56, P413, DOI 10.1097/FJC.0b013e3181f15b45; Kato J, 2015, EUR J PHARMACOL, V764, P140, DOI 10.1016/j.ejphar.2015.06.061; KIM DH, 1991, PFLUG ARCH EUR J PHY, V418, P338, DOI 10.1007/BF00550871; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kuwasako K, 2010, BIOCHEM BIOPH RES CO, V392, P380, DOI 10.1016/j.bbrc.2010.01.030; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; Ladds G, 2003, MOL MICROBIOL, V47, P781, DOI 10.1046/j.1365-2958.2003.03336.x; Ladds G, 2009, EUR J PHARMACOL, V610, P23, DOI 10.1016/j.ejphar.2009.03.042; Li Y, 2016, PHYS CHEM CHEM PHYS, V18, P12642, DOI 10.1039/c6cp00798h; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Main MJ, 1998, FEBS LETT, V441, P6, DOI 10.1016/S0014-5793(98)01507-5; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Miret JJ, 2002, J BIOL CHEM, V277, P6881, DOI 10.1074/jbc.M107384200; Perez-Castells J, 2012, BIOPOLYMERS, V97, P45, DOI 10.1002/bip.21700; Permpoonputtana K, 2016, LIFE SCI, V144, P19, DOI 10.1016/j.lfs.2015.11.015; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Qi T, 2013, BRIT J PHARMACOL, V168, P644, DOI 10.1111/j.1476-5381.2012.02197.x; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; SHIMEKAKE Y, 1995, J BIOL CHEM, V270, P4412, DOI 10.1074/jbc.270.9.4412; Singh R, 2015, J PHYS CHEM B, V119, P2806, DOI 10.1021/jp509814n; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Smillie SJ, 2011, NEUROPEPTIDES, V45, P93, DOI 10.1016/j.npep.2010.12.002; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006; Walker R. C., 2014, 248 NAT M AM CHEM SO; Watkins HA, 2014, BRIT J PHARMACOL, V171, P772, DOI 10.1111/bph.12508; Watkins HA, 2016, J BIOL CHEM, V291, P11657, DOI 10.1074/jbc.M115.688218; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weston C, 2014, BRIT J PHARMACOL, V171, P3651, DOI 10.1111/bph.12716; Weston C, 2015, J BIOL CHEM, V290, P23009, DOI 10.1074/jbc.M114.624601; WILEY JW, 1992, J PHYSIOL-LONDON, V455, P367, DOI 10.1113/jphysiol.1992.sp019306; Woolley MJ, 2013, CURR PROTEIN PEPT SC, V14, P358, DOI 10.2174/13892037113149990053; Wootten D, 2013, BRIT J PHARMACOL, V168, P822, DOI 10.1111/j.1476-5381.2012.02202.x; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wunder F, 2008, MOL PHARMACOL, V73, P1235, DOI 10.1124/mol.107.042283; Yang DH, 2016, J BIOL CHEM, V291, P12991, DOI 10.1074/jbc.M116.721977; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859	72	55	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21925	21944		10.1074/jbc.M116.751362	http://dx.doi.org/10.1074/jbc.M116.751362			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27913664	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000386332600009
